data_2n45_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n45 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.796 0.331 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -83.17 132.29 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -123.62 161.13 25.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.73 119.61 19.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.27 31.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.459 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -146.52 154.69 41.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.84 143.1 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.5 122.42 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.41 140.56 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.47 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 55.5 m95 -116.45 126.76 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 tt -148.87 141.02 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.409 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.8 t-20 -47.87 118.46 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -166.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.19 64.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.462 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.13 -56.18 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 0.0 110.929 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -137.37 78.26 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 152.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.76 -34.31 1.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.472 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.15 -46.08 36.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.933 -158.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -51.59 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -157.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.2 -48.75 57.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 tp -59.6 -42.09 91.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.05 84.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -63.22 -37.25 86.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.15 -41.65 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.05 87.65 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.453 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.35 -40.2 89.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.905 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -60.62 -46.91 88.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 33' ' ' ILE . 28.3 t80 -68.8 -36.29 78.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.49 -33.13 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.64 -36.05 73.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.16 -40.65 26.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -109.12 -18.11 13.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 -171.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.25 4.8 87.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.54 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.4 tt -72.94 121.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -68.91 121.61 16.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.946 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.3 p -102.22 142.63 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.151 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -136.09 114.24 11.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.86 127.34 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -124.8 160.61 28.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -93.48 125.0 55.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 110.855 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CB ' HD23 ' A' ' 43' ' ' LEU . 66.1 Cg_endo -87.78 81.72 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -167.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -93.88 -27.8 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 166.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -92.31 -15.02 27.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.841 -169.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD23 ' CB ' ' A' ' 40' ' ' PRO . 2.3 mp -53.14 -46.06 68.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.891 -159.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -50.03 -40.98 46.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.14 -35.05 32.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -73.0 -25.07 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.488 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.2 m-30 -50.05 -55.79 22.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 0.0 110.875 -165.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -71.18 -29.77 16.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.732 2.288 . . . . 0.0 112.382 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -76.54 -49.95 15.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -172.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.701 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 28.0 m -60.37 -34.98 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.47 86.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.86 66.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.091 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -93.73 1.36 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.114 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.57 8.32 66.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.463 171.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -171.3 95.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.898 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.701 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.99 -129.34 3.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 156.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.47 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 41.7 Cg_endo -70.21 154.53 65.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.644 2.229 . . . . 0.0 112.35 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -88.08 -39.78 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.61 136.89 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.0 mm -119.68 134.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -77.8 159.47 28.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.952 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.411 ' CB ' ' H ' ' A' ' 263' ' ' SER . 41.9 t90 -85.84 147.4 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -112.57 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.104 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -110.74 -83.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 157.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -94.58 -19.51 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -60.05 -27.59 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -163.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 105' ' ' ALA . 75.7 t80 -58.06 -33.26 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.879 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -64.3 -41.24 98.29 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.18 80.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.427 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -65.84 -36.7 84.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.72 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.105 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.96 -29.27 70.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -82.39 1.5 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.16 75.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -82.71 -6.17 59.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.46 146.17 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -91.11 163.6 14.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.71 128.76 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -110.41 148.83 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -95.64 124.6 52.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.506 0.67 . . . . 0.0 111.204 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.83 140.67 42.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -103.83 109.91 21.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.38 -42.59 98.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.415 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.9 m-30 -68.2 -35.81 78.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -55.09 -45.45 75.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.941 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.33 -39.15 93.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.16 -22.48 62.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.505 HD13 ' HG2' ' A' ' 107' ' ' PRO . 75.5 mt -105.02 -145.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.78 145.7 54.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.406 ' HA ' ' HD1' ' A' ' 94' ' ' TRP . 30.6 Cg_endo -70.0 -39.83 5.62 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -68.7 -23.28 64.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.984 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.6 p -72.29 -24.87 61.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.45 ' HA ' HG23 ' A' ' 97' ' ' VAL . 88.8 m95 -72.82 -33.02 65.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.65 -34.51 72.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.52 ' HB3' HD12 ' A' ' 329' ' ' ILE . . . -71.42 -25.14 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.171 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.508 HG22 ' HD3' ' A' ' 107' ' ' PRO . 34.6 m -108.42 14.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 79.0 mtm180 -118.02 143.87 46.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -143.4 130.86 21.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 t30 57.01 33.3 23.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.963 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.07 90.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.47 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.33 150.41 37.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 37.0 tp -81.18 123.87 28.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.0 pt -115.25 -9.67 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.449 ' HB2' ' H ' ' A' ' 264' ' ' ALA . . . -161.33 169.3 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.685 ' HB3' HD22 ' A' ' 285' ' ' LEU . 75.1 m-85 -110.03 140.0 21.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.693 0.758 . . . . 0.0 110.984 167.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.508 ' HD3' HG22 ' A' ' 97' ' ' VAL . 94.1 Cg_endo -79.04 117.14 3.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.652 2.234 . . . . 0.0 112.308 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.7 mt -109.1 -29.99 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.51 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -170.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.07 124.97 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.086 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -116.53 129.42 56.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.71 149.7 30.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 94.6 mt -72.87 144.89 47.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.6 m -143.9 160.86 40.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 tp -89.33 118.55 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.441 HG12 HG23 ' A' ' 244' ' ' VAL . 56.2 mt -109.6 119.66 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.082 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -133.24 155.09 50.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -164.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.03 115.73 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.874 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.62 -25.46 68.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -76.0 -35.76 59.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.12 -52.8 5.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.952 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.2 mt -124.59 105.18 30.45 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.546 0.689 . . . . 0.0 110.876 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.92 -12.65 19.74 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.342 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.431 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 57.5 t-20 -147.91 100.02 3.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.69 0.757 . . . . 0.0 110.911 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 56.8 Cg_endo -69.09 164.58 33.31 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.415 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 44.1 Cg_endo -72.43 145.15 42.14 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.347 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.02 -19.35 27.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.2 t -144.48 163.01 35.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -173.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -70.58 -25.16 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 -174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.48 -33.01 74.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -75.02 -22.59 58.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.615 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 77.6 mt -62.55 -53.63 55.49 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.682 0.753 . . . . 0.0 111.143 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.1 Cg_endo -60.43 -40.4 57.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.29 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.05 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.415 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 51.5 tp -61.32 -39.93 92.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 132' ' ' ILE . 9.3 t70 -65.99 -41.31 91.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.35 -38.79 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.64 -45.33 75.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.441 HD22 ' HB3' ' A' ' 146' ' ' ALA . 3.7 pp -83.58 -20.34 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 84.6 tttt -56.46 -28.81 60.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.16 -18.67 63.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.066 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.21 7.51 33.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.08 29.72 62.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.48 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -108.13 161.58 14.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.8 t -116.93 148.51 41.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.441 ' HB3' HD22 ' A' ' 139' ' ' LEU . . . -86.22 -34.63 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.2 tp -130.72 141.1 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -112.91 134.91 54.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -164.25 160.45 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.849 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -127.27 -10.56 5.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 199' ' ' ILE . 37.8 mt 50.82 35.54 12.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -93.68 -20.88 19.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -139.62 149.75 60.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.66 -22.86 74.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.355 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -50.04 -36.27 28.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -70.74 -35.7 72.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.451 HG22 HG11 ' A' ' 347' ' ' VAL . 39.2 p -80.33 -28.49 38.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 -172.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.554 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 42.1 m0 -56.91 -45.0 100.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 -164.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.603 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 98.1 Cg_exo -48.9 -38.19 38.0 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.705 2.27 . . . . 0.0 112.297 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.1 mt -80.32 -44.67 19.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.694 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.4 mt -72.18 -47.53 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 -169.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.1 -16.71 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.171 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -59.51 -27.07 65.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.079 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -97.73 8.47 44.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.41 16.78 3.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.454 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.35 161.16 38.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -168.0 150.57 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 331' ' ' PRO . . . -66.26 -62.21 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.83 146.65 47.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.19 136.79 37.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.563 ' CE2' ' HB3' ' A' ' 176' ' ' TYR . 57.4 m-85 -115.29 126.3 54.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -146.13 141.41 27.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.865 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.3 t30 49.78 45.59 24.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.878 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.34 8.85 66.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.511 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.63 148.66 52.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.848 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.563 ' HB3' ' CE2' ' A' ' 171' ' ' TYR . 49.2 p90 -93.4 138.2 31.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -96.11 109.81 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.438 ' O ' HD13 ' A' ' 178' ' ' ILE . 2.2 tp -64.13 -20.01 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.05 -4.82 53.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.921 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -117.02 97.53 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.9 154.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.132 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.75 28.76 12.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 m -99.99 -23.37 4.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.152 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -97.35 20.44 11.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.01 155.31 19.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -171.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.39 -35.01 67.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.055 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.03 93.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.458 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.03 78.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -62.87 -41.68 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.57 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.694 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.33 -42.52 97.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.42 HD21 HG13 ' A' ' 357' ' ' VAL . 24.7 tp -69.19 -34.36 74.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.884 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.9 m -58.77 -40.85 85.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.166 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -58.05 -44.22 87.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.12 -44.98 88.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -65.14 -40.71 89.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.13 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -38.6 91.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.3 OUTLIER -62.27 -38.64 90.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.423 HD12 HD11 ' A' ' 151' ' ' LEU . 53.1 mt -81.59 -42.16 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.56 -41.68 88.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.79 5.23 29.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.87 31.99 11.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.01 -28.86 60.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 170.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.8 tpt -146.09 151.62 37.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.436 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -89.19 134.76 33.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.34 -27.01 62.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 -174.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.66 -17.54 16.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 77.8 m -64.45 134.99 55.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -89.97 166.25 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -66.34 -37.05 84.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.5 p -68.68 -38.3 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.855 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.01 -43.97 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.79 -36.94 73.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.6 -38.41 83.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.29 95.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.01 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.413 ' CZ ' HG22 ' A' ' 116' ' ' ILE . 83.2 t80 -66.77 -42.15 86.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 174.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -61.29 -26.33 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.834 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.03 -9.03 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.32 67.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.66 -28.63 33.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.936 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 90.0 m -120.14 130.19 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.132 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.65 -43.68 75.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -169.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.9 mtm -140.44 150.33 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -169.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.4 p -145.47 171.77 14.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mm -118.15 126.08 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -159.8 172.36 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.2 -164.2 29.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.27 -15.97 19.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.24 . . . . 0.0 112.382 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -70.28 -29.23 65.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 28.61 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.496 ' O ' ' C ' ' A' ' 233' ' ' SER . 37.3 m0 -72.79 -46.2 54.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 232' ' ' TRP . 58.2 m 33.87 -99.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 170.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -151.1 39.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.19 157.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.094 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.657 ' O ' ' C ' ' A' ' 237' ' ' THR . 95.0 m-20 -108.13 148.73 29.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.657 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.2 m -6.62 82.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 94.6 p -61.88 161.18 10.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -134.62 -5.45 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 241' ' ' ASN . 52.5 t -89.14 73.37 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -171.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' VAL . 83.7 m-20 40.97 47.51 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.81 147.26 26.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.69 164.95 26.61 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 -175.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.441 HG23 HG12 ' A' ' 116' ' ' ILE . 52.6 t -131.52 134.99 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 177.26 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.181 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.95 160.01 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.183 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.532 ' HB2' ' HD3' ' A' ' 257' ' ' PRO . 26.8 mt -78.97 151.06 75.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.492 ' HG2' HD12 ' A' ' 132' ' ' ILE . 50.3 Cg_exo -62.05 154.57 61.34 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.404 -174.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 96.1 m -133.14 138.12 46.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -114.15 118.17 33.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 -167.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 50.48 40.14 22.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.63 24.19 73.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 98.7 mm-40 -106.14 161.7 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.599 0.714 . . . . 0.0 110.956 -169.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.7 Cg_endo -63.94 70.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.228 . . . . 0.0 112.384 173.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 68.5 m -102.63 15.29 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.808 -167.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 257' ' ' PRO . 58.4 mttp -106.97 160.8 25.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.564 0.697 . . . . 0.0 110.909 -161.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.532 ' HD3' ' HB2' ' A' ' 247' ' ' LEU . 11.5 Cg_endo -60.96 154.93 53.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.73 163.14 27.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.49 125.66 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.143 -175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.57 143.27 15.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.23 126.5 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.8 tp -64.81 129.26 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.411 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 20.1 m -135.32 155.02 51.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 -166.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.449 ' H ' ' HB2' ' A' ' 105' ' ' ALA . . . -140.3 137.04 33.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.082 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.64 146.56 18.08 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.477 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 86.2 mt -114.61 124.76 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.928 0.394 . . . . 0.0 111.087 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -58.56 122.07 12.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.892 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -67.29 -25.92 66.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.077 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.62 -8.02 59.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.103 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.2 t -69.17 128.49 92.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.669 0.747 . . . . 0.0 110.908 -175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.71 -12.58 36.5 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.683 2.255 . . . . 0.0 112.406 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -111.92 25.04 12.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -55.45 -33.09 63.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.37 -38.8 65.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.13 -44.2 97.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.47 85.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.27 -46.45 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.11 -50.79 66.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -34.87 71.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -172.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.745 HD21 ' O ' ' A' ' 280' ' ' LEU . 2.5 tt -52.48 -51.79 57.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.54 -22.39 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.828 -171.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -98.55 -14.06 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -166.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.627 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.6 m-85 -120.58 -52.38 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.54 -32.3 73.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.915 ' O ' HD12 ' A' ' 285' ' ' LEU . 1.7 pp -136.72 76.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.971 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.8 p -143.02 170.02 16.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.187 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -53.69 -46.27 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.02 -42.99 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.862 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.04 -46.78 20.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -170.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 293' ' ' VAL . 46.9 tp -66.03 -36.02 82.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.75 -43.74 85.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.07 85.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 290' ' ' LEU . 3.2 p -75.42 -31.27 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -170.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.34 -16.44 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -58.83 -22.85 59.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -89.25 -22.62 22.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.823 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -100.36 155.27 36.58 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.95 -63.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.292 . . . . 0.0 112.409 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 76.5 mt -107.35 -50.5 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.88 -49.2 0.9 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.445 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.78 72.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.46 HG23 HD22 ' A' ' 311' ' ' LEU . 20.1 m -109.2 155.86 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.121 -154.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.93 -13.77 59.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.501 ' HA ' HD21 ' A' ' 89' ' ' LEU . 58.1 tp -80.57 117.48 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.16 -44.82 96.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.6 p -65.7 -51.93 55.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -172.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -68.85 -34.03 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.929 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.1 -40.44 89.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.58 -37.78 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.79 -47.8 24.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.817 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.46 HD22 HG23 ' A' ' 302' ' ' VAL . 4.0 pp -74.72 -19.51 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.63 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.161 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.9 -10.36 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.47 130.12 52.58 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.561 0.696 . . . . 0.0 110.845 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.54 -30.51 16.24 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.737 2.291 . . . . 0.0 112.325 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -65.17 -37.9 88.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.85 -43.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.43 68.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.091 -164.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.45 79.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.11 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.8 m -68.06 -39.21 83.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.176 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 68.0 ttp -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.905 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -65.94 -46.26 78.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 327' ' ' GLY . 43.3 p30 -80.07 -13.76 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.76 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 167.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -74.7 -18.26 60.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.29 -10.54 13.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -79.46 -162.22 23.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.506 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -125.59 126.49 44.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.91 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 96' ' ' ALA . 7.4 tp -65.65 126.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -176.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 65.1 ttp -71.22 119.92 76.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.409 ' HG2' ' HB1' ' A' ' 168' ' ' ALA . 68.6 Cg_exo -55.12 144.49 69.39 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.702 2.268 . . . . 0.0 112.388 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.879 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.5 p30 -99.98 11.42 39.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.828 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.575 HG22 ' H ' ' A' ' 335' ' ' GLN . 34.5 mt -68.42 135.12 90.88 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 0.0 111.123 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.41 -34.39 50.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.575 ' H ' HG22 ' A' ' 333' ' ' ILE . 25.5 mm100 -65.34 -10.53 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.9 mmm -63.85 -25.74 68.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.4 m -63.77 -39.4 94.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.83 -33.88 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.099 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.84 -38.86 86.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 174.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -59.98 -53.33 59.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -63.27 -36.73 84.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.41 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.03 -44.18 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -57.17 -46.2 83.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.8 m -66.7 -42.94 85.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 360' ' ' ALA . . . -61.17 -42.07 97.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.451 HG11 HG22 ' A' ' 157' ' ' THR . 54.1 t -67.86 -46.74 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.37 -43.38 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 88.8 m-20 -64.77 -37.41 87.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.851 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -45.67 69.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.99 72.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.6 p -83.19 -8.26 59.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.62 13.33 83.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.95 -28.14 39.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.1 tt0 -148.2 145.17 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.0 p -73.43 164.97 25.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.42 HG13 HD21 ' A' ' 192' ' ' LEU . 58.8 t -69.77 -45.99 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.31 -36.08 82.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -74.44 -41.05 61.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . . . -64.99 -42.58 94.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.35 -32.04 70.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 -39.9 94.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -69.12 -31.49 70.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.33 73.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -69.98 -31.38 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 86.1 m -63.02 -43.19 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.38 -40.79 93.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.847 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.67 -42.43 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.11 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.9 p -89.63 -2.15 58.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -174.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.1 mt -82.86 133.17 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -126.81 159.19 34.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -74.76 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.38 21.94 55.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -142.92 162.6 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.5 mt -130.39 135.83 48.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -125.11 110.17 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.22 139.43 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 -172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.481 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 66.1 m95 -116.84 126.73 53.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.95 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.486 HG23 ' HA3' ' A' ' 16' ' ' GLY . 21.1 tt -148.93 140.09 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.033 -169.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -47.83 118.64 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.946 -166.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.09 -25.42 62.09 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.429 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -57.42 -53.39 58.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.917 -169.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -137.94 88.77 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.917 148.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -116.71 -36.98 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.486 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -77.23 -50.12 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -154.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -67.95 -52.55 34.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -154.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.74 84.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.4 -39.52 79.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.16 98.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.17 -41.02 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.23 -48.5 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.68 -33.85 86.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.385 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -64.93 -43.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.951 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.85 -45.07 86.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.909 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -68.24 -35.61 78.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.13 -34.96 79.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.6 -34.37 65.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -77.17 -41.75 40.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -108.21 -18.13 13.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.229 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.49 4.6 89.17 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.54 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.616 HG23 ' O ' ' A' ' 33' ' ' ILE . 16.1 tt -74.29 116.79 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.156 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.38 124.87 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.09 140.0 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.176 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -134.41 113.6 12.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.5 128.78 60.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -126.2 161.67 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -95.45 122.52 59.13 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.562 0.696 . . . . 0.0 110.8 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HB3' HD23 ' A' ' 43' ' ' LEU . 88.7 Cg_endo -86.84 80.05 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.284 -168.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -93.58 -25.63 17.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 168.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.17 -16.54 23.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -171.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' HB3' ' A' ' 40' ' ' PRO . 2.3 mp -56.92 -42.31 79.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.922 -157.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -52.23 -38.94 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -81.01 -34.02 33.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.838 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' O ' HG23 ' A' ' 50' ' ' VAL . 95.1 mttt -71.92 -23.65 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.498 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.9 m-30 -49.63 -55.95 19.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.915 -164.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.2 Cg_endo -70.75 -29.3 19.37 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.751 2.3 . . . . 0.0 112.323 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -76.4 -50.1 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.927 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.591 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 30.9 m -61.49 -35.78 69.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.71 86.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -27.33 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 p -95.05 2.28 55.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.98 8.83 65.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -170.76 95.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.591 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -127.63 -116.95 2.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.474 154.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 48.4 Cg_endo -69.08 152.48 72.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.614 2.209 . . . . 0.0 112.353 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -87.06 -39.97 15.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -138.09 139.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mm -110.09 133.54 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.103 -166.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.46 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 11.5 p90 -67.38 170.94 6.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.474 ' CG ' ' HG ' ' A' ' 262' ' ' LEU . 39.9 p-90 -87.03 143.76 27.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.05 -121.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 167.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.86 -79.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 154.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -84.01 -13.89 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -61.35 -20.38 62.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -167.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 263' ' ' SER . 55.2 m-85 -56.89 -30.13 63.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -174.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -62.36 -43.75 98.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.508 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.375 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 5.0 m-30 -62.91 -38.65 91.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.877 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.46 95.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -65.07 -31.03 72.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.4 m -89.86 -4.91 57.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.74 27.63 73.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.83 -9.73 59.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.875 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.533 HD21 ' HA3' ' A' ' 265' ' ' GLY . 0.0 OUTLIER -131.23 140.56 49.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.825 176.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -92.32 169.34 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.06 125.05 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.54 151.25 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.5 m -99.87 121.66 53.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.169 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.16 144.6 37.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.312 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -104.72 118.28 36.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.73 -38.98 73.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.95 81.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -70.83 -32.63 69.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.439 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 87.3 mt-30 -58.52 -46.77 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.931 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.65 -35.93 79.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -76.41 -20.56 56.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.817 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.447 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 85.3 mt -107.3 -147.35 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -129.33 143.59 49.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.665 0.745 . . . . 0.0 110.91 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.34 -36.73 65.62 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.29 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -65.34 -36.41 83.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.59 -23.13 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.211 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 88.4 m95 -70.04 -38.91 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.45 -31.49 70.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.82 -31.1 69.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.442 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 35.4 m -109.75 8.66 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -172.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -108.24 141.48 39.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -132.05 121.28 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 58.74 34.14 23.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.962 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.93 2.84 90.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.539 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -120.02 148.59 43.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.3 tp -81.0 129.02 34.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -173.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 pt -118.43 -7.6 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.121 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -162.45 166.95 24.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -175.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 82.1 m-85 -113.52 139.57 23.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.654 0.74 . . . . 0.0 110.982 171.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 19.9 Cg_exo -67.41 116.33 4.16 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.288 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.409 ' HB ' HD23 ' A' ' 262' ' ' LEU . 51.0 mm -103.35 -33.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.94 154.98 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -166.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.48 127.77 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -114.22 126.37 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.82 148.28 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.03 150.66 38.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.7 m -145.72 162.75 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.765 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.06 120.07 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.451 HG12 HG23 ' A' ' 244' ' ' VAL . 73.5 mt -106.89 124.15 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.007 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -133.43 155.43 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -89.95 115.1 27.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.852 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.55 -26.61 65.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.92 -35.01 51.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.75 -52.2 7.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.75 108.58 28.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.647 0.737 . . . . 0.0 110.959 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.38 -15.08 17.98 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.701 2.268 . . . . 0.0 112.362 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -140.82 105.33 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.24 164.25 36.22 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.784 2.322 . . . . 0.0 112.374 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.6 152.45 59.5 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.88 -24.67 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.405 HG21 ' H ' ' A' ' 131' ' ' GLU . 9.2 t -143.38 157.21 44.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -68.4 -29.95 68.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.43 -28.96 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.405 ' H ' HG21 ' A' ' 128' ' ' THR . 87.3 tt0 -75.72 -24.69 56.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.771 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.598 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 26.4 mm -55.76 -53.41 63.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.605 0.717 . . . . 0.0 110.982 -169.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.0 Cg_endo -66.1 -42.82 10.03 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.669 2.246 . . . . 0.0 112.314 -172.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.45 91.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.21 -36.81 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.79 -40.81 95.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.38 -37.75 84.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.92 -44.54 76.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 139' ' ' LEU . 3.4 pp -84.49 -20.62 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -57.01 -27.77 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.5 65.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.07 10.04 32.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.4 67.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -104.7 157.17 17.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.768 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.6 t -110.49 146.12 36.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.72 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.37 -33.96 32.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.7 tp -130.81 145.49 51.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.6 ttm -109.07 127.12 53.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.914 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -163.78 158.49 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -130.91 -9.9 3.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.876 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 mt 54.12 34.94 21.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.28 -17.07 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.35 153.43 79.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.732 0.777 . . . . 0.0 110.877 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 49.0 Cg_endo -64.11 -24.76 66.08 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -38.02 72.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -71.91 -42.2 66.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.434 HG21 HD23 ' A' ' 195' ' ' LEU . 99.3 m -80.81 -35.4 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 -170.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.521 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 85.5 t90 -53.91 -43.96 97.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.606 0.717 . . . . 0.0 110.909 -163.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.722 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 87.2 Cg_exo -48.76 -39.14 38.54 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.11 -36.71 69.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.421 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 91.7 mt -69.03 -42.23 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.253 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.25 -14.05 59.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.154 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 255' ' ' SER . . . -55.8 -32.88 63.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.32 11.58 36.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -170.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.16 18.25 6.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.41 158.38 35.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.408 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.578 ' H ' ' HA3' ' A' ' 182' ' ' GLY . 87.3 m-85 -140.01 151.72 45.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.949 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.22 -61.11 2.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -137.15 147.47 45.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.962 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -68.25 124.22 22.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.86 110.9 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.926 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -144.14 143.76 31.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 48.07 42.79 17.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.86 10.09 80.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.583 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.833 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -91.29 129.72 37.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.43 109.87 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 178' ' ' ILE . 2.5 tp -64.56 -21.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.008 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.27 -6.72 52.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -119.92 96.2 5.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.0 m -104.33 153.84 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.578 ' HA3' ' H ' ' A' ' 167' ' ' TYR . . . -105.02 30.81 9.37 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.13 -16.78 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.907 0.384 . . . . 0.0 111.148 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -101.56 12.58 37.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 171.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.98 155.19 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 -174.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.73 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.085 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.85 -38.33 94.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 182' ' ' GLY . . . -62.75 -38.01 88.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.13 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.85 -37.85 88.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.9 88.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.063 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -63.95 -41.12 98.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.457 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.23 -36.18 82.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -58.57 -39.98 81.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -55.45 -46.31 76.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.434 HD23 HG21 ' A' ' 157' ' ' THR . 60.5 tp -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.17 -40.38 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.03 -40.42 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.8 OUTLIER -60.89 -42.91 98.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 177.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.0 mt -70.17 -41.77 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.9 -34.83 78.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -81.81 4.33 22.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.0 34.16 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -75.61 -16.41 60.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 61.1 tpp -140.23 148.11 41.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.535 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.7 t-20 -89.63 134.95 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.69 70.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.062 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -96.05 -13.38 23.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 -171.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.7 m -70.15 139.02 52.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.58 174.1 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -62.43 -48.61 78.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.4 p -67.51 -34.46 77.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.97 -44.6 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.68 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.093 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -69.96 -36.77 75.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.803 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.2 82.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.076 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.59 97.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 171.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.0 -38.28 90.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.75 -24.5 65.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.64 -10.14 25.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.895 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.15 59.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.448 -174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -82.47 -24.04 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 0.0 110.993 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.2 m -121.01 130.67 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.75 69.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 76.1 mtm -135.25 150.47 50.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -168.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.4 p -145.84 165.5 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.65 124.26 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -154.29 162.59 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.64 -159.57 33.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.18 -16.42 19.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.599 2.199 . . . . 0.0 112.316 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -65.26 -37.21 86.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 59.59 17.99 6.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.493 ' O ' ' C ' ' A' ' 233' ' ' SER . 50.6 m0 -76.56 -53.21 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 232' ' ' TRP . 64.7 p 31.91 -94.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.867 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.6 t30 -151.27 38.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.943 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.8 tt -159.86 156.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.149 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -100.4 139.44 36.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.864 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 91.9 m -7.26 82.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 236' ' ' ASP . 87.7 p -62.15 160.37 12.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.761 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -139.81 -9.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.9 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.75 79.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 55.92 34.39 23.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -102.68 150.14 23.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.88 162.68 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.451 HG23 HG12 ' A' ' 116' ' ' ILE . 58.8 t -126.16 130.28 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -135.63 174.71 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.78 158.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.87 145.89 51.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.57 0.7 . . . . 0.0 110.952 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -56.36 146.1 74.92 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.738 2.292 . . . . 0.0 112.371 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 77.7 p -130.48 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -116.86 118.96 33.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -169.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 51.44 39.46 24.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.01 63.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.559 166.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -109.99 157.34 38.1 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.631 0.729 . . . . 0.0 111.007 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.9 74.67 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 49.7 m -98.52 14.37 28.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -160.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 326' ' ' LYS . 67.6 mttm -109.48 155.88 40.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.61 0.719 . . . . 0.0 110.858 -169.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.722 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 36.8 Cg_endo -68.65 171.81 12.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.394 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -56.94 159.97 3.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.41 128.7 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.45 147.26 16.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.428 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.22 125.0 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.165 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.474 ' HG ' ' CG ' ' A' ' 62' ' ' TRP . 4.3 tt -68.18 125.34 26.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 6.5 m -139.42 154.93 47.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.816 -166.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.89 137.87 36.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.533 ' HA3' HD21 ' A' ' 76' ' ' LEU . . . -119.12 152.55 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.519 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.1 mt -111.5 120.45 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.372 . . . . 0.0 111.132 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -55.9 124.35 17.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.795 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -67.61 -25.43 65.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.05 -9.2 59.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.078 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.7 t -68.85 128.35 92.86 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.637 0.732 . . . . 0.0 110.954 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.14 -11.43 32.0 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.789 2.326 . . . . 0.0 112.366 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -109.27 24.26 13.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -54.85 -33.73 62.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.36 -41.11 57.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.39 -43.4 98.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.12 94.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.129 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.67 -47.17 76.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.41 -50.22 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.794 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -69.98 -34.94 74.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -173.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.706 HD21 ' O ' ' A' ' 280' ' ' LEU . 2.5 tt -56.03 -52.14 65.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.45 -26.39 55.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.833 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.06 -22.24 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.849 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 65.4 m-85 -122.66 -50.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 37.3 tp -68.65 -39.04 80.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.648 ' C ' HD21 ' A' ' 285' ' ' LEU . 3.0 tt -124.98 79.92 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 25.3 p -142.75 171.42 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 165.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.63 -42.11 67.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.96 -44.59 39.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.795 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.849 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.36 -47.93 8.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.44 -168.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -65.13 -33.41 75.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.869 -175.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.42 -41.04 88.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.23 94.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 290' ' ' LEU . 9.5 p -78.39 -28.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -65.16 -18.79 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.987 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -18.19 43.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -30.49 65.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -107.83 153.09 41.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.626 0.727 . . . . 0.0 110.868 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.05 -61.32 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.723 2.282 . . . . 0.0 112.406 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.94 -53.78 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 116.16 -56.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.47 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 46.86 69.2 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.184 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.453 HG23 HD22 ' A' ' 311' ' ' LEU . 19.3 m -111.49 155.9 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -162.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.58 -17.01 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.3 tp -81.81 120.59 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.48 -44.2 96.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -63.59 -49.99 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.834 -168.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -70.48 -32.62 70.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.1 -42.44 98.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.793 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.57 -35.29 72.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -172.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -79.76 -46.43 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.453 HD22 HG23 ' A' ' 302' ' ' VAL . 2.5 pp -73.41 -22.91 60.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.39 -5.63 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.97 -11.75 60.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.42 131.12 51.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.693 . . . . 0.0 110.844 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.58 -30.1 20.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.271 . . . . 0.0 112.298 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -64.97 -39.23 93.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.12 -42.51 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.5 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 -166.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.35 -35.46 73.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.74 82.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.8 -35.38 74.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -65.04 -37.78 88.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 327' ' ' GLY . 95.0 m-20 -67.97 -35.71 78.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.07 78.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.03 -19.66 60.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.411 ' HB2' ' HE3' ' A' ' 256' ' ' LYS . 99.3 mttt -108.34 -7.19 15.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -86.14 -163.11 37.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -128.7 135.93 49.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.677 0.275 . . . . 0.0 110.894 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.7 126.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.4 ttm -61.15 122.11 67.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.587 0.708 . . . . 0.0 110.91 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.03 132.16 37.25 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.306 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.427 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 50.6 p30 -95.12 10.07 37.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 pt -80.57 152.11 72.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 111.128 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.91 -25.04 67.78 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.755 2.303 . . . . 0.0 112.403 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.07 -16.5 60.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.79 -29.96 70.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.6 m -61.59 -41.37 97.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.758 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.49 -33.86 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.101 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.28 -46.1 83.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -60.02 -52.31 65.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.97 -46.04 89.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.93 89.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.154 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.79 -44.85 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.176 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.45 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 44.2 ttp180 -60.95 -43.34 98.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.1 m -64.99 -43.8 91.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -65.01 -43.16 93.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.061 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.6 -47.24 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 89.7 mt -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 85.8 m-20 -63.41 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.94 68.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.58 -34.02 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 -7.49 59.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.86 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 12.36 84.69 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.452 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -79.37 -29.02 41.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 48.1 tt0 -147.07 143.86 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -175.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.6 p -72.07 163.79 27.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -175.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 67.3 t -71.27 -45.77 68.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.14 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.58 -40.8 93.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.07 -46.14 58.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . . . -65.38 -45.01 85.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.043 -176.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.71 -34.47 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.32 -39.71 94.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.94 -31.57 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.824 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -71.82 -46.99 56.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -67.24 -31.32 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 94.6 m -63.74 -40.17 96.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -70.0 -38.41 75.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.89 -41.27 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -96.04 16.13 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.958 -178.907 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.789 0.328 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.2 mt -86.91 133.79 29.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.258 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.97 160.21 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.02 119.47 19.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.03 24.39 32.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.469 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -150.59 154.99 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 110.824 -170.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 35' ' ' VAL . 1.9 pt? -151.14 146.78 26.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.2 t -129.61 124.22 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.97 140.93 45.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.442 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 56.0 m95 -115.0 123.2 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.406 HG22 HG13 ' A' ' 37' ' ' VAL . 19.0 tt -151.85 139.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 -167.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -49.59 115.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -166.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.95 61.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.485 -171.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -55.43 -50.67 69.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -135.45 83.33 2.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 147.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.01 -34.91 1.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.505 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.39 -46.81 15.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.871 -159.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -67.62 -55.28 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -155.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.516 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -66.72 -46.98 70.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.416 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.3 -38.55 80.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.841 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.98 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.14 -38.3 90.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.57 -43.52 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.103 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.43 -36.79 92.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.448 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.28 -45.51 84.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.918 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.3 -45.2 94.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -68.87 -34.98 76.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.837 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -63.69 -35.16 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -68.89 -32.37 71.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.797 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -86.57 -39.38 16.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.1 p -108.34 -22.87 12.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.195 -170.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.57 7.33 84.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.532 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.8 tt -72.07 125.36 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 111.064 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.96 125.7 27.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' HD21 ' A' ' 7' ' ' LEU . 7.4 p -109.7 140.11 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.164 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -134.85 115.64 13.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 11' ' ' ILE . 88.7 t -104.82 130.81 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -124.94 157.77 35.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.95 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -85.02 122.86 74.15 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.459 0.647 . . . . 0.0 110.931 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HA ' HD13 ' A' ' 43' ' ' LEU . 71.3 Cg_endo -84.45 80.1 2.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.241 . . . . 0.0 112.239 -171.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -110.79 -15.41 13.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 166.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.8 -21.34 29.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 40' ' ' PRO . 4.6 mp -53.33 -45.65 69.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -157.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.27 -42.18 29.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.46 -32.28 37.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.896 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.18 -26.36 56.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 6.0 m-85 -52.56 -55.32 33.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.891 -164.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 51.3 Cg_endo -69.16 -29.77 26.18 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.71 2.273 . . . . 0.0 112.384 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -76.6 -50.53 13.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.761 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 27.0 m -61.27 -35.32 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.45 85.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.74 -26.41 66.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -92.17 2.85 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 7.5 65.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.414 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -172.75 97.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.924 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.761 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.07 -132.88 3.98 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 157.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 45.2 Cg_endo -71.81 154.61 58.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.582 2.188 . . . . 0.0 112.367 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.51 -37.95 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -137.31 137.0 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.127 -172.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.9 mm -119.4 134.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -76.97 134.9 38.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.447 ' CB ' ' H ' ' A' ' 263' ' ' SER . 31.3 t90 -60.36 144.26 51.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.08 -98.09 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -127.17 -89.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.932 158.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.4 -23.02 37.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -59.59 -30.98 69.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -161.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.425 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 58.6 t80 -58.23 -33.99 69.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -174.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.49 97.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.448 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.28 76.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.512 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.425 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.1 m-30 -63.95 -37.05 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.946 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.75 97.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.01 -28.16 68.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.6 m -81.43 -0.22 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.9 73.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.88 -6.79 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.998 -177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.99 146.15 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -82.8 163.23 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.48 128.52 36.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -112.87 148.17 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 124.53 37.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.515 0.674 . . . . 0.0 111.139 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.59 142.7 44.92 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.691 2.26 . . . . 0.0 112.305 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -106.13 121.68 44.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.953 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -39.27 68.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.08 87.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -68.35 -35.0 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.418 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.2 mt-30 -60.59 -47.98 83.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.28 -37.88 84.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.932 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.33 -24.27 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.6 mt -109.41 -149.78 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.4 ' HB2' HG21 ' A' ' 93' ' ' THR . 99.3 m-85 -132.84 150.23 75.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.923 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.72 -33.55 76.39 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.343 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.947 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 63.7 p -70.13 -27.07 64.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.097 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.418 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 50.5 m95 -69.25 -39.95 78.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.77 -35.13 73.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.655 ' HB3' HD12 ' A' ' 329' ' ' ILE . . . -70.25 -30.93 68.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.428 HG22 ' HD3' ' A' ' 107' ' ' PRO . 35.3 m -105.27 14.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 -172.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -115.63 143.59 45.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -139.25 127.56 22.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.91 35.06 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.871 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.81 3.47 89.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.59 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.97 149.89 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.794 0.33 . . . . 0.0 110.957 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 tp -84.08 124.18 30.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.35 -8.8 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.425 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -161.74 167.9 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 77.4 m-85 -114.88 135.38 22.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.75 . . . . 0.0 111.008 167.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 32.2 Cg_exo -59.86 117.35 4.09 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.9 mt -102.94 -29.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 262' ' ' LEU . . . -163.15 153.32 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -172.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.05 127.22 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.161 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -118.94 132.22 56.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.06 151.11 27.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.442 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 95.4 mt -71.76 145.93 48.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -173.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -142.23 160.96 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.6 tp -90.49 121.4 32.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.977 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.455 HG12 HG23 ' A' ' 244' ' ' VAL . 66.2 mt -110.0 123.97 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.124 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -133.93 155.28 50.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -91.93 116.34 28.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.835 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.03 -27.18 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.94 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.3 -35.36 41.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.8 -46.1 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.34 110.09 21.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.613 0.721 . . . . 0.0 110.894 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.83 -15.22 16.96 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 0.0 112.372 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -149.39 108.86 3.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.617 0.723 . . . . 0.0 110.847 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.47 157.43 61.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.66 145.1 56.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.353 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.17 -24.96 19.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -173.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -149.4 163.85 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -69.85 -28.26 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.3 -28.71 69.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.987 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -77.32 -20.48 54.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.884 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 24.7 mm -57.73 -53.36 66.52 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 -171.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 35.4 Cg_endo -68.23 -43.06 4.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.82 92.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.66 -36.47 82.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.941 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.58 -41.28 96.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.55 -40.04 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.26 -45.35 76.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 pp -85.46 -20.07 30.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.32 -26.47 65.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.95 -19.51 65.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.38 9.47 33.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.881 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.31 28.36 64.08 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -106.57 158.72 16.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 110.826 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.4 t -110.68 146.95 35.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.772 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.09 -35.29 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.8 tp -132.21 145.05 51.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -109.16 128.71 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -170.32 163.92 8.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -129.11 -7.44 4.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.7 mt 54.33 32.5 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.22 -10.23 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -141.12 149.85 56.86 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.721 0.772 . . . . 0.0 110.87 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.74 -16.73 51.14 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -54.98 -41.61 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -70.5 -33.67 71.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.3 p -83.13 -22.62 33.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.524 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 7.6 m0 -58.76 -48.97 95.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.618 0.723 . . . . 0.0 111.002 -168.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 99.8 Cg_exo -49.31 -38.85 43.15 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.694 2.263 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.56 -35.41 73.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.501 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.1 mt -78.93 -39.09 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.91 -17.08 63.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.19 87.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.435 ' O ' ' HA3' ' A' ' 187' ' ' GLY . 98.9 m-20 -106.58 -0.38 23.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.35 36.01 2.01 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.666 ' HA3' ' HB3' ' A' ' 188' ' ' ALA . . . -120.75 146.38 17.54 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 166.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -155.26 156.18 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.812 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -43.7 -50.4 7.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -89.42 126.47 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.61 115.21 23.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.0 0.429 . . . . 0.0 110.879 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.43 143.49 29.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.873 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 48.09 44.03 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.936 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.51 5.77 60.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.69 148.87 51.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -93.39 126.24 38.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 171.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.84 112.93 24.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.6 tp -74.99 -23.19 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.02 -12.47 33.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -128.18 95.3 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.0 p -103.07 147.11 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.3 31.66 8.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.532 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.9 m -93.76 -19.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 172.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -103.3 24.06 11.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -87.76 160.61 17.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.09 89.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 164' ' ' ASP . . . -66.51 -41.58 94.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.509 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.666 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . . . -61.29 -40.11 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.44 -38.63 90.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.19 -44.45 88.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.126 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.34 -41.57 96.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.388 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.33 -41.01 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 70.5 m -60.15 -40.17 88.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.069 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.34 -42.64 96.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.27 -45.1 92.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.905 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.06 -40.16 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.12 -36.1 82.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.8 OUTLIER -63.97 -38.25 90.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -38.21 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.071 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.24 -39.09 91.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -83.48 3.06 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 64.42 38.51 7.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.89 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -75.01 -10.32 59.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 tpt -143.49 152.33 41.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 65.7 t30 -86.16 142.74 28.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.61 74.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.055 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -96.73 -14.4 22.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 64.3 m -66.67 134.83 53.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -110.8 171.38 7.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.835 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -64.79 -35.79 82.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.6 p -70.85 -38.42 73.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.02 -42.61 95.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.092 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.67 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.43 -39.44 77.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.45 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.03 97.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.45 -39.33 93.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -61.55 -27.15 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.83 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.41 -9.35 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.3 16.46 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -82.67 -22.7 34.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.907 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.4 m -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.87 -38.06 73.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -171.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 69.6 mtm -135.16 154.91 51.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.6 t -152.99 165.68 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.44 124.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.09 164.63 38.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.62 12.2 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.84 -16.49 33.0 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.704 2.269 . . . . 0.0 112.328 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -75.04 -25.26 58.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 56.17 21.98 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.506 ' O ' ' C ' ' A' ' 233' ' ' SER . 44.9 m0 -76.63 -48.54 18.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.506 ' C ' ' O ' ' A' ' 232' ' ' TRP . 51.1 p 32.32 -96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.034 0.445 . . . . 0.0 110.867 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.1 t30 -143.65 36.29 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.7 tt -159.99 158.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -104.2 138.31 40.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 53.0 m -8.92 82.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 85.8 p -70.29 169.31 14.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -153.65 13.76 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 47.4 t -88.78 77.84 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 53.37 36.91 24.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -102.19 151.09 22.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 169.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.78 159.82 24.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.455 HG23 HG12 ' A' ' 116' ' ' ILE . 58.1 t -128.44 130.75 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.0 0.429 . . . . 0.0 111.157 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -142.11 178.21 7.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 160.09 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.055 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.16 155.99 76.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.698 . . . . 0.0 110.932 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -56.44 140.45 89.01 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.763 2.308 . . . . 0.0 112.355 -173.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.509 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 86.6 m -123.74 130.86 53.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.121 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -103.37 112.24 25.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 46.74 41.13 9.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 168.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.87 26.2 65.29 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.443 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.417 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 96.3 mm-40 -113.56 159.07 36.85 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.639 0.733 . . . . 0.0 110.915 -169.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 71.8 Cg_endo -68.95 68.76 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.662 2.241 . . . . 0.0 112.376 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.509 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 79.6 p -92.02 24.71 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 63.3 mttp -114.88 158.91 39.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 110.87 -163.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.442 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 43.7 Cg_endo -73.57 171.79 17.05 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 0.0 112.247 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -62.0 161.76 10.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.56 127.7 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.141 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.71 143.54 15.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.454 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.3 t -123.76 126.01 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.085 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.474 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 1.5 tt -67.7 126.48 29.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.451 ' N ' HD21 ' A' ' 262' ' ' LEU . 24.9 m -129.38 148.07 51.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -166.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.413 ' H ' ' HB2' ' A' ' 105' ' ' ALA . . . -142.98 137.93 29.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.09 159.35 18.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.556 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.42 123.55 66.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -56.15 126.15 24.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -68.98 -27.5 65.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.73 -9.37 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.7 t -67.61 129.47 93.46 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 0.0 110.906 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.89 -14.03 42.2 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.792 2.328 . . . . 0.0 112.295 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -115.36 27.02 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.851 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -54.06 -30.96 50.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -72.97 -37.87 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.425 HD13 HD13 ' A' ' 33' ' ' ILE . 39.5 mt -65.42 -45.39 84.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.61 91.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -67.41 -46.75 72.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.05 -49.32 76.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 -171.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -68.2 -34.64 76.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -174.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.4 tt -57.08 -51.49 69.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.89 -38.88 73.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -102.49 -23.07 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.697 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 48.5 m-85 -118.73 -45.97 2.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 -172.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 36.0 tp -73.29 -43.97 60.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 54.9 tp -121.1 73.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 33.1 p -141.53 172.24 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -52.6 -46.71 67.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.811 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.95 -40.18 32.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.806 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.697 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.7 -45.79 20.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.568 -171.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 26.2 tp -64.86 -32.98 74.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.832 0.349 . . . . 0.0 110.94 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.42 -43.48 98.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.25 99.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.05 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.516 HG21 ' HA3' ' A' ' 19' ' ' GLY . 14.5 p -80.39 -33.27 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.506 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 39.7 t30 -72.91 -21.3 60.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -55.92 -22.97 28.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.85 -20.61 24.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -99.68 156.12 35.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -59.81 -62.42 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.346 -171.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.31 -48.0 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.506 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 101.68 -43.79 1.65 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.463 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.47 71.69 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 111.116 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.53 153.24 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.125 -155.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.6 -18.62 58.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.8 tp -79.13 114.18 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.74 -45.62 93.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -166.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.1 m -67.23 -48.45 67.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.53 -38.99 82.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -36.53 71.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.861 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.26 -47.61 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.88 -15.39 60.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.51 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.24 -9.6 58.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -87.75 125.23 65.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.541 0.686 . . . . 0.0 110.846 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -47.27 -28.73 8.45 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 0.0 112.321 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.431 ' HG2' HG22 ' A' ' 244' ' ' VAL . 88.8 mtm180 -63.93 -37.3 86.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 40.7 mm -88.69 -42.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.146 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.9 -37.56 76.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.79 -37.6 79.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 92.8 m -67.21 -39.65 86.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -65.15 -44.41 88.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -65.84 -46.32 78.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.905 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 327' ' ' GLY . 4.3 p-10 -79.49 -15.72 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.839 -174.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.42 82.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -71.3 -17.14 62.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -112.63 -9.76 13.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -81.37 -165.46 34.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -129.19 147.19 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.655 HD12 ' HB3' ' A' ' 96' ' ' ALA . 6.0 tp -64.22 128.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -172.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 64.7 ttp -55.06 136.08 67.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.543 0.687 . . . . 0.0 110.908 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.48 80.52 1.37 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -103.02 4.91 37.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 335' ' ' GLN . 50.8 mm -81.37 137.58 48.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.628 0.728 . . . . 0.0 111.127 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 333' ' ' ILE . 53.9 Cg_exo -47.41 -35.5 21.52 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.426 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.0 mm-40 -82.04 -30.97 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.946 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 60.9 mtt -67.43 -18.58 65.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 84.4 p -60.65 -25.66 66.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.836 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.27 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -66.91 -38.86 87.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.81 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -62.98 -54.05 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -59.63 -45.69 91.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.21 83.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -173.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.35 -30.3 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -59.84 -46.55 88.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.9 m -64.65 -44.44 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.639 ' HA ' ' HB2' ' A' ' 360' ' ' ALA . . . -62.73 -43.78 97.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.51 -49.26 61.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.49 -43.6 97.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 82.2 m-20 -61.31 -35.81 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.81 70.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.34 -34.87 70.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.172 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.4 p -80.95 -8.35 59.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.79 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.41 11.75 85.2 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -80.51 -24.33 39.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.661 0.267 . . . . 0.0 110.788 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 59.3 tt0 -148.39 146.84 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.009 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 56.8 p -73.58 165.19 25.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.04 -45.85 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.063 -171.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.27 -41.33 98.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -72.72 -42.43 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.934 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . . . -63.0 -43.69 98.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.1 -33.77 74.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.69 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.928 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.95 -30.98 71.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -69.45 -45.2 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -65.12 -38.3 90.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 80.5 m -59.82 -41.68 91.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.97 -40.65 78.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.9 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 53.2 p -103.4 33.78 3.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.202 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -175.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.9 mt -87.44 136.67 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.1 mt-10 -129.71 162.61 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.78 122.57 24.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.99 22.87 34.31 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.453 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 92.6 mttt -145.45 165.67 27.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.93 144.82 25.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.98 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.29 122.82 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.128 -173.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.87 140.09 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 58.8 m95 -118.41 123.71 45.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 21.2 tt -148.79 139.92 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.2 -169.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -47.49 119.03 2.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -164.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.81 -24.26 64.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.496 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -53.7 -57.0 12.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.953 -170.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -139.6 89.91 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 148.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.73 -29.13 1.92 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -80.45 -47.98 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.949 -154.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.94 -51.73 55.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -154.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.74 -45.95 71.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.483 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.2 tp -58.62 -40.26 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.75 -42.17 98.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.054 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.34 -41.61 98.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.04 -48.02 80.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.06 -35.97 92.23 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -67.02 -42.72 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.792 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -58.81 -42.71 89.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.958 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' A' ' 33' ' ' ILE . 19.7 t80 -66.81 -35.3 79.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.86 -35.93 82.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -72.25 -33.99 67.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.51 -42.16 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.3 p -107.77 -15.45 14.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.195 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.05 4.33 89.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.504 -175.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.2 tt -73.41 116.42 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 111.15 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.28 123.99 21.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.49 145.48 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -140.62 116.96 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.35 129.97 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -125.17 161.45 26.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -94.6 121.9 62.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.546 0.688 . . . . 0.0 110.809 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.422 ' CB ' HD23 ' A' ' 43' ' ' LEU . 72.0 Cg_endo -86.67 81.21 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.634 2.223 . . . . 0.0 112.318 -167.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -91.98 -26.3 18.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -92.36 -17.37 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.422 HD23 ' CB ' ' A' ' 40' ' ' PRO . 1.9 mp -54.03 -43.75 70.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -157.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -49.28 -40.98 36.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.66 -33.93 35.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -71.33 -25.67 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.487 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.9 m-30 -49.55 -55.83 20.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.797 0.808 . . . . 0.0 110.968 -163.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 58.2 Cg_endo -71.4 -29.26 16.98 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -177.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -76.72 -50.58 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.706 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 35.4 m -59.5 -34.01 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 -175.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.71 84.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.073 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -25.76 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.8 p -93.3 3.11 56.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.85 3.77 60.5 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -172.5 95.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.872 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.706 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -123.26 -132.42 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 154.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 50.6 Cg_endo -73.8 155.0 48.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.617 2.211 . . . . 0.0 112.343 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -84.6 -39.61 18.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -135.1 134.78 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.5 mm -119.1 135.28 60.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.16 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.516 ' HB3' ' HA ' ' A' ' 11' ' ' ILE . 17.7 p90 -74.13 158.67 33.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.453 ' CB ' ' H ' ' A' ' 263' ' ' SER . 49.0 t90 -88.13 147.8 24.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.46 -95.46 0.45 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.05 -85.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 156.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -86.38 -13.18 47.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -58.52 -25.94 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 -154.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.412 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -60.0 -32.13 70.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -176.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.791 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -60.74 -44.75 97.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.47 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.7 93.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.8 m-30 -61.79 -42.48 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.68 -43.82 97.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -64.97 -30.1 71.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -84.68 -1.0 55.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.843 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.34 29.02 74.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.44 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 66.0 mt -74.63 -17.38 60.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -135.02 145.78 48.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -166.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -82.64 158.29 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.112 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.42 131.05 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.38 147.82 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.244 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -101.55 123.22 45.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.536 0.684 . . . . 0.0 111.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 147.49 30.83 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.749 2.299 . . . . 0.0 112.365 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -108.38 119.05 38.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -39.61 75.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.45 -42.97 83.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -69.57 -34.05 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.461 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.5 mt-30 -60.73 -44.74 96.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.0 -41.04 91.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.53 -24.8 59.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 304' ' ' LEU . 83.6 mt -108.23 -145.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -137.29 140.18 30.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 0.0 110.866 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.18 -35.43 63.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.83 -37.74 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.882 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.6 p -74.09 -25.13 59.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.164 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 49.3 m95 -74.08 -38.39 63.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.31 -34.14 74.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.968 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.93 67.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.53 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 27.4 m -112.62 19.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.136 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 58.9 mtm180 -116.37 140.13 49.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.774 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.452 ' HB3' HG21 ' A' ' 104' ' ' ILE . 85.2 t80 -139.64 127.92 22.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -175.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 56.12 32.77 20.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.75 3.24 90.66 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.415 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -115.57 150.03 37.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.927 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.493 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 64.5 tp -85.01 120.74 26.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 99' ' ' TYR . 36.9 pt -115.19 -13.88 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -167.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.53 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -156.63 161.46 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.506 ' HB3' HD11 ' A' ' 285' ' ' LEU . 79.7 m-85 -103.22 134.66 19.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.701 0.762 . . . . 0.0 110.977 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.498 ' HD3' HG22 ' A' ' 97' ' ' VAL . 62.9 Cg_endo -81.65 118.99 3.24 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.236 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.31 -31.13 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 -171.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.51 153.69 19.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.146 -163.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.43 124.46 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -111.28 113.87 26.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.79 146.36 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.69 147.17 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.1 m -142.25 159.71 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -91.59 119.99 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.99 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.497 HG12 HG23 ' A' ' 244' ' ' VAL . 31.0 mt -112.78 124.34 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -132.65 156.06 47.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -165.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -91.96 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.71 -24.46 66.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.902 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -75.75 -37.24 59.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.52 -51.12 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.98 105.74 44.62 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.591 0.71 . . . . 0.0 110.895 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.01 -14.89 26.25 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.7 t-20 -155.92 104.08 2.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 0.0 110.837 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.6 Cg_endo -66.83 160.51 46.42 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.312 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.422 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 34.1 Cg_endo -68.46 144.27 60.69 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.722 2.282 . . . . 0.0 112.364 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.17 -17.26 31.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.985 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -148.52 166.03 29.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.136 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -69.16 -25.69 64.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.787 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.79 -30.3 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.873 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.54 -22.4 43.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.901 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 81.3 mt -63.39 -50.44 73.92 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.604 0.716 . . . . 0.0 111.12 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 36.4 Cg_endo -67.83 -40.28 9.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.686 2.257 . . . . 0.0 112.254 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.52 95.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.422 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 57.1 tp -60.66 -38.84 86.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 132' ' ' ILE . 10.3 t70 -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.62 -37.93 83.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.35 -45.47 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.819 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.5 pp -85.08 -20.32 30.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.411 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -58.23 -27.04 63.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.924 170.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -17.92 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.98 9.25 34.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 29.31 63.58 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.476 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -112.3 158.58 19.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.3 t -114.74 151.04 34.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 164.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -78.02 -43.92 28.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.042 -173.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.81 144.43 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.952 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -109.95 131.32 55.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -166.74 159.12 13.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -122.32 -16.22 7.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.4 mt 50.68 36.72 14.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -99.29 -14.07 19.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -142.59 148.66 47.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.569 0.7 . . . . 0.0 110.95 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.55 -25.07 75.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -54.23 -42.79 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.427 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 70.4 m-85 -73.19 -30.33 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 -177.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -76.83 -25.1 52.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.532 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 24.1 m0 -56.48 -46.15 99.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.602 0.715 . . . . 0.0 110.917 -164.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.775 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 74.9 Cg_exo -47.62 -44.57 25.67 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.674 2.249 . . . . 0.0 112.377 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.3 mt -75.28 -34.35 61.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.96 -42.15 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.54 -18.53 56.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.14 80.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 -160.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -98.88 13.39 32.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.08 12.45 6.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.51 170.63 53.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.498 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -165.07 165.0 20.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.919 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.94 -73.54 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.88 148.8 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -66.12 125.41 25.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.871 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -114.86 114.33 25.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -151.35 144.9 24.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.863 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 47.71 44.25 17.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.889 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.0 7.85 71.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.65 146.95 50.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -90.5 130.6 36.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -87.17 107.52 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.9 tp -64.77 -19.92 26.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.44 -2.93 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.951 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -120.57 95.98 4.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.21 153.25 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.148 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 188' ' ' ALA . . . -105.03 28.59 14.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.04 -12.9 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.313 . . . . 0.0 111.066 176.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.434 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 53.8 p-10 -103.33 13.48 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.95 156.58 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -171.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.06 66.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.1 96.7 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 182' ' ' GLY . . . -65.48 -34.88 79.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.155 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -63.94 -40.34 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.06 86.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.97 -44.03 95.09 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.428 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.426 HD21 HG13 ' A' ' 357' ' ' VAL . 34.3 tp -68.23 -40.0 82.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.957 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.7 m -58.85 -40.81 85.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.219 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.66 -43.23 99.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.974 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.32 -42.48 91.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.71 -39.98 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.27 -35.59 79.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -37.34 86.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.13 -38.2 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.222 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.56 -38.22 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.869 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -82.24 1.82 34.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.78 34.95 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.92 -16.49 58.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.811 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 205' ' ' ASN . 19.0 tmm? -137.81 141.81 40.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 60.8 t30 -92.73 134.93 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 -167.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.35 -11.0 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 51.9 m -75.49 140.12 42.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -176.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -98.64 167.28 10.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -66.48 -36.61 83.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.7 p -71.96 -36.33 69.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.69 -43.69 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.185 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 216' ' ' ALA . . . -73.39 -32.55 64.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.69 -36.11 73.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.16 84.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' A' ' 221' ' ' GLU . . . -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -63.81 -40.21 96.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.59 -21.83 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.787 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.27 -9.94 19.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.848 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.72 16.97 59.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.44 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 216' ' ' ALA . 95.8 mt-10 -84.63 -28.33 26.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.973 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.0 m -123.43 130.08 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.93 92.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 -166.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.9 mtm -137.81 155.26 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 72.4 p -141.8 167.38 22.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.8 mm -118.88 115.03 46.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.65 156.81 48.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.44 -170.05 46.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.516 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.51 -19.06 11.81 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -69.96 -30.96 68.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.97 14.9 9.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.659 ' O ' ' C ' ' A' ' 233' ' ' SER . 33.5 m0 -74.28 -50.25 19.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 172.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.659 ' C ' ' O ' ' A' ' 232' ' ' TRP . 89.4 p -4.64 -80.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.843 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -171.92 4.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.944 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.98 117.83 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.646 ' O ' ' C ' ' A' ' 237' ' ' THR . 40.6 t0 -130.58 150.61 51.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.646 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.1 m -6.68 75.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 236' ' ' ASP . 93.0 p -63.22 153.96 32.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 170.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.52 -16.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 52.3 t -88.89 75.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 44.44 44.39 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.41 148.76 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 164.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.56 165.93 26.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.47 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 116' ' ' ILE . 46.4 t -128.6 131.06 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 111.164 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -143.0 -177.59 5.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.09 158.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.209 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.542 HD23 ' HD3' ' A' ' 257' ' ' PRO . 13.3 tp -76.72 139.58 66.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.711 . . . . 0.0 110.98 -173.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.83 138.0 15.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.231 . . . . 0.0 112.419 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 96.9 m -138.82 137.39 36.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -168.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -106.02 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.798 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 45.34 42.93 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.36 52.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.442 165.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.409 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.9 mm-40 -114.83 158.36 40.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.688 0.756 . . . . 0.0 110.969 -169.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.1 Cg_endo -64.93 74.75 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 61.3 m -92.46 3.34 55.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.485 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 62.8 mttp -107.07 157.1 36.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.61 0.719 . . . . 0.0 110.9 -157.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.775 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 34.5 Cg_endo -65.82 160.42 43.96 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.621 2.214 . . . . 0.0 112.297 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -75.14 166.45 23.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.35 131.07 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 -167.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.64 147.08 16.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.483 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.12 122.73 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.927 0.394 . . . . 0.0 111.105 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.29 128.79 37.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.453 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 27.8 m -130.22 152.3 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.814 -164.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -142.97 136.44 28.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.06 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.18 17.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.472 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.0 mm -110.1 125.63 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 0.0 111.084 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 54.9 t-20 -58.91 124.71 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.813 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.572 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -67.31 -29.29 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.052 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.28 -9.7 58.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.0 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -68.15 128.55 93.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.738 0.78 . . . . 0.0 110.913 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.31 -11.7 32.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -114.91 25.0 11.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.902 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.74 -32.67 53.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.89 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.11 -37.96 63.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.63 -45.42 90.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.023 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.63 -43.28 76.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.08 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -65.11 -51.25 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.61 -44.81 92.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -35.24 74.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.65 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.5 tt -55.62 -52.04 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.21 -27.28 47.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -96.34 -7.26 35.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 -169.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.758 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 32.4 m-85 -115.94 -57.6 2.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.64 -37.61 79.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -172.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 106' ' ' TYR . 49.8 mt -99.94 41.4 1.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.96 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 75.1 p -137.74 162.09 34.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.53 -48.54 77.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.45 -38.92 71.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.758 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -76.41 -46.32 12.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.547 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.0 tp -65.44 -36.37 83.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.49 -44.75 89.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.64 95.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -30.67 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.44 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 52.2 t30 -74.12 -12.15 60.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.39 -25.99 62.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -93.57 0.0 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -116.39 155.88 47.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.717 . . . . 0.0 110.923 169.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.52 -62.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.704 2.269 . . . . 0.0 112.412 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.0 mt -108.81 -43.97 4.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.44 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 97.97 -61.31 0.95 Allowed Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.533 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 54.97 85.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.082 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.75 156.94 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.22 -156.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.99 60.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.473 ' HA ' HD21 ' A' ' 89' ' ' LEU . 47.7 tp -79.78 117.82 21.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.11 -44.26 95.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.881 -171.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 90.2 p -67.11 -52.81 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -171.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.53 -34.67 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.37 -40.11 95.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.38 -36.88 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.69 -47.83 29.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.428 HD12 HG21 ' A' ' 317' ' ' ILE . 3.9 pp -74.7 -16.59 60.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.12 -4.67 37.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.195 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.67 -10.22 59.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -87.18 131.22 45.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.536 0.684 . . . . 0.0 110.844 175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.26 -29.23 12.54 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.649 2.233 . . . . 0.0 112.336 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -66.35 -39.09 88.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 311' ' ' LEU . 36.0 mm -84.62 -42.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.91 67.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.118 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.49 -38.97 81.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.06 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.3 m -68.43 -40.81 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.214 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -64.33 -43.91 93.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.56 -45.28 79.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.485 ' HB2' ' HD3' ' A' ' 256' ' ' LYS . 44.9 p30 -78.52 -18.76 54.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.894 -173.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.81 84.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -72.98 -17.4 61.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 -9.13 14.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.16 -161.34 34.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.472 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -125.7 129.27 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.312 . . . . 0.0 110.914 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 38.2 mm -67.51 123.61 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.207 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.82 123.62 85.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.485 0.66 . . . . 0.0 110.887 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.3 146.4 40.52 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 122.627 2.218 . . . . 0.0 112.366 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.791 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 55.5 p30 -99.99 13.64 33.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.43 HG12 ' H ' ' A' ' 335' ' ' GLN . 16.7 tt -75.18 138.94 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 111.091 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.62 -25.7 20.65 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.735 2.29 . . . . 0.0 112.372 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.43 ' H ' HG12 ' A' ' 333' ' ' ILE . 99.5 mm-40 -63.89 -14.54 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.991 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.1 mmm -62.86 -25.89 68.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -58.91 -40.12 83.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.779 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.28 69.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.44 ' HA ' HG12 ' A' ' 368' ' ' ILE . 87.3 t80 -58.43 -43.67 88.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -59.87 -57.58 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -61.62 -33.69 74.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.88 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.19 84.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.2 t -69.84 -39.94 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.151 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -57.49 -49.63 75.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.817 -172.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.3 m -65.88 -43.89 86.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.39 98.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.093 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.4 t -68.94 -49.89 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.214 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 94.4 mt -61.59 -41.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.155 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 84.1 m-20 -61.86 -38.17 87.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.37 73.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.09 68.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.137 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.7 p -80.41 -7.96 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.844 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.48 11.93 84.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.446 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.98 -27.13 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.744 0.307 . . . . 0.0 110.793 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.6 tt0 -147.51 146.4 29.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.0 p -71.11 164.56 25.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.24 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.426 HG13 HD21 ' A' ' 192' ' ' LEU . 76.8 t -73.33 -45.6 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -170.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.44 -38.37 90.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.849 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -73.23 -37.75 66.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.93 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 184' ' ' ASP . 0.4 OUTLIER -64.68 -36.16 83.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.18 -40.43 97.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.888 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -69.97 -33.12 71.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.2 -48.38 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.153 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.92 -32.27 70.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 75.1 m -63.29 -41.99 99.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.99 -38.27 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.88 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 339' ' ' PHE . 86.5 mt -63.64 -43.51 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.219 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 44.3 p -102.5 35.61 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.638 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -86.47 133.77 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.9 mt-10 -123.87 158.96 30.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.29 122.35 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.79 22.62 49.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.497 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 96.4 mttt -140.54 156.04 46.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.37 137.92 50.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.5 t -123.89 113.72 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.55 137.84 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.089 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 59.8 m95 -113.66 123.28 49.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.662 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 18.1 tt -150.94 144.08 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 -168.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -48.54 119.72 3.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -170.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.5 -21.51 60.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.477 -172.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.51 -48.31 81.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.24 83.43 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 149.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.57 -46.23 1.56 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.532 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.05 -44.86 29.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.9 -157.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.09 -53.09 42.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -154.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.481 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -65.27 -48.53 68.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.446 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 11' ' ' ILE . 2.7 mp -61.84 -36.84 82.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.897 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.94 83.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.33 -41.39 96.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.44 -41.59 88.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.535 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.06 -48.74 80.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.41 -43.09 99.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.988 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.42 -36.21 80.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.91 -34.29 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.23 -34.0 77.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -88.4 -39.71 14.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.439 ' HB ' HG22 ' A' ' 33' ' ' ILE . 62.2 m -110.1 -24.46 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.191 -167.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.35 7.75 79.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.476 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.764 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -87.07 127.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 111.02 -177.343 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.94 137.34 39.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.57 140.03 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.187 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -128.52 111.84 13.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.414 HG13 HG22 ' A' ' 11' ' ' ILE . 94.4 t -104.32 127.98 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -124.77 158.23 33.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 41.5 m170 -83.67 135.98 42.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.662 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 71.8 Cg_endo -90.0 68.31 1.9 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -166.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -101.04 -32.29 10.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.793 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.22 -16.06 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.52 HD13 ' HA ' ' A' ' 40' ' ' PRO . 5.9 mp -50.94 -51.61 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -158.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.14 -35.6 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 50' ' ' VAL . 74.7 mmtt -76.13 -30.06 58.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.812 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.521 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.0 m-30 -51.29 -56.12 23.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.646 0.736 . . . . 0.0 110.844 -167.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.4 Cg_endo -67.76 -29.84 34.95 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.733 2.289 . . . . 0.0 112.314 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -78.58 -49.96 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.441 HG22 ' HD2' ' A' ' 57' ' ' PRO . 32.1 m -66.93 -32.02 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.093 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.9 92.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.16 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -94.31 1.08 55.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.35 78.88 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.422 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -169.66 101.87 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 110.924 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.419 ' CA ' ' HB ' ' A' ' 50' ' ' VAL . . . -125.05 -130.74 3.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.471 161.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HD2' HG22 ' A' ' 50' ' ' VAL . 49.2 Cg_endo -71.42 156.64 58.12 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 -175.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.07 -43.28 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -136.65 138.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.14 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.14 134.98 60.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CE1' HD22 ' A' ' 262' ' ' LEU . 83.4 t80 -78.71 136.31 37.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -62.87 143.96 57.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.1 -100.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -127.33 -85.9 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 160.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -87.13 -21.76 25.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 11.9 mmt85 -57.63 -28.92 64.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -166.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -61.72 -33.65 74.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -65.01 -43.59 95.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.546 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.43 -32.98 85.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.512 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 66' ' ' ARG . 19.3 m-30 -66.72 -34.29 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.86 99.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.43 -27.49 67.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.7 m -83.2 -1.0 51.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.907 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.84 28.63 71.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.509 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.79 -7.69 59.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.982 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.529 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.0 pp -135.13 146.01 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.66 159.65 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.1 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.64 129.37 39.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -113.33 150.6 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.153 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -105.21 124.16 37.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.255 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.9 139.58 40.09 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.718 2.278 . . . . 0.0 112.282 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.74 121.72 38.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.82 -39.36 68.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.52 95.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.082 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -65.79 -34.68 78.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.32 -43.94 95.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.23 -41.87 93.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.74 -24.43 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.98 -177.59 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.16 150.24 37.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.942 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.3 -38.13 36.6 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.737 2.291 . . . . 0.0 112.322 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -76.79 -20.13 56.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 71.7 p -75.5 -26.0 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.111 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -69.99 -37.15 75.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.995 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.67 -33.95 74.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.23 65.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 30.6 m -105.63 11.36 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -111.4 140.33 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -138.01 125.14 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.19 34.8 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.45 1.71 88.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.435 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.22 147.99 44.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 tp -78.6 129.37 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.913 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.3 pt -118.16 -5.41 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.09 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -162.42 166.67 24.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.4 m-85 -112.44 136.84 21.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.713 0.768 . . . . 0.0 110.981 167.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 39.1 Cg_exo -61.76 117.17 3.98 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.246 174.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 96.6 mt -104.33 -38.43 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 262' ' ' LEU . . . -156.74 155.33 31.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.195 -170.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.0 t -124.19 128.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.147 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 229' ' ' PRO . 49.9 mt-10 -115.59 120.0 37.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.832 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.86 147.33 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.104 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.58 148.96 36.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.0 m -141.53 161.08 38.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.76 122.16 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.08 128.39 67.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.053 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -133.49 154.37 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -91.87 116.34 28.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.829 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.86 -26.99 68.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -174.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.17 -32.25 33.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.881 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.08 -48.5 8.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.6 tp -127.69 111.71 20.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.662 0.744 . . . . 0.0 110.967 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 -15.15 17.62 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.818 2.346 . . . . 0.0 112.335 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 45.5 t30 -149.68 107.13 3.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -173.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.2 Cg_endo -67.63 161.87 41.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.336 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.43 ' HD3' HD13 ' A' ' 135' ' ' LEU . 44.8 Cg_endo -72.7 144.38 39.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.609 2.206 . . . . 0.0 112.477 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.98 -22.99 21.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 167.31 26.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -67.13 -29.93 69.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.07 -30.22 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.77 -22.76 45.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.613 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 80.9 mt -62.34 -51.37 74.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.669 0.747 . . . . 0.0 111.075 -167.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.28 -39.05 10.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.252 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.48 90.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.064 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.635 HD21 ' O ' ' A' ' 135' ' ' LEU . 4.7 tt -62.18 -37.02 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 140' ' ' LYS . 8.7 t70 -66.35 -42.76 87.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.98 -38.72 73.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.18 -49.67 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.0 pp -80.22 -18.43 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.945 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.469 ' N ' HD12 ' A' ' 139' ' ' LEU . 84.4 tttt -57.13 -30.42 64.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 171.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.88 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -103.59 7.92 37.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.5 29.86 61.11 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.486 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -106.48 164.48 12.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.1 t -116.05 149.09 39.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.8 165.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -83.5 -28.48 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.105 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 tp -137.86 143.35 40.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.4 ttm -120.46 128.94 53.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -166.32 163.19 17.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.758 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -130.14 -4.36 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.869 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.3 mt 53.07 34.31 16.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -92.11 -16.61 26.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -132.42 146.2 60.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.677 0.751 . . . . 0.0 110.866 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -59.97 -23.25 72.23 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -54.57 -32.51 58.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -71.81 -36.67 70.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.406 HG22 HG11 ' A' ' 347' ' ' VAL . 73.4 p -86.19 -23.74 26.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 -172.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.482 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.6 m95 -56.09 -44.99 99.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.585 0.707 . . . . 0.0 110.936 -168.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.543 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 72.2 Cg_exo -46.42 -40.23 22.63 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.279 . . . . 0.0 112.31 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.4 -38.08 30.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.529 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 93.3 mt -69.87 -51.41 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -172.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.71 -15.7 60.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 -176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -59.38 -31.71 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.119 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -92.02 0.78 57.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 -172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.05 13.75 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.556 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.36 166.37 31.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.423 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -174.43 154.45 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.347 . . . . 0.0 110.936 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -41.6 -63.38 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 176' ' ' TYR . 20.6 p90 -142.09 155.61 45.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.29 123.65 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -119.74 117.18 27.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -147.58 142.36 26.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -172.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 51.9 40.43 28.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.28 76.55 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.522 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.09 146.87 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.337 . . . . 0.0 110.829 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.511 ' HB2' ' CD1' ' A' ' 169' ' ' PHE . 17.1 p90 -101.56 141.61 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.63 110.97 23.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 178' ' ' ILE . 6.2 tp -71.42 -19.66 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.08 -5.23 57.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -125.25 95.03 4.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.857 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.412 ' HB ' HG23 ' A' ' 183' ' ' VAL . 32.0 m -101.09 158.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.89 16.64 39.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.451 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.412 HG23 ' HB ' ' A' ' 181' ' ' VAL . 30.8 m -100.01 -19.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -175.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -98.99 19.82 14.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.52 154.2 20.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -172.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.26 70.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.018 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.54 94.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.493 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.5 81.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 111.195 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.02 -38.55 88.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.56 97.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -61.88 -40.11 98.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.429 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.435 HD21 HG13 ' A' ' 357' ' ' VAL . 38.8 tp -67.86 -38.13 82.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 83.1 m -60.45 -41.19 93.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.182 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -57.85 -45.48 86.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.4 -45.11 94.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.5 -41.51 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 198' ' ' LEU . 1.1 mp -63.24 -38.24 90.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.43 -38.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.132 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.0 -32.03 73.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -81.56 3.32 25.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.55 33.96 10.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.999 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -77.07 -18.96 57.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 tpt -143.83 150.09 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.48 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 66.2 t30 -87.49 141.8 28.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.3 -32.62 68.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -96.16 -16.2 21.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -171.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 70.9 m -67.26 135.62 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.033 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -102.22 169.92 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -65.0 -47.54 77.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.863 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.31 -43.62 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.108 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.38 -32.67 70.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -64.22 -40.59 96.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.034 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.072 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -63.81 -39.83 95.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.934 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -61.47 -25.88 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.784 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.22 -8.11 40.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.04 17.3 63.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.495 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -83.5 -21.75 32.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.5 m -123.15 131.02 53.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.18 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.37 -38.88 65.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.2 mtm -135.51 154.88 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.902 -172.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 166.77 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.0 mm -119.17 125.33 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.169 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -147.47 155.56 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.79 -163.42 31.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.458 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HG3' ' HA ' ' A' ' 111' ' ' GLU . 66.6 Cg_endo -76.21 -14.88 18.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.755 2.303 . . . . 0.0 112.346 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -62.84 -30.55 71.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.983 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.79 20.06 12.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.666 ' O ' ' C ' ' A' ' 233' ' ' SER . 48.0 m0 -71.38 -41.1 70.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.666 ' C ' ' O ' ' A' ' 232' ' ' TRP . 52.8 p 2.92 -91.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -153.99 3.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.876 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 19.5 tt -164.92 155.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 -168.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 238' ' ' SER . 54.6 p30 -102.17 -173.86 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' THR . . . . . 0.56 ' C ' ' O ' ' A' ' 236' ' ' ASP . 48.2 m -9.96 82.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.204 163.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 236' ' ' ASP . 45.6 m -40.86 136.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 -31.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 240' ' ' VAL . 61.4 t -89.12 68.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -174.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 54.29 33.02 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 171.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 238' ' ' SER . 91.4 m-85 -105.56 152.66 22.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 167.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.09 158.86 24.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 316' ' ' ARG . 62.1 t -130.2 130.68 65.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.18 177.49 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.16 160.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.58 148.88 74.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.31 144.26 72.45 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.609 2.206 . . . . 0.0 112.417 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.1 p -129.18 150.03 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -125.77 111.19 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 48.34 37.95 9.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.96 26.08 56.51 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 167.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -109.6 156.78 39.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.551 0.691 . . . . 0.0 110.965 -169.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 75.2 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.438 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.3 p -92.24 -1.37 57.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -170.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.411 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 68.3 mttm -102.29 155.86 35.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.539 0.685 . . . . 0.0 110.945 -167.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.79 167.47 24.39 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -68.01 153.91 42.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.6 t -118.69 130.04 74.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.151 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -100.25 141.9 15.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.477 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.5 124.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.483 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -65.02 124.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.6 m -128.74 155.28 45.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.837 -168.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.409 ' H ' ' HB2' ' A' ' 105' ' ' ALA . . . -138.19 134.97 35.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.04 141.95 15.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.2 mt -113.81 125.03 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.067 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -59.09 125.07 22.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.0 -27.32 65.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.06 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.89 -8.17 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.058 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -66.21 130.3 94.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.719 0.771 . . . . 0.0 110.883 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -65.73 -16.32 52.78 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.816 2.344 . . . . 0.0 112.275 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -110.92 21.11 16.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.881 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -51.8 -34.54 40.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.21 -36.5 58.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.67 HD22 HG13 ' A' ' 33' ' ' ILE . 40.7 tp -61.06 -45.27 95.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.074 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -65.05 -45.76 84.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.76 -51.28 67.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.828 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -69.19 -35.29 76.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -172.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.64 HD21 ' O ' ' A' ' 280' ' ' LEU . 3.9 tt -55.91 -50.33 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.996 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.63 -35.68 65.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -102.74 -23.34 13.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.735 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 61.9 m-85 -122.16 -43.84 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 -171.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 30.8 tp -74.18 -42.31 60.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.918 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 51.0 tp -124.57 74.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 37.0 p -141.48 173.44 11.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.201 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.3 -45.15 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.14 -44.09 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.827 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.735 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.07 -45.89 18.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.443 -168.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.429 HD22 ' HB ' ' A' ' 302' ' ' VAL . 45.6 tp -61.99 -34.49 76.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.34 . . . . 0.0 110.879 -176.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.88 -40.26 88.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.874 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.95 94.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.481 HG21 ' HA3' ' A' ' 19' ' ' GLY . 11.1 p -81.98 -35.81 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.236 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.35 -22.55 60.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.953 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -61.84 -13.4 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -171.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -83.46 0.16 47.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.799 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -111.58 153.32 44.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.868 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.59 -61.98 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.717 2.278 . . . . 0.0 112.368 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 84.2 mt -98.63 -36.1 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 111.44 -58.09 0.41 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.498 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 49.26 70.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.126 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.429 ' HB ' HD22 ' A' ' 290' ' ' LEU . 35.6 m -112.18 152.2 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -167.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.37 -13.4 59.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 55.3 tp -76.61 120.2 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.8 -47.03 86.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -64.96 -48.36 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -172.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -69.26 -36.68 77.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -65.64 -34.54 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.45 -39.38 94.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -69.77 -43.57 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.02 -24.13 65.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.27 -5.55 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 -173.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.49 -17.75 62.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -86.96 128.62 55.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.531 0.681 . . . . 0.0 110.915 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.32 -30.7 20.67 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.445 ' HG2' HG22 ' A' ' 244' ' ' VAL . 94.4 mtt-85 -69.91 -37.39 75.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 39.2 mm -79.14 -40.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.49 -41.94 83.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.8 m -64.8 -41.52 95.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.214 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.94 -42.81 94.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -66.39 -46.2 77.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.908 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 327' ' ' GLY . 25.8 p30 -78.21 -18.12 55.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.48 82.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.112 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.24 -25.45 59.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.78 -9.97 20.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.83 -155.95 31.47 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.457 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -122.75 129.4 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.2 mm -72.73 127.47 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.264 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.413 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 59.8 ttm -63.37 124.89 85.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 330' ' ' MET . 36.5 Cg_endo -64.21 135.12 45.39 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.745 2.297 . . . . 0.0 112.329 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.671 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.7 p30 -95.08 13.22 25.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 -172.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 335' ' ' GLN . 48.3 mm -75.12 130.36 80.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 111.203 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.98 -28.11 74.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.513 ' H ' HG22 ' A' ' 333' ' ' ILE . 92.2 mt-30 -64.95 -13.86 58.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.973 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.87 -21.49 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -58.57 -35.6 72.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.58 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -63.0 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.957 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -58.69 -52.01 67.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.922 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -64.32 -44.65 90.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.53 94.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.167 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 76.5 t -71.79 -42.39 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -57.52 -45.79 84.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.3 m -65.53 -44.64 86.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.065 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 360' ' ' ALA . . . -63.76 -40.57 97.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.086 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.406 HG11 HG22 ' A' ' 157' ' ' THR . 53.8 t -67.66 -48.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.5 -45.36 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.237 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.697 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 83.5 m-20 -63.54 -37.08 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.91 -45.52 67.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.16 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.21 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.7 p -81.9 -8.98 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.11 84.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -81.0 -25.68 37.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 110.823 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.697 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 41.7 tt0 -149.9 145.38 26.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.4 p -72.55 163.73 27.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.435 HG13 HD21 ' A' ' 192' ' ' LEU . 54.3 t -65.32 -45.93 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.116 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.08 -42.82 96.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.32 -46.23 61.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . . . -62.08 -42.14 98.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.024 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.3 -39.97 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.906 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.06 -41.69 90.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.873 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.53 -44.02 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.33 -48.08 11.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.222 -168.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -70.95 -32.31 69.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 -170.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 59.0 m -60.61 -33.26 72.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.8 -27.97 67.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.78 -40.18 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.3 p -102.54 -16.7 16.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 178.259 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.27 128.99 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.02 166.28 21.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.77 123.91 25.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.946 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.01 29.46 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.453 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -141.07 154.78 46.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 110.929 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.656 ' HB2' HD13 ' A' ' 33' ' ' ILE . 7.2 tt -139.07 130.36 26.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.796 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.24 124.79 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.6 mt -118.84 134.82 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.842 ' HB3' HD22 ' A' ' 43' ' ' LEU . 39.7 m0 -111.7 123.73 50.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.965 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.51 160.22 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.879 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.7 t-20 -55.85 120.14 6.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 167.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.472 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.54 -20.89 79.42 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.482 -171.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -57.74 -45.47 85.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.844 -167.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.3 mmtt -130.67 75.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 148.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.5 -46.3 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.504 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -75.82 -45.75 34.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.939 -154.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -63.98 -52.66 58.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -157.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -64.18 -43.91 96.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.532 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.5 -37.52 83.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.99 -44.57 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.47 -52.2 66.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.6 m -75.25 -34.01 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.502 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -66.88 -39.6 93.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.484 175.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -70.11 -42.97 71.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.72 -39.64 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.98 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.28 -35.09 75.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 171.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.63 -34.12 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.81 -33.6 72.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -83.96 -39.96 19.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.2 p -109.09 -16.98 13.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.142 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.67 5.39 86.66 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.656 HD13 ' HB2' ' A' ' 7' ' ' LEU . 14.1 pt -88.07 125.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.195 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.84 129.64 39.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 ' HA3' ' A' ' 24' ' ' GLY . 14.4 p -100.78 139.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.081 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -140.95 121.41 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.19 128.67 61.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 88.3 tt0 -112.24 151.85 29.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -79.28 161.46 67.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.839 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.879 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 59.9 Cg_endo -102.97 24.05 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 -160.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -76.45 -43.62 39.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.99 -14.32 36.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.842 HD22 ' HB3' ' A' ' 10' ' ' TRP . 3.5 mp -52.03 -50.9 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 -161.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.9 -41.28 61.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.25 -35.56 61.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.863 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.25 -28.93 62.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m-30 -49.24 -54.91 24.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.593 0.711 . . . . 0.0 110.898 -162.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 86.8 Cg_endo -80.03 -31.11 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.211 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -74.65 -48.32 26.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -168.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.48 -30.76 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.55 ' HA ' ' HB3' ' A' ' 269' ' ' ALA . . . -62.52 -37.82 87.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.83 63.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 p -97.68 -1.11 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.101 -171.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' HB2' ' A' ' 269' ' ' ALA . . . 75.63 18.46 79.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.523 -176.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -109.73 -175.16 2.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.864 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.7 -165.9 12.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.505 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.627 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 89.5 Cg_endo -82.79 178.45 6.03 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -87.88 -38.72 15.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 164.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.9 mt -131.06 139.6 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.2 143.23 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.058 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -100.05 142.85 30.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.51 126.65 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.76 -90.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -110.75 -83.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -95.91 -17.44 21.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.416 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 80.3 mtp180 -59.72 -25.7 65.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CD2' HD12 ' A' ' 104' ' ' ILE . 10.1 p90 -52.39 -37.43 56.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -49.06 9.86 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.495 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.6 86.17 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.48 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.579 ' HB3' HD22 ' A' ' 75' ' ' LEU . 25.4 m-85 -71.66 -30.4 65.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.942 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.93 69.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.63 -29.86 70.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -83.98 -1.74 55.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 110.934 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.35 25.02 66.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.579 HD22 ' HB3' ' A' ' 70' ' ' TYR . 4.4 pp -85.99 -5.41 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -131.41 146.09 52.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.944 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 147.62 24.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.21 142.88 50.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' A' ' 103' ' ' LEU . 39.2 pt -101.99 145.97 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.6 p -132.25 70.26 80.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 111.08 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.37 144.35 45.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.381 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -86.61 -174.52 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.71 -37.48 84.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.46 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.14 -36.18 81.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.82 -37.76 87.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -54.42 -29.43 49.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.863 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 93.2 mttt -54.02 -36.83 63.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 1.257 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 160.22 123.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.503 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 13.7 m-85 -158.26 51.6 0.47 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.72 . . . . 0.0 110.862 167.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 55.7 Cg_endo -70.8 -71.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.642 2.228 . . . . 0.0 112.335 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -102.76 -19.06 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 168.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -69.14 -20.53 64.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.142 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 90' ' ' TYR . 17.6 t90 -58.86 -43.23 90.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.78 -27.2 68.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.581 ' HB2' ' HB ' ' A' ' 261' ' ' VAL . . . -74.5 -30.6 61.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.033 -169.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -116.43 14.99 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.494 ' HB3' HD21 ' A' ' 103' ' ' LEU . 52.4 ptt85 -118.25 147.15 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -135.43 125.39 25.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 t30 60.29 35.13 20.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.857 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 5.28 90.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.574 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 148.5 44.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 98' ' ' ARG . 83.9 mt -86.95 122.26 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.443 HD12 ' CD2' ' A' ' 67' ' ' PHE . 44.6 pt -122.79 -1.9 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.71 31.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -111.47 146.26 34.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.68 0.752 . . . . 0.0 110.902 174.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.59 122.46 6.94 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.712 2.275 . . . . 0.0 112.402 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.7 -37.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.079 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.42 152.09 10.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.5 128.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.122 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -122.55 126.37 47.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.411 ' HB3' HG13 ' A' ' 259' ' ' VAL . . . -152.53 155.97 38.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 257' ' ' PRO . 94.7 mt -76.46 144.33 39.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.1 m -140.66 156.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HB2' HD21 ' A' ' 247' ' ' LEU . 43.0 tp -94.47 127.65 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 244' ' ' VAL . 68.7 mt -113.98 130.5 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.169 172.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -136.76 155.83 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.465 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 36.4 t-20 -92.0 111.7 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.596 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.5 mttt -65.17 -28.29 69.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 31.7 t70 -76.04 -33.22 59.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.84 -44.96 13.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.4 tp -121.03 109.62 35.38 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.71 0.767 . . . . 0.0 110.954 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.5 -15.6 19.59 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.0 112.361 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -147.12 109.55 3.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 0.0 110.845 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.35 154.39 74.41 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.686 2.258 . . . . 0.0 112.356 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.24 140.71 37.78 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.64 -25.75 22.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.4 t -149.97 174.32 12.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.119 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -74.53 -24.44 58.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -169.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.73 -32.4 73.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.895 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.75 -23.18 58.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -172.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 88.7 mt -66.31 -51.78 41.52 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.63 0.728 . . . . 0.0 111.126 -168.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.56 -40.42 56.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.703 2.268 . . . . 0.0 112.303 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.2 -43.6 98.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.3 -38.36 80.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.477 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 9.8 t70 -64.59 -36.23 83.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.49 -37.05 85.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.95 -58.0 4.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.406 HD21 ' N ' ' A' ' 140' ' ' LYS . 1.3 pt? -78.7 -11.76 59.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 86.6 tttt -56.46 -30.37 62.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 169.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.03 -21.03 66.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.9 6.64 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.24 28.06 64.83 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 7.0 mptt -119.72 156.52 30.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.887 0.375 . . . . 0.0 110.92 174.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -115.76 153.97 30.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -72.55 -49.34 33.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 52.8 tp -143.44 125.7 15.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.2 mmm -133.19 131.42 40.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 174.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.93 167.65 28.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 210' ' ' TYR . 60.1 t-20 -50.87 111.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 206' ' ' ALA . 8.0 tp -115.31 19.96 15.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -92.19 -2.46 56.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.04 145.8 53.43 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.612 0.72 . . . . 0.0 110.874 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.487 ' HB3' ' HB2' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -68.15 -27.66 35.19 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -58.79 -35.43 72.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.21 -26.63 22.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.828 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.8 p -87.57 -32.31 19.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.655 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 58.6 t90 -55.01 -52.3 72.24 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.516 0.674 . . . . 0.0 110.99 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.6 Cg_endo -54.98 -32.18 77.52 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.624 2.216 . . . . 0.0 112.402 -175.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.46 -35.19 73.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.441 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -72.42 -41.66 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.17 -18.89 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.164 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.97 2.63 53.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.13 11.87 6.06 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.597 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.17 165.19 53.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.475 ' HD2' ' HA3' ' A' ' 182' ' ' GLY . 98.1 m-85 -140.33 175.86 9.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.989 0.423 . . . . 0.0 110.882 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 339' ' ' PHE . . . -112.03 -33.68 6.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.447 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -148.35 134.76 19.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.825 -173.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 1.074 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -89.89 121.55 32.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -170.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -127.46 113.12 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.02 142.66 24.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.0 32.77 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.16 -2.8 64.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.3 152.99 49.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.731 0.301 . . . . 0.0 110.888 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 64.9 m-85 -83.15 122.74 28.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.72 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 63.0 t0 -128.77 118.67 23.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -175.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.81 ' HA ' ' HE3' ' A' ' 170' ' ' LYS . 8.5 tp -57.04 -20.8 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.21 -15.77 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -174.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -110.58 47.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.72 ' HA ' ' HB3' ' A' ' 170' ' ' LYS . 8.6 p -99.11 145.66 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.475 ' HA3' ' HD2' ' A' ' 167' ' ' TYR . . . -110.75 22.8 21.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.539 -171.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 m -92.09 -23.27 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 0.0 111.143 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -106.63 25.12 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -99.06 -171.95 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.41 80.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.001 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -43.21 93.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.75 88.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.06 -41.71 97.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.22 -41.11 86.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -68.14 -47.2 60.52 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.449 -175.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.05 -38.7 86.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 72.9 m -57.67 -43.36 84.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -66.04 -43.61 87.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.574 ' C ' HD21 ' A' ' 195' ' ' LEU . 8.8 tt -55.96 -46.36 78.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.936 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.57 -39.37 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -60.1 -34.74 73.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.791 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.77 -33.86 76.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.95 -39.84 45.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.201 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.66 -38.59 87.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -86.94 2.11 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 61.69 31.41 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -83.85 -30.88 26.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.0 mtt -139.55 145.5 38.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.835 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.596 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -97.32 135.78 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.454 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -67.61 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -98.25 -12.7 21.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -166.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 53.1 m -59.03 127.36 31.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -95.5 171.3 8.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 70.5 t80 -57.8 -39.39 77.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -59.04 -43.69 91.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.91 -45.53 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.41 -41.11 80.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.822 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.36 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.29 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -64.74 -39.71 94.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.88 -24.0 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.76 -10.0 32.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.14 52.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.456 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -87.66 -21.07 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 110.898 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 91.0 m -127.17 133.25 50.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.185 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.16 -32.31 64.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -172.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 73.4 mtm -135.44 148.55 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -148.68 165.39 31.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 91.8 mt -130.99 127.9 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.415 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 46.2 p30 -152.7 167.25 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.946 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.84 -129.59 3.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -168.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.97 -18.64 18.65 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.734 2.29 . . . . 0.0 112.433 -165.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -55.02 -30.77 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.917 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.07 42.43 28.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.99 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.517 ' O ' ' C ' ' A' ' 233' ' ' SER . 67.5 m95 -56.64 -25.01 52.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.899 167.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 232' ' ' TRP . 28.1 p 30.64 64.13 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -68.48 -12.13 60.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 37.3 pt -90.24 -5.14 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.54 -48.52 10.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -61.33 -57.81 10.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 40.7 t -161.21 128.23 4.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.797 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.555 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.09 174.46 10.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.02 -66.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -163.98 94.75 0.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.465 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 27.7 m-85 -115.45 160.28 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.818 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.596 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -138.98 168.4 24.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.425 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.449 HG23 HG12 ' A' ' 116' ' ' ILE . 60.4 t -125.02 129.19 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.9 p -131.18 171.61 13.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.83 165.33 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.024 167.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.493 ' HB2' ' HE2' ' A' ' 256' ' ' LYS . 90.8 mt -77.55 145.23 71.15 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.617 0.722 . . . . 0.0 110.968 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 75.6 Cg_exo -55.63 148.87 51.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.659 2.239 . . . . 0.0 112.374 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -131.12 154.72 48.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -132.06 109.65 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 46.76 42.68 12.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 164.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.63 25.11 57.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 95.4 mm-40 -108.58 157.89 35.41 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.914 -171.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 59.6 Cg_endo -66.01 74.97 0.33 Allowed 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.727 2.285 . . . . 0.0 112.426 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 93.5 p -86.42 -7.66 58.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.8 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.493 ' HE2' ' HB2' ' A' ' 247' ' ' LEU . 13.9 ptpt -135.38 155.37 78.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.546 0.688 . . . . 0.0 110.869 -168.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.483 ' HG3' ' HG3' ' A' ' 159' ' ' PRO . 53.6 Cg_exo -61.3 164.91 13.87 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -60.34 162.27 6.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.901 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 324' ' ' ALA . 98.1 t -116.23 129.86 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.148 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.67 11.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 96' ' ' ALA . 86.8 t -122.16 125.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.112 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 54.0 tp -71.41 134.32 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.6 p -132.23 156.78 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.69 137.15 51.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.071 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.71 169.74 23.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.495 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.73 133.89 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.163 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -61.85 125.54 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.17 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.14 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.602 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . . . -80.65 -13.86 58.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.9 t -72.49 130.49 85.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 0.0 110.903 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.91 -10.32 28.16 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.716 2.277 . . . . 0.0 112.388 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 275' ' ' LEU . 93.9 m-20 -107.01 33.87 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -169.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -53.06 -40.2 63.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.9 -36.95 75.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 272' ' ' ASN . 48.0 tp -61.11 -48.26 82.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.021 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.46 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.094 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.55 -47.32 79.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.67 -42.38 82.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 37.0 t80 -60.82 -44.5 96.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 284' ' ' LEU . 31.8 tp -65.89 -51.13 61.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -76.25 -35.18 59.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -170.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -106.27 -16.45 14.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.843 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 87.2 m-85 -120.52 -50.96 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.924 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 280' ' ' LEU . 49.6 mt -71.22 -42.79 68.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.947 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.03 62.0 7.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.9 p -136.73 168.0 20.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -55.0 -45.44 75.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.95 -41.03 37.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.09 -47.43 13.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 -171.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 20.1 tp -69.54 -35.38 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.788 0.328 . . . . 0.0 110.951 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.04 -45.21 91.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.77 76.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.534 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 84.3 t -78.94 -47.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -73.84 -16.39 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.07 -23.28 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 92.6 m-20 -73.95 -19.62 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -85.69 152.2 56.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.563 0.697 . . . . 0.0 110.938 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 -22.49 52.88 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.753 2.302 . . . . 0.0 112.318 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.5 mt -101.89 -46.22 4.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.04 72.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.444 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -67.87 128.8 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 111.051 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 307' ' ' TYR . 19.8 m -117.76 151.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.02 60.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.0 tp -73.85 120.62 19.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.07 -48.36 82.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -171.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -59.13 -46.93 87.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 -170.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.474 ' HB3' HG22 ' A' ' 302' ' ' VAL . 2.2 t80 -73.93 -32.98 63.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.54 -35.65 76.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.11 -34.74 73.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -76.13 -39.69 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.833 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.462 HD12 HG23 ' A' ' 302' ' ' VAL . 96.1 mt -68.96 -23.33 64.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 176.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.62 -9.36 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.057 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.72 -17.16 59.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.907 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -88.21 120.0 70.45 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.522 0.677 . . . . 0.0 110.932 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.77 -31.96 34.97 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.23 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' A' ' 244' ' ' VAL . 94.5 mtm-85 -69.34 -44.8 70.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.12 -39.93 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.15 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.82 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.078 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.402 HG21 ' HB1' ' A' ' 112' ' ' ALA . 75.0 m -66.68 -43.01 85.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.193 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.15 -36.33 81.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.67 -33.58 72.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 176.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -65.21 -34.78 79.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.869 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -60.82 -36.86 80.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.08 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.5 -23.37 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.01 -11.44 20.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.44 -159.89 34.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -124.18 127.98 48.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.6 ' O ' ' O ' ' A' ' 330' ' ' MET . 37.5 mm -79.95 119.13 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 -165.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.6 ' O ' ' O ' ' A' ' 329' ' ' ILE . 2.1 ppp? 37.14 171.43 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 0.0 110.899 -163.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.58 ' HD2' ' HB2' ' A' ' 330' ' ' MET . 90.4 Cg_endo -69.95 -157.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 171.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -135.08 -46.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.462 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 37.9 pt -129.79 158.44 73.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.532 0.682 . . . . 0.0 111.234 167.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 33.1 Cg_endo -63.61 -21.62 70.31 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.424 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -14.89 59.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.523 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 37.1 mmt -64.94 -27.95 69.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -60.52 -39.02 86.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.66 67.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.109 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.7 t80 -55.81 -49.37 73.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -58.88 -44.12 91.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.012 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -59.03 -42.79 91.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.75 85.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.53 -40.81 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 154' ' ' PRO . 42.6 ttt180 -54.2 -52.64 60.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 74.8 p -66.41 -36.04 81.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.36 94.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.411 HG23 HD12 ' A' ' 161' ' ' ILE . 55.8 t -67.07 -49.43 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -64.6 -41.87 93.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.14 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -64.3 -38.49 91.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.37 71.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.053 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.84 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -80.36 -7.92 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.68 12.71 81.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.458 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.64 -28.56 51.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.63 0.252 . . . . 0.0 110.775 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -139.52 155.87 47.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 71.9 p -79.01 168.13 20.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.08 -47.69 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.62 -42.34 91.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -71.89 -37.92 70.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.06 94.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.075 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.99 -35.28 78.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.02 -42.36 94.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.29 -34.14 76.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.51 68.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.162 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -40.43 97.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 84.4 m -63.02 -41.88 99.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.044 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.92 -35.11 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.65 -41.51 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.228 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.5 p -94.09 -11.6 30.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -178.404 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.664 0.268 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.74 135.8 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.79 179.87 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.2 120.43 20.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.99 23.54 27.35 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.389 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -143.24 151.86 41.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.7 pp -143.77 144.0 31.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.816 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.06 125.22 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.061 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mt -117.01 134.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.681 ' CZ3' ' HD3' ' A' ' 57' ' ' PRO . 27.6 m0 -114.87 128.13 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 17.6 tt -152.4 157.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.453 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.7 t-20 -56.65 120.35 7.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 166.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.707 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -77.36 -22.07 71.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.466 -168.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.39 -48.89 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 -164.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.6 mmtt -130.32 79.6 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 145.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.62 -38.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.49 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -74.59 -44.79 49.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -160.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -66.02 -51.67 56.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.912 -159.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -60.23 -44.49 97.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.576 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.29 -39.05 81.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 110.849 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.94 85.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.062 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.17 -49.56 73.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.44 -32.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.71 93.14 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.522 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -70.04 -43.07 72.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.3 -40.41 96.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.97 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.09 -39.79 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.861 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.99 -33.58 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -73.3 -35.55 66.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -82.05 -41.32 20.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -103.0 -22.25 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -172.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.21 4.99 87.8 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.55 120.55 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 111.195 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.85 120.44 11.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 7' ' ' LEU . 78.8 t -96.9 135.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -136.31 116.65 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.73 126.4 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.169 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -110.46 162.04 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -64.87 163.34 29.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.535 0.683 . . . . 0.0 110.944 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.707 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 70.2 Cg_endo -99.03 -2.16 0.89 Allowed 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.706 2.271 . . . . 0.0 112.397 -161.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.66 -31.27 59.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -160.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.64 -10.59 24.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 40' ' ' PRO . 61.3 mt -51.56 -55.74 17.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -158.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.3 -32.35 68.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -168.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.21 -34.69 61.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.54 -28.35 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 8.2 m-30 -48.75 -54.41 27.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.789 -163.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 83.8 Cg_endo -78.59 -29.23 3.79 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.877 2.384 . . . . 0.0 112.272 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.66 -49.42 18.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.0 -170.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -65.95 -30.71 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.07 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 269' ' ' ALA . . . -62.89 -37.13 85.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 -26.25 63.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.013 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.5 p -97.96 -1.24 43.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.124 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.13 18.36 80.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -107.71 -174.95 2.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.92 -166.99 13.21 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.681 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 89.7 Cg_endo -82.89 173.5 10.18 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 7' ' ' LEU . 30.5 m-20 -85.9 -36.41 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 166.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -132.37 139.74 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' A' ' 47' ' ' PHE . 7.2 mt -131.89 143.24 40.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -105.88 139.78 39.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.518 ' O ' HD12 ' A' ' 262' ' ' LEU . 23.9 m-90 -121.14 133.2 55.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 173.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -52.29 -90.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -171.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -110.97 -81.45 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.49 -23.71 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -159.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.79 -38.06 69.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -51.17 7.69 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.496 -168.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.13 91.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.712 ' HB3' HD22 ' A' ' 75' ' ' LEU . 27.9 m-85 -74.86 -31.25 61.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.56 68.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -61.35 -28.11 68.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.809 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -85.24 3.48 39.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 25.46 64.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 70' ' ' TYR . 4.7 pp -87.41 -5.14 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 0.0 110.892 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 76' ' ' LEU . 4.2 pp -133.15 144.8 50.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.1 152.31 19.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.35 144.57 48.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.827 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -109.09 152.54 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -133.46 67.13 75.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.671 0.748 . . . . 0.0 111.139 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.66 143.05 41.18 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.617 2.211 . . . . 0.0 112.325 166.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -81.0 -176.58 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.79 -32.24 73.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.819 -173.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.97 64.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -67.23 -36.27 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.87 -43.99 94.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.21 -35.13 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 97.4 mttt -67.23 -31.33 71.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -171.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 1.235 ' O ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER 173.99 78.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 -177.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 38.0 m-85 -151.06 41.49 0.22 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 0.0 110.885 168.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 67.1 Cg_endo -72.48 -70.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.218 . . . . 0.0 112.27 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.478 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 99.1 m-85 -92.98 -28.04 16.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 303' ' ' ALA . 66.7 p -71.94 -22.17 61.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -162.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.416 ' HB2' ' HB3' ' A' ' 90' ' ' TYR . 6.3 t90 -62.47 -42.86 99.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.96 -173.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.42 -24.56 66.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.577 ' HB3' ' CG2' ' A' ' 329' ' ' ILE . . . -74.54 -31.91 62.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.08 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.37 16.08 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 -170.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -119.39 145.56 46.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -136.33 127.18 27.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 59.48 34.82 22.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.6 5.65 89.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.481 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.6 145.04 43.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.91 113.58 25.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.6 pt -124.21 -2.3 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.093 -161.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.96 157.25 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -170.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.1 m-85 -106.35 136.89 19.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.724 0.773 . . . . 0.0 110.911 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 24.4 Cg_exo -65.3 114.37 2.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.749 2.3 . . . . 0.0 112.372 174.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.42 -31.75 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.89 152.27 6.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.74 124.8 68.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.062 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -123.85 137.57 54.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.975 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.79 144.13 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.2 m -142.92 158.94 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.484 ' HB2' HD21 ' A' ' 247' ' ' LEU . 64.0 tp -92.31 120.08 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 244' ' ' VAL . 61.9 mt -108.52 126.32 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -136.13 157.49 46.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 -167.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.467 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 30.2 t-20 -94.0 112.24 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.498 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.6 mttt -63.89 -26.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.89 -33.66 30.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.86 -48.73 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 173.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -123.23 109.4 31.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.623 0.725 . . . . 0.0 110.941 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.34 -15.05 20.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.562 2.175 . . . . 0.0 112.387 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.5 t-20 -148.43 107.11 3.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.759 0.79 . . . . 0.0 110.841 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -66.06 152.34 81.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.669 2.246 . . . . 0.0 112.302 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.23 142.7 51.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.287 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -88.62 -17.08 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.9 t -147.66 166.29 27.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -68.13 -29.34 68.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.21 -27.86 69.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.21 -33.47 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.582 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 97.9 mt -67.66 -45.09 45.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 111.052 -159.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 80.3 Cg_exo -50.78 -49.56 16.47 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.22 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.454 HD21 ' O ' ' A' ' 135' ' ' LEU . 2.1 tt -54.23 -35.61 62.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 175.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.553 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 25.1 t70 -65.82 -34.82 79.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.29 -37.54 87.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 -172.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.64 -56.91 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -172.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 145' ' ' SER . 1.9 pt? -79.8 -11.87 59.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -173.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -53.53 -30.27 40.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.936 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.3 -19.8 65.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -104.71 12.58 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.829 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 24.84 73.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -117.77 156.22 28.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.857 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.466 ' O ' HD11 ' A' ' 139' ' ' LEU . 48.2 t -115.78 153.48 31.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -71.92 -53.29 13.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.8 tp -147.1 135.4 21.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mtp -124.04 134.58 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 169.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -149.24 165.34 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.807 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.455 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 55.3 t-20 -64.72 113.56 3.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -172.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.92 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.8 tm? -92.88 -23.91 18.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -77.77 -4.38 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.89 152.2 80.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.606 0.717 . . . . 0.0 110.889 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.56 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 61.7 Cg_endo -79.65 -20.71 9.1 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.616 2.21 . . . . 0.0 112.404 -174.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -57.28 -45.53 83.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 45.5 m-85 -81.32 -27.02 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.433 HG22 HD23 ' A' ' 151' ' ' LEU . 72.1 p -87.12 -30.06 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.049 -171.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.661 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 82.5 t90 -56.2 -47.72 98.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.474 0.654 . . . . 0.0 110.96 -172.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.661 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 99.1 Cg_exo -49.52 -39.31 45.56 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.614 2.209 . . . . 0.0 112.383 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 160' ' ' LEU . 4.9 tt -74.06 -38.86 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.957 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.486 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.5 mt -67.32 -37.94 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.41 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -79.41 -13.67 59.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 -174.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.92 67.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 -167.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -94.55 5.93 50.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.98 15.2 3.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.538 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -78.65 153.38 38.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.512 174.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.537 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 98.7 m-85 -135.06 152.04 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.906 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.01 -38.04 7.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -143.67 140.29 29.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.812 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -98.55 125.61 43.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.92 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.05 110.06 19.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.007 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -151.17 140.77 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 48.97 37.33 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 4.47 64.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.477 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.48 153.49 49.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 -173.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.14 131.23 39.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.979 168.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -110.79 120.2 41.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.99 -20.38 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.49 -16.77 44.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -98.94 66.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.5 p -108.47 139.16 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.537 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -107.88 32.22 7.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -168.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.0 -35.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.995 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -102.88 29.13 5.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.72 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -99.09 -172.2 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.941 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.97 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.81 -44.89 94.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.515 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.03 86.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.861 0.362 . . . . 0.0 111.12 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.77 -40.23 91.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.809 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.49 89.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.45 -43.53 94.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.522 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.01 -38.4 88.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -58.93 -43.65 91.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -63.24 -42.37 99.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.58 -45.09 92.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.84 -40.24 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.38 -39.38 94.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.7 OUTLIER -63.57 -42.67 98.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.59 -38.73 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.16 -36.82 80.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -83.78 3.62 32.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 64.56 33.73 10.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -78.91 -24.69 43.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 28.3 ptm -147.7 160.59 42.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -94.13 134.08 36.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.94 67.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -89.44 -3.27 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.897 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.2 m -56.46 126.71 27.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -103.48 170.12 8.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -65.88 -32.71 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.009 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 92.2 p -69.74 -36.08 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.2 mm -65.14 -42.31 93.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.71 94.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.103 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -69.69 -38.77 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.05 85.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.023 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.2 -39.35 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -66.5 -40.91 89.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.27 -19.77 65.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.97 -10.51 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.98 65.84 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.471 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.09 -25.82 39.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 224' ' ' MET . 73.9 m -128.23 133.82 48.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.49 -27.04 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -169.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.412 ' H ' HG23 ' A' ' 222' ' ' THR . 74.8 mtm -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -152.13 165.85 33.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 125.04 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.139 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -127.21 136.63 52.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.448 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -105.03 -134.34 7.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.479 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.448 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.0 Cg_endo -70.82 -19.47 31.03 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.764 2.309 . . . . 0.0 112.299 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -58.17 -30.32 66.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 62.09 22.82 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.018 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.53 ' O ' ' C ' ' A' ' 233' ' ' SER . 39.3 m0 -61.13 -33.78 73.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 232' ' ' TRP . 67.5 p 31.34 67.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.896 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -81.15 35.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.908 -160.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.435 HD12 HG21 ' A' ' 244' ' ' VAL . 38.3 pt -115.26 6.04 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 171.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.6 -54.27 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.5 m -60.44 -59.61 5.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -153.5 126.29 8.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.493 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.52 172.86 11.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 98.6 t -86.37 -71.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.61 76.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 44.9 m-85 -114.93 154.24 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.498 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -146.01 170.61 27.15 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.422 -174.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 116' ' ' ILE . 60.7 t -123.49 134.88 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 0.0 111.157 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.7 176.86 8.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.193 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.8 162.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.109 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.484 HD21 ' HB2' ' A' ' 115' ' ' LEU . 97.6 mt -81.38 151.3 68.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.886 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 153.47 70.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.74 2.293 . . . . 0.0 112.352 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 81.7 p -131.19 146.57 52.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -121.28 115.62 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 51.38 37.07 18.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.25 26.98 56.57 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.456 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.0 mm-40 -112.4 159.55 33.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.611 0.72 . . . . 0.0 110.907 -168.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 59.9 Cg_endo -63.39 75.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.722 2.281 . . . . 0.0 112.418 171.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 249' ' ' THR . 49.5 m -94.28 6.64 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 -164.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.509 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 12.1 ptpt -135.12 158.6 74.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.869 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 29.4 Cg_endo -69.84 168.2 22.36 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.672 2.248 . . . . 0.0 112.298 -170.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -70.18 172.16 8.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.412 ' HB ' HD11 ' A' ' 329' ' ' ILE . 69.3 t -121.6 132.84 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.185 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.14 142.99 15.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 96' ' ' ALA . 96.3 t -127.43 127.99 69.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.816 0.341 . . . . 0.0 111.165 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 62' ' ' TRP . 51.5 tp -72.47 135.1 45.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -121.27 137.24 54.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.842 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.73 132.6 53.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.74 170.73 23.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.98 130.39 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 111.16 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -59.82 128.9 39.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.43 68.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . . . -80.67 -13.22 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.0 t -69.7 133.59 88.53 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.627 0.727 . . . . 0.0 110.856 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.33 -8.9 23.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.585 2.19 . . . . 0.0 112.35 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -106.82 30.53 6.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -52.17 -43.47 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.17 -41.62 63.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.807 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.04 -52.16 65.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.008 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -65.88 -50.25 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.9 -47.58 71.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -170.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -71.95 -33.26 68.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -176.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 284' ' ' LEU . 41.6 tp -57.11 -46.39 82.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -82.9 -28.86 29.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.967 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -101.42 -9.78 20.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -168.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 76.2 t80 -125.38 -59.66 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.424 ' HB2' HD12 ' A' ' 280' ' ' LEU . 68.6 mt -71.19 -44.5 65.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 20.4 tp -85.03 67.51 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.0 p -139.69 170.19 16.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.22 -45.26 79.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.835 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -75.89 -41.3 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.17 -45.9 9.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.558 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.2 tp -71.29 -35.66 71.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.981 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -56.58 -41.04 76.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.897 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.24 69.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.466 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 76.7 t -76.95 -45.1 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.052 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -73.05 -7.75 52.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -52.83 -21.95 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.584 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 89.2 m-20 -79.15 -24.2 43.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.806 -174.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -96.34 148.47 34.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.878 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.24 -25.62 26.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.637 2.225 . . . . 0.0 112.295 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.56 -48.41 3.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.019 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.4 22.24 78.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.527 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.8 110.34 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 0.0 111.072 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 307' ' ' TYR . 5.2 p -112.77 149.13 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -159.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.578 ' HB2' HG22 ' A' ' 93' ' ' THR . . . -72.29 -18.84 61.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.21 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.447 ' H ' HG23 ' A' ' 302' ' ' VAL . 55.8 tp -79.38 124.36 28.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -45.4 90.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -174.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.2 t -62.44 -50.0 73.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.497 ' HB3' HG11 ' A' ' 302' ' ' VAL . 3.9 t80 -70.93 -36.87 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -65.58 -33.38 75.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -38.5 73.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.6 -38.69 58.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.829 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.13 -29.81 70.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.51 -8.27 45.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.53 -15.8 60.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -91.39 120.68 68.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.878 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.9 -29.03 19.8 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.766 2.31 . . . . 0.0 112.295 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -70.11 -44.72 68.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.41 -38.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.7 73.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 83.2 m -67.09 -41.86 85.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 tpt -66.82 -38.02 85.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.835 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -66.44 -35.31 79.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -65.36 -34.83 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.404 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -65.04 -41.34 95.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -74.24 -23.28 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -104.67 -5.79 21.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.11 -161.64 37.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.432 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -127.2 127.18 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.846 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.577 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 38.3 mm -74.64 121.93 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.5 mmt 63.48 156.23 0.12 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.458 0.647 . . . . 0.0 111.033 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.915 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 56.5 Cg_endo -74.67 -107.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 165.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -138.94 -58.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 165.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.562 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 34.0 pt -139.12 169.25 12.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.602 0.715 . . . . 0.0 111.158 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.1 Cg_exo -53.09 -17.01 7.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.3 -6.15 2.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.915 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.5 ptm -56.6 -29.95 62.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.9 p -66.05 -30.1 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -80.58 -34.85 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 175.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -59.65 -54.79 42.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.56 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 68.6 m95 -60.76 -38.08 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -60.02 -46.7 88.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.35 80.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.047 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.1 t -74.5 -36.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.512 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 76.0 ttt180 -56.01 -47.17 78.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.8 p -66.62 -35.81 81.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -64.95 -44.0 90.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.182 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.96 -47.57 81.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.03 -44.34 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -65.21 -36.96 85.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.72 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.051 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.05 73.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.5 p -80.86 -7.78 59.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.04 82.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.555 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.13 -28.01 54.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.807 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -140.44 157.13 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.7 p -74.62 171.98 12.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.124 167.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.55 -34.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.61 -40.28 84.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.3 -44.73 71.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.817 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.17 93.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.5 mt -69.77 -35.5 74.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.87 -46.85 88.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -69.41 -31.1 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -70.01 -48.02 59.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.157 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -64.95 -38.73 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.4 m -62.53 -41.48 98.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.051 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.52 -39.12 70.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.802 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.3 mt -62.24 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.9 p -105.51 6.95 32.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.18 -172.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 -178.119 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.698 0.285 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.403 HG21 ' HD2' ' A' ' 271' ' ' PRO . 91.8 mt -80.1 129.26 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.163 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -125.09 164.3 20.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -76.5 118.38 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.21 26.17 24.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.467 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.41 152.22 40.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 1.113 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -145.49 146.63 31.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -128.67 129.74 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.56 135.68 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.556 ' HB3' HD22 ' A' ' 43' ' ' LEU . 34.9 m0 -111.28 120.56 42.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 tt -153.16 159.21 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 -170.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.453 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.7 t-20 -60.0 119.85 8.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 168.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.766 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -76.22 -18.54 79.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.54 -173.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.27 -47.72 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.938 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.26 80.04 1.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 144.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -120.56 -48.69 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.443 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -70.0 -43.72 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.91 -164.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -66.14 -51.98 52.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 -160.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.1 -44.29 97.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.437 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 24' ' ' GLY . 64.3 mt -61.28 -37.94 84.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.37 85.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.028 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.22 -47.1 79.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.16 -33.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -67.49 -40.09 91.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.57 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -71.57 -40.01 70.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.906 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.4 -41.16 98.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -68.54 -38.58 80.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.79 -31.55 72.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.83 -37.35 67.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.3 -39.3 25.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.7 p -105.27 -18.2 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.14 90.09 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.49 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 33' ' ' ILE . 7.8 pt -97.14 132.8 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.062 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.95 131.01 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 7' ' ' LEU . 67.3 t -101.48 136.88 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 172.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -141.39 120.15 12.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.24 131.37 60.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -109.76 151.8 26.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.434 ' O ' HD13 ' A' ' 43' ' ' LEU . 32.4 p80 -74.28 167.02 39.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.548 0.69 . . . . 0.0 110.885 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.766 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 43.1 Cg_endo -104.03 12.01 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -161.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -89.53 -37.14 14.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.759 -166.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -90.82 -17.24 26.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.896 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.608 HD23 ' HA ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -57.3 -43.94 83.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -161.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -50.03 -39.94 43.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.84 -33.92 64.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.0 -25.39 59.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.547 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 5.1 m-30 -49.97 -53.99 37.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.606 0.717 . . . . 0.0 110.936 -160.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 91.5 Cg_endo -79.98 -29.93 2.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.77 2.313 . . . . 0.0 112.32 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.48 -49.69 21.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -168.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.7 m -66.09 -28.95 45.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.066 -171.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.78 -37.61 85.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.8 -24.99 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -96.97 0.35 48.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.082 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.649 ' HA2' ' HB2' ' A' ' 269' ' ' ALA . . . 77.2 17.57 79.37 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -110.88 -174.72 2.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.823 0.344 . . . . 0.0 110.864 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.33 -167.49 12.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.574 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.436 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 87.9 Cg_endo -77.64 169.44 20.89 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.668 2.245 . . . . 0.0 112.344 175.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -85.09 -37.01 20.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.5 mt -129.35 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.494 HD12 ' CE1' ' A' ' 47' ' ' PHE . 16.4 tt -137.14 135.34 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -172.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -99.96 145.09 28.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.947 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 26.7 m95 -126.82 127.05 44.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.31 -91.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.038 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -112.89 -78.7 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.46 -22.84 61.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -165.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 94.9 mtt-85 -55.44 -28.61 55.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -164.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.45 ' CG ' ' N ' ' A' ' 68' ' ' GLY . 16.7 p90 -49.39 -44.06 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.88 -174.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 67' ' ' PHE . . . -74.99 -58.7 3.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 -169.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.54 -41.34 95.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.504 -172.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.67 ' HB3' HD22 ' A' ' 75' ' ' LEU . 60.1 m-85 -75.08 -32.57 61.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.962 0.411 . . . . 0.0 110.892 -175.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.01 64.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -61.33 -27.05 68.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -83.07 2.36 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.24 24.85 63.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 70' ' ' TYR . 4.1 pp -85.81 -4.54 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.868 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.856 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.4 pp -131.57 143.58 50.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.69 154.96 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -71.43 140.45 50.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.891 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.402 ' CG1' ' HB3' ' A' ' 103' ' ' LEU . 46.1 pt -104.14 148.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.5 p -131.8 67.14 79.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.604 0.716 . . . . 0.0 111.131 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.82 144.85 49.46 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.698 2.265 . . . . 0.0 112.467 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -84.57 -175.16 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.35 -31.93 69.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.35 84.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -60.43 -43.84 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -59.65 -41.36 90.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.936 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.4 -34.5 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.834 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 75.9 mmtt -68.13 -21.3 64.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 1.198 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.94 124.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.923 -177.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p90 -173.08 49.19 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.734 0.778 . . . . 0.0 110.907 162.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 61.4 Cg_endo -73.32 -72.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.645 2.23 . . . . 0.0 112.42 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.464 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 97.3 m-85 -94.87 -29.68 14.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 174.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -71.72 -22.47 61.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.054 -161.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -60.75 -44.33 96.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.11 -30.74 71.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.897 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.584 ' HB3' ' CG2' ' A' ' 329' ' ' ILE . . . -69.73 -32.97 71.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -103.13 14.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.23 -169.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -120.99 145.89 47.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -137.96 127.94 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.6 t30 58.22 32.91 22.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.848 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.11 89.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.13 150.01 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . 69.4 mt -84.65 121.37 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -113.3 -15.14 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.49 163.88 24.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -166.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -105.18 146.81 33.43 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.684 0.754 . . . . 0.0 110.891 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HG2' HD21 ' A' ' 89' ' ' LEU . 98.0 Cg_endo -76.78 120.13 5.39 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.2 mm -99.8 -46.32 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.037 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.18 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -163.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.37 130.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -125.37 143.07 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.17 157.01 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.05 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.416 HD23 ' HG3' ' A' ' 257' ' ' PRO . 10.0 mp -75.17 146.98 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -143.58 160.38 40.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.497 ' HB2' HD21 ' A' ' 247' ' ' LEU . 60.6 tp -94.99 122.9 38.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.43 HG12 HG23 ' A' ' 244' ' ' VAL . 61.6 mt -111.74 126.65 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.096 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -136.59 158.02 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -89.82 111.61 22.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -65.41 -30.09 70.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.01 -35.95 61.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.02 -49.54 12.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 tp -122.41 108.58 33.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.659 0.742 . . . . 0.0 110.903 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.45 -15.19 17.77 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.704 2.269 . . . . 0.0 112.317 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.6 t-20 -147.55 106.81 3.78 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 49.8 Cg_endo -66.72 152.81 79.87 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.677 2.252 . . . . 0.0 112.288 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.44 144.07 60.05 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.65 2.234 . . . . 0.0 112.261 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.39 -22.03 32.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 t -150.15 170.98 17.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -172.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.74 -32.58 69.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.856 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -71.67 -22.27 61.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -170.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -74.5 -27.96 60.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.576 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 94.4 mt -66.32 -45.14 59.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 0.0 111.061 -164.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 99.1 Cg_exo -49.62 -48.24 19.85 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.645 2.23 . . . . 0.0 112.332 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.38 90.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.014 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.508 HD21 ' O ' ' A' ' 135' ' ' LEU . 2.6 tt -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.608 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 26.4 t70 -66.03 -35.05 79.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.902 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.13 -41.23 90.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.45 -54.06 13.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.916 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.455 HD21 ' N ' ' A' ' 140' ' ' LYS . 1.1 pt? -78.61 -12.54 60.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -173.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.455 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.1 tttt -54.55 -29.38 50.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 166.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.75 65.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.076 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.84 8.49 37.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.25 58.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.509 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -121.8 154.69 36.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.28 . . . . 0.0 110.974 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.7 t -110.93 154.98 23.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.608 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -70.31 -56.65 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.036 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.8 tp -144.35 129.05 18.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.958 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.7 mmm -130.25 132.53 45.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 156' ' ' PHE . 52.2 p90 -150.97 174.55 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -67.39 109.71 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.995 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.99 0.12 40.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -85.62 0.26 53.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.48 145.72 57.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.555 0.693 . . . . 0.0 110.938 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.495 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 63.9 Cg_endo -79.66 -28.16 3.61 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.603 2.202 . . . . 0.0 112.393 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -53.87 -37.94 64.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.4 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 65.8 m-85 -82.14 -36.79 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 -174.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 74.3 p -88.36 -30.28 19.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.133 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.639 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 69.4 t90 -54.85 -48.28 96.11 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.535 0.683 . . . . 0.0 110.994 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 75.2 Cg_exo -48.41 -36.44 30.65 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.677 HD21 ' O ' ' A' ' 160' ' ' LEU . 3.7 tt -73.04 -38.63 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.981 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.581 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.2 mt -68.09 -38.06 79.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.42 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -80.5 -15.01 57.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -171.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.06 69.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.25 7.19 46.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.77 12.78 4.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.474 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -76.6 158.74 49.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.489 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.651 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 91.0 m-85 -136.82 152.08 49.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 110.887 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.423 ' HB3' ' CE2' ' A' ' 158' ' ' TRP . . . -101.21 -36.16 9.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.076 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.425 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -150.1 130.02 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -175.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 55.5 tptt -92.83 120.76 33.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -173.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 55.5 t80 -112.47 112.38 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -176.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -150.53 142.74 24.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 51.2 40.67 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 6.32 78.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.492 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -127.94 146.26 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 41.7 m-85 -89.91 127.85 36.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.911 167.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -102.39 116.62 33.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 178' ' ' ILE . 7.5 tp -77.77 -19.96 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.139 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -85.9 -7.26 58.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -116.12 92.79 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.0 140.0 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.651 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -99.82 38.87 2.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -168.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.2 -14.53 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.111 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -104.97 18.78 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -106.7 -171.49 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.11 -38.93 75.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.6 90.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.78 87.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.47 -42.46 99.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.62 -44.64 89.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -67.2 -46.68 69.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.87 -38.1 85.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.916 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.8 m -56.96 -43.82 81.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -64.22 -46.01 85.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.13 -44.87 96.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.825 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.99 -40.71 89.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.54 -36.45 82.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.67 -43.97 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.76 -39.51 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.51 -32.39 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 173.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.99 2.48 38.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.97 32.66 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.949 173.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -78.93 -30.94 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.814 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 23.5 ptp -150.48 160.06 44.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.431 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.6 m-20 -100.64 138.63 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.23 -24.38 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -97.5 0.6 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 86.2 m -55.1 124.83 18.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.06 170.04 8.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 227' ' ' ASN . 52.5 t80 -62.79 -41.46 99.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -62.43 -37.63 86.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.764 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -70.06 -46.3 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.83 84.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.73 -41.36 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.52 86.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.089 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.144 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -64.52 -47.03 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.28 -25.78 65.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.77 -5.34 45.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 16.66 63.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -82.5 -26.98 32.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.825 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 224' ' ' MET . 88.0 m -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 177.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.85 -27.71 55.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 -169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.407 ' H ' HG23 ' A' ' 222' ' ' THR . 74.8 mtm -135.19 151.98 51.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -152.08 165.23 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.191 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.24 133.24 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.48 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 37.6 p30 -152.91 160.93 43.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.33 -126.83 5.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.424 -171.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.52 -19.17 19.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.715 2.277 . . . . 0.0 112.356 -166.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -53.28 -39.83 64.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.28 31.17 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.499 ' O ' ' C ' ' A' ' 233' ' ' SER . 54.2 m0 -60.44 -36.1 77.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 232' ' ' TRP . 90.1 p 34.26 71.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 163.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -74.85 3.39 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.85 -7.9 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.089 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.18 -50.15 9.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 85.5 m -64.8 -59.52 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.3 t -156.23 121.65 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.784 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . 0.655 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.28 176.02 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.884 -176.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.01 -70.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -161.37 90.0 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 239' ' ' LYS . 75.0 m-85 -114.3 162.39 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.665 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -147.17 170.18 28.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.5 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.43 HG23 HG12 ' A' ' 116' ' ' ILE . 59.2 t -123.74 131.37 73.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.942 0.401 . . . . 0.0 111.091 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -142.71 177.94 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.172 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.64 160.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 115' ' ' LEU . 89.0 mt -77.65 149.73 78.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.944 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.21 146.86 69.21 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.479 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 81.8 p -128.87 146.21 51.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -125.49 111.66 15.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 45.03 40.36 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.01 28.34 56.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 166.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.436 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.6 mm-40 -109.99 159.52 31.53 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.936 -170.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.0 Cg_endo -65.33 73.96 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 73.8 p -98.47 4.14 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -168.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 13.2 ptpt -139.84 158.37 67.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.552 0.691 . . . . 0.0 110.835 -173.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 33.4 Cg_endo -71.89 167.24 27.19 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.627 2.218 . . . . 0.0 112.389 -169.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.91 176.65 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.436 HG21 ' HA3' ' A' ' 327' ' ' GLY . 96.5 t -118.69 134.31 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 -171.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.02 146.37 16.07 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.433 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -128.48 128.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.266 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 60.4 tp -76.96 135.3 38.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.92 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 93.1 p -129.87 150.93 50.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.41 130.31 44.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.033 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.95 162.89 15.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 -170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.65 129.5 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -62.85 124.9 22.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.9 67.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.649 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . . . -81.96 -13.85 56.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 20.2 t -72.28 132.67 83.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.86 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 2' ' ' ILE . 88.8 Cg_endo -69.07 -7.75 21.7 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 0.0 112.407 170.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.04 27.62 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -168.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -50.85 -47.74 60.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.39 -38.93 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.5 tp -56.81 -53.13 61.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.11 -42.58 75.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.117 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.39 -48.93 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.29 -47.72 72.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.957 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -70.63 -33.67 71.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -176.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 284' ' ' LEU . 36.3 tp -55.97 -47.96 76.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -83.07 -27.0 30.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.31 -10.91 19.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -169.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 86.8 t80 -124.98 -60.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.433 ' HB2' HD12 ' A' ' 280' ' ' LEU . 77.6 mt -70.29 -41.27 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.981 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.32 65.22 8.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.0 p -138.09 169.34 17.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -56.92 -42.08 79.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -77.0 -42.54 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.1 -47.89 8.04 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.546 -170.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.0 -35.06 79.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.932 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.52 -42.82 99.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.95 -30.21 71.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.126 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.36 -45.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.068 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.483 ' HB3' ' CA ' ' A' ' 300' ' ' GLY . 59.0 m-20 -74.73 -5.5 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -54.41 -18.97 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.79 -18.07 60.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.06 154.18 42.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.71 -41.81 10.23 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 299' ' ' LEU . 3.3 mm? -92.59 -44.35 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.907 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.483 ' CA ' ' HB3' ' A' ' 294' ' ' ASN . . . 62.33 54.42 34.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.432 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.69 124.31 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.072 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 307' ' ' TYR . 35.2 m -110.15 149.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.61 61.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.062 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.18 119.26 22.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 87.7 tttt -61.77 -44.46 96.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -166.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.0 t -58.83 -49.84 76.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.402 ' HB3' HG22 ' A' ' 302' ' ' VAL . 71.0 t80 -74.23 -31.49 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.473 ' HG3' ' HE2' ' A' ' 321' ' ' MET . 89.0 tt0 -56.83 -39.44 74.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.829 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.23 -32.42 73.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -48.05 23.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.533 HD11 ' HE2' ' A' ' 321' ' ' MET . 3.4 pp -73.55 -18.71 61.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 308' ' ' GLU . . . -67.19 -7.93 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -175.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.9 -11.23 60.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.94 -173.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -86.43 122.01 72.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.98 -31.78 28.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.642 2.228 . . . . 0.0 112.373 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.65 -42.48 74.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 311' ' ' LEU . 3.0 tp -80.99 -29.86 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.069 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.4 86.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 65.9 m -67.38 -43.87 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.533 ' HE2' HD11 ' A' ' 311' ' ' LEU . 58.2 mtt -69.61 -34.82 74.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.799 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -66.26 -37.33 85.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -64.96 -34.04 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.042 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -70.31 -21.04 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.96 -5.96 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.436 ' HA3' HG21 ' A' ' 259' ' ' VAL . . . -96.11 -163.0 33.36 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.478 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -128.93 137.06 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.584 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 39.6 mm -78.3 115.67 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 26.3 mmt 61.72 155.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.91 -113.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 168.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -162.22 -52.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.89 164.35 31.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 111.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.41 -19.77 52.97 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.823 2.349 . . . . 0.0 112.318 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -58.87 -23.58 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.551 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 94.8 mmm -69.66 -24.83 63.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.73 -37.12 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.95 -30.76 64.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.155 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' A' ' 336' ' ' MET . 21.8 t80 -57.63 -49.95 74.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.988 175.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.495 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.7 m95 -61.36 -44.16 97.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.68 -43.81 76.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.83 78.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.76 -44.92 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.191 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -57.34 -48.11 79.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.87 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 73.9 p -66.65 -32.95 74.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.2 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.92 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.76 -47.87 81.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 41.5 mm -64.73 -44.69 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.17 -38.13 89.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.67 -44.91 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.53 -33.9 69.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.5 p -79.51 -8.46 59.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.0 82.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.455 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.44 -29.52 57.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 0.0 110.837 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -140.01 157.86 44.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.1 p -78.12 172.97 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.91 -45.26 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.43 -38.92 74.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -71.68 -39.28 70.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -173.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.54 96.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 173.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.5 -35.09 78.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.64 -42.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.17 -31.41 70.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.75 -46.43 63.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.143 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -63.21 -38.31 90.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.2 m -59.48 -40.34 86.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.02 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.94 -36.81 62.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.85 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' A' ' 339' ' ' PHE . 71.4 mt -63.02 -48.46 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.06 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.9 p -96.21 -0.72 49.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.9 tttt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.767 0.317 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.49 136.83 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.01 -178.98 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.992 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.14 119.62 19.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.04 25.27 27.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.435 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.93 152.94 41.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.7 pp -149.03 148.76 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 84.6 t -126.12 128.13 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mt -117.46 134.33 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.67 ' CH2' ' HD3' ' A' ' 57' ' ' PRO . 30.7 m0 -113.07 127.19 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 18.1 tt -152.94 159.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.684 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.3 t-20 -55.88 118.53 4.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.916 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.651 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.12 -24.72 72.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.487 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.03 -47.11 71.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 -167.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.9 mmtt -129.58 80.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 146.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -115.05 -36.63 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.527 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.54 -43.51 17.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.935 0.398 . . . . 0.0 110.957 -157.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -67.72 -52.58 35.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 -158.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.8 -45.25 96.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.582 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' GLY . 50.0 mt -59.43 -37.98 79.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.918 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.95 92.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.87 -49.7 74.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.819 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.25 -33.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -66.12 -42.57 94.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.562 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.6 -43.15 69.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 110.882 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.59 -40.21 93.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -65.39 -41.2 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.23 -31.94 72.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -74.81 -34.86 62.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.3 -40.79 20.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.1 p -104.16 -22.07 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.85 4.21 88.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.415 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 7' ' ' LEU . 97.7 mt -76.61 121.7 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.205 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.83 120.52 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.2 135.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.097 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -139.39 117.81 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.6 127.71 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.19 160.74 20.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -68.82 162.31 64.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.555 0.693 . . . . 0.0 110.859 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.684 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 60.5 Cg_endo -98.82 -3.95 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -164.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.46 -30.81 33.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -154.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.45 -16.94 31.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 10' ' ' TRP . 5.7 mp -61.18 -36.52 80.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.921 -156.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.512 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 50.2 mt-10 -48.75 -35.98 15.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.58 -36.01 57.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -75.52 -29.53 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -173.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.517 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.6 m-85 -48.18 -54.52 24.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.903 -160.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 95.7 Cg_endo -80.16 -29.31 2.63 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.825 2.35 . . . . 0.0 112.19 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -75.15 -48.93 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.016 0.436 . . . . 0.0 111.046 -167.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.92 -32.63 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.122 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 269' ' ' ALA . . . -62.7 -38.26 89.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.033 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.43 63.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -98.92 0.09 43.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.09 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 269' ' ' ALA . . . 75.14 17.91 80.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.515 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -109.72 -174.43 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.319 . . . . 0.0 110.888 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 -171.3 15.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.495 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.67 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 83.7 Cg_endo -79.46 174.67 11.59 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.357 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.36 -38.38 22.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 164.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -134.35 139.03 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.213 -172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.86 144.76 36.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -100.87 139.71 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 6.1 m95 -126.63 123.41 37.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.73 -91.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 -167.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -112.52 -82.39 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -73.9 -19.29 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 -164.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 96.4 mtt-85 -52.71 -30.71 33.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -168.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -51.09 -39.38 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 -171.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.531 -168.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.08 90.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.387 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.621 ' HB3' HD22 ' A' ' 75' ' ' LEU . 47.3 m-85 -76.47 -32.62 58.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.944 0.402 . . . . 0.0 110.874 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.39 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -62.64 -28.51 69.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -82.4 1.42 37.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.852 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.78 23.77 59.26 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.461 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.621 HD22 ' HB3' ' A' ' 70' ' ' TYR . 4.3 pp -85.89 1.15 51.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.76 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.1 pp -134.21 144.34 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -86.04 153.13 22.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.92 132.99 46.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.48 HG21 ' CE2' ' A' ' 106' ' ' TYR . 66.8 mt -109.35 139.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.182 -173.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 p -130.81 76.9 76.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.753 . . . . 0.0 111.161 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.96 152.53 31.93 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.743 2.295 . . . . 0.0 112.407 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -83.19 -176.98 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.848 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.6 -34.51 78.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.957 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.75 99.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -66.85 -35.08 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.77 -41.57 95.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.07 -30.07 33.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.857 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 45.0 mtmt -65.1 -17.78 64.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 1.174 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.62 123.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 8.2 p90 -174.75 51.16 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.692 0.758 . . . . 0.0 110.957 166.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 59.3 Cg_endo -72.22 -71.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.186 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.446 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 33.1 p90 -104.48 -19.26 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.8 p -67.55 -25.25 65.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 -168.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 90' ' ' TYR . 47.8 t-105 -62.28 -42.26 99.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.967 -174.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.34 -29.69 70.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.556 ' HB3' ' CG2' ' A' ' 329' ' ' ILE . . . -69.35 -34.35 74.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.122 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.45 13.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -117.75 149.3 41.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -139.12 128.13 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.32 34.03 23.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.71 90.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.543 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.36 149.13 42.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.949 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.4 tp -83.96 125.06 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 pt -116.71 -10.09 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.79 167.61 22.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' CE2' HG21 ' A' ' 79' ' ' ILE . 74.9 m-85 -109.6 144.78 30.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.786 0.803 . . . . 0.0 110.91 171.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.4 Cg_exo -65.41 117.11 4.3 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.751 2.301 . . . . 0.0 112.341 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.7 mm -100.54 -32.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.23 151.69 4.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.8 t -118.5 124.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.112 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -118.48 130.14 55.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.03 153.02 30.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.442 HD23 ' HG3' ' A' ' 257' ' ' PRO . 10.8 mp -74.33 147.82 41.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -175.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 85.0 p -141.46 158.64 43.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' HB2' HD21 ' A' ' 247' ' ' LEU . 46.1 tp -98.85 125.89 44.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.952 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.458 HG12 HG23 ' A' ' 244' ' ' VAL . 63.9 mt -111.7 130.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.173 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -135.35 155.8 49.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -96.16 112.92 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -24.05 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.017 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -82.88 -34.45 26.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.83 -47.36 13.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -123.37 108.88 31.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.655 0.741 . . . . 0.0 110.92 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.53 -13.43 22.54 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.67 2.247 . . . . 0.0 112.424 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -147.12 108.34 3.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 153.78 76.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 0.0 112.349 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.75 141.83 42.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.583 2.189 . . . . 0.0 112.251 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.72 -17.77 26.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -144.37 165.02 29.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -67.26 -28.87 68.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.34 -29.53 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.848 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.12 -21.09 60.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 34.6 mm -59.8 -53.47 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.133 -167.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.1 Cg_endo -64.72 -45.79 7.96 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.729 2.286 . . . . 0.0 112.31 -173.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.68 96.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.045 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 135' ' ' LEU . 25.5 mt -60.98 -38.65 86.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 10.2 t70 -64.63 -36.1 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -36.16 83.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.54 -57.53 5.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.54 HD11 ' O ' ' A' ' 145' ' ' SER . 1.7 pt? -81.09 -11.45 59.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 86.4 tttt -56.18 -29.32 60.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.783 166.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.09 65.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.88 11.17 37.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.21 75.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.426 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 39.9 mmtm -117.89 157.28 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.54 ' O ' HD11 ' A' ' 139' ' ' LEU . 30.0 t -115.14 154.44 28.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.82 175.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -73.79 -55.0 6.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.0 tp -143.69 130.62 20.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.8 mtp -122.86 134.8 54.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -149.69 165.96 30.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.487 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 57.7 t-20 -58.9 111.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.937 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.992 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.7 tm? -89.44 -21.57 22.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.981 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.31 -2.5 38.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -133.83 149.97 73.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.736 . . . . 0.0 110.94 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 71.2 Cg_endo -77.84 -21.6 10.94 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.633 2.222 . . . . 0.0 112.37 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -59.7 -40.97 89.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 56.2 m-85 -85.16 -27.75 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.753 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 76.2 p -89.07 -31.03 18.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.634 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.8 t90 -55.32 -47.84 97.65 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.558 0.694 . . . . 0.0 110.909 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 73.9 Cg_exo -47.96 -38.45 31.33 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.638 2.225 . . . . 0.0 112.294 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.702 HD21 ' O ' ' A' ' 160' ' ' LEU . 4.0 tt -73.85 -38.62 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.575 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.3 mt -67.47 -37.14 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.78 -14.35 58.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.04 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.01 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 -166.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -96.83 5.03 51.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.38 12.89 4.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.575 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.75 158.37 48.5 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.561 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.735 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 90.0 m-85 -136.85 155.2 50.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.959 0.409 . . . . 0.0 110.915 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.21 -31.12 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.049 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.11 130.11 12.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 54.9 tptt -93.55 121.73 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.852 -174.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.439 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 64.2 t80 -113.89 113.06 24.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -150.11 143.8 25.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 51.06 41.0 26.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.73 5.99 76.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.549 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.87 146.2 51.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 171' ' ' TYR . 30.2 m-85 -88.08 129.58 35.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 167.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -103.17 114.12 28.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.811 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.32 -20.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -87.3 -8.88 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -114.11 92.96 4.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.943 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.54 141.44 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.183 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.735 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -102.86 29.79 11.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.402 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.55 -22.4 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.145 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -104.95 24.75 11.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -104.45 -174.5 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.25 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.61 -44.01 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.72 84.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.775 0.321 . . . . 0.0 111.102 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.51 -42.23 98.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.832 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.99 -45.04 87.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.07 -44.21 91.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.442 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.98 -40.47 95.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.5 m -57.75 -43.3 85.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -63.73 -44.44 93.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.06 -45.34 91.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.76 -40.1 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -64.76 -39.87 94.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 198' ' ' LEU . 1.7 mp -65.77 -44.27 86.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.49 -38.39 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.221 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.3 -35.44 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.825 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.59 4.62 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.45 31.58 10.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.0 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -77.51 -29.58 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.7 ttp -147.9 150.09 33.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.415 ' HA ' ' HG ' ' A' ' 151' ' ' LEU . . . -63.95 -22.99 67.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -91.11 0.0 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.2 m -59.98 129.09 40.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -108.66 169.01 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 167.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.98 -32.61 72.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.034 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.0 p -69.37 -38.79 78.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.788 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 92.1 mt -66.87 -39.53 83.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.145 174.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.14 -36.9 85.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -69.14 -38.23 78.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.43 90.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.59 93.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.124 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.75 -40.98 92.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.81 -19.88 66.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.67 -10.11 27.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.99 63.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.44 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.78 -25.75 37.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 110.813 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.6 m -128.48 133.7 48.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.68 -28.74 60.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 70.9 mtm -131.85 151.59 51.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.5 t -150.04 161.5 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.7 128.7 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.157 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -122.29 150.85 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -120.32 -131.19 4.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.465 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.5 Cg_endo -67.06 -24.1 45.49 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.302 -170.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -53.44 -33.09 52.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 60.62 36.3 19.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.028 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.577 ' O ' ' C ' ' A' ' 233' ' ' SER . 78.3 m95 -41.97 -36.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.577 ' C ' ' O ' ' A' ' 232' ' ' TRP . 18.8 p 15.08 60.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 232' ' ' TRP . 78.8 m-20 -78.51 20.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -169.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 pt -117.59 -9.89 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -69.43 -61.27 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.4 m -54.27 -48.06 71.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.0 t -155.47 140.92 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.1 166.32 30.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.65 -70.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.134 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -150.66 70.81 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -108.93 160.51 15.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.43 167.18 25.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.458 HG23 HG12 ' A' ' 116' ' ' ILE . 41.2 t -124.23 131.39 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 0.0 111.064 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.47 175.83 9.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.61 162.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 115' ' ' LEU . 96.9 mt -77.25 149.01 78.71 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 110.96 -174.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.79 156.13 67.17 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.374 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.451 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 12.9 t -142.87 150.23 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.32 114.92 20.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.836 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 50.04 36.13 11.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.912 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.28 29.16 51.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.512 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.487 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 99.2 mm-40 -110.07 161.62 23.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 110.82 -167.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 46.4 Cg_endo -60.98 75.45 0.08 OUTLIER 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 0.0 112.416 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 81.5 p -94.85 -4.83 46.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.784 -162.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.457 ' HB2' ' HD2' ' A' ' 257' ' ' PRO . 10.7 ptpt -136.42 158.43 73.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.643 0.735 . . . . 0.0 110.871 -167.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 28.4 Cg_endo -70.26 166.92 26.62 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.643 2.229 . . . . 0.0 112.342 -169.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -68.93 170.03 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.432 HG21 ' HA3' ' A' ' 327' ' ' GLY . 61.5 t -120.13 133.31 67.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -170.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.21 141.6 16.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.0 t -125.23 128.36 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.9 tp -74.05 135.23 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 94.2 p -126.95 147.67 50.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.84 126.2 42.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.39 163.61 16.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.431 -170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.4 mt -106.36 129.96 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 111.147 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -61.98 126.52 27.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -63.79 -27.98 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.506 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . . . -80.49 -13.11 59.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.133 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 25.3 t -72.29 127.59 90.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.684 0.754 . . . . 0.0 110.934 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.59 -6.54 18.76 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.728 2.285 . . . . 0.0 112.435 169.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.43 25.65 7.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -169.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.04 -40.87 59.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.19 -39.57 89.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 70.3 mt -64.89 -52.45 56.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.28 89.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -164.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -69.78 -49.84 48.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.939 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.78 -53.63 47.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -162.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.488 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 7.5 p90 -75.21 -25.63 58.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.48 -50.44 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.19 -29.28 38.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.953 -175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -101.97 -23.45 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.846 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.488 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 93.6 t80 -118.16 -50.67 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -175.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.98 -39.31 61.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.943 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 106' ' ' TYR . 6.7 mp -83.33 62.27 6.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 52.9 p -135.74 165.29 25.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.157 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -51.91 -49.68 62.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.77 -39.02 53.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.17 -46.69 20.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.7 tp -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.825 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.46 -43.19 88.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.85 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.608 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 88.9 t -77.33 -41.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.75 -18.53 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -54.72 -18.97 5.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 87.7 m-20 -81.18 -30.15 34.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.64 150.26 36.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.668 0.747 . . . . 0.0 110.876 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.83 -22.78 10.02 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.635 2.223 . . . . 0.0 112.364 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.5 tp -68.49 -58.22 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 89.02 3.85 75.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.66 34.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 111.034 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.3 m -120.46 156.19 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.038 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.16 -12.89 60.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 51.4 tp -74.59 120.47 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 59.6 tttm -62.3 -46.82 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -172.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -57.29 -47.15 82.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.91 -33.63 70.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.951 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.17 -37.6 85.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.823 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.7 -34.96 70.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -78.2 -38.43 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.27 -25.12 66.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.07 -7.94 20.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -79.33 -16.7 55.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -88.54 120.86 70.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -50.46 -31.99 32.82 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.232 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -69.7 -48.61 58.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.2 -39.15 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.82 84.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.07 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 58.1 m -63.06 -45.76 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.2 mmt -68.67 -37.6 79.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.28 -40.06 93.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.5 -34.17 76.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.875 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.15 90.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -71.79 -20.18 61.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.991 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.83 -8.19 20.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.432 ' HA3' HG21 ' A' ' 259' ' ' VAL . . . -94.56 -160.0 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.434 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -124.51 132.1 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.871 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.556 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 39.0 mm -79.94 120.48 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 -174.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.4 ' HG3' ' HA ' ' A' ' 96' ' ' ALA . 26.2 mmt 64.59 156.12 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.513 0.673 . . . . 0.0 110.958 169.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 332' ' ' ASN . 75.3 Cg_endo -69.83 -147.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.581 2.187 . . . . 0.0 112.363 164.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.436 ' H ' ' HB2' ' A' ' 331' ' ' PRO . 48.7 t30 -147.79 -54.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.99 164.02 34.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.662 0.744 . . . . 0.0 111.176 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -58.32 -20.92 50.14 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.779 2.319 . . . . 0.0 112.411 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -59.01 -23.08 61.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.502 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 93.5 mmm -67.44 -26.9 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.6 m -62.33 -36.73 83.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.797 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.36 -31.3 65.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.089 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.4 t80 -58.19 -49.99 75.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.004 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.654 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.8 m95 -61.71 -42.56 99.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -57.31 -42.49 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.12 86.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 72.7 t -73.26 -40.27 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.173 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.665 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 78.8 ttt-85 -55.79 -44.98 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.835 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.4 m -62.11 -42.79 99.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -62.36 -43.72 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.13 -49.89 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.115 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.93 -44.09 99.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.099 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -65.04 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.44 69.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.048 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.28 73.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.161 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -79.92 -7.11 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.96 11.82 84.09 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.584 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.1 -29.87 60.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.309 . . . . 0.0 110.88 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -140.67 155.2 46.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.2 p -74.49 172.17 12.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.58 -35.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.227 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.16 -40.77 86.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.73 -45.26 68.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.917 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.4 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.184 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.18 -36.04 76.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.04 -42.44 94.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.46 -31.76 73.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -69.46 -45.04 69.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.16 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.412 ' HA ' HD13 ' A' ' 368' ' ' ILE . 65.2 tt0 -61.84 -39.1 90.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 92.4 m -59.99 -41.54 92.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -73.63 -34.68 65.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 365' ' ' GLN . 78.5 mt -59.98 -40.01 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.185 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.8 p -93.5 -11.46 31.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.5 tttt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.628 0.251 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.4 mt -90.38 132.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.189 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 93.8 mt-10 -131.75 166.91 20.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.62 124.57 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.71 23.15 43.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.465 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 90.5 mttt -144.71 159.0 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.81 ' C ' HD12 ' A' ' 7' ' ' LEU . 1.8 pp -146.45 145.91 30.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.99 124.74 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.628 HG22 ' HB ' ' A' ' 59' ' ' ILE . 7.8 pt -126.61 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.543 ' HB3' HD22 ' A' ' 43' ' ' LEU . 37.2 m0 -116.27 137.8 51.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.7 tt -148.06 154.12 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.4 t-20 -55.5 127.87 31.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.854 174.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.77 79.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.586 -167.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.36 -53.46 57.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.921 -162.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.06 73.95 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 147.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -103.31 -40.19 2.46 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.5 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -70.44 -42.1 71.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -156.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.69 -51.81 45.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.88 -157.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.77 -48.56 83.3 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.42 -177.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.2 mt -60.81 -36.78 79.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.17 95.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.37 -52.0 67.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.74 -32.55 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.047 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.12 -43.04 96.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.52 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.93 -49.22 71.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.71 -43.06 90.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.47 -44.29 94.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.93 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.12 -33.8 76.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -71.83 -42.2 67.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -83.43 -38.03 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.796 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 90.4 m -99.59 -24.0 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 -173.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.01 86.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.405 HG13 HD22 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -87.43 124.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 177.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.04 130.54 43.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG13 HD11 ' A' ' 7' ' ' LEU . 77.8 t -109.03 135.22 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.0 m -127.63 111.9 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.504 HG23 HD12 ' A' ' 9' ' ' ILE . 52.6 t -101.76 120.56 51.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.481 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 54.9 mt-10 -131.88 153.15 50.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.937 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.423 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.8 p80 -132.3 75.13 74.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.637 0.732 . . . . 0.0 110.876 173.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 12.7 Cg_endo -69.76 -29.65 23.54 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.672 2.248 . . . . 0.0 112.452 -160.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.5 m-20 78.0 4.06 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -174.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -94.36 -2.02 52.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 10' ' ' TRP . 79.9 mt -48.95 -57.25 6.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -152.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.33 -41.66 94.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -83.44 -40.33 19.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -170.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -75.51 -49.99 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -166.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.848 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 82.9 t80 -55.3 -52.22 73.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.694 0.759 . . . . 0.0 110.81 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.848 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 88.0 Cg_exo -52.48 -38.7 74.96 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 0.0 112.35 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -73.88 -47.26 39.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.0 m -74.83 -26.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.44 91.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.047 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.58 65.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -93.03 6.75 46.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.01 18.95 73.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.482 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.0 t0 -117.18 -172.96 2.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.962 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.45 167.02 22.8 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.49 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 59.8 Cg_endo -68.51 168.45 19.73 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.605 2.203 . . . . 0.0 112.337 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.27 -42.61 62.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.628 ' HB ' HG22 ' A' ' 9' ' ' ILE . 75.7 mt -136.73 143.3 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.198 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.28 136.61 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.74 122.44 47.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -147.71 157.61 43.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.919 169.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -87.5 -103.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -95.75 -50.03 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -62.04 -61.44 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 -162.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -77.92 -31.93 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -172.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -57.42 -48.23 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.77 -166.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.4 -48.21 87.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.556 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.34 -39.36 64.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 174.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.68 -32.99 74.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.943 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.408 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -64.12 -47.39 80.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.45 -25.88 65.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.0 m -82.52 0.02 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.74 30.3 76.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.41 -5.21 59.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.48 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -128.58 143.39 50.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 -173.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 154.33 20.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.05 136.76 52.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 pt -109.31 151.72 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.8 p -130.11 68.16 80.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.547 0.689 . . . . 0.0 111.197 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.3 141.8 32.64 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.719 2.279 . . . . 0.0 112.284 172.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -78.23 172.05 14.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.55 -31.97 73.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.811 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.52 84.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -79.87 -31.85 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.94 -43.63 94.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.8 -28.39 64.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -66.12 -26.49 67.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 mt -97.01 -137.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -132.33 139.59 35.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.762 0.791 . . . . 0.0 110.884 173.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.9 -42.0 70.23 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.778 2.318 . . . . 0.0 112.408 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -70.44 -24.82 62.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -77.42 -28.66 52.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.129 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.446 ' HA ' HG23 ' A' ' 97' ' ' VAL . 64.2 m95 -73.02 -33.21 65.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.53 -34.43 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' A' ' 329' ' ' ILE . . . -70.09 -28.54 65.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.482 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 34.8 m -106.47 12.48 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.158 -174.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -108.35 133.76 52.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -134.97 126.02 27.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 58.29 34.81 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.28 5.24 89.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.91 146.4 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 0.0 110.85 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.73 125.28 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.459 ' HB ' HD13 ' A' ' 76' ' ' LEU . 38.3 pt -121.65 -8.13 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -167.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.482 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -158.39 161.98 37.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -171.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.8 m-85 -109.14 130.93 22.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.623 0.725 . . . . 0.0 110.987 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 26.5 Cg_exo -62.53 115.58 2.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.749 2.299 . . . . 0.0 112.302 172.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.6 mm -104.85 -34.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.53 153.63 21.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -123.24 129.85 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 229' ' ' PRO . 10.2 pt-20 -131.16 149.21 52.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.897 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.48 154.88 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.6 tp -71.5 133.69 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.9 p -142.46 160.78 39.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -174.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -97.48 128.39 44.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 91.4 mt -111.43 129.61 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.046 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -129.06 153.9 47.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -95.33 118.87 32.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.64 -32.27 73.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -84.31 -35.43 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 -171.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.71 -44.36 50.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -139.34 109.54 7.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.985 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.8 Cg_endo -74.39 177.07 8.81 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.695 2.263 . . . . 0.0 112.436 171.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.1 t30 21.5 96.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 110.922 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.8 Cg_endo -65.51 156.74 61.98 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.373 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.408 ' HB3' HD11 ' A' ' 135' ' ' LEU . 33.7 Cg_endo -66.27 144.66 75.4 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.251 . . . . 0.0 112.363 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -87.92 -21.63 24.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.0 p -134.75 159.46 41.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -68.03 -33.44 74.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.49 -25.46 37.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.773 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.22 -20.84 60.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.588 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 27.6 mm -56.26 -54.77 49.26 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.532 0.682 . . . . 0.0 111.101 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 20.5 Cg_endo -61.86 -40.81 41.76 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.661 2.24 . . . . 0.0 112.371 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' A' ' 126' ' ' PRO . 66.0 mt -64.8 -35.22 80.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.939 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.05 -36.91 85.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.84 -43.21 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.25 -37.76 78.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 35.0 mt -70.32 -35.04 73.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.88 -32.84 64.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.82 -23.6 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -102.85 6.4 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.822 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.17 25.66 70.46 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.516 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 90.3 mttt -112.95 154.66 26.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -106.77 151.6 24.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.39 -42.44 68.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.95 146.0 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 86.8 mmm -136.7 124.25 22.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 157.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.78 167.45 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.804 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 54.7 t-20 -67.39 117.95 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.88 -167.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.08 4.61 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.42 ' N ' ' OD1' ' A' ' 150' ' ' ASN . 79.2 mt-30 -84.59 -0.96 55.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.402 ' O ' HG21 ' A' ' 157' ' ' THR . 95.7 mt-10 -138.87 143.22 36.51 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.626 0.726 . . . . 0.0 110.844 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.615 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 33.2 Cg_endo -70.61 -27.19 22.73 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.72 2.28 . . . . 0.0 112.37 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.409 ' HA ' ' CD1' ' A' ' 158' ' ' TRP . 82.7 t80 -56.11 -46.74 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.89 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 61.1 m-85 -80.37 -20.07 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -173.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 153' ' ' GLU . 80.3 p -75.45 -22.15 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.54 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 2.5 m95 -59.84 -46.18 98.31 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.522 0.677 . . . . 0.0 110.863 -168.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.579 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 52.3 Cg_exo -41.97 -36.26 3.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.334 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.5 -49.12 10.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.734 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.3 mt -81.33 -49.72 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -170.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -63.32 -19.0 64.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.138 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -61.43 -28.28 69.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.42 2.26 39.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.918 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 103.4 10.27 36.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -112.4 135.09 12.44 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.375 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -153.6 170.04 21.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.941 -165.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.62 -48.03 80.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.06 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.87 155.32 42.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -80.92 124.43 29.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -104.62 110.84 23.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -149.48 138.76 21.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -169.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 49.0 38.98 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 -173.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.88 10.39 72.4 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.393 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -136.77 154.81 50.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.735 0.303 . . . . 0.0 110.857 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -70.33 147.62 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -129.63 107.73 9.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.0 mm -76.93 -29.1 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.79 -22.81 31.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -170.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.54 65.25 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.823 166.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.37 149.59 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -169.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -86.93 11.67 64.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.404 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.54 -3.57 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.616 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 51.1 p-10 -78.42 16.64 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.938 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 74.1 m-80 91.21 0.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 166.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.54 -58.31 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -84.54 -55.66 2.67 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.0 68.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 111.137 -166.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.02 -45.16 86.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.75 96.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.121 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.734 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.8 -41.38 98.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.506 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.62 -39.18 91.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.2 m -61.17 -42.11 97.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.208 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.84 -42.99 94.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.86 -45.65 92.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.17 -40.0 87.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.12 -37.58 87.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -68.24 -34.2 75.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.55 -40.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.054 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.06 -41.16 86.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -85.46 2.49 44.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.02 31.89 10.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -81.25 -29.55 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 67.4 mtt -135.47 147.32 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.843 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -97.66 124.03 41.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.63 -22.72 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 -170.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -90.01 -6.09 55.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.4 m -57.22 131.07 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -128.68 -179.48 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.815 171.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -58.04 -34.88 70.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 -172.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 71.2 m -67.73 -36.08 79.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.55 -42.14 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.65 -41.19 98.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.05 -43.03 79.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.61 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.059 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.1 86.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.38 -35.41 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.825 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -60.54 -29.73 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.951 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.42 -21.07 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.829 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.94 23.59 32.29 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -83.43 -25.76 30.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.925 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 87.1 m -125.62 137.28 53.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.56 -38.77 25.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 77.0 mtm -140.51 157.7 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.3 t -151.8 167.83 27.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.223 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.4 mt -123.01 119.29 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 58.6 m-80 -148.62 160.87 42.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -173.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -104.6 -136.55 8.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.482 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -70.61 -26.92 23.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.289 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -66.83 -18.79 65.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -89.47 11.97 17.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.031 -176.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 298' ' ' PRO . 46.4 m0 -67.01 -28.72 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.7 t -59.31 107.95 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -150.51 130.11 13.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.2 mt -89.64 80.52 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.7 73.8 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.1 p -116.81 -1.72 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.147 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 80.3 p -114.74 -169.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.18 178.79 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 66.7 t -61.06 106.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.5 -63.45 1.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.35 154.96 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.88 160.48 25.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.9 t -123.16 130.31 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 111.177 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.38 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.78 159.21 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.2 mt -70.19 139.85 87.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.574 0.702 . . . . 0.0 110.967 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 40.6 Cg_exo -60.43 165.38 11.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.8 p -120.62 148.07 44.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.077 172.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -126.62 117.21 22.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 54.57 35.74 24.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.28 16.58 62.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -130.02 146.67 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 145.46 85.97 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.627 2.218 . . . . 0.0 112.431 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.6 t -67.17 -57.73 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.437 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 9.0 tmtt? -163.52 117.38 1.08 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.525 0.678 . . . . 0.0 110.935 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.54 128.03 11.52 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.709 2.273 . . . . 0.0 112.442 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -161.31 111.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.07 132.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.09 137.42 13.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.558 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.04 125.17 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 57.0 tp -65.35 127.35 31.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 27.0 m -133.2 148.83 52.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.815 -166.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.86 132.75 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -112.14 148.05 18.21 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.435 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.1 mt -106.1 125.79 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -59.04 118.26 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 273' ' ' LYS . . . -62.1 -24.72 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.24 -9.58 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -68.82 132.53 90.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.636 0.731 . . . . 0.0 110.913 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -14.31 39.4 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.636 2.224 . . . . 0.0 112.302 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -115.6 29.43 8.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -167.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 268' ' ' ALA . 47.5 mtmt -58.28 -35.61 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.6 -36.46 83.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.405 HD22 HG13 ' A' ' 33' ' ' ILE . 62.6 tp -64.56 -42.85 95.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.4 90.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -65.15 -43.97 90.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.85 -172.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.73 -51.36 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -172.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -32.61 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.74 -50.58 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -74.11 -42.88 59.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.66 -14.35 19.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -160.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -123.23 -53.73 1.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 59.5 tp -68.07 -46.93 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 106' ' ' TYR . 84.2 mt -83.78 63.79 7.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.1 p -135.54 165.31 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 173.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.87 -44.45 70.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -80.91 -40.85 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.59 35.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.609 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.47 -34.41 72.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 110.904 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.28 -40.04 84.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -33.2 68.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.506 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 78.7 t -79.07 -51.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.154 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -79.3 -19.84 49.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 -166.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -57.85 -18.14 20.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -93.23 -21.33 19.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 72.7 mmtt -71.98 149.75 92.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.617 0.722 . . . . 0.0 110.906 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.444 ' HB2' ' HB3' ' A' ' 232' ' ' TRP . 79.7 Cg_exo -57.87 -44.14 42.99 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.239 . . . . 0.0 112.405 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -95.06 -45.86 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 302' ' ' VAL . . . 83.54 9.74 82.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.54 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.89 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.63 HG22 ' HB3' ' A' ' 307' ' ' TYR . 29.3 m -115.83 156.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -77.18 -9.01 58.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 171.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.37 120.19 23.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.66 -43.9 97.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 38.6 t -58.75 -48.93 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.924 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.63 ' HB3' HG22 ' A' ' 302' ' ' VAL . 1.5 t80 -71.02 -35.39 72.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.849 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -62.34 -32.82 73.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.57 -36.95 77.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.83 -38.44 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.69 -26.69 67.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.981 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.44 -12.46 43.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.11 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.83 -18.1 59.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -90.19 119.0 69.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.608 0.718 . . . . 0.0 110.809 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.99 -32.92 50.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -70.75 -40.63 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.41 -40.72 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.4 72.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.191 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.59 89.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.7 m -65.13 -46.35 81.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.163 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -68.18 -34.82 76.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -63.12 -39.97 96.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.9 -38.87 66.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.69 91.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.012 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . 0.421 ' HG3' ' HG3' ' A' ' 326' ' ' LYS . 20.8 pt20 -71.3 -14.49 62.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 325' ' ' GLN . 90.3 mttt -110.35 -6.52 14.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -175.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.93 -160.55 36.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.437 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -130.16 148.25 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.875 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.438 HG22 ' HG2' ' A' ' 331' ' ' PRO . 45.5 mm -68.97 117.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.115 -171.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.562 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 tmt? -47.93 -53.73 29.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.62 0.724 . . . . 0.0 110.902 -165.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 330' ' ' MET . 45.5 Cg_endo -64.91 101.2 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.703 2.268 . . . . 0.0 112.366 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.643 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 62.8 m-80 -121.56 34.56 5.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -168.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 45.9 mm 88.94 136.56 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.071 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.26 -26.66 20.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.701 2.268 . . . . 0.0 112.266 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.446 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.7 mm-40 -57.44 -23.11 47.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 66.5 ttp -63.29 -32.7 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.9 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.3 m -64.35 -38.12 89.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.28 -45.76 83.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -57.39 -48.67 78.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -64.3 -45.66 87.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.39 93.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.082 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.62 -29.87 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.615 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 73.7 ttt-85 -58.93 -43.07 91.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.6 m -59.69 -41.5 90.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -65.32 -40.21 93.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.44 -50.93 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.05 -46.46 91.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.041 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.11 -36.34 83.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.24 -48.1 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.44 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.054 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -79.0 -9.45 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.1 10.1 86.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.82 -28.6 58.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.319 . . . . 0.0 110.85 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -138.26 155.76 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 357' ' ' VAL . 97.0 m -71.52 152.28 43.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 174.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.404 ' N ' HG23 ' A' ' 356' ' ' THR . 64.1 t -65.66 -47.25 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 -173.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.99 -41.16 99.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -71.91 -44.47 63.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . . . -64.84 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.4 -37.84 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.8 tttt -61.88 -41.99 98.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.26 -31.6 72.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -71.64 -47.16 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.083 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.9 pp0? -68.54 -31.52 70.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 98.9 m -63.26 -44.06 96.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.048 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -64.51 -37.68 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.797 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.93 -46.19 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.4 p -95.19 -6.16 42.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.233 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.1 127.68 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.123 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -128.48 165.39 20.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.81 119.95 15.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.5 24.03 34.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.497 -172.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -145.0 154.27 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.882 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.26 142.93 32.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.8 t -125.48 125.75 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.45 131.75 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.607 ' HB3' HD23 ' A' ' 43' ' ' LEU . 24.0 m0 -113.16 129.84 56.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.4 tt -151.43 153.33 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -55.37 127.04 27.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.09 -20.93 78.99 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -165.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.07 -48.84 72.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -163.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -138.42 83.21 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 145.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -111.3 -34.38 2.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -77.17 -43.83 32.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.966 -159.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -65.77 -60.01 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -155.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -45.68 96.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.54 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -58.39 -41.47 84.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.943 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.87 -48.83 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.913 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.28 -33.88 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.074 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.67 -37.2 94.37 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.369 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.35 -45.88 85.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.88 -44.48 97.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.38 -37.26 86.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -64.86 -35.29 80.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.16 -37.71 72.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.47 -41.5 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -104.67 -17.35 14.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.182 -172.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.87 88.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.55 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.3 tt -76.15 125.24 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.36 121.58 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 p -103.66 140.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -134.24 112.18 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.143 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.02 122.76 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -128.59 150.93 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 26.3 p80 -133.77 73.19 72.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.669 0.747 . . . . 0.0 110.871 170.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 16.9 Cg_endo -70.04 -28.04 24.41 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.633 2.222 . . . . 0.0 112.427 -162.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 57.8 m-20 78.23 2.39 2.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 -172.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.93 -2.04 44.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 10' ' ' TRP . 84.7 mt -46.0 -55.54 6.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.97 -154.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -70.0 -26.64 64.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -168.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -84.34 -43.43 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -79.98 -41.39 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.877 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 29.7 t80 -51.88 -52.97 56.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.825 -165.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 73.3 Cg_exo -54.25 -38.05 88.26 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.564 2.176 . . . . 0.0 112.388 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.2 -48.47 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.924 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -72.18 -30.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.14 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.09 -24.28 67.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.54 7.12 47.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.47 22.59 67.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -119.92 -170.33 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.983 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.56 -173.23 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.581 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.02 159.97 23.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.242 . . . . 0.0 112.364 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 276' ' ' ALA . 29.7 t70 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 169.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.35 142.97 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.36 132.08 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.191 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -113.8 127.28 55.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -146.99 154.46 41.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -81.34 -102.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 -51.28 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.07 -47.98 80.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -79.69 -33.38 41.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -56.52 -47.93 78.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.16 81.7 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.509 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.13 -43.22 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.59 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -70.82 -30.02 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.31 95.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.089 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.43 -24.38 65.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -83.45 3.67 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.46 36.91 69.31 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.478 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.77 -9.56 59.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.785 0.326 . . . . 0.0 110.869 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -132.68 143.18 49.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.948 -173.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.74 164.32 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.078 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -66.31 134.95 53.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -107.92 151.76 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.088 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.5 m -127.44 75.06 77.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 111.218 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.49 141.0 17.44 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.659 2.24 . . . . 0.0 112.251 169.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -80.62 179.95 7.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.913 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.71 -36.13 82.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -173.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -41.94 98.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -69.0 -40.72 78.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.81 -42.2 90.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.859 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.79 -27.11 64.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.99 -27.32 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.925 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.48 -110.26 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 31.6 t80 -156.76 134.71 7.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.667 0.746 . . . . 0.0 111.01 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 80.8 Cg_exo -56.38 -41.66 73.92 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.377 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.27 -40.58 97.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.5 p -71.5 -25.5 62.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.414 ' HA ' HG23 ' A' ' 97' ' ' VAL . 63.4 m95 -74.38 -34.31 63.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.876 173.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.15 -31.3 71.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.832 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.06 -26.45 68.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.43 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 35.9 m -108.04 15.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.149 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -100.34 131.42 46.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -130.74 121.83 26.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 59.28 34.97 23.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.9 4.17 90.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.436 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.04 146.23 47.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.772 0.32 . . . . 0.0 110.918 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -86.37 127.77 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.453 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.6 pt -117.93 -8.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 -169.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -159.67 163.23 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -170.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 78.2 m-85 -107.73 129.01 24.77 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.714 0.769 . . . . 0.0 110.966 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 17.2 Cg_exo -66.66 122.32 9.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.309 172.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -109.64 -40.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -155.54 156.25 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.023 -167.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.89 137.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.649 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 24.9 pt-20 -142.8 154.94 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.25 41.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.175 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.7 tp -66.42 142.36 57.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.874 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.4 m -138.85 156.37 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.6 tp -97.01 123.89 40.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.429 HG12 HG23 ' A' ' 244' ' ' VAL . 74.6 mt -113.3 125.23 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -134.94 157.72 46.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -170.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -91.64 112.56 24.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.717 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 96.4 mttt -67.69 -29.09 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 -174.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -78.11 -35.68 48.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.6 -45.78 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.9 tp -121.71 106.7 36.87 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.913 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 124' ' ' ASN . 97.1 Cg_endo -74.86 157.02 43.61 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.65 2.233 . . . . 0.0 112.284 168.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.6 t30 25.06 96.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.594 0.712 . . . . 0.0 110.953 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.8 Cg_endo -65.25 155.69 67.17 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.728 2.285 . . . . 0.0 112.405 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.96 142.13 55.76 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.751 2.301 . . . . 0.0 112.297 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -91.04 -25.62 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 249' ' ' THR . 68.7 p -128.69 159.99 33.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.186 -175.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -74.06 -23.59 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.979 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.5 -28.57 67.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.98 -20.08 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.637 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 31.2 mm -57.71 -56.25 36.38 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.573 0.701 . . . . 0.0 111.11 -168.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.637 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 29.9 Cg_endo -69.44 -39.69 6.79 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -172.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.18 99.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.74 -39.54 94.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.45 -41.4 98.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.02 -39.6 86.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.07 -45.87 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -84.6 -18.92 34.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.0 tttt -57.47 -30.04 64.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.48 -20.42 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.2 9.31 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.03 68.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.527 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -108.97 161.43 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.849 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.5 t -115.84 152.66 32.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 167.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.97 -42.35 57.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.109 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.97 153.15 47.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -175.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mmm -128.38 120.27 26.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.842 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -166.08 165.01 18.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -97.22 141.21 30.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -168.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 52.4 tp -105.57 2.45 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 175.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -76.54 -8.6 57.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 174.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.48 145.07 39.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.737 0.78 . . . . 0.0 110.832 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.582 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 50.5 Cg_endo -68.73 -24.59 34.62 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.532 2.155 . . . . 0.0 112.295 176.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -57.72 -47.62 81.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -71.64 -26.5 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 p -84.13 -17.19 40.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 7.2 m0 -56.97 -46.4 99.87 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 -170.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 88.9 Cg_exo -51.08 -33.57 43.84 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.765 2.31 . . . . 0.0 112.306 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.5 tp -81.37 -46.15 15.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.445 HG23 ' HA3' ' A' ' 191' ' ' GLY . 94.8 mt -83.14 -48.17 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.107 -171.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -66.62 -16.64 64.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -58.82 -28.56 66.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.51 -6.35 22.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.9 6.75 13.8 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.596 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -95.84 115.04 5.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.427 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -162.33 175.31 11.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 110.936 -161.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 339' ' ' PHE . . . -82.88 -23.64 33.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.191 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.803 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 86.1 m-85 -130.89 143.95 51.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -112.15 127.15 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.857 163.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -108.99 111.68 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.84 -170.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.15 141.32 25.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 52.42 37.96 24.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.63 4.33 70.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.35 150.63 52.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 0.0 110.907 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.803 ' CD1' ' HB3' ' A' ' 169' ' ' PHE . 57.9 m-85 -86.19 130.78 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 172.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -115.83 117.37 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.931 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -78.62 -20.17 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.03 -16.19 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -113.97 71.31 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.79 166.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.32 150.95 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.181 -165.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -88.21 22.24 20.36 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.509 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.6 m -105.65 0.02 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 52.6 p-10 -80.98 17.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.672 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.0 m-80 94.22 -4.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 167.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.81 -57.69 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.072 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -90.79 -53.73 2.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.512 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.596 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -67.38 -35.22 78.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 0.0 111.023 -165.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.81 -43.45 93.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.975 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.08 -41.27 95.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.074 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.445 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -62.79 -39.57 98.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.454 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.93 -40.86 95.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.3 m -60.2 -42.17 94.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.151 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.78 -44.0 97.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 59.1 tp -58.72 -45.52 89.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 351' ' ' ALA . 50.4 t -63.36 -39.74 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.46 -39.87 92.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' ' 133' ' ' PRO . 0.3 OUTLIER -70.05 -40.65 74.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -178.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.62 -39.29 84.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.13 -38.16 87.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -87.94 3.67 47.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 60.6 35.55 19.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -80.78 -20.19 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -139.44 153.08 47.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -98.46 132.4 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.0 72.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -89.85 -4.1 57.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 66.9 m -62.94 135.44 57.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.43 179.92 5.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.89 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -62.04 -34.64 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.931 -172.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.7 m -69.66 -41.34 75.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.838 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.07 -39.67 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.1 93.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.05 -43.45 92.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.51 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -42.39 98.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.492 ' HD1' ' HA ' ' A' ' 217' ' ' PHE . 0.9 OUTLIER -64.91 -37.08 86.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 172.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -102.64 -22.88 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.85 23.32 36.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -82.92 -22.55 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 110.923 -171.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.5 t -126.26 144.92 50.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.98 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.0 mtm -138.61 148.03 43.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -168.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.9 p -139.5 164.96 28.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.101 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.65 119.14 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.5 160.05 41.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.94 -164.42 39.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.446 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.649 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -66.46 -20.99 54.02 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.24 . . . . 0.0 112.274 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -65.56 -20.66 66.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.66 3.86 45.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -69.99 -43.15 72.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 t -68.67 105.84 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -139.69 154.05 47.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 81.6 mt -78.25 88.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.23 74.97 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 73.8 p -122.32 0.79 9.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.7 p -100.49 -170.0 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.62 179.87 7.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.74 112.33 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -119.6 -56.71 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -115.43 162.99 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.717 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -143.03 169.27 25.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.47 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.429 HG23 HG12 ' A' ' 116' ' ' ILE . 58.4 t -122.93 130.2 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.82 175.55 9.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.178 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.84 161.05 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.506 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 90.0 mt -73.48 136.44 78.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.56 0.695 . . . . 0.0 110.94 -173.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 49.0 Cg_exo -62.38 159.33 36.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.746 2.297 . . . . 0.0 112.22 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 128' ' ' THR . 81.9 p -114.09 160.02 19.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.73 116.28 15.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.7 35.12 23.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.5 57.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.543 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.21 145.24 56.48 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.902 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.92 152.07 77.42 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.652 2.234 . . . . 0.0 112.399 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 95.7 p -65.1 -61.5 2.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -165.88 147.01 5.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.566 0.698 . . . . 0.0 110.911 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.36 126.1 8.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.589 2.193 . . . . 0.0 112.417 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -163.89 111.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.77 132.87 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.129 163.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.81 139.14 15.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.62 119.52 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.803 0.335 . . . . 0.0 111.101 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 56.0 tp -64.7 129.87 41.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -132.1 139.9 48.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -170.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.59 137.77 52.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -129.89 166.54 21.96 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 70.6 mt -112.4 129.81 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 111.191 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -59.36 123.21 16.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.939 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.46 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.48 59.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -76.06 131.46 75.75 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.619 0.723 . . . . 0.0 110.852 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.52 -10.86 28.84 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.65 2.233 . . . . 0.0 112.313 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -108.91 28.62 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -166.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.35 -37.75 62.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.757 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.54 -38.59 84.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.95 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.13 -43.09 93.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.419 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . . . -65.63 -44.55 86.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -63.15 -49.64 73.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 97.9 mt-10 -66.47 -45.15 80.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.78 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 19.1 t80 -59.98 -41.65 92.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 28.6 tp -70.33 -54.6 11.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -83.34 -30.76 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 -167.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.2 m-20 -98.57 -18.45 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.799 -167.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.614 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.6 m-85 -122.15 -53.44 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 59.6 mt -72.35 -41.83 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 -176.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.79 60.7 6.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 176.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.1 p -136.9 170.2 16.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.159 172.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -55.12 -48.17 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.796 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.63 -39.93 43.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.39 -46.09 27.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.422 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.7 tp -67.74 -36.32 80.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 110.905 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.04 -41.18 96.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.21 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.06 -32.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.56 -24.39 65.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.3 -26.25 39.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.56 -15.74 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.76 154.83 61.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.53 0.681 . . . . 0.0 110.988 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.41 ' HG2' HD21 ' A' ' 299' ' ' LEU . 41.5 Cg_endo -65.02 -97.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.577 2.184 . . . . 0.0 112.433 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.41 HD21 ' HG2' ' A' ' 298' ' ' PRO . 2.4 pt? -65.29 -25.87 67.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 60.98 31.87 78.03 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.551 165.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.91 127.28 31.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 111.104 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 34.7 m -116.75 152.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.081 -164.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.95 -10.84 59.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.08 118.54 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.37 -51.73 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.7 p -62.27 -43.07 99.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 307' ' ' TYR . 1.3 t80 -70.56 -37.1 73.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.975 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -66.24 -32.61 74.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.0 -36.58 81.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -72.79 -39.68 66.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.37 -26.77 68.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.935 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.78 -11.27 44.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.047 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.07 -18.14 58.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -85.52 118.93 71.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.768 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.09 -34.94 60.08 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 0.0 112.383 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -70.17 -41.11 74.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.04 -38.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.01 73.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.57 -41.37 88.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.04 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -63.73 -44.62 93.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.159 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.6 -38.82 90.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.886 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.53 -38.56 84.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.96 85.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.3 -18.26 65.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.832 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.27 -8.13 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.889 -172.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -102.88 -162.68 25.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.502 -173.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -133.98 156.68 47.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.481 HG13 ' HD2' ' A' ' 331' ' ' PRO . 4.9 tp -63.21 124.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -171.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.606 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.9 tmt? -44.46 -52.27 17.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.525 0.678 . . . . 0.0 110.847 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 330' ' ' MET . 34.8 Cg_endo -60.71 84.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.34 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.66 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 74.0 m-80 -104.23 29.36 6.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -170.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.66 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 50.3 mt 89.62 135.45 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.704 . . . . 0.0 111.146 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.41 -26.86 22.45 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.239 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.452 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.3 mm-40 -59.97 -18.16 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 62.1 ttp -57.97 -34.61 70.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.949 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.93 -38.83 92.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.14 -38.2 66.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.649 ' HB3' ' HB2' ' A' ' 168' ' ' ALA . 7.2 m-30 -67.17 -35.97 80.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -55.5 -48.8 74.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -64.94 -42.36 94.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.79 94.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.104 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.77 -38.11 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.083 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.582 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 71.2 ttt-85 -53.51 -39.92 64.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -57.04 -45.13 83.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.072 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -65.84 -43.71 87.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.89 -58.48 5.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -166.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.7 mt -66.57 -45.0 89.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 97.9 m-20 -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.78 59.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . 0.438 ' HA ' HG23 ' A' ' 196' ' ' VAL . . . -71.74 -35.45 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.11 -172.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -75.47 -14.5 60.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.79 7.75 87.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.403 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -75.22 -24.27 57.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.962 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 83.4 mm-40 -136.01 157.08 47.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.0 m -67.17 150.62 48.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.56 -46.99 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.15 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.46 -40.14 95.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.92 -42.52 66.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.27 93.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.408 HD22 ' HB1' ' A' ' 188' ' ' ALA . 32.7 tp -71.93 -35.1 69.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.2 tttt -62.5 -40.27 96.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 173.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.97 -31.28 72.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -74.59 -43.18 56.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.174 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.9 pp0? -69.29 -28.91 66.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -66.75 -44.18 82.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.139 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.19 -40.16 68.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.38 -30.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 -171.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.8 p -92.17 -2.82 56.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.181 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -177.394 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.736 0.303 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -80.73 133.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.08 -179.44 8.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.61 126.62 30.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.991 -172.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.57 19.01 59.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.562 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -142.19 158.55 43.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -142.44 147.57 36.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 173.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.13 126.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.446 HG13 HD13 ' A' ' 7' ' ' LEU . 62.8 mt -118.74 133.22 66.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.129 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.544 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 30.2 m0 -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 174.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 tt -151.78 154.07 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.141 -172.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.404 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.4 t-20 -55.14 127.36 28.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 174.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.1 -19.44 79.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.519 -168.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.57 -51.23 70.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -163.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.19 78.84 1.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 147.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -109.0 -35.88 2.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.428 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -80.5 -44.46 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 110.989 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -66.72 -52.08 48.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -155.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -65.3 -47.71 77.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.472 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.01 -38.41 85.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.87 -45.15 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.42 -47.33 82.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.96 -45.03 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.675 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -60.8 -36.31 91.65 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.363 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.16 -45.52 93.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.19 -44.77 90.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -64.49 -41.8 96.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -63.8 -33.66 76.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.12 -38.23 85.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.1 -37.02 17.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 -173.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.407 ' HB ' HG22 ' A' ' 33' ' ' ILE . 85.8 m -101.19 -24.51 14.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 -171.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.01 3.36 87.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.407 HG22 ' HB ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -87.53 125.27 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.4 . . . . 0.0 111.185 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -66.48 128.03 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -172.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.675 HG11 ' HA3' ' A' ' 24' ' ' GLY . 95.5 t -104.26 132.9 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -135.9 116.93 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.6 125.13 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.49 153.06 47.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 27.9 p80 -133.23 75.12 71.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 0.0 110.838 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.6 Cg_endo -69.24 -29.32 26.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.238 . . . . 0.0 112.401 -162.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.6 m-20 77.67 3.42 3.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -175.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.8 2.09 49.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.544 ' CD2' ' HB3' ' A' ' 10' ' ' TRP . 82.9 mt -48.65 -55.14 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -154.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -62.65 -28.91 70.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 -169.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.48 -47.07 9.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.811 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -79.98 -46.33 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -163.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.595 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 7.6 t80 -50.66 -54.0 40.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.679 0.752 . . . . 0.0 110.88 -162.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.1 Cg_endo -62.9 -31.8 77.25 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.295 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -47.82 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.7 m -74.95 -26.41 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -174.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.25 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.33 -24.28 65.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.028 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.5 p -96.43 4.96 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.37 23.17 61.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.502 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.9 t0 -119.88 -176.24 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.32 -179.18 24.67 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.582 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.91 161.1 24.13 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -76.26 -38.58 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.63 138.77 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 tt -138.27 140.86 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -100.2 143.34 30.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -140.05 152.37 46.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.98 -114.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.46 ' NE2' ' N ' ' A' ' 261' ' ' VAL . 70.8 m80 -116.94 -57.47 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.65 -45.42 90.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -74.97 -36.67 62.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.84 -49.55 75.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.21 -49.48 61.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.453 -175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.31 94.48 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.528 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.404 ' HB3' HD23 ' A' ' 75' ' ' LEU . 12.1 m-85 -71.9 -29.94 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.67 96.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.46 -28.63 69.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.3 m -84.97 5.73 28.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.879 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.49 35.66 82.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.434 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.404 HD23 ' HB3' ' A' ' 70' ' ' TYR . 1.9 mp -76.05 -15.49 60.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.874 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.43 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -129.61 143.64 50.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -169.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -91.15 159.33 16.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.44 136.87 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.5 pt -109.41 152.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.3 p -130.49 63.07 68.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.557 0.694 . . . . 0.0 111.157 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -72.67 143.28 37.45 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.717 2.278 . . . . 0.0 112.255 167.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -75.08 177.7 6.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.81 -30.35 70.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.52 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.023 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -64.71 -38.06 89.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.801 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -65.55 -40.13 92.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.991 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.21 -36.59 83.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.93 -30.98 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.05 -107.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 23.5 t80 -168.66 131.05 1.19 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.658 0.742 . . . . 0.0 110.957 174.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 79.8 Cg_exo -54.19 -38.73 88.02 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.716 2.278 . . . . 0.0 112.328 -174.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.56 -35.47 80.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -76.3 -24.74 54.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -75.46 -26.52 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 173.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.1 -33.23 71.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.16 67.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.09 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.98 16.63 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 -175.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -109.97 138.27 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.934 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -136.29 124.96 23.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.66 34.86 25.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.27 4.72 89.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.421 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.53 144.13 48.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.52 126.4 33.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.43 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.2 pt -119.67 -10.06 10.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.104 -168.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.27 165.17 31.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -108.61 137.92 20.13 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.667 0.746 . . . . 0.0 110.867 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 21.4 Cg_exo -66.53 120.24 7.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.284 173.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.36 -36.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.93 151.28 14.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.2 133.36 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -134.09 149.9 51.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.22 156.0 34.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 tp -69.98 140.4 52.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.7 m -142.93 159.05 42.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.1 tp -99.74 129.92 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.408 HG12 HG23 ' A' ' 244' ' ' VAL . 86.9 mt -110.89 132.92 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -132.59 154.76 49.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -93.28 117.19 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.786 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.35 -31.75 73.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -173.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.89 -35.09 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.21 -52.56 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 135' ' ' LEU . 94.3 mt -127.48 115.77 21.26 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.1 Cg_endo -75.04 171.14 18.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 0.0 112.37 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.559 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.9 t30 24.81 96.6 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.1 Cg_endo -65.0 155.04 70.41 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.405 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.49 143.94 59.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.595 2.197 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.48 -20.48 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.1 p -129.35 157.93 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -71.9 -25.47 61.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.49 -30.5 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.53 -20.05 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.603 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 33.8 mm -60.77 -54.03 58.54 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.604 0.716 . . . . 0.0 111.088 -169.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 23.5 Cg_endo -61.82 -40.05 47.67 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.753 2.302 . . . . 0.0 112.304 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.36 90.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 122' ' ' LEU . 62.4 tp -64.93 -40.37 94.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.96 -40.81 95.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.45 -42.92 83.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.44 -44.07 75.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 pp -83.03 -22.83 33.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.59 -25.87 67.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -18.78 65.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.26 9.98 41.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.02 25.68 73.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.477 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -108.73 157.52 18.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.836 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.8 t -111.24 144.19 40.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 169.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.24 -44.12 63.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.11 157.05 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 mmm -138.8 116.44 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -164.39 169.51 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.47 138.14 32.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -166.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 206' ' ' ALA . 89.6 mt -114.38 3.52 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.54 -3.8 54.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.68 145.06 49.59 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.689 0.757 . . . . 0.0 110.907 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.714 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 29.7 Cg_endo -69.12 -25.85 31.14 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.63 2.22 . . . . 0.0 112.256 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -57.72 -47.95 80.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.85 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.433 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 52.7 m-85 -79.98 -21.88 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.869 -174.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 71.5 p -77.31 -22.43 51.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.458 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 9.4 m0 -56.43 -46.48 99.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.488 0.661 . . . . 0.0 110.892 -170.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 60.8 Cg_exo -45.2 -37.21 13.2 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.62 2.213 . . . . 0.0 112.35 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.44 ' HB2' HD12 ' A' ' 195' ' ' LEU . 89.2 mt -82.59 -44.15 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.1 mt -78.33 -45.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 -171.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.94 -16.14 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.013 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -63.24 -31.96 73.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.098 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.22 0.67 23.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.821 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.82 11.08 9.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 163.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -93.78 129.56 9.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.411 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -166.48 159.01 14.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.958 0.408 . . . . 0.0 110.909 -168.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.53 68.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.098 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -151.51 155.73 39.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.007 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 32.4 tptt -87.33 141.07 28.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -97.72 112.58 24.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -150.34 137.21 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.87 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.13 38.12 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.64 10.22 63.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.416 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.51 152.64 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 11.3 p90 -61.54 146.06 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -137.97 103.09 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.42 ' HA ' HG22 ' A' ' 181' ' ' VAL . 8.3 tp -65.15 -15.14 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -170.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.3 -17.62 45.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.808 -165.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -124.06 60.7 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.852 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 182' ' ' GLY . 58.2 t -130.26 157.63 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -171.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.514 ' N ' HG12 ' A' ' 181' ' ' VAL . . . -72.03 10.54 4.35 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.498 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.407 HG23 ' HB ' ' A' ' 181' ' ' VAL . 12.0 m -94.79 -24.56 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 111.101 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 4.9 p30 -83.34 3.93 29.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.8 m-20 84.1 -2.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 158.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.9 -48.45 11.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.1 11.64 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.546 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 182' ' ' GLY . . . -65.19 -43.1 92.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.158 -163.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.65 -42.85 81.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.942 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.03 97.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.82 -41.99 97.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.441 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.24 -36.18 82.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.955 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -59.84 -46.92 87.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -65.1 -44.12 89.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.802 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' A' ' 160' ' ' LEU . 5.8 tt -60.01 -54.26 48.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.71 -37.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.25 -37.55 83.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.6 OUTLIER -68.75 -36.56 78.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.095 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.65 -41.66 88.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.043 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.84 -32.94 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -84.66 -1.76 56.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 60.71 39.98 16.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.944 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -78.53 -25.81 45.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.829 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -145.84 153.01 40.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -96.97 134.7 39.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.99 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . -65.34 -31.52 72.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -173.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.0 -4.75 57.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 -166.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -61.16 135.19 57.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -134.67 -175.2 3.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -56.98 -45.3 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 -175.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -62.56 -42.73 99.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.86 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.8 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -43.47 91.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.99 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.62 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -65.07 -33.46 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.64 -26.03 68.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.48 -23.23 13.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.37 27.02 13.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.456 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.71 -25.81 37.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.907 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -127.41 139.7 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.93 26.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 52.7 mtt -140.21 164.7 29.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 -172.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.5 t -152.82 160.99 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.66 114.86 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.143 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -149.36 160.41 43.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -100.07 -139.55 10.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.335 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.702 ' HB3' HD23 ' A' ' 299' ' ' LEU . 30.3 Cg_endo -68.3 -25.88 35.97 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 0.0 112.353 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -67.94 -16.97 64.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.09 15.13 12.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -56.2 -33.71 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.5 t -62.19 120.19 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -170.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -147.65 128.1 14.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.979 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.6 mt -95.5 86.75 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -84.77 74.92 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.4 p -112.55 -6.46 13.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.095 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.8 p -115.12 -165.25 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.777 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.33 177.04 3.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 80.6 t -65.74 111.19 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.38 -70.41 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.3 158.5 17.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.34 166.57 26.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.563 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.504 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 61.9 t -124.62 132.08 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 111.176 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.37 178.51 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -90.63 160.01 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.093 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 99.2 mt -71.48 143.28 87.49 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.9 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.84 169.9 21.32 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.306 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.8 p -107.93 162.08 14.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -139.02 120.28 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 54.97 33.93 21.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.04 74.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.47 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -123.44 151.16 62.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -172.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.04 152.21 83.13 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.717 2.278 . . . . 0.0 112.395 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.9 p -64.99 -58.39 6.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.845 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -168.2 142.42 2.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.632 0.73 . . . . 0.0 110.904 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -73.15 126.03 10.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.368 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -169.36 119.98 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.77 130.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.178 159.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.94 144.26 15.8 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.463 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.46 ' N ' ' NE2' ' A' ' 64' ' ' HIS . 77.8 t -126.95 122.97 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 62.5 tp -73.09 138.22 45.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.7 m -125.75 144.7 50.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.795 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.4 132.01 51.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.087 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.64 157.12 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.427 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 96.2 mt -105.07 127.24 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -56.57 119.91 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -67.59 -23.95 65.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.08 -9.96 59.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -72.17 133.67 83.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.672 0.749 . . . . 0.0 110.827 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.45 -11.23 30.79 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.598 2.199 . . . . 0.0 112.379 172.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -106.65 36.37 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -168.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.77 -43.54 72.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.78 -174.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -68.13 -36.8 80.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.73 -48.56 76.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.798 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.442 ' HA ' ' CE2' ' A' ' 279' ' ' PHE . . . -60.32 -43.52 96.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.05 -171.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -66.39 -43.94 84.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.811 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.34 -58.63 6.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -169.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.455 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 5.5 p90 -74.94 -25.84 59.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -167.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.452 HD21 ' O ' ' A' ' 280' ' ' LEU . 1.8 tt -63.6 -45.82 88.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.968 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -86.39 -27.13 24.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -99.89 -11.64 20.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.831 -167.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.653 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.3 m-85 -128.54 -52.13 1.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 5.8 mp -70.39 -41.94 72.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -170.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 290' ' ' LEU . 4.4 mp -101.53 70.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 174.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 81.6 p -135.3 169.97 16.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -52.26 -47.85 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.07 -41.49 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.22 -48.49 8.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.591 -169.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.492 HD21 ' HB2' ' A' ' 304' ' ' LEU . 19.0 tp -70.4 -34.39 72.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 110.969 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.82 -41.14 97.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 295' ' ' LYS . . . -66.1 -34.96 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.051 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.606 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 11.6 p -84.07 -36.02 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.94 -24.68 37.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 292' ' ' ALA . 62.5 pttt -61.99 -16.1 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 176.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -94.56 -23.84 17.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 71.8 mmtt -64.63 146.54 98.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.551 0.691 . . . . 0.0 110.946 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 71.5 Cg_exo -57.93 -57.52 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.567 2.178 . . . . 0.0 112.413 -174.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 229' ' ' PRO . 58.8 tp -73.33 -48.22 36.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -172.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.05 -15.11 62.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.483 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.97 126.2 29.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -124.4 160.15 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 -171.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.5 -15.11 59.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.492 ' HB2' HD21 ' A' ' 290' ' ' LEU . 50.8 tp -74.7 120.01 19.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.41 -41.97 90.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.1 m -58.09 -48.87 78.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.634 ' HB3' HG22 ' A' ' 302' ' ' VAL . 1.2 t80 -70.02 -32.63 70.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -59.19 -36.41 75.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.69 -39.79 85.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -77.13 -38.59 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.81 -29.1 70.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -13.01 57.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.71 -22.31 46.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.848 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 64.6 t0 -87.69 119.95 70.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 110.826 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 36.4 Cg_endo -62.4 -24.83 75.86 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.504 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 17.9 ttp180 -68.08 -51.36 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.39 -37.14 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.7 84.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.185 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.54 -37.82 85.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.062 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 59.9 m -66.42 -39.93 89.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.23 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 75.9 mtm -66.3 -37.46 85.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -66.63 -35.09 79.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.83 94.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -71.43 -23.26 61.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.92 -5.94 24.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.2 41.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.55 151.18 50.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 110.841 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.507 HG13 ' HD2' ' A' ' 331' ' ' PRO . 2.2 tp -68.42 125.54 26.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.083 -166.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.582 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 95.8 mtp -56.95 -52.01 77.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.87 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 330' ' ' MET . 55.7 Cg_endo -67.97 83.55 0.44 Allowed 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.799 2.332 . . . . 0.0 112.3 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.518 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 22.3 t-20 -122.92 -6.89 8.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 333' ' ' ILE . 10.8 tp 161.77 118.24 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 0.0 111.094 -157.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.42 -31.36 91.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.6 2.2 . . . . 0.0 112.255 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.441 ' H ' HG13 ' A' ' 333' ' ' ILE . 91.9 mt-30 -62.62 -10.74 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.993 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -59.18 -35.08 72.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.7 m -62.8 -38.52 90.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.31 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 8.9 m-30 -65.28 -37.91 88.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -56.22 -49.75 73.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.973 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -65.81 -42.18 90.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.71 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.3 t -71.49 -37.74 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.714 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 57.2 ttt180 -53.25 -47.99 68.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.5 m -62.61 -41.91 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.462 ' HB3' ' HB1' ' A' ' 364' ' ' ALA . . . -64.91 -41.79 95.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.8 t -69.18 -47.72 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.19 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.92 -46.37 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 97.2 m-20 -64.98 -36.33 84.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.824 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.91 -47.39 52.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.92 70.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.101 -173.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 84.8 p -74.85 -14.99 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.3 7.21 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.74 -30.07 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 84.8 mm-40 -136.07 155.95 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.991 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.4 m -66.0 150.5 48.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.98 -49.81 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.0 -36.36 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -70.95 -40.52 71.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.76 89.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.161 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.82 -38.74 91.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.44 -45.54 93.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -74.3 -42.07 60.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 346' ' ' ALA . . . -81.56 -42.76 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.098 -167.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.447 ' HA ' ' OE1' ' A' ' 365' ' ' GLN . 8.7 mm-40 -73.52 -24.08 60.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 -171.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 63.7 m -53.06 -33.64 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.074 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -61.12 -30.96 70.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 72.5 mt -72.13 -42.62 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.3 p -89.03 -11.07 45.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.101 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.194 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.721 0.296 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.3 mt -83.58 127.34 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.179 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -126.71 163.24 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.91 119.8 14.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.006 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.18 23.79 39.55 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.427 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.48 153.52 40.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.357 . . . . 0.0 110.905 -173.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 7' ' ' LEU . 2.3 pp -145.96 146.0 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.1 126.54 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.624 HG22 ' HB ' ' A' ' 59' ' ' ILE . 1.4 pt -120.19 131.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.476 ' HB3' HD23 ' A' ' 43' ' ' LEU . 23.0 m0 -113.44 132.7 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.01 155.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.474 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.2 t-20 -56.33 126.89 28.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 172.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.57 -21.72 79.18 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.54 -51.53 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -163.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.4 mmtt -135.01 77.59 1.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 148.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.72 -35.23 1.9 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -73.36 -48.33 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.349 . . . . 0.0 111.003 -155.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -69.76 -50.47 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 -155.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.747 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.06 -48.19 87.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.2 -36.85 78.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.18 -48.36 73.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.97 -45.75 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.058 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.691 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.76 -38.32 95.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.03 -45.38 89.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 110.888 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.43 -46.79 86.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.55 -40.67 96.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -62.36 -35.21 78.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.36 -39.55 71.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -176.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.7 -39.88 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.0 m -102.78 -18.31 15.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.1 87.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.469 173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.802 HG13 HD22 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -88.02 130.96 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.166 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.91 129.5 39.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.691 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.5 t -109.73 136.68 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -128.1 113.71 16.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.437 HG23 HD12 ' A' ' 9' ' ' ILE . 61.5 t -98.57 120.58 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.062 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.9 mt-10 -129.48 145.96 51.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -134.81 72.91 67.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 0.0 110.809 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.596 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.3 Cg_endo -70.53 -25.41 25.08 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.276 . . . . 0.0 112.431 -161.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.3 m-20 77.59 4.03 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -172.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HB3' ' HG2' ' A' ' 46' ' ' LYS . 75.6 mmtt -96.55 0.8 50.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 173.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 10' ' ' TRP . 89.1 mt -48.33 -55.37 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -153.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.26 -33.97 69.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -169.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.28 -43.59 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 42' ' ' LYS . 72.5 mmtt -76.5 -48.04 20.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -164.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.713 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.1 t80 -49.08 -57.37 11.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.644 0.735 . . . . 0.0 110.916 -160.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.713 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 31.8 Cg_endo -66.9 -30.04 40.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 0.0 112.289 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.55 -46.61 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.921 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 21.0 m -74.91 -27.18 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.126 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.07 77.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.158 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -24.14 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 p -96.08 4.74 52.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.84 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.425 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.485 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.2 t0 -120.02 -174.78 2.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.783 0.325 . . . . 0.0 110.944 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.35 -173.72 23.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.51 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.03 157.04 23.56 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.64 2.226 . . . . 0.0 112.323 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.7 -40.71 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 172.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.624 ' HB ' HG22 ' A' ' 9' ' ' ILE . 97.5 mt -136.9 142.64 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -131.95 137.13 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.154 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -103.17 134.4 46.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -140.03 156.14 46.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.07 -102.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -124.13 -54.69 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.937 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.01 -50.06 72.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -71.04 -34.99 71.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.59 -49.09 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.793 -174.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.44 -51.18 54.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.432 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -42.68 95.06 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.566 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -70.01 -31.28 68.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.995 0.426 . . . . 0.0 110.994 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.43 98.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.119 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.69 -25.17 64.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -85.11 3.95 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.48 35.15 74.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.528 173.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -78.79 -10.9 59.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -131.86 144.02 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -175.056 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.89 157.96 17.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.083 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.23 137.11 56.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -109.98 151.77 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.407 ' H ' ' HE2' ' A' ' 277' ' ' LYS . 26.5 m -134.98 72.09 68.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.713 . . . . 0.0 111.117 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.83 142.21 34.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.756 2.304 . . . . 0.0 112.316 168.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -79.05 -179.64 6.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.73 -37.85 88.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.64 88.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.96 -38.58 88.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.65 -39.42 91.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.82 -29.49 70.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.69 -25.87 68.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.918 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.456 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 60.6 mt -101.87 -123.97 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -160.05 134.88 5.55 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.689 0.757 . . . . 0.0 110.956 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -54.88 -38.81 92.44 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.715 2.276 . . . . 0.0 112.345 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.72 -36.5 83.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -74.98 -23.26 58.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.185 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.456 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 57.3 m95 -69.98 -32.13 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.37 -30.16 70.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 329' ' ' ILE . . . -67.35 -27.2 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.009 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.513 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 36.0 m -112.66 8.62 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.206 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -100.27 135.31 41.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.94 124.94 25.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 58.1 34.79 24.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.58 3.92 89.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.417 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.79 145.97 47.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.933 0.397 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.97 125.99 33.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.426 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.7 pt -118.64 -8.9 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 -169.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -158.7 161.29 37.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -171.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -106.92 129.87 23.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.626 0.727 . . . . 0.0 110.94 175.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.01 120.3 7.82 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.745 2.297 . . . . 0.0 112.282 173.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.3 mm -102.39 -37.86 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.08 151.73 16.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.06 -169.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.0 t -126.75 130.57 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.16 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.92 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 94.8 mt-10 -128.16 145.05 51.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.41 155.11 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.021 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.2 tp -68.69 145.93 53.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.5 p -141.02 157.59 45.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.4 tp -98.06 126.19 43.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.468 HG12 HG23 ' A' ' 244' ' ' VAL . 75.9 mt -112.72 129.35 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -135.73 153.65 51.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.69 114.21 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.796 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.7 mttt -67.55 -27.87 67.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -172.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.55 -36.53 29.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.42 HD23 ' HE2' ' A' ' 144' ' ' LYS . 98.0 mt -78.63 -43.26 26.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 176.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.23 111.89 10.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.689 0.757 . . . . 0.0 110.904 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.551 ' O ' ' C ' ' A' ' 124' ' ' ASN . 93.1 Cg_endo -75.78 173.59 14.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.629 2.22 . . . . 0.0 112.31 174.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.551 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.3 t30 24.0 96.85 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 110.98 175.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.0 157.35 62.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.733 2.289 . . . . 0.0 112.249 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.95 144.45 58.38 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.39 -32.79 14.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 249' ' ' THR . 76.7 p -126.45 159.64 32.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.429 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 67.3 m95 -74.62 -26.81 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.97 -173.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.67 -20.64 65.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.86 -24.11 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 31.4 mm -61.33 -51.78 75.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.556 0.693 . . . . 0.0 111.079 -164.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 38.7 Cg_endo -69.06 -42.38 4.19 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.694 2.262 . . . . 0.0 112.343 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.14 91.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.156 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.81 -38.98 92.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.933 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.92 -43.37 98.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.853 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.19 -41.15 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.36 -46.49 73.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -83.41 -21.29 33.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.908 -177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.457 ' N ' HD12 ' A' ' 139' ' ' LEU . 85.8 tttt -59.38 -26.61 65.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.75 -19.59 65.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.29 9.49 39.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.63 26.97 66.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HE2' HD23 ' A' ' 121' ' ' LEU . 83.2 mttt -106.06 160.81 15.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -114.26 147.21 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 164.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.5 -30.68 61.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.095 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.0 mt -142.12 149.83 40.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.43 125.85 35.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -165.47 165.04 19.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 32.5 t-20 -84.2 134.22 34.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.808 -169.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -109.52 16.41 22.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.946 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -83.66 -12.53 55.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -137.87 147.22 55.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.719 . . . . 0.0 110.944 -171.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.774 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -65.63 -27.31 53.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.539 2.159 . . . . 0.0 112.329 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -58.55 -48.04 82.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.925 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 56.3 m-85 -80.36 -19.39 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.786 -174.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 77.8 p -79.75 -21.1 44.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.529 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.7 m0 -57.37 -42.51 96.34 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.472 0.653 . . . . 0.0 110.902 -170.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 84.1 Cg_exo -47.13 -33.45 15.47 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.674 2.25 . . . . 0.0 112.325 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 195' ' ' LEU . 86.3 mt -83.14 -43.79 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 172.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 94.0 mt -81.4 -52.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -62.59 -31.93 72.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.084 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -103.43 0.07 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.69 5.14 22.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.508 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -91.27 130.03 10.09 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.481 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -166.04 175.27 8.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -169.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.31 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.136 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -141.12 151.89 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 81.4 tttt -81.7 135.3 35.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -109.34 114.15 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -148.44 143.16 26.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.885 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 49.21 39.92 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.42 5.45 67.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.396 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.57 154.08 51.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.38 129.71 34.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 110.884 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -95.6 110.16 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -20.62 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.95 -15.32 29.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 170' ' ' LYS . 65.0 t0 -133.59 90.62 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.834 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.03 162.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.32 5.18 84.1 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.427 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.62 -2.58 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.07 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.655 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 44.3 p30 -74.15 13.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 175.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.655 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.4 m-80 94.66 -5.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.3 -56.95 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.126 173.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.79 -51.56 3.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.587 ' HB1' HD22 ' A' ' 361' ' ' LEU . . . -65.94 -35.55 80.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.35 . . . . 0.0 111.213 -164.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -68.22 -44.55 75.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -170.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.53 95.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.59 98.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.468 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.67 -37.5 84.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.4 m -61.77 -45.43 93.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.88 -42.79 99.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.444 ' HA ' HD13 ' A' ' 160' ' ' LEU . 3.6 tt -59.57 -51.53 69.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.791 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.58 -39.52 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.58 -41.17 89.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.83 -37.53 86.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.46 -40.53 77.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.065 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.01 -31.55 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.49 1.75 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 64.48 34.67 10.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.933 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -80.85 -23.22 39.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -148.17 150.05 33.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -86.63 140.51 29.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.19 68.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -93.03 0.86 57.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.922 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.0 m -59.43 128.72 38.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 57.3 p30 -133.62 179.92 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 174.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -62.22 -34.06 75.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -64.41 -44.15 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.6 -39.58 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.46 96.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.11 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.81 -46.32 79.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.7 86.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 222' ' ' THR . . . -64.4 -39.55 94.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.081 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -71.48 -44.36 64.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.838 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -66.82 -27.51 67.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.81 -9.7 39.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.29 15.26 78.89 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.79 -28.94 60.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.961 0.41 . . . . 0.0 110.957 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.507 HG21 ' HB2' ' A' ' 216' ' ' ALA . 82.4 p -129.83 149.87 51.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.166 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.43 -31.94 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -171.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 89.8 mtp -135.29 157.68 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.859 -165.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.9 t -154.17 155.83 36.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.6 mt -119.07 118.93 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -147.09 159.85 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.97 -166.66 42.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.465 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.92 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 32.6 Cg_endo -64.05 -21.66 68.11 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 0.0 112.396 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -66.13 -16.99 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.11 -1.58 58.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -62.23 -40.04 94.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.9 t -58.88 119.23 6.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -155.85 159.27 39.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.0 mt -89.2 77.18 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.091 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -80.49 73.25 7.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.5 p -122.3 5.36 9.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.134 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 67.0 p -108.09 -175.6 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.75 176.8 5.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.883 172.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.04 113.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -114.18 -53.45 2.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -117.46 164.98 14.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.496 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -140.41 167.06 25.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.432 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.468 HG23 HG12 ' A' ' 116' ' ' ILE . 56.2 t -126.02 130.41 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.056 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.18 174.83 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.73 162.52 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.33 139.98 79.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.504 0.669 . . . . 0.0 110.9 -172.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' ' 255' ' ' SER . 51.3 Cg_endo -75.04 160.34 40.16 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.228 . . . . 0.0 112.367 -177.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 128' ' ' THR . 78.4 p -114.42 158.08 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.185 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -127.67 116.28 20.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.11 35.87 23.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.2 17.68 64.31 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.511 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -127.82 147.91 64.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.96 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.04 149.29 89.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.39 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 248' ' ' PRO . 91.9 p -71.69 -53.8 12.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.495 ' HD3' ' HD3' ' A' ' 159' ' ' PRO . 46.4 pttt -168.93 144.15 2.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 170.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.428 ' HA ' ' HA2' ' A' ' 327' ' ' GLY . 87.7 Cg_endo -78.14 128.91 9.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.335 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -165.0 116.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.8 132.59 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 156.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.5 134.28 11.61 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 82.1 t -119.02 120.74 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 111.195 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 65.3 tp -65.28 132.01 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.805 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.3 m -128.9 141.29 51.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.813 -167.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.24 130.24 50.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.134 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.32 154.01 16.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.8 mt -102.92 127.81 56.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.94 0.4 . . . . 0.0 111.168 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.5 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.24 -11.15 58.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -70.04 130.86 89.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.747 0.784 . . . . 0.0 110.771 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.44 -14.05 41.23 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -112.87 27.97 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.818 -170.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -53.35 -34.14 56.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.45 -36.72 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.802 HD22 HG13 ' A' ' 33' ' ' ILE . 69.5 tp -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 174.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.12 94.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.407 ' HE2' ' H ' ' A' ' 80' ' ' THR . 63.4 tttm -64.79 -45.55 85.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -175.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -63.15 -54.24 40.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.99 -33.56 72.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.505 HD21 ' O ' ' A' ' 280' ' ' LEU . 5.0 tt -61.29 -51.61 68.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.924 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.09 -26.1 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -99.29 -23.77 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -167.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.413 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 68.3 m-85 -123.24 -50.26 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 60.1 tp -69.9 -49.02 56.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -86.41 62.65 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.4 p -135.39 167.62 20.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -57.17 -44.44 83.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -77.08 -42.0 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.61 -45.7 16.99 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.448 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 290' ' ' LEU . 14.1 tp -70.16 -29.84 66.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 110.9 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -61.49 -36.54 80.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.05 93.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.747 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 9.1 p -80.82 -36.38 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -169.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.18 -16.39 60.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -54.92 -23.39 18.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 69.3 m-20 -92.52 -19.17 22.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.58 156.23 59.05 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.51 0.671 . . . . 0.0 110.933 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.12 -93.6 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.643 2.229 . . . . 0.0 112.291 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' A' ' 229' ' ' PRO . 49.1 tp -45.13 -42.28 8.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.63 85.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.442 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.42 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -80.36 133.67 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -173.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.23 157.29 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.43 -12.49 60.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.075 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.404 ' HA ' HD21 ' A' ' 89' ' ' LEU . 50.6 tp -73.93 117.71 16.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.96 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.76 -48.85 79.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -171.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.6 t -59.95 -46.58 88.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.698 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -71.47 -35.63 70.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.74 -36.53 83.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.22 -35.06 76.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -74.79 -39.6 61.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 301' ' ' ALA . 89.6 mt -65.04 -27.92 69.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.98 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.2 34.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.72 -17.82 57.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.71 116.52 64.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 0.0 110.81 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.51 -32.51 43.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.623 2.215 . . . . 0.0 112.354 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -69.97 -39.36 76.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.19 -41.39 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.29 68.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.082 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.32 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 69.7 p -71.07 -33.89 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 33.3 mmt -72.71 -39.93 66.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.89 -38.09 82.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.912 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -68.75 -36.47 78.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.41 93.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.096 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -66.09 -17.92 65.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.46 -4.8 22.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 257' ' ' PRO . . . -97.31 -164.68 32.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.364 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -131.94 154.61 49.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.33 . . . . 0.0 110.923 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' A' ' 96' ' ' ALA . 45.0 mm -64.66 124.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.174 -171.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.554 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 18.2 tpt -56.81 -55.26 45.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 110.833 -168.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 330' ' ' MET . 42.3 Cg_endo -63.83 100.39 0.29 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.736 2.291 . . . . 0.0 112.306 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.7 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 67.1 m-80 -121.55 27.85 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -168.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.7 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 68.5 mt 93.68 134.35 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.719 0.771 . . . . 0.0 111.117 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 333' ' ' ILE . 83.8 Cg_exo -55.36 -32.21 80.58 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -172.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.448 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.4 mt-30 -61.56 -21.84 64.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.4 mmm -67.17 -28.08 67.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -65.62 -40.32 92.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.5 -37.45 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -66.05 -32.83 74.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -55.68 -43.9 76.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.976 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -66.49 -35.63 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.7 -35.47 80.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 68.8 t -70.07 -39.25 76.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.774 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 55.3 ttt180 -54.05 -45.52 71.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.7 m -62.3 -42.76 99.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.524 ' HB3' ' CB ' ' A' ' 364' ' ' ALA . . . -65.2 -44.29 88.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.92 -49.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.12 -44.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -65.01 -38.64 91.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.79 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.63 -45.54 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.114 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.83 74.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -75.91 -11.65 60.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.39 87.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -77.16 -24.81 51.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -131.76 153.86 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.981 174.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 99.5 m -69.61 147.99 49.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.95 -49.26 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.162 -170.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.09 -42.41 94.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.853 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.04 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.105 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.587 HD22 ' HB1' ' A' ' 188' ' ' ALA . 49.6 tp -70.0 -38.19 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.1 tttt -63.61 -44.72 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.814 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.57 -30.45 70.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 346' ' ' ALA . . . -77.86 -43.71 29.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.048 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.8 pp0? -64.96 -30.1 71.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 -171.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.7 m -62.11 -45.71 92.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.73 -35.32 70.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.17 -43.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.077 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.4 p -93.97 -5.93 46.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.095 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.454 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.59 129.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -126.65 166.87 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.01 119.42 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.01 24.05 39.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.431 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -144.44 154.25 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.941 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 7' ' ' LEU . 4.6 pp -151.57 148.46 28.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.868 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.48 123.01 65.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.192 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.414 HG12 ' HB ' ' A' ' 59' ' ' ILE . 59.8 mt -114.35 127.58 71.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.139 -174.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -115.12 131.64 56.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.74 155.2 7.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.431 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.6 t-20 -54.74 126.86 25.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 170.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.19 -20.57 79.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.479 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -56.14 -51.59 67.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.905 0.383 . . . . 0.0 110.882 -162.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -135.25 77.12 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 147.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.34 -33.32 2.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -77.45 -45.3 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.952 -160.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.59 -52.03 59.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 -156.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.87 -48.95 65.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.77 -41.75 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.21 -49.77 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.089 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.74 -46.24 89.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.87 -41.88 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.53 -33.55 85.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.505 175.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -66.78 -43.04 85.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.866 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.39 -39.85 94.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -61.79 -42.46 99.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.73 -34.83 75.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.8 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.02 -36.6 69.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.963 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -82.68 -42.0 18.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -172.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -100.15 -22.04 15.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.98 5.21 89.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.537 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.94 123.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.31 116.14 6.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.893 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.443 HG11 ' HA3' ' A' ' 24' ' ' GLY . 92.4 t -103.96 133.85 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.8 m -132.93 111.51 11.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.166 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.15 121.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.096 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -129.02 148.75 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.854 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -138.03 67.63 48.55 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.857 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.547 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 40.2 Cg_endo -78.65 -14.66 14.07 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 -164.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 59.1 m-20 77.16 6.44 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.34 -8.59 38.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mp -48.73 -52.82 21.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -159.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.8 -43.86 69.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.72 -40.87 20.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 -168.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.07 -43.51 28.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 -167.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.606 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 19.5 t80 -49.85 -54.6 30.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 110.887 -164.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 21.3 Cg_endo -60.4 -31.1 92.23 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -78.46 -49.88 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 19.5 m -74.23 -28.1 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.91 88.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.84 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.7 p -95.69 6.02 49.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.225 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.81 60.54 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.426 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.9 t0 -120.03 -172.95 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.38 -172.44 14.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.541 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HG3' HD12 ' A' ' 60' ' ' ILE . 94.4 Cg_endo -81.64 160.72 19.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.589 2.193 . . . . 0.0 112.391 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.14 -43.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 170.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.414 ' HB ' HG12 ' A' ' 9' ' ' ILE . 83.1 mt -132.4 141.85 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.141 -170.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.415 HD12 ' HG3' ' A' ' 57' ' ' PRO . 18.1 mm -123.15 131.95 72.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.214 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.93 121.36 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.944 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -148.11 165.0 32.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.877 169.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.49 -102.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.028 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -114.11 -56.59 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.79 -51.71 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -166.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 95.3 mtt-85 -75.36 -32.77 60.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -58.53 -49.44 77.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.852 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.62 -50.6 60.57 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.529 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -40.88 94.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.533 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 66' ' ' ARG . 14.8 m-30 -69.6 -31.94 70.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.901 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.51 96.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.039 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.44 -25.96 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -85.59 3.45 40.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.53 36.38 76.72 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.447 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.508 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 1.1 mp -75.27 -15.68 60.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.94 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -130.96 143.53 50.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 -170.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.94 162.3 14.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.143 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.51 137.71 56.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -110.66 153.35 12.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.2 p -130.07 64.92 74.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.604 0.716 . . . . 0.0 111.126 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.67 144.96 28.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.732 2.288 . . . . 0.0 112.27 167.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -76.5 178.48 6.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -68.27 -31.27 70.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.68 -34.4 67.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -61.79 -39.34 91.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -65.08 -40.22 94.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.3 -37.53 80.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.84 -29.5 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.1 -107.05 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.815 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -165.02 133.09 2.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.721 0.772 . . . . 0.0 110.974 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -66.25 -33.33 39.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -172.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.93 -36.51 83.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -75.47 -24.32 56.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.414 ' HA ' HG23 ' A' ' 97' ' ' VAL . 57.0 m95 -76.44 -28.65 56.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.951 173.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.34 -33.74 72.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.45 ' HB3' HD13 ' A' ' 329' ' ' ILE . . . -66.65 -26.43 67.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.147 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.429 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 30.2 m -109.15 16.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.2 -175.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.6 ttp-105 -109.79 136.53 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -136.76 125.65 24.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 57.71 34.71 24.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.44 89.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.461 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.76 144.91 48.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.39 125.59 32.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.434 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.0 pt -118.22 -11.65 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.144 -167.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.429 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -158.65 162.51 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.057 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -106.56 135.89 19.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.697 0.76 . . . . 0.0 110.89 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.9 Cg_exo -65.47 118.52 5.53 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 172.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.26 -36.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.065 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.83 153.25 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.58 128.35 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.192 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.507 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 53.8 mp0 -123.06 150.73 42.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.944 175.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.47 153.77 35.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 tp -71.03 136.2 48.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.002 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -138.72 158.21 44.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.435 ' HB2' HD21 ' A' ' 247' ' ' LEU . 38.7 tp -95.39 127.8 41.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 244' ' ' VAL . 81.0 mt -111.34 127.66 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.97 157.49 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -96.95 114.94 26.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -67.47 -29.44 68.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.68 -35.19 30.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.14 -43.93 27.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.21 109.2 15.09 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.637 0.732 . . . . 0.0 110.921 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.4 Cg_endo -73.29 167.65 26.77 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 112.379 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.566 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.6 t30 24.96 96.43 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.955 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -65.32 154.66 72.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.401 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.22 144.72 63.8 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.72 2.28 . . . . 0.0 112.378 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.97 -22.04 19.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.7 p -130.43 158.97 38.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.229 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.437 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 93.4 m95 -73.08 -24.58 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.91 -25.26 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.92 -21.48 57.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.594 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 32.9 mm -60.05 -51.92 77.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.534 0.683 . . . . 0.0 111.101 -166.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.4 Cg_endo -68.99 -42.74 3.89 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.448 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.43 92.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.01 -38.2 90.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.17 -39.87 94.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.66 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.85 -49.09 61.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.76 -16.52 53.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.961 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -53.59 -29.12 36.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.44 -19.88 64.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.34 7.73 38.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.92 28.45 62.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -106.49 157.23 17.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -106.88 149.66 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.902 160.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.56 -42.58 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.076 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 38.1 mt -138.2 141.98 40.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.857 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 75.4 mmm -140.22 118.18 11.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 163.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.24 168.44 26.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.791 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -72.41 104.29 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 206' ' ' ALA . 13.5 tp -87.66 -4.82 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 -174.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -87.59 10.27 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -133.64 148.1 67.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.67 0.747 . . . . 0.0 110.803 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 28.6 Cg_endo -68.68 -30.25 28.25 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.32 -174.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -57.59 -37.27 72.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.86 -28.62 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.765 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -77.75 -22.93 49.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.737 ' HB3' ' HG3' ' A' ' 256' ' ' LYS . 1.6 m95 -59.79 -46.81 98.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 -169.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 61.8 Cg_exo -44.43 -37.57 10.83 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.77 2.313 . . . . 0.0 112.337 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.32 -44.37 17.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.865 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.414 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 96.5 mt -72.97 -46.8 50.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -70.78 -17.59 62.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -63.35 -28.19 69.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.085 -166.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -100.31 7.16 44.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -170.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.7 4.66 55.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.507 169.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 187' ' ' GLY . . . -109.98 147.02 17.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.434 171.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.424 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 43.3 t80 -164.5 173.36 12.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 0.0 110.858 -167.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.48 -54.6 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -141.39 148.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -83.88 130.95 34.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -104.15 113.05 26.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.68 140.66 23.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 47.14 41.76 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.06 7.82 67.8 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 173.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.64 151.8 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -83.92 134.5 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -109.57 114.12 27.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.81 -19.99 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.63 -17.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -168.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -132.02 87.34 2.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.463 HG21 ' H ' ' A' ' 184' ' ' ASP . 13.9 m -127.23 166.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -171.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 188' ' ' ALA . . . -93.42 7.6 75.09 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.44 HG23 ' CG2' ' A' ' 181' ' ' VAL . 11.0 m -96.61 -16.45 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.072 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 6.6 p30 -79.87 10.56 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 167.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.2 m-20 84.45 -4.54 1.02 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.75 158.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.22 -48.34 10.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.58 ' O ' ' HA3' ' A' ' 166' ' ' GLY . . . -75.92 -44.1 20.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 182' ' ' GLY . . . -67.0 -34.72 78.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.841 0.353 . . . . 0.0 111.085 -160.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.49 -41.83 97.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -165.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.82 95.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 161' ' ' ILE . . . -65.48 -42.84 95.57 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -35.04 79.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.956 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 84.4 m -58.02 -47.96 81.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.117 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.11 -43.45 91.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.821 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.401 HD21 ' C ' ' A' ' 195' ' ' LEU . 10.3 tt -61.89 -48.69 79.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.2 -38.69 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.192 -175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.12 -36.27 83.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -65.19 -36.4 84.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.993 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.91 -40.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.102 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.87 -39.56 93.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -85.42 5.0 32.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.72 31.93 11.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -83.05 -27.29 30.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 168.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 66.2 mtt -133.37 151.0 51.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.421 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 57.3 t-20 -95.64 132.55 40.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.447 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -67.44 -28.01 67.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -92.11 -8.88 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -168.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 87.0 m -55.5 126.48 25.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -121.14 -174.42 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.41 -44.78 92.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.0 m -60.73 -42.62 97.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.76 -42.28 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.83 95.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.26 -44.65 78.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.71 81.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -35.62 80.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -62.38 -29.94 70.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.14 -21.95 15.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.888 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 22.9 36.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.98 -27.07 43.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.863 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.5 t -124.95 140.0 53.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.98 -35.18 50.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.2 mtm -139.68 155.92 47.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -166.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -152.1 164.87 36.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -120.63 118.08 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -151.79 163.19 39.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.783 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -100.57 -141.31 11.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.657 ' HB3' HD23 ' A' ' 299' ' ' LEU . 39.8 Cg_endo -71.24 -25.52 21.96 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.366 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -65.79 -19.98 66.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -94.77 9.4 39.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -65.99 -38.78 89.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.2 t -54.63 111.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.429 ' HB3' ' OH ' ' A' ' 242' ' ' TYR . 68.7 m-80 -152.73 142.1 21.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.82 78.18 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -83.54 75.22 10.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.6 p -115.27 -9.03 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.9 p -103.2 -171.55 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.81 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.84 177.65 3.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -59.66 110.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.59 -57.87 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.814 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.429 ' OH ' ' HB3' ' A' ' 234' ' ' ASN . 49.2 p90 -110.2 159.52 17.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.95 167.61 25.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.49 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 116' ' ' ILE . 64.0 t -129.13 130.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.215 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.06 -177.25 5.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.197 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.17 160.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.101 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 115' ' ' LEU . 83.8 mt -70.9 143.27 88.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.559 0.695 . . . . 0.0 110.937 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 255' ' ' SER . 57.7 Cg_endo -74.96 170.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.391 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -104.33 162.12 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.046 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.41 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 37.4 t80 -135.53 118.52 16.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.829 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 54.6 34.8 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.66 80.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 175.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 89.1 mm-40 -122.72 147.36 50.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.615 0.722 . . . . 0.0 110.94 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 51.4 Cg_exo -54.81 145.53 60.7 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.618 2.212 . . . . 0.0 112.424 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 248' ' ' PRO . 95.3 p -70.53 -63.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.992 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.737 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 14.1 tmtt? -172.32 125.93 0.53 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.917 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.71 134.37 12.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.716 2.277 . . . . 0.0 112.313 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -161.08 110.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.05 134.98 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.824 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -119.86 147.26 18.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.9 t -122.59 121.75 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.125 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.54 130.99 45.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.954 174.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.0 m -127.72 139.85 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -165.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.19 137.21 49.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.101 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.0 168.11 23.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.339 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.79 129.14 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.108 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -57.44 125.37 22.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.68 -22.25 66.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.97 -12.48 55.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.145 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.0 t -70.77 136.65 85.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.773 0.797 . . . . 0.0 110.826 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.16 -14.63 23.24 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.625 2.216 . . . . 0.0 112.35 174.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -108.03 36.87 2.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.832 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.94 -38.71 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.17 -38.78 91.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.38 -49.38 67.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.55 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -168.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -66.48 -47.46 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.916 -172.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -47.94 72.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -72.14 -36.02 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.656 HD21 ' O ' ' A' ' 280' ' ' LEU . 5.1 tt -56.58 -47.81 78.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.01 -25.56 34.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -99.81 -13.12 19.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -171.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.423 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 70.6 t80 -124.36 -58.83 1.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.7 mt -69.71 -39.87 76.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.02 66.34 9.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 175.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 73.7 p -136.27 168.35 19.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.52 -45.25 73.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.87 -41.86 42.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.96 -49.63 9.65 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.497 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.32 -38.92 82.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.56 -43.22 99.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.83 76.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.068 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.6 t -74.38 -45.06 47.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -73.86 -14.28 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.3 -27.07 13.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -91.91 -4.24 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -91.15 151.29 42.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.573 0.702 . . . . 0.0 110.871 172.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.55 -57.72 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' A' ' 229' ' ' PRO . 61.8 tp -65.8 -47.78 73.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -167.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.06 86.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.478 ' HB2' ' SD ' ' A' ' 321' ' ' MET . . . -75.16 125.55 29.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 0.0 111.114 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -124.71 159.71 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -173.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.36 60.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.2 tp -75.3 123.57 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.65 -39.39 93.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.1 t -59.46 -48.37 81.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.528 ' HB3' HG22 ' A' ' 302' ' ' VAL . 1.6 t80 -71.38 -33.68 69.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.12 -39.45 82.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.86 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.56 -37.82 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -76.97 -37.31 55.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.8 mt -64.87 -31.61 72.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.11 -12.66 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.11 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.03 -20.05 58.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -91.81 117.93 68.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.801 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.74 -33.64 60.93 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.673 2.248 . . . . 0.0 112.337 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.403 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 91.8 mtm-85 -72.55 -43.2 63.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -173.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.43 -38.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.99 72.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.72 89.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 80.9 m -67.2 -43.09 82.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.225 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.478 ' SD ' ' HB2' ' A' ' 301' ' ' ALA . 96.3 mmm -66.11 -34.62 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.14 -40.24 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -72.76 -34.57 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.18 -41.78 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -69.94 -17.03 63.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.03 -5.35 16.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.1 -164.07 39.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.476 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.61 147.53 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.45 HD13 ' HB3' ' A' ' 96' ' ' ALA . 39.2 mm -67.43 126.92 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 -166.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.824 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 54.2 mtt -52.64 -58.83 10.4 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 110.914 -171.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.529 ' CD ' ' HB2' ' A' ' 330' ' ' MET . 36.2 Cg_endo -63.98 101.08 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.762 2.308 . . . . 0.0 112.375 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.685 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 69.1 m-80 -123.06 28.49 7.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -169.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.8 mt 90.23 135.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.667 0.746 . . . . 0.0 111.104 -176.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -54.79 -29.94 65.13 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.618 2.212 . . . . 0.0 112.332 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.428 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.6 mt-30 -64.09 -23.69 67.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.88 -26.82 65.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.15 -34.88 49.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -66.68 -40.13 88.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.07 -38.55 83.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.966 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -64.99 -36.26 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.72 -35.01 79.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.67 -40.2 76.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.17 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.63 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 58.0 ttp180 -56.38 -44.79 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.2 m -64.2 -44.46 91.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.495 ' HB3' ' CB ' ' A' ' 364' ' ' ALA . . . -63.52 -45.38 90.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -176.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.97 -36.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.09 -171.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.5 mt -68.98 -44.16 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.068 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.39 -35.74 81.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.817 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.84 -45.58 67.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.31 68.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -75.78 -12.69 60.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.77 6.99 88.6 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.22 -30.09 64.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.864 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -139.28 156.8 46.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 70.8 p -75.02 164.09 26.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 171.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.39 -50.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.51 -36.67 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -69.21 -48.06 63.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.55 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.079 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 41.1 tp -65.09 -44.08 90.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -46.51 88.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.68 -35.07 78.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 346' ' ' ALA . . . -79.01 -43.28 24.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.172 -172.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 10.3 mm100 -77.97 -31.13 50.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -171.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 78.0 m -59.99 -38.03 81.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.48 -30.0 70.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.41 -45.42 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.4 p -97.85 -4.62 36.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -177.915 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.703 0.287 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.438 HG21 ' HD2' ' A' ' 271' ' ' PRO . 88.6 mt -61.76 125.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.083 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 164.35 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -66.93 121.99 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.73 19.76 59.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 -173.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -146.39 153.34 40.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.807 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.9 pp -143.15 145.87 33.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.08 124.79 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.574 HG22 ' HB ' ' A' ' 59' ' ' ILE . 5.7 pt -124.95 132.26 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -171.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.787 ' HB3' HD23 ' A' ' 43' ' ' LEU . 38.3 m0 -113.72 135.34 54.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.545 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.2 tt -148.17 155.09 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.461 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.1 t-20 -55.77 128.01 32.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.873 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.12 -16.86 76.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.441 -168.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -47.7 80.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 -165.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -134.58 63.46 1.62 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 152.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.545 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -100.53 -50.49 1.3 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -67.74 -43.54 79.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -160.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.38 -49.52 59.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -163.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.48 -48.44 81.97 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.488 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.2 mt -63.89 -34.57 78.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.843 0.354 . . . . 0.0 110.88 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.07 95.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.049 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -62.06 -49.37 76.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.85 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.551 HG12 ' HB1' ' A' ' 292' ' ' ALA . 25.5 m -72.84 -32.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.48 -40.15 97.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.45 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.86 -43.94 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 110.819 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.88 -47.25 78.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 27' ' ' PHE . 6.9 m-30 -64.6 -41.85 95.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.889 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -65.09 -34.22 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.89 -40.71 79.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.77 -39.64 23.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.2 m -102.11 -26.35 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.15 -172.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.89 5.45 83.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 33' ' ' ILE . 19.5 tt -76.55 126.96 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.188 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.49 124.14 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.7 t -109.35 130.51 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.185 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -125.19 114.42 18.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.476 HG23 HD12 ' A' ' 9' ' ' ILE . 51.7 t -103.83 120.23 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 57.6 mt-10 -131.12 146.46 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -139.92 67.81 35.0 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.699 0.762 . . . . 0.0 110.789 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.554 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -73.91 -16.62 23.1 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.694 2.262 . . . . 0.0 112.387 -167.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 62.0 m-20 74.74 7.6 4.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -173.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.51 -1.32 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 172.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.787 HD23 ' HB3' ' A' ' 10' ' ' TRP . 34.5 mt -48.32 -54.33 14.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -156.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.79 -27.34 66.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 -167.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.61 -47.44 10.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -80.26 -40.97 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.998 -166.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.643 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 37.4 t80 -55.48 -58.88 13.05 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.604 0.716 . . . . 0.0 110.862 -165.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.643 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.8 Cg_endo -59.74 -30.7 92.7 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -75.05 -45.1 43.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 47' ' ' PHE . 33.2 m -73.75 -23.34 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.147 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.096 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.36 -24.8 66.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.32 4.61 53.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.0 22.29 74.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -139.39 -163.18 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 110.882 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.82 -165.83 22.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.627 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.507 ' HG2' HD12 ' A' ' 60' ' ' ILE . 84.4 Cg_endo -81.62 165.09 18.33 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 -173.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' HA ' HD12 ' A' ' 2' ' ' ILE . 43.6 t0 -83.95 -49.26 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.574 ' HB ' HG22 ' A' ' 9' ' ' ILE . 82.9 mt -133.97 138.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 -171.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.507 HD12 ' HG2' ' A' ' 57' ' ' PRO . 7.1 mm -120.86 139.69 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.239 173.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -99.53 130.9 45.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -139.69 158.3 44.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.8 -100.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.628 ' HB3' ' HD3' ' A' ' 331' ' ' PRO . 3.8 p80 -110.94 -54.87 2.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -176.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.07 -49.8 75.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.37 -33.63 48.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.66 -48.36 81.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.813 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.16 65.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.559 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.04 98.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -70.14 -30.02 67.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -62.95 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -67.49 -28.09 67.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -85.57 0.14 53.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -173.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 34.85 80.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mp -87.07 -2.6 58.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.84 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.19 142.92 51.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.932 -175.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.38 152.63 22.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -67.04 135.34 53.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.496 HG13 ' HB3' ' A' ' 103' ' ' LEU . 30.5 pt -118.42 146.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -134.96 69.66 70.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.622 0.725 . . . . 0.0 111.165 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.96 144.54 43.18 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.712 2.274 . . . . 0.0 112.38 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -76.05 178.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.56 -31.91 73.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.87 95.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -67.82 -38.45 83.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.94 -41.55 95.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.14 -33.85 72.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.844 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -68.21 -22.48 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.892 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.7 mt -95.78 -125.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 34.3 t80 -153.68 136.48 9.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.743 0.782 . . . . 0.0 110.941 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.2 Cg_exo -58.24 -41.51 65.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.79 2.326 . . . . 0.0 112.316 -172.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.6 -43.54 84.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.13 -26.76 62.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.155 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -70.04 -40.07 75.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.91 -36.14 82.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 173.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.66 65.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.078 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.502 HG21 HD11 ' A' ' 103' ' ' LEU . 26.8 m -107.4 19.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -109.95 141.02 43.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -138.42 125.89 21.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.96 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.38 35.05 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.831 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.65 89.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.485 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.64 139.71 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.931 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.502 HD11 HG21 ' A' ' 97' ' ' VAL . 10.7 tp -80.44 132.99 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.483 ' HB ' HD13 ' A' ' 76' ' ' LEU . 37.7 pt -124.38 -11.25 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 -165.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.476 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -157.32 162.49 39.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.009 -170.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.424 ' HB3' HD11 ' A' ' 285' ' ' LEU . 97.1 m-85 -113.15 140.78 24.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.623 0.725 . . . . 0.0 110.995 168.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.66 121.84 8.32 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -103.86 -42.7 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.72 153.34 29.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.127 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.84 133.77 56.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 11.7 mp0 -130.8 155.87 45.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.43 155.09 41.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.05 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.3 134.3 44.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.944 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.4 p -143.16 161.3 38.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.0 tp -98.99 127.89 45.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.2 mt -108.05 131.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.013 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -132.31 149.89 52.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.69 118.77 30.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 171.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.76 -34.66 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -81.63 -35.13 30.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.819 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.59 -44.72 23.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.459 HD12 ' HG3' ' A' ' 224' ' ' MET . 72.6 mt -131.68 115.79 15.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 0.0 110.861 173.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.554 ' O ' ' C ' ' A' ' 124' ' ' ASN . 90.2 Cg_endo -74.47 170.09 21.05 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.738 2.292 . . . . 0.0 112.368 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.554 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.4 t30 25.06 97.11 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 0.0 110.916 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 41.9 Cg_endo -65.49 157.16 59.68 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.401 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.85 149.91 60.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.576 2.184 . . . . 0.0 112.342 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.66 -27.71 13.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -126.25 156.44 40.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -66.24 -30.37 70.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.81 -26.58 58.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.93 -21.51 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.7 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 32.2 mm -59.74 -55.37 46.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.655 0.741 . . . . 0.0 111.14 -167.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.7 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 52.0 Cg_endo -75.0 -37.65 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.73 2.287 . . . . 0.0 112.354 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.85 96.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.76 -42.43 90.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.62 -41.52 99.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.988 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.52 -43.86 84.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.95 -45.58 67.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.5 pp -79.4 -22.51 44.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.007 -175.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.477 ' N ' HD12 ' A' ' 139' ' ' LEU . 83.9 tttt -61.06 -30.93 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -20.4 64.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.186 173.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.36 6.54 47.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.85 60.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.516 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.428 ' HB2' HD13 ' A' ' 139' ' ' LEU . 91.6 mttt -108.79 165.18 11.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.8 t -120.31 140.1 51.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 163.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.7 -33.66 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.5 mt -137.02 150.25 47.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 93.7 mmm -133.52 131.75 40.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 166.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -160.43 162.48 33.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.6 t-20 -84.24 110.71 18.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 -177.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 39.9 tp -96.09 4.49 52.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -173.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -81.21 2.12 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.53 151.92 48.12 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.667 0.746 . . . . 0.0 110.935 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.696 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.9 Cg_endo -72.61 -17.37 26.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.256 -174.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -52.47 -48.58 65.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.95 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.432 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 51.9 m-85 -83.51 -11.68 57.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -172.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -80.49 -19.02 46.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.485 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 6.5 m95 -59.79 -44.23 96.72 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.477 0.656 . . . . 0.0 110.921 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 66.6 Cg_exo -43.82 -31.22 3.44 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.714 2.276 . . . . 0.0 112.324 176.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.569 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.4 tm? -87.61 -49.24 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.442 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -78.55 -47.66 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 -169.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -64.85 -26.42 68.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -62.09 -31.75 72.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -95.96 0.31 51.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.75 38.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.423 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -92.46 129.03 9.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.408 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -168.3 175.2 6.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 110.808 -172.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.76 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -137.42 150.7 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -99.6 127.56 45.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -97.35 112.49 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.903 -174.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -149.91 138.43 20.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.65 35.16 17.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.55 4.6 75.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.532 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.49 149.96 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -77.4 135.25 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.45 107.25 18.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.8 tp -65.5 -19.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.55 -8.45 56.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -122.63 76.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.846 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.615 ' CG2' HG23 ' A' ' 183' ' ' VAL . 31.0 m -131.19 164.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -171.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.43 13.13 56.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.602 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.615 HG23 ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -99.74 -20.17 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.754 0.312 . . . . 0.0 111.082 174.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 99.7 m-20 -78.36 3.0 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 167.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 84.4 m-20 83.81 -4.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.792 163.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.1 -50.8 17.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.13 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.61 -42.1 14.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.45 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.7 78.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -164.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -63.27 -44.69 94.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -166.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.95 98.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.039 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.442 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.95 -42.28 98.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.424 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.34 -43.15 91.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.857 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.6 m -61.76 -44.21 97.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 160' ' ' LEU . 1.1 t80 -63.11 -41.51 99.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.89 -40.53 95.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.34 -37.74 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -66.11 -35.13 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.46 -41.46 89.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.913 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.1 -36.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.65 -37.06 84.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -84.43 3.19 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 60.78 39.8 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -79.28 -26.85 42.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -149.46 150.86 33.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -95.37 149.83 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.877 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.66 -25.62 68.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -92.82 -7.28 46.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.779 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 m -58.61 125.54 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 59.6 p30 -139.07 -179.96 6.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -62.65 -33.05 74.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.9 m -63.79 -44.13 94.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.73 -40.04 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.168 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.76 99.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.9 -43.89 91.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.95 82.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.37 99.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -66.21 -35.56 80.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.807 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -64.44 -29.59 70.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.58 -19.0 19.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.01 25.18 38.4 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -84.68 -19.53 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.955 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -128.19 144.52 51.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.44 -35.29 14.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.517 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.2 mtm -142.29 160.6 39.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.933 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.0 t -150.46 160.31 43.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.21 118.92 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 65.0 m-80 -151.94 160.33 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 -173.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -107.34 -135.58 7.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.418 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.674 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 25.4 Cg_endo -68.0 -28.13 35.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 -175.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -67.38 -15.08 63.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.892 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -88.7 21.26 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -62.57 -31.36 72.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.0 t -63.72 106.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.816 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -149.13 130.01 14.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.8 mt -91.08 80.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -84.96 73.71 10.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.9 p -120.25 -12.38 9.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.9 p -110.1 -170.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.22 172.86 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.14 104.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -105.08 -59.35 1.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.02 153.85 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.41 159.54 23.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.73 128.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.999 0.428 . . . . 0.0 111.102 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.01 174.71 10.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.178 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.04 159.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.21 146.09 96.59 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.44 160.23 50.61 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.734 2.289 . . . . 0.0 112.313 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.0 p -104.52 151.54 23.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.023 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.405 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 46.7 t80 -130.78 116.08 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 55.53 33.88 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.75 68.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.518 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -126.25 148.88 65.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.36 144.25 79.5 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -74.08 -57.0 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -172.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.437 ' HG3' ' HD3' ' A' ' 159' ' ' PRO . 10.0 tmtt? -150.1 111.18 3.28 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.519 0.676 . . . . 0.0 110.974 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.96 127.62 11.6 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.784 2.323 . . . . 0.0 112.299 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.407 ' CE2' ' SD ' ' A' ' 330' ' ' MET . 31.0 t80 -158.91 119.44 3.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 -178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.43 130.89 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 167.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.05 135.09 12.05 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.455 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -124.86 128.47 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.141 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 68.3 tp -73.18 135.01 44.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -133.87 160.68 36.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.803 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.94 136.81 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.058 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -113.13 148.95 18.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.477 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 93.5 mt -108.71 124.88 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 270' ' ' SER . 45.1 t-20 -51.6 120.14 4.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -174.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.72 -22.59 66.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.5 -8.93 58.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.193 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 29.4 t -71.41 129.19 89.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.74 0.781 . . . . 0.0 110.786 -171.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.438 ' HD2' HG21 ' A' ' 2' ' ' ILE . 90.6 Cg_endo -71.59 -14.86 30.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.646 2.231 . . . . 0.0 112.267 170.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -107.79 29.14 7.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.929 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.23 -33.62 67.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.39 -38.96 92.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.832 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.88 -41.62 82.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 174.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.35 69.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.042 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -71.13 -38.62 72.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 96.4 mt-10 -72.19 -48.28 44.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 -173.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -62.73 -40.41 97.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' A' ' 284' ' ' LEU . 2.8 tt -60.68 -48.4 81.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 -177.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -83.57 -31.13 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.0 m-20 -97.99 -22.15 16.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -166.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.466 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 m-85 -121.37 -51.82 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 58.9 tp -70.64 -46.87 62.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.912 -176.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 106' ' ' TYR . 92.2 mt -87.05 63.54 7.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.6 p -135.23 169.39 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 172.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.72 -44.35 77.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.14 -44.3 22.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.952 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -70.95 -47.11 40.48 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -170.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.82 -35.41 78.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -62.05 -40.01 94.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 23' ' ' VAL . . . -64.93 -38.56 91.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -174.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.0 p -80.75 -33.71 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.126 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -72.23 -31.74 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -172.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -59.54 -22.5 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.15 -10.16 34.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.38 152.03 75.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.47 -61.58 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.559 2.173 . . . . 0.0 112.385 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.95 -43.2 18.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.939 0.4 . . . . 0.0 110.922 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.75 14.86 79.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.551 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -84.39 127.63 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.047 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.54 160.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.134 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.4 -10.32 59.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.185 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 52.8 tp -74.22 121.13 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.37 -49.05 77.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -171.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.6 m -60.76 -43.41 98.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.884 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -70.12 -35.67 74.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.834 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.03 -31.12 72.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.808 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.85 -39.19 90.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.05 -37.68 61.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.819 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 317' ' ' ILE . 90.9 mt -65.06 -27.47 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.26 -15.62 57.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.59 -21.05 61.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.843 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -86.58 120.73 72.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 110.807 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.87 -27.78 80.6 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.631 2.221 . . . . 0.0 112.383 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -70.03 -39.67 75.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 311' ' ' LEU . 47.4 mm -77.27 -36.37 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.242 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.11 76.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.243 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.38 -41.42 89.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -64.14 -47.16 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.198 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.5 tpt -66.89 -36.99 83.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -61.96 -43.27 99.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.888 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -74.97 -36.42 62.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.58 93.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -69.72 -18.99 63.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -109.51 -6.56 15.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.912 -172.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.52 36.57 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.43 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -126.38 139.26 53.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 110.813 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.561 HG13 ' HD2' ' A' ' 331' ' ' PRO . 2.2 tp -70.54 136.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 83.0 mmm -52.51 -52.57 62.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -172.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 64' ' ' HIS . 51.2 Cg_endo -66.86 82.29 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.757 2.305 . . . . 0.0 112.337 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.644 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 76.5 m-20 -107.15 29.63 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.7 mt 86.96 135.09 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.592 0.711 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -52.76 -31.81 52.8 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 0.0 112.259 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.406 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.9 mt-30 -61.46 -28.49 69.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.965 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.94 -37.06 86.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.17 -39.69 95.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -38.17 80.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.457 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.6 m-30 -65.75 -32.91 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.937 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -59.09 -40.08 84.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.984 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.99 -36.28 72.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.992 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.13 90.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.5 m -74.1 -25.38 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.696 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 75.0 ttt-85 -55.8 -40.56 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.0 m -60.79 -45.55 93.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.165 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.436 ' HB3' ' HB1' ' A' ' 364' ' ' ALA . . . -65.44 -43.52 90.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.38 -53.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 -170.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.97 -44.97 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 -173.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -63.64 -37.33 86.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.22 -46.62 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.58 -35.33 75.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.08 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -80.47 -10.83 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.841 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.95 13.2 81.65 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.496 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.36 -30.08 57.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.845 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -137.33 156.88 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.9 m -70.74 149.7 46.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.06 -49.3 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.67 -43.09 90.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.3 -47.07 65.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.59 96.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.414 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 59.6 tp -65.62 -44.8 85.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.08 -49.6 71.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.932 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.74 -38.39 83.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 346' ' ' ALA . . . -73.99 -42.74 59.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.06 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 9.5 mm100 -78.26 -27.65 47.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -173.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 51.6 m -58.27 -37.07 74.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.88 -29.6 70.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.08 -40.0 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 57.8 p -94.04 -12.76 27.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.061 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.704 0.287 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -76.38 135.1 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.163 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.19 173.63 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.53 122.5 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 23.81 39.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -145.92 154.87 42.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.3 pp -150.98 149.26 29.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 172.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 58' ' ' ASP . 97.2 t -125.63 129.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -115.32 130.46 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.576 ' HB3' HD23 ' A' ' 43' ' ' LEU . 22.6 m0 -114.6 129.82 56.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -152.67 155.24 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.406 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.2 t-20 -54.77 127.18 27.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 173.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.94 -18.34 80.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 -167.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -56.59 -50.88 70.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.857 -163.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -134.8 75.41 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 147.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -104.69 -37.56 2.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -78.18 -46.58 20.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.957 -157.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.7 -52.15 53.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.903 -153.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.46 -48.86 60.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.44 -41.59 98.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.891 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -49.05 69.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.26 -47.15 80.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.876 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -44.82 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.24 -36.48 90.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.399 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -65.48 -40.61 93.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.861 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.06 -39.87 91.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -65.27 -40.07 93.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -59.95 -35.84 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.77 -37.39 70.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.2 -40.37 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 -172.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.5 m -104.36 -18.13 14.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -172.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.29 86.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.471 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.789 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -88.46 128.18 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 111.197 177.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.28 129.6 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -172.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.5 t -110.23 136.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.6 m -133.9 112.62 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.3 t -106.52 124.02 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -129.89 152.55 49.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.428 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.7 p80 -134.38 74.05 67.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.615 0.721 . . . . 0.0 110.828 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 19.2 Cg_endo -71.13 -27.39 20.21 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.725 2.283 . . . . 0.0 112.297 -162.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 60.6 m-20 77.7 4.17 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.847 -172.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -98.04 -0.46 44.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 10' ' ' TRP . 89.2 mt -48.91 -56.59 8.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.952 -152.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -65.06 -27.8 69.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.786 -165.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -85.3 -43.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -79.32 -45.0 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.964 -166.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.892 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 5.9 t80 -52.5 -53.59 51.84 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -163.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.892 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 72.7 Cg_exo -55.11 -38.87 93.27 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.659 2.24 . . . . 0.0 112.302 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.67 -46.76 35.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.969 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.73 -28.04 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.46 84.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 -24.58 67.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -96.37 5.79 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.76 74.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.466 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -116.99 -172.23 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.872 0.368 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.34 -173.8 26.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.581 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.62 159.74 28.4 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.643 2.229 . . . . 0.0 112.45 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 276' ' ' ALA . 33.9 t70 -75.63 -38.87 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 171.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -131.99 139.83 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -136.37 136.29 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 264' ' ' ALA . 36.5 m-85 -103.36 135.39 45.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -141.35 155.9 45.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.926 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.23 -106.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.068 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.412 ' CG ' ' N ' ' A' ' 65' ' ' ASP . 12.6 p80 -109.79 -54.83 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 64' ' ' HIS . 38.9 t70 -62.37 -48.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -164.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -79.57 -36.34 38.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -58.58 -51.26 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.835 -168.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.37 -51.46 54.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.571 -171.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -40.85 92.15 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.44 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.41 ' HB3' HD23 ' A' ' 75' ' ' LEU . 10.5 m-30 -70.1 -30.38 67.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 0.0 110.994 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.451 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -64.03 -42.64 97.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.014 174.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -65.8 -28.06 68.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.923 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -85.17 2.76 42.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.74 36.1 86.75 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.522 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.41 HD23 ' HB3' ' A' ' 70' ' ' TYR . 1.4 mp -70.32 -23.83 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.24 144.71 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 -159.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.26 157.59 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.71 138.22 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.8 pt -107.81 151.03 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.2 p -128.54 69.4 79.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.555 0.693 . . . . 0.0 111.16 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.06 141.65 26.72 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.786 2.324 . . . . 0.0 112.214 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -79.27 169.59 17.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.95 -30.44 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.12 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.016 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -77.98 -35.82 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.858 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -61.64 -44.19 97.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.26 -28.32 65.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.812 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.836 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.401 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 71.0 mt -100.5 -113.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.872 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 22.4 t80 -158.92 133.08 5.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.992 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 86.1 Cg_exo -57.28 -41.0 77.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.745 2.297 . . . . 0.0 112.363 -173.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.22 -39.11 93.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.6 p -71.9 -24.84 61.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.187 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.438 ' HA ' HG23 ' A' ' 97' ' ' VAL . 60.9 m95 -71.16 -36.33 71.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.85 -28.68 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.55 -27.69 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 94' ' ' TRP . 36.0 m -110.97 10.95 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -100.22 130.05 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.973 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -129.3 120.47 25.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 58.53 35.13 24.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.46 5.01 90.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.88 145.62 47.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 110.975 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.68 125.8 34.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.464 ' HB ' HD13 ' A' ' 76' ' ' LEU . 40.9 pt -120.89 -6.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 -169.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.433 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -161.77 164.48 28.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 -172.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.1 m-85 -108.46 134.64 20.17 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.669 0.747 . . . . 0.0 110.962 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.3 Cg_exo -64.07 121.0 8.52 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.243 . . . . 0.0 112.321 171.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.98 -40.07 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.48 151.62 20.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.065 -166.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.9 t -129.67 129.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 46.1 mt-10 -128.52 153.08 47.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.93 157.04 41.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.3 tp -71.1 131.81 44.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.0 m -139.7 155.94 47.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.91 126.33 40.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 85.0 mt -108.5 127.41 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -137.48 154.71 49.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.9 t-20 -91.32 118.22 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.812 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.677 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -68.21 -29.58 68.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.906 -172.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.05 -38.56 44.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.408 HD23 ' HE2' ' A' ' 144' ' ' LYS . 93.8 mt -79.17 -35.31 42.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.95 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.2 tp -134.43 111.19 11.63 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.624 0.726 . . . . 0.0 111.006 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.594 ' O ' ' C ' ' A' ' 124' ' ' ASN . 84.2 Cg_endo -74.87 172.29 16.61 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 170.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.7 t30 22.5 96.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 110.959 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.21 156.4 65.88 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 144.98 60.44 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.744 2.296 . . . . 0.0 112.331 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.07 -29.45 15.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.8 p -126.04 158.8 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 -175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -68.75 -32.76 72.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.51 -26.45 54.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.828 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.16 -20.97 60.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.1 mm -58.86 -54.29 57.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.647 0.737 . . . . 0.0 111.129 -169.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 26.3 Cg_endo -65.15 -41.32 16.89 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.738 2.292 . . . . 0.0 112.399 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.65 93.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.02 -37.37 87.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.87 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.01 -40.15 94.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.31 -37.88 81.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 60.5 mt -70.38 -35.45 73.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.09 -32.29 64.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.998 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.45 66.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -104.29 4.79 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.83 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.49 26.42 67.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.498 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 82.4 mttt -113.16 156.44 23.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.6 t -113.4 148.8 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.817 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.22 38.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.2 mt -139.75 149.85 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.9 mmm -137.28 115.81 12.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.23 165.83 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.54 148.19 22.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 57.6 tp -107.01 -0.01 23.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -78.74 -11.17 59.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -138.45 145.44 46.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.561 0.696 . . . . 0.0 110.932 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.786 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.2 Cg_endo -68.04 -25.53 37.89 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.715 2.277 . . . . 0.0 112.286 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.03 -46.41 85.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.804 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.28 -26.04 58.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.806 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.5 p -82.39 -18.44 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.59 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -58.54 -45.55 99.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.432 0.634 . . . . 0.0 110.875 -169.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 79.2 Cg_exo -46.93 -38.66 23.88 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.627 2.218 . . . . 0.0 112.335 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.89 -41.06 26.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.443 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.7 mt -77.95 -47.57 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -68.58 -17.26 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -63.36 -33.12 74.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -99.14 -2.55 36.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.45 11.19 20.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.496 168.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -108.26 138.18 14.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.451 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.457 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 19.4 t80 -165.56 175.7 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -167.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.81 -59.74 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.221 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -142.42 150.1 40.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -85.95 133.12 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.827 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -108.34 114.28 28.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -147.47 140.08 24.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -170.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.58 41.01 9.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.03 6.64 68.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.516 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -137.32 152.75 50.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.99 133.8 36.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -107.97 109.14 20.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -174.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -67.52 -20.09 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.102 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -82.08 -16.6 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -168.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.49 87.24 2.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.515 HG21 ' H ' ' A' ' 184' ' ' ASP . 12.7 m -129.63 166.87 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.129 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -87.18 2.19 86.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.404 HG23 ' CG2' ' A' ' 181' ' ' VAL . 14.1 m -98.56 -16.77 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 111.097 175.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.515 ' H ' HG21 ' A' ' 181' ' ' VAL . 25.7 p30 -80.3 7.91 8.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 170.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 85.3 m-20 84.19 -7.05 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 161.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.55 -47.59 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.86 -46.55 22.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.457 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -71.54 -31.79 67.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.385 . . . . 0.0 111.096 -163.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.45 -44.35 94.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -160.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.69 97.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.443 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.04 -40.09 98.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.434 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.15 -41.02 90.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.7 m -62.46 -42.15 99.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.15 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.75 -40.44 88.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.45 -48.79 79.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.07 -39.6 86.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -41.11 98.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.6 OUTLIER -73.01 -32.12 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -177.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.78 -38.0 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 173.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.47 -34.82 78.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -85.91 -3.73 58.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 61.5 36.87 16.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.937 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -75.38 -17.45 60.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.69 156.15 47.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -101.71 134.18 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.792 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.14 -32.39 74.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.035 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.58 -5.72 45.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -164.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.1 m -61.74 130.72 47.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.184 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -135.87 -172.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.921 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.48 -47.47 79.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.924 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.7 m -63.65 -42.62 98.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.65 -44.93 93.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.0 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.66 -45.12 88.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.47 87.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.062 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.4 98.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -65.82 -38.69 89.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.828 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.39 -29.44 70.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.66 -19.82 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.86 21.4 50.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -77.41 -24.0 50.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.924 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -133.64 149.46 51.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.066 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.37 -20.82 20.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -138.06 154.9 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 -170.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -159.54 162.43 35.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.08 120.82 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 71.0 m-80 -145.92 158.61 43.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -176.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -95.54 -151.85 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.609 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 29.4 Cg_endo -65.2 -25.15 57.89 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.729 2.286 . . . . 0.0 112.291 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -66.0 -18.09 65.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -87.35 23.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -63.44 -29.98 71.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.1 t -66.41 107.78 2.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -149.31 129.98 14.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.45 81.18 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -84.68 72.86 10.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.4 p -114.54 -13.83 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.182 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.1 p -94.39 -169.94 2.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.61 175.74 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.852 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.31 107.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.121 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -120.42 -59.32 1.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 52.1 p90 -111.62 160.5 17.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.677 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -148.86 167.13 29.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.7 134.17 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 111.1 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -136.99 174.86 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 -171.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -79.74 161.48 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.62 142.83 86.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.508 0.671 . . . . 0.0 110.907 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.14 166.49 27.9 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.65 2.233 . . . . 0.0 112.253 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 66.8 p -118.74 150.74 39.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -128.18 115.25 18.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.81 35.13 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.29 21.14 46.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.553 173.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.8 144.78 53.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.582 0.706 . . . . 0.0 111.021 -172.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.43 141.97 70.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.626 2.217 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.7 t -68.8 -58.88 3.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.749 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 158' ' ' TRP . 5.5 tmtt? -150.8 110.59 3.12 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 0.0 110.916 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.39 122.5 7.05 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.684 2.256 . . . . 0.0 112.474 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -163.89 113.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.2 p -141.67 135.87 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.664 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -117.93 140.11 15.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.92 125.14 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.205 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 61.6 tp -73.37 137.25 44.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.7 m -123.88 141.56 51.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.401 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . . . -119.87 128.02 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 173.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.34 158.2 15.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.1 127.13 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.889 0.376 . . . . 0.0 111.15 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -56.98 120.63 8.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.85 -26.13 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.04 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.72 -11.45 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.1 t -70.77 130.1 89.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 110.748 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.08 -13.11 37.23 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -110.12 27.06 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -55.19 -33.91 63.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -67.94 -37.93 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.851 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.01 -42.42 94.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.437 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . . . -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -174.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -63.32 -45.63 90.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.25 -54.16 23.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -36.37 71.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -171.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 284' ' ' LEU . 64.6 tp -58.98 -47.74 84.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 176.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -75.26 -35.0 61.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -98.28 -9.16 25.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -164.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.829 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 80.2 m-85 -127.59 -55.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 177.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 280' ' ' LEU . 51.3 mt -76.76 -28.88 55.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -170.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.7 mm? -108.1 51.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.7 p -132.49 168.47 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -56.16 -46.05 79.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.15 -42.71 45.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.829 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.39 -50.77 6.44 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -171.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.77 -40.11 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.738 0.304 . . . . 0.0 110.899 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.24 -42.6 99.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.855 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.5 -32.57 74.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.2 t -71.04 -36.82 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.096 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -70.53 -12.75 61.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.838 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.09 -24.31 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -97.83 -7.67 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -87.18 145.15 37.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 110.96 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.47 -62.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.528 2.152 . . . . 0.0 112.369 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.17 -47.98 39.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.95 -170.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 88.23 -5.67 84.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.615 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.406 ' HB2' ' SD ' ' A' ' 321' ' ' MET . . . -71.62 119.68 16.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 111.091 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.15 160.3 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -171.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.43 -12.46 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 172.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.8 tp -73.37 118.32 16.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.38 -44.6 90.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 74.6 m -59.32 -44.66 92.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.03 -34.52 68.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -60.54 -36.72 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -75.71 -38.31 58.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.05 -28.7 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.91 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.62 -12.32 52.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.073 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.23 -19.93 55.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -88.75 118.45 69.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.599 0.714 . . . . 0.0 110.795 173.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.43 -35.35 65.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.717 2.278 . . . . 0.0 112.328 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -72.81 -44.26 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.77 -41.04 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.99 73.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.0 84.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 51.6 m -66.35 -41.92 88.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.406 ' SD ' ' HB2' ' A' ' 301' ' ' ALA . 97.7 mmm -67.53 -35.38 78.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.39 -36.11 82.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -68.2 -38.05 81.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.819 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.28 90.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -66.88 -16.39 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.92 -6.9 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.36 -165.13 36.24 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.361 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -129.97 143.41 50.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.902 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 331' ' ' PRO . 5.0 tp -67.28 134.34 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.215 -168.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.664 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 59.4 mtt -51.96 -55.69 28.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 329' ' ' ILE . 34.4 Cg_endo -62.64 86.53 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.774 2.316 . . . . 0.0 112.309 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.647 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 70.1 m-80 -107.88 22.97 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 46.0 mm 89.05 134.83 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.724 0.774 . . . . 0.0 111.02 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.65 -30.58 66.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.692 2.262 . . . . 0.0 112.252 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -59.96 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.907 -176.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.0 mmm -70.11 -24.66 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.86 -40.7 97.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.45 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -65.54 -33.79 76.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.66 -43.84 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.947 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -67.74 -34.98 77.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.4 82.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.171 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 29.4 m -75.65 -27.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.199 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.786 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 80.6 ttt180 -57.45 -41.88 81.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.809 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.6 m -63.4 -45.86 89.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.441 ' HB3' ' CB ' ' A' ' 364' ' ' ALA . . . -61.92 -43.85 97.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.39 -50.74 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.152 -174.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.96 -45.53 90.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.027 -175.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.76 -35.79 82.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.57 61.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.52 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -76.04 -13.52 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.27 7.45 87.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.34 -30.11 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 0.0 110.959 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -136.2 154.92 50.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.5 m -67.94 150.98 47.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.83 -47.97 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.177 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.42 -40.64 89.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.38 -46.13 64.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.87 85.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.457 HD11 ' HB1' ' A' ' 188' ' ' ALA . 62.0 tp -62.71 -46.91 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 110.959 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -48.7 69.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.04 -37.24 81.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 346' ' ' ALA . . . -80.39 -43.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -78.49 -31.85 47.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.81 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.9 m -59.08 -37.8 77.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.18 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.42 -29.07 68.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.88 -44.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.03 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.1 p -97.46 -6.34 34.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.191 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -178.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.759 0.314 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.4 mt -81.75 123.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.33 166.75 20.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.985 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.0 131.49 45.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.96 17.49 56.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.24 163.53 35.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.831 0.348 . . . . 0.0 110.92 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.513 HD23 HD12 ' A' ' 33' ' ' ILE . 1.8 pt? -145.65 153.93 41.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.14 127.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.66 ' HB3' HD23 ' A' ' 43' ' ' LEU . 26.8 m0 -110.08 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.5 tt -150.13 153.72 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -55.9 134.01 51.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.39 -16.21 75.42 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 -171.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.92 -43.16 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 -168.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.82 80.79 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 149.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.8 -52.56 1.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.496 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.07 -48.9 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -156.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.86 -53.16 51.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.84 -151.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.744 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -67.77 -49.89 45.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.465 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.65 -41.32 98.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.855 0.36 . . . . 0.0 110.996 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.7 73.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.56 -46.84 77.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.07 -45.81 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.082 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.423 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -62.77 -34.19 89.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.26 -45.82 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.861 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.82 -45.1 94.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -66.64 -37.86 85.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -60.56 -34.78 74.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.753 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.37 -38.88 74.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.03 -40.57 24.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -172.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -107.5 -15.35 14.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -171.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.03 1.2 88.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.418 168.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.794 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -85.99 127.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.931 0.396 . . . . 0.0 111.185 176.145 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.53 129.99 38.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.8 t -108.19 129.07 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.18 177.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.84 115.88 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.59 124.98 66.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -126.83 143.22 51.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.41 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 28.0 p80 -139.94 65.34 30.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 46.5 Cg_endo -72.18 -21.68 23.29 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.794 2.33 . . . . 0.0 112.247 -174.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 69.6 m-20 67.02 14.32 9.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 -172.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.63 -1.82 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' A' ' 10' ' ' TRP . 60.3 mt -52.33 -49.1 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 -152.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -65.84 -27.64 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.808 -169.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.39 -42.85 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -76.96 -40.19 47.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.632 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 47.1 t80 -51.39 -57.81 12.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.729 . . . . 0.0 110.839 -169.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.632 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.2 Cg_endo -60.93 -29.68 88.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.241 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.18 -47.03 30.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 33.4 m -75.0 -29.6 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.87 87.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.13 -23.94 66.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.3 p -96.05 5.33 51.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -174.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.97 67.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.538 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.7 t0 -120.0 -174.17 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.933 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.97 -170.9 13.59 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.25 162.99 19.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.35 -40.87 16.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 169.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.54 142.78 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -171.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -122.22 131.36 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -112.31 122.37 47.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CZ2' HD12 ' A' ' 43' ' ' LEU . 95.1 m95 -148.48 156.7 42.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 168.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -81.96 -103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.029 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -112.07 -54.98 2.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.75 -50.19 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 -168.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.21 -31.56 69.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.944 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -60.71 -48.17 83.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -50.41 63.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.533 -172.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.14 98.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -70.91 -29.83 66.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 110.933 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.48 98.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.083 173.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.92 -26.37 65.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.895 173.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -84.89 1.86 45.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.02 36.67 51.33 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.515 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.415 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 mp -81.16 -10.06 59.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.582 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -132.98 144.45 50.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -178.09 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.47 162.96 12.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.49 134.66 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -112.39 153.27 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.3 p -132.16 65.43 75.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 111.194 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.16 148.21 43.93 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.383 171.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -77.57 -179.82 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.49 -31.43 72.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.36 -38.49 77.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.991 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.09 -38.74 86.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.57 -43.39 97.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -71.06 -31.28 67.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.66 -30.55 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.411 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.8 mp -108.77 -92.7 0.42 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -175.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 29.6 t80 -167.19 133.05 1.74 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.997 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 99.1 Cg_exo -54.05 -40.17 82.49 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.745 2.297 . . . . 0.0 112.336 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 92' ' ' PHE . 1.3 t80 -65.27 -39.44 92.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 p -70.9 -26.74 63.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.411 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 79.1 m95 -79.75 -32.59 41.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 174.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.43 -29.67 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 169.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.78 67.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.068 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.406 HG23 ' HA ' ' A' ' 94' ' ' TRP . 28.6 m -109.29 15.79 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -98.93 133.62 42.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.917 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -136.29 125.42 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 58.43 34.5 24.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.82 2.29 90.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.507 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.45 144.84 49.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.73 132.01 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.6 pt -118.37 -8.61 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.053 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.007 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.495 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.5 m-85 -106.53 132.62 20.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.668 0.746 . . . . 0.0 110.913 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 10.1 Cg_exo -72.85 132.71 18.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.746 2.297 . . . . 0.0 112.323 173.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.79 -50.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.151 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.15 151.62 33.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 -163.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.87 132.63 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.839 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 98.1 mt-10 -129.46 150.55 50.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.93 155.06 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -71.34 141.42 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -145.24 163.73 33.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.519 HD23 ' HD3' ' A' ' 248' ' ' PRO . 45.9 tp -96.57 127.55 42.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.5 mt -113.68 125.77 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -133.49 157.07 46.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.8 t-20 -94.67 118.14 31.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -65.72 -35.33 80.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -173.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.54 -35.43 58.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.56 -45.19 17.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 223' ' ' ALA . 64.8 tp -126.62 108.62 23.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.709 . . . . 0.0 110.926 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 124' ' ' ASN . 98.7 Cg_endo -75.52 164.91 31.56 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.329 173.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.552 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.5 t30 24.96 96.3 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.56 155.4 70.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.721 2.281 . . . . 0.0 112.356 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.28 150.36 64.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.593 2.195 . . . . 0.0 112.357 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.11 -21.16 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.923 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.9 p -129.22 159.48 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.699 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 85.0 m95 -73.21 -24.66 60.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.965 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.46 -25.09 64.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.79 -20.02 50.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.687 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.2 mm -58.85 -55.43 46.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.626 0.727 . . . . 0.0 111.15 -168.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.687 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.0 Cg_endo -74.24 -37.34 2.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.45 95.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.01 -39.49 93.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 173.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.91 -37.48 87.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.54 -42.8 99.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.79 -36.29 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.764 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.607 HD12 ' HB3' ' A' ' 146' ' ' ALA . 71.6 mt -70.06 -30.93 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.39 -33.69 63.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.71 -25.03 67.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -102.55 2.82 36.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.7 30.77 61.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 89.1 mttt -116.61 162.63 17.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.508 ' H ' ' HA ' ' A' ' 222' ' ' THR . 44.7 t -120.98 146.91 46.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.607 ' HB3' HD12 ' A' ' 139' ' ' LEU . . . -82.7 -25.63 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.126 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 tp -137.79 136.27 37.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 -173.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 91.6 mmm -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -161.61 161.16 29.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.893 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -86.28 133.41 33.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 41.1 tp -103.38 4.31 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -74.39 -13.1 60.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.95 146.91 63.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 0.0 110.929 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.572 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 42.4 Cg_endo -67.77 -24.93 40.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.571 2.18 . . . . 0.0 112.331 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -49.96 -42.08 48.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -80.33 -23.31 40.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -170.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.9 p -79.27 -23.22 43.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.594 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 49.1 m0 -57.26 -45.72 99.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.533 0.682 . . . . 0.0 110.932 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 91.3 Cg_exo -50.9 -37.34 55.63 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 2.229 . . . . 0.0 112.306 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.17 -40.28 24.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.462 HD12 ' CG2' ' A' ' 347' ' ' VAL . 96.7 mt -73.44 -50.01 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -72.17 -14.96 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.048 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -61.68 -31.76 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.047 -174.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -102.28 1.77 36.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.47 1.58 40.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -86.84 136.61 14.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.363 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.479 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 21.3 t80 -169.95 176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.931 0.395 . . . . 0.0 110.978 -176.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.91 83.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -139.83 153.22 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.18 130.59 35.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.815 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -100.21 115.64 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -148.63 140.11 23.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.93 37.4 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.902 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.13 82.32 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -136.34 151.2 49.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.846 0.355 . . . . 0.0 110.958 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.48 131.71 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 171.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -94.28 109.71 21.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.49 -20.79 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.37 -10.35 46.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -130.21 95.5 3.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 174.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 183' ' ' VAL . 35.0 m -109.47 159.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -173.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -95.86 -2.24 61.26 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 167.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 181' ' ' VAL . 8.0 m -85.96 -5.94 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 54.6 p30 -76.18 10.66 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 171.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 81.8 m-20 84.55 -4.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 168.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.38 -51.98 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.34 -50.2 7.64 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.13 73.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.61 -40.49 97.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -173.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.14 96.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.67 96.46 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.435 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 361' ' ' LEU . 78.8 mt -65.36 -34.93 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.927 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.4 m -56.36 -51.91 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -172.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -68.16 -44.95 74.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.511 ' C ' HD21 ' A' ' 195' ' ' LEU . 8.9 tt -59.83 -50.82 72.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.809 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.32 -37.86 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.132 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.16 -36.83 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.818 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -36.07 83.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.67 -39.84 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.87 -39.81 94.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -84.34 5.41 27.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.1 32.17 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -87.86 -22.92 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -139.58 145.21 38.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.53 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 54.1 t-20 -94.67 134.72 36.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 176.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.09 -25.18 64.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.074 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -95.69 -15.16 22.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.732 -171.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 55.2 m -64.79 137.69 57.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.25 176.67 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.902 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -65.07 -29.64 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.2 m -64.73 -42.95 94.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.906 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.83 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.201 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.86 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.068 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.95 -43.99 90.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.798 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.77 77.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.086 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.0 97.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -64.0 -35.79 81.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 0.0 110.927 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.68 -28.88 69.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.55 -18.99 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.22 47.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.477 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.83 -19.72 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 110.91 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.508 ' HA ' ' H ' ' A' ' 145' ' ' SER . 15.2 t -130.7 144.5 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . . . -94.46 -35.01 12.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 56.2 ttp -145.55 153.81 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -154.48 168.09 27.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.5 tt -126.3 123.45 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.066 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.52 162.44 41.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.22 -165.9 37.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.549 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.839 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 35.7 Cg_endo -66.39 -21.52 53.72 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -65.96 -18.12 65.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.46 5.63 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -62.72 -40.11 96.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.5 t -55.65 109.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -150.17 159.86 44.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.832 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.22 80.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.03 75.09 10.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.976 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.4 p -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.183 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 76.6 p -104.19 -174.8 2.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.27 176.89 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.884 172.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.09 104.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -113.3 -54.56 2.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 50.8 p90 -114.09 159.31 20.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.62 165.04 27.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.463 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 85.7 t -132.34 135.15 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.092 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.41 -179.84 6.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.6 160.49 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.089 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.14 139.27 90.03 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.543 0.687 . . . . 0.0 110.915 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.519 ' HD3' HD23 ' A' ' 115' ' ' LEU . 59.1 Cg_endo -75.1 167.09 27.72 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.359 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.8 p -106.7 158.45 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -132.01 118.93 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.829 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 55.16 34.92 23.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.6 6.24 87.53 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -119.77 150.34 50.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 110.862 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.93 149.72 89.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.626 2.217 . . . . 0.0 112.38 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.699 ' HB3' ' HE1' ' A' ' 129' ' ' TRP . 87.8 p -67.37 -62.23 1.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 14.2 tmtt? -170.75 127.25 0.69 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.508 0.671 . . . . 0.0 110.818 173.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.405 ' HB2' ' HG2' ' A' ' 328' ' ' GLU . 64.8 Cg_endo -76.04 132.69 14.31 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.328 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -157.16 124.24 5.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.95 133.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 167.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.35 135.23 12.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.538 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.76 129.93 75.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.771 0.319 . . . . 0.0 111.158 -174.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 55.8 tp -74.99 132.34 41.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.9 m -130.4 145.42 51.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.04 51.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.04 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -123.54 170.15 15.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -112.77 129.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.294 . . . . 0.0 111.178 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -59.0 120.87 9.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.3 -25.14 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.94 -9.83 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.218 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.0 t -71.04 131.31 87.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.75 -15.03 43.47 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.377 172.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -109.09 21.86 16.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.51 -35.74 21.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.41 -35.07 70.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.83 -41.38 91.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.31 83.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.134 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -64.83 -34.49 78.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.936 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.62 -47.86 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.435 ' HE2' HG13 ' A' ' 33' ' ' ILE . 15.2 m-30 -65.41 -49.29 69.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.605 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.6 tt -57.05 -48.81 77.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -170.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -77.5 -22.63 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.828 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -101.96 -8.16 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -112.68 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 45.3 tp -73.49 -45.54 53.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -168.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.6 60.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.2 p -132.94 160.57 36.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -59.41 -44.93 92.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -71.47 -46.2 60.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.07 -45.45 41.02 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.42 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 302' ' ' VAL . 28.4 tp -71.33 -37.72 71.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.973 -173.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.9 -40.75 95.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.56 99.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.744 HG21 ' HA3' ' A' ' 19' ' ' GLY . 15.0 p -76.48 -29.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -65.06 -24.32 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.11 -24.02 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -91.64 -13.0 32.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -78.68 155.54 78.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.708 . . . . 0.0 110.88 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.88 -95.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.608 2.205 . . . . 0.0 112.43 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -66.09 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.13 25.1 71.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 168.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.448 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -81.77 132.11 35.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.058 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 307' ' ' TYR . 29.4 m -124.28 160.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.06 -12.67 59.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.013 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 59.5 tp -74.26 120.27 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.903 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.62 -45.75 91.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.3 m -60.6 -42.43 96.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.72 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.536 ' HB3' HG22 ' A' ' 302' ' ' VAL . 1.0 OUTLIER -71.81 -32.49 67.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.091 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -61.93 -32.02 72.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.01 -38.3 82.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -75.17 -38.28 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 301' ' ' ALA . 94.1 mt -65.13 -27.58 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.85 -16.64 43.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.109 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -71.79 -22.63 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 63.7 t0 -90.33 117.44 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.822 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 37.0 Cg_endo -61.54 -25.32 79.33 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.418 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.3 mtm-85 -70.36 -39.72 74.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 51.1 mm -79.98 -39.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.255 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.116 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.63 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.9 p -73.45 -35.83 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.2 mtm -68.06 -38.72 82.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -65.27 -42.65 92.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -71.79 -35.33 69.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.32 91.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.25 -19.07 65.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -108.37 -4.93 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.67 -167.09 42.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.532 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . 0.405 ' HG2' ' HB2' ' A' ' 257' ' ' PRO . 73.1 mm-40 -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.773 0.321 . . . . 0.0 110.948 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 329' ' ' ILE . 2.8 tp -66.35 124.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 -169.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.599 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -46.44 -52.22 30.84 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.847 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 330' ' ' MET . 38.9 Cg_endo -63.99 85.54 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.768 2.312 . . . . 0.0 112.349 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.697 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 72.0 m-80 -108.74 30.52 6.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 71.4 mt 93.56 131.07 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.71 0.767 . . . . 0.0 111.06 -169.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.18 -25.58 50.31 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.768 2.312 . . . . 0.0 112.308 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.415 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.4 mt-30 -60.7 -24.64 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 176.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.7 mmm -63.8 -30.89 71.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.8 m -62.93 -43.08 99.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.12 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -60.57 -38.97 86.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -64.43 -38.28 90.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.177 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.39 -42.97 94.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.144 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.572 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 55.7 ttp180 -55.3 -43.81 75.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.4 m -59.91 -42.93 94.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.16 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.78 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.462 ' CG2' HD12 ' A' ' 161' ' ' ILE . 54.4 t -67.05 -52.36 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.67 -45.18 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -171.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.58 -37.86 89.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.32 -44.24 68.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.79 74.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.8 p -76.05 -12.58 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.32 8.24 87.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.482 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -78.26 -25.7 46.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.917 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -135.12 155.99 49.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 90.9 m -71.88 151.5 43.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.21 -48.8 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.63 -42.34 86.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.21 -46.51 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.882 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.0 95.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.154 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 55.7 tp -66.08 -43.05 88.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.63 -48.43 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.922 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.02 -37.01 84.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.904 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.02 -43.58 64.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 7.6 mm-40 -77.16 -26.94 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.2 m -56.1 -35.64 67.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.161 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.95 -30.17 70.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.46 -41.92 89.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.3 p -94.04 -15.08 25.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.226 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.764 0.316 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.8 mt -85.74 125.97 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -136.62 176.92 8.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -171.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.95 132.06 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.96 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.79 59.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.64 159.97 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.886 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 7' ' ' LEU . 2.9 pp -147.15 149.51 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 177.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 99.5 t -120.58 127.6 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.185 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.602 HG22 ' HB ' ' A' ' 59' ' ' ILE . 3.3 pt -121.8 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.169 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.457 ' HB3' HD23 ' A' ' 43' ' ' LEU . 26.7 m0 -114.8 132.34 56.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.419 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.4 tt -149.23 153.71 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 -172.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.434 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.9 t-20 -55.87 128.54 35.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.66 -19.44 79.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.472 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.93 -46.4 90.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.904 -163.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.98 66.57 1.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.838 150.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -99.55 -46.15 2.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.552 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.402 ' HA ' HG11 ' A' ' 37' ' ' VAL . 80.7 t80 -69.95 -43.35 71.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.983 -159.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -65.63 -49.95 66.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 -160.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.66 -50.45 58.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.469 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 20' ' ' LEU . 53.7 mt -64.87 -37.24 86.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.12 -48.81 61.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -68.03 -45.77 73.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 p -69.85 -35.61 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.107 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.53 84.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.15 -46.32 89.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.32 -38.42 87.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -61.92 -35.66 79.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.782 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.39 -38.71 68.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.1 -41.05 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -171.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.0 p -105.57 -17.89 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.207 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.58 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.479 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 33' ' ' ILE . 19.5 tt -82.91 127.39 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.21 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -67.17 124.48 23.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.73 130.94 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.162 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.3 m -123.16 113.76 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.458 HG23 HD12 ' A' ' 9' ' ' ILE . 58.4 t -100.78 122.02 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.063 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.7 mt-10 -129.49 139.3 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -140.02 68.86 35.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 0.0 110.86 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 36.8 Cg_endo -75.7 -15.62 19.15 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.396 -165.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.8 m-20 73.13 8.34 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -171.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.75 -4.85 54.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.873 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 10' ' ' TRP . 81.5 mt -51.74 -50.01 61.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -156.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.01 -35.3 78.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -88.05 -40.34 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -73.91 -45.26 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -167.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.686 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.9 t80 -51.69 -58.43 11.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.642 0.734 . . . . 0.0 110.834 -166.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 19.9 Cg_endo -63.9 -31.04 67.68 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.754 2.303 . . . . 0.0 112.274 -173.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -75.35 -47.25 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.2 m -76.24 -26.05 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.171 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.35 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.044 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.99 -24.47 66.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.053 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.7 p -95.09 4.51 53.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 22.72 61.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.518 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.8 t0 -119.52 -176.12 3.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.31 -170.3 15.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.503 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.403 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 92.5 Cg_endo -82.37 158.96 17.28 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.81 -42.28 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 167.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.602 ' HB ' HG22 ' A' ' 9' ' ' ILE . 88.1 mt -133.23 139.53 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 tp -128.8 132.44 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.221 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -101.3 135.93 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -139.88 153.61 47.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.2 -102.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -122.27 -54.66 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.9 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -67.13 -46.08 75.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -73.26 -32.34 64.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.83 -47.31 85.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.859 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.17 -50.3 61.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.576 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.21 -41.98 99.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.532 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -70.05 -31.27 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.89 99.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 174.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.93 -26.28 64.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -85.02 2.1 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 37.1 61.37 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.554 173.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -80.33 -8.8 59.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 110.883 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -132.24 144.17 50.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 157.83 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 139.09 52.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.29 156.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.075 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -134.34 62.62 56.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.532 0.682 . . . . 0.0 111.161 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.01 149.93 42.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.745 2.297 . . . . 0.0 112.257 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -77.27 176.45 8.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.08 -29.92 67.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.98 69.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.07 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -63.21 -37.05 85.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HA ' ' CD1' ' A' ' 94' ' ' TRP . 90.1 mt-30 -65.39 -39.97 92.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.81 -35.85 79.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.24 -29.31 66.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.423 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.2 mp -104.71 -106.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 23.0 t80 -162.89 133.96 3.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.67 0.748 . . . . 0.0 110.952 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.4 Cg_exo -56.21 -42.96 60.76 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.297 -174.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.14 -40.53 94.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 p -71.44 -25.64 62.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.423 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 54.5 m95 -80.13 -29.33 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 173.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -62.67 -30.11 71.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.827 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.71 -25.22 66.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.52 21.95 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.131 -174.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -109.94 139.58 44.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -141.54 126.85 18.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.65 34.46 22.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.888 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.45 90.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 173.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.16 144.82 50.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.85 130.73 35.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.401 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.7 pt -118.12 -12.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -169.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.28 165.33 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.036 -170.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.2 m-85 -109.83 134.31 20.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.663 0.745 . . . . 0.0 110.927 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.4 Cg_exo -66.31 126.8 16.25 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.318 173.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -111.61 -40.29 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.95 155.83 23.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.056 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.23 131.97 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -128.91 144.7 51.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.12 155.08 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.86 138.47 44.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.948 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -147.86 163.93 35.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.88 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.31 129.84 42.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.6 mt -107.09 128.02 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -136.23 148.19 47.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -90.72 117.08 29.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.597 ' HE2' ' HA3' ' A' ' 243' ' ' GLY . 66.9 mttm -70.83 -30.61 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -171.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -76.85 -36.32 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -77.32 -38.71 49.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.5 tp -136.53 111.86 9.86 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.897 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 124' ' ' ASN . 87.8 Cg_endo -74.98 169.3 22.94 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.659 2.239 . . . . 0.0 112.35 170.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.2 t30 25.22 96.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 110.961 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 55.5 Cg_endo -68.03 158.99 54.99 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.72 147.58 69.81 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.4 -29.7 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.871 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.6 p -127.94 159.6 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -68.56 -33.4 74.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.5 -29.78 64.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.813 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.57 -21.19 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 28.5 mm -60.93 -51.5 78.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.701 0.763 . . . . 0.0 111.09 -168.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 48.5 Cg_endo -70.35 -38.78 6.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.754 2.303 . . . . 0.0 112.324 -174.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.16 94.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.91 -36.91 83.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.73 -37.44 86.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.7 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.33 -37.3 83.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 146' ' ' ALA . 58.8 mt -69.32 -36.46 76.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.73 -35.1 70.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.22 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.3 3.1 46.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.0 29.47 60.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -123.49 163.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.489 ' H ' ' HA ' ' A' ' 222' ' ' THR . 35.4 t -118.54 150.48 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 171.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -81.06 -23.96 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.82 141.73 50.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 68.8 mmm -140.1 119.93 13.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 161.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -160.05 164.99 32.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.7 t-20 -84.2 110.7 18.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.878 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 206' ' ' ALA . 27.1 tp -98.37 5.63 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -174.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.75 -2.27 57.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 148.46 69.67 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.656 0.741 . . . . 0.0 110.804 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.772 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 56.6 Cg_endo -74.76 -22.48 15.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.613 2.208 . . . . 0.0 112.265 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -52.79 -43.9 66.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 150' ' ' ASN . 81.3 m-85 -83.51 -20.4 33.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.713 -172.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.2 p -81.88 -21.26 37.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 4.4 m95 -60.08 -45.5 97.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.431 0.634 . . . . 0.0 110.884 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 99.2 Cg_exo -45.71 -31.1 7.15 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.258 . . . . 0.0 112.339 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.569 ' C ' HD13 ' A' ' 160' ' ' LEU . 2.7 tm? -82.29 -45.17 15.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.647 HG23 ' HA3' ' A' ' 191' ' ' GLY . 92.1 mt -74.66 -44.06 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.493 ' HB3' ' CD1' ' A' ' 167' ' ' TYR . . . -69.77 -19.01 63.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -63.84 -29.64 70.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -102.91 0.19 32.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.6 15.12 9.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 165.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 161' ' ' ILE . . . -114.83 126.34 7.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.423 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.493 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 17.9 t80 -159.56 172.17 18.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 110.921 -171.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.11 65.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.89 149.38 43.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -82.78 139.47 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -97.55 104.2 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 170.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.96 122.75 11.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.74 36.43 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -172.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.09 82.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.21 151.6 50.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -97.94 141.58 30.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -103.61 117.34 34.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 170.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.14 -18.07 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.04 -10.25 55.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -128.91 75.5 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.917 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.495 HG21 ' H ' ' A' ' 184' ' ' ASP . 15.4 m -134.95 172.96 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.92 -11.97 75.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.562 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.6 m -91.84 -7.68 10.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 111.044 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 35.3 p30 -85.45 7.22 23.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 86.3 m-20 83.72 -8.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 165.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.53 10.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.09 -44.68 34.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.533 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.508 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -70.15 -32.68 70.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -166.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -62.89 -45.59 91.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.949 -164.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.94 95.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.647 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.38 -41.26 99.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.43 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.19 -44.26 88.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.037 0.446 . . . . 0.0 111.008 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.5 m -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.216 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.05 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.828 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.71 -40.31 94.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.33 -36.83 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.173 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.26 -36.33 82.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.38 -41.71 80.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.63 -35.5 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.95 -35.96 81.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -84.08 2.98 36.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 62.71 35.14 14.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.914 173.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -76.98 -25.73 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.963 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -147.46 149.38 32.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.526 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 53.1 t-20 -95.1 136.73 35.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.441 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -63.02 -26.84 69.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -175.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.21 -13.79 27.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.899 -172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.8 m -65.63 134.93 54.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 49.9 p30 -112.91 173.83 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -71.36 -25.56 62.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.01 -38.47 88.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.42 -32.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.179 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.76 72.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.047 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.59 -46.96 85.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.834 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.64 76.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.42 96.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -65.09 -35.97 82.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.04 -29.31 70.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.82 -20.67 16.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.16 25.42 31.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.405 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.42 -26.75 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.489 ' HA ' ' H ' ' A' ' 145' ' ' SER . 7.2 t -128.99 147.49 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.05 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.73 18.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 175.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.1 mtm -140.23 160.05 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -169.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -150.15 161.79 41.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -121.34 120.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -146.27 159.58 43.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.472 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -104.77 -137.46 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -175.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.472 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 31.6 Cg_endo -70.49 -26.24 24.35 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.692 2.261 . . . . 0.0 112.278 -175.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -66.49 -16.13 63.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.7 23.06 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -62.5 -30.65 71.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 t -69.19 107.16 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -144.88 127.85 16.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.928 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.43 80.33 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -85.29 74.22 10.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.832 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 75.5 p -119.89 -14.97 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.2 p -92.96 -170.05 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.39 175.29 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.935 170.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.71 107.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.192 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -118.48 -57.08 2.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -113.49 160.03 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.597 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . -146.76 166.4 28.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.438 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 96.2 t -130.12 134.75 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.72 177.14 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.93 159.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.5 144.94 98.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.561 0.696 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.95 158.37 56.94 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.681 2.254 . . . . 0.0 112.252 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.1 p -107.22 151.33 25.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -128.76 116.0 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 55.18 36.47 27.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.97 69.21 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -125.32 147.08 56.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 110.996 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.3 154.83 72.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 0.0 112.379 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -67.08 -58.44 4.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 110.914 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.405 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 32.4 pttt -169.91 141.89 1.88 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 0.0 110.864 168.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.65 129.04 11.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.417 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -163.12 112.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.09 135.05 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.25 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -114.45 119.08 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.749 0.309 . . . . 0.0 111.211 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.6 130.01 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.1 m -130.54 145.04 51.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -170.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.0 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.07 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -117.09 155.19 16.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.412 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.6 mt -104.49 126.75 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 111.164 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.98 120.06 8.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.91 67.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.075 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.69 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -72.48 131.06 85.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.738 0.78 . . . . 0.0 110.846 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.65 -12.8 33.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.214 . . . . 0.0 112.32 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.05 27.54 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.854 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -53.85 -34.42 59.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.39 -38.98 91.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.37 -41.01 90.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.816 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.0 79.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.126 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.86 -47.84 79.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 98.3 mt-10 -69.36 -53.04 21.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -175.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 8.5 m-30 -65.48 -39.6 92.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.83 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.1 tt -61.55 -48.07 82.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.978 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -83.06 -26.64 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 93.0 m-20 -100.56 -21.03 15.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -169.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 21.3 m-30 -118.69 -56.38 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.862 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 280' ' ' LEU . 38.4 mt -69.02 -37.1 78.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 106' ' ' TYR . 89.2 mt -94.84 60.99 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.1 p -127.75 168.82 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.17 171.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -53.24 -44.37 68.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.48 -42.12 30.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.33 -49.33 12.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.434 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 304' ' ' LEU . 25.0 tp -72.05 -35.5 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.938 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.97 -40.06 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.835 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.36 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.98 -35.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.157 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -77.27 -24.54 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.38 -27.29 68.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -88.01 -15.33 36.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.65 153.11 93.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 0.0 110.987 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.6 -55.95 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.573 2.182 . . . . 0.0 112.33 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -82.05 -46.62 13.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 84.98 -8.84 68.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.423 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -55.29 118.54 4.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.061 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.757 HG11 ' HB3' ' A' ' 307' ' ' TYR . 4.3 p -128.72 153.49 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 -170.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.42 -17.19 56.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.503 ' HB2' HD21 ' A' ' 290' ' ' LEU . 56.1 tp -70.86 124.91 25.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.06 -37.39 84.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -61.29 -51.0 70.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.757 ' HB3' HG11 ' A' ' 302' ' ' VAL . 1.6 t80 -73.73 -33.25 64.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.67 -38.29 89.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.56 -40.18 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -73.76 -37.77 64.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.802 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.414 ' HB3' HG21 ' A' ' 317' ' ' ILE . 84.3 mt -65.89 -28.23 68.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.66 -16.62 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.43 -21.77 60.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.885 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 67.7 t0 -90.17 119.55 69.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.796 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 32.0 Cg_endo -62.32 -25.44 76.51 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.427 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.4 mtm-85 -70.12 -40.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 311' ' ' LEU . 50.9 mm -79.64 -40.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -178.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.96 76.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.06 93.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.079 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 72.0 p -71.25 -36.52 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.13 -34.64 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -65.02 -40.86 95.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -72.03 -35.04 69.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.93 90.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -72.86 -14.37 61.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.818 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -107.72 -8.34 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.858 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.25 -158.37 34.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.483 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -127.11 140.1 52.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 329' ' ' ILE . 2.9 tp -68.24 120.24 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -47.95 -51.51 47.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.608 0.718 . . . . 0.0 110.878 -174.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 330' ' ' MET . 68.8 Cg_endo -69.23 79.53 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.423 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 53.5 t-20 -119.58 -3.08 10.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' A' ' 336' ' ' MET . 18.2 tt 164.97 124.9 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 111.114 -165.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.75 -29.35 12.8 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.587 2.191 . . . . 0.0 112.334 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -64.98 -17.76 64.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.914 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.492 ' HB2' HG23 ' A' ' 333' ' ' ILE . 61.4 ttp -62.97 -27.94 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -174.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -60.77 -41.73 96.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.6 71.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.134 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -65.6 -30.61 71.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -56.57 -41.2 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.17 -37.31 78.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.46 -43.57 85.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.93 -29.11 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.772 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 60.5 ttt180 -57.31 -44.96 84.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.0 m -62.21 -44.39 96.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.23 81.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.82 -50.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.0 mm -65.9 -45.43 91.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -66.21 -37.27 85.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.85 63.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.9 -35.04 76.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -80.71 -10.85 59.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.69 14.39 81.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.575 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -79.87 -26.6 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -137.0 156.22 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.006 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 98.9 m -68.6 145.86 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.1 -49.94 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.177 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.43 -40.84 85.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.52 -46.43 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.508 HD11 ' HB1' ' A' ' 188' ' ' ALA . 63.5 tp -64.16 -46.59 83.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.97 -48.31 71.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.58 -38.8 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -78.6 -46.39 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -78.97 -30.87 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -169.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -59.0 -36.06 74.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.88 -30.1 69.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.5 mt -67.89 -44.67 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.127 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.2 p -98.18 -11.23 22.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.057 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.762 0.315 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -89.76 135.1 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.166 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 91.7 mt-10 -129.73 165.03 22.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -71.31 122.04 19.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.12 20.09 50.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.542 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 34' ' ' LYS . 93.5 mttt -139.84 155.11 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.812 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.6 pp -149.15 148.75 30.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -123.16 125.35 71.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.48 HG12 ' HB ' ' A' ' 59' ' ' ILE . 53.2 mt -119.01 130.73 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.409 ' HB2' HD11 ' A' ' 60' ' ' ILE . 21.5 m0 -110.83 136.68 49.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 -173.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 tt -144.56 147.63 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -75.0 172.4 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.62 -19.97 15.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.507 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -79.4 51.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 110.857 174.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 17' ' ' TYR . 54.5 pttt -80.14 117.63 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.956 -159.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.65 10.03 1.64 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.543 154.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' H ' ' C ' ' A' ' 15' ' ' LYS . 23.1 t80 -39.99 -36.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -57.63 -47.12 83.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.819 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -72.63 -38.18 57.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.405 174.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -36.87 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.009 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.55 95.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.221 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -62.02 -45.87 91.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.0 m -75.08 -28.28 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.6 89.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.404 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.42 -40.71 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.82 -45.85 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.972 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.78 -43.27 93.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.46 -33.16 74.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -74.99 -40.37 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.003 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -78.78 -40.53 32.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -101.04 -25.15 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -172.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.58 6.46 87.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.752 HD11 HD13 ' A' ' 275' ' ' LEU . 96.6 mt -78.69 125.05 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 111.094 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 89.3 tttt -64.42 118.06 8.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 173.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.82 129.34 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -134.8 110.1 8.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.228 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 9' ' ' ILE . 47.6 t -110.93 126.51 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.069 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -125.93 152.8 45.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -133.69 67.68 75.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.574 0.702 . . . . 0.0 110.892 172.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 30.8 Cg_endo -78.89 -15.38 13.29 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.612 2.208 . . . . 0.0 112.329 -164.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 64.3 m-20 77.28 10.97 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.22 -5.1 34.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -49.88 -60.06 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.929 -154.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.11 -34.82 77.06 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.52 -33.45 54.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -78.49 -30.17 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.805 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 8.6 m-30 -49.38 -52.15 51.84 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.586 0.707 . . . . 0.0 110.877 -168.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 60.9 Cg_endo -69.56 -27.57 27.28 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.642 2.228 . . . . 0.0 112.337 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.63 -49.98 12.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.17 -33.46 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.099 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.96 86.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.129 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.35 53.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.66 -1.21 50.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.195 -173.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.05 74.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.82 145.4 25.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.943 0.401 . . . . 0.0 110.863 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.49 82.19 0.22 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.428 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.24 124.19 12.22 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.71 2.274 . . . . 0.0 112.451 157.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.13 -42.64 23.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 -156.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.48 ' HB ' HG12 ' A' ' 9' ' ' ILE . 74.7 mt -130.07 133.19 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.096 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 10' ' ' TRP . 42.2 mm -125.01 127.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -172.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -132.93 115.64 15.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.519 ' O ' ' C ' ' A' ' 63' ' ' ALA . 26.2 p-90 -177.13 173.2 1.83 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 175.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 62' ' ' TRP . . . -25.71 96.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' TRP . 76.2 t60 -59.03 -32.37 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -172.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -51.65 -50.18 60.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.847 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -74.63 -26.64 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.04 -26.68 67.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.422 ' O ' ' HB1' ' A' ' 71' ' ' ALA . . . -64.91 -37.73 94.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.28 -35.45 84.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -72.06 -24.9 61.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 76' ' ' LEU . . . -59.73 -39.43 84.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 171.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.17 -28.64 68.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -84.96 4.16 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.98 32.4 69.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.563 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.3 tp -72.9 -24.37 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.748 0.308 . . . . 0.0 110.825 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -132.09 145.99 51.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -170.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -74.96 152.23 38.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -174.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.81 131.34 50.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.972 171.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.84 140.08 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.212 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.8 m -92.72 121.91 65.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 0.0 111.189 -174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -54.96 130.71 42.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.75 2.3 . . . . 0.0 112.343 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.46 118.32 35.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.01 -46.11 89.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.96 87.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.066 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.59 -39.95 95.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -58.06 -43.62 87.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.03 -33.0 74.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.22 -27.2 68.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 304' ' ' LEU . 5.9 mp -112.47 -125.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -129.78 148.05 67.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.671 0.748 . . . . 0.0 110.919 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.65 -30.32 60.21 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.683 2.255 . . . . 0.0 112.277 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -71.69 -35.65 70.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.4 p -71.81 -24.67 61.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.131 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -39.93 71.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 171.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.84 -34.53 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.87 74.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.033 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.799 HG22 ' HD3' ' A' ' 107' ' ' PRO . 34.3 m -111.36 14.06 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -164.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HB3' HD21 ' A' ' 103' ' ' LEU . 53.3 ptt85 -119.98 149.94 41.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -135.73 119.57 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.961 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.9 t30 61.86 35.2 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.87 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.54 89.08 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.465 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -122.18 149.92 42.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 103' ' ' LEU . 50.9 mt -74.95 133.82 41.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -174.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.8 pt -115.72 -7.36 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.99 174.03 10.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.111 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.45 139.29 28.49 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.711 0.767 . . . . 0.0 110.99 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.799 ' HD3' HG22 ' A' ' 97' ' ' VAL . 56.5 Cg_endo -79.82 132.28 9.6 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -172.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.1 -42.01 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.53 147.99 27.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -163.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.6 t -130.73 132.35 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.02 149.91 47.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.25 142.89 27.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.42 126.38 29.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.7 m -142.59 159.09 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.815 -166.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -98.93 123.87 43.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.6 mt -110.48 133.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -137.25 156.63 48.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.95 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.441 ' HB3' HD22 ' A' ' 121' ' ' LEU . 54.9 t-20 -96.53 120.08 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.03 -27.74 69.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -67.39 -42.25 83.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -165.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.627 ' H ' HD21 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -99.97 -24.76 14.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.5 tp -124.21 99.5 37.15 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.648 0.737 . . . . 0.0 110.936 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.15 -14.96 11.82 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.665 2.243 . . . . 0.0 112.326 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.4 t-20 -157.77 103.94 1.78 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.597 0.713 . . . . 0.0 110.97 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.5 Cg_endo -68.75 147.11 68.59 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 64.7 Cg_exo -55.09 145.03 66.55 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.769 2.313 . . . . 0.0 112.308 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.72 -17.65 37.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -143.79 161.13 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.295 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -68.64 -27.32 65.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.886 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.04 -29.62 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 95.9 mt-10 -78.65 -15.68 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -176.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 38.7 mm -59.17 -54.34 57.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.721 0.772 . . . . 0.0 111.12 -171.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 24.5 Cg_endo -62.51 -39.89 42.18 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.318 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.27 99.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.134 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.18 -40.29 97.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.57 ' O ' HD21 ' A' ' 139' ' ' LEU . 10.0 t70 -62.16 -41.65 98.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.97 -39.6 92.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.49 -44.19 75.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -176.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 39.0 ttpt -56.08 -26.2 48.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 169.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.11 -20.27 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.46 11.5 37.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.7 30.46 66.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.51 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 96.7 mttt -125.29 157.25 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 110.876 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 t -116.51 153.69 31.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.945 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.21 66.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.894 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.2 pp -145.88 146.07 30.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.7 ttm -148.05 132.32 17.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.914 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -156.7 169.79 23.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.16 122.89 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 -174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.58 7.41 18.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -85.1 -8.68 58.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.845 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -127.19 149.37 69.39 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 110.97 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 -31.99 9.27 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.79 -39.99 40.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -80.5 -37.57 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.9 p -83.82 -14.02 52.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.1 -170.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.613 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 24.1 m0 -49.99 -53.51 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.711 . . . . 0.0 110.827 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 9.5 Cg_endo -53.43 -33.99 69.51 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.453 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.94 -45.4 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.816 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 89.3 mt -74.22 -41.67 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -175.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.13 -6.78 51.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.13 -35.03 59.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.3 5.35 52.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.36 10.58 63.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.525 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -130.05 86.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.482 ' O ' ' HB1' ' A' ' 168' ' ' ALA . 63.1 t80 -167.49 153.88 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 167' ' ' TYR . . . 74.94 -91.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.08 170.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 181' ' ' VAL . 46.0 p90 -167.35 155.03 9.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.954 -171.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.7 129.34 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -116.89 128.91 55.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.94 140.21 25.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.956 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 51.01 45.81 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 10.91 71.05 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.513 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.65 146.87 52.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.891 -174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -99.35 137.2 38.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -94.82 112.67 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 178' ' ' ILE . 6.4 tp -71.24 -20.01 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.16 -8.76 53.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -120.19 91.34 3.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 173.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 169' ' ' PHE . 35.3 m -106.04 155.87 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.78 7.47 65.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.488 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -97.5 -19.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 111.221 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -101.6 14.3 32.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 167.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -93.95 154.23 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -170.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.35 -33.36 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.073 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.67 92.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.477 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.94 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.842 0.353 . . . . 0.0 111.082 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.4 -39.2 91.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.855 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.54 95.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.816 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -42.18 98.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.592 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.62 -39.71 91.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 110.831 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 86.1 m -59.75 -41.71 91.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.086 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.44 -47.23 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.19 -43.13 96.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.83 -40.83 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.98 -38.01 84.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.4 OUTLIER -60.97 -35.88 77.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.982 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.41 -40.0 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.97 -35.18 79.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -80.15 0.74 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.034 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 63.64 30.07 14.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -92.01 -21.61 20.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 83.9 mmm -131.98 155.0 48.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 169.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.453 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 94.4 m-20 -104.71 139.14 39.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 173.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.98 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.101 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -96.47 0.43 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 98.5 m -56.57 125.94 24.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.194 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -119.12 179.76 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.92 -39.69 90.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.1 m -58.62 -42.95 89.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.92 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.18 -43.44 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.35 -42.9 87.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.48 87.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.91 97.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.08 -37.84 84.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.867 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.0 -28.64 69.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.11 -22.25 15.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 21.67 40.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.542 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.04 -25.91 29.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 110.827 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 79.1 m -126.48 135.34 51.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.084 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.78 -40.37 48.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.185 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 78.3 mtm -133.7 156.45 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -164.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -151.8 158.34 43.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.202 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 46.2 mm -115.85 114.97 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -163.36 178.39 8.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -99.21 -171.68 31.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.463 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.77 -15.11 40.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -63.49 -12.24 30.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.919 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.6 78.21 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.143 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -66.32 -22.76 66.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 50.1 m -54.14 169.84 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.602 ' HB2' ' O ' ' A' ' 233' ' ' SER . 91.6 m-20 73.86 55.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 -169.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.0 128.46 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -68.92 81.4 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.809 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -58.18 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.3 p -69.12 -15.3 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -160.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.61 170.52 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.15 119.77 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.093 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -122.02 -42.42 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.925 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -105.13 153.38 21.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.933 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.93 160.41 24.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.427 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.33 131.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.97 0.414 . . . . 0.0 111.101 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.16 179.13 7.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -84.84 159.63 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.124 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.4 mt -68.43 150.03 97.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 110.765 -169.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 44.6 Cg_exo -56.74 150.53 53.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -91.17 163.2 14.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -136.33 113.19 10.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 56.71 43.48 25.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.735 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.68 1.29 80.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 169.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -149.99 147.04 21.3 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.524 0.678 . . . . 0.0 110.991 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.84 127.04 11.68 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 88.9 p -56.71 -57.05 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -170.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -165.09 119.97 0.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.68 149.87 23.92 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.617 2.212 . . . . 0.0 112.324 175.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 158' ' ' TRP . 69.4 m-85 -138.84 120.51 15.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.863 171.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.04 125.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.132 177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.65 139.36 15.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.459 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.14 124.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.349 . . . . 0.0 111.052 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.414 HD21 ' HA ' ' A' ' 262' ' ' LEU . 28.3 mt -78.96 144.67 34.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 169.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 53.6 p -142.42 163.77 31.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.73 135.56 52.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.099 176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.68 156.5 15.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.52 126.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.146 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -65.8 129.25 39.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -66.07 -28.99 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.44 -11.42 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -80.11 127.93 75.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.655 0.74 . . . . 0.0 110.899 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.53 -6.69 19.09 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.675 2.25 . . . . 0.0 112.319 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -108.05 24.12 13.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.889 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -57.56 -34.12 68.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 -172.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.79 -45.91 63.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.752 HD13 HD11 ' A' ' 33' ' ' ILE . 4.5 pp -76.44 -31.5 57.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.531 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -66.24 -40.83 90.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 174.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -66.56 -39.49 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.59 -38.67 77.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -56.9 -45.51 82.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 62.9 tp -63.79 -50.8 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.82 -34.65 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.8 -27.87 13.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -163.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.785 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 87.1 m-85 -120.45 -49.55 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 80.4 mt -73.63 -35.91 65.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.924 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.98 74.05 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.971 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.0 p -141.87 170.17 16.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.006 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.25 -43.09 74.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -76.45 -46.07 28.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.91 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.785 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.92 -44.15 25.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.01 -36.43 84.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.911 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.97 -41.64 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.34 -34.82 74.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.819 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 97.0 t -80.84 -45.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -71.15 -28.78 64.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.26 -10.97 12.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.47 -33.08 62.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.98 150.02 42.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 0.0 110.903 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -58.39 -57.13 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.394 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.54 -53.19 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.41 62.56 6.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.509 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -81.95 123.12 28.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.123 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.685 HG23 HD22 ' A' ' 311' ' ' LEU . 33.2 m -115.49 156.24 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.074 -163.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.43 -17.07 55.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.055 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.425 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 60.8 tp -78.25 117.85 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.95 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.7 -46.84 87.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.1 t -63.67 -50.99 67.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.771 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.09 -34.06 72.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -57.28 -39.5 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -55.51 -38.12 68.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.685 HD22 HG23 ' A' ' 302' ' ' VAL . 4.3 pp -74.88 -22.05 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -73.01 -6.37 45.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.998 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.82 -12.03 61.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.69 129.94 63.3 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -32.39 32.06 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -69.76 -37.04 76.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.883 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 311' ' ' LEU . 48.6 mm -80.37 -40.98 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.35 -35.88 70.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -169.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.71 91.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.175 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 95.4 m -68.52 -39.88 81.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mmt -67.58 -35.42 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.92 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 327' ' ' GLY . 84.5 m-20 -69.27 -35.93 76.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 176.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.15 85.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -72.83 -22.91 60.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.93 -5.71 17.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.37 -159.65 32.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -130.01 123.45 30.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 329' ' ' ILE . 1.1 mp -75.24 124.12 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 329' ' ' ILE . 92.0 mtp 60.56 160.18 0.11 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.535 0.683 . . . . 0.0 110.886 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -64.96 -103.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.0 112.438 161.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -139.96 -48.88 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 158.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.558 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 46.5 pt -130.04 161.36 60.38 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.648 0.737 . . . . 0.0 111.121 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.558 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 19.5 Cg_endo -60.72 -22.03 71.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -69.81 -16.41 63.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.3 mmt -66.18 -26.09 67.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 87.7 p -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.08 -51.33 25.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -171.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 339' ' ' PHE . 1.0 OUTLIER -65.22 -26.24 68.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.953 178.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -66.15 -39.5 89.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -63.57 -37.47 87.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.98 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.163 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.68 -32.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -49.75 -47.92 50.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.8 m -60.35 -39.67 87.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.143 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -64.47 -37.62 88.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.095 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.84 -44.86 88.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.9 -43.09 97.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.119 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.06 -39.86 93.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.74 68.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.046 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.21 -36.64 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -174.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.9 p -78.6 -9.61 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.904 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.56 9.53 85.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.37 -31.17 65.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.865 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -133.66 160.02 38.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -76.02 169.92 17.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.76 -44.52 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.83 -45.9 91.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.9 -46.45 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.48 89.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.56 -37.37 82.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.64 -35.27 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.58 -31.4 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -65.02 -47.5 77.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.7 m -60.48 -42.18 95.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.122 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.82 -39.24 80.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 89.9 mt -62.69 -42.14 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.108 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 64.9 p -90.8 -14.56 31.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.565 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 85.9 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.701 0.286 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.416 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 86.3 mt -76.04 129.08 37.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 92.6 mt-10 -130.11 166.76 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.937 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.43 121.94 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 20.02 52.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.489 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 96.3 mttt -141.49 156.36 45.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.8 pp -149.29 150.64 32.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.3 t -124.99 121.46 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.443 HG12 ' HB ' ' A' ' 59' ' ' ILE . 87.1 mt -119.58 132.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.212 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.413 ' HB2' HD11 ' A' ' 60' ' ' ILE . 25.1 m0 -115.75 140.42 49.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.953 HD11 ' HA3' ' A' ' 16' ' ' GLY . 17.3 tt -144.06 143.65 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -73.71 -179.82 3.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -172.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.0 -2.28 4.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.52 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.636 ' O ' ' C ' ' A' ' 15' ' ' LYS . 46.9 t0 -67.34 70.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.856 173.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 14' ' ' ASP . 87.2 tttt -14.55 107.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -166.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.953 ' HA3' HD11 ' A' ' 11' ' ' ILE . . . -108.98 -11.05 23.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.45 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -66.3 -41.75 89.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 110.896 -151.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.68 -52.52 62.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.911 -162.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.877 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -66.61 -44.33 90.04 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.415 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.2 mt -58.46 -40.48 82.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 110.896 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.33 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.35 -46.84 88.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 m -74.24 -28.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.32 -37.73 95.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.458 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.63 -41.46 96.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.874 0.369 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.39 -43.93 89.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.1 -43.52 95.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.83 -34.86 76.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.25 -40.1 67.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -79.08 -40.65 30.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -172.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.4 p -100.72 -24.54 14.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.174 -171.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.56 8.53 86.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.42 HG21 HD21 ' A' ' 7' ' ' LEU . 89.6 mt -80.34 124.9 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.21 118.88 8.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.433 HG11 ' HA3' ' A' ' 24' ' ' GLY . 70.0 t -98.46 134.31 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -132.65 112.39 11.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.21 121.55 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.2 mt-10 -128.21 149.98 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.822 -176.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -135.04 68.55 70.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.577 0.703 . . . . 0.0 110.918 171.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 29.0 Cg_endo -79.39 -14.35 13.13 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.683 2.256 . . . . 0.0 112.29 -162.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.4 m-20 76.49 8.95 3.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.14 -9.99 37.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.948 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 3.2 mp -51.34 -55.56 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 -156.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -54.33 -38.98 66.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.65 -32.84 62.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.94 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.96 -29.69 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 43' ' ' LEU . 8.7 m-30 -49.81 -51.59 59.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.706 0.765 . . . . 0.0 110.968 -164.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 96.0 Cg_endo -79.41 -29.11 3.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.576 2.184 . . . . 0.0 112.357 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -75.54 -46.08 34.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.835 -171.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.5 m -56.78 -33.39 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.08 87.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.58 -32.6 47.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.2 p -95.02 -4.9 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.092 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.95 24.71 66.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.435 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -80.94 143.05 32.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.843 0.354 . . . . 0.0 110.843 172.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 2' ' ' ILE . . . -122.1 62.9 0.53 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -164.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.88 121.06 7.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.686 2.257 . . . . 0.0 112.377 159.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -83.18 -48.93 9.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 -161.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' HG12 ' A' ' 9' ' ' ILE . 70.1 mt -132.55 136.08 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.168 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 10' ' ' TRP . 39.8 mm -119.07 132.36 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 264' ' ' ALA . 72.5 m-85 -116.32 115.72 26.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.889 172.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -168.36 179.76 4.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.25 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.132 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 263' ' ' SER . 73.3 t60 -60.21 -25.05 65.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -50.42 -44.16 55.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.13 -24.19 47.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.608 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 1.7 t80 -65.43 -28.79 69.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -172.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.46 -38.35 62.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.457 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.15 -37.31 71.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.631 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -71.64 -25.06 61.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB3' HD22 ' A' ' 76' ' ' LEU . . . -59.93 -39.58 85.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.15 -26.44 64.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.4 p -85.0 2.47 42.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.76 32.22 73.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.53 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -74.82 -24.33 58.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -126.86 144.11 51.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -168.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -75.99 154.52 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.83 134.07 52.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -115.98 142.27 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.191 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -93.5 123.91 58.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.516 0.674 . . . . 0.0 111.16 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 143.59 28.91 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.789 2.326 . . . . 0.0 112.275 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -107.86 116.13 31.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.14 -43.1 73.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.0 98.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.179 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.17 -35.71 74.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.24 -44.64 88.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.07 -32.45 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.2 -28.38 65.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.04 -105.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -152.69 139.29 12.37 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.745 0.783 . . . . 0.0 110.925 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.37 -28.13 22.71 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.833 2.356 . . . . 0.0 112.298 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -71.22 -34.28 70.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.9 p -74.33 -21.88 59.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.54 -35.18 80.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.017 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.86 -35.06 74.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.462 ' HB3' ' CG2' ' A' ' 329' ' ' ILE . . . -69.97 -37.83 75.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.783 HG22 ' HD3' ' A' ' 107' ' ' PRO . 35.4 m -104.32 18.36 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -169.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -123.52 149.94 44.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -138.77 124.42 19.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 58.18 35.99 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.06 88.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.538 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.03 150.66 41.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 103' ' ' LEU . 31.9 mt -75.03 135.19 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.994 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.0 pt -113.76 -12.48 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.18 169.57 20.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.053 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -112.86 130.53 23.41 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.622 0.725 . . . . 0.0 111.02 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.783 ' HD3' HG22 ' A' ' 97' ' ' VAL . 54.6 Cg_endo -72.8 125.71 10.73 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.358 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.49 -50.38 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.84 157.07 42.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.09 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 147.16 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.85 147.76 51.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.2 145.22 28.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -68.54 128.81 37.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.5 m -138.29 157.84 45.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.748 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.95 121.13 38.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.5 mt -109.87 130.06 63.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.175 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -135.23 157.53 46.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.58 117.4 29.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.943 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.14 -28.53 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.837 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.94 -35.1 32.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.29 -44.25 25.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.8 tp -127.44 105.99 21.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.65 -15.65 15.26 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.329 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -150.33 105.58 3.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.72 . . . . 0.0 110.966 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.59 146.52 73.98 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.728 2.285 . . . . 0.0 112.371 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.94 147.75 68.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.24 -21.46 24.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.8 p -131.88 159.95 37.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -74.04 -23.64 59.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.4 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 97.7 mt-10 -64.23 -21.86 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.31 -21.63 55.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.611 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 40.0 mm -64.35 -45.52 78.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.676 0.75 . . . . 0.0 111.158 -162.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.611 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 77.0 Cg_exo -53.52 -49.49 17.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 0.0 112.323 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -38.72 83.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.576 HD21 ' O ' ' A' ' 135' ' ' LEU . 4.5 tt -61.97 -39.39 91.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 25.5 t70 -64.24 -41.87 96.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.74 -40.05 75.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.23 -56.52 9.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -170.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.48 HD21 ' O ' ' A' ' 136' ' ' ASP . 1.3 pt? -82.04 -12.33 58.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -174.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.5 tttt -58.51 -27.3 64.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 168.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.35 -17.9 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.34 6.47 42.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 26.94 65.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.493 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 2.7 mptp? -118.26 159.82 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.957 173.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.414 ' O ' HD11 ' A' ' 139' ' ' LEU . 47.8 t -113.8 153.49 29.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 172.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -66.82 -52.5 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.159 -175.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 147' ' ' LEU . 2.7 pp -151.76 147.65 26.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.968 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.3 mtp -127.27 134.35 50.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -143.37 164.95 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.654 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 54.4 t-20 -70.0 110.32 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.895 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' A' ' 206' ' ' ALA . 48.7 tp -106.84 0.31 23.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.97 -5.83 59.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -132.97 149.66 73.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.528 0.68 . . . . 0.0 110.825 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -79.4 -25.92 5.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.62 2.214 . . . . 0.0 112.317 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -59.68 -44.62 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 150' ' ' ASN . 81.0 m-85 -79.31 -28.4 42.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 m -77.4 -20.89 53.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 172.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.616 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 10.7 t90 -47.37 -53.99 25.12 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.595 0.712 . . . . 0.0 110.879 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.4 Cg_endo -55.19 -32.88 82.26 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.621 2.214 . . . . 0.0 112.401 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.542 ' C ' HD21 ' A' ' 160' ' ' LEU . 7.8 tt -71.04 -54.2 12.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.007 -172.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 91.0 mt -78.61 -40.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 -173.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.22 -14.99 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 -173.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.416 ' HB2' ' HB3' ' A' ' 250' ' ' PHE . . . -59.07 -28.52 66.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -174.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -90.5 -1.88 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.21 20.41 30.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.429 ' HA3' ' N ' ' A' ' 188' ' ' ALA . . . -138.61 85.06 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.444 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.409 ' O ' ' HB1' ' A' ' 168' ' ' ALA . 9.4 t80 -177.31 154.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 167' ' ' TYR . . . 74.97 -87.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 164.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -148.84 155.58 41.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -168.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -118.28 124.3 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.943 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -113.8 129.8 56.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -145.02 136.47 25.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 52.2 38.93 25.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.889 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.08 8.93 65.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.431 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.72 145.6 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -87.92 123.65 32.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 168.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -98.85 117.71 33.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.88 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.9 tp -68.13 -21.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.35 -12.03 28.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -124.57 82.19 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.6 p -113.21 148.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.61 25.39 27.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -167.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.73 -14.51 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 111.186 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -102.27 20.39 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -102.46 -175.04 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.78 69.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.025 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.56 -38.61 96.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.429 ' N ' ' HA3' ' A' ' 166' ' ' GLY . . . -59.48 -39.85 85.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.12 -40.49 96.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.81 94.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.06 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.19 -43.88 96.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.4 ' O ' HG21 ' A' ' 196' ' ' VAL . 72.3 mt -65.93 -41.28 91.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.353 . . . . 0.0 110.883 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.4 m -60.01 -43.21 95.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -56.62 -52.43 64.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.76 65.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 192' ' ' LEU . 45.4 t -67.39 -39.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.169 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.99 -39.46 92.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.6 OUTLIER -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.826 178.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.82 -41.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.936 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -82.43 3.27 28.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.95 34.92 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.85 -28.74 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.1 mtt -137.78 152.74 49.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . 0.423 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.9 m-20 -101.24 141.41 34.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.862 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . 0.438 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -65.13 -27.28 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.045 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.63 2.85 54.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 94.5 m -58.59 130.18 45.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.654 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 2.8 p30 -125.79 165.44 18.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 172.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -70.08 -27.67 64.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.926 -172.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -65.88 -48.3 71.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.5 pt -69.45 -23.65 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.134 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.45 94.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -71.93 -34.99 69.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.972 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.84 85.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.091 171.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.06 82.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -62.88 -38.26 90.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.831 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.07 -27.42 69.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.71 -21.87 16.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.26 20.28 52.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.485 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -82.62 -26.53 32.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 86.3 m -127.34 134.38 49.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.155 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.21 -36.06 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.428 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 77.6 mtm -134.84 151.41 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -168.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -150.4 158.85 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.28 119.49 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -163.06 174.18 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.415 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -94.21 -175.75 39.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.22 -19.76 66.23 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.623 2.216 . . . . 0.0 112.383 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.415 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 43.7 p90 -68.86 -9.63 52.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.8 84.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -65.82 -25.85 67.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 61.7 m -52.54 160.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 233' ' ' SER . 73.7 m-20 72.72 56.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -170.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.77 130.07 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.71 79.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.871 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 71.2 p -58.76 -176.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 165.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.9 p -72.49 -14.7 61.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.816 -160.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.61 164.96 18.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.781 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t -93.01 114.99 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -120.77 -39.99 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.46 155.29 19.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.97 167.12 25.49 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.568 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.16 136.19 56.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.074 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -143.46 -179.66 6.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.74 159.42 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 94.0 mt -71.36 138.98 84.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 0.0 110.855 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 53.1 Cg_exo -57.05 156.0 26.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.379 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -99.18 164.74 12.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.144 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.416 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 25.7 t80 -141.95 119.98 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 -176.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 61.39 39.71 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.828 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 6.48 84.97 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.468 165.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.94 151.64 49.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.538 0.685 . . . . 0.0 111.019 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.36 130.19 24.46 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.686 2.258 . . . . 0.0 112.408 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 77.8 p -61.09 -42.65 98.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.813 -170.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -172.99 127.66 0.51 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 110.851 166.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.24 142.79 24.6 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.252 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -163.93 124.89 2.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.82 128.92 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 170.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -103.56 144.81 16.02 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.429 171.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.28 127.32 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.582 HD21 ' N ' ' A' ' 263' ' ' SER . 6.5 tt -96.97 128.6 44.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 166.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.582 ' N ' HD21 ' A' ' 262' ' ' LEU . 8.7 m -139.09 172.12 13.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.79 -172.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.517 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . . . -121.99 135.96 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.133 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.608 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -117.39 155.05 16.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 -177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.94 127.93 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 111.119 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -67.77 128.42 36.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -170.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.593 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -64.81 -28.98 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.054 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.67 -10.88 59.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.9 t -77.67 126.98 83.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.649 0.737 . . . . 0.0 110.879 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 -8.4 23.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.455 174.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.748 ' HB3' HD21 ' A' ' 275' ' ' LEU . 97.0 m-20 -112.97 27.45 9.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -172.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.73 -28.34 33.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -66.03 -40.17 90.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.748 HD21 ' HB3' ' A' ' 272' ' ' ASN . 0.7 OUTLIER -72.55 -31.27 65.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.617 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.1 -42.04 85.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.01 -40.69 91.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.63 -47.85 83.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 3.2 tt -66.85 -49.45 65.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.949 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.51 -33.73 76.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -101.35 -29.8 11.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -164.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.772 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.3 m-85 -119.93 -50.5 2.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 -169.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 94.5 mt -73.66 -37.79 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -171.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 42.3 tp -126.71 75.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.5 p -140.79 174.62 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.208 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.92 -44.26 74.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.0 -44.24 49.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.772 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.83 -45.82 19.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.545 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.4 -36.92 84.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.351 . . . . 0.0 110.953 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.78 -39.73 95.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.97 88.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.022 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.877 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 10.2 p -87.75 -32.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.76 -23.03 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -174.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.62 -15.25 6.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -82.91 -23.9 33.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -91.03 151.48 43.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.89 -61.07 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.808 2.339 . . . . 0.0 112.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 97.1 mt -98.88 -50.12 4.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 54.56 59.91 9.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.517 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.74 129.01 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 111.048 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.38 153.92 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -166.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.73 -14.99 58.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.5 tp -76.63 120.26 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.923 -175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.1 -44.91 96.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -173.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -48.11 78.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 -173.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.89 -32.94 71.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.489 ' HA ' ' HE2' ' A' ' 321' ' ' MET . 42.7 tt0 -61.69 -38.93 89.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.798 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.64 -40.67 79.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.08 -41.58 58.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.446 ' HB3' HG21 ' A' ' 317' ' ' ILE . 91.9 mt -65.34 -29.97 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.51 -9.78 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.96 -19.44 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -86.76 120.13 71.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.573 0.701 . . . . 0.0 110.892 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.87 -34.97 57.8 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.661 2.24 . . . . 0.0 112.322 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.33 -39.78 62.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.446 HG21 ' HB3' ' A' ' 311' ' ' LEU . 96.7 mt -74.12 -39.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.4 -33.24 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.03 93.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.6 m -69.75 -41.17 75.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.489 ' HE2' ' HA ' ' A' ' 308' ' ' GLU . 40.3 mtt -68.37 -34.61 76.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.12 -37.03 85.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -67.08 -36.5 82.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.78 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.31 -23.46 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.958 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 -2.05 23.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.801 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.06 -166.37 40.64 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.433 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.8 128.19 44.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 0.0 111.015 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.462 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 28.7 mm -73.28 111.54 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -176.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.0 mmm 63.23 158.15 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.578 0.704 . . . . 0.0 110.744 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . 0.487 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 66.9 Cg_endo -73.66 -111.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 169.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.73 -47.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 170.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.445 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 19.5 pt -138.82 159.78 65.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.552 0.691 . . . . 0.0 111.199 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 40.8 Cg_endo -66.74 -14.71 44.92 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.742 2.295 . . . . 0.0 112.257 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -5.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.949 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.487 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.8 ptm -52.47 -30.14 28.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -32.94 74.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.16 72.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.038 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 339' ' ' PHE . 0.7 OUTLIER -72.27 -25.14 61.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -58.79 -48.0 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -63.68 -40.55 97.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.67 95.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.099 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.04 -26.26 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -61.13 -45.85 92.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.7 p -67.18 -34.37 77.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -66.16 -47.3 74.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 348' ' ' ILE . 7.3 p -71.53 -41.61 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 -172.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.423 ' N ' HG13 ' A' ' 347' ' ' VAL . 93.7 mt -64.46 -43.97 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -64.65 -36.41 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.23 -43.85 69.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.33 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.13 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.6 p -75.03 -14.99 60.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.23 86.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.84 -29.86 67.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.614 0.245 . . . . 0.0 110.807 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -140.01 158.64 43.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.894 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.9 p -73.43 169.4 17.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.03 -48.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.98 -40.08 75.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -70.87 -42.36 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.909 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.98 89.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.098 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.412 HD22 ' HB1' ' A' ' 188' ' ' ALA . 30.3 tp -65.21 -36.4 84.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.09 -35.41 75.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.92 -29.1 70.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -65.14 -48.83 72.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -64.35 -39.84 94.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -60.75 -43.67 97.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.111 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -72.32 -35.47 68.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.96 -43.08 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 67.1 p -89.89 -12.74 38.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.796 0.331 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -83.17 132.29 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -123.62 161.13 25.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.73 119.61 19.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.27 31.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.459 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -146.52 154.69 41.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.84 143.1 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.5 122.42 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.41 140.56 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.47 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 55.5 m95 -116.45 126.76 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 tt -148.87 141.02 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.409 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.8 t-20 -47.87 118.46 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -166.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.19 64.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.462 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.13 -56.18 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 0.0 110.929 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -137.37 78.26 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 152.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.76 -34.31 1.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.472 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.15 -46.08 36.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.933 -158.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -51.59 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -157.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.2 -48.75 57.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 tp -59.6 -42.09 91.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.05 84.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -63.22 -37.25 86.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.15 -41.65 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.05 87.65 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.453 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.35 -40.2 89.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.905 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -60.62 -46.91 88.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 33' ' ' ILE . 28.3 t80 -68.8 -36.29 78.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.49 -33.13 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.64 -36.05 73.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.16 -40.65 26.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -109.12 -18.11 13.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 -171.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.25 4.8 87.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.54 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.4 tt -72.94 121.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -68.91 121.61 16.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.946 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.3 p -102.22 142.63 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.151 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -136.09 114.24 11.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.86 127.34 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -124.8 160.61 28.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -93.48 125.0 55.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 110.855 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CB ' HD23 ' A' ' 43' ' ' LEU . 66.1 Cg_endo -87.78 81.72 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -167.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -93.88 -27.8 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 166.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -92.31 -15.02 27.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.841 -169.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD23 ' CB ' ' A' ' 40' ' ' PRO . 2.3 mp -53.14 -46.06 68.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.891 -159.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -50.03 -40.98 46.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.14 -35.05 32.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -73.0 -25.07 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.488 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.2 m-30 -50.05 -55.79 22.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 0.0 110.875 -165.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -71.18 -29.77 16.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.732 2.288 . . . . 0.0 112.382 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -76.54 -49.95 15.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -172.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.701 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 28.0 m -60.37 -34.98 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.47 86.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.86 66.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.091 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -93.73 1.36 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.114 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.57 8.32 66.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.463 171.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -171.3 95.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.898 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.701 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.99 -129.34 3.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 156.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.47 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 41.7 Cg_endo -70.21 154.53 65.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.644 2.229 . . . . 0.0 112.35 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -88.08 -39.78 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.61 136.89 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.0 mm -119.68 134.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -77.8 159.47 28.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.952 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.411 ' CB ' ' H ' ' A' ' 263' ' ' SER . 41.9 t90 -85.84 147.4 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -112.57 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.104 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -110.74 -83.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 157.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -94.58 -19.51 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -60.05 -27.59 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -163.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 105' ' ' ALA . 75.7 t80 -58.06 -33.26 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.879 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -64.3 -41.24 98.29 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.18 80.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.427 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -65.84 -36.7 84.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.72 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.105 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.96 -29.27 70.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -82.39 1.5 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.16 75.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -82.71 -6.17 59.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.555 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.46 146.17 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -91.11 163.6 14.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.71 128.76 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -110.41 148.83 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -95.64 124.6 52.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.506 0.67 . . . . 0.0 111.204 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.83 140.67 42.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -103.83 109.91 21.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.38 -42.59 98.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.415 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.9 m-30 -68.2 -35.81 78.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -55.09 -45.45 75.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.941 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.33 -39.15 93.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.16 -22.48 62.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.505 HD13 ' HG2' ' A' ' 107' ' ' PRO . 75.5 mt -105.02 -145.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.78 145.7 54.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.406 ' HA ' ' HD1' ' A' ' 94' ' ' TRP . 30.6 Cg_endo -70.0 -39.83 5.62 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 -175.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -68.7 -23.28 64.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.984 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.6 p -72.29 -24.87 61.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.45 ' HA ' HG23 ' A' ' 97' ' ' VAL . 88.8 m95 -72.82 -33.02 65.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.65 -34.51 72.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.52 ' HB3' HD12 ' A' ' 329' ' ' ILE . . . -71.42 -25.14 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.171 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG22 ' HD3' ' A' ' 107' ' ' PRO . 34.6 m -108.42 14.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.419 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 79.0 mtm180 -118.02 143.87 46.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -143.4 130.86 21.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 t30 57.01 33.3 23.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.963 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.07 90.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.47 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.33 150.41 37.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 37.0 tp -81.18 123.87 28.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.0 pt -115.25 -9.67 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.449 ' HB2' ' H ' ' A' ' 264' ' ' ALA . . . -161.33 169.3 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.685 ' HB3' HD22 ' A' ' 285' ' ' LEU . 75.1 m-85 -110.03 140.0 21.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.693 0.758 . . . . 0.0 110.984 167.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.508 ' HD3' HG22 ' A' ' 97' ' ' VAL . 94.1 Cg_endo -79.04 117.14 3.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.652 2.234 . . . . 0.0 112.308 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.7 mt -109.1 -29.99 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.51 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -170.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.07 124.97 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.086 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -116.53 129.42 56.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.71 149.7 30.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 94.6 mt -72.87 144.89 47.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.6 m -143.9 160.86 40.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 tp -89.33 118.55 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.441 HG12 HG23 ' A' ' 244' ' ' VAL . 56.2 mt -109.6 119.66 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.082 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -133.24 155.09 50.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -164.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.03 115.73 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.874 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.62 -25.46 68.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -76.0 -35.76 59.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.12 -52.8 5.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.952 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.2 mt -124.59 105.18 30.45 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.546 0.689 . . . . 0.0 110.876 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.92 -12.65 19.74 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.342 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.431 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 57.5 t-20 -147.91 100.02 3.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.69 0.757 . . . . 0.0 110.911 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 56.8 Cg_endo -69.09 164.58 33.31 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.415 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 44.1 Cg_endo -72.43 145.15 42.14 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.347 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.02 -19.35 27.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.2 t -144.48 163.01 35.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -173.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -70.58 -25.16 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 -174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.48 -33.01 74.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -75.02 -22.59 58.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.615 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 77.6 mt -62.55 -53.63 55.49 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.682 0.753 . . . . 0.0 111.143 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.1 Cg_endo -60.43 -40.4 57.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.29 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.05 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.415 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 51.5 tp -61.32 -39.93 92.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 132' ' ' ILE . 9.3 t70 -65.99 -41.31 91.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.35 -38.79 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.64 -45.33 75.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.441 HD22 ' HB3' ' A' ' 146' ' ' ALA . 3.7 pp -83.58 -20.34 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 84.6 tttt -56.46 -28.81 60.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.16 -18.67 63.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.066 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.21 7.51 33.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.08 29.72 62.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.48 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -108.13 161.58 14.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.8 t -116.93 148.51 41.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.441 ' HB3' HD22 ' A' ' 139' ' ' LEU . . . -86.22 -34.63 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.2 tp -130.72 141.1 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -112.91 134.91 54.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -164.25 160.45 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.849 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -127.27 -10.56 5.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 199' ' ' ILE . 37.8 mt 50.82 35.54 12.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -93.68 -20.88 19.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -139.62 149.75 60.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.66 -22.86 74.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.355 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -50.04 -36.27 28.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -70.74 -35.7 72.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.451 HG22 HG11 ' A' ' 347' ' ' VAL . 39.2 p -80.33 -28.49 38.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 -172.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.554 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 42.1 m0 -56.91 -45.0 100.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 -164.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.603 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 98.1 Cg_exo -48.9 -38.19 38.0 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.705 2.27 . . . . 0.0 112.297 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.1 mt -80.32 -44.67 19.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.694 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.4 mt -72.18 -47.53 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 -169.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.1 -16.71 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.171 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -59.51 -27.07 65.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.079 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -97.73 8.47 44.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.41 16.78 3.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.454 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.35 161.16 38.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -168.0 150.57 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' HB1' ' HG2' ' A' ' 331' ' ' PRO . . . -66.26 -62.21 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.83 146.65 47.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.19 136.79 37.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.563 ' CE2' ' HB3' ' A' ' 176' ' ' TYR . 57.4 m-85 -115.29 126.3 54.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -146.13 141.41 27.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.865 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.3 t30 49.78 45.59 24.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.878 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.34 8.85 66.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.511 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.63 148.66 52.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.848 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.563 ' HB3' ' CE2' ' A' ' 171' ' ' TYR . 49.2 p90 -93.4 138.2 31.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -96.11 109.81 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.438 ' O ' HD13 ' A' ' 178' ' ' ILE . 2.2 tp -64.13 -20.01 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.05 -4.82 53.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.921 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -117.02 97.53 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.9 154.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.132 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.75 28.76 12.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 m -99.99 -23.37 4.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.152 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -97.35 20.44 11.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.01 155.31 19.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -171.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.39 -35.01 67.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.055 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.03 93.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.458 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.03 78.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -62.87 -41.68 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.57 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.694 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.33 -42.52 97.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.42 HD21 HG13 ' A' ' 357' ' ' VAL . 24.7 tp -69.19 -34.36 74.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.884 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.9 m -58.77 -40.85 85.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.166 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -58.05 -44.22 87.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.12 -44.98 88.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -65.14 -40.71 89.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.13 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -38.6 91.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.3 OUTLIER -62.27 -38.64 90.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.423 HD12 HD11 ' A' ' 151' ' ' LEU . 53.1 mt -81.59 -42.16 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.56 -41.68 88.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.79 5.23 29.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.87 31.99 11.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.01 -28.86 60.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 170.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.8 tpt -146.09 151.62 37.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.436 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -89.19 134.76 33.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.34 -27.01 62.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 -174.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.66 -17.54 16.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 77.8 m -64.45 134.99 55.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -89.97 166.25 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -66.34 -37.05 84.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.5 p -68.68 -38.3 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.855 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.01 -43.97 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.79 -36.94 73.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.6 -38.41 83.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.29 95.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.01 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.413 ' CZ ' HG22 ' A' ' 116' ' ' ILE . 83.2 t80 -66.77 -42.15 86.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 174.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -61.29 -26.33 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.834 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.03 -9.03 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.32 67.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.66 -28.63 33.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.936 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 90.0 m -120.14 130.19 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.132 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.65 -43.68 75.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -169.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.9 mtm -140.44 150.33 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -169.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.4 p -145.47 171.77 14.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mm -118.15 126.08 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -159.8 172.36 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.2 -164.2 29.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.27 -15.97 19.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.24 . . . . 0.0 112.382 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -70.28 -29.23 65.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 28.61 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.496 ' O ' ' C ' ' A' ' 233' ' ' SER . 37.3 m0 -72.79 -46.2 54.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 232' ' ' TRP . 58.2 m 33.87 -99.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 170.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -151.1 39.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.19 157.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.094 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.657 ' O ' ' C ' ' A' ' 237' ' ' THR . 95.0 m-20 -108.13 148.73 29.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.657 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.2 m -6.62 82.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 94.6 p -61.88 161.18 10.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -134.62 -5.45 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 241' ' ' ASN . 52.5 t -89.14 73.37 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -171.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' VAL . 83.7 m-20 40.97 47.51 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.81 147.26 26.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.69 164.95 26.61 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 -175.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.441 HG23 HG12 ' A' ' 116' ' ' ILE . 52.6 t -131.52 134.99 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 177.26 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.181 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.95 160.01 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.183 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.532 ' HB2' ' HD3' ' A' ' 257' ' ' PRO . 26.8 mt -78.97 151.06 75.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.492 ' HG2' HD12 ' A' ' 132' ' ' ILE . 50.3 Cg_exo -62.05 154.57 61.34 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.404 -174.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 96.1 m -133.14 138.12 46.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -114.15 118.17 33.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 -167.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 50.48 40.14 22.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.63 24.19 73.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 98.7 mm-40 -106.14 161.7 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.599 0.714 . . . . 0.0 110.956 -169.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.7 Cg_endo -63.94 70.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.228 . . . . 0.0 112.384 173.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 68.5 m -102.63 15.29 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.808 -167.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 257' ' ' PRO . 58.4 mttp -106.97 160.8 25.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.564 0.697 . . . . 0.0 110.909 -161.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.532 ' HD3' ' HB2' ' A' ' 247' ' ' LEU . 11.5 Cg_endo -60.96 154.93 53.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.73 163.14 27.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.49 125.66 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.143 -175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.57 143.27 15.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.23 126.5 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.8 tp -64.81 129.26 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.411 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 20.1 m -135.32 155.02 51.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 -166.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.449 ' H ' ' HB2' ' A' ' 105' ' ' ALA . . . -140.3 137.04 33.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.082 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.64 146.56 18.08 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.477 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 86.2 mt -114.61 124.76 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.928 0.394 . . . . 0.0 111.087 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -58.56 122.07 12.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.892 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -67.29 -25.92 66.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.077 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.62 -8.02 59.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.103 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.2 t -69.17 128.49 92.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.669 0.747 . . . . 0.0 110.908 -175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.71 -12.58 36.5 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.683 2.255 . . . . 0.0 112.406 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -111.92 25.04 12.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -55.45 -33.09 63.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.37 -38.8 65.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.13 -44.2 97.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.47 85.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.27 -46.45 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.11 -50.79 66.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -34.87 71.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -172.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.745 HD21 ' O ' ' A' ' 280' ' ' LEU . 2.5 tt -52.48 -51.79 57.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.54 -22.39 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.828 -171.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -98.55 -14.06 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -166.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.627 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.6 m-85 -120.58 -52.38 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.54 -32.3 73.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.915 ' O ' HD12 ' A' ' 285' ' ' LEU . 1.7 pp -136.72 76.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.971 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.8 p -143.02 170.02 16.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.187 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -53.69 -46.27 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.02 -42.99 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.862 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.627 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.04 -46.78 20.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -170.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 293' ' ' VAL . 46.9 tp -66.03 -36.02 82.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.75 -43.74 85.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.07 85.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 290' ' ' LEU . 3.2 p -75.42 -31.27 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -170.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.34 -16.44 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -58.83 -22.85 59.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -89.25 -22.62 22.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.823 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -100.36 155.27 36.58 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.95 -63.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.292 . . . . 0.0 112.409 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 76.5 mt -107.35 -50.5 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.88 -49.2 0.9 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.445 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.78 72.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.46 HG23 HD22 ' A' ' 311' ' ' LEU . 20.1 m -109.2 155.86 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.121 -154.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.93 -13.77 59.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.501 ' HA ' HD21 ' A' ' 89' ' ' LEU . 58.1 tp -80.57 117.48 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.16 -44.82 96.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.6 p -65.7 -51.93 55.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -172.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -68.85 -34.03 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.929 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.1 -40.44 89.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.58 -37.78 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.79 -47.8 24.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.817 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.46 HD22 HG23 ' A' ' 302' ' ' VAL . 4.0 pp -74.72 -19.51 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.63 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.161 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.9 -10.36 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.47 130.12 52.58 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.561 0.696 . . . . 0.0 110.845 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.54 -30.51 16.24 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.737 2.291 . . . . 0.0 112.325 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -65.17 -37.9 88.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.85 -43.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.43 68.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.091 -164.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.45 79.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.11 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.8 m -68.06 -39.21 83.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.176 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 68.0 ttp -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.905 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -65.94 -46.26 78.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 327' ' ' GLY . 43.3 p30 -80.07 -13.76 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.76 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 167.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -74.7 -18.26 60.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.29 -10.54 13.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -79.46 -162.22 23.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.506 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -125.59 126.49 44.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.91 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 96' ' ' ALA . 7.4 tp -65.65 126.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -176.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 65.1 ttp -71.22 119.92 76.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.409 ' HG2' ' HB1' ' A' ' 168' ' ' ALA . 68.6 Cg_exo -55.12 144.49 69.39 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.702 2.268 . . . . 0.0 112.388 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.879 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.5 p30 -99.98 11.42 39.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.828 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.575 HG22 ' H ' ' A' ' 335' ' ' GLN . 34.5 mt -68.42 135.12 90.88 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 0.0 111.123 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.41 -34.39 50.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.575 ' H ' HG22 ' A' ' 333' ' ' ILE . 25.5 mm100 -65.34 -10.53 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.9 mmm -63.85 -25.74 68.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.4 m -63.77 -39.4 94.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.83 -33.88 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.099 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.84 -38.86 86.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 174.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -59.98 -53.33 59.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -63.27 -36.73 84.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.41 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.03 -44.18 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -57.17 -46.2 83.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.8 m -66.7 -42.94 85.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' A' ' 360' ' ' ALA . . . -61.17 -42.07 97.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.451 HG11 HG22 ' A' ' 157' ' ' THR . 54.1 t -67.86 -46.74 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.37 -43.38 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 88.8 m-20 -64.77 -37.41 87.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.851 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -45.67 69.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.99 72.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.6 p -83.19 -8.26 59.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.62 13.33 83.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.95 -28.14 39.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.1 tt0 -148.2 145.17 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.0 p -73.43 164.97 25.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.42 HG13 HD21 ' A' ' 192' ' ' LEU . 58.8 t -69.77 -45.99 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.31 -36.08 82.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -74.44 -41.05 61.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . . . -64.99 -42.58 94.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.35 -32.04 70.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 -39.9 94.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -69.12 -31.49 70.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.33 73.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -69.98 -31.38 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 86.1 m -63.02 -43.19 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.38 -40.79 93.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.847 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.67 -42.43 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.11 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.9 p -89.63 -2.15 58.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -174.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.1 mt -82.86 133.17 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -126.81 159.19 34.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -74.76 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.38 21.94 55.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -142.92 162.6 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.5 mt -130.39 135.83 48.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -125.11 110.17 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.22 139.43 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 -172.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.481 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 66.1 m95 -116.84 126.73 53.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.95 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.486 HG23 ' HA3' ' A' ' 16' ' ' GLY . 21.1 tt -148.93 140.09 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.033 -169.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -47.83 118.64 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.946 -166.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.09 -25.42 62.09 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.429 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -57.42 -53.39 58.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.917 -169.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -137.94 88.77 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.917 148.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -116.71 -36.98 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.486 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -77.23 -50.12 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -154.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -67.95 -52.55 34.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -154.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.74 84.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.4 -39.52 79.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.16 98.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.17 -41.02 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.23 -48.5 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.68 -33.85 86.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.385 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -64.93 -43.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.951 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.85 -45.07 86.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.909 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -68.24 -35.61 78.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.13 -34.96 79.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.6 -34.37 65.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -77.17 -41.75 40.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -108.21 -18.13 13.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.229 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.49 4.6 89.17 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.54 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.616 HG23 ' O ' ' A' ' 33' ' ' ILE . 16.1 tt -74.29 116.79 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.156 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.38 124.87 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.09 140.0 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.176 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -134.41 113.6 12.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.5 128.78 60.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -126.2 161.67 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -95.45 122.52 59.13 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.562 0.696 . . . . 0.0 110.8 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HB3' HD23 ' A' ' 43' ' ' LEU . 88.7 Cg_endo -86.84 80.05 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.284 -168.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -93.58 -25.63 17.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 168.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.17 -16.54 23.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -171.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD23 ' HB3' ' A' ' 40' ' ' PRO . 2.3 mp -56.92 -42.31 79.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.922 -157.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -52.23 -38.94 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -81.01 -34.02 33.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.838 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' O ' HG23 ' A' ' 50' ' ' VAL . 95.1 mttt -71.92 -23.65 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.498 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.9 m-30 -49.63 -55.95 19.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.915 -164.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.2 Cg_endo -70.75 -29.3 19.37 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.751 2.3 . . . . 0.0 112.323 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -76.4 -50.1 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.927 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.591 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 30.9 m -61.49 -35.78 69.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.71 86.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -27.33 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 p -95.05 2.28 55.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.98 8.83 65.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -170.76 95.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.591 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -127.63 -116.95 2.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.474 154.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 48.4 Cg_endo -69.08 152.48 72.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.614 2.209 . . . . 0.0 112.353 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -87.06 -39.97 15.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -138.09 139.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mm -110.09 133.54 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.103 -166.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.46 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 11.5 p90 -67.38 170.94 6.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.474 ' CG ' ' HG ' ' A' ' 262' ' ' LEU . 39.9 p-90 -87.03 143.76 27.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.05 -121.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 167.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.86 -79.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 154.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -84.01 -13.89 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -61.35 -20.38 62.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -167.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 263' ' ' SER . 55.2 m-85 -56.89 -30.13 63.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -174.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -62.36 -43.75 98.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.508 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.375 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 5.0 m-30 -62.91 -38.65 91.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.877 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.46 95.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -65.07 -31.03 72.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.4 m -89.86 -4.91 57.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.74 27.63 73.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.83 -9.73 59.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.875 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.533 HD21 ' HA3' ' A' ' 265' ' ' GLY . 0.0 OUTLIER -131.23 140.56 49.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.825 176.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -92.32 169.34 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.06 125.05 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.54 151.25 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.5 m -99.87 121.66 53.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.169 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.16 144.6 37.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.312 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -104.72 118.28 36.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.73 -38.98 73.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.95 81.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -70.83 -32.63 69.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.439 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 87.3 mt-30 -58.52 -46.77 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.931 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.65 -35.93 79.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -76.41 -20.56 56.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.817 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.447 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 85.3 mt -107.3 -147.35 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -129.33 143.59 49.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.665 0.745 . . . . 0.0 110.91 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.34 -36.73 65.62 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.29 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -65.34 -36.41 83.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.59 -23.13 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.211 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 88.4 m95 -70.04 -38.91 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.45 -31.49 70.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.82 -31.1 69.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.442 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 35.4 m -109.75 8.66 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -172.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -108.24 141.48 39.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -132.05 121.28 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 58.74 34.14 23.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.962 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.93 2.84 90.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.539 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -120.02 148.59 43.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.3 tp -81.0 129.02 34.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -173.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 pt -118.43 -7.6 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.121 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -162.45 166.95 24.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -175.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 82.1 m-85 -113.52 139.57 23.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.654 0.74 . . . . 0.0 110.982 171.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 19.9 Cg_exo -67.41 116.33 4.16 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.288 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.409 ' HB ' HD23 ' A' ' 262' ' ' LEU . 51.0 mm -103.35 -33.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.94 154.98 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -166.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.48 127.77 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -114.22 126.37 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.82 148.28 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.03 150.66 38.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.7 m -145.72 162.75 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.765 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.06 120.07 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.451 HG12 HG23 ' A' ' 244' ' ' VAL . 73.5 mt -106.89 124.15 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.007 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -133.43 155.43 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -89.95 115.1 27.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.852 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.55 -26.61 65.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.92 -35.01 51.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.75 -52.2 7.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.75 108.58 28.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.647 0.737 . . . . 0.0 110.959 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.38 -15.08 17.98 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.701 2.268 . . . . 0.0 112.362 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -140.82 105.33 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.24 164.25 36.22 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.784 2.322 . . . . 0.0 112.374 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.6 152.45 59.5 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.88 -24.67 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.405 HG21 ' H ' ' A' ' 131' ' ' GLU . 9.2 t -143.38 157.21 44.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -68.4 -29.95 68.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.43 -28.96 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.405 ' H ' HG21 ' A' ' 128' ' ' THR . 87.3 tt0 -75.72 -24.69 56.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.771 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.598 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 26.4 mm -55.76 -53.41 63.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.605 0.717 . . . . 0.0 110.982 -169.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.0 Cg_endo -66.1 -42.82 10.03 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.669 2.246 . . . . 0.0 112.314 -172.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.45 91.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.21 -36.81 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.79 -40.81 95.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.38 -37.75 84.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.92 -44.54 76.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 139' ' ' LEU . 3.4 pp -84.49 -20.62 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -57.01 -27.77 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.5 65.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.07 10.04 32.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.4 67.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -104.7 157.17 17.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.768 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.6 t -110.49 146.12 36.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.72 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.37 -33.96 32.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.7 tp -130.81 145.49 51.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.6 ttm -109.07 127.12 53.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.914 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -163.78 158.49 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -130.91 -9.9 3.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.876 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 mt 54.12 34.94 21.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.28 -17.07 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.35 153.43 79.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.732 0.777 . . . . 0.0 110.877 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 49.0 Cg_endo -64.11 -24.76 66.08 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -38.02 72.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -71.91 -42.2 66.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.434 HG21 HD23 ' A' ' 195' ' ' LEU . 99.3 m -80.81 -35.4 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 -170.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.521 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 85.5 t90 -53.91 -43.96 97.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.606 0.717 . . . . 0.0 110.909 -163.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.722 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 87.2 Cg_exo -48.76 -39.14 38.54 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.11 -36.71 69.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.421 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 91.7 mt -69.03 -42.23 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.253 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.25 -14.05 59.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.154 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 255' ' ' SER . . . -55.8 -32.88 63.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.32 11.58 36.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -170.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.16 18.25 6.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.41 158.38 35.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.408 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.578 ' H ' ' HA3' ' A' ' 182' ' ' GLY . 87.3 m-85 -140.01 151.72 45.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.949 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.22 -61.11 2.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -137.15 147.47 45.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.962 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -68.25 124.22 22.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.86 110.9 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.926 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -144.14 143.76 31.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 48.07 42.79 17.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.86 10.09 80.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.583 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.833 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -91.29 129.72 37.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.43 109.87 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 178' ' ' ILE . 2.5 tp -64.56 -21.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.008 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.27 -6.72 52.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -119.92 96.2 5.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.0 m -104.33 153.84 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.578 ' HA3' ' H ' ' A' ' 167' ' ' TYR . . . -105.02 30.81 9.37 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.13 -16.78 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.907 0.384 . . . . 0.0 111.148 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -101.56 12.58 37.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 171.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.98 155.19 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 -174.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.73 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.085 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.85 -38.33 94.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 182' ' ' GLY . . . -62.75 -38.01 88.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.13 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.85 -37.85 88.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.9 88.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.063 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -63.95 -41.12 98.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.457 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.23 -36.18 82.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -58.57 -39.98 81.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -55.45 -46.31 76.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.434 HD23 HG21 ' A' ' 157' ' ' THR . 60.5 tp -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.17 -40.38 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.03 -40.42 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.8 OUTLIER -60.89 -42.91 98.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 177.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.0 mt -70.17 -41.77 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.9 -34.83 78.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -81.81 4.33 22.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.0 34.16 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -75.61 -16.41 60.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 61.1 tpp -140.23 148.11 41.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.535 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.7 t-20 -89.63 134.95 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.69 70.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.062 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -96.05 -13.38 23.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 -171.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.7 m -70.15 139.02 52.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.58 174.1 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -62.43 -48.61 78.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.4 p -67.51 -34.46 77.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.97 -44.6 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.68 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.093 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -69.96 -36.77 75.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.803 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.2 82.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.076 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.59 97.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 171.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.0 -38.28 90.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.75 -24.5 65.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.64 -10.14 25.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.895 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.15 59.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.448 -174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -82.47 -24.04 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 0.0 110.993 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.2 m -121.01 130.67 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.75 69.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 76.1 mtm -135.25 150.47 50.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -168.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.4 p -145.84 165.5 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.65 124.26 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -154.29 162.59 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.64 -159.57 33.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.18 -16.42 19.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.599 2.199 . . . . 0.0 112.316 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -65.26 -37.21 86.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 59.59 17.99 6.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.493 ' O ' ' C ' ' A' ' 233' ' ' SER . 50.6 m0 -76.56 -53.21 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 232' ' ' TRP . 64.7 p 31.91 -94.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.867 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.6 t30 -151.27 38.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.943 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.8 tt -159.86 156.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.149 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -100.4 139.44 36.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.864 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 91.9 m -7.26 82.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 236' ' ' ASP . 87.7 p -62.15 160.37 12.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.761 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -139.81 -9.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.9 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.75 79.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 55.92 34.39 23.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -102.68 150.14 23.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.88 162.68 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.451 HG23 HG12 ' A' ' 116' ' ' ILE . 58.8 t -126.16 130.28 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -135.63 174.71 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.78 158.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.87 145.89 51.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.57 0.7 . . . . 0.0 110.952 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -56.36 146.1 74.92 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.738 2.292 . . . . 0.0 112.371 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 77.7 p -130.48 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -116.86 118.96 33.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -169.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 51.44 39.46 24.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.01 63.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.559 166.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -109.99 157.34 38.1 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.631 0.729 . . . . 0.0 111.007 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.9 74.67 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 49.7 m -98.52 14.37 28.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -160.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 326' ' ' LYS . 67.6 mttm -109.48 155.88 40.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.61 0.719 . . . . 0.0 110.858 -169.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.722 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 36.8 Cg_endo -68.65 171.81 12.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.394 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -56.94 159.97 3.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.41 128.7 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.45 147.26 16.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.428 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.22 125.0 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.165 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.474 ' HG ' ' CG ' ' A' ' 62' ' ' TRP . 4.3 tt -68.18 125.34 26.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 6.5 m -139.42 154.93 47.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.816 -166.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.89 137.87 36.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.533 ' HA3' HD21 ' A' ' 76' ' ' LEU . . . -119.12 152.55 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.519 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.1 mt -111.5 120.45 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.372 . . . . 0.0 111.132 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -55.9 124.35 17.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.795 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.526 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -67.61 -25.43 65.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.05 -9.2 59.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.078 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.7 t -68.85 128.35 92.86 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.637 0.732 . . . . 0.0 110.954 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.14 -11.43 32.0 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.789 2.326 . . . . 0.0 112.366 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -109.27 24.26 13.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -54.85 -33.73 62.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.36 -41.11 57.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.39 -43.4 98.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.12 94.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.129 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.67 -47.17 76.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.41 -50.22 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.794 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.428 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -69.98 -34.94 74.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -173.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.706 HD21 ' O ' ' A' ' 280' ' ' LEU . 2.5 tt -56.03 -52.14 65.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.45 -26.39 55.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.833 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.06 -22.24 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.849 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 65.4 m-85 -122.66 -50.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 37.3 tp -68.65 -39.04 80.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.648 ' C ' HD21 ' A' ' 285' ' ' LEU . 3.0 tt -124.98 79.92 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 25.3 p -142.75 171.42 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 165.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.63 -42.11 67.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.96 -44.59 39.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.795 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.849 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.36 -47.93 8.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.44 -168.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -65.13 -33.41 75.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.869 -175.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.42 -41.04 88.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.23 94.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 290' ' ' LEU . 9.5 p -78.39 -28.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -65.16 -18.79 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.987 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -18.19 43.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -30.49 65.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -107.83 153.09 41.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.626 0.727 . . . . 0.0 110.868 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.05 -61.32 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.723 2.282 . . . . 0.0 112.406 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.94 -53.78 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 116.16 -56.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.47 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 46.86 69.2 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.184 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.453 HG23 HD22 ' A' ' 311' ' ' LEU . 19.3 m -111.49 155.9 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -162.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.58 -17.01 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.3 tp -81.81 120.59 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.48 -44.2 96.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -63.59 -49.99 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.834 -168.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -70.48 -32.62 70.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.1 -42.44 98.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.793 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.57 -35.29 72.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -172.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -79.76 -46.43 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.453 HD22 HG23 ' A' ' 302' ' ' VAL . 2.5 pp -73.41 -22.91 60.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.39 -5.63 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.97 -11.75 60.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.42 131.12 51.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.693 . . . . 0.0 110.844 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.58 -30.1 20.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.271 . . . . 0.0 112.298 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -64.97 -39.23 93.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.12 -42.51 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.5 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 -166.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.35 -35.46 73.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.74 82.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.8 -35.38 74.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -65.04 -37.78 88.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 327' ' ' GLY . 95.0 m-20 -67.97 -35.71 78.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.07 78.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.03 -19.66 60.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.411 ' HB2' ' HE3' ' A' ' 256' ' ' LYS . 99.3 mttt -108.34 -7.19 15.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -86.14 -163.11 37.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -128.7 135.93 49.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.677 0.275 . . . . 0.0 110.894 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.7 126.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.4 ttm -61.15 122.11 67.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.587 0.708 . . . . 0.0 110.91 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.03 132.16 37.25 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.306 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.427 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 50.6 p30 -95.12 10.07 37.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 pt -80.57 152.11 72.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 111.128 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.91 -25.04 67.78 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.755 2.303 . . . . 0.0 112.403 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.07 -16.5 60.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.79 -29.96 70.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.6 m -61.59 -41.37 97.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.758 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.49 -33.86 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.101 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.28 -46.1 83.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -60.02 -52.31 65.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.97 -46.04 89.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.93 89.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.154 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.79 -44.85 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.176 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.45 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 44.2 ttp180 -60.95 -43.34 98.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.1 m -64.99 -43.8 91.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -65.01 -43.16 93.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.061 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.6 -47.24 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 89.7 mt -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 85.8 m-20 -63.41 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.94 68.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.58 -34.02 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 -7.49 59.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.86 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 12.36 84.69 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.452 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -79.37 -29.02 41.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.679 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 48.1 tt0 -147.07 143.86 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -175.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.6 p -72.07 163.79 27.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -175.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 67.3 t -71.27 -45.77 68.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.14 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.58 -40.8 93.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.07 -46.14 58.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . . . -65.38 -45.01 85.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.043 -176.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.71 -34.47 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.32 -39.71 94.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.94 -31.57 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.824 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -71.82 -46.99 56.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -67.24 -31.32 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 94.6 m -63.74 -40.17 96.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -70.0 -38.41 75.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.89 -41.27 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -96.04 16.13 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.958 -178.907 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.789 0.328 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.2 mt -86.91 133.79 29.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.258 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.97 160.21 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.02 119.47 19.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.03 24.39 32.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.469 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -150.59 154.99 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 110.824 -170.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 35' ' ' VAL . 1.9 pt? -151.14 146.78 26.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.2 t -129.61 124.22 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.97 140.93 45.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.442 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 56.0 m95 -115.0 123.2 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 HG22 HG13 ' A' ' 37' ' ' VAL . 19.0 tt -151.85 139.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 -167.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -49.59 115.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -166.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.95 61.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.485 -171.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -55.43 -50.67 69.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -135.45 83.33 2.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 147.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.01 -34.91 1.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.505 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.39 -46.81 15.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.871 -159.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -67.62 -55.28 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -155.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.516 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -66.72 -46.98 70.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.416 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.3 -38.55 80.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.841 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.98 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.14 -38.3 90.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.57 -43.52 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.103 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.43 -36.79 92.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.448 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.28 -45.51 84.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.918 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.3 -45.2 94.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -68.87 -34.98 76.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.837 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -63.69 -35.16 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -68.89 -32.37 71.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.797 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -86.57 -39.38 16.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.1 p -108.34 -22.87 12.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.195 -170.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.57 7.33 84.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.532 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.8 tt -72.07 125.36 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 111.064 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.96 125.7 27.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 ' HA ' HD21 ' A' ' 7' ' ' LEU . 7.4 p -109.7 140.11 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.164 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -134.85 115.64 13.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 11' ' ' ILE . 88.7 t -104.82 130.81 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -124.94 157.77 35.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.95 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -85.02 122.86 74.15 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.459 0.647 . . . . 0.0 110.931 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HA ' HD13 ' A' ' 43' ' ' LEU . 71.3 Cg_endo -84.45 80.1 2.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.241 . . . . 0.0 112.239 -171.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -110.79 -15.41 13.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 166.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.8 -21.34 29.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 40' ' ' PRO . 4.6 mp -53.33 -45.65 69.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -157.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.27 -42.18 29.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.46 -32.28 37.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.896 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.18 -26.36 56.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 6.0 m-85 -52.56 -55.32 33.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.891 -164.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 51.3 Cg_endo -69.16 -29.77 26.18 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.71 2.273 . . . . 0.0 112.384 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -76.6 -50.53 13.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.761 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 27.0 m -61.27 -35.32 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.45 85.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.74 -26.41 66.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -92.17 2.85 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 7.5 65.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.414 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -172.75 97.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.924 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.761 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.07 -132.88 3.98 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 157.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 45.2 Cg_endo -71.81 154.61 58.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.582 2.188 . . . . 0.0 112.367 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.51 -37.95 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -137.31 137.0 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.127 -172.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.9 mm -119.4 134.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -76.97 134.9 38.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.447 ' CB ' ' H ' ' A' ' 263' ' ' SER . 31.3 t90 -60.36 144.26 51.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.08 -98.09 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -127.17 -89.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.932 158.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.4 -23.02 37.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -59.59 -30.98 69.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -161.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.425 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 58.6 t80 -58.23 -33.99 69.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -174.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.49 97.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.448 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.28 76.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.512 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.425 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.1 m-30 -63.95 -37.05 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.946 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.75 97.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.01 -28.16 68.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.6 m -81.43 -0.22 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.9 73.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.88 -6.79 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.998 -177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.99 146.15 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -82.8 163.23 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.48 128.52 36.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -112.87 148.17 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 124.53 37.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.515 0.674 . . . . 0.0 111.139 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.59 142.7 44.92 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.691 2.26 . . . . 0.0 112.305 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -106.13 121.68 44.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.953 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -39.27 68.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.08 87.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -68.35 -35.0 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.418 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.2 mt-30 -60.59 -47.98 83.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.28 -37.88 84.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.932 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.33 -24.27 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.6 mt -109.41 -149.78 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.4 ' HB2' HG21 ' A' ' 93' ' ' THR . 99.3 m-85 -132.84 150.23 75.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.923 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.72 -33.55 76.39 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.343 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.947 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 63.7 p -70.13 -27.07 64.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.097 -172.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.418 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 50.5 m95 -69.25 -39.95 78.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.77 -35.13 73.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.655 ' HB3' HD12 ' A' ' 329' ' ' ILE . . . -70.25 -30.93 68.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.428 HG22 ' HD3' ' A' ' 107' ' ' PRO . 35.3 m -105.27 14.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 -172.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -115.63 143.59 45.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -139.25 127.56 22.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.91 35.06 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.871 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.81 3.47 89.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.59 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.97 149.89 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.794 0.33 . . . . 0.0 110.957 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 tp -84.08 124.18 30.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.35 -8.8 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.425 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -161.74 167.9 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 77.4 m-85 -114.88 135.38 22.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.75 . . . . 0.0 111.008 167.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 32.2 Cg_exo -59.86 117.35 4.09 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.9 mt -102.94 -29.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 262' ' ' LEU . . . -163.15 153.32 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -172.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.05 127.22 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.161 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -118.94 132.22 56.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.06 151.11 27.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.442 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 95.4 mt -71.76 145.93 48.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -173.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -142.23 160.96 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.6 tp -90.49 121.4 32.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.977 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.455 HG12 HG23 ' A' ' 244' ' ' VAL . 66.2 mt -110.0 123.97 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.124 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -133.93 155.28 50.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -91.93 116.34 28.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.835 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.03 -27.18 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.94 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.3 -35.36 41.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.8 -46.1 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.34 110.09 21.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.613 0.721 . . . . 0.0 110.894 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.83 -15.22 16.96 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 0.0 112.372 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -149.39 108.86 3.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.617 0.723 . . . . 0.0 110.847 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.47 157.43 61.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.66 145.1 56.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.353 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.17 -24.96 19.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -173.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -149.4 163.85 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -69.85 -28.26 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.3 -28.71 69.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.987 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -77.32 -20.48 54.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.884 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 24.7 mm -57.73 -53.36 66.52 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 -171.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 35.4 Cg_endo -68.23 -43.06 4.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.82 92.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.66 -36.47 82.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.941 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.58 -41.28 96.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.55 -40.04 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.26 -45.35 76.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 pp -85.46 -20.07 30.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.32 -26.47 65.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.95 -19.51 65.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.38 9.47 33.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.881 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.31 28.36 64.08 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -106.57 158.72 16.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 110.826 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.4 t -110.68 146.95 35.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.772 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.09 -35.29 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.8 tp -132.21 145.05 51.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -109.16 128.71 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -170.32 163.92 8.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -129.11 -7.44 4.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.7 mt 54.33 32.5 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.22 -10.23 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -141.12 149.85 56.86 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.721 0.772 . . . . 0.0 110.87 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.74 -16.73 51.14 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -54.98 -41.61 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -70.5 -33.67 71.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.3 p -83.13 -22.62 33.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.524 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 7.6 m0 -58.76 -48.97 95.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.618 0.723 . . . . 0.0 111.002 -168.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 99.8 Cg_exo -49.31 -38.85 43.15 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.694 2.263 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.56 -35.41 73.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.501 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.1 mt -78.93 -39.09 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.91 -17.08 63.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.19 87.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.435 ' O ' ' HA3' ' A' ' 187' ' ' GLY . 98.9 m-20 -106.58 -0.38 23.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.35 36.01 2.01 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.666 ' HA3' ' HB3' ' A' ' 188' ' ' ALA . . . -120.75 146.38 17.54 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 166.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -155.26 156.18 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.812 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -43.7 -50.4 7.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -89.42 126.47 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.61 115.21 23.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.0 0.429 . . . . 0.0 110.879 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.43 143.49 29.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.873 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 48.09 44.03 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.936 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.51 5.77 60.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.69 148.87 51.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -93.39 126.24 38.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 171.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.84 112.93 24.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.6 tp -74.99 -23.19 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.02 -12.47 33.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -128.18 95.3 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.0 p -103.07 147.11 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.3 31.66 8.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.532 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.9 m -93.76 -19.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 172.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -103.3 24.06 11.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -87.76 160.61 17.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.09 89.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 164' ' ' ASP . . . -66.51 -41.58 94.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.509 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.666 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . . . -61.29 -40.11 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.44 -38.63 90.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.19 -44.45 88.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.126 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.34 -41.57 96.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.388 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.33 -41.01 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 70.5 m -60.15 -40.17 88.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.069 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.34 -42.64 96.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.27 -45.1 92.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.905 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.06 -40.16 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.12 -36.1 82.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.8 OUTLIER -63.97 -38.25 90.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -38.21 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.071 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.24 -39.09 91.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -83.48 3.06 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 64.42 38.51 7.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.89 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -75.01 -10.32 59.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 tpt -143.49 152.33 41.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 65.7 t30 -86.16 142.74 28.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.61 74.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.055 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -96.73 -14.4 22.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 64.3 m -66.67 134.83 53.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -110.8 171.38 7.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.835 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -64.79 -35.79 82.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.6 p -70.85 -38.42 73.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.02 -42.61 95.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.092 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.67 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.43 -39.44 77.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.45 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.03 97.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.45 -39.33 93.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -61.55 -27.15 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.83 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.41 -9.35 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.3 16.46 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -82.67 -22.7 34.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.907 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.4 m -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.87 -38.06 73.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -171.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 69.6 mtm -135.16 154.91 51.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.6 t -152.99 165.68 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.44 124.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.09 164.63 38.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.62 12.2 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.84 -16.49 33.0 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.704 2.269 . . . . 0.0 112.328 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -75.04 -25.26 58.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 56.17 21.98 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.506 ' O ' ' C ' ' A' ' 233' ' ' SER . 44.9 m0 -76.63 -48.54 18.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.506 ' C ' ' O ' ' A' ' 232' ' ' TRP . 51.1 p 32.32 -96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.034 0.445 . . . . 0.0 110.867 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.1 t30 -143.65 36.29 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.7 tt -159.99 158.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -104.2 138.31 40.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 53.0 m -8.92 82.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 85.8 p -70.29 169.31 14.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -153.65 13.76 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 47.4 t -88.78 77.84 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 53.37 36.91 24.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -102.19 151.09 22.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 169.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.78 159.82 24.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.455 HG23 HG12 ' A' ' 116' ' ' ILE . 58.1 t -128.44 130.75 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.0 0.429 . . . . 0.0 111.157 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -142.11 178.21 7.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 160.09 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.055 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.16 155.99 76.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.698 . . . . 0.0 110.932 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -56.44 140.45 89.01 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.763 2.308 . . . . 0.0 112.355 -173.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.509 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 86.6 m -123.74 130.86 53.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.121 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -103.37 112.24 25.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 46.74 41.13 9.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 168.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.87 26.2 65.29 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.443 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.417 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 96.3 mm-40 -113.56 159.07 36.85 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.639 0.733 . . . . 0.0 110.915 -169.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 71.8 Cg_endo -68.95 68.76 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.662 2.241 . . . . 0.0 112.376 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.509 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 79.6 p -92.02 24.71 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 63.3 mttp -114.88 158.91 39.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 110.87 -163.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.442 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 43.7 Cg_endo -73.57 171.79 17.05 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 0.0 112.247 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -62.0 161.76 10.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.56 127.7 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.141 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.71 143.54 15.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.454 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.3 t -123.76 126.01 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.085 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.474 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 1.5 tt -67.7 126.48 29.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.451 ' N ' HD21 ' A' ' 262' ' ' LEU . 24.9 m -129.38 148.07 51.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -166.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.413 ' H ' ' HB2' ' A' ' 105' ' ' ALA . . . -142.98 137.93 29.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.09 159.35 18.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.556 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.42 123.55 66.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -56.15 126.15 24.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -68.98 -27.5 65.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.73 -9.37 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.7 t -67.61 129.47 93.46 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 0.0 110.906 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.89 -14.03 42.2 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.792 2.328 . . . . 0.0 112.295 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -115.36 27.02 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.851 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -54.06 -30.96 50.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -72.97 -37.87 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.425 HD13 HD13 ' A' ' 33' ' ' ILE . 39.5 mt -65.42 -45.39 84.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.61 91.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -67.41 -46.75 72.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.05 -49.32 76.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 -171.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -68.2 -34.64 76.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -174.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.593 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.4 tt -57.08 -51.49 69.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.89 -38.88 73.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -102.49 -23.07 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.697 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 48.5 m-85 -118.73 -45.97 2.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 -172.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 36.0 tp -73.29 -43.97 60.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 54.9 tp -121.1 73.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 33.1 p -141.53 172.24 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -52.6 -46.71 67.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.811 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.95 -40.18 32.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.806 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.697 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.7 -45.79 20.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.568 -171.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 26.2 tp -64.86 -32.98 74.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.832 0.349 . . . . 0.0 110.94 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.42 -43.48 98.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.25 99.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.05 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.516 HG21 ' HA3' ' A' ' 19' ' ' GLY . 14.5 p -80.39 -33.27 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.506 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 39.7 t30 -72.91 -21.3 60.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -55.92 -22.97 28.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.85 -20.61 24.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -99.68 156.12 35.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -59.81 -62.42 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.346 -171.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.31 -48.0 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.506 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 101.68 -43.79 1.65 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.463 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.47 71.69 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 111.116 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.53 153.24 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.125 -155.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.6 -18.62 58.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.8 tp -79.13 114.18 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.74 -45.62 93.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -166.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.1 m -67.23 -48.45 67.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.53 -38.99 82.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -36.53 71.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.861 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.26 -47.61 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.88 -15.39 60.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.51 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.24 -9.6 58.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -87.75 125.23 65.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.541 0.686 . . . . 0.0 110.846 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -47.27 -28.73 8.45 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 0.0 112.321 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.431 ' HG2' HG22 ' A' ' 244' ' ' VAL . 88.8 mtm180 -63.93 -37.3 86.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 40.7 mm -88.69 -42.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.146 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.9 -37.56 76.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.79 -37.6 79.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 92.8 m -67.21 -39.65 86.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -65.15 -44.41 88.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -65.84 -46.32 78.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.905 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 327' ' ' GLY . 4.3 p-10 -79.49 -15.72 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.839 -174.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.42 82.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -71.3 -17.14 62.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -112.63 -9.76 13.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -81.37 -165.46 34.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -129.19 147.19 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.655 HD12 ' HB3' ' A' ' 96' ' ' ALA . 6.0 tp -64.22 128.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -172.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 64.7 ttp -55.06 136.08 67.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.543 0.687 . . . . 0.0 110.908 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.48 80.52 1.37 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -103.02 4.91 37.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 335' ' ' GLN . 50.8 mm -81.37 137.58 48.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.628 0.728 . . . . 0.0 111.127 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 333' ' ' ILE . 53.9 Cg_exo -47.41 -35.5 21.52 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.426 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.0 mm-40 -82.04 -30.97 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.946 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 60.9 mtt -67.43 -18.58 65.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 84.4 p -60.65 -25.66 66.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.836 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.27 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -66.91 -38.86 87.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.81 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -62.98 -54.05 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -59.63 -45.69 91.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.21 83.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -173.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.35 -30.3 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -59.84 -46.55 88.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.9 m -64.65 -44.44 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.639 ' HA ' ' HB2' ' A' ' 360' ' ' ALA . . . -62.73 -43.78 97.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.51 -49.26 61.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.49 -43.6 97.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 82.2 m-20 -61.31 -35.81 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.81 70.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.34 -34.87 70.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.172 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.4 p -80.95 -8.35 59.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.79 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.41 11.75 85.2 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -80.51 -24.33 39.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.661 0.267 . . . . 0.0 110.788 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 59.3 tt0 -148.39 146.84 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.009 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 56.8 p -73.58 165.19 25.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.04 -45.85 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.063 -171.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.27 -41.33 98.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -72.72 -42.43 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.934 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . . . -63.0 -43.69 98.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.1 -33.77 74.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.69 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.928 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.95 -30.98 71.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -69.45 -45.2 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -65.12 -38.3 90.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 80.5 m -59.82 -41.68 91.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.97 -40.65 78.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.9 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 53.2 p -103.4 33.78 3.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.202 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -175.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.9 mt -87.44 136.67 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.453 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.1 mt-10 -129.71 162.61 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.78 122.57 24.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.99 22.87 34.31 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.453 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 92.6 mttt -145.45 165.67 27.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.93 144.82 25.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.98 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.29 122.82 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.128 -173.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.87 140.09 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 58.8 m95 -118.41 123.71 45.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 21.2 tt -148.79 139.92 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.2 -169.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -47.49 119.03 2.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -164.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.81 -24.26 64.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.496 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -53.7 -57.0 12.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.953 -170.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -139.6 89.91 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 148.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.73 -29.13 1.92 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -80.45 -47.98 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.949 -154.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.94 -51.73 55.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -154.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.74 -45.95 71.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.483 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.2 tp -58.62 -40.26 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.75 -42.17 98.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.054 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.34 -41.61 98.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.04 -48.02 80.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.06 -35.97 92.23 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -67.02 -42.72 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.792 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -58.81 -42.71 89.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.958 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' A' ' 33' ' ' ILE . 19.7 t80 -66.81 -35.3 79.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.86 -35.93 82.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -72.25 -33.99 67.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.51 -42.16 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.3 p -107.77 -15.45 14.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.195 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.05 4.33 89.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.504 -175.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.2 tt -73.41 116.42 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 111.15 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.28 123.99 21.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.49 145.48 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -140.62 116.96 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.35 129.97 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -125.17 161.45 26.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -94.6 121.9 62.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.546 0.688 . . . . 0.0 110.809 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.422 ' CB ' HD23 ' A' ' 43' ' ' LEU . 72.0 Cg_endo -86.67 81.21 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.634 2.223 . . . . 0.0 112.318 -167.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -91.98 -26.3 18.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -92.36 -17.37 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.422 HD23 ' CB ' ' A' ' 40' ' ' PRO . 1.9 mp -54.03 -43.75 70.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -157.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -49.28 -40.98 36.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.66 -33.93 35.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -71.33 -25.67 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.487 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.9 m-30 -49.55 -55.83 20.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.797 0.808 . . . . 0.0 110.968 -163.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 58.2 Cg_endo -71.4 -29.26 16.98 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -177.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -76.72 -50.58 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.706 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 35.4 m -59.5 -34.01 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 -175.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.71 84.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.073 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -25.76 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.8 p -93.3 3.11 56.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.85 3.77 60.5 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -172.5 95.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.872 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.706 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -123.26 -132.42 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 154.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 50.6 Cg_endo -73.8 155.0 48.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.617 2.211 . . . . 0.0 112.343 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -84.6 -39.61 18.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -135.1 134.78 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.5 mm -119.1 135.28 60.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.16 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.516 ' HB3' ' HA ' ' A' ' 11' ' ' ILE . 17.7 p90 -74.13 158.67 33.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.453 ' CB ' ' H ' ' A' ' 263' ' ' SER . 49.0 t90 -88.13 147.8 24.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.46 -95.46 0.45 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.05 -85.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 156.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -86.38 -13.18 47.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -58.52 -25.94 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 -154.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.412 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -60.0 -32.13 70.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -176.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.791 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -60.74 -44.75 97.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.47 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.7 93.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.8 m-30 -61.79 -42.48 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.68 -43.82 97.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -64.97 -30.1 71.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -84.68 -1.0 55.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.843 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.34 29.02 74.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.44 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 66.0 mt -74.63 -17.38 60.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.515 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -135.02 145.78 48.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -166.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -82.64 158.29 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.112 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.42 131.05 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.38 147.82 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.244 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -101.55 123.22 45.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.536 0.684 . . . . 0.0 111.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 147.49 30.83 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.749 2.299 . . . . 0.0 112.365 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -108.38 119.05 38.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -39.61 75.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.45 -42.97 83.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -69.57 -34.05 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.461 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.5 mt-30 -60.73 -44.74 96.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.0 -41.04 91.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.53 -24.8 59.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 304' ' ' LEU . 83.6 mt -108.23 -145.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -137.29 140.18 30.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 0.0 110.866 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.18 -35.43 63.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.83 -37.74 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.882 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.6 p -74.09 -25.13 59.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.164 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 49.3 m95 -74.08 -38.39 63.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.31 -34.14 74.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.968 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.93 67.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.53 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 27.4 m -112.62 19.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.136 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.493 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 58.9 mtm180 -116.37 140.13 49.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.774 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.452 ' HB3' HG21 ' A' ' 104' ' ' ILE . 85.2 t80 -139.64 127.92 22.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -175.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 56.12 32.77 20.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -174.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.75 3.24 90.66 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.415 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -115.57 150.03 37.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.927 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.493 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 64.5 tp -85.01 120.74 26.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 99' ' ' TYR . 36.9 pt -115.19 -13.88 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -167.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.53 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -156.63 161.46 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.506 ' HB3' HD11 ' A' ' 285' ' ' LEU . 79.7 m-85 -103.22 134.66 19.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.701 0.762 . . . . 0.0 110.977 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.498 ' HD3' HG22 ' A' ' 97' ' ' VAL . 62.9 Cg_endo -81.65 118.99 3.24 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.236 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.31 -31.13 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 -171.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.51 153.69 19.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.146 -163.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.43 124.46 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -111.28 113.87 26.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.79 146.36 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.69 147.17 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.1 m -142.25 159.71 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -91.59 119.99 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.99 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.497 HG12 HG23 ' A' ' 244' ' ' VAL . 31.0 mt -112.78 124.34 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -132.65 156.06 47.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -165.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -91.96 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.71 -24.46 66.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.902 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -75.75 -37.24 59.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.52 -51.12 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.98 105.74 44.62 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.591 0.71 . . . . 0.0 110.895 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.01 -14.89 26.25 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.7 t-20 -155.92 104.08 2.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 0.0 110.837 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.6 Cg_endo -66.83 160.51 46.42 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.312 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.422 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 34.1 Cg_endo -68.46 144.27 60.69 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.722 2.282 . . . . 0.0 112.364 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.17 -17.26 31.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.985 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -148.52 166.03 29.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.136 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -69.16 -25.69 64.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.787 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.79 -30.3 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.873 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.54 -22.4 43.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.901 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 81.3 mt -63.39 -50.44 73.92 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.604 0.716 . . . . 0.0 111.12 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 36.4 Cg_endo -67.83 -40.28 9.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.686 2.257 . . . . 0.0 112.254 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.52 95.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.422 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 57.1 tp -60.66 -38.84 86.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 132' ' ' ILE . 10.3 t70 -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.62 -37.93 83.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.35 -45.47 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.819 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.5 pp -85.08 -20.32 30.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.411 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -58.23 -27.04 63.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.924 170.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -17.92 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.98 9.25 34.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 29.31 63.58 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.476 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -112.3 158.58 19.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.3 t -114.74 151.04 34.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 164.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -78.02 -43.92 28.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.042 -173.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.81 144.43 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.952 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -109.95 131.32 55.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -166.74 159.12 13.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -122.32 -16.22 7.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.4 mt 50.68 36.72 14.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -99.29 -14.07 19.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -142.59 148.66 47.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.569 0.7 . . . . 0.0 110.95 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.55 -25.07 75.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -54.23 -42.79 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.427 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 70.4 m-85 -73.19 -30.33 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 -177.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -76.83 -25.1 52.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.532 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 24.1 m0 -56.48 -46.15 99.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.602 0.715 . . . . 0.0 110.917 -164.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.775 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 74.9 Cg_exo -47.62 -44.57 25.67 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.674 2.249 . . . . 0.0 112.377 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.3 mt -75.28 -34.35 61.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.96 -42.15 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.54 -18.53 56.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.14 80.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 -160.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -98.88 13.39 32.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.08 12.45 6.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.51 170.63 53.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.498 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -165.07 165.0 20.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.919 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.94 -73.54 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.88 148.8 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -66.12 125.41 25.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.871 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -114.86 114.33 25.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -151.35 144.9 24.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.863 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 47.71 44.25 17.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.889 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.0 7.85 71.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.65 146.95 50.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -90.5 130.6 36.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -87.17 107.52 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.9 tp -64.77 -19.92 26.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.44 -2.93 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.951 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -120.57 95.98 4.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.21 153.25 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.148 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 188' ' ' ALA . . . -105.03 28.59 14.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.04 -12.9 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.313 . . . . 0.0 111.066 176.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.434 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 53.8 p-10 -103.33 13.48 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.95 156.58 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -171.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.06 66.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.1 96.7 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 182' ' ' GLY . . . -65.48 -34.88 79.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.155 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -63.94 -40.34 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.06 86.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.97 -44.03 95.09 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.428 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.426 HD21 HG13 ' A' ' 357' ' ' VAL . 34.3 tp -68.23 -40.0 82.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.957 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.7 m -58.85 -40.81 85.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.219 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.66 -43.23 99.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.974 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.32 -42.48 91.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.71 -39.98 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.27 -35.59 79.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -37.34 86.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.13 -38.2 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.222 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.56 -38.22 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.869 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -82.24 1.82 34.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.78 34.95 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.92 -16.49 58.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.811 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 205' ' ' ASN . 19.0 tmm? -137.81 141.81 40.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 60.8 t30 -92.73 134.93 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 -167.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.35 -11.0 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 51.9 m -75.49 140.12 42.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -176.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -98.64 167.28 10.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -66.48 -36.61 83.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.7 p -71.96 -36.33 69.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.69 -43.69 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.185 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 216' ' ' ALA . . . -73.39 -32.55 64.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.69 -36.11 73.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.16 84.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' A' ' 221' ' ' GLU . . . -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -63.81 -40.21 96.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.59 -21.83 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.787 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.27 -9.94 19.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.848 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.72 16.97 59.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.44 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 216' ' ' ALA . 95.8 mt-10 -84.63 -28.33 26.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.973 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.0 m -123.43 130.08 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.93 92.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 -166.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.412 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.9 mtm -137.81 155.26 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 72.4 p -141.8 167.38 22.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.8 mm -118.88 115.03 46.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.65 156.81 48.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.44 -170.05 46.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.516 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.51 -19.06 11.81 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -69.96 -30.96 68.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.97 14.9 9.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.659 ' O ' ' C ' ' A' ' 233' ' ' SER . 33.5 m0 -74.28 -50.25 19.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 172.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.659 ' C ' ' O ' ' A' ' 232' ' ' TRP . 89.4 p -4.64 -80.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.843 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -171.92 4.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.944 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.98 117.83 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.646 ' O ' ' C ' ' A' ' 237' ' ' THR . 40.6 t0 -130.58 150.61 51.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.646 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.1 m -6.68 75.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 236' ' ' ASP . 93.0 p -63.22 153.96 32.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 170.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.52 -16.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 52.3 t -88.89 75.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 44.44 44.39 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.41 148.76 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 164.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.56 165.93 26.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.47 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.497 HG23 HG12 ' A' ' 116' ' ' ILE . 46.4 t -128.6 131.06 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 111.164 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -143.0 -177.59 5.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.09 158.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.209 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.542 HD23 ' HD3' ' A' ' 257' ' ' PRO . 13.3 tp -76.72 139.58 66.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.711 . . . . 0.0 110.98 -173.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.83 138.0 15.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.231 . . . . 0.0 112.419 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 96.9 m -138.82 137.39 36.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -168.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -106.02 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.798 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 45.34 42.93 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.36 52.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.442 165.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.409 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.9 mm-40 -114.83 158.36 40.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.688 0.756 . . . . 0.0 110.969 -169.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.1 Cg_endo -64.93 74.75 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 61.3 m -92.46 3.34 55.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.485 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 62.8 mttp -107.07 157.1 36.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.61 0.719 . . . . 0.0 110.9 -157.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.775 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 34.5 Cg_endo -65.82 160.42 43.96 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.621 2.214 . . . . 0.0 112.297 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -75.14 166.45 23.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.35 131.07 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 -167.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.64 147.08 16.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.483 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.12 122.73 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.927 0.394 . . . . 0.0 111.105 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.29 128.79 37.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.453 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 27.8 m -130.22 152.3 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.814 -164.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -142.97 136.44 28.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.06 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.18 17.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.472 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.0 mm -110.1 125.63 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 0.0 111.084 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 54.9 t-20 -58.91 124.71 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.813 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.572 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -67.31 -29.29 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.052 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.28 -9.7 58.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.0 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -68.15 128.55 93.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.738 0.78 . . . . 0.0 110.913 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.31 -11.7 32.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -114.91 25.0 11.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.902 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.74 -32.67 53.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.89 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.11 -37.96 63.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.63 -45.42 90.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.023 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.63 -43.28 76.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.08 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -65.11 -51.25 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.61 -44.81 92.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -35.24 74.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.65 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.5 tt -55.62 -52.04 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.21 -27.28 47.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -96.34 -7.26 35.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 -169.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.758 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 32.4 m-85 -115.94 -57.6 2.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.64 -37.61 79.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -172.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' A' ' 106' ' ' TYR . 49.8 mt -99.94 41.4 1.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.96 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 75.1 p -137.74 162.09 34.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.53 -48.54 77.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.45 -38.92 71.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.758 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -76.41 -46.32 12.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.547 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.0 tp -65.44 -36.37 83.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.49 -44.75 89.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.64 95.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -30.67 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.44 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 52.2 t30 -74.12 -12.15 60.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.39 -25.99 62.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -93.57 0.0 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -116.39 155.88 47.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.717 . . . . 0.0 110.923 169.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.52 -62.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.704 2.269 . . . . 0.0 112.412 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.0 mt -108.81 -43.97 4.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.44 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 97.97 -61.31 0.95 Allowed Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.533 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 54.97 85.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.082 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.75 156.94 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.22 -156.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.99 60.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.473 ' HA ' HD21 ' A' ' 89' ' ' LEU . 47.7 tp -79.78 117.82 21.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.11 -44.26 95.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.881 -171.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 90.2 p -67.11 -52.81 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -171.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.53 -34.67 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.37 -40.11 95.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.38 -36.88 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.69 -47.83 29.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.428 HD12 HG21 ' A' ' 317' ' ' ILE . 3.9 pp -74.7 -16.59 60.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.12 -4.67 37.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.195 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.67 -10.22 59.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -87.18 131.22 45.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.536 0.684 . . . . 0.0 110.844 175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.26 -29.23 12.54 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.649 2.233 . . . . 0.0 112.336 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -66.35 -39.09 88.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 311' ' ' LEU . 36.0 mm -84.62 -42.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.91 67.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.118 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.49 -38.97 81.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.06 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.3 m -68.43 -40.81 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.214 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -64.33 -43.91 93.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.56 -45.28 79.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.485 ' HB2' ' HD3' ' A' ' 256' ' ' LYS . 44.9 p30 -78.52 -18.76 54.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.894 -173.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.81 84.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -72.98 -17.4 61.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 -9.13 14.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.16 -161.34 34.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.472 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -125.7 129.27 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.312 . . . . 0.0 110.914 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 38.2 mm -67.51 123.61 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.207 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.82 123.62 85.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.485 0.66 . . . . 0.0 110.887 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.3 146.4 40.52 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 122.627 2.218 . . . . 0.0 112.366 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.791 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 55.5 p30 -99.99 13.64 33.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.43 HG12 ' H ' ' A' ' 335' ' ' GLN . 16.7 tt -75.18 138.94 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 111.091 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.62 -25.7 20.65 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.735 2.29 . . . . 0.0 112.372 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.43 ' H ' HG12 ' A' ' 333' ' ' ILE . 99.5 mm-40 -63.89 -14.54 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.991 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.1 mmm -62.86 -25.89 68.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -58.91 -40.12 83.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.779 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.28 69.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.44 ' HA ' HG12 ' A' ' 368' ' ' ILE . 87.3 t80 -58.43 -43.67 88.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -59.87 -57.58 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -61.62 -33.69 74.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.88 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.19 84.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.2 t -69.84 -39.94 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.151 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -57.49 -49.63 75.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.817 -172.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.3 m -65.88 -43.89 86.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.39 98.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.093 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.4 t -68.94 -49.89 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.214 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 94.4 mt -61.59 -41.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.155 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 84.1 m-20 -61.86 -38.17 87.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.37 73.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.09 68.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.137 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.7 p -80.41 -7.96 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.844 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.48 11.93 84.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.446 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.98 -27.13 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.744 0.307 . . . . 0.0 110.793 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.6 tt0 -147.51 146.4 29.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.0 p -71.11 164.56 25.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.24 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.426 HG13 HD21 ' A' ' 192' ' ' LEU . 76.8 t -73.33 -45.6 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -170.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.44 -38.37 90.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.849 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -73.23 -37.75 66.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.93 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 184' ' ' ASP . 0.4 OUTLIER -64.68 -36.16 83.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.18 -40.43 97.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.888 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -69.97 -33.12 71.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.2 -48.38 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.153 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.92 -32.27 70.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 75.1 m -63.29 -41.99 99.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.99 -38.27 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.88 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 339' ' ' PHE . 86.5 mt -63.64 -43.51 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.219 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 44.3 p -102.5 35.61 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.638 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -86.47 133.77 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.426 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.9 mt-10 -123.87 158.96 30.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.29 122.35 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.79 22.62 49.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.497 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 96.4 mttt -140.54 156.04 46.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.37 137.92 50.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.5 t -123.89 113.72 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.55 137.84 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.089 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 59.8 m95 -113.66 123.28 49.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.662 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 18.1 tt -150.94 144.08 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 -168.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -48.54 119.72 3.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -170.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.5 -21.51 60.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.477 -172.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.51 -48.31 81.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.24 83.43 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 149.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.57 -46.23 1.56 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.532 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.05 -44.86 29.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.9 -157.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.09 -53.09 42.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -154.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.481 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -65.27 -48.53 68.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.446 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 HG21 ' A' ' 11' ' ' ILE . 2.7 mp -61.84 -36.84 82.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.897 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.94 83.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.33 -41.39 96.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.44 -41.59 88.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.535 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.06 -48.74 80.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.41 -43.09 99.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.988 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.42 -36.21 80.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.91 -34.29 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.23 -34.0 77.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -88.4 -39.71 14.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.439 ' HB ' HG22 ' A' ' 33' ' ' ILE . 62.2 m -110.1 -24.46 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.191 -167.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.35 7.75 79.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.476 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.764 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -87.07 127.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 111.02 -177.343 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.94 137.34 39.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.57 140.03 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.187 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -128.52 111.84 13.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.414 HG13 HG22 ' A' ' 11' ' ' ILE . 94.4 t -104.32 127.98 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -124.77 158.23 33.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 41.5 m170 -83.67 135.98 42.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.662 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 71.8 Cg_endo -90.0 68.31 1.9 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -166.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -101.04 -32.29 10.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.793 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.22 -16.06 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.52 HD13 ' HA ' ' A' ' 40' ' ' PRO . 5.9 mp -50.94 -51.61 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -158.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.14 -35.6 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 50' ' ' VAL . 74.7 mmtt -76.13 -30.06 58.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.812 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.521 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.0 m-30 -51.29 -56.12 23.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.646 0.736 . . . . 0.0 110.844 -167.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.4 Cg_endo -67.76 -29.84 34.95 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.733 2.289 . . . . 0.0 112.314 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -78.58 -49.96 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.441 HG22 ' HD2' ' A' ' 57' ' ' PRO . 32.1 m -66.93 -32.02 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.093 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.9 92.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.16 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -94.31 1.08 55.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.35 78.88 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.422 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -169.66 101.87 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 110.924 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' CA ' ' HB ' ' A' ' 50' ' ' VAL . . . -125.05 -130.74 3.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.471 161.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HD2' HG22 ' A' ' 50' ' ' VAL . 49.2 Cg_endo -71.42 156.64 58.12 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 -175.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.07 -43.28 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -136.65 138.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.14 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.14 134.98 60.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' CE1' HD22 ' A' ' 262' ' ' LEU . 83.4 t80 -78.71 136.31 37.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -62.87 143.96 57.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.1 -100.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -127.33 -85.9 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 160.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -87.13 -21.76 25.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 11.9 mmt85 -57.63 -28.92 64.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -166.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -61.72 -33.65 74.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.671 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -65.01 -43.59 95.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.546 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.43 -32.98 85.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.512 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 66' ' ' ARG . 19.3 m-30 -66.72 -34.29 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.86 99.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.43 -27.49 67.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.7 m -83.2 -1.0 51.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.907 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.84 28.63 71.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.509 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.79 -7.69 59.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.982 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.529 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.0 pp -135.13 146.01 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.66 159.65 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.1 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.64 129.37 39.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -113.33 150.6 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.153 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -105.21 124.16 37.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.255 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.9 139.58 40.09 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.718 2.278 . . . . 0.0 112.282 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.74 121.72 38.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.82 -39.36 68.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.52 95.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.082 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -65.79 -34.68 78.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.32 -43.94 95.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.23 -41.87 93.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.74 -24.43 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.98 -177.59 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.16 150.24 37.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.942 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.3 -38.13 36.6 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.737 2.291 . . . . 0.0 112.322 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -76.79 -20.13 56.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 71.7 p -75.5 -26.0 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.111 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -69.99 -37.15 75.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.995 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.67 -33.95 74.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.23 65.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.463 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 30.6 m -105.63 11.36 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -111.4 140.33 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -138.01 125.14 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.19 34.8 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.45 1.71 88.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.435 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.22 147.99 44.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 tp -78.6 129.37 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.913 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.3 pt -118.16 -5.41 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.09 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -162.42 166.67 24.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.4 m-85 -112.44 136.84 21.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.713 0.768 . . . . 0.0 110.981 167.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 39.1 Cg_exo -61.76 117.17 3.98 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.246 174.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 96.6 mt -104.33 -38.43 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 262' ' ' LEU . . . -156.74 155.33 31.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.195 -170.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.0 t -124.19 128.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.147 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 229' ' ' PRO . 49.9 mt-10 -115.59 120.0 37.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.832 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.86 147.33 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.104 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.58 148.96 36.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.0 m -141.53 161.08 38.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.76 122.16 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.08 128.39 67.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.053 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -133.49 154.37 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -91.87 116.34 28.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.829 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.86 -26.99 68.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -174.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.17 -32.25 33.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.881 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.08 -48.5 8.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.6 tp -127.69 111.71 20.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.662 0.744 . . . . 0.0 110.967 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 -15.15 17.62 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.818 2.346 . . . . 0.0 112.335 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 45.5 t30 -149.68 107.13 3.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -173.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.2 Cg_endo -67.63 161.87 41.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.336 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.43 ' HD3' HD13 ' A' ' 135' ' ' LEU . 44.8 Cg_endo -72.7 144.38 39.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.609 2.206 . . . . 0.0 112.477 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.98 -22.99 21.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 167.31 26.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -67.13 -29.93 69.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.07 -30.22 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.77 -22.76 45.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.613 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 80.9 mt -62.34 -51.37 74.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.669 0.747 . . . . 0.0 111.075 -167.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.28 -39.05 10.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.252 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.48 90.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.064 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.635 HD21 ' O ' ' A' ' 135' ' ' LEU . 4.7 tt -62.18 -37.02 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 140' ' ' LYS . 8.7 t70 -66.35 -42.76 87.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.98 -38.72 73.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.18 -49.67 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.469 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.0 pp -80.22 -18.43 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.945 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.469 ' N ' HD12 ' A' ' 139' ' ' LEU . 84.4 tttt -57.13 -30.42 64.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 171.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.88 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -103.59 7.92 37.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.5 29.86 61.11 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.486 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -106.48 164.48 12.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.1 t -116.05 149.09 39.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.8 165.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -83.5 -28.48 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.105 175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 tp -137.86 143.35 40.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.4 ttm -120.46 128.94 53.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -166.32 163.19 17.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.758 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -130.14 -4.36 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.869 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.3 mt 53.07 34.31 16.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -92.11 -16.61 26.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -132.42 146.2 60.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.677 0.751 . . . . 0.0 110.866 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -59.97 -23.25 72.23 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -54.57 -32.51 58.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -71.81 -36.67 70.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.406 HG22 HG11 ' A' ' 347' ' ' VAL . 73.4 p -86.19 -23.74 26.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 -172.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.482 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.6 m95 -56.09 -44.99 99.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.585 0.707 . . . . 0.0 110.936 -168.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.543 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 72.2 Cg_exo -46.42 -40.23 22.63 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.279 . . . . 0.0 112.31 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.4 -38.08 30.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.529 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 93.3 mt -69.87 -51.41 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -172.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.71 -15.7 60.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 -176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -59.38 -31.71 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.119 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -92.02 0.78 57.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 -172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.05 13.75 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.556 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.36 166.37 31.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.423 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -174.43 154.45 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.347 . . . . 0.0 110.936 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -41.6 -63.38 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 176' ' ' TYR . 20.6 p90 -142.09 155.61 45.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.29 123.65 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -119.74 117.18 27.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -147.58 142.36 26.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -172.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 51.9 40.43 28.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.28 76.55 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.522 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.09 146.87 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.337 . . . . 0.0 110.829 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.511 ' HB2' ' CD1' ' A' ' 169' ' ' PHE . 17.1 p90 -101.56 141.61 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.63 110.97 23.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 178' ' ' ILE . 6.2 tp -71.42 -19.66 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.08 -5.23 57.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -125.25 95.03 4.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.857 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.412 ' HB ' HG23 ' A' ' 183' ' ' VAL . 32.0 m -101.09 158.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.89 16.64 39.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.451 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.412 HG23 ' HB ' ' A' ' 181' ' ' VAL . 30.8 m -100.01 -19.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -175.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -98.99 19.82 14.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.52 154.2 20.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -172.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.26 70.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.018 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.54 94.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.493 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.5 81.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 111.195 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.02 -38.55 88.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.56 97.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -61.88 -40.11 98.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.429 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.435 HD21 HG13 ' A' ' 357' ' ' VAL . 38.8 tp -67.86 -38.13 82.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 83.1 m -60.45 -41.19 93.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.182 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -57.85 -45.48 86.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.4 -45.11 94.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.5 -41.51 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 198' ' ' LEU . 1.1 mp -63.24 -38.24 90.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.43 -38.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.132 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.0 -32.03 73.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -81.56 3.32 25.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.55 33.96 10.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.999 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -77.07 -18.96 57.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 tpt -143.83 150.09 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.48 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 66.2 t30 -87.49 141.8 28.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.3 -32.62 68.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -96.16 -16.2 21.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -171.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 70.9 m -67.26 135.62 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.033 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -102.22 169.92 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -65.0 -47.54 77.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.863 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.31 -43.62 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.108 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.38 -32.67 70.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -64.22 -40.59 96.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.034 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.072 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -63.81 -39.83 95.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.934 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -61.47 -25.88 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.784 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.22 -8.11 40.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.04 17.3 63.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.495 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -83.5 -21.75 32.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.5 m -123.15 131.02 53.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.18 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.37 -38.88 65.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.2 mtm -135.51 154.88 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.902 -172.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 166.77 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.0 mm -119.17 125.33 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.169 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -147.47 155.56 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.79 -163.42 31.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.458 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.417 ' HG3' ' HA ' ' A' ' 111' ' ' GLU . 66.6 Cg_endo -76.21 -14.88 18.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.755 2.303 . . . . 0.0 112.346 -175.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -62.84 -30.55 71.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.983 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.79 20.06 12.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.666 ' O ' ' C ' ' A' ' 233' ' ' SER . 48.0 m0 -71.38 -41.1 70.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.666 ' C ' ' O ' ' A' ' 232' ' ' TRP . 52.8 p 2.92 -91.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -153.99 3.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.876 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 19.5 tt -164.92 155.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 -168.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 238' ' ' SER . 54.6 p30 -102.17 -173.86 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.56 ' C ' ' O ' ' A' ' 236' ' ' ASP . 48.2 m -9.96 82.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.204 163.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 236' ' ' ASP . 45.6 m -40.86 136.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 -31.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 240' ' ' VAL . 61.4 t -89.12 68.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -174.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 54.29 33.02 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 171.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.435 ' HB2' ' HB3' ' A' ' 238' ' ' SER . 91.4 m-85 -105.56 152.66 22.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 167.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.09 158.86 24.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 316' ' ' ARG . 62.1 t -130.2 130.68 65.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.18 177.49 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.16 160.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.58 148.88 74.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.31 144.26 72.45 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.609 2.206 . . . . 0.0 112.417 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.1 p -129.18 150.03 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -125.77 111.19 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 48.34 37.95 9.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.96 26.08 56.51 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 167.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -109.6 156.78 39.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.551 0.691 . . . . 0.0 110.965 -169.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 75.2 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.438 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.3 p -92.24 -1.37 57.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -170.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.411 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 68.3 mttm -102.29 155.86 35.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.539 0.685 . . . . 0.0 110.945 -167.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.79 167.47 24.39 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -68.01 153.91 42.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.6 t -118.69 130.04 74.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.151 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -100.25 141.9 15.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.477 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.5 124.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.483 ' HB2' ' HB1' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -65.02 124.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.6 m -128.74 155.28 45.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.837 -168.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.409 ' H ' ' HB2' ' A' ' 105' ' ' ALA . . . -138.19 134.97 35.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.04 141.95 15.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.2 mt -113.81 125.03 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.067 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -59.09 125.07 22.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.0 -27.32 65.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.06 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.89 -8.17 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.058 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -66.21 130.3 94.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.719 0.771 . . . . 0.0 110.883 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -65.73 -16.32 52.78 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.816 2.344 . . . . 0.0 112.275 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -110.92 21.11 16.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.881 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -51.8 -34.54 40.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.21 -36.5 58.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.67 HD22 HG13 ' A' ' 33' ' ' ILE . 40.7 tp -61.06 -45.27 95.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.074 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -65.05 -45.76 84.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.76 -51.28 67.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.828 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -69.19 -35.29 76.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -172.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.64 HD21 ' O ' ' A' ' 280' ' ' LEU . 3.9 tt -55.91 -50.33 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.996 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.63 -35.68 65.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -102.74 -23.34 13.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.735 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 61.9 m-85 -122.16 -43.84 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 -171.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 30.8 tp -74.18 -42.31 60.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.918 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 51.0 tp -124.57 74.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 37.0 p -141.48 173.44 11.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.201 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.3 -45.15 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.14 -44.09 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.827 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.735 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.07 -45.89 18.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.443 -168.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.429 HD22 ' HB ' ' A' ' 302' ' ' VAL . 45.6 tp -61.99 -34.49 76.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.34 . . . . 0.0 110.879 -176.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.88 -40.26 88.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.874 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.95 94.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.481 HG21 ' HA3' ' A' ' 19' ' ' GLY . 11.1 p -81.98 -35.81 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.236 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.35 -22.55 60.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.953 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -61.84 -13.4 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -171.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -83.46 0.16 47.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.799 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -111.58 153.32 44.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.868 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.59 -61.98 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.717 2.278 . . . . 0.0 112.368 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 84.2 mt -98.63 -36.1 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 111.44 -58.09 0.41 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.498 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 49.26 70.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.126 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.429 ' HB ' HD22 ' A' ' 290' ' ' LEU . 35.6 m -112.18 152.2 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -167.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.37 -13.4 59.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 55.3 tp -76.61 120.2 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.8 -47.03 86.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -64.96 -48.36 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -172.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -69.26 -36.68 77.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -65.64 -34.54 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.45 -39.38 94.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -69.77 -43.57 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.02 -24.13 65.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.27 -5.55 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 -173.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.49 -17.75 62.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -86.96 128.62 55.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.531 0.681 . . . . 0.0 110.915 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.32 -30.7 20.67 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.445 ' HG2' HG22 ' A' ' 244' ' ' VAL . 94.4 mtt-85 -69.91 -37.39 75.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 39.2 mm -79.14 -40.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.49 -41.94 83.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.8 m -64.8 -41.52 95.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.214 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.94 -42.81 94.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -66.39 -46.2 77.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.908 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 327' ' ' GLY . 25.8 p30 -78.21 -18.12 55.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.48 82.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.112 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.24 -25.45 59.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.78 -9.97 20.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.83 -155.95 31.47 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.457 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -122.75 129.4 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.2 mm -72.73 127.47 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.264 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.413 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 59.8 ttm -63.37 124.89 85.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 330' ' ' MET . 36.5 Cg_endo -64.21 135.12 45.39 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.745 2.297 . . . . 0.0 112.329 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.671 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.7 p30 -95.08 13.22 25.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 -172.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 335' ' ' GLN . 48.3 mm -75.12 130.36 80.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 111.203 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.98 -28.11 74.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.513 ' H ' HG22 ' A' ' 333' ' ' ILE . 92.2 mt-30 -64.95 -13.86 58.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.973 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.87 -21.49 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -58.57 -35.6 72.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.58 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -63.0 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.957 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -58.69 -52.01 67.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.922 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -64.32 -44.65 90.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.53 94.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.167 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 76.5 t -71.79 -42.39 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -57.52 -45.79 84.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.3 m -65.53 -44.64 86.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.065 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.476 ' HA ' ' HB2' ' A' ' 360' ' ' ALA . . . -63.76 -40.57 97.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.086 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.406 HG11 HG22 ' A' ' 157' ' ' THR . 53.8 t -67.66 -48.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.5 -45.36 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.237 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.697 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 83.5 m-20 -63.54 -37.08 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.91 -45.52 67.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.16 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.21 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.7 p -81.9 -8.98 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.11 84.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -81.0 -25.68 37.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 110.823 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.697 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 41.7 tt0 -149.9 145.38 26.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.4 p -72.55 163.73 27.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.435 HG13 HD21 ' A' ' 192' ' ' LEU . 54.3 t -65.32 -45.93 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.116 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.08 -42.82 96.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.32 -46.23 61.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . . . -62.08 -42.14 98.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.024 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.3 -39.97 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.906 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.06 -41.69 90.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.873 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.53 -44.02 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.33 -48.08 11.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.222 -168.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -70.95 -32.31 69.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 -170.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 59.0 m -60.61 -33.26 72.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.8 -27.97 67.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.78 -40.18 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.3 p -102.54 -16.7 16.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 178.259 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.27 128.99 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.02 166.28 21.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.77 123.91 25.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.946 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.01 29.46 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.453 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -141.07 154.78 46.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 110.929 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.656 ' HB2' HD13 ' A' ' 33' ' ' ILE . 7.2 tt -139.07 130.36 26.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.796 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.24 124.79 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.6 mt -118.84 134.82 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.842 ' HB3' HD22 ' A' ' 43' ' ' LEU . 39.7 m0 -111.7 123.73 50.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.965 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.51 160.22 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.879 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.7 t-20 -55.85 120.14 6.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 167.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.472 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.54 -20.89 79.42 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.482 -171.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -57.74 -45.47 85.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.844 -167.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.3 mmtt -130.67 75.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 148.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.5 -46.3 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.504 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -75.82 -45.75 34.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.939 -154.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -63.98 -52.66 58.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -157.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -64.18 -43.91 96.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.532 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.5 -37.52 83.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.99 -44.57 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.47 -52.2 66.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.6 m -75.25 -34.01 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.502 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -66.88 -39.6 93.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.484 175.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -70.11 -42.97 71.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.72 -39.64 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.98 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.28 -35.09 75.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 171.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.63 -34.12 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.81 -33.6 72.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -83.96 -39.96 19.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.2 p -109.09 -16.98 13.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.142 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.67 5.39 86.66 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.656 HD13 ' HB2' ' A' ' 7' ' ' LEU . 14.1 pt -88.07 125.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.195 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.84 129.64 39.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 ' HA3' ' A' ' 24' ' ' GLY . 14.4 p -100.78 139.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.081 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -140.95 121.41 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.19 128.67 61.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 88.3 tt0 -112.24 151.85 29.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -79.28 161.46 67.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.839 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.879 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 59.9 Cg_endo -102.97 24.05 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 -160.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -76.45 -43.62 39.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.99 -14.32 36.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.842 HD22 ' HB3' ' A' ' 10' ' ' TRP . 3.5 mp -52.03 -50.9 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 -161.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.9 -41.28 61.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.25 -35.56 61.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.863 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.25 -28.93 62.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m-30 -49.24 -54.91 24.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.593 0.711 . . . . 0.0 110.898 -162.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 86.8 Cg_endo -80.03 -31.11 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.211 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -74.65 -48.32 26.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -168.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.48 -30.76 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.55 ' HA ' ' HB3' ' A' ' 269' ' ' ALA . . . -62.52 -37.82 87.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.83 63.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 p -97.68 -1.11 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.101 -171.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.602 ' HA2' ' HB2' ' A' ' 269' ' ' ALA . . . 75.63 18.46 79.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.523 -176.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -109.73 -175.16 2.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.864 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.7 -165.9 12.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.505 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.627 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 89.5 Cg_endo -82.79 178.45 6.03 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -87.88 -38.72 15.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 164.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.9 mt -131.06 139.6 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.2 143.23 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.058 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -100.05 142.85 30.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.51 126.65 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.76 -90.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -110.75 -83.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -95.91 -17.44 21.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.416 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 80.3 mtp180 -59.72 -25.7 65.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CD2' HD12 ' A' ' 104' ' ' ILE . 10.1 p90 -52.39 -37.43 56.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -49.06 9.86 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.495 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.6 86.17 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.48 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.579 ' HB3' HD22 ' A' ' 75' ' ' LEU . 25.4 m-85 -71.66 -30.4 65.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.942 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.93 69.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.63 -29.86 70.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -83.98 -1.74 55.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 110.934 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.35 25.02 66.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.579 HD22 ' HB3' ' A' ' 70' ' ' TYR . 4.4 pp -85.99 -5.41 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -131.41 146.09 52.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.944 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 147.62 24.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.21 142.88 50.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' A' ' 103' ' ' LEU . 39.2 pt -101.99 145.97 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.6 p -132.25 70.26 80.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 111.08 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.37 144.35 45.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.381 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -86.61 -174.52 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.71 -37.48 84.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.46 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.14 -36.18 81.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.82 -37.76 87.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -54.42 -29.43 49.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.863 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 93.2 mttt -54.02 -36.83 63.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 1.257 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 160.22 123.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.503 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 13.7 m-85 -158.26 51.6 0.47 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.72 . . . . 0.0 110.862 167.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 55.7 Cg_endo -70.8 -71.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.642 2.228 . . . . 0.0 112.335 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -102.76 -19.06 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 168.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -69.14 -20.53 64.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.142 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 90' ' ' TYR . 17.6 t90 -58.86 -43.23 90.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.78 -27.2 68.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.581 ' HB2' ' HB ' ' A' ' 261' ' ' VAL . . . -74.5 -30.6 61.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.033 -169.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -116.43 14.99 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.494 ' HB3' HD21 ' A' ' 103' ' ' LEU . 52.4 ptt85 -118.25 147.15 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -135.43 125.39 25.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 t30 60.29 35.13 20.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.857 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 5.28 90.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.574 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 148.5 44.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.494 HD21 ' HB3' ' A' ' 98' ' ' ARG . 83.9 mt -86.95 122.26 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.443 HD12 ' CD2' ' A' ' 67' ' ' PHE . 44.6 pt -122.79 -1.9 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.71 31.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -111.47 146.26 34.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.68 0.752 . . . . 0.0 110.902 174.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.59 122.46 6.94 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.712 2.275 . . . . 0.0 112.402 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.7 -37.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.079 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.42 152.09 10.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.5 128.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.122 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -122.55 126.37 47.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.411 ' HB3' HG13 ' A' ' 259' ' ' VAL . . . -152.53 155.97 38.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.461 HD12 ' HG2' ' A' ' 257' ' ' PRO . 94.7 mt -76.46 144.33 39.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.1 m -140.66 156.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.472 ' HB2' HD21 ' A' ' 247' ' ' LEU . 43.0 tp -94.47 127.65 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.449 HG12 HG23 ' A' ' 244' ' ' VAL . 68.7 mt -113.98 130.5 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.169 172.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -136.76 155.83 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.465 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 36.4 t-20 -92.0 111.7 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.596 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.5 mttt -65.17 -28.29 69.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 31.7 t70 -76.04 -33.22 59.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.84 -44.96 13.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.4 tp -121.03 109.62 35.38 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.71 0.767 . . . . 0.0 110.954 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.5 -15.6 19.59 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.0 112.361 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -147.12 109.55 3.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 0.0 110.845 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.35 154.39 74.41 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.686 2.258 . . . . 0.0 112.356 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.24 140.71 37.78 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.64 -25.75 22.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.4 t -149.97 174.32 12.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.119 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -74.53 -24.44 58.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -169.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.73 -32.4 73.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.895 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.75 -23.18 58.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -172.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.645 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 88.7 mt -66.31 -51.78 41.52 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.63 0.728 . . . . 0.0 111.126 -168.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.645 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.56 -40.42 56.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.703 2.268 . . . . 0.0 112.303 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.2 -43.6 98.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.3 -38.36 80.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.477 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 9.8 t70 -64.59 -36.23 83.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.49 -37.05 85.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.95 -58.0 4.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.406 HD21 ' N ' ' A' ' 140' ' ' LYS . 1.3 pt? -78.7 -11.76 59.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 86.6 tttt -56.46 -30.37 62.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 169.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.03 -21.03 66.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.9 6.64 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.24 28.06 64.83 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 7.0 mptt -119.72 156.52 30.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.887 0.375 . . . . 0.0 110.92 174.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -115.76 153.97 30.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -72.55 -49.34 33.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 52.8 tp -143.44 125.7 15.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.2 mmm -133.19 131.42 40.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 174.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.93 167.65 28.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 210' ' ' TYR . 60.1 t-20 -50.87 111.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 206' ' ' ALA . 8.0 tp -115.31 19.96 15.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -92.19 -2.46 56.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.04 145.8 53.43 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.612 0.72 . . . . 0.0 110.874 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.487 ' HB3' ' HB2' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -68.15 -27.66 35.19 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -58.79 -35.43 72.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.21 -26.63 22.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.828 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.8 p -87.57 -32.31 19.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.655 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 58.6 t90 -55.01 -52.3 72.24 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.516 0.674 . . . . 0.0 110.99 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.6 Cg_endo -54.98 -32.18 77.52 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.624 2.216 . . . . 0.0 112.402 -175.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.46 -35.19 73.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.441 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -72.42 -41.66 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.17 -18.89 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.164 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.97 2.63 53.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.13 11.87 6.06 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.597 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.17 165.19 53.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.475 ' HD2' ' HA3' ' A' ' 182' ' ' GLY . 98.1 m-85 -140.33 175.86 9.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.989 0.423 . . . . 0.0 110.882 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 339' ' ' PHE . . . -112.03 -33.68 6.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.447 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -148.35 134.76 19.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.825 -173.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 1.074 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -89.89 121.55 32.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -170.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -127.46 113.12 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.02 142.66 24.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.0 32.77 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.16 -2.8 64.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.3 152.99 49.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.731 0.301 . . . . 0.0 110.888 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 64.9 m-85 -83.15 122.74 28.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.72 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 63.0 t0 -128.77 118.67 23.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -175.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.81 ' HA ' ' HE3' ' A' ' 170' ' ' LYS . 8.5 tp -57.04 -20.8 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.21 -15.77 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -174.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -110.58 47.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.72 ' HA ' ' HB3' ' A' ' 170' ' ' LYS . 8.6 p -99.11 145.66 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.475 ' HA3' ' HD2' ' A' ' 167' ' ' TYR . . . -110.75 22.8 21.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.539 -171.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 m -92.09 -23.27 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 0.0 111.143 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -106.63 25.12 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -99.06 -171.95 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.41 80.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.001 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -43.21 93.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.75 88.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.06 -41.71 97.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.22 -41.11 86.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -68.14 -47.2 60.52 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.449 -175.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.05 -38.7 86.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 72.9 m -57.67 -43.36 84.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -66.04 -43.61 87.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.574 ' C ' HD21 ' A' ' 195' ' ' LEU . 8.8 tt -55.96 -46.36 78.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.936 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.57 -39.37 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -60.1 -34.74 73.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.791 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.77 -33.86 76.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.95 -39.84 45.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.201 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.66 -38.59 87.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -86.94 2.11 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 61.69 31.41 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -83.85 -30.88 26.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.0 mtt -139.55 145.5 38.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.835 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.596 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -97.32 135.78 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.454 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -67.61 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -98.25 -12.7 21.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -166.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 53.1 m -59.03 127.36 31.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -95.5 171.3 8.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 70.5 t80 -57.8 -39.39 77.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -59.04 -43.69 91.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.91 -45.53 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.41 -41.11 80.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.822 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.36 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.29 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -64.74 -39.71 94.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.88 -24.0 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.76 -10.0 32.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.14 52.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.456 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -87.66 -21.07 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 110.898 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 91.0 m -127.17 133.25 50.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.185 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.16 -32.31 64.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -172.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 73.4 mtm -135.44 148.55 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -148.68 165.39 31.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 91.8 mt -130.99 127.9 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.415 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 46.2 p30 -152.7 167.25 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.946 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.84 -129.59 3.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -168.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.97 -18.64 18.65 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.734 2.29 . . . . 0.0 112.433 -165.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -55.02 -30.77 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.917 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.07 42.43 28.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.99 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.517 ' O ' ' C ' ' A' ' 233' ' ' SER . 67.5 m95 -56.64 -25.01 52.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.899 167.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 232' ' ' TRP . 28.1 p 30.64 64.13 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -68.48 -12.13 60.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 37.3 pt -90.24 -5.14 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.54 -48.52 10.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -61.33 -57.81 10.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 40.7 t -161.21 128.23 4.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.797 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.555 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.09 174.46 10.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.02 -66.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -163.98 94.75 0.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.465 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 27.7 m-85 -115.45 160.28 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.818 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.596 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -138.98 168.4 24.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.425 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.449 HG23 HG12 ' A' ' 116' ' ' ILE . 60.4 t -125.02 129.19 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.9 p -131.18 171.61 13.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.83 165.33 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.024 167.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.493 ' HB2' ' HE2' ' A' ' 256' ' ' LYS . 90.8 mt -77.55 145.23 71.15 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.617 0.722 . . . . 0.0 110.968 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 75.6 Cg_exo -55.63 148.87 51.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.659 2.239 . . . . 0.0 112.374 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -131.12 154.72 48.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -132.06 109.65 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 46.76 42.68 12.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 164.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.63 25.11 57.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 95.4 mm-40 -108.58 157.89 35.41 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.914 -171.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 59.6 Cg_endo -66.01 74.97 0.33 Allowed 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.727 2.285 . . . . 0.0 112.426 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 93.5 p -86.42 -7.66 58.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.8 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.493 ' HE2' ' HB2' ' A' ' 247' ' ' LEU . 13.9 ptpt -135.38 155.37 78.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.546 0.688 . . . . 0.0 110.869 -168.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.483 ' HG3' ' HG3' ' A' ' 159' ' ' PRO . 53.6 Cg_exo -61.3 164.91 13.87 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -60.34 162.27 6.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.901 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 324' ' ' ALA . 98.1 t -116.23 129.86 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.148 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.67 11.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 96' ' ' ALA . 86.8 t -122.16 125.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.112 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 54.0 tp -71.41 134.32 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.6 p -132.23 156.78 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.69 137.15 51.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.071 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.71 169.74 23.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.495 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.73 133.89 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.163 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -61.85 125.54 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.17 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.14 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.602 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . . . -80.65 -13.86 58.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.9 t -72.49 130.49 85.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 0.0 110.903 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.91 -10.32 28.16 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.716 2.277 . . . . 0.0 112.388 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 275' ' ' LEU . 93.9 m-20 -107.01 33.87 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -169.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -53.06 -40.2 63.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.9 -36.95 75.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 272' ' ' ASN . 48.0 tp -61.11 -48.26 82.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.021 176.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.46 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.094 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.55 -47.32 79.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.67 -42.38 82.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 37.0 t80 -60.82 -44.5 96.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 284' ' ' LEU . 31.8 tp -65.89 -51.13 61.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -76.25 -35.18 59.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -170.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -106.27 -16.45 14.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.843 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 87.2 m-85 -120.52 -50.96 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.924 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 280' ' ' LEU . 49.6 mt -71.22 -42.79 68.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.947 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.03 62.0 7.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.9 p -136.73 168.0 20.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -55.0 -45.44 75.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.95 -41.03 37.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.09 -47.43 13.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 -171.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 20.1 tp -69.54 -35.38 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.788 0.328 . . . . 0.0 110.951 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.04 -45.21 91.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.77 76.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.534 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 84.3 t -78.94 -47.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -73.84 -16.39 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.07 -23.28 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 92.6 m-20 -73.95 -19.62 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -85.69 152.2 56.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.563 0.697 . . . . 0.0 110.938 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 -22.49 52.88 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.753 2.302 . . . . 0.0 112.318 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.5 mt -101.89 -46.22 4.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.04 72.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.444 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -67.87 128.8 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 111.051 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.474 HG22 ' HB3' ' A' ' 307' ' ' TYR . 19.8 m -117.76 151.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.02 60.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.0 tp -73.85 120.62 19.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.07 -48.36 82.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -171.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -59.13 -46.93 87.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 -170.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.474 ' HB3' HG22 ' A' ' 302' ' ' VAL . 2.2 t80 -73.93 -32.98 63.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.54 -35.65 76.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.11 -34.74 73.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -76.13 -39.69 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.833 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.462 HD12 HG23 ' A' ' 302' ' ' VAL . 96.1 mt -68.96 -23.33 64.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 176.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.62 -9.36 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.057 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.72 -17.16 59.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.907 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -88.21 120.0 70.45 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.522 0.677 . . . . 0.0 110.932 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.77 -31.96 34.97 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.23 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' A' ' 244' ' ' VAL . 94.5 mtm-85 -69.34 -44.8 70.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.12 -39.93 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.15 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.82 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.078 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.402 HG21 ' HB1' ' A' ' 112' ' ' ALA . 75.0 m -66.68 -43.01 85.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.193 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.15 -36.33 81.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.67 -33.58 72.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 176.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -65.21 -34.78 79.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.869 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -60.82 -36.86 80.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.08 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.5 -23.37 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.01 -11.44 20.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.44 -159.89 34.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -124.18 127.98 48.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.6 ' O ' ' O ' ' A' ' 330' ' ' MET . 37.5 mm -79.95 119.13 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 -165.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.6 ' O ' ' O ' ' A' ' 329' ' ' ILE . 2.1 ppp? 37.14 171.43 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 0.0 110.899 -163.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.58 ' HD2' ' HB2' ' A' ' 330' ' ' MET . 90.4 Cg_endo -69.95 -157.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 171.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -135.08 -46.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.462 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 37.9 pt -129.79 158.44 73.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.532 0.682 . . . . 0.0 111.234 167.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 33.1 Cg_endo -63.61 -21.62 70.31 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.424 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -14.89 59.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.523 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 37.1 mmt -64.94 -27.95 69.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -60.52 -39.02 86.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.66 67.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.109 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.7 t80 -55.81 -49.37 73.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -58.88 -44.12 91.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.012 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -59.03 -42.79 91.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.75 85.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.53 -40.81 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 154' ' ' PRO . 42.6 ttt180 -54.2 -52.64 60.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 74.8 p -66.41 -36.04 81.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.36 94.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.411 HG23 HD12 ' A' ' 161' ' ' ILE . 55.8 t -67.07 -49.43 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -64.6 -41.87 93.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.14 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -64.3 -38.49 91.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.37 71.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.053 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.84 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -80.36 -7.92 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.68 12.71 81.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.458 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.64 -28.56 51.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.63 0.252 . . . . 0.0 110.775 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -139.52 155.87 47.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 71.9 p -79.01 168.13 20.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.08 -47.69 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.62 -42.34 91.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -71.89 -37.92 70.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.06 94.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.075 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.99 -35.28 78.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.02 -42.36 94.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.29 -34.14 76.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.51 68.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.162 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -40.43 97.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 84.4 m -63.02 -41.88 99.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.044 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.92 -35.11 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.65 -41.51 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.228 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.5 p -94.09 -11.6 30.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -178.404 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.664 0.268 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.74 135.8 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.79 179.87 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.2 120.43 20.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.99 23.54 27.35 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.389 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -143.24 151.86 41.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.7 pp -143.77 144.0 31.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.816 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.06 125.22 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.061 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mt -117.01 134.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.681 ' CZ3' ' HD3' ' A' ' 57' ' ' PRO . 27.6 m0 -114.87 128.13 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 17.6 tt -152.4 157.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.453 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.7 t-20 -56.65 120.35 7.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 166.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.707 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -77.36 -22.07 71.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.466 -168.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.39 -48.89 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 -164.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.584 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.6 mmtt -130.32 79.6 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 145.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.62 -38.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.49 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -74.59 -44.79 49.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -160.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -66.02 -51.67 56.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.912 -159.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -60.23 -44.49 97.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.576 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.29 -39.05 81.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 110.849 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.94 85.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.062 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.17 -49.56 73.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.44 -32.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.71 93.14 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.522 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -70.04 -43.07 72.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.3 -40.41 96.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.97 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.09 -39.79 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.861 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.99 -33.58 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -73.3 -35.55 66.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -82.05 -41.32 20.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -103.0 -22.25 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -172.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.21 4.99 87.8 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.55 120.55 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 111.195 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.85 120.44 11.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 7' ' ' LEU . 78.8 t -96.9 135.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -136.31 116.65 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.73 126.4 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.169 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -110.46 162.04 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -64.87 163.34 29.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.535 0.683 . . . . 0.0 110.944 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.707 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 70.2 Cg_endo -99.03 -2.16 0.89 Allowed 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.706 2.271 . . . . 0.0 112.397 -161.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.66 -31.27 59.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -160.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.64 -10.59 24.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 40' ' ' PRO . 61.3 mt -51.56 -55.74 17.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -158.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.3 -32.35 68.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -168.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.21 -34.69 61.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.54 -28.35 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 8.2 m-30 -48.75 -54.41 27.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.789 -163.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 83.8 Cg_endo -78.59 -29.23 3.79 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.877 2.384 . . . . 0.0 112.272 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.66 -49.42 18.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.0 -170.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -65.95 -30.71 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.07 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.524 ' HA ' ' HB3' ' A' ' 269' ' ' ALA . . . -62.89 -37.13 85.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 -26.25 63.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.013 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.5 p -97.96 -1.24 43.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.124 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.13 18.36 80.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -107.71 -174.95 2.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.92 -166.99 13.21 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.681 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 89.7 Cg_endo -82.89 173.5 10.18 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD2' ' HA ' ' A' ' 7' ' ' LEU . 30.5 m-20 -85.9 -36.41 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 166.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -132.37 139.74 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.491 HD11 ' CE1' ' A' ' 47' ' ' PHE . 7.2 mt -131.89 143.24 40.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -105.88 139.78 39.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.518 ' O ' HD12 ' A' ' 262' ' ' LEU . 23.9 m-90 -121.14 133.2 55.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 173.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -52.29 -90.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -171.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -110.97 -81.45 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.49 -23.71 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -159.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.79 -38.06 69.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -51.17 7.69 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.496 -168.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.13 91.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.712 ' HB3' HD22 ' A' ' 75' ' ' LEU . 27.9 m-85 -74.86 -31.25 61.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.56 68.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -61.35 -28.11 68.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.809 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -85.24 3.48 39.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 25.46 64.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 70' ' ' TYR . 4.7 pp -87.41 -5.14 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 0.0 110.892 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 76' ' ' LEU . 4.2 pp -133.15 144.8 50.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.1 152.31 19.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.35 144.57 48.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.827 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -109.09 152.54 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -133.46 67.13 75.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.671 0.748 . . . . 0.0 111.139 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.66 143.05 41.18 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.617 2.211 . . . . 0.0 112.325 166.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -81.0 -176.58 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.79 -32.24 73.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.819 -173.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.97 64.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -67.23 -36.27 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.87 -43.99 94.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.21 -35.13 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 97.4 mttt -67.23 -31.33 71.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -171.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 1.235 ' O ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER 173.99 78.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 -177.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 38.0 m-85 -151.06 41.49 0.22 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 0.0 110.885 168.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 67.1 Cg_endo -72.48 -70.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.218 . . . . 0.0 112.27 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.478 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 99.1 m-85 -92.98 -28.04 16.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 303' ' ' ALA . 66.7 p -71.94 -22.17 61.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -162.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.416 ' HB2' ' HB3' ' A' ' 90' ' ' TYR . 6.3 t90 -62.47 -42.86 99.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.96 -173.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.42 -24.56 66.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.577 ' HB3' ' CG2' ' A' ' 329' ' ' ILE . . . -74.54 -31.91 62.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.08 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.37 16.08 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 -170.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -119.39 145.56 46.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -136.33 127.18 27.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 59.48 34.82 22.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.6 5.65 89.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.481 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.6 145.04 43.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.91 113.58 25.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.6 pt -124.21 -2.3 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.093 -161.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.96 157.25 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -170.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.1 m-85 -106.35 136.89 19.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.724 0.773 . . . . 0.0 110.911 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 24.4 Cg_exo -65.3 114.37 2.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.749 2.3 . . . . 0.0 112.372 174.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.42 -31.75 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.89 152.27 6.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.74 124.8 68.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.062 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -123.85 137.57 54.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.975 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.79 144.13 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.2 m -142.92 158.94 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.484 ' HB2' HD21 ' A' ' 247' ' ' LEU . 64.0 tp -92.31 120.08 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -173.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 244' ' ' VAL . 61.9 mt -108.52 126.32 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -136.13 157.49 46.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 -167.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.467 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 30.2 t-20 -94.0 112.24 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.498 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.6 mttt -63.89 -26.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.89 -33.66 30.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.86 -48.73 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 173.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -123.23 109.4 31.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.623 0.725 . . . . 0.0 110.941 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.34 -15.05 20.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.562 2.175 . . . . 0.0 112.387 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.5 t-20 -148.43 107.11 3.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.759 0.79 . . . . 0.0 110.841 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -66.06 152.34 81.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.669 2.246 . . . . 0.0 112.302 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.23 142.7 51.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.287 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -88.62 -17.08 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.9 t -147.66 166.29 27.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -68.13 -29.34 68.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.21 -27.86 69.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.21 -33.47 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.582 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 97.9 mt -67.66 -45.09 45.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 111.052 -159.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 80.3 Cg_exo -50.78 -49.56 16.47 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.22 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.454 HD21 ' O ' ' A' ' 135' ' ' LEU . 2.1 tt -54.23 -35.61 62.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 175.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.553 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 25.1 t70 -65.82 -34.82 79.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.29 -37.54 87.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 -172.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.64 -56.91 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -172.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 145' ' ' SER . 1.9 pt? -79.8 -11.87 59.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -173.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -53.53 -30.27 40.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.936 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.3 -19.8 65.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -104.71 12.58 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.829 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 24.84 73.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -117.77 156.22 28.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.857 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.466 ' O ' HD11 ' A' ' 139' ' ' LEU . 48.2 t -115.78 153.48 31.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -71.92 -53.29 13.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.8 tp -147.1 135.4 21.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mtp -124.04 134.58 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 169.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -149.24 165.34 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.807 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.455 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 55.3 t-20 -64.72 113.56 3.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -172.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.92 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.8 tm? -92.88 -23.91 18.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -77.77 -4.38 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.89 152.2 80.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.606 0.717 . . . . 0.0 110.889 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.56 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 61.7 Cg_endo -79.65 -20.71 9.1 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.616 2.21 . . . . 0.0 112.404 -174.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -57.28 -45.53 83.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.455 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 45.5 m-85 -81.32 -27.02 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.433 HG22 HD23 ' A' ' 151' ' ' LEU . 72.1 p -87.12 -30.06 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.049 -171.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.661 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 82.5 t90 -56.2 -47.72 98.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.474 0.654 . . . . 0.0 110.96 -172.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.661 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 99.1 Cg_exo -49.52 -39.31 45.56 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.614 2.209 . . . . 0.0 112.383 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.699 HD21 ' O ' ' A' ' 160' ' ' LEU . 4.9 tt -74.06 -38.86 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.957 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.486 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.5 mt -67.32 -37.94 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.41 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -79.41 -13.67 59.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 -174.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.92 67.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 -167.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -94.55 5.93 50.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.98 15.2 3.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.538 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -78.65 153.38 38.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.512 174.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.537 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 98.7 m-85 -135.06 152.04 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.906 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.01 -38.04 7.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -143.67 140.29 29.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.812 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -98.55 125.61 43.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.92 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.05 110.06 19.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.007 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -151.17 140.77 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 48.97 37.33 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 4.47 64.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.477 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.48 153.49 49.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 -173.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.14 131.23 39.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.979 168.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -110.79 120.2 41.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.99 -20.38 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.49 -16.77 44.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -98.94 66.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.5 p -108.47 139.16 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.537 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -107.88 32.22 7.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -168.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.0 -35.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.995 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -102.88 29.13 5.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.72 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -99.09 -172.2 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.941 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.97 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.81 -44.89 94.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.515 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.03 86.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.861 0.362 . . . . 0.0 111.12 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.77 -40.23 91.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.809 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.49 89.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.45 -43.53 94.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.522 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.01 -38.4 88.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -58.93 -43.65 91.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -63.24 -42.37 99.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.58 -45.09 92.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.84 -40.24 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.38 -39.38 94.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.7 OUTLIER -63.57 -42.67 98.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.59 -38.73 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.16 -36.82 80.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -83.78 3.62 32.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 64.56 33.73 10.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -78.91 -24.69 43.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 28.3 ptm -147.7 160.59 42.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -94.13 134.08 36.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.94 67.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -89.44 -3.27 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.897 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.2 m -56.46 126.71 27.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -103.48 170.12 8.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -65.88 -32.71 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.009 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 92.2 p -69.74 -36.08 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.2 mm -65.14 -42.31 93.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.71 94.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.103 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -69.69 -38.77 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.05 85.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.023 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.2 -39.35 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -66.5 -40.91 89.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.27 -19.77 65.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.97 -10.51 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.98 65.84 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.471 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.09 -25.82 39.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 224' ' ' MET . 73.9 m -128.23 133.82 48.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.49 -27.04 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -169.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.412 ' H ' HG23 ' A' ' 222' ' ' THR . 74.8 mtm -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -152.13 165.85 33.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 125.04 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.139 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -127.21 136.63 52.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.448 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -105.03 -134.34 7.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.479 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.448 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.0 Cg_endo -70.82 -19.47 31.03 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.764 2.309 . . . . 0.0 112.299 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -58.17 -30.32 66.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 62.09 22.82 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.018 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.53 ' O ' ' C ' ' A' ' 233' ' ' SER . 39.3 m0 -61.13 -33.78 73.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 232' ' ' TRP . 67.5 p 31.34 67.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.896 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -81.15 35.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.908 -160.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.435 HD12 HG21 ' A' ' 244' ' ' VAL . 38.3 pt -115.26 6.04 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 171.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.6 -54.27 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.5 m -60.44 -59.61 5.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -153.5 126.29 8.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.493 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.52 172.86 11.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 98.6 t -86.37 -71.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.61 76.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.467 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 44.9 m-85 -114.93 154.24 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.498 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -146.01 170.61 27.15 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.422 -174.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 116' ' ' ILE . 60.7 t -123.49 134.88 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 0.0 111.157 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.7 176.86 8.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.193 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.8 162.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.109 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.484 HD21 ' HB2' ' A' ' 115' ' ' LEU . 97.6 mt -81.38 151.3 68.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.886 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 153.47 70.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.74 2.293 . . . . 0.0 112.352 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 81.7 p -131.19 146.57 52.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -121.28 115.62 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 51.38 37.07 18.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.25 26.98 56.57 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.456 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.443 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.0 mm-40 -112.4 159.55 33.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.611 0.72 . . . . 0.0 110.907 -168.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 59.9 Cg_endo -63.39 75.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.722 2.281 . . . . 0.0 112.418 171.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 249' ' ' THR . 49.5 m -94.28 6.64 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 -164.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.509 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 12.1 ptpt -135.12 158.6 74.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.869 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 29.4 Cg_endo -69.84 168.2 22.36 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.672 2.248 . . . . 0.0 112.298 -170.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -70.18 172.16 8.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.412 ' HB ' HD11 ' A' ' 329' ' ' ILE . 69.3 t -121.6 132.84 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.185 -175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.14 142.99 15.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 96' ' ' ALA . 96.3 t -127.43 127.99 69.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.816 0.341 . . . . 0.0 111.165 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 62' ' ' TRP . 51.5 tp -72.47 135.1 45.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -121.27 137.24 54.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.842 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.73 132.6 53.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.74 170.73 23.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.98 130.39 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 111.16 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -59.82 128.9 39.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.43 68.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . . . -80.67 -13.22 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.0 t -69.7 133.59 88.53 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.627 0.727 . . . . 0.0 110.856 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.33 -8.9 23.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.585 2.19 . . . . 0.0 112.35 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -106.82 30.53 6.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -52.17 -43.47 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.17 -41.62 63.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.807 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.04 -52.16 65.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.008 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -65.88 -50.25 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.9 -47.58 71.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -170.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -71.95 -33.26 68.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -176.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 284' ' ' LEU . 41.6 tp -57.11 -46.39 82.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -82.9 -28.86 29.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.967 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -101.42 -9.78 20.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -168.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 76.2 t80 -125.38 -59.66 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.424 ' HB2' HD12 ' A' ' 280' ' ' LEU . 68.6 mt -71.19 -44.5 65.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 20.4 tp -85.03 67.51 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.0 p -139.69 170.19 16.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.22 -45.26 79.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.835 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -75.89 -41.3 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.17 -45.9 9.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.558 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.2 tp -71.29 -35.66 71.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.981 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -56.58 -41.04 76.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.897 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.24 69.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.466 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 76.7 t -76.95 -45.1 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.052 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -73.05 -7.75 52.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -52.83 -21.95 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.584 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 89.2 m-20 -79.15 -24.2 43.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.806 -174.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -96.34 148.47 34.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.878 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.24 -25.62 26.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.637 2.225 . . . . 0.0 112.295 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.56 -48.41 3.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.019 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.4 22.24 78.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.527 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.8 110.34 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 0.0 111.072 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 307' ' ' TYR . 5.2 p -112.77 149.13 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -159.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.578 ' HB2' HG22 ' A' ' 93' ' ' THR . . . -72.29 -18.84 61.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.21 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.447 ' H ' HG23 ' A' ' 302' ' ' VAL . 55.8 tp -79.38 124.36 28.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -45.4 90.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -174.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.2 t -62.44 -50.0 73.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.497 ' HB3' HG11 ' A' ' 302' ' ' VAL . 3.9 t80 -70.93 -36.87 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -65.58 -33.38 75.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -38.5 73.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.6 -38.69 58.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.829 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.13 -29.81 70.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.51 -8.27 45.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.53 -15.8 60.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -91.39 120.68 68.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.878 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.9 -29.03 19.8 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.766 2.31 . . . . 0.0 112.295 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -70.11 -44.72 68.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.41 -38.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.7 73.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 83.2 m -67.09 -41.86 85.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 tpt -66.82 -38.02 85.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.835 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -66.44 -35.31 79.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -65.36 -34.83 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.404 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -65.04 -41.34 95.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -74.24 -23.28 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -104.67 -5.79 21.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.11 -161.64 37.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.432 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -127.2 127.18 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.846 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.577 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 38.3 mm -74.64 121.93 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.5 mmt 63.48 156.23 0.12 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.458 0.647 . . . . 0.0 111.033 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.915 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 56.5 Cg_endo -74.67 -107.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 165.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -138.94 -58.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 165.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.562 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 34.0 pt -139.12 169.25 12.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.602 0.715 . . . . 0.0 111.158 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.1 Cg_exo -53.09 -17.01 7.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.3 -6.15 2.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.915 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.5 ptm -56.6 -29.95 62.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.9 p -66.05 -30.1 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -80.58 -34.85 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 175.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -59.65 -54.79 42.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.56 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 68.6 m95 -60.76 -38.08 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -60.02 -46.7 88.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.35 80.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.047 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.1 t -74.5 -36.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.512 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 76.0 ttt180 -56.01 -47.17 78.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.8 p -66.62 -35.81 81.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -64.95 -44.0 90.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.182 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.96 -47.57 81.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.03 -44.34 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -65.21 -36.96 85.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.72 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.051 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.05 73.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.5 p -80.86 -7.78 59.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.04 82.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.555 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.13 -28.01 54.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.807 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -140.44 157.13 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.7 p -74.62 171.98 12.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.124 167.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.55 -34.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.61 -40.28 84.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.3 -44.73 71.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.817 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.17 93.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.5 mt -69.77 -35.5 74.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.87 -46.85 88.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -69.41 -31.1 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -70.01 -48.02 59.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.157 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -64.95 -38.73 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.4 m -62.53 -41.48 98.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.051 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.52 -39.12 70.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.802 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.3 mt -62.24 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.9 p -105.51 6.95 32.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.18 -172.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 -178.119 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.698 0.285 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.403 HG21 ' HD2' ' A' ' 271' ' ' PRO . 91.8 mt -80.1 129.26 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.163 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -125.09 164.3 20.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -76.5 118.38 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.21 26.17 24.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.467 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.41 152.22 40.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 1.113 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -145.49 146.63 31.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -128.67 129.74 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.56 135.68 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.556 ' HB3' HD22 ' A' ' 43' ' ' LEU . 34.9 m0 -111.28 120.56 42.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 tt -153.16 159.21 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 -170.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.453 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.7 t-20 -60.0 119.85 8.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 168.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.766 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -76.22 -18.54 79.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.54 -173.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.27 -47.72 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.938 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.26 80.04 1.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 144.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -120.56 -48.69 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.443 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -70.0 -43.72 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.91 -164.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -66.14 -51.98 52.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 -160.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.1 -44.29 97.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.437 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 24' ' ' GLY . 64.3 mt -61.28 -37.94 84.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.37 85.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.028 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.22 -47.1 79.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.16 -33.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -67.49 -40.09 91.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.57 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -71.57 -40.01 70.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.906 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.4 -41.16 98.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -68.54 -38.58 80.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.79 -31.55 72.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.83 -37.35 67.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.3 -39.3 25.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.7 p -105.27 -18.2 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.14 90.09 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.49 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 33' ' ' ILE . 7.8 pt -97.14 132.8 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.062 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.95 131.01 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG13 HD11 ' A' ' 7' ' ' LEU . 67.3 t -101.48 136.88 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 172.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -141.39 120.15 12.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.24 131.37 60.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -109.76 151.8 26.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.434 ' O ' HD13 ' A' ' 43' ' ' LEU . 32.4 p80 -74.28 167.02 39.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.548 0.69 . . . . 0.0 110.885 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.766 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 43.1 Cg_endo -104.03 12.01 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -161.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -89.53 -37.14 14.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.759 -166.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -90.82 -17.24 26.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.896 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.608 HD23 ' HA ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -57.3 -43.94 83.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -161.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -50.03 -39.94 43.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.84 -33.92 64.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.0 -25.39 59.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.547 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 5.1 m-30 -49.97 -53.99 37.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.606 0.717 . . . . 0.0 110.936 -160.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 91.5 Cg_endo -79.98 -29.93 2.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.77 2.313 . . . . 0.0 112.32 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.48 -49.69 21.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -168.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.7 m -66.09 -28.95 45.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.066 -171.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.78 -37.61 85.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.8 -24.99 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -96.97 0.35 48.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.082 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.649 ' HA2' ' HB2' ' A' ' 269' ' ' ALA . . . 77.2 17.57 79.37 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -110.88 -174.72 2.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.823 0.344 . . . . 0.0 110.864 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.33 -167.49 12.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.574 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.436 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 87.9 Cg_endo -77.64 169.44 20.89 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.668 2.245 . . . . 0.0 112.344 175.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -85.09 -37.01 20.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.5 mt -129.35 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.494 HD12 ' CE1' ' A' ' 47' ' ' PHE . 16.4 tt -137.14 135.34 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -172.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -99.96 145.09 28.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.947 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 26.7 m95 -126.82 127.05 44.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.31 -91.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.038 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -112.89 -78.7 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.46 -22.84 61.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -165.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.697 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 94.9 mtt-85 -55.44 -28.61 55.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -164.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.45 ' CG ' ' N ' ' A' ' 68' ' ' GLY . 16.7 p90 -49.39 -44.06 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.88 -174.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 67' ' ' PHE . . . -74.99 -58.7 3.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 -169.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.54 -41.34 95.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.504 -172.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.67 ' HB3' HD22 ' A' ' 75' ' ' LEU . 60.1 m-85 -75.08 -32.57 61.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.962 0.411 . . . . 0.0 110.892 -175.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.01 64.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -61.33 -27.05 68.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -83.07 2.36 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.24 24.85 63.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 70' ' ' TYR . 4.1 pp -85.81 -4.54 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.868 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.856 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.4 pp -131.57 143.58 50.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.69 154.96 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -71.43 140.45 50.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.891 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.402 ' CG1' ' HB3' ' A' ' 103' ' ' LEU . 46.1 pt -104.14 148.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.5 p -131.8 67.14 79.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.604 0.716 . . . . 0.0 111.131 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.82 144.85 49.46 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.698 2.265 . . . . 0.0 112.467 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -84.57 -175.16 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.35 -31.93 69.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.35 84.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -60.43 -43.84 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -59.65 -41.36 90.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.936 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.4 -34.5 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.834 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 75.9 mmtt -68.13 -21.3 64.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 1.198 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.94 124.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.923 -177.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p90 -173.08 49.19 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.734 0.778 . . . . 0.0 110.907 162.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 61.4 Cg_endo -73.32 -72.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.645 2.23 . . . . 0.0 112.42 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.464 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 97.3 m-85 -94.87 -29.68 14.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 174.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -71.72 -22.47 61.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.054 -161.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -60.75 -44.33 96.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.11 -30.74 71.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.897 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.584 ' HB3' ' CG2' ' A' ' 329' ' ' ILE . . . -69.73 -32.97 71.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -103.13 14.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.23 -169.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -120.99 145.89 47.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -137.96 127.94 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.6 t30 58.22 32.91 22.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.848 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.11 89.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.13 150.01 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.402 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . 69.4 mt -84.65 121.37 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -113.3 -15.14 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.49 163.88 24.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -166.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -105.18 146.81 33.43 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.684 0.754 . . . . 0.0 110.891 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.469 ' HG2' HD21 ' A' ' 89' ' ' LEU . 98.0 Cg_endo -76.78 120.13 5.39 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.2 mm -99.8 -46.32 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.037 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.18 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -163.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.37 130.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -125.37 143.07 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.17 157.01 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.05 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.416 HD23 ' HG3' ' A' ' 257' ' ' PRO . 10.0 mp -75.17 146.98 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -143.58 160.38 40.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.497 ' HB2' HD21 ' A' ' 247' ' ' LEU . 60.6 tp -94.99 122.9 38.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.43 HG12 HG23 ' A' ' 244' ' ' VAL . 61.6 mt -111.74 126.65 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.096 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -136.59 158.02 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -89.82 111.61 22.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.665 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -65.41 -30.09 70.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.01 -35.95 61.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.02 -49.54 12.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 tp -122.41 108.58 33.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.659 0.742 . . . . 0.0 110.903 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.45 -15.19 17.77 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.704 2.269 . . . . 0.0 112.317 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.6 t-20 -147.55 106.81 3.78 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 49.8 Cg_endo -66.72 152.81 79.87 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.677 2.252 . . . . 0.0 112.288 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.44 144.07 60.05 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.65 2.234 . . . . 0.0 112.261 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.39 -22.03 32.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 t -150.15 170.98 17.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -172.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.74 -32.58 69.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.856 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -71.67 -22.27 61.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -170.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -74.5 -27.96 60.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.576 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 94.4 mt -66.32 -45.14 59.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 0.0 111.061 -164.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 99.1 Cg_exo -49.62 -48.24 19.85 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.645 2.23 . . . . 0.0 112.332 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.38 90.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.014 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.508 HD21 ' O ' ' A' ' 135' ' ' LEU . 2.6 tt -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.608 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 26.4 t70 -66.03 -35.05 79.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.902 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.13 -41.23 90.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.45 -54.06 13.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.916 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.455 HD21 ' N ' ' A' ' 140' ' ' LYS . 1.1 pt? -78.61 -12.54 60.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -173.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.455 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.1 tttt -54.55 -29.38 50.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 166.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.75 65.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.076 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.84 8.49 37.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.25 58.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.509 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -121.8 154.69 36.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.28 . . . . 0.0 110.974 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.7 t -110.93 154.98 23.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.608 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -70.31 -56.65 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.036 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.8 tp -144.35 129.05 18.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.958 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.7 mmm -130.25 132.53 45.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 156' ' ' PHE . 52.2 p90 -150.97 174.55 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -67.39 109.71 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.995 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.99 0.12 40.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -85.62 0.26 53.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.48 145.72 57.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.555 0.693 . . . . 0.0 110.938 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.495 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 63.9 Cg_endo -79.66 -28.16 3.61 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.603 2.202 . . . . 0.0 112.393 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -53.87 -37.94 64.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.4 ' HB3' ' CD1' ' A' ' 149' ' ' PHE . 65.8 m-85 -82.14 -36.79 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 -174.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 74.3 p -88.36 -30.28 19.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.133 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.639 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 69.4 t90 -54.85 -48.28 96.11 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.535 0.683 . . . . 0.0 110.994 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.639 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 75.2 Cg_exo -48.41 -36.44 30.65 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.677 HD21 ' O ' ' A' ' 160' ' ' LEU . 3.7 tt -73.04 -38.63 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.981 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.581 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.2 mt -68.09 -38.06 79.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.42 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -80.5 -15.01 57.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -171.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.06 69.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.25 7.19 46.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.77 12.78 4.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.474 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -76.6 158.74 49.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.489 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.651 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 91.0 m-85 -136.82 152.08 49.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 110.887 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.423 ' HB3' ' CE2' ' A' ' 158' ' ' TRP . . . -101.21 -36.16 9.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.076 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.425 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -150.1 130.02 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -175.435 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 55.5 tptt -92.83 120.76 33.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -173.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.415 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 55.5 t80 -112.47 112.38 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -176.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -150.53 142.74 24.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 51.2 40.67 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 6.32 78.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.492 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -127.94 146.26 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 41.7 m-85 -89.91 127.85 36.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.911 167.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -102.39 116.62 33.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 178' ' ' ILE . 7.5 tp -77.77 -19.96 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.139 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -85.9 -7.26 58.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -116.12 92.79 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.0 140.0 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.651 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -99.82 38.87 2.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -168.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.2 -14.53 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.111 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -104.97 18.78 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -106.7 -171.49 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.11 -38.93 75.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.6 90.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.78 87.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.47 -42.46 99.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.62 -44.64 89.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -67.2 -46.68 69.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.87 -38.1 85.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.916 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.8 m -56.96 -43.82 81.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -64.22 -46.01 85.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.13 -44.87 96.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.825 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.99 -40.71 89.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.54 -36.45 82.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.67 -43.97 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.76 -39.51 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.51 -32.39 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 173.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.99 2.48 38.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.97 32.66 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.949 173.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -78.93 -30.94 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.814 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 23.5 ptp -150.48 160.06 44.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.431 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.6 m-20 -100.64 138.63 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.23 -24.38 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -97.5 0.6 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.431 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 86.2 m -55.1 124.83 18.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.06 170.04 8.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 227' ' ' ASN . 52.5 t80 -62.79 -41.46 99.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -62.43 -37.63 86.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.764 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -70.06 -46.3 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.83 84.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.73 -41.36 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.52 86.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.089 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.144 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -64.52 -47.03 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.28 -25.78 65.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.77 -5.34 45.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 16.66 63.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -82.5 -26.98 32.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.825 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 224' ' ' MET . 88.0 m -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 177.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.85 -27.71 55.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 -169.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.407 ' H ' HG23 ' A' ' 222' ' ' THR . 74.8 mtm -135.19 151.98 51.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -152.08 165.23 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.191 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.24 133.24 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.48 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 37.6 p30 -152.91 160.93 43.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.33 -126.83 5.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.424 -171.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.52 -19.17 19.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.715 2.277 . . . . 0.0 112.356 -166.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -53.28 -39.83 64.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.28 31.17 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.499 ' O ' ' C ' ' A' ' 233' ' ' SER . 54.2 m0 -60.44 -36.1 77.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 232' ' ' TRP . 90.1 p 34.26 71.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 163.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -74.85 3.39 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.85 -7.9 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.089 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.18 -50.15 9.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 85.5 m -64.8 -59.52 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.3 t -156.23 121.65 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.784 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.655 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.28 176.02 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.884 -176.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.01 -70.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -161.37 90.0 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 239' ' ' LYS . 75.0 m-85 -114.3 162.39 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.665 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -147.17 170.18 28.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.5 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.43 HG23 HG12 ' A' ' 116' ' ' ILE . 59.2 t -123.74 131.37 73.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.942 0.401 . . . . 0.0 111.091 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -142.71 177.94 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.172 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.64 160.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.497 HD21 ' HB2' ' A' ' 115' ' ' LEU . 89.0 mt -77.65 149.73 78.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.944 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.21 146.86 69.21 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.479 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 81.8 p -128.87 146.21 51.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -125.49 111.66 15.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 45.03 40.36 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.01 28.34 56.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 166.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.436 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.6 mm-40 -109.99 159.52 31.53 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.936 -170.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.0 Cg_endo -65.33 73.96 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 73.8 p -98.47 4.14 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -168.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.482 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 13.2 ptpt -139.84 158.37 67.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.552 0.691 . . . . 0.0 110.835 -173.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 33.4 Cg_endo -71.89 167.24 27.19 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.627 2.218 . . . . 0.0 112.389 -169.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.91 176.65 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.436 HG21 ' HA3' ' A' ' 327' ' ' GLY . 96.5 t -118.69 134.31 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 -171.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.02 146.37 16.07 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.433 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -128.48 128.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.266 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 60.4 tp -76.96 135.3 38.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.92 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 93.1 p -129.87 150.93 50.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.41 130.31 44.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.033 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.95 162.89 15.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 -170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.65 129.5 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -62.85 124.9 22.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.9 67.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.649 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . . . -81.96 -13.85 56.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 20.2 t -72.28 132.67 83.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.86 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 2' ' ' ILE . 88.8 Cg_endo -69.07 -7.75 21.7 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 0.0 112.407 170.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.04 27.62 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -168.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -50.85 -47.74 60.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.39 -38.93 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.5 tp -56.81 -53.13 61.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.11 -42.58 75.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.117 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.39 -48.93 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.29 -47.72 72.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.957 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -70.63 -33.67 71.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -176.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 284' ' ' LEU . 36.3 tp -55.97 -47.96 76.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -83.07 -27.0 30.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.31 -10.91 19.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -169.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 86.8 t80 -124.98 -60.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.433 ' HB2' HD12 ' A' ' 280' ' ' LEU . 77.6 mt -70.29 -41.27 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.981 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.32 65.22 8.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.0 p -138.09 169.34 17.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -56.92 -42.08 79.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -77.0 -42.54 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.1 -47.89 8.04 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.546 -170.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.0 -35.06 79.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.932 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.52 -42.82 99.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.95 -30.21 71.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.126 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.36 -45.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.068 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.483 ' HB3' ' CA ' ' A' ' 300' ' ' GLY . 59.0 m-20 -74.73 -5.5 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -54.41 -18.97 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.79 -18.07 60.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.06 154.18 42.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.71 -41.81 10.23 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 299' ' ' LEU . 3.3 mm? -92.59 -44.35 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.907 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.483 ' CA ' ' HB3' ' A' ' 294' ' ' ASN . . . 62.33 54.42 34.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.432 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.69 124.31 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.072 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 307' ' ' TYR . 35.2 m -110.15 149.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.61 61.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.062 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.18 119.26 22.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 87.7 tttt -61.77 -44.46 96.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -166.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.0 t -58.83 -49.84 76.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.402 ' HB3' HG22 ' A' ' 302' ' ' VAL . 71.0 t80 -74.23 -31.49 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.473 ' HG3' ' HE2' ' A' ' 321' ' ' MET . 89.0 tt0 -56.83 -39.44 74.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.829 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.23 -32.42 73.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -48.05 23.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.533 HD11 ' HE2' ' A' ' 321' ' ' MET . 3.4 pp -73.55 -18.71 61.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 308' ' ' GLU . . . -67.19 -7.93 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -175.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.9 -11.23 60.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.94 -173.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -86.43 122.01 72.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.98 -31.78 28.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.642 2.228 . . . . 0.0 112.373 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.65 -42.48 74.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 311' ' ' LEU . 3.0 tp -80.99 -29.86 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.069 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.4 86.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 65.9 m -67.38 -43.87 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.533 ' HE2' HD11 ' A' ' 311' ' ' LEU . 58.2 mtt -69.61 -34.82 74.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.799 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -66.26 -37.33 85.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -64.96 -34.04 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.042 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -70.31 -21.04 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.96 -5.96 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.436 ' HA3' HG21 ' A' ' 259' ' ' VAL . . . -96.11 -163.0 33.36 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.478 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -128.93 137.06 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.584 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 39.6 mm -78.3 115.67 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 26.3 mmt 61.72 155.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.91 -113.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 168.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -162.22 -52.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.89 164.35 31.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 111.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.41 -19.77 52.97 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.823 2.349 . . . . 0.0 112.318 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -58.87 -23.58 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.551 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 94.8 mmm -69.66 -24.83 63.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.73 -37.12 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.95 -30.76 64.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.155 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' A' ' 336' ' ' MET . 21.8 t80 -57.63 -49.95 74.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.988 175.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.495 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.7 m95 -61.36 -44.16 97.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.68 -43.81 76.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.83 78.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.76 -44.92 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.191 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -57.34 -48.11 79.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.87 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 73.9 p -66.65 -32.95 74.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.2 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.92 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.76 -47.87 81.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 41.5 mm -64.73 -44.69 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.17 -38.13 89.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.67 -44.91 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.53 -33.9 69.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.5 p -79.51 -8.46 59.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.0 82.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.455 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.44 -29.52 57.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 0.0 110.837 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -140.01 157.86 44.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.1 p -78.12 172.97 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.91 -45.26 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.43 -38.92 74.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -71.68 -39.28 70.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -173.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.54 96.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 173.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.5 -35.09 78.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.64 -42.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.17 -31.41 70.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.75 -46.43 63.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.143 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -63.21 -38.31 90.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.2 m -59.48 -40.34 86.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.02 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.94 -36.81 62.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.85 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' A' ' 339' ' ' PHE . 71.4 mt -63.02 -48.46 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.06 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.9 p -96.21 -0.72 49.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.9 tttt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.767 0.317 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.49 136.83 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.01 -178.98 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.992 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.14 119.62 19.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.04 25.27 27.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.435 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.93 152.94 41.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.7 pp -149.03 148.76 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 84.6 t -126.12 128.13 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mt -117.46 134.33 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.67 ' CH2' ' HD3' ' A' ' 57' ' ' PRO . 30.7 m0 -113.07 127.19 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 18.1 tt -152.94 159.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.684 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.3 t-20 -55.88 118.53 4.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.916 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.651 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.12 -24.72 72.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.487 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.03 -47.11 71.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 -167.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.9 mmtt -129.58 80.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 146.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -115.05 -36.63 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.527 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.54 -43.51 17.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.935 0.398 . . . . 0.0 110.957 -157.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -67.72 -52.58 35.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 -158.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.8 -45.25 96.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.582 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' GLY . 50.0 mt -59.43 -37.98 79.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.918 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.95 92.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.87 -49.7 74.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.819 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.25 -33.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -66.12 -42.57 94.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.562 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.6 -43.15 69.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 110.882 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.59 -40.21 93.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -65.39 -41.2 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.23 -31.94 72.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -74.81 -34.86 62.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.3 -40.79 20.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.1 p -104.16 -22.07 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.85 4.21 88.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.415 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.427 HG21 HD21 ' A' ' 7' ' ' LEU . 97.7 mt -76.61 121.7 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.205 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.83 120.52 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.2 135.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.097 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -139.39 117.81 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.6 127.71 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.19 160.74 20.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -68.82 162.31 64.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.555 0.693 . . . . 0.0 110.859 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.684 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 60.5 Cg_endo -98.82 -3.95 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -164.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.46 -30.81 33.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -154.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.45 -16.94 31.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 10' ' ' TRP . 5.7 mp -61.18 -36.52 80.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.921 -156.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.512 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 50.2 mt-10 -48.75 -35.98 15.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.58 -36.01 57.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -75.52 -29.53 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -173.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.517 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.6 m-85 -48.18 -54.52 24.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.903 -160.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 95.7 Cg_endo -80.16 -29.31 2.63 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.825 2.35 . . . . 0.0 112.19 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -75.15 -48.93 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.016 0.436 . . . . 0.0 111.046 -167.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.92 -32.63 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.122 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 269' ' ' ALA . . . -62.7 -38.26 89.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.033 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.43 63.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -98.92 0.09 43.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.09 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 269' ' ' ALA . . . 75.14 17.91 80.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.515 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -109.72 -174.43 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.319 . . . . 0.0 110.888 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 -171.3 15.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.495 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.67 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 83.7 Cg_endo -79.46 174.67 11.59 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.357 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.36 -38.38 22.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 164.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -134.35 139.03 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.213 -172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.86 144.76 36.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -100.87 139.71 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 6.1 m95 -126.63 123.41 37.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.73 -91.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 -167.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -112.52 -82.39 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -73.9 -19.29 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 -164.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 96.4 mtt-85 -52.71 -30.71 33.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -168.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -51.09 -39.38 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 -171.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.531 -168.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.08 90.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.387 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.621 ' HB3' HD22 ' A' ' 75' ' ' LEU . 47.3 m-85 -76.47 -32.62 58.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.944 0.402 . . . . 0.0 110.874 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.39 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -62.64 -28.51 69.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -82.4 1.42 37.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.852 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.78 23.77 59.26 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.461 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.621 HD22 ' HB3' ' A' ' 70' ' ' TYR . 4.3 pp -85.89 1.15 51.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.76 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.1 pp -134.21 144.34 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -86.04 153.13 22.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.92 132.99 46.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.48 HG21 ' CE2' ' A' ' 106' ' ' TYR . 66.8 mt -109.35 139.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.182 -173.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 p -130.81 76.9 76.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.753 . . . . 0.0 111.161 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.96 152.53 31.93 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.743 2.295 . . . . 0.0 112.407 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -83.19 -176.98 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.848 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.6 -34.51 78.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.957 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.75 99.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -66.85 -35.08 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.77 -41.57 95.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.07 -30.07 33.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.857 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 45.0 mtmt -65.1 -17.78 64.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 1.174 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.62 123.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 8.2 p90 -174.75 51.16 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.692 0.758 . . . . 0.0 110.957 166.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 59.3 Cg_endo -72.22 -71.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.186 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.446 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 33.1 p90 -104.48 -19.26 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.8 p -67.55 -25.25 65.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 -168.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.457 ' HB2' ' HB2' ' A' ' 90' ' ' TYR . 47.8 t-105 -62.28 -42.26 99.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.967 -174.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.34 -29.69 70.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.556 ' HB3' ' CG2' ' A' ' 329' ' ' ILE . . . -69.35 -34.35 74.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.122 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.45 13.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -117.75 149.3 41.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -139.12 128.13 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.32 34.03 23.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.71 90.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.543 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.36 149.13 42.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.949 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.4 tp -83.96 125.06 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 pt -116.71 -10.09 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.79 167.61 22.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' CE2' HG21 ' A' ' 79' ' ' ILE . 74.9 m-85 -109.6 144.78 30.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.786 0.803 . . . . 0.0 110.91 171.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.4 Cg_exo -65.41 117.11 4.3 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.751 2.301 . . . . 0.0 112.341 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.7 mm -100.54 -32.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.23 151.69 4.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.8 t -118.5 124.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.112 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -118.48 130.14 55.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.03 153.02 30.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.442 HD23 ' HG3' ' A' ' 257' ' ' PRO . 10.8 mp -74.33 147.82 41.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -175.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 85.0 p -141.46 158.64 43.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' HB2' HD21 ' A' ' 247' ' ' LEU . 46.1 tp -98.85 125.89 44.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.952 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.458 HG12 HG23 ' A' ' 244' ' ' VAL . 63.9 mt -111.7 130.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.173 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -135.35 155.8 49.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -96.16 112.92 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -24.05 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.017 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -82.88 -34.45 26.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.83 -47.36 13.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -123.37 108.88 31.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.655 0.741 . . . . 0.0 110.92 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.53 -13.43 22.54 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.67 2.247 . . . . 0.0 112.424 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -147.12 108.34 3.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 153.78 76.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 0.0 112.349 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.75 141.83 42.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.583 2.189 . . . . 0.0 112.251 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.72 -17.77 26.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -144.37 165.02 29.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -67.26 -28.87 68.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.34 -29.53 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.848 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.12 -21.09 60.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 34.6 mm -59.8 -53.47 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.133 -167.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.1 Cg_endo -64.72 -45.79 7.96 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.729 2.286 . . . . 0.0 112.31 -173.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.68 96.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.045 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.409 HD21 ' HA ' ' A' ' 135' ' ' LEU . 25.5 mt -60.98 -38.65 86.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 10.2 t70 -64.63 -36.1 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -36.16 83.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.54 -57.53 5.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.54 HD11 ' O ' ' A' ' 145' ' ' SER . 1.7 pt? -81.09 -11.45 59.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 86.4 tttt -56.18 -29.32 60.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.783 166.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.09 65.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.88 11.17 37.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.21 75.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.426 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 39.9 mmtm -117.89 157.28 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.54 ' O ' HD11 ' A' ' 139' ' ' LEU . 30.0 t -115.14 154.44 28.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.82 175.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -73.79 -55.0 6.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.0 tp -143.69 130.62 20.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.8 mtp -122.86 134.8 54.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -149.69 165.96 30.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.487 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 57.7 t-20 -58.9 111.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.937 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.992 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.7 tm? -89.44 -21.57 22.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.981 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.31 -2.5 38.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -133.83 149.97 73.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.736 . . . . 0.0 110.94 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 71.2 Cg_endo -77.84 -21.6 10.94 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.633 2.222 . . . . 0.0 112.37 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -59.7 -40.97 89.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 56.2 m-85 -85.16 -27.75 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.753 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 76.2 p -89.07 -31.03 18.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.634 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.8 t90 -55.32 -47.84 97.65 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.558 0.694 . . . . 0.0 110.909 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.634 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 73.9 Cg_exo -47.96 -38.45 31.33 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.638 2.225 . . . . 0.0 112.294 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.702 HD21 ' O ' ' A' ' 160' ' ' LEU . 4.0 tt -73.85 -38.62 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.575 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.3 mt -67.47 -37.14 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.78 -14.35 58.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.04 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.01 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 -166.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -96.83 5.03 51.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.38 12.89 4.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.575 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.75 158.37 48.5 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.561 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.735 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 90.0 m-85 -136.85 155.2 50.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.959 0.409 . . . . 0.0 110.915 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.21 -31.12 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.049 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.11 130.11 12.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 54.9 tptt -93.55 121.73 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.852 -174.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.439 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 64.2 t80 -113.89 113.06 24.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -150.11 143.8 25.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 51.06 41.0 26.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.73 5.99 76.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.549 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.87 146.2 51.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 171' ' ' TYR . 30.2 m-85 -88.08 129.58 35.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 167.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -103.17 114.12 28.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.811 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.32 -20.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -87.3 -8.88 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -114.11 92.96 4.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.943 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.54 141.44 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.183 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.735 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -102.86 29.79 11.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.402 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.55 -22.4 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.145 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -104.95 24.75 11.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -104.45 -174.5 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.25 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.61 -44.01 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.72 84.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.775 0.321 . . . . 0.0 111.102 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.51 -42.23 98.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.832 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.99 -45.04 87.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.07 -44.21 91.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.442 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.98 -40.47 95.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.5 m -57.75 -43.3 85.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -63.73 -44.44 93.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.06 -45.34 91.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.76 -40.1 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -64.76 -39.87 94.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 198' ' ' LEU . 1.7 mp -65.77 -44.27 86.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.49 -38.39 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.221 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.3 -35.44 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.825 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.59 4.62 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.45 31.58 10.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.0 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -77.51 -29.58 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.7 ttp -147.9 150.09 33.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.415 ' HA ' ' HG ' ' A' ' 151' ' ' LEU . . . -63.95 -22.99 67.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -91.11 0.0 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.2 m -59.98 129.09 40.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -108.66 169.01 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 167.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.98 -32.61 72.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.034 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.0 p -69.37 -38.79 78.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.788 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 92.1 mt -66.87 -39.53 83.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.145 174.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.14 -36.9 85.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -69.14 -38.23 78.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.43 90.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.59 93.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.124 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.75 -40.98 92.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.81 -19.88 66.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.67 -10.11 27.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.99 63.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.44 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.78 -25.75 37.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 110.813 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.6 m -128.48 133.7 48.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.68 -28.74 60.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 70.9 mtm -131.85 151.59 51.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.5 t -150.04 161.5 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.7 128.7 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.157 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -122.29 150.85 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -120.32 -131.19 4.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.465 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.5 Cg_endo -67.06 -24.1 45.49 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.302 -170.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -53.44 -33.09 52.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 60.62 36.3 19.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.028 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.577 ' O ' ' C ' ' A' ' 233' ' ' SER . 78.3 m95 -41.97 -36.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.577 ' C ' ' O ' ' A' ' 232' ' ' TRP . 18.8 p 15.08 60.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 232' ' ' TRP . 78.8 m-20 -78.51 20.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -169.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 pt -117.59 -9.89 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -69.43 -61.27 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.4 m -54.27 -48.06 71.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.0 t -155.47 140.92 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.1 166.32 30.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.65 -70.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.134 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -150.66 70.81 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -108.93 160.51 15.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.43 167.18 25.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.458 HG23 HG12 ' A' ' 116' ' ' ILE . 41.2 t -124.23 131.39 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 0.0 111.064 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.47 175.83 9.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.61 162.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 115' ' ' LEU . 96.9 mt -77.25 149.01 78.71 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 110.96 -174.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.79 156.13 67.17 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.374 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.451 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 12.9 t -142.87 150.23 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.32 114.92 20.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.836 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 50.04 36.13 11.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.912 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.28 29.16 51.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.512 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.487 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 99.2 mm-40 -110.07 161.62 23.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 110.82 -167.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 46.4 Cg_endo -60.98 75.45 0.08 OUTLIER 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 0.0 112.416 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 81.5 p -94.85 -4.83 46.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.784 -162.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.457 ' HB2' ' HD2' ' A' ' 257' ' ' PRO . 10.7 ptpt -136.42 158.43 73.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.643 0.735 . . . . 0.0 110.871 -167.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 28.4 Cg_endo -70.26 166.92 26.62 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.643 2.229 . . . . 0.0 112.342 -169.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -68.93 170.03 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.432 HG21 ' HA3' ' A' ' 327' ' ' GLY . 61.5 t -120.13 133.31 67.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -170.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.21 141.6 16.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.0 t -125.23 128.36 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.9 tp -74.05 135.23 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 94.2 p -126.95 147.67 50.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.84 126.2 42.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.39 163.61 16.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.431 -170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.4 mt -106.36 129.96 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 111.147 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -61.98 126.52 27.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -63.79 -27.98 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.506 ' HB2' ' HA2' ' A' ' 54' ' ' GLY . . . -80.49 -13.11 59.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.133 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 25.3 t -72.29 127.59 90.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.684 0.754 . . . . 0.0 110.934 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.59 -6.54 18.76 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.728 2.285 . . . . 0.0 112.435 169.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.43 25.65 7.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -169.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.04 -40.87 59.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.19 -39.57 89.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 70.3 mt -64.89 -52.45 56.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.28 89.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -164.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -69.78 -49.84 48.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.939 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.78 -53.63 47.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -162.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.488 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 7.5 p90 -75.21 -25.63 58.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.48 -50.44 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.19 -29.28 38.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.953 -175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -101.97 -23.45 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.846 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.488 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 93.6 t80 -118.16 -50.67 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -175.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.98 -39.31 61.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.943 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 106' ' ' TYR . 6.7 mp -83.33 62.27 6.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 52.9 p -135.74 165.29 25.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.157 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -51.91 -49.68 62.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.77 -39.02 53.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.17 -46.69 20.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.7 tp -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.825 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.46 -43.19 88.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.85 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.608 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 88.9 t -77.33 -41.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.75 -18.53 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -54.72 -18.97 5.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 87.7 m-20 -81.18 -30.15 34.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.64 150.26 36.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.668 0.747 . . . . 0.0 110.876 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.83 -22.78 10.02 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.635 2.223 . . . . 0.0 112.364 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.5 tp -68.49 -58.22 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 89.02 3.85 75.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.66 34.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 111.034 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.3 m -120.46 156.19 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.038 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.16 -12.89 60.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 51.4 tp -74.59 120.47 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.444 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 59.6 tttm -62.3 -46.82 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -172.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -57.29 -47.15 82.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.91 -33.63 70.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.951 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.17 -37.6 85.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.823 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.7 -34.96 70.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -78.2 -38.43 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.27 -25.12 66.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.07 -7.94 20.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -79.33 -16.7 55.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -88.54 120.86 70.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -50.46 -31.99 32.82 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.232 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -69.7 -48.61 58.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.2 -39.15 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.82 84.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.07 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 58.1 m -63.06 -45.76 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.2 mmt -68.67 -37.6 79.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.28 -40.06 93.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.5 -34.17 76.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.875 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.15 90.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -71.79 -20.18 61.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.991 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.83 -8.19 20.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.432 ' HA3' HG21 ' A' ' 259' ' ' VAL . . . -94.56 -160.0 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.434 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -124.51 132.1 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.871 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.556 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 39.0 mm -79.94 120.48 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 -174.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.4 ' HG3' ' HA ' ' A' ' 96' ' ' ALA . 26.2 mmt 64.59 156.12 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.513 0.673 . . . . 0.0 110.958 169.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.436 ' HB2' ' H ' ' A' ' 332' ' ' ASN . 75.3 Cg_endo -69.83 -147.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.581 2.187 . . . . 0.0 112.363 164.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.436 ' H ' ' HB2' ' A' ' 331' ' ' PRO . 48.7 t30 -147.79 -54.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.99 164.02 34.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.662 0.744 . . . . 0.0 111.176 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -58.32 -20.92 50.14 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.779 2.319 . . . . 0.0 112.411 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -59.01 -23.08 61.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.502 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 93.5 mmm -67.44 -26.9 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.6 m -62.33 -36.73 83.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.797 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.36 -31.3 65.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.089 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.4 t80 -58.19 -49.99 75.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.004 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.654 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.8 m95 -61.71 -42.56 99.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -57.31 -42.49 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.12 86.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 72.7 t -73.26 -40.27 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.173 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.665 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 78.8 ttt-85 -55.79 -44.98 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.835 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.4 m -62.11 -42.79 99.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -62.36 -43.72 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.13 -49.89 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.115 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.93 -44.09 99.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.099 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -65.04 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.44 69.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.048 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.28 73.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.161 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -79.92 -7.11 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.96 11.82 84.09 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.584 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.1 -29.87 60.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.309 . . . . 0.0 110.88 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -140.67 155.2 46.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.2 p -74.49 172.17 12.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.58 -35.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.227 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.16 -40.77 86.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.73 -45.26 68.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.917 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.4 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.184 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.18 -36.04 76.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.04 -42.44 94.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.46 -31.76 73.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -69.46 -45.04 69.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.16 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.412 ' HA ' HD13 ' A' ' 368' ' ' ILE . 65.2 tt0 -61.84 -39.1 90.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 92.4 m -59.99 -41.54 92.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -73.63 -34.68 65.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 365' ' ' GLN . 78.5 mt -59.98 -40.01 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.185 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.8 p -93.5 -11.46 31.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.5 tttt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.628 0.251 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.4 mt -90.38 132.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.189 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 93.8 mt-10 -131.75 166.91 20.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.62 124.57 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.71 23.15 43.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.465 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 90.5 mttt -144.71 159.0 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.81 ' C ' HD12 ' A' ' 7' ' ' LEU . 1.8 pp -146.45 145.91 30.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.99 124.74 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.628 HG22 ' HB ' ' A' ' 59' ' ' ILE . 7.8 pt -126.61 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.543 ' HB3' HD22 ' A' ' 43' ' ' LEU . 37.2 m0 -116.27 137.8 51.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.7 tt -148.06 154.12 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.4 t-20 -55.5 127.87 31.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.854 174.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.77 79.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.586 -167.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.36 -53.46 57.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.921 -162.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.06 73.95 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 147.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -103.31 -40.19 2.46 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.5 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -70.44 -42.1 71.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -156.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.69 -51.81 45.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.88 -157.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.77 -48.56 83.3 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.42 -177.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.2 mt -60.81 -36.78 79.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.17 95.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.37 -52.0 67.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.74 -32.55 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.047 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.12 -43.04 96.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.52 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.93 -49.22 71.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.71 -43.06 90.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.47 -44.29 94.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.93 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.12 -33.8 76.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -71.83 -42.2 67.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -83.43 -38.03 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.796 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 90.4 m -99.59 -24.0 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 -173.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.01 86.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.405 HG13 HD22 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -87.43 124.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 177.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.04 130.54 43.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG13 HD11 ' A' ' 7' ' ' LEU . 77.8 t -109.03 135.22 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.0 m -127.63 111.9 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.504 HG23 HD12 ' A' ' 9' ' ' ILE . 52.6 t -101.76 120.56 51.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.481 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 54.9 mt-10 -131.88 153.15 50.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.937 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.423 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.8 p80 -132.3 75.13 74.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.637 0.732 . . . . 0.0 110.876 173.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 12.7 Cg_endo -69.76 -29.65 23.54 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.672 2.248 . . . . 0.0 112.452 -160.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.5 m-20 78.0 4.06 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -174.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -94.36 -2.02 52.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' A' ' 10' ' ' TRP . 79.9 mt -48.95 -57.25 6.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -152.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.33 -41.66 94.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -83.44 -40.33 19.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -170.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -75.51 -49.99 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -166.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.848 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 82.9 t80 -55.3 -52.22 73.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.694 0.759 . . . . 0.0 110.81 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.848 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 88.0 Cg_exo -52.48 -38.7 74.96 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 0.0 112.35 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -73.88 -47.26 39.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.0 m -74.83 -26.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.44 91.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.047 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.58 65.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -93.03 6.75 46.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.01 18.95 73.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.482 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.0 t0 -117.18 -172.96 2.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.962 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.45 167.02 22.8 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.49 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 59.8 Cg_endo -68.51 168.45 19.73 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.605 2.203 . . . . 0.0 112.337 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.27 -42.61 62.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.628 ' HB ' HG22 ' A' ' 9' ' ' ILE . 75.7 mt -136.73 143.3 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.198 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.28 136.61 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.74 122.44 47.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -147.71 157.61 43.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.919 169.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -87.5 -103.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -95.75 -50.03 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -62.04 -61.44 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 -162.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -77.92 -31.93 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -172.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -57.42 -48.23 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.77 -166.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.4 -48.21 87.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.556 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.34 -39.36 64.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 174.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.68 -32.99 74.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.943 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.408 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -64.12 -47.39 80.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.45 -25.88 65.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.0 m -82.52 0.02 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.74 30.3 76.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.41 -5.21 59.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.48 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -128.58 143.39 50.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 -173.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 154.33 20.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.05 136.76 52.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 pt -109.31 151.72 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.8 p -130.11 68.16 80.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.547 0.689 . . . . 0.0 111.197 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.3 141.8 32.64 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.719 2.279 . . . . 0.0 112.284 172.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -78.23 172.05 14.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.55 -31.97 73.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.811 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.52 84.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -79.87 -31.85 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.94 -43.63 94.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.8 -28.39 64.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -66.12 -26.49 67.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 mt -97.01 -137.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -132.33 139.59 35.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.762 0.791 . . . . 0.0 110.884 173.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.9 -42.0 70.23 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.778 2.318 . . . . 0.0 112.408 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -70.44 -24.82 62.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -77.42 -28.66 52.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.129 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.446 ' HA ' HG23 ' A' ' 97' ' ' VAL . 64.2 m95 -73.02 -33.21 65.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.53 -34.43 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' A' ' 329' ' ' ILE . . . -70.09 -28.54 65.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.482 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 34.8 m -106.47 12.48 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.158 -174.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -108.35 133.76 52.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -134.97 126.02 27.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 58.29 34.81 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.28 5.24 89.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.91 146.4 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 0.0 110.85 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.73 125.28 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.459 ' HB ' HD13 ' A' ' 76' ' ' LEU . 38.3 pt -121.65 -8.13 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -167.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.482 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -158.39 161.98 37.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -171.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.8 m-85 -109.14 130.93 22.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.623 0.725 . . . . 0.0 110.987 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 26.5 Cg_exo -62.53 115.58 2.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.749 2.299 . . . . 0.0 112.302 172.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.6 mm -104.85 -34.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.53 153.63 21.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -123.24 129.85 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 229' ' ' PRO . 10.2 pt-20 -131.16 149.21 52.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.897 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.48 154.88 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.6 tp -71.5 133.69 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.9 p -142.46 160.78 39.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -174.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -97.48 128.39 44.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 91.4 mt -111.43 129.61 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.046 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -129.06 153.9 47.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -95.33 118.87 32.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.64 -32.27 73.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -84.31 -35.43 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 -171.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.71 -44.36 50.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -139.34 109.54 7.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.985 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.8 Cg_endo -74.39 177.07 8.81 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.695 2.263 . . . . 0.0 112.436 171.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.1 t30 21.5 96.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 110.922 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.8 Cg_endo -65.51 156.74 61.98 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.373 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.408 ' HB3' HD11 ' A' ' 135' ' ' LEU . 33.7 Cg_endo -66.27 144.66 75.4 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.251 . . . . 0.0 112.363 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -87.92 -21.63 24.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.0 p -134.75 159.46 41.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -68.03 -33.44 74.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.49 -25.46 37.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.773 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.22 -20.84 60.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.588 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 27.6 mm -56.26 -54.77 49.26 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.532 0.682 . . . . 0.0 111.101 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 20.5 Cg_endo -61.86 -40.81 41.76 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.661 2.24 . . . . 0.0 112.371 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' A' ' 126' ' ' PRO . 66.0 mt -64.8 -35.22 80.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.939 177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.05 -36.91 85.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.84 -43.21 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.25 -37.76 78.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 35.0 mt -70.32 -35.04 73.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.88 -32.84 64.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.82 -23.6 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -102.85 6.4 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.822 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.17 25.66 70.46 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.516 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 90.3 mttt -112.95 154.66 26.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -106.77 151.6 24.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.39 -42.44 68.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.95 146.0 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 86.8 mmm -136.7 124.25 22.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 157.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.78 167.45 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.804 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 54.7 t-20 -67.39 117.95 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.88 -167.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.08 4.61 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.42 ' N ' ' OD1' ' A' ' 150' ' ' ASN . 79.2 mt-30 -84.59 -0.96 55.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.402 ' O ' HG21 ' A' ' 157' ' ' THR . 95.7 mt-10 -138.87 143.22 36.51 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.626 0.726 . . . . 0.0 110.844 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.615 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 33.2 Cg_endo -70.61 -27.19 22.73 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.72 2.28 . . . . 0.0 112.37 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.409 ' HA ' ' CD1' ' A' ' 158' ' ' TRP . 82.7 t80 -56.11 -46.74 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.89 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 61.1 m-85 -80.37 -20.07 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -173.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 153' ' ' GLU . 80.3 p -75.45 -22.15 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.54 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 2.5 m95 -59.84 -46.18 98.31 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.522 0.677 . . . . 0.0 110.863 -168.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.579 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 52.3 Cg_exo -41.97 -36.26 3.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.334 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.5 -49.12 10.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.734 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.3 mt -81.33 -49.72 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -170.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -63.32 -19.0 64.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.138 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -61.43 -28.28 69.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.42 2.26 39.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.918 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 103.4 10.27 36.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -112.4 135.09 12.44 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.375 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -153.6 170.04 21.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.941 -165.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.62 -48.03 80.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.06 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.87 155.32 42.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -80.92 124.43 29.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -104.62 110.84 23.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -149.48 138.76 21.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -169.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 49.0 38.98 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 -173.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.88 10.39 72.4 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.393 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -136.77 154.81 50.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.735 0.303 . . . . 0.0 110.857 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -70.33 147.62 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -129.63 107.73 9.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.0 mm -76.93 -29.1 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.79 -22.81 31.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -170.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.54 65.25 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.823 166.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.37 149.59 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -169.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -86.93 11.67 64.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.404 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.54 -3.57 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.616 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 51.1 p-10 -78.42 16.64 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.938 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 74.1 m-80 91.21 0.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 166.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.54 -58.31 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -84.54 -55.66 2.67 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.0 68.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 111.137 -166.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.02 -45.16 86.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.75 96.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.121 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.734 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.8 -41.38 98.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.506 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.62 -39.18 91.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.2 m -61.17 -42.11 97.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.208 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.84 -42.99 94.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.86 -45.65 92.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.17 -40.0 87.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.12 -37.58 87.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.1 OUTLIER -68.24 -34.2 75.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.55 -40.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.054 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.06 -41.16 86.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -85.46 2.49 44.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.02 31.89 10.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -81.25 -29.55 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 67.4 mtt -135.47 147.32 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.843 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -97.66 124.03 41.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.63 -22.72 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 -170.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -90.01 -6.09 55.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.4 m -57.22 131.07 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -128.68 -179.48 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.815 171.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -58.04 -34.88 70.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 -172.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 71.2 m -67.73 -36.08 79.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.55 -42.14 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.65 -41.19 98.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.05 -43.03 79.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.61 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.059 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.1 86.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.38 -35.41 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.825 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -60.54 -29.73 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.951 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.42 -21.07 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.829 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.94 23.59 32.29 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -83.43 -25.76 30.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.925 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 87.1 m -125.62 137.28 53.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.56 -38.77 25.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 77.0 mtm -140.51 157.7 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.3 t -151.8 167.83 27.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.223 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.4 mt -123.01 119.29 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 58.6 m-80 -148.62 160.87 42.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -173.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -104.6 -136.55 8.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.482 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -70.61 -26.92 23.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.289 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -66.83 -18.79 65.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -89.47 11.97 17.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.031 -176.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 298' ' ' PRO . 46.4 m0 -67.01 -28.72 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.7 t -59.31 107.95 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -150.51 130.11 13.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.2 mt -89.64 80.52 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.7 73.8 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.1 p -116.81 -1.72 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.147 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 80.3 p -114.74 -169.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.18 178.79 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 66.7 t -61.06 106.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.5 -63.45 1.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.35 154.96 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.88 160.48 25.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.9 t -123.16 130.31 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 111.177 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.38 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.78 159.21 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.2 mt -70.19 139.85 87.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.574 0.702 . . . . 0.0 110.967 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 40.6 Cg_exo -60.43 165.38 11.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.8 p -120.62 148.07 44.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.077 172.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -126.62 117.21 22.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 54.57 35.74 24.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.28 16.58 62.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -130.02 146.67 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 145.46 85.97 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.627 2.218 . . . . 0.0 112.431 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.6 t -67.17 -57.73 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.437 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 9.0 tmtt? -163.52 117.38 1.08 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.525 0.678 . . . . 0.0 110.935 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.54 128.03 11.52 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.709 2.273 . . . . 0.0 112.442 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -161.31 111.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.07 132.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.09 137.42 13.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.558 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.04 125.17 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 57.0 tp -65.35 127.35 31.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 27.0 m -133.2 148.83 52.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.815 -166.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.86 132.75 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -112.14 148.05 18.21 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.435 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.1 mt -106.1 125.79 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -59.04 118.26 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 273' ' ' LYS . . . -62.1 -24.72 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.24 -9.58 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -68.82 132.53 90.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.636 0.731 . . . . 0.0 110.913 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -14.31 39.4 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.636 2.224 . . . . 0.0 112.302 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -115.6 29.43 8.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -167.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 268' ' ' ALA . 47.5 mtmt -58.28 -35.61 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 -177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.6 -36.46 83.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.405 HD22 HG13 ' A' ' 33' ' ' ILE . 62.6 tp -64.56 -42.85 95.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 175.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.4 90.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -65.15 -43.97 90.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.85 -172.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.73 -51.36 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -172.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -32.61 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.74 -50.58 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -74.11 -42.88 59.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.66 -14.35 19.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -160.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -123.23 -53.73 1.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 59.5 tp -68.07 -46.93 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.428 HD11 ' HB3' ' A' ' 106' ' ' TYR . 84.2 mt -83.78 63.79 7.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.1 p -135.54 165.31 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 173.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.87 -44.45 70.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -80.91 -40.85 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.59 35.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.609 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.47 -34.41 72.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 110.904 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.28 -40.04 84.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -33.2 68.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.506 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 78.7 t -79.07 -51.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.154 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -79.3 -19.84 49.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 -166.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -57.85 -18.14 20.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -93.23 -21.33 19.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 72.7 mmtt -71.98 149.75 92.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.617 0.722 . . . . 0.0 110.906 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.444 ' HB2' ' HB3' ' A' ' 232' ' ' TRP . 79.7 Cg_exo -57.87 -44.14 42.99 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.239 . . . . 0.0 112.405 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -95.06 -45.86 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 302' ' ' VAL . . . 83.54 9.74 82.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.54 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.89 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.63 HG22 ' HB3' ' A' ' 307' ' ' TYR . 29.3 m -115.83 156.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -77.18 -9.01 58.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 171.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.37 120.19 23.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.66 -43.9 97.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 38.6 t -58.75 -48.93 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.924 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.63 ' HB3' HG22 ' A' ' 302' ' ' VAL . 1.5 t80 -71.02 -35.39 72.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.849 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -62.34 -32.82 73.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.57 -36.95 77.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.83 -38.44 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.69 -26.69 67.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.981 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.44 -12.46 43.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.11 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.83 -18.1 59.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -90.19 119.0 69.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.608 0.718 . . . . 0.0 110.809 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.99 -32.92 50.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -70.75 -40.63 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.41 -40.72 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.4 72.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.191 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.59 89.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.7 m -65.13 -46.35 81.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.163 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -68.18 -34.82 76.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -63.12 -39.97 96.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.9 -38.87 66.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.69 91.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.012 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . 0.421 ' HG3' ' HG3' ' A' ' 326' ' ' LYS . 20.8 pt20 -71.3 -14.49 62.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 325' ' ' GLN . 90.3 mttt -110.35 -6.52 14.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -175.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.93 -160.55 36.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.437 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -130.16 148.25 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.875 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.438 HG22 ' HG2' ' A' ' 331' ' ' PRO . 45.5 mm -68.97 117.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.115 -171.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.562 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 tmt? -47.93 -53.73 29.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.62 0.724 . . . . 0.0 110.902 -165.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 330' ' ' MET . 45.5 Cg_endo -64.91 101.2 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.703 2.268 . . . . 0.0 112.366 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.643 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 62.8 m-80 -121.56 34.56 5.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -168.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.643 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 45.9 mm 88.94 136.56 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.071 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.26 -26.66 20.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.701 2.268 . . . . 0.0 112.266 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.446 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.7 mm-40 -57.44 -23.11 47.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 66.5 ttp -63.29 -32.7 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.9 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.3 m -64.35 -38.12 89.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.28 -45.76 83.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -57.39 -48.67 78.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -64.3 -45.66 87.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.39 93.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.082 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.62 -29.87 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.615 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 73.7 ttt-85 -58.93 -43.07 91.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.6 m -59.69 -41.5 90.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -65.32 -40.21 93.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.44 -50.93 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.05 -46.46 91.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.041 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.11 -36.34 83.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.24 -48.1 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.44 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.054 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -79.0 -9.45 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.1 10.1 86.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.82 -28.6 58.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.319 . . . . 0.0 110.85 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -138.26 155.76 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 357' ' ' VAL . 97.0 m -71.52 152.28 43.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 174.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.404 ' N ' HG23 ' A' ' 356' ' ' THR . 64.1 t -65.66 -47.25 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 -173.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.99 -41.16 99.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -71.91 -44.47 63.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 346' ' ' ALA . . . -64.84 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.4 -37.84 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.8 tttt -61.88 -41.99 98.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.26 -31.6 72.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -71.64 -47.16 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.083 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.9 pp0? -68.54 -31.52 70.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 98.9 m -63.26 -44.06 96.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.048 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -64.51 -37.68 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.797 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.93 -46.19 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.4 p -95.19 -6.16 42.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.233 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.1 127.68 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.123 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -128.48 165.39 20.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.81 119.95 15.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.5 24.03 34.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.497 -172.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -145.0 154.27 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.882 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.26 142.93 32.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.8 t -125.48 125.75 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.45 131.75 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.607 ' HB3' HD23 ' A' ' 43' ' ' LEU . 24.0 m0 -113.16 129.84 56.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.4 tt -151.43 153.33 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -55.37 127.04 27.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.09 -20.93 78.99 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -165.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.07 -48.84 72.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -163.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -138.42 83.21 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 145.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -111.3 -34.38 2.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -77.17 -43.83 32.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.966 -159.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -65.77 -60.01 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -155.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -45.68 96.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.54 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -58.39 -41.47 84.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.943 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.87 -48.83 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.913 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.28 -33.88 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.074 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.67 -37.2 94.37 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.369 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.35 -45.88 85.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.88 -44.48 97.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.38 -37.26 86.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -64.86 -35.29 80.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.16 -37.71 72.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.47 -41.5 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -104.67 -17.35 14.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.182 -172.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.87 88.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.55 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.3 tt -76.15 125.24 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.36 121.58 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 p -103.66 140.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -134.24 112.18 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.143 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.02 122.76 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -128.59 150.93 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 26.3 p80 -133.77 73.19 72.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.669 0.747 . . . . 0.0 110.871 170.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.576 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 16.9 Cg_endo -70.04 -28.04 24.41 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.633 2.222 . . . . 0.0 112.427 -162.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 57.8 m-20 78.23 2.39 2.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 -172.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.93 -2.04 44.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 10' ' ' TRP . 84.7 mt -46.0 -55.54 6.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.97 -154.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -70.0 -26.64 64.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -168.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -84.34 -43.43 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -79.98 -41.39 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.877 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 29.7 t80 -51.88 -52.97 56.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.825 -165.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 73.3 Cg_exo -54.25 -38.05 88.26 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.564 2.176 . . . . 0.0 112.388 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.2 -48.47 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.924 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -72.18 -30.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.14 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.09 -24.28 67.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.54 7.12 47.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.47 22.59 67.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -119.92 -170.33 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.983 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.56 -173.23 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.581 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.02 159.97 23.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.242 . . . . 0.0 112.364 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' OD2' ' HB3' ' A' ' 276' ' ' ALA . 29.7 t70 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 169.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.35 142.97 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.36 132.08 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.191 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -113.8 127.28 55.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -146.99 154.46 41.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -81.34 -102.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -176.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 -51.28 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.07 -47.98 80.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -79.69 -33.38 41.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -56.52 -47.93 78.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.16 81.7 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.509 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.13 -43.22 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.59 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -70.82 -30.02 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.31 95.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.089 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.43 -24.38 65.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -83.45 3.67 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.46 36.91 69.31 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.478 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.77 -9.56 59.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.785 0.326 . . . . 0.0 110.869 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.571 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -132.68 143.18 49.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.948 -173.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.74 164.32 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.078 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -66.31 134.95 53.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -107.92 151.76 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.088 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.5 m -127.44 75.06 77.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 111.218 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.49 141.0 17.44 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.659 2.24 . . . . 0.0 112.251 169.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -80.62 179.95 7.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.913 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.71 -36.13 82.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -173.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -41.94 98.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -69.0 -40.72 78.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.81 -42.2 90.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.859 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.79 -27.11 64.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.99 -27.32 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.925 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.48 -110.26 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 31.6 t80 -156.76 134.71 7.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.667 0.746 . . . . 0.0 111.01 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 80.8 Cg_exo -56.38 -41.66 73.92 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.377 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.27 -40.58 97.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.5 p -71.5 -25.5 62.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.414 ' HA ' HG23 ' A' ' 97' ' ' VAL . 63.4 m95 -74.38 -34.31 63.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.876 173.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.15 -31.3 71.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.832 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.06 -26.45 68.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.43 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 35.9 m -108.04 15.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.149 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -100.34 131.42 46.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -130.74 121.83 26.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 59.28 34.97 23.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.9 4.17 90.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.436 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.04 146.23 47.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.772 0.32 . . . . 0.0 110.918 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -86.37 127.77 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.453 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.6 pt -117.93 -8.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 -169.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -159.67 163.23 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -170.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 78.2 m-85 -107.73 129.01 24.77 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.714 0.769 . . . . 0.0 110.966 175.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 17.2 Cg_exo -66.66 122.32 9.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.309 172.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -109.64 -40.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -155.54 156.25 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.023 -167.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.89 137.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.649 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 24.9 pt-20 -142.8 154.94 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.25 41.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.175 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.7 tp -66.42 142.36 57.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.874 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.4 m -138.85 156.37 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.6 tp -97.01 123.89 40.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.429 HG12 HG23 ' A' ' 244' ' ' VAL . 74.6 mt -113.3 125.23 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -134.94 157.72 46.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -170.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -91.64 112.56 24.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.717 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 96.4 mttt -67.69 -29.09 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 -174.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -78.11 -35.68 48.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.6 -45.78 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.9 tp -121.71 106.7 36.87 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.913 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 124' ' ' ASN . 97.1 Cg_endo -74.86 157.02 43.61 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.65 2.233 . . . . 0.0 112.284 168.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.6 t30 25.06 96.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.594 0.712 . . . . 0.0 110.953 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.8 Cg_endo -65.25 155.69 67.17 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.728 2.285 . . . . 0.0 112.405 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.96 142.13 55.76 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.751 2.301 . . . . 0.0 112.297 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -91.04 -25.62 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 249' ' ' THR . 68.7 p -128.69 159.99 33.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.186 -175.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -74.06 -23.59 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.979 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.5 -28.57 67.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.98 -20.08 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.637 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 31.2 mm -57.71 -56.25 36.38 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.573 0.701 . . . . 0.0 111.11 -168.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.637 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 29.9 Cg_endo -69.44 -39.69 6.79 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -172.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.18 99.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.74 -39.54 94.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.45 -41.4 98.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.02 -39.6 86.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.07 -45.87 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -84.6 -18.92 34.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.424 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.0 tttt -57.47 -30.04 64.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.48 -20.42 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.2 9.31 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.03 68.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.527 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -108.97 161.43 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.849 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.5 t -115.84 152.66 32.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 167.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.97 -42.35 57.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.109 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.97 153.15 47.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -175.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mmm -128.38 120.27 26.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.842 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -166.08 165.01 18.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -97.22 141.21 30.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -168.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.426 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 52.4 tp -105.57 2.45 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 175.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -76.54 -8.6 57.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 174.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.48 145.07 39.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.737 0.78 . . . . 0.0 110.832 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.582 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 50.5 Cg_endo -68.73 -24.59 34.62 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.532 2.155 . . . . 0.0 112.295 176.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -57.72 -47.62 81.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -71.64 -26.5 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 p -84.13 -17.19 40.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 7.2 m0 -56.97 -46.4 99.87 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 -170.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 88.9 Cg_exo -51.08 -33.57 43.84 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.765 2.31 . . . . 0.0 112.306 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.5 tp -81.37 -46.15 15.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.445 HG23 ' HA3' ' A' ' 191' ' ' GLY . 94.8 mt -83.14 -48.17 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.107 -171.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -66.62 -16.64 64.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -58.82 -28.56 66.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.51 -6.35 22.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.9 6.75 13.8 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.596 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -95.84 115.04 5.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.427 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -162.33 175.31 11.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 110.936 -161.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 339' ' ' PHE . . . -82.88 -23.64 33.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.191 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.803 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 86.1 m-85 -130.89 143.95 51.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -112.15 127.15 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.857 163.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -108.99 111.68 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.84 -170.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.15 141.32 25.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 52.42 37.96 24.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.63 4.33 70.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.35 150.63 52.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 0.0 110.907 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.803 ' CD1' ' HB3' ' A' ' 169' ' ' PHE . 57.9 m-85 -86.19 130.78 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 172.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -115.83 117.37 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.931 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -78.62 -20.17 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.03 -16.19 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -113.97 71.31 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.79 166.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.32 150.95 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.181 -165.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -88.21 22.24 20.36 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.509 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.6 m -105.65 0.02 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 52.6 p-10 -80.98 17.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.672 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.0 m-80 94.22 -4.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 167.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.81 -57.69 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.072 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -90.79 -53.73 2.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.512 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.596 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -67.38 -35.22 78.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 0.0 111.023 -165.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.81 -43.45 93.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.975 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.08 -41.27 95.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.074 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.445 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -62.79 -39.57 98.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.454 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.93 -40.86 95.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.3 m -60.2 -42.17 94.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.151 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.78 -44.0 97.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 59.1 tp -58.72 -45.52 89.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 351' ' ' ALA . 50.4 t -63.36 -39.74 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.46 -39.87 92.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.521 HD11 ' HB3' ' A' ' 133' ' ' PRO . 0.3 OUTLIER -70.05 -40.65 74.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -178.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.62 -39.29 84.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.13 -38.16 87.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -87.94 3.67 47.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 60.6 35.55 19.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -80.78 -20.19 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -139.44 153.08 47.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -98.46 132.4 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.0 72.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -89.85 -4.1 57.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 66.9 m -62.94 135.44 57.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.43 179.92 5.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.89 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -62.04 -34.64 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.931 -172.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.7 m -69.66 -41.34 75.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.838 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.07 -39.67 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.1 93.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.05 -43.45 92.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.51 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -42.39 98.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.492 ' HD1' ' HA ' ' A' ' 217' ' ' PHE . 0.9 OUTLIER -64.91 -37.08 86.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 172.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -102.64 -22.88 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.85 23.32 36.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -82.92 -22.55 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 110.923 -171.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.5 t -126.26 144.92 50.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.98 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.0 mtm -138.61 148.03 43.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -168.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.9 p -139.5 164.96 28.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.101 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.65 119.14 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.5 160.05 41.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.94 -164.42 39.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.446 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.649 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -66.46 -20.99 54.02 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.24 . . . . 0.0 112.274 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -65.56 -20.66 66.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.66 3.86 45.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -69.99 -43.15 72.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 t -68.67 105.84 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -139.69 154.05 47.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 81.6 mt -78.25 88.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.23 74.97 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 73.8 p -122.32 0.79 9.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.7 p -100.49 -170.0 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.62 179.87 7.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.74 112.33 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -119.6 -56.71 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -115.43 162.99 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.717 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -143.03 169.27 25.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.47 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.429 HG23 HG12 ' A' ' 116' ' ' ILE . 58.4 t -122.93 130.2 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.82 175.55 9.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.178 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.84 161.05 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.506 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 90.0 mt -73.48 136.44 78.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.56 0.695 . . . . 0.0 110.94 -173.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 49.0 Cg_exo -62.38 159.33 36.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.746 2.297 . . . . 0.0 112.22 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 128' ' ' THR . 81.9 p -114.09 160.02 19.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.73 116.28 15.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.7 35.12 23.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.5 57.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.543 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.21 145.24 56.48 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.902 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.92 152.07 77.42 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.652 2.234 . . . . 0.0 112.399 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 95.7 p -65.1 -61.5 2.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -165.88 147.01 5.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.566 0.698 . . . . 0.0 110.911 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.36 126.1 8.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.589 2.193 . . . . 0.0 112.417 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -163.89 111.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.77 132.87 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.129 163.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.81 139.14 15.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.62 119.52 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.803 0.335 . . . . 0.0 111.101 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 56.0 tp -64.7 129.87 41.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -132.1 139.9 48.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -170.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.59 137.77 52.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.511 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -129.89 166.54 21.96 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 70.6 mt -112.4 129.81 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 111.191 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -59.36 123.21 16.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.939 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.46 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.48 59.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -76.06 131.46 75.75 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.619 0.723 . . . . 0.0 110.852 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.52 -10.86 28.84 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.65 2.233 . . . . 0.0 112.313 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -108.91 28.62 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -166.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.35 -37.75 62.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.757 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.54 -38.59 84.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.95 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.13 -43.09 93.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.419 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . . . -65.63 -44.55 86.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -63.15 -49.64 73.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 97.9 mt-10 -66.47 -45.15 80.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.78 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 19.1 t80 -59.98 -41.65 92.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 28.6 tp -70.33 -54.6 11.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -83.34 -30.76 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 -167.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.583 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.2 m-20 -98.57 -18.45 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.799 -167.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.614 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.6 m-85 -122.15 -53.44 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 59.6 mt -72.35 -41.83 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 -176.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.79 60.7 6.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 176.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.1 p -136.9 170.2 16.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.159 172.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -55.12 -48.17 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.796 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.63 -39.93 43.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.39 -46.09 27.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.422 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.7 tp -67.74 -36.32 80.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 110.905 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.04 -41.18 96.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.21 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.06 -32.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.56 -24.39 65.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.3 -26.25 39.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.56 -15.74 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.76 154.83 61.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.53 0.681 . . . . 0.0 110.988 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.41 ' HG2' HD21 ' A' ' 299' ' ' LEU . 41.5 Cg_endo -65.02 -97.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.577 2.184 . . . . 0.0 112.433 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.41 HD21 ' HG2' ' A' ' 298' ' ' PRO . 2.4 pt? -65.29 -25.87 67.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 60.98 31.87 78.03 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.551 165.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.91 127.28 31.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 111.104 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 34.7 m -116.75 152.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.081 -164.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.95 -10.84 59.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.08 118.54 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.37 -51.73 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.7 p -62.27 -43.07 99.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 307' ' ' TYR . 1.3 t80 -70.56 -37.1 73.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.975 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -66.24 -32.61 74.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.0 -36.58 81.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -72.79 -39.68 66.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.37 -26.77 68.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.935 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.78 -11.27 44.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.047 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.07 -18.14 58.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -85.52 118.93 71.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.768 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.09 -34.94 60.08 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 0.0 112.383 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -70.17 -41.11 74.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.04 -38.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.01 73.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.57 -41.37 88.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.04 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -63.73 -44.62 93.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.159 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.6 -38.82 90.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.886 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.53 -38.56 84.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.96 85.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.3 -18.26 65.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.832 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.27 -8.13 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.889 -172.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -102.88 -162.68 25.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.502 -173.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -133.98 156.68 47.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.481 HG13 ' HD2' ' A' ' 331' ' ' PRO . 4.9 tp -63.21 124.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -171.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.606 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.9 tmt? -44.46 -52.27 17.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.525 0.678 . . . . 0.0 110.847 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 330' ' ' MET . 34.8 Cg_endo -60.71 84.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.34 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.66 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 74.0 m-80 -104.23 29.36 6.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -170.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.66 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 50.3 mt 89.62 135.45 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.704 . . . . 0.0 111.146 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.41 -26.86 22.45 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.239 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.452 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.3 mm-40 -59.97 -18.16 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 62.1 ttp -57.97 -34.61 70.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.949 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.93 -38.83 92.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.14 -38.2 66.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.649 ' HB3' ' HB2' ' A' ' 168' ' ' ALA . 7.2 m-30 -67.17 -35.97 80.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -55.5 -48.8 74.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -64.94 -42.36 94.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.79 94.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.104 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.77 -38.11 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.083 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.582 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 71.2 ttt-85 -53.51 -39.92 64.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -57.04 -45.13 83.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.072 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -65.84 -43.71 87.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.89 -58.48 5.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -166.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.7 mt -66.57 -45.0 89.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 97.9 m-20 -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.78 59.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.438 ' HA ' HG23 ' A' ' 196' ' ' VAL . . . -71.74 -35.45 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.11 -172.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -75.47 -14.5 60.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.79 7.75 87.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.403 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -75.22 -24.27 57.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.962 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 83.4 mm-40 -136.01 157.08 47.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.0 m -67.17 150.62 48.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.56 -46.99 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.15 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.46 -40.14 95.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.92 -42.52 66.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.27 93.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.408 HD22 ' HB1' ' A' ' 188' ' ' ALA . 32.7 tp -71.93 -35.1 69.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 177.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.2 tttt -62.5 -40.27 96.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 173.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.97 -31.28 72.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -74.59 -43.18 56.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.174 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.9 pp0? -69.29 -28.91 66.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -66.75 -44.18 82.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.139 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.19 -40.16 68.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.38 -30.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 -171.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.8 p -92.17 -2.82 56.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.181 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -177.394 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.736 0.303 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -80.73 133.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.08 -179.44 8.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.61 126.62 30.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.991 -172.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.57 19.01 59.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.562 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -142.19 158.55 43.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.929 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -142.44 147.57 36.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 173.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.13 126.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.446 HG13 HD13 ' A' ' 7' ' ' LEU . 62.8 mt -118.74 133.22 66.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.129 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.544 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 30.2 m0 -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 174.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 tt -151.78 154.07 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.141 -172.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.404 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.4 t-20 -55.14 127.36 28.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 174.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.1 -19.44 79.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.519 -168.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.57 -51.23 70.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -163.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.19 78.84 1.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 147.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -109.0 -35.88 2.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.428 178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -80.5 -44.46 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 110.989 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -66.72 -52.08 48.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -155.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -65.3 -47.71 77.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.472 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.01 -38.41 85.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.87 -45.15 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.42 -47.33 82.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.96 -45.03 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.675 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -60.8 -36.31 91.65 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.363 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.16 -45.52 93.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.19 -44.77 90.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -64.49 -41.8 96.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -63.8 -33.66 76.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.12 -38.23 85.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.1 -37.02 17.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 -173.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.407 ' HB ' HG22 ' A' ' 33' ' ' ILE . 85.8 m -101.19 -24.51 14.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 -171.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.01 3.36 87.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.407 HG22 ' HB ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -87.53 125.27 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.4 . . . . 0.0 111.185 179.125 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -66.48 128.03 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -172.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.675 HG11 ' HA3' ' A' ' 24' ' ' GLY . 95.5 t -104.26 132.9 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -135.9 116.93 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.6 125.13 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.49 153.06 47.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 27.9 p80 -133.23 75.12 71.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 0.0 110.838 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.563 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.6 Cg_endo -69.24 -29.32 26.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.238 . . . . 0.0 112.401 -162.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.6 m-20 77.67 3.42 3.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -175.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.8 2.09 49.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.544 ' CD2' ' HB3' ' A' ' 10' ' ' TRP . 82.9 mt -48.65 -55.14 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -154.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -62.65 -28.91 70.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 -169.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.48 -47.07 9.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.811 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -79.98 -46.33 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -163.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.595 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 7.6 t80 -50.66 -54.0 40.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.679 0.752 . . . . 0.0 110.88 -162.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.1 Cg_endo -62.9 -31.8 77.25 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.295 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -47.82 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.7 m -74.95 -26.41 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -174.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.25 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.33 -24.28 65.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.028 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.5 p -96.43 4.96 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.37 23.17 61.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.502 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.9 t0 -119.88 -176.24 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.32 -179.18 24.67 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.582 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.91 161.1 24.13 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -76.26 -38.58 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.63 138.77 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 tt -138.27 140.86 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -100.2 143.34 30.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -140.05 152.37 46.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.98 -114.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.46 ' NE2' ' N ' ' A' ' 261' ' ' VAL . 70.8 m80 -116.94 -57.47 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.65 -45.42 90.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -74.97 -36.67 62.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.84 -49.55 75.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.21 -49.48 61.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.453 -175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.31 94.48 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.528 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.404 ' HB3' HD23 ' A' ' 75' ' ' LEU . 12.1 m-85 -71.9 -29.94 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.67 96.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.46 -28.63 69.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.3 m -84.97 5.73 28.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.879 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.49 35.66 82.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.434 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.404 HD23 ' HB3' ' A' ' 70' ' ' TYR . 1.9 mp -76.05 -15.49 60.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.874 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.43 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -129.61 143.64 50.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -169.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -91.15 159.33 16.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 177.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.44 136.87 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.5 pt -109.41 152.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.3 p -130.49 63.07 68.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.557 0.694 . . . . 0.0 111.157 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -72.67 143.28 37.45 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.717 2.278 . . . . 0.0 112.255 167.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -75.08 177.7 6.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.81 -30.35 70.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.52 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.023 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -64.71 -38.06 89.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.801 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -65.55 -40.13 92.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.991 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.21 -36.59 83.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.93 -30.98 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.05 -107.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 23.5 t80 -168.66 131.05 1.19 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.658 0.742 . . . . 0.0 110.957 174.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 79.8 Cg_exo -54.19 -38.73 88.02 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.716 2.278 . . . . 0.0 112.328 -174.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.56 -35.47 80.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -76.3 -24.74 54.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -75.46 -26.52 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 173.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.1 -33.23 71.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.16 67.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.09 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.98 16.63 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 -175.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -109.97 138.27 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.934 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -136.29 124.96 23.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.66 34.86 25.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.27 4.72 89.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.421 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.53 144.13 48.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.52 126.4 33.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.43 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.2 pt -119.67 -10.06 10.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.104 -168.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.27 165.17 31.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -108.61 137.92 20.13 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.667 0.746 . . . . 0.0 110.867 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 21.4 Cg_exo -66.53 120.24 7.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.284 173.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.36 -36.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.93 151.28 14.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.2 133.36 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -134.09 149.9 51.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.22 156.0 34.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 tp -69.98 140.4 52.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.7 m -142.93 159.05 42.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.1 tp -99.74 129.92 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.408 HG12 HG23 ' A' ' 244' ' ' VAL . 86.9 mt -110.89 132.92 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -132.59 154.76 49.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -93.28 117.19 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.786 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.35 -31.75 73.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -173.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.89 -35.09 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.21 -52.56 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 135' ' ' LEU . 94.3 mt -127.48 115.77 21.26 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.1 Cg_endo -75.04 171.14 18.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 0.0 112.37 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.559 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.9 t30 24.81 96.6 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.1 Cg_endo -65.0 155.04 70.41 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.405 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.49 143.94 59.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.595 2.197 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.48 -20.48 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.1 p -129.35 157.93 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -71.9 -25.47 61.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.49 -30.5 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.53 -20.05 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.603 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 33.8 mm -60.77 -54.03 58.54 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.604 0.716 . . . . 0.0 111.088 -169.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 23.5 Cg_endo -61.82 -40.05 47.67 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.753 2.302 . . . . 0.0 112.304 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.36 90.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 122' ' ' LEU . 62.4 tp -64.93 -40.37 94.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.96 -40.81 95.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.45 -42.92 83.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.44 -44.07 75.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 pp -83.03 -22.83 33.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.59 -25.87 67.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -18.78 65.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.26 9.98 41.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.02 25.68 73.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.477 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -108.73 157.52 18.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.836 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.8 t -111.24 144.19 40.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 169.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.24 -44.12 63.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.11 157.05 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 mmm -138.8 116.44 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -164.39 169.51 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.47 138.14 32.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -166.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 206' ' ' ALA . 89.6 mt -114.38 3.52 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.54 -3.8 54.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.68 145.06 49.59 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.689 0.757 . . . . 0.0 110.907 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.714 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 29.7 Cg_endo -69.12 -25.85 31.14 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.63 2.22 . . . . 0.0 112.256 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -57.72 -47.95 80.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.85 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.433 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 52.7 m-85 -79.98 -21.88 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.869 -174.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 71.5 p -77.31 -22.43 51.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.458 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 9.4 m0 -56.43 -46.48 99.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.488 0.661 . . . . 0.0 110.892 -170.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 60.8 Cg_exo -45.2 -37.21 13.2 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.62 2.213 . . . . 0.0 112.35 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.44 ' HB2' HD12 ' A' ' 195' ' ' LEU . 89.2 mt -82.59 -44.15 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.1 mt -78.33 -45.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 -171.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.94 -16.14 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.013 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -63.24 -31.96 73.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.098 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.22 0.67 23.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.821 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.82 11.08 9.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 163.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -93.78 129.56 9.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.411 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -166.48 159.01 14.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.958 0.408 . . . . 0.0 110.909 -168.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.53 68.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.098 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -151.51 155.73 39.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.007 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 32.4 tptt -87.33 141.07 28.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -97.72 112.58 24.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -150.34 137.21 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.87 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.13 38.12 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.64 10.22 63.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.416 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.51 152.64 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 11.3 p90 -61.54 146.06 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -137.97 103.09 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.42 ' HA ' HG22 ' A' ' 181' ' ' VAL . 8.3 tp -65.15 -15.14 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -170.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.3 -17.62 45.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.808 -165.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -124.06 60.7 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.852 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 182' ' ' GLY . 58.2 t -130.26 157.63 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -171.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.514 ' N ' HG12 ' A' ' 181' ' ' VAL . . . -72.03 10.54 4.35 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.498 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.407 HG23 ' HB ' ' A' ' 181' ' ' VAL . 12.0 m -94.79 -24.56 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 111.101 172.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 4.9 p30 -83.34 3.93 29.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.8 m-20 84.1 -2.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 158.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.9 -48.45 11.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.1 11.64 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.546 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 182' ' ' GLY . . . -65.19 -43.1 92.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.158 -163.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.65 -42.85 81.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.942 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.03 97.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.82 -41.99 97.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.441 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.24 -36.18 82.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.955 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -59.84 -46.92 87.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -65.1 -44.12 89.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.802 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' A' ' 160' ' ' LEU . 5.8 tt -60.01 -54.26 48.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.71 -37.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.25 -37.55 83.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.6 OUTLIER -68.75 -36.56 78.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.095 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.65 -41.66 88.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.043 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.84 -32.94 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -84.66 -1.76 56.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 60.71 39.98 16.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.944 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -78.53 -25.81 45.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.829 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -145.84 153.01 40.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -96.97 134.7 39.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.99 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . -65.34 -31.52 72.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -173.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.0 -4.75 57.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 -166.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -61.16 135.19 57.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -134.67 -175.2 3.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -56.98 -45.3 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 -175.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -62.56 -42.73 99.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.86 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.8 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -43.47 91.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.99 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.62 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -65.07 -33.46 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.64 -26.03 68.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.48 -23.23 13.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.37 27.02 13.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.456 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.71 -25.81 37.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.907 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -127.41 139.7 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.93 26.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 52.7 mtt -140.21 164.7 29.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 -172.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.5 t -152.82 160.99 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.66 114.86 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.143 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -149.36 160.41 43.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -100.07 -139.55 10.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.335 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.702 ' HB3' HD23 ' A' ' 299' ' ' LEU . 30.3 Cg_endo -68.3 -25.88 35.97 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 0.0 112.353 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -67.94 -16.97 64.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.09 15.13 12.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -56.2 -33.71 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.5 t -62.19 120.19 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -170.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -147.65 128.1 14.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.979 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.6 mt -95.5 86.75 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -84.77 74.92 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.4 p -112.55 -6.46 13.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.095 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.8 p -115.12 -165.25 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.777 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.33 177.04 3.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 80.6 t -65.74 111.19 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.38 -70.41 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.3 158.5 17.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.34 166.57 26.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.563 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.504 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 61.9 t -124.62 132.08 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 111.176 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.37 178.51 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -90.63 160.01 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.093 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 99.2 mt -71.48 143.28 87.49 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.9 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.84 169.9 21.32 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.306 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.8 p -107.93 162.08 14.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -139.02 120.28 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 54.97 33.93 21.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.04 74.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.47 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -123.44 151.16 62.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -172.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.04 152.21 83.13 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.717 2.278 . . . . 0.0 112.395 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.9 p -64.99 -58.39 6.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.845 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -168.2 142.42 2.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.632 0.73 . . . . 0.0 110.904 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -73.15 126.03 10.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.368 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -169.36 119.98 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.77 130.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.178 159.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.94 144.26 15.8 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.463 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.46 ' N ' ' NE2' ' A' ' 64' ' ' HIS . 77.8 t -126.95 122.97 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 62.5 tp -73.09 138.22 45.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.7 m -125.75 144.7 50.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.795 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.4 132.01 51.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.087 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.64 157.12 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.427 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 96.2 mt -105.07 127.24 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -56.57 119.91 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -67.59 -23.95 65.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 178.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.08 -9.96 59.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -72.17 133.67 83.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.672 0.749 . . . . 0.0 110.827 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.45 -11.23 30.79 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.598 2.199 . . . . 0.0 112.379 172.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -106.65 36.37 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -168.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.77 -43.54 72.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.78 -174.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -68.13 -36.8 80.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.73 -48.56 76.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.798 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.442 ' HA ' ' CE2' ' A' ' 279' ' ' PHE . . . -60.32 -43.52 96.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.05 -171.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -66.39 -43.94 84.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.811 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.34 -58.63 6.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -169.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.455 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 5.5 p90 -74.94 -25.84 59.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -167.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.452 HD21 ' O ' ' A' ' 280' ' ' LEU . 1.8 tt -63.6 -45.82 88.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.968 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -86.39 -27.13 24.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -99.89 -11.64 20.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.831 -167.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.653 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.3 m-85 -128.54 -52.13 1.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 5.8 mp -70.39 -41.94 72.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -170.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 290' ' ' LEU . 4.4 mp -101.53 70.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 174.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 81.6 p -135.3 169.97 16.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -52.26 -47.85 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.07 -41.49 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.22 -48.49 8.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.591 -169.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.492 HD21 ' HB2' ' A' ' 304' ' ' LEU . 19.0 tp -70.4 -34.39 72.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 110.969 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.82 -41.14 97.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.426 ' O ' ' HG2' ' A' ' 295' ' ' LYS . . . -66.1 -34.96 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.051 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.606 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 11.6 p -84.07 -36.02 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.94 -24.68 37.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 292' ' ' ALA . 62.5 pttt -61.99 -16.1 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 176.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -94.56 -23.84 17.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 71.8 mmtt -64.63 146.54 98.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.551 0.691 . . . . 0.0 110.946 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 71.5 Cg_exo -57.93 -57.52 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.567 2.178 . . . . 0.0 112.413 -174.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.702 HD23 ' HB3' ' A' ' 229' ' ' PRO . 58.8 tp -73.33 -48.22 36.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -172.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.05 -15.11 62.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.483 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.97 126.2 29.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -124.4 160.15 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 -171.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.5 -15.11 59.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.492 ' HB2' HD21 ' A' ' 290' ' ' LEU . 50.8 tp -74.7 120.01 19.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.41 -41.97 90.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.1 m -58.09 -48.87 78.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.634 ' HB3' HG22 ' A' ' 302' ' ' VAL . 1.2 t80 -70.02 -32.63 70.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -59.19 -36.41 75.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.69 -39.79 85.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -77.13 -38.59 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.81 -29.1 70.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -13.01 57.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.71 -22.31 46.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.848 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 64.6 t0 -87.69 119.95 70.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 110.826 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 36.4 Cg_endo -62.4 -24.83 75.86 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.504 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 17.9 ttp180 -68.08 -51.36 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.39 -37.14 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.7 84.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.185 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.54 -37.82 85.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.062 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 59.9 m -66.42 -39.93 89.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.23 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 75.9 mtm -66.3 -37.46 85.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -66.63 -35.09 79.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.83 94.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -71.43 -23.26 61.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.92 -5.94 24.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.2 41.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.55 151.18 50.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 110.841 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.507 HG13 ' HD2' ' A' ' 331' ' ' PRO . 2.2 tp -68.42 125.54 26.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.083 -166.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.582 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 95.8 mtp -56.95 -52.01 77.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.87 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 330' ' ' MET . 55.7 Cg_endo -67.97 83.55 0.44 Allowed 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.799 2.332 . . . . 0.0 112.3 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.518 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 22.3 t-20 -122.92 -6.89 8.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 333' ' ' ILE . 10.8 tp 161.77 118.24 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 0.0 111.094 -157.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.42 -31.36 91.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.6 2.2 . . . . 0.0 112.255 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.441 ' H ' HG13 ' A' ' 333' ' ' ILE . 91.9 mt-30 -62.62 -10.74 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.993 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -59.18 -35.08 72.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.7 m -62.8 -38.52 90.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.31 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 8.9 m-30 -65.28 -37.91 88.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -56.22 -49.75 73.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.973 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -65.81 -42.18 90.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.71 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.3 t -71.49 -37.74 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.714 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 57.2 ttt180 -53.25 -47.99 68.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.5 m -62.61 -41.91 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.462 ' HB3' ' HB1' ' A' ' 364' ' ' ALA . . . -64.91 -41.79 95.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.8 t -69.18 -47.72 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.19 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.92 -46.37 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 97.2 m-20 -64.98 -36.33 84.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.824 -177.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.91 -47.39 52.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.92 70.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.101 -173.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 84.8 p -74.85 -14.99 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.3 7.21 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.74 -30.07 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 84.8 mm-40 -136.07 155.95 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.991 177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.4 m -66.0 150.5 48.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.98 -49.81 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.0 -36.36 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -70.95 -40.52 71.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.76 89.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.161 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.82 -38.74 91.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.44 -45.54 93.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -74.3 -42.07 60.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' A' ' 346' ' ' ALA . . . -81.56 -42.76 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.098 -167.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.447 ' HA ' ' OE1' ' A' ' 365' ' ' GLN . 8.7 mm-40 -73.52 -24.08 60.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 -171.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 63.7 m -53.06 -33.64 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.074 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -61.12 -30.96 70.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 72.5 mt -72.13 -42.62 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.3 p -89.03 -11.07 45.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.101 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.194 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.721 0.296 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.3 mt -83.58 127.34 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.179 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -126.71 163.24 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.91 119.8 14.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.006 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.18 23.79 39.55 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.427 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.48 153.52 40.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.357 . . . . 0.0 110.905 -173.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 7' ' ' LEU . 2.3 pp -145.96 146.0 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.1 126.54 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.624 HG22 ' HB ' ' A' ' 59' ' ' ILE . 1.4 pt -120.19 131.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.476 ' HB3' HD23 ' A' ' 43' ' ' LEU . 23.0 m0 -113.44 132.7 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.01 155.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.474 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.2 t-20 -56.33 126.89 28.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 172.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.57 -21.72 79.18 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.54 -51.53 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -163.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.4 mmtt -135.01 77.59 1.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 148.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.72 -35.23 1.9 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -73.36 -48.33 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.349 . . . . 0.0 111.003 -155.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -69.76 -50.47 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 -155.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.747 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.06 -48.19 87.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.2 -36.85 78.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.18 -48.36 73.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.97 -45.75 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.058 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.691 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.76 -38.32 95.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.03 -45.38 89.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 110.888 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.43 -46.79 86.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.55 -40.67 96.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -62.36 -35.21 78.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.36 -39.55 71.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -176.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.7 -39.88 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.0 m -102.78 -18.31 15.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.1 87.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.469 173.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.802 HG13 HD22 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -88.02 130.96 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.166 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.91 129.5 39.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.691 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.5 t -109.73 136.68 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -128.1 113.71 16.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.437 HG23 HD12 ' A' ' 9' ' ' ILE . 61.5 t -98.57 120.58 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.062 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.463 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.9 mt-10 -129.48 145.96 51.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -134.81 72.91 67.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 0.0 110.809 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.596 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.3 Cg_endo -70.53 -25.41 25.08 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.276 . . . . 0.0 112.431 -161.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.596 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.3 m-20 77.59 4.03 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -172.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HB3' ' HG2' ' A' ' 46' ' ' LYS . 75.6 mmtt -96.55 0.8 50.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 173.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.476 HD23 ' HB3' ' A' ' 10' ' ' TRP . 89.1 mt -48.33 -55.37 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -153.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.26 -33.97 69.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -169.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.28 -43.59 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 42' ' ' LYS . 72.5 mmtt -76.5 -48.04 20.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -164.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.713 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.1 t80 -49.08 -57.37 11.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.644 0.735 . . . . 0.0 110.916 -160.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.713 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 31.8 Cg_endo -66.9 -30.04 40.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 0.0 112.289 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.55 -46.61 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.921 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 21.0 m -74.91 -27.18 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.126 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.07 77.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.158 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -24.14 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 p -96.08 4.74 52.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.84 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.425 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.485 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.2 t0 -120.02 -174.78 2.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.783 0.325 . . . . 0.0 110.944 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.35 -173.72 23.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.51 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.03 157.04 23.56 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.64 2.226 . . . . 0.0 112.323 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.7 -40.71 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 172.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.624 ' HB ' HG22 ' A' ' 9' ' ' ILE . 97.5 mt -136.9 142.64 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -131.95 137.13 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.154 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -103.17 134.4 46.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -140.03 156.14 46.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.07 -102.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -124.13 -54.69 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.937 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.01 -50.06 72.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -71.04 -34.99 71.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.59 -49.09 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.793 -174.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.44 -51.18 54.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.432 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -42.68 95.06 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.566 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -70.01 -31.28 68.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.995 0.426 . . . . 0.0 110.994 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.43 98.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.119 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.69 -25.17 64.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -85.11 3.95 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.48 35.15 74.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.528 173.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -78.79 -10.9 59.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -131.86 144.02 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -175.056 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.89 157.96 17.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.083 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.23 137.11 56.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -109.98 151.77 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.407 ' H ' ' HE2' ' A' ' 277' ' ' LYS . 26.5 m -134.98 72.09 68.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.713 . . . . 0.0 111.117 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.83 142.21 34.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.756 2.304 . . . . 0.0 112.316 168.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -79.05 -179.64 6.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.73 -37.85 88.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.64 88.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.96 -38.58 88.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.65 -39.42 91.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.82 -29.49 70.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.69 -25.87 68.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.918 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.456 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 60.6 mt -101.87 -123.97 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -160.05 134.88 5.55 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.689 0.757 . . . . 0.0 110.956 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -54.88 -38.81 92.44 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.715 2.276 . . . . 0.0 112.345 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.72 -36.5 83.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -74.98 -23.26 58.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.185 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.456 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 57.3 m95 -69.98 -32.13 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.37 -30.16 70.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 329' ' ' ILE . . . -67.35 -27.2 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.009 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.513 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 36.0 m -112.66 8.62 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.206 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -100.27 135.31 41.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.94 124.94 25.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 58.1 34.79 24.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.58 3.92 89.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.417 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.79 145.97 47.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.933 0.397 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.97 125.99 33.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.426 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.7 pt -118.64 -8.9 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 -169.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -158.7 161.29 37.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -171.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -106.92 129.87 23.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.626 0.727 . . . . 0.0 110.94 175.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.01 120.3 7.82 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.745 2.297 . . . . 0.0 112.282 173.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.3 mm -102.39 -37.86 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.08 151.73 16.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.06 -169.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.0 t -126.75 130.57 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.16 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.92 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 94.8 mt-10 -128.16 145.05 51.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.41 155.11 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.021 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.2 tp -68.69 145.93 53.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.5 p -141.02 157.59 45.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.4 tp -98.06 126.19 43.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.468 HG12 HG23 ' A' ' 244' ' ' VAL . 75.9 mt -112.72 129.35 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -135.73 153.65 51.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.69 114.21 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.796 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.7 mttt -67.55 -27.87 67.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -172.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.55 -36.53 29.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.42 HD23 ' HE2' ' A' ' 144' ' ' LYS . 98.0 mt -78.63 -43.26 26.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 176.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.23 111.89 10.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.689 0.757 . . . . 0.0 110.904 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.551 ' O ' ' C ' ' A' ' 124' ' ' ASN . 93.1 Cg_endo -75.78 173.59 14.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.629 2.22 . . . . 0.0 112.31 174.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.551 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.3 t30 24.0 96.85 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 110.98 175.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.0 157.35 62.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.733 2.289 . . . . 0.0 112.249 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.95 144.45 58.38 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.39 -32.79 14.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 249' ' ' THR . 76.7 p -126.45 159.64 32.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.429 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 67.3 m95 -74.62 -26.81 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.97 -173.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.67 -20.64 65.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.86 -24.11 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 31.4 mm -61.33 -51.78 75.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.556 0.693 . . . . 0.0 111.079 -164.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 38.7 Cg_endo -69.06 -42.38 4.19 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.694 2.262 . . . . 0.0 112.343 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.14 91.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.156 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.81 -38.98 92.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.933 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.92 -43.37 98.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.853 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.19 -41.15 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.36 -46.49 73.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -83.41 -21.29 33.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.908 -177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.457 ' N ' HD12 ' A' ' 139' ' ' LEU . 85.8 tttt -59.38 -26.61 65.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.75 -19.59 65.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.29 9.49 39.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.63 26.97 66.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HE2' HD23 ' A' ' 121' ' ' LEU . 83.2 mttt -106.06 160.81 15.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -114.26 147.21 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 164.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.5 -30.68 61.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.095 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.0 mt -142.12 149.83 40.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.43 125.85 35.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -165.47 165.04 19.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 32.5 t-20 -84.2 134.22 34.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.808 -169.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -109.52 16.41 22.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.946 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -83.66 -12.53 55.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -137.87 147.22 55.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.719 . . . . 0.0 110.944 -171.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.774 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -65.63 -27.31 53.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.539 2.159 . . . . 0.0 112.329 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -58.55 -48.04 82.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.925 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 56.3 m-85 -80.36 -19.39 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.786 -174.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 77.8 p -79.75 -21.1 44.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.529 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.7 m0 -57.37 -42.51 96.34 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.472 0.653 . . . . 0.0 110.902 -170.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 84.1 Cg_exo -47.13 -33.45 15.47 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.674 2.25 . . . . 0.0 112.325 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 195' ' ' LEU . 86.3 mt -83.14 -43.79 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 172.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 94.0 mt -81.4 -52.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -62.59 -31.93 72.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.084 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -103.43 0.07 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.69 5.14 22.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.508 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -91.27 130.03 10.09 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.481 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -166.04 175.27 8.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -169.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.31 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.136 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -141.12 151.89 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 81.4 tttt -81.7 135.3 35.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -109.34 114.15 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -148.44 143.16 26.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.885 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 49.21 39.92 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.42 5.45 67.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.396 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.57 154.08 51.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.38 129.71 34.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 110.884 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -95.6 110.16 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -20.62 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.95 -15.32 29.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 170' ' ' LYS . 65.0 t0 -133.59 90.62 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.834 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.03 162.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.32 5.18 84.1 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.427 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.62 -2.58 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.07 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.655 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 44.3 p30 -74.15 13.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 175.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.655 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.4 m-80 94.66 -5.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.3 -56.95 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.126 173.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.79 -51.56 3.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.587 ' HB1' HD22 ' A' ' 361' ' ' LEU . . . -65.94 -35.55 80.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.35 . . . . 0.0 111.213 -164.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -68.22 -44.55 75.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -170.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.53 95.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.59 98.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.468 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.67 -37.5 84.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.4 m -61.77 -45.43 93.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.88 -42.79 99.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.444 ' HA ' HD13 ' A' ' 160' ' ' LEU . 3.6 tt -59.57 -51.53 69.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.791 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.58 -39.52 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.58 -41.17 89.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.83 -37.53 86.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.46 -40.53 77.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.065 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.01 -31.55 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.49 1.75 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 64.48 34.67 10.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.933 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -80.85 -23.22 39.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -148.17 150.05 33.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -86.63 140.51 29.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.19 68.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -93.03 0.86 57.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.922 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.0 m -59.43 128.72 38.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 57.3 p30 -133.62 179.92 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 174.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -62.22 -34.06 75.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -64.41 -44.15 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.6 -39.58 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.46 96.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.11 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.81 -46.32 79.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.7 86.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 222' ' ' THR . . . -64.4 -39.55 94.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.081 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -71.48 -44.36 64.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.838 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -66.82 -27.51 67.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.81 -9.7 39.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.29 15.26 78.89 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.79 -28.94 60.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.961 0.41 . . . . 0.0 110.957 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.507 HG21 ' HB2' ' A' ' 216' ' ' ALA . 82.4 p -129.83 149.87 51.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.166 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.43 -31.94 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -171.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 89.8 mtp -135.29 157.68 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.859 -165.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.9 t -154.17 155.83 36.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.6 mt -119.07 118.93 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -147.09 159.85 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.97 -166.66 42.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.465 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.92 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 32.6 Cg_endo -64.05 -21.66 68.11 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 0.0 112.396 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -66.13 -16.99 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.11 -1.58 58.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -62.23 -40.04 94.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.9 t -58.88 119.23 6.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -155.85 159.27 39.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.0 mt -89.2 77.18 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.091 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -80.49 73.25 7.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.5 p -122.3 5.36 9.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.134 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 67.0 p -108.09 -175.6 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.75 176.8 5.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.883 172.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.04 113.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -114.18 -53.45 2.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -117.46 164.98 14.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.496 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -140.41 167.06 25.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.432 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.468 HG23 HG12 ' A' ' 116' ' ' ILE . 56.2 t -126.02 130.41 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.056 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.18 174.83 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.73 162.52 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.33 139.98 79.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.504 0.669 . . . . 0.0 110.9 -172.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.47 ' O ' ' HB3' ' A' ' 255' ' ' SER . 51.3 Cg_endo -75.04 160.34 40.16 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.228 . . . . 0.0 112.367 -177.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 128' ' ' THR . 78.4 p -114.42 158.08 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.185 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -127.67 116.28 20.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.11 35.87 23.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.2 17.68 64.31 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.511 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -127.82 147.91 64.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.96 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.04 149.29 89.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.39 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 248' ' ' PRO . 91.9 p -71.69 -53.8 12.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.495 ' HD3' ' HD3' ' A' ' 159' ' ' PRO . 46.4 pttt -168.93 144.15 2.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 170.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.428 ' HA ' ' HA2' ' A' ' 327' ' ' GLY . 87.7 Cg_endo -78.14 128.91 9.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.335 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -165.0 116.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.8 132.59 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 156.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.5 134.28 11.61 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 82.1 t -119.02 120.74 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 111.195 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 65.3 tp -65.28 132.01 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.805 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.3 m -128.9 141.29 51.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.813 -167.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.24 130.24 50.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.134 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.32 154.01 16.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.8 mt -102.92 127.81 56.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.94 0.4 . . . . 0.0 111.168 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.5 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.24 -11.15 58.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -70.04 130.86 89.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.747 0.784 . . . . 0.0 110.771 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.44 -14.05 41.23 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -112.87 27.97 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.818 -170.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -53.35 -34.14 56.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.45 -36.72 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.802 HD22 HG13 ' A' ' 33' ' ' ILE . 69.5 tp -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 174.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.12 94.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.407 ' HE2' ' H ' ' A' ' 80' ' ' THR . 63.4 tttm -64.79 -45.55 85.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -175.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -63.15 -54.24 40.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.99 -33.56 72.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.505 HD21 ' O ' ' A' ' 280' ' ' LEU . 5.0 tt -61.29 -51.61 68.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.924 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.09 -26.1 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -99.29 -23.77 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -167.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.413 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 68.3 m-85 -123.24 -50.26 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 60.1 tp -69.9 -49.02 56.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -86.41 62.65 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.4 p -135.39 167.62 20.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -57.17 -44.44 83.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -77.08 -42.0 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.61 -45.7 16.99 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.448 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 290' ' ' LEU . 14.1 tp -70.16 -29.84 66.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 110.9 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -61.49 -36.54 80.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.05 93.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.747 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 9.1 p -80.82 -36.38 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -169.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.18 -16.39 60.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -54.92 -23.39 18.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 69.3 m-20 -92.52 -19.17 22.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.58 156.23 59.05 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.51 0.671 . . . . 0.0 110.933 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.12 -93.6 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.643 2.229 . . . . 0.0 112.291 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' A' ' 229' ' ' PRO . 49.1 tp -45.13 -42.28 8.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.63 85.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.442 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.42 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -80.36 133.67 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -173.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.23 157.29 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.43 -12.49 60.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.075 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.404 ' HA ' HD21 ' A' ' 89' ' ' LEU . 50.6 tp -73.93 117.71 16.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.96 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.76 -48.85 79.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -171.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.6 t -59.95 -46.58 88.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.698 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -71.47 -35.63 70.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.74 -36.53 83.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.22 -35.06 76.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -74.79 -39.6 61.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 301' ' ' ALA . 89.6 mt -65.04 -27.92 69.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.98 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.2 34.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.72 -17.82 57.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.71 116.52 64.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 0.0 110.81 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.51 -32.51 43.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.623 2.215 . . . . 0.0 112.354 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -69.97 -39.36 76.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.19 -41.39 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.29 68.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.082 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.32 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 69.7 p -71.07 -33.89 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 33.3 mmt -72.71 -39.93 66.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.89 -38.09 82.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.912 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -68.75 -36.47 78.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.41 93.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.096 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -66.09 -17.92 65.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.46 -4.8 22.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 257' ' ' PRO . . . -97.31 -164.68 32.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.364 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -131.94 154.61 49.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.33 . . . . 0.0 110.923 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.458 HD13 ' HB3' ' A' ' 96' ' ' ALA . 45.0 mm -64.66 124.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.174 -171.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.554 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 18.2 tpt -56.81 -55.26 45.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 110.833 -168.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 330' ' ' MET . 42.3 Cg_endo -63.83 100.39 0.29 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.736 2.291 . . . . 0.0 112.306 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.7 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 67.1 m-80 -121.55 27.85 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -168.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.7 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 68.5 mt 93.68 134.35 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.719 0.771 . . . . 0.0 111.117 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 333' ' ' ILE . 83.8 Cg_exo -55.36 -32.21 80.58 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -172.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.448 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.4 mt-30 -61.56 -21.84 64.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.4 mmm -67.17 -28.08 67.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -65.62 -40.32 92.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.5 -37.45 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -66.05 -32.83 74.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -55.68 -43.9 76.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.976 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -66.49 -35.63 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.7 -35.47 80.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 68.8 t -70.07 -39.25 76.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.774 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 55.3 ttt180 -54.05 -45.52 71.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.7 m -62.3 -42.76 99.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.524 ' HB3' ' CB ' ' A' ' 364' ' ' ALA . . . -65.2 -44.29 88.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.92 -49.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.12 -44.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -65.01 -38.64 91.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.79 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.63 -45.54 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.114 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.83 74.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -75.91 -11.65 60.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.39 87.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -77.16 -24.81 51.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -131.76 153.86 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.981 174.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 99.5 m -69.61 147.99 49.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.95 -49.26 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.162 -170.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.09 -42.41 94.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.853 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.04 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.105 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.587 HD22 ' HB1' ' A' ' 188' ' ' ALA . 49.6 tp -70.0 -38.19 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.1 tttt -63.61 -44.72 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.814 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.57 -30.45 70.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 346' ' ' ALA . . . -77.86 -43.71 29.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.048 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.8 pp0? -64.96 -30.1 71.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 -171.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.7 m -62.11 -45.71 92.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.73 -35.32 70.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.17 -43.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.077 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.4 p -93.97 -5.93 46.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.095 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.454 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.59 129.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -126.65 166.87 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.01 119.42 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.01 24.05 39.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.431 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -144.44 154.25 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.941 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 7' ' ' LEU . 4.6 pp -151.57 148.46 28.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.868 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.48 123.01 65.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.192 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.414 HG12 ' HB ' ' A' ' 59' ' ' ILE . 59.8 mt -114.35 127.58 71.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.139 -174.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -115.12 131.64 56.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.74 155.2 7.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.431 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.6 t-20 -54.74 126.86 25.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 170.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.19 -20.57 79.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.479 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -56.14 -51.59 67.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.905 0.383 . . . . 0.0 110.882 -162.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -135.25 77.12 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 147.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.34 -33.32 2.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -77.45 -45.3 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.952 -160.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.59 -52.03 59.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 -156.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.87 -48.95 65.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.77 -41.75 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.21 -49.77 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.089 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.74 -46.24 89.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.87 -41.88 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.53 -33.55 85.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.505 175.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -66.78 -43.04 85.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.866 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.39 -39.85 94.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -61.79 -42.46 99.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.73 -34.83 75.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.8 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.02 -36.6 69.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.963 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -82.68 -42.0 18.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -172.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -100.15 -22.04 15.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.98 5.21 89.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.537 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.94 123.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.31 116.14 6.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.893 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.443 HG11 ' HA3' ' A' ' 24' ' ' GLY . 92.4 t -103.96 133.85 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.8 m -132.93 111.51 11.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.166 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.15 121.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.096 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -129.02 148.75 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.854 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -138.03 67.63 48.55 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.857 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 40.2 Cg_endo -78.65 -14.66 14.07 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 -164.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 59.1 m-20 77.16 6.44 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.34 -8.59 38.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mp -48.73 -52.82 21.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -159.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.8 -43.86 69.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.72 -40.87 20.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 -168.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.07 -43.51 28.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 -167.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.606 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 19.5 t80 -49.85 -54.6 30.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 110.887 -164.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 21.3 Cg_endo -60.4 -31.1 92.23 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -78.46 -49.88 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 19.5 m -74.23 -28.1 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.91 88.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.84 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.7 p -95.69 6.02 49.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.225 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.81 60.54 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.426 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.547 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.9 t0 -120.03 -172.95 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.38 -172.44 14.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.541 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HG3' HD12 ' A' ' 60' ' ' ILE . 94.4 Cg_endo -81.64 160.72 19.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.589 2.193 . . . . 0.0 112.391 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.14 -43.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 170.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.414 ' HB ' HG12 ' A' ' 9' ' ' ILE . 83.1 mt -132.4 141.85 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.141 -170.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.415 HD12 ' HG3' ' A' ' 57' ' ' PRO . 18.1 mm -123.15 131.95 72.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.214 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.93 121.36 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.944 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -148.11 165.0 32.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.877 169.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.49 -102.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.028 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -114.11 -56.59 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.79 -51.71 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -166.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 95.3 mtt-85 -75.36 -32.77 60.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -58.53 -49.44 77.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.852 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.62 -50.6 60.57 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.529 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -40.88 94.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.533 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 66' ' ' ARG . 14.8 m-30 -69.6 -31.94 70.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.901 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.51 96.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.039 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.44 -25.96 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -85.59 3.45 40.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.53 36.38 76.72 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.447 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.508 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 1.1 mp -75.27 -15.68 60.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.94 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -130.96 143.53 50.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 -170.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.94 162.3 14.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.143 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.51 137.71 56.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -110.66 153.35 12.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.2 p -130.07 64.92 74.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.604 0.716 . . . . 0.0 111.126 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.67 144.96 28.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.732 2.288 . . . . 0.0 112.27 167.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -76.5 178.48 6.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -68.27 -31.27 70.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.68 -34.4 67.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -61.79 -39.34 91.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -65.08 -40.22 94.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.3 -37.53 80.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.84 -29.5 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.1 -107.05 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.815 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -165.02 133.09 2.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.721 0.772 . . . . 0.0 110.974 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -66.25 -33.33 39.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -172.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.93 -36.51 83.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -75.47 -24.32 56.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.414 ' HA ' HG23 ' A' ' 97' ' ' VAL . 57.0 m95 -76.44 -28.65 56.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.951 173.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.34 -33.74 72.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.45 ' HB3' HD13 ' A' ' 329' ' ' ILE . . . -66.65 -26.43 67.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.147 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.429 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 30.2 m -109.15 16.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.2 -175.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.6 ttp-105 -109.79 136.53 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -136.76 125.65 24.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 57.71 34.71 24.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.44 89.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.461 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.76 144.91 48.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.39 125.59 32.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.434 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.0 pt -118.22 -11.65 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.144 -167.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.429 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -158.65 162.51 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.057 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -106.56 135.89 19.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.697 0.76 . . . . 0.0 110.89 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.9 Cg_exo -65.47 118.52 5.53 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 172.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.26 -36.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.065 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.83 153.25 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.58 128.35 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.192 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.507 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 53.8 mp0 -123.06 150.73 42.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.944 175.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.47 153.77 35.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 tp -71.03 136.2 48.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.002 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -138.72 158.21 44.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.435 ' HB2' HD21 ' A' ' 247' ' ' LEU . 38.7 tp -95.39 127.8 41.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 244' ' ' VAL . 81.0 mt -111.34 127.66 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.97 157.49 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -96.95 114.94 26.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -67.47 -29.44 68.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.68 -35.19 30.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.14 -43.93 27.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.21 109.2 15.09 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.637 0.732 . . . . 0.0 110.921 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.4 Cg_endo -73.29 167.65 26.77 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 112.379 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.566 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.6 t30 24.96 96.43 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.955 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -65.32 154.66 72.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.401 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.22 144.72 63.8 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.72 2.28 . . . . 0.0 112.378 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.97 -22.04 19.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.7 p -130.43 158.97 38.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.229 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.437 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 93.4 m95 -73.08 -24.58 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.91 -25.26 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.92 -21.48 57.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.594 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 32.9 mm -60.05 -51.92 77.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.534 0.683 . . . . 0.0 111.101 -166.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.4 Cg_endo -68.99 -42.74 3.89 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.448 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.43 92.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.01 -38.2 90.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.17 -39.87 94.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.66 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.85 -49.09 61.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.76 -16.52 53.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.961 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -53.59 -29.12 36.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.44 -19.88 64.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.34 7.73 38.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.92 28.45 62.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -106.49 157.23 17.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -106.88 149.66 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.902 160.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.56 -42.58 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.076 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 38.1 mt -138.2 141.98 40.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.857 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 75.4 mmm -140.22 118.18 11.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 163.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.24 168.44 26.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.791 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -72.41 104.29 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 206' ' ' ALA . 13.5 tp -87.66 -4.82 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 -174.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -87.59 10.27 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -133.64 148.1 67.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.67 0.747 . . . . 0.0 110.803 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 28.6 Cg_endo -68.68 -30.25 28.25 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.32 -174.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -57.59 -37.27 72.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.86 -28.62 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.765 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -77.75 -22.93 49.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.737 ' HB3' ' HG3' ' A' ' 256' ' ' LYS . 1.6 m95 -59.79 -46.81 98.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 -169.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 61.8 Cg_exo -44.43 -37.57 10.83 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.77 2.313 . . . . 0.0 112.337 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.32 -44.37 17.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.865 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.414 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 96.5 mt -72.97 -46.8 50.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -70.78 -17.59 62.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -63.35 -28.19 69.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.085 -166.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -100.31 7.16 44.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -170.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.7 4.66 55.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.507 169.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.58 ' HA3' ' O ' ' A' ' 187' ' ' GLY . . . -109.98 147.02 17.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.434 171.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.424 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 43.3 t80 -164.5 173.36 12.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 0.0 110.858 -167.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.48 -54.6 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -141.39 148.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -83.88 130.95 34.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -104.15 113.05 26.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.68 140.66 23.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 47.14 41.76 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.06 7.82 67.8 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 173.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.64 151.8 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -83.92 134.5 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -109.57 114.12 27.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.81 -19.99 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.63 -17.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -168.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -132.02 87.34 2.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.463 HG21 ' H ' ' A' ' 184' ' ' ASP . 13.9 m -127.23 166.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -171.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 188' ' ' ALA . . . -93.42 7.6 75.09 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.44 HG23 ' CG2' ' A' ' 181' ' ' VAL . 11.0 m -96.61 -16.45 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.072 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 6.6 p30 -79.87 10.56 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 167.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.2 m-20 84.45 -4.54 1.02 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.75 158.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.22 -48.34 10.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.58 ' O ' ' HA3' ' A' ' 166' ' ' GLY . . . -75.92 -44.1 20.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 182' ' ' GLY . . . -67.0 -34.72 78.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.841 0.353 . . . . 0.0 111.085 -160.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.49 -41.83 97.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -165.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.82 95.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 161' ' ' ILE . . . -65.48 -42.84 95.57 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -35.04 79.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.956 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 84.4 m -58.02 -47.96 81.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.117 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.11 -43.45 91.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.821 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.401 HD21 ' C ' ' A' ' 195' ' ' LEU . 10.3 tt -61.89 -48.69 79.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.2 -38.69 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.192 -175.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.12 -36.27 83.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -65.19 -36.4 84.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.993 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.91 -40.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.102 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.87 -39.56 93.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -85.42 5.0 32.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.72 31.93 11.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -83.05 -27.29 30.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 168.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 66.2 mtt -133.37 151.0 51.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.421 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 57.3 t-20 -95.64 132.55 40.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.447 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -67.44 -28.01 67.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -92.11 -8.88 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -168.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 87.0 m -55.5 126.48 25.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -121.14 -174.42 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.41 -44.78 92.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.0 m -60.73 -42.62 97.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.76 -42.28 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.83 95.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.26 -44.65 78.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.71 81.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -35.62 80.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -62.38 -29.94 70.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.14 -21.95 15.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.888 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 22.9 36.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.98 -27.07 43.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.863 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.5 t -124.95 140.0 53.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.98 -35.18 50.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.2 mtm -139.68 155.92 47.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -166.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -152.1 164.87 36.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -120.63 118.08 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -151.79 163.19 39.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.783 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -100.57 -141.31 11.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.657 ' HB3' HD23 ' A' ' 299' ' ' LEU . 39.8 Cg_endo -71.24 -25.52 21.96 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.366 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -65.79 -19.98 66.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -94.77 9.4 39.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -65.99 -38.78 89.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.2 t -54.63 111.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.429 ' HB3' ' OH ' ' A' ' 242' ' ' TYR . 68.7 m-80 -152.73 142.1 21.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.82 78.18 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -83.54 75.22 10.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.6 p -115.27 -9.03 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.9 p -103.2 -171.55 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.81 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.84 177.65 3.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -59.66 110.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.59 -57.87 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.814 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.429 ' OH ' ' HB3' ' A' ' 234' ' ' ASN . 49.2 p90 -110.2 159.52 17.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.95 167.61 25.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.49 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 116' ' ' ILE . 64.0 t -129.13 130.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.215 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.06 -177.25 5.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.197 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.17 160.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.101 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.435 HD21 ' HB2' ' A' ' 115' ' ' LEU . 83.8 mt -70.9 143.27 88.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.559 0.695 . . . . 0.0 110.937 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 255' ' ' SER . 57.7 Cg_endo -74.96 170.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.391 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -104.33 162.12 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.046 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.41 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 37.4 t80 -135.53 118.52 16.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.829 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 54.6 34.8 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.66 80.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 175.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 89.1 mm-40 -122.72 147.36 50.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.615 0.722 . . . . 0.0 110.94 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 51.4 Cg_exo -54.81 145.53 60.7 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.618 2.212 . . . . 0.0 112.424 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 248' ' ' PRO . 95.3 p -70.53 -63.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.992 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.737 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 14.1 tmtt? -172.32 125.93 0.53 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.917 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.71 134.37 12.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.716 2.277 . . . . 0.0 112.313 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -161.08 110.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.05 134.98 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.824 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -119.86 147.26 18.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.9 t -122.59 121.75 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.125 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.54 130.99 45.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.954 174.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.0 m -127.72 139.85 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -165.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.19 137.21 49.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.101 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.0 168.11 23.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.339 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.79 129.14 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.108 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -57.44 125.37 22.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.68 -22.25 66.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.97 -12.48 55.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.145 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.0 t -70.77 136.65 85.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.773 0.797 . . . . 0.0 110.826 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.16 -14.63 23.24 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.625 2.216 . . . . 0.0 112.35 174.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -108.03 36.87 2.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.832 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.94 -38.71 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.17 -38.78 91.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.38 -49.38 67.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.55 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -168.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -66.48 -47.46 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.916 -172.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -47.94 72.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -72.14 -36.02 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.656 HD21 ' O ' ' A' ' 280' ' ' LEU . 5.1 tt -56.58 -47.81 78.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.01 -25.56 34.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -99.81 -13.12 19.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -171.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.423 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 70.6 t80 -124.36 -58.83 1.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.7 mt -69.71 -39.87 76.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.02 66.34 9.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 175.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 73.7 p -136.27 168.35 19.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.52 -45.25 73.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.87 -41.86 42.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.96 -49.63 9.65 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.497 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.32 -38.92 82.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.56 -43.22 99.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.83 76.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.068 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.6 t -74.38 -45.06 47.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -73.86 -14.28 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.3 -27.07 13.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -91.91 -4.24 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -91.15 151.29 42.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.573 0.702 . . . . 0.0 110.871 172.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.55 -57.72 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' A' ' 229' ' ' PRO . 61.8 tp -65.8 -47.78 73.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -167.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.06 86.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.478 ' HB2' ' SD ' ' A' ' 321' ' ' MET . . . -75.16 125.55 29.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 0.0 111.114 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -124.71 159.71 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -173.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.36 60.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.2 tp -75.3 123.57 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.65 -39.39 93.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.1 t -59.46 -48.37 81.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.528 ' HB3' HG22 ' A' ' 302' ' ' VAL . 1.6 t80 -71.38 -33.68 69.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.12 -39.45 82.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.86 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.56 -37.82 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -76.97 -37.31 55.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.8 mt -64.87 -31.61 72.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.11 -12.66 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.11 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.03 -20.05 58.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -91.81 117.93 68.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.801 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.74 -33.64 60.93 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.673 2.248 . . . . 0.0 112.337 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.403 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 91.8 mtm-85 -72.55 -43.2 63.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -173.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.43 -38.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.99 72.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.72 89.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 80.9 m -67.2 -43.09 82.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.225 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.478 ' SD ' ' HB2' ' A' ' 301' ' ' ALA . 96.3 mmm -66.11 -34.62 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.14 -40.24 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -72.76 -34.57 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.18 -41.78 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -69.94 -17.03 63.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.03 -5.35 16.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.1 -164.07 39.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.476 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.61 147.53 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.45 HD13 ' HB3' ' A' ' 96' ' ' ALA . 39.2 mm -67.43 126.92 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 -166.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.824 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 54.2 mtt -52.64 -58.83 10.4 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 110.914 -171.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.529 ' CD ' ' HB2' ' A' ' 330' ' ' MET . 36.2 Cg_endo -63.98 101.08 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.762 2.308 . . . . 0.0 112.375 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.685 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 69.1 m-80 -123.06 28.49 7.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -169.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.685 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.8 mt 90.23 135.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.667 0.746 . . . . 0.0 111.104 -176.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -54.79 -29.94 65.13 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.618 2.212 . . . . 0.0 112.332 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.428 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.6 mt-30 -64.09 -23.69 67.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.88 -26.82 65.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.15 -34.88 49.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -66.68 -40.13 88.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.07 -38.55 83.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.966 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -64.99 -36.26 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.72 -35.01 79.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.67 -40.2 76.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.17 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.63 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 58.0 ttp180 -56.38 -44.79 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.2 m -64.2 -44.46 91.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.495 ' HB3' ' CB ' ' A' ' 364' ' ' ALA . . . -63.52 -45.38 90.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -176.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.97 -36.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.09 -171.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.5 mt -68.98 -44.16 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.068 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.39 -35.74 81.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.817 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.84 -45.58 67.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.31 68.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -75.78 -12.69 60.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.77 6.99 88.6 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.22 -30.09 64.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.864 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -139.28 156.8 46.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 70.8 p -75.02 164.09 26.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 171.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.39 -50.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.51 -36.67 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -69.21 -48.06 63.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.55 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.079 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.441 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 41.1 tp -65.09 -44.08 90.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -46.51 88.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.68 -35.07 78.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.495 ' CB ' ' HB3' ' A' ' 346' ' ' ALA . . . -79.01 -43.28 24.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.172 -172.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 10.3 mm100 -77.97 -31.13 50.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -171.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 78.0 m -59.99 -38.03 81.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.48 -30.0 70.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.41 -45.42 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.4 p -97.85 -4.62 36.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -177.915 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.703 0.287 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.438 HG21 ' HD2' ' A' ' 271' ' ' PRO . 88.6 mt -61.76 125.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.083 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 164.35 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -66.93 121.99 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.73 19.76 59.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 -173.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -146.39 153.34 40.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.807 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.9 pp -143.15 145.87 33.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.08 124.79 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.574 HG22 ' HB ' ' A' ' 59' ' ' ILE . 5.7 pt -124.95 132.26 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -171.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.787 ' HB3' HD23 ' A' ' 43' ' ' LEU . 38.3 m0 -113.72 135.34 54.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.545 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.2 tt -148.17 155.09 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.461 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.1 t-20 -55.77 128.01 32.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.873 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.12 -16.86 76.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.441 -168.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -47.7 80.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 -165.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -134.58 63.46 1.62 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 152.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.545 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -100.53 -50.49 1.3 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -67.74 -43.54 79.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -160.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.38 -49.52 59.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -163.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.48 -48.44 81.97 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.488 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.2 mt -63.89 -34.57 78.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.843 0.354 . . . . 0.0 110.88 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.07 95.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.049 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -62.06 -49.37 76.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.85 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.551 HG12 ' HB1' ' A' ' 292' ' ' ALA . 25.5 m -72.84 -32.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.48 -40.15 97.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.45 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.86 -43.94 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 110.819 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.88 -47.25 78.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 27' ' ' PHE . 6.9 m-30 -64.6 -41.85 95.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.889 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -65.09 -34.22 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.89 -40.71 79.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.77 -39.64 23.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.2 m -102.11 -26.35 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.15 -172.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.89 5.45 83.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 33' ' ' ILE . 19.5 tt -76.55 126.96 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.188 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.49 124.14 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.7 t -109.35 130.51 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.185 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -125.19 114.42 18.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.476 HG23 HD12 ' A' ' 9' ' ' ILE . 51.7 t -103.83 120.23 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 57.6 mt-10 -131.12 146.46 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -139.92 67.81 35.0 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.699 0.762 . . . . 0.0 110.789 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.554 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -73.91 -16.62 23.1 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.694 2.262 . . . . 0.0 112.387 -167.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 62.0 m-20 74.74 7.6 4.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -173.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.51 -1.32 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 172.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.787 HD23 ' HB3' ' A' ' 10' ' ' TRP . 34.5 mt -48.32 -54.33 14.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -156.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.79 -27.34 66.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 -167.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.61 -47.44 10.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -80.26 -40.97 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.998 -166.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.643 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 37.4 t80 -55.48 -58.88 13.05 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.604 0.716 . . . . 0.0 110.862 -165.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.643 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.8 Cg_endo -59.74 -30.7 92.7 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -75.05 -45.1 43.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 47' ' ' PHE . 33.2 m -73.75 -23.34 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.147 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.096 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.36 -24.8 66.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.32 4.61 53.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.0 22.29 74.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -139.39 -163.18 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 110.882 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.82 -165.83 22.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.627 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.507 ' HG2' HD12 ' A' ' 60' ' ' ILE . 84.4 Cg_endo -81.62 165.09 18.33 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 -173.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' HA ' HD12 ' A' ' 2' ' ' ILE . 43.6 t0 -83.95 -49.26 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.574 ' HB ' HG22 ' A' ' 9' ' ' ILE . 82.9 mt -133.97 138.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 -171.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.507 HD12 ' HG2' ' A' ' 57' ' ' PRO . 7.1 mm -120.86 139.69 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.239 173.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -99.53 130.9 45.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -139.69 158.3 44.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.8 -100.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.628 ' HB3' ' HD3' ' A' ' 331' ' ' PRO . 3.8 p80 -110.94 -54.87 2.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -176.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.07 -49.8 75.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.37 -33.63 48.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.66 -48.36 81.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.813 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.16 65.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.559 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.04 98.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -70.14 -30.02 67.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -62.95 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -67.49 -28.09 67.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -85.57 0.14 53.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -173.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 34.85 80.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mp -87.07 -2.6 58.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.84 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.483 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.19 142.92 51.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.932 -175.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.38 152.63 22.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -67.04 135.34 53.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.496 HG13 ' HB3' ' A' ' 103' ' ' LEU . 30.5 pt -118.42 146.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -134.96 69.66 70.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.622 0.725 . . . . 0.0 111.165 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.96 144.54 43.18 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.712 2.274 . . . . 0.0 112.38 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -76.05 178.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.56 -31.91 73.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.87 95.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -67.82 -38.45 83.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.94 -41.55 95.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.14 -33.85 72.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.844 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -68.21 -22.48 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.892 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.7 mt -95.78 -125.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 34.3 t80 -153.68 136.48 9.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.743 0.782 . . . . 0.0 110.941 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.2 Cg_exo -58.24 -41.51 65.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.79 2.326 . . . . 0.0 112.316 -172.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.6 -43.54 84.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.13 -26.76 62.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.155 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -70.04 -40.07 75.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.91 -36.14 82.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 173.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.66 65.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.078 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.502 HG21 HD11 ' A' ' 103' ' ' LEU . 26.8 m -107.4 19.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -109.95 141.02 43.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -138.42 125.89 21.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.96 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.38 35.05 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.831 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.65 89.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.485 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.64 139.71 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.931 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.502 HD11 HG21 ' A' ' 97' ' ' VAL . 10.7 tp -80.44 132.99 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.483 ' HB ' HD13 ' A' ' 76' ' ' LEU . 37.7 pt -124.38 -11.25 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 -165.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.476 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -157.32 162.49 39.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.009 -170.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.424 ' HB3' HD11 ' A' ' 285' ' ' LEU . 97.1 m-85 -113.15 140.78 24.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.623 0.725 . . . . 0.0 110.995 168.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.66 121.84 8.32 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -103.86 -42.7 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.72 153.34 29.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.127 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.84 133.77 56.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 11.7 mp0 -130.8 155.87 45.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.43 155.09 41.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.05 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.3 134.3 44.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.944 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.4 p -143.16 161.3 38.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.0 tp -98.99 127.89 45.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.2 mt -108.05 131.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.013 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -132.31 149.89 52.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.69 118.77 30.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 171.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.76 -34.66 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -81.63 -35.13 30.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.819 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.59 -44.72 23.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.459 HD12 ' HG3' ' A' ' 224' ' ' MET . 72.6 mt -131.68 115.79 15.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 0.0 110.861 173.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.554 ' O ' ' C ' ' A' ' 124' ' ' ASN . 90.2 Cg_endo -74.47 170.09 21.05 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.738 2.292 . . . . 0.0 112.368 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.554 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.4 t30 25.06 97.11 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 0.0 110.916 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 41.9 Cg_endo -65.49 157.16 59.68 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.401 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.85 149.91 60.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.576 2.184 . . . . 0.0 112.342 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.66 -27.71 13.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -126.25 156.44 40.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -66.24 -30.37 70.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.81 -26.58 58.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.93 -21.51 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.7 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 32.2 mm -59.74 -55.37 46.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.655 0.741 . . . . 0.0 111.14 -167.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.7 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 52.0 Cg_endo -75.0 -37.65 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.73 2.287 . . . . 0.0 112.354 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.85 96.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.76 -42.43 90.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.62 -41.52 99.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.988 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.52 -43.86 84.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.95 -45.58 67.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.5 pp -79.4 -22.51 44.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.007 -175.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.477 ' N ' HD12 ' A' ' 139' ' ' LEU . 83.9 tttt -61.06 -30.93 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -20.4 64.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.186 173.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.36 6.54 47.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.85 60.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.516 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.428 ' HB2' HD13 ' A' ' 139' ' ' LEU . 91.6 mttt -108.79 165.18 11.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.8 t -120.31 140.1 51.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 163.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.7 -33.66 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.5 mt -137.02 150.25 47.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 93.7 mmm -133.52 131.75 40.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 166.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -160.43 162.48 33.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.6 t-20 -84.24 110.71 18.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 -177.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.425 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 39.9 tp -96.09 4.49 52.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -173.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -81.21 2.12 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.53 151.92 48.12 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.667 0.746 . . . . 0.0 110.935 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.696 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.9 Cg_endo -72.61 -17.37 26.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.256 -174.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -52.47 -48.58 65.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.95 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.432 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 51.9 m-85 -83.51 -11.68 57.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -172.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -80.49 -19.02 46.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.485 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 6.5 m95 -59.79 -44.23 96.72 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.477 0.656 . . . . 0.0 110.921 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 66.6 Cg_exo -43.82 -31.22 3.44 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.714 2.276 . . . . 0.0 112.324 176.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.569 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.4 tm? -87.61 -49.24 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.442 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -78.55 -47.66 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 -169.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -64.85 -26.42 68.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -62.09 -31.75 72.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -95.96 0.31 51.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.75 38.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.423 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -92.46 129.03 9.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.408 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -168.3 175.2 6.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 110.808 -172.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.76 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -137.42 150.7 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -99.6 127.56 45.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -97.35 112.49 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.903 -174.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -149.91 138.43 20.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.65 35.16 17.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.55 4.6 75.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.532 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.49 149.96 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -77.4 135.25 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.45 107.25 18.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.8 tp -65.5 -19.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.55 -8.45 56.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -122.63 76.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.846 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.615 ' CG2' HG23 ' A' ' 183' ' ' VAL . 31.0 m -131.19 164.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -171.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.43 13.13 56.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.602 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.615 HG23 ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -99.74 -20.17 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.754 0.312 . . . . 0.0 111.082 174.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 99.7 m-20 -78.36 3.0 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 167.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 84.4 m-20 83.81 -4.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.792 163.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.1 -50.8 17.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.13 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.61 -42.1 14.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.45 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.7 78.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -164.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -63.27 -44.69 94.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -166.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.95 98.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.039 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.442 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.95 -42.28 98.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.424 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.34 -43.15 91.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.857 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.6 m -61.76 -44.21 97.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.522 ' HB3' HD11 ' A' ' 160' ' ' LEU . 1.1 t80 -63.11 -41.51 99.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.89 -40.53 95.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.34 -37.74 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -66.11 -35.13 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.46 -41.46 89.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.913 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.1 -36.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.65 -37.06 84.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -84.43 3.19 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 60.78 39.8 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -79.28 -26.85 42.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -149.46 150.86 33.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -95.37 149.83 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.877 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.66 -25.62 68.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -92.82 -7.28 46.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.779 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 m -58.61 125.54 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 59.6 p30 -139.07 -179.96 6.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -62.65 -33.05 74.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.9 m -63.79 -44.13 94.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.73 -40.04 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.168 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.76 99.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.9 -43.89 91.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.95 82.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.37 99.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -66.21 -35.56 80.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.807 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -64.44 -29.59 70.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.58 -19.0 19.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.01 25.18 38.4 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -84.68 -19.53 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.955 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -128.19 144.52 51.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.44 -35.29 14.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.517 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.2 mtm -142.29 160.6 39.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.933 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.0 t -150.46 160.31 43.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.21 118.92 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 65.0 m-80 -151.94 160.33 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 -173.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -107.34 -135.58 7.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.418 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.674 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 25.4 Cg_endo -68.0 -28.13 35.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 -175.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -67.38 -15.08 63.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.892 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -88.7 21.26 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -62.57 -31.36 72.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.0 t -63.72 106.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.816 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -149.13 130.01 14.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.8 mt -91.08 80.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -84.96 73.71 10.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.9 p -120.25 -12.38 9.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.9 p -110.1 -170.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.22 172.86 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.14 104.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -105.08 -59.35 1.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.02 153.85 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.41 159.54 23.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.73 128.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.999 0.428 . . . . 0.0 111.102 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.01 174.71 10.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.178 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.04 159.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.21 146.09 96.59 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.44 160.23 50.61 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.734 2.289 . . . . 0.0 112.313 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.0 p -104.52 151.54 23.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.023 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.405 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 46.7 t80 -130.78 116.08 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 55.53 33.88 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.75 68.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.518 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -126.25 148.88 65.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.36 144.25 79.5 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -74.08 -57.0 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -172.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.437 ' HG3' ' HD3' ' A' ' 159' ' ' PRO . 10.0 tmtt? -150.1 111.18 3.28 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.519 0.676 . . . . 0.0 110.974 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.96 127.62 11.6 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.784 2.323 . . . . 0.0 112.299 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.407 ' CE2' ' SD ' ' A' ' 330' ' ' MET . 31.0 t80 -158.91 119.44 3.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 -178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.43 130.89 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 167.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.05 135.09 12.05 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.455 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -124.86 128.47 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.141 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 68.3 tp -73.18 135.01 44.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -133.87 160.68 36.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.803 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.94 136.81 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.058 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -113.13 148.95 18.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.477 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 93.5 mt -108.71 124.88 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 270' ' ' SER . 45.1 t-20 -51.6 120.14 4.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -174.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.72 -22.59 66.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.5 -8.93 58.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.193 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 29.4 t -71.41 129.19 89.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.74 0.781 . . . . 0.0 110.786 -171.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.438 ' HD2' HG21 ' A' ' 2' ' ' ILE . 90.6 Cg_endo -71.59 -14.86 30.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.646 2.231 . . . . 0.0 112.267 170.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -107.79 29.14 7.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.929 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.23 -33.62 67.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.39 -38.96 92.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.832 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.88 -41.62 82.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 174.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.35 69.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.042 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -71.13 -38.62 72.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 96.4 mt-10 -72.19 -48.28 44.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 -173.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -62.73 -40.41 97.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.427 ' O ' ' HB3' ' A' ' 284' ' ' LEU . 2.8 tt -60.68 -48.4 81.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 -177.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -83.57 -31.13 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.0 m-20 -97.99 -22.15 16.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -166.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.466 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 m-85 -121.37 -51.82 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 58.9 tp -70.64 -46.87 62.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.912 -176.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 106' ' ' TYR . 92.2 mt -87.05 63.54 7.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.6 p -135.23 169.39 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 172.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.72 -44.35 77.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.14 -44.3 22.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.952 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -70.95 -47.11 40.48 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -170.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.82 -35.41 78.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -62.05 -40.01 94.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 23' ' ' VAL . . . -64.93 -38.56 91.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -174.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.0 p -80.75 -33.71 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.126 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -72.23 -31.74 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -172.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -59.54 -22.5 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.15 -10.16 34.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.38 152.03 75.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.47 -61.58 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.559 2.173 . . . . 0.0 112.385 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.95 -43.2 18.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.939 0.4 . . . . 0.0 110.922 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.75 14.86 79.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.551 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -84.39 127.63 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.047 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.54 160.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.134 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.4 -10.32 59.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.185 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 52.8 tp -74.22 121.13 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.37 -49.05 77.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -171.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.6 m -60.76 -43.41 98.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.884 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -70.12 -35.67 74.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.834 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.03 -31.12 72.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.808 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.85 -39.19 90.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.05 -37.68 61.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.819 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.423 ' HB3' HG21 ' A' ' 317' ' ' ILE . 90.9 mt -65.06 -27.47 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.26 -15.62 57.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.59 -21.05 61.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.843 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -86.58 120.73 72.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 110.807 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.87 -27.78 80.6 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.631 2.221 . . . . 0.0 112.383 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -70.03 -39.67 75.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 311' ' ' LEU . 47.4 mm -77.27 -36.37 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.242 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.11 76.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.243 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.38 -41.42 89.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -64.14 -47.16 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.198 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.5 tpt -66.89 -36.99 83.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -61.96 -43.27 99.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.888 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -74.97 -36.42 62.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.58 93.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -69.72 -18.99 63.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -109.51 -6.56 15.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.912 -172.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.52 36.57 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.43 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -126.38 139.26 53.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 110.813 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.561 HG13 ' HD2' ' A' ' 331' ' ' PRO . 2.2 tp -70.54 136.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.578 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 83.0 mmm -52.51 -52.57 62.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -172.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 64' ' ' HIS . 51.2 Cg_endo -66.86 82.29 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.757 2.305 . . . . 0.0 112.337 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.644 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 76.5 m-20 -107.15 29.63 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.7 mt 86.96 135.09 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.592 0.711 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -52.76 -31.81 52.8 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 0.0 112.259 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.406 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.9 mt-30 -61.46 -28.49 69.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.965 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.94 -37.06 86.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.17 -39.69 95.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -38.17 80.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.457 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.6 m-30 -65.75 -32.91 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.937 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -59.09 -40.08 84.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.984 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.99 -36.28 72.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.992 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.13 90.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.5 m -74.1 -25.38 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.696 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 75.0 ttt-85 -55.8 -40.56 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.0 m -60.79 -45.55 93.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.165 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.436 ' HB3' ' HB1' ' A' ' 364' ' ' ALA . . . -65.44 -43.52 90.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.38 -53.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 -170.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.97 -44.97 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 -173.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -63.64 -37.33 86.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.22 -46.62 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.58 -35.33 75.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.08 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -80.47 -10.83 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.841 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.95 13.2 81.65 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.496 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.36 -30.08 57.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.845 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -137.33 156.88 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.9 m -70.74 149.7 46.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.06 -49.3 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.67 -43.09 90.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.3 -47.07 65.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.59 96.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.414 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 59.6 tp -65.62 -44.8 85.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.08 -49.6 71.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.932 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.74 -38.39 83.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 346' ' ' ALA . . . -73.99 -42.74 59.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.06 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 9.5 mm100 -78.26 -27.65 47.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -173.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 51.6 m -58.27 -37.07 74.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.88 -29.6 70.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.08 -40.0 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 57.8 p -94.04 -12.76 27.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.061 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.704 0.287 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -76.38 135.1 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.163 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.19 173.63 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.53 122.5 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 23.81 39.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -145.92 154.87 42.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.3 pp -150.98 149.26 29.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 172.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 58' ' ' ASP . 97.2 t -125.63 129.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -115.32 130.46 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.576 ' HB3' HD23 ' A' ' 43' ' ' LEU . 22.6 m0 -114.6 129.82 56.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -152.67 155.24 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.406 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.2 t-20 -54.77 127.18 27.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 173.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.94 -18.34 80.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 -167.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -56.59 -50.88 70.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.857 -163.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -134.8 75.41 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 147.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -104.69 -37.56 2.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -78.18 -46.58 20.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.957 -157.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.7 -52.15 53.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.903 -153.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.46 -48.86 60.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.44 -41.59 98.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.891 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -49.05 69.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.26 -47.15 80.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.876 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -44.82 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.24 -36.48 90.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.399 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -65.48 -40.61 93.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.861 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.06 -39.87 91.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -65.27 -40.07 93.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -59.95 -35.84 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.77 -37.39 70.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.2 -40.37 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 -172.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.5 m -104.36 -18.13 14.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -172.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.29 86.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.471 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.789 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -88.46 128.18 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 111.197 177.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.28 129.6 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -172.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.5 t -110.23 136.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.6 m -133.9 112.62 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.3 t -106.52 124.02 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -129.89 152.55 49.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.428 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.7 p80 -134.38 74.05 67.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.615 0.721 . . . . 0.0 110.828 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 19.2 Cg_endo -71.13 -27.39 20.21 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.725 2.283 . . . . 0.0 112.297 -162.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 60.6 m-20 77.7 4.17 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.847 -172.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -98.04 -0.46 44.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' A' ' 10' ' ' TRP . 89.2 mt -48.91 -56.59 8.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.952 -152.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -65.06 -27.8 69.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.786 -165.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -85.3 -43.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -79.32 -45.0 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.964 -166.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.892 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 5.9 t80 -52.5 -53.59 51.84 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -163.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.892 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 72.7 Cg_exo -55.11 -38.87 93.27 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.659 2.24 . . . . 0.0 112.302 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.67 -46.76 35.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.969 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.73 -28.04 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.46 84.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 -24.58 67.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -96.37 5.79 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.76 74.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.466 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -116.99 -172.23 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.872 0.368 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.34 -173.8 26.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.581 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.62 159.74 28.4 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.643 2.229 . . . . 0.0 112.45 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' OD2' ' HB3' ' A' ' 276' ' ' ALA . 33.9 t70 -75.63 -38.87 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 171.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -131.99 139.83 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -136.37 136.29 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 264' ' ' ALA . 36.5 m-85 -103.36 135.39 45.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -141.35 155.9 45.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.926 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.23 -106.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.068 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.412 ' CG ' ' N ' ' A' ' 65' ' ' ASP . 12.6 p80 -109.79 -54.83 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 64' ' ' HIS . 38.9 t70 -62.37 -48.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -164.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -79.57 -36.34 38.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -58.58 -51.26 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.835 -168.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.37 -51.46 54.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.571 -171.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -40.85 92.15 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.44 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.41 ' HB3' HD23 ' A' ' 75' ' ' LEU . 10.5 m-30 -70.1 -30.38 67.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 0.0 110.994 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.451 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -64.03 -42.64 97.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.014 174.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -65.8 -28.06 68.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.923 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -85.17 2.76 42.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.74 36.1 86.75 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.522 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.41 HD23 ' HB3' ' A' ' 70' ' ' TYR . 1.4 mp -70.32 -23.83 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.24 144.71 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 -159.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.26 157.59 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.71 138.22 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.8 pt -107.81 151.03 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.2 p -128.54 69.4 79.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.555 0.693 . . . . 0.0 111.16 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.06 141.65 26.72 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.786 2.324 . . . . 0.0 112.214 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -79.27 169.59 17.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.95 -30.44 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.12 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.016 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -77.98 -35.82 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.858 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -61.64 -44.19 97.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.26 -28.32 65.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.812 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.836 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.401 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 71.0 mt -100.5 -113.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.872 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 22.4 t80 -158.92 133.08 5.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.992 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 86.1 Cg_exo -57.28 -41.0 77.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.745 2.297 . . . . 0.0 112.363 -173.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.22 -39.11 93.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.6 p -71.9 -24.84 61.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.187 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.438 ' HA ' HG23 ' A' ' 97' ' ' VAL . 60.9 m95 -71.16 -36.33 71.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.85 -28.68 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.55 -27.69 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 94' ' ' TRP . 36.0 m -110.97 10.95 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -100.22 130.05 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.973 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -129.3 120.47 25.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 58.53 35.13 24.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.46 5.01 90.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.88 145.62 47.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 110.975 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.68 125.8 34.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.464 ' HB ' HD13 ' A' ' 76' ' ' LEU . 40.9 pt -120.89 -6.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 -169.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.433 ' HB1' ' HB ' ' A' ' 97' ' ' VAL . . . -161.77 164.48 28.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 -172.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.1 m-85 -108.46 134.64 20.17 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.669 0.747 . . . . 0.0 110.962 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.3 Cg_exo -64.07 121.0 8.52 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.243 . . . . 0.0 112.321 171.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.98 -40.07 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.48 151.62 20.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.065 -166.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.9 t -129.67 129.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 46.1 mt-10 -128.52 153.08 47.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.93 157.04 41.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.3 tp -71.1 131.81 44.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.0 m -139.7 155.94 47.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.91 126.33 40.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 85.0 mt -108.5 127.41 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -137.48 154.71 49.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.9 t-20 -91.32 118.22 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.812 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.677 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -68.21 -29.58 68.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.906 -172.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.05 -38.56 44.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.408 HD23 ' HE2' ' A' ' 144' ' ' LYS . 93.8 mt -79.17 -35.31 42.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.95 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.2 tp -134.43 111.19 11.63 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.624 0.726 . . . . 0.0 111.006 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.594 ' O ' ' C ' ' A' ' 124' ' ' ASN . 84.2 Cg_endo -74.87 172.29 16.61 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 170.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.7 t30 22.5 96.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 110.959 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.21 156.4 65.88 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 144.98 60.44 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.744 2.296 . . . . 0.0 112.331 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.07 -29.45 15.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.8 p -126.04 158.8 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 -175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -68.75 -32.76 72.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.51 -26.45 54.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.828 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.16 -20.97 60.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.1 mm -58.86 -54.29 57.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.647 0.737 . . . . 0.0 111.129 -169.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 26.3 Cg_endo -65.15 -41.32 16.89 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.738 2.292 . . . . 0.0 112.399 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.65 93.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.02 -37.37 87.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.87 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.01 -40.15 94.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.31 -37.88 81.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 60.5 mt -70.38 -35.45 73.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.09 -32.29 64.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.998 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.45 66.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -104.29 4.79 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.83 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.49 26.42 67.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.498 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 82.4 mttt -113.16 156.44 23.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.6 t -113.4 148.8 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.817 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.22 38.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.2 mt -139.75 149.85 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.9 mmm -137.28 115.81 12.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.23 165.83 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.54 148.19 22.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 57.6 tp -107.01 -0.01 23.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -78.74 -11.17 59.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -138.45 145.44 46.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.561 0.696 . . . . 0.0 110.932 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.786 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.2 Cg_endo -68.04 -25.53 37.89 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.715 2.277 . . . . 0.0 112.286 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.03 -46.41 85.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.804 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.28 -26.04 58.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.806 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.5 p -82.39 -18.44 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.59 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -58.54 -45.55 99.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.432 0.634 . . . . 0.0 110.875 -169.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 79.2 Cg_exo -46.93 -38.66 23.88 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.627 2.218 . . . . 0.0 112.335 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.89 -41.06 26.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.443 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.7 mt -77.95 -47.57 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -68.58 -17.26 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -63.36 -33.12 74.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -99.14 -2.55 36.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.45 11.19 20.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.496 168.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -108.26 138.18 14.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.451 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.457 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 19.4 t80 -165.56 175.7 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -167.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.81 -59.74 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.221 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -142.42 150.1 40.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -85.95 133.12 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.827 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -108.34 114.28 28.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -147.47 140.08 24.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -170.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.58 41.01 9.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.03 6.64 68.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.516 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -137.32 152.75 50.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.99 133.8 36.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -107.97 109.14 20.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -174.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -67.52 -20.09 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.102 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -82.08 -16.6 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -168.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.49 87.24 2.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.515 HG21 ' H ' ' A' ' 184' ' ' ASP . 12.7 m -129.63 166.87 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.129 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -87.18 2.19 86.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.404 HG23 ' CG2' ' A' ' 181' ' ' VAL . 14.1 m -98.56 -16.77 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 111.097 175.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.515 ' H ' HG21 ' A' ' 181' ' ' VAL . 25.7 p30 -80.3 7.91 8.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 170.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 85.3 m-20 84.19 -7.05 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 161.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.55 -47.59 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.86 -46.55 22.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.457 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -71.54 -31.79 67.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.385 . . . . 0.0 111.096 -163.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.45 -44.35 94.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -160.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.69 97.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.443 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.04 -40.09 98.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.434 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.15 -41.02 90.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.7 m -62.46 -42.15 99.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.15 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.75 -40.44 88.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.45 -48.79 79.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.07 -39.6 86.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -41.11 98.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.6 OUTLIER -73.01 -32.12 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -177.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.78 -38.0 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 173.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.47 -34.82 78.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -85.91 -3.73 58.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 61.5 36.87 16.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.937 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -75.38 -17.45 60.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.69 156.15 47.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -101.71 134.18 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.792 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.14 -32.39 74.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.035 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.58 -5.72 45.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -164.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.1 m -61.74 130.72 47.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.184 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -135.87 -172.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.921 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.48 -47.47 79.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.924 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.7 m -63.65 -42.62 98.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.65 -44.93 93.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.0 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.66 -45.12 88.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.47 87.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.062 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.4 98.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -65.82 -38.69 89.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.828 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.39 -29.44 70.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.66 -19.82 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.86 21.4 50.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -77.41 -24.0 50.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.924 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -133.64 149.46 51.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.066 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.37 -20.82 20.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -138.06 154.9 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 -170.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -159.54 162.43 35.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.08 120.82 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 71.0 m-80 -145.92 158.61 43.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -176.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.427 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -95.54 -151.85 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.609 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 29.4 Cg_endo -65.2 -25.15 57.89 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.729 2.286 . . . . 0.0 112.291 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -66.0 -18.09 65.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -87.35 23.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -63.44 -29.98 71.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.1 t -66.41 107.78 2.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -149.31 129.98 14.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.45 81.18 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -84.68 72.86 10.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.4 p -114.54 -13.83 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.182 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.1 p -94.39 -169.94 2.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.61 175.74 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.852 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.31 107.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.121 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -120.42 -59.32 1.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 52.1 p90 -111.62 160.5 17.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.677 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -148.86 167.13 29.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.7 134.17 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 111.1 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -136.99 174.86 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 -171.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -79.74 161.48 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.62 142.83 86.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.508 0.671 . . . . 0.0 110.907 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.14 166.49 27.9 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.65 2.233 . . . . 0.0 112.253 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 66.8 p -118.74 150.74 39.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -128.18 115.25 18.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.81 35.13 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.29 21.14 46.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.553 173.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.8 144.78 53.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.582 0.706 . . . . 0.0 111.021 -172.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.43 141.97 70.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.626 2.217 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.7 t -68.8 -58.88 3.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.749 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 158' ' ' TRP . 5.5 tmtt? -150.8 110.59 3.12 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 0.0 110.916 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.39 122.5 7.05 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.684 2.256 . . . . 0.0 112.474 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -163.89 113.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.2 p -141.67 135.87 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.664 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -117.93 140.11 15.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.92 125.14 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.205 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 61.6 tp -73.37 137.25 44.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.7 m -123.88 141.56 51.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.401 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . . . -119.87 128.02 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 173.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.34 158.2 15.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.1 127.13 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.889 0.376 . . . . 0.0 111.15 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -56.98 120.63 8.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.85 -26.13 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.04 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.72 -11.45 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.1 t -70.77 130.1 89.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 110.748 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.08 -13.11 37.23 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -110.12 27.06 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -55.19 -33.91 63.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -67.94 -37.93 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.851 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.01 -42.42 94.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.437 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . . . -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -174.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -63.32 -45.63 90.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.25 -54.16 23.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -36.37 71.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -171.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 284' ' ' LEU . 64.6 tp -58.98 -47.74 84.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 176.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -75.26 -35.0 61.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -98.28 -9.16 25.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -164.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.829 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 80.2 m-85 -127.59 -55.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 177.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 280' ' ' LEU . 51.3 mt -76.76 -28.88 55.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -170.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.7 mm? -108.1 51.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.7 p -132.49 168.47 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -56.16 -46.05 79.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.15 -42.71 45.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.829 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.39 -50.77 6.44 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -171.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.77 -40.11 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.738 0.304 . . . . 0.0 110.899 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.24 -42.6 99.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.855 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.5 -32.57 74.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.2 t -71.04 -36.82 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.096 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -70.53 -12.75 61.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.838 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.09 -24.31 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -97.83 -7.67 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -87.18 145.15 37.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 110.96 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.47 -62.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.528 2.152 . . . . 0.0 112.369 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.17 -47.98 39.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.95 -170.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 88.23 -5.67 84.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.615 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.406 ' HB2' ' SD ' ' A' ' 321' ' ' MET . . . -71.62 119.68 16.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 111.091 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.15 160.3 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -171.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.43 -12.46 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 172.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.8 tp -73.37 118.32 16.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.38 -44.6 90.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 74.6 m -59.32 -44.66 92.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.03 -34.52 68.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -60.54 -36.72 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -75.71 -38.31 58.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.05 -28.7 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.91 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.62 -12.32 52.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.073 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.23 -19.93 55.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -88.75 118.45 69.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.599 0.714 . . . . 0.0 110.795 173.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.43 -35.35 65.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.717 2.278 . . . . 0.0 112.328 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -72.81 -44.26 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.77 -41.04 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.99 73.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.0 84.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 51.6 m -66.35 -41.92 88.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.406 ' SD ' ' HB2' ' A' ' 301' ' ' ALA . 97.7 mmm -67.53 -35.38 78.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.39 -36.11 82.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -68.2 -38.05 81.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.819 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.28 90.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -66.88 -16.39 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.92 -6.9 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.36 -165.13 36.24 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.361 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -129.97 143.41 50.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.902 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.593 HG13 ' HD2' ' A' ' 331' ' ' PRO . 5.0 tp -67.28 134.34 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.215 -168.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.664 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 59.4 mtt -51.96 -55.69 28.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.593 ' HD2' HG13 ' A' ' 329' ' ' ILE . 34.4 Cg_endo -62.64 86.53 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.774 2.316 . . . . 0.0 112.309 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.647 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 70.1 m-80 -107.88 22.97 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 46.0 mm 89.05 134.83 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.724 0.774 . . . . 0.0 111.02 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.65 -30.58 66.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.692 2.262 . . . . 0.0 112.252 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -59.96 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.907 -176.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.0 mmm -70.11 -24.66 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.86 -40.7 97.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.45 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -65.54 -33.79 76.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.66 -43.84 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.947 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -67.74 -34.98 77.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.4 82.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.171 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 29.4 m -75.65 -27.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.199 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.786 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 80.6 ttt180 -57.45 -41.88 81.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.809 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.6 m -63.4 -45.86 89.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.441 ' HB3' ' CB ' ' A' ' 364' ' ' ALA . . . -61.92 -43.85 97.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.39 -50.74 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.152 -174.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.96 -45.53 90.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.027 -175.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.76 -35.79 82.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.57 61.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.52 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -76.04 -13.52 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.27 7.45 87.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.34 -30.11 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 0.0 110.959 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -136.2 154.92 50.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.5 m -67.94 150.98 47.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.83 -47.97 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.177 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.42 -40.64 89.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.38 -46.13 64.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.87 85.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.457 HD11 ' HB1' ' A' ' 188' ' ' ALA . 62.0 tp -62.71 -46.91 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 110.959 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -48.7 69.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.04 -37.24 81.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.441 ' CB ' ' HB3' ' A' ' 346' ' ' ALA . . . -80.39 -43.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -78.49 -31.85 47.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.81 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.9 m -59.08 -37.8 77.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.18 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.42 -29.07 68.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.88 -44.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.03 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.1 p -97.46 -6.34 34.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.191 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -178.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.759 0.314 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.4 mt -81.75 123.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.33 166.75 20.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.985 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.0 131.49 45.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.96 17.49 56.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.24 163.53 35.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.831 0.348 . . . . 0.0 110.92 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.513 HD23 HD12 ' A' ' 33' ' ' ILE . 1.8 pt? -145.65 153.93 41.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.14 127.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.66 ' HB3' HD23 ' A' ' 43' ' ' LEU . 26.8 m0 -110.08 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.5 tt -150.13 153.72 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -55.9 134.01 51.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.39 -16.21 75.42 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 -171.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.92 -43.16 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 -168.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.82 80.79 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 149.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.8 -52.56 1.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.496 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.07 -48.9 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -156.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.86 -53.16 51.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.84 -151.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.744 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -67.77 -49.89 45.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.465 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.65 -41.32 98.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.855 0.36 . . . . 0.0 110.996 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.7 73.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.56 -46.84 77.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.07 -45.81 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.082 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.423 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -62.77 -34.19 89.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.26 -45.82 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.861 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.82 -45.1 94.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -66.64 -37.86 85.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -60.56 -34.78 74.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.753 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.37 -38.88 74.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.03 -40.57 24.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -172.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -107.5 -15.35 14.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -171.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.03 1.2 88.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.418 168.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.794 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -85.99 127.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.931 0.396 . . . . 0.0 111.185 176.145 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.53 129.99 38.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.8 t -108.19 129.07 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.18 177.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.84 115.88 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.59 124.98 66.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -126.83 143.22 51.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.41 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 28.0 p80 -139.94 65.34 30.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 46.5 Cg_endo -72.18 -21.68 23.29 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.794 2.33 . . . . 0.0 112.247 -174.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 69.6 m-20 67.02 14.32 9.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 -172.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.63 -1.82 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' A' ' 10' ' ' TRP . 60.3 mt -52.33 -49.1 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 -152.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -65.84 -27.64 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.808 -169.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.39 -42.85 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -76.96 -40.19 47.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.632 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 47.1 t80 -51.39 -57.81 12.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.729 . . . . 0.0 110.839 -169.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.632 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.2 Cg_endo -60.93 -29.68 88.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.241 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.18 -47.03 30.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 33.4 m -75.0 -29.6 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.87 87.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.13 -23.94 66.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.3 p -96.05 5.33 51.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -174.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.97 67.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.538 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.7 t0 -120.0 -174.17 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.933 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.97 -170.9 13.59 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.25 162.99 19.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.35 -40.87 16.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 169.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.54 142.78 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -171.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -122.22 131.36 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -112.31 122.37 47.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CZ2' HD12 ' A' ' 43' ' ' LEU . 95.1 m95 -148.48 156.7 42.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 168.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -81.96 -103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.029 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -112.07 -54.98 2.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.75 -50.19 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 -168.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.21 -31.56 69.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.944 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -60.71 -48.17 83.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -50.41 63.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.533 -172.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.14 98.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -70.91 -29.83 66.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 110.933 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.48 98.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.083 173.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.92 -26.37 65.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.895 173.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -84.89 1.86 45.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.02 36.67 51.33 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.515 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.415 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 mp -81.16 -10.06 59.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.582 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -132.98 144.45 50.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -178.09 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.47 162.96 12.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.49 134.66 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -112.39 153.27 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.3 p -132.16 65.43 75.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 111.194 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.16 148.21 43.93 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.383 171.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -77.57 -179.82 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.49 -31.43 72.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.36 -38.49 77.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.991 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.09 -38.74 86.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.57 -43.39 97.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -71.06 -31.28 67.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.66 -30.55 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.411 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.8 mp -108.77 -92.7 0.42 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -175.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 29.6 t80 -167.19 133.05 1.74 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.997 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 99.1 Cg_exo -54.05 -40.17 82.49 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.745 2.297 . . . . 0.0 112.336 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 92' ' ' PHE . 1.3 t80 -65.27 -39.44 92.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 p -70.9 -26.74 63.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.411 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 79.1 m95 -79.75 -32.59 41.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 174.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.43 -29.67 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 169.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.78 67.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.068 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.406 HG23 ' HA ' ' A' ' 94' ' ' TRP . 28.6 m -109.29 15.79 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 178.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -98.93 133.62 42.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.917 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -136.29 125.42 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 58.43 34.5 24.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.82 2.29 90.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.507 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.45 144.84 49.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.73 132.01 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.6 pt -118.37 -8.61 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.053 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.007 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.495 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.5 m-85 -106.53 132.62 20.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.668 0.746 . . . . 0.0 110.913 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 10.1 Cg_exo -72.85 132.71 18.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.746 2.297 . . . . 0.0 112.323 173.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.79 -50.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.151 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.15 151.62 33.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 -163.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.87 132.63 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.839 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 98.1 mt-10 -129.46 150.55 50.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.93 155.06 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -71.34 141.42 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -145.24 163.73 33.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.519 HD23 ' HD3' ' A' ' 248' ' ' PRO . 45.9 tp -96.57 127.55 42.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.5 mt -113.68 125.77 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -133.49 157.07 46.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.8 t-20 -94.67 118.14 31.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -65.72 -35.33 80.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -173.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.54 -35.43 58.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.56 -45.19 17.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 223' ' ' ALA . 64.8 tp -126.62 108.62 23.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.709 . . . . 0.0 110.926 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 124' ' ' ASN . 98.7 Cg_endo -75.52 164.91 31.56 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.329 173.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.552 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.5 t30 24.96 96.3 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.56 155.4 70.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.721 2.281 . . . . 0.0 112.356 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.28 150.36 64.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.593 2.195 . . . . 0.0 112.357 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.11 -21.16 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.923 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.9 p -129.22 159.48 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.699 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 85.0 m95 -73.21 -24.66 60.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.965 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.46 -25.09 64.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.79 -20.02 50.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.687 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.2 mm -58.85 -55.43 46.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.626 0.727 . . . . 0.0 111.15 -168.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.687 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.0 Cg_endo -74.24 -37.34 2.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.45 95.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.01 -39.49 93.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 173.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.91 -37.48 87.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.54 -42.8 99.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.79 -36.29 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.764 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.607 HD12 ' HB3' ' A' ' 146' ' ' ALA . 71.6 mt -70.06 -30.93 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.39 -33.69 63.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.71 -25.03 67.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -102.55 2.82 36.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.7 30.77 61.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 89.1 mttt -116.61 162.63 17.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.508 ' H ' ' HA ' ' A' ' 222' ' ' THR . 44.7 t -120.98 146.91 46.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.607 ' HB3' HD12 ' A' ' 139' ' ' LEU . . . -82.7 -25.63 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.126 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 tp -137.79 136.27 37.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 -173.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 91.6 mmm -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -161.61 161.16 29.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.893 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -86.28 133.41 33.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 41.1 tp -103.38 4.31 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -74.39 -13.1 60.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.95 146.91 63.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 0.0 110.929 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.572 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 42.4 Cg_endo -67.77 -24.93 40.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.571 2.18 . . . . 0.0 112.331 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -49.96 -42.08 48.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -80.33 -23.31 40.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -170.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.9 p -79.27 -23.22 43.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.594 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 49.1 m0 -57.26 -45.72 99.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.533 0.682 . . . . 0.0 110.932 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 91.3 Cg_exo -50.9 -37.34 55.63 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 2.229 . . . . 0.0 112.306 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.17 -40.28 24.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.462 HD12 ' CG2' ' A' ' 347' ' ' VAL . 96.7 mt -73.44 -50.01 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -72.17 -14.96 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.048 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -61.68 -31.76 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.047 -174.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -102.28 1.77 36.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.47 1.58 40.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -86.84 136.61 14.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.363 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.479 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 21.3 t80 -169.95 176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.931 0.395 . . . . 0.0 110.978 -176.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.91 83.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -139.83 153.22 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.18 130.59 35.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.815 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -100.21 115.64 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -148.63 140.11 23.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.93 37.4 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.902 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.13 82.32 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -136.34 151.2 49.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.846 0.355 . . . . 0.0 110.958 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.48 131.71 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 171.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -94.28 109.71 21.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.49 -20.79 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.37 -10.35 46.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -130.21 95.5 3.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 174.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 183' ' ' VAL . 35.0 m -109.47 159.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -173.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -95.86 -2.24 61.26 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 167.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 181' ' ' VAL . 8.0 m -85.96 -5.94 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 54.6 p30 -76.18 10.66 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 171.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 81.8 m-20 84.55 -4.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 168.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.38 -51.98 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.34 -50.2 7.64 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.13 73.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.61 -40.49 97.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -173.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.14 96.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.67 96.46 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.435 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.456 HD11 HD13 ' A' ' 361' ' ' LEU . 78.8 mt -65.36 -34.93 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.927 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.4 m -56.36 -51.91 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -172.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -68.16 -44.95 74.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.511 ' C ' HD21 ' A' ' 195' ' ' LEU . 8.9 tt -59.83 -50.82 72.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.809 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.32 -37.86 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.132 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.16 -36.83 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.818 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -36.07 83.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.67 -39.84 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.87 -39.81 94.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -84.34 5.41 27.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.1 32.17 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -87.86 -22.92 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -139.58 145.21 38.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.53 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 54.1 t-20 -94.67 134.72 36.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 176.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.09 -25.18 64.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.074 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -95.69 -15.16 22.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.732 -171.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.53 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 55.2 m -64.79 137.69 57.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.25 176.67 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.902 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -65.07 -29.64 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.2 m -64.73 -42.95 94.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.906 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.83 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.201 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.86 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.068 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.95 -43.99 90.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.798 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.77 77.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.086 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.0 97.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -64.0 -35.79 81.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 0.0 110.927 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.68 -28.88 69.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.55 -18.99 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.22 47.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.477 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.83 -19.72 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 110.91 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.508 ' HA ' ' H ' ' A' ' 145' ' ' SER . 15.2 t -130.7 144.5 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 122' ' ' LEU . . . -94.46 -35.01 12.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 56.2 ttp -145.55 153.81 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -154.48 168.09 27.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.5 tt -126.3 123.45 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.066 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.52 162.44 41.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.22 -165.9 37.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.549 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.839 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 35.7 Cg_endo -66.39 -21.52 53.72 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -65.96 -18.12 65.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.46 5.63 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -62.72 -40.11 96.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.5 t -55.65 109.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -150.17 159.86 44.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.832 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.22 80.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.03 75.09 10.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.976 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.4 p -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.183 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 76.6 p -104.19 -174.8 2.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.27 176.89 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.884 172.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.09 104.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -113.3 -54.56 2.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 50.8 p90 -114.09 159.31 20.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.62 165.04 27.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.463 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 85.7 t -132.34 135.15 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.092 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.41 -179.84 6.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.6 160.49 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.089 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.14 139.27 90.03 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.543 0.687 . . . . 0.0 110.915 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.519 ' HD3' HD23 ' A' ' 115' ' ' LEU . 59.1 Cg_endo -75.1 167.09 27.72 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.359 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.8 p -106.7 158.45 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -132.01 118.93 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.829 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 55.16 34.92 23.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.6 6.24 87.53 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -119.77 150.34 50.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 110.862 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.93 149.72 89.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.626 2.217 . . . . 0.0 112.38 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.699 ' HB3' ' HE1' ' A' ' 129' ' ' TRP . 87.8 p -67.37 -62.23 1.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.409 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 14.2 tmtt? -170.75 127.25 0.69 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.508 0.671 . . . . 0.0 110.818 173.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.405 ' HB2' ' HG2' ' A' ' 328' ' ' GLU . 64.8 Cg_endo -76.04 132.69 14.31 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.328 -176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -157.16 124.24 5.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.95 133.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 167.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.35 135.23 12.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.538 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.76 129.93 75.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.771 0.319 . . . . 0.0 111.158 -174.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 55.8 tp -74.99 132.34 41.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.9 m -130.4 145.42 51.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.04 51.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.04 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -123.54 170.15 15.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -112.77 129.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.294 . . . . 0.0 111.178 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -59.0 120.87 9.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.3 -25.14 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.94 -9.83 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.218 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.0 t -71.04 131.31 87.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.75 -15.03 43.47 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.377 172.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -109.09 21.86 16.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.51 -35.74 21.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.41 -35.07 70.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.83 -41.38 91.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.31 83.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.134 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -64.83 -34.49 78.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.936 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.62 -47.86 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.435 ' HE2' HG13 ' A' ' 33' ' ' ILE . 15.2 m-30 -65.41 -49.29 69.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.605 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.6 tt -57.05 -48.81 77.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -170.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -77.5 -22.63 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.828 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -101.96 -8.16 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -112.68 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 45.3 tp -73.49 -45.54 53.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -168.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.6 60.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.2 p -132.94 160.57 36.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -59.41 -44.93 92.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -71.47 -46.2 60.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.07 -45.45 41.02 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.42 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 302' ' ' VAL . 28.4 tp -71.33 -37.72 71.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.973 -173.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.9 -40.75 95.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.56 99.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.744 HG21 ' HA3' ' A' ' 19' ' ' GLY . 15.0 p -76.48 -29.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -65.06 -24.32 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.11 -24.02 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -91.64 -13.0 32.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -78.68 155.54 78.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.708 . . . . 0.0 110.88 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.88 -95.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.608 2.205 . . . . 0.0 112.43 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -66.09 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.13 25.1 71.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 168.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.448 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -81.77 132.11 35.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.058 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 307' ' ' TYR . 29.4 m -124.28 160.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.06 -12.67 59.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.013 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 59.5 tp -74.26 120.27 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.903 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.62 -45.75 91.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.3 m -60.6 -42.43 96.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.72 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.536 ' HB3' HG22 ' A' ' 302' ' ' VAL . 1.0 OUTLIER -71.81 -32.49 67.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.091 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -61.93 -32.02 72.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.01 -38.3 82.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -75.17 -38.28 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 301' ' ' ALA . 94.1 mt -65.13 -27.58 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.85 -16.64 43.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.109 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -71.79 -22.63 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 63.7 t0 -90.33 117.44 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.822 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 37.0 Cg_endo -61.54 -25.32 79.33 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.418 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.3 mtm-85 -70.36 -39.72 74.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 51.1 mm -79.98 -39.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.255 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.116 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.63 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.9 p -73.45 -35.83 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.2 mtm -68.06 -38.72 82.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -65.27 -42.65 92.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -71.79 -35.33 69.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.32 91.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.25 -19.07 65.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -108.37 -4.93 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.67 -167.09 42.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.532 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.405 ' HG2' ' HB2' ' A' ' 257' ' ' PRO . 73.1 mm-40 -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.773 0.321 . . . . 0.0 110.948 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 329' ' ' ILE . 2.8 tp -66.35 124.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 -169.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.599 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -46.44 -52.22 30.84 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.847 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 330' ' ' MET . 38.9 Cg_endo -63.99 85.54 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.768 2.312 . . . . 0.0 112.349 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.697 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 72.0 m-80 -108.74 30.52 6.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.697 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 71.4 mt 93.56 131.07 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.71 0.767 . . . . 0.0 111.06 -169.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.18 -25.58 50.31 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.768 2.312 . . . . 0.0 112.308 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.415 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.4 mt-30 -60.7 -24.64 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 176.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.7 mmm -63.8 -30.89 71.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.8 m -62.93 -43.08 99.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.12 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -60.57 -38.97 86.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -64.43 -38.28 90.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.177 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.39 -42.97 94.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.144 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.572 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 55.7 ttp180 -55.3 -43.81 75.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.4 m -59.91 -42.93 94.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.16 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.78 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.462 ' CG2' HD12 ' A' ' 161' ' ' ILE . 54.4 t -67.05 -52.36 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.67 -45.18 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -171.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.58 -37.86 89.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.32 -44.24 68.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.79 74.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.8 p -76.05 -12.58 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.32 8.24 87.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.482 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -78.26 -25.7 46.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.917 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -135.12 155.99 49.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 90.9 m -71.88 151.5 43.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.21 -48.8 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.63 -42.34 86.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.21 -46.51 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.882 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.0 95.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.154 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 55.7 tp -66.08 -43.05 88.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.63 -48.43 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.922 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.02 -37.01 84.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.904 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.02 -43.58 64.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 7.6 mm-40 -77.16 -26.94 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.2 m -56.1 -35.64 67.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.161 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.95 -30.17 70.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.46 -41.92 89.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.3 p -94.04 -15.08 25.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.226 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.764 0.316 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.8 mt -85.74 125.97 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -136.62 176.92 8.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -171.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.95 132.06 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.96 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.79 59.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.64 159.97 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.886 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.878 HD12 ' O ' ' A' ' 7' ' ' LEU . 2.9 pp -147.15 149.51 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 177.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 99.5 t -120.58 127.6 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.185 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.602 HG22 ' HB ' ' A' ' 59' ' ' ILE . 3.3 pt -121.8 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.169 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.457 ' HB3' HD23 ' A' ' 43' ' ' LEU . 26.7 m0 -114.8 132.34 56.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.419 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.4 tt -149.23 153.71 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 -172.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.434 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.9 t-20 -55.87 128.54 35.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.66 -19.44 79.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.472 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.93 -46.4 90.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.904 -163.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.98 66.57 1.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.838 150.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -99.55 -46.15 2.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.552 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.402 ' HA ' HG11 ' A' ' 37' ' ' VAL . 80.7 t80 -69.95 -43.35 71.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.983 -159.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -65.63 -49.95 66.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 -160.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.66 -50.45 58.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.469 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 20' ' ' LEU . 53.7 mt -64.87 -37.24 86.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.12 -48.81 61.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -68.03 -45.77 73.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 p -69.85 -35.61 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.107 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.53 84.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.15 -46.32 89.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.32 -38.42 87.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -61.92 -35.66 79.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.782 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.39 -38.71 68.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.1 -41.05 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -171.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.0 p -105.57 -17.89 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.207 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.58 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.479 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.436 HG23 ' O ' ' A' ' 33' ' ' ILE . 19.5 tt -82.91 127.39 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.21 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -67.17 124.48 23.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.73 130.94 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.162 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.3 m -123.16 113.76 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.458 HG23 HD12 ' A' ' 9' ' ' ILE . 58.4 t -100.78 122.02 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.063 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.7 mt-10 -129.49 139.3 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -140.02 68.86 35.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 0.0 110.86 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 36.8 Cg_endo -75.7 -15.62 19.15 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.396 -165.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.8 m-20 73.13 8.34 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -171.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.75 -4.85 54.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.873 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 10' ' ' TRP . 81.5 mt -51.74 -50.01 61.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -156.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.01 -35.3 78.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -88.05 -40.34 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -73.91 -45.26 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -167.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.686 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.9 t80 -51.69 -58.43 11.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.642 0.734 . . . . 0.0 110.834 -166.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.686 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 19.9 Cg_endo -63.9 -31.04 67.68 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.754 2.303 . . . . 0.0 112.274 -173.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -75.35 -47.25 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.2 m -76.24 -26.05 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.171 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.35 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.044 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.99 -24.47 66.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.053 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.7 p -95.09 4.51 53.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 22.72 61.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.518 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.8 t0 -119.52 -176.12 3.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.31 -170.3 15.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.503 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.403 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 92.5 Cg_endo -82.37 158.96 17.28 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.81 -42.28 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 167.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.602 ' HB ' HG22 ' A' ' 9' ' ' ILE . 88.1 mt -133.23 139.53 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 tp -128.8 132.44 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.221 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -101.3 135.93 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -139.88 153.61 47.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.2 -102.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -122.27 -54.66 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.9 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -67.13 -46.08 75.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -73.26 -32.34 64.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.83 -47.31 85.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.859 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.17 -50.3 61.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.576 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.21 -41.98 99.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.532 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -70.05 -31.27 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.89 99.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 174.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.93 -26.28 64.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -85.02 2.1 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 37.1 61.37 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.554 173.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -80.33 -8.8 59.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 110.883 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -132.24 144.17 50.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 157.83 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 139.09 52.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.29 156.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.075 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -134.34 62.62 56.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.532 0.682 . . . . 0.0 111.161 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.01 149.93 42.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.745 2.297 . . . . 0.0 112.257 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -77.27 176.45 8.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.08 -29.92 67.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.98 69.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.07 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -63.21 -37.05 85.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HA ' ' CD1' ' A' ' 94' ' ' TRP . 90.1 mt-30 -65.39 -39.97 92.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 177.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.81 -35.85 79.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.24 -29.31 66.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.423 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.2 mp -104.71 -106.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 23.0 t80 -162.89 133.96 3.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.67 0.748 . . . . 0.0 110.952 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.4 Cg_exo -56.21 -42.96 60.76 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.297 -174.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.14 -40.53 94.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 p -71.44 -25.64 62.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.423 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 54.5 m95 -80.13 -29.33 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 173.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -62.67 -30.11 71.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.827 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.71 -25.22 66.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.52 21.95 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.131 -174.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -109.94 139.58 44.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -141.54 126.85 18.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.65 34.46 22.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.888 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.45 90.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 173.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.16 144.82 50.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.85 130.73 35.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.401 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.7 pt -118.12 -12.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -169.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.28 165.33 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.036 -170.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.461 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.2 m-85 -109.83 134.31 20.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.663 0.745 . . . . 0.0 110.927 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.4 Cg_exo -66.31 126.8 16.25 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.318 173.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -111.61 -40.29 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.95 155.83 23.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.056 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.23 131.97 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -128.91 144.7 51.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.12 155.08 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.86 138.47 44.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.948 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -147.86 163.93 35.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.88 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.31 129.84 42.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.6 mt -107.09 128.02 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -136.23 148.19 47.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -90.72 117.08 29.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.597 ' HE2' ' HA3' ' A' ' 243' ' ' GLY . 66.9 mttm -70.83 -30.61 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -171.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -76.85 -36.32 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -77.32 -38.71 49.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.5 tp -136.53 111.86 9.86 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.897 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 124' ' ' ASN . 87.8 Cg_endo -74.98 169.3 22.94 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.659 2.239 . . . . 0.0 112.35 170.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.2 t30 25.22 96.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 110.961 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 55.5 Cg_endo -68.03 158.99 54.99 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.72 147.58 69.81 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.4 -29.7 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.871 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.6 p -127.94 159.6 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -68.56 -33.4 74.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.5 -29.78 64.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.813 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.57 -21.19 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 28.5 mm -60.93 -51.5 78.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.701 0.763 . . . . 0.0 111.09 -168.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 48.5 Cg_endo -70.35 -38.78 6.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.754 2.303 . . . . 0.0 112.324 -174.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.16 94.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.91 -36.91 83.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.73 -37.44 86.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.7 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.33 -37.3 83.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 146' ' ' ALA . 58.8 mt -69.32 -36.46 76.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.73 -35.1 70.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.22 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.3 3.1 46.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.0 29.47 60.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -123.49 163.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.489 ' H ' ' HA ' ' A' ' 222' ' ' THR . 35.4 t -118.54 150.48 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 171.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -81.06 -23.96 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.82 141.73 50.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 68.8 mmm -140.1 119.93 13.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 161.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -160.05 164.99 32.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.7 t-20 -84.2 110.7 18.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.878 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 206' ' ' ALA . 27.1 tp -98.37 5.63 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -174.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.75 -2.27 57.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 148.46 69.67 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.656 0.741 . . . . 0.0 110.804 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.772 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 56.6 Cg_endo -74.76 -22.48 15.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.613 2.208 . . . . 0.0 112.265 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -52.79 -43.9 66.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 150' ' ' ASN . 81.3 m-85 -83.51 -20.4 33.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.713 -172.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.2 p -81.88 -21.26 37.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 4.4 m95 -60.08 -45.5 97.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.431 0.634 . . . . 0.0 110.884 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 99.2 Cg_exo -45.71 -31.1 7.15 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.258 . . . . 0.0 112.339 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.569 ' C ' HD13 ' A' ' 160' ' ' LEU . 2.7 tm? -82.29 -45.17 15.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.647 HG23 ' HA3' ' A' ' 191' ' ' GLY . 92.1 mt -74.66 -44.06 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.493 ' HB3' ' CD1' ' A' ' 167' ' ' TYR . . . -69.77 -19.01 63.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -63.84 -29.64 70.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -102.91 0.19 32.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.6 15.12 9.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 165.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 161' ' ' ILE . . . -114.83 126.34 7.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.423 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.493 ' CD1' ' HB3' ' A' ' 162' ' ' ALA . 17.9 t80 -159.56 172.17 18.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 110.921 -171.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.11 65.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.89 149.38 43.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -82.78 139.47 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -97.55 104.2 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 170.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.96 122.75 11.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.74 36.43 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -172.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.09 82.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.21 151.6 50.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -97.94 141.58 30.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -103.61 117.34 34.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 170.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.14 -18.07 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.04 -10.25 55.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -128.91 75.5 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.917 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.495 HG21 ' H ' ' A' ' 184' ' ' ASP . 15.4 m -134.95 172.96 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.92 -11.97 75.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.562 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.6 m -91.84 -7.68 10.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 111.044 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 35.3 p30 -85.45 7.22 23.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 86.3 m-20 83.72 -8.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 165.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.53 10.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.09 -44.68 34.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.533 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.508 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -70.15 -32.68 70.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -166.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -62.89 -45.59 91.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.949 -164.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.94 95.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.647 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.38 -41.26 99.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.43 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.19 -44.26 88.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.037 0.446 . . . . 0.0 111.008 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.5 m -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.216 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.05 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.828 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.71 -40.31 94.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.33 -36.83 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.173 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.26 -36.33 82.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.38 -41.71 80.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.63 -35.5 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.95 -35.96 81.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -84.08 2.98 36.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 62.71 35.14 14.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.914 173.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -76.98 -25.73 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.963 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -147.46 149.38 32.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.526 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 53.1 t-20 -95.1 136.73 35.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.441 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -63.02 -26.84 69.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -175.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.21 -13.79 27.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.899 -172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.8 m -65.63 134.93 54.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 49.9 p30 -112.91 173.83 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -71.36 -25.56 62.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.01 -38.47 88.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.42 -32.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.179 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.76 72.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.047 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.59 -46.96 85.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.834 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.64 76.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.42 96.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -65.09 -35.97 82.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.04 -29.31 70.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.82 -20.67 16.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.16 25.42 31.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.405 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.42 -26.75 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.489 ' HA ' ' H ' ' A' ' 145' ' ' SER . 7.2 t -128.99 147.49 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.05 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.73 18.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 175.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.1 mtm -140.23 160.05 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -169.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -150.15 161.79 41.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -121.34 120.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -146.27 159.58 43.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.472 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -104.77 -137.46 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -175.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.472 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 31.6 Cg_endo -70.49 -26.24 24.35 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.692 2.261 . . . . 0.0 112.278 -175.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -66.49 -16.13 63.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.7 23.06 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -62.5 -30.65 71.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 t -69.19 107.16 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -144.88 127.85 16.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.928 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.43 80.33 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -85.29 74.22 10.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.832 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 75.5 p -119.89 -14.97 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.2 p -92.96 -170.05 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.39 175.29 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.935 170.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.71 107.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.192 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -118.48 -57.08 2.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -113.49 160.03 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.597 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . -146.76 166.4 28.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.438 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 96.2 t -130.12 134.75 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.72 177.14 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.93 159.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.5 144.94 98.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.561 0.696 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.95 158.37 56.94 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.681 2.254 . . . . 0.0 112.252 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.1 p -107.22 151.33 25.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -128.76 116.0 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 55.18 36.47 27.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.97 69.21 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -125.32 147.08 56.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 110.996 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.3 154.83 72.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 0.0 112.379 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -67.08 -58.44 4.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 110.914 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.405 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 32.4 pttt -169.91 141.89 1.88 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 0.0 110.864 168.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.65 129.04 11.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.417 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -163.12 112.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.09 135.05 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.25 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -114.45 119.08 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.749 0.309 . . . . 0.0 111.211 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.6 130.01 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.1 m -130.54 145.04 51.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -170.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.0 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.07 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -117.09 155.19 16.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.412 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.6 mt -104.49 126.75 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 111.164 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.98 120.06 8.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.91 67.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.075 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.69 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -72.48 131.06 85.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.738 0.78 . . . . 0.0 110.846 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.65 -12.8 33.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.214 . . . . 0.0 112.32 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.05 27.54 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.854 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -53.85 -34.42 59.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.39 -38.98 91.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.37 -41.01 90.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.816 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.0 79.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.126 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.86 -47.84 79.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 98.3 mt-10 -69.36 -53.04 21.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -175.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 8.5 m-30 -65.48 -39.6 92.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.83 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.1 tt -61.55 -48.07 82.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.978 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -83.06 -26.64 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 93.0 m-20 -100.56 -21.03 15.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -169.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 21.3 m-30 -118.69 -56.38 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.862 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 280' ' ' LEU . 38.4 mt -69.02 -37.1 78.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 106' ' ' TYR . 89.2 mt -94.84 60.99 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.1 p -127.75 168.82 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.17 171.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -53.24 -44.37 68.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.48 -42.12 30.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.33 -49.33 12.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.434 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 304' ' ' LEU . 25.0 tp -72.05 -35.5 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.938 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.97 -40.06 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.835 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.36 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.98 -35.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.157 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -77.27 -24.54 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.38 -27.29 68.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -88.01 -15.33 36.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.65 153.11 93.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 0.0 110.987 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.6 -55.95 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.573 2.182 . . . . 0.0 112.33 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -82.05 -46.62 13.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 84.98 -8.84 68.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.423 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -55.29 118.54 4.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.061 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.757 HG11 ' HB3' ' A' ' 307' ' ' TYR . 4.3 p -128.72 153.49 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 -170.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.42 -17.19 56.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.503 ' HB2' HD21 ' A' ' 290' ' ' LEU . 56.1 tp -70.86 124.91 25.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.06 -37.39 84.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -61.29 -51.0 70.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.757 ' HB3' HG11 ' A' ' 302' ' ' VAL . 1.6 t80 -73.73 -33.25 64.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.67 -38.29 89.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.56 -40.18 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -73.76 -37.77 64.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.802 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.414 ' HB3' HG21 ' A' ' 317' ' ' ILE . 84.3 mt -65.89 -28.23 68.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.66 -16.62 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.43 -21.77 60.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.885 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.4 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 67.7 t0 -90.17 119.55 69.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.796 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 32.0 Cg_endo -62.32 -25.44 76.51 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.427 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.4 mtm-85 -70.12 -40.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 311' ' ' LEU . 50.9 mm -79.64 -40.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -178.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.96 76.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.06 93.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.079 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 72.0 p -71.25 -36.52 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.13 -34.64 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -65.02 -40.86 95.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -72.03 -35.04 69.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.93 90.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -72.86 -14.37 61.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.818 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -107.72 -8.34 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.858 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.25 -158.37 34.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.483 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -127.11 140.1 52.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 329' ' ' ILE . 2.9 tp -68.24 120.24 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -47.95 -51.51 47.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.608 0.718 . . . . 0.0 110.878 -174.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 330' ' ' MET . 68.8 Cg_endo -69.23 79.53 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.423 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 53.5 t-20 -119.58 -3.08 10.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' A' ' 336' ' ' MET . 18.2 tt 164.97 124.9 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 111.114 -165.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.75 -29.35 12.8 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.587 2.191 . . . . 0.0 112.334 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -64.98 -17.76 64.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.914 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.492 ' HB2' HG23 ' A' ' 333' ' ' ILE . 61.4 ttp -62.97 -27.94 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -174.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -60.77 -41.73 96.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.6 71.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.134 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -65.6 -30.61 71.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -56.57 -41.2 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.17 -37.31 78.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.46 -43.57 85.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.93 -29.11 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.772 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 60.5 ttt180 -57.31 -44.96 84.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.0 m -62.21 -44.39 96.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.23 81.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.82 -50.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.0 mm -65.9 -45.43 91.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -66.21 -37.27 85.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.85 63.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.9 -35.04 76.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -80.71 -10.85 59.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.69 14.39 81.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.575 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -79.87 -26.6 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -137.0 156.22 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.006 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 98.9 m -68.6 145.86 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.1 -49.94 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.177 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.43 -40.84 85.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.52 -46.43 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.508 HD11 ' HB1' ' A' ' 188' ' ' ALA . 63.5 tp -64.16 -46.59 83.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.97 -48.31 71.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.58 -38.8 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -78.6 -46.39 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -78.97 -30.87 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -169.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -59.0 -36.06 74.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.88 -30.1 69.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.5 mt -67.89 -44.67 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.127 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.2 p -98.18 -11.23 22.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.057 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.762 0.315 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -89.76 135.1 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.166 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 91.7 mt-10 -129.73 165.03 22.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -71.31 122.04 19.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.12 20.09 50.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.542 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 34' ' ' LYS . 93.5 mttt -139.84 155.11 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.812 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.6 pp -149.15 148.75 30.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -123.16 125.35 71.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.48 HG12 ' HB ' ' A' ' 59' ' ' ILE . 53.2 mt -119.01 130.73 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.409 ' HB2' HD11 ' A' ' 60' ' ' ILE . 21.5 m0 -110.83 136.68 49.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 -173.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 tt -144.56 147.63 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -75.0 172.4 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.62 -19.97 15.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.507 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -79.4 51.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 110.857 174.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 17' ' ' TYR . 54.5 pttt -80.14 117.63 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.956 -159.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.65 10.03 1.64 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.543 154.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' H ' ' C ' ' A' ' 15' ' ' LYS . 23.1 t80 -39.99 -36.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -57.63 -47.12 83.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.819 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -72.63 -38.18 57.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.405 174.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -36.87 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.009 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.55 95.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.221 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -62.02 -45.87 91.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.0 m -75.08 -28.28 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.6 89.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.404 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.42 -40.71 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.82 -45.85 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.972 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.78 -43.27 93.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.46 -33.16 74.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -74.99 -40.37 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.003 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -78.78 -40.53 32.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -101.04 -25.15 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -172.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.58 6.46 87.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.752 HD11 HD13 ' A' ' 275' ' ' LEU . 96.6 mt -78.69 125.05 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 111.094 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 89.3 tttt -64.42 118.06 8.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 173.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.82 129.34 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -134.8 110.1 8.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.228 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' HB ' ' A' ' 9' ' ' ILE . 47.6 t -110.93 126.51 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.069 -176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -125.93 152.8 45.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -133.69 67.68 75.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.574 0.702 . . . . 0.0 110.892 172.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 30.8 Cg_endo -78.89 -15.38 13.29 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.612 2.208 . . . . 0.0 112.329 -164.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 64.3 m-20 77.28 10.97 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.22 -5.1 34.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -49.88 -60.06 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.929 -154.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.11 -34.82 77.06 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.52 -33.45 54.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -78.49 -30.17 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.805 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 8.6 m-30 -49.38 -52.15 51.84 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.586 0.707 . . . . 0.0 110.877 -168.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 60.9 Cg_endo -69.56 -27.57 27.28 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.642 2.228 . . . . 0.0 112.337 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.63 -49.98 12.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.17 -33.46 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.099 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.96 86.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.129 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.35 53.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.66 -1.21 50.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.195 -173.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.05 74.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.82 145.4 25.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.943 0.401 . . . . 0.0 110.863 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.49 82.19 0.22 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.428 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.24 124.19 12.22 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.71 2.274 . . . . 0.0 112.451 157.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.13 -42.64 23.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 -156.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.48 ' HB ' HG12 ' A' ' 9' ' ' ILE . 74.7 mt -130.07 133.19 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.096 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 10' ' ' TRP . 42.2 mm -125.01 127.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -172.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -132.93 115.64 15.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.519 ' O ' ' C ' ' A' ' 63' ' ' ALA . 26.2 p-90 -177.13 173.2 1.83 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 175.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 62' ' ' TRP . . . -25.71 96.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' TRP . 76.2 t60 -59.03 -32.37 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -172.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -51.65 -50.18 60.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.847 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -74.63 -26.64 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.04 -26.68 67.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.422 ' O ' ' HB1' ' A' ' 71' ' ' ALA . . . -64.91 -37.73 94.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.28 -35.45 84.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -72.06 -24.9 61.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 76' ' ' LEU . . . -59.73 -39.43 84.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 171.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.17 -28.64 68.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -84.96 4.16 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.98 32.4 69.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.563 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.3 tp -72.9 -24.37 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.748 0.308 . . . . 0.0 110.825 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -132.09 145.99 51.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -170.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -74.96 152.23 38.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -174.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.81 131.34 50.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.972 171.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.84 140.08 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.212 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.8 m -92.72 121.91 65.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 0.0 111.189 -174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -54.96 130.71 42.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.75 2.3 . . . . 0.0 112.343 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.46 118.32 35.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.01 -46.11 89.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.96 87.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.066 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.59 -39.95 95.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -58.06 -43.62 87.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.03 -33.0 74.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.22 -27.2 68.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 304' ' ' LEU . 5.9 mp -112.47 -125.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -129.78 148.05 67.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.671 0.748 . . . . 0.0 110.919 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.65 -30.32 60.21 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.683 2.255 . . . . 0.0 112.277 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -71.69 -35.65 70.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.4 p -71.81 -24.67 61.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.131 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -39.93 71.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 171.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.84 -34.53 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.87 74.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.033 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.799 HG22 ' HD3' ' A' ' 107' ' ' PRO . 34.3 m -111.36 14.06 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -164.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HB3' HD21 ' A' ' 103' ' ' LEU . 53.3 ptt85 -119.98 149.94 41.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -135.73 119.57 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.961 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.9 t30 61.86 35.2 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.87 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.54 89.08 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.465 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -122.18 149.92 42.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 103' ' ' LEU . 50.9 mt -74.95 133.82 41.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -174.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.8 pt -115.72 -7.36 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.99 174.03 10.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.111 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.45 139.29 28.49 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.711 0.767 . . . . 0.0 110.99 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.799 ' HD3' HG22 ' A' ' 97' ' ' VAL . 56.5 Cg_endo -79.82 132.28 9.6 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -172.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.1 -42.01 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.53 147.99 27.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -163.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.6 t -130.73 132.35 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.02 149.91 47.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.25 142.89 27.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.42 126.38 29.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.7 m -142.59 159.09 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.815 -166.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -98.93 123.87 43.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.6 mt -110.48 133.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -137.25 156.63 48.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.95 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.441 ' HB3' HD22 ' A' ' 121' ' ' LEU . 54.9 t-20 -96.53 120.08 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.03 -27.74 69.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -67.39 -42.25 83.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -165.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.627 ' H ' HD21 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -99.97 -24.76 14.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.5 tp -124.21 99.5 37.15 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.648 0.737 . . . . 0.0 110.936 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.15 -14.96 11.82 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.665 2.243 . . . . 0.0 112.326 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.4 t-20 -157.77 103.94 1.78 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.597 0.713 . . . . 0.0 110.97 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.5 Cg_endo -68.75 147.11 68.59 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 64.7 Cg_exo -55.09 145.03 66.55 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.769 2.313 . . . . 0.0 112.308 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.72 -17.65 37.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -143.79 161.13 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.295 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -68.64 -27.32 65.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.886 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.04 -29.62 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 126' ' ' PRO . 95.9 mt-10 -78.65 -15.68 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -176.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 38.7 mm -59.17 -54.34 57.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.721 0.772 . . . . 0.0 111.12 -171.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 24.5 Cg_endo -62.51 -39.89 42.18 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.318 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.27 99.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.134 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.18 -40.29 97.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.57 ' O ' HD21 ' A' ' 139' ' ' LEU . 10.0 t70 -62.16 -41.65 98.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.97 -39.6 92.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.49 -44.19 75.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.57 HD21 ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -176.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 39.0 ttpt -56.08 -26.2 48.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 169.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.11 -20.27 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.46 11.5 37.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.7 30.46 66.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.51 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 96.7 mttt -125.29 157.25 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 110.876 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 t -116.51 153.69 31.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.945 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.21 66.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.894 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.2 pp -145.88 146.07 30.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.7 ttm -148.05 132.32 17.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.914 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -156.7 169.79 23.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.16 122.89 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 -174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.58 7.41 18.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -85.1 -8.68 58.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.845 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -127.19 149.37 69.39 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 110.97 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 -31.99 9.27 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.79 -39.99 40.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -80.5 -37.57 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.9 p -83.82 -14.02 52.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.1 -170.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.613 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 24.1 m0 -49.99 -53.51 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.711 . . . . 0.0 110.827 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 9.5 Cg_endo -53.43 -33.99 69.51 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.453 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.94 -45.4 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.816 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 89.3 mt -74.22 -41.67 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -175.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.13 -6.78 51.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.13 -35.03 59.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.3 5.35 52.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.36 10.58 63.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.525 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -130.05 86.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.482 ' O ' ' HB1' ' A' ' 168' ' ' ALA . 63.1 t80 -167.49 153.88 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 167' ' ' TYR . . . 74.94 -91.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.08 170.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 181' ' ' VAL . 46.0 p90 -167.35 155.03 9.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.954 -171.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.7 129.34 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -116.89 128.91 55.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.94 140.21 25.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.956 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 51.01 45.81 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 10.91 71.05 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.513 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.65 146.87 52.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.891 -174.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -99.35 137.2 38.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -94.82 112.67 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 178' ' ' ILE . 6.4 tp -71.24 -20.01 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.16 -8.76 53.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -120.19 91.34 3.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 173.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 169' ' ' PHE . 35.3 m -106.04 155.87 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 -175.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.78 7.47 65.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.488 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -97.5 -19.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 111.221 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -101.6 14.3 32.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 167.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -93.95 154.23 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -170.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.35 -33.36 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.073 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.67 92.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.477 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.94 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.842 0.353 . . . . 0.0 111.082 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.4 -39.2 91.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.855 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.54 95.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.816 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -42.18 98.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.592 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.62 -39.71 91.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 110.831 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 86.1 m -59.75 -41.71 91.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.086 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.44 -47.23 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.19 -43.13 96.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.83 -40.83 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.98 -38.01 84.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.4 OUTLIER -60.97 -35.88 77.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.982 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.41 -40.0 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.97 -35.18 79.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -80.15 0.74 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.034 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 63.64 30.07 14.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -92.01 -21.61 20.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 83.9 mmm -131.98 155.0 48.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 169.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.453 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 94.4 m-20 -104.71 139.14 39.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 173.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.98 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.101 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -96.47 0.43 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 98.5 m -56.57 125.94 24.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.194 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -119.12 179.76 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.92 -39.69 90.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.1 m -58.62 -42.95 89.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.92 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.18 -43.44 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.35 -42.9 87.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.48 87.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.91 97.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.08 -37.84 84.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.867 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.0 -28.64 69.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.11 -22.25 15.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 21.67 40.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.542 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.04 -25.91 29.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 110.827 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 79.1 m -126.48 135.34 51.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.084 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.78 -40.37 48.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.185 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 78.3 mtm -133.7 156.45 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -164.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -151.8 158.34 43.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.202 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 46.2 mm -115.85 114.97 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -163.36 178.39 8.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -99.21 -171.68 31.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.463 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.77 -15.11 40.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -63.49 -12.24 30.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.919 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.6 78.21 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.143 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -66.32 -22.76 66.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 50.1 m -54.14 169.84 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.602 ' HB2' ' O ' ' A' ' 233' ' ' SER . 91.6 m-20 73.86 55.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 -169.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.0 128.46 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -68.92 81.4 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.809 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -58.18 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.3 p -69.12 -15.3 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -160.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.61 170.52 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.15 119.77 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.093 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -122.02 -42.42 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.925 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -105.13 153.38 21.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.933 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.93 160.41 24.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.427 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.33 131.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.97 0.414 . . . . 0.0 111.101 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.16 179.13 7.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -84.84 159.63 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.124 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.4 mt -68.43 150.03 97.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 110.765 -169.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 44.6 Cg_exo -56.74 150.53 53.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -91.17 163.2 14.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -136.33 113.19 10.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 56.71 43.48 25.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.735 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.68 1.29 80.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 169.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -149.99 147.04 21.3 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.524 0.678 . . . . 0.0 110.991 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.84 127.04 11.68 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 88.9 p -56.71 -57.05 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -170.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -165.09 119.97 0.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.68 149.87 23.92 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.617 2.212 . . . . 0.0 112.324 175.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 158' ' ' TRP . 69.4 m-85 -138.84 120.51 15.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.863 171.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.04 125.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.132 177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.65 139.36 15.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.459 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.14 124.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.349 . . . . 0.0 111.052 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.414 HD21 ' HA ' ' A' ' 262' ' ' LEU . 28.3 mt -78.96 144.67 34.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 169.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 53.6 p -142.42 163.77 31.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.73 135.56 52.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.099 176.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.68 156.5 15.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.52 126.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.146 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -65.8 129.25 39.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.541 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -66.07 -28.99 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.44 -11.42 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -80.11 127.93 75.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.655 0.74 . . . . 0.0 110.899 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.53 -6.69 19.09 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.675 2.25 . . . . 0.0 112.319 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -108.05 24.12 13.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.889 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -57.56 -34.12 68.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 -172.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.79 -45.91 63.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -171.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.752 HD13 HD11 ' A' ' 33' ' ' ILE . 4.5 pp -76.44 -31.5 57.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.531 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -66.24 -40.83 90.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 174.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -66.56 -39.49 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.59 -38.67 77.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -56.9 -45.51 82.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.513 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 62.9 tp -63.79 -50.8 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.82 -34.65 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.8 -27.87 13.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -163.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.785 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 87.1 m-85 -120.45 -49.55 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 80.4 mt -73.63 -35.91 65.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.924 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.98 74.05 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.971 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.0 p -141.87 170.17 16.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.006 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.25 -43.09 74.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -76.45 -46.07 28.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.91 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.785 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.92 -44.15 25.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.01 -36.43 84.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.911 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.97 -41.64 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.34 -34.82 74.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.819 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 97.0 t -80.84 -45.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -71.15 -28.78 64.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.26 -10.97 12.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.47 -33.08 62.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.98 150.02 42.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 0.0 110.903 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -58.39 -57.13 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.394 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.54 -53.19 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.41 62.56 6.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.509 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -81.95 123.12 28.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.123 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.685 HG23 HD22 ' A' ' 311' ' ' LEU . 33.2 m -115.49 156.24 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.074 -163.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.43 -17.07 55.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.055 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.425 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 60.8 tp -78.25 117.85 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.95 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.7 -46.84 87.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.1 t -63.67 -50.99 67.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.771 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.09 -34.06 72.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -57.28 -39.5 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -55.51 -38.12 68.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.685 HD22 HG23 ' A' ' 302' ' ' VAL . 4.3 pp -74.88 -22.05 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -73.01 -6.37 45.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.998 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.82 -12.03 61.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.69 129.94 63.3 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -32.39 32.06 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -69.76 -37.04 76.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.883 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.445 HG21 HD12 ' A' ' 311' ' ' LEU . 48.6 mm -80.37 -40.98 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.35 -35.88 70.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -169.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.71 91.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.175 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 95.4 m -68.52 -39.88 81.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mmt -67.58 -35.42 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.92 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 327' ' ' GLY . 84.5 m-20 -69.27 -35.93 76.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 176.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.15 85.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -72.83 -22.91 60.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.93 -5.71 17.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.37 -159.65 32.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -130.01 123.45 30.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.439 ' O ' HG22 ' A' ' 329' ' ' ILE . 1.1 mp -75.24 124.12 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 329' ' ' ILE . 92.0 mtp 60.56 160.18 0.11 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.535 0.683 . . . . 0.0 110.886 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -64.96 -103.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.0 112.438 161.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -139.96 -48.88 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 158.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.558 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 46.5 pt -130.04 161.36 60.38 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.648 0.737 . . . . 0.0 111.121 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.558 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 19.5 Cg_endo -60.72 -22.03 71.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -69.81 -16.41 63.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.3 mmt -66.18 -26.09 67.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 87.7 p -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.08 -51.33 25.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -171.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 339' ' ' PHE . 1.0 OUTLIER -65.22 -26.24 68.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.953 178.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -66.15 -39.5 89.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -63.57 -37.47 87.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.98 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.163 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.68 -32.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -49.75 -47.92 50.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.8 m -60.35 -39.67 87.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.143 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -64.47 -37.62 88.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.095 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.84 -44.86 88.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.9 -43.09 97.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.119 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.06 -39.86 93.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.74 68.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.046 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.21 -36.64 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -174.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.9 p -78.6 -9.61 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.904 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.56 9.53 85.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.37 -31.17 65.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.865 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -133.66 160.02 38.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -76.02 169.92 17.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.76 -44.52 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.83 -45.9 91.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.9 -46.45 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.48 89.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.56 -37.37 82.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.64 -35.27 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.58 -31.4 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -65.02 -47.5 77.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.7 m -60.48 -42.18 95.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.122 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.82 -39.24 80.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 89.9 mt -62.69 -42.14 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.108 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 64.9 p -90.8 -14.56 31.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.565 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 85.9 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.701 0.286 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.416 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 86.3 mt -76.04 129.08 37.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.409 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 92.6 mt-10 -130.11 166.76 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.937 -176.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.43 121.94 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 20.02 52.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.489 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 96.3 mttt -141.49 156.36 45.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 -177.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.8 pp -149.29 150.64 32.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.3 t -124.99 121.46 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.443 HG12 ' HB ' ' A' ' 59' ' ' ILE . 87.1 mt -119.58 132.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.212 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.413 ' HB2' HD11 ' A' ' 60' ' ' ILE . 25.1 m0 -115.75 140.42 49.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -178.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.953 HD11 ' HA3' ' A' ' 16' ' ' GLY . 17.3 tt -144.06 143.65 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -73.71 -179.82 3.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -172.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.0 -2.28 4.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.52 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.636 ' O ' ' C ' ' A' ' 15' ' ' LYS . 46.9 t0 -67.34 70.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.856 173.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 14' ' ' ASP . 87.2 tttt -14.55 107.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -166.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.953 ' HA3' HD11 ' A' ' 11' ' ' ILE . . . -108.98 -11.05 23.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.45 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -66.3 -41.75 89.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 110.896 -151.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.68 -52.52 62.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.911 -162.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.877 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -66.61 -44.33 90.04 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.415 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.2 mt -58.46 -40.48 82.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 110.896 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.33 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.35 -46.84 88.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 m -74.24 -28.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.32 -37.73 95.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.458 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.63 -41.46 96.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.874 0.369 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.39 -43.93 89.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.1 -43.52 95.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.83 -34.86 76.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.25 -40.1 67.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -79.08 -40.65 30.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -172.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.4 p -100.72 -24.54 14.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.174 -171.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.56 8.53 86.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.42 HG21 HD21 ' A' ' 7' ' ' LEU . 89.6 mt -80.34 124.9 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.21 118.88 8.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.433 HG11 ' HA3' ' A' ' 24' ' ' GLY . 70.0 t -98.46 134.31 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -132.65 112.39 11.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.21 121.55 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.2 mt-10 -128.21 149.98 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.822 -176.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -135.04 68.55 70.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.577 0.703 . . . . 0.0 110.918 171.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.536 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 29.0 Cg_endo -79.39 -14.35 13.13 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.683 2.256 . . . . 0.0 112.29 -162.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.4 m-20 76.49 8.95 3.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.14 -9.99 37.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.948 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 3.2 mp -51.34 -55.56 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 -156.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -54.33 -38.98 66.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.65 -32.84 62.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.94 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.96 -29.69 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.559 ' CZ ' ' HB3' ' A' ' 43' ' ' LEU . 8.7 m-30 -49.81 -51.59 59.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.706 0.765 . . . . 0.0 110.968 -164.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 96.0 Cg_endo -79.41 -29.11 3.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.576 2.184 . . . . 0.0 112.357 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -75.54 -46.08 34.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.835 -171.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.5 m -56.78 -33.39 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.08 87.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.58 -32.6 47.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.2 p -95.02 -4.9 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.092 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.95 24.71 66.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.435 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -80.94 143.05 32.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.843 0.354 . . . . 0.0 110.843 172.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' A' ' 2' ' ' ILE . . . -122.1 62.9 0.53 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -164.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.88 121.06 7.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.686 2.257 . . . . 0.0 112.377 159.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -83.18 -48.93 9.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 -161.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' HG12 ' A' ' 9' ' ' ILE . 70.1 mt -132.55 136.08 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.168 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 10' ' ' TRP . 39.8 mm -119.07 132.36 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 264' ' ' ALA . 72.5 m-85 -116.32 115.72 26.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.889 172.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -168.36 179.76 4.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.25 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.132 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 263' ' ' SER . 73.3 t60 -60.21 -25.05 65.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -50.42 -44.16 55.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.13 -24.19 47.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.608 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 1.7 t80 -65.43 -28.79 69.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -172.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.46 -38.35 62.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.457 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.15 -37.31 71.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.631 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -71.64 -25.06 61.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB3' HD22 ' A' ' 76' ' ' LEU . . . -59.93 -39.58 85.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.15 -26.44 64.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.4 p -85.0 2.47 42.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.76 32.22 73.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.53 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -74.82 -24.33 58.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -126.86 144.11 51.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -168.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -75.99 154.52 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.83 134.07 52.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -115.98 142.27 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.191 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -93.5 123.91 58.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.516 0.674 . . . . 0.0 111.16 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 143.59 28.91 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.789 2.326 . . . . 0.0 112.275 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -107.86 116.13 31.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.14 -43.1 73.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.0 98.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.179 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.17 -35.71 74.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.24 -44.64 88.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.07 -32.45 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.2 -28.38 65.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.04 -105.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -152.69 139.29 12.37 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.745 0.783 . . . . 0.0 110.925 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.37 -28.13 22.71 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.833 2.356 . . . . 0.0 112.298 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -71.22 -34.28 70.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.9 p -74.33 -21.88 59.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.54 -35.18 80.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.017 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.86 -35.06 74.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.462 ' HB3' ' CG2' ' A' ' 329' ' ' ILE . . . -69.97 -37.83 75.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.783 HG22 ' HD3' ' A' ' 107' ' ' PRO . 35.4 m -104.32 18.36 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -169.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -123.52 149.94 44.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -138.77 124.42 19.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 58.18 35.99 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.06 88.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.538 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.03 150.66 41.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' A' ' 103' ' ' LEU . 31.9 mt -75.03 135.19 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.994 -177.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.0 pt -113.76 -12.48 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.18 169.57 20.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.053 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -112.86 130.53 23.41 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.622 0.725 . . . . 0.0 111.02 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.783 ' HD3' HG22 ' A' ' 97' ' ' VAL . 54.6 Cg_endo -72.8 125.71 10.73 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.358 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.49 -50.38 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.84 157.07 42.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.09 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 147.16 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.85 147.76 51.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.2 145.22 28.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -68.54 128.81 37.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.5 m -138.29 157.84 45.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.748 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.95 121.13 38.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.5 mt -109.87 130.06 63.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.175 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -135.23 157.53 46.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.58 117.4 29.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.943 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.14 -28.53 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.837 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.94 -35.1 32.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.29 -44.25 25.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.8 tp -127.44 105.99 21.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.65 -15.65 15.26 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.329 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -150.33 105.58 3.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.72 . . . . 0.0 110.966 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.59 146.52 73.98 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.728 2.285 . . . . 0.0 112.371 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.94 147.75 68.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.24 -21.46 24.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.8 p -131.88 159.95 37.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -74.04 -23.64 59.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.4 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 97.7 mt-10 -64.23 -21.86 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.31 -21.63 55.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.611 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 40.0 mm -64.35 -45.52 78.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.676 0.75 . . . . 0.0 111.158 -162.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.611 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 77.0 Cg_exo -53.52 -49.49 17.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 0.0 112.323 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -38.72 83.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.576 HD21 ' O ' ' A' ' 135' ' ' LEU . 4.5 tt -61.97 -39.39 91.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.497 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 25.5 t70 -64.24 -41.87 96.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.74 -40.05 75.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.23 -56.52 9.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -170.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.48 HD21 ' O ' ' A' ' 136' ' ' ASP . 1.3 pt? -82.04 -12.33 58.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -174.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.5 tttt -58.51 -27.3 64.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 168.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.35 -17.9 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.34 6.47 42.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 26.94 65.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.493 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 2.7 mptp? -118.26 159.82 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.957 173.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.414 ' O ' HD11 ' A' ' 139' ' ' LEU . 47.8 t -113.8 153.49 29.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 172.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -66.82 -52.5 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.159 -175.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.838 ' O ' HD12 ' A' ' 147' ' ' LEU . 2.7 pp -151.76 147.65 26.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.968 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.3 mtp -127.27 134.35 50.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -143.37 164.95 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.654 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 54.4 t-20 -70.0 110.32 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.895 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.438 HD21 ' HA ' ' A' ' 206' ' ' ALA . 48.7 tp -106.84 0.31 23.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.97 -5.83 59.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -132.97 149.66 73.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.528 0.68 . . . . 0.0 110.825 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -79.4 -25.92 5.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.62 2.214 . . . . 0.0 112.317 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -59.68 -44.62 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.496 ' CD2' ' HB3' ' A' ' 150' ' ' ASN . 81.0 m-85 -79.31 -28.4 42.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 m -77.4 -20.89 53.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 172.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.616 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 10.7 t90 -47.37 -53.99 25.12 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.595 0.712 . . . . 0.0 110.879 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.4 Cg_endo -55.19 -32.88 82.26 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.621 2.214 . . . . 0.0 112.401 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.542 ' C ' HD21 ' A' ' 160' ' ' LEU . 7.8 tt -71.04 -54.2 12.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.007 -172.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 91.0 mt -78.61 -40.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 -173.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.22 -14.99 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 -173.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.416 ' HB2' ' HB3' ' A' ' 250' ' ' PHE . . . -59.07 -28.52 66.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -174.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -90.5 -1.88 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.21 20.41 30.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.429 ' HA3' ' N ' ' A' ' 188' ' ' ALA . . . -138.61 85.06 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.444 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.409 ' O ' ' HB1' ' A' ' 168' ' ' ALA . 9.4 t80 -177.31 154.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.409 ' HB1' ' O ' ' A' ' 167' ' ' TYR . . . 74.97 -87.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 164.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -148.84 155.58 41.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -168.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -118.28 124.3 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.943 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -113.8 129.8 56.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -145.02 136.47 25.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 52.2 38.93 25.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.889 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.08 8.93 65.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.431 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.72 145.6 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -87.92 123.65 32.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 168.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -98.85 117.71 33.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.88 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.9 tp -68.13 -21.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.35 -12.03 28.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -124.57 82.19 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.6 p -113.21 148.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.61 25.39 27.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -167.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.73 -14.51 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 111.186 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -102.27 20.39 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -102.46 -175.04 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.78 69.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.025 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.56 -38.61 96.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.429 ' N ' ' HA3' ' A' ' 166' ' ' GLY . . . -59.48 -39.85 85.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.12 -40.49 96.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.81 94.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.06 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.19 -43.88 96.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.4 ' O ' HG21 ' A' ' 196' ' ' VAL . 72.3 mt -65.93 -41.28 91.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.353 . . . . 0.0 110.883 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.4 m -60.01 -43.21 95.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -56.62 -52.43 64.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.76 65.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 192' ' ' LEU . 45.4 t -67.39 -39.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.169 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.99 -39.46 92.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.6 OUTLIER -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.826 178.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.82 -41.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.936 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -82.43 3.27 28.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.95 34.92 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.85 -28.74 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.1 mtt -137.78 152.74 49.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . 0.423 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.9 m-20 -101.24 141.41 34.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.862 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.438 ' HA ' HD21 ' A' ' 151' ' ' LEU . . . -65.13 -27.28 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.045 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.63 2.85 54.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 94.5 m -58.59 130.18 45.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.654 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 2.8 p30 -125.79 165.44 18.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 172.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -70.08 -27.67 64.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.926 -172.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -65.88 -48.3 71.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.5 pt -69.45 -23.65 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.134 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.45 94.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -71.93 -34.99 69.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.972 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.84 85.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.091 171.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.06 82.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -62.88 -38.26 90.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.831 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.07 -27.42 69.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.71 -21.87 16.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.26 20.28 52.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.485 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -82.62 -26.53 32.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 86.3 m -127.34 134.38 49.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.155 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.21 -36.06 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.428 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 77.6 mtm -134.84 151.41 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -168.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -150.4 158.85 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.28 119.49 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -163.06 174.18 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.415 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -94.21 -175.75 39.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.22 -19.76 66.23 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.623 2.216 . . . . 0.0 112.383 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.415 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 43.7 p90 -68.86 -9.63 52.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.8 84.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -65.82 -25.85 67.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 61.7 m -52.54 160.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 233' ' ' SER . 73.7 m-20 72.72 56.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -170.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.77 130.07 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.71 79.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.871 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 71.2 p -58.76 -176.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 165.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.9 p -72.49 -14.7 61.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.816 -160.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.61 164.96 18.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.781 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t -93.01 114.99 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -120.77 -39.99 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.46 155.29 19.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.97 167.12 25.49 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.568 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.16 136.19 56.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.074 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -143.46 -179.66 6.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.74 159.42 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 94.0 mt -71.36 138.98 84.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 0.0 110.855 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 53.1 Cg_exo -57.05 156.0 26.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.379 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -99.18 164.74 12.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.144 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.416 ' HB3' ' HB2' ' A' ' 163' ' ' ALA . 25.7 t80 -141.95 119.98 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 -176.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 61.39 39.71 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.828 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 6.48 84.97 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.468 165.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.94 151.64 49.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.538 0.685 . . . . 0.0 111.019 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.36 130.19 24.46 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.686 2.258 . . . . 0.0 112.408 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 77.8 p -61.09 -42.65 98.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.813 -170.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -172.99 127.66 0.51 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 110.851 166.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.24 142.79 24.6 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.252 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -163.93 124.89 2.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.82 128.92 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 170.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -103.56 144.81 16.02 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.429 171.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.28 127.32 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.582 HD21 ' N ' ' A' ' 263' ' ' SER . 6.5 tt -96.97 128.6 44.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 166.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.582 ' N ' HD21 ' A' ' 262' ' ' LEU . 8.7 m -139.09 172.12 13.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.79 -172.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.517 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . . . -121.99 135.96 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.133 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.608 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -117.39 155.05 16.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 -177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.94 127.93 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 111.119 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -67.77 128.42 36.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -170.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.593 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -64.81 -28.98 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.054 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.67 -10.88 59.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.9 t -77.67 126.98 83.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.649 0.737 . . . . 0.0 110.879 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 -8.4 23.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.455 174.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.748 ' HB3' HD21 ' A' ' 275' ' ' LEU . 97.0 m-20 -112.97 27.45 9.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -172.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.73 -28.34 33.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -66.03 -40.17 90.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.748 HD21 ' HB3' ' A' ' 272' ' ' ASN . 0.7 OUTLIER -72.55 -31.27 65.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.617 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.1 -42.04 85.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.01 -40.69 91.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.63 -47.85 83.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 3.2 tt -66.85 -49.45 65.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.949 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.51 -33.73 76.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -101.35 -29.8 11.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -164.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.772 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.3 m-85 -119.93 -50.5 2.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 -169.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 94.5 mt -73.66 -37.79 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -171.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 42.3 tp -126.71 75.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.5 p -140.79 174.62 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.208 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.92 -44.26 74.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.0 -44.24 49.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.772 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.83 -45.82 19.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.545 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.4 -36.92 84.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.351 . . . . 0.0 110.953 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.78 -39.73 95.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.97 88.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.022 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.877 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 10.2 p -87.75 -32.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.76 -23.03 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -174.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.62 -15.25 6.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -82.91 -23.9 33.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -91.03 151.48 43.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.89 -61.07 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.808 2.339 . . . . 0.0 112.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 97.1 mt -98.88 -50.12 4.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 54.56 59.91 9.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.517 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.74 129.01 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 111.048 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.38 153.92 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -166.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.73 -14.99 58.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.5 tp -76.63 120.26 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.923 -175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.1 -44.91 96.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -173.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -48.11 78.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 -173.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.89 -32.94 71.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.489 ' HA ' ' HE2' ' A' ' 321' ' ' MET . 42.7 tt0 -61.69 -38.93 89.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.798 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.64 -40.67 79.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.08 -41.58 58.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.446 ' HB3' HG21 ' A' ' 317' ' ' ILE . 91.9 mt -65.34 -29.97 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.51 -9.78 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.96 -19.44 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -86.76 120.13 71.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.573 0.701 . . . . 0.0 110.892 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.87 -34.97 57.8 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.661 2.24 . . . . 0.0 112.322 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.33 -39.78 62.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.446 HG21 ' HB3' ' A' ' 311' ' ' LEU . 96.7 mt -74.12 -39.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.4 -33.24 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.03 93.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.6 m -69.75 -41.17 75.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.489 ' HE2' ' HA ' ' A' ' 308' ' ' GLU . 40.3 mtt -68.37 -34.61 76.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.12 -37.03 85.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -67.08 -36.5 82.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.78 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.31 -23.46 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.958 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 -2.05 23.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.801 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.06 -166.37 40.64 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.433 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.8 128.19 44.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 0.0 111.015 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.462 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 28.7 mm -73.28 111.54 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -176.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.0 mmm 63.23 158.15 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.578 0.704 . . . . 0.0 110.744 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.487 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 66.9 Cg_endo -73.66 -111.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 169.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.73 -47.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 170.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.445 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 19.5 pt -138.82 159.78 65.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.552 0.691 . . . . 0.0 111.199 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 40.8 Cg_endo -66.74 -14.71 44.92 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.742 2.295 . . . . 0.0 112.257 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -5.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.949 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.487 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.8 ptm -52.47 -30.14 28.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -32.94 74.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.16 72.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.038 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 339' ' ' PHE . 0.7 OUTLIER -72.27 -25.14 61.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -58.79 -48.0 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -63.68 -40.55 97.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.67 95.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.099 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.04 -26.26 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -61.13 -45.85 92.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.7 p -67.18 -34.37 77.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -66.16 -47.3 74.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.423 HG13 ' N ' ' A' ' 348' ' ' ILE . 7.3 p -71.53 -41.61 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 -172.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.423 ' N ' HG13 ' A' ' 347' ' ' VAL . 93.7 mt -64.46 -43.97 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -64.65 -36.41 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.23 -43.85 69.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.33 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.13 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.6 p -75.03 -14.99 60.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.23 86.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.84 -29.86 67.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.614 0.245 . . . . 0.0 110.807 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -140.01 158.64 43.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.894 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.9 p -73.43 169.4 17.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.03 -48.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.98 -40.08 75.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -70.87 -42.36 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.909 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.98 89.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.098 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.412 HD22 ' HB1' ' A' ' 188' ' ' ALA . 30.3 tp -65.21 -36.4 84.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.09 -35.41 75.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.92 -29.1 70.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -65.14 -48.83 72.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -64.35 -39.84 94.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -60.75 -43.67 97.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.111 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -72.32 -35.47 68.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.96 -43.08 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 67.1 p -89.89 -12.74 38.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.796 0.331 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -83.17 132.29 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -123.62 161.13 25.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.73 119.61 19.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.27 31.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.459 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -146.52 154.69 41.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.84 143.1 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.5 122.42 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.41 140.56 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.462 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 55.5 m95 -116.45 126.76 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 tt -148.87 141.02 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.406 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.8 t-20 -47.87 118.46 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -166.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.19 64.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.462 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.13 -56.18 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 0.0 110.929 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -137.37 78.26 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 152.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.76 -34.31 1.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.472 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.15 -46.08 36.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.933 -158.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -51.59 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -157.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.2 -48.75 57.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 tp -59.6 -42.09 91.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.05 84.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -63.22 -37.25 86.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.15 -41.65 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.05 87.65 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.453 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.35 -40.2 89.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.905 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -60.62 -46.91 88.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 33' ' ' ILE . 28.3 t80 -68.8 -36.29 78.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.49 -33.13 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.64 -36.05 73.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.16 -40.65 26.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -109.12 -18.11 13.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 -171.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.25 4.8 87.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.54 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.4 tt -72.94 121.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -68.91 121.61 16.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.946 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.3 p -102.22 142.63 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.151 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -136.09 114.24 11.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.86 127.34 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -124.8 160.61 28.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -93.48 125.0 55.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 110.855 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.436 ' CB ' HD22 ' A' ' 43' ' ' LEU . 66.1 Cg_endo -87.78 81.72 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -167.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -93.88 -27.8 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 166.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -92.31 -15.02 27.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.841 -169.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD22 ' CB ' ' A' ' 40' ' ' PRO . 2.3 mp -53.14 -46.06 68.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.891 -159.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -50.03 -40.98 46.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.14 -35.05 32.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -73.0 -25.07 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.2 m-30 -50.05 -55.79 22.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 0.0 110.875 -165.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -71.18 -29.77 16.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.732 2.288 . . . . 0.0 112.382 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -76.54 -49.95 15.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -172.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.691 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 28.0 m -60.37 -34.98 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.47 86.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.86 66.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.091 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -93.73 1.36 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.114 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.57 8.32 66.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.463 171.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -171.3 95.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.898 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.99 -129.34 3.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 156.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 41.7 Cg_endo -70.21 154.53 65.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.644 2.229 . . . . 0.0 112.35 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -88.08 -39.78 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.61 136.89 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.0 mm -119.68 134.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -77.8 159.47 28.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.952 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CB ' ' H ' ' A' ' 263' ' ' SER . 41.9 t90 -85.84 147.4 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -112.57 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.104 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -110.74 -83.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 157.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -94.58 -19.51 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -60.05 -27.59 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -163.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -58.06 -33.26 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.87 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -64.3 -41.24 98.29 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.18 80.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.427 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -65.84 -36.7 84.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.72 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.105 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.96 -29.27 70.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -82.39 1.5 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.16 75.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -82.71 -6.17 59.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.46 146.17 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -91.11 163.6 14.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.71 128.76 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -110.41 148.83 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -95.64 124.6 52.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.506 0.67 . . . . 0.0 111.204 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.83 140.67 42.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -103.83 109.91 21.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.38 -42.59 98.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.9 m-30 -68.2 -35.81 78.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -55.09 -45.45 75.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.941 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.33 -39.15 93.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.16 -22.48 62.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 304' ' ' LEU . 75.5 mt -105.02 -145.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.78 145.7 54.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -70.0 -39.83 5.62 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -68.7 -23.28 64.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.984 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.6 p -72.29 -24.87 61.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.438 ' HA ' HG22 ' A' ' 97' ' ' VAL . 88.8 m95 -72.82 -33.02 65.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.65 -34.51 72.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -71.42 -25.14 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.171 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.49 HG21 ' HD3' ' A' ' 107' ' ' PRO . 34.6 m -108.42 14.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 79.0 mtm180 -118.02 143.87 46.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -143.4 130.86 21.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 t30 57.01 33.3 23.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.963 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.07 90.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.47 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.33 150.41 37.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 37.0 tp -81.18 123.87 28.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.0 pt -115.25 -9.67 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.459 ' HB1' ' H ' ' A' ' 264' ' ' ALA . . . -161.33 169.3 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.668 ' HB3' HD21 ' A' ' 285' ' ' LEU . 75.1 m-85 -110.03 140.0 21.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.693 0.758 . . . . 0.0 110.984 167.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD3' HG21 ' A' ' 97' ' ' VAL . 94.1 Cg_endo -79.04 117.14 3.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.652 2.234 . . . . 0.0 112.308 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.7 mt -109.1 -29.99 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.51 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -170.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.07 124.97 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.086 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -116.53 129.42 56.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.71 149.7 30.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 94.6 mt -72.87 144.89 47.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.6 m -143.9 160.86 40.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 tp -89.33 118.55 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 244' ' ' VAL . 56.2 mt -109.6 119.66 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.082 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -133.24 155.09 50.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -164.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.03 115.73 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.874 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.62 -25.46 68.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -76.0 -35.76 59.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.12 -52.8 5.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.952 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.2 mt -124.59 105.18 30.45 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.546 0.689 . . . . 0.0 110.876 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.92 -12.65 19.74 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.342 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 57.5 t-20 -147.91 100.02 3.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.69 0.757 . . . . 0.0 110.911 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 56.8 Cg_endo -69.09 164.58 33.31 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.407 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 44.1 Cg_endo -72.43 145.15 42.14 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.347 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.02 -19.35 27.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.2 t -144.48 163.01 35.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -173.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -70.58 -25.16 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 -174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.48 -33.01 74.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -75.02 -22.59 58.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.609 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 77.6 mt -62.55 -53.63 55.49 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.682 0.753 . . . . 0.0 111.143 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.1 Cg_endo -60.43 -40.4 57.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.29 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.05 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 51.5 tp -61.32 -39.93 92.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 132' ' ' ILE . 9.3 t70 -65.99 -41.31 91.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.35 -38.79 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.64 -45.33 75.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 146' ' ' ALA . 3.7 pp -83.58 -20.34 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 84.6 tttt -56.46 -28.81 60.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.16 -18.67 63.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.066 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.21 7.51 33.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.08 29.72 62.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.48 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -108.13 161.58 14.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.8 t -116.93 148.51 41.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 139' ' ' LEU . . . -86.22 -34.63 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.2 tp -130.72 141.1 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -112.91 134.91 54.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -164.25 160.45 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.849 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -127.27 -10.56 5.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 199' ' ' ILE . 37.8 mt 50.82 35.54 12.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -93.68 -20.88 19.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -139.62 149.75 60.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.66 -22.86 74.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.355 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -50.04 -36.27 28.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -70.74 -35.7 72.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.436 HG21 HG11 ' A' ' 347' ' ' VAL . 39.2 p -80.33 -28.49 38.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 -172.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.541 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 42.1 m0 -56.91 -45.0 100.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 -164.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.593 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 98.1 Cg_exo -48.9 -38.19 38.0 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.705 2.27 . . . . 0.0 112.297 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.1 mt -80.32 -44.67 19.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.681 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.4 mt -72.18 -47.53 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 -169.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.1 -16.71 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.171 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.51 -27.07 65.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.079 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -97.73 8.47 44.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.41 16.78 3.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.454 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.35 161.16 38.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -168.0 150.57 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.26 -62.21 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.83 146.65 47.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.19 136.79 37.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.553 ' CE2' ' HB3' ' A' ' 176' ' ' TYR . 57.4 m-85 -115.29 126.3 54.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -146.13 141.41 27.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.865 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.3 t30 49.78 45.59 24.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.878 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.34 8.85 66.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.511 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.63 148.66 52.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.848 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.553 ' HB3' ' CE2' ' A' ' 171' ' ' TYR . 49.2 p90 -93.4 138.2 31.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -96.11 109.81 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 178' ' ' ILE . 2.2 tp -64.13 -20.01 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.05 -4.82 53.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.921 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -117.02 97.53 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.9 154.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.132 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.75 28.76 12.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 m -99.99 -23.37 4.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.152 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -97.35 20.44 11.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.01 155.31 19.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -171.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.39 -35.01 67.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.055 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.03 93.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.458 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.03 78.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -62.87 -41.68 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.57 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.33 -42.52 97.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 357' ' ' VAL . 24.7 tp -69.19 -34.36 74.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.884 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.9 m -58.77 -40.85 85.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.166 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -58.05 -44.22 87.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.12 -44.98 88.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -65.14 -40.71 89.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.13 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -38.6 91.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.3 OUTLIER -62.27 -38.64 90.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.407 HD11 HD11 ' A' ' 151' ' ' LEU . 53.1 mt -81.59 -42.16 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.56 -41.68 88.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.79 5.23 29.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.87 31.99 11.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.01 -28.86 60.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 170.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.8 tpt -146.09 151.62 37.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.428 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -89.19 134.76 33.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.34 -27.01 62.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 -174.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.66 -17.54 16.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 77.8 m -64.45 134.99 55.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -89.97 166.25 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -66.34 -37.05 84.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.5 p -68.68 -38.3 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.855 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.01 -43.97 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.79 -36.94 73.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.6 -38.41 83.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.29 95.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.01 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CZ ' HG22 ' A' ' 116' ' ' ILE . 83.2 t80 -66.77 -42.15 86.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 174.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -61.29 -26.33 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.834 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.03 -9.03 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.32 67.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.66 -28.63 33.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.936 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 90.0 m -120.14 130.19 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.132 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.65 -43.68 75.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -169.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.9 mtm -140.44 150.33 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -169.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.4 p -145.47 171.77 14.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mm -118.15 126.08 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -159.8 172.36 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.2 -164.2 29.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.27 -15.97 19.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.24 . . . . 0.0 112.382 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -70.28 -29.23 65.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 28.61 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.496 ' O ' ' C ' ' A' ' 233' ' ' SER . 37.3 m0 -72.79 -46.2 54.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 232' ' ' TRP . 58.2 m 33.87 -99.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 170.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -151.1 39.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.19 157.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.094 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.657 ' O ' ' C ' ' A' ' 237' ' ' THR . 95.0 m-20 -108.13 148.73 29.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.657 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.2 m -6.62 82.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 94.6 p -61.88 161.18 10.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -134.62 -5.45 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 241' ' ' ASN . 52.5 t -89.14 73.37 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -171.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' VAL . 83.7 m-20 40.97 47.51 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.81 147.26 26.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.69 164.95 26.61 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 -175.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.424 HG22 HG12 ' A' ' 116' ' ' ILE . 52.6 t -131.52 134.99 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 177.26 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.181 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.95 160.01 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.183 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.518 ' HB2' ' HD3' ' A' ' 257' ' ' PRO . 26.8 mt -78.97 151.06 75.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.473 ' HG2' HD11 ' A' ' 132' ' ' ILE . 50.3 Cg_exo -62.05 154.57 61.34 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.404 -174.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 96.1 m -133.14 138.12 46.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -114.15 118.17 33.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 -167.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 50.48 40.14 22.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.63 24.19 73.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 98.7 mm-40 -106.14 161.7 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.599 0.714 . . . . 0.0 110.956 -169.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.7 Cg_endo -63.94 70.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.228 . . . . 0.0 112.384 173.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 68.5 m -102.63 15.29 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.808 -167.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 257' ' ' PRO . 58.4 mttp -106.97 160.8 25.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.564 0.697 . . . . 0.0 110.909 -161.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 247' ' ' LEU . 11.5 Cg_endo -60.96 154.93 53.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.73 163.14 27.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.49 125.66 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.143 -175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.57 143.27 15.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.23 126.5 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.8 tp -64.81 129.26 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.428 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 20.1 m -135.32 155.02 51.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 -166.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.459 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -140.3 137.04 33.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.082 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.64 146.56 18.08 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.477 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 86.2 mt -114.61 124.76 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.928 0.394 . . . . 0.0 111.087 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -58.56 122.07 12.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.892 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.29 -25.92 66.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.077 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.62 -8.02 59.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.103 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.2 t -69.17 128.49 92.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.669 0.747 . . . . 0.0 110.908 -175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.71 -12.58 36.5 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.683 2.255 . . . . 0.0 112.406 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -111.92 25.04 12.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -55.45 -33.09 63.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.37 -38.8 65.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.13 -44.2 97.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.47 85.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.27 -46.45 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.11 -50.79 66.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -34.87 71.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -172.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 280' ' ' LEU . 2.5 tt -52.48 -51.79 57.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.54 -22.39 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.828 -171.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -98.55 -14.06 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -166.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.6 m-85 -120.58 -52.38 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.54 -32.3 73.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.908 ' O ' HD12 ' A' ' 285' ' ' LEU . 1.7 pp -136.72 76.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.971 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.8 p -143.02 170.02 16.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.187 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -53.69 -46.27 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.02 -42.99 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.862 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.04 -46.78 20.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -170.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 46.9 tp -66.03 -36.02 82.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.75 -43.74 85.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.07 85.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 3.2 p -75.42 -31.27 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.34 -16.44 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -58.83 -22.85 59.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -89.25 -22.62 22.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.823 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -100.36 155.27 36.58 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.95 -63.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.292 . . . . 0.0 112.409 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 76.5 mt -107.35 -50.5 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.88 -49.2 0.9 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.445 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.78 72.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.443 HG22 HD21 ' A' ' 311' ' ' LEU . 20.1 m -109.2 155.86 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.121 -154.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.93 -13.77 59.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 89' ' ' LEU . 58.1 tp -80.57 117.48 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.16 -44.82 96.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.6 p -65.7 -51.93 55.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -172.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -68.85 -34.03 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.929 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.1 -40.44 89.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.58 -37.78 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.79 -47.8 24.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.817 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.443 HD21 HG22 ' A' ' 302' ' ' VAL . 4.0 pp -74.72 -19.51 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.63 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.161 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.9 -10.36 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.47 130.12 52.58 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.561 0.696 . . . . 0.0 110.845 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.54 -30.51 16.24 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.737 2.291 . . . . 0.0 112.325 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -65.17 -37.9 88.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.85 -43.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.43 68.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.091 -164.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.45 79.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.11 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.8 m -68.06 -39.21 83.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.176 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 68.0 ttp -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.905 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -65.94 -46.26 78.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 327' ' ' GLY . 43.3 p30 -80.07 -13.76 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.76 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 167.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -74.7 -18.26 60.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.29 -10.54 13.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -79.46 -162.22 23.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.506 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -125.59 126.49 44.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.91 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 96' ' ' ALA . 7.4 tp -65.65 126.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -176.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 65.1 ttp -71.22 119.92 76.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.12 144.49 69.39 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.702 2.268 . . . . 0.0 112.388 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.87 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.5 p30 -99.98 11.42 39.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.828 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 335' ' ' GLN . 34.5 mt -68.42 135.12 90.88 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 0.0 111.123 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.41 -34.39 50.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.585 ' H ' HG22 ' A' ' 333' ' ' ILE . 25.5 mm100 -65.34 -10.53 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.9 mmm -63.85 -25.74 68.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.4 m -63.77 -39.4 94.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.83 -33.88 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.099 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.84 -38.86 86.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 174.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -59.98 -53.33 59.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -63.27 -36.73 84.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.41 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.03 -44.18 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -57.17 -46.2 83.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.8 m -66.7 -42.94 85.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.464 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -61.17 -42.07 97.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 157' ' ' THR . 54.1 t -67.86 -46.74 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.37 -43.38 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 88.8 m-20 -64.77 -37.41 87.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.851 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -45.67 69.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.99 72.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.6 p -83.19 -8.26 59.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.62 13.33 83.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.95 -28.14 39.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.1 tt0 -148.2 145.17 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.0 p -73.43 164.97 25.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.404 HG13 HD23 ' A' ' 192' ' ' LEU . 58.8 t -69.77 -45.99 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.31 -36.08 82.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -74.44 -41.05 61.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -64.99 -42.58 94.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.35 -32.04 70.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 -39.9 94.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -69.12 -31.49 70.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.33 73.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -69.98 -31.38 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 86.1 m -63.02 -43.19 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.38 -40.79 93.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.847 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.67 -42.43 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.11 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.9 p -89.63 -2.15 58.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -174.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.1 mt -82.86 133.17 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -126.81 159.19 34.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -74.76 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.38 21.94 55.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -142.92 162.6 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.5 mt -130.39 135.83 48.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -125.11 110.17 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.22 139.43 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 -172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.473 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 66.1 m95 -116.84 126.73 53.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.95 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.469 HG23 ' HA3' ' A' ' 16' ' ' GLY . 21.1 tt -148.93 140.09 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.033 -169.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -47.83 118.64 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.946 -166.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.09 -25.42 62.09 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.429 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -57.42 -53.39 58.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.917 -169.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -137.94 88.77 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.917 148.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.469 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -116.71 -36.98 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.486 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -77.23 -50.12 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -154.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -67.95 -52.55 34.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -154.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.74 84.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.4 -39.52 79.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.16 98.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.17 -41.02 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.23 -48.5 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.68 -33.85 86.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.385 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -64.93 -43.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.951 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.85 -45.07 86.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.909 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -68.24 -35.61 78.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.13 -34.96 79.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.6 -34.37 65.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -77.17 -41.75 40.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -108.21 -18.13 13.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.229 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.49 4.6 89.17 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.54 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 33' ' ' ILE . 16.1 tt -74.29 116.79 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.156 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.38 124.87 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.09 140.0 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.176 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -134.41 113.6 12.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.5 128.78 60.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -126.2 161.67 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -95.45 122.52 59.13 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.562 0.696 . . . . 0.0 110.8 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HB3' HD22 ' A' ' 43' ' ' LEU . 88.7 Cg_endo -86.84 80.05 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.284 -168.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -93.58 -25.63 17.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 168.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.17 -16.54 23.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -171.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 40' ' ' PRO . 2.3 mp -56.92 -42.31 79.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.922 -157.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -52.23 -38.94 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -81.01 -34.02 33.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.838 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -71.92 -23.65 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.494 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.9 m-30 -49.63 -55.95 19.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.915 -164.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.2 Cg_endo -70.75 -29.3 19.37 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.751 2.3 . . . . 0.0 112.323 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -76.4 -50.1 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.927 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.578 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 30.9 m -61.49 -35.78 69.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.71 86.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -27.33 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 p -95.05 2.28 55.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.98 8.83 65.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -170.76 95.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -127.63 -116.95 2.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.474 154.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 48.4 Cg_endo -69.08 152.48 72.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.614 2.209 . . . . 0.0 112.353 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -87.06 -39.97 15.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -138.09 139.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mm -110.09 133.54 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.103 -166.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.451 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 11.5 p90 -67.38 170.94 6.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.468 ' CG ' ' HG ' ' A' ' 262' ' ' LEU . 39.9 p-90 -87.03 143.76 27.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.05 -121.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 167.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.86 -79.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 154.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -84.01 -13.89 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -61.35 -20.38 62.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -167.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 263' ' ' SER . 55.2 m-85 -56.89 -30.13 63.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -174.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -62.36 -43.75 98.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.508 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.375 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 5.0 m-30 -62.91 -38.65 91.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.877 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.46 95.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -65.07 -31.03 72.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.4 m -89.86 -4.91 57.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.74 27.63 73.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.83 -9.73 59.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.875 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 265' ' ' GLY . 0.0 OUTLIER -131.23 140.56 49.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.825 176.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -92.32 169.34 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.06 125.05 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.54 151.25 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.5 m -99.87 121.66 53.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.169 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.16 144.6 37.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.312 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -104.72 118.28 36.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.73 -38.98 73.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.95 81.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -70.83 -32.63 69.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.444 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 87.3 mt-30 -58.52 -46.77 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.931 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.65 -35.93 79.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -76.41 -20.56 56.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.817 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.438 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 85.3 mt -107.3 -147.35 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -129.33 143.59 49.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.665 0.745 . . . . 0.0 110.91 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.34 -36.73 65.62 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.29 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -65.34 -36.41 83.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.59 -23.13 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.211 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.444 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 88.4 m95 -70.04 -38.91 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.45 -31.49 70.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.82 -31.1 69.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 35.4 m -109.75 8.66 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -172.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -108.24 141.48 39.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -132.05 121.28 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 58.74 34.14 23.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.962 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.93 2.84 90.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.539 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -120.02 148.59 43.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.3 tp -81.0 129.02 34.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -173.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 pt -118.43 -7.6 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.121 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -162.45 166.95 24.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -175.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 82.1 m-85 -113.52 139.57 23.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.654 0.74 . . . . 0.0 110.982 171.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 19.9 Cg_exo -67.41 116.33 4.16 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.288 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.35 -33.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.94 154.98 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -166.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.48 127.77 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -114.22 126.37 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.82 148.28 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.03 150.66 38.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.7 m -145.72 162.75 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.765 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.06 120.07 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.431 HG12 HG22 ' A' ' 244' ' ' VAL . 73.5 mt -106.89 124.15 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.007 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -133.43 155.43 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -89.95 115.1 27.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.852 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.55 -26.61 65.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.92 -35.01 51.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.75 -52.2 7.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.75 108.58 28.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.647 0.737 . . . . 0.0 110.959 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.38 -15.08 17.98 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.701 2.268 . . . . 0.0 112.362 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -140.82 105.33 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.24 164.25 36.22 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.784 2.322 . . . . 0.0 112.374 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.6 152.45 59.5 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.88 -24.67 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 131' ' ' GLU . 9.2 t -143.38 157.21 44.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -68.4 -29.95 68.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.43 -28.96 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 128' ' ' THR . 87.3 tt0 -75.72 -24.69 56.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.771 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 26.4 mm -55.76 -53.41 63.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.605 0.717 . . . . 0.0 110.982 -169.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.0 Cg_endo -66.1 -42.82 10.03 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.669 2.246 . . . . 0.0 112.314 -172.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.45 91.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.21 -36.81 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.79 -40.81 95.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.38 -37.75 84.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.92 -44.54 76.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 139' ' ' LEU . 3.4 pp -84.49 -20.62 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -57.01 -27.77 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.5 65.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.07 10.04 32.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.4 67.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -104.7 157.17 17.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.768 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.6 t -110.49 146.12 36.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.72 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.37 -33.96 32.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.7 tp -130.81 145.49 51.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.6 ttm -109.07 127.12 53.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.914 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -163.78 158.49 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -130.91 -9.9 3.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.876 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 mt 54.12 34.94 21.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.28 -17.07 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.35 153.43 79.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.732 0.777 . . . . 0.0 110.877 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 49.0 Cg_endo -64.11 -24.76 66.08 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -38.02 72.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -71.91 -42.2 66.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.416 HG23 HD22 ' A' ' 195' ' ' LEU . 99.3 m -80.81 -35.4 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 -170.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.513 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 85.5 t90 -53.91 -43.96 97.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.606 0.717 . . . . 0.0 110.909 -163.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.707 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 87.2 Cg_exo -48.76 -39.14 38.54 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.11 -36.71 69.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.412 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 91.7 mt -69.03 -42.23 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.253 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.25 -14.05 59.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.154 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 255' ' ' SER . . . -55.8 -32.88 63.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.32 11.58 36.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -170.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.16 18.25 6.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.41 158.38 35.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.408 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.589 ' H ' ' HA3' ' A' ' 182' ' ' GLY . 87.3 m-85 -140.01 151.72 45.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.949 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.22 -61.11 2.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -137.15 147.47 45.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.962 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -68.25 124.22 22.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.86 110.9 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.926 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -144.14 143.76 31.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 48.07 42.79 17.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.86 10.09 80.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.583 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.833 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -91.29 129.72 37.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.43 109.87 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 178' ' ' ILE . 2.5 tp -64.56 -21.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.008 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.27 -6.72 52.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -119.92 96.2 5.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.0 m -104.33 153.84 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.589 ' HA3' ' H ' ' A' ' 167' ' ' TYR . . . -105.02 30.81 9.37 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.13 -16.78 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.907 0.384 . . . . 0.0 111.148 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -101.56 12.58 37.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 171.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.98 155.19 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 -174.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.73 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.085 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.85 -38.33 94.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -62.75 -38.01 88.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.13 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.85 -37.85 88.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.9 88.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.063 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -63.95 -41.12 98.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.457 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.23 -36.18 82.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -58.57 -39.98 81.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -55.45 -46.31 76.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.416 HD22 HG23 ' A' ' 157' ' ' THR . 60.5 tp -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.17 -40.38 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.03 -40.42 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.8 OUTLIER -60.89 -42.91 98.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 177.085 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.0 mt -70.17 -41.77 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.9 -34.83 78.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -81.81 4.33 22.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.0 34.16 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -75.61 -16.41 60.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 61.1 tpp -140.23 148.11 41.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.527 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.7 t-20 -89.63 134.95 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.69 70.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.062 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -96.05 -13.38 23.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 -171.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.527 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.7 m -70.15 139.02 52.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.58 174.1 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -62.43 -48.61 78.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.4 p -67.51 -34.46 77.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.97 -44.6 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.68 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.093 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -69.96 -36.77 75.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.803 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.2 82.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.076 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.59 97.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 171.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.0 -38.28 90.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.75 -24.5 65.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.64 -10.14 25.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.895 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.15 59.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.448 -174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -82.47 -24.04 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 0.0 110.993 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.2 m -121.01 130.67 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.75 69.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 76.1 mtm -135.25 150.47 50.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -168.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.4 p -145.84 165.5 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.65 124.26 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -154.29 162.59 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.64 -159.57 33.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.18 -16.42 19.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.599 2.199 . . . . 0.0 112.316 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -65.26 -37.21 86.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 59.59 17.99 6.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.493 ' O ' ' C ' ' A' ' 233' ' ' SER . 50.6 m0 -76.56 -53.21 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 232' ' ' TRP . 64.7 p 31.91 -94.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.867 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.6 t30 -151.27 38.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.943 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.8 tt -159.86 156.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.149 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -100.4 139.44 36.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.864 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 91.9 m -7.26 82.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 236' ' ' ASP . 87.7 p -62.15 160.37 12.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.761 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -139.81 -9.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.9 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.75 79.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 55.92 34.39 23.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -102.68 150.14 23.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.88 162.68 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 116' ' ' ILE . 58.8 t -126.16 130.28 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -135.63 174.71 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.78 158.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.87 145.89 51.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.57 0.7 . . . . 0.0 110.952 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -56.36 146.1 74.92 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.738 2.292 . . . . 0.0 112.371 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 77.7 p -130.48 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -116.86 118.96 33.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -169.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 51.44 39.46 24.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.01 63.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.559 166.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -109.99 157.34 38.1 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.631 0.729 . . . . 0.0 111.007 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.9 74.67 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 49.7 m -98.52 14.37 28.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -160.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -109.48 155.88 40.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.61 0.719 . . . . 0.0 110.858 -169.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.707 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 36.8 Cg_endo -68.65 171.81 12.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.394 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -56.94 159.97 3.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.41 128.7 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.45 147.26 16.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.428 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.22 125.0 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.165 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.468 ' HG ' ' CG ' ' A' ' 62' ' ' TRP . 4.3 tt -68.18 125.34 26.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 6.5 m -139.42 154.93 47.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.816 -166.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.89 137.87 36.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 76' ' ' LEU . . . -119.12 152.55 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.519 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.1 mt -111.5 120.45 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.372 . . . . 0.0 111.132 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -55.9 124.35 17.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.795 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.61 -25.43 65.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.05 -9.2 59.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.078 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.7 t -68.85 128.35 92.86 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.637 0.732 . . . . 0.0 110.954 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.14 -11.43 32.0 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.789 2.326 . . . . 0.0 112.366 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -109.27 24.26 13.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -54.85 -33.73 62.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.36 -41.11 57.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.39 -43.4 98.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.12 94.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.129 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.67 -47.17 76.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.41 -50.22 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.794 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -69.98 -34.94 74.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -173.407 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 280' ' ' LEU . 2.5 tt -56.03 -52.14 65.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.45 -26.39 55.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.833 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.06 -22.24 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.84 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 65.4 m-85 -122.66 -50.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 37.3 tp -68.65 -39.04 80.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.642 ' C ' HD23 ' A' ' 285' ' ' LEU . 3.0 tt -124.98 79.92 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 25.3 p -142.75 171.42 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 165.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.63 -42.11 67.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.96 -44.59 39.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.795 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.84 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.36 -47.93 8.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.44 -168.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -65.13 -33.41 75.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.869 -175.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.42 -41.04 88.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.23 94.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 290' ' ' LEU . 9.5 p -78.39 -28.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -65.16 -18.79 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.987 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -18.19 43.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -30.49 65.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -107.83 153.09 41.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.626 0.727 . . . . 0.0 110.868 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.05 -61.32 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.723 2.282 . . . . 0.0 112.406 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.94 -53.78 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 116.16 -56.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.47 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 46.86 69.2 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.184 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.437 HG22 HD21 ' A' ' 311' ' ' LEU . 19.3 m -111.49 155.9 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -162.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.58 -17.01 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.3 tp -81.81 120.59 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.48 -44.2 96.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -63.59 -49.99 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.834 -168.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -70.48 -32.62 70.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.1 -42.44 98.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.793 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.57 -35.29 72.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -172.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -79.76 -46.43 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.437 HD21 HG22 ' A' ' 302' ' ' VAL . 2.5 pp -73.41 -22.91 60.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.39 -5.63 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.97 -11.75 60.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.42 131.12 51.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.693 . . . . 0.0 110.844 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.58 -30.1 20.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.271 . . . . 0.0 112.298 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -64.97 -39.23 93.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.12 -42.51 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.5 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 -166.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.35 -35.46 73.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.74 82.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.8 -35.38 74.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -65.04 -37.78 88.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 327' ' ' GLY . 95.0 m-20 -67.97 -35.71 78.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.07 78.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.03 -19.66 60.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.34 -7.19 15.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -86.14 -163.11 37.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -128.7 135.93 49.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.677 0.275 . . . . 0.0 110.894 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.7 126.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.4 ttm -61.15 122.11 67.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.587 0.708 . . . . 0.0 110.91 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.03 132.16 37.25 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.306 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.424 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 50.6 p30 -95.12 10.07 37.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 pt -80.57 152.11 72.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 111.128 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.91 -25.04 67.78 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.755 2.303 . . . . 0.0 112.403 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.07 -16.5 60.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.79 -29.96 70.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.6 m -61.59 -41.37 97.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.758 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.49 -33.86 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.101 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.28 -46.1 83.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -60.02 -52.31 65.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.97 -46.04 89.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.93 89.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.154 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.79 -44.85 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.176 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.436 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 44.2 ttp180 -60.95 -43.34 98.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.1 m -64.99 -43.8 91.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.01 -43.16 93.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.061 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.6 -47.24 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 89.7 mt -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 85.8 m-20 -63.41 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.94 68.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.58 -34.02 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 -7.49 59.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.86 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 12.36 84.69 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.452 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -79.37 -29.02 41.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 48.1 tt0 -147.07 143.86 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -175.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.6 p -72.07 163.79 27.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -175.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 67.3 t -71.27 -45.77 68.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.14 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.58 -40.8 93.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.07 -46.14 58.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -65.38 -45.01 85.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.043 -176.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.71 -34.47 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.32 -39.71 94.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.94 -31.57 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.824 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -71.82 -46.99 56.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -31.32 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 94.6 m -63.74 -40.17 96.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -70.0 -38.41 75.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.89 -41.27 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -96.04 16.13 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.958 -178.907 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.789 0.328 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.2 mt -86.91 133.79 29.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.258 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.97 160.21 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.02 119.47 19.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.03 24.39 32.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.469 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -150.59 154.99 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 110.824 -170.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -151.14 146.78 26.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.2 t -129.61 124.22 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.97 140.93 45.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.435 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 56.0 m95 -115.0 123.2 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.0 tt -151.85 139.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 -167.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -49.59 115.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -166.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.95 61.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.485 -171.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -55.43 -50.67 69.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -135.45 83.33 2.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 147.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.01 -34.91 1.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.505 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.39 -46.81 15.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.871 -159.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -67.62 -55.28 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -155.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.505 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -66.72 -46.98 70.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.416 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.3 -38.55 80.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.841 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.98 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.14 -38.3 90.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.57 -43.52 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.103 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.43 -36.79 92.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.448 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.28 -45.51 84.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.918 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.3 -45.2 94.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -68.87 -34.98 76.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.837 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -63.69 -35.16 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -68.89 -32.37 71.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.797 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -86.57 -39.38 16.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.1 p -108.34 -22.87 12.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.195 -170.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.57 7.33 84.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.532 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.8 tt -72.07 125.36 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 111.064 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.96 125.7 27.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.7 140.11 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.164 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -134.85 115.64 13.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.7 t -104.82 130.81 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -124.94 157.77 35.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.95 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -85.02 122.86 74.15 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.459 0.647 . . . . 0.0 110.931 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HA ' HD13 ' A' ' 43' ' ' LEU . 71.3 Cg_endo -84.45 80.1 2.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.241 . . . . 0.0 112.239 -171.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -110.79 -15.41 13.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 166.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.8 -21.34 29.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 40' ' ' PRO . 4.6 mp -53.33 -45.65 69.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -157.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.27 -42.18 29.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.46 -32.28 37.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.896 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.18 -26.36 56.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 6.0 m-85 -52.56 -55.32 33.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.891 -164.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 51.3 Cg_endo -69.16 -29.77 26.18 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.71 2.273 . . . . 0.0 112.384 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -76.6 -50.53 13.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.744 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 27.0 m -61.27 -35.32 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.45 85.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.74 -26.41 66.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -92.17 2.85 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 7.5 65.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.414 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -172.75 97.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.924 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.744 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.07 -132.88 3.98 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 157.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 45.2 Cg_endo -71.81 154.61 58.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.582 2.188 . . . . 0.0 112.367 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.51 -37.95 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -137.31 137.0 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.127 -172.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.9 mm -119.4 134.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -76.97 134.9 38.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.466 ' CB ' ' H ' ' A' ' 263' ' ' SER . 31.3 t90 -60.36 144.26 51.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.08 -98.09 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -127.17 -89.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.932 158.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.4 -23.02 37.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -59.59 -30.98 69.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -161.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.415 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 58.6 t80 -58.23 -33.99 69.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -174.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.49 97.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.448 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.28 76.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.512 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.1 m-30 -63.95 -37.05 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.946 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.75 97.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.01 -28.16 68.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.6 m -81.43 -0.22 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.9 73.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.88 -6.79 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.998 -177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.99 146.15 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.8 163.23 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.48 128.52 36.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -112.87 148.17 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 124.53 37.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.515 0.674 . . . . 0.0 111.139 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.59 142.7 44.92 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.691 2.26 . . . . 0.0 112.305 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -106.13 121.68 44.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.953 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -39.27 68.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.08 87.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -68.35 -35.0 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.421 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.2 mt-30 -60.59 -47.98 83.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.28 -37.88 84.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.932 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.33 -24.27 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.6 mt -109.41 -149.78 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.84 150.23 75.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.923 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.72 -33.55 76.39 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.343 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.947 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.7 p -70.13 -27.07 64.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.097 -172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.421 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 50.5 m95 -69.25 -39.95 78.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.77 -35.13 73.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -70.25 -30.93 68.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.413 HG21 ' HD3' ' A' ' 107' ' ' PRO . 35.3 m -105.27 14.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 -172.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -115.63 143.59 45.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -139.25 127.56 22.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.91 35.06 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.871 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.81 3.47 89.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.59 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.97 149.89 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.794 0.33 . . . . 0.0 110.957 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 tp -84.08 124.18 30.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.35 -8.8 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.421 ' HB1' ' H ' ' A' ' 264' ' ' ALA . . . -161.74 167.9 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 77.4 m-85 -114.88 135.38 22.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.75 . . . . 0.0 111.008 167.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 32.2 Cg_exo -59.86 117.35 4.09 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.9 mt -102.94 -29.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -163.15 153.32 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -172.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.05 127.22 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.161 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -118.94 132.22 56.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.06 151.11 27.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 95.4 mt -71.76 145.93 48.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -173.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -142.23 160.96 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.6 tp -90.49 121.4 32.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.977 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 244' ' ' VAL . 66.2 mt -110.0 123.97 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.124 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -133.93 155.28 50.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -91.93 116.34 28.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.835 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.03 -27.18 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.94 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.3 -35.36 41.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.8 -46.1 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.34 110.09 21.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.613 0.721 . . . . 0.0 110.894 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.83 -15.22 16.96 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 0.0 112.372 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -149.39 108.86 3.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.617 0.723 . . . . 0.0 110.847 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.47 157.43 61.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.66 145.1 56.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.353 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.17 -24.96 19.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -173.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -149.4 163.85 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -69.85 -28.26 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.3 -28.71 69.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.987 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -77.32 -20.48 54.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.884 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 24.7 mm -57.73 -53.36 66.52 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 -171.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 35.4 Cg_endo -68.23 -43.06 4.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.82 92.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.66 -36.47 82.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.941 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.58 -41.28 96.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.55 -40.04 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.26 -45.35 76.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 139' ' ' LEU . 3.4 pp -85.46 -20.07 30.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.32 -26.47 65.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.95 -19.51 65.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.38 9.47 33.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.881 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.31 28.36 64.08 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -106.57 158.72 16.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 110.826 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.4 t -110.68 146.95 35.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.772 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.09 -35.29 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.8 tp -132.21 145.05 51.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -109.16 128.71 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -170.32 163.92 8.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -129.11 -7.44 4.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.7 mt 54.33 32.5 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.22 -10.23 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -141.12 149.85 56.86 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.721 0.772 . . . . 0.0 110.87 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.74 -16.73 51.14 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -54.98 -41.61 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -70.5 -33.67 71.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.3 p -83.13 -22.62 33.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 7.6 m0 -58.76 -48.97 95.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.618 0.723 . . . . 0.0 111.002 -168.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 99.8 Cg_exo -49.31 -38.85 43.15 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.694 2.263 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.56 -35.41 73.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.482 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.1 mt -78.93 -39.09 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.91 -17.08 63.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.19 87.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.428 ' O ' ' HA3' ' A' ' 187' ' ' GLY . 98.9 m-20 -106.58 -0.38 23.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.35 36.01 2.01 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.661 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -120.75 146.38 17.54 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 166.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -155.26 156.18 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.812 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -43.7 -50.4 7.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -89.42 126.47 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.61 115.21 23.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.0 0.429 . . . . 0.0 110.879 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.43 143.49 29.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.873 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 48.09 44.03 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.936 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.51 5.77 60.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.69 148.87 51.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -93.39 126.24 38.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 171.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.84 112.93 24.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.6 tp -74.99 -23.19 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.02 -12.47 33.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -128.18 95.3 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.0 p -103.07 147.11 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.3 31.66 8.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.532 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.9 m -93.76 -19.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 172.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -103.3 24.06 11.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -87.76 160.61 17.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.09 89.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 164' ' ' ASP . . . -66.51 -41.58 94.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.509 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.661 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -61.29 -40.11 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.44 -38.63 90.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.19 -44.45 88.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.126 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.34 -41.57 96.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.388 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.33 -41.01 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 70.5 m -60.15 -40.17 88.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.069 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.34 -42.64 96.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.27 -45.1 92.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.905 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.06 -40.16 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.12 -36.1 82.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.8 OUTLIER -63.97 -38.25 90.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -38.21 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.071 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.24 -39.09 91.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -83.48 3.06 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 64.42 38.51 7.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.89 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -75.01 -10.32 59.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 tpt -143.49 152.33 41.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.509 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 65.7 t30 -86.16 142.74 28.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.61 74.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.055 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -96.73 -14.4 22.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 64.3 m -66.67 134.83 53.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -110.8 171.38 7.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.835 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -64.79 -35.79 82.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.6 p -70.85 -38.42 73.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.02 -42.61 95.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.092 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.67 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.43 -39.44 77.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.45 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.03 97.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.45 -39.33 93.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -61.55 -27.15 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.83 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.41 -9.35 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.3 16.46 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -82.67 -22.7 34.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.907 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.4 m -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.87 -38.06 73.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -171.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 69.6 mtm -135.16 154.91 51.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.6 t -152.99 165.68 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.44 124.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.09 164.63 38.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.62 12.2 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.84 -16.49 33.0 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.704 2.269 . . . . 0.0 112.328 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -75.04 -25.26 58.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 56.17 21.98 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.506 ' O ' ' C ' ' A' ' 233' ' ' SER . 44.9 m0 -76.63 -48.54 18.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.506 ' C ' ' O ' ' A' ' 232' ' ' TRP . 51.1 p 32.32 -96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.034 0.445 . . . . 0.0 110.867 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.1 t30 -143.65 36.29 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.7 tt -159.99 158.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -104.2 138.31 40.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 53.0 m -8.92 82.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 85.8 p -70.29 169.31 14.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -153.65 13.76 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 47.4 t -88.78 77.84 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 53.37 36.91 24.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -102.19 151.09 22.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 169.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.78 159.82 24.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 116' ' ' ILE . 58.1 t -128.44 130.75 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.0 0.429 . . . . 0.0 111.157 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -142.11 178.21 7.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 160.09 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.055 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.16 155.99 76.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.698 . . . . 0.0 110.932 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -56.44 140.45 89.01 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.763 2.308 . . . . 0.0 112.355 -173.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.5 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 86.6 m -123.74 130.86 53.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.121 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -103.37 112.24 25.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 46.74 41.13 9.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 168.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.87 26.2 65.29 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.443 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 96.3 mm-40 -113.56 159.07 36.85 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.639 0.733 . . . . 0.0 110.915 -169.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 71.8 Cg_endo -68.95 68.76 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.662 2.241 . . . . 0.0 112.376 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 79.6 p -92.02 24.71 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.417 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 63.3 mttp -114.88 158.91 39.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 110.87 -163.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.426 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 43.7 Cg_endo -73.57 171.79 17.05 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 0.0 112.247 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -62.0 161.76 10.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.56 127.7 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.141 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.71 143.54 15.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.454 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.3 t -123.76 126.01 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.085 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.5 tt -67.7 126.48 29.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.466 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 24.9 m -129.38 148.07 51.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -166.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.421 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -142.98 137.93 29.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.09 159.35 18.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.556 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.42 123.55 66.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -56.15 126.15 24.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.98 -27.5 65.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.73 -9.37 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.7 t -67.61 129.47 93.46 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 0.0 110.906 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.89 -14.03 42.2 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.792 2.328 . . . . 0.0 112.295 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -115.36 27.02 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.851 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -54.06 -30.96 50.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -72.97 -37.87 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.413 HD13 HD12 ' A' ' 33' ' ' ILE . 39.5 mt -65.42 -45.39 84.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.61 91.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -67.41 -46.75 72.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.05 -49.32 76.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 -171.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -68.2 -34.64 76.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -174.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.4 tt -57.08 -51.49 69.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.89 -38.88 73.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -102.49 -23.07 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.691 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 48.5 m-85 -118.73 -45.97 2.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 -172.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 36.0 tp -73.29 -43.97 60.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 54.9 tp -121.1 73.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 33.1 p -141.53 172.24 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -52.6 -46.71 67.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.811 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.95 -40.18 32.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.806 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.691 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.7 -45.79 20.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.568 -171.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 26.2 tp -64.86 -32.98 74.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.832 0.349 . . . . 0.0 110.94 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.42 -43.48 98.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.25 99.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.05 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.505 HG23 ' HA3' ' A' ' 19' ' ' GLY . 14.5 p -80.39 -33.27 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.502 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 39.7 t30 -72.91 -21.3 60.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -55.92 -22.97 28.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.85 -20.61 24.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -99.68 156.12 35.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -59.81 -62.42 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.346 -171.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.31 -48.0 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.502 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 101.68 -43.79 1.65 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.463 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.47 71.69 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 111.116 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.53 153.24 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.125 -155.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.6 -18.62 58.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.8 tp -79.13 114.18 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.74 -45.62 93.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -166.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.1 m -67.23 -48.45 67.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.53 -38.99 82.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -36.53 71.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.861 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.26 -47.61 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.88 -15.39 60.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.51 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.24 -9.6 58.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -87.75 125.23 65.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.541 0.686 . . . . 0.0 110.846 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -47.27 -28.73 8.45 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 0.0 112.321 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.414 ' HG2' HG21 ' A' ' 244' ' ' VAL . 88.8 mtm180 -63.93 -37.3 86.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 40.7 mm -88.69 -42.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.146 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.9 -37.56 76.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.79 -37.6 79.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 92.8 m -67.21 -39.65 86.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -65.15 -44.41 88.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -65.84 -46.32 78.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.905 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 327' ' ' GLY . 4.3 p-10 -79.49 -15.72 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.839 -174.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.42 82.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -71.3 -17.14 62.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -112.63 -9.76 13.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -81.37 -165.46 34.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -129.19 147.19 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 96' ' ' ALA . 6.0 tp -64.22 128.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -172.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 64.7 ttp -55.06 136.08 67.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.543 0.687 . . . . 0.0 110.908 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.48 80.52 1.37 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -103.02 4.91 37.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.434 HG22 ' H ' ' A' ' 335' ' ' GLN . 50.8 mm -81.37 137.58 48.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.628 0.728 . . . . 0.0 111.127 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.41 -35.5 21.52 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.434 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.0 mm-40 -82.04 -30.97 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.946 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 60.9 mtt -67.43 -18.58 65.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 84.4 p -60.65 -25.66 66.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.836 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.27 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -66.91 -38.86 87.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.81 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -62.98 -54.05 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -59.63 -45.69 91.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.21 83.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -173.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.35 -30.3 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -59.84 -46.55 88.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.9 m -64.65 -44.44 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.625 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -62.73 -43.78 97.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.51 -49.26 61.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.49 -43.6 97.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 82.2 m-20 -61.31 -35.81 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.81 70.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.34 -34.87 70.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.172 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.4 p -80.95 -8.35 59.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.79 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.41 11.75 85.2 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -80.51 -24.33 39.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.661 0.267 . . . . 0.0 110.788 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 59.3 tt0 -148.39 146.84 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.009 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 56.8 p -73.58 165.19 25.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.04 -45.85 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.063 -171.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.27 -41.33 98.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -72.72 -42.43 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.934 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.625 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -63.0 -43.69 98.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.1 -33.77 74.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.69 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.928 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.95 -30.98 71.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -69.45 -45.2 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -65.12 -38.3 90.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 80.5 m -59.82 -41.68 91.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.97 -40.65 78.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.9 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 53.2 p -103.4 33.78 3.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.202 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -175.991 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.9 mt -87.44 136.67 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.1 mt-10 -129.71 162.61 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.78 122.57 24.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.99 22.87 34.31 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 92.6 mttt -145.45 165.67 27.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.93 144.82 25.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.98 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.29 122.82 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.128 -173.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.87 140.09 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 58.8 m95 -118.41 123.71 45.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 21.2 tt -148.79 139.92 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.2 -169.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -47.49 119.03 2.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -164.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.81 -24.26 64.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.496 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -53.7 -57.0 12.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.953 -170.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -139.6 89.91 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 148.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.73 -29.13 1.92 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -80.45 -47.98 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.949 -154.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.94 -51.73 55.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -154.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.74 -45.95 71.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.483 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.2 tp -58.62 -40.26 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.75 -42.17 98.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.054 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.34 -41.61 98.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.04 -48.02 80.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.06 -35.97 92.23 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -67.02 -42.72 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.792 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -58.81 -42.71 89.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.958 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.492 ' CE2' HG21 ' A' ' 33' ' ' ILE . 19.7 t80 -66.81 -35.3 79.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.86 -35.93 82.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -72.25 -33.99 67.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.51 -42.16 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.3 p -107.77 -15.45 14.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.195 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.05 4.33 89.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.504 -175.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.2 tt -73.41 116.42 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 111.15 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.28 123.99 21.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.49 145.48 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -140.62 116.96 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.35 129.97 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -125.17 161.45 26.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -94.6 121.9 62.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.546 0.688 . . . . 0.0 110.809 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' CB ' HD22 ' A' ' 43' ' ' LEU . 72.0 Cg_endo -86.67 81.21 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.634 2.223 . . . . 0.0 112.318 -167.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -91.98 -26.3 18.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -92.36 -17.37 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.412 HD22 ' CB ' ' A' ' 40' ' ' PRO . 1.9 mp -54.03 -43.75 70.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -157.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -49.28 -40.98 36.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.66 -33.93 35.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -71.33 -25.67 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.484 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.9 m-30 -49.55 -55.83 20.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.797 0.808 . . . . 0.0 110.968 -163.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 58.2 Cg_endo -71.4 -29.26 16.98 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -177.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -76.72 -50.58 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.694 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 35.4 m -59.5 -34.01 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 -175.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.71 84.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.073 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -25.76 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.8 p -93.3 3.11 56.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.85 3.77 60.5 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -172.5 95.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.872 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.694 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -123.26 -132.42 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 154.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 50.6 Cg_endo -73.8 155.0 48.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.617 2.211 . . . . 0.0 112.343 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -84.6 -39.61 18.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -135.1 134.78 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.5 mm -119.1 135.28 60.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.16 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' A' ' 11' ' ' ILE . 17.7 p90 -74.13 158.67 33.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CB ' ' H ' ' A' ' 263' ' ' SER . 49.0 t90 -88.13 147.8 24.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.46 -95.46 0.45 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.05 -85.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 156.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -86.38 -13.18 47.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -58.52 -25.94 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 -154.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -60.0 -32.13 70.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -176.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.782 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -60.74 -44.75 97.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.47 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.7 93.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.8 m-30 -61.79 -42.48 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.68 -43.82 97.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -64.97 -30.1 71.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -84.68 -1.0 55.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.843 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.34 29.02 74.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.44 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 66.0 mt -74.63 -17.38 60.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -135.02 145.78 48.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -166.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.64 158.29 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.112 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.42 131.05 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.38 147.82 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.244 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -101.55 123.22 45.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.536 0.684 . . . . 0.0 111.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 147.49 30.83 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.749 2.299 . . . . 0.0 112.365 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -108.38 119.05 38.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -39.61 75.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.45 -42.97 83.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -69.57 -34.05 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.466 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.5 mt-30 -60.73 -44.74 96.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.0 -41.04 91.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.53 -24.8 59.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 304' ' ' LEU . 83.6 mt -108.23 -145.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -137.29 140.18 30.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 0.0 110.866 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.18 -35.43 63.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.83 -37.74 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.882 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.6 p -74.09 -25.13 59.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.164 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.466 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 49.3 m95 -74.08 -38.39 63.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.31 -34.14 74.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.968 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.93 67.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 27.4 m -112.62 19.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.136 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 58.9 mtm180 -116.37 140.13 49.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.774 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' HB3' HG21 ' A' ' 104' ' ' ILE . 85.2 t80 -139.64 127.92 22.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -175.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 56.12 32.77 20.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.75 3.24 90.66 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.415 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -115.57 150.03 37.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.927 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 64.5 tp -85.01 120.74 26.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' A' ' 99' ' ' TYR . 36.9 pt -115.19 -13.88 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -167.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -156.63 161.46 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.486 ' HB3' HD11 ' A' ' 285' ' ' LEU . 79.7 m-85 -103.22 134.66 19.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.701 0.762 . . . . 0.0 110.977 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.479 ' HD3' HG21 ' A' ' 97' ' ' VAL . 62.9 Cg_endo -81.65 118.99 3.24 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.236 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.31 -31.13 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 -171.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.51 153.69 19.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.146 -163.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.43 124.46 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -111.28 113.87 26.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.79 146.36 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.69 147.17 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.1 m -142.25 159.71 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -91.59 119.99 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.99 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 244' ' ' VAL . 31.0 mt -112.78 124.34 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -132.65 156.06 47.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -165.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -91.96 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.71 -24.46 66.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.902 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -75.75 -37.24 59.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.52 -51.12 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.98 105.74 44.62 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.591 0.71 . . . . 0.0 110.895 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.01 -14.89 26.25 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.438 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.7 t-20 -155.92 104.08 2.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 0.0 110.837 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.6 Cg_endo -66.83 160.51 46.42 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.312 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 34.1 Cg_endo -68.46 144.27 60.69 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.722 2.282 . . . . 0.0 112.364 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.17 -17.26 31.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.985 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -148.52 166.03 29.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.136 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -69.16 -25.69 64.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.787 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.79 -30.3 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.873 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.54 -22.4 43.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.901 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.631 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 81.3 mt -63.39 -50.44 73.92 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.604 0.716 . . . . 0.0 111.12 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 36.4 Cg_endo -67.83 -40.28 9.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.686 2.257 . . . . 0.0 112.254 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.52 95.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.414 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 57.1 tp -60.66 -38.84 86.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 132' ' ' ILE . 10.3 t70 -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.62 -37.93 83.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.35 -45.47 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.819 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 139' ' ' LEU . 3.5 pp -85.08 -20.32 30.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.402 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -58.23 -27.04 63.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.924 170.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -17.92 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.98 9.25 34.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 29.31 63.58 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.476 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -112.3 158.58 19.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.3 t -114.74 151.04 34.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 164.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -78.02 -43.92 28.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.042 -173.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.81 144.43 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.952 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -109.95 131.32 55.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -166.74 159.12 13.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -122.32 -16.22 7.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.4 mt 50.68 36.72 14.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -99.29 -14.07 19.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -142.59 148.66 47.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.569 0.7 . . . . 0.0 110.95 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.55 -25.07 75.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -54.23 -42.79 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.418 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 70.4 m-85 -73.19 -30.33 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 -177.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -76.83 -25.1 52.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.519 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 24.1 m0 -56.48 -46.15 99.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.602 0.715 . . . . 0.0 110.917 -164.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.758 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 74.9 Cg_exo -47.62 -44.57 25.67 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.674 2.249 . . . . 0.0 112.377 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.3 mt -75.28 -34.35 61.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.96 -42.15 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.54 -18.53 56.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.14 80.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 -160.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -98.88 13.39 32.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.08 12.45 6.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.51 170.63 53.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.498 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -165.07 165.0 20.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.919 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.94 -73.54 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.88 148.8 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -66.12 125.41 25.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.871 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -114.86 114.33 25.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -151.35 144.9 24.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.863 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 47.71 44.25 17.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.889 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.0 7.85 71.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.65 146.95 50.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -90.5 130.6 36.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -87.17 107.52 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.9 tp -64.77 -19.92 26.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.44 -2.93 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.951 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -120.57 95.98 4.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.21 153.25 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.148 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . -105.03 28.59 14.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.04 -12.9 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.313 . . . . 0.0 111.066 176.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.418 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 53.8 p-10 -103.33 13.48 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.95 156.58 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -171.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.06 66.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.1 96.7 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -65.48 -34.88 79.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.155 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -63.94 -40.34 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.06 86.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.97 -44.03 95.09 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.428 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 357' ' ' VAL . 34.3 tp -68.23 -40.0 82.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.957 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.7 m -58.85 -40.81 85.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.219 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.66 -43.23 99.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.974 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.32 -42.48 91.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.71 -39.98 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.27 -35.59 79.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -37.34 86.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.13 -38.2 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.222 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.56 -38.22 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.869 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -82.24 1.82 34.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.78 34.95 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.92 -16.49 58.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.811 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 205' ' ' ASN . 19.0 tmm? -137.81 141.81 40.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.444 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 60.8 t30 -92.73 134.93 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 -167.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.35 -11.0 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 51.9 m -75.49 140.12 42.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -98.64 167.28 10.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -66.48 -36.61 83.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.7 p -71.96 -36.33 69.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.69 -43.69 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.185 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 216' ' ' ALA . . . -73.39 -32.55 64.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.69 -36.11 73.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.16 84.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -63.81 -40.21 96.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.59 -21.83 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.787 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.27 -9.94 19.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.848 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.72 16.97 59.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.44 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.547 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 95.8 mt-10 -84.63 -28.33 26.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.973 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.0 m -123.43 130.08 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.93 92.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 -166.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.9 mtm -137.81 155.26 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 72.4 p -141.8 167.38 22.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.8 mm -118.88 115.03 46.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.65 156.81 48.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.44 -170.05 46.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.516 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.51 -19.06 11.81 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -69.96 -30.96 68.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.97 14.9 9.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.659 ' O ' ' C ' ' A' ' 233' ' ' SER . 33.5 m0 -74.28 -50.25 19.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 172.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.659 ' C ' ' O ' ' A' ' 232' ' ' TRP . 89.4 p -4.64 -80.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.843 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -171.92 4.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.944 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.98 117.83 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.646 ' O ' ' C ' ' A' ' 237' ' ' THR . 40.6 t0 -130.58 150.61 51.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.646 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.1 m -6.68 75.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 236' ' ' ASP . 93.0 p -63.22 153.96 32.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 170.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.52 -16.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 52.3 t -88.89 75.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 44.44 44.39 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.41 148.76 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 164.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.56 165.93 26.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.47 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 116' ' ' ILE . 46.4 t -128.6 131.06 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 111.164 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -143.0 -177.59 5.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.09 158.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.209 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.532 HD22 ' HD3' ' A' ' 257' ' ' PRO . 13.3 tp -76.72 139.58 66.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.711 . . . . 0.0 110.98 -173.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.83 138.0 15.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.231 . . . . 0.0 112.419 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 96.9 m -138.82 137.39 36.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -168.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -106.02 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.798 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 45.34 42.93 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.36 52.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.442 165.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -114.83 158.36 40.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.688 0.756 . . . . 0.0 110.969 -169.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -64.93 74.75 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 61.3 m -92.46 3.34 55.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 62.8 mttp -107.07 157.1 36.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.61 0.719 . . . . 0.0 110.9 -157.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.758 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 34.5 Cg_endo -65.82 160.42 43.96 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.621 2.214 . . . . 0.0 112.297 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -75.14 166.45 23.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.35 131.07 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 -167.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.64 147.08 16.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.483 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.12 122.73 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.927 0.394 . . . . 0.0 111.105 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.29 128.79 37.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.473 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 27.8 m -130.22 152.3 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.814 -164.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -142.97 136.44 28.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.06 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.18 17.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.472 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.0 mm -110.1 125.63 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 0.0 111.084 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 54.9 t-20 -58.91 124.71 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.813 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.31 -29.29 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.052 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.28 -9.7 58.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.0 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -68.15 128.55 93.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.738 0.78 . . . . 0.0 110.913 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.31 -11.7 32.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -114.91 25.0 11.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.902 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.74 -32.67 53.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.89 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.11 -37.96 63.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.63 -45.42 90.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.023 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.63 -43.28 76.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.08 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -65.11 -51.25 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.61 -44.81 92.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -35.24 74.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.5 tt -55.62 -52.04 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.21 -27.28 47.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -96.34 -7.26 35.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 -169.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.751 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 32.4 m-85 -115.94 -57.6 2.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.64 -37.61 79.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -172.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 106' ' ' TYR . 49.8 mt -99.94 41.4 1.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.96 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 75.1 p -137.74 162.09 34.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.53 -48.54 77.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.45 -38.92 71.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.751 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -76.41 -46.32 12.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.547 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.0 tp -65.44 -36.37 83.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.49 -44.75 89.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.64 95.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -30.67 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.436 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 52.2 t30 -74.12 -12.15 60.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.39 -25.99 62.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -93.57 0.0 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -116.39 155.88 47.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.717 . . . . 0.0 110.923 169.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.52 -62.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.704 2.269 . . . . 0.0 112.412 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.0 mt -108.81 -43.97 4.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.436 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 97.97 -61.31 0.95 Allowed Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.533 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 54.97 85.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.082 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.75 156.94 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.22 -156.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.99 60.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 89' ' ' LEU . 47.7 tp -79.78 117.82 21.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.11 -44.26 95.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.881 -171.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 90.2 p -67.11 -52.81 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -171.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.53 -34.67 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.37 -40.11 95.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.38 -36.88 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.69 -47.83 29.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.413 HD12 HG21 ' A' ' 317' ' ' ILE . 3.9 pp -74.7 -16.59 60.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.12 -4.67 37.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.195 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.67 -10.22 59.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -87.18 131.22 45.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.536 0.684 . . . . 0.0 110.844 175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.26 -29.23 12.54 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.649 2.233 . . . . 0.0 112.336 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -66.35 -39.09 88.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 311' ' ' LEU . 36.0 mm -84.62 -42.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.91 67.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.118 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.49 -38.97 81.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.06 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.3 m -68.43 -40.81 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.214 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -64.33 -43.91 93.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.56 -45.28 79.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 256' ' ' LYS . 44.9 p30 -78.52 -18.76 54.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.894 -173.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.81 84.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -72.98 -17.4 61.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 -9.13 14.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.16 -161.34 34.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.472 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -125.7 129.27 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.312 . . . . 0.0 110.914 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 38.2 mm -67.51 123.61 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.207 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.82 123.62 85.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.485 0.66 . . . . 0.0 110.887 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.3 146.4 40.52 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 122.627 2.218 . . . . 0.0 112.366 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.782 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 55.5 p30 -99.99 13.64 33.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.441 HG12 ' H ' ' A' ' 335' ' ' GLN . 16.7 tt -75.18 138.94 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 111.091 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.62 -25.7 20.65 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.735 2.29 . . . . 0.0 112.372 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.441 ' H ' HG12 ' A' ' 333' ' ' ILE . 99.5 mm-40 -63.89 -14.54 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.991 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.1 mmm -62.86 -25.89 68.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -58.91 -40.12 83.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.779 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.28 69.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 368' ' ' ILE . 87.3 t80 -58.43 -43.67 88.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -59.87 -57.58 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -61.62 -33.69 74.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.88 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.19 84.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.2 t -69.84 -39.94 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.151 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -57.49 -49.63 75.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.817 -172.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.3 m -65.88 -43.89 86.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.39 98.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.093 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.4 t -68.94 -49.89 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.214 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 94.4 mt -61.59 -41.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.155 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 84.1 m-20 -61.86 -38.17 87.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.37 73.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.09 68.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.137 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.7 p -80.41 -7.96 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.844 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.48 11.93 84.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.446 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.98 -27.13 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.744 0.307 . . . . 0.0 110.793 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.6 tt0 -147.51 146.4 29.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.0 p -71.11 164.56 25.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.24 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.407 HG13 HD23 ' A' ' 192' ' ' LEU . 76.8 t -73.33 -45.6 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -170.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.44 -38.37 90.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.849 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -73.23 -37.75 66.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.93 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 184' ' ' ASP . 0.4 OUTLIER -64.68 -36.16 83.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.18 -40.43 97.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.888 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -69.97 -33.12 71.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.2 -48.38 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.153 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.92 -32.27 70.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 75.1 m -63.29 -41.99 99.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.99 -38.27 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.88 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 339' ' ' PHE . 86.5 mt -63.64 -43.51 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.219 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 44.3 p -102.5 35.61 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.638 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -86.47 133.77 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.9 mt-10 -123.87 158.96 30.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.29 122.35 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.79 22.62 49.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.497 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 96.4 mttt -140.54 156.04 46.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.37 137.92 50.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.5 t -123.89 113.72 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.55 137.84 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.089 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 59.8 m95 -113.66 123.28 49.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.654 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 18.1 tt -150.94 144.08 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 -168.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -48.54 119.72 3.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -170.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.5 -21.51 60.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.477 -172.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.51 -48.31 81.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.24 83.43 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 149.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.57 -46.23 1.56 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.532 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.05 -44.86 29.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.9 -157.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.09 -53.09 42.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -154.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -65.27 -48.53 68.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.446 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 11' ' ' ILE . 2.7 mp -61.84 -36.84 82.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.897 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.94 83.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.33 -41.39 96.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.44 -41.59 88.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.535 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.06 -48.74 80.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.41 -43.09 99.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.988 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.42 -36.21 80.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.91 -34.29 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.23 -34.0 77.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -88.4 -39.71 14.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.429 ' HB ' HG22 ' A' ' 33' ' ' ILE . 62.2 m -110.1 -24.46 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.191 -167.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.35 7.75 79.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.476 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.757 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -87.07 127.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 111.02 -177.343 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.94 137.34 39.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.57 140.03 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.187 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -128.52 111.84 13.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 11' ' ' ILE . 94.4 t -104.32 127.98 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -124.77 158.23 33.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -83.67 135.98 42.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.654 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 71.8 Cg_endo -90.0 68.31 1.9 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -166.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -101.04 -32.29 10.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.793 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.22 -16.06 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 40' ' ' PRO . 5.9 mp -50.94 -51.61 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -158.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.14 -35.6 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.7 mmtt -76.13 -30.06 58.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.812 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.516 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.0 m-30 -51.29 -56.12 23.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.646 0.736 . . . . 0.0 110.844 -167.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.4 Cg_endo -67.76 -29.84 34.95 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.733 2.289 . . . . 0.0 112.314 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -78.58 -49.96 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.429 HG21 ' HD2' ' A' ' 57' ' ' PRO . 32.1 m -66.93 -32.02 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.093 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.9 92.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.16 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -94.31 1.08 55.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.35 78.88 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.422 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -169.66 101.87 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 110.924 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' CA ' ' HB ' ' A' ' 50' ' ' VAL . . . -125.05 -130.74 3.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.471 161.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.429 ' HD2' HG21 ' A' ' 50' ' ' VAL . 49.2 Cg_endo -71.42 156.64 58.12 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 -175.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.07 -43.28 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -136.65 138.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.14 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.14 134.98 60.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.427 ' CE1' HD21 ' A' ' 262' ' ' LEU . 83.4 t80 -78.71 136.31 37.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -62.87 143.96 57.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.1 -100.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -127.33 -85.9 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 160.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -87.13 -21.76 25.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -57.63 -28.92 64.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -166.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -61.72 -33.65 74.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -65.01 -43.59 95.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.546 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.43 -32.98 85.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.512 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -66.72 -34.29 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.86 99.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.43 -27.49 67.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.7 m -83.2 -1.0 51.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.907 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.84 28.63 71.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.509 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.79 -7.69 59.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.982 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.0 pp -135.13 146.01 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.66 159.65 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.1 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.64 129.37 39.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -113.33 150.6 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.153 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -105.21 124.16 37.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.255 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.9 139.58 40.09 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.718 2.278 . . . . 0.0 112.282 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.74 121.72 38.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.82 -39.36 68.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.52 95.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.082 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -65.79 -34.68 78.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.32 -43.94 95.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.23 -41.87 93.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.74 -24.43 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.98 -177.59 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.16 150.24 37.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.942 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.3 -38.13 36.6 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.737 2.291 . . . . 0.0 112.322 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -76.79 -20.13 56.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 71.7 p -75.5 -26.0 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.111 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -69.99 -37.15 75.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.995 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.67 -33.95 74.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.23 65.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 30.6 m -105.63 11.36 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -111.4 140.33 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -138.01 125.14 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.19 34.8 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.45 1.71 88.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.435 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.22 147.99 44.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 tp -78.6 129.37 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.913 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.3 pt -118.16 -5.41 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.09 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -162.42 166.67 24.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.477 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.4 m-85 -112.44 136.84 21.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.713 0.768 . . . . 0.0 110.981 167.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 39.1 Cg_exo -61.76 117.17 3.98 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.246 174.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 96.6 mt -104.33 -38.43 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -156.74 155.33 31.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.195 -170.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.0 t -124.19 128.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.147 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -115.59 120.0 37.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.832 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.86 147.33 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.104 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.58 148.96 36.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.0 m -141.53 161.08 38.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.76 122.16 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.08 128.39 67.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.053 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -133.49 154.37 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -91.87 116.34 28.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.829 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.86 -26.99 68.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -174.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.17 -32.25 33.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.881 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.08 -48.5 8.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.6 tp -127.69 111.71 20.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.662 0.744 . . . . 0.0 110.967 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 -15.15 17.62 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.818 2.346 . . . . 0.0 112.335 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 45.5 t30 -149.68 107.13 3.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -173.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.2 Cg_endo -67.63 161.87 41.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.336 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HD3' HD13 ' A' ' 135' ' ' LEU . 44.8 Cg_endo -72.7 144.38 39.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.609 2.206 . . . . 0.0 112.477 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.98 -22.99 21.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 167.31 26.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -67.13 -29.93 69.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.07 -30.22 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.77 -22.76 45.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 80.9 mt -62.34 -51.37 74.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.669 0.747 . . . . 0.0 111.075 -167.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.28 -39.05 10.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.252 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.48 90.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.064 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 135' ' ' LEU . 4.7 tt -62.18 -37.02 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 140' ' ' LYS . 8.7 t70 -66.35 -42.76 87.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.98 -38.72 73.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.18 -49.67 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.0 pp -80.22 -18.43 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.945 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' N ' HD12 ' A' ' 139' ' ' LEU . 84.4 tttt -57.13 -30.42 64.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 171.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.88 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -103.59 7.92 37.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.5 29.86 61.11 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.486 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -106.48 164.48 12.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.1 t -116.05 149.09 39.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.8 165.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.5 -28.48 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.105 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 tp -137.86 143.35 40.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.4 ttm -120.46 128.94 53.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -166.32 163.19 17.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.758 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -130.14 -4.36 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.869 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.3 mt 53.07 34.31 16.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -92.11 -16.61 26.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -132.42 146.2 60.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.677 0.751 . . . . 0.0 110.866 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -59.97 -23.25 72.23 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -54.57 -32.51 58.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -71.81 -36.67 70.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 p -86.19 -23.74 26.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.482 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.6 m95 -56.09 -44.99 99.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.585 0.707 . . . . 0.0 110.936 -168.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 72.2 Cg_exo -46.42 -40.23 22.63 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.279 . . . . 0.0 112.31 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.4 -38.08 30.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 93.3 mt -69.87 -51.41 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -172.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.71 -15.7 60.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 -176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.38 -31.71 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.119 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -92.02 0.78 57.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 -172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.05 13.75 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.556 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.36 166.37 31.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.423 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -174.43 154.45 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.347 . . . . 0.0 110.936 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -41.6 -63.38 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 176' ' ' TYR . 20.6 p90 -142.09 155.61 45.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.29 123.65 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -119.74 117.18 27.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -147.58 142.36 26.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -172.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 51.9 40.43 28.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.28 76.55 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.522 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.09 146.87 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.337 . . . . 0.0 110.829 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.503 ' HB2' ' CD1' ' A' ' 169' ' ' PHE . 17.1 p90 -101.56 141.61 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.63 110.97 23.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.2 tp -71.42 -19.66 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.08 -5.23 57.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -125.25 95.03 4.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.857 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.0 m -101.09 158.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.89 16.64 39.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.451 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.8 m -100.01 -19.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -98.99 19.82 14.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.52 154.2 20.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -172.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.26 70.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.018 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.54 94.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.493 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.5 81.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 111.195 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.02 -38.55 88.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.56 97.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -61.88 -40.11 98.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.429 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 357' ' ' VAL . 38.8 tp -67.86 -38.13 82.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 83.1 m -60.45 -41.19 93.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.182 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -57.85 -45.48 86.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.4 -45.11 94.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.5 -41.51 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.24 -38.24 90.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.43 -38.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.132 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.0 -32.03 73.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -81.56 3.32 25.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.55 33.96 10.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.999 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -77.07 -18.96 57.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 tpt -143.83 150.09 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 66.2 t30 -87.49 141.8 28.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.3 -32.62 68.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -175.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -96.16 -16.2 21.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -171.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 70.9 m -67.26 135.62 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.033 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -102.22 169.92 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -65.0 -47.54 77.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.863 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.31 -43.62 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.108 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.38 -32.67 70.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -64.22 -40.59 96.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.034 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.072 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -63.81 -39.83 95.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.934 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -61.47 -25.88 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.784 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.22 -8.11 40.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.04 17.3 63.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.495 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -83.5 -21.75 32.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.5 m -123.15 131.02 53.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.18 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.37 -38.88 65.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 74.2 mtm -135.51 154.88 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.902 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 166.77 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.0 mm -119.17 125.33 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.169 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -147.47 155.56 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.79 -163.42 31.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.458 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.21 -14.88 18.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.755 2.303 . . . . 0.0 112.346 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -62.84 -30.55 71.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.983 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.79 20.06 12.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.666 ' O ' ' C ' ' A' ' 233' ' ' SER . 48.0 m0 -71.38 -41.1 70.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.666 ' C ' ' O ' ' A' ' 232' ' ' TRP . 52.8 p 2.92 -91.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -153.99 3.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.876 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 19.5 tt -164.92 155.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 -168.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 238' ' ' SER . 54.6 p30 -102.17 -173.86 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' THR . . . . . 0.56 ' C ' ' O ' ' A' ' 236' ' ' ASP . 48.2 m -9.96 82.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.204 163.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 236' ' ' ASP . 45.6 m -40.86 136.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 -31.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 240' ' ' VAL . 61.4 t -89.12 68.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -174.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 54.29 33.02 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 171.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 238' ' ' SER . 91.4 m-85 -105.56 152.66 22.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 167.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.09 158.86 24.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 316' ' ' ARG . 62.1 t -130.2 130.68 65.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.18 177.49 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.16 160.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.58 148.88 74.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.31 144.26 72.45 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.609 2.206 . . . . 0.0 112.417 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.1 p -129.18 150.03 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -125.77 111.19 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 48.34 37.95 9.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.96 26.08 56.51 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 167.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -109.6 156.78 39.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.551 0.691 . . . . 0.0 110.965 -169.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 75.2 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.438 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.3 p -92.24 -1.37 57.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -170.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -102.29 155.86 35.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.539 0.685 . . . . 0.0 110.945 -167.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.79 167.47 24.39 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -68.01 153.91 42.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.6 t -118.69 130.04 74.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.151 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -100.25 141.9 15.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.477 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.5 124.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -65.02 124.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.6 m -128.74 155.28 45.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.837 -168.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.417 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -138.19 134.97 35.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.04 141.95 15.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.2 mt -113.81 125.03 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.067 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -59.09 125.07 22.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.0 -27.32 65.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.06 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.89 -8.17 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.058 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -66.21 130.3 94.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.719 0.771 . . . . 0.0 110.883 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -65.73 -16.32 52.78 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.816 2.344 . . . . 0.0 112.275 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -110.92 21.11 16.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.881 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -51.8 -34.54 40.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.21 -36.5 58.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 33' ' ' ILE . 40.7 tp -61.06 -45.27 95.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.074 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -65.05 -45.76 84.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.76 -51.28 67.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.828 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.19 -35.29 76.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -172.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 280' ' ' LEU . 3.9 tt -55.91 -50.33 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.996 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.63 -35.68 65.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -102.74 -23.34 13.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.729 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 61.9 m-85 -122.16 -43.84 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 -171.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 30.8 tp -74.18 -42.31 60.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.918 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 51.0 tp -124.57 74.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 37.0 p -141.48 173.44 11.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.201 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.3 -45.15 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.14 -44.09 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.827 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.729 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.07 -45.89 18.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.443 -168.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 302' ' ' VAL . 45.6 tp -61.99 -34.49 76.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.34 . . . . 0.0 110.879 -176.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.88 -40.26 88.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.874 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.95 94.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.472 HG23 ' HA3' ' A' ' 19' ' ' GLY . 11.1 p -81.98 -35.81 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.236 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.35 -22.55 60.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.953 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -61.84 -13.4 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -171.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -83.46 0.16 47.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.799 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -111.58 153.32 44.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.868 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.59 -61.98 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.717 2.278 . . . . 0.0 112.368 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 84.2 mt -98.63 -36.1 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 111.44 -58.09 0.41 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.498 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 49.26 70.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.126 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.412 ' HB ' HD21 ' A' ' 290' ' ' LEU . 35.6 m -112.18 152.2 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -167.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.37 -13.4 59.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 55.3 tp -76.61 120.2 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.8 -47.03 86.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -64.96 -48.36 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -172.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -69.26 -36.68 77.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -65.64 -34.54 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.45 -39.38 94.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -69.77 -43.57 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.02 -24.13 65.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.27 -5.55 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 -173.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.49 -17.75 62.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -86.96 128.62 55.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.531 0.681 . . . . 0.0 110.915 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.32 -30.7 20.67 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.429 ' HG2' HG21 ' A' ' 244' ' ' VAL . 94.4 mtt-85 -69.91 -37.39 75.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 39.2 mm -79.14 -40.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.49 -41.94 83.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.8 m -64.8 -41.52 95.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.214 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.94 -42.81 94.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -66.39 -46.2 77.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.908 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 327' ' ' GLY . 25.8 p30 -78.21 -18.12 55.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.48 82.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.112 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.24 -25.45 59.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.78 -9.97 20.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.83 -155.95 31.47 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.457 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -122.75 129.4 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.2 mm -72.73 127.47 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.264 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.406 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 59.8 ttm -63.37 124.89 85.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 330' ' ' MET . 36.5 Cg_endo -64.21 135.12 45.39 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.745 2.297 . . . . 0.0 112.329 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.662 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.7 p30 -95.08 13.22 25.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 -172.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 335' ' ' GLN . 48.3 mm -75.12 130.36 80.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 111.203 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.98 -28.11 74.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.518 ' H ' HG22 ' A' ' 333' ' ' ILE . 92.2 mt-30 -64.95 -13.86 58.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.973 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.87 -21.49 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -58.57 -35.6 72.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.58 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -63.0 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.957 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -58.69 -52.01 67.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.922 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -64.32 -44.65 90.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.53 94.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.167 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 76.5 t -71.79 -42.39 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -57.52 -45.79 84.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.3 m -65.53 -44.64 86.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.065 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.456 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -63.76 -40.57 97.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.086 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.66 -48.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.5 -45.36 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.237 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 83.5 m-20 -63.54 -37.08 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.91 -45.52 67.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.16 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.21 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.7 p -81.9 -8.98 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.11 84.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -81.0 -25.68 37.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 110.823 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 41.7 tt0 -149.9 145.38 26.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.4 p -72.55 163.73 27.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.418 HG13 HD23 ' A' ' 192' ' ' LEU . 54.3 t -65.32 -45.93 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.116 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.08 -42.82 96.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.32 -46.23 61.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -62.08 -42.14 98.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.024 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.3 -39.97 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.906 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.06 -41.69 90.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.873 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.53 -44.02 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.33 -48.08 11.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.222 -168.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -70.95 -32.31 69.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 -170.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 59.0 m -60.61 -33.26 72.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.8 -27.97 67.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.78 -40.18 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.3 p -102.54 -16.7 16.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 178.259 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.27 128.99 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.02 166.28 21.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.77 123.91 25.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.946 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.01 29.46 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.453 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -141.07 154.78 46.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 110.929 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 33' ' ' ILE . 7.2 tt -139.07 130.36 26.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.796 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.24 124.79 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.6 mt -118.84 134.82 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.824 ' HB3' HD21 ' A' ' 43' ' ' LEU . 39.7 m0 -111.7 123.73 50.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.965 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.51 160.22 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.867 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.7 t-20 -55.85 120.14 6.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 167.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.54 -20.89 79.42 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.482 -171.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -57.74 -45.47 85.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.844 -167.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.3 mmtt -130.67 75.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 148.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.5 -46.3 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.504 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -75.82 -45.75 34.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.939 -154.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -63.98 -52.66 58.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -157.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -64.18 -43.91 96.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.532 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.5 -37.52 83.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.99 -44.57 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.47 -52.2 66.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.6 m -75.25 -34.01 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.88 -39.6 93.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.484 175.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -70.11 -42.97 71.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.72 -39.64 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.98 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.28 -35.09 75.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 171.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.63 -34.12 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.81 -33.6 72.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -83.96 -39.96 19.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.2 p -109.09 -16.98 13.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.142 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.67 5.39 86.66 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 7' ' ' LEU . 14.1 pt -88.07 125.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.195 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.84 129.64 39.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG21 ' HA3' ' A' ' 24' ' ' GLY . 14.4 p -100.78 139.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.081 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -140.95 121.41 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.19 128.67 61.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 88.3 tt0 -112.24 151.85 29.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -79.28 161.46 67.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.839 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.867 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 59.9 Cg_endo -102.97 24.05 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 -160.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -76.45 -43.62 39.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.99 -14.32 36.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.824 HD21 ' HB3' ' A' ' 10' ' ' TRP . 3.5 mp -52.03 -50.9 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 -161.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.9 -41.28 61.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.25 -35.56 61.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.863 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.25 -28.93 62.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.53 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m-30 -49.24 -54.91 24.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.593 0.711 . . . . 0.0 110.898 -162.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 86.8 Cg_endo -80.03 -31.11 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.211 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -74.65 -48.32 26.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -168.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.48 -30.76 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.52 -37.82 87.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.83 63.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 p -97.68 -1.11 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.101 -171.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.591 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 75.63 18.46 79.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.523 -176.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -109.73 -175.16 2.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.864 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.7 -165.9 12.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.505 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.617 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 89.5 Cg_endo -82.79 178.45 6.03 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -87.88 -38.72 15.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 164.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.9 mt -131.06 139.6 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.2 143.23 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.058 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -100.05 142.85 30.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.51 126.65 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.76 -90.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -110.75 -83.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -95.91 -17.44 21.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 80.3 mtp180 -59.72 -25.7 65.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.435 ' CD2' HD11 ' A' ' 104' ' ' ILE . 10.1 p90 -52.39 -37.43 56.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -49.06 9.86 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.495 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.6 86.17 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.48 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.568 ' HB3' HD21 ' A' ' 75' ' ' LEU . 25.4 m-85 -71.66 -30.4 65.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.942 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.93 69.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.63 -29.86 70.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -83.98 -1.74 55.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 110.934 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.35 25.02 66.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.4 pp -85.99 -5.41 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.825 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -131.41 146.09 52.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.944 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 147.62 24.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.21 142.88 50.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 103' ' ' LEU . 39.2 pt -101.99 145.97 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.6 p -132.25 70.26 80.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 111.08 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.37 144.35 45.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.381 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -86.61 -174.52 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.71 -37.48 84.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.46 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.14 -36.18 81.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.82 -37.76 87.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -54.42 -29.43 49.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.856 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 93.2 mttt -54.02 -36.83 63.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.254 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 160.22 123.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.503 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 13.7 m-85 -158.26 51.6 0.47 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.72 . . . . 0.0 110.862 167.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 55.7 Cg_endo -70.8 -71.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.642 2.228 . . . . 0.0 112.335 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.41 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 42.9 p90 -102.76 -19.06 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 168.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -69.14 -20.53 64.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.142 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 90' ' ' TYR . 17.6 t90 -58.86 -43.23 90.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.78 -27.2 68.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.565 ' HB1' ' HB ' ' A' ' 261' ' ' VAL . . . -74.5 -30.6 61.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.033 -169.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -116.43 14.99 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.479 ' HB3' HD23 ' A' ' 103' ' ' LEU . 52.4 ptt85 -118.25 147.15 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -135.43 125.39 25.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 t30 60.29 35.13 20.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.857 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 5.28 90.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.574 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 148.5 44.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 98' ' ' ARG . 83.9 mt -86.95 122.26 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.435 HD11 ' CD2' ' A' ' 67' ' ' PHE . 44.6 pt -122.79 -1.9 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.71 31.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -111.47 146.26 34.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.68 0.752 . . . . 0.0 110.902 174.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.59 122.46 6.94 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.712 2.275 . . . . 0.0 112.402 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.7 -37.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.079 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.42 152.09 10.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.5 128.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.122 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -122.55 126.37 47.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.53 155.97 38.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.447 HD12 ' HG2' ' A' ' 257' ' ' PRO . 94.7 mt -76.46 144.33 39.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.1 m -140.66 156.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.453 ' HB2' HD23 ' A' ' 247' ' ' LEU . 43.0 tp -94.47 127.65 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 244' ' ' VAL . 68.7 mt -113.98 130.5 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.169 172.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -136.76 155.83 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 36.4 t-20 -92.0 111.7 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.581 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.5 mttt -65.17 -28.29 69.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 31.7 t70 -76.04 -33.22 59.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.84 -44.96 13.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.4 tp -121.03 109.62 35.38 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.71 0.767 . . . . 0.0 110.954 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.5 -15.6 19.59 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.0 112.361 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -147.12 109.55 3.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 0.0 110.845 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.35 154.39 74.41 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.686 2.258 . . . . 0.0 112.356 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.24 140.71 37.78 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.64 -25.75 22.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.4 t -149.97 174.32 12.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.119 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -74.53 -24.44 58.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -169.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.73 -32.4 73.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.895 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.75 -23.18 58.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -172.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 88.7 mt -66.31 -51.78 41.52 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.63 0.728 . . . . 0.0 111.126 -168.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.56 -40.42 56.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.703 2.268 . . . . 0.0 112.303 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.2 -43.6 98.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.3 -38.36 80.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 9.8 t70 -64.59 -36.23 83.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.49 -37.05 85.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.95 -58.0 4.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -78.7 -11.76 59.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 86.6 tttt -56.46 -30.37 62.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 169.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.03 -21.03 66.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.9 6.64 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.24 28.06 64.83 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 7.0 mptt -119.72 156.52 30.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.887 0.375 . . . . 0.0 110.92 174.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -115.76 153.97 30.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -72.55 -49.34 33.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 52.8 tp -143.44 125.7 15.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.2 mmm -133.19 131.42 40.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 174.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.93 167.65 28.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 210' ' ' TYR . 60.1 t-20 -50.87 111.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 206' ' ' ALA . 8.0 tp -115.31 19.96 15.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -92.19 -2.46 56.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.04 145.8 53.43 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.612 0.72 . . . . 0.0 110.874 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.477 ' HB3' ' HB2' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -68.15 -27.66 35.19 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -58.79 -35.43 72.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.21 -26.63 22.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.828 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.8 p -87.57 -32.31 19.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.65 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 58.6 t90 -55.01 -52.3 72.24 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.516 0.674 . . . . 0.0 110.99 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.6 Cg_endo -54.98 -32.18 77.52 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.624 2.216 . . . . 0.0 112.402 -175.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.46 -35.19 73.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.424 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -72.42 -41.66 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.17 -18.89 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.164 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.97 2.63 53.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.13 11.87 6.06 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.597 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.17 165.19 53.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.45 ' HD2' ' HA3' ' A' ' 182' ' ' GLY . 98.1 m-85 -140.33 175.86 9.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.989 0.423 . . . . 0.0 110.882 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 339' ' ' PHE . . . -112.03 -33.68 6.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -148.35 134.76 19.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.825 -173.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 1.072 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -89.89 121.55 32.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -170.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -127.46 113.12 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.02 142.66 24.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.0 32.77 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.16 -2.8 64.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.3 152.99 49.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.731 0.301 . . . . 0.0 110.888 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 64.9 m-85 -83.15 122.74 28.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 63.0 t0 -128.77 118.67 23.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -175.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.793 ' HA ' ' HE3' ' A' ' 170' ' ' LYS . 8.5 tp -57.04 -20.8 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.21 -15.77 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -174.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -110.58 47.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.704 ' HA ' ' HB3' ' A' ' 170' ' ' LYS . 8.6 p -99.11 145.66 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.45 ' HA3' ' HD2' ' A' ' 167' ' ' TYR . . . -110.75 22.8 21.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.539 -171.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 m -92.09 -23.27 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 0.0 111.143 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -106.63 25.12 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -99.06 -171.95 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.41 80.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.001 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -43.21 93.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.75 88.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.06 -41.71 97.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.22 -41.11 86.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -68.14 -47.2 60.52 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.449 -175.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.05 -38.7 86.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 72.9 m -57.67 -43.36 84.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -66.04 -43.61 87.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.8 tt -55.96 -46.36 78.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.936 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.57 -39.37 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -60.1 -34.74 73.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.791 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.77 -33.86 76.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.95 -39.84 45.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.201 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.66 -38.59 87.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -86.94 2.11 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 61.69 31.41 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -83.85 -30.88 26.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.0 mtt -139.55 145.5 38.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.835 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.587 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -97.32 135.78 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.434 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -67.61 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -98.25 -12.7 21.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -166.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 53.1 m -59.03 127.36 31.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -95.5 171.3 8.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 70.5 t80 -57.8 -39.39 77.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -59.04 -43.69 91.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.91 -45.53 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.41 -41.11 80.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.822 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.36 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.29 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -64.74 -39.71 94.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.88 -24.0 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.76 -10.0 32.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.14 52.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.456 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -87.66 -21.07 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 110.898 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 91.0 m -127.17 133.25 50.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.185 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.16 -32.31 64.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -172.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 73.4 mtm -135.44 148.55 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -148.68 165.39 31.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 91.8 mt -130.99 127.9 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.406 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 46.2 p30 -152.7 167.25 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.946 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.84 -129.59 3.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -168.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.97 -18.64 18.65 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.734 2.29 . . . . 0.0 112.433 -165.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -55.02 -30.77 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.917 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.07 42.43 28.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.99 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.517 ' O ' ' C ' ' A' ' 233' ' ' SER . 67.5 m95 -56.64 -25.01 52.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.899 167.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 232' ' ' TRP . 28.1 p 30.64 64.13 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -68.48 -12.13 60.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 37.3 pt -90.24 -5.14 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.54 -48.52 10.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -61.33 -57.81 10.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 40.7 t -161.21 128.23 4.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.797 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.55 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.09 174.46 10.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.02 -66.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -163.98 94.75 0.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 27.7 m-85 -115.45 160.28 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.818 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.581 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -138.98 168.4 24.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.425 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.432 HG22 HG12 ' A' ' 116' ' ' ILE . 60.4 t -125.02 129.19 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.9 p -131.18 171.61 13.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.83 165.33 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.024 167.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.483 ' HB2' ' HE2' ' A' ' 256' ' ' LYS . 90.8 mt -77.55 145.23 71.15 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.617 0.722 . . . . 0.0 110.968 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 75.6 Cg_exo -55.63 148.87 51.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.659 2.239 . . . . 0.0 112.374 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -131.12 154.72 48.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -132.06 109.65 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 46.76 42.68 12.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 164.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.63 25.11 57.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -108.58 157.89 35.41 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.914 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.01 74.97 0.33 Allowed 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.727 2.285 . . . . 0.0 112.426 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 93.5 p -86.42 -7.66 58.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.8 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 247' ' ' LEU . 13.9 ptpt -135.38 155.37 78.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.546 0.688 . . . . 0.0 110.869 -168.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.466 ' HG3' ' HG3' ' A' ' 159' ' ' PRO . 53.6 Cg_exo -61.3 164.91 13.87 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -60.34 162.27 6.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.901 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 324' ' ' ALA . 98.1 t -116.23 129.86 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.148 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.67 11.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.565 ' HB ' ' HB1' ' A' ' 96' ' ' ALA . 86.8 t -122.16 125.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.112 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 54.0 tp -71.41 134.32 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.6 p -132.23 156.78 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.69 137.15 51.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.071 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.71 169.74 23.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.495 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.73 133.89 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.163 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -61.85 125.54 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.17 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.14 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.591 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -80.65 -13.86 58.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.9 t -72.49 130.49 85.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 0.0 110.903 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.91 -10.32 28.16 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.716 2.277 . . . . 0.0 112.388 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -107.01 33.87 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -169.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -53.06 -40.2 63.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.9 -36.95 75.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 48.0 tp -61.11 -48.26 82.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.021 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.46 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.094 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.55 -47.32 79.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.67 -42.38 82.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 37.0 t80 -60.82 -44.5 96.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 284' ' ' LEU . 31.8 tp -65.89 -51.13 61.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -76.25 -35.18 59.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -170.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -106.27 -16.45 14.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.843 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 87.2 m-85 -120.52 -50.96 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.924 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 280' ' ' LEU . 49.6 mt -71.22 -42.79 68.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.947 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.03 62.0 7.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.9 p -136.73 168.0 20.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -55.0 -45.44 75.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.95 -41.03 37.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.09 -47.43 13.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 -171.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 20.1 tp -69.54 -35.38 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.788 0.328 . . . . 0.0 110.951 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.04 -45.21 91.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.77 76.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.517 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 84.3 t -78.94 -47.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -73.84 -16.39 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.07 -23.28 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 92.6 m-20 -73.95 -19.62 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -85.69 152.2 56.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.563 0.697 . . . . 0.0 110.938 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 -22.49 52.88 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.753 2.302 . . . . 0.0 112.318 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.5 mt -101.89 -46.22 4.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.04 72.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.444 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -67.87 128.8 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 111.051 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 307' ' ' TYR . 19.8 m -117.76 151.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.02 60.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.0 tp -73.85 120.62 19.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.07 -48.36 82.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -171.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -59.13 -46.93 87.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 -170.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.457 ' HB3' HG21 ' A' ' 302' ' ' VAL . 2.2 t80 -73.93 -32.98 63.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.54 -35.65 76.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.11 -34.74 73.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -76.13 -39.69 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.833 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 302' ' ' VAL . 96.1 mt -68.96 -23.33 64.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 176.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.62 -9.36 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.057 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.72 -17.16 59.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.907 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -88.21 120.0 70.45 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.522 0.677 . . . . 0.0 110.932 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.77 -31.96 34.97 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.23 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.422 ' HG2' HG21 ' A' ' 244' ' ' VAL . 94.5 mtm-85 -69.34 -44.8 70.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.12 -39.93 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.15 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.82 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.078 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 75.0 m -66.68 -43.01 85.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.193 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.15 -36.33 81.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.67 -33.58 72.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 176.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -65.21 -34.78 79.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.869 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.437 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -60.82 -36.86 80.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.08 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.5 -23.37 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.01 -11.44 20.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.44 -159.89 34.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -124.18 127.98 48.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.6 ' O ' ' O ' ' A' ' 330' ' ' MET . 37.5 mm -79.95 119.13 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 -165.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.6 ' O ' ' O ' ' A' ' 329' ' ' ILE . 2.1 ppp? 37.14 171.43 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 0.0 110.899 -163.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 330' ' ' MET . 90.4 Cg_endo -69.95 -157.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 171.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -135.08 -46.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 37.9 pt -129.79 158.44 73.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.532 0.682 . . . . 0.0 111.234 167.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 33.1 Cg_endo -63.61 -21.62 70.31 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.424 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -14.89 59.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.515 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 37.1 mmt -64.94 -27.95 69.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -60.52 -39.02 86.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.66 67.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.109 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.7 t80 -55.81 -49.37 73.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -58.88 -44.12 91.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.012 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -59.03 -42.79 91.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.75 85.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.53 -40.81 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 154' ' ' PRO . 42.6 ttt180 -54.2 -52.64 60.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 74.8 p -66.41 -36.04 81.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.36 94.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.07 -49.43 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -64.6 -41.87 93.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.14 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -64.3 -38.49 91.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.37 71.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.053 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.84 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -80.36 -7.92 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.68 12.71 81.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.458 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.64 -28.56 51.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.63 0.252 . . . . 0.0 110.775 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -139.52 155.87 47.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 71.9 p -79.01 168.13 20.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.08 -47.69 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.62 -42.34 91.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -71.89 -37.92 70.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.06 94.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.075 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.99 -35.28 78.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.02 -42.36 94.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.29 -34.14 76.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.51 68.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.162 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -40.43 97.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 84.4 m -63.02 -41.88 99.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.044 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.92 -35.11 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.65 -41.51 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.228 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.5 p -94.09 -11.6 30.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -178.404 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.664 0.268 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.74 135.8 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.79 179.87 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.2 120.43 20.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.99 23.54 27.35 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.389 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -143.24 151.86 41.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.7 pp -143.77 144.0 31.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.816 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.06 125.22 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.061 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mt -117.01 134.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.672 ' CZ3' ' HD3' ' A' ' 57' ' ' PRO . 27.6 m0 -114.87 128.13 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 17.6 tt -152.4 157.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.448 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.7 t-20 -56.65 120.35 7.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 166.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.713 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -77.36 -22.07 71.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.466 -168.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.39 -48.89 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 -164.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.6 mmtt -130.32 79.6 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 145.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.62 -38.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.49 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -74.59 -44.79 49.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -160.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -66.02 -51.67 56.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.912 -159.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -60.23 -44.49 97.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.576 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.29 -39.05 81.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 110.849 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.94 85.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.062 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.17 -49.56 73.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.44 -32.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.71 93.14 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.522 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -70.04 -43.07 72.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.3 -40.41 96.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.97 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.09 -39.79 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.861 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.99 -33.58 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -73.3 -35.55 66.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -82.05 -41.32 20.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -103.0 -22.25 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -172.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.21 4.99 87.8 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.55 120.55 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 111.195 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.85 120.44 11.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG13 HD11 ' A' ' 7' ' ' LEU . 78.8 t -96.9 135.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -136.31 116.65 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.73 126.4 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.169 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -110.46 162.04 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -64.87 163.34 29.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.535 0.683 . . . . 0.0 110.944 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.713 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 70.2 Cg_endo -99.03 -2.16 0.89 Allowed 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.706 2.271 . . . . 0.0 112.397 -161.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.66 -31.27 59.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -160.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.64 -10.59 24.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 61.3 mt -51.56 -55.74 17.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -158.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.3 -32.35 68.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -168.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.21 -34.69 61.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.54 -28.35 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.515 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 8.2 m-30 -48.75 -54.41 27.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.789 -163.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 83.8 Cg_endo -78.59 -29.23 3.79 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.877 2.384 . . . . 0.0 112.272 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.66 -49.42 18.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.0 -170.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -65.95 -30.71 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.07 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.89 -37.13 85.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 -26.25 63.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.013 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.5 p -97.96 -1.24 43.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.124 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.13 18.36 80.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -107.71 -174.95 2.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.92 -166.99 13.21 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.672 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 89.7 Cg_endo -82.89 173.5 10.18 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 7' ' ' LEU . 30.5 m-20 -85.9 -36.41 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 166.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -132.37 139.74 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 47' ' ' PHE . 7.2 mt -131.89 143.24 40.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -105.88 139.78 39.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.51 ' O ' HD12 ' A' ' 262' ' ' LEU . 23.9 m-90 -121.14 133.2 55.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 173.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -52.29 -90.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -171.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -110.97 -81.45 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.49 -23.71 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -159.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.79 -38.06 69.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -51.17 7.69 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.496 -168.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.13 91.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' HB3' HD21 ' A' ' 75' ' ' LEU . 27.9 m-85 -74.86 -31.25 61.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.56 68.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -61.35 -28.11 68.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.809 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -85.24 3.48 39.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 25.46 64.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.7 pp -87.41 -5.14 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 0.0 110.892 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 76' ' ' LEU . 4.2 pp -133.15 144.8 50.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.1 152.31 19.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.35 144.57 48.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.827 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -109.09 152.54 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -133.46 67.13 75.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.671 0.748 . . . . 0.0 111.139 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.66 143.05 41.18 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.617 2.211 . . . . 0.0 112.325 166.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -81.0 -176.58 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.79 -32.24 73.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.819 -173.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.97 64.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -67.23 -36.27 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.87 -43.99 94.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.21 -35.13 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 97.4 mttt -67.23 -31.33 71.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -171.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.235 ' O ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER 173.99 78.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 -177.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 38.0 m-85 -151.06 41.49 0.22 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 0.0 110.885 168.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 67.1 Cg_endo -72.48 -70.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.218 . . . . 0.0 112.27 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.493 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 99.1 m-85 -92.98 -28.04 16.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.564 HG21 ' HB1' ' A' ' 303' ' ' ALA . 66.7 p -71.94 -22.17 61.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -162.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -62.47 -42.86 99.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.96 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.42 -24.56 66.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.568 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -74.54 -31.91 62.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.08 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.37 16.08 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 -170.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -119.39 145.56 46.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -136.33 127.18 27.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 59.48 34.82 22.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.6 5.65 89.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.481 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.6 145.04 43.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.91 113.58 25.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.6 pt -124.21 -2.3 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.093 -161.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.96 157.25 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -170.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.1 m-85 -106.35 136.89 19.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.724 0.773 . . . . 0.0 110.911 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 24.4 Cg_exo -65.3 114.37 2.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.749 2.3 . . . . 0.0 112.372 174.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.42 -31.75 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.89 152.27 6.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.74 124.8 68.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.062 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -123.85 137.57 54.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.975 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.79 144.13 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.2 m -142.92 158.94 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB2' HD23 ' A' ' 247' ' ' LEU . 64.0 tp -92.31 120.08 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 244' ' ' VAL . 61.9 mt -108.52 126.32 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -136.13 157.49 46.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 -167.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 30.2 t-20 -94.0 112.24 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.484 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.6 mttt -63.89 -26.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.89 -33.66 30.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.86 -48.73 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 173.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -123.23 109.4 31.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.623 0.725 . . . . 0.0 110.941 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.34 -15.05 20.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.562 2.175 . . . . 0.0 112.387 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.5 t-20 -148.43 107.11 3.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.759 0.79 . . . . 0.0 110.841 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -66.06 152.34 81.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.669 2.246 . . . . 0.0 112.302 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.23 142.7 51.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.287 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -88.62 -17.08 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.9 t -147.66 166.29 27.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -68.13 -29.34 68.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.21 -27.86 69.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.21 -33.47 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.568 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 97.9 mt -67.66 -45.09 45.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 111.052 -159.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 80.3 Cg_exo -50.78 -49.56 16.47 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.22 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 135' ' ' LEU . 2.1 tt -54.23 -35.61 62.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 175.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 25.1 t70 -65.82 -34.82 79.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.29 -37.54 87.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 -172.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.64 -56.91 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -172.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 145' ' ' SER . 1.9 pt? -79.8 -11.87 59.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -173.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -53.53 -30.27 40.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.936 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.3 -19.8 65.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -104.71 12.58 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.829 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 24.84 73.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -117.77 156.22 28.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.857 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.456 ' O ' HD11 ' A' ' 139' ' ' LEU . 48.2 t -115.78 153.48 31.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -71.92 -53.29 13.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.8 tp -147.1 135.4 21.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mtp -124.04 134.58 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 169.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -149.24 165.34 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.807 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.448 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 55.3 t-20 -64.72 113.56 3.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -172.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.8 tm? -92.88 -23.91 18.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -77.77 -4.38 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.89 152.2 80.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.606 0.717 . . . . 0.0 110.889 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 61.7 Cg_endo -79.65 -20.71 9.1 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.616 2.21 . . . . 0.0 112.404 -174.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -57.28 -45.53 83.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 45.5 m-85 -81.32 -27.02 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.419 HG21 HD22 ' A' ' 151' ' ' LEU . 72.1 p -87.12 -30.06 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.049 -171.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 82.5 t90 -56.2 -47.72 98.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.474 0.654 . . . . 0.0 110.96 -172.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 99.1 Cg_exo -49.52 -39.31 45.56 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.614 2.209 . . . . 0.0 112.383 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 160' ' ' LEU . 4.9 tt -74.06 -38.86 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.957 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.5 mt -67.32 -37.94 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.41 -13.67 59.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.92 67.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 -167.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -94.55 5.93 50.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.98 15.2 3.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.538 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.65 153.38 38.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.512 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.519 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 98.7 m-85 -135.06 152.04 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.906 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.01 -38.04 7.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -143.67 140.29 29.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.812 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -98.55 125.61 43.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.92 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.05 110.06 19.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.007 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -151.17 140.77 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 48.97 37.33 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 4.47 64.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.477 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.48 153.49 49.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 -173.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.14 131.23 39.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.979 168.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -110.79 120.2 41.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.99 -20.38 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.49 -16.77 44.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -98.94 66.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.5 p -108.47 139.16 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.519 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -107.88 32.22 7.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -168.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.0 -35.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.995 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -102.88 29.13 5.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.72 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -99.09 -172.2 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.941 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.97 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.81 -44.89 94.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.515 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.03 86.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.861 0.362 . . . . 0.0 111.12 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.77 -40.23 91.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.809 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.49 89.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.45 -43.53 94.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.522 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.01 -38.4 88.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -58.93 -43.65 91.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -63.24 -42.37 99.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.58 -45.09 92.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.84 -40.24 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.38 -39.38 94.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.7 OUTLIER -63.57 -42.67 98.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.59 -38.73 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.16 -36.82 80.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -83.78 3.62 32.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 64.56 33.73 10.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -78.91 -24.69 43.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 28.3 ptm -147.7 160.59 42.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -94.13 134.08 36.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.94 67.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -89.44 -3.27 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.897 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.2 m -56.46 126.71 27.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -103.48 170.12 8.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -65.88 -32.71 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.009 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 92.2 p -69.74 -36.08 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.2 mm -65.14 -42.31 93.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.71 94.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.103 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -69.69 -38.77 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.05 85.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.023 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.2 -39.35 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -66.5 -40.91 89.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.27 -19.77 65.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.97 -10.51 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.98 65.84 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.471 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.09 -25.82 39.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 224' ' ' MET . 73.9 m -128.23 133.82 48.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.49 -27.04 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -169.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.419 ' H ' HG22 ' A' ' 222' ' ' THR . 74.8 mtm -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -152.13 165.85 33.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 125.04 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.139 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -127.21 136.63 52.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.438 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -105.03 -134.34 7.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.479 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.438 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.0 Cg_endo -70.82 -19.47 31.03 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.764 2.309 . . . . 0.0 112.299 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -58.17 -30.32 66.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 62.09 22.82 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.018 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.53 ' O ' ' C ' ' A' ' 233' ' ' SER . 39.3 m0 -61.13 -33.78 73.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 232' ' ' TRP . 67.5 p 31.34 67.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.896 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -81.15 35.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.908 -160.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 244' ' ' VAL . 38.3 pt -115.26 6.04 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 171.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.6 -54.27 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.5 m -60.44 -59.61 5.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -153.5 126.29 8.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.488 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.52 172.86 11.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 98.6 t -86.37 -71.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.61 76.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 44.9 m-85 -114.93 154.24 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.484 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -146.01 170.61 27.15 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.422 -174.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.456 HG22 HG12 ' A' ' 116' ' ' ILE . 60.7 t -123.49 134.88 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 0.0 111.157 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.7 176.86 8.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.193 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.8 162.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.109 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 115' ' ' LEU . 97.6 mt -81.38 151.3 68.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.886 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 153.47 70.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.74 2.293 . . . . 0.0 112.352 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 81.7 p -131.19 146.57 52.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -121.28 115.62 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 51.38 37.07 18.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.25 26.98 56.57 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.456 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.0 mm-40 -112.4 159.55 33.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.611 0.72 . . . . 0.0 110.907 -168.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 59.9 Cg_endo -63.39 75.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.722 2.281 . . . . 0.0 112.418 171.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' A' ' 249' ' ' THR . 49.5 m -94.28 6.64 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 -164.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.499 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 12.1 ptpt -135.12 158.6 74.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.869 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 29.4 Cg_endo -69.84 168.2 22.36 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.672 2.248 . . . . 0.0 112.298 -170.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -70.18 172.16 8.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.3 t -121.6 132.84 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.185 -175.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.14 142.99 15.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.502 ' HB ' ' HB1' ' A' ' 96' ' ' ALA . 96.3 t -127.43 127.99 69.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.816 0.341 . . . . 0.0 111.165 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 62' ' ' TRP . 51.5 tp -72.47 135.1 45.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -121.27 137.24 54.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.842 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.73 132.6 53.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.74 170.73 23.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.98 130.39 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 111.16 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -59.82 128.9 39.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.43 68.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . . . -80.67 -13.22 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.0 t -69.7 133.59 88.53 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.627 0.727 . . . . 0.0 110.856 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.33 -8.9 23.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.585 2.19 . . . . 0.0 112.35 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -106.82 30.53 6.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -52.17 -43.47 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.17 -41.62 63.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.807 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.04 -52.16 65.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.008 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -65.88 -50.25 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.9 -47.58 71.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -170.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -71.95 -33.26 68.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -176.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 284' ' ' LEU . 41.6 tp -57.11 -46.39 82.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -82.9 -28.86 29.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.967 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -101.42 -9.78 20.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -168.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 76.2 t80 -125.38 -59.66 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.407 ' HB2' HD12 ' A' ' 280' ' ' LEU . 68.6 mt -71.19 -44.5 65.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 20.4 tp -85.03 67.51 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.0 p -139.69 170.19 16.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.22 -45.26 79.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.835 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -75.89 -41.3 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.17 -45.9 9.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.558 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.2 tp -71.29 -35.66 71.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.981 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -56.58 -41.04 76.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.897 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.24 69.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.451 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 76.7 t -76.95 -45.1 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.052 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -73.05 -7.75 52.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -52.83 -21.95 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 89.2 m-20 -79.15 -24.2 43.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.806 -174.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -96.34 148.47 34.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.878 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.24 -25.62 26.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.637 2.225 . . . . 0.0 112.295 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.56 -48.41 3.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.019 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.4 22.24 78.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.527 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.8 110.34 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 0.0 111.072 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 307' ' ' TYR . 5.2 p -112.77 149.13 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -159.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 93' ' ' THR . . . -72.29 -18.84 61.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.21 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.457 ' H ' HG22 ' A' ' 302' ' ' VAL . 55.8 tp -79.38 124.36 28.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -45.4 90.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -174.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.2 t -62.44 -50.0 73.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.481 ' HB3' HG11 ' A' ' 302' ' ' VAL . 3.9 t80 -70.93 -36.87 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -65.58 -33.38 75.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -38.5 73.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.6 -38.69 58.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.829 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.13 -29.81 70.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.51 -8.27 45.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.53 -15.8 60.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -91.39 120.68 68.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.878 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.9 -29.03 19.8 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.766 2.31 . . . . 0.0 112.295 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -70.11 -44.72 68.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.41 -38.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.7 73.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 83.2 m -67.09 -41.86 85.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 tpt -66.82 -38.02 85.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.835 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -66.44 -35.31 79.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -65.36 -34.83 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.34 95.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -74.24 -23.28 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -104.67 -5.79 21.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.11 -161.64 37.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.432 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -127.2 127.18 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.846 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.568 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 38.3 mm -74.64 121.93 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.5 mmt 63.48 156.23 0.12 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.458 0.647 . . . . 0.0 111.033 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.905 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 56.5 Cg_endo -74.67 -107.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 165.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -138.94 -58.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 165.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.55 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 34.0 pt -139.12 169.25 12.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.602 0.715 . . . . 0.0 111.158 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.1 Cg_exo -53.09 -17.01 7.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.3 -6.15 2.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.905 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.5 ptm -56.6 -29.95 62.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.9 p -66.05 -30.1 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -80.58 -34.85 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 175.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -59.65 -54.79 42.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.551 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 68.6 m95 -60.76 -38.08 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -60.02 -46.7 88.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.35 80.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.047 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.1 t -74.5 -36.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.501 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 76.0 ttt180 -56.01 -47.17 78.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.8 p -66.62 -35.81 81.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -64.95 -44.0 90.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.182 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.96 -47.57 81.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.03 -44.34 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -65.21 -36.96 85.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.72 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.051 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.05 73.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.5 p -80.86 -7.78 59.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.04 82.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.555 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.13 -28.01 54.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.807 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -140.44 157.13 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.7 p -74.62 171.98 12.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.124 167.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.55 -34.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.61 -40.28 84.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.3 -44.73 71.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.817 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.17 93.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.5 mt -69.77 -35.5 74.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.87 -46.85 88.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -69.41 -31.1 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -70.01 -48.02 59.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.157 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.95 -38.73 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.4 m -62.53 -41.48 98.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.051 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.52 -39.12 70.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.802 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.3 mt -62.24 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.9 p -105.51 6.95 32.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.18 -172.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 -178.119 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.698 0.285 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.8 mt -80.1 129.26 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.163 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -125.09 164.3 20.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -76.5 118.38 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.21 26.17 24.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.467 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.41 152.22 40.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.109 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -145.49 146.63 31.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -128.67 129.74 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.56 135.68 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.548 ' HB3' HD21 ' A' ' 43' ' ' LEU . 34.9 m0 -111.28 120.56 42.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 tt -153.16 159.21 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 -170.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.7 t-20 -60.0 119.85 8.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 168.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.776 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -76.22 -18.54 79.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.54 -173.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.27 -47.72 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.938 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.26 80.04 1.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 144.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -120.56 -48.69 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.443 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -70.0 -43.72 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.91 -164.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -66.14 -51.98 52.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 -160.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.1 -44.29 97.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.437 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 24' ' ' GLY . 64.3 mt -61.28 -37.94 84.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.37 85.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.028 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.22 -47.1 79.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.16 -33.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -67.49 -40.09 91.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.57 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -71.57 -40.01 70.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.906 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.4 -41.16 98.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -68.54 -38.58 80.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.79 -31.55 72.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.83 -37.35 67.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.3 -39.3 25.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.7 p -105.27 -18.2 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.14 90.09 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.49 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 33' ' ' ILE . 7.8 pt -97.14 132.8 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.062 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.95 131.01 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 7' ' ' LEU . 67.3 t -101.48 136.88 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 172.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -141.39 120.15 12.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.24 131.37 60.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -109.76 151.8 26.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.424 ' O ' HD13 ' A' ' 43' ' ' LEU . 32.4 p80 -74.28 167.02 39.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.548 0.69 . . . . 0.0 110.885 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.776 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 43.1 Cg_endo -104.03 12.01 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -161.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -89.53 -37.14 14.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.759 -166.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -90.82 -17.24 26.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.896 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -57.3 -43.94 83.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -161.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -50.03 -39.94 43.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.84 -33.92 64.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.0 -25.39 59.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.537 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 5.1 m-30 -49.97 -53.99 37.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.606 0.717 . . . . 0.0 110.936 -160.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 91.5 Cg_endo -79.98 -29.93 2.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.77 2.313 . . . . 0.0 112.32 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.48 -49.69 21.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -168.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.7 m -66.09 -28.95 45.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.066 -171.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.78 -37.61 85.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.8 -24.99 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -96.97 0.35 48.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.082 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 77.2 17.57 79.37 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -110.88 -174.72 2.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.823 0.344 . . . . 0.0 110.864 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.33 -167.49 12.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.574 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 87.9 Cg_endo -77.64 169.44 20.89 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.668 2.245 . . . . 0.0 112.344 175.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -85.09 -37.01 20.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.5 mt -129.35 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 47' ' ' PHE . 16.4 tt -137.14 135.34 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -172.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -99.96 145.09 28.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.947 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.681 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 26.7 m95 -126.82 127.05 44.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.31 -91.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.038 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -112.89 -78.7 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.46 -22.84 61.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -165.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.681 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 94.9 mtt-85 -55.44 -28.61 55.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -164.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.45 ' CG ' ' N ' ' A' ' 68' ' ' GLY . 16.7 p90 -49.39 -44.06 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.88 -174.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 67' ' ' PHE . . . -74.99 -58.7 3.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 -169.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.54 -41.34 95.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.504 -172.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.656 ' HB3' HD21 ' A' ' 75' ' ' LEU . 60.1 m-85 -75.08 -32.57 61.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.962 0.411 . . . . 0.0 110.892 -175.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.01 64.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -61.33 -27.05 68.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -83.07 2.36 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.24 24.85 63.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.1 pp -85.81 -4.54 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.868 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.848 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.4 pp -131.57 143.58 50.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.69 154.96 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -71.43 140.45 50.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.891 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 pt -104.14 148.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.5 p -131.8 67.14 79.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.604 0.716 . . . . 0.0 111.131 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.82 144.85 49.46 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.698 2.265 . . . . 0.0 112.467 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -84.57 -175.16 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.35 -31.93 69.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.35 84.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -60.43 -43.84 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -59.65 -41.36 90.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.936 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.4 -34.5 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.826 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 75.9 mmtt -68.13 -21.3 64.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.189 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.94 124.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.923 -177.449 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p90 -173.08 49.19 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.734 0.778 . . . . 0.0 110.907 162.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 61.4 Cg_endo -73.32 -72.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.645 2.23 . . . . 0.0 112.42 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.473 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 97.3 m-85 -94.87 -29.68 14.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 174.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -71.72 -22.47 61.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.054 -161.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -60.75 -44.33 96.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.11 -30.74 71.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.897 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.73 -32.97 71.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -103.13 14.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.23 -169.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -120.99 145.89 47.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -137.96 127.94 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.6 t30 58.22 32.91 22.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.848 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.11 89.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.13 150.01 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.4 mt -84.65 121.37 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -113.3 -15.14 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.49 163.88 24.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -166.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -105.18 146.81 33.43 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.684 0.754 . . . . 0.0 110.891 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HG2' HD21 ' A' ' 89' ' ' LEU . 98.0 Cg_endo -76.78 120.13 5.39 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.2 mm -99.8 -46.32 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.037 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.18 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -163.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.37 130.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -125.37 143.07 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.17 157.01 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.05 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.402 HD22 ' HG3' ' A' ' 257' ' ' PRO . 10.0 mp -75.17 146.98 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -143.58 160.38 40.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.479 ' HB2' HD23 ' A' ' 247' ' ' LEU . 60.6 tp -94.99 122.9 38.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.413 HG12 HG22 ' A' ' 244' ' ' VAL . 61.6 mt -111.74 126.65 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.096 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -136.59 158.02 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -89.82 111.61 22.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.649 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -65.41 -30.09 70.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.01 -35.95 61.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.02 -49.54 12.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 tp -122.41 108.58 33.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.659 0.742 . . . . 0.0 110.903 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.45 -15.19 17.77 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.704 2.269 . . . . 0.0 112.317 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.6 t-20 -147.55 106.81 3.78 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 49.8 Cg_endo -66.72 152.81 79.87 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.677 2.252 . . . . 0.0 112.288 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.44 144.07 60.05 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.65 2.234 . . . . 0.0 112.261 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.39 -22.03 32.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 t -150.15 170.98 17.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -172.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.74 -32.58 69.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.856 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -71.67 -22.27 61.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -170.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -74.5 -27.96 60.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.562 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 94.4 mt -66.32 -45.14 59.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 0.0 111.061 -164.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.562 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 99.1 Cg_exo -49.62 -48.24 19.85 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.645 2.23 . . . . 0.0 112.332 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.38 90.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.014 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 135' ' ' LEU . 2.6 tt -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 26.4 t70 -66.03 -35.05 79.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.902 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.13 -41.23 90.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.45 -54.06 13.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.916 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 140' ' ' LYS . 1.1 pt? -78.61 -12.54 60.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -173.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.1 tttt -54.55 -29.38 50.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 166.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.75 65.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.076 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.84 8.49 37.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.25 58.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.509 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -121.8 154.69 36.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.28 . . . . 0.0 110.974 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.7 t -110.93 154.98 23.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -70.31 -56.65 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.036 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.8 tp -144.35 129.05 18.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.958 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.7 mmm -130.25 132.53 45.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -150.97 174.55 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -67.39 109.71 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.995 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.99 0.12 40.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -85.62 0.26 53.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.48 145.72 57.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.555 0.693 . . . . 0.0 110.938 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.489 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 63.9 Cg_endo -79.66 -28.16 3.61 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.603 2.202 . . . . 0.0 112.393 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -53.87 -37.94 64.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -82.14 -36.79 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 -174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 74.3 p -88.36 -30.28 19.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.133 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.626 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 69.4 t90 -54.85 -48.28 96.11 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.535 0.683 . . . . 0.0 110.994 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 75.2 Cg_exo -48.41 -36.44 30.65 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 160' ' ' LEU . 3.7 tt -73.04 -38.63 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.981 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.566 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.2 mt -68.09 -38.06 79.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -80.5 -15.01 57.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -171.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.06 69.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.25 7.19 46.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.77 12.78 4.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.474 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -76.6 158.74 49.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.489 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.633 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 91.0 m-85 -136.82 152.08 49.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 110.887 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . . . -101.21 -36.16 9.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.076 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.414 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -150.1 130.02 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -175.435 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 55.5 tptt -92.83 120.76 33.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -173.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.406 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 55.5 t80 -112.47 112.38 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -176.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -150.53 142.74 24.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 51.2 40.67 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 6.32 78.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.492 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -127.94 146.26 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 41.7 m-85 -89.91 127.85 36.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.911 167.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -102.39 116.62 33.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 178' ' ' ILE . 7.5 tp -77.77 -19.96 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.139 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -85.9 -7.26 58.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -116.12 92.79 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.0 140.0 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -99.82 38.87 2.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -168.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.2 -14.53 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.111 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -104.97 18.78 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -106.7 -171.49 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.11 -38.93 75.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.6 90.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.78 87.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.47 -42.46 99.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.62 -44.64 89.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -67.2 -46.68 69.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.87 -38.1 85.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.916 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.8 m -56.96 -43.82 81.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -64.22 -46.01 85.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.13 -44.87 96.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.825 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.99 -40.71 89.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.54 -36.45 82.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.67 -43.97 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.76 -39.51 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.51 -32.39 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 173.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.99 2.48 38.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.97 32.66 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.949 173.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -78.93 -30.94 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.814 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 23.5 ptp -150.48 160.06 44.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.422 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.6 m-20 -100.64 138.63 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.23 -24.38 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -97.5 0.6 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 86.2 m -55.1 124.83 18.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.06 170.04 8.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 227' ' ' ASN . 52.5 t80 -62.79 -41.46 99.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -62.43 -37.63 86.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.764 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -70.06 -46.3 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.83 84.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.73 -41.36 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.52 86.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.089 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.144 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -64.52 -47.03 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.28 -25.78 65.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.77 -5.34 45.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 16.66 63.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -82.5 -26.98 32.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.825 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 224' ' ' MET . 88.0 m -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 177.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.85 -27.71 55.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 -169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.412 ' H ' HG22 ' A' ' 222' ' ' THR . 74.8 mtm -135.19 151.98 51.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -152.08 165.23 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.191 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.24 133.24 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 37.6 p30 -152.91 160.93 43.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.33 -126.83 5.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.424 -171.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.52 -19.17 19.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.715 2.277 . . . . 0.0 112.356 -166.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -53.28 -39.83 64.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.28 31.17 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.499 ' O ' ' C ' ' A' ' 233' ' ' SER . 54.2 m0 -60.44 -36.1 77.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 232' ' ' TRP . 90.1 p 34.26 71.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 163.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -74.85 3.39 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.85 -7.9 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.089 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.18 -50.15 9.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 85.5 m -64.8 -59.52 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.3 t -156.23 121.65 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.784 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LYS . . . . . 0.65 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.28 176.02 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.884 -176.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.01 -70.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -161.37 90.0 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 239' ' ' LYS . 75.0 m-85 -114.3 162.39 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.649 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -147.17 170.18 28.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.5 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.413 HG22 HG12 ' A' ' 116' ' ' ILE . 59.2 t -123.74 131.37 73.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.942 0.401 . . . . 0.0 111.091 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -142.71 177.94 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.172 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.64 160.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 115' ' ' LEU . 89.0 mt -77.65 149.73 78.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.944 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.21 146.86 69.21 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.47 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 81.8 p -128.87 146.21 51.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -125.49 111.66 15.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 45.03 40.36 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.01 28.34 56.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 166.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.6 mm-40 -109.99 159.52 31.53 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.936 -170.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.0 Cg_endo -65.33 73.96 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 73.8 p -98.47 4.14 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -168.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 13.2 ptpt -139.84 158.37 67.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.552 0.691 . . . . 0.0 110.835 -173.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 33.4 Cg_endo -71.89 167.24 27.19 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.627 2.218 . . . . 0.0 112.389 -169.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.91 176.65 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.423 HG23 ' HA3' ' A' ' 327' ' ' GLY . 96.5 t -118.69 134.31 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 -171.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.02 146.37 16.07 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.433 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -128.48 128.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.266 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 60.4 tp -76.96 135.3 38.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.92 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 93.1 p -129.87 150.93 50.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.41 130.31 44.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.033 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.95 162.89 15.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 -170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.65 129.5 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -62.85 124.9 22.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.9 67.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.632 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -81.96 -13.85 56.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 20.2 t -72.28 132.67 83.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.86 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.07 -7.75 21.7 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 0.0 112.407 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.04 27.62 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -168.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -50.85 -47.74 60.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.39 -38.93 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.5 tp -56.81 -53.13 61.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.11 -42.58 75.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.117 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.39 -48.93 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.29 -47.72 72.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.957 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -70.63 -33.67 71.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -176.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 284' ' ' LEU . 36.3 tp -55.97 -47.96 76.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -83.07 -27.0 30.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.31 -10.91 19.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -169.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 86.8 t80 -124.98 -60.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.416 ' HB2' HD12 ' A' ' 280' ' ' LEU . 77.6 mt -70.29 -41.27 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.981 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.32 65.22 8.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.0 p -138.09 169.34 17.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -56.92 -42.08 79.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -77.0 -42.54 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.1 -47.89 8.04 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.546 -170.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.0 -35.06 79.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.932 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.52 -42.82 99.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.95 -30.21 71.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.126 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.36 -45.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.068 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.473 ' HB3' ' CA ' ' A' ' 300' ' ' GLY . 59.0 m-20 -74.73 -5.5 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -54.41 -18.97 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.79 -18.07 60.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.06 154.18 42.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.71 -41.81 10.23 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 299' ' ' LEU . 3.3 mm? -92.59 -44.35 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.907 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 294' ' ' ASN . . . 62.33 54.42 34.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.432 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.69 124.31 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.072 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.15 149.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.61 61.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.062 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.18 119.26 22.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 87.7 tttt -61.77 -44.46 96.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -166.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.0 t -58.83 -49.84 76.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -74.23 -31.49 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.445 ' HG3' ' HE1' ' A' ' 321' ' ' MET . 89.0 tt0 -56.83 -39.44 74.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.829 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.23 -32.42 73.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -48.05 23.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.536 HD11 ' HE1' ' A' ' 321' ' ' MET . 3.4 pp -73.55 -18.71 61.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.19 -7.93 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.9 -11.23 60.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.94 -173.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -86.43 122.01 72.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.98 -31.78 28.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.642 2.228 . . . . 0.0 112.373 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.65 -42.48 74.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 311' ' ' LEU . 3.0 tp -80.99 -29.86 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.069 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.4 86.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 65.9 m -67.38 -43.87 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.536 ' HE1' HD11 ' A' ' 311' ' ' LEU . 58.2 mtt -69.61 -34.82 74.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.799 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -66.26 -37.33 85.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -64.96 -34.04 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.042 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -70.31 -21.04 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.96 -5.96 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -96.11 -163.0 33.36 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.478 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -128.93 137.06 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 39.6 mm -78.3 115.67 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 26.3 mmt 61.72 155.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.91 -113.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 168.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -162.22 -52.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.89 164.35 31.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 111.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.41 -19.77 52.97 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.823 2.349 . . . . 0.0 112.318 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -58.87 -23.58 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.543 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 94.8 mmm -69.66 -24.83 63.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.73 -37.12 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.95 -30.76 64.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.155 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 336' ' ' MET . 21.8 t80 -57.63 -49.95 74.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.988 175.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.489 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.7 m95 -61.36 -44.16 97.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.68 -43.81 76.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.83 78.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.76 -44.92 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.191 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -57.34 -48.11 79.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.87 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 73.9 p -66.65 -32.95 74.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.2 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.92 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.76 -47.87 81.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 41.5 mm -64.73 -44.69 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.17 -38.13 89.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.67 -44.91 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.53 -33.9 69.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.5 p -79.51 -8.46 59.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.0 82.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.455 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.44 -29.52 57.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 0.0 110.837 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -140.01 157.86 44.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.1 p -78.12 172.97 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.91 -45.26 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.43 -38.92 74.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -71.68 -39.28 70.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -173.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.54 96.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 173.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.5 -35.09 78.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.64 -42.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.17 -31.41 70.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.75 -46.43 63.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.143 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -63.21 -38.31 90.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.2 m -59.48 -40.34 86.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.02 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.94 -36.81 62.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.85 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 339' ' ' PHE . 71.4 mt -63.02 -48.46 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.06 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.9 p -96.21 -0.72 49.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.9 tttt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.767 0.317 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.49 136.83 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.01 -178.98 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.992 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.14 119.62 19.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.04 25.27 27.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.435 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.93 152.94 41.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.7 pp -149.03 148.76 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 84.6 t -126.12 128.13 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mt -117.46 134.33 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.66 ' CH2' ' HD3' ' A' ' 57' ' ' PRO . 30.7 m0 -113.07 127.19 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 18.1 tt -152.94 159.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.67 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.3 t-20 -55.88 118.53 4.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.916 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.661 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.12 -24.72 72.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.487 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.03 -47.11 71.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 -167.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.9 mmtt -129.58 80.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 146.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -115.05 -36.63 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.527 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.54 -43.51 17.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.935 0.398 . . . . 0.0 110.957 -157.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -67.72 -52.58 35.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 -158.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.8 -45.25 96.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.582 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' GLY . 50.0 mt -59.43 -37.98 79.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.918 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.95 92.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.87 -49.7 74.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.819 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.25 -33.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -66.12 -42.57 94.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.562 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.6 -43.15 69.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 110.882 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.59 -40.21 93.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -65.39 -41.2 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.23 -31.94 72.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -74.81 -34.86 62.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.3 -40.79 20.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.1 p -104.16 -22.07 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.85 4.21 88.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.415 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.415 HG21 HD23 ' A' ' 7' ' ' LEU . 97.7 mt -76.61 121.7 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.205 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.83 120.52 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.2 135.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.097 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -139.39 117.81 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.6 127.71 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.19 160.74 20.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -68.82 162.31 64.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.555 0.693 . . . . 0.0 110.859 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.67 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 60.5 Cg_endo -98.82 -3.95 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -164.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.46 -30.81 33.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -154.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.45 -16.94 31.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 10' ' ' TRP . 5.7 mp -61.18 -36.52 80.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.921 -156.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 50.2 mt-10 -48.75 -35.98 15.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.58 -36.01 57.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -75.52 -29.53 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -173.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.6 m-85 -48.18 -54.52 24.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.903 -160.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 95.7 Cg_endo -80.16 -29.31 2.63 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.825 2.35 . . . . 0.0 112.19 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -75.15 -48.93 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.016 0.436 . . . . 0.0 111.046 -167.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.92 -32.63 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.122 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.7 -38.26 89.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.033 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.43 63.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -98.92 0.09 43.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.09 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 75.14 17.91 80.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.515 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -109.72 -174.43 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.319 . . . . 0.0 110.888 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 -171.3 15.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.495 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.66 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 83.7 Cg_endo -79.46 174.67 11.59 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.357 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.36 -38.38 22.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 164.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -134.35 139.03 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.213 -172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.86 144.76 36.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -100.87 139.71 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 6.1 m95 -126.63 123.41 37.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.73 -91.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 -167.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -112.52 -82.39 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -73.9 -19.29 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 -164.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 96.4 mtt-85 -52.71 -30.71 33.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -168.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -51.09 -39.38 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 -171.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.531 -168.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.08 90.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.387 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.609 ' HB3' HD21 ' A' ' 75' ' ' LEU . 47.3 m-85 -76.47 -32.62 58.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.944 0.402 . . . . 0.0 110.874 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.39 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -62.64 -28.51 69.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -82.4 1.42 37.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.852 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.78 23.77 59.26 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.461 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.3 pp -85.89 1.15 51.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.752 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.1 pp -134.21 144.34 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -86.04 153.13 22.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.92 132.99 46.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG21 ' CE2' ' A' ' 106' ' ' TYR . 66.8 mt -109.35 139.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.182 -173.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 p -130.81 76.9 76.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.753 . . . . 0.0 111.161 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.96 152.53 31.93 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.743 2.295 . . . . 0.0 112.407 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -83.19 -176.98 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.848 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.6 -34.51 78.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.957 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.75 99.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -66.85 -35.08 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.77 -41.57 95.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.07 -30.07 33.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.851 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 45.0 mtmt -65.1 -17.78 64.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.167 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.62 123.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 8.2 p90 -174.75 51.16 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.692 0.758 . . . . 0.0 110.957 166.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 59.3 Cg_endo -72.22 -71.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.186 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.46 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 33.1 p90 -104.48 -19.26 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.8 p -67.55 -25.25 65.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 -168.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 90' ' ' TYR . 47.8 t-105 -62.28 -42.26 99.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.967 -174.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.34 -29.69 70.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.547 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.35 -34.35 74.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.122 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.45 13.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -117.75 149.3 41.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -139.12 128.13 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.32 34.03 23.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.71 90.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.543 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.36 149.13 42.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.949 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.4 tp -83.96 125.06 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 pt -116.71 -10.09 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.79 167.61 22.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 79' ' ' ILE . 74.9 m-85 -109.6 144.78 30.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.786 0.803 . . . . 0.0 110.91 171.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.4 Cg_exo -65.41 117.11 4.3 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.751 2.301 . . . . 0.0 112.341 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.7 mm -100.54 -32.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.23 151.69 4.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.8 t -118.5 124.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.112 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -118.48 130.14 55.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.03 153.02 30.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.427 HD22 ' HG3' ' A' ' 257' ' ' PRO . 10.8 mp -74.33 147.82 41.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -175.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 85.0 p -141.46 158.64 43.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.43 ' HB2' HD23 ' A' ' 247' ' ' LEU . 46.1 tp -98.85 125.89 44.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.952 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.44 HG12 HG22 ' A' ' 244' ' ' VAL . 63.9 mt -111.7 130.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.173 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -135.35 155.8 49.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -96.16 112.92 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -24.05 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.017 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -82.88 -34.45 26.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.83 -47.36 13.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -123.37 108.88 31.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.655 0.741 . . . . 0.0 110.92 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.53 -13.43 22.54 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.67 2.247 . . . . 0.0 112.424 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -147.12 108.34 3.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 153.78 76.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 0.0 112.349 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.75 141.83 42.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.583 2.189 . . . . 0.0 112.251 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.72 -17.77 26.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -144.37 165.02 29.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -67.26 -28.87 68.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.34 -29.53 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.848 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.12 -21.09 60.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.588 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 34.6 mm -59.8 -53.47 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.133 -167.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.1 Cg_endo -64.72 -45.79 7.96 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.729 2.286 . . . . 0.0 112.31 -173.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.68 96.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.045 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.5 mt -60.98 -38.65 86.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 10.2 t70 -64.63 -36.1 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -36.16 83.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.54 -57.53 5.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 145' ' ' SER . 1.7 pt? -81.09 -11.45 59.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 86.4 tttt -56.18 -29.32 60.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.783 166.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.09 65.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.88 11.17 37.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.21 75.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.426 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 39.9 mmtm -117.89 157.28 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.53 ' O ' HD11 ' A' ' 139' ' ' LEU . 30.0 t -115.14 154.44 28.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.82 175.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -73.79 -55.0 6.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.0 tp -143.69 130.62 20.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.8 mtp -122.86 134.8 54.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -149.69 165.96 30.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 57.7 t-20 -58.9 111.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.937 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.7 tm? -89.44 -21.57 22.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.981 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.31 -2.5 38.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -133.83 149.97 73.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.736 . . . . 0.0 110.94 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 71.2 Cg_endo -77.84 -21.6 10.94 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.633 2.222 . . . . 0.0 112.37 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -59.7 -40.97 89.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 56.2 m-85 -85.16 -27.75 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.753 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 76.2 p -89.07 -31.03 18.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.619 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.8 t90 -55.32 -47.84 97.65 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.558 0.694 . . . . 0.0 110.909 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 73.9 Cg_exo -47.96 -38.45 31.33 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.638 2.225 . . . . 0.0 112.294 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 160' ' ' LEU . 4.0 tt -73.85 -38.62 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.56 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.3 mt -67.47 -37.14 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.78 -14.35 58.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.04 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.01 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 -166.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -96.83 5.03 51.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.38 12.89 4.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.575 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.75 158.37 48.5 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.561 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.718 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 90.0 m-85 -136.85 155.2 50.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.959 0.409 . . . . 0.0 110.915 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.21 -31.12 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.049 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.11 130.11 12.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 54.9 tptt -93.55 121.73 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.852 -174.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.429 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 64.2 t80 -113.89 113.06 24.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -150.11 143.8 25.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 51.06 41.0 26.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.73 5.99 76.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.549 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.87 146.2 51.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 171' ' ' TYR . 30.2 m-85 -88.08 129.58 35.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 167.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -103.17 114.12 28.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.811 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.32 -20.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -87.3 -8.88 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -114.11 92.96 4.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.943 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.54 141.44 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.183 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.718 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -102.86 29.79 11.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.402 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.55 -22.4 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.145 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -104.95 24.75 11.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -104.45 -174.5 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.25 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.61 -44.01 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.72 84.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.775 0.321 . . . . 0.0 111.102 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.51 -42.23 98.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.832 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.99 -45.04 87.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.07 -44.21 91.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.442 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.98 -40.47 95.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.5 m -57.75 -43.3 85.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -63.73 -44.44 93.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.06 -45.34 91.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.76 -40.1 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -64.76 -39.87 94.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 198' ' ' LEU . 1.7 mp -65.77 -44.27 86.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.49 -38.39 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.221 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.3 -35.44 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.825 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.59 4.62 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.45 31.58 10.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.0 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -77.51 -29.58 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.7 ttp -147.9 150.09 33.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.95 -22.99 67.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -91.11 0.0 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.2 m -59.98 129.09 40.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -108.66 169.01 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 167.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.98 -32.61 72.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.034 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.0 p -69.37 -38.79 78.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.788 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 92.1 mt -66.87 -39.53 83.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.145 174.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.14 -36.9 85.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -69.14 -38.23 78.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.43 90.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.59 93.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.124 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.75 -40.98 92.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.81 -19.88 66.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.67 -10.11 27.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.99 63.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.44 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.78 -25.75 37.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 110.813 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.6 m -128.48 133.7 48.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.68 -28.74 60.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 70.9 mtm -131.85 151.59 51.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.5 t -150.04 161.5 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.7 128.7 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.157 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -122.29 150.85 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -120.32 -131.19 4.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.465 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.5 Cg_endo -67.06 -24.1 45.49 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.302 -170.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -53.44 -33.09 52.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 60.62 36.3 19.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.028 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.577 ' O ' ' C ' ' A' ' 233' ' ' SER . 78.3 m95 -41.97 -36.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.577 ' C ' ' O ' ' A' ' 232' ' ' TRP . 18.8 p 15.08 60.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 232' ' ' TRP . 78.8 m-20 -78.51 20.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -169.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 pt -117.59 -9.89 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -69.43 -61.27 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.4 m -54.27 -48.06 71.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.0 t -155.47 140.92 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.1 166.32 30.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.65 -70.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.134 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -150.66 70.81 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -108.93 160.51 15.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.43 167.18 25.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 116' ' ' ILE . 41.2 t -124.23 131.39 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 0.0 111.064 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.47 175.83 9.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.61 162.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 115' ' ' LEU . 96.9 mt -77.25 149.01 78.71 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 110.96 -174.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.79 156.13 67.17 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.374 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.443 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 12.9 t -142.87 150.23 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.32 114.92 20.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.836 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 50.04 36.13 11.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.912 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.28 29.16 51.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.512 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.48 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 99.2 mm-40 -110.07 161.62 23.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 110.82 -167.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 46.4 Cg_endo -60.98 75.45 0.08 OUTLIER 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 0.0 112.416 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 81.5 p -94.85 -4.83 46.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.784 -162.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 257' ' ' PRO . 10.7 ptpt -136.42 158.43 73.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.643 0.735 . . . . 0.0 110.871 -167.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 28.4 Cg_endo -70.26 166.92 26.62 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.643 2.229 . . . . 0.0 112.342 -169.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -68.93 170.03 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.42 HG23 ' HA3' ' A' ' 327' ' ' GLY . 61.5 t -120.13 133.31 67.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -170.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.21 141.6 16.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.0 t -125.23 128.36 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.9 tp -74.05 135.23 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 94.2 p -126.95 147.67 50.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.84 126.2 42.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.39 163.61 16.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.431 -170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.4 mt -106.36 129.96 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 111.147 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -61.98 126.52 27.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.79 -27.98 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.492 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -80.49 -13.11 59.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.133 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 25.3 t -72.29 127.59 90.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.684 0.754 . . . . 0.0 110.934 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.59 -6.54 18.76 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.728 2.285 . . . . 0.0 112.435 169.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.43 25.65 7.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -169.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.04 -40.87 59.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.19 -39.57 89.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 70.3 mt -64.89 -52.45 56.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.28 89.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -164.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -69.78 -49.84 48.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.939 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.78 -53.63 47.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -162.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 7.5 p90 -75.21 -25.63 58.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.48 -50.44 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.19 -29.28 38.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.953 -175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -101.97 -23.45 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.846 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 93.6 t80 -118.16 -50.67 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -175.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.98 -39.31 61.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.943 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 106' ' ' TYR . 6.7 mp -83.33 62.27 6.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 52.9 p -135.74 165.29 25.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.157 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -51.91 -49.68 62.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.77 -39.02 53.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.17 -46.69 20.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.7 tp -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.825 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.46 -43.19 88.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.85 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.592 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 88.9 t -77.33 -41.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.75 -18.53 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -54.72 -18.97 5.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 87.7 m-20 -81.18 -30.15 34.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.64 150.26 36.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.668 0.747 . . . . 0.0 110.876 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.83 -22.78 10.02 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.635 2.223 . . . . 0.0 112.364 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.5 tp -68.49 -58.22 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 89.02 3.85 75.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.66 34.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 111.034 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.3 m -120.46 156.19 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.038 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.16 -12.89 60.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 51.4 tp -74.59 120.47 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 59.6 tttm -62.3 -46.82 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -172.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -57.29 -47.15 82.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.91 -33.63 70.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.951 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.17 -37.6 85.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.823 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.7 -34.96 70.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -78.2 -38.43 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.27 -25.12 66.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.07 -7.94 20.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -79.33 -16.7 55.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -88.54 120.86 70.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -50.46 -31.99 32.82 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.232 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -69.7 -48.61 58.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.2 -39.15 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.82 84.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.07 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 58.1 m -63.06 -45.76 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.2 mmt -68.67 -37.6 79.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.28 -40.06 93.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.5 -34.17 76.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.875 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.15 90.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -71.79 -20.18 61.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.991 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.83 -8.19 20.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.42 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -94.56 -160.0 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.434 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -124.51 132.1 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.871 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 39.0 mm -79.94 120.48 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 -174.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 26.2 mmt 64.59 156.12 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.513 0.673 . . . . 0.0 110.958 169.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 332' ' ' ASN . 75.3 Cg_endo -69.83 -147.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.581 2.187 . . . . 0.0 112.363 164.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.433 ' H ' ' HB2' ' A' ' 331' ' ' PRO . 48.7 t30 -147.79 -54.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.99 164.02 34.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.662 0.744 . . . . 0.0 111.176 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -58.32 -20.92 50.14 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.779 2.319 . . . . 0.0 112.411 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -59.01 -23.08 61.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.494 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 93.5 mmm -67.44 -26.9 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.6 m -62.33 -36.73 83.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.797 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.36 -31.3 65.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.089 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.4 t80 -58.19 -49.99 75.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.004 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.644 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.8 m95 -61.71 -42.56 99.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -57.31 -42.49 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.12 86.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 72.7 t -73.26 -40.27 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.173 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.654 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 78.8 ttt-85 -55.79 -44.98 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.835 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.4 m -62.11 -42.79 99.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -62.36 -43.72 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.13 -49.89 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.115 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.93 -44.09 99.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.099 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -65.04 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.44 69.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.048 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.28 73.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.161 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -79.92 -7.11 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.96 11.82 84.09 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.584 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.1 -29.87 60.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.309 . . . . 0.0 110.88 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -140.67 155.2 46.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.2 p -74.49 172.17 12.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.58 -35.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.227 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.16 -40.77 86.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.73 -45.26 68.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.917 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.4 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.184 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.18 -36.04 76.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.04 -42.44 94.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.46 -31.76 73.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -69.46 -45.04 69.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.16 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -61.84 -39.1 90.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 92.4 m -59.99 -41.54 92.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -73.63 -34.68 65.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.5 mt -59.98 -40.01 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.185 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.8 p -93.5 -11.46 31.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.5 tttt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.628 0.251 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.4 mt -90.38 132.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.189 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 93.8 mt-10 -131.75 166.91 20.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.62 124.57 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.71 23.15 43.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.465 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 90.5 mttt -144.71 159.0 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.803 ' C ' HD12 ' A' ' 7' ' ' LEU . 1.8 pp -146.45 145.91 30.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.99 124.74 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -175.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.61 HG22 ' HB ' ' A' ' 59' ' ' ILE . 7.8 pt -126.61 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.529 ' HB3' HD21 ' A' ' 43' ' ' LEU . 37.2 m0 -116.27 137.8 51.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.7 tt -148.06 154.12 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.479 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.4 t-20 -55.5 127.87 31.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.854 174.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.77 79.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.586 -167.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.36 -53.46 57.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.921 -162.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.06 73.95 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 147.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -103.31 -40.19 2.46 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.5 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -70.44 -42.1 71.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -156.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.69 -51.81 45.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.88 -157.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.77 -48.56 83.3 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.42 -177.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.2 mt -60.81 -36.78 79.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.17 95.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.37 -52.0 67.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.74 -32.55 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.047 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.12 -43.04 96.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.52 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.93 -49.22 71.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.71 -43.06 90.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.47 -44.29 94.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.93 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.12 -33.8 76.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -71.83 -42.2 67.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -83.43 -38.03 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.796 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 90.4 m -99.59 -24.0 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 -173.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.01 86.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.43 124.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.04 130.54 43.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 7' ' ' LEU . 77.8 t -109.03 135.22 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.0 m -127.63 111.9 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 9' ' ' ILE . 52.6 t -101.76 120.56 51.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 54.9 mt-10 -131.88 153.15 50.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.937 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.423 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.8 p80 -132.3 75.13 74.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.637 0.732 . . . . 0.0 110.876 173.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 12.7 Cg_endo -69.76 -29.65 23.54 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.672 2.248 . . . . 0.0 112.452 -160.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.5 m-20 78.0 4.06 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -174.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -94.36 -2.02 52.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 10' ' ' TRP . 79.9 mt -48.95 -57.25 6.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -152.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.33 -41.66 94.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -83.44 -40.33 19.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -170.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -75.51 -49.99 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -166.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.831 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 82.9 t80 -55.3 -52.22 73.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.694 0.759 . . . . 0.0 110.81 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 88.0 Cg_exo -52.48 -38.7 74.96 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 0.0 112.35 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -73.88 -47.26 39.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.0 m -74.83 -26.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.44 91.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.047 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.58 65.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -93.03 6.75 46.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.01 18.95 73.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.482 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.0 t0 -117.18 -172.96 2.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.962 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.45 167.02 22.8 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.49 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 59.8 Cg_endo -68.51 168.45 19.73 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.605 2.203 . . . . 0.0 112.337 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.27 -42.61 62.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' A' ' 9' ' ' ILE . 75.7 mt -136.73 143.3 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.198 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.28 136.61 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.74 122.44 47.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -147.71 157.61 43.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.919 169.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -87.5 -103.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -95.75 -50.03 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -62.04 -61.44 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 -162.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -77.92 -31.93 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -172.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -57.42 -48.23 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.77 -166.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.4 -48.21 87.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.556 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.34 -39.36 64.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 174.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.68 -32.99 74.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.943 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.39 80.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.45 -25.88 65.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.0 m -82.52 0.02 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.74 30.3 76.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.41 -5.21 59.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -128.58 143.39 50.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 -173.028 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 154.33 20.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.05 136.76 52.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 pt -109.31 151.72 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.8 p -130.11 68.16 80.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.547 0.689 . . . . 0.0 111.197 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.3 141.8 32.64 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.719 2.279 . . . . 0.0 112.284 172.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -78.23 172.05 14.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.55 -31.97 73.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.811 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.52 84.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -79.87 -31.85 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.94 -43.63 94.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.8 -28.39 64.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -66.12 -26.49 67.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 mt -97.01 -137.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -132.33 139.59 35.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.762 0.791 . . . . 0.0 110.884 173.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.9 -42.0 70.23 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.778 2.318 . . . . 0.0 112.408 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -70.44 -24.82 62.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -77.42 -28.66 52.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.129 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.432 ' HA ' HG22 ' A' ' 97' ' ' VAL . 64.2 m95 -73.02 -33.21 65.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.53 -34.43 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.09 -28.54 65.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 34.8 m -106.47 12.48 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.158 -174.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -108.35 133.76 52.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -134.97 126.02 27.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 58.29 34.81 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.28 5.24 89.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.91 146.4 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 0.0 110.85 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.73 125.28 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 76' ' ' LEU . 38.3 pt -121.65 -8.13 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -167.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.39 161.98 37.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -171.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.8 m-85 -109.14 130.93 22.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.623 0.725 . . . . 0.0 110.987 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 26.5 Cg_exo -62.53 115.58 2.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.749 2.299 . . . . 0.0 112.302 172.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.6 mm -104.85 -34.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.53 153.63 21.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -123.24 129.85 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 229' ' ' PRO . 10.2 pt-20 -131.16 149.21 52.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.897 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.48 154.88 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.6 tp -71.5 133.69 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.9 p -142.46 160.78 39.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -174.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -97.48 128.39 44.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 91.4 mt -111.43 129.61 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.046 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -129.06 153.9 47.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -95.33 118.87 32.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.64 -32.27 73.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -84.31 -35.43 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 -171.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.71 -44.36 50.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -139.34 109.54 7.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.985 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.8 Cg_endo -74.39 177.07 8.81 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.695 2.263 . . . . 0.0 112.436 171.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.1 t30 21.5 96.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 110.922 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.8 Cg_endo -65.51 156.74 61.98 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.373 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.27 144.66 75.4 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.251 . . . . 0.0 112.363 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -87.92 -21.63 24.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.0 p -134.75 159.46 41.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -68.03 -33.44 74.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.49 -25.46 37.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.773 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.22 -20.84 60.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 27.6 mm -56.26 -54.77 49.26 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.532 0.682 . . . . 0.0 111.101 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 20.5 Cg_endo -61.86 -40.81 41.76 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.661 2.24 . . . . 0.0 112.371 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 mt -64.8 -35.22 80.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.939 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.05 -36.91 85.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.84 -43.21 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.25 -37.76 78.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 35.0 mt -70.32 -35.04 73.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.88 -32.84 64.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.82 -23.6 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -102.85 6.4 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.822 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.17 25.66 70.46 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.516 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 90.3 mttt -112.95 154.66 26.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -106.77 151.6 24.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.39 -42.44 68.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.95 146.0 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 86.8 mmm -136.7 124.25 22.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 157.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.78 167.45 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.804 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 54.7 t-20 -67.39 117.95 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.88 -167.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.08 4.61 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.42 ' N ' ' OD1' ' A' ' 150' ' ' ASN . 79.2 mt-30 -84.59 -0.96 55.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.87 143.22 36.51 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.626 0.726 . . . . 0.0 110.844 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.6 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 33.2 Cg_endo -70.61 -27.19 22.73 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.72 2.28 . . . . 0.0 112.37 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.401 ' HA ' ' CD1' ' A' ' 158' ' ' TRP . 82.7 t80 -56.11 -46.74 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.89 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 61.1 m-85 -80.37 -20.07 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -173.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -75.45 -22.15 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 162' ' ' ALA . 2.5 m95 -59.84 -46.18 98.31 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.522 0.677 . . . . 0.0 110.863 -168.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.569 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 52.3 Cg_exo -41.97 -36.26 3.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.334 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.5 -49.12 10.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.717 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.3 mt -81.33 -49.72 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -170.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -63.32 -19.0 64.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.138 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -61.43 -28.28 69.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.42 2.26 39.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.918 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 103.4 10.27 36.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -112.4 135.09 12.44 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.375 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -153.6 170.04 21.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.941 -165.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.62 -48.03 80.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.06 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.87 155.32 42.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -80.92 124.43 29.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -104.62 110.84 23.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -149.48 138.76 21.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -169.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 49.0 38.98 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 -173.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.88 10.39 72.4 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.393 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -136.77 154.81 50.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.735 0.303 . . . . 0.0 110.857 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -70.33 147.62 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -129.63 107.73 9.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.0 mm -76.93 -29.1 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.79 -22.81 31.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -170.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.54 65.25 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.823 166.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.37 149.59 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -169.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -86.93 11.67 64.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.404 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.54 -3.57 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 51.1 p-10 -78.42 16.64 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.938 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 74.1 m-80 91.21 0.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 166.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.54 -58.31 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -84.54 -55.66 2.67 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.0 68.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 111.137 -166.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.02 -45.16 86.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.75 96.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.121 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.717 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.8 -41.38 98.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.506 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.62 -39.18 91.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.2 m -61.17 -42.11 97.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.208 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.84 -42.99 94.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.86 -45.65 92.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.17 -40.0 87.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.12 -37.58 87.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.439 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -68.24 -34.2 75.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.55 -40.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.054 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.06 -41.16 86.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -85.46 2.49 44.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.02 31.89 10.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -81.25 -29.55 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 67.4 mtt -135.47 147.32 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.843 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -97.66 124.03 41.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.63 -22.72 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 -170.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -90.01 -6.09 55.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.4 m -57.22 131.07 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -128.68 -179.48 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.815 171.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -58.04 -34.88 70.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 -172.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 71.2 m -67.73 -36.08 79.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.55 -42.14 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.65 -41.19 98.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.05 -43.03 79.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.61 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.059 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.1 86.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.38 -35.41 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.825 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -60.54 -29.73 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.951 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.42 -21.07 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.829 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.94 23.59 32.29 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -83.43 -25.76 30.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.925 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 87.1 m -125.62 137.28 53.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.56 -38.77 25.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 77.0 mtm -140.51 157.7 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.3 t -151.8 167.83 27.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.223 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.4 mt -123.01 119.29 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 58.6 m-80 -148.62 160.87 42.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -173.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -104.6 -136.55 8.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.482 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -70.61 -26.92 23.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.289 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -66.83 -18.79 65.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -89.47 11.97 17.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.031 -176.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' TRP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 298' ' ' PRO . 46.4 m0 -67.01 -28.72 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.7 t -59.31 107.95 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -150.51 130.11 13.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.2 mt -89.64 80.52 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.7 73.8 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.1 p -116.81 -1.72 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.147 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 80.3 p -114.74 -169.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.18 178.79 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 66.7 t -61.06 106.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -106.5 -63.45 1.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.35 154.96 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.88 160.48 25.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.9 t -123.16 130.31 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 111.177 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.38 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.78 159.21 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.2 mt -70.19 139.85 87.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.574 0.702 . . . . 0.0 110.967 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 40.6 Cg_exo -60.43 165.38 11.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.8 p -120.62 148.07 44.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.077 172.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -126.62 117.21 22.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 54.57 35.74 24.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.28 16.58 62.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -130.02 146.67 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 145.46 85.97 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.627 2.218 . . . . 0.0 112.431 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.6 t -67.17 -57.73 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.432 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 9.0 tmtt? -163.52 117.38 1.08 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.525 0.678 . . . . 0.0 110.935 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.54 128.03 11.52 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.709 2.273 . . . . 0.0 112.442 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -161.31 111.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.07 132.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.09 137.42 13.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.558 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.04 125.17 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 57.0 tp -65.35 127.35 31.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 27.0 m -133.2 148.83 52.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.815 -166.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.86 132.75 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -112.14 148.05 18.21 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.435 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.1 mt -106.1 125.79 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -59.04 118.26 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.1 -24.72 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.24 -9.58 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -68.82 132.53 90.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.636 0.731 . . . . 0.0 110.913 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -14.31 39.4 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.636 2.224 . . . . 0.0 112.302 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -115.6 29.43 8.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -167.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -58.28 -35.61 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.6 -36.46 83.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 62.6 tp -64.56 -42.85 95.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.4 90.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -65.15 -43.97 90.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.85 -172.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.73 -51.36 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -172.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -32.61 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.74 -50.58 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -74.11 -42.88 59.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.66 -14.35 19.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -160.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -123.23 -53.73 1.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 59.5 tp -68.07 -46.93 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 106' ' ' TYR . 84.2 mt -83.78 63.79 7.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.1 p -135.54 165.31 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 173.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.87 -44.45 70.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -80.91 -40.85 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.59 35.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.609 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.47 -34.41 72.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 110.904 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.28 -40.04 84.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -33.2 68.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.496 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 78.7 t -79.07 -51.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.154 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -79.3 -19.84 49.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 -166.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -57.85 -18.14 20.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -93.23 -21.33 19.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.98 149.75 92.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.617 0.722 . . . . 0.0 110.906 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.429 ' HB2' ' HB3' ' A' ' 232' ' ' TRP . 79.7 Cg_exo -57.87 -44.14 42.99 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.239 . . . . 0.0 112.405 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -95.06 -45.86 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 83.54 9.74 82.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.54 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.89 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.3 m -115.83 156.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -77.18 -9.01 58.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 171.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.37 120.19 23.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.66 -43.9 97.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 38.6 t -58.75 -48.93 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.924 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.615 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.5 t80 -71.02 -35.39 72.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.849 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -62.34 -32.82 73.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.57 -36.95 77.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.83 -38.44 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.69 -26.69 67.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.981 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.44 -12.46 43.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.11 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.83 -18.1 59.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -90.19 119.0 69.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.608 0.718 . . . . 0.0 110.809 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.99 -32.92 50.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -70.75 -40.63 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.41 -40.72 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.4 72.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.191 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.59 89.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.7 m -65.13 -46.35 81.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.163 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -68.18 -34.82 76.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -63.12 -39.97 96.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.9 -38.87 66.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.69 91.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.012 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLN . . . . . 0.403 ' HG3' ' HG3' ' A' ' 326' ' ' LYS . 20.8 pt20 -71.3 -14.49 62.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.403 ' HG3' ' HG3' ' A' ' 325' ' ' GLN . 90.3 mttt -110.35 -6.52 14.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -175.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.93 -160.55 36.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.437 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -130.16 148.25 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.875 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.426 HG22 ' HG2' ' A' ' 331' ' ' PRO . 45.5 mm -68.97 117.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.115 -171.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 tmt? -47.93 -53.73 29.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.62 0.724 . . . . 0.0 110.902 -165.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 330' ' ' MET . 45.5 Cg_endo -64.91 101.2 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.703 2.268 . . . . 0.0 112.366 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.641 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 22.9 m120 -121.56 34.56 5.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -168.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 45.9 mm 88.94 136.56 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.071 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.26 -26.66 20.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.701 2.268 . . . . 0.0 112.266 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.7 mm-40 -57.44 -23.11 47.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 66.5 ttp -63.29 -32.7 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.9 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.3 m -64.35 -38.12 89.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.28 -45.76 83.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -57.39 -48.67 78.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -64.3 -45.66 87.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.39 93.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.082 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.62 -29.87 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.6 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 73.7 ttt-85 -58.93 -43.07 91.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.6 m -59.69 -41.5 90.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.32 -40.21 93.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.44 -50.93 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.05 -46.46 91.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.041 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.11 -36.34 83.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.24 -48.1 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.44 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.054 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -79.0 -9.45 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.1 10.1 86.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.82 -28.6 58.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.319 . . . . 0.0 110.85 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -138.26 155.76 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 357' ' ' VAL . 97.0 m -71.52 152.28 43.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 174.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 356' ' ' THR . 64.1 t -65.66 -47.25 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 -173.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.99 -41.16 99.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -71.91 -44.47 63.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -64.84 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.4 -37.84 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.8 tttt -61.88 -41.99 98.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.26 -31.6 72.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -71.64 -47.16 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.083 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.9 pp0? -68.54 -31.52 70.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 98.9 m -63.26 -44.06 96.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.048 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -64.51 -37.68 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.797 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.93 -46.19 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.4 p -95.19 -6.16 42.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.233 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.1 127.68 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.123 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -128.48 165.39 20.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.81 119.95 15.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.5 24.03 34.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.497 -172.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -145.0 154.27 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.882 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.26 142.93 32.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.8 t -125.48 125.75 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.45 131.75 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.594 ' HB3' HD22 ' A' ' 43' ' ' LEU . 24.0 m0 -113.16 129.84 56.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.4 tt -151.43 153.33 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -55.37 127.04 27.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.09 -20.93 78.99 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -165.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.07 -48.84 72.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -163.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -138.42 83.21 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 145.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -111.3 -34.38 2.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -77.17 -43.83 32.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.966 -159.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -65.77 -60.01 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -155.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -45.68 96.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.54 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -58.39 -41.47 84.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.943 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.87 -48.83 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.913 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.28 -33.88 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.074 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.67 -37.2 94.37 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.369 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.35 -45.88 85.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.88 -44.48 97.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.38 -37.26 86.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -64.86 -35.29 80.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.16 -37.71 72.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.47 -41.5 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -104.67 -17.35 14.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.182 -172.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.87 88.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.55 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.3 tt -76.15 125.24 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.36 121.58 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 p -103.66 140.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -134.24 112.18 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.143 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.02 122.76 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -128.59 150.93 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 26.3 p80 -133.77 73.19 72.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.669 0.747 . . . . 0.0 110.871 170.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 16.9 Cg_endo -70.04 -28.04 24.41 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.633 2.222 . . . . 0.0 112.427 -162.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 57.8 m-20 78.23 2.39 2.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 -172.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.93 -2.04 44.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 10' ' ' TRP . 84.7 mt -46.0 -55.54 6.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.97 -154.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -70.0 -26.64 64.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -168.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -84.34 -43.43 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -79.98 -41.39 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.864 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 29.7 t80 -51.88 -52.97 56.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.825 -165.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 73.3 Cg_exo -54.25 -38.05 88.26 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.564 2.176 . . . . 0.0 112.388 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.2 -48.47 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.924 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -72.18 -30.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.14 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.09 -24.28 67.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.54 7.12 47.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.47 22.59 67.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -119.92 -170.33 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.983 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.56 -173.23 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.581 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.02 159.97 23.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.242 . . . . 0.0 112.364 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 276' ' ' ALA . 29.7 t70 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 169.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.35 142.97 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.36 132.08 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.191 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -113.8 127.28 55.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -146.99 154.46 41.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.34 -102.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -176.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 -51.28 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.07 -47.98 80.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -79.69 -33.38 41.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -56.52 -47.93 78.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.16 81.7 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.509 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.13 -43.22 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.59 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -70.82 -30.02 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.31 95.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.089 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.43 -24.38 65.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -83.45 3.67 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.46 36.91 69.31 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.478 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.77 -9.56 59.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.785 0.326 . . . . 0.0 110.869 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -132.68 143.18 49.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.948 -173.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.74 164.32 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.078 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -66.31 134.95 53.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -107.92 151.76 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.088 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.5 m -127.44 75.06 77.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 111.218 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.49 141.0 17.44 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.659 2.24 . . . . 0.0 112.251 169.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -80.62 179.95 7.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.913 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.71 -36.13 82.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -173.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -41.94 98.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -69.0 -40.72 78.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.81 -42.2 90.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.859 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.79 -27.11 64.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.99 -27.32 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.925 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.48 -110.26 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 31.6 t80 -156.76 134.71 7.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.667 0.746 . . . . 0.0 111.01 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 80.8 Cg_exo -56.38 -41.66 73.92 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.377 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.27 -40.58 97.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.5 p -71.5 -25.5 62.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.402 ' HA ' HG22 ' A' ' 97' ' ' VAL . 63.4 m95 -74.38 -34.31 63.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.876 173.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.15 -31.3 71.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.832 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.06 -26.45 68.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 35.9 m -108.04 15.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.149 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -100.34 131.42 46.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -130.74 121.83 26.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 59.28 34.97 23.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.9 4.17 90.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.436 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.04 146.23 47.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.772 0.32 . . . . 0.0 110.918 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -86.37 127.77 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.6 pt -117.93 -8.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 -169.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -159.67 163.23 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -170.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.73 129.01 24.77 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.714 0.769 . . . . 0.0 110.966 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.66 122.32 9.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.309 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -109.64 -40.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -155.54 156.25 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.023 -167.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.89 137.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.635 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 24.9 pt-20 -142.8 154.94 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.25 41.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.175 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.7 tp -66.42 142.36 57.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.874 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.4 m -138.85 156.37 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.6 tp -97.01 123.89 40.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 244' ' ' VAL . 74.6 mt -113.3 125.23 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -134.94 157.72 46.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -170.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -91.64 112.56 24.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.698 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 96.4 mttt -67.69 -29.09 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 -174.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -78.11 -35.68 48.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.6 -45.78 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.9 tp -121.71 106.7 36.87 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.913 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 124' ' ' ASN . 97.1 Cg_endo -74.86 157.02 43.61 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.65 2.233 . . . . 0.0 112.284 168.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.6 t30 25.06 96.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.594 0.712 . . . . 0.0 110.953 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.8 Cg_endo -65.25 155.69 67.17 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.728 2.285 . . . . 0.0 112.405 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.96 142.13 55.76 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.751 2.301 . . . . 0.0 112.297 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -91.04 -25.62 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 249' ' ' THR . 68.7 p -128.69 159.99 33.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.186 -175.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -74.06 -23.59 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.979 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.5 -28.57 67.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.98 -20.08 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.628 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 31.2 mm -57.71 -56.25 36.38 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.573 0.701 . . . . 0.0 111.11 -168.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 29.9 Cg_endo -69.44 -39.69 6.79 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -172.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.18 99.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.74 -39.54 94.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.45 -41.4 98.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.02 -39.6 86.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.07 -45.87 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -84.6 -18.92 34.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.415 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.0 tttt -57.47 -30.04 64.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.48 -20.42 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.2 9.31 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.03 68.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.527 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -108.97 161.43 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.849 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.5 t -115.84 152.66 32.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 167.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.97 -42.35 57.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.109 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.97 153.15 47.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -175.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mmm -128.38 120.27 26.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.842 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -166.08 165.01 18.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -97.22 141.21 30.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -168.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 52.4 tp -105.57 2.45 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 175.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -76.54 -8.6 57.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 174.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.48 145.07 39.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.737 0.78 . . . . 0.0 110.832 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.568 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 50.5 Cg_endo -68.73 -24.59 34.62 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.532 2.155 . . . . 0.0 112.295 176.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -57.72 -47.62 81.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -71.64 -26.5 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 p -84.13 -17.19 40.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 7.2 m0 -56.97 -46.4 99.87 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 -170.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.554 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 88.9 Cg_exo -51.08 -33.57 43.84 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.765 2.31 . . . . 0.0 112.306 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.5 tp -81.37 -46.15 15.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.429 HG23 ' HA3' ' A' ' 191' ' ' GLY . 94.8 mt -83.14 -48.17 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.107 -171.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -66.62 -16.64 64.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.82 -28.56 66.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.51 -6.35 22.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.9 6.75 13.8 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -95.84 115.04 5.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.427 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -162.33 175.31 11.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 110.936 -161.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.634 ' HB1' ' HB3' ' A' ' 339' ' ' PHE . . . -82.88 -23.64 33.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.191 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.794 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 86.1 m-85 -130.89 143.95 51.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -112.15 127.15 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.857 163.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -108.99 111.68 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.84 -170.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.15 141.32 25.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 52.42 37.96 24.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.63 4.33 70.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.35 150.63 52.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 0.0 110.907 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.794 ' CD1' ' HB3' ' A' ' 169' ' ' PHE . 57.9 m-85 -86.19 130.78 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 172.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -115.83 117.37 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.931 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -78.62 -20.17 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.03 -16.19 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -113.97 71.31 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.79 166.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.32 150.95 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.181 -165.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -88.21 22.24 20.36 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.509 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.6 m -105.65 0.02 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.668 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 52.6 p-10 -80.98 17.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.0 m-80 94.22 -4.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 167.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.81 -57.69 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.072 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -90.79 -53.73 2.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.512 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.58 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -67.38 -35.22 78.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 0.0 111.023 -165.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.81 -43.45 93.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.975 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.08 -41.27 95.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.074 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.429 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -62.79 -39.57 98.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.454 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.93 -40.86 95.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.3 m -60.2 -42.17 94.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.151 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.78 -44.0 97.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 59.1 tp -58.72 -45.52 89.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 351' ' ' ALA . 50.4 t -63.36 -39.74 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.46 -39.87 92.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 133' ' ' PRO . 0.3 OUTLIER -70.05 -40.65 74.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -178.482 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.62 -39.29 84.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.13 -38.16 87.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -87.94 3.67 47.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 60.6 35.55 19.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -80.78 -20.19 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -139.44 153.08 47.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -98.46 132.4 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.0 72.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -89.85 -4.1 57.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 66.9 m -62.94 135.44 57.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.43 179.92 5.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.89 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -62.04 -34.64 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.931 -172.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.7 m -69.66 -41.34 75.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.838 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.07 -39.67 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.1 93.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.05 -43.45 92.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.51 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -42.39 98.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.48 ' HD1' ' HA ' ' A' ' 217' ' ' PHE . 0.9 OUTLIER -64.91 -37.08 86.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 172.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -102.64 -22.88 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.85 23.32 36.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -82.92 -22.55 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 110.923 -171.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.5 t -126.26 144.92 50.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.98 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.0 mtm -138.61 148.03 43.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -168.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.9 p -139.5 164.96 28.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.101 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.65 119.14 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.5 160.05 41.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.94 -164.42 39.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.446 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.635 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -66.46 -20.99 54.02 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.24 . . . . 0.0 112.274 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -65.56 -20.66 66.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.66 3.86 45.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -69.99 -43.15 72.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 t -68.67 105.84 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -139.69 154.05 47.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 81.6 mt -78.25 88.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.23 74.97 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 73.8 p -122.32 0.79 9.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.7 p -100.49 -170.0 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.62 179.87 7.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.74 112.33 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -119.6 -56.71 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -115.43 162.99 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.698 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -143.03 169.27 25.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.47 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 116' ' ' ILE . 58.4 t -122.93 130.2 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.82 175.55 9.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.178 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.84 161.05 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 90.0 mt -73.48 136.44 78.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.56 0.695 . . . . 0.0 110.94 -173.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 49.0 Cg_exo -62.38 159.33 36.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.746 2.297 . . . . 0.0 112.22 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 128' ' ' THR . 81.9 p -114.09 160.02 19.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.73 116.28 15.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.7 35.12 23.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.5 57.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.543 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.21 145.24 56.48 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.902 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.92 152.07 77.42 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.652 2.234 . . . . 0.0 112.399 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 95.7 p -65.1 -61.5 2.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -165.88 147.01 5.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.566 0.698 . . . . 0.0 110.911 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.36 126.1 8.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.589 2.193 . . . . 0.0 112.417 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -163.89 111.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.77 132.87 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.129 163.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.81 139.14 15.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.62 119.52 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.803 0.335 . . . . 0.0 111.101 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.7 129.87 41.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -132.1 139.9 48.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -170.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.59 137.77 52.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -129.89 166.54 21.96 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 70.6 mt -112.4 129.81 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 111.191 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -59.36 123.21 16.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.939 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.46 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.48 59.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -76.06 131.46 75.75 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.619 0.723 . . . . 0.0 110.852 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.52 -10.86 28.84 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.65 2.233 . . . . 0.0 112.313 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -108.91 28.62 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -166.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.35 -37.75 62.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.757 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.54 -38.59 84.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.95 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.13 -43.09 93.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.409 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . . . -65.63 -44.55 86.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -63.15 -49.64 73.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 97.9 mt-10 -66.47 -45.15 80.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.78 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 19.1 t80 -59.98 -41.65 92.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 28.6 tp -70.33 -54.6 11.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -83.34 -30.76 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 -167.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.575 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.2 m-20 -98.57 -18.45 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.799 -167.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.605 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.6 m-85 -122.15 -53.44 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 59.6 mt -72.35 -41.83 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 -176.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.79 60.7 6.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 176.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.1 p -136.9 170.2 16.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.159 172.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -55.12 -48.17 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.796 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.63 -39.93 43.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.39 -46.09 27.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.422 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.7 tp -67.74 -36.32 80.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 110.905 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.04 -41.18 96.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.21 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.06 -32.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.56 -24.39 65.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.3 -26.25 39.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.56 -15.74 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.76 154.83 61.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.53 0.681 . . . . 0.0 110.988 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.02 -97.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.577 2.184 . . . . 0.0 112.433 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.29 -25.87 67.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 60.98 31.87 78.03 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.551 165.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.91 127.28 31.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 111.104 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 34.7 m -116.75 152.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.081 -164.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.95 -10.84 59.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.08 118.54 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.37 -51.73 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.7 p -62.27 -43.07 99.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 307' ' ' TYR . 1.3 t80 -70.56 -37.1 73.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.975 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -66.24 -32.61 74.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.0 -36.58 81.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -72.79 -39.68 66.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.37 -26.77 68.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.935 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.78 -11.27 44.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.047 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.07 -18.14 58.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -85.52 118.93 71.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.768 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.09 -34.94 60.08 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 0.0 112.383 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -70.17 -41.11 74.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.04 -38.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.01 73.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.57 -41.37 88.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.04 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -63.73 -44.62 93.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.159 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.6 -38.82 90.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.886 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.53 -38.56 84.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.96 85.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.3 -18.26 65.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.832 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.27 -8.13 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.889 -172.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -102.88 -162.68 25.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.502 -173.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -133.98 156.68 47.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.469 HG13 ' HD2' ' A' ' 331' ' ' PRO . 4.9 tp -63.21 124.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -171.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.602 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.9 tmt? -44.46 -52.27 17.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.525 0.678 . . . . 0.0 110.847 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 330' ' ' MET . 34.8 Cg_endo -60.71 84.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.34 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.657 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 74.0 m-80 -104.23 29.36 6.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -170.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.657 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 50.3 mt 89.62 135.45 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.704 . . . . 0.0 111.146 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.41 -26.86 22.45 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.239 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.461 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.3 mm-40 -59.97 -18.16 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 62.1 ttp -57.97 -34.61 70.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.949 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.93 -38.83 92.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.14 -38.2 66.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.634 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 7.2 m-30 -67.17 -35.97 80.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -55.5 -48.8 74.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -64.94 -42.36 94.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.79 94.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.104 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.77 -38.11 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.083 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 71.2 ttt-85 -53.51 -39.92 64.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -57.04 -45.13 83.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.072 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.84 -43.71 87.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.89 -58.48 5.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -166.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.7 mt -66.57 -45.0 89.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 97.9 m-20 -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.78 59.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 196' ' ' VAL . . . -71.74 -35.45 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.11 -172.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -75.47 -14.5 60.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.79 7.75 87.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.403 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -75.22 -24.27 57.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.962 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 83.4 mm-40 -136.01 157.08 47.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.0 m -67.17 150.62 48.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.56 -46.99 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.15 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.46 -40.14 95.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.92 -42.52 66.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.27 93.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 32.7 tp -71.93 -35.1 69.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.2 tttt -62.5 -40.27 96.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 173.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.97 -31.28 72.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -74.59 -43.18 56.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.174 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.0 OUTLIER -69.29 -28.91 66.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -178.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -66.75 -44.18 82.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.139 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.19 -40.16 68.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.38 -30.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 -171.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.8 p -92.17 -2.82 56.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.181 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -177.394 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.736 0.303 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -80.73 133.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.08 -179.44 8.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.61 126.62 30.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.991 -172.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.57 19.01 59.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.562 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -142.19 158.55 43.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -142.44 147.57 36.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 173.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.13 126.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.431 HG13 HD13 ' A' ' 7' ' ' LEU . 62.8 mt -118.74 133.22 66.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.129 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 30.2 m0 -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 174.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 tt -151.78 154.07 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.141 -172.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -55.14 127.36 28.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.1 -19.44 79.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.519 -168.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.57 -51.23 70.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -163.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.19 78.84 1.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 147.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.0 -35.88 2.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.428 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -80.5 -44.46 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 110.989 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -66.72 -52.08 48.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -155.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -65.3 -47.71 77.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.472 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.01 -38.41 85.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.87 -45.15 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.42 -47.33 82.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.96 -45.03 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.659 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -60.8 -36.31 91.65 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.363 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.16 -45.52 93.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.19 -44.77 90.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -64.49 -41.8 96.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -63.8 -33.66 76.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.12 -38.23 85.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.1 -37.02 17.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 -173.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.8 m -101.19 -24.51 14.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 -171.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.01 3.36 87.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.53 125.27 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.4 . . . . 0.0 111.185 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -66.48 128.03 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -172.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.659 HG11 ' HA3' ' A' ' 24' ' ' GLY . 95.5 t -104.26 132.9 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -135.9 116.93 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.6 125.13 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.49 153.06 47.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 27.9 p80 -133.23 75.12 71.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 0.0 110.838 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.561 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.6 Cg_endo -69.24 -29.32 26.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.238 . . . . 0.0 112.401 -162.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.6 m-20 77.67 3.42 3.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -175.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.8 2.09 49.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 10' ' ' TRP . 82.9 mt -48.65 -55.14 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -154.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -62.65 -28.91 70.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 -169.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.48 -47.07 9.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.811 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -79.98 -46.33 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -163.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 7.6 t80 -50.66 -54.0 40.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.679 0.752 . . . . 0.0 110.88 -162.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.1 Cg_endo -62.9 -31.8 77.25 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.295 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -47.82 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.7 m -74.95 -26.41 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -174.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.25 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.33 -24.28 65.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.028 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.5 p -96.43 4.96 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.37 23.17 61.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.502 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.9 t0 -119.88 -176.24 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.32 -179.18 24.67 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.582 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.91 161.1 24.13 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -76.26 -38.58 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.63 138.77 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 tt -138.27 140.86 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -100.2 143.34 30.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -140.05 152.37 46.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.98 -114.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.46 ' NE2' ' N ' ' A' ' 261' ' ' VAL . 70.8 m80 -116.94 -57.47 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.65 -45.42 90.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -74.97 -36.67 62.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.84 -49.55 75.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.21 -49.48 61.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.453 -175.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.31 94.48 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.528 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -71.9 -29.94 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.67 96.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.46 -28.63 69.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.3 m -84.97 5.73 28.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.879 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.49 35.66 82.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.434 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.05 -15.49 60.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.874 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.415 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -129.61 143.64 50.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -169.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.15 159.33 16.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.44 136.87 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.5 pt -109.41 152.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.3 p -130.49 63.07 68.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.557 0.694 . . . . 0.0 111.157 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -72.67 143.28 37.45 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.717 2.278 . . . . 0.0 112.255 167.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -75.08 177.7 6.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.81 -30.35 70.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.52 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.023 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -64.71 -38.06 89.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.801 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -65.55 -40.13 92.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.991 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.21 -36.59 83.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.93 -30.98 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.05 -107.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -168.66 131.05 1.19 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.658 0.742 . . . . 0.0 110.957 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -54.19 -38.73 88.02 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.716 2.278 . . . . 0.0 112.328 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.56 -35.47 80.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -76.3 -24.74 54.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -75.46 -26.52 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 173.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.1 -33.23 71.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.16 67.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.09 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.98 16.63 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 -175.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -109.97 138.27 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.934 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -136.29 124.96 23.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.66 34.86 25.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.27 4.72 89.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.421 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.53 144.13 48.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.52 126.4 33.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.415 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.2 pt -119.67 -10.06 10.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.104 -168.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.27 165.17 31.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -108.61 137.92 20.13 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.667 0.746 . . . . 0.0 110.867 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 21.4 Cg_exo -66.53 120.24 7.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.284 173.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.36 -36.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.93 151.28 14.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.2 133.36 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -134.09 149.9 51.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.22 156.0 34.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 tp -69.98 140.4 52.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.7 m -142.93 159.05 42.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.1 tp -99.74 129.92 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.9 mt -110.89 132.92 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -132.59 154.76 49.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -93.28 117.19 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.786 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.35 -31.75 73.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -173.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.89 -35.09 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.21 -52.56 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.402 HD13 HD21 ' A' ' 135' ' ' LEU . 94.3 mt -127.48 115.77 21.26 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.1 Cg_endo -75.04 171.14 18.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 0.0 112.37 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.559 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.9 t30 24.81 96.6 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.1 Cg_endo -65.0 155.04 70.41 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.405 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.49 143.94 59.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.595 2.197 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.48 -20.48 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.1 p -129.35 157.93 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -71.9 -25.47 61.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.49 -30.5 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.53 -20.05 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.597 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 33.8 mm -60.77 -54.03 58.54 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.604 0.716 . . . . 0.0 111.088 -169.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 23.5 Cg_endo -61.82 -40.05 47.67 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.753 2.302 . . . . 0.0 112.304 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.36 90.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.402 HD21 HD13 ' A' ' 122' ' ' LEU . 62.4 tp -64.93 -40.37 94.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.96 -40.81 95.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.45 -42.92 83.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.44 -44.07 75.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 pp -83.03 -22.83 33.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.59 -25.87 67.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -18.78 65.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.26 9.98 41.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.02 25.68 73.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.477 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -108.73 157.52 18.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.836 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.8 t -111.24 144.19 40.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 169.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.24 -44.12 63.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.11 157.05 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 mmm -138.8 116.44 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -164.39 169.51 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.47 138.14 32.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -166.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 206' ' ' ALA . 89.6 mt -114.38 3.52 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.54 -3.8 54.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.68 145.06 49.59 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.689 0.757 . . . . 0.0 110.907 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.699 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 29.7 Cg_endo -69.12 -25.85 31.14 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.63 2.22 . . . . 0.0 112.256 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -57.72 -47.95 80.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.85 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.425 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 52.7 m-85 -79.98 -21.88 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.869 -174.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 71.5 p -77.31 -22.43 51.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.458 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 9.4 m0 -56.43 -46.48 99.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.488 0.661 . . . . 0.0 110.892 -170.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 60.8 Cg_exo -45.2 -37.21 13.2 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.62 2.213 . . . . 0.0 112.35 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.424 ' HB2' HD12 ' A' ' 195' ' ' LEU . 89.2 mt -82.59 -44.15 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.1 mt -78.33 -45.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 -171.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.94 -16.14 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.013 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.24 -31.96 73.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.098 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.22 0.67 23.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.821 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.82 11.08 9.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 163.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -93.78 129.56 9.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.411 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -166.48 159.01 14.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.958 0.408 . . . . 0.0 110.909 -168.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.53 68.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.098 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -151.51 155.73 39.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.007 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 32.4 tptt -87.33 141.07 28.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -97.72 112.58 24.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -150.34 137.21 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.87 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.13 38.12 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.64 10.22 63.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.416 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.51 152.64 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 11.3 p90 -61.54 146.06 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -137.97 103.09 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' A' ' 181' ' ' VAL . 8.3 tp -65.15 -15.14 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -170.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.3 -17.62 45.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.808 -165.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -124.06 60.7 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.852 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 182' ' ' GLY . 58.2 t -130.26 157.63 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -171.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.509 ' N ' HG12 ' A' ' 181' ' ' VAL . . . -72.03 10.54 4.35 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.498 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 m -94.79 -24.56 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 111.101 172.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 4.9 p30 -83.34 3.93 29.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.8 m-20 84.1 -2.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 158.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.9 -48.45 11.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.1 11.64 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.546 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -65.19 -43.1 92.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.158 -163.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.65 -42.85 81.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.942 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.03 97.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.82 -41.99 97.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.441 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.24 -36.18 82.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.955 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -59.84 -46.92 87.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -65.1 -44.12 89.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.802 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 160' ' ' LEU . 5.8 tt -60.01 -54.26 48.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.71 -37.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.25 -37.55 83.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -36.56 78.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.65 -41.66 88.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.043 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.84 -32.94 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -84.66 -1.76 56.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 60.71 39.98 16.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.944 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -78.53 -25.81 45.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.829 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -145.84 153.01 40.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -96.97 134.7 39.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.99 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.419 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . -65.34 -31.52 72.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -173.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.0 -4.75 57.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 -166.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -61.16 135.19 57.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -134.67 -175.2 3.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -56.98 -45.3 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 -175.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -62.56 -42.73 99.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.86 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.8 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -43.47 91.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.99 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.62 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -65.07 -33.46 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.64 -26.03 68.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.48 -23.23 13.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.37 27.02 13.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.456 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.71 -25.81 37.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.907 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -127.41 139.7 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.93 26.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 52.7 mtt -140.21 164.7 29.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 -172.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.5 t -152.82 160.99 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.66 114.86 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.143 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -149.36 160.41 43.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -100.07 -139.55 10.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.335 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.681 ' HB3' HD22 ' A' ' 299' ' ' LEU . 30.3 Cg_endo -68.3 -25.88 35.97 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 0.0 112.353 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -67.94 -16.97 64.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.09 15.13 12.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -56.2 -33.71 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.5 t -62.19 120.19 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -170.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -147.65 128.1 14.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.979 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.6 mt -95.5 86.75 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -84.77 74.92 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.4 p -112.55 -6.46 13.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.095 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.8 p -115.12 -165.25 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.777 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.33 177.04 3.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 80.6 t -65.74 111.19 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.38 -70.41 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.3 158.5 17.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.34 166.57 26.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.563 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 61.9 t -124.62 132.08 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 111.176 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.37 178.51 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -90.63 160.01 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.093 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 99.2 mt -71.48 143.28 87.49 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.9 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.84 169.9 21.32 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.306 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.8 p -107.93 162.08 14.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -139.02 120.28 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 54.97 33.93 21.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.04 74.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.47 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -123.44 151.16 62.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -172.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.04 152.21 83.13 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.717 2.278 . . . . 0.0 112.395 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.9 p -64.99 -58.39 6.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.845 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -168.2 142.42 2.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.632 0.73 . . . . 0.0 110.904 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -73.15 126.03 10.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.368 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -169.36 119.98 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.77 130.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.178 159.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.94 144.26 15.8 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.463 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.46 ' N ' ' NE2' ' A' ' 64' ' ' HIS . 77.8 t -126.95 122.97 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 62.5 tp -73.09 138.22 45.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.7 m -125.75 144.7 50.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.795 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.4 132.01 51.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.087 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.64 157.12 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.427 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 96.2 mt -105.07 127.24 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -56.57 119.91 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.95 65.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.08 -9.96 59.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -72.17 133.67 83.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.672 0.749 . . . . 0.0 110.827 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.45 -11.23 30.79 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.598 2.199 . . . . 0.0 112.379 172.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -106.65 36.37 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -168.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.77 -43.54 72.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.78 -174.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -68.13 -36.8 80.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.73 -48.56 76.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.798 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.432 ' HA ' ' CE2' ' A' ' 279' ' ' PHE . . . -60.32 -43.52 96.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.05 -171.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -66.39 -43.94 84.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.811 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.34 -58.63 6.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -169.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.455 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 5.5 p90 -74.94 -25.84 59.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -167.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 280' ' ' LEU . 1.8 tt -63.6 -45.82 88.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.968 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -86.39 -27.13 24.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -99.89 -11.64 20.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.831 -167.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.642 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.3 m-85 -128.54 -52.13 1.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 5.8 mp -70.39 -41.94 72.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -170.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.53 70.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 81.6 p -135.3 169.97 16.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -52.26 -47.85 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.07 -41.49 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.22 -48.49 8.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.591 -169.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 304' ' ' LEU . 19.0 tp -70.4 -34.39 72.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 110.969 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.82 -41.14 97.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 295' ' ' LYS . . . -66.1 -34.96 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.051 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.594 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 11.6 p -84.07 -36.02 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.94 -24.68 37.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 292' ' ' ALA . 62.5 pttt -61.99 -16.1 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -94.56 -23.84 17.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 71.8 mmtt -64.63 146.54 98.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.551 0.691 . . . . 0.0 110.946 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 71.5 Cg_exo -57.93 -57.52 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.567 2.178 . . . . 0.0 112.413 -174.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 229' ' ' PRO . 58.8 tp -73.33 -48.22 36.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -172.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.05 -15.11 62.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.483 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.97 126.2 29.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -124.4 160.15 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 -171.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.5 -15.11 59.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.479 ' HB2' HD23 ' A' ' 290' ' ' LEU . 50.8 tp -74.7 120.01 19.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.41 -41.97 90.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.1 m -58.09 -48.87 78.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.619 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.2 t80 -70.02 -32.63 70.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -59.19 -36.41 75.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.69 -39.79 85.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -77.13 -38.59 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.81 -29.1 70.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -13.01 57.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.71 -22.31 46.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.848 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 64.6 t0 -87.69 119.95 70.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 110.826 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 36.4 Cg_endo -62.4 -24.83 75.86 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.489 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 17.9 ttp180 -68.08 -51.36 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.39 -37.14 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.7 84.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.185 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.54 -37.82 85.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.062 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 59.9 m -66.42 -39.93 89.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.23 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 75.9 mtm -66.3 -37.46 85.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -66.63 -35.09 79.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.83 94.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -71.43 -23.26 61.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.92 -5.94 24.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.2 41.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.55 151.18 50.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 110.841 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.494 ' CG2' ' O ' ' A' ' 329' ' ' ILE . 2.2 tp -68.42 125.54 26.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.083 -166.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.577 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 95.8 mtp -56.95 -52.01 77.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.87 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 330' ' ' MET . 55.7 Cg_endo -67.97 83.55 0.44 Allowed 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.799 2.332 . . . . 0.0 112.3 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.513 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 22.3 t-20 -122.92 -6.89 8.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 333' ' ' ILE . 10.8 tp 161.77 118.24 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 0.0 111.094 -157.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.42 -31.36 91.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.6 2.2 . . . . 0.0 112.255 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.442 ' H ' HG13 ' A' ' 333' ' ' ILE . 91.9 mt-30 -62.62 -10.74 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.993 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -59.18 -35.08 72.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.7 m -62.8 -38.52 90.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.31 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 8.9 m-30 -65.28 -37.91 88.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -56.22 -49.75 73.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.973 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -65.81 -42.18 90.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.71 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.3 t -71.49 -37.74 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.699 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 57.2 ttt180 -53.25 -47.99 68.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.5 m -62.61 -41.91 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 364' ' ' ALA . . . -64.91 -41.79 95.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.8 t -69.18 -47.72 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.19 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.92 -46.37 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -64.98 -36.33 84.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.824 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.91 -47.39 52.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.92 70.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.101 -173.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 84.8 p -74.85 -14.99 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.3 7.21 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.74 -30.07 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -136.07 155.95 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.991 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.4 m -66.0 150.5 48.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.98 -49.81 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.0 -36.36 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -70.95 -40.52 71.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.76 89.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.161 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.82 -38.74 91.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.44 -45.54 93.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -74.3 -42.07 60.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 346' ' ' ALA . . . -81.56 -42.76 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.098 -167.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 365' ' ' GLN . 8.7 mm-40 -73.52 -24.08 60.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 -171.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 63.7 m -53.06 -33.64 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.074 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -61.12 -30.96 70.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 72.5 mt -72.13 -42.62 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.3 p -89.03 -11.07 45.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.101 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.194 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.721 0.296 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.3 mt -83.58 127.34 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.179 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -126.71 163.24 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.91 119.8 14.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.006 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.18 23.79 39.55 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.427 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.48 153.52 40.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.357 . . . . 0.0 110.905 -173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 7' ' ' LEU . 2.3 pp -145.96 146.0 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.1 126.54 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.606 HG22 ' HB ' ' A' ' 59' ' ' ILE . 1.4 pt -120.19 131.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.467 ' HB3' HD22 ' A' ' 43' ' ' LEU . 23.0 m0 -113.44 132.7 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.01 155.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.2 t-20 -56.33 126.89 28.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 172.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.57 -21.72 79.18 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.54 -51.53 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -163.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -135.01 77.59 1.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 148.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.72 -35.23 1.9 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -73.36 -48.33 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.349 . . . . 0.0 111.003 -155.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -69.76 -50.47 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 -155.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.06 -48.19 87.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.2 -36.85 78.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.18 -48.36 73.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.97 -45.75 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.058 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.675 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.76 -38.32 95.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.03 -45.38 89.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 110.888 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.43 -46.79 86.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.55 -40.67 96.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -62.36 -35.21 78.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.36 -39.55 71.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -176.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.7 -39.88 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.0 m -102.78 -18.31 15.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.1 87.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.469 173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.788 HG13 HD21 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -88.02 130.96 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.166 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.91 129.5 39.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.675 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.5 t -109.73 136.68 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -128.1 113.71 16.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 9' ' ' ILE . 61.5 t -98.57 120.58 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.062 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.9 mt-10 -129.48 145.96 51.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -134.81 72.91 67.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 0.0 110.809 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.3 Cg_endo -70.53 -25.41 25.08 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.276 . . . . 0.0 112.431 -161.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.3 m-20 77.59 4.03 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -172.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.55 0.8 50.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 173.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 10' ' ' TRP . 89.1 mt -48.33 -55.37 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -153.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.26 -33.97 69.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -169.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.28 -43.59 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -76.5 -48.04 20.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -164.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.7 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.1 t80 -49.08 -57.37 11.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.644 0.735 . . . . 0.0 110.916 -160.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 31.8 Cg_endo -66.9 -30.04 40.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 0.0 112.289 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.55 -46.61 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.921 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 21.0 m -74.91 -27.18 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.126 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.07 77.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.158 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -24.14 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 p -96.08 4.74 52.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.84 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.425 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.2 t0 -120.02 -174.78 2.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.783 0.325 . . . . 0.0 110.944 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.35 -173.72 23.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.51 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.03 157.04 23.56 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.64 2.226 . . . . 0.0 112.323 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.7 -40.71 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 172.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.606 ' HB ' HG22 ' A' ' 9' ' ' ILE . 97.5 mt -136.9 142.64 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -131.95 137.13 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.154 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -103.17 134.4 46.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -140.03 156.14 46.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.07 -102.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -124.13 -54.69 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.937 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.01 -50.06 72.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -71.04 -34.99 71.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.59 -49.09 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.793 -174.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.44 -51.18 54.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.432 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -42.68 95.06 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.566 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -70.01 -31.28 68.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.995 0.426 . . . . 0.0 110.994 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.43 98.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.119 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.69 -25.17 64.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -85.11 3.95 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.48 35.15 74.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.528 173.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -78.79 -10.9 59.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -131.86 144.02 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -175.056 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.89 157.96 17.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.083 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.23 137.11 56.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -109.98 151.77 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.422 ' H ' ' HE2' ' A' ' 277' ' ' LYS . 26.5 m -134.98 72.09 68.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.713 . . . . 0.0 111.117 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.83 142.21 34.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.756 2.304 . . . . 0.0 112.316 168.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -79.05 -179.64 6.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.73 -37.85 88.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.64 88.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.96 -38.58 88.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.65 -39.42 91.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.82 -29.49 70.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.69 -25.87 68.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.918 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.448 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 60.6 mt -101.87 -123.97 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -160.05 134.88 5.55 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.689 0.757 . . . . 0.0 110.956 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -54.88 -38.81 92.44 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.715 2.276 . . . . 0.0 112.345 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.72 -36.5 83.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -74.98 -23.26 58.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.185 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.448 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 57.3 m95 -69.98 -32.13 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.37 -30.16 70.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 329' ' ' ILE . . . -67.35 -27.2 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.009 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 36.0 m -112.66 8.62 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.206 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -100.27 135.31 41.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.94 124.94 25.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 58.1 34.79 24.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.58 3.92 89.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.417 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.79 145.97 47.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.933 0.397 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.97 125.99 33.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.41 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.7 pt -118.64 -8.9 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 -169.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.7 161.29 37.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -171.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -106.92 129.87 23.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.626 0.727 . . . . 0.0 110.94 175.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.01 120.3 7.82 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.745 2.297 . . . . 0.0 112.282 173.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.3 mm -102.39 -37.86 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.08 151.73 16.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.06 -169.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.0 t -126.75 130.57 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.16 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.905 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 94.8 mt-10 -128.16 145.05 51.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.41 155.11 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.021 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.2 tp -68.69 145.93 53.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.5 p -141.02 157.59 45.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.4 tp -98.06 126.19 43.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 244' ' ' VAL . 75.9 mt -112.72 129.35 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -135.73 153.65 51.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.69 114.21 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.796 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.48 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.7 mttt -67.55 -27.87 67.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -172.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.55 -36.53 29.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.401 HD22 ' HE2' ' A' ' 144' ' ' LYS . 98.0 mt -78.63 -43.26 26.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 176.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.23 111.89 10.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.689 0.757 . . . . 0.0 110.904 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.551 ' O ' ' C ' ' A' ' 124' ' ' ASN . 93.1 Cg_endo -75.78 173.59 14.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.629 2.22 . . . . 0.0 112.31 174.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.551 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.3 t30 24.0 96.85 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 110.98 175.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.0 157.35 62.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.733 2.289 . . . . 0.0 112.249 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.95 144.45 58.38 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.39 -32.79 14.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 249' ' ' THR . 76.7 p -126.45 159.64 32.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 67.3 m95 -74.62 -26.81 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.97 -173.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.67 -20.64 65.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.86 -24.11 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.586 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 31.4 mm -61.33 -51.78 75.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.556 0.693 . . . . 0.0 111.079 -164.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 38.7 Cg_endo -69.06 -42.38 4.19 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.694 2.262 . . . . 0.0 112.343 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.14 91.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.156 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.81 -38.98 92.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.933 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.92 -43.37 98.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.853 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.19 -41.15 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.36 -46.49 73.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -83.41 -21.29 33.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.908 -177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.449 ' N ' HD12 ' A' ' 139' ' ' LEU . 85.8 tttt -59.38 -26.61 65.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.75 -19.59 65.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.29 9.49 39.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.63 26.97 66.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.401 ' HE2' HD22 ' A' ' 121' ' ' LEU . 83.2 mttt -106.06 160.81 15.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -114.26 147.21 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 164.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.5 -30.68 61.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.095 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.0 mt -142.12 149.83 40.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.43 125.85 35.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -165.47 165.04 19.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 32.5 t-20 -84.2 134.22 34.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.808 -169.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -109.52 16.41 22.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.946 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -83.66 -12.53 55.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -137.87 147.22 55.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.719 . . . . 0.0 110.944 -171.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.758 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -65.63 -27.31 53.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.539 2.159 . . . . 0.0 112.329 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -58.55 -48.04 82.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.925 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 56.3 m-85 -80.36 -19.39 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.786 -174.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 77.8 p -79.75 -21.1 44.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.529 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.7 m0 -57.37 -42.51 96.34 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.472 0.653 . . . . 0.0 110.902 -170.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.599 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 84.1 Cg_exo -47.13 -33.45 15.47 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.674 2.25 . . . . 0.0 112.325 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 195' ' ' LEU . 86.3 mt -83.14 -43.79 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 172.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 94.0 mt -81.4 -52.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.59 -31.93 72.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.084 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -103.43 0.07 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.69 5.14 22.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.508 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -91.27 130.03 10.09 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.481 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -166.04 175.27 8.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -169.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.31 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.136 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -141.12 151.89 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 81.4 tttt -81.7 135.3 35.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -109.34 114.15 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -148.44 143.16 26.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.885 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 49.21 39.92 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.42 5.45 67.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.396 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.57 154.08 51.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.38 129.71 34.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 110.884 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -95.6 110.16 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -20.62 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.95 -15.32 29.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 170' ' ' LYS . 65.0 t0 -133.59 90.62 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.834 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.03 162.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.32 5.18 84.1 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.427 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.62 -2.58 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.07 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 44.3 p30 -74.15 13.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 175.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.65 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.4 m-80 94.66 -5.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.3 -56.95 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.126 173.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.79 -51.56 3.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB3' HD21 ' A' ' 361' ' ' LEU . . . -65.94 -35.55 80.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.35 . . . . 0.0 111.213 -164.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -68.22 -44.55 75.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -170.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.53 95.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.59 98.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.468 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.67 -37.5 84.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.4 m -61.77 -45.43 93.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.88 -42.79 99.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 160' ' ' LEU . 3.6 tt -59.57 -51.53 69.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.791 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.58 -39.52 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.58 -41.17 89.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.83 -37.53 86.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.46 -40.53 77.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.065 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.01 -31.55 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.49 1.75 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 64.48 34.67 10.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.933 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -80.85 -23.22 39.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -148.17 150.05 33.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -86.63 140.51 29.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.19 68.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -93.03 0.86 57.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.922 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.0 m -59.43 128.72 38.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -133.62 179.92 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -62.22 -34.06 75.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -64.41 -44.15 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.6 -39.58 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.46 96.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.11 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.81 -46.32 79.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.7 86.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 222' ' ' THR . . . -64.4 -39.55 94.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.081 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -71.48 -44.36 64.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.838 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -66.82 -27.51 67.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.81 -9.7 39.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.29 15.26 78.89 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.79 -28.94 60.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.961 0.41 . . . . 0.0 110.957 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.493 HG23 ' HB1' ' A' ' 216' ' ' ALA . 82.4 p -129.83 149.87 51.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.166 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.43 -31.94 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -171.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 89.8 mtp -135.29 157.68 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.859 -165.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.9 t -154.17 155.83 36.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.6 mt -119.07 118.93 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -147.09 159.85 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.97 -166.66 42.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.465 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.905 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 32.6 Cg_endo -64.05 -21.66 68.11 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 0.0 112.396 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -66.13 -16.99 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.11 -1.58 58.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -62.23 -40.04 94.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.9 t -58.88 119.23 6.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -155.85 159.27 39.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.0 mt -89.2 77.18 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.091 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -80.49 73.25 7.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.5 p -122.3 5.36 9.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.134 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 67.0 p -108.09 -175.6 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.75 176.8 5.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.883 172.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.04 113.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -114.18 -53.45 2.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -117.46 164.98 14.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.48 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -140.41 167.06 25.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.432 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 116' ' ' ILE . 56.2 t -126.02 130.41 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.056 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.18 174.83 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.73 162.52 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.33 139.98 79.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.504 0.669 . . . . 0.0 110.9 -172.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 255' ' ' SER . 51.3 Cg_endo -75.04 160.34 40.16 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.228 . . . . 0.0 112.367 -177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 128' ' ' THR . 78.4 p -114.42 158.08 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.185 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -127.67 116.28 20.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -174.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.11 35.87 23.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.2 17.68 64.31 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.511 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -127.82 147.91 64.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.96 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.04 149.29 89.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.39 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 248' ' ' PRO . 91.9 p -71.69 -53.8 12.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.479 ' HD3' ' HD3' ' A' ' 159' ' ' PRO . 46.4 pttt -168.93 144.15 2.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 170.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.413 ' HA ' ' HA2' ' A' ' 327' ' ' GLY . 87.7 Cg_endo -78.14 128.91 9.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.335 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -165.0 116.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.8 132.59 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 156.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.5 134.28 11.61 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 82.1 t -119.02 120.74 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 111.195 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 65.3 tp -65.28 132.01 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.805 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.3 m -128.9 141.29 51.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.813 -167.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.24 130.24 50.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.134 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.32 154.01 16.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.8 mt -102.92 127.81 56.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.94 0.4 . . . . 0.0 111.168 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.5 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.24 -11.15 58.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -70.04 130.86 89.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.747 0.784 . . . . 0.0 110.771 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.44 -14.05 41.23 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -112.87 27.97 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.818 -170.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -53.35 -34.14 56.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.45 -36.72 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.788 HD21 HG13 ' A' ' 33' ' ' ILE . 69.5 tp -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 174.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.12 94.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.422 ' HE2' ' H ' ' A' ' 80' ' ' THR . 63.4 tttm -64.79 -45.55 85.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -175.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -63.15 -54.24 40.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.99 -33.56 72.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 280' ' ' LEU . 5.0 tt -61.29 -51.61 68.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.924 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.09 -26.1 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -99.29 -23.77 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -167.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.403 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 68.3 m-85 -123.24 -50.26 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 60.1 tp -69.9 -49.02 56.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -86.41 62.65 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.4 p -135.39 167.62 20.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -57.17 -44.44 83.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -77.08 -42.0 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.61 -45.7 16.99 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.448 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 290' ' ' LEU . 14.1 tp -70.16 -29.84 66.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 110.9 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -61.49 -36.54 80.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.05 93.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.73 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 9.1 p -80.82 -36.38 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -169.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.18 -16.39 60.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -54.92 -23.39 18.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -92.52 -19.17 22.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.58 156.23 59.05 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.51 0.671 . . . . 0.0 110.933 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.12 -93.6 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.643 2.229 . . . . 0.0 112.291 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.725 HD22 ' HB3' ' A' ' 229' ' ' PRO . 49.1 tp -45.13 -42.28 8.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.63 85.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.442 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.401 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -80.36 133.67 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -173.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.23 157.29 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.43 -12.49 60.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.075 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.93 117.71 16.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.96 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.76 -48.85 79.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -171.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.6 t -59.95 -46.58 88.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.698 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -71.47 -35.63 70.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.74 -36.53 83.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.22 -35.06 76.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -74.79 -39.6 61.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 301' ' ' ALA . 89.6 mt -65.04 -27.92 69.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.98 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.2 34.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.72 -17.82 57.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.71 116.52 64.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 0.0 110.81 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.51 -32.51 43.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.623 2.215 . . . . 0.0 112.354 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -69.97 -39.36 76.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.19 -41.39 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.29 68.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.082 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.32 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 69.7 p -71.07 -33.89 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 33.3 mmt -72.71 -39.93 66.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.89 -38.09 82.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.912 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -68.75 -36.47 78.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.41 93.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.096 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -66.09 -17.92 65.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.46 -4.8 22.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 257' ' ' PRO . . . -97.31 -164.68 32.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.364 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -131.94 154.61 49.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.33 . . . . 0.0 110.923 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 96' ' ' ALA . 45.0 mm -64.66 124.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.174 -171.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.549 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 18.2 tpt -56.81 -55.26 45.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 110.833 -168.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 330' ' ' MET . 42.3 Cg_endo -63.83 100.39 0.29 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.736 2.291 . . . . 0.0 112.306 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.698 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 67.1 m-80 -121.55 27.85 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -168.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.698 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 68.5 mt 93.68 134.35 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.719 0.771 . . . . 0.0 111.117 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.36 -32.21 80.58 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.457 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.4 mt-30 -61.56 -21.84 64.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.4 mmm -67.17 -28.08 67.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -65.62 -40.32 92.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.5 -37.45 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -66.05 -32.83 74.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -55.68 -43.9 76.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.976 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -66.49 -35.63 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.7 -35.47 80.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 68.8 t -70.07 -39.25 76.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.758 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 55.3 ttt180 -54.05 -45.52 71.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.7 m -62.3 -42.76 99.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -65.2 -44.29 88.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.92 -49.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.12 -44.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -65.01 -38.64 91.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.79 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.63 -45.54 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.114 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.83 74.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -75.91 -11.65 60.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.39 87.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -77.16 -24.81 51.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -131.76 153.86 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.981 174.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 99.5 m -69.61 147.99 49.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.95 -49.26 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.162 -170.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.09 -42.41 94.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.853 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.04 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.105 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.571 HD21 ' HB3' ' A' ' 188' ' ' ALA . 49.6 tp -70.0 -38.19 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.61 -44.72 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.814 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.57 -30.45 70.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -77.86 -43.71 29.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.048 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -64.96 -30.1 71.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.7 m -62.11 -45.71 92.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.73 -35.32 70.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.17 -43.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.077 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.4 p -93.97 -5.93 46.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.095 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.454 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.59 129.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -126.65 166.87 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.01 119.42 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.01 24.05 39.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.431 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -144.44 154.25 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.941 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 7' ' ' LEU . 4.6 pp -151.57 148.46 28.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.868 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.48 123.01 65.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.192 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.8 mt -114.35 127.58 71.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.139 -174.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -115.12 131.64 56.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.74 155.2 7.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.426 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.6 t-20 -54.74 126.86 25.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 170.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.19 -20.57 79.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.479 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -56.14 -51.59 67.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.905 0.383 . . . . 0.0 110.882 -162.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -135.25 77.12 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 147.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.34 -33.32 2.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -77.45 -45.3 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.952 -160.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.59 -52.03 59.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 -156.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.87 -48.95 65.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.77 -41.75 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.21 -49.77 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.089 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.74 -46.24 89.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.87 -41.88 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.53 -33.55 85.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.505 175.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -66.78 -43.04 85.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.866 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.39 -39.85 94.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -61.79 -42.46 99.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.73 -34.83 75.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.8 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.02 -36.6 69.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.963 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -82.68 -42.0 18.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -172.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -100.15 -22.04 15.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.98 5.21 89.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.537 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.94 123.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.31 116.14 6.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.893 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG11 ' HA3' ' A' ' 24' ' ' GLY . 92.4 t -103.96 133.85 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.8 m -132.93 111.51 11.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.166 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.15 121.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.096 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -129.02 148.75 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.854 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -138.03 67.63 48.55 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.857 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 40.2 Cg_endo -78.65 -14.66 14.07 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 -164.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 59.1 m-20 77.16 6.44 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.34 -8.59 38.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mp -48.73 -52.82 21.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -159.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.8 -43.86 69.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.72 -40.87 20.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 -168.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.07 -43.51 28.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 -167.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.6 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 19.5 t80 -49.85 -54.6 30.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 110.887 -164.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 21.3 Cg_endo -60.4 -31.1 92.23 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -78.46 -49.88 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 19.5 m -74.23 -28.1 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.91 88.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.84 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.7 p -95.69 6.02 49.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.225 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.81 60.54 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.426 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.9 t0 -120.03 -172.95 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.38 -172.44 14.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.541 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HG3' HD11 ' A' ' 60' ' ' ILE . 94.4 Cg_endo -81.64 160.72 19.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.589 2.193 . . . . 0.0 112.391 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.14 -43.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 170.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.1 mt -132.4 141.85 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.141 -170.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.4 HD11 ' HG3' ' A' ' 57' ' ' PRO . 18.1 mm -123.15 131.95 72.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.214 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.93 121.36 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.944 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -148.11 165.0 32.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.877 169.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.49 -102.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.028 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -114.11 -56.59 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.79 -51.71 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -166.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 95.3 mtt-85 -75.36 -32.77 60.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -58.53 -49.44 77.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.852 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.62 -50.6 60.57 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.529 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -40.88 94.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.533 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 66' ' ' ARG . 14.8 m-30 -69.6 -31.94 70.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.901 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.51 96.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.039 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.44 -25.96 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -85.59 3.45 40.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.53 36.38 76.72 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.447 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.498 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 1.1 mp -75.27 -15.68 60.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.94 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -130.96 143.53 50.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 -170.086 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.94 162.3 14.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.143 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.51 137.71 56.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -110.66 153.35 12.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.2 p -130.07 64.92 74.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.604 0.716 . . . . 0.0 111.126 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.67 144.96 28.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.732 2.288 . . . . 0.0 112.27 167.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -76.5 178.48 6.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -68.27 -31.27 70.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.68 -34.4 67.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -61.79 -39.34 91.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -65.08 -40.22 94.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.3 -37.53 80.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.84 -29.5 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.1 -107.05 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.815 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -165.02 133.09 2.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.721 0.772 . . . . 0.0 110.974 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -66.25 -33.33 39.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -172.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.93 -36.51 83.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -75.47 -24.32 56.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.406 ' HA ' HG22 ' A' ' 97' ' ' VAL . 57.0 m95 -76.44 -28.65 56.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.951 173.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.34 -33.74 72.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' HD12 ' A' ' 329' ' ' ILE . . . -66.65 -26.43 67.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.147 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 30.2 m -109.15 16.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.2 -175.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.6 ttp-105 -109.79 136.53 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -136.76 125.65 24.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 57.71 34.71 24.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.44 89.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.461 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.76 144.91 48.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.39 125.59 32.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.0 pt -118.22 -11.65 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.144 -167.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.65 162.51 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.057 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -106.56 135.89 19.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.697 0.76 . . . . 0.0 110.89 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.9 Cg_exo -65.47 118.52 5.53 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 172.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.26 -36.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.065 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.83 153.25 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.58 128.35 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.192 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 53.8 mp0 -123.06 150.73 42.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.944 175.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.47 153.77 35.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 tp -71.03 136.2 48.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.002 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -138.72 158.21 44.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.418 ' HB2' HD23 ' A' ' 247' ' ' LEU . 38.7 tp -95.39 127.8 41.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 244' ' ' VAL . 81.0 mt -111.34 127.66 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.97 157.49 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -96.95 114.94 26.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -67.47 -29.44 68.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.68 -35.19 30.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.14 -43.93 27.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.21 109.2 15.09 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.637 0.732 . . . . 0.0 110.921 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.4 Cg_endo -73.29 167.65 26.77 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 112.379 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.566 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.6 t30 24.96 96.43 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.955 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -65.32 154.66 72.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.401 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.22 144.72 63.8 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.72 2.28 . . . . 0.0 112.378 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.97 -22.04 19.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.7 p -130.43 158.97 38.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.229 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.453 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 93.4 m95 -73.08 -24.58 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.91 -25.26 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.92 -21.48 57.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 32.9 mm -60.05 -51.92 77.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.534 0.683 . . . . 0.0 111.101 -166.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.4 Cg_endo -68.99 -42.74 3.89 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.448 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.43 92.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.01 -38.2 90.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.17 -39.87 94.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.66 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.85 -49.09 61.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.76 -16.52 53.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.961 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -53.59 -29.12 36.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.44 -19.88 64.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.34 7.73 38.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.92 28.45 62.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -106.49 157.23 17.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -106.88 149.66 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.902 160.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.56 -42.58 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.076 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 38.1 mt -138.2 141.98 40.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.857 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 75.4 mmm -140.22 118.18 11.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 163.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.24 168.44 26.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.791 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -72.41 104.29 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 206' ' ' ALA . 13.5 tp -87.66 -4.82 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 -174.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -87.59 10.27 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -133.64 148.1 67.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.67 0.747 . . . . 0.0 110.803 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 28.6 Cg_endo -68.68 -30.25 28.25 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.32 -174.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -57.59 -37.27 72.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.86 -28.62 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.765 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -77.75 -22.93 49.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.72 ' HB3' ' HG3' ' A' ' 256' ' ' LYS . 1.6 m95 -59.79 -46.81 98.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 -169.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 61.8 Cg_exo -44.43 -37.57 10.83 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.77 2.313 . . . . 0.0 112.337 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.32 -44.37 17.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.865 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.408 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 96.5 mt -72.97 -46.8 50.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -70.78 -17.59 62.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.35 -28.19 69.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.085 -166.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -100.31 7.16 44.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -170.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.7 4.66 55.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.507 169.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 187' ' ' GLY . . . -109.98 147.02 17.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.434 171.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.419 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 43.3 t80 -164.5 173.36 12.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 0.0 110.858 -167.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.48 -54.6 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -141.39 148.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -83.88 130.95 34.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -104.15 113.05 26.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.68 140.66 23.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 47.14 41.76 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.06 7.82 67.8 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 173.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.64 151.8 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -83.92 134.5 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -109.57 114.12 27.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.81 -19.99 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.63 -17.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -168.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -132.02 87.34 2.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 184' ' ' ASP . 13.9 m -127.23 166.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -171.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . -93.42 7.6 75.09 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 181' ' ' VAL . 11.0 m -96.61 -16.45 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.072 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 6.6 p30 -79.87 10.56 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 167.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.2 m-20 84.45 -4.54 1.02 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.75 158.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.22 -48.34 10.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.571 ' O ' ' HA3' ' A' ' 166' ' ' GLY . . . -75.92 -44.1 20.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -67.0 -34.72 78.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.841 0.353 . . . . 0.0 111.085 -160.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.49 -41.83 97.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -165.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.82 95.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 161' ' ' ILE . . . -65.48 -42.84 95.57 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -35.04 79.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.956 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 84.4 m -58.02 -47.96 81.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.117 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.11 -43.45 91.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.821 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.89 -48.69 79.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.2 -38.69 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.192 -175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.12 -36.27 83.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -65.19 -36.4 84.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.993 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.91 -40.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.102 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.87 -39.56 93.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -85.42 5.0 32.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.72 31.93 11.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -83.05 -27.29 30.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 168.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 66.2 mtt -133.37 151.0 51.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.411 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 57.3 t-20 -95.64 132.55 40.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.431 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -67.44 -28.01 67.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -92.11 -8.88 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -168.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 87.0 m -55.5 126.48 25.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -121.14 -174.42 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.41 -44.78 92.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.0 m -60.73 -42.62 97.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.76 -42.28 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.83 95.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.26 -44.65 78.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.71 81.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -35.62 80.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -62.38 -29.94 70.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.14 -21.95 15.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.888 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 22.9 36.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.98 -27.07 43.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.863 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.5 t -124.95 140.0 53.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.98 -35.18 50.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.2 mtm -139.68 155.92 47.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -166.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -152.1 164.87 36.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -120.63 118.08 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -151.79 163.19 39.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.783 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.415 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -100.57 -141.31 11.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.638 ' HB3' HD22 ' A' ' 299' ' ' LEU . 39.8 Cg_endo -71.24 -25.52 21.96 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.366 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -65.79 -19.98 66.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -94.77 9.4 39.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -65.99 -38.78 89.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.2 t -54.63 111.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.424 ' HB3' ' OH ' ' A' ' 242' ' ' TYR . 68.7 m-80 -152.73 142.1 21.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.82 78.18 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -83.54 75.22 10.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.6 p -115.27 -9.03 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.9 p -103.2 -171.55 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.81 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.84 177.65 3.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -59.66 110.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.59 -57.87 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.814 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.424 ' OH ' ' HB3' ' A' ' 234' ' ' ASN . 49.2 p90 -110.2 159.52 17.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.95 167.61 25.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.49 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 116' ' ' ILE . 64.0 t -129.13 130.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.215 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.06 -177.25 5.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.197 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.17 160.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.101 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 115' ' ' LEU . 83.8 mt -70.9 143.27 88.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.559 0.695 . . . . 0.0 110.937 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' A' ' 255' ' ' SER . 57.7 Cg_endo -74.96 170.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.391 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -104.33 162.12 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.046 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -135.53 118.52 16.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.829 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 54.6 34.8 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.66 80.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 175.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 89.1 mm-40 -122.72 147.36 50.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.615 0.722 . . . . 0.0 110.94 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 51.4 Cg_exo -54.81 145.53 60.7 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.618 2.212 . . . . 0.0 112.424 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.453 ' HB3' ' HE1' ' A' ' 129' ' ' TRP . 95.3 p -70.53 -63.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.992 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 14.1 tmtt? -172.32 125.93 0.53 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.917 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.71 134.37 12.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.716 2.277 . . . . 0.0 112.313 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -161.08 110.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.05 134.98 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.816 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -119.86 147.26 18.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.9 t -122.59 121.75 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.125 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.54 130.99 45.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.954 174.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.0 m -127.72 139.85 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -165.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.19 137.21 49.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.101 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.0 168.11 23.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.339 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.79 129.14 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.108 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -57.44 125.37 22.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.68 -22.25 66.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.97 -12.48 55.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.145 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.0 t -70.77 136.65 85.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.773 0.797 . . . . 0.0 110.826 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.16 -14.63 23.24 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.625 2.216 . . . . 0.0 112.35 174.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -108.03 36.87 2.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.832 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.94 -38.71 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.17 -38.78 91.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.38 -49.38 67.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.55 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -168.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -66.48 -47.46 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.916 -172.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -47.94 72.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -72.14 -36.02 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 280' ' ' LEU . 5.1 tt -56.58 -47.81 78.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.01 -25.56 34.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -99.81 -13.12 19.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -171.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 70.6 t80 -124.36 -58.83 1.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.7 mt -69.71 -39.87 76.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.02 66.34 9.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 175.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 73.7 p -136.27 168.35 19.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.52 -45.25 73.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.87 -41.86 42.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.96 -49.63 9.65 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.497 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.32 -38.92 82.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.56 -43.22 99.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.83 76.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.068 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.6 t -74.38 -45.06 47.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -73.86 -14.28 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.3 -27.07 13.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -91.91 -4.24 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -91.15 151.29 42.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.573 0.702 . . . . 0.0 110.871 172.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.55 -57.72 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.638 HD22 ' HB3' ' A' ' 229' ' ' PRO . 61.8 tp -65.8 -47.78 73.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -167.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.06 86.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.469 ' HB1' ' SD ' ' A' ' 321' ' ' MET . . . -75.16 125.55 29.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 0.0 111.114 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.515 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -124.71 159.71 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -173.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.36 60.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.2 tp -75.3 123.57 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.65 -39.39 93.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.1 t -59.46 -48.37 81.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.515 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.6 t80 -71.38 -33.68 69.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.12 -39.45 82.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.86 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.56 -37.82 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -76.97 -37.31 55.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.8 mt -64.87 -31.61 72.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.11 -12.66 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.11 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.03 -20.05 58.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -91.81 117.93 68.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.801 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.74 -33.64 60.93 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.673 2.248 . . . . 0.0 112.337 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -72.55 -43.2 63.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -173.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.43 -38.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.99 72.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.72 89.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 80.9 m -67.2 -43.09 82.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.225 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.469 ' SD ' ' HB1' ' A' ' 301' ' ' ALA . 96.3 mmm -66.11 -34.62 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.14 -40.24 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -72.76 -34.57 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.18 -41.78 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -69.94 -17.03 63.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.03 -5.35 16.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.1 -164.07 39.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.476 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.61 147.53 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.432 HD12 ' HB2' ' A' ' 96' ' ' ALA . 39.2 mm -67.43 126.92 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 -166.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.816 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 54.2 mtt -52.64 -58.83 10.4 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 110.914 -171.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.524 ' CD ' ' HB2' ' A' ' 330' ' ' MET . 36.2 Cg_endo -63.98 101.08 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.762 2.308 . . . . 0.0 112.375 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.68 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 28.2 m120 -123.06 28.49 7.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -169.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.8 mt 90.23 135.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.667 0.746 . . . . 0.0 111.104 -176.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -54.79 -29.94 65.13 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.618 2.212 . . . . 0.0 112.332 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.437 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.6 mt-30 -64.09 -23.69 67.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.88 -26.82 65.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.15 -34.88 49.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -66.68 -40.13 88.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.07 -38.55 83.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.966 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -64.99 -36.26 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.72 -35.01 79.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.67 -40.2 76.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.17 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.613 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 58.0 ttp180 -56.38 -44.79 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.2 m -64.2 -44.46 91.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.485 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -63.52 -45.38 90.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -176.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.97 -36.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.09 -171.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.5 mt -68.98 -44.16 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.068 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.39 -35.74 81.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.817 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.84 -45.58 67.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.31 68.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -75.78 -12.69 60.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.77 6.99 88.6 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.22 -30.09 64.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.864 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -139.28 156.8 46.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 70.8 p -75.02 164.09 26.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 171.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.39 -50.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.51 -36.67 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -69.21 -48.06 63.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.55 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.079 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 41.1 tp -65.09 -44.08 90.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -46.51 88.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.68 -35.07 78.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.485 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -79.01 -43.28 24.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.172 -172.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 10.3 mm100 -77.97 -31.13 50.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -171.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 78.0 m -59.99 -38.03 81.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.48 -30.0 70.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.41 -45.42 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.4 p -97.85 -4.62 36.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -177.915 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.703 0.287 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.422 HG21 ' HD2' ' A' ' 271' ' ' PRO . 88.6 mt -61.76 125.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.083 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 164.35 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -66.93 121.99 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.73 19.76 59.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 -173.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -146.39 153.34 40.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.798 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.9 pp -143.15 145.87 33.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.08 124.79 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.553 HG22 ' HB ' ' A' ' 59' ' ' ILE . 5.7 pt -124.95 132.26 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -171.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.774 ' HB3' HD22 ' A' ' 43' ' ' LEU . 38.3 m0 -113.72 135.34 54.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.533 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.2 tt -148.17 155.09 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.455 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.1 t-20 -55.77 128.01 32.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.873 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.12 -16.86 76.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.441 -168.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -47.7 80.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 -165.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -134.58 63.46 1.62 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 152.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.533 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -100.53 -50.49 1.3 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -67.74 -43.54 79.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -160.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.38 -49.52 59.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -163.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.48 -48.44 81.97 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.488 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.2 mt -63.89 -34.57 78.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.843 0.354 . . . . 0.0 110.88 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.07 95.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.049 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -62.06 -49.37 76.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.85 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 292' ' ' ALA . 25.5 m -72.84 -32.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.48 -40.15 97.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.45 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.86 -43.94 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 110.819 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.88 -47.25 78.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 27' ' ' PHE . 6.9 m-30 -64.6 -41.85 95.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.889 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -65.09 -34.22 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.89 -40.71 79.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.77 -39.64 23.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.2 m -102.11 -26.35 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.15 -172.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.89 5.45 83.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 33' ' ' ILE . 19.5 tt -76.55 126.96 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.188 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.49 124.14 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.7 t -109.35 130.51 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.185 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -125.19 114.42 18.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 9' ' ' ILE . 51.7 t -103.83 120.23 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 57.6 mt-10 -131.12 146.46 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -139.92 67.81 35.0 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.699 0.762 . . . . 0.0 110.789 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.548 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -73.91 -16.62 23.1 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.694 2.262 . . . . 0.0 112.387 -167.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 62.0 m-20 74.74 7.6 4.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -173.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.51 -1.32 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 172.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 10' ' ' TRP . 34.5 mt -48.32 -54.33 14.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -156.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.79 -27.34 66.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 -167.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.61 -47.44 10.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -80.26 -40.97 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.998 -166.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 37.4 t80 -55.48 -58.88 13.05 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.604 0.716 . . . . 0.0 110.862 -165.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.8 Cg_endo -59.74 -30.7 92.7 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -75.05 -45.1 43.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 47' ' ' PHE . 33.2 m -73.75 -23.34 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.147 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.096 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.36 -24.8 66.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.32 4.61 53.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.0 22.29 74.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -139.39 -163.18 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 110.882 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.82 -165.83 22.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.627 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.495 ' HG2' HD11 ' A' ' 60' ' ' ILE . 84.4 Cg_endo -81.62 165.09 18.33 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 -173.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' HA ' HD11 ' A' ' 2' ' ' ILE . 43.6 t0 -83.95 -49.26 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.553 ' HB ' HG22 ' A' ' 9' ' ' ILE . 82.9 mt -133.97 138.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 -171.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.495 HD11 ' HG2' ' A' ' 57' ' ' PRO . 7.1 mm -120.86 139.69 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.239 173.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -99.53 130.9 45.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -139.69 158.3 44.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.8 -100.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 331' ' ' PRO . 3.8 p80 -110.94 -54.87 2.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -176.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.07 -49.8 75.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.37 -33.63 48.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.66 -48.36 81.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.813 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.16 65.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.559 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.04 98.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -70.14 -30.02 67.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -62.95 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -67.49 -28.09 67.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -85.57 0.14 53.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -173.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 34.85 80.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mp -87.07 -2.6 58.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.84 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.19 142.92 51.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.932 -175.47 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.38 152.63 22.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -67.04 135.34 53.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.48 HG13 ' HB3' ' A' ' 103' ' ' LEU . 30.5 pt -118.42 146.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -134.96 69.66 70.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.622 0.725 . . . . 0.0 111.165 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.96 144.54 43.18 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.712 2.274 . . . . 0.0 112.38 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -76.05 178.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.56 -31.91 73.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.87 95.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -67.82 -38.45 83.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.94 -41.55 95.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.14 -33.85 72.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.844 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -68.21 -22.48 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.892 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.7 mt -95.78 -125.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 34.3 t80 -153.68 136.48 9.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.743 0.782 . . . . 0.0 110.941 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.2 Cg_exo -58.24 -41.51 65.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.79 2.326 . . . . 0.0 112.316 -172.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.6 -43.54 84.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.13 -26.76 62.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.155 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -70.04 -40.07 75.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.91 -36.14 82.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 173.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.66 65.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.078 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.491 HG23 HD11 ' A' ' 103' ' ' LEU . 26.8 m -107.4 19.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -109.95 141.02 43.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -138.42 125.89 21.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.96 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.38 35.05 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.831 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.65 89.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.485 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.64 139.71 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.931 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 97' ' ' VAL . 10.7 tp -80.44 132.99 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.467 ' HB ' HD13 ' A' ' 76' ' ' LEU . 37.7 pt -124.38 -11.25 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 -165.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -157.32 162.49 39.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.009 -170.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.412 ' HB3' HD11 ' A' ' 285' ' ' LEU . 97.1 m-85 -113.15 140.78 24.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.623 0.725 . . . . 0.0 110.995 168.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.66 121.84 8.32 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -103.86 -42.7 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.72 153.34 29.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.127 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.84 133.77 56.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 11.7 mp0 -130.8 155.87 45.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.43 155.09 41.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.05 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.3 134.3 44.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.944 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.4 p -143.16 161.3 38.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.0 tp -98.99 127.89 45.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.2 mt -108.05 131.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.013 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -132.31 149.89 52.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.69 118.77 30.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 171.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.76 -34.66 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -81.63 -35.13 30.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.819 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.59 -44.72 23.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.44 HD12 ' HG3' ' A' ' 224' ' ' MET . 72.6 mt -131.68 115.79 15.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 0.0 110.861 173.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.554 ' O ' ' C ' ' A' ' 124' ' ' ASN . 90.2 Cg_endo -74.47 170.09 21.05 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.738 2.292 . . . . 0.0 112.368 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.554 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.4 t30 25.06 97.11 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 0.0 110.916 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 41.9 Cg_endo -65.49 157.16 59.68 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.401 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.85 149.91 60.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.576 2.184 . . . . 0.0 112.342 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.66 -27.71 13.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -126.25 156.44 40.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -66.24 -30.37 70.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.81 -26.58 58.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.93 -21.51 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.686 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 32.2 mm -59.74 -55.37 46.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.655 0.741 . . . . 0.0 111.14 -167.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.686 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 52.0 Cg_endo -75.0 -37.65 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.73 2.287 . . . . 0.0 112.354 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.85 96.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.76 -42.43 90.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.62 -41.52 99.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.988 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.52 -43.86 84.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.95 -45.58 67.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.5 pp -79.4 -22.51 44.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.007 -175.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' N ' HD12 ' A' ' 139' ' ' LEU . 83.9 tttt -61.06 -30.93 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -20.4 64.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.186 173.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.36 6.54 47.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.85 60.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.516 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.417 ' HB2' HD13 ' A' ' 139' ' ' LEU . 91.6 mttt -108.79 165.18 11.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.8 t -120.31 140.1 51.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 163.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.7 -33.66 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.5 mt -137.02 150.25 47.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 93.7 mmm -133.52 131.75 40.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 166.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -160.43 162.48 33.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.6 t-20 -84.24 110.71 18.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 -177.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 39.9 tp -96.09 4.49 52.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -173.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -81.21 2.12 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.53 151.92 48.12 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.667 0.746 . . . . 0.0 110.935 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.681 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.9 Cg_endo -72.61 -17.37 26.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.256 -174.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -52.47 -48.58 65.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.95 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.423 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 51.9 m-85 -83.51 -11.68 57.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -172.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -80.49 -19.02 46.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.485 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 6.5 m95 -59.79 -44.23 96.72 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.477 0.656 . . . . 0.0 110.921 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 66.6 Cg_exo -43.82 -31.22 3.44 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.714 2.276 . . . . 0.0 112.324 176.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.4 tm? -87.61 -49.24 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.423 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -78.55 -47.66 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 -169.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -64.85 -26.42 68.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.09 -31.75 72.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -95.96 0.31 51.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.75 38.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.423 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -92.46 129.03 9.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.408 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -168.3 175.2 6.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 110.808 -172.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.76 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -137.42 150.7 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -99.6 127.56 45.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -97.35 112.49 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.903 -174.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -149.91 138.43 20.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.65 35.16 17.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.55 4.6 75.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.532 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.49 149.96 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -77.4 135.25 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.45 107.25 18.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.8 tp -65.5 -19.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.55 -8.45 56.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -122.63 76.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.846 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.604 ' CG2' HG22 ' A' ' 183' ' ' VAL . 31.0 m -131.19 164.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -171.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.43 13.13 56.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.602 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.604 HG22 ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -99.74 -20.17 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.754 0.312 . . . . 0.0 111.082 174.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 99.7 m-20 -78.36 3.0 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 167.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 84.4 m-20 83.81 -4.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.792 163.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.1 -50.8 17.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.13 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.61 -42.1 14.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.45 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.7 78.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -164.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -63.27 -44.69 94.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -166.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.95 98.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.039 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.95 -42.28 98.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.424 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.34 -43.15 91.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.857 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.6 m -61.76 -44.21 97.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.505 ' CD2' HD21 ' A' ' 160' ' ' LEU . 1.1 t80 -63.11 -41.51 99.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.89 -40.53 95.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.34 -37.74 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -66.11 -35.13 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.46 -41.46 89.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.913 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.1 -36.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.65 -37.06 84.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -84.43 3.19 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 60.78 39.8 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -79.28 -26.85 42.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -149.46 150.86 33.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -95.37 149.83 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.877 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.66 -25.62 68.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -92.82 -7.28 46.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.779 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 m -58.61 125.54 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 59.6 p30 -139.07 -179.96 6.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -62.65 -33.05 74.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.9 m -63.79 -44.13 94.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.73 -40.04 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.168 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.76 99.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.9 -43.89 91.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.95 82.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.37 99.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -66.21 -35.56 80.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.807 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -64.44 -29.59 70.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.58 -19.0 19.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.01 25.18 38.4 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -84.68 -19.53 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.955 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -128.19 144.52 51.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.44 -35.29 14.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.506 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.2 mtm -142.29 160.6 39.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.933 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.0 t -150.46 160.31 43.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.21 118.92 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 65.0 m-80 -151.94 160.33 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 -173.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -107.34 -135.58 7.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.418 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.659 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 25.4 Cg_endo -68.0 -28.13 35.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 -175.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -67.38 -15.08 63.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.892 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -88.7 21.26 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -62.57 -31.36 72.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.0 t -63.72 106.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.816 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -149.13 130.01 14.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.8 mt -91.08 80.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -84.96 73.71 10.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.9 p -120.25 -12.38 9.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.9 p -110.1 -170.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.22 172.86 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.14 104.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -105.08 -59.35 1.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.02 153.85 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.41 159.54 23.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.73 128.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.999 0.428 . . . . 0.0 111.102 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.01 174.71 10.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.178 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.04 159.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.21 146.09 96.59 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.44 160.23 50.61 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.734 2.289 . . . . 0.0 112.313 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.0 p -104.52 151.54 23.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.023 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -130.78 116.08 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 55.53 33.88 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.75 68.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.518 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -126.25 148.88 65.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.36 144.25 79.5 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -74.08 -57.0 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -172.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.421 ' HG3' ' HD3' ' A' ' 159' ' ' PRO . 10.0 tmtt? -150.1 111.18 3.28 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.519 0.676 . . . . 0.0 110.974 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.96 127.62 11.6 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.784 2.323 . . . . 0.0 112.299 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.407 ' CE2' ' SD ' ' A' ' 330' ' ' MET . 31.0 t80 -158.91 119.44 3.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 -178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.43 130.89 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 167.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.05 135.09 12.05 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.455 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -124.86 128.47 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.141 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 68.3 tp -73.18 135.01 44.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -133.87 160.68 36.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.803 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.94 136.81 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.058 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -113.13 148.95 18.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.477 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 93.5 mt -108.71 124.88 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 270' ' ' SER . 45.1 t-20 -51.6 120.14 4.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -174.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.72 -22.59 66.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.5 -8.93 58.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.193 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 29.4 t -71.41 129.19 89.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.74 0.781 . . . . 0.0 110.786 -171.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.422 ' HD2' HG21 ' A' ' 2' ' ' ILE . 90.6 Cg_endo -71.59 -14.86 30.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.646 2.231 . . . . 0.0 112.267 170.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -107.79 29.14 7.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.929 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.23 -33.62 67.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.39 -38.96 92.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.832 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.88 -41.62 82.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 174.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.35 69.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.042 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -71.13 -38.62 72.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 96.4 mt-10 -72.19 -48.28 44.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 -173.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -62.73 -40.41 97.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 284' ' ' LEU . 2.8 tt -60.68 -48.4 81.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 -177.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -83.57 -31.13 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.0 m-20 -97.99 -22.15 16.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -166.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.456 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 m-85 -121.37 -51.82 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 58.9 tp -70.64 -46.87 62.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.912 -176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 106' ' ' TYR . 92.2 mt -87.05 63.54 7.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.6 p -135.23 169.39 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 172.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.72 -44.35 77.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.14 -44.3 22.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.952 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -70.95 -47.11 40.48 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -170.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.82 -35.41 78.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -62.05 -40.01 94.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -64.93 -38.56 91.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -174.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.0 p -80.75 -33.71 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.126 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -72.23 -31.74 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -172.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -59.54 -22.5 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.15 -10.16 34.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.38 152.03 75.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.47 -61.58 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.559 2.173 . . . . 0.0 112.385 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.95 -43.2 18.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.939 0.4 . . . . 0.0 110.922 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.75 14.86 79.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.551 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -84.39 127.63 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.047 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.54 160.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.134 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.4 -10.32 59.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.185 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 52.8 tp -74.22 121.13 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.37 -49.05 77.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -171.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.6 m -60.76 -43.41 98.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.884 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -70.12 -35.67 74.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.834 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.03 -31.12 72.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.808 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.85 -39.19 90.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.05 -37.68 61.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.819 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.405 ' HB3' HG21 ' A' ' 317' ' ' ILE . 90.9 mt -65.06 -27.47 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.26 -15.62 57.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.59 -21.05 61.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.843 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -86.58 120.73 72.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 110.807 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.87 -27.78 80.6 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.631 2.221 . . . . 0.0 112.383 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -70.03 -39.67 75.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 311' ' ' LEU . 47.4 mm -77.27 -36.37 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.242 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.11 76.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.243 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.38 -41.42 89.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -64.14 -47.16 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.198 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.5 tpt -66.89 -36.99 83.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -61.96 -43.27 99.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.888 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -74.97 -36.42 62.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.58 93.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -69.72 -18.99 63.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -109.51 -6.56 15.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.912 -172.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.52 36.57 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.43 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -126.38 139.26 53.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 110.813 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.544 HG13 ' HD2' ' A' ' 331' ' ' PRO . 2.2 tp -70.54 136.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.573 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 83.0 mmm -52.51 -52.57 62.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -172.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 64' ' ' HIS . 51.2 Cg_endo -66.86 82.29 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.757 2.305 . . . . 0.0 112.337 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.639 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 76.5 m-20 -107.15 29.63 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.7 mt 86.96 135.09 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.592 0.711 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -52.76 -31.81 52.8 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 0.0 112.259 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.414 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.9 mt-30 -61.46 -28.49 69.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.965 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.94 -37.06 86.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.17 -39.69 95.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -38.17 80.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.448 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.6 m-30 -65.75 -32.91 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.937 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -59.09 -40.08 84.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.984 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.99 -36.28 72.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.992 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.13 90.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.5 m -74.1 -25.38 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.681 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 75.0 ttt-85 -55.8 -40.56 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.0 m -60.79 -45.55 93.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.165 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 364' ' ' ALA . . . -65.44 -43.52 90.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.38 -53.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 -170.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.97 -44.97 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 -173.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -63.64 -37.33 86.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.22 -46.62 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.58 -35.33 75.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.08 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -80.47 -10.83 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.841 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.95 13.2 81.65 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.496 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.36 -30.08 57.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.845 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -137.33 156.88 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.9 m -70.74 149.7 46.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.06 -49.3 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.67 -43.09 90.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.3 -47.07 65.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.59 96.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 59.6 tp -65.62 -44.8 85.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.08 -49.6 71.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.932 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.74 -38.39 83.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 346' ' ' ALA . . . -73.99 -42.74 59.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.06 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 9.5 mm100 -78.26 -27.65 47.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -173.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 51.6 m -58.27 -37.07 74.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.88 -29.6 70.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.08 -40.0 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 57.8 p -94.04 -12.76 27.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.061 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.704 0.287 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -76.38 135.1 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.163 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.19 173.63 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.53 122.5 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 23.81 39.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -145.92 154.87 42.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.3 pp -150.98 149.26 29.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 172.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 58' ' ' ASP . 97.2 t -125.63 129.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -115.32 130.46 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.567 ' HB3' HD22 ' A' ' 43' ' ' LEU . 22.6 m0 -114.6 129.82 56.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -152.67 155.24 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.2 t-20 -54.77 127.18 27.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 173.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.94 -18.34 80.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 -167.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -56.59 -50.88 70.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.857 -163.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -134.8 75.41 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 147.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -104.69 -37.56 2.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -78.18 -46.58 20.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.957 -157.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.7 -52.15 53.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.903 -153.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.46 -48.86 60.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.44 -41.59 98.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.891 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -49.05 69.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.26 -47.15 80.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.876 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -44.82 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.24 -36.48 90.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.399 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -65.48 -40.61 93.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.861 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.06 -39.87 91.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -65.27 -40.07 93.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -59.95 -35.84 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.77 -37.39 70.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.2 -40.37 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 -172.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.5 m -104.36 -18.13 14.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -172.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.29 86.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.471 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -88.46 128.18 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 111.197 177.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.28 129.6 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -172.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.5 t -110.23 136.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.6 m -133.9 112.62 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.3 t -106.52 124.02 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -129.89 152.55 49.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.428 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.7 p80 -134.38 74.05 67.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.615 0.721 . . . . 0.0 110.828 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 19.2 Cg_endo -71.13 -27.39 20.21 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.725 2.283 . . . . 0.0 112.297 -162.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 60.6 m-20 77.7 4.17 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.847 -172.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -98.04 -0.46 44.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 10' ' ' TRP . 89.2 mt -48.91 -56.59 8.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.952 -152.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -65.06 -27.8 69.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.786 -165.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -85.3 -43.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -79.32 -45.0 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.964 -166.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.877 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 5.9 t80 -52.5 -53.59 51.84 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -163.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 72.7 Cg_exo -55.11 -38.87 93.27 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.659 2.24 . . . . 0.0 112.302 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.67 -46.76 35.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.969 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.73 -28.04 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.46 84.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 -24.58 67.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -96.37 5.79 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.76 74.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.466 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -116.99 -172.23 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.872 0.368 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.34 -173.8 26.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.581 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.62 159.74 28.4 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.643 2.229 . . . . 0.0 112.45 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 276' ' ' ALA . 33.9 t70 -75.63 -38.87 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 171.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -131.99 139.83 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -136.37 136.29 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -103.36 135.39 45.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -141.35 155.9 45.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.926 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.23 -106.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.068 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.412 ' CG ' ' N ' ' A' ' 65' ' ' ASP . 12.6 p80 -109.79 -54.83 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 64' ' ' HIS . 38.9 t70 -62.37 -48.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -164.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -79.57 -36.34 38.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -58.58 -51.26 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.835 -168.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.37 -51.46 54.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.571 -171.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -40.85 92.15 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.44 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -70.1 -30.38 67.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 0.0 110.994 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -64.03 -42.64 97.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.014 174.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -65.8 -28.06 68.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.923 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -85.17 2.76 42.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.74 36.1 86.75 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.522 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.32 -23.83 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.24 144.71 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 -159.289 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.26 157.59 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.71 138.22 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.8 pt -107.81 151.03 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.2 p -128.54 69.4 79.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.555 0.693 . . . . 0.0 111.16 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.06 141.65 26.72 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.786 2.324 . . . . 0.0 112.214 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -79.27 169.59 17.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.95 -30.44 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.12 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.016 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -77.98 -35.82 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.858 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -61.64 -44.19 97.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.26 -28.32 65.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.812 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.836 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.0 mt -100.5 -113.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.872 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 22.4 t80 -158.92 133.08 5.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.992 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 86.1 Cg_exo -57.28 -41.0 77.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.745 2.297 . . . . 0.0 112.363 -173.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.22 -39.11 93.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.6 p -71.9 -24.84 61.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.187 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.427 ' HA ' HG22 ' A' ' 97' ' ' VAL . 60.9 m95 -71.16 -36.33 71.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.85 -28.68 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.55 -27.69 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 94' ' ' TRP . 36.0 m -110.97 10.95 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -100.22 130.05 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.973 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -129.3 120.47 25.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 58.53 35.13 24.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.46 5.01 90.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.88 145.62 47.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 110.975 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.68 125.8 34.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.45 ' HB ' HD13 ' A' ' 76' ' ' LEU . 40.9 pt -120.89 -6.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 -169.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -161.77 164.48 28.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 -172.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.1 m-85 -108.46 134.64 20.17 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.669 0.747 . . . . 0.0 110.962 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.3 Cg_exo -64.07 121.0 8.52 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.243 . . . . 0.0 112.321 171.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.98 -40.07 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.48 151.62 20.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.065 -166.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.9 t -129.67 129.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 46.1 mt-10 -128.52 153.08 47.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.93 157.04 41.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.3 tp -71.1 131.81 44.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.0 m -139.7 155.94 47.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.91 126.33 40.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 85.0 mt -108.5 127.41 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -137.48 154.71 49.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.9 t-20 -91.32 118.22 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.812 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.659 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -68.21 -29.58 68.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.906 -172.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.05 -38.56 44.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.17 -35.31 42.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.95 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.2 tp -134.43 111.19 11.63 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.624 0.726 . . . . 0.0 111.006 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.594 ' O ' ' C ' ' A' ' 124' ' ' ASN . 84.2 Cg_endo -74.87 172.29 16.61 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 170.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.7 t30 22.5 96.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 110.959 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.21 156.4 65.88 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 144.98 60.44 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.744 2.296 . . . . 0.0 112.331 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.07 -29.45 15.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.8 p -126.04 158.8 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 -175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -68.75 -32.76 72.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.51 -26.45 54.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.828 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.16 -20.97 60.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.1 mm -58.86 -54.29 57.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.647 0.737 . . . . 0.0 111.129 -169.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 26.3 Cg_endo -65.15 -41.32 16.89 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.738 2.292 . . . . 0.0 112.399 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.65 93.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.02 -37.37 87.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.87 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.01 -40.15 94.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.31 -37.88 81.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 60.5 mt -70.38 -35.45 73.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.09 -32.29 64.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.998 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.45 66.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -104.29 4.79 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.83 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.49 26.42 67.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.498 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 82.4 mttt -113.16 156.44 23.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.6 t -113.4 148.8 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.817 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.22 38.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.2 mt -139.75 149.85 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.9 mmm -137.28 115.81 12.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.23 165.83 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.54 148.19 22.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 57.6 tp -107.01 -0.01 23.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -78.74 -11.17 59.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -138.45 145.44 46.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.561 0.696 . . . . 0.0 110.932 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.771 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.2 Cg_endo -68.04 -25.53 37.89 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.715 2.277 . . . . 0.0 112.286 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.03 -46.41 85.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.804 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.28 -26.04 58.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.806 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.5 p -82.39 -18.44 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -58.54 -45.55 99.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.432 0.634 . . . . 0.0 110.875 -169.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 79.2 Cg_exo -46.93 -38.66 23.88 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.627 2.218 . . . . 0.0 112.335 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.89 -41.06 26.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.428 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.7 mt -77.95 -47.57 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -68.58 -17.26 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.36 -33.12 74.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -99.14 -2.55 36.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.45 11.19 20.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.496 168.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -108.26 138.18 14.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.451 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 19.4 t80 -165.56 175.7 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -167.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.81 -59.74 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.221 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -142.42 150.1 40.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -85.95 133.12 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.827 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -108.34 114.28 28.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -147.47 140.08 24.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -170.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.58 41.01 9.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.03 6.64 68.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.516 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -137.32 152.75 50.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.99 133.8 36.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -107.97 109.14 20.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -174.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -67.52 -20.09 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.102 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -82.08 -16.6 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -168.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.49 87.24 2.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 184' ' ' ASP . 12.7 m -129.63 166.87 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.129 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -87.18 2.19 86.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.1 m -98.56 -16.77 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 111.097 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 181' ' ' VAL . 25.7 p30 -80.3 7.91 8.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 170.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 85.3 m-20 84.19 -7.05 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 161.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.55 -47.59 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.86 -46.55 22.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -71.54 -31.79 67.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.385 . . . . 0.0 111.096 -163.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.45 -44.35 94.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -160.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.69 97.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.428 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.04 -40.09 98.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.434 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.15 -41.02 90.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.7 m -62.46 -42.15 99.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.15 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.75 -40.44 88.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.45 -48.79 79.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.07 -39.6 86.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -41.11 98.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.6 OUTLIER -73.01 -32.12 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -177.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.78 -38.0 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 173.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.47 -34.82 78.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -85.91 -3.73 58.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 61.5 36.87 16.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.937 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -75.38 -17.45 60.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.69 156.15 47.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -101.71 134.18 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.792 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.14 -32.39 74.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.035 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.58 -5.72 45.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -164.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.1 m -61.74 130.72 47.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.184 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -135.87 -172.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.921 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.48 -47.47 79.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.924 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.7 m -63.65 -42.62 98.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.65 -44.93 93.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.0 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.66 -45.12 88.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.47 87.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.062 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.4 98.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -65.82 -38.69 89.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.828 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.39 -29.44 70.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.66 -19.82 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.86 21.4 50.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -77.41 -24.0 50.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.924 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -133.64 149.46 51.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.066 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.37 -20.82 20.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -138.06 154.9 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 -170.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -159.54 162.43 35.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.08 120.82 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 71.0 m-80 -145.92 158.61 43.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -176.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -95.54 -151.85 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.592 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 29.4 Cg_endo -65.2 -25.15 57.89 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.729 2.286 . . . . 0.0 112.291 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -66.0 -18.09 65.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -87.35 23.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -63.44 -29.98 71.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.1 t -66.41 107.78 2.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -149.31 129.98 14.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.45 81.18 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -84.68 72.86 10.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.4 p -114.54 -13.83 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.182 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.1 p -94.39 -169.94 2.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.61 175.74 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.852 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.31 107.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.121 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -120.42 -59.32 1.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 52.1 p90 -111.62 160.5 17.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.659 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -148.86 167.13 29.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.7 134.17 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 111.1 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -136.99 174.86 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 -171.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -79.74 161.48 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -176.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.62 142.83 86.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.508 0.671 . . . . 0.0 110.907 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.14 166.49 27.9 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.65 2.233 . . . . 0.0 112.253 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 66.8 p -118.74 150.74 39.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -128.18 115.25 18.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.81 35.13 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.29 21.14 46.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.553 173.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.8 144.78 53.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.582 0.706 . . . . 0.0 111.021 -172.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.43 141.97 70.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.626 2.217 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.7 t -68.8 -58.88 3.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.749 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 158' ' ' TRP . 5.5 tmtt? -150.8 110.59 3.12 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 0.0 110.916 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.39 122.5 7.05 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.684 2.256 . . . . 0.0 112.474 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -163.89 113.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.2 p -141.67 135.87 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.655 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -117.93 140.11 15.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.92 125.14 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.205 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 61.6 tp -73.37 137.25 44.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.7 m -123.88 141.56 51.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -119.87 128.02 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.34 158.2 15.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.1 127.13 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.889 0.376 . . . . 0.0 111.15 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -56.98 120.63 8.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.85 -26.13 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.04 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.72 -11.45 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.1 t -70.77 130.1 89.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 110.748 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.08 -13.11 37.23 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -110.12 27.06 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -55.19 -33.91 63.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -67.94 -37.93 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.851 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.01 -42.42 94.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.429 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . . . -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -174.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -63.32 -45.63 90.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.25 -54.16 23.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -36.37 71.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -171.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 284' ' ' LEU . 64.6 tp -58.98 -47.74 84.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 176.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -75.26 -35.0 61.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -98.28 -9.16 25.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -164.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.819 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 80.2 m-85 -127.59 -55.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 177.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.477 ' HB2' HD12 ' A' ' 280' ' ' LEU . 51.3 mt -76.76 -28.88 55.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -170.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.7 mm? -108.1 51.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.7 p -132.49 168.47 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -56.16 -46.05 79.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.15 -42.71 45.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.819 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.39 -50.77 6.44 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -171.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.77 -40.11 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.738 0.304 . . . . 0.0 110.899 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.24 -42.6 99.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.855 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.5 -32.57 74.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.2 t -71.04 -36.82 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.096 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.53 -12.75 61.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.838 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.09 -24.31 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -97.83 -7.67 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -87.18 145.15 37.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 110.96 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.47 -62.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.528 2.152 . . . . 0.0 112.369 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.17 -47.98 39.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.95 -170.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 88.23 -5.67 84.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.615 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.62 119.68 16.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 111.091 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.15 160.3 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -171.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.43 -12.46 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 172.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.8 tp -73.37 118.32 16.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.38 -44.6 90.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 74.6 m -59.32 -44.66 92.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.03 -34.52 68.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -60.54 -36.72 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -75.71 -38.31 58.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.05 -28.7 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.91 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.62 -12.32 52.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.073 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.23 -19.93 55.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -88.75 118.45 69.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.599 0.714 . . . . 0.0 110.795 173.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.43 -35.35 65.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.717 2.278 . . . . 0.0 112.328 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -72.81 -44.26 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.77 -41.04 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.99 73.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.0 84.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 51.6 m -66.35 -41.92 88.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.7 mmm -67.53 -35.38 78.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.39 -36.11 82.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -68.2 -38.05 81.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.819 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.28 90.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -66.88 -16.39 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.92 -6.9 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.36 -165.13 36.24 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.361 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -129.97 143.41 50.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.902 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.577 HG13 ' HD2' ' A' ' 331' ' ' PRO . 5.0 tp -67.28 134.34 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.215 -168.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.655 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 59.4 mtt -51.96 -55.69 28.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.577 ' HD2' HG13 ' A' ' 329' ' ' ILE . 34.4 Cg_endo -62.64 86.53 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.774 2.316 . . . . 0.0 112.309 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.642 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 70.1 m-80 -107.88 22.97 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 46.0 mm 89.05 134.83 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.724 0.774 . . . . 0.0 111.02 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.65 -30.58 66.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.692 2.262 . . . . 0.0 112.252 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -59.96 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.907 -176.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.0 mmm -70.11 -24.66 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.86 -40.7 97.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.45 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -65.54 -33.79 76.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.66 -43.84 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.947 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -67.74 -34.98 77.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.4 82.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.171 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 29.4 m -75.65 -27.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.199 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.771 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 80.6 ttt180 -57.45 -41.88 81.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.809 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.6 m -63.4 -45.86 89.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -61.92 -43.85 97.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.39 -50.74 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.152 -174.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.96 -45.53 90.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.027 -175.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.76 -35.79 82.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.57 61.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.52 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -76.04 -13.52 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.27 7.45 87.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.34 -30.11 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 0.0 110.959 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -136.2 154.92 50.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.5 m -67.94 150.98 47.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.83 -47.97 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.177 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.42 -40.64 89.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.38 -46.13 64.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.87 85.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 188' ' ' ALA . 62.0 tp -62.71 -46.91 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 110.959 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -48.7 69.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.04 -37.24 81.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -80.39 -43.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -78.49 -31.85 47.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.81 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.9 m -59.08 -37.8 77.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.18 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.42 -29.07 68.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.88 -44.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.03 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.1 p -97.46 -6.34 34.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.191 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -178.946 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.759 0.314 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.4 mt -81.75 123.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.33 166.75 20.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.985 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.0 131.49 45.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.96 17.49 56.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.24 163.53 35.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.831 0.348 . . . . 0.0 110.92 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 33' ' ' ILE . 1.8 pt? -145.65 153.93 41.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.14 127.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.645 ' HB3' HD22 ' A' ' 43' ' ' LEU . 26.8 m0 -110.08 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.5 tt -150.13 153.72 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -55.9 134.01 51.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.39 -16.21 75.42 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 -171.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.92 -43.16 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 -168.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.82 80.79 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 149.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.8 -52.56 1.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.496 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.07 -48.9 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -156.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.86 -53.16 51.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.84 -151.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.726 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -67.77 -49.89 45.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.465 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.65 -41.32 98.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.855 0.36 . . . . 0.0 110.996 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.7 73.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.56 -46.84 77.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.07 -45.81 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.082 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -62.77 -34.19 89.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.26 -45.82 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.861 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.82 -45.1 94.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -66.64 -37.86 85.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -60.56 -34.78 74.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.753 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.37 -38.88 74.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.03 -40.57 24.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -172.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -107.5 -15.35 14.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -171.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.03 1.2 88.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.418 168.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -85.99 127.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.931 0.396 . . . . 0.0 111.185 176.145 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.53 129.99 38.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.8 t -108.19 129.07 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.18 177.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.84 115.88 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.59 124.98 66.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -126.83 143.22 51.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.41 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 28.0 p80 -139.94 65.34 30.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 46.5 Cg_endo -72.18 -21.68 23.29 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.794 2.33 . . . . 0.0 112.247 -174.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 69.6 m-20 67.02 14.32 9.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 -172.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.63 -1.82 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.645 HD22 ' HB3' ' A' ' 10' ' ' TRP . 60.3 mt -52.33 -49.1 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 -152.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -65.84 -27.64 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.808 -169.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.39 -42.85 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -76.96 -40.19 47.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.627 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 47.1 t80 -51.39 -57.81 12.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.729 . . . . 0.0 110.839 -169.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.2 Cg_endo -60.93 -29.68 88.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.241 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.18 -47.03 30.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 33.4 m -75.0 -29.6 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.87 87.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.13 -23.94 66.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.3 p -96.05 5.33 51.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -174.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.97 67.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.538 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.7 t0 -120.0 -174.17 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.933 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.97 -170.9 13.59 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.25 162.99 19.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.35 -40.87 16.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 169.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.54 142.78 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -171.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -122.22 131.36 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -112.31 122.37 47.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.464 ' CZ2' HD12 ' A' ' 43' ' ' LEU . 95.1 m95 -148.48 156.7 42.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 168.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -81.96 -103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.029 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -112.07 -54.98 2.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.75 -50.19 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 -168.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.21 -31.56 69.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.944 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -60.71 -48.17 83.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -50.41 63.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.533 -172.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.14 98.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -70.91 -29.83 66.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 110.933 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.48 98.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.083 173.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.92 -26.37 65.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.895 173.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -84.89 1.86 45.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.02 36.67 51.33 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.515 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 mp -81.16 -10.06 59.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.564 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -132.98 144.45 50.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -178.09 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.47 162.96 12.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.49 134.66 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -112.39 153.27 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.3 p -132.16 65.43 75.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 111.194 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.16 148.21 43.93 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.383 171.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -77.57 -179.82 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.49 -31.43 72.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.36 -38.49 77.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.991 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.09 -38.74 86.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.57 -43.39 97.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -71.06 -31.28 67.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.66 -30.55 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.414 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.8 mp -108.77 -92.7 0.42 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -175.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 29.6 t80 -167.19 133.05 1.74 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.997 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 99.1 Cg_exo -54.05 -40.17 82.49 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.745 2.297 . . . . 0.0 112.336 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 92' ' ' PHE . 1.3 t80 -65.27 -39.44 92.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 p -70.9 -26.74 63.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.414 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 79.1 m95 -79.75 -32.59 41.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 174.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.43 -29.67 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 169.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.78 67.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.068 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.29 15.79 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -98.93 133.62 42.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.917 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -136.29 125.42 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 58.43 34.5 24.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.82 2.29 90.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.507 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.45 144.84 49.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.73 132.01 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.6 pt -118.37 -8.61 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.053 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.007 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.5 m-85 -106.53 132.62 20.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.668 0.746 . . . . 0.0 110.913 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 10.1 Cg_exo -72.85 132.71 18.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.746 2.297 . . . . 0.0 112.323 173.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.79 -50.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.151 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.15 151.62 33.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 -163.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.87 132.63 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.823 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 98.1 mt-10 -129.46 150.55 50.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.93 155.06 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -71.34 141.42 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -145.24 163.73 33.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' A' ' 248' ' ' PRO . 45.9 tp -96.57 127.55 42.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.5 mt -113.68 125.77 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -133.49 157.07 46.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.8 t-20 -94.67 118.14 31.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -65.72 -35.33 80.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -173.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.54 -35.43 58.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.56 -45.19 17.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 64.8 tp -126.62 108.62 23.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.709 . . . . 0.0 110.926 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 124' ' ' ASN . 98.7 Cg_endo -75.52 164.91 31.56 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.329 173.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.552 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.5 t30 24.96 96.3 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.56 155.4 70.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.721 2.281 . . . . 0.0 112.356 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.28 150.36 64.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.593 2.195 . . . . 0.0 112.357 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.11 -21.16 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.923 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.9 p -129.22 159.48 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.706 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 85.0 m95 -73.21 -24.66 60.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.965 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.46 -25.09 64.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.79 -20.02 50.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.675 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.2 mm -58.85 -55.43 46.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.626 0.727 . . . . 0.0 111.15 -168.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.0 Cg_endo -74.24 -37.34 2.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.45 95.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.01 -39.49 93.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 173.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.91 -37.48 87.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.54 -42.8 99.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.79 -36.29 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.764 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.594 HD12 ' HB2' ' A' ' 146' ' ' ALA . 71.6 mt -70.06 -30.93 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.39 -33.69 63.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.71 -25.03 67.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -102.55 2.82 36.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.7 30.77 61.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 89.1 mttt -116.61 162.63 17.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.517 ' H ' ' HA ' ' A' ' 222' ' ' THR . 44.7 t -120.98 146.91 46.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.594 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -82.7 -25.63 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.126 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 tp -137.79 136.27 37.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 -173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 91.6 mmm -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -161.61 161.16 29.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.893 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -86.28 133.41 33.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 41.1 tp -103.38 4.31 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -74.39 -13.1 60.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.95 146.91 63.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 0.0 110.929 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.556 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 42.4 Cg_endo -67.77 -24.93 40.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.571 2.18 . . . . 0.0 112.331 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -49.96 -42.08 48.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -80.33 -23.31 40.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -170.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.9 p -79.27 -23.22 43.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.581 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 49.1 m0 -57.26 -45.72 99.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.533 0.682 . . . . 0.0 110.932 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 91.3 Cg_exo -50.9 -37.34 55.63 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 2.229 . . . . 0.0 112.306 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.17 -40.28 24.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 347' ' ' VAL . 96.7 mt -73.44 -50.01 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -72.17 -14.96 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.048 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -61.68 -31.76 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.047 -174.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -102.28 1.77 36.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.47 1.58 40.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -86.84 136.61 14.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.363 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.472 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 21.3 t80 -169.95 176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.931 0.395 . . . . 0.0 110.978 -176.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.91 83.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -139.83 153.22 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.18 130.59 35.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.815 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -100.21 115.64 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -148.63 140.11 23.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.93 37.4 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.902 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.13 82.32 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -136.34 151.2 49.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.846 0.355 . . . . 0.0 110.958 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.48 131.71 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 171.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -94.28 109.71 21.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.49 -20.79 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.37 -10.35 46.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -130.21 95.5 3.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 174.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 183' ' ' VAL . 35.0 m -109.47 159.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -173.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -95.86 -2.24 61.26 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 167.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.437 HG22 ' HB ' ' A' ' 181' ' ' VAL . 8.0 m -85.96 -5.94 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 54.6 p30 -76.18 10.66 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 171.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 81.8 m-20 84.55 -4.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 168.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.38 -51.98 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.34 -50.2 7.64 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.13 73.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.61 -40.49 97.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -173.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.14 96.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.67 96.46 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.435 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 361' ' ' LEU . 78.8 mt -65.36 -34.93 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.927 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.4 m -56.36 -51.91 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -172.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -68.16 -44.95 74.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.9 tt -59.83 -50.82 72.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.809 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.32 -37.86 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.132 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.16 -36.83 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.818 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -36.07 83.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.67 -39.84 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.87 -39.81 94.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -84.34 5.41 27.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.1 32.17 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -87.86 -22.92 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -139.58 145.21 38.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.52 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 54.1 t-20 -94.67 134.72 36.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 176.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.09 -25.18 64.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.074 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -95.69 -15.16 22.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.732 -171.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.52 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 55.2 m -64.79 137.69 57.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.25 176.67 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.902 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -65.07 -29.64 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.2 m -64.73 -42.95 94.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.906 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.83 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.201 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.86 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.068 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.95 -43.99 90.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.798 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.77 77.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.086 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.0 97.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -64.0 -35.79 81.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 0.0 110.927 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.68 -28.88 69.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.55 -18.99 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.22 47.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.477 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.83 -19.72 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 110.91 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.517 ' HA ' ' H ' ' A' ' 145' ' ' SER . 15.2 t -130.7 144.5 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -94.46 -35.01 12.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 56.2 ttp -145.55 153.81 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -154.48 168.09 27.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.5 tt -126.3 123.45 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.066 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.52 162.44 41.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.22 -165.9 37.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.549 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.823 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 35.7 Cg_endo -66.39 -21.52 53.72 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -65.96 -18.12 65.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.46 5.63 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -62.72 -40.11 96.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.5 t -55.65 109.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -150.17 159.86 44.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.832 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.22 80.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.03 75.09 10.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.976 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.4 p -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.183 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 76.6 p -104.19 -174.8 2.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.27 176.89 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.884 172.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.09 104.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -113.3 -54.56 2.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 50.8 p90 -114.09 159.31 20.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.62 165.04 27.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.463 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 85.7 t -132.34 135.15 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.092 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.41 -179.84 6.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.6 160.49 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.089 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.14 139.27 90.03 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.543 0.687 . . . . 0.0 110.915 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.503 ' HD3' HD22 ' A' ' 115' ' ' LEU . 59.1 Cg_endo -75.1 167.09 27.72 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.359 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.8 p -106.7 158.45 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -132.01 118.93 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.829 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 55.16 34.92 23.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.6 6.24 87.53 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -119.77 150.34 50.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 110.862 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.93 149.72 89.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.626 2.217 . . . . 0.0 112.38 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.706 ' HB3' ' HE1' ' A' ' 129' ' ' TRP . 87.8 p -67.37 -62.23 1.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -170.75 127.25 0.69 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.508 0.671 . . . . 0.0 110.818 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.04 132.69 14.31 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.328 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -157.16 124.24 5.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.95 133.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 167.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.35 135.23 12.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.538 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.76 129.93 75.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.771 0.319 . . . . 0.0 111.158 -174.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 55.8 tp -74.99 132.34 41.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.9 m -130.4 145.42 51.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.04 51.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.04 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -123.54 170.15 15.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -112.77 129.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.294 . . . . 0.0 111.178 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -59.0 120.87 9.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.3 -25.14 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.94 -9.83 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.218 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.0 t -71.04 131.31 87.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.75 -15.03 43.47 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.377 172.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -109.09 21.86 16.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.51 -35.74 21.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.41 -35.07 70.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -178.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.83 -41.38 91.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.31 83.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.134 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -64.83 -34.49 78.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.936 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.62 -47.86 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.412 ' HE2' HG13 ' A' ' 33' ' ' ILE . 15.2 m-30 -65.41 -49.29 69.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.6 tt -57.05 -48.81 77.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -170.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -77.5 -22.63 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.828 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -101.96 -8.16 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -112.68 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 45.3 tp -73.49 -45.54 53.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -168.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.6 60.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.2 p -132.94 160.57 36.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -59.41 -44.93 92.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -71.47 -46.2 60.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.07 -45.45 41.02 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.42 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.445 HD21 ' HB ' ' A' ' 302' ' ' VAL . 28.4 tp -71.33 -37.72 71.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.973 -173.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.9 -40.75 95.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.56 99.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.726 HG23 ' HA3' ' A' ' 19' ' ' GLY . 15.0 p -76.48 -29.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -65.06 -24.32 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.11 -24.02 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -91.64 -13.0 32.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -78.68 155.54 78.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.708 . . . . 0.0 110.88 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.88 -95.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.608 2.205 . . . . 0.0 112.43 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -66.09 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.13 25.1 71.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 168.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.431 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -81.77 132.11 35.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.058 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.4 m -124.28 160.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.06 -12.67 59.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.013 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 59.5 tp -74.26 120.27 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.903 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.62 -45.75 91.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.3 m -60.6 -42.43 96.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.72 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.527 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.0 OUTLIER -71.81 -32.49 67.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.091 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -61.93 -32.02 72.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.01 -38.3 82.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -75.17 -38.28 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 301' ' ' ALA . 94.1 mt -65.13 -27.58 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.85 -16.64 43.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.109 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -71.79 -22.63 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 63.7 t0 -90.33 117.44 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.822 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 37.0 Cg_endo -61.54 -25.32 79.33 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.3 mtm-85 -70.36 -39.72 74.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 51.1 mm -79.98 -39.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.255 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.116 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.63 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.9 p -73.45 -35.83 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.2 mtm -68.06 -38.72 82.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -65.27 -42.65 92.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -71.79 -35.33 69.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.32 91.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.25 -19.07 65.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -108.37 -4.93 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.67 -167.09 42.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.532 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.773 0.321 . . . . 0.0 110.948 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 329' ' ' ILE . 2.8 tp -66.35 124.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 -169.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.594 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -46.44 -52.22 30.84 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.847 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 330' ' ' MET . 38.9 Cg_endo -63.99 85.54 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.768 2.312 . . . . 0.0 112.349 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.691 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 72.0 m-80 -108.74 30.52 6.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.691 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 71.4 mt 93.56 131.07 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.71 0.767 . . . . 0.0 111.06 -169.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.18 -25.58 50.31 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.768 2.312 . . . . 0.0 112.308 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.423 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.4 mt-30 -60.7 -24.64 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 176.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.7 mmm -63.8 -30.89 71.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.8 m -62.93 -43.08 99.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.12 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -60.57 -38.97 86.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -64.43 -38.28 90.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.177 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.39 -42.97 94.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.144 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.556 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 55.7 ttp180 -55.3 -43.81 75.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.4 m -59.91 -42.93 94.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.16 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.78 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 161' ' ' ILE . 54.4 t -67.05 -52.36 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.67 -45.18 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -171.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.58 -37.86 89.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.32 -44.24 68.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.79 74.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.8 p -76.05 -12.58 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.32 8.24 87.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.482 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -78.26 -25.7 46.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.917 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -135.12 155.99 49.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 90.9 m -71.88 151.5 43.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.21 -48.8 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.63 -42.34 86.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.21 -46.51 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.882 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.0 95.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.154 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 55.7 tp -66.08 -43.05 88.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.63 -48.43 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.922 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.02 -37.01 84.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.904 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.02 -43.58 64.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 7.6 mm-40 -77.16 -26.94 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.2 m -56.1 -35.64 67.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.161 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.95 -30.17 70.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.46 -41.92 89.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.3 p -94.04 -15.08 25.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.226 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.764 0.316 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.8 mt -85.74 125.97 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -136.62 176.92 8.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -171.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.95 132.06 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.96 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.79 59.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.64 159.97 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.886 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 7' ' ' LEU . 2.9 pp -147.15 149.51 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 177.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -120.58 127.6 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.185 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.583 HG22 ' HB ' ' A' ' 59' ' ' ILE . 3.3 pt -121.8 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.169 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.444 ' HB3' HD22 ' A' ' 43' ' ' LEU . 26.7 m0 -114.8 132.34 56.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.404 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.4 tt -149.23 153.71 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 -172.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.429 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.9 t-20 -55.87 128.54 35.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.66 -19.44 79.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.472 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.93 -46.4 90.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.904 -163.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.98 66.57 1.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.838 150.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -99.55 -46.15 2.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.552 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -69.95 -43.35 71.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.983 -159.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -65.63 -49.95 66.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 -160.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.66 -50.45 58.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.469 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 20' ' ' LEU . 53.7 mt -64.87 -37.24 86.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.12 -48.81 61.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -68.03 -45.77 73.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 p -69.85 -35.61 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.107 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.53 84.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.15 -46.32 89.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.32 -38.42 87.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -61.92 -35.66 79.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.782 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.39 -38.71 68.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.1 -41.05 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -171.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.0 p -105.57 -17.89 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.207 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.58 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.479 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 33' ' ' ILE . 19.5 tt -82.91 127.39 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.21 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -67.17 124.48 23.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.73 130.94 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.162 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.3 m -123.16 113.76 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.445 HG22 HD11 ' A' ' 9' ' ' ILE . 58.4 t -100.78 122.02 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.063 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.7 mt-10 -129.49 139.3 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -140.02 68.86 35.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 0.0 110.86 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 36.8 Cg_endo -75.7 -15.62 19.15 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.396 -165.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.8 m-20 73.13 8.34 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -171.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.75 -4.85 54.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.873 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' A' ' 10' ' ' TRP . 81.5 mt -51.74 -50.01 61.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -156.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.01 -35.3 78.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -88.05 -40.34 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -73.91 -45.26 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -167.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.675 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.9 t80 -51.69 -58.43 11.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.642 0.734 . . . . 0.0 110.834 -166.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 19.9 Cg_endo -63.9 -31.04 67.68 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.754 2.303 . . . . 0.0 112.274 -173.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -75.35 -47.25 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.2 m -76.24 -26.05 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.171 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.35 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.044 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.99 -24.47 66.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.053 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.7 p -95.09 4.51 53.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 22.72 61.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.518 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.8 t0 -119.52 -176.12 3.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.31 -170.3 15.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.503 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.37 158.96 17.28 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.81 -42.28 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 167.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.583 ' HB ' HG22 ' A' ' 9' ' ' ILE . 88.1 mt -133.23 139.53 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 tp -128.8 132.44 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.221 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -101.3 135.93 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -139.88 153.61 47.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.2 -102.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -122.27 -54.66 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.9 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -67.13 -46.08 75.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -73.26 -32.34 64.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.83 -47.31 85.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.859 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.17 -50.3 61.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.576 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.21 -41.98 99.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.532 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -70.05 -31.27 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.89 99.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 174.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.93 -26.28 64.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -85.02 2.1 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 37.1 61.37 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.554 173.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -80.33 -8.8 59.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 110.883 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -132.24 144.17 50.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 157.83 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 139.09 52.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.29 156.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.075 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -134.34 62.62 56.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.532 0.682 . . . . 0.0 111.161 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.01 149.93 42.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.745 2.297 . . . . 0.0 112.257 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -77.27 176.45 8.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.08 -29.92 67.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.98 69.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.07 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -63.21 -37.05 85.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -65.39 -39.97 92.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.81 -35.85 79.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.24 -29.31 66.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.2 mp -104.71 -106.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 23.0 t80 -162.89 133.96 3.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.67 0.748 . . . . 0.0 110.952 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.4 Cg_exo -56.21 -42.96 60.76 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.297 -174.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.14 -40.53 94.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 p -71.44 -25.64 62.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.429 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 54.5 m95 -80.13 -29.33 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 173.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -62.67 -30.11 71.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.827 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.71 -25.22 66.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.52 21.95 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.131 -174.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -109.94 139.58 44.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -141.54 126.85 18.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.65 34.46 22.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.888 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.45 90.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 173.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.16 144.82 50.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.85 130.73 35.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 pt -118.12 -12.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -169.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.28 165.33 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.036 -170.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.2 m-85 -109.83 134.31 20.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.663 0.745 . . . . 0.0 110.927 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.4 Cg_exo -66.31 126.8 16.25 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.318 173.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -111.61 -40.29 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.95 155.83 23.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.056 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.23 131.97 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -128.91 144.7 51.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.12 155.08 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.86 138.47 44.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.948 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -147.86 163.93 35.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.88 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.31 129.84 42.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.6 mt -107.09 128.02 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -136.23 148.19 47.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -90.72 117.08 29.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HE2' ' HA3' ' A' ' 243' ' ' GLY . 66.9 mttm -70.83 -30.61 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -171.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -76.85 -36.32 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -77.32 -38.71 49.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.5 tp -136.53 111.86 9.86 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.897 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 124' ' ' ASN . 87.8 Cg_endo -74.98 169.3 22.94 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.659 2.239 . . . . 0.0 112.35 170.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.2 t30 25.22 96.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 110.961 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.03 158.99 54.99 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.72 147.58 69.81 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.4 -29.7 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.871 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.6 p -127.94 159.6 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -68.56 -33.4 74.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.5 -29.78 64.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.813 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.57 -21.19 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.577 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 28.5 mm -60.93 -51.5 78.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.701 0.763 . . . . 0.0 111.09 -168.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 48.5 Cg_endo -70.35 -38.78 6.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.754 2.303 . . . . 0.0 112.324 -174.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.16 94.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.91 -36.91 83.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.73 -37.44 86.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.7 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.33 -37.3 83.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.8 mt -69.32 -36.46 76.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.73 -35.1 70.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.22 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.3 3.1 46.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.0 29.47 60.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -123.49 163.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.498 ' H ' ' HA ' ' A' ' 222' ' ' THR . 35.4 t -118.54 150.48 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 171.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -81.06 -23.96 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.82 141.73 50.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 68.8 mmm -140.1 119.93 13.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 161.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -160.05 164.99 32.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.7 t-20 -84.2 110.7 18.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.878 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 206' ' ' ALA . 27.1 tp -98.37 5.63 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -174.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.75 -2.27 57.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 148.46 69.67 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.656 0.741 . . . . 0.0 110.804 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.757 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 56.6 Cg_endo -74.76 -22.48 15.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.613 2.208 . . . . 0.0 112.265 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -52.79 -43.9 66.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 150' ' ' ASN . 81.3 m-85 -83.51 -20.4 33.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.713 -172.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.2 p -81.88 -21.26 37.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 4.4 m95 -60.08 -45.5 97.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.431 0.634 . . . . 0.0 110.884 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 99.2 Cg_exo -45.71 -31.1 7.15 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.258 . . . . 0.0 112.339 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 160' ' ' LEU . 2.7 tm? -82.29 -45.17 15.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.629 HG23 ' HA3' ' A' ' 191' ' ' GLY . 92.1 mt -74.66 -44.06 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 167' ' ' TYR . . . -69.77 -19.01 63.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.84 -29.64 70.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -102.91 0.19 32.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.6 15.12 9.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 165.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 161' ' ' ILE . . . -114.83 126.34 7.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.423 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 162' ' ' ALA . 17.9 t80 -159.56 172.17 18.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 110.921 -171.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.11 65.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.89 149.38 43.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -82.78 139.47 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -97.55 104.2 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 170.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.96 122.75 11.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.74 36.43 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -172.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.09 82.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.21 151.6 50.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -97.94 141.58 30.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -103.61 117.34 34.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 170.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.14 -18.07 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.04 -10.25 55.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -128.91 75.5 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.917 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.498 HG23 ' H ' ' A' ' 184' ' ' ASP . 15.4 m -134.95 172.96 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.92 -11.97 75.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.562 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.6 m -91.84 -7.68 10.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 111.044 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 35.3 p30 -85.45 7.22 23.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 86.3 m-20 83.72 -8.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 165.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.53 10.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.09 -44.68 34.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.533 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.495 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -70.15 -32.68 70.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -166.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -62.89 -45.59 91.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.949 -164.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.94 95.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.629 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.38 -41.26 99.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.43 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.19 -44.26 88.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.037 0.446 . . . . 0.0 111.008 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.5 m -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.216 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.05 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.828 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.71 -40.31 94.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.33 -36.83 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.173 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.26 -36.33 82.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.38 -41.71 80.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.63 -35.5 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.95 -35.96 81.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -84.08 2.98 36.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 62.71 35.14 14.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.914 173.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -76.98 -25.73 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.963 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -147.46 149.38 32.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 53.1 t-20 -95.1 136.73 35.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.43 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -63.02 -26.84 69.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -175.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.21 -13.79 27.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.899 -172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.8 m -65.63 134.93 54.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 49.9 p30 -112.91 173.83 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -71.36 -25.56 62.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.01 -38.47 88.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.42 -32.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.179 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.76 72.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.047 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.59 -46.96 85.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.834 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.64 76.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.42 96.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -65.09 -35.97 82.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.04 -29.31 70.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.82 -20.67 16.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.16 25.42 31.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.405 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.42 -26.75 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.498 ' HA ' ' H ' ' A' ' 145' ' ' SER . 7.2 t -128.99 147.49 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.05 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.73 18.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 175.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.1 mtm -140.23 160.05 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -169.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -150.15 161.79 41.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -121.34 120.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -146.27 159.58 43.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -104.77 -137.46 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -70.49 -26.24 24.35 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.692 2.261 . . . . 0.0 112.278 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -66.49 -16.13 63.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.7 23.06 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -62.5 -30.65 71.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 t -69.19 107.16 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -144.88 127.85 16.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.928 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.43 80.33 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -85.29 74.22 10.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.832 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 75.5 p -119.89 -14.97 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.2 p -92.96 -170.05 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.39 175.29 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.935 170.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.71 107.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.192 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -118.48 -57.08 2.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -113.49 160.03 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.578 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . -146.76 166.4 28.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.438 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 96.2 t -130.12 134.75 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.72 177.14 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.93 159.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.5 144.94 98.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.561 0.696 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.95 158.37 56.94 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.681 2.254 . . . . 0.0 112.252 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.1 p -107.22 151.33 25.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -128.76 116.0 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 55.18 36.47 27.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.97 69.21 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -125.32 147.08 56.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 110.996 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.3 154.83 72.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 0.0 112.379 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -67.08 -58.44 4.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 110.914 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -169.91 141.89 1.88 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 0.0 110.864 168.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.65 129.04 11.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.417 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -163.12 112.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.09 135.05 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.25 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -114.45 119.08 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.749 0.309 . . . . 0.0 111.211 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.6 130.01 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.1 m -130.54 145.04 51.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -170.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.0 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.07 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -117.09 155.19 16.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.412 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.6 mt -104.49 126.75 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 111.164 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.98 120.06 8.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.91 67.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.075 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.69 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -72.48 131.06 85.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.738 0.78 . . . . 0.0 110.846 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.65 -12.8 33.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.214 . . . . 0.0 112.32 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.05 27.54 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.854 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -53.85 -34.42 59.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.39 -38.98 91.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.37 -41.01 90.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.816 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.0 79.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.126 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.86 -47.84 79.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 98.3 mt-10 -69.36 -53.04 21.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -175.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 8.5 m-30 -65.48 -39.6 92.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.83 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.1 tt -61.55 -48.07 82.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.978 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -83.06 -26.64 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 93.0 m-20 -100.56 -21.03 15.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -169.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 21.3 m-30 -118.69 -56.38 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.862 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.02 -37.1 78.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -174.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' A' ' 106' ' ' TYR . 89.2 mt -94.84 60.99 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.1 p -127.75 168.82 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.17 171.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -53.24 -44.37 68.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.48 -42.12 30.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.33 -49.33 12.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.434 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 304' ' ' LEU . 25.0 tp -72.05 -35.5 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.938 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.97 -40.06 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.835 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.36 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.98 -35.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.157 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -77.27 -24.54 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.38 -27.29 68.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -88.01 -15.33 36.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.65 153.11 93.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 0.0 110.987 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.6 -55.95 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.573 2.182 . . . . 0.0 112.33 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -82.05 -46.62 13.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 84.98 -8.84 68.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.423 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -55.29 118.54 4.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.061 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 307' ' ' TYR . 4.3 p -128.72 153.49 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 -170.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.42 -17.19 56.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.489 ' HB2' HD23 ' A' ' 290' ' ' LEU . 56.1 tp -70.86 124.91 25.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.06 -37.39 84.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -61.29 -51.0 70.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.739 ' HB3' HG11 ' A' ' 302' ' ' VAL . 1.6 t80 -73.73 -33.25 64.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.67 -38.29 89.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.56 -40.18 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -73.76 -37.77 64.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.802 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.89 -28.23 68.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.66 -16.62 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.43 -21.77 60.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.885 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -90.17 119.55 69.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.796 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -62.32 -25.44 76.51 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.408 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.4 mtm-85 -70.12 -40.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 50.9 mm -79.64 -40.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.96 76.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.06 93.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.079 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 72.0 p -71.25 -36.52 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.13 -34.64 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -65.02 -40.86 95.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -72.03 -35.04 69.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.93 90.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -72.86 -14.37 61.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.818 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -107.72 -8.34 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.858 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.25 -158.37 34.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.483 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -127.11 140.1 52.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 329' ' ' ILE . 2.9 tp -68.24 120.24 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.551 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -47.95 -51.51 47.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.608 0.718 . . . . 0.0 110.878 -174.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 330' ' ' MET . 68.8 Cg_endo -69.23 79.53 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.423 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 53.5 t-20 -119.58 -3.08 10.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 336' ' ' MET . 18.2 tt 164.97 124.9 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 111.114 -165.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.75 -29.35 12.8 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.587 2.191 . . . . 0.0 112.334 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -64.98 -17.76 64.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.914 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 333' ' ' ILE . 61.4 ttp -62.97 -27.94 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -174.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -60.77 -41.73 96.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.6 71.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.134 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -65.6 -30.61 71.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -56.57 -41.2 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.17 -37.31 78.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.46 -43.57 85.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.93 -29.11 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.757 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 60.5 ttt180 -57.31 -44.96 84.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.0 m -62.21 -44.39 96.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.23 81.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.82 -50.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.0 mm -65.9 -45.43 91.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -66.21 -37.27 85.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.85 63.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.9 -35.04 76.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -80.71 -10.85 59.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.69 14.39 81.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.575 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -79.87 -26.6 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -137.0 156.22 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.006 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 98.9 m -68.6 145.86 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.1 -49.94 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.177 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.43 -40.84 85.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.52 -46.43 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 188' ' ' ALA . 63.5 tp -64.16 -46.59 83.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.97 -48.31 71.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.58 -38.8 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -78.6 -46.39 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -78.97 -30.87 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -169.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -59.0 -36.06 74.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.88 -30.1 69.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.5 mt -67.89 -44.67 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.127 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.2 p -98.18 -11.23 22.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.057 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.762 0.315 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -89.76 135.1 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.166 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -129.73 165.03 22.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -71.31 122.04 19.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.12 20.09 50.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.542 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 34' ' ' LYS . 93.5 mttt -139.84 155.11 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.6 pp -149.15 148.75 30.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -123.16 125.35 71.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.464 HG12 ' HB ' ' A' ' 59' ' ' ILE . 53.2 mt -119.01 130.73 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -110.83 136.68 49.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 -173.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 tt -144.56 147.63 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -75.0 172.4 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.62 -19.97 15.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.507 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -79.4 51.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 110.857 174.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 17' ' ' TYR . 54.5 pttt -80.14 117.63 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.956 -159.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.65 10.03 1.64 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.543 154.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' H ' ' C ' ' A' ' 15' ' ' LYS . 23.1 t80 -39.99 -36.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -57.63 -47.12 83.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.8 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -72.63 -38.18 57.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.405 174.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -36.87 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.009 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.55 95.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.221 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -62.02 -45.87 91.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.0 m -75.08 -28.28 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.6 89.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.404 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.42 -40.71 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.82 -45.85 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.972 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.78 -43.27 93.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.46 -33.16 74.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -74.99 -40.37 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.003 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -78.78 -40.53 32.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -101.04 -25.15 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -172.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.58 6.46 87.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.735 HD13 HD13 ' A' ' 275' ' ' LEU . 96.6 mt -78.69 125.05 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 111.094 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 89.3 tttt -64.42 118.06 8.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 173.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.82 129.34 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -134.8 110.1 8.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.228 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.93 126.51 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.069 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -125.93 152.8 45.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -133.69 67.68 75.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.574 0.702 . . . . 0.0 110.892 172.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 30.8 Cg_endo -78.89 -15.38 13.29 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.612 2.208 . . . . 0.0 112.329 -164.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 64.3 m-20 77.28 10.97 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.22 -5.1 34.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -49.88 -60.06 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.929 -154.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.11 -34.82 77.06 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.52 -33.45 54.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -78.49 -30.17 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.805 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.551 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 8.6 m-30 -49.38 -52.15 51.84 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.586 0.707 . . . . 0.0 110.877 -168.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 60.9 Cg_endo -69.56 -27.57 27.28 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.642 2.228 . . . . 0.0 112.337 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.63 -49.98 12.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.17 -33.46 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.099 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.96 86.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.129 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.35 53.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.66 -1.21 50.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.195 -173.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.05 74.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.82 145.4 25.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.943 0.401 . . . . 0.0 110.863 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.49 82.19 0.22 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.428 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.24 124.19 12.22 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.71 2.274 . . . . 0.0 112.451 157.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.13 -42.64 23.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 -156.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.464 ' HB ' HG12 ' A' ' 9' ' ' ILE . 74.7 mt -130.07 133.19 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.096 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.2 mm -125.01 127.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -132.93 115.64 15.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.519 ' O ' ' C ' ' A' ' 63' ' ' ALA . 26.2 p-90 -177.13 173.2 1.83 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 175.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 62' ' ' TRP . . . -25.71 96.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' TRP . 76.2 t60 -59.03 -32.37 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -172.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -51.65 -50.18 60.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.847 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -74.63 -26.64 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.04 -26.68 67.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -64.91 -37.73 94.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.28 -35.45 84.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -72.06 -24.9 61.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' A' ' 76' ' ' LEU . . . -59.73 -39.43 84.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 171.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.17 -28.64 68.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -84.96 4.16 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.98 32.4 69.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.563 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.3 tp -72.9 -24.37 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.748 0.308 . . . . 0.0 110.825 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -132.09 145.99 51.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -170.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -74.96 152.23 38.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -174.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.81 131.34 50.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.972 171.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.84 140.08 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.212 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.8 m -92.72 121.91 65.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 0.0 111.189 -174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -54.96 130.71 42.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.75 2.3 . . . . 0.0 112.343 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.46 118.32 35.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.01 -46.11 89.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.96 87.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.066 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.59 -39.95 95.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -58.06 -43.62 87.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.03 -33.0 74.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.22 -27.2 68.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 304' ' ' LEU . 5.9 mp -112.47 -125.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -129.78 148.05 67.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.671 0.748 . . . . 0.0 110.919 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.65 -30.32 60.21 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.683 2.255 . . . . 0.0 112.277 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -71.69 -35.65 70.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.4 p -71.81 -24.67 61.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.131 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -39.93 71.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 171.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.84 -34.53 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.87 74.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.033 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.78 HG21 ' HD3' ' A' ' 107' ' ' PRO . 34.3 m -111.36 14.06 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -164.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -119.98 149.94 41.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -135.73 119.57 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.961 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.9 t30 61.86 35.2 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.87 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.54 89.08 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.465 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -122.18 149.92 42.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 103' ' ' LEU . 50.9 mt -74.95 133.82 41.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -174.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.8 pt -115.72 -7.36 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.99 174.03 10.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.111 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.45 139.29 28.49 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.711 0.767 . . . . 0.0 110.99 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.78 ' HD3' HG21 ' A' ' 97' ' ' VAL . 56.5 Cg_endo -79.82 132.28 9.6 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -172.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.1 -42.01 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.53 147.99 27.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -163.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.6 t -130.73 132.35 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.02 149.91 47.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.25 142.89 27.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.42 126.38 29.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.7 m -142.59 159.09 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.815 -166.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -98.93 123.87 43.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.6 mt -110.48 133.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -137.25 156.63 48.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.95 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.425 ' HB3' HD21 ' A' ' 121' ' ' LEU . 54.9 t-20 -96.53 120.08 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.03 -27.74 69.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -67.39 -42.25 83.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -165.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.636 HD23 ' H ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -99.97 -24.76 14.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.5 tp -124.21 99.5 37.15 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.648 0.737 . . . . 0.0 110.936 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.15 -14.96 11.82 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.665 2.243 . . . . 0.0 112.326 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.441 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.4 t-20 -157.77 103.94 1.78 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.597 0.713 . . . . 0.0 110.97 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.5 Cg_endo -68.75 147.11 68.59 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 64.7 Cg_exo -55.09 145.03 66.55 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.769 2.313 . . . . 0.0 112.308 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.72 -17.65 37.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -143.79 161.13 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.295 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -68.64 -27.32 65.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.886 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.04 -29.62 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.65 -15.68 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 38.7 mm -59.17 -54.34 57.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.721 0.772 . . . . 0.0 111.12 -171.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 24.5 Cg_endo -62.51 -39.89 42.18 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.318 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.27 99.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.134 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.18 -40.29 97.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.561 ' O ' HD23 ' A' ' 139' ' ' LEU . 10.0 t70 -62.16 -41.65 98.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.97 -39.6 92.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.49 -44.19 75.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -176.385 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 39.0 ttpt -56.08 -26.2 48.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 169.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.11 -20.27 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.46 11.5 37.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.7 30.46 66.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.51 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 96.7 mttt -125.29 157.25 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 110.876 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 t -116.51 153.69 31.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.945 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.21 66.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.2 pp -145.88 146.07 30.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.7 ttm -148.05 132.32 17.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.914 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -156.7 169.79 23.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.16 122.89 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 -174.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.58 7.41 18.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -85.1 -8.68 58.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.845 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -127.19 149.37 69.39 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 110.97 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 -31.99 9.27 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.79 -39.99 40.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -80.5 -37.57 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.9 p -83.82 -14.02 52.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.1 -170.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.609 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 24.1 m0 -49.99 -53.51 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.711 . . . . 0.0 110.827 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 9.5 Cg_endo -53.43 -33.99 69.51 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.453 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.94 -45.4 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.801 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 89.3 mt -74.22 -41.67 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -175.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.13 -6.78 51.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.13 -35.03 59.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.3 5.35 52.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.36 10.58 63.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.525 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -130.05 86.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 63.1 t80 -167.49 153.88 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 74.94 -91.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.08 170.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -167.35 155.03 9.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.954 -171.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.7 129.34 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -116.89 128.91 55.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.94 140.21 25.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.956 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 51.01 45.81 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 10.91 71.05 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.513 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.65 146.87 52.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.891 -174.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -99.35 137.2 38.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -94.82 112.67 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 178' ' ' ILE . 6.4 tp -71.24 -20.01 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.16 -8.76 53.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -120.19 91.34 3.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 173.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.3 m -106.04 155.87 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.78 7.47 65.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.488 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -97.5 -19.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 111.221 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -101.6 14.3 32.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 167.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -93.95 154.23 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -170.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.35 -33.36 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.073 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.67 92.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.477 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.94 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.842 0.353 . . . . 0.0 111.082 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.4 -39.2 91.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.855 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.54 95.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.801 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -42.18 98.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.592 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.62 -39.71 91.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 110.831 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 86.1 m -59.75 -41.71 91.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.086 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.44 -47.23 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.19 -43.13 96.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.83 -40.83 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.98 -38.01 84.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.4 OUTLIER -60.97 -35.88 77.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.982 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.41 -40.0 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.97 -35.18 79.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -80.15 0.74 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.034 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 63.64 30.07 14.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -92.01 -21.61 20.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 83.9 mmm -131.98 155.0 48.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 169.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 94.4 m-20 -104.71 139.14 39.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 173.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.98 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.101 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -96.47 0.43 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 98.5 m -56.57 125.94 24.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.194 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -119.12 179.76 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.92 -39.69 90.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.1 m -58.62 -42.95 89.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.92 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.18 -43.44 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.35 -42.9 87.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.48 87.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.91 97.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.08 -37.84 84.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.867 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.0 -28.64 69.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.11 -22.25 15.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 21.67 40.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.542 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.04 -25.91 29.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 110.827 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 79.1 m -126.48 135.34 51.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.084 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.78 -40.37 48.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.185 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 78.3 mtm -133.7 156.45 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -164.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -151.8 158.34 43.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.202 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 46.2 mm -115.85 114.97 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -163.36 178.39 8.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -99.21 -171.68 31.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.463 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.77 -15.11 40.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -63.49 -12.24 30.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.919 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.6 78.21 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.143 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -66.32 -22.76 66.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 50.1 m -54.14 169.84 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 233' ' ' SER . 91.6 m-20 73.86 55.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 -169.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.0 128.46 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -68.92 81.4 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.809 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -58.18 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.3 p -69.12 -15.3 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -160.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.61 170.52 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.15 119.77 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.093 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -122.02 -42.42 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.925 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -105.13 153.38 21.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.933 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.93 160.41 24.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.427 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.33 131.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.97 0.414 . . . . 0.0 111.101 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.16 179.13 7.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -84.84 159.63 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.124 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.4 mt -68.43 150.03 97.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 110.765 -169.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 44.6 Cg_exo -56.74 150.53 53.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -91.17 163.2 14.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -136.33 113.19 10.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 56.71 43.48 25.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.735 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.68 1.29 80.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 169.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -149.99 147.04 21.3 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.524 0.678 . . . . 0.0 110.991 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.84 127.04 11.68 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 88.9 p -56.71 -57.05 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -170.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -165.09 119.97 0.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.68 149.87 23.92 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.617 2.212 . . . . 0.0 112.324 175.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -138.84 120.51 15.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.863 171.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.04 125.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.132 177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.65 139.36 15.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.459 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.14 124.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.349 . . . . 0.0 111.052 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 262' ' ' LEU . 28.3 mt -78.96 144.67 34.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 169.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 53.6 p -142.42 163.77 31.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.73 135.56 52.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.099 176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.68 156.5 15.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.52 126.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.146 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -65.8 129.25 39.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.07 -28.99 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.44 -11.42 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -80.11 127.93 75.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.655 0.74 . . . . 0.0 110.899 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.53 -6.69 19.09 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.675 2.25 . . . . 0.0 112.319 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -108.05 24.12 13.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.889 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -57.56 -34.12 68.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 -172.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.79 -45.91 63.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.735 HD13 HD13 ' A' ' 33' ' ' ILE . 4.5 pp -76.44 -31.5 57.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.524 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -66.24 -40.83 90.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 174.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -66.56 -39.49 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.59 -38.67 77.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -56.9 -45.51 82.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 62.9 tp -63.79 -50.8 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.82 -34.65 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.8 -27.87 13.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -163.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.777 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 87.1 m-85 -120.45 -49.55 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 80.4 mt -73.63 -35.91 65.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.924 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.98 74.05 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.971 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.0 p -141.87 170.17 16.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.006 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.25 -43.09 74.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -76.45 -46.07 28.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.91 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.777 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.92 -44.15 25.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.01 -36.43 84.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.911 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.97 -41.64 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.34 -34.82 74.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.8 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 97.0 t -80.84 -45.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -71.15 -28.78 64.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.26 -10.97 12.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.47 -33.08 62.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.98 150.02 42.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 0.0 110.903 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -58.39 -57.13 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.394 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.54 -53.19 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.41 62.56 6.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.509 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -81.95 123.12 28.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.123 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.667 HG22 HD21 ' A' ' 311' ' ' LEU . 33.2 m -115.49 156.24 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.074 -163.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.43 -17.07 55.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.055 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.407 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 60.8 tp -78.25 117.85 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.95 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.7 -46.84 87.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.1 t -63.67 -50.99 67.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.771 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.09 -34.06 72.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -57.28 -39.5 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -55.51 -38.12 68.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.667 HD21 HG22 ' A' ' 302' ' ' VAL . 4.3 pp -74.88 -22.05 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -73.01 -6.37 45.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.998 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.82 -12.03 61.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.69 129.94 63.3 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -32.39 32.06 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -69.76 -37.04 76.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.883 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.43 HG21 HD12 ' A' ' 311' ' ' LEU . 48.6 mm -80.37 -40.98 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.35 -35.88 70.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -169.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.71 91.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.175 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 95.4 m -68.52 -39.88 81.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mmt -67.58 -35.42 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.92 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 327' ' ' GLY . 84.5 m-20 -69.27 -35.93 76.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 176.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.15 85.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -72.83 -22.91 60.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.93 -5.71 17.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.37 -159.65 32.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -130.01 123.45 30.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 329' ' ' ILE . 1.1 mp -75.24 124.12 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 329' ' ' ILE . 92.0 mtp 60.56 160.18 0.11 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.535 0.683 . . . . 0.0 110.886 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -64.96 -103.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.0 112.438 161.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -139.96 -48.88 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 158.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.545 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 46.5 pt -130.04 161.36 60.38 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.648 0.737 . . . . 0.0 111.121 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 19.5 Cg_endo -60.72 -22.03 71.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -69.81 -16.41 63.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.3 mmt -66.18 -26.09 67.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 87.7 p -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.08 -51.33 25.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -171.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 339' ' ' PHE . 1.0 OUTLIER -65.22 -26.24 68.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.953 178.354 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -66.15 -39.5 89.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -63.57 -37.47 87.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.98 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.163 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.68 -32.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -49.75 -47.92 50.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.8 m -60.35 -39.67 87.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.143 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -64.47 -37.62 88.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.095 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.84 -44.86 88.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.9 -43.09 97.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.119 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.06 -39.86 93.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.74 68.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.046 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.21 -36.64 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -174.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.9 p -78.6 -9.61 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.904 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.56 9.53 85.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.37 -31.17 65.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.865 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -133.66 160.02 38.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -76.02 169.92 17.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.76 -44.52 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.83 -45.9 91.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.9 -46.45 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.48 89.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.56 -37.37 82.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.64 -35.27 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.58 -31.4 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -65.02 -47.5 77.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.7 m -60.48 -42.18 95.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.122 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.82 -39.24 80.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 89.9 mt -62.69 -42.14 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.108 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 64.9 p -90.8 -14.56 31.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.565 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 85.9 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.701 0.286 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.411 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 86.3 mt -76.04 129.08 37.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -130.11 166.76 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.937 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.43 121.94 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 20.02 52.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.489 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -141.49 156.36 45.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.8 pp -149.29 150.64 32.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.3 t -124.99 121.46 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.426 HG12 ' HB ' ' A' ' 59' ' ' ILE . 87.1 mt -119.58 132.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.212 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.1 m0 -115.75 140.42 49.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.935 HD13 ' HA3' ' A' ' 16' ' ' GLY . 17.3 tt -144.06 143.65 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -73.71 -179.82 3.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -172.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.0 -2.28 4.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.52 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.636 ' O ' ' C ' ' A' ' 15' ' ' LYS . 46.9 t0 -67.34 70.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.856 173.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 14' ' ' ASP . 87.2 tttt -14.55 107.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -166.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.935 ' HA3' HD13 ' A' ' 11' ' ' ILE . . . -108.98 -11.05 23.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.45 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -66.3 -41.75 89.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 110.896 -151.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.68 -52.52 62.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.911 -162.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -66.61 -44.33 90.04 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.415 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.2 mt -58.46 -40.48 82.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 110.896 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.33 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.35 -46.84 88.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 m -74.24 -28.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.32 -37.73 95.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.458 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.63 -41.46 96.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.874 0.369 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.39 -43.93 89.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.1 -43.52 95.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.83 -34.86 76.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.25 -40.1 67.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -79.08 -40.65 30.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -172.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.4 p -100.72 -24.54 14.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.174 -171.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.56 8.53 86.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.406 HG21 HD23 ' A' ' 7' ' ' LEU . 89.6 mt -80.34 124.9 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.21 118.88 8.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 24' ' ' GLY . 70.0 t -98.46 134.31 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -132.65 112.39 11.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.21 121.55 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -128.21 149.98 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.822 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -135.04 68.55 70.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.577 0.703 . . . . 0.0 110.918 171.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 29.0 Cg_endo -79.39 -14.35 13.13 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.683 2.256 . . . . 0.0 112.29 -162.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.4 m-20 76.49 8.95 3.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.14 -9.99 37.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.948 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 3.2 mp -51.34 -55.56 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 -156.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -54.33 -38.98 66.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.65 -32.84 62.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.94 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.96 -29.69 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 43' ' ' LEU . 8.7 m-30 -49.81 -51.59 59.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.706 0.765 . . . . 0.0 110.968 -164.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 96.0 Cg_endo -79.41 -29.11 3.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.576 2.184 . . . . 0.0 112.357 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -75.54 -46.08 34.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.835 -171.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.5 m -56.78 -33.39 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.08 87.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.58 -32.6 47.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.2 p -95.02 -4.9 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.092 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.95 24.71 66.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.435 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -80.94 143.05 32.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.843 0.354 . . . . 0.0 110.843 172.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' A' ' 2' ' ' ILE . . . -122.1 62.9 0.53 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -164.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.88 121.06 7.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.686 2.257 . . . . 0.0 112.377 159.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -83.18 -48.93 9.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 -161.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.426 ' HB ' HG12 ' A' ' 9' ' ' ILE . 70.1 mt -132.55 136.08 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.168 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.07 132.36 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 72.5 m-85 -116.32 115.72 26.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.889 172.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -168.36 179.76 4.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.25 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.132 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 263' ' ' SER . 73.3 t60 -60.21 -25.05 65.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -50.42 -44.16 55.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.13 -24.19 47.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.585 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 1.7 t80 -65.43 -28.79 69.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -172.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.46 -38.35 62.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.457 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.15 -37.31 71.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.631 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -71.64 -25.06 61.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' A' ' 76' ' ' LEU . . . -59.93 -39.58 85.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.15 -26.44 64.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.4 p -85.0 2.47 42.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.76 32.22 73.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.53 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -74.82 -24.33 58.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -126.86 144.11 51.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -168.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -75.99 154.52 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.83 134.07 52.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -115.98 142.27 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.191 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -93.5 123.91 58.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.516 0.674 . . . . 0.0 111.16 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 143.59 28.91 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.789 2.326 . . . . 0.0 112.275 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -107.86 116.13 31.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.14 -43.1 73.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.0 98.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.179 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.17 -35.71 74.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.24 -44.64 88.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.07 -32.45 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.2 -28.38 65.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.04 -105.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -152.69 139.29 12.37 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.745 0.783 . . . . 0.0 110.925 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.37 -28.13 22.71 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.833 2.356 . . . . 0.0 112.298 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -71.22 -34.28 70.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.9 p -74.33 -21.88 59.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.54 -35.18 80.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.017 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.86 -35.06 74.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.97 -37.83 75.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.767 HG21 ' HD3' ' A' ' 107' ' ' PRO . 35.4 m -104.32 18.36 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -169.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -123.52 149.94 44.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -138.77 124.42 19.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 58.18 35.99 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.06 88.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.538 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.03 150.66 41.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 31.9 mt -75.03 135.19 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.994 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.0 pt -113.76 -12.48 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.18 169.57 20.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.053 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -112.86 130.53 23.41 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.622 0.725 . . . . 0.0 111.02 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.767 ' HD3' HG21 ' A' ' 97' ' ' VAL . 54.6 Cg_endo -72.8 125.71 10.73 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.358 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.49 -50.38 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.84 157.07 42.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.09 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 147.16 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.85 147.76 51.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.2 145.22 28.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -68.54 128.81 37.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.5 m -138.29 157.84 45.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.748 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.95 121.13 38.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.5 mt -109.87 130.06 63.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.175 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -135.23 157.53 46.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.58 117.4 29.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.943 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.14 -28.53 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.837 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.94 -35.1 32.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.29 -44.25 25.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.8 tp -127.44 105.99 21.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.65 -15.65 15.26 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.329 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -150.33 105.58 3.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.72 . . . . 0.0 110.966 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.59 146.52 73.98 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.728 2.285 . . . . 0.0 112.371 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.94 147.75 68.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.24 -21.46 24.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.8 p -131.88 159.95 37.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -74.04 -23.64 59.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.23 -21.86 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.31 -21.63 55.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.597 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 40.0 mm -64.35 -45.52 78.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.676 0.75 . . . . 0.0 111.158 -162.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 77.0 Cg_exo -53.52 -49.49 17.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 0.0 112.323 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -38.72 83.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 135' ' ' LEU . 4.5 tt -61.97 -39.39 91.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 25.5 t70 -64.24 -41.87 96.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.74 -40.05 75.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.23 -56.52 9.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -170.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 136' ' ' ASP . 1.3 pt? -82.04 -12.33 58.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -174.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.5 tttt -58.51 -27.3 64.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 168.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.35 -17.9 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.34 6.47 42.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 26.94 65.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.493 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 2.7 mptp? -118.26 159.82 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.957 173.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.404 ' O ' HD11 ' A' ' 139' ' ' LEU . 47.8 t -113.8 153.49 29.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 172.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -66.82 -52.5 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.159 -175.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.83 ' O ' HD12 ' A' ' 147' ' ' LEU . 2.7 pp -151.76 147.65 26.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.968 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.3 mtp -127.27 134.35 50.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -143.37 164.95 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 54.4 t-20 -70.0 110.32 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.895 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 206' ' ' ALA . 48.7 tp -106.84 0.31 23.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.97 -5.83 59.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -132.97 149.66 73.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.528 0.68 . . . . 0.0 110.825 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -79.4 -25.92 5.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.62 2.214 . . . . 0.0 112.317 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -59.68 -44.62 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 150' ' ' ASN . 81.0 m-85 -79.31 -28.4 42.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 m -77.4 -20.89 53.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 172.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.612 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 10.7 t90 -47.37 -53.99 25.12 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.595 0.712 . . . . 0.0 110.879 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.4 Cg_endo -55.19 -32.88 82.26 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.621 2.214 . . . . 0.0 112.401 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.536 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.8 tt -71.04 -54.2 12.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.007 -172.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 91.0 mt -78.61 -40.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 -173.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.22 -14.99 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 -173.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 250' ' ' PHE . . . -59.07 -28.52 66.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -174.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -90.5 -1.88 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.21 20.41 30.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.419 ' HA3' ' N ' ' A' ' 188' ' ' ALA . . . -138.61 85.06 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.444 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 9.4 t80 -177.31 154.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 74.97 -87.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 164.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -148.84 155.58 41.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -168.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -118.28 124.3 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.943 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -113.8 129.8 56.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -145.02 136.47 25.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 52.2 38.93 25.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.889 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.08 8.93 65.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.431 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.72 145.6 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -87.92 123.65 32.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 168.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -98.85 117.71 33.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.88 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.9 tp -68.13 -21.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.35 -12.03 28.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -124.57 82.19 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.6 p -113.21 148.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.61 25.39 27.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -167.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.73 -14.51 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 111.186 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -102.27 20.39 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -102.46 -175.04 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.78 69.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.025 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.56 -38.61 96.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.419 ' N ' ' HA3' ' A' ' 166' ' ' GLY . . . -59.48 -39.85 85.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.12 -40.49 96.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.81 94.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.06 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.19 -43.88 96.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.93 -41.28 91.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.353 . . . . 0.0 110.883 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.4 m -60.01 -43.21 95.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -56.62 -52.43 64.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.76 65.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.39 -39.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.169 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.99 -39.46 92.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.826 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.82 -41.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.936 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -82.43 3.27 28.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.95 34.92 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.85 -28.74 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.1 mtt -137.78 152.74 49.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ASN . . . . . 0.414 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.9 m-20 -101.24 141.41 34.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.862 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ALA . . . . . 0.422 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -65.13 -27.28 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.045 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.63 2.85 54.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 94.5 m -58.59 130.18 45.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 2.8 p30 -125.79 165.44 18.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 172.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -70.08 -27.67 64.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.926 -172.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -65.88 -48.3 71.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.5 pt -69.45 -23.65 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.134 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.45 94.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -71.93 -34.99 69.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.972 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.84 85.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.091 171.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.06 82.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -62.88 -38.26 90.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.831 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.07 -27.42 69.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.71 -21.87 16.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.26 20.28 52.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.485 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -82.62 -26.53 32.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 86.3 m -127.34 134.38 49.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.155 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.21 -36.06 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.415 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 77.6 mtm -134.84 151.41 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -168.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -150.4 158.85 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.28 119.49 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -163.06 174.18 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.405 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -94.21 -175.75 39.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.22 -19.76 66.23 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.623 2.216 . . . . 0.0 112.383 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.405 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 43.7 p90 -68.86 -9.63 52.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.8 84.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -65.82 -25.85 67.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 61.7 m -52.54 160.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 233' ' ' SER . 73.7 m-20 72.72 56.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -170.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.77 130.07 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.71 79.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.871 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 71.2 p -58.76 -176.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 165.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.9 p -72.49 -14.7 61.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.816 -160.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.61 164.96 18.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.781 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t -93.01 114.99 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -120.77 -39.99 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.46 155.29 19.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.97 167.12 25.49 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.568 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.16 136.19 56.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.074 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -143.46 -179.66 6.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.74 159.42 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 94.0 mt -71.36 138.98 84.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 0.0 110.855 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 53.1 Cg_exo -57.05 156.0 26.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.379 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -99.18 164.74 12.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.144 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.401 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 25.7 t80 -141.95 119.98 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 -176.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 61.39 39.71 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.828 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 6.48 84.97 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.468 165.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.94 151.64 49.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.538 0.685 . . . . 0.0 111.019 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.36 130.19 24.46 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.686 2.258 . . . . 0.0 112.408 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 77.8 p -61.09 -42.65 98.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.813 -170.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -172.99 127.66 0.51 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 110.851 166.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.24 142.79 24.6 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.252 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -163.93 124.89 2.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.82 128.92 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 170.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -103.56 144.81 16.02 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.429 171.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.28 127.32 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 263' ' ' SER . 6.5 tt -96.97 128.6 44.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 166.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.573 ' N ' HD23 ' A' ' 262' ' ' LEU . 8.7 m -139.09 172.12 13.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.79 -172.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.508 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -121.99 135.96 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.133 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.585 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -117.39 155.05 16.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 -177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.94 127.93 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 111.119 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -67.77 128.42 36.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -170.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.81 -28.98 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.054 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.67 -10.88 59.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.9 t -77.67 126.98 83.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.649 0.737 . . . . 0.0 110.879 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 -8.4 23.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.455 174.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.736 ' HB3' HD23 ' A' ' 275' ' ' LEU . 97.0 m-20 -112.97 27.45 9.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -172.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.73 -28.34 33.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -66.03 -40.17 90.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 272' ' ' ASN . 0.7 OUTLIER -72.55 -31.27 65.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.617 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.1 -42.04 85.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.01 -40.69 91.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.63 -47.85 83.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 3.2 tt -66.85 -49.45 65.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.949 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.51 -33.73 76.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -101.35 -29.8 11.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -164.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.764 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.3 m-85 -119.93 -50.5 2.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 -169.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 94.5 mt -73.66 -37.79 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -171.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 42.3 tp -126.71 75.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.5 p -140.79 174.62 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.208 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.92 -44.26 74.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.0 -44.24 49.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.764 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.83 -45.82 19.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.545 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.4 -36.92 84.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.351 . . . . 0.0 110.953 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.78 -39.73 95.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.97 88.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.022 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.862 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 10.2 p -87.75 -32.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.76 -23.03 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -174.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.62 -15.25 6.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -82.91 -23.9 33.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -91.03 151.48 43.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.89 -61.07 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.808 2.339 . . . . 0.0 112.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 97.1 mt -98.88 -50.12 4.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 54.56 59.91 9.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.517 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.74 129.01 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 111.048 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.38 153.92 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -166.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.73 -14.99 58.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.5 tp -76.63 120.26 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.923 -175.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.1 -44.91 96.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -173.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -48.11 78.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 -173.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.89 -32.94 71.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.472 ' HA ' ' HE1' ' A' ' 321' ' ' MET . 42.7 tt0 -61.69 -38.93 89.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.798 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.64 -40.67 79.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.08 -41.58 58.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.428 ' HB3' HG21 ' A' ' 317' ' ' ILE . 91.9 mt -65.34 -29.97 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.51 -9.78 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.96 -19.44 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -86.76 120.13 71.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.573 0.701 . . . . 0.0 110.892 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.87 -34.97 57.8 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.661 2.24 . . . . 0.0 112.322 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.33 -39.78 62.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.428 HG21 ' HB3' ' A' ' 311' ' ' LEU . 96.7 mt -74.12 -39.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.4 -33.24 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.03 93.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.6 m -69.75 -41.17 75.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.472 ' HE1' ' HA ' ' A' ' 308' ' ' GLU . 40.3 mtt -68.37 -34.61 76.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.12 -37.03 85.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -67.08 -36.5 82.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.78 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.31 -23.46 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.958 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 -2.05 23.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.801 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.06 -166.37 40.64 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.433 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.8 128.19 44.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 0.0 111.015 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.452 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 28.7 mm -73.28 111.54 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -176.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.0 mmm 63.23 158.15 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.578 0.704 . . . . 0.0 110.744 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' PRO . . . . . 0.477 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 66.9 Cg_endo -73.66 -111.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 169.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.73 -47.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 170.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 19.5 pt -138.82 159.78 65.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.552 0.691 . . . . 0.0 111.199 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 40.8 Cg_endo -66.74 -14.71 44.92 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.742 2.295 . . . . 0.0 112.257 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -5.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.949 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.477 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.8 ptm -52.47 -30.14 28.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -32.94 74.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.16 72.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.038 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 339' ' ' PHE . 0.7 OUTLIER -72.27 -25.14 61.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.772 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -58.79 -48.0 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -63.68 -40.55 97.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.67 95.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.099 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.04 -26.26 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -61.13 -45.85 92.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.7 p -67.18 -34.37 77.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -66.16 -47.3 74.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 348' ' ' ILE . 7.3 p -71.53 -41.61 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 -172.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.418 ' N ' HG13 ' A' ' 347' ' ' VAL . 93.7 mt -64.46 -43.97 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -64.65 -36.41 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.23 -43.85 69.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.33 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.13 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.6 p -75.03 -14.99 60.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.23 86.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.84 -29.86 67.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.614 0.245 . . . . 0.0 110.807 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -140.01 158.64 43.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.894 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.9 p -73.43 169.4 17.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.03 -48.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.98 -40.08 75.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -70.87 -42.36 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.909 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.98 89.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.098 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 30.3 tp -65.21 -36.4 84.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.09 -35.41 75.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.92 -29.1 70.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -65.14 -48.83 72.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -64.35 -39.84 94.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -60.75 -43.67 97.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.111 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -72.32 -35.47 68.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.96 -43.08 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 67.1 p -89.89 -12.74 38.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.796 0.331 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -83.17 132.29 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -123.62 161.13 25.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.73 119.61 19.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.27 31.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.459 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -146.52 154.69 41.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.84 143.1 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.5 122.42 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.41 140.56 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.462 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 55.5 m95 -116.45 126.76 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 tt -148.87 141.02 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.406 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.8 t-20 -47.87 118.46 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -166.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.19 64.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.462 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.13 -56.18 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 0.0 110.929 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -137.37 78.26 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 152.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.76 -34.31 1.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.472 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.15 -46.08 36.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.933 -158.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -51.59 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -157.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.2 -48.75 57.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 tp -59.6 -42.09 91.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.05 84.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -63.22 -37.25 86.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.15 -41.65 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.05 87.65 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.453 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.35 -40.2 89.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.905 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -60.62 -46.91 88.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 33' ' ' ILE . 28.3 t80 -68.8 -36.29 78.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.49 -33.13 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.64 -36.05 73.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.16 -40.65 26.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -109.12 -18.11 13.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 -171.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.25 4.8 87.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.54 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.4 tt -72.94 121.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -68.91 121.61 16.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.946 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.3 p -102.22 142.63 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.151 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -136.09 114.24 11.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.86 127.34 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -124.8 160.61 28.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -93.48 125.0 55.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 110.855 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.436 ' CB ' HD22 ' A' ' 43' ' ' LEU . 66.1 Cg_endo -87.78 81.72 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -167.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -93.88 -27.8 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 166.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -92.31 -15.02 27.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.841 -169.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD22 ' CB ' ' A' ' 40' ' ' PRO . 2.3 mp -53.14 -46.06 68.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.891 -159.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -50.03 -40.98 46.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.14 -35.05 32.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -73.0 -25.07 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.2 m-30 -50.05 -55.79 22.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 0.0 110.875 -165.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -71.18 -29.77 16.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.732 2.288 . . . . 0.0 112.382 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -76.54 -49.95 15.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -172.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.691 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 28.0 m -60.37 -34.98 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.47 86.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.86 66.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.091 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -93.73 1.36 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.114 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.57 8.32 66.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.463 171.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -171.3 95.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.898 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.99 -129.34 3.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 156.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 41.7 Cg_endo -70.21 154.53 65.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.644 2.229 . . . . 0.0 112.35 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -88.08 -39.78 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.61 136.89 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.0 mm -119.68 134.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -77.8 159.47 28.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.952 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CB ' ' H ' ' A' ' 263' ' ' SER . 41.9 t90 -85.84 147.4 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -112.57 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.104 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -110.74 -83.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 157.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -94.58 -19.51 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -60.05 -27.59 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -163.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -58.06 -33.26 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.87 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -64.3 -41.24 98.29 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.18 80.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.427 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -65.84 -36.7 84.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.72 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.105 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.96 -29.27 70.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -82.39 1.5 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.16 75.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -82.71 -6.17 59.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.46 146.17 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -91.11 163.6 14.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.71 128.76 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -110.41 148.83 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -95.64 124.6 52.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.506 0.67 . . . . 0.0 111.204 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.83 140.67 42.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -103.83 109.91 21.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.38 -42.59 98.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.9 m-30 -68.2 -35.81 78.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -55.09 -45.45 75.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.941 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.33 -39.15 93.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.16 -22.48 62.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 304' ' ' LEU . 75.5 mt -105.02 -145.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.78 145.7 54.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -70.0 -39.83 5.62 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -68.7 -23.28 64.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.984 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.6 p -72.29 -24.87 61.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.438 ' HA ' HG22 ' A' ' 97' ' ' VAL . 88.8 m95 -72.82 -33.02 65.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.65 -34.51 72.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -71.42 -25.14 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.171 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.49 HG21 ' HD3' ' A' ' 107' ' ' PRO . 34.6 m -108.42 14.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 79.0 mtm180 -118.02 143.87 46.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -143.4 130.86 21.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 t30 57.01 33.3 23.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.963 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.07 90.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.47 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.33 150.41 37.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 37.0 tp -81.18 123.87 28.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.0 pt -115.25 -9.67 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.459 ' HB1' ' H ' ' A' ' 264' ' ' ALA . . . -161.33 169.3 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.668 ' HB3' HD21 ' A' ' 285' ' ' LEU . 75.1 m-85 -110.03 140.0 21.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.693 0.758 . . . . 0.0 110.984 167.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD3' HG21 ' A' ' 97' ' ' VAL . 94.1 Cg_endo -79.04 117.14 3.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.652 2.234 . . . . 0.0 112.308 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.7 mt -109.1 -29.99 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.51 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -170.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.07 124.97 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.086 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -116.53 129.42 56.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.71 149.7 30.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 94.6 mt -72.87 144.89 47.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.6 m -143.9 160.86 40.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 tp -89.33 118.55 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 244' ' ' VAL . 56.2 mt -109.6 119.66 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.082 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -133.24 155.09 50.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -164.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.03 115.73 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.874 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.62 -25.46 68.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -76.0 -35.76 59.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.12 -52.8 5.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.952 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.2 mt -124.59 105.18 30.45 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.546 0.689 . . . . 0.0 110.876 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.92 -12.65 19.74 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.342 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 57.5 t-20 -147.91 100.02 3.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.69 0.757 . . . . 0.0 110.911 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 56.8 Cg_endo -69.09 164.58 33.31 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.407 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 44.1 Cg_endo -72.43 145.15 42.14 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.347 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.02 -19.35 27.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.2 t -144.48 163.01 35.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -173.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -70.58 -25.16 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 -174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.48 -33.01 74.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -75.02 -22.59 58.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.609 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 77.6 mt -62.55 -53.63 55.49 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.682 0.753 . . . . 0.0 111.143 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.1 Cg_endo -60.43 -40.4 57.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.29 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.05 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 51.5 tp -61.32 -39.93 92.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 132' ' ' ILE . 9.3 t70 -65.99 -41.31 91.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.35 -38.79 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.64 -45.33 75.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 146' ' ' ALA . 3.7 pp -83.58 -20.34 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 84.6 tttt -56.46 -28.81 60.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.16 -18.67 63.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.066 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.21 7.51 33.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.08 29.72 62.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.48 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -108.13 161.58 14.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.8 t -116.93 148.51 41.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 139' ' ' LEU . . . -86.22 -34.63 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.2 tp -130.72 141.1 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -112.91 134.91 54.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -164.25 160.45 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.849 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -127.27 -10.56 5.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 199' ' ' ILE . 37.8 mt 50.82 35.54 12.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -93.68 -20.88 19.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -139.62 149.75 60.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.66 -22.86 74.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.355 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -50.04 -36.27 28.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -70.74 -35.7 72.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.436 HG21 HG11 ' A' ' 347' ' ' VAL . 39.2 p -80.33 -28.49 38.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 -172.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.541 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 42.1 m0 -56.91 -45.0 100.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 -164.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.593 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 98.1 Cg_exo -48.9 -38.19 38.0 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.705 2.27 . . . . 0.0 112.297 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.1 mt -80.32 -44.67 19.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.681 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.4 mt -72.18 -47.53 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 -169.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.1 -16.71 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.171 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.51 -27.07 65.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.079 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -97.73 8.47 44.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.41 16.78 3.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.454 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.35 161.16 38.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -168.0 150.57 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.26 -62.21 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.83 146.65 47.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.19 136.79 37.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.553 ' CE2' ' HB3' ' A' ' 176' ' ' TYR . 57.4 m-85 -115.29 126.3 54.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -146.13 141.41 27.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.865 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.3 t30 49.78 45.59 24.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.878 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.34 8.85 66.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.511 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.63 148.66 52.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.848 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.553 ' HB3' ' CE2' ' A' ' 171' ' ' TYR . 49.2 p90 -93.4 138.2 31.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -96.11 109.81 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 178' ' ' ILE . 2.2 tp -64.13 -20.01 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.05 -4.82 53.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.921 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -117.02 97.53 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.9 154.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.132 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.75 28.76 12.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 m -99.99 -23.37 4.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.152 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -97.35 20.44 11.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.01 155.31 19.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -171.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.39 -35.01 67.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.055 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.03 93.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.458 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.03 78.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -62.87 -41.68 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.57 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.33 -42.52 97.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 357' ' ' VAL . 24.7 tp -69.19 -34.36 74.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.884 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.9 m -58.77 -40.85 85.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.166 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -58.05 -44.22 87.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.12 -44.98 88.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -65.14 -40.71 89.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.13 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -38.6 91.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.3 OUTLIER -62.27 -38.64 90.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.407 HD11 HD11 ' A' ' 151' ' ' LEU . 53.1 mt -81.59 -42.16 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.56 -41.68 88.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.79 5.23 29.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.87 31.99 11.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.01 -28.86 60.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 170.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.8 tpt -146.09 151.62 37.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.428 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -89.19 134.76 33.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.34 -27.01 62.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 -174.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.66 -17.54 16.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 77.8 m -64.45 134.99 55.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -89.97 166.25 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -66.34 -37.05 84.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.5 p -68.68 -38.3 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.855 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.01 -43.97 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.79 -36.94 73.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.6 -38.41 83.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.29 95.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.01 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CZ ' HG22 ' A' ' 116' ' ' ILE . 83.2 t80 -66.77 -42.15 86.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 174.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -61.29 -26.33 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.834 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.03 -9.03 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.32 67.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.66 -28.63 33.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.936 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 90.0 m -120.14 130.19 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.132 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.65 -43.68 75.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -169.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.9 mtm -140.44 150.33 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -169.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.4 p -145.47 171.77 14.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mm -118.15 126.08 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -159.8 172.36 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.2 -164.2 29.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.27 -15.97 19.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.24 . . . . 0.0 112.382 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -70.28 -29.23 65.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 28.61 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.496 ' O ' ' C ' ' A' ' 233' ' ' SER . 37.3 m0 -72.79 -46.2 54.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 232' ' ' TRP . 58.2 m 33.87 -99.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 170.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -151.1 39.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.19 157.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.094 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.657 ' O ' ' C ' ' A' ' 237' ' ' THR . 95.0 m-20 -108.13 148.73 29.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.657 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.2 m -6.62 82.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 94.6 p -61.88 161.18 10.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -134.62 -5.45 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 241' ' ' ASN . 52.5 t -89.14 73.37 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -171.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' VAL . 83.7 m-20 40.97 47.51 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.81 147.26 26.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.69 164.95 26.61 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 -175.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.424 HG22 HG12 ' A' ' 116' ' ' ILE . 52.6 t -131.52 134.99 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 177.26 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.181 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.95 160.01 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.183 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.518 ' HB2' ' HD3' ' A' ' 257' ' ' PRO . 26.8 mt -78.97 151.06 75.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.473 ' HG2' HD11 ' A' ' 132' ' ' ILE . 50.3 Cg_exo -62.05 154.57 61.34 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.404 -174.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 96.1 m -133.14 138.12 46.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -114.15 118.17 33.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 -167.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 50.48 40.14 22.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.63 24.19 73.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 98.7 mm-40 -106.14 161.7 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.599 0.714 . . . . 0.0 110.956 -169.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.7 Cg_endo -63.94 70.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.228 . . . . 0.0 112.384 173.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 68.5 m -102.63 15.29 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.808 -167.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 257' ' ' PRO . 58.4 mttp -106.97 160.8 25.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.564 0.697 . . . . 0.0 110.909 -161.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 247' ' ' LEU . 11.5 Cg_endo -60.96 154.93 53.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.73 163.14 27.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.49 125.66 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.143 -175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.57 143.27 15.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.23 126.5 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.8 tp -64.81 129.26 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.428 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 20.1 m -135.32 155.02 51.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 -166.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.459 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -140.3 137.04 33.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.082 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.64 146.56 18.08 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.477 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 86.2 mt -114.61 124.76 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.928 0.394 . . . . 0.0 111.087 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -58.56 122.07 12.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.892 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.29 -25.92 66.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.077 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.62 -8.02 59.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.103 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.2 t -69.17 128.49 92.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.669 0.747 . . . . 0.0 110.908 -175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.71 -12.58 36.5 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.683 2.255 . . . . 0.0 112.406 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -111.92 25.04 12.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -55.45 -33.09 63.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.37 -38.8 65.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.13 -44.2 97.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.47 85.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.27 -46.45 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.11 -50.79 66.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -34.87 71.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -172.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 280' ' ' LEU . 2.5 tt -52.48 -51.79 57.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.54 -22.39 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.828 -171.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -98.55 -14.06 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -166.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.6 m-85 -120.58 -52.38 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.54 -32.3 73.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.908 ' O ' HD12 ' A' ' 285' ' ' LEU . 1.7 pp -136.72 76.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.971 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.8 p -143.02 170.02 16.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.187 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -53.69 -46.27 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.02 -42.99 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.862 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.04 -46.78 20.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -170.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 46.9 tp -66.03 -36.02 82.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.75 -43.74 85.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.07 85.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 3.2 p -75.42 -31.27 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.34 -16.44 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -58.83 -22.85 59.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -89.25 -22.62 22.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.823 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -100.36 155.27 36.58 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.95 -63.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.292 . . . . 0.0 112.409 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 76.5 mt -107.35 -50.5 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.88 -49.2 0.9 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.445 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.78 72.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.443 HG22 HD21 ' A' ' 311' ' ' LEU . 20.1 m -109.2 155.86 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.121 -154.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.93 -13.77 59.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 89' ' ' LEU . 58.1 tp -80.57 117.48 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.16 -44.82 96.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.6 p -65.7 -51.93 55.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -172.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -68.85 -34.03 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.929 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.1 -40.44 89.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.58 -37.78 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.79 -47.8 24.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.817 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.443 HD21 HG22 ' A' ' 302' ' ' VAL . 4.0 pp -74.72 -19.51 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.63 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.161 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.9 -10.36 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.47 130.12 52.58 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.561 0.696 . . . . 0.0 110.845 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.54 -30.51 16.24 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.737 2.291 . . . . 0.0 112.325 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -65.17 -37.9 88.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.85 -43.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.43 68.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.091 -164.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.45 79.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.11 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.8 m -68.06 -39.21 83.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.176 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 68.0 ttp -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.905 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -65.94 -46.26 78.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 327' ' ' GLY . 43.3 p30 -80.07 -13.76 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.76 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 167.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -74.7 -18.26 60.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.29 -10.54 13.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -79.46 -162.22 23.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.506 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -125.59 126.49 44.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.91 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 96' ' ' ALA . 7.4 tp -65.65 126.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -176.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 65.1 ttp -71.22 119.92 76.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.12 144.49 69.39 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.702 2.268 . . . . 0.0 112.388 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.87 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.5 p30 -99.98 11.42 39.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.828 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 335' ' ' GLN . 34.5 mt -68.42 135.12 90.88 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 0.0 111.123 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.41 -34.39 50.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.585 ' H ' HG22 ' A' ' 333' ' ' ILE . 25.5 mm100 -65.34 -10.53 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.9 mmm -63.85 -25.74 68.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.4 m -63.77 -39.4 94.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.83 -33.88 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.099 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.84 -38.86 86.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 174.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -59.98 -53.33 59.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -63.27 -36.73 84.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.41 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.03 -44.18 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -57.17 -46.2 83.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.8 m -66.7 -42.94 85.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.464 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -61.17 -42.07 97.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 157' ' ' THR . 54.1 t -67.86 -46.74 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.37 -43.38 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 88.8 m-20 -64.77 -37.41 87.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.851 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -45.67 69.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.99 72.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.6 p -83.19 -8.26 59.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.62 13.33 83.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.95 -28.14 39.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.1 tt0 -148.2 145.17 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.0 p -73.43 164.97 25.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.404 HG13 HD23 ' A' ' 192' ' ' LEU . 58.8 t -69.77 -45.99 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.31 -36.08 82.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -74.44 -41.05 61.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -64.99 -42.58 94.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.35 -32.04 70.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 -39.9 94.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -69.12 -31.49 70.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.33 73.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -69.98 -31.38 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 86.1 m -63.02 -43.19 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.38 -40.79 93.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.847 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.67 -42.43 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.11 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.9 p -89.63 -2.15 58.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -174.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.1 mt -82.86 133.17 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -126.81 159.19 34.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -74.76 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.38 21.94 55.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -142.92 162.6 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.5 mt -130.39 135.83 48.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -125.11 110.17 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.22 139.43 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 -172.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.473 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 66.1 m95 -116.84 126.73 53.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.95 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.469 HG23 ' HA3' ' A' ' 16' ' ' GLY . 21.1 tt -148.93 140.09 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.033 -169.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -47.83 118.64 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.946 -166.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.09 -25.42 62.09 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.429 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -57.42 -53.39 58.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.917 -169.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -137.94 88.77 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.917 148.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.469 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -116.71 -36.98 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.486 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -77.23 -50.12 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -154.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -67.95 -52.55 34.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -154.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.74 84.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.4 -39.52 79.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.16 98.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.17 -41.02 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.23 -48.5 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.68 -33.85 86.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.385 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -64.93 -43.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.951 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.85 -45.07 86.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.909 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -68.24 -35.61 78.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.13 -34.96 79.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.6 -34.37 65.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -77.17 -41.75 40.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -108.21 -18.13 13.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.229 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.49 4.6 89.17 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.54 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 33' ' ' ILE . 16.1 tt -74.29 116.79 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.156 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.38 124.87 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.09 140.0 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.176 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -134.41 113.6 12.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.5 128.78 60.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -126.2 161.67 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -95.45 122.52 59.13 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.562 0.696 . . . . 0.0 110.8 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HB3' HD22 ' A' ' 43' ' ' LEU . 88.7 Cg_endo -86.84 80.05 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.284 -168.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -93.58 -25.63 17.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 168.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.17 -16.54 23.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -171.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 40' ' ' PRO . 2.3 mp -56.92 -42.31 79.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.922 -157.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -52.23 -38.94 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -81.01 -34.02 33.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.838 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -71.92 -23.65 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.494 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.9 m-30 -49.63 -55.95 19.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.915 -164.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.2 Cg_endo -70.75 -29.3 19.37 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.751 2.3 . . . . 0.0 112.323 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -76.4 -50.1 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.927 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.578 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 30.9 m -61.49 -35.78 69.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.71 86.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -27.33 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 p -95.05 2.28 55.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.98 8.83 65.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -170.76 95.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -127.63 -116.95 2.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.474 154.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 48.4 Cg_endo -69.08 152.48 72.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.614 2.209 . . . . 0.0 112.353 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -87.06 -39.97 15.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -138.09 139.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mm -110.09 133.54 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.103 -166.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.451 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 11.5 p90 -67.38 170.94 6.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.468 ' CG ' ' HG ' ' A' ' 262' ' ' LEU . 39.9 p-90 -87.03 143.76 27.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.05 -121.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 167.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.86 -79.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 154.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -84.01 -13.89 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -61.35 -20.38 62.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -167.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 263' ' ' SER . 55.2 m-85 -56.89 -30.13 63.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -174.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -62.36 -43.75 98.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.508 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.375 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 70' ' ' TYR . 5.0 m-30 -62.91 -38.65 91.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.877 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.46 95.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.8 mm100 -65.07 -31.03 72.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.4 m -89.86 -4.91 57.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.74 27.63 73.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.83 -9.73 59.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.875 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 265' ' ' GLY . 0.0 OUTLIER -131.23 140.56 49.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.825 176.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -92.32 169.34 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.06 125.05 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.54 151.25 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.5 m -99.87 121.66 53.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.169 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.16 144.6 37.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.312 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -104.72 118.28 36.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.73 -38.98 73.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.95 81.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -70.83 -32.63 69.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.444 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 87.3 mt-30 -58.52 -46.77 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.931 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.65 -35.93 79.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -76.41 -20.56 56.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.817 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.438 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 85.3 mt -107.3 -147.35 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -129.33 143.59 49.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.665 0.745 . . . . 0.0 110.91 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.34 -36.73 65.62 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.29 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -65.34 -36.41 83.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.59 -23.13 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.211 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.444 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 88.4 m95 -70.04 -38.91 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.45 -31.49 70.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.82 -31.1 69.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 35.4 m -109.75 8.66 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -172.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -108.24 141.48 39.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -132.05 121.28 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 58.74 34.14 23.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.962 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.93 2.84 90.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.539 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -120.02 148.59 43.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.3 tp -81.0 129.02 34.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -173.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 pt -118.43 -7.6 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.121 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -162.45 166.95 24.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -175.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 82.1 m-85 -113.52 139.57 23.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.654 0.74 . . . . 0.0 110.982 171.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 19.9 Cg_exo -67.41 116.33 4.16 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.288 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.35 -33.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.94 154.98 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -166.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.48 127.77 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -114.22 126.37 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.82 148.28 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.03 150.66 38.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.7 m -145.72 162.75 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.765 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.06 120.07 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.431 HG12 HG22 ' A' ' 244' ' ' VAL . 73.5 mt -106.89 124.15 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.007 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -133.43 155.43 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -89.95 115.1 27.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.852 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.55 -26.61 65.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.92 -35.01 51.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.75 -52.2 7.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.75 108.58 28.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.647 0.737 . . . . 0.0 110.959 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.38 -15.08 17.98 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.701 2.268 . . . . 0.0 112.362 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -140.82 105.33 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.24 164.25 36.22 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.784 2.322 . . . . 0.0 112.374 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.6 152.45 59.5 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.88 -24.67 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 131' ' ' GLU . 9.2 t -143.38 157.21 44.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -68.4 -29.95 68.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.43 -28.96 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 128' ' ' THR . 87.3 tt0 -75.72 -24.69 56.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.771 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 26.4 mm -55.76 -53.41 63.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.605 0.717 . . . . 0.0 110.982 -169.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.0 Cg_endo -66.1 -42.82 10.03 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.669 2.246 . . . . 0.0 112.314 -172.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.45 91.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.21 -36.81 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.79 -40.81 95.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.38 -37.75 84.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.92 -44.54 76.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 139' ' ' LEU . 3.4 pp -84.49 -20.62 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -57.01 -27.77 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.5 65.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.07 10.04 32.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.4 67.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -104.7 157.17 17.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.768 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.6 t -110.49 146.12 36.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.72 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.37 -33.96 32.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.7 tp -130.81 145.49 51.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.6 ttm -109.07 127.12 53.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.914 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -163.78 158.49 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -130.91 -9.9 3.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.876 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 mt 54.12 34.94 21.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.28 -17.07 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.35 153.43 79.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.732 0.777 . . . . 0.0 110.877 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 49.0 Cg_endo -64.11 -24.76 66.08 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -38.02 72.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -71.91 -42.2 66.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.416 HG23 HD22 ' A' ' 195' ' ' LEU . 99.3 m -80.81 -35.4 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 -170.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.513 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 85.5 t90 -53.91 -43.96 97.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.606 0.717 . . . . 0.0 110.909 -163.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.707 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 87.2 Cg_exo -48.76 -39.14 38.54 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.11 -36.71 69.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.412 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 91.7 mt -69.03 -42.23 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.253 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.25 -14.05 59.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.154 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 255' ' ' SER . . . -55.8 -32.88 63.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.32 11.58 36.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -170.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.16 18.25 6.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.41 158.38 35.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.408 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.589 ' H ' ' HA3' ' A' ' 182' ' ' GLY . 87.3 m-85 -140.01 151.72 45.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.949 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.22 -61.11 2.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -137.15 147.47 45.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.962 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -68.25 124.22 22.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.86 110.9 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.926 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -144.14 143.76 31.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 48.07 42.79 17.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.86 10.09 80.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.583 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.833 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -91.29 129.72 37.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.43 109.87 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 178' ' ' ILE . 2.5 tp -64.56 -21.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.008 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.27 -6.72 52.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -119.92 96.2 5.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.0 m -104.33 153.84 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.589 ' HA3' ' H ' ' A' ' 167' ' ' TYR . . . -105.02 30.81 9.37 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.13 -16.78 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.907 0.384 . . . . 0.0 111.148 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -101.56 12.58 37.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 171.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.98 155.19 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 -174.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.73 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.085 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.85 -38.33 94.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -62.75 -38.01 88.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.13 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.85 -37.85 88.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.9 88.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.063 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -63.95 -41.12 98.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.457 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.23 -36.18 82.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -58.57 -39.98 81.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -55.45 -46.31 76.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.416 HD22 HG23 ' A' ' 157' ' ' THR . 60.5 tp -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.17 -40.38 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.03 -40.42 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.8 OUTLIER -60.89 -42.91 98.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 177.085 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.0 mt -70.17 -41.77 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.9 -34.83 78.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -81.81 4.33 22.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.0 34.16 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -75.61 -16.41 60.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 61.1 tpp -140.23 148.11 41.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.527 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.7 t-20 -89.63 134.95 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.69 70.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.062 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -96.05 -13.38 23.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 -171.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.527 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.7 m -70.15 139.02 52.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.58 174.1 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -62.43 -48.61 78.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.4 p -67.51 -34.46 77.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.97 -44.6 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.68 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.093 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -69.96 -36.77 75.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.803 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.2 82.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.076 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.59 97.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 171.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.0 -38.28 90.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.75 -24.5 65.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.64 -10.14 25.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.895 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.15 59.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.448 -174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -82.47 -24.04 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 0.0 110.993 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.2 m -121.01 130.67 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.75 69.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 76.1 mtm -135.25 150.47 50.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -168.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.4 p -145.84 165.5 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.65 124.26 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -154.29 162.59 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.64 -159.57 33.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.18 -16.42 19.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.599 2.199 . . . . 0.0 112.316 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -65.26 -37.21 86.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 59.59 17.99 6.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.493 ' O ' ' C ' ' A' ' 233' ' ' SER . 50.6 m0 -76.56 -53.21 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 232' ' ' TRP . 64.7 p 31.91 -94.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.867 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.6 t30 -151.27 38.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.943 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.8 tt -159.86 156.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.149 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -100.4 139.44 36.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.864 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 91.9 m -7.26 82.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 236' ' ' ASP . 87.7 p -62.15 160.37 12.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.761 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -139.81 -9.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.9 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.75 79.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 55.92 34.39 23.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -102.68 150.14 23.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.88 162.68 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 116' ' ' ILE . 58.8 t -126.16 130.28 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -135.63 174.71 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.78 158.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.87 145.89 51.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.57 0.7 . . . . 0.0 110.952 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -56.36 146.1 74.92 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.738 2.292 . . . . 0.0 112.371 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 77.7 p -130.48 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -116.86 118.96 33.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -169.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 51.44 39.46 24.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.01 63.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.559 166.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -109.99 157.34 38.1 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.631 0.729 . . . . 0.0 111.007 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.9 74.67 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 49.7 m -98.52 14.37 28.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -160.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -109.48 155.88 40.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.61 0.719 . . . . 0.0 110.858 -169.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.707 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 36.8 Cg_endo -68.65 171.81 12.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.394 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -56.94 159.97 3.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.41 128.7 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.45 147.26 16.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.428 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.22 125.0 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.165 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.468 ' HG ' ' CG ' ' A' ' 62' ' ' TRP . 4.3 tt -68.18 125.34 26.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 6.5 m -139.42 154.93 47.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.816 -166.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.89 137.87 36.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 76' ' ' LEU . . . -119.12 152.55 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.519 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.1 mt -111.5 120.45 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.372 . . . . 0.0 111.132 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -55.9 124.35 17.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.795 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.61 -25.43 65.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.05 -9.2 59.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.078 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.7 t -68.85 128.35 92.86 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.637 0.732 . . . . 0.0 110.954 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.14 -11.43 32.0 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.789 2.326 . . . . 0.0 112.366 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -109.27 24.26 13.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -54.85 -33.73 62.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.36 -41.11 57.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.39 -43.4 98.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.12 94.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.129 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.67 -47.17 76.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.41 -50.22 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.794 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -69.98 -34.94 74.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -173.407 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 280' ' ' LEU . 2.5 tt -56.03 -52.14 65.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.45 -26.39 55.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.833 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.06 -22.24 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.84 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 65.4 m-85 -122.66 -50.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 37.3 tp -68.65 -39.04 80.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.642 ' C ' HD23 ' A' ' 285' ' ' LEU . 3.0 tt -124.98 79.92 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 25.3 p -142.75 171.42 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 165.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.63 -42.11 67.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.96 -44.59 39.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.795 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.84 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.36 -47.93 8.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.44 -168.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -65.13 -33.41 75.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.869 -175.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.42 -41.04 88.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.23 94.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 290' ' ' LEU . 9.5 p -78.39 -28.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -65.16 -18.79 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.987 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -18.19 43.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -30.49 65.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -107.83 153.09 41.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.626 0.727 . . . . 0.0 110.868 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.05 -61.32 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.723 2.282 . . . . 0.0 112.406 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.94 -53.78 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 116.16 -56.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.47 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 46.86 69.2 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.184 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.437 HG22 HD21 ' A' ' 311' ' ' LEU . 19.3 m -111.49 155.9 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -162.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.58 -17.01 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.3 tp -81.81 120.59 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.48 -44.2 96.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -63.59 -49.99 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.834 -168.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -70.48 -32.62 70.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.1 -42.44 98.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.793 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.57 -35.29 72.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -172.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -79.76 -46.43 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.437 HD21 HG22 ' A' ' 302' ' ' VAL . 2.5 pp -73.41 -22.91 60.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.39 -5.63 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.97 -11.75 60.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.42 131.12 51.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.693 . . . . 0.0 110.844 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.58 -30.1 20.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.271 . . . . 0.0 112.298 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -64.97 -39.23 93.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.12 -42.51 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.5 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 -166.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.35 -35.46 73.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.74 82.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.8 -35.38 74.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -65.04 -37.78 88.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 327' ' ' GLY . 95.0 m-20 -67.97 -35.71 78.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.07 78.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.03 -19.66 60.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.34 -7.19 15.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -86.14 -163.11 37.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -128.7 135.93 49.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.677 0.275 . . . . 0.0 110.894 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.7 126.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.4 ttm -61.15 122.11 67.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.587 0.708 . . . . 0.0 110.91 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.03 132.16 37.25 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.306 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.424 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 50.6 p30 -95.12 10.07 37.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 pt -80.57 152.11 72.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 111.128 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.91 -25.04 67.78 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.755 2.303 . . . . 0.0 112.403 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.07 -16.5 60.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.79 -29.96 70.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.6 m -61.59 -41.37 97.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.758 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.49 -33.86 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.101 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.28 -46.1 83.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -60.02 -52.31 65.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.97 -46.04 89.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.93 89.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.154 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.79 -44.85 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.176 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.436 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 44.2 ttp180 -60.95 -43.34 98.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.1 m -64.99 -43.8 91.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.01 -43.16 93.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.061 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.6 -47.24 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 89.7 mt -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 85.8 m-20 -63.41 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.94 68.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.58 -34.02 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 -7.49 59.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.86 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 12.36 84.69 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.452 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -79.37 -29.02 41.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 48.1 tt0 -147.07 143.86 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -175.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.6 p -72.07 163.79 27.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -175.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 67.3 t -71.27 -45.77 68.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.14 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.58 -40.8 93.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.07 -46.14 58.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -65.38 -45.01 85.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.043 -176.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.71 -34.47 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.32 -39.71 94.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.94 -31.57 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.824 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -71.82 -46.99 56.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.24 -31.32 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 94.6 m -63.74 -40.17 96.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -70.0 -38.41 75.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.89 -41.27 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -96.04 16.13 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.958 -178.907 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.789 0.328 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.2 mt -86.91 133.79 29.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.258 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.97 160.21 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.02 119.47 19.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.03 24.39 32.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.469 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -150.59 154.99 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 110.824 -170.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -151.14 146.78 26.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.2 t -129.61 124.22 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.97 140.93 45.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.435 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 56.0 m95 -115.0 123.2 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.0 tt -151.85 139.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 -167.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -49.59 115.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -166.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.95 61.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.485 -171.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -55.43 -50.67 69.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -135.45 83.33 2.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 147.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.01 -34.91 1.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.505 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.39 -46.81 15.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.871 -159.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -67.62 -55.28 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -155.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -66.72 -46.98 70.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.416 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.3 -38.55 80.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.841 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.98 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.14 -38.3 90.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.57 -43.52 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.103 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.43 -36.79 92.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.448 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.28 -45.51 84.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.918 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.3 -45.2 94.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -68.87 -34.98 76.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.837 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -63.69 -35.16 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -68.89 -32.37 71.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.797 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -86.57 -39.38 16.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.1 p -108.34 -22.87 12.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.195 -170.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.57 7.33 84.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.532 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.8 tt -72.07 125.36 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 111.064 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.96 125.7 27.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.7 140.11 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.164 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -134.85 115.64 13.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.7 t -104.82 130.81 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -124.94 157.77 35.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.95 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -85.02 122.86 74.15 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.459 0.647 . . . . 0.0 110.931 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HA ' HD13 ' A' ' 43' ' ' LEU . 71.3 Cg_endo -84.45 80.1 2.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.241 . . . . 0.0 112.239 -171.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -110.79 -15.41 13.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 166.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.8 -21.34 29.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 40' ' ' PRO . 4.6 mp -53.33 -45.65 69.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -157.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.27 -42.18 29.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.46 -32.28 37.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.896 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.18 -26.36 56.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 6.0 m-85 -52.56 -55.32 33.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.891 -164.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 51.3 Cg_endo -69.16 -29.77 26.18 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.71 2.273 . . . . 0.0 112.384 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -76.6 -50.53 13.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.744 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 27.0 m -61.27 -35.32 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.45 85.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.74 -26.41 66.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -92.17 2.85 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 7.5 65.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.414 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -172.75 97.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.924 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.744 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.07 -132.88 3.98 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 157.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 45.2 Cg_endo -71.81 154.61 58.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.582 2.188 . . . . 0.0 112.367 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.51 -37.95 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -137.31 137.0 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.127 -172.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.9 mm -119.4 134.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -76.97 134.9 38.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.466 ' CB ' ' H ' ' A' ' 263' ' ' SER . 31.3 t90 -60.36 144.26 51.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.08 -98.09 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -127.17 -89.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.932 158.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.4 -23.02 37.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -59.59 -30.98 69.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -161.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.415 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 58.6 t80 -58.23 -33.99 69.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -174.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.49 97.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.448 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.28 76.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.512 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.1 m-30 -63.95 -37.05 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.946 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.75 97.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.01 -28.16 68.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.6 m -81.43 -0.22 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.9 73.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.88 -6.79 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.998 -177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.99 146.15 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.8 163.23 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.48 128.52 36.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -112.87 148.17 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 124.53 37.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.515 0.674 . . . . 0.0 111.139 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.59 142.7 44.92 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.691 2.26 . . . . 0.0 112.305 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -106.13 121.68 44.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.953 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -39.27 68.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.08 87.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -68.35 -35.0 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.421 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.2 mt-30 -60.59 -47.98 83.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.28 -37.88 84.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.932 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.33 -24.27 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.6 mt -109.41 -149.78 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.84 150.23 75.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.923 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.72 -33.55 76.39 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.343 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.947 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.7 p -70.13 -27.07 64.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.097 -172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.421 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 50.5 m95 -69.25 -39.95 78.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.77 -35.13 73.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -70.25 -30.93 68.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.413 HG21 ' HD3' ' A' ' 107' ' ' PRO . 35.3 m -105.27 14.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 -172.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -115.63 143.59 45.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -139.25 127.56 22.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.91 35.06 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.871 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.81 3.47 89.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.59 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.97 149.89 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.794 0.33 . . . . 0.0 110.957 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 tp -84.08 124.18 30.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.35 -8.8 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.421 ' HB1' ' H ' ' A' ' 264' ' ' ALA . . . -161.74 167.9 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 77.4 m-85 -114.88 135.38 22.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.75 . . . . 0.0 111.008 167.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 32.2 Cg_exo -59.86 117.35 4.09 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.9 mt -102.94 -29.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -163.15 153.32 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -172.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.05 127.22 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.161 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -118.94 132.22 56.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.06 151.11 27.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 95.4 mt -71.76 145.93 48.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -173.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -142.23 160.96 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.6 tp -90.49 121.4 32.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.977 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 244' ' ' VAL . 66.2 mt -110.0 123.97 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.124 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -133.93 155.28 50.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -91.93 116.34 28.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.835 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.03 -27.18 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.94 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.3 -35.36 41.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.8 -46.1 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.34 110.09 21.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.613 0.721 . . . . 0.0 110.894 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.83 -15.22 16.96 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 0.0 112.372 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -149.39 108.86 3.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.617 0.723 . . . . 0.0 110.847 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.47 157.43 61.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.66 145.1 56.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.353 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.17 -24.96 19.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -173.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -149.4 163.85 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -69.85 -28.26 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.3 -28.71 69.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.987 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -77.32 -20.48 54.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.884 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 24.7 mm -57.73 -53.36 66.52 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 -171.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 35.4 Cg_endo -68.23 -43.06 4.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.82 92.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.66 -36.47 82.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.941 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.58 -41.28 96.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.55 -40.04 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.26 -45.35 76.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 139' ' ' LEU . 3.4 pp -85.46 -20.07 30.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.32 -26.47 65.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.95 -19.51 65.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.38 9.47 33.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.881 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.31 28.36 64.08 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -106.57 158.72 16.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 110.826 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.4 t -110.68 146.95 35.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.772 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.09 -35.29 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.8 tp -132.21 145.05 51.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -109.16 128.71 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -170.32 163.92 8.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -129.11 -7.44 4.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.7 mt 54.33 32.5 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.22 -10.23 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -141.12 149.85 56.86 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.721 0.772 . . . . 0.0 110.87 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.74 -16.73 51.14 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -54.98 -41.61 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -70.5 -33.67 71.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.3 p -83.13 -22.62 33.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 7.6 m0 -58.76 -48.97 95.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.618 0.723 . . . . 0.0 111.002 -168.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 99.8 Cg_exo -49.31 -38.85 43.15 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.694 2.263 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.56 -35.41 73.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.482 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.1 mt -78.93 -39.09 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.91 -17.08 63.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.19 87.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.428 ' O ' ' HA3' ' A' ' 187' ' ' GLY . 98.9 m-20 -106.58 -0.38 23.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.35 36.01 2.01 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.661 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -120.75 146.38 17.54 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 166.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -155.26 156.18 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.812 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -43.7 -50.4 7.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -89.42 126.47 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.61 115.21 23.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.0 0.429 . . . . 0.0 110.879 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.43 143.49 29.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.873 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 48.09 44.03 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.936 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.51 5.77 60.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.69 148.87 51.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -93.39 126.24 38.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 171.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.84 112.93 24.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.6 tp -74.99 -23.19 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.02 -12.47 33.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -128.18 95.3 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.0 p -103.07 147.11 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.3 31.66 8.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.532 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.9 m -93.76 -19.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 172.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -103.3 24.06 11.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -87.76 160.61 17.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.09 89.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 164' ' ' ASP . . . -66.51 -41.58 94.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.509 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.661 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -61.29 -40.11 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.44 -38.63 90.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.19 -44.45 88.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.126 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.34 -41.57 96.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.388 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.33 -41.01 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 70.5 m -60.15 -40.17 88.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.069 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.34 -42.64 96.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.27 -45.1 92.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.905 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.06 -40.16 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.12 -36.1 82.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.8 OUTLIER -63.97 -38.25 90.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -38.21 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.071 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.24 -39.09 91.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -83.48 3.06 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 64.42 38.51 7.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.89 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -75.01 -10.32 59.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 tpt -143.49 152.33 41.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.509 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 65.7 t30 -86.16 142.74 28.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.61 74.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.055 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -96.73 -14.4 22.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 64.3 m -66.67 134.83 53.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -110.8 171.38 7.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.835 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -64.79 -35.79 82.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.6 p -70.85 -38.42 73.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.02 -42.61 95.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.092 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.67 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.43 -39.44 77.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.45 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.03 97.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.45 -39.33 93.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -61.55 -27.15 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.83 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.41 -9.35 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.3 16.46 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -82.67 -22.7 34.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.907 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.4 m -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.87 -38.06 73.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -171.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 69.6 mtm -135.16 154.91 51.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.6 t -152.99 165.68 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.44 124.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.09 164.63 38.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.62 12.2 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.84 -16.49 33.0 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.704 2.269 . . . . 0.0 112.328 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -75.04 -25.26 58.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 56.17 21.98 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.506 ' O ' ' C ' ' A' ' 233' ' ' SER . 44.9 m0 -76.63 -48.54 18.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.506 ' C ' ' O ' ' A' ' 232' ' ' TRP . 51.1 p 32.32 -96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.034 0.445 . . . . 0.0 110.867 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.1 t30 -143.65 36.29 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.7 tt -159.99 158.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -104.2 138.31 40.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 53.0 m -8.92 82.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 85.8 p -70.29 169.31 14.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -153.65 13.76 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 47.4 t -88.78 77.84 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 53.37 36.91 24.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -102.19 151.09 22.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 169.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.78 159.82 24.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 116' ' ' ILE . 58.1 t -128.44 130.75 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.0 0.429 . . . . 0.0 111.157 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -142.11 178.21 7.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 160.09 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.055 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.16 155.99 76.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.698 . . . . 0.0 110.932 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -56.44 140.45 89.01 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.763 2.308 . . . . 0.0 112.355 -173.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.5 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 86.6 m -123.74 130.86 53.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.121 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -103.37 112.24 25.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 46.74 41.13 9.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 168.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.87 26.2 65.29 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.443 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 96.3 mm-40 -113.56 159.07 36.85 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.639 0.733 . . . . 0.0 110.915 -169.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 71.8 Cg_endo -68.95 68.76 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.662 2.241 . . . . 0.0 112.376 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 79.6 p -92.02 24.71 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.417 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 63.3 mttp -114.88 158.91 39.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 110.87 -163.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.426 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 43.7 Cg_endo -73.57 171.79 17.05 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 0.0 112.247 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -62.0 161.76 10.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.56 127.7 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.141 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.71 143.54 15.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.454 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.3 t -123.76 126.01 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.085 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.5 tt -67.7 126.48 29.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.466 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 24.9 m -129.38 148.07 51.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -166.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.421 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -142.98 137.93 29.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.09 159.35 18.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.556 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.42 123.55 66.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -56.15 126.15 24.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.98 -27.5 65.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.73 -9.37 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.7 t -67.61 129.47 93.46 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 0.0 110.906 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.89 -14.03 42.2 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.792 2.328 . . . . 0.0 112.295 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -115.36 27.02 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.851 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -54.06 -30.96 50.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -72.97 -37.87 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.413 HD13 HD12 ' A' ' 33' ' ' ILE . 39.5 mt -65.42 -45.39 84.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.61 91.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -67.41 -46.75 72.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.05 -49.32 76.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 -171.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -68.2 -34.64 76.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -174.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.4 tt -57.08 -51.49 69.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.89 -38.88 73.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -102.49 -23.07 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.691 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 48.5 m-85 -118.73 -45.97 2.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 -172.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 36.0 tp -73.29 -43.97 60.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 54.9 tp -121.1 73.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 33.1 p -141.53 172.24 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -52.6 -46.71 67.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.811 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.95 -40.18 32.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.806 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.691 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.7 -45.79 20.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.568 -171.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 26.2 tp -64.86 -32.98 74.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.832 0.349 . . . . 0.0 110.94 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.42 -43.48 98.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.25 99.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.05 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.505 HG23 ' HA3' ' A' ' 19' ' ' GLY . 14.5 p -80.39 -33.27 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.502 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 39.7 t30 -72.91 -21.3 60.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -55.92 -22.97 28.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.85 -20.61 24.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -99.68 156.12 35.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -59.81 -62.42 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.346 -171.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.31 -48.0 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.502 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 101.68 -43.79 1.65 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.463 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.47 71.69 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 111.116 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.53 153.24 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.125 -155.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.6 -18.62 58.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.8 tp -79.13 114.18 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.74 -45.62 93.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -166.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.1 m -67.23 -48.45 67.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.53 -38.99 82.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -36.53 71.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.861 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.26 -47.61 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.88 -15.39 60.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.51 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.24 -9.6 58.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -87.75 125.23 65.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.541 0.686 . . . . 0.0 110.846 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -47.27 -28.73 8.45 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 0.0 112.321 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.414 ' HG2' HG21 ' A' ' 244' ' ' VAL . 88.8 mtm180 -63.93 -37.3 86.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 40.7 mm -88.69 -42.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.146 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.9 -37.56 76.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.79 -37.6 79.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 92.8 m -67.21 -39.65 86.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -65.15 -44.41 88.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -65.84 -46.32 78.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.905 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 327' ' ' GLY . 4.3 p-10 -79.49 -15.72 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.839 -174.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.42 82.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -71.3 -17.14 62.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -112.63 -9.76 13.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -81.37 -165.46 34.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -129.19 147.19 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 96' ' ' ALA . 6.0 tp -64.22 128.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -172.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 64.7 ttp -55.06 136.08 67.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.543 0.687 . . . . 0.0 110.908 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.48 80.52 1.37 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -103.02 4.91 37.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.434 HG22 ' H ' ' A' ' 335' ' ' GLN . 50.8 mm -81.37 137.58 48.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.628 0.728 . . . . 0.0 111.127 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.41 -35.5 21.52 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.434 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.0 mm-40 -82.04 -30.97 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.946 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 60.9 mtt -67.43 -18.58 65.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 84.4 p -60.65 -25.66 66.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.836 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.27 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -66.91 -38.86 87.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.81 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -62.98 -54.05 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -59.63 -45.69 91.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.21 83.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -173.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.35 -30.3 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -59.84 -46.55 88.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.9 m -64.65 -44.44 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.625 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -62.73 -43.78 97.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.51 -49.26 61.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.49 -43.6 97.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 82.2 m-20 -61.31 -35.81 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.81 70.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.34 -34.87 70.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.172 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.4 p -80.95 -8.35 59.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.79 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.41 11.75 85.2 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -80.51 -24.33 39.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.661 0.267 . . . . 0.0 110.788 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 59.3 tt0 -148.39 146.84 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.009 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 56.8 p -73.58 165.19 25.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.04 -45.85 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.063 -171.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.27 -41.33 98.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -72.72 -42.43 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.934 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.625 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -63.0 -43.69 98.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.1 -33.77 74.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.69 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.928 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.95 -30.98 71.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -69.45 -45.2 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -65.12 -38.3 90.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 80.5 m -59.82 -41.68 91.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.97 -40.65 78.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.9 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 53.2 p -103.4 33.78 3.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.202 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -175.991 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.9 mt -87.44 136.67 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.1 mt-10 -129.71 162.61 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.78 122.57 24.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.99 22.87 34.31 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 92.6 mttt -145.45 165.67 27.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.93 144.82 25.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.98 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.29 122.82 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.128 -173.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.87 140.09 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 58.8 m95 -118.41 123.71 45.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 21.2 tt -148.79 139.92 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.2 -169.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -47.49 119.03 2.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -164.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.81 -24.26 64.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.496 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -53.7 -57.0 12.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.953 -170.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -139.6 89.91 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 148.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.73 -29.13 1.92 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -80.45 -47.98 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.949 -154.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.94 -51.73 55.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -154.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.74 -45.95 71.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.483 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.2 tp -58.62 -40.26 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.75 -42.17 98.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.054 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.34 -41.61 98.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.04 -48.02 80.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.06 -35.97 92.23 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -67.02 -42.72 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.792 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -58.81 -42.71 89.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.958 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.492 ' CE2' HG21 ' A' ' 33' ' ' ILE . 19.7 t80 -66.81 -35.3 79.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.86 -35.93 82.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -72.25 -33.99 67.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.51 -42.16 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.3 p -107.77 -15.45 14.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.195 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.05 4.33 89.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.504 -175.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.2 tt -73.41 116.42 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 111.15 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.28 123.99 21.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.49 145.48 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -140.62 116.96 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.35 129.97 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -125.17 161.45 26.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -94.6 121.9 62.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.546 0.688 . . . . 0.0 110.809 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' CB ' HD22 ' A' ' 43' ' ' LEU . 72.0 Cg_endo -86.67 81.21 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.634 2.223 . . . . 0.0 112.318 -167.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -91.98 -26.3 18.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -92.36 -17.37 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.412 HD22 ' CB ' ' A' ' 40' ' ' PRO . 1.9 mp -54.03 -43.75 70.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -157.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -49.28 -40.98 36.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.66 -33.93 35.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -71.33 -25.67 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.484 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.9 m-30 -49.55 -55.83 20.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.797 0.808 . . . . 0.0 110.968 -163.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 58.2 Cg_endo -71.4 -29.26 16.98 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -177.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -76.72 -50.58 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.694 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 35.4 m -59.5 -34.01 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 -175.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.71 84.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.073 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -25.76 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.8 p -93.3 3.11 56.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.85 3.77 60.5 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -172.5 95.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.872 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.694 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -123.26 -132.42 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 154.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 50.6 Cg_endo -73.8 155.0 48.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.617 2.211 . . . . 0.0 112.343 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -84.6 -39.61 18.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -135.1 134.78 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.5 mm -119.1 135.28 60.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.16 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' A' ' 11' ' ' ILE . 17.7 p90 -74.13 158.67 33.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CB ' ' H ' ' A' ' 263' ' ' SER . 49.0 t90 -88.13 147.8 24.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.46 -95.46 0.45 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.05 -85.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 156.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -86.38 -13.18 47.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -58.52 -25.94 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 -154.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -60.0 -32.13 70.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -176.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.782 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -60.74 -44.75 97.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.47 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.7 93.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.8 m-30 -61.79 -42.48 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.68 -43.82 97.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -64.97 -30.1 71.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -84.68 -1.0 55.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.843 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.34 29.02 74.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.44 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 66.0 mt -74.63 -17.38 60.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -135.02 145.78 48.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -166.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.64 158.29 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.112 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.42 131.05 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.38 147.82 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.244 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -101.55 123.22 45.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.536 0.684 . . . . 0.0 111.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 147.49 30.83 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.749 2.299 . . . . 0.0 112.365 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -108.38 119.05 38.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -39.61 75.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.45 -42.97 83.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -69.57 -34.05 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.466 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.5 mt-30 -60.73 -44.74 96.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.0 -41.04 91.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.53 -24.8 59.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 304' ' ' LEU . 83.6 mt -108.23 -145.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -137.29 140.18 30.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 0.0 110.866 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.18 -35.43 63.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.83 -37.74 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.882 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.6 p -74.09 -25.13 59.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.164 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.466 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 49.3 m95 -74.08 -38.39 63.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.31 -34.14 74.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.968 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.93 67.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 27.4 m -112.62 19.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.136 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 58.9 mtm180 -116.37 140.13 49.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.774 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' HB3' HG21 ' A' ' 104' ' ' ILE . 85.2 t80 -139.64 127.92 22.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -175.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 56.12 32.77 20.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -174.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.75 3.24 90.66 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.415 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -115.57 150.03 37.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.927 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 64.5 tp -85.01 120.74 26.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' A' ' 99' ' ' TYR . 36.9 pt -115.19 -13.88 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -167.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -156.63 161.46 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.486 ' HB3' HD11 ' A' ' 285' ' ' LEU . 79.7 m-85 -103.22 134.66 19.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.701 0.762 . . . . 0.0 110.977 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.479 ' HD3' HG21 ' A' ' 97' ' ' VAL . 62.9 Cg_endo -81.65 118.99 3.24 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.236 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.31 -31.13 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 -171.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.51 153.69 19.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.146 -163.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.43 124.46 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -111.28 113.87 26.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.79 146.36 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.69 147.17 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.1 m -142.25 159.71 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -91.59 119.99 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.99 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 244' ' ' VAL . 31.0 mt -112.78 124.34 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -132.65 156.06 47.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -165.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -91.96 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.71 -24.46 66.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.902 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -75.75 -37.24 59.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.52 -51.12 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.98 105.74 44.62 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.591 0.71 . . . . 0.0 110.895 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.01 -14.89 26.25 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.438 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.7 t-20 -155.92 104.08 2.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 0.0 110.837 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.6 Cg_endo -66.83 160.51 46.42 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.312 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 34.1 Cg_endo -68.46 144.27 60.69 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.722 2.282 . . . . 0.0 112.364 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.17 -17.26 31.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.985 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -148.52 166.03 29.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.136 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -69.16 -25.69 64.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.787 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.79 -30.3 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.873 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.54 -22.4 43.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.901 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.631 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 81.3 mt -63.39 -50.44 73.92 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.604 0.716 . . . . 0.0 111.12 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 36.4 Cg_endo -67.83 -40.28 9.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.686 2.257 . . . . 0.0 112.254 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.52 95.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.414 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 57.1 tp -60.66 -38.84 86.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 132' ' ' ILE . 10.3 t70 -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.62 -37.93 83.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.35 -45.47 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.819 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 139' ' ' LEU . 3.5 pp -85.08 -20.32 30.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.402 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -58.23 -27.04 63.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.924 170.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -17.92 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.98 9.25 34.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 29.31 63.58 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.476 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -112.3 158.58 19.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.3 t -114.74 151.04 34.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 164.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -78.02 -43.92 28.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.042 -173.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.81 144.43 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.952 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -109.95 131.32 55.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -166.74 159.12 13.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -122.32 -16.22 7.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.4 mt 50.68 36.72 14.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -99.29 -14.07 19.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -142.59 148.66 47.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.569 0.7 . . . . 0.0 110.95 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.55 -25.07 75.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -54.23 -42.79 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.418 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 70.4 m-85 -73.19 -30.33 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 -177.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -76.83 -25.1 52.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.519 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 24.1 m0 -56.48 -46.15 99.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.602 0.715 . . . . 0.0 110.917 -164.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.758 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 74.9 Cg_exo -47.62 -44.57 25.67 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.674 2.249 . . . . 0.0 112.377 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.3 mt -75.28 -34.35 61.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.96 -42.15 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.54 -18.53 56.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.14 80.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 -160.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -98.88 13.39 32.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.08 12.45 6.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.51 170.63 53.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.498 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -165.07 165.0 20.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.919 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.94 -73.54 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.88 148.8 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -66.12 125.41 25.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.871 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -114.86 114.33 25.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -151.35 144.9 24.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.863 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 47.71 44.25 17.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.889 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.0 7.85 71.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.65 146.95 50.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -90.5 130.6 36.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -87.17 107.52 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.9 tp -64.77 -19.92 26.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.44 -2.93 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.951 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -120.57 95.98 4.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.21 153.25 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.148 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . -105.03 28.59 14.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.04 -12.9 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.313 . . . . 0.0 111.066 176.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.418 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 53.8 p-10 -103.33 13.48 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.95 156.58 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -171.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.06 66.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.1 96.7 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -65.48 -34.88 79.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.155 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -63.94 -40.34 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.06 86.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.97 -44.03 95.09 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.428 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 357' ' ' VAL . 34.3 tp -68.23 -40.0 82.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.957 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.7 m -58.85 -40.81 85.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.219 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.66 -43.23 99.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.974 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.32 -42.48 91.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.71 -39.98 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.27 -35.59 79.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -37.34 86.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.13 -38.2 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.222 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.56 -38.22 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.869 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -82.24 1.82 34.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.78 34.95 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.92 -16.49 58.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.811 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 205' ' ' ASN . 19.0 tmm? -137.81 141.81 40.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.444 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 60.8 t30 -92.73 134.93 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 -167.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.35 -11.0 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 51.9 m -75.49 140.12 42.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -176.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -98.64 167.28 10.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -66.48 -36.61 83.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.7 p -71.96 -36.33 69.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.69 -43.69 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.185 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 216' ' ' ALA . . . -73.39 -32.55 64.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.69 -36.11 73.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.16 84.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -63.81 -40.21 96.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.59 -21.83 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.787 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.27 -9.94 19.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.848 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.72 16.97 59.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.44 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.547 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 95.8 mt-10 -84.63 -28.33 26.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.973 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.0 m -123.43 130.08 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.93 92.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 -166.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.9 mtm -137.81 155.26 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 72.4 p -141.8 167.38 22.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.8 mm -118.88 115.03 46.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.65 156.81 48.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.44 -170.05 46.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.516 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.51 -19.06 11.81 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -69.96 -30.96 68.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.97 14.9 9.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.659 ' O ' ' C ' ' A' ' 233' ' ' SER . 33.5 m0 -74.28 -50.25 19.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 172.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.659 ' C ' ' O ' ' A' ' 232' ' ' TRP . 89.4 p -4.64 -80.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.843 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -171.92 4.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.944 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.98 117.83 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.646 ' O ' ' C ' ' A' ' 237' ' ' THR . 40.6 t0 -130.58 150.61 51.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.646 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.1 m -6.68 75.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 236' ' ' ASP . 93.0 p -63.22 153.96 32.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 170.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.52 -16.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 52.3 t -88.89 75.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 44.44 44.39 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.41 148.76 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 164.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.56 165.93 26.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.47 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 116' ' ' ILE . 46.4 t -128.6 131.06 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 111.164 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -143.0 -177.59 5.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.09 158.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.209 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.532 HD22 ' HD3' ' A' ' 257' ' ' PRO . 13.3 tp -76.72 139.58 66.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.711 . . . . 0.0 110.98 -173.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.83 138.0 15.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.231 . . . . 0.0 112.419 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 96.9 m -138.82 137.39 36.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -168.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -106.02 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.798 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 45.34 42.93 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.36 52.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.442 165.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -114.83 158.36 40.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.688 0.756 . . . . 0.0 110.969 -169.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -64.93 74.75 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 61.3 m -92.46 3.34 55.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 62.8 mttp -107.07 157.1 36.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.61 0.719 . . . . 0.0 110.9 -157.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.758 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 34.5 Cg_endo -65.82 160.42 43.96 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.621 2.214 . . . . 0.0 112.297 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -75.14 166.45 23.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.35 131.07 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 -167.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.64 147.08 16.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.483 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.12 122.73 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.927 0.394 . . . . 0.0 111.105 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.29 128.79 37.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.473 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 27.8 m -130.22 152.3 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.814 -164.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -142.97 136.44 28.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.06 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.18 17.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.472 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.0 mm -110.1 125.63 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 0.0 111.084 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 54.9 t-20 -58.91 124.71 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.813 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.31 -29.29 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.052 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.28 -9.7 58.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.0 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -68.15 128.55 93.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.738 0.78 . . . . 0.0 110.913 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.31 -11.7 32.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -114.91 25.0 11.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.902 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.74 -32.67 53.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.89 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.11 -37.96 63.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.63 -45.42 90.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.023 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.63 -43.28 76.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.08 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -65.11 -51.25 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.61 -44.81 92.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -35.24 74.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.642 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.5 tt -55.62 -52.04 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.21 -27.28 47.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -96.34 -7.26 35.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 -169.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.751 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 32.4 m-85 -115.94 -57.6 2.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.64 -37.61 79.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -172.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 106' ' ' TYR . 49.8 mt -99.94 41.4 1.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.96 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 75.1 p -137.74 162.09 34.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.53 -48.54 77.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.45 -38.92 71.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.751 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -76.41 -46.32 12.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.547 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.0 tp -65.44 -36.37 83.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.49 -44.75 89.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.64 95.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -30.67 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.436 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 52.2 t30 -74.12 -12.15 60.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.39 -25.99 62.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -93.57 0.0 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -116.39 155.88 47.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.717 . . . . 0.0 110.923 169.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.52 -62.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.704 2.269 . . . . 0.0 112.412 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.0 mt -108.81 -43.97 4.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.436 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 97.97 -61.31 0.95 Allowed Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.533 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 54.97 85.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.082 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.75 156.94 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.22 -156.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.99 60.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 89' ' ' LEU . 47.7 tp -79.78 117.82 21.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.11 -44.26 95.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.881 -171.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 90.2 p -67.11 -52.81 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -171.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.53 -34.67 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.37 -40.11 95.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.38 -36.88 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.69 -47.83 29.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.413 HD12 HG21 ' A' ' 317' ' ' ILE . 3.9 pp -74.7 -16.59 60.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.12 -4.67 37.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.195 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.67 -10.22 59.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -87.18 131.22 45.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.536 0.684 . . . . 0.0 110.844 175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.26 -29.23 12.54 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.649 2.233 . . . . 0.0 112.336 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -66.35 -39.09 88.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 311' ' ' LEU . 36.0 mm -84.62 -42.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.91 67.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.118 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.49 -38.97 81.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.06 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.3 m -68.43 -40.81 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.214 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -64.33 -43.91 93.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.56 -45.28 79.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 256' ' ' LYS . 44.9 p30 -78.52 -18.76 54.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.894 -173.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.81 84.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -72.98 -17.4 61.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 -9.13 14.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.16 -161.34 34.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.472 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -125.7 129.27 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.312 . . . . 0.0 110.914 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 38.2 mm -67.51 123.61 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.207 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.82 123.62 85.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.485 0.66 . . . . 0.0 110.887 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.3 146.4 40.52 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 122.627 2.218 . . . . 0.0 112.366 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.782 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 55.5 p30 -99.99 13.64 33.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.441 HG12 ' H ' ' A' ' 335' ' ' GLN . 16.7 tt -75.18 138.94 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 111.091 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.62 -25.7 20.65 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.735 2.29 . . . . 0.0 112.372 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.441 ' H ' HG12 ' A' ' 333' ' ' ILE . 99.5 mm-40 -63.89 -14.54 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.991 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.1 mmm -62.86 -25.89 68.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -58.91 -40.12 83.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.779 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.28 69.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 368' ' ' ILE . 87.3 t80 -58.43 -43.67 88.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -59.87 -57.58 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -61.62 -33.69 74.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.88 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.19 84.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.2 t -69.84 -39.94 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.151 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -57.49 -49.63 75.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.817 -172.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.3 m -65.88 -43.89 86.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.39 98.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.093 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.4 t -68.94 -49.89 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.214 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 94.4 mt -61.59 -41.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.155 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 84.1 m-20 -61.86 -38.17 87.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.37 73.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.09 68.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.137 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.7 p -80.41 -7.96 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.844 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.48 11.93 84.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.446 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.98 -27.13 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.744 0.307 . . . . 0.0 110.793 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.6 tt0 -147.51 146.4 29.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.0 p -71.11 164.56 25.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.24 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.407 HG13 HD23 ' A' ' 192' ' ' LEU . 76.8 t -73.33 -45.6 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -170.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.44 -38.37 90.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.849 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -73.23 -37.75 66.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.93 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 184' ' ' ASP . 0.4 OUTLIER -64.68 -36.16 83.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.18 -40.43 97.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.888 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -69.97 -33.12 71.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.2 -48.38 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.153 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.92 -32.27 70.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 75.1 m -63.29 -41.99 99.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.99 -38.27 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.88 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 339' ' ' PHE . 86.5 mt -63.64 -43.51 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.219 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 44.3 p -102.5 35.61 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.638 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -86.47 133.77 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.9 mt-10 -123.87 158.96 30.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.29 122.35 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.79 22.62 49.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.497 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 96.4 mttt -140.54 156.04 46.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.37 137.92 50.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.5 t -123.89 113.72 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.55 137.84 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.089 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 59.8 m95 -113.66 123.28 49.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.654 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 18.1 tt -150.94 144.08 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 -168.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -48.54 119.72 3.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -170.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.5 -21.51 60.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.477 -172.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.51 -48.31 81.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.24 83.43 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 149.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.57 -46.23 1.56 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.532 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.05 -44.86 29.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.9 -157.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.09 -53.09 42.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -154.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -65.27 -48.53 68.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.446 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 11' ' ' ILE . 2.7 mp -61.84 -36.84 82.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.897 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.94 83.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.33 -41.39 96.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.44 -41.59 88.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.535 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.06 -48.74 80.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.41 -43.09 99.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.988 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.42 -36.21 80.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.91 -34.29 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.23 -34.0 77.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -88.4 -39.71 14.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.429 ' HB ' HG22 ' A' ' 33' ' ' ILE . 62.2 m -110.1 -24.46 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.191 -167.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.35 7.75 79.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.476 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.757 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -87.07 127.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 111.02 -177.343 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.94 137.34 39.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.57 140.03 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.187 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -128.52 111.84 13.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 11' ' ' ILE . 94.4 t -104.32 127.98 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -124.77 158.23 33.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -83.67 135.98 42.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.654 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 71.8 Cg_endo -90.0 68.31 1.9 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -166.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -101.04 -32.29 10.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.793 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.22 -16.06 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 40' ' ' PRO . 5.9 mp -50.94 -51.61 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -158.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.14 -35.6 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.7 mmtt -76.13 -30.06 58.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.812 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.516 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.0 m-30 -51.29 -56.12 23.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.646 0.736 . . . . 0.0 110.844 -167.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.4 Cg_endo -67.76 -29.84 34.95 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.733 2.289 . . . . 0.0 112.314 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -78.58 -49.96 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.429 HG21 ' HD2' ' A' ' 57' ' ' PRO . 32.1 m -66.93 -32.02 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.093 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.9 92.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.16 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -94.31 1.08 55.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.35 78.88 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.422 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -169.66 101.87 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 110.924 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' CA ' ' HB ' ' A' ' 50' ' ' VAL . . . -125.05 -130.74 3.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.471 161.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.429 ' HD2' HG21 ' A' ' 50' ' ' VAL . 49.2 Cg_endo -71.42 156.64 58.12 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 -175.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.07 -43.28 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -136.65 138.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.14 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.14 134.98 60.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.427 ' CE1' HD21 ' A' ' 262' ' ' LEU . 83.4 t80 -78.71 136.31 37.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -62.87 143.96 57.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.1 -100.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -127.33 -85.9 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 160.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -87.13 -21.76 25.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -57.63 -28.92 64.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -166.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -61.72 -33.65 74.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -65.01 -43.59 95.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.546 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.43 -32.98 85.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.512 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -66.72 -34.29 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.86 99.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.43 -27.49 67.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.7 m -83.2 -1.0 51.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.907 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.84 28.63 71.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.509 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.79 -7.69 59.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.982 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.0 pp -135.13 146.01 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.66 159.65 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.1 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.64 129.37 39.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -113.33 150.6 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.153 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -105.21 124.16 37.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.255 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.9 139.58 40.09 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.718 2.278 . . . . 0.0 112.282 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.74 121.72 38.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.82 -39.36 68.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.52 95.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.082 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -65.79 -34.68 78.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.32 -43.94 95.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.23 -41.87 93.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.74 -24.43 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.98 -177.59 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.16 150.24 37.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.942 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.3 -38.13 36.6 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.737 2.291 . . . . 0.0 112.322 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -76.79 -20.13 56.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 71.7 p -75.5 -26.0 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.111 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -69.99 -37.15 75.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.995 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.67 -33.95 74.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.23 65.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 30.6 m -105.63 11.36 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -111.4 140.33 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -138.01 125.14 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.19 34.8 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.45 1.71 88.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.435 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.22 147.99 44.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 tp -78.6 129.37 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.913 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.3 pt -118.16 -5.41 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.09 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -162.42 166.67 24.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.477 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.4 m-85 -112.44 136.84 21.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.713 0.768 . . . . 0.0 110.981 167.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 39.1 Cg_exo -61.76 117.17 3.98 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.246 174.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 96.6 mt -104.33 -38.43 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -156.74 155.33 31.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.195 -170.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.0 t -124.19 128.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.147 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -115.59 120.0 37.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.832 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.86 147.33 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.104 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.58 148.96 36.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.0 m -141.53 161.08 38.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.76 122.16 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.08 128.39 67.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.053 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -133.49 154.37 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -91.87 116.34 28.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.829 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.86 -26.99 68.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -174.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.17 -32.25 33.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.881 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.08 -48.5 8.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.6 tp -127.69 111.71 20.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.662 0.744 . . . . 0.0 110.967 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 -15.15 17.62 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.818 2.346 . . . . 0.0 112.335 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 45.5 t30 -149.68 107.13 3.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -173.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.2 Cg_endo -67.63 161.87 41.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.336 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HD3' HD13 ' A' ' 135' ' ' LEU . 44.8 Cg_endo -72.7 144.38 39.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.609 2.206 . . . . 0.0 112.477 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.98 -22.99 21.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 167.31 26.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -67.13 -29.93 69.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.07 -30.22 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.77 -22.76 45.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 80.9 mt -62.34 -51.37 74.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.669 0.747 . . . . 0.0 111.075 -167.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.28 -39.05 10.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.252 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.48 90.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.064 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 135' ' ' LEU . 4.7 tt -62.18 -37.02 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 140' ' ' LYS . 8.7 t70 -66.35 -42.76 87.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.98 -38.72 73.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.18 -49.67 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.0 pp -80.22 -18.43 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.945 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' N ' HD12 ' A' ' 139' ' ' LEU . 84.4 tttt -57.13 -30.42 64.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 171.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.88 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -103.59 7.92 37.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.5 29.86 61.11 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.486 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -106.48 164.48 12.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.1 t -116.05 149.09 39.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.8 165.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.5 -28.48 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.105 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 tp -137.86 143.35 40.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.4 ttm -120.46 128.94 53.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -166.32 163.19 17.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.758 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -130.14 -4.36 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.869 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.3 mt 53.07 34.31 16.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -92.11 -16.61 26.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -132.42 146.2 60.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.677 0.751 . . . . 0.0 110.866 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -59.97 -23.25 72.23 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -54.57 -32.51 58.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -71.81 -36.67 70.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 p -86.19 -23.74 26.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.482 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.6 m95 -56.09 -44.99 99.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.585 0.707 . . . . 0.0 110.936 -168.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 72.2 Cg_exo -46.42 -40.23 22.63 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.279 . . . . 0.0 112.31 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.4 -38.08 30.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 93.3 mt -69.87 -51.41 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -172.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.71 -15.7 60.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 -176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.38 -31.71 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.119 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -92.02 0.78 57.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 -172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.05 13.75 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.556 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.36 166.37 31.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.423 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -174.43 154.45 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.347 . . . . 0.0 110.936 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -41.6 -63.38 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 176' ' ' TYR . 20.6 p90 -142.09 155.61 45.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.29 123.65 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -119.74 117.18 27.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -147.58 142.36 26.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -172.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 51.9 40.43 28.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.28 76.55 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.522 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.09 146.87 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.337 . . . . 0.0 110.829 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.503 ' HB2' ' CD1' ' A' ' 169' ' ' PHE . 17.1 p90 -101.56 141.61 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.63 110.97 23.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.2 tp -71.42 -19.66 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.08 -5.23 57.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -125.25 95.03 4.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.857 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.0 m -101.09 158.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.89 16.64 39.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.451 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.8 m -100.01 -19.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -98.99 19.82 14.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.52 154.2 20.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -172.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.26 70.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.018 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.54 94.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.493 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.5 81.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 111.195 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.02 -38.55 88.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.56 97.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -61.88 -40.11 98.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.429 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 357' ' ' VAL . 38.8 tp -67.86 -38.13 82.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 83.1 m -60.45 -41.19 93.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.182 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -57.85 -45.48 86.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.4 -45.11 94.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.5 -41.51 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.24 -38.24 90.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.43 -38.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.132 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.0 -32.03 73.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -81.56 3.32 25.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.55 33.96 10.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.999 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -77.07 -18.96 57.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 tpt -143.83 150.09 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 66.2 t30 -87.49 141.8 28.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.3 -32.62 68.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -175.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -96.16 -16.2 21.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -171.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 70.9 m -67.26 135.62 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.033 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -102.22 169.92 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -65.0 -47.54 77.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.863 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.31 -43.62 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.108 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.38 -32.67 70.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -64.22 -40.59 96.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.034 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.072 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -63.81 -39.83 95.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.934 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -61.47 -25.88 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.784 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.22 -8.11 40.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.04 17.3 63.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.495 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -83.5 -21.75 32.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.5 m -123.15 131.02 53.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.18 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.37 -38.88 65.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 74.2 mtm -135.51 154.88 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.902 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 166.77 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.0 mm -119.17 125.33 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.169 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -147.47 155.56 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.79 -163.42 31.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.458 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.21 -14.88 18.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.755 2.303 . . . . 0.0 112.346 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -62.84 -30.55 71.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.983 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.79 20.06 12.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.666 ' O ' ' C ' ' A' ' 233' ' ' SER . 48.0 m0 -71.38 -41.1 70.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.666 ' C ' ' O ' ' A' ' 232' ' ' TRP . 52.8 p 2.92 -91.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -153.99 3.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.876 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 19.5 tt -164.92 155.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 -168.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 238' ' ' SER . 54.6 p30 -102.17 -173.86 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.56 ' C ' ' O ' ' A' ' 236' ' ' ASP . 48.2 m -9.96 82.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.204 163.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 236' ' ' ASP . 45.6 m -40.86 136.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 -31.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 240' ' ' VAL . 61.4 t -89.12 68.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -174.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 54.29 33.02 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 171.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 238' ' ' SER . 91.4 m-85 -105.56 152.66 22.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 167.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.09 158.86 24.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 316' ' ' ARG . 62.1 t -130.2 130.68 65.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.18 177.49 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.16 160.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.58 148.88 74.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.31 144.26 72.45 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.609 2.206 . . . . 0.0 112.417 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.1 p -129.18 150.03 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -125.77 111.19 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 48.34 37.95 9.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.96 26.08 56.51 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 167.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -109.6 156.78 39.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.551 0.691 . . . . 0.0 110.965 -169.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 75.2 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.438 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.3 p -92.24 -1.37 57.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -170.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -102.29 155.86 35.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.539 0.685 . . . . 0.0 110.945 -167.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.79 167.47 24.39 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -68.01 153.91 42.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.6 t -118.69 130.04 74.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.151 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -100.25 141.9 15.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.477 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.5 124.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -65.02 124.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.6 m -128.74 155.28 45.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.837 -168.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.417 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -138.19 134.97 35.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.04 141.95 15.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.2 mt -113.81 125.03 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.067 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -59.09 125.07 22.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.0 -27.32 65.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.06 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.89 -8.17 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.058 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -66.21 130.3 94.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.719 0.771 . . . . 0.0 110.883 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -65.73 -16.32 52.78 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.816 2.344 . . . . 0.0 112.275 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -110.92 21.11 16.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.881 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -51.8 -34.54 40.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.21 -36.5 58.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 33' ' ' ILE . 40.7 tp -61.06 -45.27 95.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.074 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -65.05 -45.76 84.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.76 -51.28 67.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.828 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.19 -35.29 76.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -172.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.632 HD23 ' O ' ' A' ' 280' ' ' LEU . 3.9 tt -55.91 -50.33 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.996 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.63 -35.68 65.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -102.74 -23.34 13.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.729 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 61.9 m-85 -122.16 -43.84 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 -171.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 30.8 tp -74.18 -42.31 60.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.918 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 51.0 tp -124.57 74.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 37.0 p -141.48 173.44 11.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.201 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.3 -45.15 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.14 -44.09 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.827 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.729 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.07 -45.89 18.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.443 -168.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 302' ' ' VAL . 45.6 tp -61.99 -34.49 76.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.34 . . . . 0.0 110.879 -176.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.88 -40.26 88.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.874 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.95 94.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.472 HG23 ' HA3' ' A' ' 19' ' ' GLY . 11.1 p -81.98 -35.81 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.236 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.35 -22.55 60.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.953 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -61.84 -13.4 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -171.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -83.46 0.16 47.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.799 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -111.58 153.32 44.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.868 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.59 -61.98 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.717 2.278 . . . . 0.0 112.368 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 84.2 mt -98.63 -36.1 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 111.44 -58.09 0.41 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.498 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 49.26 70.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.126 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.412 ' HB ' HD21 ' A' ' 290' ' ' LEU . 35.6 m -112.18 152.2 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -167.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.37 -13.4 59.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 55.3 tp -76.61 120.2 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.8 -47.03 86.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -64.96 -48.36 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -172.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -69.26 -36.68 77.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -65.64 -34.54 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.45 -39.38 94.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -69.77 -43.57 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.02 -24.13 65.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.27 -5.55 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 -173.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.49 -17.75 62.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -86.96 128.62 55.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.531 0.681 . . . . 0.0 110.915 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.32 -30.7 20.67 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.429 ' HG2' HG21 ' A' ' 244' ' ' VAL . 94.4 mtt-85 -69.91 -37.39 75.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 39.2 mm -79.14 -40.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.49 -41.94 83.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.8 m -64.8 -41.52 95.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.214 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.94 -42.81 94.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -66.39 -46.2 77.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.908 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 327' ' ' GLY . 25.8 p30 -78.21 -18.12 55.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.48 82.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.112 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.24 -25.45 59.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.78 -9.97 20.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.83 -155.95 31.47 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.457 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -122.75 129.4 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.2 mm -72.73 127.47 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.264 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.406 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 59.8 ttm -63.37 124.89 85.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 330' ' ' MET . 36.5 Cg_endo -64.21 135.12 45.39 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.745 2.297 . . . . 0.0 112.329 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.662 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.7 p30 -95.08 13.22 25.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 -172.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 335' ' ' GLN . 48.3 mm -75.12 130.36 80.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 111.203 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.98 -28.11 74.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.518 ' H ' HG22 ' A' ' 333' ' ' ILE . 92.2 mt-30 -64.95 -13.86 58.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.973 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.87 -21.49 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -58.57 -35.6 72.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.58 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -63.0 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.957 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -58.69 -52.01 67.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.922 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -64.32 -44.65 90.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.53 94.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.167 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 76.5 t -71.79 -42.39 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -57.52 -45.79 84.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.3 m -65.53 -44.64 86.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.065 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.456 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -63.76 -40.57 97.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.086 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.66 -48.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.5 -45.36 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.237 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 83.5 m-20 -63.54 -37.08 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.91 -45.52 67.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.16 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.21 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.7 p -81.9 -8.98 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.11 84.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -81.0 -25.68 37.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 110.823 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 41.7 tt0 -149.9 145.38 26.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.4 p -72.55 163.73 27.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.418 HG13 HD23 ' A' ' 192' ' ' LEU . 54.3 t -65.32 -45.93 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.116 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.08 -42.82 96.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.32 -46.23 61.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -62.08 -42.14 98.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.024 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.3 -39.97 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.906 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.06 -41.69 90.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.873 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.53 -44.02 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.33 -48.08 11.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.222 -168.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -70.95 -32.31 69.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 -170.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 59.0 m -60.61 -33.26 72.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.8 -27.97 67.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.78 -40.18 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.3 p -102.54 -16.7 16.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 178.259 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.27 128.99 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.02 166.28 21.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.77 123.91 25.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.946 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.01 29.46 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.453 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -141.07 154.78 46.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 110.929 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 33' ' ' ILE . 7.2 tt -139.07 130.36 26.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.796 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.24 124.79 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.6 mt -118.84 134.82 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.824 ' HB3' HD21 ' A' ' 43' ' ' LEU . 39.7 m0 -111.7 123.73 50.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.965 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.51 160.22 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.867 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.7 t-20 -55.85 120.14 6.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 167.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.54 -20.89 79.42 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.482 -171.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -57.74 -45.47 85.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.844 -167.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.3 mmtt -130.67 75.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 148.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.5 -46.3 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.504 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -75.82 -45.75 34.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.939 -154.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -63.98 -52.66 58.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -157.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -64.18 -43.91 96.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.532 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.5 -37.52 83.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.99 -44.57 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.47 -52.2 66.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.6 m -75.25 -34.01 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.88 -39.6 93.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.484 175.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -70.11 -42.97 71.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.72 -39.64 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.98 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.28 -35.09 75.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 171.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.63 -34.12 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.81 -33.6 72.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -83.96 -39.96 19.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.2 p -109.09 -16.98 13.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.142 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.67 5.39 86.66 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 7' ' ' LEU . 14.1 pt -88.07 125.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.195 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.84 129.64 39.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG21 ' HA3' ' A' ' 24' ' ' GLY . 14.4 p -100.78 139.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.081 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -140.95 121.41 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.19 128.67 61.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 88.3 tt0 -112.24 151.85 29.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -79.28 161.46 67.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.839 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.867 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 59.9 Cg_endo -102.97 24.05 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 -160.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -76.45 -43.62 39.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.99 -14.32 36.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.824 HD21 ' HB3' ' A' ' 10' ' ' TRP . 3.5 mp -52.03 -50.9 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 -161.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.9 -41.28 61.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.25 -35.56 61.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.863 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.25 -28.93 62.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.53 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m-30 -49.24 -54.91 24.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.593 0.711 . . . . 0.0 110.898 -162.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 86.8 Cg_endo -80.03 -31.11 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.211 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -74.65 -48.32 26.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -168.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.48 -30.76 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.52 -37.82 87.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.83 63.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 p -97.68 -1.11 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.101 -171.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.591 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 75.63 18.46 79.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.523 -176.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -109.73 -175.16 2.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.864 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.7 -165.9 12.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.505 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.617 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 89.5 Cg_endo -82.79 178.45 6.03 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -87.88 -38.72 15.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 164.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.9 mt -131.06 139.6 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.2 143.23 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.058 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -100.05 142.85 30.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.51 126.65 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.76 -90.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -110.75 -83.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -95.91 -17.44 21.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 80.3 mtp180 -59.72 -25.7 65.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.435 ' CD2' HD11 ' A' ' 104' ' ' ILE . 10.1 p90 -52.39 -37.43 56.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -49.06 9.86 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.495 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.6 86.17 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.48 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.568 ' HB3' HD21 ' A' ' 75' ' ' LEU . 25.4 m-85 -71.66 -30.4 65.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.942 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.93 69.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.63 -29.86 70.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -83.98 -1.74 55.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 110.934 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.35 25.02 66.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.4 pp -85.99 -5.41 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.825 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -131.41 146.09 52.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.944 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 147.62 24.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.21 142.88 50.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 103' ' ' LEU . 39.2 pt -101.99 145.97 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.6 p -132.25 70.26 80.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 111.08 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.37 144.35 45.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.381 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -86.61 -174.52 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.71 -37.48 84.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.46 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.14 -36.18 81.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.82 -37.76 87.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -54.42 -29.43 49.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.856 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 93.2 mttt -54.02 -36.83 63.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.254 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 160.22 123.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.503 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 13.7 m-85 -158.26 51.6 0.47 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.72 . . . . 0.0 110.862 167.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 55.7 Cg_endo -70.8 -71.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.642 2.228 . . . . 0.0 112.335 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.41 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 42.9 p90 -102.76 -19.06 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 168.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -69.14 -20.53 64.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.142 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 90' ' ' TYR . 17.6 t90 -58.86 -43.23 90.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.78 -27.2 68.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.565 ' HB1' ' HB ' ' A' ' 261' ' ' VAL . . . -74.5 -30.6 61.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.033 -169.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -116.43 14.99 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.479 ' HB3' HD23 ' A' ' 103' ' ' LEU . 52.4 ptt85 -118.25 147.15 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -135.43 125.39 25.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 t30 60.29 35.13 20.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.857 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 5.28 90.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.574 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 148.5 44.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 98' ' ' ARG . 83.9 mt -86.95 122.26 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.435 HD11 ' CD2' ' A' ' 67' ' ' PHE . 44.6 pt -122.79 -1.9 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.71 31.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -111.47 146.26 34.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.68 0.752 . . . . 0.0 110.902 174.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.59 122.46 6.94 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.712 2.275 . . . . 0.0 112.402 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.7 -37.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.079 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.42 152.09 10.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.5 128.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.122 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -122.55 126.37 47.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.53 155.97 38.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.447 HD12 ' HG2' ' A' ' 257' ' ' PRO . 94.7 mt -76.46 144.33 39.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.1 m -140.66 156.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.453 ' HB2' HD23 ' A' ' 247' ' ' LEU . 43.0 tp -94.47 127.65 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 244' ' ' VAL . 68.7 mt -113.98 130.5 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.169 172.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -136.76 155.83 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 36.4 t-20 -92.0 111.7 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.581 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.5 mttt -65.17 -28.29 69.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 31.7 t70 -76.04 -33.22 59.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.84 -44.96 13.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.4 tp -121.03 109.62 35.38 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.71 0.767 . . . . 0.0 110.954 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.5 -15.6 19.59 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.0 112.361 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -147.12 109.55 3.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 0.0 110.845 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.35 154.39 74.41 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.686 2.258 . . . . 0.0 112.356 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.24 140.71 37.78 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.64 -25.75 22.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.4 t -149.97 174.32 12.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.119 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -74.53 -24.44 58.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -169.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.73 -32.4 73.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.895 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.75 -23.18 58.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -172.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 88.7 mt -66.31 -51.78 41.52 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.63 0.728 . . . . 0.0 111.126 -168.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.56 -40.42 56.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.703 2.268 . . . . 0.0 112.303 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.2 -43.6 98.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.3 -38.36 80.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 9.8 t70 -64.59 -36.23 83.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.49 -37.05 85.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.95 -58.0 4.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -78.7 -11.76 59.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 86.6 tttt -56.46 -30.37 62.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 169.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.03 -21.03 66.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.9 6.64 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.24 28.06 64.83 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 7.0 mptt -119.72 156.52 30.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.887 0.375 . . . . 0.0 110.92 174.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -115.76 153.97 30.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -72.55 -49.34 33.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 52.8 tp -143.44 125.7 15.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.2 mmm -133.19 131.42 40.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 174.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.93 167.65 28.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 210' ' ' TYR . 60.1 t-20 -50.87 111.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 206' ' ' ALA . 8.0 tp -115.31 19.96 15.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -92.19 -2.46 56.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.04 145.8 53.43 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.612 0.72 . . . . 0.0 110.874 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.477 ' HB3' ' HB2' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -68.15 -27.66 35.19 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -58.79 -35.43 72.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.21 -26.63 22.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.828 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.8 p -87.57 -32.31 19.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.65 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 58.6 t90 -55.01 -52.3 72.24 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.516 0.674 . . . . 0.0 110.99 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.6 Cg_endo -54.98 -32.18 77.52 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.624 2.216 . . . . 0.0 112.402 -175.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.46 -35.19 73.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.424 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -72.42 -41.66 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.17 -18.89 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.164 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.97 2.63 53.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.13 11.87 6.06 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.597 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.17 165.19 53.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.45 ' HD2' ' HA3' ' A' ' 182' ' ' GLY . 98.1 m-85 -140.33 175.86 9.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.989 0.423 . . . . 0.0 110.882 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 339' ' ' PHE . . . -112.03 -33.68 6.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -148.35 134.76 19.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.825 -173.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 1.072 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -89.89 121.55 32.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -170.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -127.46 113.12 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.02 142.66 24.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.0 32.77 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.16 -2.8 64.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.3 152.99 49.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.731 0.301 . . . . 0.0 110.888 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 64.9 m-85 -83.15 122.74 28.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 63.0 t0 -128.77 118.67 23.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -175.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.793 ' HA ' ' HE3' ' A' ' 170' ' ' LYS . 8.5 tp -57.04 -20.8 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.21 -15.77 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -174.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -110.58 47.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.704 ' HA ' ' HB3' ' A' ' 170' ' ' LYS . 8.6 p -99.11 145.66 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.45 ' HA3' ' HD2' ' A' ' 167' ' ' TYR . . . -110.75 22.8 21.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.539 -171.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 m -92.09 -23.27 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 0.0 111.143 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -106.63 25.12 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -99.06 -171.95 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.41 80.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.001 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -43.21 93.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.75 88.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.06 -41.71 97.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.22 -41.11 86.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -68.14 -47.2 60.52 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.449 -175.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.05 -38.7 86.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 72.9 m -57.67 -43.36 84.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -66.04 -43.61 87.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.8 tt -55.96 -46.36 78.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.936 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.57 -39.37 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -60.1 -34.74 73.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.791 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.77 -33.86 76.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.95 -39.84 45.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.201 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.66 -38.59 87.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -86.94 2.11 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 61.69 31.41 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -83.85 -30.88 26.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.0 mtt -139.55 145.5 38.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.835 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.587 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -97.32 135.78 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.434 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -67.61 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -98.25 -12.7 21.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -166.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 53.1 m -59.03 127.36 31.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -95.5 171.3 8.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 70.5 t80 -57.8 -39.39 77.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -59.04 -43.69 91.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.91 -45.53 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.41 -41.11 80.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.822 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.36 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.29 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -64.74 -39.71 94.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.88 -24.0 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.76 -10.0 32.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.14 52.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.456 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -87.66 -21.07 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 110.898 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 91.0 m -127.17 133.25 50.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.185 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.16 -32.31 64.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -172.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 73.4 mtm -135.44 148.55 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -148.68 165.39 31.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 91.8 mt -130.99 127.9 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.406 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 46.2 p30 -152.7 167.25 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.946 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.84 -129.59 3.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -168.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.97 -18.64 18.65 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.734 2.29 . . . . 0.0 112.433 -165.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -55.02 -30.77 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.917 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.07 42.43 28.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.99 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.517 ' O ' ' C ' ' A' ' 233' ' ' SER . 67.5 m95 -56.64 -25.01 52.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.899 167.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 232' ' ' TRP . 28.1 p 30.64 64.13 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -68.48 -12.13 60.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 37.3 pt -90.24 -5.14 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.54 -48.52 10.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -61.33 -57.81 10.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 40.7 t -161.21 128.23 4.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.797 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.55 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.09 174.46 10.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.02 -66.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -163.98 94.75 0.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 27.7 m-85 -115.45 160.28 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.818 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.581 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -138.98 168.4 24.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.425 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.432 HG22 HG12 ' A' ' 116' ' ' ILE . 60.4 t -125.02 129.19 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.9 p -131.18 171.61 13.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.83 165.33 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.024 167.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.483 ' HB2' ' HE2' ' A' ' 256' ' ' LYS . 90.8 mt -77.55 145.23 71.15 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.617 0.722 . . . . 0.0 110.968 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 75.6 Cg_exo -55.63 148.87 51.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.659 2.239 . . . . 0.0 112.374 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -131.12 154.72 48.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -132.06 109.65 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 46.76 42.68 12.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 164.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.63 25.11 57.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -108.58 157.89 35.41 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.914 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.01 74.97 0.33 Allowed 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.727 2.285 . . . . 0.0 112.426 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 93.5 p -86.42 -7.66 58.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.8 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 247' ' ' LEU . 13.9 ptpt -135.38 155.37 78.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.546 0.688 . . . . 0.0 110.869 -168.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.466 ' HG3' ' HG3' ' A' ' 159' ' ' PRO . 53.6 Cg_exo -61.3 164.91 13.87 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -60.34 162.27 6.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.901 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 324' ' ' ALA . 98.1 t -116.23 129.86 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.148 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.67 11.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.565 ' HB ' ' HB1' ' A' ' 96' ' ' ALA . 86.8 t -122.16 125.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.112 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 54.0 tp -71.41 134.32 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.6 p -132.23 156.78 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.69 137.15 51.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.071 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.71 169.74 23.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.495 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.73 133.89 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.163 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -61.85 125.54 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.17 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.14 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.591 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -80.65 -13.86 58.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.9 t -72.49 130.49 85.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 0.0 110.903 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.91 -10.32 28.16 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.716 2.277 . . . . 0.0 112.388 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -107.01 33.87 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -169.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -53.06 -40.2 63.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.9 -36.95 75.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 48.0 tp -61.11 -48.26 82.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.021 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.46 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.094 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.55 -47.32 79.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.67 -42.38 82.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 37.0 t80 -60.82 -44.5 96.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 284' ' ' LEU . 31.8 tp -65.89 -51.13 61.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -76.25 -35.18 59.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -170.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -106.27 -16.45 14.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.843 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 87.2 m-85 -120.52 -50.96 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.924 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 280' ' ' LEU . 49.6 mt -71.22 -42.79 68.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.947 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.03 62.0 7.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.9 p -136.73 168.0 20.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -55.0 -45.44 75.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.95 -41.03 37.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.09 -47.43 13.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 -171.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 20.1 tp -69.54 -35.38 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.788 0.328 . . . . 0.0 110.951 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.04 -45.21 91.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.77 76.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.517 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 84.3 t -78.94 -47.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -73.84 -16.39 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.07 -23.28 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 92.6 m-20 -73.95 -19.62 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -85.69 152.2 56.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.563 0.697 . . . . 0.0 110.938 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 -22.49 52.88 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.753 2.302 . . . . 0.0 112.318 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.5 mt -101.89 -46.22 4.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.04 72.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.444 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -67.87 128.8 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 111.051 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 307' ' ' TYR . 19.8 m -117.76 151.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.02 60.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.0 tp -73.85 120.62 19.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.07 -48.36 82.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -171.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -59.13 -46.93 87.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 -170.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.457 ' HB3' HG21 ' A' ' 302' ' ' VAL . 2.2 t80 -73.93 -32.98 63.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.54 -35.65 76.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.11 -34.74 73.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -76.13 -39.69 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.833 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 302' ' ' VAL . 96.1 mt -68.96 -23.33 64.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 176.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.62 -9.36 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.057 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.72 -17.16 59.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.907 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -88.21 120.0 70.45 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.522 0.677 . . . . 0.0 110.932 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.77 -31.96 34.97 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.23 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.422 ' HG2' HG21 ' A' ' 244' ' ' VAL . 94.5 mtm-85 -69.34 -44.8 70.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.12 -39.93 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.15 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.82 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.078 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 75.0 m -66.68 -43.01 85.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.193 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.15 -36.33 81.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.67 -33.58 72.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 176.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -65.21 -34.78 79.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.869 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.437 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -60.82 -36.86 80.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.08 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.5 -23.37 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.01 -11.44 20.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.44 -159.89 34.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -124.18 127.98 48.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.6 ' O ' ' O ' ' A' ' 330' ' ' MET . 37.5 mm -79.95 119.13 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 -165.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.6 ' O ' ' O ' ' A' ' 329' ' ' ILE . 2.1 ppp? 37.14 171.43 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 0.0 110.899 -163.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 330' ' ' MET . 90.4 Cg_endo -69.95 -157.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 171.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -135.08 -46.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 37.9 pt -129.79 158.44 73.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.532 0.682 . . . . 0.0 111.234 167.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 33.1 Cg_endo -63.61 -21.62 70.31 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.424 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -14.89 59.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.515 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 37.1 mmt -64.94 -27.95 69.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -60.52 -39.02 86.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.66 67.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.109 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.7 t80 -55.81 -49.37 73.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -58.88 -44.12 91.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.012 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -59.03 -42.79 91.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.75 85.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.53 -40.81 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 154' ' ' PRO . 42.6 ttt180 -54.2 -52.64 60.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 74.8 p -66.41 -36.04 81.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.36 94.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.07 -49.43 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -64.6 -41.87 93.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.14 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -64.3 -38.49 91.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.37 71.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.053 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.84 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -80.36 -7.92 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.68 12.71 81.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.458 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.64 -28.56 51.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.63 0.252 . . . . 0.0 110.775 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -139.52 155.87 47.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 71.9 p -79.01 168.13 20.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.08 -47.69 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.62 -42.34 91.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -71.89 -37.92 70.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.06 94.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.075 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.99 -35.28 78.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.02 -42.36 94.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.29 -34.14 76.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.51 68.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.162 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -40.43 97.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 84.4 m -63.02 -41.88 99.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.044 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.92 -35.11 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.65 -41.51 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.228 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.5 p -94.09 -11.6 30.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -178.404 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.664 0.268 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.74 135.8 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.79 179.87 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.2 120.43 20.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.99 23.54 27.35 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.389 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -143.24 151.86 41.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 7' ' ' LEU . 1.7 pp -143.77 144.0 31.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.816 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.06 125.22 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.061 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mt -117.01 134.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.672 ' CZ3' ' HD3' ' A' ' 57' ' ' PRO . 27.6 m0 -114.87 128.13 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 17.6 tt -152.4 157.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.448 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.7 t-20 -56.65 120.35 7.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 166.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.713 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -77.36 -22.07 71.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.466 -168.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.39 -48.89 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 -164.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.6 mmtt -130.32 79.6 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 145.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.62 -38.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.49 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -74.59 -44.79 49.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -160.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -66.02 -51.67 56.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.912 -159.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -60.23 -44.49 97.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.576 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.29 -39.05 81.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 110.849 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.94 85.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.062 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.17 -49.56 73.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.44 -32.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.71 93.14 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.522 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -70.04 -43.07 72.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.3 -40.41 96.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.97 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.09 -39.79 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.861 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.99 -33.58 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -73.3 -35.55 66.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -82.05 -41.32 20.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -103.0 -22.25 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -172.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.21 4.99 87.8 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.55 120.55 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 111.195 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.85 120.44 11.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG13 HD11 ' A' ' 7' ' ' LEU . 78.8 t -96.9 135.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -136.31 116.65 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.73 126.4 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.169 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -110.46 162.04 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -64.87 163.34 29.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.535 0.683 . . . . 0.0 110.944 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.713 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 70.2 Cg_endo -99.03 -2.16 0.89 Allowed 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.706 2.271 . . . . 0.0 112.397 -161.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.66 -31.27 59.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -160.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.64 -10.59 24.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 61.3 mt -51.56 -55.74 17.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -158.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.3 -32.35 68.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -168.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.21 -34.69 61.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.54 -28.35 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.515 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 8.2 m-30 -48.75 -54.41 27.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.789 -163.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 83.8 Cg_endo -78.59 -29.23 3.79 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.877 2.384 . . . . 0.0 112.272 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.66 -49.42 18.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.0 -170.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -65.95 -30.71 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.07 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.89 -37.13 85.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 -26.25 63.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.013 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.5 p -97.96 -1.24 43.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.124 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.13 18.36 80.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -107.71 -174.95 2.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.92 -166.99 13.21 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.672 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 89.7 Cg_endo -82.89 173.5 10.18 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 7' ' ' LEU . 30.5 m-20 -85.9 -36.41 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 166.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -132.37 139.74 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 47' ' ' PHE . 7.2 mt -131.89 143.24 40.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -105.88 139.78 39.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.51 ' O ' HD12 ' A' ' 262' ' ' LEU . 23.9 m-90 -121.14 133.2 55.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 173.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -52.29 -90.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -171.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -110.97 -81.45 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.49 -23.71 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -159.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.79 -38.06 69.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -51.17 7.69 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.496 -168.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.13 91.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' HB3' HD21 ' A' ' 75' ' ' LEU . 27.9 m-85 -74.86 -31.25 61.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.56 68.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -61.35 -28.11 68.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.809 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -85.24 3.48 39.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 25.46 64.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.7 pp -87.41 -5.14 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 0.0 110.892 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 76' ' ' LEU . 4.2 pp -133.15 144.8 50.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.1 152.31 19.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.35 144.57 48.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.827 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -109.09 152.54 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -133.46 67.13 75.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.671 0.748 . . . . 0.0 111.139 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.66 143.05 41.18 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.617 2.211 . . . . 0.0 112.325 166.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -81.0 -176.58 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.79 -32.24 73.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.819 -173.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.97 64.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -67.23 -36.27 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.87 -43.99 94.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.21 -35.13 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 97.4 mttt -67.23 -31.33 71.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -171.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.235 ' O ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER 173.99 78.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 -177.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 38.0 m-85 -151.06 41.49 0.22 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 0.0 110.885 168.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 67.1 Cg_endo -72.48 -70.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.218 . . . . 0.0 112.27 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.493 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 99.1 m-85 -92.98 -28.04 16.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.564 HG21 ' HB1' ' A' ' 303' ' ' ALA . 66.7 p -71.94 -22.17 61.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -162.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -62.47 -42.86 99.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.96 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.42 -24.56 66.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.568 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -74.54 -31.91 62.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.08 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.37 16.08 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 -170.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -119.39 145.56 46.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -136.33 127.18 27.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 59.48 34.82 22.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.6 5.65 89.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.481 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.6 145.04 43.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.91 113.58 25.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.6 pt -124.21 -2.3 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.093 -161.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.96 157.25 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -170.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.1 m-85 -106.35 136.89 19.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.724 0.773 . . . . 0.0 110.911 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 24.4 Cg_exo -65.3 114.37 2.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.749 2.3 . . . . 0.0 112.372 174.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.42 -31.75 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.89 152.27 6.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.74 124.8 68.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.062 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -123.85 137.57 54.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.975 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.79 144.13 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.2 m -142.92 158.94 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB2' HD23 ' A' ' 247' ' ' LEU . 64.0 tp -92.31 120.08 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -173.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 244' ' ' VAL . 61.9 mt -108.52 126.32 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -136.13 157.49 46.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 -167.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 30.2 t-20 -94.0 112.24 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.484 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.6 mttt -63.89 -26.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.89 -33.66 30.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.86 -48.73 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 173.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -123.23 109.4 31.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.623 0.725 . . . . 0.0 110.941 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.34 -15.05 20.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.562 2.175 . . . . 0.0 112.387 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.5 t-20 -148.43 107.11 3.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.759 0.79 . . . . 0.0 110.841 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -66.06 152.34 81.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.669 2.246 . . . . 0.0 112.302 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.23 142.7 51.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.287 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -88.62 -17.08 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.9 t -147.66 166.29 27.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -68.13 -29.34 68.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.21 -27.86 69.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.21 -33.47 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.568 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 97.9 mt -67.66 -45.09 45.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 111.052 -159.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 80.3 Cg_exo -50.78 -49.56 16.47 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.22 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 135' ' ' LEU . 2.1 tt -54.23 -35.61 62.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 175.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 25.1 t70 -65.82 -34.82 79.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.29 -37.54 87.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 -172.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.64 -56.91 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -172.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 145' ' ' SER . 1.9 pt? -79.8 -11.87 59.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -173.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -53.53 -30.27 40.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.936 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.3 -19.8 65.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -104.71 12.58 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.829 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 24.84 73.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -117.77 156.22 28.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.857 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.456 ' O ' HD11 ' A' ' 139' ' ' LEU . 48.2 t -115.78 153.48 31.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -71.92 -53.29 13.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.8 tp -147.1 135.4 21.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mtp -124.04 134.58 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 169.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -149.24 165.34 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.807 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.448 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 55.3 t-20 -64.72 113.56 3.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -172.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.8 tm? -92.88 -23.91 18.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -77.77 -4.38 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.89 152.2 80.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.606 0.717 . . . . 0.0 110.889 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 61.7 Cg_endo -79.65 -20.71 9.1 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.616 2.21 . . . . 0.0 112.404 -174.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -57.28 -45.53 83.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 45.5 m-85 -81.32 -27.02 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.419 HG21 HD22 ' A' ' 151' ' ' LEU . 72.1 p -87.12 -30.06 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.049 -171.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 82.5 t90 -56.2 -47.72 98.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.474 0.654 . . . . 0.0 110.96 -172.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 99.1 Cg_exo -49.52 -39.31 45.56 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.614 2.209 . . . . 0.0 112.383 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 160' ' ' LEU . 4.9 tt -74.06 -38.86 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.957 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.5 mt -67.32 -37.94 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.41 -13.67 59.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.92 67.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 -167.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -94.55 5.93 50.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.98 15.2 3.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.538 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.65 153.38 38.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.512 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.519 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 98.7 m-85 -135.06 152.04 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.906 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.01 -38.04 7.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -143.67 140.29 29.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.812 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -98.55 125.61 43.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.92 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.05 110.06 19.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.007 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -151.17 140.77 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 48.97 37.33 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 4.47 64.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.477 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.48 153.49 49.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 -173.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.14 131.23 39.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.979 168.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -110.79 120.2 41.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.99 -20.38 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.49 -16.77 44.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -98.94 66.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.5 p -108.47 139.16 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.519 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -107.88 32.22 7.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -168.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.0 -35.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.995 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -102.88 29.13 5.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.72 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -99.09 -172.2 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.941 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.97 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.81 -44.89 94.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.515 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.03 86.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.861 0.362 . . . . 0.0 111.12 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.77 -40.23 91.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.809 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.49 89.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.45 -43.53 94.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.522 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.01 -38.4 88.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -58.93 -43.65 91.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -63.24 -42.37 99.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.58 -45.09 92.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.84 -40.24 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.38 -39.38 94.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.7 OUTLIER -63.57 -42.67 98.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.59 -38.73 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.16 -36.82 80.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -83.78 3.62 32.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 64.56 33.73 10.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -78.91 -24.69 43.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 28.3 ptm -147.7 160.59 42.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -94.13 134.08 36.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.94 67.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -89.44 -3.27 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.897 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.2 m -56.46 126.71 27.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -103.48 170.12 8.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -65.88 -32.71 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.009 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 92.2 p -69.74 -36.08 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.2 mm -65.14 -42.31 93.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.71 94.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.103 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -69.69 -38.77 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.05 85.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.023 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.2 -39.35 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -66.5 -40.91 89.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.27 -19.77 65.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.97 -10.51 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.98 65.84 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.471 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.09 -25.82 39.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 224' ' ' MET . 73.9 m -128.23 133.82 48.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.49 -27.04 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -169.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.419 ' H ' HG22 ' A' ' 222' ' ' THR . 74.8 mtm -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -152.13 165.85 33.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 125.04 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.139 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -127.21 136.63 52.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.438 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -105.03 -134.34 7.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.479 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.438 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.0 Cg_endo -70.82 -19.47 31.03 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.764 2.309 . . . . 0.0 112.299 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -58.17 -30.32 66.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 62.09 22.82 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.018 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.53 ' O ' ' C ' ' A' ' 233' ' ' SER . 39.3 m0 -61.13 -33.78 73.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 232' ' ' TRP . 67.5 p 31.34 67.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.896 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -81.15 35.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.908 -160.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 244' ' ' VAL . 38.3 pt -115.26 6.04 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 171.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.6 -54.27 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.5 m -60.44 -59.61 5.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -153.5 126.29 8.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.488 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.52 172.86 11.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 98.6 t -86.37 -71.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.61 76.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 44.9 m-85 -114.93 154.24 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.484 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -146.01 170.61 27.15 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.422 -174.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.456 HG22 HG12 ' A' ' 116' ' ' ILE . 60.7 t -123.49 134.88 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 0.0 111.157 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.7 176.86 8.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.193 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.8 162.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.109 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 115' ' ' LEU . 97.6 mt -81.38 151.3 68.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.886 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 153.47 70.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.74 2.293 . . . . 0.0 112.352 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 81.7 p -131.19 146.57 52.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -121.28 115.62 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 51.38 37.07 18.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.25 26.98 56.57 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.456 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.0 mm-40 -112.4 159.55 33.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.611 0.72 . . . . 0.0 110.907 -168.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 59.9 Cg_endo -63.39 75.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.722 2.281 . . . . 0.0 112.418 171.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' A' ' 249' ' ' THR . 49.5 m -94.28 6.64 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 -164.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.499 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 12.1 ptpt -135.12 158.6 74.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.869 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 29.4 Cg_endo -69.84 168.2 22.36 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.672 2.248 . . . . 0.0 112.298 -170.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -70.18 172.16 8.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.3 t -121.6 132.84 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.185 -175.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.14 142.99 15.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.502 ' HB ' ' HB1' ' A' ' 96' ' ' ALA . 96.3 t -127.43 127.99 69.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.816 0.341 . . . . 0.0 111.165 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 62' ' ' TRP . 51.5 tp -72.47 135.1 45.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -121.27 137.24 54.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.842 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.73 132.6 53.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.74 170.73 23.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.98 130.39 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 111.16 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -59.82 128.9 39.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.43 68.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . . . -80.67 -13.22 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.0 t -69.7 133.59 88.53 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.627 0.727 . . . . 0.0 110.856 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.33 -8.9 23.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.585 2.19 . . . . 0.0 112.35 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -106.82 30.53 6.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -52.17 -43.47 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.17 -41.62 63.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.807 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.04 -52.16 65.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.008 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -65.88 -50.25 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.9 -47.58 71.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -170.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -71.95 -33.26 68.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -176.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 284' ' ' LEU . 41.6 tp -57.11 -46.39 82.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -82.9 -28.86 29.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.967 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -101.42 -9.78 20.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -168.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 76.2 t80 -125.38 -59.66 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.407 ' HB2' HD12 ' A' ' 280' ' ' LEU . 68.6 mt -71.19 -44.5 65.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 20.4 tp -85.03 67.51 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.0 p -139.69 170.19 16.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.22 -45.26 79.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.835 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -75.89 -41.3 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.17 -45.9 9.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.558 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.2 tp -71.29 -35.66 71.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.981 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -56.58 -41.04 76.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.897 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.24 69.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.451 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 76.7 t -76.95 -45.1 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.052 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -73.05 -7.75 52.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -52.83 -21.95 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 89.2 m-20 -79.15 -24.2 43.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.806 -174.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -96.34 148.47 34.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.878 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.24 -25.62 26.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.637 2.225 . . . . 0.0 112.295 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.56 -48.41 3.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.019 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.4 22.24 78.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.527 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.8 110.34 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 0.0 111.072 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 307' ' ' TYR . 5.2 p -112.77 149.13 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -159.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 93' ' ' THR . . . -72.29 -18.84 61.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.21 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.457 ' H ' HG22 ' A' ' 302' ' ' VAL . 55.8 tp -79.38 124.36 28.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -45.4 90.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -174.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.2 t -62.44 -50.0 73.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.481 ' HB3' HG11 ' A' ' 302' ' ' VAL . 3.9 t80 -70.93 -36.87 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -65.58 -33.38 75.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -38.5 73.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.6 -38.69 58.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.829 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.13 -29.81 70.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.51 -8.27 45.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.53 -15.8 60.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -91.39 120.68 68.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.878 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.9 -29.03 19.8 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.766 2.31 . . . . 0.0 112.295 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -70.11 -44.72 68.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.41 -38.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.7 73.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 83.2 m -67.09 -41.86 85.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 tpt -66.82 -38.02 85.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.835 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -66.44 -35.31 79.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -65.36 -34.83 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.34 95.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -74.24 -23.28 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -104.67 -5.79 21.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.11 -161.64 37.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.432 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -127.2 127.18 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.846 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.568 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 38.3 mm -74.64 121.93 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.5 mmt 63.48 156.23 0.12 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.458 0.647 . . . . 0.0 111.033 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.905 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 56.5 Cg_endo -74.67 -107.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 165.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -138.94 -58.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 165.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.55 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 34.0 pt -139.12 169.25 12.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.602 0.715 . . . . 0.0 111.158 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.1 Cg_exo -53.09 -17.01 7.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.3 -6.15 2.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.905 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.5 ptm -56.6 -29.95 62.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.9 p -66.05 -30.1 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -80.58 -34.85 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 175.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -59.65 -54.79 42.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.551 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 68.6 m95 -60.76 -38.08 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -60.02 -46.7 88.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.35 80.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.047 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.1 t -74.5 -36.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.501 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 76.0 ttt180 -56.01 -47.17 78.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.8 p -66.62 -35.81 81.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -64.95 -44.0 90.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.182 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.96 -47.57 81.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.03 -44.34 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -65.21 -36.96 85.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.72 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.051 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.05 73.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.5 p -80.86 -7.78 59.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.04 82.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.555 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.13 -28.01 54.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.807 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -140.44 157.13 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.7 p -74.62 171.98 12.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.124 167.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.55 -34.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.61 -40.28 84.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.3 -44.73 71.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.817 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.17 93.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.5 mt -69.77 -35.5 74.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.87 -46.85 88.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -69.41 -31.1 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -70.01 -48.02 59.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.157 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.95 -38.73 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.4 m -62.53 -41.48 98.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.051 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.52 -39.12 70.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.802 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.3 mt -62.24 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.9 p -105.51 6.95 32.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.18 -172.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 -178.119 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.698 0.285 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.8 mt -80.1 129.26 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.163 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -125.09 164.3 20.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -76.5 118.38 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.21 26.17 24.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.467 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.41 152.22 40.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.109 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -145.49 146.63 31.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -128.67 129.74 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.56 135.68 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.548 ' HB3' HD21 ' A' ' 43' ' ' LEU . 34.9 m0 -111.28 120.56 42.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 tt -153.16 159.21 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 -170.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.7 t-20 -60.0 119.85 8.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 168.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.776 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -76.22 -18.54 79.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.54 -173.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.27 -47.72 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.938 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.26 80.04 1.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 144.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -120.56 -48.69 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.443 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -70.0 -43.72 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.91 -164.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -66.14 -51.98 52.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 -160.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.1 -44.29 97.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.437 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 24' ' ' GLY . 64.3 mt -61.28 -37.94 84.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.37 85.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.028 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.22 -47.1 79.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.16 -33.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -67.49 -40.09 91.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.57 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -71.57 -40.01 70.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.906 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.4 -41.16 98.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -68.54 -38.58 80.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.79 -31.55 72.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.83 -37.35 67.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.3 -39.3 25.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.7 p -105.27 -18.2 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.14 90.09 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.49 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 33' ' ' ILE . 7.8 pt -97.14 132.8 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.062 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.95 131.01 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 7' ' ' LEU . 67.3 t -101.48 136.88 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 172.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -141.39 120.15 12.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.24 131.37 60.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -109.76 151.8 26.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.424 ' O ' HD13 ' A' ' 43' ' ' LEU . 32.4 p80 -74.28 167.02 39.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.548 0.69 . . . . 0.0 110.885 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.776 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 43.1 Cg_endo -104.03 12.01 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -161.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -89.53 -37.14 14.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.759 -166.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -90.82 -17.24 26.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.896 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -57.3 -43.94 83.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -161.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -50.03 -39.94 43.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.84 -33.92 64.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.0 -25.39 59.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.537 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 5.1 m-30 -49.97 -53.99 37.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.606 0.717 . . . . 0.0 110.936 -160.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 91.5 Cg_endo -79.98 -29.93 2.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.77 2.313 . . . . 0.0 112.32 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.48 -49.69 21.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -168.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.7 m -66.09 -28.95 45.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.066 -171.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.78 -37.61 85.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.8 -24.99 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -96.97 0.35 48.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.082 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 77.2 17.57 79.37 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -110.88 -174.72 2.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.823 0.344 . . . . 0.0 110.864 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.33 -167.49 12.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.574 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 87.9 Cg_endo -77.64 169.44 20.89 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.668 2.245 . . . . 0.0 112.344 175.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -85.09 -37.01 20.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.5 mt -129.35 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 47' ' ' PHE . 16.4 tt -137.14 135.34 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -172.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -99.96 145.09 28.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.947 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.681 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 26.7 m95 -126.82 127.05 44.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.31 -91.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.038 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -112.89 -78.7 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.46 -22.84 61.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -165.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.681 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 94.9 mtt-85 -55.44 -28.61 55.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -164.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.45 ' CG ' ' N ' ' A' ' 68' ' ' GLY . 16.7 p90 -49.39 -44.06 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.88 -174.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 67' ' ' PHE . . . -74.99 -58.7 3.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 -169.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.54 -41.34 95.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.504 -172.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.656 ' HB3' HD21 ' A' ' 75' ' ' LEU . 60.1 m-85 -75.08 -32.57 61.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.962 0.411 . . . . 0.0 110.892 -175.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.01 64.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -61.33 -27.05 68.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -83.07 2.36 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.24 24.85 63.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.1 pp -85.81 -4.54 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.868 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.848 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.4 pp -131.57 143.58 50.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.69 154.96 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -71.43 140.45 50.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.891 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 pt -104.14 148.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.5 p -131.8 67.14 79.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.604 0.716 . . . . 0.0 111.131 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.82 144.85 49.46 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.698 2.265 . . . . 0.0 112.467 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -84.57 -175.16 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.35 -31.93 69.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.35 84.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -60.43 -43.84 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -59.65 -41.36 90.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.936 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.4 -34.5 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.826 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 75.9 mmtt -68.13 -21.3 64.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.189 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.94 124.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.923 -177.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p90 -173.08 49.19 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.734 0.778 . . . . 0.0 110.907 162.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 61.4 Cg_endo -73.32 -72.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.645 2.23 . . . . 0.0 112.42 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.473 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 97.3 m-85 -94.87 -29.68 14.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 174.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -71.72 -22.47 61.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.054 -161.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -60.75 -44.33 96.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.11 -30.74 71.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.897 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.73 -32.97 71.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -103.13 14.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.23 -169.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -120.99 145.89 47.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -137.96 127.94 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.6 t30 58.22 32.91 22.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.848 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.11 89.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.13 150.01 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.4 mt -84.65 121.37 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -113.3 -15.14 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.49 163.88 24.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -166.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -105.18 146.81 33.43 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.684 0.754 . . . . 0.0 110.891 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HG2' HD21 ' A' ' 89' ' ' LEU . 98.0 Cg_endo -76.78 120.13 5.39 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.2 mm -99.8 -46.32 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.037 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.18 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -163.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.37 130.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -125.37 143.07 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.17 157.01 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.05 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.402 HD22 ' HG3' ' A' ' 257' ' ' PRO . 10.0 mp -75.17 146.98 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -143.58 160.38 40.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.479 ' HB2' HD23 ' A' ' 247' ' ' LEU . 60.6 tp -94.99 122.9 38.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.413 HG12 HG22 ' A' ' 244' ' ' VAL . 61.6 mt -111.74 126.65 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.096 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -136.59 158.02 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -89.82 111.61 22.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.649 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -65.41 -30.09 70.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.01 -35.95 61.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.02 -49.54 12.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 tp -122.41 108.58 33.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.659 0.742 . . . . 0.0 110.903 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.45 -15.19 17.77 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.704 2.269 . . . . 0.0 112.317 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.6 t-20 -147.55 106.81 3.78 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 49.8 Cg_endo -66.72 152.81 79.87 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.677 2.252 . . . . 0.0 112.288 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.44 144.07 60.05 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.65 2.234 . . . . 0.0 112.261 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.39 -22.03 32.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 t -150.15 170.98 17.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -172.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.74 -32.58 69.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.856 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -71.67 -22.27 61.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -170.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -74.5 -27.96 60.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.562 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 94.4 mt -66.32 -45.14 59.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 0.0 111.061 -164.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.562 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 99.1 Cg_exo -49.62 -48.24 19.85 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.645 2.23 . . . . 0.0 112.332 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.38 90.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.014 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 135' ' ' LEU . 2.6 tt -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 26.4 t70 -66.03 -35.05 79.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.902 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.13 -41.23 90.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.45 -54.06 13.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.916 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 140' ' ' LYS . 1.1 pt? -78.61 -12.54 60.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -173.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.1 tttt -54.55 -29.38 50.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 166.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.75 65.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.076 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.84 8.49 37.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.25 58.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.509 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -121.8 154.69 36.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.28 . . . . 0.0 110.974 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.7 t -110.93 154.98 23.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -70.31 -56.65 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.036 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.8 tp -144.35 129.05 18.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.958 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.7 mmm -130.25 132.53 45.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -150.97 174.55 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -67.39 109.71 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.995 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.99 0.12 40.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -85.62 0.26 53.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.48 145.72 57.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.555 0.693 . . . . 0.0 110.938 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.489 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 63.9 Cg_endo -79.66 -28.16 3.61 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.603 2.202 . . . . 0.0 112.393 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -53.87 -37.94 64.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -82.14 -36.79 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 -174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 74.3 p -88.36 -30.28 19.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.133 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.626 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 69.4 t90 -54.85 -48.28 96.11 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.535 0.683 . . . . 0.0 110.994 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 75.2 Cg_exo -48.41 -36.44 30.65 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 160' ' ' LEU . 3.7 tt -73.04 -38.63 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.981 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.566 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.2 mt -68.09 -38.06 79.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -80.5 -15.01 57.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -171.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.06 69.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.25 7.19 46.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.77 12.78 4.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.474 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -76.6 158.74 49.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.489 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.633 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 91.0 m-85 -136.82 152.08 49.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 110.887 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . . . -101.21 -36.16 9.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.076 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.414 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -150.1 130.02 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -175.435 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 55.5 tptt -92.83 120.76 33.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -173.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.406 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 55.5 t80 -112.47 112.38 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -176.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -150.53 142.74 24.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 51.2 40.67 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 6.32 78.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.492 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -127.94 146.26 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 41.7 m-85 -89.91 127.85 36.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.911 167.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -102.39 116.62 33.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 178' ' ' ILE . 7.5 tp -77.77 -19.96 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.139 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -85.9 -7.26 58.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -116.12 92.79 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.0 140.0 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -99.82 38.87 2.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -168.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.2 -14.53 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.111 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -104.97 18.78 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -106.7 -171.49 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.11 -38.93 75.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.6 90.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.78 87.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.47 -42.46 99.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.62 -44.64 89.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -67.2 -46.68 69.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.87 -38.1 85.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.916 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.8 m -56.96 -43.82 81.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -64.22 -46.01 85.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.13 -44.87 96.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.825 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.99 -40.71 89.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.54 -36.45 82.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.67 -43.97 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.76 -39.51 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.51 -32.39 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 173.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.99 2.48 38.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.97 32.66 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.949 173.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -78.93 -30.94 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.814 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 23.5 ptp -150.48 160.06 44.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.422 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.6 m-20 -100.64 138.63 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.23 -24.38 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -97.5 0.6 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 86.2 m -55.1 124.83 18.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.06 170.04 8.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 227' ' ' ASN . 52.5 t80 -62.79 -41.46 99.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -62.43 -37.63 86.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.764 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -70.06 -46.3 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.83 84.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.73 -41.36 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.52 86.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.089 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.144 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -64.52 -47.03 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.28 -25.78 65.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.77 -5.34 45.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 16.66 63.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -82.5 -26.98 32.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.825 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 224' ' ' MET . 88.0 m -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 177.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.85 -27.71 55.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 -169.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.412 ' H ' HG22 ' A' ' 222' ' ' THR . 74.8 mtm -135.19 151.98 51.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -152.08 165.23 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.191 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.24 133.24 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 37.6 p30 -152.91 160.93 43.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.33 -126.83 5.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.424 -171.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.52 -19.17 19.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.715 2.277 . . . . 0.0 112.356 -166.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -53.28 -39.83 64.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.28 31.17 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.499 ' O ' ' C ' ' A' ' 233' ' ' SER . 54.2 m0 -60.44 -36.1 77.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 232' ' ' TRP . 90.1 p 34.26 71.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 163.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -74.85 3.39 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.85 -7.9 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.089 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.18 -50.15 9.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 85.5 m -64.8 -59.52 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.3 t -156.23 121.65 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.784 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.65 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.28 176.02 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.884 -176.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.01 -70.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -161.37 90.0 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 239' ' ' LYS . 75.0 m-85 -114.3 162.39 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.649 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -147.17 170.18 28.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.5 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.413 HG22 HG12 ' A' ' 116' ' ' ILE . 59.2 t -123.74 131.37 73.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.942 0.401 . . . . 0.0 111.091 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -142.71 177.94 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.172 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.64 160.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 115' ' ' LEU . 89.0 mt -77.65 149.73 78.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.944 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.21 146.86 69.21 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.47 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 81.8 p -128.87 146.21 51.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -125.49 111.66 15.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 45.03 40.36 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.01 28.34 56.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 166.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.6 mm-40 -109.99 159.52 31.53 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.936 -170.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.0 Cg_endo -65.33 73.96 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 73.8 p -98.47 4.14 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -168.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 13.2 ptpt -139.84 158.37 67.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.552 0.691 . . . . 0.0 110.835 -173.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 33.4 Cg_endo -71.89 167.24 27.19 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.627 2.218 . . . . 0.0 112.389 -169.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.91 176.65 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.423 HG23 ' HA3' ' A' ' 327' ' ' GLY . 96.5 t -118.69 134.31 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 -171.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.02 146.37 16.07 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.433 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -128.48 128.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.266 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 60.4 tp -76.96 135.3 38.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.92 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 93.1 p -129.87 150.93 50.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.41 130.31 44.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.033 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.95 162.89 15.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 -170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.65 129.5 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -62.85 124.9 22.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.9 67.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.632 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -81.96 -13.85 56.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 20.2 t -72.28 132.67 83.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.86 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.07 -7.75 21.7 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 0.0 112.407 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.04 27.62 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -168.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -50.85 -47.74 60.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.39 -38.93 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.5 tp -56.81 -53.13 61.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.11 -42.58 75.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.117 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.39 -48.93 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.29 -47.72 72.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.957 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -70.63 -33.67 71.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -176.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 284' ' ' LEU . 36.3 tp -55.97 -47.96 76.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -83.07 -27.0 30.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.31 -10.91 19.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -169.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 86.8 t80 -124.98 -60.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.416 ' HB2' HD12 ' A' ' 280' ' ' LEU . 77.6 mt -70.29 -41.27 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.981 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.32 65.22 8.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.0 p -138.09 169.34 17.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -56.92 -42.08 79.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -77.0 -42.54 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.1 -47.89 8.04 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.546 -170.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.0 -35.06 79.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.932 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.52 -42.82 99.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.95 -30.21 71.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.126 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.36 -45.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.068 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.473 ' HB3' ' CA ' ' A' ' 300' ' ' GLY . 59.0 m-20 -74.73 -5.5 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -54.41 -18.97 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.79 -18.07 60.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.06 154.18 42.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.71 -41.81 10.23 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 299' ' ' LEU . 3.3 mm? -92.59 -44.35 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.907 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 294' ' ' ASN . . . 62.33 54.42 34.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.432 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.69 124.31 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.072 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.15 149.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.61 61.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.062 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.18 119.26 22.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 87.7 tttt -61.77 -44.46 96.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -166.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.0 t -58.83 -49.84 76.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -74.23 -31.49 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.445 ' HG3' ' HE1' ' A' ' 321' ' ' MET . 89.0 tt0 -56.83 -39.44 74.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.829 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.23 -32.42 73.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -48.05 23.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.536 HD11 ' HE1' ' A' ' 321' ' ' MET . 3.4 pp -73.55 -18.71 61.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.19 -7.93 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.9 -11.23 60.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.94 -173.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -86.43 122.01 72.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.98 -31.78 28.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.642 2.228 . . . . 0.0 112.373 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.65 -42.48 74.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 311' ' ' LEU . 3.0 tp -80.99 -29.86 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.069 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.4 86.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 65.9 m -67.38 -43.87 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.536 ' HE1' HD11 ' A' ' 311' ' ' LEU . 58.2 mtt -69.61 -34.82 74.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.799 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -66.26 -37.33 85.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -64.96 -34.04 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.042 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -70.31 -21.04 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.96 -5.96 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -96.11 -163.0 33.36 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.478 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -128.93 137.06 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 39.6 mm -78.3 115.67 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 26.3 mmt 61.72 155.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.91 -113.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 168.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -162.22 -52.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.89 164.35 31.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 111.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.41 -19.77 52.97 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.823 2.349 . . . . 0.0 112.318 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -58.87 -23.58 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.543 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 94.8 mmm -69.66 -24.83 63.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.73 -37.12 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.95 -30.76 64.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.155 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 336' ' ' MET . 21.8 t80 -57.63 -49.95 74.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.988 175.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.489 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.7 m95 -61.36 -44.16 97.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.68 -43.81 76.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.83 78.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.76 -44.92 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.191 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -57.34 -48.11 79.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.87 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 73.9 p -66.65 -32.95 74.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.2 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.92 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.76 -47.87 81.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 41.5 mm -64.73 -44.69 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.17 -38.13 89.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.67 -44.91 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.53 -33.9 69.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.5 p -79.51 -8.46 59.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.0 82.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.455 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.44 -29.52 57.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 0.0 110.837 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -140.01 157.86 44.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.1 p -78.12 172.97 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.91 -45.26 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.43 -38.92 74.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -71.68 -39.28 70.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -173.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.54 96.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 173.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.5 -35.09 78.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.64 -42.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.17 -31.41 70.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.75 -46.43 63.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.143 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -63.21 -38.31 90.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.2 m -59.48 -40.34 86.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.02 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.94 -36.81 62.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.85 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 339' ' ' PHE . 71.4 mt -63.02 -48.46 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.06 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.9 p -96.21 -0.72 49.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.9 tttt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.767 0.317 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.49 136.83 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.01 -178.98 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.992 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.14 119.62 19.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.04 25.27 27.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.435 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.93 152.94 41.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.7 pp -149.03 148.76 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 84.6 t -126.12 128.13 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mt -117.46 134.33 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.66 ' CH2' ' HD3' ' A' ' 57' ' ' PRO . 30.7 m0 -113.07 127.19 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 18.1 tt -152.94 159.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.67 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.3 t-20 -55.88 118.53 4.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.916 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.661 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.12 -24.72 72.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.487 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.03 -47.11 71.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 -167.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.9 mmtt -129.58 80.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 146.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -115.05 -36.63 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.527 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.54 -43.51 17.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.935 0.398 . . . . 0.0 110.957 -157.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -67.72 -52.58 35.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 -158.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.8 -45.25 96.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.582 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' GLY . 50.0 mt -59.43 -37.98 79.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.918 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.95 92.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.87 -49.7 74.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.819 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.25 -33.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -66.12 -42.57 94.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.562 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.6 -43.15 69.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 110.882 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.59 -40.21 93.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -65.39 -41.2 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.23 -31.94 72.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -74.81 -34.86 62.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.3 -40.79 20.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.1 p -104.16 -22.07 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.85 4.21 88.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.415 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.415 HG21 HD23 ' A' ' 7' ' ' LEU . 97.7 mt -76.61 121.7 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.205 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.83 120.52 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.2 135.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.097 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -139.39 117.81 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.6 127.71 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.19 160.74 20.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -68.82 162.31 64.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.555 0.693 . . . . 0.0 110.859 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.67 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 60.5 Cg_endo -98.82 -3.95 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -164.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.46 -30.81 33.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -154.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.45 -16.94 31.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 10' ' ' TRP . 5.7 mp -61.18 -36.52 80.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.921 -156.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 50.2 mt-10 -48.75 -35.98 15.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.58 -36.01 57.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -75.52 -29.53 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -173.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.6 m-85 -48.18 -54.52 24.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.903 -160.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 95.7 Cg_endo -80.16 -29.31 2.63 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.825 2.35 . . . . 0.0 112.19 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -75.15 -48.93 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.016 0.436 . . . . 0.0 111.046 -167.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.92 -32.63 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.122 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.7 -38.26 89.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.033 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.43 63.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -98.92 0.09 43.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.09 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 75.14 17.91 80.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.515 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -109.72 -174.43 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.319 . . . . 0.0 110.888 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 -171.3 15.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.495 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.66 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 83.7 Cg_endo -79.46 174.67 11.59 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.357 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.36 -38.38 22.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 164.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -134.35 139.03 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.213 -172.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.86 144.76 36.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -100.87 139.71 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 6.1 m95 -126.63 123.41 37.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.73 -91.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 -167.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -112.52 -82.39 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -73.9 -19.29 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 -164.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 96.4 mtt-85 -52.71 -30.71 33.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -168.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -51.09 -39.38 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 -171.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.531 -168.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.08 90.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.387 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.609 ' HB3' HD21 ' A' ' 75' ' ' LEU . 47.3 m-85 -76.47 -32.62 58.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.944 0.402 . . . . 0.0 110.874 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.39 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -62.64 -28.51 69.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -82.4 1.42 37.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.852 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.78 23.77 59.26 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.461 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.3 pp -85.89 1.15 51.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.752 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.1 pp -134.21 144.34 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -86.04 153.13 22.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.92 132.99 46.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG21 ' CE2' ' A' ' 106' ' ' TYR . 66.8 mt -109.35 139.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.182 -173.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 p -130.81 76.9 76.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.753 . . . . 0.0 111.161 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.96 152.53 31.93 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.743 2.295 . . . . 0.0 112.407 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -83.19 -176.98 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.848 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.6 -34.51 78.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.957 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.75 99.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -66.85 -35.08 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.77 -41.57 95.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.07 -30.07 33.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.851 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 45.0 mtmt -65.1 -17.78 64.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.167 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.62 123.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 8.2 p90 -174.75 51.16 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.692 0.758 . . . . 0.0 110.957 166.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 59.3 Cg_endo -72.22 -71.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.186 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.46 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 33.1 p90 -104.48 -19.26 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.8 p -67.55 -25.25 65.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 -168.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 90' ' ' TYR . 47.8 t-105 -62.28 -42.26 99.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.967 -174.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.34 -29.69 70.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.547 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.35 -34.35 74.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.122 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.45 13.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -117.75 149.3 41.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -139.12 128.13 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.32 34.03 23.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.71 90.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.543 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.36 149.13 42.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.949 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.4 tp -83.96 125.06 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 pt -116.71 -10.09 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.79 167.61 22.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 79' ' ' ILE . 74.9 m-85 -109.6 144.78 30.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.786 0.803 . . . . 0.0 110.91 171.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.4 Cg_exo -65.41 117.11 4.3 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.751 2.301 . . . . 0.0 112.341 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.7 mm -100.54 -32.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.23 151.69 4.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.8 t -118.5 124.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.112 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -118.48 130.14 55.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.03 153.02 30.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.427 HD22 ' HG3' ' A' ' 257' ' ' PRO . 10.8 mp -74.33 147.82 41.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -175.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 85.0 p -141.46 158.64 43.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.43 ' HB2' HD23 ' A' ' 247' ' ' LEU . 46.1 tp -98.85 125.89 44.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.952 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.44 HG12 HG22 ' A' ' 244' ' ' VAL . 63.9 mt -111.7 130.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.173 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -135.35 155.8 49.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -96.16 112.92 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -24.05 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.017 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -82.88 -34.45 26.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.83 -47.36 13.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -123.37 108.88 31.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.655 0.741 . . . . 0.0 110.92 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.53 -13.43 22.54 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.67 2.247 . . . . 0.0 112.424 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -147.12 108.34 3.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 153.78 76.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 0.0 112.349 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.75 141.83 42.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.583 2.189 . . . . 0.0 112.251 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.72 -17.77 26.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -144.37 165.02 29.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -67.26 -28.87 68.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.34 -29.53 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.848 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.12 -21.09 60.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.588 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 34.6 mm -59.8 -53.47 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.133 -167.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.1 Cg_endo -64.72 -45.79 7.96 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.729 2.286 . . . . 0.0 112.31 -173.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.68 96.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.045 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.5 mt -60.98 -38.65 86.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 10.2 t70 -64.63 -36.1 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -36.16 83.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.54 -57.53 5.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 145' ' ' SER . 1.7 pt? -81.09 -11.45 59.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 86.4 tttt -56.18 -29.32 60.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.783 166.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.09 65.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.88 11.17 37.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.21 75.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.426 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 39.9 mmtm -117.89 157.28 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.53 ' O ' HD11 ' A' ' 139' ' ' LEU . 30.0 t -115.14 154.44 28.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.82 175.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -73.79 -55.0 6.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.0 tp -143.69 130.62 20.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.8 mtp -122.86 134.8 54.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -149.69 165.96 30.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 57.7 t-20 -58.9 111.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.937 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.7 tm? -89.44 -21.57 22.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.981 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.31 -2.5 38.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -133.83 149.97 73.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.736 . . . . 0.0 110.94 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 71.2 Cg_endo -77.84 -21.6 10.94 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.633 2.222 . . . . 0.0 112.37 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -59.7 -40.97 89.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 56.2 m-85 -85.16 -27.75 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.753 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 76.2 p -89.07 -31.03 18.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.619 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.8 t90 -55.32 -47.84 97.65 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.558 0.694 . . . . 0.0 110.909 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 73.9 Cg_exo -47.96 -38.45 31.33 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.638 2.225 . . . . 0.0 112.294 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 160' ' ' LEU . 4.0 tt -73.85 -38.62 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.56 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.3 mt -67.47 -37.14 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.78 -14.35 58.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.04 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.01 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 -166.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -96.83 5.03 51.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.38 12.89 4.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.575 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.75 158.37 48.5 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.561 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.718 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 90.0 m-85 -136.85 155.2 50.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.959 0.409 . . . . 0.0 110.915 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.21 -31.12 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.049 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.11 130.11 12.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 54.9 tptt -93.55 121.73 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.852 -174.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.429 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 64.2 t80 -113.89 113.06 24.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -150.11 143.8 25.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 51.06 41.0 26.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.73 5.99 76.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.549 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.87 146.2 51.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 171' ' ' TYR . 30.2 m-85 -88.08 129.58 35.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 167.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -103.17 114.12 28.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.811 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.32 -20.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -87.3 -8.88 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -114.11 92.96 4.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.943 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.54 141.44 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.183 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.718 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -102.86 29.79 11.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.402 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.55 -22.4 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.145 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -104.95 24.75 11.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -104.45 -174.5 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.25 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.61 -44.01 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.72 84.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.775 0.321 . . . . 0.0 111.102 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.51 -42.23 98.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.832 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.99 -45.04 87.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.07 -44.21 91.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.442 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.98 -40.47 95.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.5 m -57.75 -43.3 85.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -63.73 -44.44 93.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.06 -45.34 91.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.76 -40.1 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -64.76 -39.87 94.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 198' ' ' LEU . 1.7 mp -65.77 -44.27 86.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.49 -38.39 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.221 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.3 -35.44 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.825 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.59 4.62 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.45 31.58 10.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.0 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -77.51 -29.58 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.7 ttp -147.9 150.09 33.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.95 -22.99 67.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -91.11 0.0 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.2 m -59.98 129.09 40.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -108.66 169.01 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 167.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.98 -32.61 72.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.034 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.0 p -69.37 -38.79 78.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.788 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 92.1 mt -66.87 -39.53 83.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.145 174.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.14 -36.9 85.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -69.14 -38.23 78.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.43 90.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.59 93.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.124 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.75 -40.98 92.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.81 -19.88 66.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.67 -10.11 27.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.99 63.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.44 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.78 -25.75 37.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 110.813 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.6 m -128.48 133.7 48.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.68 -28.74 60.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 70.9 mtm -131.85 151.59 51.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.5 t -150.04 161.5 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.7 128.7 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.157 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -122.29 150.85 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -120.32 -131.19 4.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.465 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.5 Cg_endo -67.06 -24.1 45.49 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.302 -170.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -53.44 -33.09 52.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 60.62 36.3 19.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.028 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.577 ' O ' ' C ' ' A' ' 233' ' ' SER . 78.3 m95 -41.97 -36.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.577 ' C ' ' O ' ' A' ' 232' ' ' TRP . 18.8 p 15.08 60.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 232' ' ' TRP . 78.8 m-20 -78.51 20.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -169.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 pt -117.59 -9.89 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -69.43 -61.27 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.4 m -54.27 -48.06 71.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.0 t -155.47 140.92 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.1 166.32 30.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.65 -70.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.134 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -150.66 70.81 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -108.93 160.51 15.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.43 167.18 25.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 116' ' ' ILE . 41.2 t -124.23 131.39 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 0.0 111.064 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.47 175.83 9.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.61 162.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 115' ' ' LEU . 96.9 mt -77.25 149.01 78.71 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 110.96 -174.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.79 156.13 67.17 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.374 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.443 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 12.9 t -142.87 150.23 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.32 114.92 20.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.836 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 50.04 36.13 11.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.912 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.28 29.16 51.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.512 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.48 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 99.2 mm-40 -110.07 161.62 23.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 110.82 -167.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 46.4 Cg_endo -60.98 75.45 0.08 OUTLIER 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 0.0 112.416 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 81.5 p -94.85 -4.83 46.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.784 -162.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 257' ' ' PRO . 10.7 ptpt -136.42 158.43 73.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.643 0.735 . . . . 0.0 110.871 -167.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 28.4 Cg_endo -70.26 166.92 26.62 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.643 2.229 . . . . 0.0 112.342 -169.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -68.93 170.03 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.42 HG23 ' HA3' ' A' ' 327' ' ' GLY . 61.5 t -120.13 133.31 67.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -170.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.21 141.6 16.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.0 t -125.23 128.36 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.9 tp -74.05 135.23 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 94.2 p -126.95 147.67 50.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.84 126.2 42.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.39 163.61 16.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.431 -170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.4 mt -106.36 129.96 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 111.147 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -61.98 126.52 27.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.79 -27.98 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.492 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -80.49 -13.11 59.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.133 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 25.3 t -72.29 127.59 90.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.684 0.754 . . . . 0.0 110.934 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.59 -6.54 18.76 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.728 2.285 . . . . 0.0 112.435 169.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.43 25.65 7.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -169.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.04 -40.87 59.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.19 -39.57 89.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 70.3 mt -64.89 -52.45 56.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.28 89.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -164.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -69.78 -49.84 48.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.939 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.78 -53.63 47.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -162.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 7.5 p90 -75.21 -25.63 58.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.48 -50.44 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.19 -29.28 38.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.953 -175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -101.97 -23.45 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.846 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 93.6 t80 -118.16 -50.67 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -175.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.98 -39.31 61.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.943 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 106' ' ' TYR . 6.7 mp -83.33 62.27 6.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 52.9 p -135.74 165.29 25.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.157 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -51.91 -49.68 62.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.77 -39.02 53.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.17 -46.69 20.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.7 tp -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.825 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.46 -43.19 88.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.85 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.592 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 88.9 t -77.33 -41.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.75 -18.53 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -54.72 -18.97 5.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 87.7 m-20 -81.18 -30.15 34.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.64 150.26 36.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.668 0.747 . . . . 0.0 110.876 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.83 -22.78 10.02 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.635 2.223 . . . . 0.0 112.364 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.5 tp -68.49 -58.22 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 89.02 3.85 75.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.66 34.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 111.034 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.3 m -120.46 156.19 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.038 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.16 -12.89 60.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 51.4 tp -74.59 120.47 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 59.6 tttm -62.3 -46.82 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -172.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -57.29 -47.15 82.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.91 -33.63 70.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.951 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.17 -37.6 85.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.823 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.7 -34.96 70.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -78.2 -38.43 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.27 -25.12 66.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.07 -7.94 20.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -79.33 -16.7 55.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -88.54 120.86 70.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -50.46 -31.99 32.82 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.232 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -69.7 -48.61 58.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.2 -39.15 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.82 84.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.07 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 58.1 m -63.06 -45.76 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.2 mmt -68.67 -37.6 79.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.28 -40.06 93.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.5 -34.17 76.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.875 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.15 90.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -71.79 -20.18 61.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.991 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.83 -8.19 20.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.42 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -94.56 -160.0 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.434 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -124.51 132.1 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.871 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 39.0 mm -79.94 120.48 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 -174.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 26.2 mmt 64.59 156.12 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.513 0.673 . . . . 0.0 110.958 169.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 332' ' ' ASN . 75.3 Cg_endo -69.83 -147.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.581 2.187 . . . . 0.0 112.363 164.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.433 ' H ' ' HB2' ' A' ' 331' ' ' PRO . 48.7 t30 -147.79 -54.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.99 164.02 34.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.662 0.744 . . . . 0.0 111.176 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -58.32 -20.92 50.14 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.779 2.319 . . . . 0.0 112.411 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -59.01 -23.08 61.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.494 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 93.5 mmm -67.44 -26.9 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.6 m -62.33 -36.73 83.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.797 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.36 -31.3 65.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.089 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.4 t80 -58.19 -49.99 75.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.004 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.644 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.8 m95 -61.71 -42.56 99.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -57.31 -42.49 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.12 86.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 72.7 t -73.26 -40.27 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.173 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.654 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 78.8 ttt-85 -55.79 -44.98 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.835 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.4 m -62.11 -42.79 99.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -62.36 -43.72 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.13 -49.89 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.115 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.93 -44.09 99.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.099 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -65.04 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.44 69.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.048 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.28 73.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.161 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -79.92 -7.11 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.96 11.82 84.09 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.584 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.1 -29.87 60.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.309 . . . . 0.0 110.88 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -140.67 155.2 46.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.2 p -74.49 172.17 12.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.58 -35.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.227 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.16 -40.77 86.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.73 -45.26 68.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.917 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.4 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.184 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.18 -36.04 76.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.04 -42.44 94.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.46 -31.76 73.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -69.46 -45.04 69.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.16 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -61.84 -39.1 90.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 92.4 m -59.99 -41.54 92.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -73.63 -34.68 65.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.5 mt -59.98 -40.01 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.185 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.8 p -93.5 -11.46 31.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.5 tttt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.628 0.251 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.4 mt -90.38 132.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.189 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 93.8 mt-10 -131.75 166.91 20.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.62 124.57 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.71 23.15 43.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.465 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 90.5 mttt -144.71 159.0 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.803 ' C ' HD12 ' A' ' 7' ' ' LEU . 1.8 pp -146.45 145.91 30.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.99 124.74 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -175.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.61 HG22 ' HB ' ' A' ' 59' ' ' ILE . 7.8 pt -126.61 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.529 ' HB3' HD21 ' A' ' 43' ' ' LEU . 37.2 m0 -116.27 137.8 51.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.7 tt -148.06 154.12 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.479 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.4 t-20 -55.5 127.87 31.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.854 174.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.77 79.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.586 -167.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.36 -53.46 57.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.921 -162.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.06 73.95 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 147.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -103.31 -40.19 2.46 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.5 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -70.44 -42.1 71.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -156.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.69 -51.81 45.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.88 -157.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.77 -48.56 83.3 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.42 -177.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.2 mt -60.81 -36.78 79.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.17 95.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.37 -52.0 67.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.74 -32.55 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.047 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.12 -43.04 96.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.52 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.93 -49.22 71.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.71 -43.06 90.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.47 -44.29 94.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.93 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.12 -33.8 76.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -71.83 -42.2 67.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -83.43 -38.03 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.796 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 90.4 m -99.59 -24.0 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 -173.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.01 86.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.43 124.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.04 130.54 43.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 7' ' ' LEU . 77.8 t -109.03 135.22 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.0 m -127.63 111.9 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 9' ' ' ILE . 52.6 t -101.76 120.56 51.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 54.9 mt-10 -131.88 153.15 50.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.937 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.423 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.8 p80 -132.3 75.13 74.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.637 0.732 . . . . 0.0 110.876 173.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 12.7 Cg_endo -69.76 -29.65 23.54 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.672 2.248 . . . . 0.0 112.452 -160.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.5 m-20 78.0 4.06 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -174.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -94.36 -2.02 52.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 10' ' ' TRP . 79.9 mt -48.95 -57.25 6.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -152.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.33 -41.66 94.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -83.44 -40.33 19.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -170.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -75.51 -49.99 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -166.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.831 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 82.9 t80 -55.3 -52.22 73.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.694 0.759 . . . . 0.0 110.81 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 88.0 Cg_exo -52.48 -38.7 74.96 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 0.0 112.35 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -73.88 -47.26 39.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.0 m -74.83 -26.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.44 91.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.047 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.58 65.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -93.03 6.75 46.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.01 18.95 73.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.482 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.0 t0 -117.18 -172.96 2.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.962 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.45 167.02 22.8 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.49 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 59.8 Cg_endo -68.51 168.45 19.73 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.605 2.203 . . . . 0.0 112.337 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.27 -42.61 62.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' A' ' 9' ' ' ILE . 75.7 mt -136.73 143.3 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.198 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.28 136.61 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.74 122.44 47.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -147.71 157.61 43.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.919 169.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -87.5 -103.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -95.75 -50.03 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -62.04 -61.44 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 -162.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -77.92 -31.93 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -172.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -57.42 -48.23 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.77 -166.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.4 -48.21 87.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.556 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.34 -39.36 64.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 174.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.68 -32.99 74.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.943 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.39 80.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.45 -25.88 65.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.0 m -82.52 0.02 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.74 30.3 76.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.41 -5.21 59.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -128.58 143.39 50.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 -173.028 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 154.33 20.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.05 136.76 52.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 pt -109.31 151.72 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.8 p -130.11 68.16 80.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.547 0.689 . . . . 0.0 111.197 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.3 141.8 32.64 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.719 2.279 . . . . 0.0 112.284 172.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -78.23 172.05 14.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.55 -31.97 73.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.811 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.52 84.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -79.87 -31.85 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.94 -43.63 94.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.8 -28.39 64.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -66.12 -26.49 67.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 mt -97.01 -137.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -132.33 139.59 35.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.762 0.791 . . . . 0.0 110.884 173.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.9 -42.0 70.23 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.778 2.318 . . . . 0.0 112.408 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -70.44 -24.82 62.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -77.42 -28.66 52.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.129 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.432 ' HA ' HG22 ' A' ' 97' ' ' VAL . 64.2 m95 -73.02 -33.21 65.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.53 -34.43 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.09 -28.54 65.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 34.8 m -106.47 12.48 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.158 -174.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -108.35 133.76 52.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -134.97 126.02 27.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 58.29 34.81 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.28 5.24 89.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.91 146.4 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 0.0 110.85 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.73 125.28 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 76' ' ' LEU . 38.3 pt -121.65 -8.13 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -167.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.39 161.98 37.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -171.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.8 m-85 -109.14 130.93 22.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.623 0.725 . . . . 0.0 110.987 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 26.5 Cg_exo -62.53 115.58 2.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.749 2.299 . . . . 0.0 112.302 172.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.6 mm -104.85 -34.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.53 153.63 21.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -123.24 129.85 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 229' ' ' PRO . 10.2 pt-20 -131.16 149.21 52.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.897 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.48 154.88 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.6 tp -71.5 133.69 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.9 p -142.46 160.78 39.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -174.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -97.48 128.39 44.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 91.4 mt -111.43 129.61 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.046 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -129.06 153.9 47.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -95.33 118.87 32.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.64 -32.27 73.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -84.31 -35.43 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 -171.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.71 -44.36 50.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -139.34 109.54 7.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.985 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.8 Cg_endo -74.39 177.07 8.81 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.695 2.263 . . . . 0.0 112.436 171.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.1 t30 21.5 96.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 110.922 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.8 Cg_endo -65.51 156.74 61.98 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.373 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.27 144.66 75.4 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.251 . . . . 0.0 112.363 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -87.92 -21.63 24.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.0 p -134.75 159.46 41.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -68.03 -33.44 74.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.49 -25.46 37.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.773 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.22 -20.84 60.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 27.6 mm -56.26 -54.77 49.26 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.532 0.682 . . . . 0.0 111.101 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 20.5 Cg_endo -61.86 -40.81 41.76 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.661 2.24 . . . . 0.0 112.371 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 mt -64.8 -35.22 80.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.939 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.05 -36.91 85.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.84 -43.21 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.25 -37.76 78.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 35.0 mt -70.32 -35.04 73.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.88 -32.84 64.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.82 -23.6 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -102.85 6.4 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.822 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.17 25.66 70.46 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.516 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 90.3 mttt -112.95 154.66 26.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -106.77 151.6 24.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.39 -42.44 68.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.95 146.0 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 86.8 mmm -136.7 124.25 22.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 157.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.78 167.45 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.804 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 54.7 t-20 -67.39 117.95 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.88 -167.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.08 4.61 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.42 ' N ' ' OD1' ' A' ' 150' ' ' ASN . 79.2 mt-30 -84.59 -0.96 55.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.87 143.22 36.51 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.626 0.726 . . . . 0.0 110.844 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.6 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 33.2 Cg_endo -70.61 -27.19 22.73 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.72 2.28 . . . . 0.0 112.37 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.401 ' HA ' ' CD1' ' A' ' 158' ' ' TRP . 82.7 t80 -56.11 -46.74 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.89 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 61.1 m-85 -80.37 -20.07 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -173.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -75.45 -22.15 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 162' ' ' ALA . 2.5 m95 -59.84 -46.18 98.31 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.522 0.677 . . . . 0.0 110.863 -168.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.569 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 52.3 Cg_exo -41.97 -36.26 3.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.334 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.5 -49.12 10.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.717 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.3 mt -81.33 -49.72 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -170.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -63.32 -19.0 64.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.138 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -61.43 -28.28 69.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.42 2.26 39.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.918 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 103.4 10.27 36.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -112.4 135.09 12.44 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.375 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -153.6 170.04 21.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.941 -165.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.62 -48.03 80.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.06 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.87 155.32 42.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -80.92 124.43 29.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -104.62 110.84 23.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -149.48 138.76 21.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -169.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 49.0 38.98 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 -173.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.88 10.39 72.4 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.393 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -136.77 154.81 50.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.735 0.303 . . . . 0.0 110.857 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -70.33 147.62 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -129.63 107.73 9.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.0 mm -76.93 -29.1 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.79 -22.81 31.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -170.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.54 65.25 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.823 166.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.37 149.59 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -169.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -86.93 11.67 64.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.404 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.54 -3.57 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 51.1 p-10 -78.42 16.64 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.938 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 74.1 m-80 91.21 0.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 166.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.54 -58.31 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -84.54 -55.66 2.67 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.0 68.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 111.137 -166.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.02 -45.16 86.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.75 96.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.121 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.717 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.8 -41.38 98.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.506 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.62 -39.18 91.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.2 m -61.17 -42.11 97.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.208 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.84 -42.99 94.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.86 -45.65 92.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.17 -40.0 87.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.12 -37.58 87.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.439 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -68.24 -34.2 75.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.55 -40.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.054 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.06 -41.16 86.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -85.46 2.49 44.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.02 31.89 10.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -81.25 -29.55 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 67.4 mtt -135.47 147.32 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.843 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -97.66 124.03 41.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.63 -22.72 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 -170.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -90.01 -6.09 55.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.4 m -57.22 131.07 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -128.68 -179.48 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.815 171.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -58.04 -34.88 70.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 -172.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 71.2 m -67.73 -36.08 79.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.55 -42.14 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.65 -41.19 98.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.05 -43.03 79.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.61 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.059 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.1 86.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.38 -35.41 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.825 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -60.54 -29.73 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.951 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.42 -21.07 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.829 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.94 23.59 32.29 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -83.43 -25.76 30.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.925 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 87.1 m -125.62 137.28 53.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.56 -38.77 25.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 77.0 mtm -140.51 157.7 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.3 t -151.8 167.83 27.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.223 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.4 mt -123.01 119.29 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 58.6 m-80 -148.62 160.87 42.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -173.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -104.6 -136.55 8.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.482 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -70.61 -26.92 23.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.289 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -66.83 -18.79 65.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -89.47 11.97 17.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.031 -176.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 298' ' ' PRO . 46.4 m0 -67.01 -28.72 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.7 t -59.31 107.95 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -150.51 130.11 13.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.2 mt -89.64 80.52 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.7 73.8 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.1 p -116.81 -1.72 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.147 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 80.3 p -114.74 -169.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.18 178.79 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 66.7 t -61.06 106.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -106.5 -63.45 1.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.35 154.96 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.88 160.48 25.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.9 t -123.16 130.31 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 111.177 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.38 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.78 159.21 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.2 mt -70.19 139.85 87.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.574 0.702 . . . . 0.0 110.967 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 40.6 Cg_exo -60.43 165.38 11.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.8 p -120.62 148.07 44.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.077 172.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -126.62 117.21 22.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 54.57 35.74 24.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.28 16.58 62.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -130.02 146.67 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 145.46 85.97 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.627 2.218 . . . . 0.0 112.431 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.6 t -67.17 -57.73 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.432 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 9.0 tmtt? -163.52 117.38 1.08 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.525 0.678 . . . . 0.0 110.935 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.54 128.03 11.52 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.709 2.273 . . . . 0.0 112.442 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -161.31 111.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.07 132.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.09 137.42 13.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.558 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.04 125.17 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 57.0 tp -65.35 127.35 31.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 27.0 m -133.2 148.83 52.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.815 -166.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.86 132.75 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -112.14 148.05 18.21 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.435 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.1 mt -106.1 125.79 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -59.04 118.26 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.1 -24.72 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.24 -9.58 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -68.82 132.53 90.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.636 0.731 . . . . 0.0 110.913 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -14.31 39.4 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.636 2.224 . . . . 0.0 112.302 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -115.6 29.43 8.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -167.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -58.28 -35.61 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.6 -36.46 83.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 62.6 tp -64.56 -42.85 95.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.4 90.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -65.15 -43.97 90.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.85 -172.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.73 -51.36 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -172.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -32.61 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.74 -50.58 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -74.11 -42.88 59.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.66 -14.35 19.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -160.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -123.23 -53.73 1.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 59.5 tp -68.07 -46.93 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 106' ' ' TYR . 84.2 mt -83.78 63.79 7.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.1 p -135.54 165.31 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 173.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.87 -44.45 70.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -80.91 -40.85 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.59 35.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.609 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.47 -34.41 72.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 110.904 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.28 -40.04 84.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -33.2 68.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.496 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 78.7 t -79.07 -51.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.154 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -79.3 -19.84 49.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 -166.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -57.85 -18.14 20.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -93.23 -21.33 19.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.98 149.75 92.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.617 0.722 . . . . 0.0 110.906 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.429 ' HB2' ' HB3' ' A' ' 232' ' ' TRP . 79.7 Cg_exo -57.87 -44.14 42.99 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.239 . . . . 0.0 112.405 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -95.06 -45.86 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 83.54 9.74 82.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.54 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.89 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.3 m -115.83 156.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -77.18 -9.01 58.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 171.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.37 120.19 23.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.66 -43.9 97.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 38.6 t -58.75 -48.93 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.924 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.615 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.5 t80 -71.02 -35.39 72.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.849 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -62.34 -32.82 73.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.57 -36.95 77.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.83 -38.44 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.69 -26.69 67.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.981 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.44 -12.46 43.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.11 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.83 -18.1 59.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -90.19 119.0 69.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.608 0.718 . . . . 0.0 110.809 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.99 -32.92 50.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -70.75 -40.63 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.41 -40.72 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.4 72.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.191 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.59 89.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.7 m -65.13 -46.35 81.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.163 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -68.18 -34.82 76.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -63.12 -39.97 96.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.9 -38.87 66.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.69 91.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.012 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLN . . . . . 0.403 ' HG3' ' HG3' ' A' ' 326' ' ' LYS . 20.8 pt20 -71.3 -14.49 62.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.403 ' HG3' ' HG3' ' A' ' 325' ' ' GLN . 90.3 mttt -110.35 -6.52 14.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -175.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.93 -160.55 36.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.437 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -130.16 148.25 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.875 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.426 HG22 ' HG2' ' A' ' 331' ' ' PRO . 45.5 mm -68.97 117.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.115 -171.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 tmt? -47.93 -53.73 29.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.62 0.724 . . . . 0.0 110.902 -165.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 330' ' ' MET . 45.5 Cg_endo -64.91 101.2 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.703 2.268 . . . . 0.0 112.366 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.641 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 22.9 m120 -121.56 34.56 5.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -168.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 45.9 mm 88.94 136.56 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.071 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.26 -26.66 20.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.701 2.268 . . . . 0.0 112.266 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.7 mm-40 -57.44 -23.11 47.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 66.5 ttp -63.29 -32.7 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.9 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.3 m -64.35 -38.12 89.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.28 -45.76 83.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -57.39 -48.67 78.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -64.3 -45.66 87.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.39 93.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.082 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.62 -29.87 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.6 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 73.7 ttt-85 -58.93 -43.07 91.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.6 m -59.69 -41.5 90.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.32 -40.21 93.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.44 -50.93 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.05 -46.46 91.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.041 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.11 -36.34 83.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.24 -48.1 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.44 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.054 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -79.0 -9.45 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.1 10.1 86.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.82 -28.6 58.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.319 . . . . 0.0 110.85 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -138.26 155.76 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 357' ' ' VAL . 97.0 m -71.52 152.28 43.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 174.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 356' ' ' THR . 64.1 t -65.66 -47.25 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 -173.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.99 -41.16 99.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -71.91 -44.47 63.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -64.84 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.4 -37.84 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.8 tttt -61.88 -41.99 98.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.26 -31.6 72.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -71.64 -47.16 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.083 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.9 pp0? -68.54 -31.52 70.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 98.9 m -63.26 -44.06 96.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.048 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -64.51 -37.68 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.797 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.93 -46.19 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.4 p -95.19 -6.16 42.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.233 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.1 127.68 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.123 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -128.48 165.39 20.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.81 119.95 15.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.5 24.03 34.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.497 -172.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -145.0 154.27 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.882 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.26 142.93 32.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.8 t -125.48 125.75 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.45 131.75 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.594 ' HB3' HD22 ' A' ' 43' ' ' LEU . 24.0 m0 -113.16 129.84 56.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.4 tt -151.43 153.33 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -55.37 127.04 27.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.09 -20.93 78.99 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -165.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.07 -48.84 72.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -163.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -138.42 83.21 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 145.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -111.3 -34.38 2.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -77.17 -43.83 32.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.966 -159.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -65.77 -60.01 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -155.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -45.68 96.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.54 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -58.39 -41.47 84.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.943 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.87 -48.83 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.913 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.28 -33.88 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.074 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.67 -37.2 94.37 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.369 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.35 -45.88 85.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.88 -44.48 97.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.38 -37.26 86.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -64.86 -35.29 80.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.16 -37.71 72.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.47 -41.5 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -104.67 -17.35 14.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.182 -172.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.87 88.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.55 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.3 tt -76.15 125.24 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.36 121.58 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 p -103.66 140.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -134.24 112.18 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.143 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.02 122.76 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -128.59 150.93 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 26.3 p80 -133.77 73.19 72.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.669 0.747 . . . . 0.0 110.871 170.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 16.9 Cg_endo -70.04 -28.04 24.41 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.633 2.222 . . . . 0.0 112.427 -162.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 57.8 m-20 78.23 2.39 2.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 -172.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.93 -2.04 44.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 10' ' ' TRP . 84.7 mt -46.0 -55.54 6.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.97 -154.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -70.0 -26.64 64.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -168.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -84.34 -43.43 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -79.98 -41.39 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.864 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 29.7 t80 -51.88 -52.97 56.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.825 -165.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 73.3 Cg_exo -54.25 -38.05 88.26 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.564 2.176 . . . . 0.0 112.388 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.2 -48.47 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.924 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -72.18 -30.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.14 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.09 -24.28 67.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.54 7.12 47.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.47 22.59 67.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -119.92 -170.33 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.983 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.56 -173.23 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.581 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.02 159.97 23.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.242 . . . . 0.0 112.364 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 276' ' ' ALA . 29.7 t70 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 169.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.35 142.97 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.36 132.08 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.191 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -113.8 127.28 55.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -146.99 154.46 41.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.34 -102.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -176.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 -51.28 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.07 -47.98 80.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -79.69 -33.38 41.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -56.52 -47.93 78.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.16 81.7 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.509 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.13 -43.22 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.59 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -70.82 -30.02 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.31 95.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.089 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.43 -24.38 65.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -83.45 3.67 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.46 36.91 69.31 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.478 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.77 -9.56 59.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.785 0.326 . . . . 0.0 110.869 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -132.68 143.18 49.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.948 -173.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.74 164.32 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.078 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -66.31 134.95 53.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -107.92 151.76 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.088 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.5 m -127.44 75.06 77.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 111.218 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.49 141.0 17.44 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.659 2.24 . . . . 0.0 112.251 169.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -80.62 179.95 7.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.913 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.71 -36.13 82.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -173.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -41.94 98.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -69.0 -40.72 78.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.81 -42.2 90.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.859 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.79 -27.11 64.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.99 -27.32 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.925 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.48 -110.26 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -175.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 31.6 t80 -156.76 134.71 7.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.667 0.746 . . . . 0.0 111.01 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 80.8 Cg_exo -56.38 -41.66 73.92 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.377 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.27 -40.58 97.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.5 p -71.5 -25.5 62.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.402 ' HA ' HG22 ' A' ' 97' ' ' VAL . 63.4 m95 -74.38 -34.31 63.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.876 173.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.15 -31.3 71.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.832 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.06 -26.45 68.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 35.9 m -108.04 15.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.149 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -100.34 131.42 46.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -130.74 121.83 26.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 59.28 34.97 23.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.9 4.17 90.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.436 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.04 146.23 47.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.772 0.32 . . . . 0.0 110.918 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -86.37 127.77 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.6 pt -117.93 -8.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 -169.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -159.67 163.23 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -170.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.73 129.01 24.77 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.714 0.769 . . . . 0.0 110.966 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.66 122.32 9.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.309 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -109.64 -40.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -155.54 156.25 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.023 -167.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.89 137.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.635 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 24.9 pt-20 -142.8 154.94 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.25 41.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.175 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.7 tp -66.42 142.36 57.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.874 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.4 m -138.85 156.37 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.6 tp -97.01 123.89 40.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 244' ' ' VAL . 74.6 mt -113.3 125.23 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -134.94 157.72 46.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -170.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -91.64 112.56 24.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.698 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 96.4 mttt -67.69 -29.09 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 -174.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -78.11 -35.68 48.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.6 -45.78 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.9 tp -121.71 106.7 36.87 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.913 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 124' ' ' ASN . 97.1 Cg_endo -74.86 157.02 43.61 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.65 2.233 . . . . 0.0 112.284 168.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.6 t30 25.06 96.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.594 0.712 . . . . 0.0 110.953 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.8 Cg_endo -65.25 155.69 67.17 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.728 2.285 . . . . 0.0 112.405 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.96 142.13 55.76 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.751 2.301 . . . . 0.0 112.297 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -91.04 -25.62 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 249' ' ' THR . 68.7 p -128.69 159.99 33.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.186 -175.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -74.06 -23.59 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.979 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.5 -28.57 67.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.98 -20.08 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.628 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 31.2 mm -57.71 -56.25 36.38 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.573 0.701 . . . . 0.0 111.11 -168.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 29.9 Cg_endo -69.44 -39.69 6.79 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -172.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.18 99.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.74 -39.54 94.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.45 -41.4 98.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.02 -39.6 86.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.07 -45.87 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -84.6 -18.92 34.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.415 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.0 tttt -57.47 -30.04 64.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.48 -20.42 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.2 9.31 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.03 68.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.527 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -108.97 161.43 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.849 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.5 t -115.84 152.66 32.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 167.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.97 -42.35 57.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.109 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.97 153.15 47.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -175.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mmm -128.38 120.27 26.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.842 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -166.08 165.01 18.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -97.22 141.21 30.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -168.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.423 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 52.4 tp -105.57 2.45 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 175.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -76.54 -8.6 57.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 174.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.48 145.07 39.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.737 0.78 . . . . 0.0 110.832 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.568 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 50.5 Cg_endo -68.73 -24.59 34.62 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.532 2.155 . . . . 0.0 112.295 176.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -57.72 -47.62 81.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -71.64 -26.5 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 p -84.13 -17.19 40.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 7.2 m0 -56.97 -46.4 99.87 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 -170.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.554 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 88.9 Cg_exo -51.08 -33.57 43.84 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.765 2.31 . . . . 0.0 112.306 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.5 tp -81.37 -46.15 15.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.429 HG23 ' HA3' ' A' ' 191' ' ' GLY . 94.8 mt -83.14 -48.17 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.107 -171.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -66.62 -16.64 64.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.82 -28.56 66.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.51 -6.35 22.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.9 6.75 13.8 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -95.84 115.04 5.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.427 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -162.33 175.31 11.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 110.936 -161.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.634 ' HB1' ' HB3' ' A' ' 339' ' ' PHE . . . -82.88 -23.64 33.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.191 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.794 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 86.1 m-85 -130.89 143.95 51.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -112.15 127.15 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.857 163.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -108.99 111.68 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.84 -170.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.15 141.32 25.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 52.42 37.96 24.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.63 4.33 70.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.35 150.63 52.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 0.0 110.907 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.794 ' CD1' ' HB3' ' A' ' 169' ' ' PHE . 57.9 m-85 -86.19 130.78 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 172.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -115.83 117.37 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.931 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -78.62 -20.17 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.03 -16.19 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -113.97 71.31 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.79 166.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.32 150.95 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.181 -165.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -88.21 22.24 20.36 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.509 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.6 m -105.65 0.02 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.668 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 52.6 p-10 -80.98 17.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.0 m-80 94.22 -4.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 167.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.81 -57.69 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.072 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -90.79 -53.73 2.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.512 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.58 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -67.38 -35.22 78.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 0.0 111.023 -165.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.81 -43.45 93.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.975 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.08 -41.27 95.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.074 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.429 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -62.79 -39.57 98.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.454 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.93 -40.86 95.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.3 m -60.2 -42.17 94.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.151 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.78 -44.0 97.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 59.1 tp -58.72 -45.52 89.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 351' ' ' ALA . 50.4 t -63.36 -39.74 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.46 -39.87 92.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 133' ' ' PRO . 0.3 OUTLIER -70.05 -40.65 74.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -178.482 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.62 -39.29 84.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.13 -38.16 87.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -87.94 3.67 47.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 60.6 35.55 19.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -80.78 -20.19 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -139.44 153.08 47.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -98.46 132.4 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.0 72.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -89.85 -4.1 57.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 66.9 m -62.94 135.44 57.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.43 179.92 5.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.89 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -62.04 -34.64 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.931 -172.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.7 m -69.66 -41.34 75.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.838 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.07 -39.67 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.1 93.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.05 -43.45 92.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.51 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -42.39 98.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.48 ' HD1' ' HA ' ' A' ' 217' ' ' PHE . 0.9 OUTLIER -64.91 -37.08 86.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 172.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -102.64 -22.88 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.85 23.32 36.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -82.92 -22.55 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 110.923 -171.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.5 t -126.26 144.92 50.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.98 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.0 mtm -138.61 148.03 43.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -168.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.9 p -139.5 164.96 28.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.101 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.65 119.14 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.5 160.05 41.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.94 -164.42 39.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.446 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.635 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -66.46 -20.99 54.02 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.24 . . . . 0.0 112.274 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -65.56 -20.66 66.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.66 3.86 45.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -69.99 -43.15 72.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 t -68.67 105.84 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -139.69 154.05 47.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 81.6 mt -78.25 88.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.23 74.97 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 73.8 p -122.32 0.79 9.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.7 p -100.49 -170.0 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.62 179.87 7.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.74 112.33 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -119.6 -56.71 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -115.43 162.99 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.698 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -143.03 169.27 25.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.47 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 116' ' ' ILE . 58.4 t -122.93 130.2 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.82 175.55 9.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.178 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.84 161.05 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 90.0 mt -73.48 136.44 78.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.56 0.695 . . . . 0.0 110.94 -173.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 49.0 Cg_exo -62.38 159.33 36.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.746 2.297 . . . . 0.0 112.22 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 128' ' ' THR . 81.9 p -114.09 160.02 19.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.73 116.28 15.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.7 35.12 23.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.5 57.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.543 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.21 145.24 56.48 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.902 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.92 152.07 77.42 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.652 2.234 . . . . 0.0 112.399 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 95.7 p -65.1 -61.5 2.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -165.88 147.01 5.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.566 0.698 . . . . 0.0 110.911 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.36 126.1 8.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.589 2.193 . . . . 0.0 112.417 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -163.89 111.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.77 132.87 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.129 163.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.81 139.14 15.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.62 119.52 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.803 0.335 . . . . 0.0 111.101 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.7 129.87 41.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -132.1 139.9 48.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -170.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.59 137.77 52.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -129.89 166.54 21.96 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 70.6 mt -112.4 129.81 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 111.191 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -59.36 123.21 16.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.939 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.46 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.48 59.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -76.06 131.46 75.75 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.619 0.723 . . . . 0.0 110.852 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.52 -10.86 28.84 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.65 2.233 . . . . 0.0 112.313 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -108.91 28.62 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -166.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.35 -37.75 62.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.757 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.54 -38.59 84.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.95 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.13 -43.09 93.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.409 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . . . -65.63 -44.55 86.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -63.15 -49.64 73.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 97.9 mt-10 -66.47 -45.15 80.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.78 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 19.1 t80 -59.98 -41.65 92.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 28.6 tp -70.33 -54.6 11.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -83.34 -30.76 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 -167.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.575 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.2 m-20 -98.57 -18.45 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.799 -167.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.605 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.6 m-85 -122.15 -53.44 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 59.6 mt -72.35 -41.83 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 -176.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.79 60.7 6.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 176.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.1 p -136.9 170.2 16.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.159 172.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -55.12 -48.17 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.796 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.63 -39.93 43.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.39 -46.09 27.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.422 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.7 tp -67.74 -36.32 80.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 110.905 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.04 -41.18 96.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.21 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.06 -32.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.56 -24.39 65.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.3 -26.25 39.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.56 -15.74 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.76 154.83 61.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.53 0.681 . . . . 0.0 110.988 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.02 -97.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.577 2.184 . . . . 0.0 112.433 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.29 -25.87 67.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 60.98 31.87 78.03 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.551 165.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.91 127.28 31.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 111.104 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 34.7 m -116.75 152.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.081 -164.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.95 -10.84 59.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.08 118.54 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.37 -51.73 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.7 p -62.27 -43.07 99.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 307' ' ' TYR . 1.3 t80 -70.56 -37.1 73.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.975 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -66.24 -32.61 74.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.0 -36.58 81.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -72.79 -39.68 66.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.37 -26.77 68.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.935 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.78 -11.27 44.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.047 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.07 -18.14 58.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -85.52 118.93 71.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.768 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.09 -34.94 60.08 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 0.0 112.383 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -70.17 -41.11 74.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.04 -38.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.01 73.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.57 -41.37 88.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.04 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -63.73 -44.62 93.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.159 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.6 -38.82 90.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.886 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.53 -38.56 84.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.96 85.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.3 -18.26 65.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.832 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.27 -8.13 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.889 -172.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -102.88 -162.68 25.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.502 -173.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -133.98 156.68 47.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.469 HG13 ' HD2' ' A' ' 331' ' ' PRO . 4.9 tp -63.21 124.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -171.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.602 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.9 tmt? -44.46 -52.27 17.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.525 0.678 . . . . 0.0 110.847 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 330' ' ' MET . 34.8 Cg_endo -60.71 84.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.34 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.657 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 74.0 m-80 -104.23 29.36 6.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -170.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.657 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 50.3 mt 89.62 135.45 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.704 . . . . 0.0 111.146 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.41 -26.86 22.45 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.239 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.461 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.3 mm-40 -59.97 -18.16 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 62.1 ttp -57.97 -34.61 70.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.949 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.93 -38.83 92.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.14 -38.2 66.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.634 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 7.2 m-30 -67.17 -35.97 80.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -55.5 -48.8 74.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -64.94 -42.36 94.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.79 94.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.104 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.77 -38.11 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.083 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 71.2 ttt-85 -53.51 -39.92 64.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -57.04 -45.13 83.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.072 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.84 -43.71 87.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.89 -58.48 5.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -166.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.7 mt -66.57 -45.0 89.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 97.9 m-20 -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.78 59.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 196' ' ' VAL . . . -71.74 -35.45 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.11 -172.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -75.47 -14.5 60.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.79 7.75 87.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.403 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -75.22 -24.27 57.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.962 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 83.4 mm-40 -136.01 157.08 47.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.0 m -67.17 150.62 48.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.56 -46.99 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.15 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.46 -40.14 95.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.92 -42.52 66.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.27 93.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 32.7 tp -71.93 -35.1 69.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.2 tttt -62.5 -40.27 96.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 173.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.97 -31.28 72.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -74.59 -43.18 56.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.174 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.0 OUTLIER -69.29 -28.91 66.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -178.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -66.75 -44.18 82.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.139 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.19 -40.16 68.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.38 -30.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 -171.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.8 p -92.17 -2.82 56.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.181 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -177.394 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.736 0.303 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -80.73 133.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.08 -179.44 8.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.61 126.62 30.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.991 -172.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.57 19.01 59.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.562 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -142.19 158.55 43.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -142.44 147.57 36.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 173.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.13 126.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.431 HG13 HD13 ' A' ' 7' ' ' LEU . 62.8 mt -118.74 133.22 66.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.129 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 30.2 m0 -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 174.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 tt -151.78 154.07 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.141 -172.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -55.14 127.36 28.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.1 -19.44 79.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.519 -168.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.57 -51.23 70.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -163.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.19 78.84 1.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 147.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.0 -35.88 2.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.428 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -80.5 -44.46 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 110.989 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -66.72 -52.08 48.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -155.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -65.3 -47.71 77.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.472 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.01 -38.41 85.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.87 -45.15 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.42 -47.33 82.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.96 -45.03 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.659 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -60.8 -36.31 91.65 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.363 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.16 -45.52 93.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.19 -44.77 90.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -64.49 -41.8 96.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -63.8 -33.66 76.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.12 -38.23 85.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.1 -37.02 17.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 -173.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.8 m -101.19 -24.51 14.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 -171.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.01 3.36 87.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.53 125.27 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.4 . . . . 0.0 111.185 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -66.48 128.03 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -172.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.659 HG11 ' HA3' ' A' ' 24' ' ' GLY . 95.5 t -104.26 132.9 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -135.9 116.93 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.6 125.13 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.49 153.06 47.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 27.9 p80 -133.23 75.12 71.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 0.0 110.838 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.561 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.6 Cg_endo -69.24 -29.32 26.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.238 . . . . 0.0 112.401 -162.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.6 m-20 77.67 3.42 3.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -175.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.8 2.09 49.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 10' ' ' TRP . 82.9 mt -48.65 -55.14 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -154.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -62.65 -28.91 70.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 -169.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.48 -47.07 9.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.811 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -79.98 -46.33 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -163.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 7.6 t80 -50.66 -54.0 40.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.679 0.752 . . . . 0.0 110.88 -162.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.1 Cg_endo -62.9 -31.8 77.25 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.295 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -47.82 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.7 m -74.95 -26.41 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -174.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.25 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.33 -24.28 65.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.028 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.5 p -96.43 4.96 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.37 23.17 61.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.502 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.9 t0 -119.88 -176.24 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.32 -179.18 24.67 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.582 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.91 161.1 24.13 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -76.26 -38.58 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.63 138.77 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 tt -138.27 140.86 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -100.2 143.34 30.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -140.05 152.37 46.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.98 -114.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.46 ' NE2' ' N ' ' A' ' 261' ' ' VAL . 70.8 m80 -116.94 -57.47 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.65 -45.42 90.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -74.97 -36.67 62.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.84 -49.55 75.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.21 -49.48 61.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.453 -175.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.31 94.48 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.528 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -71.9 -29.94 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.67 96.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.46 -28.63 69.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.3 m -84.97 5.73 28.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.879 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.49 35.66 82.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.434 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.05 -15.49 60.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.874 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.415 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -129.61 143.64 50.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -169.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.15 159.33 16.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.44 136.87 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.5 pt -109.41 152.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.3 p -130.49 63.07 68.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.557 0.694 . . . . 0.0 111.157 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -72.67 143.28 37.45 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.717 2.278 . . . . 0.0 112.255 167.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -75.08 177.7 6.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.81 -30.35 70.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.52 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.023 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -64.71 -38.06 89.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.801 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -65.55 -40.13 92.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.991 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.21 -36.59 83.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.93 -30.98 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.05 -107.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -168.66 131.05 1.19 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.658 0.742 . . . . 0.0 110.957 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -54.19 -38.73 88.02 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.716 2.278 . . . . 0.0 112.328 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.56 -35.47 80.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -76.3 -24.74 54.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -75.46 -26.52 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 173.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.1 -33.23 71.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.16 67.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.09 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.98 16.63 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 -175.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -109.97 138.27 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.934 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -136.29 124.96 23.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.66 34.86 25.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.27 4.72 89.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.421 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.53 144.13 48.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.52 126.4 33.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.415 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.2 pt -119.67 -10.06 10.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.104 -168.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.27 165.17 31.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -108.61 137.92 20.13 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.667 0.746 . . . . 0.0 110.867 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 21.4 Cg_exo -66.53 120.24 7.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.284 173.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.36 -36.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.93 151.28 14.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.2 133.36 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -134.09 149.9 51.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.22 156.0 34.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 tp -69.98 140.4 52.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.7 m -142.93 159.05 42.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.1 tp -99.74 129.92 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.9 mt -110.89 132.92 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -132.59 154.76 49.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -93.28 117.19 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.786 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.35 -31.75 73.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -173.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.89 -35.09 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.21 -52.56 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.402 HD13 HD21 ' A' ' 135' ' ' LEU . 94.3 mt -127.48 115.77 21.26 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.1 Cg_endo -75.04 171.14 18.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 0.0 112.37 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.559 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.9 t30 24.81 96.6 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.1 Cg_endo -65.0 155.04 70.41 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.405 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.49 143.94 59.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.595 2.197 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.48 -20.48 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.1 p -129.35 157.93 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -71.9 -25.47 61.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.49 -30.5 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.53 -20.05 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.597 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 33.8 mm -60.77 -54.03 58.54 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.604 0.716 . . . . 0.0 111.088 -169.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 23.5 Cg_endo -61.82 -40.05 47.67 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.753 2.302 . . . . 0.0 112.304 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.36 90.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.402 HD21 HD13 ' A' ' 122' ' ' LEU . 62.4 tp -64.93 -40.37 94.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.96 -40.81 95.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.45 -42.92 83.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.44 -44.07 75.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 pp -83.03 -22.83 33.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.59 -25.87 67.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -18.78 65.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.26 9.98 41.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.02 25.68 73.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.477 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -108.73 157.52 18.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.836 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.8 t -111.24 144.19 40.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 169.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.24 -44.12 63.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.11 157.05 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 mmm -138.8 116.44 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -164.39 169.51 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.47 138.14 32.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -166.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 206' ' ' ALA . 89.6 mt -114.38 3.52 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.54 -3.8 54.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.68 145.06 49.59 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.689 0.757 . . . . 0.0 110.907 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.699 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 29.7 Cg_endo -69.12 -25.85 31.14 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.63 2.22 . . . . 0.0 112.256 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -57.72 -47.95 80.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.85 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.425 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 52.7 m-85 -79.98 -21.88 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.869 -174.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 71.5 p -77.31 -22.43 51.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.458 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 9.4 m0 -56.43 -46.48 99.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.488 0.661 . . . . 0.0 110.892 -170.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 60.8 Cg_exo -45.2 -37.21 13.2 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.62 2.213 . . . . 0.0 112.35 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.424 ' HB2' HD12 ' A' ' 195' ' ' LEU . 89.2 mt -82.59 -44.15 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.1 mt -78.33 -45.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 -171.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.94 -16.14 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.013 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.24 -31.96 73.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.098 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.22 0.67 23.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.821 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.82 11.08 9.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 163.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -93.78 129.56 9.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.411 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -166.48 159.01 14.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.958 0.408 . . . . 0.0 110.909 -168.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.53 68.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.098 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -151.51 155.73 39.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.007 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 32.4 tptt -87.33 141.07 28.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -97.72 112.58 24.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -150.34 137.21 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.87 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.13 38.12 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.64 10.22 63.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.416 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.51 152.64 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 11.3 p90 -61.54 146.06 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -137.97 103.09 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' A' ' 181' ' ' VAL . 8.3 tp -65.15 -15.14 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -170.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.3 -17.62 45.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.808 -165.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -124.06 60.7 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.852 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 182' ' ' GLY . 58.2 t -130.26 157.63 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -171.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.509 ' N ' HG12 ' A' ' 181' ' ' VAL . . . -72.03 10.54 4.35 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.498 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 m -94.79 -24.56 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 111.101 172.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 4.9 p30 -83.34 3.93 29.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.8 m-20 84.1 -2.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 158.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.9 -48.45 11.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.1 11.64 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.546 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -65.19 -43.1 92.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.158 -163.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.65 -42.85 81.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.942 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.03 97.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.82 -41.99 97.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.441 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.24 -36.18 82.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.955 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -59.84 -46.92 87.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -65.1 -44.12 89.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.802 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 160' ' ' LEU . 5.8 tt -60.01 -54.26 48.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.71 -37.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.25 -37.55 83.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -36.56 78.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.65 -41.66 88.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.043 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.84 -32.94 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -84.66 -1.76 56.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 60.71 39.98 16.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.944 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -78.53 -25.81 45.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.829 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -145.84 153.01 40.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -96.97 134.7 39.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.99 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.419 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . -65.34 -31.52 72.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -173.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.0 -4.75 57.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 -166.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -61.16 135.19 57.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -134.67 -175.2 3.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -56.98 -45.3 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 -175.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -62.56 -42.73 99.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.86 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.8 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -43.47 91.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.99 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.62 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -65.07 -33.46 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.64 -26.03 68.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.48 -23.23 13.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.37 27.02 13.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.456 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.71 -25.81 37.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.907 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -127.41 139.7 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.93 26.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 52.7 mtt -140.21 164.7 29.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 -172.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.5 t -152.82 160.99 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.66 114.86 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.143 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -149.36 160.41 43.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -100.07 -139.55 10.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.335 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.681 ' HB3' HD22 ' A' ' 299' ' ' LEU . 30.3 Cg_endo -68.3 -25.88 35.97 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 0.0 112.353 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -67.94 -16.97 64.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.09 15.13 12.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -56.2 -33.71 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.5 t -62.19 120.19 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -170.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -147.65 128.1 14.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.979 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.6 mt -95.5 86.75 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -84.77 74.92 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.4 p -112.55 -6.46 13.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.095 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.8 p -115.12 -165.25 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.777 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.33 177.04 3.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 80.6 t -65.74 111.19 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.38 -70.41 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.3 158.5 17.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.34 166.57 26.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.563 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 61.9 t -124.62 132.08 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 111.176 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.37 178.51 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -90.63 160.01 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.093 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 99.2 mt -71.48 143.28 87.49 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.9 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.84 169.9 21.32 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.306 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.8 p -107.93 162.08 14.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -139.02 120.28 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 54.97 33.93 21.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.04 74.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.47 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -123.44 151.16 62.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -172.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.04 152.21 83.13 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.717 2.278 . . . . 0.0 112.395 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.9 p -64.99 -58.39 6.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.845 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -168.2 142.42 2.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.632 0.73 . . . . 0.0 110.904 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -73.15 126.03 10.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.368 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -169.36 119.98 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.77 130.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.178 159.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.94 144.26 15.8 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.463 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.46 ' N ' ' NE2' ' A' ' 64' ' ' HIS . 77.8 t -126.95 122.97 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 62.5 tp -73.09 138.22 45.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.7 m -125.75 144.7 50.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.795 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.4 132.01 51.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.087 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.64 157.12 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.427 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 96.2 mt -105.07 127.24 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -56.57 119.91 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.95 65.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.08 -9.96 59.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -72.17 133.67 83.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.672 0.749 . . . . 0.0 110.827 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.45 -11.23 30.79 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.598 2.199 . . . . 0.0 112.379 172.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -106.65 36.37 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -168.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.77 -43.54 72.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.78 -174.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -68.13 -36.8 80.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.73 -48.56 76.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.798 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.432 ' HA ' ' CE2' ' A' ' 279' ' ' PHE . . . -60.32 -43.52 96.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.05 -171.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -66.39 -43.94 84.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.811 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.34 -58.63 6.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -169.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.455 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 5.5 p90 -74.94 -25.84 59.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -167.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 280' ' ' LEU . 1.8 tt -63.6 -45.82 88.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.968 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -86.39 -27.13 24.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -99.89 -11.64 20.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.831 -167.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.642 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.3 m-85 -128.54 -52.13 1.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 5.8 mp -70.39 -41.94 72.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -170.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.53 70.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 81.6 p -135.3 169.97 16.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -52.26 -47.85 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.07 -41.49 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.22 -48.49 8.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.591 -169.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 304' ' ' LEU . 19.0 tp -70.4 -34.39 72.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 110.969 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.82 -41.14 97.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 295' ' ' LYS . . . -66.1 -34.96 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.051 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.594 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 11.6 p -84.07 -36.02 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.94 -24.68 37.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 292' ' ' ALA . 62.5 pttt -61.99 -16.1 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -94.56 -23.84 17.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 71.8 mmtt -64.63 146.54 98.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.551 0.691 . . . . 0.0 110.946 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 71.5 Cg_exo -57.93 -57.52 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.567 2.178 . . . . 0.0 112.413 -174.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 229' ' ' PRO . 58.8 tp -73.33 -48.22 36.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -172.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.05 -15.11 62.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.483 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.97 126.2 29.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -124.4 160.15 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 -171.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.5 -15.11 59.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.479 ' HB2' HD23 ' A' ' 290' ' ' LEU . 50.8 tp -74.7 120.01 19.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.41 -41.97 90.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.1 m -58.09 -48.87 78.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.619 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.2 t80 -70.02 -32.63 70.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -59.19 -36.41 75.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.69 -39.79 85.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -77.13 -38.59 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.81 -29.1 70.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -13.01 57.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.71 -22.31 46.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.848 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 64.6 t0 -87.69 119.95 70.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 110.826 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 36.4 Cg_endo -62.4 -24.83 75.86 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.489 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 17.9 ttp180 -68.08 -51.36 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.39 -37.14 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.7 84.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.185 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.54 -37.82 85.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.062 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 59.9 m -66.42 -39.93 89.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.23 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 75.9 mtm -66.3 -37.46 85.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -66.63 -35.09 79.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.83 94.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -71.43 -23.26 61.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.92 -5.94 24.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.2 41.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.55 151.18 50.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 110.841 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.494 ' CG2' ' O ' ' A' ' 329' ' ' ILE . 2.2 tp -68.42 125.54 26.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.083 -166.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.577 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 95.8 mtp -56.95 -52.01 77.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.87 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 330' ' ' MET . 55.7 Cg_endo -67.97 83.55 0.44 Allowed 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.799 2.332 . . . . 0.0 112.3 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.513 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 22.3 t-20 -122.92 -6.89 8.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 333' ' ' ILE . 10.8 tp 161.77 118.24 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 0.0 111.094 -157.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.42 -31.36 91.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.6 2.2 . . . . 0.0 112.255 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.442 ' H ' HG13 ' A' ' 333' ' ' ILE . 91.9 mt-30 -62.62 -10.74 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.993 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -59.18 -35.08 72.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.7 m -62.8 -38.52 90.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.31 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 8.9 m-30 -65.28 -37.91 88.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -56.22 -49.75 73.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.973 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -65.81 -42.18 90.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.71 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.3 t -71.49 -37.74 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.699 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 57.2 ttt180 -53.25 -47.99 68.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.5 m -62.61 -41.91 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 364' ' ' ALA . . . -64.91 -41.79 95.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.8 t -69.18 -47.72 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.19 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.92 -46.37 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -64.98 -36.33 84.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.824 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.91 -47.39 52.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.92 70.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.101 -173.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 84.8 p -74.85 -14.99 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.3 7.21 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.74 -30.07 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -136.07 155.95 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.991 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.4 m -66.0 150.5 48.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.98 -49.81 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.0 -36.36 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -70.95 -40.52 71.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.76 89.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.161 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.82 -38.74 91.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.44 -45.54 93.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -74.3 -42.07 60.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 346' ' ' ALA . . . -81.56 -42.76 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.098 -167.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 365' ' ' GLN . 8.7 mm-40 -73.52 -24.08 60.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 -171.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 63.7 m -53.06 -33.64 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.074 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -61.12 -30.96 70.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 72.5 mt -72.13 -42.62 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.3 p -89.03 -11.07 45.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.101 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.194 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.721 0.296 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.3 mt -83.58 127.34 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.179 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -126.71 163.24 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.91 119.8 14.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.006 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.18 23.79 39.55 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.427 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.48 153.52 40.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.357 . . . . 0.0 110.905 -173.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 7' ' ' LEU . 2.3 pp -145.96 146.0 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.1 126.54 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.606 HG22 ' HB ' ' A' ' 59' ' ' ILE . 1.4 pt -120.19 131.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.467 ' HB3' HD22 ' A' ' 43' ' ' LEU . 23.0 m0 -113.44 132.7 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.01 155.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.2 t-20 -56.33 126.89 28.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 172.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.57 -21.72 79.18 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.54 -51.53 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -163.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -135.01 77.59 1.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 148.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.72 -35.23 1.9 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -73.36 -48.33 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.349 . . . . 0.0 111.003 -155.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -69.76 -50.47 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 -155.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.06 -48.19 87.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.2 -36.85 78.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.18 -48.36 73.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.97 -45.75 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.058 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.675 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.76 -38.32 95.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.03 -45.38 89.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 110.888 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.43 -46.79 86.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.55 -40.67 96.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -62.36 -35.21 78.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.36 -39.55 71.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -176.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.7 -39.88 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.0 m -102.78 -18.31 15.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.1 87.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.469 173.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.788 HG13 HD21 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -88.02 130.96 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.166 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.91 129.5 39.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.675 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.5 t -109.73 136.68 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -128.1 113.71 16.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 9' ' ' ILE . 61.5 t -98.57 120.58 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.062 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.9 mt-10 -129.48 145.96 51.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -134.81 72.91 67.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 0.0 110.809 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.3 Cg_endo -70.53 -25.41 25.08 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.276 . . . . 0.0 112.431 -161.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.3 m-20 77.59 4.03 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -172.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.55 0.8 50.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 173.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 10' ' ' TRP . 89.1 mt -48.33 -55.37 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -153.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.26 -33.97 69.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -169.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.28 -43.59 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -76.5 -48.04 20.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -164.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.7 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.1 t80 -49.08 -57.37 11.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.644 0.735 . . . . 0.0 110.916 -160.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 31.8 Cg_endo -66.9 -30.04 40.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 0.0 112.289 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.55 -46.61 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.921 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 21.0 m -74.91 -27.18 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.126 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.07 77.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.158 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -24.14 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 p -96.08 4.74 52.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.84 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.425 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.2 t0 -120.02 -174.78 2.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.783 0.325 . . . . 0.0 110.944 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.35 -173.72 23.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.51 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.03 157.04 23.56 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.64 2.226 . . . . 0.0 112.323 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.7 -40.71 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 172.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.606 ' HB ' HG22 ' A' ' 9' ' ' ILE . 97.5 mt -136.9 142.64 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -131.95 137.13 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.154 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -103.17 134.4 46.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -140.03 156.14 46.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.07 -102.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -124.13 -54.69 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.937 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.01 -50.06 72.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -71.04 -34.99 71.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.59 -49.09 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.793 -174.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.44 -51.18 54.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.432 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -42.68 95.06 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.566 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -70.01 -31.28 68.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.995 0.426 . . . . 0.0 110.994 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.43 98.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.119 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.69 -25.17 64.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -85.11 3.95 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.48 35.15 74.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.528 173.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -78.79 -10.9 59.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -131.86 144.02 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -175.056 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.89 157.96 17.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.083 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.23 137.11 56.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -109.98 151.77 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.422 ' H ' ' HE2' ' A' ' 277' ' ' LYS . 26.5 m -134.98 72.09 68.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.713 . . . . 0.0 111.117 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.83 142.21 34.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.756 2.304 . . . . 0.0 112.316 168.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -79.05 -179.64 6.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.73 -37.85 88.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.64 88.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.96 -38.58 88.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.65 -39.42 91.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.82 -29.49 70.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.69 -25.87 68.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.918 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.448 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 60.6 mt -101.87 -123.97 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -160.05 134.88 5.55 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.689 0.757 . . . . 0.0 110.956 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -54.88 -38.81 92.44 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.715 2.276 . . . . 0.0 112.345 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.72 -36.5 83.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -74.98 -23.26 58.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.185 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.448 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 57.3 m95 -69.98 -32.13 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.37 -30.16 70.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 329' ' ' ILE . . . -67.35 -27.2 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.009 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 36.0 m -112.66 8.62 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.206 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -100.27 135.31 41.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.94 124.94 25.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 58.1 34.79 24.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.58 3.92 89.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.417 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.79 145.97 47.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.933 0.397 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.97 125.99 33.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.41 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.7 pt -118.64 -8.9 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 -169.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.7 161.29 37.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -171.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -106.92 129.87 23.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.626 0.727 . . . . 0.0 110.94 175.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.01 120.3 7.82 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.745 2.297 . . . . 0.0 112.282 173.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.3 mm -102.39 -37.86 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.08 151.73 16.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.06 -169.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.0 t -126.75 130.57 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.16 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.905 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 94.8 mt-10 -128.16 145.05 51.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.41 155.11 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.021 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.2 tp -68.69 145.93 53.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.5 p -141.02 157.59 45.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.4 tp -98.06 126.19 43.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 244' ' ' VAL . 75.9 mt -112.72 129.35 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -135.73 153.65 51.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.69 114.21 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.796 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.48 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.7 mttt -67.55 -27.87 67.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -172.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.55 -36.53 29.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.401 HD22 ' HE2' ' A' ' 144' ' ' LYS . 98.0 mt -78.63 -43.26 26.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 176.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.23 111.89 10.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.689 0.757 . . . . 0.0 110.904 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.551 ' O ' ' C ' ' A' ' 124' ' ' ASN . 93.1 Cg_endo -75.78 173.59 14.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.629 2.22 . . . . 0.0 112.31 174.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.551 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.3 t30 24.0 96.85 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 110.98 175.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.0 157.35 62.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.733 2.289 . . . . 0.0 112.249 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.95 144.45 58.38 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.39 -32.79 14.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 249' ' ' THR . 76.7 p -126.45 159.64 32.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 67.3 m95 -74.62 -26.81 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.97 -173.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.67 -20.64 65.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.86 -24.11 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.586 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 31.4 mm -61.33 -51.78 75.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.556 0.693 . . . . 0.0 111.079 -164.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 38.7 Cg_endo -69.06 -42.38 4.19 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.694 2.262 . . . . 0.0 112.343 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.14 91.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.156 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.81 -38.98 92.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.933 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.92 -43.37 98.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.853 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.19 -41.15 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.36 -46.49 73.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -83.41 -21.29 33.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.908 -177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.449 ' N ' HD12 ' A' ' 139' ' ' LEU . 85.8 tttt -59.38 -26.61 65.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.75 -19.59 65.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.29 9.49 39.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.63 26.97 66.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.401 ' HE2' HD22 ' A' ' 121' ' ' LEU . 83.2 mttt -106.06 160.81 15.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -114.26 147.21 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 164.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.5 -30.68 61.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.095 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.0 mt -142.12 149.83 40.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.43 125.85 35.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -165.47 165.04 19.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 32.5 t-20 -84.2 134.22 34.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.808 -169.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -109.52 16.41 22.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.946 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -83.66 -12.53 55.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -137.87 147.22 55.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.719 . . . . 0.0 110.944 -171.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.758 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -65.63 -27.31 53.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.539 2.159 . . . . 0.0 112.329 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -58.55 -48.04 82.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.925 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 56.3 m-85 -80.36 -19.39 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.786 -174.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 77.8 p -79.75 -21.1 44.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.529 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.7 m0 -57.37 -42.51 96.34 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.472 0.653 . . . . 0.0 110.902 -170.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.599 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 84.1 Cg_exo -47.13 -33.45 15.47 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.674 2.25 . . . . 0.0 112.325 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 195' ' ' LEU . 86.3 mt -83.14 -43.79 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 172.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 94.0 mt -81.4 -52.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.59 -31.93 72.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.084 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -103.43 0.07 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.69 5.14 22.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.508 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -91.27 130.03 10.09 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.481 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -166.04 175.27 8.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -169.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.31 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.136 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -141.12 151.89 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 81.4 tttt -81.7 135.3 35.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -109.34 114.15 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -148.44 143.16 26.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.885 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 49.21 39.92 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.42 5.45 67.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.396 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.57 154.08 51.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.38 129.71 34.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 110.884 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -95.6 110.16 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -20.62 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.95 -15.32 29.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 170' ' ' LYS . 65.0 t0 -133.59 90.62 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.834 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.03 162.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.32 5.18 84.1 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.427 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.62 -2.58 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.07 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 44.3 p30 -74.15 13.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 175.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.65 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.4 m-80 94.66 -5.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.3 -56.95 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.126 173.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.79 -51.56 3.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB3' HD21 ' A' ' 361' ' ' LEU . . . -65.94 -35.55 80.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.35 . . . . 0.0 111.213 -164.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -68.22 -44.55 75.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -170.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.53 95.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.59 98.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.468 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.67 -37.5 84.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.4 m -61.77 -45.43 93.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.88 -42.79 99.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 160' ' ' LEU . 3.6 tt -59.57 -51.53 69.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.791 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.58 -39.52 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.58 -41.17 89.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.83 -37.53 86.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.46 -40.53 77.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.065 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.01 -31.55 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.49 1.75 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 64.48 34.67 10.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.933 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -80.85 -23.22 39.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -148.17 150.05 33.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -86.63 140.51 29.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.19 68.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -93.03 0.86 57.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.922 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.0 m -59.43 128.72 38.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -133.62 179.92 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -62.22 -34.06 75.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -64.41 -44.15 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.6 -39.58 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.46 96.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.11 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.81 -46.32 79.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.7 86.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 222' ' ' THR . . . -64.4 -39.55 94.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.081 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -71.48 -44.36 64.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.838 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -66.82 -27.51 67.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.81 -9.7 39.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.29 15.26 78.89 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.79 -28.94 60.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.961 0.41 . . . . 0.0 110.957 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.493 HG23 ' HB1' ' A' ' 216' ' ' ALA . 82.4 p -129.83 149.87 51.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.166 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.43 -31.94 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -171.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 89.8 mtp -135.29 157.68 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.859 -165.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.9 t -154.17 155.83 36.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.6 mt -119.07 118.93 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -147.09 159.85 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.97 -166.66 42.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.465 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.905 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 32.6 Cg_endo -64.05 -21.66 68.11 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 0.0 112.396 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -66.13 -16.99 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.11 -1.58 58.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -62.23 -40.04 94.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.9 t -58.88 119.23 6.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -155.85 159.27 39.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.0 mt -89.2 77.18 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.091 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -80.49 73.25 7.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.5 p -122.3 5.36 9.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.134 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 67.0 p -108.09 -175.6 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.75 176.8 5.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.883 172.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.04 113.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -114.18 -53.45 2.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -117.46 164.98 14.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.48 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -140.41 167.06 25.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.432 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 116' ' ' ILE . 56.2 t -126.02 130.41 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.056 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.18 174.83 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.73 162.52 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.33 139.98 79.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.504 0.669 . . . . 0.0 110.9 -172.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 255' ' ' SER . 51.3 Cg_endo -75.04 160.34 40.16 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.228 . . . . 0.0 112.367 -177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 128' ' ' THR . 78.4 p -114.42 158.08 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.185 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -127.67 116.28 20.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -174.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.11 35.87 23.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.2 17.68 64.31 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.511 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -127.82 147.91 64.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.96 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.04 149.29 89.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.39 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 248' ' ' PRO . 91.9 p -71.69 -53.8 12.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.479 ' HD3' ' HD3' ' A' ' 159' ' ' PRO . 46.4 pttt -168.93 144.15 2.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 170.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.413 ' HA ' ' HA2' ' A' ' 327' ' ' GLY . 87.7 Cg_endo -78.14 128.91 9.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.335 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -165.0 116.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.8 132.59 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 156.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.5 134.28 11.61 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 82.1 t -119.02 120.74 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 111.195 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 65.3 tp -65.28 132.01 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.805 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.3 m -128.9 141.29 51.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.813 -167.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.24 130.24 50.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.134 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.32 154.01 16.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.8 mt -102.92 127.81 56.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.94 0.4 . . . . 0.0 111.168 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.5 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.24 -11.15 58.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -70.04 130.86 89.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.747 0.784 . . . . 0.0 110.771 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.44 -14.05 41.23 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -112.87 27.97 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.818 -170.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -53.35 -34.14 56.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.45 -36.72 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.788 HD21 HG13 ' A' ' 33' ' ' ILE . 69.5 tp -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 174.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.12 94.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.422 ' HE2' ' H ' ' A' ' 80' ' ' THR . 63.4 tttm -64.79 -45.55 85.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -175.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -63.15 -54.24 40.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.99 -33.56 72.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 280' ' ' LEU . 5.0 tt -61.29 -51.61 68.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.924 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.09 -26.1 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -99.29 -23.77 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -167.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.403 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 68.3 m-85 -123.24 -50.26 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 60.1 tp -69.9 -49.02 56.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -86.41 62.65 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.4 p -135.39 167.62 20.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -57.17 -44.44 83.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -77.08 -42.0 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.61 -45.7 16.99 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.448 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 290' ' ' LEU . 14.1 tp -70.16 -29.84 66.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 110.9 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -61.49 -36.54 80.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.05 93.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.73 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 9.1 p -80.82 -36.38 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -169.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.18 -16.39 60.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -54.92 -23.39 18.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -92.52 -19.17 22.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.58 156.23 59.05 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.51 0.671 . . . . 0.0 110.933 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.12 -93.6 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.643 2.229 . . . . 0.0 112.291 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.725 HD22 ' HB3' ' A' ' 229' ' ' PRO . 49.1 tp -45.13 -42.28 8.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.63 85.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.442 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.401 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -80.36 133.67 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -173.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.23 157.29 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.43 -12.49 60.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.075 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.93 117.71 16.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.96 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.76 -48.85 79.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -171.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.6 t -59.95 -46.58 88.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.698 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -71.47 -35.63 70.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.74 -36.53 83.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.22 -35.06 76.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -74.79 -39.6 61.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 301' ' ' ALA . 89.6 mt -65.04 -27.92 69.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.98 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.2 34.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.72 -17.82 57.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.71 116.52 64.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 0.0 110.81 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.51 -32.51 43.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.623 2.215 . . . . 0.0 112.354 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -69.97 -39.36 76.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.19 -41.39 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.29 68.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.082 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.32 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 69.7 p -71.07 -33.89 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 33.3 mmt -72.71 -39.93 66.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.89 -38.09 82.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.912 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -68.75 -36.47 78.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.41 93.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.096 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -66.09 -17.92 65.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.46 -4.8 22.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 257' ' ' PRO . . . -97.31 -164.68 32.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.364 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -131.94 154.61 49.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.33 . . . . 0.0 110.923 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 96' ' ' ALA . 45.0 mm -64.66 124.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.174 -171.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.549 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 18.2 tpt -56.81 -55.26 45.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 110.833 -168.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 330' ' ' MET . 42.3 Cg_endo -63.83 100.39 0.29 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.736 2.291 . . . . 0.0 112.306 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.698 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 67.1 m-80 -121.55 27.85 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -168.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.698 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 68.5 mt 93.68 134.35 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.719 0.771 . . . . 0.0 111.117 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.36 -32.21 80.58 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.457 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.4 mt-30 -61.56 -21.84 64.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.4 mmm -67.17 -28.08 67.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -65.62 -40.32 92.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.5 -37.45 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -66.05 -32.83 74.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -55.68 -43.9 76.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.976 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -66.49 -35.63 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.7 -35.47 80.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 68.8 t -70.07 -39.25 76.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.758 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 55.3 ttt180 -54.05 -45.52 71.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.7 m -62.3 -42.76 99.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -65.2 -44.29 88.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.92 -49.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.12 -44.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -65.01 -38.64 91.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.79 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.63 -45.54 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.114 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.83 74.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -75.91 -11.65 60.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.39 87.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -77.16 -24.81 51.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -131.76 153.86 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.981 174.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 99.5 m -69.61 147.99 49.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.95 -49.26 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.162 -170.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.09 -42.41 94.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.853 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.04 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.105 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.571 HD21 ' HB3' ' A' ' 188' ' ' ALA . 49.6 tp -70.0 -38.19 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.61 -44.72 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.814 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.57 -30.45 70.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -77.86 -43.71 29.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.048 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -64.96 -30.1 71.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.7 m -62.11 -45.71 92.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.73 -35.32 70.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.17 -43.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.077 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.4 p -93.97 -5.93 46.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.095 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.454 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.59 129.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -126.65 166.87 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.01 119.42 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.01 24.05 39.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.431 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -144.44 154.25 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.941 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 7' ' ' LEU . 4.6 pp -151.57 148.46 28.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.868 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.48 123.01 65.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.192 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.8 mt -114.35 127.58 71.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.139 -174.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -115.12 131.64 56.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.74 155.2 7.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.426 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.6 t-20 -54.74 126.86 25.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 170.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.19 -20.57 79.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.479 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -56.14 -51.59 67.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.905 0.383 . . . . 0.0 110.882 -162.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -135.25 77.12 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 147.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.34 -33.32 2.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -77.45 -45.3 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.952 -160.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.59 -52.03 59.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 -156.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.87 -48.95 65.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.77 -41.75 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.21 -49.77 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.089 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.74 -46.24 89.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.87 -41.88 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.53 -33.55 85.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.505 175.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -66.78 -43.04 85.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.866 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.39 -39.85 94.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -61.79 -42.46 99.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.73 -34.83 75.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.8 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.02 -36.6 69.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.963 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -82.68 -42.0 18.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -172.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -100.15 -22.04 15.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.98 5.21 89.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.537 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.94 123.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.31 116.14 6.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.893 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG11 ' HA3' ' A' ' 24' ' ' GLY . 92.4 t -103.96 133.85 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.8 m -132.93 111.51 11.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.166 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.15 121.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.096 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -129.02 148.75 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.854 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -138.03 67.63 48.55 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.857 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 40.2 Cg_endo -78.65 -14.66 14.07 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 -164.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 59.1 m-20 77.16 6.44 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.34 -8.59 38.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mp -48.73 -52.82 21.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -159.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.8 -43.86 69.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.72 -40.87 20.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 -168.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.07 -43.51 28.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 -167.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.6 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 19.5 t80 -49.85 -54.6 30.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 110.887 -164.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 21.3 Cg_endo -60.4 -31.1 92.23 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -78.46 -49.88 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 19.5 m -74.23 -28.1 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.91 88.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.84 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.7 p -95.69 6.02 49.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.225 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.81 60.54 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.426 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.9 t0 -120.03 -172.95 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.38 -172.44 14.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.541 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HG3' HD11 ' A' ' 60' ' ' ILE . 94.4 Cg_endo -81.64 160.72 19.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.589 2.193 . . . . 0.0 112.391 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.14 -43.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 170.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.1 mt -132.4 141.85 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.141 -170.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.4 HD11 ' HG3' ' A' ' 57' ' ' PRO . 18.1 mm -123.15 131.95 72.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.214 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.93 121.36 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.944 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -148.11 165.0 32.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.877 169.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.49 -102.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.028 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -114.11 -56.59 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.79 -51.71 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -166.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 95.3 mtt-85 -75.36 -32.77 60.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -58.53 -49.44 77.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.852 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.62 -50.6 60.57 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.529 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -40.88 94.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.533 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 66' ' ' ARG . 14.8 m-30 -69.6 -31.94 70.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.901 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.51 96.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.039 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.44 -25.96 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -85.59 3.45 40.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.53 36.38 76.72 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.447 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.498 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 1.1 mp -75.27 -15.68 60.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.94 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -130.96 143.53 50.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 -170.086 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.94 162.3 14.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.143 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.51 137.71 56.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -110.66 153.35 12.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.2 p -130.07 64.92 74.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.604 0.716 . . . . 0.0 111.126 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.67 144.96 28.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.732 2.288 . . . . 0.0 112.27 167.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -76.5 178.48 6.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -68.27 -31.27 70.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.68 -34.4 67.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -61.79 -39.34 91.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -65.08 -40.22 94.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.3 -37.53 80.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.84 -29.5 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.1 -107.05 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.815 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -165.02 133.09 2.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.721 0.772 . . . . 0.0 110.974 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -66.25 -33.33 39.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -172.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.93 -36.51 83.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -75.47 -24.32 56.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.406 ' HA ' HG22 ' A' ' 97' ' ' VAL . 57.0 m95 -76.44 -28.65 56.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.951 173.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.34 -33.74 72.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' HD12 ' A' ' 329' ' ' ILE . . . -66.65 -26.43 67.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.147 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 30.2 m -109.15 16.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.2 -175.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.6 ttp-105 -109.79 136.53 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -136.76 125.65 24.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 57.71 34.71 24.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.44 89.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.461 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.76 144.91 48.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.39 125.59 32.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.0 pt -118.22 -11.65 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.144 -167.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.65 162.51 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.057 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -106.56 135.89 19.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.697 0.76 . . . . 0.0 110.89 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.9 Cg_exo -65.47 118.52 5.53 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 172.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.26 -36.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.065 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.83 153.25 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.58 128.35 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.192 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 53.8 mp0 -123.06 150.73 42.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.944 175.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.47 153.77 35.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 tp -71.03 136.2 48.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.002 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -138.72 158.21 44.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' HB2' HD23 ' A' ' 247' ' ' LEU . 38.7 tp -95.39 127.8 41.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 244' ' ' VAL . 81.0 mt -111.34 127.66 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.97 157.49 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -96.95 114.94 26.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -67.47 -29.44 68.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.68 -35.19 30.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.14 -43.93 27.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.21 109.2 15.09 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.637 0.732 . . . . 0.0 110.921 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.4 Cg_endo -73.29 167.65 26.77 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 112.379 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.566 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.6 t30 24.96 96.43 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.955 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -65.32 154.66 72.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.401 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.22 144.72 63.8 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.72 2.28 . . . . 0.0 112.378 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.97 -22.04 19.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.7 p -130.43 158.97 38.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.229 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.453 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 93.4 m95 -73.08 -24.58 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.91 -25.26 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.92 -21.48 57.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 32.9 mm -60.05 -51.92 77.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.534 0.683 . . . . 0.0 111.101 -166.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.4 Cg_endo -68.99 -42.74 3.89 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.448 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.43 92.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.01 -38.2 90.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.17 -39.87 94.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.66 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.85 -49.09 61.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.76 -16.52 53.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.961 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -53.59 -29.12 36.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.44 -19.88 64.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.34 7.73 38.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.92 28.45 62.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -106.49 157.23 17.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -106.88 149.66 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.902 160.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.56 -42.58 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.076 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 38.1 mt -138.2 141.98 40.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.857 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 75.4 mmm -140.22 118.18 11.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 163.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.24 168.44 26.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.791 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -72.41 104.29 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 206' ' ' ALA . 13.5 tp -87.66 -4.82 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 -174.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -87.59 10.27 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -133.64 148.1 67.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.67 0.747 . . . . 0.0 110.803 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 28.6 Cg_endo -68.68 -30.25 28.25 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.32 -174.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -57.59 -37.27 72.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.86 -28.62 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.765 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -77.75 -22.93 49.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.72 ' HB3' ' HG3' ' A' ' 256' ' ' LYS . 1.6 m95 -59.79 -46.81 98.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 -169.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 61.8 Cg_exo -44.43 -37.57 10.83 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.77 2.313 . . . . 0.0 112.337 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.32 -44.37 17.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.865 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.408 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 96.5 mt -72.97 -46.8 50.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -70.78 -17.59 62.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.35 -28.19 69.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.085 -166.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -100.31 7.16 44.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -170.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.7 4.66 55.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.507 169.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 187' ' ' GLY . . . -109.98 147.02 17.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.434 171.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.419 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 43.3 t80 -164.5 173.36 12.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 0.0 110.858 -167.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.48 -54.6 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -141.39 148.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -83.88 130.95 34.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -104.15 113.05 26.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.68 140.66 23.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 47.14 41.76 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.06 7.82 67.8 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 173.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.64 151.8 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -83.92 134.5 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -109.57 114.12 27.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.81 -19.99 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.63 -17.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -168.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -132.02 87.34 2.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 184' ' ' ASP . 13.9 m -127.23 166.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -171.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . -93.42 7.6 75.09 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 181' ' ' VAL . 11.0 m -96.61 -16.45 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.072 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 6.6 p30 -79.87 10.56 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 167.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.2 m-20 84.45 -4.54 1.02 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.75 158.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.22 -48.34 10.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.571 ' O ' ' HA3' ' A' ' 166' ' ' GLY . . . -75.92 -44.1 20.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -67.0 -34.72 78.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.841 0.353 . . . . 0.0 111.085 -160.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.49 -41.83 97.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -165.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.82 95.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 161' ' ' ILE . . . -65.48 -42.84 95.57 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -35.04 79.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.956 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 84.4 m -58.02 -47.96 81.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.117 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.11 -43.45 91.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.821 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.89 -48.69 79.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.2 -38.69 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.192 -175.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.12 -36.27 83.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -65.19 -36.4 84.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.993 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.91 -40.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.102 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.87 -39.56 93.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -85.42 5.0 32.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.72 31.93 11.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -83.05 -27.29 30.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 168.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 66.2 mtt -133.37 151.0 51.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.411 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 57.3 t-20 -95.64 132.55 40.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.431 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -67.44 -28.01 67.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -92.11 -8.88 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -168.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 87.0 m -55.5 126.48 25.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -121.14 -174.42 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.41 -44.78 92.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.0 m -60.73 -42.62 97.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.76 -42.28 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.83 95.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.26 -44.65 78.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.71 81.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -35.62 80.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -62.38 -29.94 70.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.14 -21.95 15.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.888 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 22.9 36.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.98 -27.07 43.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.863 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.5 t -124.95 140.0 53.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.98 -35.18 50.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.2 mtm -139.68 155.92 47.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -166.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -152.1 164.87 36.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -120.63 118.08 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -151.79 163.19 39.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.783 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.415 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -100.57 -141.31 11.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.638 ' HB3' HD22 ' A' ' 299' ' ' LEU . 39.8 Cg_endo -71.24 -25.52 21.96 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.366 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -65.79 -19.98 66.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -94.77 9.4 39.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -65.99 -38.78 89.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.2 t -54.63 111.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.424 ' HB3' ' OH ' ' A' ' 242' ' ' TYR . 68.7 m-80 -152.73 142.1 21.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.82 78.18 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -83.54 75.22 10.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.6 p -115.27 -9.03 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.9 p -103.2 -171.55 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.81 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.84 177.65 3.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -59.66 110.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.59 -57.87 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.814 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.424 ' OH ' ' HB3' ' A' ' 234' ' ' ASN . 49.2 p90 -110.2 159.52 17.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.95 167.61 25.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.49 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 116' ' ' ILE . 64.0 t -129.13 130.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.215 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.06 -177.25 5.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.197 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.17 160.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.101 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 115' ' ' LEU . 83.8 mt -70.9 143.27 88.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.559 0.695 . . . . 0.0 110.937 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' A' ' 255' ' ' SER . 57.7 Cg_endo -74.96 170.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.391 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -104.33 162.12 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.046 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -135.53 118.52 16.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.829 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 54.6 34.8 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.66 80.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 175.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 89.1 mm-40 -122.72 147.36 50.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.615 0.722 . . . . 0.0 110.94 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 51.4 Cg_exo -54.81 145.53 60.7 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.618 2.212 . . . . 0.0 112.424 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.453 ' HB3' ' HE1' ' A' ' 129' ' ' TRP . 95.3 p -70.53 -63.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.992 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 14.1 tmtt? -172.32 125.93 0.53 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.917 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.71 134.37 12.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.716 2.277 . . . . 0.0 112.313 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -161.08 110.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.05 134.98 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.816 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -119.86 147.26 18.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.9 t -122.59 121.75 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.125 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.54 130.99 45.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.954 174.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.0 m -127.72 139.85 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -165.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.19 137.21 49.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.101 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.0 168.11 23.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.339 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.79 129.14 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.108 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -57.44 125.37 22.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.68 -22.25 66.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.97 -12.48 55.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.145 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.0 t -70.77 136.65 85.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.773 0.797 . . . . 0.0 110.826 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.16 -14.63 23.24 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.625 2.216 . . . . 0.0 112.35 174.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -108.03 36.87 2.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.832 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.94 -38.71 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.17 -38.78 91.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.38 -49.38 67.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.55 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -168.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -66.48 -47.46 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.916 -172.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -47.94 72.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -72.14 -36.02 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 280' ' ' LEU . 5.1 tt -56.58 -47.81 78.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.01 -25.56 34.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -99.81 -13.12 19.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -171.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 70.6 t80 -124.36 -58.83 1.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.7 mt -69.71 -39.87 76.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.02 66.34 9.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 175.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 73.7 p -136.27 168.35 19.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.52 -45.25 73.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.87 -41.86 42.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.96 -49.63 9.65 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.497 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.32 -38.92 82.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.56 -43.22 99.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.83 76.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.068 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.6 t -74.38 -45.06 47.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -73.86 -14.28 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.3 -27.07 13.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -91.91 -4.24 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -91.15 151.29 42.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.573 0.702 . . . . 0.0 110.871 172.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.55 -57.72 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.638 HD22 ' HB3' ' A' ' 229' ' ' PRO . 61.8 tp -65.8 -47.78 73.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -167.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.06 86.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.469 ' HB1' ' SD ' ' A' ' 321' ' ' MET . . . -75.16 125.55 29.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 0.0 111.114 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.515 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -124.71 159.71 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -173.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.36 60.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.2 tp -75.3 123.57 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.65 -39.39 93.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.1 t -59.46 -48.37 81.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.515 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.6 t80 -71.38 -33.68 69.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.12 -39.45 82.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.86 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.56 -37.82 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -76.97 -37.31 55.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.8 mt -64.87 -31.61 72.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.11 -12.66 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.11 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.03 -20.05 58.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -91.81 117.93 68.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.801 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.74 -33.64 60.93 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.673 2.248 . . . . 0.0 112.337 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -72.55 -43.2 63.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -173.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.43 -38.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.99 72.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.72 89.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 80.9 m -67.2 -43.09 82.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.225 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.469 ' SD ' ' HB1' ' A' ' 301' ' ' ALA . 96.3 mmm -66.11 -34.62 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.14 -40.24 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -72.76 -34.57 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.18 -41.78 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -69.94 -17.03 63.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.03 -5.35 16.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.1 -164.07 39.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.476 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.61 147.53 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.432 HD12 ' HB2' ' A' ' 96' ' ' ALA . 39.2 mm -67.43 126.92 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 -166.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.816 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 54.2 mtt -52.64 -58.83 10.4 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 110.914 -171.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.524 ' CD ' ' HB2' ' A' ' 330' ' ' MET . 36.2 Cg_endo -63.98 101.08 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.762 2.308 . . . . 0.0 112.375 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.68 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 28.2 m120 -123.06 28.49 7.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -169.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.8 mt 90.23 135.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.667 0.746 . . . . 0.0 111.104 -176.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -54.79 -29.94 65.13 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.618 2.212 . . . . 0.0 112.332 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.437 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.6 mt-30 -64.09 -23.69 67.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.88 -26.82 65.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.15 -34.88 49.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -66.68 -40.13 88.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.07 -38.55 83.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.966 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -64.99 -36.26 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.72 -35.01 79.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.67 -40.2 76.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.17 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.613 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 58.0 ttp180 -56.38 -44.79 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.2 m -64.2 -44.46 91.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.485 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -63.52 -45.38 90.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -176.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.97 -36.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.09 -171.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.5 mt -68.98 -44.16 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.068 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.39 -35.74 81.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.817 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.84 -45.58 67.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.31 68.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -75.78 -12.69 60.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.77 6.99 88.6 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.22 -30.09 64.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.864 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -139.28 156.8 46.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 70.8 p -75.02 164.09 26.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 171.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.39 -50.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.51 -36.67 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -69.21 -48.06 63.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.55 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.079 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 41.1 tp -65.09 -44.08 90.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -46.51 88.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.68 -35.07 78.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.485 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -79.01 -43.28 24.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.172 -172.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 10.3 mm100 -77.97 -31.13 50.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -171.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 78.0 m -59.99 -38.03 81.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.48 -30.0 70.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.41 -45.42 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.4 p -97.85 -4.62 36.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -177.915 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.703 0.287 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.422 HG21 ' HD2' ' A' ' 271' ' ' PRO . 88.6 mt -61.76 125.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.083 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 164.35 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -66.93 121.99 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.73 19.76 59.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 -173.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -146.39 153.34 40.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.798 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.9 pp -143.15 145.87 33.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.08 124.79 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.553 HG22 ' HB ' ' A' ' 59' ' ' ILE . 5.7 pt -124.95 132.26 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -171.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.774 ' HB3' HD22 ' A' ' 43' ' ' LEU . 38.3 m0 -113.72 135.34 54.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.533 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.2 tt -148.17 155.09 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.455 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.1 t-20 -55.77 128.01 32.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.873 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.12 -16.86 76.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.441 -168.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -47.7 80.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 -165.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -134.58 63.46 1.62 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 152.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.533 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -100.53 -50.49 1.3 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -67.74 -43.54 79.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -160.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.38 -49.52 59.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -163.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.48 -48.44 81.97 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.488 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.2 mt -63.89 -34.57 78.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.843 0.354 . . . . 0.0 110.88 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.07 95.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.049 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -62.06 -49.37 76.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.85 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 292' ' ' ALA . 25.5 m -72.84 -32.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.48 -40.15 97.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.45 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.86 -43.94 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 110.819 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.88 -47.25 78.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 27' ' ' PHE . 6.9 m-30 -64.6 -41.85 95.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.889 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -65.09 -34.22 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.89 -40.71 79.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.77 -39.64 23.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.2 m -102.11 -26.35 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.15 -172.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.89 5.45 83.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 33' ' ' ILE . 19.5 tt -76.55 126.96 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.188 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.49 124.14 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.7 t -109.35 130.51 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.185 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -125.19 114.42 18.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 9' ' ' ILE . 51.7 t -103.83 120.23 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 57.6 mt-10 -131.12 146.46 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -139.92 67.81 35.0 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.699 0.762 . . . . 0.0 110.789 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.548 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -73.91 -16.62 23.1 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.694 2.262 . . . . 0.0 112.387 -167.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 62.0 m-20 74.74 7.6 4.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -173.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.51 -1.32 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 172.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 10' ' ' TRP . 34.5 mt -48.32 -54.33 14.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -156.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.79 -27.34 66.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 -167.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.61 -47.44 10.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -80.26 -40.97 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.998 -166.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 37.4 t80 -55.48 -58.88 13.05 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.604 0.716 . . . . 0.0 110.862 -165.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.8 Cg_endo -59.74 -30.7 92.7 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -75.05 -45.1 43.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 47' ' ' PHE . 33.2 m -73.75 -23.34 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.147 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.096 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.36 -24.8 66.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.32 4.61 53.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.0 22.29 74.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -139.39 -163.18 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 110.882 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.82 -165.83 22.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.627 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.495 ' HG2' HD11 ' A' ' 60' ' ' ILE . 84.4 Cg_endo -81.62 165.09 18.33 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 -173.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' HA ' HD11 ' A' ' 2' ' ' ILE . 43.6 t0 -83.95 -49.26 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.553 ' HB ' HG22 ' A' ' 9' ' ' ILE . 82.9 mt -133.97 138.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 -171.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.495 HD11 ' HG2' ' A' ' 57' ' ' PRO . 7.1 mm -120.86 139.69 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.239 173.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -99.53 130.9 45.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -139.69 158.3 44.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.8 -100.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 331' ' ' PRO . 3.8 p80 -110.94 -54.87 2.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -176.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.07 -49.8 75.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.37 -33.63 48.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.66 -48.36 81.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.813 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.16 65.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.559 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.04 98.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -70.14 -30.02 67.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -62.95 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -67.49 -28.09 67.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -85.57 0.14 53.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -173.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 34.85 80.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mp -87.07 -2.6 58.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.84 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.19 142.92 51.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.932 -175.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.38 152.63 22.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -67.04 135.34 53.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.48 HG13 ' HB3' ' A' ' 103' ' ' LEU . 30.5 pt -118.42 146.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -134.96 69.66 70.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.622 0.725 . . . . 0.0 111.165 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.96 144.54 43.18 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.712 2.274 . . . . 0.0 112.38 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -76.05 178.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.56 -31.91 73.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.87 95.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -67.82 -38.45 83.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.94 -41.55 95.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.14 -33.85 72.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.844 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -68.21 -22.48 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.892 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.7 mt -95.78 -125.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 34.3 t80 -153.68 136.48 9.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.743 0.782 . . . . 0.0 110.941 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.2 Cg_exo -58.24 -41.51 65.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.79 2.326 . . . . 0.0 112.316 -172.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.6 -43.54 84.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.13 -26.76 62.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.155 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -70.04 -40.07 75.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.91 -36.14 82.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 173.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.66 65.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.078 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.491 HG23 HD11 ' A' ' 103' ' ' LEU . 26.8 m -107.4 19.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -109.95 141.02 43.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -138.42 125.89 21.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.96 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.38 35.05 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.831 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.65 89.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.485 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.64 139.71 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.931 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 97' ' ' VAL . 10.7 tp -80.44 132.99 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.467 ' HB ' HD13 ' A' ' 76' ' ' LEU . 37.7 pt -124.38 -11.25 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 -165.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -157.32 162.49 39.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.009 -170.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.412 ' HB3' HD11 ' A' ' 285' ' ' LEU . 97.1 m-85 -113.15 140.78 24.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.623 0.725 . . . . 0.0 110.995 168.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.66 121.84 8.32 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -103.86 -42.7 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.72 153.34 29.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.127 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.84 133.77 56.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 11.7 mp0 -130.8 155.87 45.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.43 155.09 41.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.05 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.3 134.3 44.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.944 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.4 p -143.16 161.3 38.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.0 tp -98.99 127.89 45.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.2 mt -108.05 131.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.013 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -132.31 149.89 52.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.69 118.77 30.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 171.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.76 -34.66 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -81.63 -35.13 30.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.819 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.59 -44.72 23.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.44 HD12 ' HG3' ' A' ' 224' ' ' MET . 72.6 mt -131.68 115.79 15.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 0.0 110.861 173.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.554 ' O ' ' C ' ' A' ' 124' ' ' ASN . 90.2 Cg_endo -74.47 170.09 21.05 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.738 2.292 . . . . 0.0 112.368 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.554 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.4 t30 25.06 97.11 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 0.0 110.916 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 41.9 Cg_endo -65.49 157.16 59.68 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.401 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.85 149.91 60.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.576 2.184 . . . . 0.0 112.342 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.66 -27.71 13.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -126.25 156.44 40.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -66.24 -30.37 70.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.81 -26.58 58.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.93 -21.51 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.686 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 32.2 mm -59.74 -55.37 46.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.655 0.741 . . . . 0.0 111.14 -167.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.686 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 52.0 Cg_endo -75.0 -37.65 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.73 2.287 . . . . 0.0 112.354 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.85 96.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.76 -42.43 90.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.62 -41.52 99.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.988 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.52 -43.86 84.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.95 -45.58 67.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.5 pp -79.4 -22.51 44.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.007 -175.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' N ' HD12 ' A' ' 139' ' ' LEU . 83.9 tttt -61.06 -30.93 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -20.4 64.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.186 173.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.36 6.54 47.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.85 60.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.516 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.417 ' HB2' HD13 ' A' ' 139' ' ' LEU . 91.6 mttt -108.79 165.18 11.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.8 t -120.31 140.1 51.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 163.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.7 -33.66 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.5 mt -137.02 150.25 47.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 93.7 mmm -133.52 131.75 40.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 166.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -160.43 162.48 33.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.6 t-20 -84.24 110.71 18.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 -177.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 39.9 tp -96.09 4.49 52.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -173.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -81.21 2.12 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.53 151.92 48.12 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.667 0.746 . . . . 0.0 110.935 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.681 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.9 Cg_endo -72.61 -17.37 26.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.256 -174.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -52.47 -48.58 65.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.95 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.423 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 51.9 m-85 -83.51 -11.68 57.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -172.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -80.49 -19.02 46.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.485 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 6.5 m95 -59.79 -44.23 96.72 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.477 0.656 . . . . 0.0 110.921 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 66.6 Cg_exo -43.82 -31.22 3.44 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.714 2.276 . . . . 0.0 112.324 176.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 160' ' ' LEU . 3.4 tm? -87.61 -49.24 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.423 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -78.55 -47.66 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 -169.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -64.85 -26.42 68.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.09 -31.75 72.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -95.96 0.31 51.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.75 38.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.423 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -92.46 129.03 9.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.408 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -168.3 175.2 6.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 110.808 -172.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.76 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -137.42 150.7 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -99.6 127.56 45.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -97.35 112.49 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.903 -174.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -149.91 138.43 20.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.65 35.16 17.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.55 4.6 75.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.532 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.49 149.96 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -77.4 135.25 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.45 107.25 18.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.8 tp -65.5 -19.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.55 -8.45 56.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -122.63 76.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.846 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.604 ' CG2' HG22 ' A' ' 183' ' ' VAL . 31.0 m -131.19 164.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -171.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.43 13.13 56.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.602 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.604 HG22 ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -99.74 -20.17 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.754 0.312 . . . . 0.0 111.082 174.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 99.7 m-20 -78.36 3.0 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 167.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 84.4 m-20 83.81 -4.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.792 163.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.1 -50.8 17.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.13 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.61 -42.1 14.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.45 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.7 78.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -164.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -63.27 -44.69 94.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -166.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.95 98.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.039 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.95 -42.28 98.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.424 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.34 -43.15 91.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.857 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.6 m -61.76 -44.21 97.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.505 ' CD2' HD21 ' A' ' 160' ' ' LEU . 1.1 t80 -63.11 -41.51 99.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.89 -40.53 95.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.34 -37.74 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -66.11 -35.13 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.46 -41.46 89.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.913 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.1 -36.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.65 -37.06 84.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -84.43 3.19 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 60.78 39.8 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -79.28 -26.85 42.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -149.46 150.86 33.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -95.37 149.83 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.877 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.66 -25.62 68.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -92.82 -7.28 46.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.779 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 m -58.61 125.54 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 59.6 p30 -139.07 -179.96 6.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -62.65 -33.05 74.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.9 m -63.79 -44.13 94.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.73 -40.04 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.168 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.76 99.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.9 -43.89 91.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.95 82.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.37 99.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -66.21 -35.56 80.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.807 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -64.44 -29.59 70.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.58 -19.0 19.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.01 25.18 38.4 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -84.68 -19.53 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.955 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -128.19 144.52 51.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.44 -35.29 14.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.506 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.2 mtm -142.29 160.6 39.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.933 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.0 t -150.46 160.31 43.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.21 118.92 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 65.0 m-80 -151.94 160.33 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 -173.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -107.34 -135.58 7.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.418 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.659 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 25.4 Cg_endo -68.0 -28.13 35.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 -175.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -67.38 -15.08 63.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.892 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -88.7 21.26 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -62.57 -31.36 72.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.0 t -63.72 106.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.816 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -149.13 130.01 14.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.8 mt -91.08 80.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -84.96 73.71 10.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.9 p -120.25 -12.38 9.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.9 p -110.1 -170.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.22 172.86 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.14 104.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -105.08 -59.35 1.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.02 153.85 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.41 159.54 23.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.73 128.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.999 0.428 . . . . 0.0 111.102 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.01 174.71 10.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.178 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.04 159.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.21 146.09 96.59 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.44 160.23 50.61 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.734 2.289 . . . . 0.0 112.313 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.0 p -104.52 151.54 23.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.023 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -130.78 116.08 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 55.53 33.88 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.75 68.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.518 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -126.25 148.88 65.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.36 144.25 79.5 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -74.08 -57.0 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -172.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.421 ' HG3' ' HD3' ' A' ' 159' ' ' PRO . 10.0 tmtt? -150.1 111.18 3.28 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.519 0.676 . . . . 0.0 110.974 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.96 127.62 11.6 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.784 2.323 . . . . 0.0 112.299 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.407 ' CE2' ' SD ' ' A' ' 330' ' ' MET . 31.0 t80 -158.91 119.44 3.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 -178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.43 130.89 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 167.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.05 135.09 12.05 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.455 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -124.86 128.47 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.141 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 68.3 tp -73.18 135.01 44.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -133.87 160.68 36.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.803 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.94 136.81 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.058 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -113.13 148.95 18.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.477 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 93.5 mt -108.71 124.88 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 270' ' ' SER . 45.1 t-20 -51.6 120.14 4.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -174.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.72 -22.59 66.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.5 -8.93 58.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.193 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 29.4 t -71.41 129.19 89.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.74 0.781 . . . . 0.0 110.786 -171.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.422 ' HD2' HG21 ' A' ' 2' ' ' ILE . 90.6 Cg_endo -71.59 -14.86 30.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.646 2.231 . . . . 0.0 112.267 170.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -107.79 29.14 7.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.929 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.23 -33.62 67.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.39 -38.96 92.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.832 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.88 -41.62 82.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 174.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.35 69.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.042 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -71.13 -38.62 72.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 96.4 mt-10 -72.19 -48.28 44.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 -173.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -62.73 -40.41 97.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 284' ' ' LEU . 2.8 tt -60.68 -48.4 81.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 -177.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -83.57 -31.13 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.0 m-20 -97.99 -22.15 16.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -166.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.456 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 m-85 -121.37 -51.82 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 58.9 tp -70.64 -46.87 62.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.912 -176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 106' ' ' TYR . 92.2 mt -87.05 63.54 7.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.6 p -135.23 169.39 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 172.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.72 -44.35 77.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.14 -44.3 22.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.952 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -70.95 -47.11 40.48 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -170.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.82 -35.41 78.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -62.05 -40.01 94.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -64.93 -38.56 91.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -174.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.0 p -80.75 -33.71 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.126 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -72.23 -31.74 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -172.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -59.54 -22.5 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.15 -10.16 34.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.38 152.03 75.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.47 -61.58 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.559 2.173 . . . . 0.0 112.385 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.95 -43.2 18.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.939 0.4 . . . . 0.0 110.922 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.75 14.86 79.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.551 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -84.39 127.63 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.047 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.54 160.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.134 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.4 -10.32 59.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.185 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 52.8 tp -74.22 121.13 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.37 -49.05 77.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -171.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.6 m -60.76 -43.41 98.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.884 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -70.12 -35.67 74.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.834 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.03 -31.12 72.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.808 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.85 -39.19 90.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.05 -37.68 61.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.819 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.405 ' HB3' HG21 ' A' ' 317' ' ' ILE . 90.9 mt -65.06 -27.47 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.26 -15.62 57.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.59 -21.05 61.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.843 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -86.58 120.73 72.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 110.807 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.87 -27.78 80.6 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.631 2.221 . . . . 0.0 112.383 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -70.03 -39.67 75.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 311' ' ' LEU . 47.4 mm -77.27 -36.37 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.242 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.11 76.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.243 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.38 -41.42 89.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -64.14 -47.16 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.198 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.5 tpt -66.89 -36.99 83.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -61.96 -43.27 99.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.888 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -74.97 -36.42 62.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.58 93.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -69.72 -18.99 63.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -109.51 -6.56 15.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.912 -172.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.52 36.57 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.43 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -126.38 139.26 53.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 110.813 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.544 HG13 ' HD2' ' A' ' 331' ' ' PRO . 2.2 tp -70.54 136.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.573 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 83.0 mmm -52.51 -52.57 62.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -172.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 64' ' ' HIS . 51.2 Cg_endo -66.86 82.29 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.757 2.305 . . . . 0.0 112.337 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.639 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 76.5 m-20 -107.15 29.63 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.7 mt 86.96 135.09 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.592 0.711 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -52.76 -31.81 52.8 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 0.0 112.259 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.414 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.9 mt-30 -61.46 -28.49 69.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.965 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.94 -37.06 86.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.17 -39.69 95.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -38.17 80.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.448 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.6 m-30 -65.75 -32.91 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.937 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -59.09 -40.08 84.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.984 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.99 -36.28 72.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.992 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.13 90.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.5 m -74.1 -25.38 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.681 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 75.0 ttt-85 -55.8 -40.56 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.0 m -60.79 -45.55 93.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.165 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 364' ' ' ALA . . . -65.44 -43.52 90.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.38 -53.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 -170.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.97 -44.97 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 -173.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -63.64 -37.33 86.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.22 -46.62 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.58 -35.33 75.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.08 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -80.47 -10.83 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.841 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.95 13.2 81.65 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.496 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.36 -30.08 57.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.845 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -137.33 156.88 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.9 m -70.74 149.7 46.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.06 -49.3 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.67 -43.09 90.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.3 -47.07 65.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.59 96.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 59.6 tp -65.62 -44.8 85.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.08 -49.6 71.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.932 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.74 -38.39 83.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 346' ' ' ALA . . . -73.99 -42.74 59.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.06 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 9.5 mm100 -78.26 -27.65 47.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -173.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 51.6 m -58.27 -37.07 74.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.88 -29.6 70.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.08 -40.0 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 57.8 p -94.04 -12.76 27.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.061 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.704 0.287 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -76.38 135.1 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.163 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.19 173.63 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.53 122.5 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 23.81 39.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -145.92 154.87 42.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.3 pp -150.98 149.26 29.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 172.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 58' ' ' ASP . 97.2 t -125.63 129.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -115.32 130.46 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.567 ' HB3' HD22 ' A' ' 43' ' ' LEU . 22.6 m0 -114.6 129.82 56.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -152.67 155.24 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.2 t-20 -54.77 127.18 27.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 173.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.94 -18.34 80.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 -167.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -56.59 -50.88 70.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.857 -163.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -134.8 75.41 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 147.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -104.69 -37.56 2.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -78.18 -46.58 20.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.957 -157.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.7 -52.15 53.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.903 -153.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.46 -48.86 60.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.44 -41.59 98.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.891 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -49.05 69.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.26 -47.15 80.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.876 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -44.82 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.24 -36.48 90.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.399 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -65.48 -40.61 93.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.861 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.06 -39.87 91.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -65.27 -40.07 93.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -59.95 -35.84 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.77 -37.39 70.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.2 -40.37 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 -172.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.5 m -104.36 -18.13 14.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -172.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.29 86.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.471 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -88.46 128.18 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 111.197 177.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.28 129.6 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -172.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.5 t -110.23 136.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.6 m -133.9 112.62 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.3 t -106.52 124.02 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -129.89 152.55 49.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.428 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.7 p80 -134.38 74.05 67.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.615 0.721 . . . . 0.0 110.828 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 19.2 Cg_endo -71.13 -27.39 20.21 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.725 2.283 . . . . 0.0 112.297 -162.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 60.6 m-20 77.7 4.17 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.847 -172.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -98.04 -0.46 44.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 10' ' ' TRP . 89.2 mt -48.91 -56.59 8.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.952 -152.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -65.06 -27.8 69.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.786 -165.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -85.3 -43.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -79.32 -45.0 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.964 -166.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.877 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 5.9 t80 -52.5 -53.59 51.84 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -163.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 72.7 Cg_exo -55.11 -38.87 93.27 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.659 2.24 . . . . 0.0 112.302 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.67 -46.76 35.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.969 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.73 -28.04 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.46 84.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 -24.58 67.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -96.37 5.79 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.76 74.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.466 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -116.99 -172.23 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.872 0.368 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.34 -173.8 26.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.581 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.62 159.74 28.4 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.643 2.229 . . . . 0.0 112.45 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 276' ' ' ALA . 33.9 t70 -75.63 -38.87 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 171.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -131.99 139.83 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -136.37 136.29 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -103.36 135.39 45.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -141.35 155.9 45.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.926 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.23 -106.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.068 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.412 ' CG ' ' N ' ' A' ' 65' ' ' ASP . 12.6 p80 -109.79 -54.83 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 64' ' ' HIS . 38.9 t70 -62.37 -48.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -164.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -79.57 -36.34 38.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -58.58 -51.26 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.835 -168.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.37 -51.46 54.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.571 -171.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -40.85 92.15 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.44 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -70.1 -30.38 67.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 0.0 110.994 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -64.03 -42.64 97.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.014 174.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -65.8 -28.06 68.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.923 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -85.17 2.76 42.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.74 36.1 86.75 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.522 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.32 -23.83 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.24 144.71 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 -159.289 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.26 157.59 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.71 138.22 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.8 pt -107.81 151.03 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.2 p -128.54 69.4 79.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.555 0.693 . . . . 0.0 111.16 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.06 141.65 26.72 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.786 2.324 . . . . 0.0 112.214 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -79.27 169.59 17.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.95 -30.44 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.12 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.016 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -77.98 -35.82 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.858 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -61.64 -44.19 97.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.26 -28.32 65.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.812 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.836 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.0 mt -100.5 -113.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.872 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 22.4 t80 -158.92 133.08 5.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.992 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 86.1 Cg_exo -57.28 -41.0 77.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.745 2.297 . . . . 0.0 112.363 -173.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.22 -39.11 93.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.6 p -71.9 -24.84 61.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.187 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.427 ' HA ' HG22 ' A' ' 97' ' ' VAL . 60.9 m95 -71.16 -36.33 71.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.85 -28.68 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.55 -27.69 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 94' ' ' TRP . 36.0 m -110.97 10.95 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -100.22 130.05 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.973 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -129.3 120.47 25.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 58.53 35.13 24.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.46 5.01 90.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.88 145.62 47.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 110.975 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.68 125.8 34.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.45 ' HB ' HD13 ' A' ' 76' ' ' LEU . 40.9 pt -120.89 -6.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 -169.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -161.77 164.48 28.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 -172.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.1 m-85 -108.46 134.64 20.17 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.669 0.747 . . . . 0.0 110.962 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.3 Cg_exo -64.07 121.0 8.52 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.243 . . . . 0.0 112.321 171.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.98 -40.07 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.48 151.62 20.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.065 -166.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.9 t -129.67 129.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 46.1 mt-10 -128.52 153.08 47.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.93 157.04 41.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.3 tp -71.1 131.81 44.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.0 m -139.7 155.94 47.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.91 126.33 40.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 85.0 mt -108.5 127.41 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -137.48 154.71 49.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.9 t-20 -91.32 118.22 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.812 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.659 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -68.21 -29.58 68.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.906 -172.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.05 -38.56 44.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.17 -35.31 42.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.95 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.2 tp -134.43 111.19 11.63 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.624 0.726 . . . . 0.0 111.006 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.594 ' O ' ' C ' ' A' ' 124' ' ' ASN . 84.2 Cg_endo -74.87 172.29 16.61 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 170.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.7 t30 22.5 96.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 110.959 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.21 156.4 65.88 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 144.98 60.44 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.744 2.296 . . . . 0.0 112.331 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.07 -29.45 15.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.8 p -126.04 158.8 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 -175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -68.75 -32.76 72.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.51 -26.45 54.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.828 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.16 -20.97 60.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.1 mm -58.86 -54.29 57.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.647 0.737 . . . . 0.0 111.129 -169.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 26.3 Cg_endo -65.15 -41.32 16.89 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.738 2.292 . . . . 0.0 112.399 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.65 93.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.02 -37.37 87.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.87 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.01 -40.15 94.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.31 -37.88 81.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 60.5 mt -70.38 -35.45 73.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.09 -32.29 64.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.998 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.45 66.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -104.29 4.79 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.83 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.49 26.42 67.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.498 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 82.4 mttt -113.16 156.44 23.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.6 t -113.4 148.8 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.817 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.22 38.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.2 mt -139.75 149.85 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.9 mmm -137.28 115.81 12.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.23 165.83 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.54 148.19 22.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.416 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 57.6 tp -107.01 -0.01 23.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -78.74 -11.17 59.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -138.45 145.44 46.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.561 0.696 . . . . 0.0 110.932 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.771 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.2 Cg_endo -68.04 -25.53 37.89 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.715 2.277 . . . . 0.0 112.286 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.03 -46.41 85.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.804 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.28 -26.04 58.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.806 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.5 p -82.39 -18.44 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -58.54 -45.55 99.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.432 0.634 . . . . 0.0 110.875 -169.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 79.2 Cg_exo -46.93 -38.66 23.88 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.627 2.218 . . . . 0.0 112.335 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.89 -41.06 26.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.428 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.7 mt -77.95 -47.57 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -68.58 -17.26 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.36 -33.12 74.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -99.14 -2.55 36.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.45 11.19 20.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.496 168.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -108.26 138.18 14.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.451 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 19.4 t80 -165.56 175.7 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -167.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.81 -59.74 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.221 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -142.42 150.1 40.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -85.95 133.12 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.827 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -108.34 114.28 28.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -147.47 140.08 24.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -170.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.58 41.01 9.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.03 6.64 68.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.516 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -137.32 152.75 50.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.99 133.8 36.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -107.97 109.14 20.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -174.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -67.52 -20.09 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.102 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -82.08 -16.6 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -168.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.49 87.24 2.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 184' ' ' ASP . 12.7 m -129.63 166.87 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.129 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -87.18 2.19 86.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.1 m -98.56 -16.77 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 111.097 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 181' ' ' VAL . 25.7 p30 -80.3 7.91 8.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 170.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 85.3 m-20 84.19 -7.05 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 161.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.55 -47.59 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.86 -46.55 22.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -71.54 -31.79 67.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.385 . . . . 0.0 111.096 -163.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.45 -44.35 94.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -160.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.69 97.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.428 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.04 -40.09 98.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.434 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.15 -41.02 90.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.7 m -62.46 -42.15 99.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.15 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.75 -40.44 88.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.45 -48.79 79.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.07 -39.6 86.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -41.11 98.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.6 OUTLIER -73.01 -32.12 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -177.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.78 -38.0 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 173.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.47 -34.82 78.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -85.91 -3.73 58.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 61.5 36.87 16.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.937 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -75.38 -17.45 60.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.69 156.15 47.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -101.71 134.18 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.792 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.14 -32.39 74.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.035 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.58 -5.72 45.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -164.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.1 m -61.74 130.72 47.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.184 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -135.87 -172.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.921 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.48 -47.47 79.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.924 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.7 m -63.65 -42.62 98.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.65 -44.93 93.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.0 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.66 -45.12 88.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.47 87.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.062 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.4 98.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -65.82 -38.69 89.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.828 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.39 -29.44 70.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.66 -19.82 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.86 21.4 50.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -77.41 -24.0 50.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.924 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -133.64 149.46 51.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.066 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.37 -20.82 20.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -138.06 154.9 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 -170.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -159.54 162.43 35.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.08 120.82 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 71.0 m-80 -145.92 158.61 43.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -176.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -95.54 -151.85 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.592 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 29.4 Cg_endo -65.2 -25.15 57.89 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.729 2.286 . . . . 0.0 112.291 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -66.0 -18.09 65.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -87.35 23.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -63.44 -29.98 71.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.1 t -66.41 107.78 2.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -149.31 129.98 14.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.45 81.18 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -84.68 72.86 10.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.4 p -114.54 -13.83 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.182 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.1 p -94.39 -169.94 2.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.61 175.74 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.852 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.31 107.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.121 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -120.42 -59.32 1.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 52.1 p90 -111.62 160.5 17.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.659 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -148.86 167.13 29.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.7 134.17 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 111.1 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -136.99 174.86 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 -171.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -79.74 161.48 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -176.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.62 142.83 86.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.508 0.671 . . . . 0.0 110.907 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.14 166.49 27.9 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.65 2.233 . . . . 0.0 112.253 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 66.8 p -118.74 150.74 39.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -128.18 115.25 18.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.81 35.13 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.29 21.14 46.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.553 173.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.8 144.78 53.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.582 0.706 . . . . 0.0 111.021 -172.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.43 141.97 70.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.626 2.217 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.7 t -68.8 -58.88 3.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.749 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 158' ' ' TRP . 5.5 tmtt? -150.8 110.59 3.12 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 0.0 110.916 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.39 122.5 7.05 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.684 2.256 . . . . 0.0 112.474 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -163.89 113.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.2 p -141.67 135.87 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.655 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -117.93 140.11 15.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.92 125.14 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.205 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 61.6 tp -73.37 137.25 44.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.7 m -123.88 141.56 51.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -119.87 128.02 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.34 158.2 15.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.1 127.13 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.889 0.376 . . . . 0.0 111.15 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -56.98 120.63 8.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.85 -26.13 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.04 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.72 -11.45 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.1 t -70.77 130.1 89.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 110.748 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.08 -13.11 37.23 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -110.12 27.06 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -55.19 -33.91 63.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -67.94 -37.93 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.851 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.01 -42.42 94.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.429 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . . . -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -174.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -63.32 -45.63 90.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.25 -54.16 23.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -36.37 71.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -171.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 284' ' ' LEU . 64.6 tp -58.98 -47.74 84.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 176.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -75.26 -35.0 61.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -98.28 -9.16 25.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -164.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.819 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 80.2 m-85 -127.59 -55.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 177.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.477 ' HB2' HD12 ' A' ' 280' ' ' LEU . 51.3 mt -76.76 -28.88 55.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -170.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.7 mm? -108.1 51.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.7 p -132.49 168.47 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -56.16 -46.05 79.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.15 -42.71 45.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.819 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.39 -50.77 6.44 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -171.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.77 -40.11 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.738 0.304 . . . . 0.0 110.899 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.24 -42.6 99.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.855 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.5 -32.57 74.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.2 t -71.04 -36.82 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.096 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.53 -12.75 61.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.838 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.09 -24.31 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -97.83 -7.67 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -87.18 145.15 37.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 110.96 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.47 -62.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.528 2.152 . . . . 0.0 112.369 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.17 -47.98 39.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.95 -170.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 88.23 -5.67 84.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.615 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.62 119.68 16.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 111.091 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.15 160.3 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -171.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.43 -12.46 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 172.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.8 tp -73.37 118.32 16.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.38 -44.6 90.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 74.6 m -59.32 -44.66 92.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.03 -34.52 68.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -60.54 -36.72 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -75.71 -38.31 58.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.05 -28.7 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.91 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.62 -12.32 52.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.073 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.23 -19.93 55.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -88.75 118.45 69.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.599 0.714 . . . . 0.0 110.795 173.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.43 -35.35 65.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.717 2.278 . . . . 0.0 112.328 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -72.81 -44.26 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.77 -41.04 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.99 73.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.0 84.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 51.6 m -66.35 -41.92 88.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.7 mmm -67.53 -35.38 78.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.39 -36.11 82.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -68.2 -38.05 81.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.819 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.28 90.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -66.88 -16.39 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.92 -6.9 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.36 -165.13 36.24 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.361 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -129.97 143.41 50.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.902 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.577 HG13 ' HD2' ' A' ' 331' ' ' PRO . 5.0 tp -67.28 134.34 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.215 -168.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.655 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 59.4 mtt -51.96 -55.69 28.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.577 ' HD2' HG13 ' A' ' 329' ' ' ILE . 34.4 Cg_endo -62.64 86.53 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.774 2.316 . . . . 0.0 112.309 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.642 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 70.1 m-80 -107.88 22.97 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 46.0 mm 89.05 134.83 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.724 0.774 . . . . 0.0 111.02 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.65 -30.58 66.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.692 2.262 . . . . 0.0 112.252 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -59.96 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.907 -176.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.0 mmm -70.11 -24.66 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.86 -40.7 97.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.45 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -65.54 -33.79 76.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.66 -43.84 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.947 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -67.74 -34.98 77.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.4 82.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.171 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 29.4 m -75.65 -27.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.199 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.771 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 80.6 ttt180 -57.45 -41.88 81.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.809 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.6 m -63.4 -45.86 89.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -61.92 -43.85 97.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.39 -50.74 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.152 -174.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.96 -45.53 90.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.027 -175.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.76 -35.79 82.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.57 61.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.52 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -76.04 -13.52 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.27 7.45 87.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.34 -30.11 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 0.0 110.959 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -136.2 154.92 50.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.5 m -67.94 150.98 47.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.83 -47.97 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.177 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.42 -40.64 89.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.38 -46.13 64.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.87 85.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 188' ' ' ALA . 62.0 tp -62.71 -46.91 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 110.959 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -48.7 69.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.04 -37.24 81.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -80.39 -43.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -78.49 -31.85 47.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.81 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.9 m -59.08 -37.8 77.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.18 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.42 -29.07 68.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.88 -44.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.03 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.1 p -97.46 -6.34 34.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.191 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -178.946 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.759 0.314 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.4 mt -81.75 123.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.33 166.75 20.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.985 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.0 131.49 45.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.96 17.49 56.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.24 163.53 35.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.831 0.348 . . . . 0.0 110.92 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 33' ' ' ILE . 1.8 pt? -145.65 153.93 41.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.14 127.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.645 ' HB3' HD22 ' A' ' 43' ' ' LEU . 26.8 m0 -110.08 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.5 tt -150.13 153.72 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -55.9 134.01 51.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.39 -16.21 75.42 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 -171.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.92 -43.16 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 -168.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.82 80.79 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 149.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.8 -52.56 1.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.496 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.07 -48.9 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -156.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.86 -53.16 51.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.84 -151.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.726 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -67.77 -49.89 45.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.465 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.65 -41.32 98.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.855 0.36 . . . . 0.0 110.996 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.7 73.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.56 -46.84 77.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.07 -45.81 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.082 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -62.77 -34.19 89.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.26 -45.82 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.861 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.82 -45.1 94.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -66.64 -37.86 85.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -60.56 -34.78 74.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.753 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.37 -38.88 74.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.03 -40.57 24.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -172.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -107.5 -15.35 14.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -171.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.03 1.2 88.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.418 168.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -85.99 127.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.931 0.396 . . . . 0.0 111.185 176.145 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.53 129.99 38.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.8 t -108.19 129.07 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.18 177.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.84 115.88 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.59 124.98 66.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -126.83 143.22 51.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.41 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 28.0 p80 -139.94 65.34 30.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 46.5 Cg_endo -72.18 -21.68 23.29 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.794 2.33 . . . . 0.0 112.247 -174.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 69.6 m-20 67.02 14.32 9.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 -172.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.63 -1.82 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.645 HD22 ' HB3' ' A' ' 10' ' ' TRP . 60.3 mt -52.33 -49.1 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 -152.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -65.84 -27.64 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.808 -169.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.39 -42.85 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -76.96 -40.19 47.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.627 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 47.1 t80 -51.39 -57.81 12.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.729 . . . . 0.0 110.839 -169.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.2 Cg_endo -60.93 -29.68 88.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.241 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.18 -47.03 30.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 33.4 m -75.0 -29.6 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.87 87.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.13 -23.94 66.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.3 p -96.05 5.33 51.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -174.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.97 67.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.538 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.7 t0 -120.0 -174.17 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.933 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.97 -170.9 13.59 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.25 162.99 19.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.35 -40.87 16.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 169.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.54 142.78 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -171.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -122.22 131.36 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -112.31 122.37 47.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.464 ' CZ2' HD12 ' A' ' 43' ' ' LEU . 95.1 m95 -148.48 156.7 42.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 168.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -81.96 -103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.029 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -112.07 -54.98 2.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.75 -50.19 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 -168.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.21 -31.56 69.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.944 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -60.71 -48.17 83.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -50.41 63.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.533 -172.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.14 98.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -70.91 -29.83 66.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 110.933 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.48 98.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.083 173.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.92 -26.37 65.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.895 173.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -84.89 1.86 45.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.02 36.67 51.33 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.515 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 mp -81.16 -10.06 59.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.564 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -132.98 144.45 50.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -178.09 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.47 162.96 12.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.49 134.66 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -112.39 153.27 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.3 p -132.16 65.43 75.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 111.194 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.16 148.21 43.93 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.383 171.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -77.57 -179.82 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.49 -31.43 72.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.36 -38.49 77.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.991 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.09 -38.74 86.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.57 -43.39 97.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -71.06 -31.28 67.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.66 -30.55 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.414 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.8 mp -108.77 -92.7 0.42 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -175.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 29.6 t80 -167.19 133.05 1.74 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.997 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 99.1 Cg_exo -54.05 -40.17 82.49 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.745 2.297 . . . . 0.0 112.336 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 92' ' ' PHE . 1.3 t80 -65.27 -39.44 92.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 p -70.9 -26.74 63.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.414 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 79.1 m95 -79.75 -32.59 41.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 174.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.43 -29.67 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 169.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.78 67.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.068 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.29 15.79 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -98.93 133.62 42.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.917 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -136.29 125.42 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 58.43 34.5 24.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.82 2.29 90.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.507 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.45 144.84 49.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.73 132.01 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.6 pt -118.37 -8.61 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.053 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.007 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.5 m-85 -106.53 132.62 20.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.668 0.746 . . . . 0.0 110.913 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 10.1 Cg_exo -72.85 132.71 18.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.746 2.297 . . . . 0.0 112.323 173.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.79 -50.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.151 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.15 151.62 33.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 -163.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.87 132.63 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.823 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 98.1 mt-10 -129.46 150.55 50.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.93 155.06 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -71.34 141.42 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -145.24 163.73 33.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' A' ' 248' ' ' PRO . 45.9 tp -96.57 127.55 42.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.5 mt -113.68 125.77 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -133.49 157.07 46.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.8 t-20 -94.67 118.14 31.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -65.72 -35.33 80.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -173.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.54 -35.43 58.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.56 -45.19 17.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 64.8 tp -126.62 108.62 23.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.709 . . . . 0.0 110.926 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 124' ' ' ASN . 98.7 Cg_endo -75.52 164.91 31.56 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.329 173.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.552 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.5 t30 24.96 96.3 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.56 155.4 70.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.721 2.281 . . . . 0.0 112.356 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.28 150.36 64.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.593 2.195 . . . . 0.0 112.357 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.11 -21.16 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.923 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.9 p -129.22 159.48 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.706 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 85.0 m95 -73.21 -24.66 60.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.965 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.46 -25.09 64.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.79 -20.02 50.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.675 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.2 mm -58.85 -55.43 46.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.626 0.727 . . . . 0.0 111.15 -168.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.0 Cg_endo -74.24 -37.34 2.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.45 95.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.01 -39.49 93.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 173.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.91 -37.48 87.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.54 -42.8 99.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.79 -36.29 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.764 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.594 HD12 ' HB2' ' A' ' 146' ' ' ALA . 71.6 mt -70.06 -30.93 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.39 -33.69 63.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.71 -25.03 67.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -102.55 2.82 36.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.7 30.77 61.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 89.1 mttt -116.61 162.63 17.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.517 ' H ' ' HA ' ' A' ' 222' ' ' THR . 44.7 t -120.98 146.91 46.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.594 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -82.7 -25.63 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.126 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 tp -137.79 136.27 37.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 -173.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 91.6 mmm -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -161.61 161.16 29.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.893 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -86.28 133.41 33.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 41.1 tp -103.38 4.31 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -74.39 -13.1 60.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.95 146.91 63.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 0.0 110.929 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.556 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 42.4 Cg_endo -67.77 -24.93 40.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.571 2.18 . . . . 0.0 112.331 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -49.96 -42.08 48.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -80.33 -23.31 40.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -170.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.9 p -79.27 -23.22 43.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.581 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 49.1 m0 -57.26 -45.72 99.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.533 0.682 . . . . 0.0 110.932 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 91.3 Cg_exo -50.9 -37.34 55.63 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 2.229 . . . . 0.0 112.306 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.17 -40.28 24.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 347' ' ' VAL . 96.7 mt -73.44 -50.01 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -72.17 -14.96 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.048 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -61.68 -31.76 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.047 -174.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -102.28 1.77 36.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.47 1.58 40.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -86.84 136.61 14.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.363 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.472 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 21.3 t80 -169.95 176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.931 0.395 . . . . 0.0 110.978 -176.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.91 83.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -139.83 153.22 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.18 130.59 35.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.815 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -100.21 115.64 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -148.63 140.11 23.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.93 37.4 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.902 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.13 82.32 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -136.34 151.2 49.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.846 0.355 . . . . 0.0 110.958 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.48 131.71 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 171.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -94.28 109.71 21.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.49 -20.79 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.37 -10.35 46.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -130.21 95.5 3.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 174.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 183' ' ' VAL . 35.0 m -109.47 159.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -173.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -95.86 -2.24 61.26 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 167.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.437 HG22 ' HB ' ' A' ' 181' ' ' VAL . 8.0 m -85.96 -5.94 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 54.6 p30 -76.18 10.66 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 171.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 81.8 m-20 84.55 -4.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 168.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.38 -51.98 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.34 -50.2 7.64 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.13 73.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.61 -40.49 97.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -173.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.14 96.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.67 96.46 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.435 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 361' ' ' LEU . 78.8 mt -65.36 -34.93 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.927 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.4 m -56.36 -51.91 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -172.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -68.16 -44.95 74.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.9 tt -59.83 -50.82 72.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.809 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.32 -37.86 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.132 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.16 -36.83 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.818 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -36.07 83.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.67 -39.84 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.87 -39.81 94.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -84.34 5.41 27.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.1 32.17 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -87.86 -22.92 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -139.58 145.21 38.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.52 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 54.1 t-20 -94.67 134.72 36.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 176.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.09 -25.18 64.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.074 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -95.69 -15.16 22.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.732 -171.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.52 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 55.2 m -64.79 137.69 57.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.25 176.67 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.902 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -65.07 -29.64 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.2 m -64.73 -42.95 94.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.906 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.83 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.201 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.86 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.068 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.95 -43.99 90.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.798 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.77 77.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.086 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.0 97.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -64.0 -35.79 81.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 0.0 110.927 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.68 -28.88 69.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.55 -18.99 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.22 47.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.477 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.83 -19.72 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 110.91 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.517 ' HA ' ' H ' ' A' ' 145' ' ' SER . 15.2 t -130.7 144.5 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -94.46 -35.01 12.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 56.2 ttp -145.55 153.81 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -154.48 168.09 27.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.5 tt -126.3 123.45 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.066 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.52 162.44 41.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.22 -165.9 37.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.549 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.823 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 35.7 Cg_endo -66.39 -21.52 53.72 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -65.96 -18.12 65.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.46 5.63 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -62.72 -40.11 96.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.5 t -55.65 109.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -150.17 159.86 44.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.832 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.22 80.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.03 75.09 10.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.976 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.4 p -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.183 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 76.6 p -104.19 -174.8 2.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.27 176.89 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.884 172.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.09 104.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -113.3 -54.56 2.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 50.8 p90 -114.09 159.31 20.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.62 165.04 27.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.463 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 85.7 t -132.34 135.15 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.092 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.41 -179.84 6.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.6 160.49 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.089 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.14 139.27 90.03 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.543 0.687 . . . . 0.0 110.915 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.503 ' HD3' HD22 ' A' ' 115' ' ' LEU . 59.1 Cg_endo -75.1 167.09 27.72 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.359 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.8 p -106.7 158.45 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -132.01 118.93 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.829 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 55.16 34.92 23.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.6 6.24 87.53 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -119.77 150.34 50.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 110.862 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.93 149.72 89.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.626 2.217 . . . . 0.0 112.38 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.706 ' HB3' ' HE1' ' A' ' 129' ' ' TRP . 87.8 p -67.37 -62.23 1.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -170.75 127.25 0.69 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.508 0.671 . . . . 0.0 110.818 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.04 132.69 14.31 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.328 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -157.16 124.24 5.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.95 133.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 167.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.35 135.23 12.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.538 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.76 129.93 75.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.771 0.319 . . . . 0.0 111.158 -174.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 55.8 tp -74.99 132.34 41.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.9 m -130.4 145.42 51.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.04 51.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.04 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -123.54 170.15 15.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -112.77 129.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.294 . . . . 0.0 111.178 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -59.0 120.87 9.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.3 -25.14 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.94 -9.83 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.218 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.0 t -71.04 131.31 87.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.75 -15.03 43.47 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.377 172.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -109.09 21.86 16.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.51 -35.74 21.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.41 -35.07 70.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -178.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.83 -41.38 91.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.31 83.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.134 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -64.83 -34.49 78.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.936 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.62 -47.86 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.412 ' HE2' HG13 ' A' ' 33' ' ' ILE . 15.2 m-30 -65.41 -49.29 69.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.6 tt -57.05 -48.81 77.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -170.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -77.5 -22.63 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.828 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -101.96 -8.16 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -112.68 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 45.3 tp -73.49 -45.54 53.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -168.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.6 60.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.2 p -132.94 160.57 36.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -59.41 -44.93 92.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -71.47 -46.2 60.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.07 -45.45 41.02 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.42 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.445 HD21 ' HB ' ' A' ' 302' ' ' VAL . 28.4 tp -71.33 -37.72 71.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.973 -173.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.9 -40.75 95.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.56 99.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.726 HG23 ' HA3' ' A' ' 19' ' ' GLY . 15.0 p -76.48 -29.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -65.06 -24.32 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.11 -24.02 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -91.64 -13.0 32.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -78.68 155.54 78.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.708 . . . . 0.0 110.88 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.88 -95.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.608 2.205 . . . . 0.0 112.43 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -66.09 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.13 25.1 71.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 168.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.431 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -81.77 132.11 35.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.058 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.4 m -124.28 160.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.06 -12.67 59.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.013 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 59.5 tp -74.26 120.27 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.903 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.62 -45.75 91.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.3 m -60.6 -42.43 96.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.72 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.527 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.0 OUTLIER -71.81 -32.49 67.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.091 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -61.93 -32.02 72.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.01 -38.3 82.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -75.17 -38.28 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 301' ' ' ALA . 94.1 mt -65.13 -27.58 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.85 -16.64 43.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.109 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -71.79 -22.63 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 63.7 t0 -90.33 117.44 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.822 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 37.0 Cg_endo -61.54 -25.32 79.33 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.3 mtm-85 -70.36 -39.72 74.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 51.1 mm -79.98 -39.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.255 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.116 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.63 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.9 p -73.45 -35.83 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.2 mtm -68.06 -38.72 82.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -65.27 -42.65 92.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -71.79 -35.33 69.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.32 91.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.25 -19.07 65.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -108.37 -4.93 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.67 -167.09 42.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.532 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.773 0.321 . . . . 0.0 110.948 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 329' ' ' ILE . 2.8 tp -66.35 124.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 -169.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.594 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -46.44 -52.22 30.84 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.847 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 330' ' ' MET . 38.9 Cg_endo -63.99 85.54 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.768 2.312 . . . . 0.0 112.349 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.691 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 72.0 m-80 -108.74 30.52 6.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.691 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 71.4 mt 93.56 131.07 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.71 0.767 . . . . 0.0 111.06 -169.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.18 -25.58 50.31 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.768 2.312 . . . . 0.0 112.308 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.423 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.4 mt-30 -60.7 -24.64 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 176.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.7 mmm -63.8 -30.89 71.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.8 m -62.93 -43.08 99.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.12 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -60.57 -38.97 86.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -64.43 -38.28 90.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.177 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.39 -42.97 94.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.144 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.556 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 55.7 ttp180 -55.3 -43.81 75.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.4 m -59.91 -42.93 94.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.16 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.78 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 161' ' ' ILE . 54.4 t -67.05 -52.36 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.67 -45.18 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -171.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.58 -37.86 89.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.32 -44.24 68.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.79 74.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.8 p -76.05 -12.58 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.32 8.24 87.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.482 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -78.26 -25.7 46.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.917 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -135.12 155.99 49.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 90.9 m -71.88 151.5 43.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.21 -48.8 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.63 -42.34 86.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.21 -46.51 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.882 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.0 95.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.154 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 55.7 tp -66.08 -43.05 88.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.63 -48.43 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.922 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.02 -37.01 84.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.904 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.02 -43.58 64.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 7.6 mm-40 -77.16 -26.94 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.2 m -56.1 -35.64 67.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.161 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.95 -30.17 70.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.46 -41.92 89.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.3 p -94.04 -15.08 25.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.226 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.764 0.316 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.8 mt -85.74 125.97 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -136.62 176.92 8.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -171.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.95 132.06 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.96 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.79 59.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.64 159.97 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.886 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 7' ' ' LEU . 2.9 pp -147.15 149.51 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 177.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -120.58 127.6 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.185 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.583 HG22 ' HB ' ' A' ' 59' ' ' ILE . 3.3 pt -121.8 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.169 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.444 ' HB3' HD22 ' A' ' 43' ' ' LEU . 26.7 m0 -114.8 132.34 56.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.404 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.4 tt -149.23 153.71 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 -172.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.429 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.9 t-20 -55.87 128.54 35.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.66 -19.44 79.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.472 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.93 -46.4 90.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.904 -163.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.98 66.57 1.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.838 150.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -99.55 -46.15 2.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.552 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -69.95 -43.35 71.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.983 -159.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -65.63 -49.95 66.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 -160.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.66 -50.45 58.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.469 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 20' ' ' LEU . 53.7 mt -64.87 -37.24 86.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.12 -48.81 61.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -68.03 -45.77 73.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 p -69.85 -35.61 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.107 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.53 84.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.15 -46.32 89.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.32 -38.42 87.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -61.92 -35.66 79.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.782 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.39 -38.71 68.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.1 -41.05 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -171.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.0 p -105.57 -17.89 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.207 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.58 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.479 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 33' ' ' ILE . 19.5 tt -82.91 127.39 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.21 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -67.17 124.48 23.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.73 130.94 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.162 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.3 m -123.16 113.76 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.445 HG22 HD11 ' A' ' 9' ' ' ILE . 58.4 t -100.78 122.02 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.063 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.7 mt-10 -129.49 139.3 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -140.02 68.86 35.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 0.0 110.86 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 36.8 Cg_endo -75.7 -15.62 19.15 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.396 -165.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.8 m-20 73.13 8.34 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -171.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.75 -4.85 54.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.873 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' A' ' 10' ' ' TRP . 81.5 mt -51.74 -50.01 61.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -156.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.01 -35.3 78.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -88.05 -40.34 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -73.91 -45.26 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -167.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.675 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.9 t80 -51.69 -58.43 11.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.642 0.734 . . . . 0.0 110.834 -166.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 19.9 Cg_endo -63.9 -31.04 67.68 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.754 2.303 . . . . 0.0 112.274 -173.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -75.35 -47.25 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.2 m -76.24 -26.05 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.171 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.35 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.044 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.99 -24.47 66.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.053 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.7 p -95.09 4.51 53.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 22.72 61.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.518 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.8 t0 -119.52 -176.12 3.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.31 -170.3 15.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.503 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.37 158.96 17.28 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.81 -42.28 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 167.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.583 ' HB ' HG22 ' A' ' 9' ' ' ILE . 88.1 mt -133.23 139.53 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 tp -128.8 132.44 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.221 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -101.3 135.93 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -139.88 153.61 47.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.2 -102.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -122.27 -54.66 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.9 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -67.13 -46.08 75.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -73.26 -32.34 64.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.83 -47.31 85.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.859 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.17 -50.3 61.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.576 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.21 -41.98 99.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.532 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -70.05 -31.27 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.89 99.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 174.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.93 -26.28 64.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -85.02 2.1 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 37.1 61.37 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.554 173.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -80.33 -8.8 59.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 110.883 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -132.24 144.17 50.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 157.83 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 139.09 52.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.29 156.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.075 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -134.34 62.62 56.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.532 0.682 . . . . 0.0 111.161 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.01 149.93 42.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.745 2.297 . . . . 0.0 112.257 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -77.27 176.45 8.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.08 -29.92 67.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.98 69.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.07 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -63.21 -37.05 85.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -65.39 -39.97 92.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.81 -35.85 79.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.24 -29.31 66.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.2 mp -104.71 -106.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 23.0 t80 -162.89 133.96 3.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.67 0.748 . . . . 0.0 110.952 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.4 Cg_exo -56.21 -42.96 60.76 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.297 -174.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.14 -40.53 94.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 p -71.44 -25.64 62.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.429 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 54.5 m95 -80.13 -29.33 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 173.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -62.67 -30.11 71.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.827 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.71 -25.22 66.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.52 21.95 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.131 -174.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -109.94 139.58 44.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -141.54 126.85 18.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.65 34.46 22.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.888 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.45 90.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 173.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.16 144.82 50.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.85 130.73 35.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 pt -118.12 -12.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -169.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.28 165.33 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.036 -170.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.2 m-85 -109.83 134.31 20.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.663 0.745 . . . . 0.0 110.927 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.4 Cg_exo -66.31 126.8 16.25 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.318 173.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -111.61 -40.29 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.95 155.83 23.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.056 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.23 131.97 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -128.91 144.7 51.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.12 155.08 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.86 138.47 44.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.948 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -147.86 163.93 35.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.88 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.31 129.84 42.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.6 mt -107.09 128.02 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -136.23 148.19 47.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -90.72 117.08 29.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HE2' ' HA3' ' A' ' 243' ' ' GLY . 66.9 mttm -70.83 -30.61 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -171.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -76.85 -36.32 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -77.32 -38.71 49.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.5 tp -136.53 111.86 9.86 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.897 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 124' ' ' ASN . 87.8 Cg_endo -74.98 169.3 22.94 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.659 2.239 . . . . 0.0 112.35 170.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.2 t30 25.22 96.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 110.961 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.03 158.99 54.99 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.72 147.58 69.81 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.4 -29.7 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.871 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.6 p -127.94 159.6 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -68.56 -33.4 74.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.5 -29.78 64.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.813 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.57 -21.19 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.577 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 28.5 mm -60.93 -51.5 78.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.701 0.763 . . . . 0.0 111.09 -168.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 48.5 Cg_endo -70.35 -38.78 6.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.754 2.303 . . . . 0.0 112.324 -174.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.16 94.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.91 -36.91 83.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.73 -37.44 86.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.7 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.33 -37.3 83.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.8 mt -69.32 -36.46 76.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.73 -35.1 70.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.22 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.3 3.1 46.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.0 29.47 60.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -123.49 163.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.498 ' H ' ' HA ' ' A' ' 222' ' ' THR . 35.4 t -118.54 150.48 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 171.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -81.06 -23.96 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.82 141.73 50.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 68.8 mmm -140.1 119.93 13.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 161.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -160.05 164.99 32.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.7 t-20 -84.2 110.7 18.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.878 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 206' ' ' ALA . 27.1 tp -98.37 5.63 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -174.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.75 -2.27 57.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 148.46 69.67 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.656 0.741 . . . . 0.0 110.804 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.757 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 56.6 Cg_endo -74.76 -22.48 15.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.613 2.208 . . . . 0.0 112.265 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -52.79 -43.9 66.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 150' ' ' ASN . 81.3 m-85 -83.51 -20.4 33.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.713 -172.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.2 p -81.88 -21.26 37.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 4.4 m95 -60.08 -45.5 97.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.431 0.634 . . . . 0.0 110.884 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 99.2 Cg_exo -45.71 -31.1 7.15 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.258 . . . . 0.0 112.339 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 160' ' ' LEU . 2.7 tm? -82.29 -45.17 15.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.629 HG23 ' HA3' ' A' ' 191' ' ' GLY . 92.1 mt -74.66 -44.06 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 167' ' ' TYR . . . -69.77 -19.01 63.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.84 -29.64 70.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -102.91 0.19 32.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.6 15.12 9.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 165.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 161' ' ' ILE . . . -114.83 126.34 7.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.423 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 162' ' ' ALA . 17.9 t80 -159.56 172.17 18.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 110.921 -171.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.11 65.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.89 149.38 43.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -82.78 139.47 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -97.55 104.2 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 170.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.96 122.75 11.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.74 36.43 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -172.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.09 82.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.21 151.6 50.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -97.94 141.58 30.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -103.61 117.34 34.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 170.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.14 -18.07 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.04 -10.25 55.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -128.91 75.5 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.917 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.498 HG23 ' H ' ' A' ' 184' ' ' ASP . 15.4 m -134.95 172.96 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.92 -11.97 75.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.562 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.6 m -91.84 -7.68 10.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 111.044 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 35.3 p30 -85.45 7.22 23.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 86.3 m-20 83.72 -8.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 165.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.53 10.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.09 -44.68 34.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.533 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.495 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -70.15 -32.68 70.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -166.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -62.89 -45.59 91.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.949 -164.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.94 95.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.629 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.38 -41.26 99.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.43 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.19 -44.26 88.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.037 0.446 . . . . 0.0 111.008 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.5 m -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.216 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.05 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.828 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.71 -40.31 94.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.33 -36.83 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.173 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.26 -36.33 82.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.38 -41.71 80.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.63 -35.5 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.95 -35.96 81.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -84.08 2.98 36.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 62.71 35.14 14.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.914 173.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -76.98 -25.73 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.963 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -147.46 149.38 32.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 53.1 t-20 -95.1 136.73 35.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.43 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -63.02 -26.84 69.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -175.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.21 -13.79 27.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.899 -172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.8 m -65.63 134.93 54.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 49.9 p30 -112.91 173.83 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -71.36 -25.56 62.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.01 -38.47 88.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.42 -32.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.179 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.76 72.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.047 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.59 -46.96 85.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.834 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.64 76.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.42 96.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -65.09 -35.97 82.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.04 -29.31 70.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.82 -20.67 16.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.16 25.42 31.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.405 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.42 -26.75 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.498 ' HA ' ' H ' ' A' ' 145' ' ' SER . 7.2 t -128.99 147.49 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.05 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.73 18.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 175.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.1 mtm -140.23 160.05 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -169.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -150.15 161.79 41.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -121.34 120.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -146.27 159.58 43.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -104.77 -137.46 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -70.49 -26.24 24.35 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.692 2.261 . . . . 0.0 112.278 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -66.49 -16.13 63.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.7 23.06 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -62.5 -30.65 71.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 t -69.19 107.16 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -144.88 127.85 16.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.928 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.43 80.33 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -85.29 74.22 10.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.832 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 75.5 p -119.89 -14.97 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.2 p -92.96 -170.05 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.39 175.29 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.935 170.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.71 107.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.192 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -118.48 -57.08 2.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -113.49 160.03 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.578 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . -146.76 166.4 28.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.438 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 96.2 t -130.12 134.75 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.72 177.14 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.93 159.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.5 144.94 98.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.561 0.696 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.95 158.37 56.94 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.681 2.254 . . . . 0.0 112.252 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.1 p -107.22 151.33 25.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -128.76 116.0 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 55.18 36.47 27.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.97 69.21 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -125.32 147.08 56.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 110.996 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.3 154.83 72.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 0.0 112.379 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -67.08 -58.44 4.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 110.914 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -169.91 141.89 1.88 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 0.0 110.864 168.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.65 129.04 11.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.417 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -163.12 112.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.09 135.05 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.25 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -114.45 119.08 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.749 0.309 . . . . 0.0 111.211 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.6 130.01 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.1 m -130.54 145.04 51.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -170.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.0 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.07 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -117.09 155.19 16.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.412 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.6 mt -104.49 126.75 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 111.164 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.98 120.06 8.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.91 67.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.075 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.69 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -72.48 131.06 85.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.738 0.78 . . . . 0.0 110.846 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.65 -12.8 33.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.214 . . . . 0.0 112.32 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.05 27.54 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.854 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -53.85 -34.42 59.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.39 -38.98 91.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.37 -41.01 90.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.816 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.0 79.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.126 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.86 -47.84 79.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 98.3 mt-10 -69.36 -53.04 21.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -175.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 8.5 m-30 -65.48 -39.6 92.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.83 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.1 tt -61.55 -48.07 82.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.978 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -83.06 -26.64 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 93.0 m-20 -100.56 -21.03 15.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -169.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 21.3 m-30 -118.69 -56.38 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.862 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.02 -37.1 78.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -174.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' A' ' 106' ' ' TYR . 89.2 mt -94.84 60.99 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.1 p -127.75 168.82 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.17 171.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -53.24 -44.37 68.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.48 -42.12 30.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.33 -49.33 12.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.434 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 304' ' ' LEU . 25.0 tp -72.05 -35.5 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.938 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.97 -40.06 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.835 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.36 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.98 -35.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.157 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -77.27 -24.54 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.38 -27.29 68.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -88.01 -15.33 36.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.65 153.11 93.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 0.0 110.987 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.6 -55.95 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.573 2.182 . . . . 0.0 112.33 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -82.05 -46.62 13.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 84.98 -8.84 68.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.423 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -55.29 118.54 4.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.061 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 307' ' ' TYR . 4.3 p -128.72 153.49 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 -170.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.42 -17.19 56.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.489 ' HB2' HD23 ' A' ' 290' ' ' LEU . 56.1 tp -70.86 124.91 25.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.06 -37.39 84.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -61.29 -51.0 70.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.739 ' HB3' HG11 ' A' ' 302' ' ' VAL . 1.6 t80 -73.73 -33.25 64.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.67 -38.29 89.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.56 -40.18 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -73.76 -37.77 64.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.802 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.89 -28.23 68.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.66 -16.62 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.43 -21.77 60.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.885 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -90.17 119.55 69.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.796 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -62.32 -25.44 76.51 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.408 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.4 mtm-85 -70.12 -40.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 50.9 mm -79.64 -40.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.96 76.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.06 93.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.079 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 72.0 p -71.25 -36.52 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.13 -34.64 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -65.02 -40.86 95.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -72.03 -35.04 69.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.93 90.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -72.86 -14.37 61.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.818 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -107.72 -8.34 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.858 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.25 -158.37 34.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.483 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -127.11 140.1 52.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 329' ' ' ILE . 2.9 tp -68.24 120.24 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.551 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -47.95 -51.51 47.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.608 0.718 . . . . 0.0 110.878 -174.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 330' ' ' MET . 68.8 Cg_endo -69.23 79.53 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.423 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 53.5 t-20 -119.58 -3.08 10.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 336' ' ' MET . 18.2 tt 164.97 124.9 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 111.114 -165.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.75 -29.35 12.8 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.587 2.191 . . . . 0.0 112.334 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -64.98 -17.76 64.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.914 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 333' ' ' ILE . 61.4 ttp -62.97 -27.94 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -174.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -60.77 -41.73 96.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.6 71.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.134 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -65.6 -30.61 71.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -56.57 -41.2 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.17 -37.31 78.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.46 -43.57 85.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.93 -29.11 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.757 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 60.5 ttt180 -57.31 -44.96 84.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.0 m -62.21 -44.39 96.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.23 81.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.82 -50.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.0 mm -65.9 -45.43 91.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -66.21 -37.27 85.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.85 63.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.9 -35.04 76.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -80.71 -10.85 59.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.69 14.39 81.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.575 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -79.87 -26.6 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -137.0 156.22 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.006 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 98.9 m -68.6 145.86 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.1 -49.94 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.177 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.43 -40.84 85.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.52 -46.43 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 188' ' ' ALA . 63.5 tp -64.16 -46.59 83.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.97 -48.31 71.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.58 -38.8 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -78.6 -46.39 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -78.97 -30.87 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -169.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -59.0 -36.06 74.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.88 -30.1 69.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.5 mt -67.89 -44.67 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.127 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.2 p -98.18 -11.23 22.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.057 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.762 0.315 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -89.76 135.1 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.166 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -129.73 165.03 22.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -71.31 122.04 19.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.12 20.09 50.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.542 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 34' ' ' LYS . 93.5 mttt -139.84 155.11 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.6 pp -149.15 148.75 30.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -123.16 125.35 71.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.464 HG12 ' HB ' ' A' ' 59' ' ' ILE . 53.2 mt -119.01 130.73 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -110.83 136.68 49.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 -173.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 tt -144.56 147.63 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -75.0 172.4 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.62 -19.97 15.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.507 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -79.4 51.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 110.857 174.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 17' ' ' TYR . 54.5 pttt -80.14 117.63 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.956 -159.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.65 10.03 1.64 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.543 154.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' H ' ' C ' ' A' ' 15' ' ' LYS . 23.1 t80 -39.99 -36.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -57.63 -47.12 83.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.8 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -72.63 -38.18 57.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.405 174.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -36.87 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.009 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.55 95.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.221 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -62.02 -45.87 91.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.0 m -75.08 -28.28 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.6 89.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.404 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.42 -40.71 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.82 -45.85 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.972 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.78 -43.27 93.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.46 -33.16 74.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -74.99 -40.37 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.003 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -78.78 -40.53 32.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -101.04 -25.15 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -172.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.58 6.46 87.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.735 HD13 HD13 ' A' ' 275' ' ' LEU . 96.6 mt -78.69 125.05 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 111.094 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 89.3 tttt -64.42 118.06 8.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 173.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.82 129.34 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -134.8 110.1 8.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.228 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.93 126.51 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.069 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -125.93 152.8 45.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -133.69 67.68 75.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.574 0.702 . . . . 0.0 110.892 172.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 30.8 Cg_endo -78.89 -15.38 13.29 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.612 2.208 . . . . 0.0 112.329 -164.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 64.3 m-20 77.28 10.97 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.22 -5.1 34.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -49.88 -60.06 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.929 -154.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.11 -34.82 77.06 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.52 -33.45 54.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -78.49 -30.17 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.805 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.551 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 8.6 m-30 -49.38 -52.15 51.84 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.586 0.707 . . . . 0.0 110.877 -168.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 60.9 Cg_endo -69.56 -27.57 27.28 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.642 2.228 . . . . 0.0 112.337 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.63 -49.98 12.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.17 -33.46 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.099 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.96 86.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.129 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.35 53.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.66 -1.21 50.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.195 -173.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.05 74.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.82 145.4 25.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.943 0.401 . . . . 0.0 110.863 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.49 82.19 0.22 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.428 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.24 124.19 12.22 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.71 2.274 . . . . 0.0 112.451 157.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.13 -42.64 23.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 -156.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.464 ' HB ' HG12 ' A' ' 9' ' ' ILE . 74.7 mt -130.07 133.19 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.096 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.2 mm -125.01 127.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -132.93 115.64 15.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.519 ' O ' ' C ' ' A' ' 63' ' ' ALA . 26.2 p-90 -177.13 173.2 1.83 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 175.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 62' ' ' TRP . . . -25.71 96.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' TRP . 76.2 t60 -59.03 -32.37 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -172.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -51.65 -50.18 60.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.847 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -74.63 -26.64 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.04 -26.68 67.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -64.91 -37.73 94.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.28 -35.45 84.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -72.06 -24.9 61.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' A' ' 76' ' ' LEU . . . -59.73 -39.43 84.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 171.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.17 -28.64 68.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -84.96 4.16 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.98 32.4 69.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.563 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.3 tp -72.9 -24.37 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.748 0.308 . . . . 0.0 110.825 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -132.09 145.99 51.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -170.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -74.96 152.23 38.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -174.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.81 131.34 50.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.972 171.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.84 140.08 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.212 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.8 m -92.72 121.91 65.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 0.0 111.189 -174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -54.96 130.71 42.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.75 2.3 . . . . 0.0 112.343 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.46 118.32 35.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.01 -46.11 89.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.96 87.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.066 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.59 -39.95 95.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -58.06 -43.62 87.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.03 -33.0 74.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.22 -27.2 68.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 304' ' ' LEU . 5.9 mp -112.47 -125.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -129.78 148.05 67.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.671 0.748 . . . . 0.0 110.919 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.65 -30.32 60.21 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.683 2.255 . . . . 0.0 112.277 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -71.69 -35.65 70.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.4 p -71.81 -24.67 61.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.131 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -39.93 71.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 171.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.84 -34.53 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.87 74.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.033 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.78 HG21 ' HD3' ' A' ' 107' ' ' PRO . 34.3 m -111.36 14.06 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -164.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -119.98 149.94 41.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -135.73 119.57 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.961 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.9 t30 61.86 35.2 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.87 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.54 89.08 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.465 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -122.18 149.92 42.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 103' ' ' LEU . 50.9 mt -74.95 133.82 41.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -174.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.8 pt -115.72 -7.36 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.99 174.03 10.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.111 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.45 139.29 28.49 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.711 0.767 . . . . 0.0 110.99 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.78 ' HD3' HG21 ' A' ' 97' ' ' VAL . 56.5 Cg_endo -79.82 132.28 9.6 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -172.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.1 -42.01 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.53 147.99 27.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -163.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.6 t -130.73 132.35 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.02 149.91 47.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.25 142.89 27.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.42 126.38 29.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.7 m -142.59 159.09 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.815 -166.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -98.93 123.87 43.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.6 mt -110.48 133.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -137.25 156.63 48.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.95 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.425 ' HB3' HD21 ' A' ' 121' ' ' LEU . 54.9 t-20 -96.53 120.08 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.03 -27.74 69.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -67.39 -42.25 83.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -165.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.636 HD23 ' H ' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -99.97 -24.76 14.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.5 tp -124.21 99.5 37.15 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.648 0.737 . . . . 0.0 110.936 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.15 -14.96 11.82 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.665 2.243 . . . . 0.0 112.326 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.441 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.4 t-20 -157.77 103.94 1.78 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.597 0.713 . . . . 0.0 110.97 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.5 Cg_endo -68.75 147.11 68.59 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 64.7 Cg_exo -55.09 145.03 66.55 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.769 2.313 . . . . 0.0 112.308 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.72 -17.65 37.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -143.79 161.13 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.295 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -68.64 -27.32 65.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.886 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.04 -29.62 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.65 -15.68 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 38.7 mm -59.17 -54.34 57.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.721 0.772 . . . . 0.0 111.12 -171.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 24.5 Cg_endo -62.51 -39.89 42.18 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.318 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.27 99.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.134 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.18 -40.29 97.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.561 ' O ' HD23 ' A' ' 139' ' ' LEU . 10.0 t70 -62.16 -41.65 98.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.97 -39.6 92.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.49 -44.19 75.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -176.385 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 39.0 ttpt -56.08 -26.2 48.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 169.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.11 -20.27 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.46 11.5 37.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.7 30.46 66.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.51 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 96.7 mttt -125.29 157.25 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 110.876 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 t -116.51 153.69 31.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.945 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.21 66.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.2 pp -145.88 146.07 30.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.7 ttm -148.05 132.32 17.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.914 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -156.7 169.79 23.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.16 122.89 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 -174.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.58 7.41 18.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -85.1 -8.68 58.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.845 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -127.19 149.37 69.39 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 110.97 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 -31.99 9.27 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.79 -39.99 40.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -80.5 -37.57 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.9 p -83.82 -14.02 52.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.1 -170.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.609 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 24.1 m0 -49.99 -53.51 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.711 . . . . 0.0 110.827 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 9.5 Cg_endo -53.43 -33.99 69.51 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.453 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.94 -45.4 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.801 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 89.3 mt -74.22 -41.67 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -175.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.13 -6.78 51.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.13 -35.03 59.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.3 5.35 52.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.36 10.58 63.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.525 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -130.05 86.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 63.1 t80 -167.49 153.88 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 74.94 -91.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.08 170.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -167.35 155.03 9.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.954 -171.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.7 129.34 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -116.89 128.91 55.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.94 140.21 25.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.956 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 51.01 45.81 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 10.91 71.05 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.513 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.65 146.87 52.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.891 -174.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -99.35 137.2 38.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -94.82 112.67 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 178' ' ' ILE . 6.4 tp -71.24 -20.01 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.16 -8.76 53.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -120.19 91.34 3.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 173.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.3 m -106.04 155.87 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.78 7.47 65.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.488 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -97.5 -19.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 111.221 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -101.6 14.3 32.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 167.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -93.95 154.23 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -170.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.35 -33.36 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.073 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.67 92.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.477 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.94 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.842 0.353 . . . . 0.0 111.082 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.4 -39.2 91.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.855 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.54 95.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.801 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -42.18 98.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.592 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.62 -39.71 91.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 110.831 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 86.1 m -59.75 -41.71 91.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.086 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.44 -47.23 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.19 -43.13 96.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.83 -40.83 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.98 -38.01 84.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.4 OUTLIER -60.97 -35.88 77.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.982 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.41 -40.0 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.97 -35.18 79.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -80.15 0.74 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.034 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 63.64 30.07 14.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -92.01 -21.61 20.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 83.9 mmm -131.98 155.0 48.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 169.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 94.4 m-20 -104.71 139.14 39.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 173.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.98 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.101 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -96.47 0.43 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 98.5 m -56.57 125.94 24.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.194 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -119.12 179.76 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.92 -39.69 90.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.1 m -58.62 -42.95 89.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.92 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.18 -43.44 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.35 -42.9 87.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.48 87.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.91 97.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.08 -37.84 84.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.867 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.0 -28.64 69.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.11 -22.25 15.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 21.67 40.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.542 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.04 -25.91 29.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 110.827 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 79.1 m -126.48 135.34 51.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.084 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.78 -40.37 48.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.185 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 78.3 mtm -133.7 156.45 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -164.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -151.8 158.34 43.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.202 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 46.2 mm -115.85 114.97 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -163.36 178.39 8.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -99.21 -171.68 31.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.463 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.77 -15.11 40.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -63.49 -12.24 30.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.919 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.6 78.21 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.143 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -66.32 -22.76 66.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 50.1 m -54.14 169.84 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 233' ' ' SER . 91.6 m-20 73.86 55.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 -169.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.0 128.46 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -68.92 81.4 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.809 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -58.18 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.3 p -69.12 -15.3 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -160.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.61 170.52 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.15 119.77 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.093 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -122.02 -42.42 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.925 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -105.13 153.38 21.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.933 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.93 160.41 24.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.427 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.33 131.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.97 0.414 . . . . 0.0 111.101 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.16 179.13 7.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -84.84 159.63 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.124 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.4 mt -68.43 150.03 97.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 110.765 -169.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 44.6 Cg_exo -56.74 150.53 53.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -91.17 163.2 14.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -136.33 113.19 10.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 56.71 43.48 25.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.735 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.68 1.29 80.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 169.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -149.99 147.04 21.3 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.524 0.678 . . . . 0.0 110.991 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.84 127.04 11.68 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 88.9 p -56.71 -57.05 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -170.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -165.09 119.97 0.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.68 149.87 23.92 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.617 2.212 . . . . 0.0 112.324 175.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -138.84 120.51 15.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.863 171.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.04 125.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.132 177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.65 139.36 15.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.459 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.14 124.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.349 . . . . 0.0 111.052 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 262' ' ' LEU . 28.3 mt -78.96 144.67 34.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 169.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 53.6 p -142.42 163.77 31.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.73 135.56 52.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.099 176.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.68 156.5 15.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.52 126.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.146 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -65.8 129.25 39.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.07 -28.99 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.44 -11.42 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -80.11 127.93 75.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.655 0.74 . . . . 0.0 110.899 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.53 -6.69 19.09 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.675 2.25 . . . . 0.0 112.319 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -108.05 24.12 13.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.889 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -57.56 -34.12 68.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 -172.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.79 -45.91 63.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -171.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.735 HD13 HD13 ' A' ' 33' ' ' ILE . 4.5 pp -76.44 -31.5 57.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.524 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -66.24 -40.83 90.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 174.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -66.56 -39.49 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.59 -38.67 77.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -56.9 -45.51 82.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 62.9 tp -63.79 -50.8 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.82 -34.65 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.8 -27.87 13.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -163.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.777 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 87.1 m-85 -120.45 -49.55 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 80.4 mt -73.63 -35.91 65.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.924 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.98 74.05 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.971 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.0 p -141.87 170.17 16.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.006 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.25 -43.09 74.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -76.45 -46.07 28.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.91 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.777 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.92 -44.15 25.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.01 -36.43 84.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.911 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.97 -41.64 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.34 -34.82 74.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.8 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 97.0 t -80.84 -45.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -71.15 -28.78 64.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.26 -10.97 12.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.47 -33.08 62.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.98 150.02 42.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 0.0 110.903 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -58.39 -57.13 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.394 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.54 -53.19 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.41 62.56 6.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.509 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -81.95 123.12 28.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.123 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.667 HG22 HD21 ' A' ' 311' ' ' LEU . 33.2 m -115.49 156.24 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.074 -163.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.43 -17.07 55.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.055 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.407 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 60.8 tp -78.25 117.85 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.95 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.7 -46.84 87.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.1 t -63.67 -50.99 67.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.771 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.09 -34.06 72.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -57.28 -39.5 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -55.51 -38.12 68.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.667 HD21 HG22 ' A' ' 302' ' ' VAL . 4.3 pp -74.88 -22.05 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -73.01 -6.37 45.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.998 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.82 -12.03 61.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.69 129.94 63.3 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -32.39 32.06 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -69.76 -37.04 76.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.883 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.43 HG21 HD12 ' A' ' 311' ' ' LEU . 48.6 mm -80.37 -40.98 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.35 -35.88 70.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -169.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.71 91.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.175 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 95.4 m -68.52 -39.88 81.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mmt -67.58 -35.42 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.92 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 327' ' ' GLY . 84.5 m-20 -69.27 -35.93 76.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 176.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.15 85.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -72.83 -22.91 60.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.93 -5.71 17.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.37 -159.65 32.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -130.01 123.45 30.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 329' ' ' ILE . 1.1 mp -75.24 124.12 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 329' ' ' ILE . 92.0 mtp 60.56 160.18 0.11 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.535 0.683 . . . . 0.0 110.886 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -64.96 -103.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.0 112.438 161.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -139.96 -48.88 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 158.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.545 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 46.5 pt -130.04 161.36 60.38 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.648 0.737 . . . . 0.0 111.121 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 19.5 Cg_endo -60.72 -22.03 71.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -69.81 -16.41 63.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.3 mmt -66.18 -26.09 67.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 87.7 p -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.08 -51.33 25.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -171.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 339' ' ' PHE . 1.0 OUTLIER -65.22 -26.24 68.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.953 178.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -66.15 -39.5 89.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -63.57 -37.47 87.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.98 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.163 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.68 -32.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -49.75 -47.92 50.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.8 m -60.35 -39.67 87.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.143 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -64.47 -37.62 88.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.095 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.84 -44.86 88.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.9 -43.09 97.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.119 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.06 -39.86 93.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.74 68.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.046 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.21 -36.64 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -174.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.9 p -78.6 -9.61 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.904 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.56 9.53 85.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.37 -31.17 65.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.865 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -133.66 160.02 38.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -76.02 169.92 17.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.76 -44.52 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.83 -45.9 91.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.9 -46.45 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.48 89.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.56 -37.37 82.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.64 -35.27 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.58 -31.4 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -65.02 -47.5 77.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.7 m -60.48 -42.18 95.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.122 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.82 -39.24 80.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 89.9 mt -62.69 -42.14 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.108 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 64.9 p -90.8 -14.56 31.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.565 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 85.9 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.701 0.286 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.411 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 86.3 mt -76.04 129.08 37.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -130.11 166.76 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.937 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.43 121.94 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 20.02 52.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.489 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -141.49 156.36 45.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.744 HD12 ' O ' ' A' ' 7' ' ' LEU . 3.8 pp -149.29 150.64 32.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.3 t -124.99 121.46 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.426 HG12 ' HB ' ' A' ' 59' ' ' ILE . 87.1 mt -119.58 132.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.212 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.1 m0 -115.75 140.42 49.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.935 HD13 ' HA3' ' A' ' 16' ' ' GLY . 17.3 tt -144.06 143.65 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -73.71 -179.82 3.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -172.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.0 -2.28 4.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.52 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.636 ' O ' ' C ' ' A' ' 15' ' ' LYS . 46.9 t0 -67.34 70.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.856 173.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 14' ' ' ASP . 87.2 tttt -14.55 107.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -166.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.935 ' HA3' HD13 ' A' ' 11' ' ' ILE . . . -108.98 -11.05 23.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.45 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -66.3 -41.75 89.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 110.896 -151.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.68 -52.52 62.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.911 -162.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -66.61 -44.33 90.04 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.415 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.2 mt -58.46 -40.48 82.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 110.896 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.33 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.35 -46.84 88.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 m -74.24 -28.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.32 -37.73 95.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.458 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.63 -41.46 96.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.874 0.369 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.39 -43.93 89.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.1 -43.52 95.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.83 -34.86 76.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.25 -40.1 67.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -79.08 -40.65 30.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -172.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.4 p -100.72 -24.54 14.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.174 -171.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.56 8.53 86.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.406 HG21 HD23 ' A' ' 7' ' ' LEU . 89.6 mt -80.34 124.9 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.21 118.88 8.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 24' ' ' GLY . 70.0 t -98.46 134.31 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -132.65 112.39 11.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.21 121.55 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -128.21 149.98 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.822 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -135.04 68.55 70.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.577 0.703 . . . . 0.0 110.918 171.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 29.0 Cg_endo -79.39 -14.35 13.13 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.683 2.256 . . . . 0.0 112.29 -162.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.4 m-20 76.49 8.95 3.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.14 -9.99 37.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.948 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 3.2 mp -51.34 -55.56 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 -156.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -54.33 -38.98 66.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.65 -32.84 62.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.94 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.96 -29.69 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 43' ' ' LEU . 8.7 m-30 -49.81 -51.59 59.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.706 0.765 . . . . 0.0 110.968 -164.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 96.0 Cg_endo -79.41 -29.11 3.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.576 2.184 . . . . 0.0 112.357 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -75.54 -46.08 34.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.835 -171.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.5 m -56.78 -33.39 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.08 87.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.58 -32.6 47.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.2 p -95.02 -4.9 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.092 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.95 24.71 66.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.435 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -80.94 143.05 32.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.843 0.354 . . . . 0.0 110.843 172.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' A' ' 2' ' ' ILE . . . -122.1 62.9 0.53 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -164.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.88 121.06 7.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.686 2.257 . . . . 0.0 112.377 159.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -83.18 -48.93 9.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 -161.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.426 ' HB ' HG12 ' A' ' 9' ' ' ILE . 70.1 mt -132.55 136.08 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.168 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.07 132.36 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 72.5 m-85 -116.32 115.72 26.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.889 172.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -168.36 179.76 4.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.25 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.132 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 263' ' ' SER . 73.3 t60 -60.21 -25.05 65.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -50.42 -44.16 55.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.13 -24.19 47.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.585 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 1.7 t80 -65.43 -28.79 69.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -172.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.46 -38.35 62.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.457 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.15 -37.31 71.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.631 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -71.64 -25.06 61.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' A' ' 76' ' ' LEU . . . -59.93 -39.58 85.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.15 -26.44 64.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.4 p -85.0 2.47 42.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.76 32.22 73.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.53 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -74.82 -24.33 58.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -126.86 144.11 51.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -168.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -75.99 154.52 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.83 134.07 52.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -115.98 142.27 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.191 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -93.5 123.91 58.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.516 0.674 . . . . 0.0 111.16 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 143.59 28.91 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.789 2.326 . . . . 0.0 112.275 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -107.86 116.13 31.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.14 -43.1 73.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.0 98.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.179 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.17 -35.71 74.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.24 -44.64 88.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.07 -32.45 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.2 -28.38 65.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.04 -105.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -152.69 139.29 12.37 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.745 0.783 . . . . 0.0 110.925 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.37 -28.13 22.71 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.833 2.356 . . . . 0.0 112.298 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -71.22 -34.28 70.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.9 p -74.33 -21.88 59.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.54 -35.18 80.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.017 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.86 -35.06 74.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.97 -37.83 75.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.767 HG21 ' HD3' ' A' ' 107' ' ' PRO . 35.4 m -104.32 18.36 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -169.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -123.52 149.94 44.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -138.77 124.42 19.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 58.18 35.99 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.06 88.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.538 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.03 150.66 41.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 31.9 mt -75.03 135.19 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.994 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.0 pt -113.76 -12.48 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.18 169.57 20.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.053 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -112.86 130.53 23.41 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.622 0.725 . . . . 0.0 111.02 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.767 ' HD3' HG21 ' A' ' 97' ' ' VAL . 54.6 Cg_endo -72.8 125.71 10.73 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.358 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.49 -50.38 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.84 157.07 42.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.09 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 147.16 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.85 147.76 51.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.2 145.22 28.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -68.54 128.81 37.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.5 m -138.29 157.84 45.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.748 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.95 121.13 38.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.5 mt -109.87 130.06 63.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.175 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -135.23 157.53 46.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.58 117.4 29.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.943 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.14 -28.53 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.837 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.94 -35.1 32.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.29 -44.25 25.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.8 tp -127.44 105.99 21.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.65 -15.65 15.26 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.329 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -150.33 105.58 3.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.72 . . . . 0.0 110.966 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.59 146.52 73.98 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.728 2.285 . . . . 0.0 112.371 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.94 147.75 68.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.24 -21.46 24.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.8 p -131.88 159.95 37.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -74.04 -23.64 59.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.23 -21.86 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.31 -21.63 55.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.597 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 40.0 mm -64.35 -45.52 78.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.676 0.75 . . . . 0.0 111.158 -162.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 77.0 Cg_exo -53.52 -49.49 17.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 0.0 112.323 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -38.72 83.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 135' ' ' LEU . 4.5 tt -61.97 -39.39 91.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 25.5 t70 -64.24 -41.87 96.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.74 -40.05 75.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.23 -56.52 9.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -170.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 136' ' ' ASP . 1.3 pt? -82.04 -12.33 58.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -174.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.5 tttt -58.51 -27.3 64.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 168.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.35 -17.9 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.34 6.47 42.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 26.94 65.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.493 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 2.7 mptp? -118.26 159.82 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.957 173.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.404 ' O ' HD11 ' A' ' 139' ' ' LEU . 47.8 t -113.8 153.49 29.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 172.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -66.82 -52.5 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.159 -175.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.83 ' O ' HD12 ' A' ' 147' ' ' LEU . 2.7 pp -151.76 147.65 26.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.968 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.3 mtp -127.27 134.35 50.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -143.37 164.95 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 54.4 t-20 -70.0 110.32 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.895 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 206' ' ' ALA . 48.7 tp -106.84 0.31 23.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.97 -5.83 59.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -132.97 149.66 73.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.528 0.68 . . . . 0.0 110.825 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -79.4 -25.92 5.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.62 2.214 . . . . 0.0 112.317 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -59.68 -44.62 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 150' ' ' ASN . 81.0 m-85 -79.31 -28.4 42.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 m -77.4 -20.89 53.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 172.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.612 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 10.7 t90 -47.37 -53.99 25.12 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.595 0.712 . . . . 0.0 110.879 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.4 Cg_endo -55.19 -32.88 82.26 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.621 2.214 . . . . 0.0 112.401 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.536 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.8 tt -71.04 -54.2 12.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.007 -172.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 91.0 mt -78.61 -40.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 -173.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.22 -14.99 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 -173.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 250' ' ' PHE . . . -59.07 -28.52 66.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -174.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -90.5 -1.88 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.21 20.41 30.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.419 ' HA3' ' N ' ' A' ' 188' ' ' ALA . . . -138.61 85.06 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.444 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 9.4 t80 -177.31 154.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 74.97 -87.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 164.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -148.84 155.58 41.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -168.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -118.28 124.3 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.943 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -113.8 129.8 56.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -145.02 136.47 25.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 52.2 38.93 25.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.889 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.08 8.93 65.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.431 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.72 145.6 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -87.92 123.65 32.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 168.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -98.85 117.71 33.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.88 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.9 tp -68.13 -21.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.35 -12.03 28.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -124.57 82.19 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.6 p -113.21 148.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.61 25.39 27.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -167.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.73 -14.51 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 111.186 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -102.27 20.39 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -102.46 -175.04 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.78 69.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.025 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.56 -38.61 96.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.419 ' N ' ' HA3' ' A' ' 166' ' ' GLY . . . -59.48 -39.85 85.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.12 -40.49 96.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.81 94.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.06 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.19 -43.88 96.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.93 -41.28 91.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.353 . . . . 0.0 110.883 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.4 m -60.01 -43.21 95.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -56.62 -52.43 64.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.76 65.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.39 -39.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.169 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.99 -39.46 92.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.826 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.82 -41.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.936 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -82.43 3.27 28.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.95 34.92 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.85 -28.74 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.1 mtt -137.78 152.74 49.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ASN . . . . . 0.414 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.9 m-20 -101.24 141.41 34.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.862 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.422 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -65.13 -27.28 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.045 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.63 2.85 54.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 94.5 m -58.59 130.18 45.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 2.8 p30 -125.79 165.44 18.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 172.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -70.08 -27.67 64.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.926 -172.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -65.88 -48.3 71.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.5 pt -69.45 -23.65 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.134 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.45 94.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -71.93 -34.99 69.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.972 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.84 85.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.091 171.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.06 82.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -62.88 -38.26 90.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.831 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.07 -27.42 69.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.71 -21.87 16.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.26 20.28 52.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.485 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -82.62 -26.53 32.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 86.3 m -127.34 134.38 49.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.155 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.21 -36.06 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.415 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 77.6 mtm -134.84 151.41 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -168.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -150.4 158.85 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.28 119.49 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -163.06 174.18 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.405 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -94.21 -175.75 39.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.22 -19.76 66.23 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.623 2.216 . . . . 0.0 112.383 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.405 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 43.7 p90 -68.86 -9.63 52.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.8 84.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -65.82 -25.85 67.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 61.7 m -52.54 160.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 233' ' ' SER . 73.7 m-20 72.72 56.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -170.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.77 130.07 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.71 79.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.871 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 71.2 p -58.76 -176.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 165.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.9 p -72.49 -14.7 61.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.816 -160.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.61 164.96 18.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.781 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t -93.01 114.99 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -120.77 -39.99 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.46 155.29 19.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.97 167.12 25.49 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.568 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.16 136.19 56.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.074 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -143.46 -179.66 6.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.74 159.42 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 94.0 mt -71.36 138.98 84.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 0.0 110.855 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 53.1 Cg_exo -57.05 156.0 26.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.379 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -99.18 164.74 12.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.144 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.401 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 25.7 t80 -141.95 119.98 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 -176.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 61.39 39.71 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.828 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 6.48 84.97 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.468 165.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.94 151.64 49.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.538 0.685 . . . . 0.0 111.019 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.36 130.19 24.46 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.686 2.258 . . . . 0.0 112.408 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 77.8 p -61.09 -42.65 98.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.813 -170.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -172.99 127.66 0.51 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 110.851 166.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.24 142.79 24.6 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.252 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -163.93 124.89 2.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.82 128.92 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 170.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -103.56 144.81 16.02 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.429 171.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.28 127.32 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 263' ' ' SER . 6.5 tt -96.97 128.6 44.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 166.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.573 ' N ' HD23 ' A' ' 262' ' ' LEU . 8.7 m -139.09 172.12 13.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.79 -172.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.508 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -121.99 135.96 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.133 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.585 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -117.39 155.05 16.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 -177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.94 127.93 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 111.119 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -67.77 128.42 36.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -170.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.81 -28.98 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.054 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.67 -10.88 59.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.9 t -77.67 126.98 83.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.649 0.737 . . . . 0.0 110.879 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 -8.4 23.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.455 174.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.736 ' HB3' HD23 ' A' ' 275' ' ' LEU . 97.0 m-20 -112.97 27.45 9.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -172.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.73 -28.34 33.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -66.03 -40.17 90.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 272' ' ' ASN . 0.7 OUTLIER -72.55 -31.27 65.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.617 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.1 -42.04 85.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.01 -40.69 91.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.63 -47.85 83.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 3.2 tt -66.85 -49.45 65.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.949 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.51 -33.73 76.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -101.35 -29.8 11.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -164.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.764 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.3 m-85 -119.93 -50.5 2.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 -169.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 94.5 mt -73.66 -37.79 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -171.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 42.3 tp -126.71 75.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.5 p -140.79 174.62 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.208 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.92 -44.26 74.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.0 -44.24 49.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.764 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.83 -45.82 19.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.545 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.4 -36.92 84.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.351 . . . . 0.0 110.953 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.78 -39.73 95.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.97 88.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.022 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.862 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 10.2 p -87.75 -32.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.76 -23.03 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -174.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.62 -15.25 6.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -82.91 -23.9 33.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -91.03 151.48 43.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.89 -61.07 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.808 2.339 . . . . 0.0 112.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 97.1 mt -98.88 -50.12 4.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 54.56 59.91 9.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.517 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.74 129.01 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 111.048 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.38 153.92 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -166.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.73 -14.99 58.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.5 tp -76.63 120.26 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.923 -175.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.1 -44.91 96.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -173.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -48.11 78.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 -173.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.89 -32.94 71.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.472 ' HA ' ' HE1' ' A' ' 321' ' ' MET . 42.7 tt0 -61.69 -38.93 89.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.798 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.64 -40.67 79.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.08 -41.58 58.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.428 ' HB3' HG21 ' A' ' 317' ' ' ILE . 91.9 mt -65.34 -29.97 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.51 -9.78 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.96 -19.44 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -86.76 120.13 71.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.573 0.701 . . . . 0.0 110.892 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.87 -34.97 57.8 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.661 2.24 . . . . 0.0 112.322 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.33 -39.78 62.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.428 HG21 ' HB3' ' A' ' 311' ' ' LEU . 96.7 mt -74.12 -39.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.4 -33.24 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.03 93.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.6 m -69.75 -41.17 75.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.472 ' HE1' ' HA ' ' A' ' 308' ' ' GLU . 40.3 mtt -68.37 -34.61 76.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.12 -37.03 85.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -67.08 -36.5 82.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.78 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.31 -23.46 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.958 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 -2.05 23.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.801 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.06 -166.37 40.64 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.433 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.8 128.19 44.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 0.0 111.015 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.452 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 28.7 mm -73.28 111.54 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -176.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.0 mmm 63.23 158.15 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.578 0.704 . . . . 0.0 110.744 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.477 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 66.9 Cg_endo -73.66 -111.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 169.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.73 -47.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 170.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 19.5 pt -138.82 159.78 65.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.552 0.691 . . . . 0.0 111.199 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 40.8 Cg_endo -66.74 -14.71 44.92 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.742 2.295 . . . . 0.0 112.257 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -5.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.949 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.477 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.8 ptm -52.47 -30.14 28.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -32.94 74.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.16 72.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.038 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 339' ' ' PHE . 0.7 OUTLIER -72.27 -25.14 61.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -58.79 -48.0 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -63.68 -40.55 97.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.67 95.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.099 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.04 -26.26 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -61.13 -45.85 92.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.7 p -67.18 -34.37 77.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -66.16 -47.3 74.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 348' ' ' ILE . 7.3 p -71.53 -41.61 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 -172.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.418 ' N ' HG13 ' A' ' 347' ' ' VAL . 93.7 mt -64.46 -43.97 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -64.65 -36.41 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.23 -43.85 69.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.33 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.13 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.6 p -75.03 -14.99 60.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.23 86.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.84 -29.86 67.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.614 0.245 . . . . 0.0 110.807 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -140.01 158.64 43.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.894 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.9 p -73.43 169.4 17.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.03 -48.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.98 -40.08 75.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -70.87 -42.36 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.909 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.98 89.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.098 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 30.3 tp -65.21 -36.4 84.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.09 -35.41 75.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.92 -29.1 70.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -65.14 -48.83 72.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -64.35 -39.84 94.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -60.75 -43.67 97.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.111 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -72.32 -35.47 68.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.96 -43.08 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 67.1 p -89.89 -12.74 38.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.796 0.331 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -83.17 132.29 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -123.62 161.13 25.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.73 119.61 19.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.27 31.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.459 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -146.52 154.69 41.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.84 143.1 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.5 122.42 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.41 140.56 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.462 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 55.5 m95 -116.45 126.76 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 tt -148.87 141.02 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.406 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.8 t-20 -47.87 118.46 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -166.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.19 64.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.462 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.13 -56.18 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 0.0 110.929 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -137.37 78.26 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 152.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.76 -34.31 1.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.472 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.15 -46.08 36.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.933 -158.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -51.59 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -157.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.2 -48.75 57.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 tp -59.6 -42.09 91.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.05 84.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -63.22 -37.25 86.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.15 -41.65 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.05 87.65 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.453 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.35 -40.2 89.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.905 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -60.62 -46.91 88.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 33' ' ' ILE . 28.3 t80 -68.8 -36.29 78.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.49 -33.13 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.64 -36.05 73.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.16 -40.65 26.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -109.12 -18.11 13.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 -171.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.25 4.8 87.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.54 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.4 tt -72.94 121.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -68.91 121.61 16.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.946 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.3 p -102.22 142.63 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.151 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -136.09 114.24 11.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.86 127.34 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -124.8 160.61 28.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -93.48 125.0 55.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 110.855 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.436 ' CB ' HD22 ' A' ' 43' ' ' LEU . 66.1 Cg_endo -87.78 81.72 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -167.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -93.88 -27.8 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 166.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -92.31 -15.02 27.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.841 -169.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD22 ' CB ' ' A' ' 40' ' ' PRO . 2.3 mp -53.14 -46.06 68.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.891 -159.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -50.03 -40.98 46.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.14 -35.05 32.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -73.0 -25.07 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.2 m-30 -50.05 -55.79 22.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 0.0 110.875 -165.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -71.18 -29.77 16.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.732 2.288 . . . . 0.0 112.382 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -76.54 -49.95 15.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -172.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.691 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 28.0 m -60.37 -34.98 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.47 86.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.86 66.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.091 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -93.73 1.36 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.114 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.57 8.32 66.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.463 171.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -171.3 95.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.898 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.99 -129.34 3.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 156.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 41.7 Cg_endo -70.21 154.53 65.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.644 2.229 . . . . 0.0 112.35 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -88.08 -39.78 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.61 136.89 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.0 mm -119.68 134.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -77.8 159.47 28.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.952 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CB ' ' H ' ' A' ' 263' ' ' SER . 41.9 t90 -85.84 147.4 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -112.57 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.104 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -110.74 -83.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 157.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -94.58 -19.51 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -60.05 -27.59 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -163.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -58.06 -33.26 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.87 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -64.3 -41.24 98.29 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.18 80.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.427 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -65.84 -36.7 84.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.72 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.105 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.96 -29.27 70.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -82.39 1.5 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.16 75.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -82.71 -6.17 59.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.46 146.17 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -91.11 163.6 14.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.71 128.76 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -110.41 148.83 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -95.64 124.6 52.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.506 0.67 . . . . 0.0 111.204 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.83 140.67 42.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -103.83 109.91 21.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.38 -42.59 98.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.9 m-30 -68.2 -35.81 78.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -55.09 -45.45 75.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.941 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.33 -39.15 93.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.16 -22.48 62.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 304' ' ' LEU . 75.5 mt -105.02 -145.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.78 145.7 54.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -70.0 -39.83 5.62 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -68.7 -23.28 64.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.984 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.6 p -72.29 -24.87 61.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.438 ' HA ' HG22 ' A' ' 97' ' ' VAL . 88.8 m95 -72.82 -33.02 65.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.65 -34.51 72.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -71.42 -25.14 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.171 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.49 HG21 ' HD3' ' A' ' 107' ' ' PRO . 34.6 m -108.42 14.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 79.0 mtm180 -118.02 143.87 46.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -143.4 130.86 21.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 t30 57.01 33.3 23.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.963 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.07 90.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.47 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.33 150.41 37.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 37.0 tp -81.18 123.87 28.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.0 pt -115.25 -9.67 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.459 ' HB1' ' H ' ' A' ' 264' ' ' ALA . . . -161.33 169.3 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.668 ' HB3' HD21 ' A' ' 285' ' ' LEU . 75.1 m-85 -110.03 140.0 21.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.693 0.758 . . . . 0.0 110.984 167.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD3' HG21 ' A' ' 97' ' ' VAL . 94.1 Cg_endo -79.04 117.14 3.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.652 2.234 . . . . 0.0 112.308 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.7 mt -109.1 -29.99 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.51 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -170.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.07 124.97 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.086 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -116.53 129.42 56.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.71 149.7 30.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 94.6 mt -72.87 144.89 47.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.6 m -143.9 160.86 40.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 tp -89.33 118.55 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 244' ' ' VAL . 56.2 mt -109.6 119.66 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.082 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -133.24 155.09 50.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -164.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.03 115.73 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.874 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.62 -25.46 68.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -76.0 -35.76 59.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.12 -52.8 5.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.952 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.2 mt -124.59 105.18 30.45 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.546 0.689 . . . . 0.0 110.876 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.92 -12.65 19.74 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.342 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 57.5 t-20 -147.91 100.02 3.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.69 0.757 . . . . 0.0 110.911 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 56.8 Cg_endo -69.09 164.58 33.31 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.407 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 44.1 Cg_endo -72.43 145.15 42.14 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.347 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.02 -19.35 27.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.2 t -144.48 163.01 35.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -173.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -70.58 -25.16 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 -174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.48 -33.01 74.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -75.02 -22.59 58.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.609 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 77.6 mt -62.55 -53.63 55.49 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.682 0.753 . . . . 0.0 111.143 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.1 Cg_endo -60.43 -40.4 57.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.29 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.05 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 51.5 tp -61.32 -39.93 92.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 132' ' ' ILE . 9.3 t70 -65.99 -41.31 91.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.35 -38.79 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.64 -45.33 75.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 146' ' ' ALA . 3.7 pp -83.58 -20.34 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 84.6 tttt -56.46 -28.81 60.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.16 -18.67 63.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.066 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.21 7.51 33.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.08 29.72 62.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.48 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -108.13 161.58 14.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.8 t -116.93 148.51 41.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 139' ' ' LEU . . . -86.22 -34.63 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.2 tp -130.72 141.1 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -112.91 134.91 54.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -164.25 160.45 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.849 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -127.27 -10.56 5.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 199' ' ' ILE . 37.8 mt 50.82 35.54 12.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -93.68 -20.88 19.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -139.62 149.75 60.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.66 -22.86 74.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.355 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -50.04 -36.27 28.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -70.74 -35.7 72.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.436 HG21 HG11 ' A' ' 347' ' ' VAL . 39.2 p -80.33 -28.49 38.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 -172.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.541 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 42.1 m0 -56.91 -45.0 100.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 -164.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.593 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 98.1 Cg_exo -48.9 -38.19 38.0 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.705 2.27 . . . . 0.0 112.297 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.1 mt -80.32 -44.67 19.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.681 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.4 mt -72.18 -47.53 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 -169.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.1 -16.71 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.171 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.51 -27.07 65.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.079 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -97.73 8.47 44.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.41 16.78 3.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.454 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.35 161.16 38.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -168.0 150.57 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.26 -62.21 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.83 146.65 47.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.19 136.79 37.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.553 ' CE2' ' HB3' ' A' ' 176' ' ' TYR . 57.4 m-85 -115.29 126.3 54.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -146.13 141.41 27.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.865 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.3 t30 49.78 45.59 24.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.878 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.34 8.85 66.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.511 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.63 148.66 52.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.848 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.553 ' HB3' ' CE2' ' A' ' 171' ' ' TYR . 49.2 p90 -93.4 138.2 31.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -96.11 109.81 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.434 ' O ' HD12 ' A' ' 178' ' ' ILE . 2.2 tp -64.13 -20.01 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.05 -4.82 53.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.921 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -117.02 97.53 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.9 154.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.132 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.75 28.76 12.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 m -99.99 -23.37 4.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.152 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -97.35 20.44 11.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.01 155.31 19.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -171.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.39 -35.01 67.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.055 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.03 93.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.458 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.03 78.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -62.87 -41.68 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.57 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.33 -42.52 97.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 357' ' ' VAL . 24.7 tp -69.19 -34.36 74.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.884 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.9 m -58.77 -40.85 85.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.166 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -58.05 -44.22 87.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.12 -44.98 88.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -65.14 -40.71 89.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.13 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -38.6 91.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.3 OUTLIER -62.27 -38.64 90.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.407 HD11 HD11 ' A' ' 151' ' ' LEU . 53.1 mt -81.59 -42.16 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.56 -41.68 88.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.79 5.23 29.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.87 31.99 11.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.01 -28.86 60.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 170.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.8 tpt -146.09 151.62 37.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.428 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -89.19 134.76 33.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.34 -27.01 62.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 -174.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.66 -17.54 16.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 77.8 m -64.45 134.99 55.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -89.97 166.25 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -66.34 -37.05 84.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.5 p -68.68 -38.3 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.855 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.01 -43.97 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.79 -36.94 73.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.6 -38.41 83.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.29 95.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.01 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CZ ' HG22 ' A' ' 116' ' ' ILE . 83.2 t80 -66.77 -42.15 86.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 174.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -61.29 -26.33 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.834 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.03 -9.03 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.32 67.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.66 -28.63 33.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.936 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 90.0 m -120.14 130.19 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.132 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.65 -43.68 75.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -169.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.9 mtm -140.44 150.33 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -169.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.4 p -145.47 171.77 14.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mm -118.15 126.08 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -159.8 172.36 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.2 -164.2 29.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.27 -15.97 19.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.24 . . . . 0.0 112.382 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -70.28 -29.23 65.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 28.61 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.496 ' O ' ' C ' ' A' ' 233' ' ' SER . 37.3 m0 -72.79 -46.2 54.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 232' ' ' TRP . 58.2 m 33.87 -99.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 170.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -151.1 39.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.19 157.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.094 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.657 ' O ' ' C ' ' A' ' 237' ' ' THR . 95.0 m-20 -108.13 148.73 29.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.657 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.2 m -6.62 82.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 94.6 p -61.88 161.18 10.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -134.62 -5.45 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 241' ' ' ASN . 52.5 t -89.14 73.37 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -171.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' VAL . 83.7 m-20 40.97 47.51 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.81 147.26 26.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.69 164.95 26.61 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 -175.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.424 HG22 HG12 ' A' ' 116' ' ' ILE . 52.6 t -131.52 134.99 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 177.26 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.181 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.95 160.01 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.183 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.518 ' HB2' ' HD3' ' A' ' 257' ' ' PRO . 26.8 mt -78.97 151.06 75.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.473 ' HG2' HD11 ' A' ' 132' ' ' ILE . 50.3 Cg_exo -62.05 154.57 61.34 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.404 -174.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 96.1 m -133.14 138.12 46.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -114.15 118.17 33.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 -167.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 50.48 40.14 22.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.63 24.19 73.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 98.7 mm-40 -106.14 161.7 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.599 0.714 . . . . 0.0 110.956 -169.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.7 Cg_endo -63.94 70.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.228 . . . . 0.0 112.384 173.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 68.5 m -102.63 15.29 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.808 -167.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 257' ' ' PRO . 58.4 mttp -106.97 160.8 25.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.564 0.697 . . . . 0.0 110.909 -161.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 247' ' ' LEU . 11.5 Cg_endo -60.96 154.93 53.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.73 163.14 27.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.49 125.66 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.143 -175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.57 143.27 15.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.23 126.5 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.8 tp -64.81 129.26 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.428 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 20.1 m -135.32 155.02 51.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 -166.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.459 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -140.3 137.04 33.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.082 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.64 146.56 18.08 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.477 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 86.2 mt -114.61 124.76 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.928 0.394 . . . . 0.0 111.087 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -58.56 122.07 12.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.892 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.29 -25.92 66.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.077 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.62 -8.02 59.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.103 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.2 t -69.17 128.49 92.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.669 0.747 . . . . 0.0 110.908 -175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.71 -12.58 36.5 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.683 2.255 . . . . 0.0 112.406 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -111.92 25.04 12.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -55.45 -33.09 63.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.37 -38.8 65.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.13 -44.2 97.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.47 85.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.27 -46.45 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.11 -50.79 66.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -34.87 71.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -172.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.737 ' O ' HD23 ' A' ' 280' ' ' LEU . 2.5 tt -52.48 -51.79 57.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.54 -22.39 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.828 -171.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -98.55 -14.06 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -166.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.6 m-85 -120.58 -52.38 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.54 -32.3 73.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.908 ' O ' HD12 ' A' ' 285' ' ' LEU . 1.7 pp -136.72 76.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.971 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.8 p -143.02 170.02 16.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.187 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -53.69 -46.27 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.02 -42.99 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.862 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.04 -46.78 20.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -170.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 46.9 tp -66.03 -36.02 82.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.75 -43.74 85.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.07 85.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 3.2 p -75.42 -31.27 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.34 -16.44 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -58.83 -22.85 59.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -89.25 -22.62 22.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.823 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -100.36 155.27 36.58 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.95 -63.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.292 . . . . 0.0 112.409 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 76.5 mt -107.35 -50.5 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.88 -49.2 0.9 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.445 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.78 72.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.443 HG22 HD21 ' A' ' 311' ' ' LEU . 20.1 m -109.2 155.86 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.121 -154.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.93 -13.77 59.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 89' ' ' LEU . 58.1 tp -80.57 117.48 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.16 -44.82 96.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.6 p -65.7 -51.93 55.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -172.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -68.85 -34.03 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.929 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.1 -40.44 89.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.58 -37.78 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.79 -47.8 24.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.817 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.443 HD21 HG22 ' A' ' 302' ' ' VAL . 4.0 pp -74.72 -19.51 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.63 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.161 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.9 -10.36 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.47 130.12 52.58 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.561 0.696 . . . . 0.0 110.845 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.54 -30.51 16.24 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.737 2.291 . . . . 0.0 112.325 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -65.17 -37.9 88.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.85 -43.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.43 68.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.091 -164.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.45 79.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.11 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.8 m -68.06 -39.21 83.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.176 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 68.0 ttp -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.905 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -65.94 -46.26 78.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 327' ' ' GLY . 43.3 p30 -80.07 -13.76 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.76 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 167.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -74.7 -18.26 60.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.29 -10.54 13.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -79.46 -162.22 23.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.506 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -125.59 126.49 44.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.91 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 96' ' ' ALA . 7.4 tp -65.65 126.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -176.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 65.1 ttp -71.22 119.92 76.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.12 144.49 69.39 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.702 2.268 . . . . 0.0 112.388 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.87 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.5 p30 -99.98 11.42 39.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.828 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 335' ' ' GLN . 34.5 mt -68.42 135.12 90.88 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 0.0 111.123 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.41 -34.39 50.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.585 ' H ' HG22 ' A' ' 333' ' ' ILE . 25.5 mm100 -65.34 -10.53 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.9 mmm -63.85 -25.74 68.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.4 m -63.77 -39.4 94.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.83 -33.88 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.099 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.84 -38.86 86.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 174.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -59.98 -53.33 59.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -63.27 -36.73 84.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.41 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.03 -44.18 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -57.17 -46.2 83.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.8 m -66.7 -42.94 85.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.464 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -61.17 -42.07 97.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 157' ' ' THR . 54.1 t -67.86 -46.74 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.37 -43.38 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 88.8 m-20 -64.77 -37.41 87.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.851 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -45.67 69.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.99 72.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.6 p -83.19 -8.26 59.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.62 13.33 83.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.95 -28.14 39.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.1 tt0 -148.2 145.17 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.0 p -73.43 164.97 25.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.404 HG13 HD23 ' A' ' 192' ' ' LEU . 58.8 t -69.77 -45.99 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.31 -36.08 82.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -74.44 -41.05 61.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -64.99 -42.58 94.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.35 -32.04 70.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 -39.9 94.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -69.12 -31.49 70.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.33 73.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -69.98 -31.38 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 86.1 m -63.02 -43.19 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.38 -40.79 93.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.847 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.67 -42.43 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.11 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.9 p -89.63 -2.15 58.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -174.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.1 mt -82.86 133.17 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -126.81 159.19 34.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -74.76 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.38 21.94 55.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -142.92 162.6 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.5 mt -130.39 135.83 48.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -125.11 110.17 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.22 139.43 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 -172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.473 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 66.1 m95 -116.84 126.73 53.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.95 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.469 HG23 ' HA3' ' A' ' 16' ' ' GLY . 21.1 tt -148.93 140.09 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.033 -169.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -47.83 118.64 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.946 -166.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.09 -25.42 62.09 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.429 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -57.42 -53.39 58.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.917 -169.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -137.94 88.77 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.917 148.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.469 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -116.71 -36.98 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.486 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -77.23 -50.12 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -154.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -67.95 -52.55 34.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -154.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.74 84.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.4 -39.52 79.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.16 98.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.17 -41.02 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.23 -48.5 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.68 -33.85 86.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.385 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -64.93 -43.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.951 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.85 -45.07 86.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.909 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -68.24 -35.61 78.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.13 -34.96 79.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.6 -34.37 65.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -77.17 -41.75 40.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -108.21 -18.13 13.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.229 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.49 4.6 89.17 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.54 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 33' ' ' ILE . 16.1 tt -74.29 116.79 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.156 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.38 124.87 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.09 140.0 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.176 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -134.41 113.6 12.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.5 128.78 60.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -126.2 161.67 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -95.45 122.52 59.13 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.562 0.696 . . . . 0.0 110.8 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HB3' HD22 ' A' ' 43' ' ' LEU . 88.7 Cg_endo -86.84 80.05 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.284 -168.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -93.58 -25.63 17.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 168.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.17 -16.54 23.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -171.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 40' ' ' PRO . 2.3 mp -56.92 -42.31 79.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.922 -157.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -52.23 -38.94 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -81.01 -34.02 33.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.838 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -71.92 -23.65 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.494 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.9 m-30 -49.63 -55.95 19.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.915 -164.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.2 Cg_endo -70.75 -29.3 19.37 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.751 2.3 . . . . 0.0 112.323 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -76.4 -50.1 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.927 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.578 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 30.9 m -61.49 -35.78 69.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.71 86.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -27.33 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 p -95.05 2.28 55.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.98 8.83 65.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -170.76 95.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -127.63 -116.95 2.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.474 154.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 48.4 Cg_endo -69.08 152.48 72.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.614 2.209 . . . . 0.0 112.353 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -87.06 -39.97 15.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -138.09 139.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mm -110.09 133.54 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.103 -166.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.451 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 11.5 p90 -67.38 170.94 6.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.468 ' CG ' ' HG ' ' A' ' 262' ' ' LEU . 39.9 p-90 -87.03 143.76 27.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.05 -121.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 167.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.86 -79.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 154.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -84.01 -13.89 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -61.35 -20.38 62.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -167.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 263' ' ' SER . 55.2 m-85 -56.89 -30.13 63.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -174.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -62.36 -43.75 98.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.508 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.375 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 70' ' ' TYR . 5.0 m-30 -62.91 -38.65 91.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.877 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.46 95.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -65.07 -31.03 72.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.4 m -89.86 -4.91 57.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.74 27.63 73.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.83 -9.73 59.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.875 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 265' ' ' GLY . 0.0 OUTLIER -131.23 140.56 49.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.825 176.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -92.32 169.34 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.06 125.05 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.54 151.25 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.5 m -99.87 121.66 53.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.169 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.16 144.6 37.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.312 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -104.72 118.28 36.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.73 -38.98 73.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.95 81.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -70.83 -32.63 69.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.444 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 87.3 mt-30 -58.52 -46.77 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.931 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.65 -35.93 79.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -76.41 -20.56 56.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.817 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.438 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 85.3 mt -107.3 -147.35 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -129.33 143.59 49.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.665 0.745 . . . . 0.0 110.91 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.34 -36.73 65.62 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.29 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -65.34 -36.41 83.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.59 -23.13 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.211 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.444 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 88.4 m95 -70.04 -38.91 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.45 -31.49 70.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.82 -31.1 69.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 35.4 m -109.75 8.66 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -172.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -108.24 141.48 39.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -132.05 121.28 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 58.74 34.14 23.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.962 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.93 2.84 90.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.539 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -120.02 148.59 43.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.3 tp -81.0 129.02 34.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -173.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 pt -118.43 -7.6 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.121 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -162.45 166.95 24.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -175.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 82.1 m-85 -113.52 139.57 23.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.654 0.74 . . . . 0.0 110.982 171.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 19.9 Cg_exo -67.41 116.33 4.16 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.288 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.35 -33.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.94 154.98 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -166.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.48 127.77 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -114.22 126.37 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.82 148.28 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.03 150.66 38.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.7 m -145.72 162.75 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.765 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.06 120.07 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.431 HG12 HG22 ' A' ' 244' ' ' VAL . 73.5 mt -106.89 124.15 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.007 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -133.43 155.43 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -89.95 115.1 27.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.852 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.55 -26.61 65.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.92 -35.01 51.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.75 -52.2 7.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.75 108.58 28.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.647 0.737 . . . . 0.0 110.959 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.38 -15.08 17.98 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.701 2.268 . . . . 0.0 112.362 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -140.82 105.33 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.24 164.25 36.22 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.784 2.322 . . . . 0.0 112.374 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.6 152.45 59.5 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.88 -24.67 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 131' ' ' GLU . 9.2 t -143.38 157.21 44.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -68.4 -29.95 68.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.43 -28.96 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 128' ' ' THR . 87.3 tt0 -75.72 -24.69 56.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.771 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 26.4 mm -55.76 -53.41 63.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.605 0.717 . . . . 0.0 110.982 -169.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.0 Cg_endo -66.1 -42.82 10.03 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.669 2.246 . . . . 0.0 112.314 -172.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.45 91.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.21 -36.81 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.79 -40.81 95.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.38 -37.75 84.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.92 -44.54 76.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 139' ' ' LEU . 3.4 pp -84.49 -20.62 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -57.01 -27.77 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.5 65.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.07 10.04 32.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.4 67.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -104.7 157.17 17.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.768 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.6 t -110.49 146.12 36.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.72 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.37 -33.96 32.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.7 tp -130.81 145.49 51.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.6 ttm -109.07 127.12 53.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.914 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -163.78 158.49 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -130.91 -9.9 3.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.876 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 mt 54.12 34.94 21.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.28 -17.07 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.35 153.43 79.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.732 0.777 . . . . 0.0 110.877 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 49.0 Cg_endo -64.11 -24.76 66.08 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -38.02 72.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -71.91 -42.2 66.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.416 HG23 HD22 ' A' ' 195' ' ' LEU . 99.3 m -80.81 -35.4 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 -170.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.513 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 85.5 t90 -53.91 -43.96 97.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.606 0.717 . . . . 0.0 110.909 -163.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.707 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 87.2 Cg_exo -48.76 -39.14 38.54 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.11 -36.71 69.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.412 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 91.7 mt -69.03 -42.23 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.253 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.25 -14.05 59.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.154 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 255' ' ' SER . . . -55.8 -32.88 63.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.32 11.58 36.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -170.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.16 18.25 6.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.41 158.38 35.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.408 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.589 ' H ' ' HA3' ' A' ' 182' ' ' GLY . 87.3 m-85 -140.01 151.72 45.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.949 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.22 -61.11 2.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -137.15 147.47 45.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.962 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -68.25 124.22 22.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.86 110.9 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.926 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -144.14 143.76 31.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 48.07 42.79 17.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.86 10.09 80.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.583 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.833 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -91.29 129.72 37.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.43 109.87 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 178' ' ' ILE . 2.5 tp -64.56 -21.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.008 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.27 -6.72 52.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -119.92 96.2 5.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.0 m -104.33 153.84 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.589 ' HA3' ' H ' ' A' ' 167' ' ' TYR . . . -105.02 30.81 9.37 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.13 -16.78 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.907 0.384 . . . . 0.0 111.148 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -101.56 12.58 37.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 171.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.98 155.19 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 -174.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.73 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.085 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.85 -38.33 94.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -62.75 -38.01 88.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.13 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.85 -37.85 88.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.9 88.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.063 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -63.95 -41.12 98.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.457 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.23 -36.18 82.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -58.57 -39.98 81.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -55.45 -46.31 76.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.416 HD22 HG23 ' A' ' 157' ' ' THR . 60.5 tp -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.17 -40.38 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.03 -40.42 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.8 OUTLIER -60.89 -42.91 98.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 177.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.0 mt -70.17 -41.77 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.9 -34.83 78.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -81.81 4.33 22.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.0 34.16 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -75.61 -16.41 60.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 61.1 tpp -140.23 148.11 41.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.527 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.7 t-20 -89.63 134.95 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.69 70.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.062 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -96.05 -13.38 23.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 -171.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.527 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.7 m -70.15 139.02 52.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.58 174.1 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -62.43 -48.61 78.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.4 p -67.51 -34.46 77.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.97 -44.6 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.68 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.093 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -69.96 -36.77 75.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.803 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.2 82.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.076 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.59 97.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 171.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.0 -38.28 90.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.75 -24.5 65.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.64 -10.14 25.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.895 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.15 59.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.448 -174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -82.47 -24.04 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 0.0 110.993 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.2 m -121.01 130.67 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.75 69.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 76.1 mtm -135.25 150.47 50.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -168.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.4 p -145.84 165.5 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.65 124.26 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -154.29 162.59 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.64 -159.57 33.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.18 -16.42 19.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.599 2.199 . . . . 0.0 112.316 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -65.26 -37.21 86.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 59.59 17.99 6.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.493 ' O ' ' C ' ' A' ' 233' ' ' SER . 50.6 m0 -76.56 -53.21 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 232' ' ' TRP . 64.7 p 31.91 -94.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.867 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.6 t30 -151.27 38.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.943 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.8 tt -159.86 156.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.149 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -100.4 139.44 36.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.864 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 91.9 m -7.26 82.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 236' ' ' ASP . 87.7 p -62.15 160.37 12.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.761 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -139.81 -9.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.9 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.75 79.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 55.92 34.39 23.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -102.68 150.14 23.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.88 162.68 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 116' ' ' ILE . 58.8 t -126.16 130.28 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -135.63 174.71 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.78 158.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.87 145.89 51.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.57 0.7 . . . . 0.0 110.952 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -56.36 146.1 74.92 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.738 2.292 . . . . 0.0 112.371 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 77.7 p -130.48 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -116.86 118.96 33.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -169.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 51.44 39.46 24.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.01 63.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.559 166.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -109.99 157.34 38.1 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.631 0.729 . . . . 0.0 111.007 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.9 74.67 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 49.7 m -98.52 14.37 28.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -160.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -109.48 155.88 40.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.61 0.719 . . . . 0.0 110.858 -169.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.707 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 36.8 Cg_endo -68.65 171.81 12.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.394 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -56.94 159.97 3.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.41 128.7 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.45 147.26 16.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.428 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.22 125.0 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.165 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.468 ' HG ' ' CG ' ' A' ' 62' ' ' TRP . 4.3 tt -68.18 125.34 26.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 6.5 m -139.42 154.93 47.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.816 -166.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.89 137.87 36.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 76' ' ' LEU . . . -119.12 152.55 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.519 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.1 mt -111.5 120.45 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.372 . . . . 0.0 111.132 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -55.9 124.35 17.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.795 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.61 -25.43 65.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.05 -9.2 59.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.078 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.7 t -68.85 128.35 92.86 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.637 0.732 . . . . 0.0 110.954 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.14 -11.43 32.0 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.789 2.326 . . . . 0.0 112.366 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -109.27 24.26 13.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -54.85 -33.73 62.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.36 -41.11 57.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.39 -43.4 98.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.12 94.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.129 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.67 -47.17 76.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.41 -50.22 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.794 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -69.98 -34.94 74.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -173.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.699 ' O ' HD23 ' A' ' 280' ' ' LEU . 2.5 tt -56.03 -52.14 65.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.45 -26.39 55.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.833 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.06 -22.24 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.84 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 65.4 m-85 -122.66 -50.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 37.3 tp -68.65 -39.04 80.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.642 ' C ' HD23 ' A' ' 285' ' ' LEU . 3.0 tt -124.98 79.92 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 25.3 p -142.75 171.42 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 165.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.63 -42.11 67.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.96 -44.59 39.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.795 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.84 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.36 -47.93 8.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.44 -168.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -65.13 -33.41 75.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.869 -175.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.42 -41.04 88.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.23 94.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 290' ' ' LEU . 9.5 p -78.39 -28.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -65.16 -18.79 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.987 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -18.19 43.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -30.49 65.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -107.83 153.09 41.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.626 0.727 . . . . 0.0 110.868 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.05 -61.32 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.723 2.282 . . . . 0.0 112.406 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.94 -53.78 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 116.16 -56.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.47 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 46.86 69.2 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.184 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.437 HG22 HD21 ' A' ' 311' ' ' LEU . 19.3 m -111.49 155.9 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -162.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.58 -17.01 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.3 tp -81.81 120.59 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.48 -44.2 96.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -63.59 -49.99 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.834 -168.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -70.48 -32.62 70.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.1 -42.44 98.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.793 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.57 -35.29 72.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -172.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -79.76 -46.43 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.437 HD21 HG22 ' A' ' 302' ' ' VAL . 2.5 pp -73.41 -22.91 60.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.39 -5.63 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.97 -11.75 60.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.42 131.12 51.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.693 . . . . 0.0 110.844 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.58 -30.1 20.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.271 . . . . 0.0 112.298 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -64.97 -39.23 93.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.12 -42.51 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.5 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 -166.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.35 -35.46 73.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.74 82.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.8 -35.38 74.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -65.04 -37.78 88.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 327' ' ' GLY . 95.0 m-20 -67.97 -35.71 78.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.07 78.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.03 -19.66 60.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.34 -7.19 15.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -86.14 -163.11 37.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -128.7 135.93 49.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.677 0.275 . . . . 0.0 110.894 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.7 126.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.4 ttm -61.15 122.11 67.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.587 0.708 . . . . 0.0 110.91 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.03 132.16 37.25 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.306 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.424 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 50.6 p30 -95.12 10.07 37.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 pt -80.57 152.11 72.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 111.128 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.91 -25.04 67.78 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.755 2.303 . . . . 0.0 112.403 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.07 -16.5 60.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.79 -29.96 70.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.6 m -61.59 -41.37 97.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.758 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.49 -33.86 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.101 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.28 -46.1 83.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -60.02 -52.31 65.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.97 -46.04 89.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.93 89.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.154 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.79 -44.85 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.176 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.436 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 44.2 ttp180 -60.95 -43.34 98.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.1 m -64.99 -43.8 91.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.01 -43.16 93.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.061 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.6 -47.24 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 89.7 mt -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 85.8 m-20 -63.41 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.94 68.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.58 -34.02 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 -7.49 59.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.86 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 12.36 84.69 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.452 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -79.37 -29.02 41.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 48.1 tt0 -147.07 143.86 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -175.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.6 p -72.07 163.79 27.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -175.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 67.3 t -71.27 -45.77 68.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.14 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.58 -40.8 93.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.07 -46.14 58.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -65.38 -45.01 85.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.043 -176.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.71 -34.47 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.32 -39.71 94.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.94 -31.57 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.824 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -71.82 -46.99 56.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -67.24 -31.32 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 94.6 m -63.74 -40.17 96.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -70.0 -38.41 75.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.89 -41.27 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -96.04 16.13 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.958 -178.907 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.789 0.328 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.2 mt -86.91 133.79 29.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.258 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.97 160.21 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.02 119.47 19.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.03 24.39 32.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.469 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -150.59 154.99 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 110.824 -170.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -151.14 146.78 26.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.2 t -129.61 124.22 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.97 140.93 45.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.435 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 56.0 m95 -115.0 123.2 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.0 tt -151.85 139.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 -167.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -49.59 115.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -166.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.95 61.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.485 -171.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -55.43 -50.67 69.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -135.45 83.33 2.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 147.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.01 -34.91 1.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.505 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.39 -46.81 15.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.871 -159.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -67.62 -55.28 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -155.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.505 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -66.72 -46.98 70.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.416 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.3 -38.55 80.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.841 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.98 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.14 -38.3 90.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.57 -43.52 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.103 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.43 -36.79 92.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.448 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.28 -45.51 84.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.918 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.3 -45.2 94.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -68.87 -34.98 76.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.837 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -63.69 -35.16 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -68.89 -32.37 71.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.797 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -86.57 -39.38 16.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.1 p -108.34 -22.87 12.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.195 -170.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.57 7.33 84.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.532 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.8 tt -72.07 125.36 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 111.064 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.96 125.7 27.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.7 140.11 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.164 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -134.85 115.64 13.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.7 t -104.82 130.81 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -124.94 157.77 35.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.95 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -85.02 122.86 74.15 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.459 0.647 . . . . 0.0 110.931 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HA ' HD13 ' A' ' 43' ' ' LEU . 71.3 Cg_endo -84.45 80.1 2.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.241 . . . . 0.0 112.239 -171.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -110.79 -15.41 13.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 166.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.8 -21.34 29.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 40' ' ' PRO . 4.6 mp -53.33 -45.65 69.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -157.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.27 -42.18 29.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.46 -32.28 37.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.896 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.18 -26.36 56.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 6.0 m-85 -52.56 -55.32 33.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.891 -164.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 51.3 Cg_endo -69.16 -29.77 26.18 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.71 2.273 . . . . 0.0 112.384 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -76.6 -50.53 13.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.744 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 27.0 m -61.27 -35.32 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.45 85.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.74 -26.41 66.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -92.17 2.85 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 7.5 65.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.414 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -172.75 97.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.924 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.744 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.07 -132.88 3.98 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 157.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 45.2 Cg_endo -71.81 154.61 58.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.582 2.188 . . . . 0.0 112.367 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.51 -37.95 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -137.31 137.0 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.127 -172.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.9 mm -119.4 134.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -76.97 134.9 38.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.466 ' CB ' ' H ' ' A' ' 263' ' ' SER . 31.3 t90 -60.36 144.26 51.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.08 -98.09 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -127.17 -89.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.932 158.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.4 -23.02 37.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -59.59 -30.98 69.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -161.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.415 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 58.6 t80 -58.23 -33.99 69.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -174.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.49 97.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.448 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.28 76.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.512 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.1 m-30 -63.95 -37.05 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.946 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.75 97.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.01 -28.16 68.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.6 m -81.43 -0.22 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.9 73.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.88 -6.79 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.998 -177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.99 146.15 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.8 163.23 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.48 128.52 36.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -112.87 148.17 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 124.53 37.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.515 0.674 . . . . 0.0 111.139 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.59 142.7 44.92 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.691 2.26 . . . . 0.0 112.305 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -106.13 121.68 44.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.953 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -39.27 68.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.08 87.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -68.35 -35.0 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.421 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.2 mt-30 -60.59 -47.98 83.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.28 -37.88 84.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.932 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.33 -24.27 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.6 mt -109.41 -149.78 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.84 150.23 75.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.923 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.72 -33.55 76.39 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.343 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.947 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.7 p -70.13 -27.07 64.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.097 -172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.421 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 50.5 m95 -69.25 -39.95 78.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.77 -35.13 73.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -70.25 -30.93 68.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.413 HG21 ' HD3' ' A' ' 107' ' ' PRO . 35.3 m -105.27 14.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 -172.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -115.63 143.59 45.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -139.25 127.56 22.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.91 35.06 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.871 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.81 3.47 89.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.59 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.97 149.89 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.794 0.33 . . . . 0.0 110.957 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 tp -84.08 124.18 30.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.35 -8.8 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.421 ' HB1' ' H ' ' A' ' 264' ' ' ALA . . . -161.74 167.9 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 77.4 m-85 -114.88 135.38 22.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.75 . . . . 0.0 111.008 167.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 32.2 Cg_exo -59.86 117.35 4.09 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.9 mt -102.94 -29.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -163.15 153.32 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -172.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.05 127.22 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.161 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -118.94 132.22 56.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.06 151.11 27.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 95.4 mt -71.76 145.93 48.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -173.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -142.23 160.96 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.6 tp -90.49 121.4 32.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.977 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 244' ' ' VAL . 66.2 mt -110.0 123.97 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.124 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -133.93 155.28 50.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -91.93 116.34 28.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.835 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.03 -27.18 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.94 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.3 -35.36 41.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.8 -46.1 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.34 110.09 21.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.613 0.721 . . . . 0.0 110.894 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.83 -15.22 16.96 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 0.0 112.372 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -149.39 108.86 3.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.617 0.723 . . . . 0.0 110.847 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.47 157.43 61.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.66 145.1 56.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.353 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.17 -24.96 19.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -173.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -149.4 163.85 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -69.85 -28.26 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.3 -28.71 69.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.987 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -77.32 -20.48 54.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.884 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 24.7 mm -57.73 -53.36 66.52 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 -171.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 35.4 Cg_endo -68.23 -43.06 4.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.82 92.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.66 -36.47 82.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.941 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.58 -41.28 96.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.55 -40.04 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.26 -45.35 76.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 139' ' ' LEU . 3.4 pp -85.46 -20.07 30.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.32 -26.47 65.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.95 -19.51 65.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.38 9.47 33.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.881 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.31 28.36 64.08 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -106.57 158.72 16.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 110.826 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.4 t -110.68 146.95 35.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.772 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.09 -35.29 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.8 tp -132.21 145.05 51.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -109.16 128.71 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -170.32 163.92 8.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -129.11 -7.44 4.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.7 mt 54.33 32.5 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.22 -10.23 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -141.12 149.85 56.86 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.721 0.772 . . . . 0.0 110.87 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.74 -16.73 51.14 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -54.98 -41.61 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -70.5 -33.67 71.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.3 p -83.13 -22.62 33.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 7.6 m0 -58.76 -48.97 95.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.618 0.723 . . . . 0.0 111.002 -168.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 99.8 Cg_exo -49.31 -38.85 43.15 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.694 2.263 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.56 -35.41 73.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.482 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.1 mt -78.93 -39.09 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.91 -17.08 63.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.19 87.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.428 ' O ' ' HA3' ' A' ' 187' ' ' GLY . 98.9 m-20 -106.58 -0.38 23.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.35 36.01 2.01 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.661 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -120.75 146.38 17.54 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 166.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -155.26 156.18 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.812 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -43.7 -50.4 7.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -89.42 126.47 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.61 115.21 23.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.0 0.429 . . . . 0.0 110.879 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.43 143.49 29.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.873 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 48.09 44.03 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.936 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.51 5.77 60.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.69 148.87 51.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -93.39 126.24 38.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 171.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.84 112.93 24.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.6 tp -74.99 -23.19 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.02 -12.47 33.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -128.18 95.3 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.0 p -103.07 147.11 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.3 31.66 8.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.532 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.9 m -93.76 -19.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 172.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -103.3 24.06 11.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -87.76 160.61 17.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.09 89.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 164' ' ' ASP . . . -66.51 -41.58 94.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.509 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.661 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -61.29 -40.11 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.44 -38.63 90.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.19 -44.45 88.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.126 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.34 -41.57 96.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.388 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.33 -41.01 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 70.5 m -60.15 -40.17 88.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.069 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.34 -42.64 96.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.27 -45.1 92.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.905 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.06 -40.16 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.12 -36.1 82.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.8 OUTLIER -63.97 -38.25 90.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -38.21 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.071 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.24 -39.09 91.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -83.48 3.06 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 64.42 38.51 7.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.89 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -75.01 -10.32 59.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 tpt -143.49 152.33 41.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.509 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 65.7 t30 -86.16 142.74 28.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.61 74.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.055 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -96.73 -14.4 22.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 64.3 m -66.67 134.83 53.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -110.8 171.38 7.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.835 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -64.79 -35.79 82.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.6 p -70.85 -38.42 73.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.02 -42.61 95.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.092 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.67 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.43 -39.44 77.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.45 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.03 97.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.45 -39.33 93.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -61.55 -27.15 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.83 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.41 -9.35 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.3 16.46 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -82.67 -22.7 34.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.907 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.4 m -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.87 -38.06 73.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -171.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 69.6 mtm -135.16 154.91 51.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.6 t -152.99 165.68 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.44 124.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.09 164.63 38.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.62 12.2 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.84 -16.49 33.0 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.704 2.269 . . . . 0.0 112.328 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -75.04 -25.26 58.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 56.17 21.98 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.506 ' O ' ' C ' ' A' ' 233' ' ' SER . 44.9 m0 -76.63 -48.54 18.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.506 ' C ' ' O ' ' A' ' 232' ' ' TRP . 51.1 p 32.32 -96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.034 0.445 . . . . 0.0 110.867 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.1 t30 -143.65 36.29 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.7 tt -159.99 158.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -104.2 138.31 40.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 53.0 m -8.92 82.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 85.8 p -70.29 169.31 14.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -153.65 13.76 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 47.4 t -88.78 77.84 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 53.37 36.91 24.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -102.19 151.09 22.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 169.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.78 159.82 24.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 116' ' ' ILE . 58.1 t -128.44 130.75 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.0 0.429 . . . . 0.0 111.157 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -142.11 178.21 7.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 160.09 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.055 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.16 155.99 76.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.698 . . . . 0.0 110.932 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -56.44 140.45 89.01 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.763 2.308 . . . . 0.0 112.355 -173.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.5 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 86.6 m -123.74 130.86 53.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.121 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -103.37 112.24 25.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 46.74 41.13 9.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 168.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.87 26.2 65.29 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.443 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 96.3 mm-40 -113.56 159.07 36.85 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.639 0.733 . . . . 0.0 110.915 -169.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 71.8 Cg_endo -68.95 68.76 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.662 2.241 . . . . 0.0 112.376 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 79.6 p -92.02 24.71 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.417 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 63.3 mttp -114.88 158.91 39.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 110.87 -163.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.426 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 43.7 Cg_endo -73.57 171.79 17.05 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 0.0 112.247 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -62.0 161.76 10.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.56 127.7 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.141 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.71 143.54 15.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.454 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.3 t -123.76 126.01 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.085 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.5 tt -67.7 126.48 29.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.466 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 24.9 m -129.38 148.07 51.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -166.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.421 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -142.98 137.93 29.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.09 159.35 18.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.556 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.42 123.55 66.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -56.15 126.15 24.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.98 -27.5 65.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.73 -9.37 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.7 t -67.61 129.47 93.46 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 0.0 110.906 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.89 -14.03 42.2 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.792 2.328 . . . . 0.0 112.295 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -115.36 27.02 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.851 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -54.06 -30.96 50.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -72.97 -37.87 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.413 HD13 HD12 ' A' ' 33' ' ' ILE . 39.5 mt -65.42 -45.39 84.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.61 91.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -67.41 -46.75 72.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.05 -49.32 76.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 -171.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -68.2 -34.64 76.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -174.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.4 tt -57.08 -51.49 69.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.89 -38.88 73.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -102.49 -23.07 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.691 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 48.5 m-85 -118.73 -45.97 2.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 -172.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 36.0 tp -73.29 -43.97 60.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 54.9 tp -121.1 73.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 33.1 p -141.53 172.24 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -52.6 -46.71 67.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.811 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.95 -40.18 32.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.806 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.691 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.7 -45.79 20.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.568 -171.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 26.2 tp -64.86 -32.98 74.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.832 0.349 . . . . 0.0 110.94 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.42 -43.48 98.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.25 99.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.05 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.505 HG23 ' HA3' ' A' ' 19' ' ' GLY . 14.5 p -80.39 -33.27 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.502 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 39.7 t30 -72.91 -21.3 60.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -55.92 -22.97 28.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.85 -20.61 24.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -99.68 156.12 35.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -59.81 -62.42 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.346 -171.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.31 -48.0 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.502 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 101.68 -43.79 1.65 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.463 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.47 71.69 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 111.116 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.53 153.24 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.125 -155.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.6 -18.62 58.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.8 tp -79.13 114.18 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.74 -45.62 93.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -166.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.1 m -67.23 -48.45 67.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.53 -38.99 82.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -36.53 71.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.861 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.26 -47.61 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.88 -15.39 60.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.51 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.24 -9.6 58.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -87.75 125.23 65.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.541 0.686 . . . . 0.0 110.846 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -47.27 -28.73 8.45 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 0.0 112.321 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.414 ' HG2' HG21 ' A' ' 244' ' ' VAL . 88.8 mtm180 -63.93 -37.3 86.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 40.7 mm -88.69 -42.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.146 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.9 -37.56 76.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.79 -37.6 79.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 92.8 m -67.21 -39.65 86.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -65.15 -44.41 88.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -65.84 -46.32 78.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.905 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 327' ' ' GLY . 4.3 p-10 -79.49 -15.72 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.839 -174.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.42 82.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -71.3 -17.14 62.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -112.63 -9.76 13.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -81.37 -165.46 34.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -129.19 147.19 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 96' ' ' ALA . 6.0 tp -64.22 128.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -172.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 64.7 ttp -55.06 136.08 67.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.543 0.687 . . . . 0.0 110.908 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.48 80.52 1.37 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -103.02 4.91 37.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.434 HG22 ' H ' ' A' ' 335' ' ' GLN . 50.8 mm -81.37 137.58 48.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.628 0.728 . . . . 0.0 111.127 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.41 -35.5 21.52 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.434 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.0 mm-40 -82.04 -30.97 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.946 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 60.9 mtt -67.43 -18.58 65.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 84.4 p -60.65 -25.66 66.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.836 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.27 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -66.91 -38.86 87.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.81 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -62.98 -54.05 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -59.63 -45.69 91.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.21 83.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -173.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.35 -30.3 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -59.84 -46.55 88.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.9 m -64.65 -44.44 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.625 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -62.73 -43.78 97.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.51 -49.26 61.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.49 -43.6 97.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 82.2 m-20 -61.31 -35.81 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.81 70.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.34 -34.87 70.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.172 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.4 p -80.95 -8.35 59.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.79 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.41 11.75 85.2 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -80.51 -24.33 39.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.661 0.267 . . . . 0.0 110.788 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 59.3 tt0 -148.39 146.84 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.009 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 56.8 p -73.58 165.19 25.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.04 -45.85 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.063 -171.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.27 -41.33 98.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -72.72 -42.43 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.934 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.625 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -63.0 -43.69 98.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.1 -33.77 74.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.69 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.928 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.95 -30.98 71.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -69.45 -45.2 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -65.12 -38.3 90.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 80.5 m -59.82 -41.68 91.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.97 -40.65 78.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.9 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 53.2 p -103.4 33.78 3.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.202 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -175.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.9 mt -87.44 136.67 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.1 mt-10 -129.71 162.61 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.78 122.57 24.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.99 22.87 34.31 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 92.6 mttt -145.45 165.67 27.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.93 144.82 25.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.98 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.29 122.82 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.128 -173.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.87 140.09 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 58.8 m95 -118.41 123.71 45.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 21.2 tt -148.79 139.92 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.2 -169.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -47.49 119.03 2.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -164.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.81 -24.26 64.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.496 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -53.7 -57.0 12.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.953 -170.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -139.6 89.91 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 148.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.73 -29.13 1.92 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -80.45 -47.98 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.949 -154.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.94 -51.73 55.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -154.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.74 -45.95 71.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.483 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.2 tp -58.62 -40.26 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.75 -42.17 98.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.054 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.34 -41.61 98.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.04 -48.02 80.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.06 -35.97 92.23 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -67.02 -42.72 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.792 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -58.81 -42.71 89.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.958 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.492 ' CE2' HG21 ' A' ' 33' ' ' ILE . 19.7 t80 -66.81 -35.3 79.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.86 -35.93 82.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -72.25 -33.99 67.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.51 -42.16 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.3 p -107.77 -15.45 14.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.195 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.05 4.33 89.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.504 -175.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.2 tt -73.41 116.42 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 111.15 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.28 123.99 21.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.49 145.48 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -140.62 116.96 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.35 129.97 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -125.17 161.45 26.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -94.6 121.9 62.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.546 0.688 . . . . 0.0 110.809 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' CB ' HD22 ' A' ' 43' ' ' LEU . 72.0 Cg_endo -86.67 81.21 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.634 2.223 . . . . 0.0 112.318 -167.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -91.98 -26.3 18.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -92.36 -17.37 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.412 HD22 ' CB ' ' A' ' 40' ' ' PRO . 1.9 mp -54.03 -43.75 70.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -157.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -49.28 -40.98 36.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.66 -33.93 35.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -71.33 -25.67 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.484 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.9 m-30 -49.55 -55.83 20.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.797 0.808 . . . . 0.0 110.968 -163.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 58.2 Cg_endo -71.4 -29.26 16.98 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -177.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -76.72 -50.58 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.694 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 35.4 m -59.5 -34.01 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 -175.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.71 84.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.073 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -25.76 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.8 p -93.3 3.11 56.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.85 3.77 60.5 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -172.5 95.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.872 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.694 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -123.26 -132.42 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 154.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 50.6 Cg_endo -73.8 155.0 48.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.617 2.211 . . . . 0.0 112.343 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -84.6 -39.61 18.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -135.1 134.78 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.5 mm -119.1 135.28 60.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.16 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' A' ' 11' ' ' ILE . 17.7 p90 -74.13 158.67 33.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CB ' ' H ' ' A' ' 263' ' ' SER . 49.0 t90 -88.13 147.8 24.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.46 -95.46 0.45 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.05 -85.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 156.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -86.38 -13.18 47.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -58.52 -25.94 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 -154.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -60.0 -32.13 70.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -176.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.782 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -60.74 -44.75 97.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.47 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.7 93.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.8 m-30 -61.79 -42.48 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.68 -43.82 97.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -64.97 -30.1 71.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -84.68 -1.0 55.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.843 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.34 29.02 74.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.44 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 66.0 mt -74.63 -17.38 60.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -135.02 145.78 48.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -166.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.64 158.29 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.112 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.42 131.05 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.38 147.82 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.244 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -101.55 123.22 45.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.536 0.684 . . . . 0.0 111.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 147.49 30.83 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.749 2.299 . . . . 0.0 112.365 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -108.38 119.05 38.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -39.61 75.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.45 -42.97 83.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -69.57 -34.05 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.466 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.5 mt-30 -60.73 -44.74 96.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.0 -41.04 91.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.53 -24.8 59.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 304' ' ' LEU . 83.6 mt -108.23 -145.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -137.29 140.18 30.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 0.0 110.866 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.18 -35.43 63.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.83 -37.74 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.882 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.6 p -74.09 -25.13 59.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.164 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.466 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 49.3 m95 -74.08 -38.39 63.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.31 -34.14 74.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.968 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.93 67.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 27.4 m -112.62 19.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.136 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 58.9 mtm180 -116.37 140.13 49.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.774 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' HB3' HG21 ' A' ' 104' ' ' ILE . 85.2 t80 -139.64 127.92 22.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -175.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 56.12 32.77 20.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.75 3.24 90.66 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.415 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -115.57 150.03 37.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.927 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 64.5 tp -85.01 120.74 26.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' A' ' 99' ' ' TYR . 36.9 pt -115.19 -13.88 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -167.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -156.63 161.46 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.486 ' HB3' HD11 ' A' ' 285' ' ' LEU . 79.7 m-85 -103.22 134.66 19.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.701 0.762 . . . . 0.0 110.977 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.479 ' HD3' HG21 ' A' ' 97' ' ' VAL . 62.9 Cg_endo -81.65 118.99 3.24 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.236 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.31 -31.13 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 -171.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.51 153.69 19.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.146 -163.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.43 124.46 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -111.28 113.87 26.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.79 146.36 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.69 147.17 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.1 m -142.25 159.71 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -91.59 119.99 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.99 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 244' ' ' VAL . 31.0 mt -112.78 124.34 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -132.65 156.06 47.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -165.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -91.96 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.71 -24.46 66.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.902 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -75.75 -37.24 59.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.52 -51.12 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.98 105.74 44.62 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.591 0.71 . . . . 0.0 110.895 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.01 -14.89 26.25 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.438 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.7 t-20 -155.92 104.08 2.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 0.0 110.837 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.6 Cg_endo -66.83 160.51 46.42 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.312 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 34.1 Cg_endo -68.46 144.27 60.69 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.722 2.282 . . . . 0.0 112.364 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.17 -17.26 31.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.985 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -148.52 166.03 29.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.136 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -69.16 -25.69 64.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.787 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.79 -30.3 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.873 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.54 -22.4 43.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.901 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.631 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 81.3 mt -63.39 -50.44 73.92 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.604 0.716 . . . . 0.0 111.12 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 36.4 Cg_endo -67.83 -40.28 9.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.686 2.257 . . . . 0.0 112.254 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.52 95.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.414 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 57.1 tp -60.66 -38.84 86.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 132' ' ' ILE . 10.3 t70 -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.62 -37.93 83.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.35 -45.47 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.819 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 139' ' ' LEU . 3.5 pp -85.08 -20.32 30.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.402 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -58.23 -27.04 63.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.924 170.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -17.92 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.98 9.25 34.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 29.31 63.58 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.476 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -112.3 158.58 19.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.3 t -114.74 151.04 34.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 164.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -78.02 -43.92 28.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.042 -173.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.81 144.43 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.952 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -109.95 131.32 55.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -166.74 159.12 13.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -122.32 -16.22 7.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.4 mt 50.68 36.72 14.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -99.29 -14.07 19.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -142.59 148.66 47.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.569 0.7 . . . . 0.0 110.95 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.55 -25.07 75.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -54.23 -42.79 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.418 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 70.4 m-85 -73.19 -30.33 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 -177.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -76.83 -25.1 52.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.519 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 24.1 m0 -56.48 -46.15 99.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.602 0.715 . . . . 0.0 110.917 -164.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.758 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 74.9 Cg_exo -47.62 -44.57 25.67 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.674 2.249 . . . . 0.0 112.377 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.3 mt -75.28 -34.35 61.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.96 -42.15 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.54 -18.53 56.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.14 80.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 -160.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -98.88 13.39 32.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.08 12.45 6.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.51 170.63 53.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.498 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -165.07 165.0 20.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.919 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.94 -73.54 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.88 148.8 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -66.12 125.41 25.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.871 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -114.86 114.33 25.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -151.35 144.9 24.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.863 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 47.71 44.25 17.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.889 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.0 7.85 71.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.65 146.95 50.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -90.5 130.6 36.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -87.17 107.52 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.9 tp -64.77 -19.92 26.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.44 -2.93 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.951 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -120.57 95.98 4.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.21 153.25 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.148 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . -105.03 28.59 14.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.04 -12.9 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.313 . . . . 0.0 111.066 176.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.418 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 53.8 p-10 -103.33 13.48 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.95 156.58 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -171.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.06 66.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.1 96.7 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -65.48 -34.88 79.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.155 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -63.94 -40.34 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.06 86.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.97 -44.03 95.09 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.428 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 357' ' ' VAL . 34.3 tp -68.23 -40.0 82.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.957 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.7 m -58.85 -40.81 85.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.219 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.66 -43.23 99.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.974 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.32 -42.48 91.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.71 -39.98 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.27 -35.59 79.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -37.34 86.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.13 -38.2 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.222 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.56 -38.22 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.869 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -82.24 1.82 34.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.78 34.95 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.92 -16.49 58.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.811 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 205' ' ' ASN . 19.0 tmm? -137.81 141.81 40.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.444 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 60.8 t30 -92.73 134.93 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 -167.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.35 -11.0 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 51.9 m -75.49 140.12 42.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -98.64 167.28 10.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -66.48 -36.61 83.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.7 p -71.96 -36.33 69.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.69 -43.69 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.185 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 216' ' ' ALA . . . -73.39 -32.55 64.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.69 -36.11 73.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.16 84.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -63.81 -40.21 96.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.59 -21.83 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.787 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.27 -9.94 19.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.848 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.72 16.97 59.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.44 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.547 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 95.8 mt-10 -84.63 -28.33 26.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.973 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.0 m -123.43 130.08 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.93 92.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 -166.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.9 mtm -137.81 155.26 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 72.4 p -141.8 167.38 22.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.8 mm -118.88 115.03 46.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.65 156.81 48.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.44 -170.05 46.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.516 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.51 -19.06 11.81 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -69.96 -30.96 68.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.97 14.9 9.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.659 ' O ' ' C ' ' A' ' 233' ' ' SER . 33.5 m0 -74.28 -50.25 19.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 172.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.659 ' C ' ' O ' ' A' ' 232' ' ' TRP . 89.4 p -4.64 -80.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.843 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -171.92 4.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.944 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.98 117.83 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.646 ' O ' ' C ' ' A' ' 237' ' ' THR . 40.6 t0 -130.58 150.61 51.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.646 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.1 m -6.68 75.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 236' ' ' ASP . 93.0 p -63.22 153.96 32.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 170.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.52 -16.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 52.3 t -88.89 75.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 44.44 44.39 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.41 148.76 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 164.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.56 165.93 26.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.47 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 116' ' ' ILE . 46.4 t -128.6 131.06 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 111.164 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -143.0 -177.59 5.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.09 158.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.209 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.532 HD22 ' HD3' ' A' ' 257' ' ' PRO . 13.3 tp -76.72 139.58 66.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.711 . . . . 0.0 110.98 -173.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.83 138.0 15.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.231 . . . . 0.0 112.419 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 96.9 m -138.82 137.39 36.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -168.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -106.02 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.798 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 45.34 42.93 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.36 52.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.442 165.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -114.83 158.36 40.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.688 0.756 . . . . 0.0 110.969 -169.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -64.93 74.75 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 61.3 m -92.46 3.34 55.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 62.8 mttp -107.07 157.1 36.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.61 0.719 . . . . 0.0 110.9 -157.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.758 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 34.5 Cg_endo -65.82 160.42 43.96 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.621 2.214 . . . . 0.0 112.297 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -75.14 166.45 23.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.35 131.07 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 -167.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.64 147.08 16.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.483 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.12 122.73 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.927 0.394 . . . . 0.0 111.105 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.29 128.79 37.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.473 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 27.8 m -130.22 152.3 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.814 -164.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -142.97 136.44 28.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.06 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.18 17.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.472 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.0 mm -110.1 125.63 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 0.0 111.084 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 54.9 t-20 -58.91 124.71 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.813 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.31 -29.29 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.052 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.28 -9.7 58.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.0 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -68.15 128.55 93.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.738 0.78 . . . . 0.0 110.913 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.31 -11.7 32.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -114.91 25.0 11.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.902 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.74 -32.67 53.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.89 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.11 -37.96 63.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.63 -45.42 90.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.023 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.63 -43.28 76.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.08 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -65.11 -51.25 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.61 -44.81 92.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -35.24 74.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.642 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.5 tt -55.62 -52.04 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.21 -27.28 47.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -96.34 -7.26 35.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 -169.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.751 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 32.4 m-85 -115.94 -57.6 2.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.64 -37.61 79.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -172.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 106' ' ' TYR . 49.8 mt -99.94 41.4 1.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.96 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 75.1 p -137.74 162.09 34.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.53 -48.54 77.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.45 -38.92 71.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.751 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -76.41 -46.32 12.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.547 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.0 tp -65.44 -36.37 83.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.49 -44.75 89.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.64 95.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -30.67 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.436 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 52.2 t30 -74.12 -12.15 60.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.39 -25.99 62.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -93.57 0.0 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -116.39 155.88 47.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.717 . . . . 0.0 110.923 169.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.52 -62.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.704 2.269 . . . . 0.0 112.412 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.0 mt -108.81 -43.97 4.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.436 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 97.97 -61.31 0.95 Allowed Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.533 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 54.97 85.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.082 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.75 156.94 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.22 -156.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.99 60.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 89' ' ' LEU . 47.7 tp -79.78 117.82 21.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.11 -44.26 95.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.881 -171.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 90.2 p -67.11 -52.81 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -171.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.53 -34.67 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.37 -40.11 95.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.38 -36.88 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.69 -47.83 29.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.413 HD12 HG21 ' A' ' 317' ' ' ILE . 3.9 pp -74.7 -16.59 60.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.12 -4.67 37.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.195 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.67 -10.22 59.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -87.18 131.22 45.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.536 0.684 . . . . 0.0 110.844 175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.26 -29.23 12.54 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.649 2.233 . . . . 0.0 112.336 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -66.35 -39.09 88.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 311' ' ' LEU . 36.0 mm -84.62 -42.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.91 67.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.118 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.49 -38.97 81.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.06 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.3 m -68.43 -40.81 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.214 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -64.33 -43.91 93.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.56 -45.28 79.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 256' ' ' LYS . 44.9 p30 -78.52 -18.76 54.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.894 -173.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.81 84.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -72.98 -17.4 61.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 -9.13 14.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.16 -161.34 34.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.472 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -125.7 129.27 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.312 . . . . 0.0 110.914 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 38.2 mm -67.51 123.61 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.207 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.82 123.62 85.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.485 0.66 . . . . 0.0 110.887 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.3 146.4 40.52 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 122.627 2.218 . . . . 0.0 112.366 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.782 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 55.5 p30 -99.99 13.64 33.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.441 HG12 ' H ' ' A' ' 335' ' ' GLN . 16.7 tt -75.18 138.94 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 111.091 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.62 -25.7 20.65 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.735 2.29 . . . . 0.0 112.372 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.441 ' H ' HG12 ' A' ' 333' ' ' ILE . 99.5 mm-40 -63.89 -14.54 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.991 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.1 mmm -62.86 -25.89 68.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -58.91 -40.12 83.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.779 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.28 69.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 368' ' ' ILE . 87.3 t80 -58.43 -43.67 88.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -59.87 -57.58 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -61.62 -33.69 74.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.88 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.19 84.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.2 t -69.84 -39.94 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.151 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -57.49 -49.63 75.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.817 -172.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.3 m -65.88 -43.89 86.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.39 98.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.093 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.4 t -68.94 -49.89 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.214 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 94.4 mt -61.59 -41.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.155 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 84.1 m-20 -61.86 -38.17 87.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.37 73.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.09 68.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.137 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.7 p -80.41 -7.96 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.844 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.48 11.93 84.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.446 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.98 -27.13 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.744 0.307 . . . . 0.0 110.793 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.6 tt0 -147.51 146.4 29.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.0 p -71.11 164.56 25.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.24 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.407 HG13 HD23 ' A' ' 192' ' ' LEU . 76.8 t -73.33 -45.6 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -170.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.44 -38.37 90.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.849 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -73.23 -37.75 66.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.93 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 184' ' ' ASP . 0.4 OUTLIER -64.68 -36.16 83.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.18 -40.43 97.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.888 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -69.97 -33.12 71.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.2 -48.38 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.153 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.92 -32.27 70.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 75.1 m -63.29 -41.99 99.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.99 -38.27 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.88 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 339' ' ' PHE . 86.5 mt -63.64 -43.51 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.219 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 44.3 p -102.5 35.61 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.638 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -86.47 133.77 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.9 mt-10 -123.87 158.96 30.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.29 122.35 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.79 22.62 49.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.497 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 96.4 mttt -140.54 156.04 46.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.37 137.92 50.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.5 t -123.89 113.72 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.55 137.84 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.089 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 59.8 m95 -113.66 123.28 49.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.654 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 18.1 tt -150.94 144.08 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 -168.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -48.54 119.72 3.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -170.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.5 -21.51 60.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.477 -172.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.51 -48.31 81.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.24 83.43 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 149.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.57 -46.23 1.56 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.532 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.05 -44.86 29.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.9 -157.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.09 -53.09 42.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -154.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -65.27 -48.53 68.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.446 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 11' ' ' ILE . 2.7 mp -61.84 -36.84 82.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.897 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.94 83.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.33 -41.39 96.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.44 -41.59 88.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.535 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.06 -48.74 80.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.41 -43.09 99.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.988 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.42 -36.21 80.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.91 -34.29 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.23 -34.0 77.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -88.4 -39.71 14.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.429 ' HB ' HG22 ' A' ' 33' ' ' ILE . 62.2 m -110.1 -24.46 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.191 -167.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.35 7.75 79.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.476 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.757 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -87.07 127.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 111.02 -177.343 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.94 137.34 39.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.57 140.03 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.187 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -128.52 111.84 13.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 11' ' ' ILE . 94.4 t -104.32 127.98 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -124.77 158.23 33.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -83.67 135.98 42.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.654 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 71.8 Cg_endo -90.0 68.31 1.9 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -166.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -101.04 -32.29 10.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.793 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.22 -16.06 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 40' ' ' PRO . 5.9 mp -50.94 -51.61 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -158.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.14 -35.6 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.7 mmtt -76.13 -30.06 58.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.812 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.516 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.0 m-30 -51.29 -56.12 23.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.646 0.736 . . . . 0.0 110.844 -167.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.4 Cg_endo -67.76 -29.84 34.95 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.733 2.289 . . . . 0.0 112.314 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -78.58 -49.96 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.429 HG21 ' HD2' ' A' ' 57' ' ' PRO . 32.1 m -66.93 -32.02 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.093 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.9 92.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.16 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -94.31 1.08 55.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.35 78.88 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.422 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -169.66 101.87 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 110.924 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' CA ' ' HB ' ' A' ' 50' ' ' VAL . . . -125.05 -130.74 3.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.471 161.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.429 ' HD2' HG21 ' A' ' 50' ' ' VAL . 49.2 Cg_endo -71.42 156.64 58.12 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 -175.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.07 -43.28 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -136.65 138.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.14 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.14 134.98 60.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.427 ' CE1' HD21 ' A' ' 262' ' ' LEU . 83.4 t80 -78.71 136.31 37.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -62.87 143.96 57.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.1 -100.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -127.33 -85.9 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 160.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -87.13 -21.76 25.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -57.63 -28.92 64.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -166.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -61.72 -33.65 74.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -65.01 -43.59 95.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.546 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.43 -32.98 85.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.512 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -66.72 -34.29 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.86 99.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.43 -27.49 67.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.7 m -83.2 -1.0 51.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.907 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.84 28.63 71.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.509 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.79 -7.69 59.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.982 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.0 pp -135.13 146.01 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.66 159.65 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.1 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.64 129.37 39.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -113.33 150.6 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.153 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -105.21 124.16 37.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.255 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.9 139.58 40.09 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.718 2.278 . . . . 0.0 112.282 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.74 121.72 38.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.82 -39.36 68.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.52 95.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.082 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -65.79 -34.68 78.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.32 -43.94 95.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.23 -41.87 93.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.74 -24.43 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.98 -177.59 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.16 150.24 37.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.942 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.3 -38.13 36.6 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.737 2.291 . . . . 0.0 112.322 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -76.79 -20.13 56.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 71.7 p -75.5 -26.0 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.111 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -69.99 -37.15 75.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.995 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.67 -33.95 74.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.23 65.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 30.6 m -105.63 11.36 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -111.4 140.33 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -138.01 125.14 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.19 34.8 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.45 1.71 88.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.435 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.22 147.99 44.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 tp -78.6 129.37 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.913 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.3 pt -118.16 -5.41 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.09 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -162.42 166.67 24.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.477 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.4 m-85 -112.44 136.84 21.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.713 0.768 . . . . 0.0 110.981 167.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 39.1 Cg_exo -61.76 117.17 3.98 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.246 174.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 96.6 mt -104.33 -38.43 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -156.74 155.33 31.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.195 -170.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.0 t -124.19 128.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.147 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -115.59 120.0 37.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.832 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.86 147.33 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.104 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.58 148.96 36.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.0 m -141.53 161.08 38.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.76 122.16 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.08 128.39 67.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.053 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -133.49 154.37 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -91.87 116.34 28.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.829 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.86 -26.99 68.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -174.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.17 -32.25 33.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.881 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.08 -48.5 8.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.6 tp -127.69 111.71 20.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.662 0.744 . . . . 0.0 110.967 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 -15.15 17.62 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.818 2.346 . . . . 0.0 112.335 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 45.5 t30 -149.68 107.13 3.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -173.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.2 Cg_endo -67.63 161.87 41.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.336 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HD3' HD13 ' A' ' 135' ' ' LEU . 44.8 Cg_endo -72.7 144.38 39.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.609 2.206 . . . . 0.0 112.477 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.98 -22.99 21.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 167.31 26.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -67.13 -29.93 69.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.07 -30.22 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.77 -22.76 45.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 80.9 mt -62.34 -51.37 74.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.669 0.747 . . . . 0.0 111.075 -167.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.28 -39.05 10.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.252 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.48 90.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.064 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.625 ' O ' HD23 ' A' ' 135' ' ' LEU . 4.7 tt -62.18 -37.02 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 140' ' ' LYS . 8.7 t70 -66.35 -42.76 87.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.98 -38.72 73.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.18 -49.67 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.0 pp -80.22 -18.43 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.945 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.461 ' N ' HD12 ' A' ' 139' ' ' LEU . 84.4 tttt -57.13 -30.42 64.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 171.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.88 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -103.59 7.92 37.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.5 29.86 61.11 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.486 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -106.48 164.48 12.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.1 t -116.05 149.09 39.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.8 165.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.5 -28.48 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.105 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 tp -137.86 143.35 40.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.4 ttm -120.46 128.94 53.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -166.32 163.19 17.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.758 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -130.14 -4.36 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.869 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.3 mt 53.07 34.31 16.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -92.11 -16.61 26.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -132.42 146.2 60.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.677 0.751 . . . . 0.0 110.866 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -59.97 -23.25 72.23 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -54.57 -32.51 58.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -71.81 -36.67 70.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 p -86.19 -23.74 26.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.482 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.6 m95 -56.09 -44.99 99.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.585 0.707 . . . . 0.0 110.936 -168.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 72.2 Cg_exo -46.42 -40.23 22.63 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.279 . . . . 0.0 112.31 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.4 -38.08 30.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 93.3 mt -69.87 -51.41 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -172.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.71 -15.7 60.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 -176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.38 -31.71 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.119 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -92.02 0.78 57.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 -172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.05 13.75 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.556 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.36 166.37 31.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.423 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -174.43 154.45 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.347 . . . . 0.0 110.936 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -41.6 -63.38 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 176' ' ' TYR . 20.6 p90 -142.09 155.61 45.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.29 123.65 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -119.74 117.18 27.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -147.58 142.36 26.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -172.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 51.9 40.43 28.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.28 76.55 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.522 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.09 146.87 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.337 . . . . 0.0 110.829 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.503 ' HB2' ' CD1' ' A' ' 169' ' ' PHE . 17.1 p90 -101.56 141.61 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.63 110.97 23.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.2 tp -71.42 -19.66 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.08 -5.23 57.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -125.25 95.03 4.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.857 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.0 m -101.09 158.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.89 16.64 39.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.451 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.8 m -100.01 -19.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -98.99 19.82 14.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.52 154.2 20.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -172.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.26 70.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.018 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.54 94.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.493 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.5 81.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 111.195 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.02 -38.55 88.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.56 97.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -61.88 -40.11 98.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.429 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 357' ' ' VAL . 38.8 tp -67.86 -38.13 82.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 83.1 m -60.45 -41.19 93.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.182 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -57.85 -45.48 86.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.4 -45.11 94.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.5 -41.51 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.24 -38.24 90.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.43 -38.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.132 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.0 -32.03 73.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -81.56 3.32 25.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.55 33.96 10.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.999 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -77.07 -18.96 57.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 tpt -143.83 150.09 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 66.2 t30 -87.49 141.8 28.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.3 -32.62 68.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -175.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -96.16 -16.2 21.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -171.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 70.9 m -67.26 135.62 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.033 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -102.22 169.92 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -65.0 -47.54 77.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.863 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.31 -43.62 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.108 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.38 -32.67 70.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -64.22 -40.59 96.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.034 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.072 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -63.81 -39.83 95.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.934 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -61.47 -25.88 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.784 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.22 -8.11 40.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.04 17.3 63.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.495 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -83.5 -21.75 32.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.5 m -123.15 131.02 53.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.18 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.37 -38.88 65.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 74.2 mtm -135.51 154.88 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.902 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 166.77 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.0 mm -119.17 125.33 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.169 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -147.47 155.56 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.79 -163.42 31.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.458 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.21 -14.88 18.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.755 2.303 . . . . 0.0 112.346 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -62.84 -30.55 71.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.983 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.79 20.06 12.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.666 ' O ' ' C ' ' A' ' 233' ' ' SER . 48.0 m0 -71.38 -41.1 70.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.666 ' C ' ' O ' ' A' ' 232' ' ' TRP . 52.8 p 2.92 -91.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -153.99 3.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.876 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 19.5 tt -164.92 155.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 -168.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 238' ' ' SER . 54.6 p30 -102.17 -173.86 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . 0.56 ' C ' ' O ' ' A' ' 236' ' ' ASP . 48.2 m -9.96 82.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.204 163.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 236' ' ' ASP . 45.6 m -40.86 136.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 -31.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 240' ' ' VAL . 61.4 t -89.12 68.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -174.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 54.29 33.02 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 171.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 238' ' ' SER . 91.4 m-85 -105.56 152.66 22.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 167.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.09 158.86 24.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 316' ' ' ARG . 62.1 t -130.2 130.68 65.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.18 177.49 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.16 160.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.58 148.88 74.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.31 144.26 72.45 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.609 2.206 . . . . 0.0 112.417 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.1 p -129.18 150.03 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -125.77 111.19 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 48.34 37.95 9.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.96 26.08 56.51 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 167.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -109.6 156.78 39.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.551 0.691 . . . . 0.0 110.965 -169.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 75.2 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.438 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.3 p -92.24 -1.37 57.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -170.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -102.29 155.86 35.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.539 0.685 . . . . 0.0 110.945 -167.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.79 167.47 24.39 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -68.01 153.91 42.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.6 t -118.69 130.04 74.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.151 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -100.25 141.9 15.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.477 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.5 124.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -65.02 124.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.6 m -128.74 155.28 45.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.837 -168.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.417 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -138.19 134.97 35.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.04 141.95 15.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.2 mt -113.81 125.03 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.067 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -59.09 125.07 22.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.0 -27.32 65.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.06 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.89 -8.17 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.058 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -66.21 130.3 94.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.719 0.771 . . . . 0.0 110.883 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -65.73 -16.32 52.78 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.816 2.344 . . . . 0.0 112.275 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -110.92 21.11 16.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.881 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -51.8 -34.54 40.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.21 -36.5 58.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 33' ' ' ILE . 40.7 tp -61.06 -45.27 95.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.074 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -65.05 -45.76 84.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.76 -51.28 67.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.828 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.19 -35.29 76.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -172.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 280' ' ' LEU . 3.9 tt -55.91 -50.33 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.996 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.63 -35.68 65.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -102.74 -23.34 13.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.729 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 61.9 m-85 -122.16 -43.84 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 -171.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 30.8 tp -74.18 -42.31 60.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.918 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 51.0 tp -124.57 74.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 37.0 p -141.48 173.44 11.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.201 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.3 -45.15 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.14 -44.09 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.827 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.729 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.07 -45.89 18.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.443 -168.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 302' ' ' VAL . 45.6 tp -61.99 -34.49 76.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.34 . . . . 0.0 110.879 -176.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.88 -40.26 88.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.874 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.95 94.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.472 HG23 ' HA3' ' A' ' 19' ' ' GLY . 11.1 p -81.98 -35.81 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.236 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.35 -22.55 60.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.953 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -61.84 -13.4 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -171.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -83.46 0.16 47.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.799 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -111.58 153.32 44.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.868 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.59 -61.98 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.717 2.278 . . . . 0.0 112.368 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 84.2 mt -98.63 -36.1 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 111.44 -58.09 0.41 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.498 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 49.26 70.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.126 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.412 ' HB ' HD21 ' A' ' 290' ' ' LEU . 35.6 m -112.18 152.2 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -167.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.37 -13.4 59.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 55.3 tp -76.61 120.2 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.8 -47.03 86.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -64.96 -48.36 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -172.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -69.26 -36.68 77.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -65.64 -34.54 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.45 -39.38 94.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -69.77 -43.57 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.02 -24.13 65.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.27 -5.55 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 -173.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.49 -17.75 62.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -86.96 128.62 55.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.531 0.681 . . . . 0.0 110.915 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.32 -30.7 20.67 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.429 ' HG2' HG21 ' A' ' 244' ' ' VAL . 94.4 mtt-85 -69.91 -37.39 75.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 39.2 mm -79.14 -40.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.49 -41.94 83.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.8 m -64.8 -41.52 95.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.214 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.94 -42.81 94.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -66.39 -46.2 77.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.908 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 327' ' ' GLY . 25.8 p30 -78.21 -18.12 55.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.48 82.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.112 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.24 -25.45 59.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.78 -9.97 20.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.83 -155.95 31.47 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.457 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -122.75 129.4 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.2 mm -72.73 127.47 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.264 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.406 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 59.8 ttm -63.37 124.89 85.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 330' ' ' MET . 36.5 Cg_endo -64.21 135.12 45.39 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.745 2.297 . . . . 0.0 112.329 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.662 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.7 p30 -95.08 13.22 25.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 -172.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 335' ' ' GLN . 48.3 mm -75.12 130.36 80.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 111.203 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.98 -28.11 74.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.518 ' H ' HG22 ' A' ' 333' ' ' ILE . 92.2 mt-30 -64.95 -13.86 58.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.973 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.87 -21.49 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -58.57 -35.6 72.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.58 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -63.0 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.957 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -58.69 -52.01 67.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.922 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -64.32 -44.65 90.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.53 94.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.167 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 76.5 t -71.79 -42.39 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -57.52 -45.79 84.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.3 m -65.53 -44.64 86.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.065 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.456 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -63.76 -40.57 97.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.086 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.66 -48.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.5 -45.36 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.237 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 83.5 m-20 -63.54 -37.08 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.91 -45.52 67.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.16 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.21 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.7 p -81.9 -8.98 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.11 84.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -81.0 -25.68 37.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 110.823 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 41.7 tt0 -149.9 145.38 26.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.4 p -72.55 163.73 27.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.418 HG13 HD23 ' A' ' 192' ' ' LEU . 54.3 t -65.32 -45.93 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.116 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.08 -42.82 96.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.32 -46.23 61.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -62.08 -42.14 98.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.024 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.3 -39.97 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.906 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.06 -41.69 90.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.873 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.53 -44.02 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.33 -48.08 11.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.222 -168.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -70.95 -32.31 69.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 -170.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 59.0 m -60.61 -33.26 72.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.8 -27.97 67.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.78 -40.18 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.3 p -102.54 -16.7 16.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 178.259 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.27 128.99 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.02 166.28 21.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.77 123.91 25.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.946 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.01 29.46 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.453 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -141.07 154.78 46.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 110.929 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 33' ' ' ILE . 7.2 tt -139.07 130.36 26.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.796 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.24 124.79 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.6 mt -118.84 134.82 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.824 ' HB3' HD21 ' A' ' 43' ' ' LEU . 39.7 m0 -111.7 123.73 50.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.965 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.51 160.22 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.867 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.7 t-20 -55.85 120.14 6.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 167.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.54 -20.89 79.42 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.482 -171.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -57.74 -45.47 85.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.844 -167.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.3 mmtt -130.67 75.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 148.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.5 -46.3 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.504 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -75.82 -45.75 34.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.939 -154.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -63.98 -52.66 58.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -157.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -64.18 -43.91 96.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.532 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.5 -37.52 83.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.99 -44.57 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.47 -52.2 66.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.6 m -75.25 -34.01 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.88 -39.6 93.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.484 175.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -70.11 -42.97 71.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.72 -39.64 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.98 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.28 -35.09 75.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 171.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.63 -34.12 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.81 -33.6 72.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -83.96 -39.96 19.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.2 p -109.09 -16.98 13.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.142 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.67 5.39 86.66 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 7' ' ' LEU . 14.1 pt -88.07 125.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.195 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.84 129.64 39.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG21 ' HA3' ' A' ' 24' ' ' GLY . 14.4 p -100.78 139.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.081 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -140.95 121.41 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.19 128.67 61.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 88.3 tt0 -112.24 151.85 29.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -79.28 161.46 67.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.839 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.867 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 59.9 Cg_endo -102.97 24.05 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 -160.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -76.45 -43.62 39.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.99 -14.32 36.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.824 HD21 ' HB3' ' A' ' 10' ' ' TRP . 3.5 mp -52.03 -50.9 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 -161.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.9 -41.28 61.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.25 -35.56 61.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.863 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.25 -28.93 62.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.53 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m-30 -49.24 -54.91 24.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.593 0.711 . . . . 0.0 110.898 -162.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 86.8 Cg_endo -80.03 -31.11 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.211 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -74.65 -48.32 26.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -168.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.48 -30.76 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.52 -37.82 87.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.83 63.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 p -97.68 -1.11 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.101 -171.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.591 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 75.63 18.46 79.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.523 -176.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -109.73 -175.16 2.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.864 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.7 -165.9 12.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.505 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.617 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 89.5 Cg_endo -82.79 178.45 6.03 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -87.88 -38.72 15.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 164.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.9 mt -131.06 139.6 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.2 143.23 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.058 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -100.05 142.85 30.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.51 126.65 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.76 -90.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -110.75 -83.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -95.91 -17.44 21.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 80.3 mtp180 -59.72 -25.7 65.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.435 ' CD2' HD11 ' A' ' 104' ' ' ILE . 10.1 p90 -52.39 -37.43 56.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -49.06 9.86 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.495 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.6 86.17 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.48 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.568 ' HB3' HD21 ' A' ' 75' ' ' LEU . 25.4 m-85 -71.66 -30.4 65.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.942 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.93 69.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.63 -29.86 70.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -83.98 -1.74 55.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 110.934 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.35 25.02 66.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.4 pp -85.99 -5.41 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.825 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -131.41 146.09 52.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.944 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 147.62 24.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.21 142.88 50.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 103' ' ' LEU . 39.2 pt -101.99 145.97 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.6 p -132.25 70.26 80.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 111.08 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.37 144.35 45.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.381 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -86.61 -174.52 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.71 -37.48 84.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.46 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.14 -36.18 81.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.82 -37.76 87.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -54.42 -29.43 49.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.856 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 93.2 mttt -54.02 -36.83 63.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.254 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 160.22 123.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.503 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 13.7 m-85 -158.26 51.6 0.47 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.72 . . . . 0.0 110.862 167.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 55.7 Cg_endo -70.8 -71.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.642 2.228 . . . . 0.0 112.335 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.41 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 42.9 p90 -102.76 -19.06 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 168.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -69.14 -20.53 64.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.142 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 90' ' ' TYR . 17.6 t90 -58.86 -43.23 90.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.78 -27.2 68.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.565 ' HB1' ' HB ' ' A' ' 261' ' ' VAL . . . -74.5 -30.6 61.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.033 -169.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -116.43 14.99 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.479 ' HB3' HD23 ' A' ' 103' ' ' LEU . 52.4 ptt85 -118.25 147.15 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -135.43 125.39 25.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 t30 60.29 35.13 20.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.857 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 5.28 90.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.574 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 148.5 44.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 98' ' ' ARG . 83.9 mt -86.95 122.26 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.435 HD11 ' CD2' ' A' ' 67' ' ' PHE . 44.6 pt -122.79 -1.9 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.71 31.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -111.47 146.26 34.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.68 0.752 . . . . 0.0 110.902 174.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.59 122.46 6.94 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.712 2.275 . . . . 0.0 112.402 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.7 -37.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.079 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.42 152.09 10.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.5 128.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.122 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -122.55 126.37 47.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.53 155.97 38.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.447 HD12 ' HG2' ' A' ' 257' ' ' PRO . 94.7 mt -76.46 144.33 39.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.1 m -140.66 156.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.453 ' HB2' HD23 ' A' ' 247' ' ' LEU . 43.0 tp -94.47 127.65 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 244' ' ' VAL . 68.7 mt -113.98 130.5 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.169 172.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -136.76 155.83 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 36.4 t-20 -92.0 111.7 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.581 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.5 mttt -65.17 -28.29 69.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 31.7 t70 -76.04 -33.22 59.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.84 -44.96 13.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.4 tp -121.03 109.62 35.38 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.71 0.767 . . . . 0.0 110.954 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.5 -15.6 19.59 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.0 112.361 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -147.12 109.55 3.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 0.0 110.845 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.35 154.39 74.41 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.686 2.258 . . . . 0.0 112.356 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.24 140.71 37.78 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.64 -25.75 22.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.4 t -149.97 174.32 12.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.119 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -74.53 -24.44 58.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -169.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.73 -32.4 73.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.895 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.75 -23.18 58.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -172.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 88.7 mt -66.31 -51.78 41.52 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.63 0.728 . . . . 0.0 111.126 -168.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.56 -40.42 56.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.703 2.268 . . . . 0.0 112.303 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.2 -43.6 98.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.3 -38.36 80.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 9.8 t70 -64.59 -36.23 83.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.49 -37.05 85.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.95 -58.0 4.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -78.7 -11.76 59.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 86.6 tttt -56.46 -30.37 62.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 169.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.03 -21.03 66.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.9 6.64 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.24 28.06 64.83 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 7.0 mptt -119.72 156.52 30.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.887 0.375 . . . . 0.0 110.92 174.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -115.76 153.97 30.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -72.55 -49.34 33.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 52.8 tp -143.44 125.7 15.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.2 mmm -133.19 131.42 40.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 174.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.93 167.65 28.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 210' ' ' TYR . 60.1 t-20 -50.87 111.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 206' ' ' ALA . 8.0 tp -115.31 19.96 15.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -92.19 -2.46 56.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.04 145.8 53.43 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.612 0.72 . . . . 0.0 110.874 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.477 ' HB3' ' HB2' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -68.15 -27.66 35.19 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -58.79 -35.43 72.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.21 -26.63 22.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.828 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.8 p -87.57 -32.31 19.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.65 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 58.6 t90 -55.01 -52.3 72.24 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.516 0.674 . . . . 0.0 110.99 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.6 Cg_endo -54.98 -32.18 77.52 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.624 2.216 . . . . 0.0 112.402 -175.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.46 -35.19 73.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.424 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -72.42 -41.66 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.17 -18.89 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.164 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.97 2.63 53.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.13 11.87 6.06 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.597 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.17 165.19 53.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.45 ' HD2' ' HA3' ' A' ' 182' ' ' GLY . 98.1 m-85 -140.33 175.86 9.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.989 0.423 . . . . 0.0 110.882 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 339' ' ' PHE . . . -112.03 -33.68 6.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -148.35 134.76 19.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.825 -173.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 1.072 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -89.89 121.55 32.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -170.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -127.46 113.12 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.02 142.66 24.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.0 32.77 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.16 -2.8 64.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.3 152.99 49.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.731 0.301 . . . . 0.0 110.888 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 64.9 m-85 -83.15 122.74 28.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 63.0 t0 -128.77 118.67 23.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -175.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.793 ' HA ' ' HE3' ' A' ' 170' ' ' LYS . 8.5 tp -57.04 -20.8 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.21 -15.77 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -174.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -110.58 47.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.704 ' HA ' ' HB3' ' A' ' 170' ' ' LYS . 8.6 p -99.11 145.66 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.45 ' HA3' ' HD2' ' A' ' 167' ' ' TYR . . . -110.75 22.8 21.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.539 -171.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 m -92.09 -23.27 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 0.0 111.143 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -106.63 25.12 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -99.06 -171.95 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.41 80.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.001 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -43.21 93.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.75 88.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.06 -41.71 97.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.22 -41.11 86.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -68.14 -47.2 60.52 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.449 -175.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.05 -38.7 86.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 72.9 m -57.67 -43.36 84.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -66.04 -43.61 87.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.8 tt -55.96 -46.36 78.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.936 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.57 -39.37 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -60.1 -34.74 73.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.791 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.77 -33.86 76.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.95 -39.84 45.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.201 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.66 -38.59 87.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -86.94 2.11 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 61.69 31.41 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -83.85 -30.88 26.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.0 mtt -139.55 145.5 38.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.835 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.587 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -97.32 135.78 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.434 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -67.61 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -98.25 -12.7 21.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -166.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 53.1 m -59.03 127.36 31.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -95.5 171.3 8.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 70.5 t80 -57.8 -39.39 77.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -59.04 -43.69 91.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.91 -45.53 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.41 -41.11 80.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.822 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.36 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.29 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -64.74 -39.71 94.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.88 -24.0 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.76 -10.0 32.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.14 52.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.456 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -87.66 -21.07 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 110.898 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 91.0 m -127.17 133.25 50.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.185 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.16 -32.31 64.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -172.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 73.4 mtm -135.44 148.55 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -148.68 165.39 31.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 91.8 mt -130.99 127.9 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.406 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 46.2 p30 -152.7 167.25 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.946 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.84 -129.59 3.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -168.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.97 -18.64 18.65 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.734 2.29 . . . . 0.0 112.433 -165.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -55.02 -30.77 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.917 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.07 42.43 28.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.99 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.517 ' O ' ' C ' ' A' ' 233' ' ' SER . 67.5 m95 -56.64 -25.01 52.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.899 167.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 232' ' ' TRP . 28.1 p 30.64 64.13 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -68.48 -12.13 60.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 37.3 pt -90.24 -5.14 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.54 -48.52 10.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -61.33 -57.81 10.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 40.7 t -161.21 128.23 4.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.797 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.55 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.09 174.46 10.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.02 -66.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -163.98 94.75 0.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 27.7 m-85 -115.45 160.28 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.818 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.581 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -138.98 168.4 24.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.425 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.432 HG22 HG12 ' A' ' 116' ' ' ILE . 60.4 t -125.02 129.19 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.9 p -131.18 171.61 13.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.83 165.33 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.024 167.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.483 ' HB2' ' HE2' ' A' ' 256' ' ' LYS . 90.8 mt -77.55 145.23 71.15 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.617 0.722 . . . . 0.0 110.968 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 75.6 Cg_exo -55.63 148.87 51.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.659 2.239 . . . . 0.0 112.374 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -131.12 154.72 48.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -132.06 109.65 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 46.76 42.68 12.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 164.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.63 25.11 57.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -108.58 157.89 35.41 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.914 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.01 74.97 0.33 Allowed 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.727 2.285 . . . . 0.0 112.426 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 93.5 p -86.42 -7.66 58.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.8 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 247' ' ' LEU . 13.9 ptpt -135.38 155.37 78.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.546 0.688 . . . . 0.0 110.869 -168.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.466 ' HG3' ' HG3' ' A' ' 159' ' ' PRO . 53.6 Cg_exo -61.3 164.91 13.87 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -60.34 162.27 6.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.901 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 324' ' ' ALA . 98.1 t -116.23 129.86 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.148 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.67 11.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.565 ' HB ' ' HB1' ' A' ' 96' ' ' ALA . 86.8 t -122.16 125.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.112 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 54.0 tp -71.41 134.32 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.6 p -132.23 156.78 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.69 137.15 51.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.071 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.71 169.74 23.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.495 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.73 133.89 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.163 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -61.85 125.54 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.17 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.14 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.591 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -80.65 -13.86 58.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.9 t -72.49 130.49 85.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 0.0 110.903 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.91 -10.32 28.16 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.716 2.277 . . . . 0.0 112.388 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -107.01 33.87 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -169.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -53.06 -40.2 63.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.9 -36.95 75.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 48.0 tp -61.11 -48.26 82.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.021 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.46 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.094 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.55 -47.32 79.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.67 -42.38 82.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 37.0 t80 -60.82 -44.5 96.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 284' ' ' LEU . 31.8 tp -65.89 -51.13 61.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -76.25 -35.18 59.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -170.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -106.27 -16.45 14.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.843 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 87.2 m-85 -120.52 -50.96 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.924 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 280' ' ' LEU . 49.6 mt -71.22 -42.79 68.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.947 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.03 62.0 7.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.9 p -136.73 168.0 20.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -55.0 -45.44 75.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.95 -41.03 37.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.09 -47.43 13.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 -171.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 20.1 tp -69.54 -35.38 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.788 0.328 . . . . 0.0 110.951 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.04 -45.21 91.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.77 76.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.517 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 84.3 t -78.94 -47.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -73.84 -16.39 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.07 -23.28 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 92.6 m-20 -73.95 -19.62 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -85.69 152.2 56.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.563 0.697 . . . . 0.0 110.938 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 -22.49 52.88 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.753 2.302 . . . . 0.0 112.318 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.5 mt -101.89 -46.22 4.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.04 72.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.444 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -67.87 128.8 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 111.051 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 307' ' ' TYR . 19.8 m -117.76 151.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.02 60.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.0 tp -73.85 120.62 19.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.07 -48.36 82.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -171.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -59.13 -46.93 87.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 -170.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.457 ' HB3' HG21 ' A' ' 302' ' ' VAL . 2.2 t80 -73.93 -32.98 63.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.54 -35.65 76.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.11 -34.74 73.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -76.13 -39.69 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.833 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 302' ' ' VAL . 96.1 mt -68.96 -23.33 64.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 176.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.62 -9.36 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.057 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.72 -17.16 59.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.907 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -88.21 120.0 70.45 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.522 0.677 . . . . 0.0 110.932 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.77 -31.96 34.97 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.23 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.422 ' HG2' HG21 ' A' ' 244' ' ' VAL . 94.5 mtm-85 -69.34 -44.8 70.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.12 -39.93 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.15 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.82 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.078 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 75.0 m -66.68 -43.01 85.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.193 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.15 -36.33 81.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.67 -33.58 72.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 176.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -65.21 -34.78 79.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.869 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.437 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -60.82 -36.86 80.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.08 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.5 -23.37 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.01 -11.44 20.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.44 -159.89 34.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -124.18 127.98 48.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.6 ' O ' ' O ' ' A' ' 330' ' ' MET . 37.5 mm -79.95 119.13 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 -165.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.6 ' O ' ' O ' ' A' ' 329' ' ' ILE . 2.1 ppp? 37.14 171.43 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 0.0 110.899 -163.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 330' ' ' MET . 90.4 Cg_endo -69.95 -157.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 171.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -135.08 -46.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 37.9 pt -129.79 158.44 73.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.532 0.682 . . . . 0.0 111.234 167.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 33.1 Cg_endo -63.61 -21.62 70.31 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.424 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -14.89 59.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.515 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 37.1 mmt -64.94 -27.95 69.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -60.52 -39.02 86.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.66 67.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.109 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.7 t80 -55.81 -49.37 73.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -58.88 -44.12 91.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.012 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -59.03 -42.79 91.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.75 85.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.53 -40.81 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 154' ' ' PRO . 42.6 ttt180 -54.2 -52.64 60.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 74.8 p -66.41 -36.04 81.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.36 94.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.07 -49.43 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -64.6 -41.87 93.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.14 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -64.3 -38.49 91.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.37 71.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.053 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.84 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -80.36 -7.92 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.68 12.71 81.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.458 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.64 -28.56 51.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.63 0.252 . . . . 0.0 110.775 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -139.52 155.87 47.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 71.9 p -79.01 168.13 20.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.08 -47.69 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.62 -42.34 91.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -71.89 -37.92 70.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.06 94.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.075 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.99 -35.28 78.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.02 -42.36 94.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.29 -34.14 76.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.51 68.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.162 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -40.43 97.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 84.4 m -63.02 -41.88 99.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.044 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.92 -35.11 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.65 -41.51 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.228 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.5 p -94.09 -11.6 30.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -178.404 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.664 0.268 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.74 135.8 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.79 179.87 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.2 120.43 20.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.99 23.54 27.35 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.389 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -143.24 151.86 41.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 7' ' ' LEU . 1.7 pp -143.77 144.0 31.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.816 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.06 125.22 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.061 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mt -117.01 134.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.672 ' CZ3' ' HD3' ' A' ' 57' ' ' PRO . 27.6 m0 -114.87 128.13 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 17.6 tt -152.4 157.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.448 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.7 t-20 -56.65 120.35 7.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 166.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.713 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -77.36 -22.07 71.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.466 -168.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.39 -48.89 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 -164.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.6 mmtt -130.32 79.6 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 145.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.62 -38.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.49 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -74.59 -44.79 49.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -160.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -66.02 -51.67 56.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.912 -159.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -60.23 -44.49 97.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.576 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.29 -39.05 81.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 110.849 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.94 85.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.062 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.17 -49.56 73.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.44 -32.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.71 93.14 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.522 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -70.04 -43.07 72.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.3 -40.41 96.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.97 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.09 -39.79 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.861 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.99 -33.58 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -73.3 -35.55 66.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -82.05 -41.32 20.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -103.0 -22.25 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -172.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.21 4.99 87.8 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.55 120.55 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 111.195 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.85 120.44 11.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG13 HD11 ' A' ' 7' ' ' LEU . 78.8 t -96.9 135.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -136.31 116.65 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.73 126.4 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.169 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -110.46 162.04 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -64.87 163.34 29.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.535 0.683 . . . . 0.0 110.944 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.713 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 70.2 Cg_endo -99.03 -2.16 0.89 Allowed 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.706 2.271 . . . . 0.0 112.397 -161.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.66 -31.27 59.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -160.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.64 -10.59 24.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 61.3 mt -51.56 -55.74 17.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -158.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.3 -32.35 68.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -168.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.21 -34.69 61.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.54 -28.35 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.515 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 8.2 m-30 -48.75 -54.41 27.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.789 -163.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 83.8 Cg_endo -78.59 -29.23 3.79 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.877 2.384 . . . . 0.0 112.272 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.66 -49.42 18.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.0 -170.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -65.95 -30.71 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.07 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.89 -37.13 85.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 -26.25 63.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.013 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.5 p -97.96 -1.24 43.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.124 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.13 18.36 80.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -107.71 -174.95 2.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.92 -166.99 13.21 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.672 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 89.7 Cg_endo -82.89 173.5 10.18 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 7' ' ' LEU . 30.5 m-20 -85.9 -36.41 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 166.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -132.37 139.74 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 47' ' ' PHE . 7.2 mt -131.89 143.24 40.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -105.88 139.78 39.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.51 ' O ' HD12 ' A' ' 262' ' ' LEU . 23.9 m-90 -121.14 133.2 55.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 173.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -52.29 -90.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -171.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -110.97 -81.45 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.49 -23.71 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -159.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.79 -38.06 69.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -51.17 7.69 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.496 -168.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.13 91.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' HB3' HD21 ' A' ' 75' ' ' LEU . 27.9 m-85 -74.86 -31.25 61.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.56 68.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -61.35 -28.11 68.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.809 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -85.24 3.48 39.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 25.46 64.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.7 pp -87.41 -5.14 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 0.0 110.892 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 76' ' ' LEU . 4.2 pp -133.15 144.8 50.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.1 152.31 19.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.35 144.57 48.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.827 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -109.09 152.54 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -133.46 67.13 75.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.671 0.748 . . . . 0.0 111.139 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.66 143.05 41.18 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.617 2.211 . . . . 0.0 112.325 166.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -81.0 -176.58 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.79 -32.24 73.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.819 -173.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.97 64.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -67.23 -36.27 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.87 -43.99 94.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.21 -35.13 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 97.4 mttt -67.23 -31.33 71.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -171.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.235 ' O ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER 173.99 78.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 -177.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 38.0 m-85 -151.06 41.49 0.22 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 0.0 110.885 168.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 67.1 Cg_endo -72.48 -70.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.218 . . . . 0.0 112.27 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.493 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 99.1 m-85 -92.98 -28.04 16.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.564 HG21 ' HB1' ' A' ' 303' ' ' ALA . 66.7 p -71.94 -22.17 61.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -162.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -62.47 -42.86 99.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.96 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.42 -24.56 66.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.568 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -74.54 -31.91 62.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.08 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.37 16.08 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 -170.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -119.39 145.56 46.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -136.33 127.18 27.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 59.48 34.82 22.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.6 5.65 89.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.481 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.6 145.04 43.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.91 113.58 25.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.6 pt -124.21 -2.3 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.093 -161.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.96 157.25 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -170.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.1 m-85 -106.35 136.89 19.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.724 0.773 . . . . 0.0 110.911 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 24.4 Cg_exo -65.3 114.37 2.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.749 2.3 . . . . 0.0 112.372 174.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.42 -31.75 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.89 152.27 6.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.74 124.8 68.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.062 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -123.85 137.57 54.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.975 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.79 144.13 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.2 m -142.92 158.94 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB2' HD23 ' A' ' 247' ' ' LEU . 64.0 tp -92.31 120.08 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 244' ' ' VAL . 61.9 mt -108.52 126.32 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -136.13 157.49 46.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 -167.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 30.2 t-20 -94.0 112.24 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.484 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.6 mttt -63.89 -26.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.89 -33.66 30.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.86 -48.73 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 173.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -123.23 109.4 31.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.623 0.725 . . . . 0.0 110.941 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.34 -15.05 20.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.562 2.175 . . . . 0.0 112.387 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.5 t-20 -148.43 107.11 3.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.759 0.79 . . . . 0.0 110.841 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -66.06 152.34 81.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.669 2.246 . . . . 0.0 112.302 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.23 142.7 51.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.287 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -88.62 -17.08 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.9 t -147.66 166.29 27.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -68.13 -29.34 68.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.21 -27.86 69.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.21 -33.47 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.568 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 97.9 mt -67.66 -45.09 45.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 111.052 -159.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 80.3 Cg_exo -50.78 -49.56 16.47 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.22 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 135' ' ' LEU . 2.1 tt -54.23 -35.61 62.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 175.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 25.1 t70 -65.82 -34.82 79.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.29 -37.54 87.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 -172.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.64 -56.91 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -172.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 145' ' ' SER . 1.9 pt? -79.8 -11.87 59.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -173.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -53.53 -30.27 40.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.936 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.3 -19.8 65.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -104.71 12.58 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.829 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 24.84 73.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -117.77 156.22 28.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.857 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.456 ' O ' HD11 ' A' ' 139' ' ' LEU . 48.2 t -115.78 153.48 31.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -71.92 -53.29 13.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.8 tp -147.1 135.4 21.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mtp -124.04 134.58 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 169.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -149.24 165.34 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.807 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.448 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 55.3 t-20 -64.72 113.56 3.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -172.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.8 tm? -92.88 -23.91 18.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -77.77 -4.38 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.89 152.2 80.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.606 0.717 . . . . 0.0 110.889 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 61.7 Cg_endo -79.65 -20.71 9.1 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.616 2.21 . . . . 0.0 112.404 -174.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -57.28 -45.53 83.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 45.5 m-85 -81.32 -27.02 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.419 HG21 HD22 ' A' ' 151' ' ' LEU . 72.1 p -87.12 -30.06 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.049 -171.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 82.5 t90 -56.2 -47.72 98.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.474 0.654 . . . . 0.0 110.96 -172.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 99.1 Cg_exo -49.52 -39.31 45.56 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.614 2.209 . . . . 0.0 112.383 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.691 ' O ' HD23 ' A' ' 160' ' ' LEU . 4.9 tt -74.06 -38.86 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.957 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.5 mt -67.32 -37.94 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.41 -13.67 59.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.92 67.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 -167.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -94.55 5.93 50.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.98 15.2 3.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.538 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.65 153.38 38.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.512 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.519 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 98.7 m-85 -135.06 152.04 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.906 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.01 -38.04 7.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -143.67 140.29 29.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.812 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -98.55 125.61 43.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.92 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.05 110.06 19.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.007 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -151.17 140.77 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 48.97 37.33 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 4.47 64.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.477 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.48 153.49 49.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 -173.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.14 131.23 39.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.979 168.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -110.79 120.2 41.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.99 -20.38 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.49 -16.77 44.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -98.94 66.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.5 p -108.47 139.16 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.519 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -107.88 32.22 7.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -168.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.0 -35.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.995 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -102.88 29.13 5.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.72 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -99.09 -172.2 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.941 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.97 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.81 -44.89 94.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.515 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.03 86.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.861 0.362 . . . . 0.0 111.12 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.77 -40.23 91.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.809 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.49 89.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.45 -43.53 94.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.522 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.01 -38.4 88.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -58.93 -43.65 91.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -63.24 -42.37 99.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.58 -45.09 92.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.84 -40.24 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.38 -39.38 94.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.7 OUTLIER -63.57 -42.67 98.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.59 -38.73 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.16 -36.82 80.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -83.78 3.62 32.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 64.56 33.73 10.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -78.91 -24.69 43.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 28.3 ptm -147.7 160.59 42.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -94.13 134.08 36.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.94 67.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -89.44 -3.27 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.897 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.2 m -56.46 126.71 27.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -103.48 170.12 8.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -65.88 -32.71 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.009 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 92.2 p -69.74 -36.08 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.2 mm -65.14 -42.31 93.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.71 94.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.103 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -69.69 -38.77 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.05 85.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.023 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.2 -39.35 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -66.5 -40.91 89.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.27 -19.77 65.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.97 -10.51 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.98 65.84 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.471 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.09 -25.82 39.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 224' ' ' MET . 73.9 m -128.23 133.82 48.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.49 -27.04 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -169.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.419 ' H ' HG22 ' A' ' 222' ' ' THR . 74.8 mtm -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -152.13 165.85 33.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 125.04 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.139 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -127.21 136.63 52.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.438 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -105.03 -134.34 7.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.479 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.438 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.0 Cg_endo -70.82 -19.47 31.03 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.764 2.309 . . . . 0.0 112.299 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -58.17 -30.32 66.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 62.09 22.82 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.018 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.53 ' O ' ' C ' ' A' ' 233' ' ' SER . 39.3 m0 -61.13 -33.78 73.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 232' ' ' TRP . 67.5 p 31.34 67.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.896 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -81.15 35.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.908 -160.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 244' ' ' VAL . 38.3 pt -115.26 6.04 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 171.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.6 -54.27 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.5 m -60.44 -59.61 5.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -153.5 126.29 8.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.488 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.52 172.86 11.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 98.6 t -86.37 -71.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.61 76.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 44.9 m-85 -114.93 154.24 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.484 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -146.01 170.61 27.15 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.422 -174.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.456 HG22 HG12 ' A' ' 116' ' ' ILE . 60.7 t -123.49 134.88 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 0.0 111.157 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.7 176.86 8.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.193 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.8 162.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.109 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 115' ' ' LEU . 97.6 mt -81.38 151.3 68.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.886 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 153.47 70.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.74 2.293 . . . . 0.0 112.352 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 81.7 p -131.19 146.57 52.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -121.28 115.62 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 51.38 37.07 18.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.25 26.98 56.57 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.456 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.0 mm-40 -112.4 159.55 33.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.611 0.72 . . . . 0.0 110.907 -168.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 59.9 Cg_endo -63.39 75.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.722 2.281 . . . . 0.0 112.418 171.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' A' ' 249' ' ' THR . 49.5 m -94.28 6.64 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 -164.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.499 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 12.1 ptpt -135.12 158.6 74.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.869 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 29.4 Cg_endo -69.84 168.2 22.36 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.672 2.248 . . . . 0.0 112.298 -170.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -70.18 172.16 8.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.3 t -121.6 132.84 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.185 -175.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.14 142.99 15.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.502 ' HB ' ' HB1' ' A' ' 96' ' ' ALA . 96.3 t -127.43 127.99 69.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.816 0.341 . . . . 0.0 111.165 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 62' ' ' TRP . 51.5 tp -72.47 135.1 45.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -121.27 137.24 54.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.842 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.73 132.6 53.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.74 170.73 23.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.98 130.39 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 111.16 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -59.82 128.9 39.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.43 68.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . . . -80.67 -13.22 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.0 t -69.7 133.59 88.53 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.627 0.727 . . . . 0.0 110.856 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.33 -8.9 23.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.585 2.19 . . . . 0.0 112.35 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -106.82 30.53 6.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -52.17 -43.47 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.17 -41.62 63.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.807 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.04 -52.16 65.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.008 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -65.88 -50.25 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.9 -47.58 71.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -170.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -71.95 -33.26 68.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -176.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 284' ' ' LEU . 41.6 tp -57.11 -46.39 82.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -82.9 -28.86 29.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.967 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -101.42 -9.78 20.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -168.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 76.2 t80 -125.38 -59.66 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.407 ' HB2' HD12 ' A' ' 280' ' ' LEU . 68.6 mt -71.19 -44.5 65.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 20.4 tp -85.03 67.51 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.0 p -139.69 170.19 16.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.22 -45.26 79.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.835 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -75.89 -41.3 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.17 -45.9 9.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.558 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.2 tp -71.29 -35.66 71.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.981 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -56.58 -41.04 76.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.897 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.24 69.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.451 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 76.7 t -76.95 -45.1 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.052 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -73.05 -7.75 52.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -52.83 -21.95 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 89.2 m-20 -79.15 -24.2 43.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.806 -174.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -96.34 148.47 34.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.878 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.24 -25.62 26.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.637 2.225 . . . . 0.0 112.295 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.56 -48.41 3.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.019 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.4 22.24 78.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.527 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.8 110.34 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 0.0 111.072 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 307' ' ' TYR . 5.2 p -112.77 149.13 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -159.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 93' ' ' THR . . . -72.29 -18.84 61.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.21 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.457 ' H ' HG22 ' A' ' 302' ' ' VAL . 55.8 tp -79.38 124.36 28.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -45.4 90.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -174.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.2 t -62.44 -50.0 73.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.481 ' HB3' HG11 ' A' ' 302' ' ' VAL . 3.9 t80 -70.93 -36.87 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -65.58 -33.38 75.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -38.5 73.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.6 -38.69 58.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.829 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.13 -29.81 70.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.51 -8.27 45.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.53 -15.8 60.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -91.39 120.68 68.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.878 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.9 -29.03 19.8 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.766 2.31 . . . . 0.0 112.295 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -70.11 -44.72 68.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.41 -38.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.7 73.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 83.2 m -67.09 -41.86 85.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 tpt -66.82 -38.02 85.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.835 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -66.44 -35.31 79.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -65.36 -34.83 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.34 95.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -74.24 -23.28 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -104.67 -5.79 21.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.11 -161.64 37.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.432 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -127.2 127.18 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.846 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.568 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 38.3 mm -74.64 121.93 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.5 mmt 63.48 156.23 0.12 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.458 0.647 . . . . 0.0 111.033 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.905 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 56.5 Cg_endo -74.67 -107.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 165.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -138.94 -58.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 165.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.55 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 34.0 pt -139.12 169.25 12.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.602 0.715 . . . . 0.0 111.158 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.1 Cg_exo -53.09 -17.01 7.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.3 -6.15 2.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.905 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.5 ptm -56.6 -29.95 62.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.9 p -66.05 -30.1 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -80.58 -34.85 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 175.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -59.65 -54.79 42.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.551 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 68.6 m95 -60.76 -38.08 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -60.02 -46.7 88.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.35 80.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.047 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.1 t -74.5 -36.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.501 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 76.0 ttt180 -56.01 -47.17 78.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.8 p -66.62 -35.81 81.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -64.95 -44.0 90.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.182 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.96 -47.57 81.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.03 -44.34 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -65.21 -36.96 85.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.72 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.051 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.05 73.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.5 p -80.86 -7.78 59.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.04 82.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.555 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.13 -28.01 54.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.807 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -140.44 157.13 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.7 p -74.62 171.98 12.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.124 167.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.55 -34.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.61 -40.28 84.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.3 -44.73 71.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.817 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.17 93.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.5 mt -69.77 -35.5 74.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.87 -46.85 88.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -69.41 -31.1 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -70.01 -48.02 59.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.157 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -64.95 -38.73 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.4 m -62.53 -41.48 98.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.051 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.52 -39.12 70.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.802 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.3 mt -62.24 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.9 p -105.51 6.95 32.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.18 -172.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 -178.119 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.698 0.285 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.8 mt -80.1 129.26 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.163 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -125.09 164.3 20.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -76.5 118.38 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.21 26.17 24.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.467 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.41 152.22 40.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.109 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -145.49 146.63 31.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -128.67 129.74 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.56 135.68 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.548 ' HB3' HD21 ' A' ' 43' ' ' LEU . 34.9 m0 -111.28 120.56 42.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 tt -153.16 159.21 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 -170.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.7 t-20 -60.0 119.85 8.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 168.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.776 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -76.22 -18.54 79.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.54 -173.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.27 -47.72 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.938 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.26 80.04 1.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 144.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -120.56 -48.69 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.443 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -70.0 -43.72 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.91 -164.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -66.14 -51.98 52.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 -160.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.1 -44.29 97.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.437 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 24' ' ' GLY . 64.3 mt -61.28 -37.94 84.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.37 85.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.028 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.22 -47.1 79.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.16 -33.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -67.49 -40.09 91.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.57 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -71.57 -40.01 70.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.906 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.4 -41.16 98.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -68.54 -38.58 80.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.79 -31.55 72.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.83 -37.35 67.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.3 -39.3 25.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.7 p -105.27 -18.2 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.14 90.09 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.49 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 33' ' ' ILE . 7.8 pt -97.14 132.8 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.062 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.95 131.01 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 7' ' ' LEU . 67.3 t -101.48 136.88 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 172.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -141.39 120.15 12.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.24 131.37 60.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -109.76 151.8 26.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.424 ' O ' HD13 ' A' ' 43' ' ' LEU . 32.4 p80 -74.28 167.02 39.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.548 0.69 . . . . 0.0 110.885 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.776 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 43.1 Cg_endo -104.03 12.01 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -161.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -89.53 -37.14 14.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.759 -166.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -90.82 -17.24 26.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.896 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -57.3 -43.94 83.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -161.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -50.03 -39.94 43.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.84 -33.92 64.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.0 -25.39 59.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.537 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 5.1 m-30 -49.97 -53.99 37.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.606 0.717 . . . . 0.0 110.936 -160.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 91.5 Cg_endo -79.98 -29.93 2.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.77 2.313 . . . . 0.0 112.32 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.48 -49.69 21.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -168.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.7 m -66.09 -28.95 45.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.066 -171.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.78 -37.61 85.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.8 -24.99 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -96.97 0.35 48.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.082 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 77.2 17.57 79.37 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -110.88 -174.72 2.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.823 0.344 . . . . 0.0 110.864 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.33 -167.49 12.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.574 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 87.9 Cg_endo -77.64 169.44 20.89 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.668 2.245 . . . . 0.0 112.344 175.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -85.09 -37.01 20.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.5 mt -129.35 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 47' ' ' PHE . 16.4 tt -137.14 135.34 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -172.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -99.96 145.09 28.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.947 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.681 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 26.7 m95 -126.82 127.05 44.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.31 -91.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.038 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -112.89 -78.7 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.46 -22.84 61.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -165.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.681 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 94.9 mtt-85 -55.44 -28.61 55.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -164.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.45 ' CG ' ' N ' ' A' ' 68' ' ' GLY . 16.7 p90 -49.39 -44.06 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.88 -174.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 67' ' ' PHE . . . -74.99 -58.7 3.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 -169.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.54 -41.34 95.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.504 -172.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.656 ' HB3' HD21 ' A' ' 75' ' ' LEU . 60.1 m-85 -75.08 -32.57 61.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.962 0.411 . . . . 0.0 110.892 -175.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.01 64.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -61.33 -27.05 68.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -83.07 2.36 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.24 24.85 63.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.1 pp -85.81 -4.54 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.868 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.848 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.4 pp -131.57 143.58 50.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.69 154.96 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -71.43 140.45 50.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.891 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 pt -104.14 148.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.5 p -131.8 67.14 79.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.604 0.716 . . . . 0.0 111.131 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.82 144.85 49.46 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.698 2.265 . . . . 0.0 112.467 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -84.57 -175.16 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.35 -31.93 69.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.35 84.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -60.43 -43.84 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -59.65 -41.36 90.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.936 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.4 -34.5 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.826 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 75.9 mmtt -68.13 -21.3 64.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.189 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.94 124.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.923 -177.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p90 -173.08 49.19 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.734 0.778 . . . . 0.0 110.907 162.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 61.4 Cg_endo -73.32 -72.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.645 2.23 . . . . 0.0 112.42 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.473 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 97.3 m-85 -94.87 -29.68 14.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 174.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -71.72 -22.47 61.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.054 -161.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -60.75 -44.33 96.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.11 -30.74 71.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.897 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.73 -32.97 71.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -103.13 14.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.23 -169.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -120.99 145.89 47.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -137.96 127.94 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.6 t30 58.22 32.91 22.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.848 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.11 89.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.13 150.01 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.4 mt -84.65 121.37 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -113.3 -15.14 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.49 163.88 24.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -166.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -105.18 146.81 33.43 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.684 0.754 . . . . 0.0 110.891 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HG2' HD21 ' A' ' 89' ' ' LEU . 98.0 Cg_endo -76.78 120.13 5.39 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.2 mm -99.8 -46.32 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.037 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.18 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -163.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.37 130.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -125.37 143.07 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.17 157.01 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.05 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.402 HD22 ' HG3' ' A' ' 257' ' ' PRO . 10.0 mp -75.17 146.98 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -143.58 160.38 40.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.479 ' HB2' HD23 ' A' ' 247' ' ' LEU . 60.6 tp -94.99 122.9 38.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.413 HG12 HG22 ' A' ' 244' ' ' VAL . 61.6 mt -111.74 126.65 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.096 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -136.59 158.02 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -89.82 111.61 22.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.649 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -65.41 -30.09 70.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.01 -35.95 61.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.02 -49.54 12.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 tp -122.41 108.58 33.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.659 0.742 . . . . 0.0 110.903 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.45 -15.19 17.77 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.704 2.269 . . . . 0.0 112.317 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.6 t-20 -147.55 106.81 3.78 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 49.8 Cg_endo -66.72 152.81 79.87 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.677 2.252 . . . . 0.0 112.288 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.44 144.07 60.05 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.65 2.234 . . . . 0.0 112.261 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.39 -22.03 32.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 t -150.15 170.98 17.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -172.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.74 -32.58 69.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.856 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -71.67 -22.27 61.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -170.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -74.5 -27.96 60.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.562 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 94.4 mt -66.32 -45.14 59.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 0.0 111.061 -164.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.562 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 99.1 Cg_exo -49.62 -48.24 19.85 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.645 2.23 . . . . 0.0 112.332 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.38 90.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.014 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.5 ' O ' HD23 ' A' ' 135' ' ' LEU . 2.6 tt -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 26.4 t70 -66.03 -35.05 79.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.902 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.13 -41.23 90.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.45 -54.06 13.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.916 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 140' ' ' LYS . 1.1 pt? -78.61 -12.54 60.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -173.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.1 tttt -54.55 -29.38 50.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 166.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.75 65.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.076 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.84 8.49 37.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.25 58.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.509 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -121.8 154.69 36.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.28 . . . . 0.0 110.974 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.7 t -110.93 154.98 23.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -70.31 -56.65 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.036 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.8 tp -144.35 129.05 18.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.958 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.7 mmm -130.25 132.53 45.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -150.97 174.55 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -67.39 109.71 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.995 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.99 0.12 40.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -85.62 0.26 53.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.48 145.72 57.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.555 0.693 . . . . 0.0 110.938 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.489 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 63.9 Cg_endo -79.66 -28.16 3.61 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.603 2.202 . . . . 0.0 112.393 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -53.87 -37.94 64.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -82.14 -36.79 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 -174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 74.3 p -88.36 -30.28 19.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.133 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.626 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 69.4 t90 -54.85 -48.28 96.11 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.535 0.683 . . . . 0.0 110.994 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 75.2 Cg_exo -48.41 -36.44 30.65 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.668 ' O ' HD23 ' A' ' 160' ' ' LEU . 3.7 tt -73.04 -38.63 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.981 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.566 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.2 mt -68.09 -38.06 79.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -80.5 -15.01 57.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -171.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.06 69.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.25 7.19 46.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.77 12.78 4.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.474 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -76.6 158.74 49.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.489 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.633 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 91.0 m-85 -136.82 152.08 49.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 110.887 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . . . -101.21 -36.16 9.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.076 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.414 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -150.1 130.02 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -175.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 55.5 tptt -92.83 120.76 33.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -173.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.406 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 55.5 t80 -112.47 112.38 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -176.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -150.53 142.74 24.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 51.2 40.67 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 6.32 78.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.492 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -127.94 146.26 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 41.7 m-85 -89.91 127.85 36.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.911 167.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -102.39 116.62 33.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 178' ' ' ILE . 7.5 tp -77.77 -19.96 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.139 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -85.9 -7.26 58.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -116.12 92.79 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.0 140.0 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -99.82 38.87 2.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -168.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.2 -14.53 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.111 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -104.97 18.78 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -106.7 -171.49 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.11 -38.93 75.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.6 90.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.78 87.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.47 -42.46 99.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.62 -44.64 89.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -67.2 -46.68 69.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.87 -38.1 85.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.916 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.8 m -56.96 -43.82 81.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -64.22 -46.01 85.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.13 -44.87 96.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.825 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.99 -40.71 89.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.54 -36.45 82.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.67 -43.97 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.76 -39.51 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.51 -32.39 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 173.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.99 2.48 38.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.97 32.66 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.949 173.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -78.93 -30.94 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.814 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 23.5 ptp -150.48 160.06 44.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.422 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.6 m-20 -100.64 138.63 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.23 -24.38 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -97.5 0.6 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 86.2 m -55.1 124.83 18.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.06 170.04 8.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 227' ' ' ASN . 52.5 t80 -62.79 -41.46 99.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -62.43 -37.63 86.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.764 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -70.06 -46.3 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.83 84.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.73 -41.36 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.52 86.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.089 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.144 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -64.52 -47.03 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.28 -25.78 65.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.77 -5.34 45.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 16.66 63.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -82.5 -26.98 32.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.825 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 224' ' ' MET . 88.0 m -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 177.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.85 -27.71 55.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 -169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.412 ' H ' HG22 ' A' ' 222' ' ' THR . 74.8 mtm -135.19 151.98 51.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -152.08 165.23 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.191 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.24 133.24 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 37.6 p30 -152.91 160.93 43.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.33 -126.83 5.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.424 -171.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.52 -19.17 19.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.715 2.277 . . . . 0.0 112.356 -166.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -53.28 -39.83 64.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.28 31.17 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.499 ' O ' ' C ' ' A' ' 233' ' ' SER . 54.2 m0 -60.44 -36.1 77.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 232' ' ' TRP . 90.1 p 34.26 71.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 163.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -74.85 3.39 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.85 -7.9 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.089 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.18 -50.15 9.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 85.5 m -64.8 -59.52 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.3 t -156.23 121.65 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.784 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . 0.65 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.28 176.02 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.884 -176.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.01 -70.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -161.37 90.0 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 239' ' ' LYS . 75.0 m-85 -114.3 162.39 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.649 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -147.17 170.18 28.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.5 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.413 HG22 HG12 ' A' ' 116' ' ' ILE . 59.2 t -123.74 131.37 73.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.942 0.401 . . . . 0.0 111.091 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -142.71 177.94 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.172 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.64 160.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 115' ' ' LEU . 89.0 mt -77.65 149.73 78.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.944 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.21 146.86 69.21 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.47 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 81.8 p -128.87 146.21 51.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -125.49 111.66 15.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 45.03 40.36 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.01 28.34 56.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 166.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.6 mm-40 -109.99 159.52 31.53 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.936 -170.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.0 Cg_endo -65.33 73.96 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 73.8 p -98.47 4.14 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -168.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 13.2 ptpt -139.84 158.37 67.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.552 0.691 . . . . 0.0 110.835 -173.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 33.4 Cg_endo -71.89 167.24 27.19 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.627 2.218 . . . . 0.0 112.389 -169.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.91 176.65 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.423 HG23 ' HA3' ' A' ' 327' ' ' GLY . 96.5 t -118.69 134.31 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 -171.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.02 146.37 16.07 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.433 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -128.48 128.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.266 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 60.4 tp -76.96 135.3 38.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.92 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 93.1 p -129.87 150.93 50.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.41 130.31 44.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.033 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.95 162.89 15.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 -170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.65 129.5 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -62.85 124.9 22.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.9 67.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.632 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -81.96 -13.85 56.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 20.2 t -72.28 132.67 83.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.86 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.07 -7.75 21.7 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 0.0 112.407 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.04 27.62 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -168.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -50.85 -47.74 60.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.39 -38.93 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.5 tp -56.81 -53.13 61.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.11 -42.58 75.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.117 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.39 -48.93 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.29 -47.72 72.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.957 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -70.63 -33.67 71.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -176.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 284' ' ' LEU . 36.3 tp -55.97 -47.96 76.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -83.07 -27.0 30.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.31 -10.91 19.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -169.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 86.8 t80 -124.98 -60.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.416 ' HB2' HD12 ' A' ' 280' ' ' LEU . 77.6 mt -70.29 -41.27 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.981 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.32 65.22 8.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.0 p -138.09 169.34 17.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -56.92 -42.08 79.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -77.0 -42.54 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.1 -47.89 8.04 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.546 -170.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.0 -35.06 79.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.932 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.52 -42.82 99.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.95 -30.21 71.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.126 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.36 -45.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.068 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.473 ' HB3' ' CA ' ' A' ' 300' ' ' GLY . 59.0 m-20 -74.73 -5.5 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -54.41 -18.97 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.79 -18.07 60.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.06 154.18 42.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.71 -41.81 10.23 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 299' ' ' LEU . 3.3 mm? -92.59 -44.35 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.907 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 294' ' ' ASN . . . 62.33 54.42 34.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.432 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.69 124.31 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.072 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.15 149.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.61 61.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.062 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.18 119.26 22.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 87.7 tttt -61.77 -44.46 96.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -166.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.0 t -58.83 -49.84 76.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -74.23 -31.49 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.445 ' HG3' ' HE1' ' A' ' 321' ' ' MET . 89.0 tt0 -56.83 -39.44 74.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.829 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.23 -32.42 73.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -48.05 23.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.536 HD11 ' HE1' ' A' ' 321' ' ' MET . 3.4 pp -73.55 -18.71 61.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.19 -7.93 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.9 -11.23 60.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.94 -173.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -86.43 122.01 72.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.98 -31.78 28.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.642 2.228 . . . . 0.0 112.373 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.65 -42.48 74.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 311' ' ' LEU . 3.0 tp -80.99 -29.86 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.069 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.4 86.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 65.9 m -67.38 -43.87 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.536 ' HE1' HD11 ' A' ' 311' ' ' LEU . 58.2 mtt -69.61 -34.82 74.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.799 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -66.26 -37.33 85.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -64.96 -34.04 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.042 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -70.31 -21.04 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.96 -5.96 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -96.11 -163.0 33.36 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.478 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -128.93 137.06 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 39.6 mm -78.3 115.67 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 26.3 mmt 61.72 155.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.91 -113.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 168.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -162.22 -52.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.89 164.35 31.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 111.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.41 -19.77 52.97 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.823 2.349 . . . . 0.0 112.318 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -58.87 -23.58 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.543 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 94.8 mmm -69.66 -24.83 63.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.73 -37.12 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.95 -30.76 64.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.155 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 336' ' ' MET . 21.8 t80 -57.63 -49.95 74.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.988 175.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.489 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.7 m95 -61.36 -44.16 97.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.68 -43.81 76.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.83 78.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.76 -44.92 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.191 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -57.34 -48.11 79.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.87 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 73.9 p -66.65 -32.95 74.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.2 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.92 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.76 -47.87 81.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 41.5 mm -64.73 -44.69 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.17 -38.13 89.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.67 -44.91 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.53 -33.9 69.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.5 p -79.51 -8.46 59.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.0 82.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.455 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.44 -29.52 57.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 0.0 110.837 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -140.01 157.86 44.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.1 p -78.12 172.97 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.91 -45.26 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.43 -38.92 74.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -71.68 -39.28 70.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -173.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.54 96.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 173.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.5 -35.09 78.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.64 -42.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.17 -31.41 70.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.75 -46.43 63.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.143 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -63.21 -38.31 90.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.2 m -59.48 -40.34 86.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.02 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.94 -36.81 62.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.85 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 339' ' ' PHE . 71.4 mt -63.02 -48.46 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.06 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.9 p -96.21 -0.72 49.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.9 tttt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.767 0.317 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.49 136.83 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.01 -178.98 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.992 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.14 119.62 19.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.04 25.27 27.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.435 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.93 152.94 41.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.695 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.7 pp -149.03 148.76 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 84.6 t -126.12 128.13 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mt -117.46 134.33 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.66 ' CH2' ' HD3' ' A' ' 57' ' ' PRO . 30.7 m0 -113.07 127.19 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 18.1 tt -152.94 159.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.67 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.3 t-20 -55.88 118.53 4.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.916 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.661 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.12 -24.72 72.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.487 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.03 -47.11 71.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 -167.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.9 mmtt -129.58 80.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 146.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -115.05 -36.63 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.527 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.54 -43.51 17.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.935 0.398 . . . . 0.0 110.957 -157.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -67.72 -52.58 35.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 -158.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.8 -45.25 96.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.582 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' GLY . 50.0 mt -59.43 -37.98 79.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.918 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.95 92.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.87 -49.7 74.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.819 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.25 -33.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -66.12 -42.57 94.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.562 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.6 -43.15 69.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 110.882 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.59 -40.21 93.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -65.39 -41.2 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.23 -31.94 72.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -74.81 -34.86 62.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.3 -40.79 20.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.1 p -104.16 -22.07 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.85 4.21 88.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.415 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.415 HG21 HD23 ' A' ' 7' ' ' LEU . 97.7 mt -76.61 121.7 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.205 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.83 120.52 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.2 135.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.097 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -139.39 117.81 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.6 127.71 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.19 160.74 20.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -68.82 162.31 64.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.555 0.693 . . . . 0.0 110.859 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.67 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 60.5 Cg_endo -98.82 -3.95 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -164.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.46 -30.81 33.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -154.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.45 -16.94 31.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 10' ' ' TRP . 5.7 mp -61.18 -36.52 80.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.921 -156.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 50.2 mt-10 -48.75 -35.98 15.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.58 -36.01 57.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -75.52 -29.53 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -173.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.6 m-85 -48.18 -54.52 24.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.903 -160.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 95.7 Cg_endo -80.16 -29.31 2.63 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.825 2.35 . . . . 0.0 112.19 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -75.15 -48.93 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.016 0.436 . . . . 0.0 111.046 -167.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.92 -32.63 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.122 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.7 -38.26 89.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.033 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.43 63.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -98.92 0.09 43.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.09 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 75.14 17.91 80.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.515 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -109.72 -174.43 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.319 . . . . 0.0 110.888 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 -171.3 15.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.495 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.66 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 83.7 Cg_endo -79.46 174.67 11.59 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.357 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.36 -38.38 22.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 164.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -134.35 139.03 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.213 -172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.86 144.76 36.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -100.87 139.71 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 6.1 m95 -126.63 123.41 37.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.73 -91.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 -167.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -112.52 -82.39 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -73.9 -19.29 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 -164.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 96.4 mtt-85 -52.71 -30.71 33.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -168.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -51.09 -39.38 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 -171.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.531 -168.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.08 90.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.387 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.609 ' HB3' HD21 ' A' ' 75' ' ' LEU . 47.3 m-85 -76.47 -32.62 58.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.944 0.402 . . . . 0.0 110.874 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.39 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -62.64 -28.51 69.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -82.4 1.42 37.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.852 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.78 23.77 59.26 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.461 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.3 pp -85.89 1.15 51.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.752 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.1 pp -134.21 144.34 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -86.04 153.13 22.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.92 132.99 46.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG21 ' CE2' ' A' ' 106' ' ' TYR . 66.8 mt -109.35 139.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.182 -173.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 p -130.81 76.9 76.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.753 . . . . 0.0 111.161 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.96 152.53 31.93 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.743 2.295 . . . . 0.0 112.407 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -83.19 -176.98 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.848 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.6 -34.51 78.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.957 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.75 99.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -66.85 -35.08 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.77 -41.57 95.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.07 -30.07 33.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.851 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 45.0 mtmt -65.1 -17.78 64.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.167 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.62 123.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 8.2 p90 -174.75 51.16 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.692 0.758 . . . . 0.0 110.957 166.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 59.3 Cg_endo -72.22 -71.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.186 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.46 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 33.1 p90 -104.48 -19.26 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.8 p -67.55 -25.25 65.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 -168.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 90' ' ' TYR . 47.8 t-105 -62.28 -42.26 99.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.967 -174.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.34 -29.69 70.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.547 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.35 -34.35 74.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.122 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.45 13.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -117.75 149.3 41.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -139.12 128.13 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.32 34.03 23.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.71 90.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.543 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.36 149.13 42.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.949 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.4 tp -83.96 125.06 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 pt -116.71 -10.09 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.79 167.61 22.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 79' ' ' ILE . 74.9 m-85 -109.6 144.78 30.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.786 0.803 . . . . 0.0 110.91 171.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.4 Cg_exo -65.41 117.11 4.3 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.751 2.301 . . . . 0.0 112.341 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.7 mm -100.54 -32.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.23 151.69 4.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.8 t -118.5 124.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.112 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -118.48 130.14 55.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.03 153.02 30.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.427 HD22 ' HG3' ' A' ' 257' ' ' PRO . 10.8 mp -74.33 147.82 41.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -175.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 85.0 p -141.46 158.64 43.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.43 ' HB2' HD23 ' A' ' 247' ' ' LEU . 46.1 tp -98.85 125.89 44.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.952 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.44 HG12 HG22 ' A' ' 244' ' ' VAL . 63.9 mt -111.7 130.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.173 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -135.35 155.8 49.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -96.16 112.92 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -24.05 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.017 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -82.88 -34.45 26.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.83 -47.36 13.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -123.37 108.88 31.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.655 0.741 . . . . 0.0 110.92 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.53 -13.43 22.54 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.67 2.247 . . . . 0.0 112.424 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -147.12 108.34 3.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 153.78 76.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 0.0 112.349 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.75 141.83 42.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.583 2.189 . . . . 0.0 112.251 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.72 -17.77 26.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -144.37 165.02 29.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -67.26 -28.87 68.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.34 -29.53 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.848 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.12 -21.09 60.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.588 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 34.6 mm -59.8 -53.47 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.133 -167.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.1 Cg_endo -64.72 -45.79 7.96 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.729 2.286 . . . . 0.0 112.31 -173.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.68 96.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.045 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.5 mt -60.98 -38.65 86.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 10.2 t70 -64.63 -36.1 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -36.16 83.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.54 -57.53 5.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 145' ' ' SER . 1.7 pt? -81.09 -11.45 59.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 86.4 tttt -56.18 -29.32 60.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.783 166.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.09 65.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.88 11.17 37.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.21 75.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.426 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 39.9 mmtm -117.89 157.28 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.53 ' O ' HD11 ' A' ' 139' ' ' LEU . 30.0 t -115.14 154.44 28.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.82 175.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -73.79 -55.0 6.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.0 tp -143.69 130.62 20.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.8 mtp -122.86 134.8 54.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -149.69 165.96 30.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 57.7 t-20 -58.9 111.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.937 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.7 tm? -89.44 -21.57 22.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.981 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.31 -2.5 38.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -133.83 149.97 73.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.736 . . . . 0.0 110.94 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 71.2 Cg_endo -77.84 -21.6 10.94 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.633 2.222 . . . . 0.0 112.37 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -59.7 -40.97 89.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 56.2 m-85 -85.16 -27.75 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.753 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 76.2 p -89.07 -31.03 18.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.619 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.8 t90 -55.32 -47.84 97.65 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.558 0.694 . . . . 0.0 110.909 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 73.9 Cg_exo -47.96 -38.45 31.33 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.638 2.225 . . . . 0.0 112.294 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 160' ' ' LEU . 4.0 tt -73.85 -38.62 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.56 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.3 mt -67.47 -37.14 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.78 -14.35 58.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.04 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.01 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 -166.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -96.83 5.03 51.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.38 12.89 4.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.575 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.75 158.37 48.5 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.561 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.718 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 90.0 m-85 -136.85 155.2 50.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.959 0.409 . . . . 0.0 110.915 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.21 -31.12 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.049 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.11 130.11 12.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 54.9 tptt -93.55 121.73 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.852 -174.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.429 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 64.2 t80 -113.89 113.06 24.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -150.11 143.8 25.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 51.06 41.0 26.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.73 5.99 76.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.549 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.87 146.2 51.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 171' ' ' TYR . 30.2 m-85 -88.08 129.58 35.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 167.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -103.17 114.12 28.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.811 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.32 -20.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -87.3 -8.88 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -114.11 92.96 4.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.943 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.54 141.44 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.183 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.718 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -102.86 29.79 11.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.402 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.55 -22.4 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.145 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -104.95 24.75 11.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -104.45 -174.5 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.25 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.61 -44.01 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.72 84.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.775 0.321 . . . . 0.0 111.102 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.51 -42.23 98.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.832 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.99 -45.04 87.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.07 -44.21 91.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.442 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.98 -40.47 95.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.5 m -57.75 -43.3 85.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -63.73 -44.44 93.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.06 -45.34 91.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.76 -40.1 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -64.76 -39.87 94.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 198' ' ' LEU . 1.7 mp -65.77 -44.27 86.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.49 -38.39 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.221 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.3 -35.44 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.825 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.59 4.62 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.45 31.58 10.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.0 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -77.51 -29.58 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.7 ttp -147.9 150.09 33.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.95 -22.99 67.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -91.11 0.0 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.2 m -59.98 129.09 40.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -108.66 169.01 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 167.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.98 -32.61 72.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.034 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.0 p -69.37 -38.79 78.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.788 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 92.1 mt -66.87 -39.53 83.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.145 174.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.14 -36.9 85.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -69.14 -38.23 78.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.43 90.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.59 93.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.124 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.75 -40.98 92.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.81 -19.88 66.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.67 -10.11 27.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.99 63.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.44 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.78 -25.75 37.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 110.813 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.6 m -128.48 133.7 48.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.68 -28.74 60.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 70.9 mtm -131.85 151.59 51.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.5 t -150.04 161.5 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.7 128.7 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.157 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -122.29 150.85 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -120.32 -131.19 4.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.465 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.5 Cg_endo -67.06 -24.1 45.49 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.302 -170.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -53.44 -33.09 52.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 60.62 36.3 19.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.028 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.577 ' O ' ' C ' ' A' ' 233' ' ' SER . 78.3 m95 -41.97 -36.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.577 ' C ' ' O ' ' A' ' 232' ' ' TRP . 18.8 p 15.08 60.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 232' ' ' TRP . 78.8 m-20 -78.51 20.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -169.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 pt -117.59 -9.89 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -69.43 -61.27 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.4 m -54.27 -48.06 71.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.0 t -155.47 140.92 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.1 166.32 30.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.65 -70.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.134 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -150.66 70.81 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -108.93 160.51 15.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.43 167.18 25.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 116' ' ' ILE . 41.2 t -124.23 131.39 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 0.0 111.064 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.47 175.83 9.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.61 162.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 115' ' ' LEU . 96.9 mt -77.25 149.01 78.71 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 110.96 -174.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.79 156.13 67.17 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.374 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.443 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 12.9 t -142.87 150.23 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.32 114.92 20.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.836 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 50.04 36.13 11.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.912 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.28 29.16 51.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.512 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.48 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 99.2 mm-40 -110.07 161.62 23.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 110.82 -167.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 46.4 Cg_endo -60.98 75.45 0.08 OUTLIER 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 0.0 112.416 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 81.5 p -94.85 -4.83 46.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.784 -162.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 257' ' ' PRO . 10.7 ptpt -136.42 158.43 73.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.643 0.735 . . . . 0.0 110.871 -167.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 28.4 Cg_endo -70.26 166.92 26.62 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.643 2.229 . . . . 0.0 112.342 -169.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -68.93 170.03 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.42 HG23 ' HA3' ' A' ' 327' ' ' GLY . 61.5 t -120.13 133.31 67.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -170.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.21 141.6 16.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.0 t -125.23 128.36 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.9 tp -74.05 135.23 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 94.2 p -126.95 147.67 50.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.84 126.2 42.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.39 163.61 16.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.431 -170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.4 mt -106.36 129.96 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 111.147 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -61.98 126.52 27.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.79 -27.98 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.492 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -80.49 -13.11 59.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.133 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 25.3 t -72.29 127.59 90.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.684 0.754 . . . . 0.0 110.934 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.59 -6.54 18.76 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.728 2.285 . . . . 0.0 112.435 169.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.43 25.65 7.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -169.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.04 -40.87 59.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.19 -39.57 89.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 70.3 mt -64.89 -52.45 56.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.28 89.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -164.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -69.78 -49.84 48.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.939 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.78 -53.63 47.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -162.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 7.5 p90 -75.21 -25.63 58.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.48 -50.44 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.19 -29.28 38.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.953 -175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -101.97 -23.45 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.846 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 93.6 t80 -118.16 -50.67 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -175.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.98 -39.31 61.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.943 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 106' ' ' TYR . 6.7 mp -83.33 62.27 6.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 52.9 p -135.74 165.29 25.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.157 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -51.91 -49.68 62.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.77 -39.02 53.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.17 -46.69 20.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.7 tp -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.825 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.46 -43.19 88.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.85 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.592 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 88.9 t -77.33 -41.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.75 -18.53 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -54.72 -18.97 5.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 87.7 m-20 -81.18 -30.15 34.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.64 150.26 36.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.668 0.747 . . . . 0.0 110.876 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.83 -22.78 10.02 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.635 2.223 . . . . 0.0 112.364 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.5 tp -68.49 -58.22 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 89.02 3.85 75.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.66 34.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 111.034 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.3 m -120.46 156.19 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.038 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.16 -12.89 60.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 51.4 tp -74.59 120.47 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 59.6 tttm -62.3 -46.82 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -172.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -57.29 -47.15 82.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.91 -33.63 70.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.951 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.17 -37.6 85.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.823 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.7 -34.96 70.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -78.2 -38.43 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.27 -25.12 66.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.07 -7.94 20.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -79.33 -16.7 55.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -88.54 120.86 70.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -50.46 -31.99 32.82 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.232 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -69.7 -48.61 58.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.2 -39.15 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.82 84.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.07 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 58.1 m -63.06 -45.76 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.2 mmt -68.67 -37.6 79.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.28 -40.06 93.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.5 -34.17 76.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.875 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.15 90.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -71.79 -20.18 61.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.991 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.83 -8.19 20.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.42 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -94.56 -160.0 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.434 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -124.51 132.1 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.871 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 39.0 mm -79.94 120.48 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 -174.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 26.2 mmt 64.59 156.12 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.513 0.673 . . . . 0.0 110.958 169.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 332' ' ' ASN . 75.3 Cg_endo -69.83 -147.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.581 2.187 . . . . 0.0 112.363 164.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.433 ' H ' ' HB2' ' A' ' 331' ' ' PRO . 48.7 t30 -147.79 -54.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.99 164.02 34.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.662 0.744 . . . . 0.0 111.176 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -58.32 -20.92 50.14 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.779 2.319 . . . . 0.0 112.411 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -59.01 -23.08 61.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.494 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 93.5 mmm -67.44 -26.9 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.6 m -62.33 -36.73 83.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.797 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.36 -31.3 65.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.089 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.4 t80 -58.19 -49.99 75.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.004 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.644 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.8 m95 -61.71 -42.56 99.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -57.31 -42.49 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.12 86.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 72.7 t -73.26 -40.27 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.173 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.654 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 78.8 ttt-85 -55.79 -44.98 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.835 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.4 m -62.11 -42.79 99.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -62.36 -43.72 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.13 -49.89 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.115 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.93 -44.09 99.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.099 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -65.04 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.44 69.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.048 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.28 73.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.161 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -79.92 -7.11 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.96 11.82 84.09 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.584 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.1 -29.87 60.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.309 . . . . 0.0 110.88 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -140.67 155.2 46.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.2 p -74.49 172.17 12.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.58 -35.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.227 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.16 -40.77 86.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.73 -45.26 68.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.917 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.4 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.184 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.18 -36.04 76.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.04 -42.44 94.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.46 -31.76 73.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -69.46 -45.04 69.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.16 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -61.84 -39.1 90.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 92.4 m -59.99 -41.54 92.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -73.63 -34.68 65.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.5 mt -59.98 -40.01 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.185 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.8 p -93.5 -11.46 31.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.5 tttt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.628 0.251 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.4 mt -90.38 132.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.189 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 93.8 mt-10 -131.75 166.91 20.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.62 124.57 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.71 23.15 43.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.465 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 90.5 mttt -144.71 159.0 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.803 ' C ' HD12 ' A' ' 7' ' ' LEU . 1.8 pp -146.45 145.91 30.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.99 124.74 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -175.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.61 HG22 ' HB ' ' A' ' 59' ' ' ILE . 7.8 pt -126.61 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.529 ' HB3' HD21 ' A' ' 43' ' ' LEU . 37.2 m0 -116.27 137.8 51.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.7 tt -148.06 154.12 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.479 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.4 t-20 -55.5 127.87 31.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.854 174.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.77 79.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.586 -167.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.36 -53.46 57.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.921 -162.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.06 73.95 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 147.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -103.31 -40.19 2.46 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.5 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -70.44 -42.1 71.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -156.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.69 -51.81 45.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.88 -157.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.77 -48.56 83.3 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.42 -177.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.2 mt -60.81 -36.78 79.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.17 95.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.37 -52.0 67.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.74 -32.55 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.047 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.12 -43.04 96.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.52 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.93 -49.22 71.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.71 -43.06 90.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.47 -44.29 94.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.93 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.12 -33.8 76.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -71.83 -42.2 67.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -83.43 -38.03 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.796 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 90.4 m -99.59 -24.0 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 -173.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.01 86.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.43 124.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.04 130.54 43.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 7' ' ' LEU . 77.8 t -109.03 135.22 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.0 m -127.63 111.9 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 9' ' ' ILE . 52.6 t -101.76 120.56 51.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 54.9 mt-10 -131.88 153.15 50.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.937 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.423 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.8 p80 -132.3 75.13 74.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.637 0.732 . . . . 0.0 110.876 173.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 12.7 Cg_endo -69.76 -29.65 23.54 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.672 2.248 . . . . 0.0 112.452 -160.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.5 m-20 78.0 4.06 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -174.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -94.36 -2.02 52.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 10' ' ' TRP . 79.9 mt -48.95 -57.25 6.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -152.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.33 -41.66 94.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -83.44 -40.33 19.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -170.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -75.51 -49.99 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -166.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.831 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 82.9 t80 -55.3 -52.22 73.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.694 0.759 . . . . 0.0 110.81 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 88.0 Cg_exo -52.48 -38.7 74.96 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 0.0 112.35 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -73.88 -47.26 39.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.0 m -74.83 -26.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.44 91.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.047 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.58 65.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -93.03 6.75 46.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.01 18.95 73.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.482 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.0 t0 -117.18 -172.96 2.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.962 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.45 167.02 22.8 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.49 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 59.8 Cg_endo -68.51 168.45 19.73 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.605 2.203 . . . . 0.0 112.337 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.27 -42.61 62.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' A' ' 9' ' ' ILE . 75.7 mt -136.73 143.3 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.198 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.28 136.61 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.74 122.44 47.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -147.71 157.61 43.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.919 169.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -87.5 -103.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -95.75 -50.03 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -62.04 -61.44 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 -162.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -77.92 -31.93 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -172.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -57.42 -48.23 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.77 -166.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.4 -48.21 87.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.556 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.34 -39.36 64.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 174.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.68 -32.99 74.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.943 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.39 80.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.45 -25.88 65.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.0 m -82.52 0.02 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.74 30.3 76.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.41 -5.21 59.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -128.58 143.39 50.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 -173.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 154.33 20.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.05 136.76 52.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 pt -109.31 151.72 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.8 p -130.11 68.16 80.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.547 0.689 . . . . 0.0 111.197 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.3 141.8 32.64 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.719 2.279 . . . . 0.0 112.284 172.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -78.23 172.05 14.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.55 -31.97 73.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.811 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.52 84.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -79.87 -31.85 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.94 -43.63 94.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.8 -28.39 64.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -66.12 -26.49 67.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 mt -97.01 -137.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -132.33 139.59 35.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.762 0.791 . . . . 0.0 110.884 173.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.9 -42.0 70.23 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.778 2.318 . . . . 0.0 112.408 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -70.44 -24.82 62.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -77.42 -28.66 52.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.129 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.432 ' HA ' HG22 ' A' ' 97' ' ' VAL . 64.2 m95 -73.02 -33.21 65.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.53 -34.43 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.09 -28.54 65.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 34.8 m -106.47 12.48 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.158 -174.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -108.35 133.76 52.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -134.97 126.02 27.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 58.29 34.81 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.28 5.24 89.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.91 146.4 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 0.0 110.85 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.73 125.28 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 76' ' ' LEU . 38.3 pt -121.65 -8.13 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -167.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.39 161.98 37.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -171.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.8 m-85 -109.14 130.93 22.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.623 0.725 . . . . 0.0 110.987 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 26.5 Cg_exo -62.53 115.58 2.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.749 2.299 . . . . 0.0 112.302 172.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.6 mm -104.85 -34.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.53 153.63 21.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -123.24 129.85 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 229' ' ' PRO . 10.2 pt-20 -131.16 149.21 52.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.897 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.48 154.88 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.6 tp -71.5 133.69 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.9 p -142.46 160.78 39.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -174.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -97.48 128.39 44.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 91.4 mt -111.43 129.61 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.046 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -129.06 153.9 47.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -95.33 118.87 32.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.64 -32.27 73.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -84.31 -35.43 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 -171.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.71 -44.36 50.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -139.34 109.54 7.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.985 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.8 Cg_endo -74.39 177.07 8.81 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.695 2.263 . . . . 0.0 112.436 171.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.1 t30 21.5 96.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 110.922 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.8 Cg_endo -65.51 156.74 61.98 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.373 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.27 144.66 75.4 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.251 . . . . 0.0 112.363 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -87.92 -21.63 24.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.0 p -134.75 159.46 41.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -68.03 -33.44 74.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.49 -25.46 37.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.773 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.22 -20.84 60.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 27.6 mm -56.26 -54.77 49.26 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.532 0.682 . . . . 0.0 111.101 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 20.5 Cg_endo -61.86 -40.81 41.76 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.661 2.24 . . . . 0.0 112.371 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 mt -64.8 -35.22 80.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.939 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.05 -36.91 85.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.84 -43.21 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.25 -37.76 78.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 35.0 mt -70.32 -35.04 73.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.88 -32.84 64.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.82 -23.6 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -102.85 6.4 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.822 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.17 25.66 70.46 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.516 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 90.3 mttt -112.95 154.66 26.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -106.77 151.6 24.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.39 -42.44 68.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.95 146.0 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 86.8 mmm -136.7 124.25 22.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 157.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.78 167.45 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.804 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 54.7 t-20 -67.39 117.95 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.88 -167.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.08 4.61 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.42 ' N ' ' OD1' ' A' ' 150' ' ' ASN . 79.2 mt-30 -84.59 -0.96 55.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.87 143.22 36.51 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.626 0.726 . . . . 0.0 110.844 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.6 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 33.2 Cg_endo -70.61 -27.19 22.73 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.72 2.28 . . . . 0.0 112.37 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.401 ' HA ' ' CD1' ' A' ' 158' ' ' TRP . 82.7 t80 -56.11 -46.74 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.89 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 61.1 m-85 -80.37 -20.07 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -173.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -75.45 -22.15 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 162' ' ' ALA . 2.5 m95 -59.84 -46.18 98.31 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.522 0.677 . . . . 0.0 110.863 -168.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.569 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 52.3 Cg_exo -41.97 -36.26 3.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.334 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.5 -49.12 10.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.717 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.3 mt -81.33 -49.72 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -170.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -63.32 -19.0 64.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.138 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -61.43 -28.28 69.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.42 2.26 39.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.918 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 103.4 10.27 36.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -112.4 135.09 12.44 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.375 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -153.6 170.04 21.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.941 -165.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.62 -48.03 80.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.06 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.87 155.32 42.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -80.92 124.43 29.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -104.62 110.84 23.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -149.48 138.76 21.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -169.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 49.0 38.98 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 -173.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.88 10.39 72.4 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.393 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -136.77 154.81 50.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.735 0.303 . . . . 0.0 110.857 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -70.33 147.62 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -129.63 107.73 9.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.0 mm -76.93 -29.1 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.79 -22.81 31.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -170.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.54 65.25 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.823 166.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.37 149.59 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -169.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -86.93 11.67 64.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.404 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.54 -3.57 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 51.1 p-10 -78.42 16.64 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.938 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 74.1 m-80 91.21 0.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 166.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.54 -58.31 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -84.54 -55.66 2.67 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.0 68.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 111.137 -166.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.02 -45.16 86.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.75 96.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.121 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.717 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.8 -41.38 98.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.506 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.62 -39.18 91.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.2 m -61.17 -42.11 97.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.208 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.84 -42.99 94.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.86 -45.65 92.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.17 -40.0 87.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.12 -37.58 87.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.439 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -68.24 -34.2 75.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.55 -40.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.054 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.06 -41.16 86.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -85.46 2.49 44.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.02 31.89 10.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -81.25 -29.55 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 67.4 mtt -135.47 147.32 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.843 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -97.66 124.03 41.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.63 -22.72 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 -170.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -90.01 -6.09 55.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.4 m -57.22 131.07 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -128.68 -179.48 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.815 171.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -58.04 -34.88 70.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 -172.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 71.2 m -67.73 -36.08 79.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.55 -42.14 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.65 -41.19 98.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.05 -43.03 79.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.61 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.059 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.1 86.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.38 -35.41 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.825 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -60.54 -29.73 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.951 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.42 -21.07 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.829 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.94 23.59 32.29 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -83.43 -25.76 30.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.925 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 87.1 m -125.62 137.28 53.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.56 -38.77 25.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 77.0 mtm -140.51 157.7 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.3 t -151.8 167.83 27.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.223 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.4 mt -123.01 119.29 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 58.6 m-80 -148.62 160.87 42.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -173.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -104.6 -136.55 8.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.482 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -70.61 -26.92 23.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.289 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -66.83 -18.79 65.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -89.47 11.97 17.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.031 -176.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 298' ' ' PRO . 46.4 m0 -67.01 -28.72 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.7 t -59.31 107.95 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -150.51 130.11 13.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.2 mt -89.64 80.52 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.7 73.8 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.1 p -116.81 -1.72 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.147 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 80.3 p -114.74 -169.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.18 178.79 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 66.7 t -61.06 106.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.5 -63.45 1.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.35 154.96 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.88 160.48 25.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.9 t -123.16 130.31 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 111.177 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.38 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.78 159.21 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.2 mt -70.19 139.85 87.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.574 0.702 . . . . 0.0 110.967 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 40.6 Cg_exo -60.43 165.38 11.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.8 p -120.62 148.07 44.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.077 172.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -126.62 117.21 22.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 54.57 35.74 24.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.28 16.58 62.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -130.02 146.67 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 145.46 85.97 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.627 2.218 . . . . 0.0 112.431 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.6 t -67.17 -57.73 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.432 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 9.0 tmtt? -163.52 117.38 1.08 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.525 0.678 . . . . 0.0 110.935 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.54 128.03 11.52 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.709 2.273 . . . . 0.0 112.442 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -161.31 111.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.07 132.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.09 137.42 13.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.558 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.04 125.17 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 57.0 tp -65.35 127.35 31.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 27.0 m -133.2 148.83 52.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.815 -166.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.86 132.75 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -112.14 148.05 18.21 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.435 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.1 mt -106.1 125.79 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -59.04 118.26 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.1 -24.72 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.24 -9.58 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -68.82 132.53 90.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.636 0.731 . . . . 0.0 110.913 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -14.31 39.4 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.636 2.224 . . . . 0.0 112.302 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -115.6 29.43 8.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -167.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -58.28 -35.61 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.6 -36.46 83.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 62.6 tp -64.56 -42.85 95.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.4 90.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -65.15 -43.97 90.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.85 -172.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.73 -51.36 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -172.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -32.61 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.74 -50.58 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -74.11 -42.88 59.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.66 -14.35 19.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -160.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -123.23 -53.73 1.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 59.5 tp -68.07 -46.93 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 106' ' ' TYR . 84.2 mt -83.78 63.79 7.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.1 p -135.54 165.31 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 173.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.87 -44.45 70.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -80.91 -40.85 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.59 35.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.609 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.47 -34.41 72.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 110.904 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.28 -40.04 84.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -33.2 68.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.496 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 78.7 t -79.07 -51.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.154 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -79.3 -19.84 49.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 -166.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -57.85 -18.14 20.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -93.23 -21.33 19.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.98 149.75 92.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.617 0.722 . . . . 0.0 110.906 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.429 ' HB2' ' HB3' ' A' ' 232' ' ' TRP . 79.7 Cg_exo -57.87 -44.14 42.99 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.239 . . . . 0.0 112.405 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -95.06 -45.86 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 83.54 9.74 82.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.54 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.89 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.3 m -115.83 156.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -77.18 -9.01 58.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 171.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.37 120.19 23.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.66 -43.9 97.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 38.6 t -58.75 -48.93 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.924 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.615 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.5 t80 -71.02 -35.39 72.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.849 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -62.34 -32.82 73.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.57 -36.95 77.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.83 -38.44 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.69 -26.69 67.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.981 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.44 -12.46 43.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.11 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.83 -18.1 59.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -90.19 119.0 69.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.608 0.718 . . . . 0.0 110.809 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.99 -32.92 50.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -70.75 -40.63 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.41 -40.72 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.4 72.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.191 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.59 89.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.7 m -65.13 -46.35 81.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.163 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -68.18 -34.82 76.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -63.12 -39.97 96.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.9 -38.87 66.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.69 91.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.012 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . 0.403 ' HG3' ' HG3' ' A' ' 326' ' ' LYS . 20.8 pt20 -71.3 -14.49 62.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.403 ' HG3' ' HG3' ' A' ' 325' ' ' GLN . 90.3 mttt -110.35 -6.52 14.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -175.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.93 -160.55 36.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.437 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -130.16 148.25 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.875 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.426 HG22 ' HG2' ' A' ' 331' ' ' PRO . 45.5 mm -68.97 117.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.115 -171.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 tmt? -47.93 -53.73 29.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.62 0.724 . . . . 0.0 110.902 -165.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 330' ' ' MET . 45.5 Cg_endo -64.91 101.2 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.703 2.268 . . . . 0.0 112.366 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.641 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 62.8 m-80 -121.56 34.56 5.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -168.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 45.9 mm 88.94 136.56 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.071 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.26 -26.66 20.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.701 2.268 . . . . 0.0 112.266 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.7 mm-40 -57.44 -23.11 47.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 66.5 ttp -63.29 -32.7 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.9 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.3 m -64.35 -38.12 89.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.28 -45.76 83.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -57.39 -48.67 78.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -64.3 -45.66 87.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.39 93.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.082 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.62 -29.87 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.6 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 73.7 ttt-85 -58.93 -43.07 91.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.6 m -59.69 -41.5 90.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.32 -40.21 93.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.44 -50.93 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.05 -46.46 91.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.041 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.11 -36.34 83.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.24 -48.1 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.44 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.054 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -79.0 -9.45 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.1 10.1 86.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.82 -28.6 58.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.319 . . . . 0.0 110.85 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -138.26 155.76 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 357' ' ' VAL . 97.0 m -71.52 152.28 43.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 174.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 356' ' ' THR . 64.1 t -65.66 -47.25 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 -173.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.99 -41.16 99.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -71.91 -44.47 63.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -64.84 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.4 -37.84 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.8 tttt -61.88 -41.99 98.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.26 -31.6 72.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -71.64 -47.16 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.083 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.9 pp0? -68.54 -31.52 70.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 98.9 m -63.26 -44.06 96.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.048 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -64.51 -37.68 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.797 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.93 -46.19 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.4 p -95.19 -6.16 42.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.233 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.1 127.68 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.123 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -128.48 165.39 20.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.81 119.95 15.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.5 24.03 34.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.497 -172.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -145.0 154.27 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.882 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.26 142.93 32.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.8 t -125.48 125.75 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.45 131.75 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.594 ' HB3' HD22 ' A' ' 43' ' ' LEU . 24.0 m0 -113.16 129.84 56.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.4 tt -151.43 153.33 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -55.37 127.04 27.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.09 -20.93 78.99 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -165.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.07 -48.84 72.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -163.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -138.42 83.21 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 145.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -111.3 -34.38 2.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -77.17 -43.83 32.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.966 -159.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -65.77 -60.01 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -155.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -45.68 96.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.54 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -58.39 -41.47 84.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.943 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.87 -48.83 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.913 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.28 -33.88 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.074 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.67 -37.2 94.37 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.369 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.35 -45.88 85.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.88 -44.48 97.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.38 -37.26 86.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -64.86 -35.29 80.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.16 -37.71 72.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.47 -41.5 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -104.67 -17.35 14.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.182 -172.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.87 88.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.55 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.3 tt -76.15 125.24 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.36 121.58 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 p -103.66 140.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -134.24 112.18 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.143 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.02 122.76 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -128.59 150.93 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 26.3 p80 -133.77 73.19 72.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.669 0.747 . . . . 0.0 110.871 170.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 16.9 Cg_endo -70.04 -28.04 24.41 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.633 2.222 . . . . 0.0 112.427 -162.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 57.8 m-20 78.23 2.39 2.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 -172.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.93 -2.04 44.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 10' ' ' TRP . 84.7 mt -46.0 -55.54 6.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.97 -154.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -70.0 -26.64 64.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -168.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -84.34 -43.43 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -79.98 -41.39 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.864 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 29.7 t80 -51.88 -52.97 56.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.825 -165.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 73.3 Cg_exo -54.25 -38.05 88.26 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.564 2.176 . . . . 0.0 112.388 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.2 -48.47 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.924 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -72.18 -30.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.14 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.09 -24.28 67.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.54 7.12 47.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.47 22.59 67.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -119.92 -170.33 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.983 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.56 -173.23 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.581 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.02 159.97 23.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.242 . . . . 0.0 112.364 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 276' ' ' ALA . 29.7 t70 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 169.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.35 142.97 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.36 132.08 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.191 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -113.8 127.28 55.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -146.99 154.46 41.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.34 -102.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -176.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 -51.28 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.07 -47.98 80.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -79.69 -33.38 41.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -56.52 -47.93 78.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.16 81.7 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.509 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.13 -43.22 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.59 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -70.82 -30.02 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.31 95.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.089 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.43 -24.38 65.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -83.45 3.67 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.46 36.91 69.31 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.478 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.77 -9.56 59.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.785 0.326 . . . . 0.0 110.869 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -132.68 143.18 49.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.948 -173.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.74 164.32 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.078 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -66.31 134.95 53.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -107.92 151.76 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.088 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.5 m -127.44 75.06 77.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 111.218 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.49 141.0 17.44 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.659 2.24 . . . . 0.0 112.251 169.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -80.62 179.95 7.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.913 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.71 -36.13 82.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -173.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -41.94 98.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -69.0 -40.72 78.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.81 -42.2 90.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.859 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.79 -27.11 64.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.99 -27.32 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.925 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.48 -110.26 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 31.6 t80 -156.76 134.71 7.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.667 0.746 . . . . 0.0 111.01 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 80.8 Cg_exo -56.38 -41.66 73.92 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.377 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.27 -40.58 97.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.5 p -71.5 -25.5 62.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.402 ' HA ' HG22 ' A' ' 97' ' ' VAL . 63.4 m95 -74.38 -34.31 63.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.876 173.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.15 -31.3 71.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.832 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.06 -26.45 68.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 35.9 m -108.04 15.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.149 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -100.34 131.42 46.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -130.74 121.83 26.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 59.28 34.97 23.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.9 4.17 90.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.436 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.04 146.23 47.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.772 0.32 . . . . 0.0 110.918 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -86.37 127.77 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.6 pt -117.93 -8.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 -169.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -159.67 163.23 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -170.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.73 129.01 24.77 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.714 0.769 . . . . 0.0 110.966 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.66 122.32 9.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.309 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -109.64 -40.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -155.54 156.25 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.023 -167.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.89 137.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.635 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 24.9 pt-20 -142.8 154.94 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.25 41.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.175 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.7 tp -66.42 142.36 57.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.874 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.4 m -138.85 156.37 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.6 tp -97.01 123.89 40.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 244' ' ' VAL . 74.6 mt -113.3 125.23 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -134.94 157.72 46.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -170.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -91.64 112.56 24.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.698 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 96.4 mttt -67.69 -29.09 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 -174.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -78.11 -35.68 48.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.6 -45.78 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.9 tp -121.71 106.7 36.87 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.913 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 124' ' ' ASN . 97.1 Cg_endo -74.86 157.02 43.61 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.65 2.233 . . . . 0.0 112.284 168.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.6 t30 25.06 96.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.594 0.712 . . . . 0.0 110.953 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.8 Cg_endo -65.25 155.69 67.17 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.728 2.285 . . . . 0.0 112.405 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.96 142.13 55.76 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.751 2.301 . . . . 0.0 112.297 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -91.04 -25.62 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 249' ' ' THR . 68.7 p -128.69 159.99 33.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.186 -175.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -74.06 -23.59 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.979 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.5 -28.57 67.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.98 -20.08 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.628 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 31.2 mm -57.71 -56.25 36.38 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.573 0.701 . . . . 0.0 111.11 -168.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 29.9 Cg_endo -69.44 -39.69 6.79 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -172.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.18 99.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.74 -39.54 94.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.45 -41.4 98.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.02 -39.6 86.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.07 -45.87 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -84.6 -18.92 34.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.415 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.0 tttt -57.47 -30.04 64.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.48 -20.42 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.2 9.31 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.03 68.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.527 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -108.97 161.43 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.849 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.5 t -115.84 152.66 32.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 167.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.97 -42.35 57.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.109 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.97 153.15 47.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -175.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mmm -128.38 120.27 26.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.842 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -166.08 165.01 18.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -97.22 141.21 30.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -168.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 52.4 tp -105.57 2.45 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 175.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -76.54 -8.6 57.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 174.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.48 145.07 39.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.737 0.78 . . . . 0.0 110.832 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.568 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 50.5 Cg_endo -68.73 -24.59 34.62 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.532 2.155 . . . . 0.0 112.295 176.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -57.72 -47.62 81.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -71.64 -26.5 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 p -84.13 -17.19 40.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.5 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 7.2 m0 -56.97 -46.4 99.87 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 -170.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.554 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 88.9 Cg_exo -51.08 -33.57 43.84 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.765 2.31 . . . . 0.0 112.306 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.5 tp -81.37 -46.15 15.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.429 HG23 ' HA3' ' A' ' 191' ' ' GLY . 94.8 mt -83.14 -48.17 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.107 -171.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -66.62 -16.64 64.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.82 -28.56 66.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.51 -6.35 22.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.9 6.75 13.8 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -95.84 115.04 5.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.427 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -162.33 175.31 11.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 110.936 -161.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.634 ' HB1' ' HB3' ' A' ' 339' ' ' PHE . . . -82.88 -23.64 33.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.191 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.794 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 86.1 m-85 -130.89 143.95 51.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -112.15 127.15 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.857 163.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -108.99 111.68 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.84 -170.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.15 141.32 25.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 52.42 37.96 24.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.63 4.33 70.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.35 150.63 52.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 0.0 110.907 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.794 ' CD1' ' HB3' ' A' ' 169' ' ' PHE . 57.9 m-85 -86.19 130.78 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 172.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -115.83 117.37 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.931 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -78.62 -20.17 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.03 -16.19 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -113.97 71.31 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.79 166.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.32 150.95 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.181 -165.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -88.21 22.24 20.36 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.509 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.6 m -105.65 0.02 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.668 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 52.6 p-10 -80.98 17.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.0 m-80 94.22 -4.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 167.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.81 -57.69 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.072 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -90.79 -53.73 2.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.512 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.58 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -67.38 -35.22 78.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 0.0 111.023 -165.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.81 -43.45 93.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.975 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.08 -41.27 95.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.074 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.429 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -62.79 -39.57 98.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.454 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.93 -40.86 95.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.3 m -60.2 -42.17 94.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.151 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.78 -44.0 97.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 59.1 tp -58.72 -45.52 89.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 351' ' ' ALA . 50.4 t -63.36 -39.74 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.46 -39.87 92.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 133' ' ' PRO . 0.3 OUTLIER -70.05 -40.65 74.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -178.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.62 -39.29 84.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.13 -38.16 87.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -87.94 3.67 47.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 60.6 35.55 19.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -80.78 -20.19 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -139.44 153.08 47.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -98.46 132.4 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.0 72.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -89.85 -4.1 57.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 66.9 m -62.94 135.44 57.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.43 179.92 5.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.89 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -62.04 -34.64 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.931 -172.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.7 m -69.66 -41.34 75.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.838 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.07 -39.67 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.1 93.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.05 -43.45 92.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.51 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -42.39 98.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.48 ' HD1' ' HA ' ' A' ' 217' ' ' PHE . 0.9 OUTLIER -64.91 -37.08 86.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 172.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -102.64 -22.88 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.85 23.32 36.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -82.92 -22.55 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 110.923 -171.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.5 t -126.26 144.92 50.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.98 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.0 mtm -138.61 148.03 43.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -168.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.9 p -139.5 164.96 28.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.101 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.65 119.14 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.5 160.05 41.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.94 -164.42 39.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.446 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.635 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -66.46 -20.99 54.02 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.24 . . . . 0.0 112.274 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -65.56 -20.66 66.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.66 3.86 45.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -69.99 -43.15 72.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 t -68.67 105.84 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -139.69 154.05 47.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 81.6 mt -78.25 88.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.23 74.97 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 73.8 p -122.32 0.79 9.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.7 p -100.49 -170.0 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.62 179.87 7.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.74 112.33 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -119.6 -56.71 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -115.43 162.99 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.698 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -143.03 169.27 25.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.47 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 116' ' ' ILE . 58.4 t -122.93 130.2 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.82 175.55 9.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.178 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.84 161.05 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 90.0 mt -73.48 136.44 78.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.56 0.695 . . . . 0.0 110.94 -173.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 49.0 Cg_exo -62.38 159.33 36.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.746 2.297 . . . . 0.0 112.22 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 128' ' ' THR . 81.9 p -114.09 160.02 19.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.73 116.28 15.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.7 35.12 23.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.5 57.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.543 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.21 145.24 56.48 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.902 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.92 152.07 77.42 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.652 2.234 . . . . 0.0 112.399 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 95.7 p -65.1 -61.5 2.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -165.88 147.01 5.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.566 0.698 . . . . 0.0 110.911 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.36 126.1 8.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.589 2.193 . . . . 0.0 112.417 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -163.89 111.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.77 132.87 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.129 163.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.81 139.14 15.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.62 119.52 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.803 0.335 . . . . 0.0 111.101 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.7 129.87 41.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -132.1 139.9 48.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -170.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.59 137.77 52.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -129.89 166.54 21.96 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 70.6 mt -112.4 129.81 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 111.191 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -59.36 123.21 16.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.939 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.46 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.48 59.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -76.06 131.46 75.75 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.619 0.723 . . . . 0.0 110.852 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.52 -10.86 28.84 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.65 2.233 . . . . 0.0 112.313 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -108.91 28.62 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -166.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.35 -37.75 62.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.757 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.54 -38.59 84.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.95 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.13 -43.09 93.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.409 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . . . -65.63 -44.55 86.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -63.15 -49.64 73.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 97.9 mt-10 -66.47 -45.15 80.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.78 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 19.1 t80 -59.98 -41.65 92.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 28.6 tp -70.33 -54.6 11.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -83.34 -30.76 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 -167.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.575 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.2 m-20 -98.57 -18.45 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.799 -167.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.605 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.6 m-85 -122.15 -53.44 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 59.6 mt -72.35 -41.83 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 -176.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.79 60.7 6.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 176.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.1 p -136.9 170.2 16.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.159 172.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -55.12 -48.17 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.796 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.63 -39.93 43.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.39 -46.09 27.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.422 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.7 tp -67.74 -36.32 80.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 110.905 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.04 -41.18 96.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.21 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.06 -32.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.56 -24.39 65.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.3 -26.25 39.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.56 -15.74 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.76 154.83 61.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.53 0.681 . . . . 0.0 110.988 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.02 -97.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.577 2.184 . . . . 0.0 112.433 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.29 -25.87 67.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 60.98 31.87 78.03 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.551 165.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.91 127.28 31.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 111.104 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 34.7 m -116.75 152.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.081 -164.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.95 -10.84 59.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.08 118.54 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.37 -51.73 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.7 p -62.27 -43.07 99.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.429 ' O ' ' CD1' ' A' ' 307' ' ' TYR . 1.3 t80 -70.56 -37.1 73.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.975 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -66.24 -32.61 74.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.0 -36.58 81.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -72.79 -39.68 66.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.37 -26.77 68.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.935 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.78 -11.27 44.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.047 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.07 -18.14 58.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -85.52 118.93 71.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.768 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.09 -34.94 60.08 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 0.0 112.383 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -70.17 -41.11 74.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.04 -38.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.01 73.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.57 -41.37 88.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.04 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -63.73 -44.62 93.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.159 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.6 -38.82 90.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.886 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.53 -38.56 84.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.96 85.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.3 -18.26 65.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.832 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.27 -8.13 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.889 -172.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -102.88 -162.68 25.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.502 -173.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -133.98 156.68 47.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.469 HG13 ' HD2' ' A' ' 331' ' ' PRO . 4.9 tp -63.21 124.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -171.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.602 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.9 tmt? -44.46 -52.27 17.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.525 0.678 . . . . 0.0 110.847 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 330' ' ' MET . 34.8 Cg_endo -60.71 84.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.34 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.657 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 74.0 m-80 -104.23 29.36 6.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -170.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.657 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 50.3 mt 89.62 135.45 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.704 . . . . 0.0 111.146 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.41 -26.86 22.45 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.239 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.461 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.3 mm-40 -59.97 -18.16 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 62.1 ttp -57.97 -34.61 70.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.949 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.93 -38.83 92.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.14 -38.2 66.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.634 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 7.2 m-30 -67.17 -35.97 80.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -55.5 -48.8 74.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -64.94 -42.36 94.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.79 94.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.104 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.77 -38.11 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.083 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 71.2 ttt-85 -53.51 -39.92 64.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -57.04 -45.13 83.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.072 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.84 -43.71 87.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.89 -58.48 5.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -166.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.7 mt -66.57 -45.0 89.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 97.9 m-20 -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.78 59.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 196' ' ' VAL . . . -71.74 -35.45 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.11 -172.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -75.47 -14.5 60.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.79 7.75 87.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.403 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -75.22 -24.27 57.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.962 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 83.4 mm-40 -136.01 157.08 47.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.0 m -67.17 150.62 48.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.56 -46.99 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.15 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.46 -40.14 95.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.92 -42.52 66.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.27 93.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 32.7 tp -71.93 -35.1 69.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.2 tttt -62.5 -40.27 96.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 173.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.97 -31.28 72.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -74.59 -43.18 56.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.174 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.9 pp0? -69.29 -28.91 66.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -66.75 -44.18 82.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.139 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.19 -40.16 68.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.38 -30.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 -171.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.8 p -92.17 -2.82 56.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.181 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -177.394 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.736 0.303 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -80.73 133.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.08 -179.44 8.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.61 126.62 30.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.991 -172.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.57 19.01 59.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.562 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -142.19 158.55 43.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.922 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -142.44 147.57 36.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 173.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.13 126.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.431 HG13 HD13 ' A' ' 7' ' ' LEU . 62.8 mt -118.74 133.22 66.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.129 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 30.2 m0 -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 174.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 tt -151.78 154.07 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.141 -172.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -55.14 127.36 28.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.1 -19.44 79.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.519 -168.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.57 -51.23 70.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -163.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.19 78.84 1.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 147.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.0 -35.88 2.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.428 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -80.5 -44.46 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 110.989 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -66.72 -52.08 48.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -155.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -65.3 -47.71 77.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.472 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.01 -38.41 85.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.87 -45.15 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.42 -47.33 82.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.96 -45.03 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.659 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -60.8 -36.31 91.65 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.363 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.16 -45.52 93.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.19 -44.77 90.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -64.49 -41.8 96.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -63.8 -33.66 76.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.12 -38.23 85.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.1 -37.02 17.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 -173.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.8 m -101.19 -24.51 14.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 -171.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.01 3.36 87.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.53 125.27 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.4 . . . . 0.0 111.185 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -66.48 128.03 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -172.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.659 HG11 ' HA3' ' A' ' 24' ' ' GLY . 95.5 t -104.26 132.9 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -135.9 116.93 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.6 125.13 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.49 153.06 47.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 27.9 p80 -133.23 75.12 71.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 0.0 110.838 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.561 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.6 Cg_endo -69.24 -29.32 26.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.238 . . . . 0.0 112.401 -162.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.6 m-20 77.67 3.42 3.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -175.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.8 2.09 49.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 10' ' ' TRP . 82.9 mt -48.65 -55.14 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -154.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -62.65 -28.91 70.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 -169.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.48 -47.07 9.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.811 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -79.98 -46.33 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -163.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 7.6 t80 -50.66 -54.0 40.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.679 0.752 . . . . 0.0 110.88 -162.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.1 Cg_endo -62.9 -31.8 77.25 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.295 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -47.82 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.7 m -74.95 -26.41 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -174.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.25 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.33 -24.28 65.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.028 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.5 p -96.43 4.96 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.37 23.17 61.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.502 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.9 t0 -119.88 -176.24 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.32 -179.18 24.67 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.582 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.91 161.1 24.13 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -76.26 -38.58 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.63 138.77 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 tt -138.27 140.86 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -100.2 143.34 30.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -140.05 152.37 46.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.98 -114.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.46 ' NE2' ' N ' ' A' ' 261' ' ' VAL . 70.8 m80 -116.94 -57.47 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.65 -45.42 90.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -74.97 -36.67 62.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.84 -49.55 75.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.21 -49.48 61.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.453 -175.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.31 94.48 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.528 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -71.9 -29.94 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.67 96.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.46 -28.63 69.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.3 m -84.97 5.73 28.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.879 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.49 35.66 82.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.434 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.05 -15.49 60.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.874 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.415 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -129.61 143.64 50.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -169.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.15 159.33 16.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.44 136.87 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.5 pt -109.41 152.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.3 p -130.49 63.07 68.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.557 0.694 . . . . 0.0 111.157 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -72.67 143.28 37.45 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.717 2.278 . . . . 0.0 112.255 167.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -75.08 177.7 6.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.81 -30.35 70.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.52 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.023 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -64.71 -38.06 89.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.801 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -65.55 -40.13 92.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.991 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.21 -36.59 83.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.93 -30.98 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.05 -107.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -168.66 131.05 1.19 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.658 0.742 . . . . 0.0 110.957 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -54.19 -38.73 88.02 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.716 2.278 . . . . 0.0 112.328 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.56 -35.47 80.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -76.3 -24.74 54.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -75.46 -26.52 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 173.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.1 -33.23 71.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.16 67.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.09 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.98 16.63 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 -175.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -109.97 138.27 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.934 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -136.29 124.96 23.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.66 34.86 25.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.27 4.72 89.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.421 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.53 144.13 48.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.52 126.4 33.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.415 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.2 pt -119.67 -10.06 10.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.104 -168.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.27 165.17 31.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -108.61 137.92 20.13 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.667 0.746 . . . . 0.0 110.867 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 21.4 Cg_exo -66.53 120.24 7.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.284 173.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.36 -36.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.93 151.28 14.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.2 133.36 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -134.09 149.9 51.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.22 156.0 34.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 tp -69.98 140.4 52.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.7 m -142.93 159.05 42.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.1 tp -99.74 129.92 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.9 mt -110.89 132.92 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -132.59 154.76 49.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -93.28 117.19 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.786 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.35 -31.75 73.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -173.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.89 -35.09 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.21 -52.56 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.402 HD13 HD21 ' A' ' 135' ' ' LEU . 94.3 mt -127.48 115.77 21.26 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.1 Cg_endo -75.04 171.14 18.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 0.0 112.37 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.559 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.9 t30 24.81 96.6 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.1 Cg_endo -65.0 155.04 70.41 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.405 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.49 143.94 59.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.595 2.197 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.48 -20.48 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.1 p -129.35 157.93 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -71.9 -25.47 61.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.49 -30.5 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.53 -20.05 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.597 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 33.8 mm -60.77 -54.03 58.54 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.604 0.716 . . . . 0.0 111.088 -169.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 23.5 Cg_endo -61.82 -40.05 47.67 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.753 2.302 . . . . 0.0 112.304 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.36 90.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.402 HD21 HD13 ' A' ' 122' ' ' LEU . 62.4 tp -64.93 -40.37 94.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.96 -40.81 95.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.45 -42.92 83.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.44 -44.07 75.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 pp -83.03 -22.83 33.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.59 -25.87 67.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -18.78 65.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.26 9.98 41.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.02 25.68 73.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.477 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -108.73 157.52 18.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.836 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.8 t -111.24 144.19 40.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 169.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.24 -44.12 63.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.11 157.05 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 mmm -138.8 116.44 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -164.39 169.51 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.47 138.14 32.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -166.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 206' ' ' ALA . 89.6 mt -114.38 3.52 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.54 -3.8 54.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.68 145.06 49.59 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.689 0.757 . . . . 0.0 110.907 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.699 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 29.7 Cg_endo -69.12 -25.85 31.14 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.63 2.22 . . . . 0.0 112.256 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -57.72 -47.95 80.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.85 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.425 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 52.7 m-85 -79.98 -21.88 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.869 -174.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 71.5 p -77.31 -22.43 51.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.458 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 9.4 m0 -56.43 -46.48 99.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.488 0.661 . . . . 0.0 110.892 -170.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 60.8 Cg_exo -45.2 -37.21 13.2 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.62 2.213 . . . . 0.0 112.35 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.424 ' HB2' HD12 ' A' ' 195' ' ' LEU . 89.2 mt -82.59 -44.15 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.1 mt -78.33 -45.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 -171.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.94 -16.14 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.013 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.24 -31.96 73.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.098 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.22 0.67 23.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.821 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.82 11.08 9.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 163.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -93.78 129.56 9.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.411 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -166.48 159.01 14.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.958 0.408 . . . . 0.0 110.909 -168.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.53 68.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.098 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -151.51 155.73 39.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.007 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 32.4 tptt -87.33 141.07 28.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -97.72 112.58 24.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -150.34 137.21 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.87 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.13 38.12 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.64 10.22 63.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.416 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.51 152.64 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 11.3 p90 -61.54 146.06 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -137.97 103.09 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' A' ' 181' ' ' VAL . 8.3 tp -65.15 -15.14 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -170.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.3 -17.62 45.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.808 -165.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -124.06 60.7 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.852 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 182' ' ' GLY . 58.2 t -130.26 157.63 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -171.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.509 ' N ' HG12 ' A' ' 181' ' ' VAL . . . -72.03 10.54 4.35 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.498 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 m -94.79 -24.56 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 111.101 172.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 4.9 p30 -83.34 3.93 29.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.8 m-20 84.1 -2.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 158.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.9 -48.45 11.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.1 11.64 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.546 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -65.19 -43.1 92.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.158 -163.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.65 -42.85 81.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.942 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.03 97.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.82 -41.99 97.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.441 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.24 -36.18 82.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.955 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -59.84 -46.92 87.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -65.1 -44.12 89.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.802 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 160' ' ' LEU . 5.8 tt -60.01 -54.26 48.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.71 -37.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.25 -37.55 83.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -36.56 78.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.65 -41.66 88.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.043 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.84 -32.94 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -84.66 -1.76 56.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 60.71 39.98 16.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.944 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -78.53 -25.81 45.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.829 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -145.84 153.01 40.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -96.97 134.7 39.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.99 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.419 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . -65.34 -31.52 72.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -173.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.0 -4.75 57.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 -166.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -61.16 135.19 57.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -134.67 -175.2 3.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -56.98 -45.3 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 -175.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -62.56 -42.73 99.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.86 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.8 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -43.47 91.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.99 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.62 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -65.07 -33.46 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.64 -26.03 68.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.48 -23.23 13.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.37 27.02 13.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.456 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.71 -25.81 37.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.907 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -127.41 139.7 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.93 26.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 52.7 mtt -140.21 164.7 29.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 -172.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.5 t -152.82 160.99 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.66 114.86 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.143 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -149.36 160.41 43.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -100.07 -139.55 10.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.335 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.681 ' HB3' HD22 ' A' ' 299' ' ' LEU . 30.3 Cg_endo -68.3 -25.88 35.97 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 0.0 112.353 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -67.94 -16.97 64.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.09 15.13 12.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -56.2 -33.71 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.5 t -62.19 120.19 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -170.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -147.65 128.1 14.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.979 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.6 mt -95.5 86.75 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -84.77 74.92 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.4 p -112.55 -6.46 13.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.095 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.8 p -115.12 -165.25 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.777 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.33 177.04 3.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 80.6 t -65.74 111.19 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.38 -70.41 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.3 158.5 17.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.34 166.57 26.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.563 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 61.9 t -124.62 132.08 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 111.176 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.37 178.51 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -90.63 160.01 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.093 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 99.2 mt -71.48 143.28 87.49 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.9 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.84 169.9 21.32 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.306 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.8 p -107.93 162.08 14.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -139.02 120.28 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 54.97 33.93 21.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.04 74.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.47 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -123.44 151.16 62.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -172.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.04 152.21 83.13 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.717 2.278 . . . . 0.0 112.395 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.9 p -64.99 -58.39 6.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.845 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -168.2 142.42 2.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.632 0.73 . . . . 0.0 110.904 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -73.15 126.03 10.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.368 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -169.36 119.98 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.77 130.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.178 159.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.94 144.26 15.8 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.463 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.46 ' N ' ' NE2' ' A' ' 64' ' ' HIS . 77.8 t -126.95 122.97 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 62.5 tp -73.09 138.22 45.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.7 m -125.75 144.7 50.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.795 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.4 132.01 51.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.087 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.64 157.12 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.427 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 96.2 mt -105.07 127.24 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -56.57 119.91 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.95 65.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.08 -9.96 59.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -72.17 133.67 83.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.672 0.749 . . . . 0.0 110.827 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.45 -11.23 30.79 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.598 2.199 . . . . 0.0 112.379 172.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -106.65 36.37 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -168.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.77 -43.54 72.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.78 -174.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -68.13 -36.8 80.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.73 -48.56 76.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.798 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.432 ' HA ' ' CE2' ' A' ' 279' ' ' PHE . . . -60.32 -43.52 96.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.05 -171.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -66.39 -43.94 84.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.811 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.34 -58.63 6.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -169.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.455 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 5.5 p90 -74.94 -25.84 59.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -167.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.445 ' O ' HD23 ' A' ' 280' ' ' LEU . 1.8 tt -63.6 -45.82 88.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.968 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -86.39 -27.13 24.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -99.89 -11.64 20.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.831 -167.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.642 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.3 m-85 -128.54 -52.13 1.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 5.8 mp -70.39 -41.94 72.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -170.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.53 70.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 81.6 p -135.3 169.97 16.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -52.26 -47.85 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.07 -41.49 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.22 -48.49 8.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.591 -169.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 304' ' ' LEU . 19.0 tp -70.4 -34.39 72.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 110.969 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.82 -41.14 97.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 295' ' ' LYS . . . -66.1 -34.96 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.051 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.594 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 11.6 p -84.07 -36.02 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.94 -24.68 37.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 292' ' ' ALA . 62.5 pttt -61.99 -16.1 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 176.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -94.56 -23.84 17.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 71.8 mmtt -64.63 146.54 98.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.551 0.691 . . . . 0.0 110.946 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 71.5 Cg_exo -57.93 -57.52 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.567 2.178 . . . . 0.0 112.413 -174.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 229' ' ' PRO . 58.8 tp -73.33 -48.22 36.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -172.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.05 -15.11 62.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.483 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.97 126.2 29.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -124.4 160.15 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 -171.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.5 -15.11 59.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.479 ' HB2' HD23 ' A' ' 290' ' ' LEU . 50.8 tp -74.7 120.01 19.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.41 -41.97 90.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.1 m -58.09 -48.87 78.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.619 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.2 t80 -70.02 -32.63 70.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -59.19 -36.41 75.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.69 -39.79 85.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -77.13 -38.59 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.81 -29.1 70.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -13.01 57.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.71 -22.31 46.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.848 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 64.6 t0 -87.69 119.95 70.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 110.826 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 36.4 Cg_endo -62.4 -24.83 75.86 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.489 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 17.9 ttp180 -68.08 -51.36 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.39 -37.14 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.7 84.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.185 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.54 -37.82 85.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.062 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 59.9 m -66.42 -39.93 89.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.23 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 75.9 mtm -66.3 -37.46 85.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -66.63 -35.09 79.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.83 94.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -71.43 -23.26 61.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.92 -5.94 24.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.2 41.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.55 151.18 50.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 110.841 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.494 ' O ' ' CG2' ' A' ' 329' ' ' ILE . 2.2 tp -68.42 125.54 26.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.083 -166.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.577 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 95.8 mtp -56.95 -52.01 77.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.87 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 330' ' ' MET . 55.7 Cg_endo -67.97 83.55 0.44 Allowed 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.799 2.332 . . . . 0.0 112.3 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.513 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 22.3 t-20 -122.92 -6.89 8.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 333' ' ' ILE . 10.8 tp 161.77 118.24 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 0.0 111.094 -157.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.42 -31.36 91.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.6 2.2 . . . . 0.0 112.255 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.442 ' H ' HG13 ' A' ' 333' ' ' ILE . 91.9 mt-30 -62.62 -10.74 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.993 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -59.18 -35.08 72.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.7 m -62.8 -38.52 90.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.31 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 8.9 m-30 -65.28 -37.91 88.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -56.22 -49.75 73.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.973 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -65.81 -42.18 90.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.71 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.3 t -71.49 -37.74 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.699 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 57.2 ttt180 -53.25 -47.99 68.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.5 m -62.61 -41.91 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 364' ' ' ALA . . . -64.91 -41.79 95.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.8 t -69.18 -47.72 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.19 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.92 -46.37 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -64.98 -36.33 84.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.824 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.91 -47.39 52.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.92 70.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.101 -173.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 84.8 p -74.85 -14.99 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.3 7.21 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.74 -30.07 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -136.07 155.95 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.991 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.4 m -66.0 150.5 48.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.98 -49.81 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.0 -36.36 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -70.95 -40.52 71.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.76 89.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.161 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.82 -38.74 91.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.44 -45.54 93.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -74.3 -42.07 60.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 346' ' ' ALA . . . -81.56 -42.76 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.098 -167.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 365' ' ' GLN . 8.7 mm-40 -73.52 -24.08 60.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 -171.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 63.7 m -53.06 -33.64 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.074 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -61.12 -30.96 70.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 72.5 mt -72.13 -42.62 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.3 p -89.03 -11.07 45.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.101 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.194 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.721 0.296 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.3 mt -83.58 127.34 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.179 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -126.71 163.24 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.91 119.8 14.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.006 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.18 23.79 39.55 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.427 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.48 153.52 40.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.357 . . . . 0.0 110.905 -173.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 7' ' ' LEU . 2.3 pp -145.96 146.0 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.1 126.54 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.606 HG22 ' HB ' ' A' ' 59' ' ' ILE . 1.4 pt -120.19 131.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.467 ' HB3' HD22 ' A' ' 43' ' ' LEU . 23.0 m0 -113.44 132.7 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.01 155.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.2 t-20 -56.33 126.89 28.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 172.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.57 -21.72 79.18 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.54 -51.53 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -163.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -135.01 77.59 1.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 148.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.72 -35.23 1.9 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -73.36 -48.33 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.349 . . . . 0.0 111.003 -155.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -69.76 -50.47 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 -155.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.06 -48.19 87.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.2 -36.85 78.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.18 -48.36 73.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.97 -45.75 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.058 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.675 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.76 -38.32 95.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.03 -45.38 89.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 110.888 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.43 -46.79 86.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.55 -40.67 96.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -62.36 -35.21 78.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.36 -39.55 71.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -176.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.7 -39.88 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.0 m -102.78 -18.31 15.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.1 87.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.469 173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.788 HG13 HD21 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -88.02 130.96 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.166 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.91 129.5 39.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.675 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.5 t -109.73 136.68 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -128.1 113.71 16.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 9' ' ' ILE . 61.5 t -98.57 120.58 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.062 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.9 mt-10 -129.48 145.96 51.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -134.81 72.91 67.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 0.0 110.809 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.3 Cg_endo -70.53 -25.41 25.08 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.276 . . . . 0.0 112.431 -161.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.3 m-20 77.59 4.03 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -172.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.55 0.8 50.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 173.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 10' ' ' TRP . 89.1 mt -48.33 -55.37 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -153.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.26 -33.97 69.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -169.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.28 -43.59 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -76.5 -48.04 20.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -164.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.7 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.1 t80 -49.08 -57.37 11.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.644 0.735 . . . . 0.0 110.916 -160.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 31.8 Cg_endo -66.9 -30.04 40.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 0.0 112.289 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.55 -46.61 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.921 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 21.0 m -74.91 -27.18 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.126 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.07 77.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.158 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -24.14 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 p -96.08 4.74 52.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.84 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.425 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.2 t0 -120.02 -174.78 2.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.783 0.325 . . . . 0.0 110.944 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.35 -173.72 23.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.51 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.03 157.04 23.56 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.64 2.226 . . . . 0.0 112.323 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.7 -40.71 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 172.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.606 ' HB ' HG22 ' A' ' 9' ' ' ILE . 97.5 mt -136.9 142.64 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -131.95 137.13 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.154 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -103.17 134.4 46.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -140.03 156.14 46.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.07 -102.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -124.13 -54.69 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.937 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.01 -50.06 72.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -71.04 -34.99 71.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.59 -49.09 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.793 -174.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.44 -51.18 54.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.432 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -42.68 95.06 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.566 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -70.01 -31.28 68.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.995 0.426 . . . . 0.0 110.994 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.43 98.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.119 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.69 -25.17 64.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -85.11 3.95 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.48 35.15 74.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.528 173.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -78.79 -10.9 59.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -131.86 144.02 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -175.056 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.89 157.96 17.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.083 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.23 137.11 56.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -109.98 151.77 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.422 ' H ' ' HE2' ' A' ' 277' ' ' LYS . 26.5 m -134.98 72.09 68.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.713 . . . . 0.0 111.117 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.83 142.21 34.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.756 2.304 . . . . 0.0 112.316 168.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -79.05 -179.64 6.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.73 -37.85 88.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.64 88.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.96 -38.58 88.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.65 -39.42 91.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.82 -29.49 70.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.69 -25.87 68.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.918 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.448 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 60.6 mt -101.87 -123.97 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -160.05 134.88 5.55 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.689 0.757 . . . . 0.0 110.956 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -54.88 -38.81 92.44 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.715 2.276 . . . . 0.0 112.345 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.72 -36.5 83.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -74.98 -23.26 58.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.185 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.448 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 57.3 m95 -69.98 -32.13 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.37 -30.16 70.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 329' ' ' ILE . . . -67.35 -27.2 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.009 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 36.0 m -112.66 8.62 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.206 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -100.27 135.31 41.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.94 124.94 25.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 58.1 34.79 24.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.58 3.92 89.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.417 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.79 145.97 47.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.933 0.397 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.97 125.99 33.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.41 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.7 pt -118.64 -8.9 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 -169.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.7 161.29 37.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -171.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -106.92 129.87 23.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.626 0.727 . . . . 0.0 110.94 175.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.01 120.3 7.82 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.745 2.297 . . . . 0.0 112.282 173.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.3 mm -102.39 -37.86 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.08 151.73 16.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.06 -169.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.0 t -126.75 130.57 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.16 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.905 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 94.8 mt-10 -128.16 145.05 51.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.41 155.11 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.021 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.2 tp -68.69 145.93 53.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.5 p -141.02 157.59 45.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.4 tp -98.06 126.19 43.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 244' ' ' VAL . 75.9 mt -112.72 129.35 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -135.73 153.65 51.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.69 114.21 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.796 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.48 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.7 mttt -67.55 -27.87 67.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -172.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.55 -36.53 29.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.401 HD22 ' HE2' ' A' ' 144' ' ' LYS . 98.0 mt -78.63 -43.26 26.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 176.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.23 111.89 10.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.689 0.757 . . . . 0.0 110.904 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.551 ' O ' ' C ' ' A' ' 124' ' ' ASN . 93.1 Cg_endo -75.78 173.59 14.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.629 2.22 . . . . 0.0 112.31 174.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.551 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.3 t30 24.0 96.85 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 110.98 175.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.0 157.35 62.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.733 2.289 . . . . 0.0 112.249 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.95 144.45 58.38 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.39 -32.79 14.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 249' ' ' THR . 76.7 p -126.45 159.64 32.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 67.3 m95 -74.62 -26.81 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.97 -173.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.67 -20.64 65.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.86 -24.11 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.586 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 31.4 mm -61.33 -51.78 75.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.556 0.693 . . . . 0.0 111.079 -164.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 38.7 Cg_endo -69.06 -42.38 4.19 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.694 2.262 . . . . 0.0 112.343 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.14 91.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.156 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.81 -38.98 92.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.933 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.92 -43.37 98.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.853 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.19 -41.15 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.36 -46.49 73.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -83.41 -21.29 33.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.908 -177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.449 ' N ' HD12 ' A' ' 139' ' ' LEU . 85.8 tttt -59.38 -26.61 65.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.75 -19.59 65.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.29 9.49 39.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.63 26.97 66.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.401 ' HE2' HD22 ' A' ' 121' ' ' LEU . 83.2 mttt -106.06 160.81 15.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -114.26 147.21 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 164.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.5 -30.68 61.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.095 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.0 mt -142.12 149.83 40.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.43 125.85 35.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -165.47 165.04 19.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 32.5 t-20 -84.2 134.22 34.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.808 -169.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -109.52 16.41 22.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.946 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -83.66 -12.53 55.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -137.87 147.22 55.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.719 . . . . 0.0 110.944 -171.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.758 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -65.63 -27.31 53.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.539 2.159 . . . . 0.0 112.329 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -58.55 -48.04 82.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.925 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 56.3 m-85 -80.36 -19.39 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.786 -174.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 77.8 p -79.75 -21.1 44.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.529 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.7 m0 -57.37 -42.51 96.34 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.472 0.653 . . . . 0.0 110.902 -170.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.599 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 84.1 Cg_exo -47.13 -33.45 15.47 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.674 2.25 . . . . 0.0 112.325 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 195' ' ' LEU . 86.3 mt -83.14 -43.79 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 172.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 94.0 mt -81.4 -52.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.59 -31.93 72.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.084 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -103.43 0.07 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.69 5.14 22.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.508 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -91.27 130.03 10.09 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.481 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -166.04 175.27 8.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -169.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.31 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.136 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -141.12 151.89 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 81.4 tttt -81.7 135.3 35.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -109.34 114.15 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -148.44 143.16 26.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.885 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 49.21 39.92 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.42 5.45 67.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.396 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.57 154.08 51.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.38 129.71 34.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 110.884 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -95.6 110.16 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -20.62 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.95 -15.32 29.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 170' ' ' LYS . 65.0 t0 -133.59 90.62 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.834 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.03 162.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.32 5.18 84.1 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.427 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.62 -2.58 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.07 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 44.3 p30 -74.15 13.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 175.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.65 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.4 m-80 94.66 -5.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.3 -56.95 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.126 173.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.79 -51.56 3.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB3' HD21 ' A' ' 361' ' ' LEU . . . -65.94 -35.55 80.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.35 . . . . 0.0 111.213 -164.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -68.22 -44.55 75.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -170.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.53 95.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.59 98.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.468 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.67 -37.5 84.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.4 m -61.77 -45.43 93.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.88 -42.79 99.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 160' ' ' LEU . 3.6 tt -59.57 -51.53 69.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.791 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.58 -39.52 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.58 -41.17 89.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.83 -37.53 86.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.46 -40.53 77.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.065 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.01 -31.55 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.49 1.75 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 64.48 34.67 10.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.933 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -80.85 -23.22 39.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -148.17 150.05 33.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -86.63 140.51 29.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.19 68.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -93.03 0.86 57.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.922 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.0 m -59.43 128.72 38.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -133.62 179.92 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -62.22 -34.06 75.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -64.41 -44.15 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.6 -39.58 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.46 96.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.11 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.81 -46.32 79.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.7 86.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 222' ' ' THR . . . -64.4 -39.55 94.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.081 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -71.48 -44.36 64.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.838 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -66.82 -27.51 67.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.81 -9.7 39.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.29 15.26 78.89 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.79 -28.94 60.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.961 0.41 . . . . 0.0 110.957 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.493 HG23 ' HB1' ' A' ' 216' ' ' ALA . 82.4 p -129.83 149.87 51.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.166 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.43 -31.94 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -171.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 89.8 mtp -135.29 157.68 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.859 -165.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.9 t -154.17 155.83 36.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.6 mt -119.07 118.93 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -147.09 159.85 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.97 -166.66 42.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.465 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.905 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 32.6 Cg_endo -64.05 -21.66 68.11 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 0.0 112.396 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -66.13 -16.99 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.11 -1.58 58.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -62.23 -40.04 94.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.9 t -58.88 119.23 6.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -155.85 159.27 39.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.0 mt -89.2 77.18 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.091 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -80.49 73.25 7.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.5 p -122.3 5.36 9.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.134 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 67.0 p -108.09 -175.6 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.75 176.8 5.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.883 172.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.04 113.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -114.18 -53.45 2.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -117.46 164.98 14.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.48 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -140.41 167.06 25.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.432 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 116' ' ' ILE . 56.2 t -126.02 130.41 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.056 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.18 174.83 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.73 162.52 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.33 139.98 79.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.504 0.669 . . . . 0.0 110.9 -172.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 255' ' ' SER . 51.3 Cg_endo -75.04 160.34 40.16 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.228 . . . . 0.0 112.367 -177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 128' ' ' THR . 78.4 p -114.42 158.08 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.185 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -127.67 116.28 20.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -174.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.11 35.87 23.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.2 17.68 64.31 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.511 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -127.82 147.91 64.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.96 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.04 149.29 89.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.39 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 248' ' ' PRO . 91.9 p -71.69 -53.8 12.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.479 ' HD3' ' HD3' ' A' ' 159' ' ' PRO . 46.4 pttt -168.93 144.15 2.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 170.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.413 ' HA ' ' HA2' ' A' ' 327' ' ' GLY . 87.7 Cg_endo -78.14 128.91 9.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.335 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -165.0 116.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.8 132.59 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 156.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.5 134.28 11.61 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 82.1 t -119.02 120.74 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 111.195 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 65.3 tp -65.28 132.01 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.805 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.3 m -128.9 141.29 51.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.813 -167.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.24 130.24 50.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.134 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.32 154.01 16.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.8 mt -102.92 127.81 56.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.94 0.4 . . . . 0.0 111.168 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.5 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.24 -11.15 58.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -70.04 130.86 89.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.747 0.784 . . . . 0.0 110.771 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.44 -14.05 41.23 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -112.87 27.97 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.818 -170.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -53.35 -34.14 56.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.45 -36.72 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.788 HD21 HG13 ' A' ' 33' ' ' ILE . 69.5 tp -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 174.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.12 94.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.422 ' HE2' ' H ' ' A' ' 80' ' ' THR . 63.4 tttm -64.79 -45.55 85.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -175.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -63.15 -54.24 40.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.99 -33.56 72.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.498 ' O ' HD23 ' A' ' 280' ' ' LEU . 5.0 tt -61.29 -51.61 68.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.924 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.09 -26.1 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -99.29 -23.77 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -167.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.403 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 68.3 m-85 -123.24 -50.26 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 60.1 tp -69.9 -49.02 56.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -86.41 62.65 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.4 p -135.39 167.62 20.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -57.17 -44.44 83.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -77.08 -42.0 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.61 -45.7 16.99 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.448 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 290' ' ' LEU . 14.1 tp -70.16 -29.84 66.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 110.9 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -61.49 -36.54 80.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.05 93.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.73 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 9.1 p -80.82 -36.38 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -169.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.18 -16.39 60.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -54.92 -23.39 18.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -92.52 -19.17 22.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.58 156.23 59.05 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.51 0.671 . . . . 0.0 110.933 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.12 -93.6 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.643 2.229 . . . . 0.0 112.291 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.725 HD22 ' HB3' ' A' ' 229' ' ' PRO . 49.1 tp -45.13 -42.28 8.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.63 85.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.442 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.401 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -80.36 133.67 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -173.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.23 157.29 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.43 -12.49 60.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.075 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.93 117.71 16.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.96 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.76 -48.85 79.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -171.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.6 t -59.95 -46.58 88.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.698 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -71.47 -35.63 70.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.74 -36.53 83.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.22 -35.06 76.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -74.79 -39.6 61.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 301' ' ' ALA . 89.6 mt -65.04 -27.92 69.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.98 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.2 34.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.72 -17.82 57.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.71 116.52 64.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 0.0 110.81 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.51 -32.51 43.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.623 2.215 . . . . 0.0 112.354 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -69.97 -39.36 76.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.19 -41.39 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.29 68.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.082 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.32 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 69.7 p -71.07 -33.89 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 33.3 mmt -72.71 -39.93 66.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.89 -38.09 82.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.912 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -68.75 -36.47 78.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.41 93.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.096 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -66.09 -17.92 65.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.46 -4.8 22.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 257' ' ' PRO . . . -97.31 -164.68 32.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.364 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -131.94 154.61 49.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.33 . . . . 0.0 110.923 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 96' ' ' ALA . 45.0 mm -64.66 124.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.174 -171.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.549 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 18.2 tpt -56.81 -55.26 45.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 110.833 -168.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 330' ' ' MET . 42.3 Cg_endo -63.83 100.39 0.29 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.736 2.291 . . . . 0.0 112.306 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.698 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 67.1 m-80 -121.55 27.85 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -168.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.698 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 68.5 mt 93.68 134.35 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.719 0.771 . . . . 0.0 111.117 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.36 -32.21 80.58 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.457 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.4 mt-30 -61.56 -21.84 64.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.4 mmm -67.17 -28.08 67.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -65.62 -40.32 92.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.5 -37.45 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -66.05 -32.83 74.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -55.68 -43.9 76.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.976 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -66.49 -35.63 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.7 -35.47 80.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 68.8 t -70.07 -39.25 76.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.758 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 55.3 ttt180 -54.05 -45.52 71.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.7 m -62.3 -42.76 99.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -65.2 -44.29 88.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.92 -49.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.12 -44.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -65.01 -38.64 91.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.79 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.63 -45.54 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.114 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.83 74.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -75.91 -11.65 60.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.39 87.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -77.16 -24.81 51.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -131.76 153.86 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.981 174.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 99.5 m -69.61 147.99 49.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.95 -49.26 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.162 -170.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.09 -42.41 94.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.853 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.04 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.105 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.571 HD21 ' HB3' ' A' ' 188' ' ' ALA . 49.6 tp -70.0 -38.19 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.61 -44.72 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.814 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.57 -30.45 70.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -77.86 -43.71 29.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.048 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -64.96 -30.1 71.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.7 m -62.11 -45.71 92.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.73 -35.32 70.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.17 -43.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.077 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.4 p -93.97 -5.93 46.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.095 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.454 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.59 129.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -126.65 166.87 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.01 119.42 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.01 24.05 39.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.431 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -144.44 154.25 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.941 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 7' ' ' LEU . 4.6 pp -151.57 148.46 28.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.868 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.48 123.01 65.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.192 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.8 mt -114.35 127.58 71.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.139 -174.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -115.12 131.64 56.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.74 155.2 7.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.426 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.6 t-20 -54.74 126.86 25.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 170.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.19 -20.57 79.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.479 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -56.14 -51.59 67.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.905 0.383 . . . . 0.0 110.882 -162.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -135.25 77.12 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 147.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.34 -33.32 2.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -77.45 -45.3 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.952 -160.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.59 -52.03 59.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 -156.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.87 -48.95 65.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.77 -41.75 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.21 -49.77 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.089 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.74 -46.24 89.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.87 -41.88 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.53 -33.55 85.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.505 175.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -66.78 -43.04 85.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.866 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.39 -39.85 94.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -61.79 -42.46 99.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.73 -34.83 75.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.8 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.02 -36.6 69.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.963 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -82.68 -42.0 18.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -172.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -100.15 -22.04 15.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.98 5.21 89.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.537 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.94 123.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.31 116.14 6.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.893 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG11 ' HA3' ' A' ' 24' ' ' GLY . 92.4 t -103.96 133.85 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.8 m -132.93 111.51 11.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.166 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.15 121.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.096 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -129.02 148.75 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.854 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -138.03 67.63 48.55 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.857 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 40.2 Cg_endo -78.65 -14.66 14.07 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 -164.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 59.1 m-20 77.16 6.44 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.34 -8.59 38.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mp -48.73 -52.82 21.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -159.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.8 -43.86 69.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.72 -40.87 20.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 -168.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.07 -43.51 28.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 -167.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.6 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 19.5 t80 -49.85 -54.6 30.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 110.887 -164.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 21.3 Cg_endo -60.4 -31.1 92.23 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -78.46 -49.88 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 19.5 m -74.23 -28.1 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.91 88.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.84 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.7 p -95.69 6.02 49.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.225 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.81 60.54 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.426 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.9 t0 -120.03 -172.95 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.38 -172.44 14.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.541 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HG3' HD11 ' A' ' 60' ' ' ILE . 94.4 Cg_endo -81.64 160.72 19.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.589 2.193 . . . . 0.0 112.391 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.14 -43.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 170.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.1 mt -132.4 141.85 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.141 -170.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.4 HD11 ' HG3' ' A' ' 57' ' ' PRO . 18.1 mm -123.15 131.95 72.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.214 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.93 121.36 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.944 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -148.11 165.0 32.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.877 169.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.49 -102.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.028 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -114.11 -56.59 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.79 -51.71 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -166.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 95.3 mtt-85 -75.36 -32.77 60.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -58.53 -49.44 77.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.852 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.62 -50.6 60.57 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.529 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -40.88 94.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.533 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 66' ' ' ARG . 14.8 m-30 -69.6 -31.94 70.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.901 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.51 96.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.039 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.44 -25.96 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -85.59 3.45 40.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.53 36.38 76.72 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.447 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.498 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 1.1 mp -75.27 -15.68 60.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.94 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -130.96 143.53 50.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 -170.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.94 162.3 14.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.143 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.51 137.71 56.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -110.66 153.35 12.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.2 p -130.07 64.92 74.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.604 0.716 . . . . 0.0 111.126 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.67 144.96 28.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.732 2.288 . . . . 0.0 112.27 167.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -76.5 178.48 6.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -68.27 -31.27 70.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.68 -34.4 67.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -61.79 -39.34 91.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -65.08 -40.22 94.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.3 -37.53 80.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.84 -29.5 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.1 -107.05 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.815 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -165.02 133.09 2.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.721 0.772 . . . . 0.0 110.974 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -66.25 -33.33 39.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -172.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.93 -36.51 83.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -75.47 -24.32 56.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.406 ' HA ' HG22 ' A' ' 97' ' ' VAL . 57.0 m95 -76.44 -28.65 56.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.951 173.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.34 -33.74 72.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' HD12 ' A' ' 329' ' ' ILE . . . -66.65 -26.43 67.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.147 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 30.2 m -109.15 16.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.2 -175.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.6 ttp-105 -109.79 136.53 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -136.76 125.65 24.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 57.71 34.71 24.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.44 89.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.461 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.76 144.91 48.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.39 125.59 32.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.0 pt -118.22 -11.65 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.144 -167.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.65 162.51 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.057 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -106.56 135.89 19.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.697 0.76 . . . . 0.0 110.89 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.9 Cg_exo -65.47 118.52 5.53 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 172.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.26 -36.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.065 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.83 153.25 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.58 128.35 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.192 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 53.8 mp0 -123.06 150.73 42.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.944 175.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.47 153.77 35.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 tp -71.03 136.2 48.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.002 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -138.72 158.21 44.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.418 ' HB2' HD23 ' A' ' 247' ' ' LEU . 38.7 tp -95.39 127.8 41.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 244' ' ' VAL . 81.0 mt -111.34 127.66 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.97 157.49 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -96.95 114.94 26.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -67.47 -29.44 68.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.68 -35.19 30.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.14 -43.93 27.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.21 109.2 15.09 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.637 0.732 . . . . 0.0 110.921 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.4 Cg_endo -73.29 167.65 26.77 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 112.379 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.566 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.6 t30 24.96 96.43 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.955 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -65.32 154.66 72.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.401 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.22 144.72 63.8 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.72 2.28 . . . . 0.0 112.378 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.97 -22.04 19.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.7 p -130.43 158.97 38.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.229 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.453 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 93.4 m95 -73.08 -24.58 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.91 -25.26 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.92 -21.48 57.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 32.9 mm -60.05 -51.92 77.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.534 0.683 . . . . 0.0 111.101 -166.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.4 Cg_endo -68.99 -42.74 3.89 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.448 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.43 92.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.01 -38.2 90.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.17 -39.87 94.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.66 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.85 -49.09 61.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.76 -16.52 53.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.961 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -53.59 -29.12 36.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.44 -19.88 64.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.34 7.73 38.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.92 28.45 62.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -106.49 157.23 17.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -106.88 149.66 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.902 160.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.56 -42.58 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.076 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 38.1 mt -138.2 141.98 40.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.857 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 75.4 mmm -140.22 118.18 11.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 163.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.24 168.44 26.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.791 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -72.41 104.29 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 206' ' ' ALA . 13.5 tp -87.66 -4.82 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 -174.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -87.59 10.27 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -133.64 148.1 67.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.67 0.747 . . . . 0.0 110.803 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 28.6 Cg_endo -68.68 -30.25 28.25 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.32 -174.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -57.59 -37.27 72.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.86 -28.62 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.765 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -77.75 -22.93 49.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.72 ' HB3' ' HG3' ' A' ' 256' ' ' LYS . 1.6 m95 -59.79 -46.81 98.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 -169.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 61.8 Cg_exo -44.43 -37.57 10.83 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.77 2.313 . . . . 0.0 112.337 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.32 -44.37 17.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.865 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.408 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 96.5 mt -72.97 -46.8 50.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -70.78 -17.59 62.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.35 -28.19 69.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.085 -166.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -100.31 7.16 44.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -170.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.7 4.66 55.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.507 169.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 187' ' ' GLY . . . -109.98 147.02 17.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.434 171.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.419 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 43.3 t80 -164.5 173.36 12.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 0.0 110.858 -167.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.48 -54.6 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -141.39 148.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -83.88 130.95 34.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -104.15 113.05 26.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.68 140.66 23.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 47.14 41.76 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.06 7.82 67.8 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 173.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.64 151.8 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -83.92 134.5 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -109.57 114.12 27.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.81 -19.99 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.63 -17.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -168.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -132.02 87.34 2.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 184' ' ' ASP . 13.9 m -127.23 166.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -171.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . -93.42 7.6 75.09 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 181' ' ' VAL . 11.0 m -96.61 -16.45 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.072 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 6.6 p30 -79.87 10.56 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 167.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.2 m-20 84.45 -4.54 1.02 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.75 158.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.22 -48.34 10.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.571 ' O ' ' HA3' ' A' ' 166' ' ' GLY . . . -75.92 -44.1 20.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -67.0 -34.72 78.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.841 0.353 . . . . 0.0 111.085 -160.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.49 -41.83 97.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -165.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.82 95.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 161' ' ' ILE . . . -65.48 -42.84 95.57 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -35.04 79.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.956 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 84.4 m -58.02 -47.96 81.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.117 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.11 -43.45 91.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.821 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.89 -48.69 79.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.2 -38.69 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.192 -175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.12 -36.27 83.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -65.19 -36.4 84.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.993 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.91 -40.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.102 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.87 -39.56 93.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -85.42 5.0 32.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.72 31.93 11.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -83.05 -27.29 30.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 168.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 66.2 mtt -133.37 151.0 51.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.411 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 57.3 t-20 -95.64 132.55 40.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.431 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -67.44 -28.01 67.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -92.11 -8.88 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -168.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 87.0 m -55.5 126.48 25.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -121.14 -174.42 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.41 -44.78 92.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.0 m -60.73 -42.62 97.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.76 -42.28 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.83 95.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.26 -44.65 78.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.71 81.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -35.62 80.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -62.38 -29.94 70.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.14 -21.95 15.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.888 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 22.9 36.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.98 -27.07 43.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.863 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.5 t -124.95 140.0 53.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.98 -35.18 50.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.2 mtm -139.68 155.92 47.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -166.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -152.1 164.87 36.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -120.63 118.08 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -151.79 163.19 39.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.783 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.415 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -100.57 -141.31 11.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.638 ' HB3' HD22 ' A' ' 299' ' ' LEU . 39.8 Cg_endo -71.24 -25.52 21.96 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.366 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -65.79 -19.98 66.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -94.77 9.4 39.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -65.99 -38.78 89.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.2 t -54.63 111.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.424 ' HB3' ' OH ' ' A' ' 242' ' ' TYR . 68.7 m-80 -152.73 142.1 21.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.82 78.18 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -83.54 75.22 10.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.6 p -115.27 -9.03 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.9 p -103.2 -171.55 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.81 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.84 177.65 3.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -59.66 110.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.59 -57.87 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.814 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.424 ' OH ' ' HB3' ' A' ' 234' ' ' ASN . 49.2 p90 -110.2 159.52 17.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.95 167.61 25.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.49 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 116' ' ' ILE . 64.0 t -129.13 130.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.215 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.06 -177.25 5.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.197 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.17 160.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.101 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 115' ' ' LEU . 83.8 mt -70.9 143.27 88.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.559 0.695 . . . . 0.0 110.937 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' A' ' 255' ' ' SER . 57.7 Cg_endo -74.96 170.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.391 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -104.33 162.12 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.046 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -135.53 118.52 16.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.829 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 54.6 34.8 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.66 80.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 175.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 89.1 mm-40 -122.72 147.36 50.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.615 0.722 . . . . 0.0 110.94 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 51.4 Cg_exo -54.81 145.53 60.7 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.618 2.212 . . . . 0.0 112.424 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.453 ' HB3' ' HE1' ' A' ' 129' ' ' TRP . 95.3 p -70.53 -63.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.992 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 14.1 tmtt? -172.32 125.93 0.53 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.917 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.71 134.37 12.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.716 2.277 . . . . 0.0 112.313 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -161.08 110.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.05 134.98 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.816 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -119.86 147.26 18.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.9 t -122.59 121.75 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.125 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.54 130.99 45.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.954 174.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.0 m -127.72 139.85 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -165.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.19 137.21 49.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.101 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.0 168.11 23.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.339 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.79 129.14 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.108 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -57.44 125.37 22.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.68 -22.25 66.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.97 -12.48 55.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.145 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.0 t -70.77 136.65 85.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.773 0.797 . . . . 0.0 110.826 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.16 -14.63 23.24 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.625 2.216 . . . . 0.0 112.35 174.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -108.03 36.87 2.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.832 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.94 -38.71 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.17 -38.78 91.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.38 -49.38 67.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.55 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -168.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -66.48 -47.46 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.916 -172.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -47.94 72.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -72.14 -36.02 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 280' ' ' LEU . 5.1 tt -56.58 -47.81 78.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.01 -25.56 34.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -99.81 -13.12 19.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -171.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 70.6 t80 -124.36 -58.83 1.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.7 mt -69.71 -39.87 76.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.02 66.34 9.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 175.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 73.7 p -136.27 168.35 19.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.52 -45.25 73.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.87 -41.86 42.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.96 -49.63 9.65 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.497 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.32 -38.92 82.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.56 -43.22 99.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.83 76.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.068 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.6 t -74.38 -45.06 47.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -73.86 -14.28 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.3 -27.07 13.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -91.91 -4.24 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -91.15 151.29 42.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.573 0.702 . . . . 0.0 110.871 172.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.55 -57.72 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.638 HD22 ' HB3' ' A' ' 229' ' ' PRO . 61.8 tp -65.8 -47.78 73.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -167.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.06 86.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.469 ' HB1' ' SD ' ' A' ' 321' ' ' MET . . . -75.16 125.55 29.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 0.0 111.114 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.515 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -124.71 159.71 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -173.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.36 60.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.2 tp -75.3 123.57 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.65 -39.39 93.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.1 t -59.46 -48.37 81.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.515 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.6 t80 -71.38 -33.68 69.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.12 -39.45 82.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.86 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.56 -37.82 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -76.97 -37.31 55.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.8 mt -64.87 -31.61 72.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.11 -12.66 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.11 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.03 -20.05 58.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -91.81 117.93 68.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.801 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.74 -33.64 60.93 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.673 2.248 . . . . 0.0 112.337 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -72.55 -43.2 63.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -173.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.43 -38.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.99 72.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.72 89.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 80.9 m -67.2 -43.09 82.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.225 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.469 ' SD ' ' HB1' ' A' ' 301' ' ' ALA . 96.3 mmm -66.11 -34.62 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.14 -40.24 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -72.76 -34.57 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.18 -41.78 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -69.94 -17.03 63.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.03 -5.35 16.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.1 -164.07 39.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.476 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.61 147.53 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.432 HD12 ' HB2' ' A' ' 96' ' ' ALA . 39.2 mm -67.43 126.92 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 -166.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.816 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 54.2 mtt -52.64 -58.83 10.4 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 110.914 -171.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.524 ' CD ' ' HB2' ' A' ' 330' ' ' MET . 36.2 Cg_endo -63.98 101.08 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.762 2.308 . . . . 0.0 112.375 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.68 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 69.1 m-80 -123.06 28.49 7.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -169.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.8 mt 90.23 135.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.667 0.746 . . . . 0.0 111.104 -176.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -54.79 -29.94 65.13 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.618 2.212 . . . . 0.0 112.332 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.437 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.6 mt-30 -64.09 -23.69 67.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.88 -26.82 65.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.15 -34.88 49.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -66.68 -40.13 88.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.07 -38.55 83.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.966 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -64.99 -36.26 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.72 -35.01 79.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.67 -40.2 76.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.17 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.613 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 58.0 ttp180 -56.38 -44.79 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.2 m -64.2 -44.46 91.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.485 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -63.52 -45.38 90.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -176.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.97 -36.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.09 -171.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.5 mt -68.98 -44.16 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.068 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.39 -35.74 81.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.817 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.84 -45.58 67.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.31 68.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -75.78 -12.69 60.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.77 6.99 88.6 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.22 -30.09 64.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.864 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -139.28 156.8 46.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 70.8 p -75.02 164.09 26.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 171.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.39 -50.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.51 -36.67 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -69.21 -48.06 63.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.55 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.079 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 41.1 tp -65.09 -44.08 90.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -46.51 88.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.68 -35.07 78.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.485 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -79.01 -43.28 24.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.172 -172.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 10.3 mm100 -77.97 -31.13 50.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -171.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 78.0 m -59.99 -38.03 81.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.48 -30.0 70.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.41 -45.42 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.4 p -97.85 -4.62 36.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -177.915 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.703 0.287 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.422 HG21 ' HD2' ' A' ' 271' ' ' PRO . 88.6 mt -61.76 125.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.083 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 164.35 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -66.93 121.99 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.73 19.76 59.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 -173.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -146.39 153.34 40.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.798 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.9 pp -143.15 145.87 33.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.08 124.79 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.553 HG22 ' HB ' ' A' ' 59' ' ' ILE . 5.7 pt -124.95 132.26 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -171.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.774 ' HB3' HD22 ' A' ' 43' ' ' LEU . 38.3 m0 -113.72 135.34 54.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.533 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.2 tt -148.17 155.09 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.455 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.1 t-20 -55.77 128.01 32.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.873 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.12 -16.86 76.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.441 -168.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -47.7 80.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 -165.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -134.58 63.46 1.62 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 152.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.533 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -100.53 -50.49 1.3 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -67.74 -43.54 79.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -160.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.38 -49.52 59.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -163.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.48 -48.44 81.97 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.488 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.2 mt -63.89 -34.57 78.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.843 0.354 . . . . 0.0 110.88 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.07 95.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.049 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -62.06 -49.37 76.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.85 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 292' ' ' ALA . 25.5 m -72.84 -32.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.48 -40.15 97.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.45 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.86 -43.94 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 110.819 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.88 -47.25 78.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 27' ' ' PHE . 6.9 m-30 -64.6 -41.85 95.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.889 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -65.09 -34.22 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.89 -40.71 79.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.77 -39.64 23.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.2 m -102.11 -26.35 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.15 -172.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.89 5.45 83.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 33' ' ' ILE . 19.5 tt -76.55 126.96 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.188 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.49 124.14 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.7 t -109.35 130.51 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.185 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -125.19 114.42 18.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 9' ' ' ILE . 51.7 t -103.83 120.23 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 57.6 mt-10 -131.12 146.46 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -139.92 67.81 35.0 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.699 0.762 . . . . 0.0 110.789 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.548 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -73.91 -16.62 23.1 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.694 2.262 . . . . 0.0 112.387 -167.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 62.0 m-20 74.74 7.6 4.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -173.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.51 -1.32 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 172.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 10' ' ' TRP . 34.5 mt -48.32 -54.33 14.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -156.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.79 -27.34 66.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 -167.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.61 -47.44 10.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -80.26 -40.97 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.998 -166.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 37.4 t80 -55.48 -58.88 13.05 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.604 0.716 . . . . 0.0 110.862 -165.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.8 Cg_endo -59.74 -30.7 92.7 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -75.05 -45.1 43.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 47' ' ' PHE . 33.2 m -73.75 -23.34 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.147 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.096 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.36 -24.8 66.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.32 4.61 53.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.0 22.29 74.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -139.39 -163.18 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 110.882 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.82 -165.83 22.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.627 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.495 ' HG2' HD11 ' A' ' 60' ' ' ILE . 84.4 Cg_endo -81.62 165.09 18.33 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 -173.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' HA ' HD11 ' A' ' 2' ' ' ILE . 43.6 t0 -83.95 -49.26 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.553 ' HB ' HG22 ' A' ' 9' ' ' ILE . 82.9 mt -133.97 138.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 -171.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.495 HD11 ' HG2' ' A' ' 57' ' ' PRO . 7.1 mm -120.86 139.69 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.239 173.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -99.53 130.9 45.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -139.69 158.3 44.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.8 -100.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 331' ' ' PRO . 3.8 p80 -110.94 -54.87 2.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -176.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.07 -49.8 75.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.37 -33.63 48.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.66 -48.36 81.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.813 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.16 65.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.559 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.04 98.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -70.14 -30.02 67.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -62.95 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -67.49 -28.09 67.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -85.57 0.14 53.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -173.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 34.85 80.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mp -87.07 -2.6 58.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.84 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.19 142.92 51.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.932 -175.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.38 152.63 22.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -67.04 135.34 53.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.48 HG13 ' HB3' ' A' ' 103' ' ' LEU . 30.5 pt -118.42 146.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -134.96 69.66 70.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.622 0.725 . . . . 0.0 111.165 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.96 144.54 43.18 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.712 2.274 . . . . 0.0 112.38 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -76.05 178.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.56 -31.91 73.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.87 95.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -67.82 -38.45 83.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.94 -41.55 95.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.14 -33.85 72.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.844 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -68.21 -22.48 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.892 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.7 mt -95.78 -125.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 34.3 t80 -153.68 136.48 9.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.743 0.782 . . . . 0.0 110.941 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.2 Cg_exo -58.24 -41.51 65.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.79 2.326 . . . . 0.0 112.316 -172.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.6 -43.54 84.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.13 -26.76 62.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.155 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -70.04 -40.07 75.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.91 -36.14 82.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 173.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.66 65.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.078 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.491 HG23 HD11 ' A' ' 103' ' ' LEU . 26.8 m -107.4 19.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -109.95 141.02 43.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -138.42 125.89 21.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.96 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.38 35.05 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.831 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.65 89.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.485 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.64 139.71 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.931 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 97' ' ' VAL . 10.7 tp -80.44 132.99 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.467 ' HB ' HD13 ' A' ' 76' ' ' LEU . 37.7 pt -124.38 -11.25 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 -165.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -157.32 162.49 39.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.009 -170.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.412 ' HB3' HD11 ' A' ' 285' ' ' LEU . 97.1 m-85 -113.15 140.78 24.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.623 0.725 . . . . 0.0 110.995 168.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.66 121.84 8.32 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -103.86 -42.7 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.72 153.34 29.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.127 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.84 133.77 56.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 11.7 mp0 -130.8 155.87 45.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.43 155.09 41.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.05 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.3 134.3 44.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.944 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.4 p -143.16 161.3 38.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.0 tp -98.99 127.89 45.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.2 mt -108.05 131.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.013 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -132.31 149.89 52.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.69 118.77 30.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 171.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.76 -34.66 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -81.63 -35.13 30.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.819 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.59 -44.72 23.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.44 HD12 ' HG3' ' A' ' 224' ' ' MET . 72.6 mt -131.68 115.79 15.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 0.0 110.861 173.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.554 ' O ' ' C ' ' A' ' 124' ' ' ASN . 90.2 Cg_endo -74.47 170.09 21.05 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.738 2.292 . . . . 0.0 112.368 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.554 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.4 t30 25.06 97.11 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 0.0 110.916 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 41.9 Cg_endo -65.49 157.16 59.68 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.401 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.85 149.91 60.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.576 2.184 . . . . 0.0 112.342 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.66 -27.71 13.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -126.25 156.44 40.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -66.24 -30.37 70.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.81 -26.58 58.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.93 -21.51 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.686 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 32.2 mm -59.74 -55.37 46.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.655 0.741 . . . . 0.0 111.14 -167.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.686 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 52.0 Cg_endo -75.0 -37.65 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.73 2.287 . . . . 0.0 112.354 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.85 96.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.76 -42.43 90.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.62 -41.52 99.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.988 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.52 -43.86 84.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.95 -45.58 67.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.5 pp -79.4 -22.51 44.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.007 -175.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' N ' HD12 ' A' ' 139' ' ' LEU . 83.9 tttt -61.06 -30.93 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -20.4 64.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.186 173.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.36 6.54 47.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.85 60.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.516 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.417 ' HB2' HD13 ' A' ' 139' ' ' LEU . 91.6 mttt -108.79 165.18 11.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.8 t -120.31 140.1 51.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 163.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.7 -33.66 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.5 mt -137.02 150.25 47.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 93.7 mmm -133.52 131.75 40.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 166.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -160.43 162.48 33.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.6 t-20 -84.24 110.71 18.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 -177.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 39.9 tp -96.09 4.49 52.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -173.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -81.21 2.12 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.53 151.92 48.12 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.667 0.746 . . . . 0.0 110.935 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.681 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.9 Cg_endo -72.61 -17.37 26.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.256 -174.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -52.47 -48.58 65.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.95 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.423 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 51.9 m-85 -83.51 -11.68 57.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -172.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -80.49 -19.02 46.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.485 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 6.5 m95 -59.79 -44.23 96.72 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.477 0.656 . . . . 0.0 110.921 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 66.6 Cg_exo -43.82 -31.22 3.44 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.714 2.276 . . . . 0.0 112.324 176.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.4 tm? -87.61 -49.24 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.423 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -78.55 -47.66 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 -169.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -64.85 -26.42 68.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.09 -31.75 72.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -95.96 0.31 51.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.75 38.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.423 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -92.46 129.03 9.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.408 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -168.3 175.2 6.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 110.808 -172.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.76 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -137.42 150.7 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -99.6 127.56 45.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -97.35 112.49 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.903 -174.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -149.91 138.43 20.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.65 35.16 17.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.55 4.6 75.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.532 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.49 149.96 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -77.4 135.25 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.45 107.25 18.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.8 tp -65.5 -19.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.55 -8.45 56.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -122.63 76.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.846 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.604 ' CG2' HG22 ' A' ' 183' ' ' VAL . 31.0 m -131.19 164.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -171.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.43 13.13 56.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.602 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.604 HG22 ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -99.74 -20.17 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.754 0.312 . . . . 0.0 111.082 174.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 99.7 m-20 -78.36 3.0 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 167.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 84.4 m-20 83.81 -4.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.792 163.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.1 -50.8 17.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.13 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.61 -42.1 14.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.45 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.7 78.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -164.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -63.27 -44.69 94.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -166.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.95 98.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.039 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.95 -42.28 98.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.424 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.34 -43.15 91.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.857 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.6 m -61.76 -44.21 97.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.505 ' CD2' HD21 ' A' ' 160' ' ' LEU . 1.1 t80 -63.11 -41.51 99.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.89 -40.53 95.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.34 -37.74 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -66.11 -35.13 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.46 -41.46 89.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.913 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.1 -36.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.65 -37.06 84.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -84.43 3.19 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 60.78 39.8 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -79.28 -26.85 42.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -149.46 150.86 33.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -95.37 149.83 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.877 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.66 -25.62 68.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -92.82 -7.28 46.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.779 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 m -58.61 125.54 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 59.6 p30 -139.07 -179.96 6.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -62.65 -33.05 74.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.9 m -63.79 -44.13 94.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.73 -40.04 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.168 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.76 99.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.9 -43.89 91.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.95 82.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.37 99.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -66.21 -35.56 80.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.807 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -64.44 -29.59 70.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.58 -19.0 19.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.01 25.18 38.4 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -84.68 -19.53 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.955 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -128.19 144.52 51.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.44 -35.29 14.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.506 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.2 mtm -142.29 160.6 39.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.933 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.0 t -150.46 160.31 43.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.21 118.92 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 65.0 m-80 -151.94 160.33 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 -173.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -107.34 -135.58 7.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.418 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.659 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 25.4 Cg_endo -68.0 -28.13 35.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 -175.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -67.38 -15.08 63.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.892 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -88.7 21.26 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -62.57 -31.36 72.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.0 t -63.72 106.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.816 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -149.13 130.01 14.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.8 mt -91.08 80.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -84.96 73.71 10.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.9 p -120.25 -12.38 9.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.9 p -110.1 -170.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.22 172.86 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.14 104.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -105.08 -59.35 1.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.02 153.85 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.41 159.54 23.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.73 128.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.999 0.428 . . . . 0.0 111.102 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.01 174.71 10.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.178 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.04 159.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.21 146.09 96.59 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.44 160.23 50.61 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.734 2.289 . . . . 0.0 112.313 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.0 p -104.52 151.54 23.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.023 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -130.78 116.08 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 55.53 33.88 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.75 68.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.518 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -126.25 148.88 65.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.36 144.25 79.5 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -74.08 -57.0 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -172.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.421 ' HG3' ' HD3' ' A' ' 159' ' ' PRO . 10.0 tmtt? -150.1 111.18 3.28 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.519 0.676 . . . . 0.0 110.974 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.96 127.62 11.6 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.784 2.323 . . . . 0.0 112.299 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.407 ' CE2' ' SD ' ' A' ' 330' ' ' MET . 31.0 t80 -158.91 119.44 3.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 -178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.43 130.89 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 167.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.05 135.09 12.05 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.455 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -124.86 128.47 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.141 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 68.3 tp -73.18 135.01 44.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -133.87 160.68 36.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.803 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.94 136.81 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.058 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -113.13 148.95 18.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.477 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 93.5 mt -108.71 124.88 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 270' ' ' SER . 45.1 t-20 -51.6 120.14 4.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -174.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.72 -22.59 66.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.5 -8.93 58.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.193 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 29.4 t -71.41 129.19 89.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.74 0.781 . . . . 0.0 110.786 -171.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.422 ' HD2' HG21 ' A' ' 2' ' ' ILE . 90.6 Cg_endo -71.59 -14.86 30.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.646 2.231 . . . . 0.0 112.267 170.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -107.79 29.14 7.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.929 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.23 -33.62 67.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.39 -38.96 92.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.832 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.88 -41.62 82.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 174.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.35 69.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.042 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -71.13 -38.62 72.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 96.4 mt-10 -72.19 -48.28 44.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 -173.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -62.73 -40.41 97.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 284' ' ' LEU . 2.8 tt -60.68 -48.4 81.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 -177.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -83.57 -31.13 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.0 m-20 -97.99 -22.15 16.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -166.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.456 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 m-85 -121.37 -51.82 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 58.9 tp -70.64 -46.87 62.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.912 -176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 106' ' ' TYR . 92.2 mt -87.05 63.54 7.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.6 p -135.23 169.39 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 172.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.72 -44.35 77.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.14 -44.3 22.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.952 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -70.95 -47.11 40.48 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -170.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.82 -35.41 78.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -62.05 -40.01 94.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -64.93 -38.56 91.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -174.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.0 p -80.75 -33.71 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.126 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -72.23 -31.74 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -172.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -59.54 -22.5 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.15 -10.16 34.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.38 152.03 75.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.47 -61.58 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.559 2.173 . . . . 0.0 112.385 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.95 -43.2 18.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.939 0.4 . . . . 0.0 110.922 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.75 14.86 79.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.551 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -84.39 127.63 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.047 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.54 160.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.134 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.4 -10.32 59.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.185 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 52.8 tp -74.22 121.13 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.37 -49.05 77.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -171.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.6 m -60.76 -43.41 98.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.884 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -70.12 -35.67 74.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.834 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.03 -31.12 72.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.808 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.85 -39.19 90.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.05 -37.68 61.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.819 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.405 ' HB3' HG21 ' A' ' 317' ' ' ILE . 90.9 mt -65.06 -27.47 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.26 -15.62 57.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.59 -21.05 61.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.843 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -86.58 120.73 72.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 110.807 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.87 -27.78 80.6 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.631 2.221 . . . . 0.0 112.383 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -70.03 -39.67 75.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 311' ' ' LEU . 47.4 mm -77.27 -36.37 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.242 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.11 76.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.243 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.38 -41.42 89.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -64.14 -47.16 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.198 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.5 tpt -66.89 -36.99 83.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -61.96 -43.27 99.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.888 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -74.97 -36.42 62.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.58 93.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -69.72 -18.99 63.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -109.51 -6.56 15.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.912 -172.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.52 36.57 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.43 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -126.38 139.26 53.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 110.813 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.544 HG13 ' HD2' ' A' ' 331' ' ' PRO . 2.2 tp -70.54 136.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.573 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 83.0 mmm -52.51 -52.57 62.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -172.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 64' ' ' HIS . 51.2 Cg_endo -66.86 82.29 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.757 2.305 . . . . 0.0 112.337 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.639 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 76.5 m-20 -107.15 29.63 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.7 mt 86.96 135.09 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.592 0.711 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -52.76 -31.81 52.8 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 0.0 112.259 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.414 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.9 mt-30 -61.46 -28.49 69.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.965 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.94 -37.06 86.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.17 -39.69 95.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -38.17 80.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.448 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.6 m-30 -65.75 -32.91 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.937 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -59.09 -40.08 84.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.984 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.99 -36.28 72.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.992 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.13 90.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.5 m -74.1 -25.38 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.681 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 75.0 ttt-85 -55.8 -40.56 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.0 m -60.79 -45.55 93.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.165 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 364' ' ' ALA . . . -65.44 -43.52 90.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.38 -53.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 -170.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.97 -44.97 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 -173.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -63.64 -37.33 86.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.22 -46.62 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.58 -35.33 75.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.08 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -80.47 -10.83 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.841 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.95 13.2 81.65 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.496 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.36 -30.08 57.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.845 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -137.33 156.88 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.9 m -70.74 149.7 46.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.06 -49.3 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.67 -43.09 90.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.3 -47.07 65.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.59 96.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 59.6 tp -65.62 -44.8 85.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.08 -49.6 71.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.932 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.74 -38.39 83.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 346' ' ' ALA . . . -73.99 -42.74 59.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.06 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 9.5 mm100 -78.26 -27.65 47.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -173.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 51.6 m -58.27 -37.07 74.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.88 -29.6 70.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.08 -40.0 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 57.8 p -94.04 -12.76 27.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.061 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.704 0.287 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -76.38 135.1 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.163 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.19 173.63 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.53 122.5 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 23.81 39.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -145.92 154.87 42.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.3 pp -150.98 149.26 29.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 172.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 58' ' ' ASP . 97.2 t -125.63 129.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -115.32 130.46 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.567 ' HB3' HD22 ' A' ' 43' ' ' LEU . 22.6 m0 -114.6 129.82 56.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -152.67 155.24 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.2 t-20 -54.77 127.18 27.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 173.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.94 -18.34 80.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 -167.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -56.59 -50.88 70.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.857 -163.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -134.8 75.41 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 147.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -104.69 -37.56 2.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -78.18 -46.58 20.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.957 -157.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.7 -52.15 53.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.903 -153.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.46 -48.86 60.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.44 -41.59 98.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.891 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -49.05 69.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.26 -47.15 80.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.876 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -44.82 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.24 -36.48 90.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.399 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -65.48 -40.61 93.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.861 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.06 -39.87 91.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -65.27 -40.07 93.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -59.95 -35.84 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.77 -37.39 70.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.2 -40.37 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 -172.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.5 m -104.36 -18.13 14.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -172.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.29 86.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.471 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -88.46 128.18 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 111.197 177.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.28 129.6 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -172.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.5 t -110.23 136.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.6 m -133.9 112.62 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.3 t -106.52 124.02 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -129.89 152.55 49.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.428 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.7 p80 -134.38 74.05 67.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.615 0.721 . . . . 0.0 110.828 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 19.2 Cg_endo -71.13 -27.39 20.21 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.725 2.283 . . . . 0.0 112.297 -162.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 60.6 m-20 77.7 4.17 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.847 -172.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -98.04 -0.46 44.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 10' ' ' TRP . 89.2 mt -48.91 -56.59 8.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.952 -152.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -65.06 -27.8 69.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.786 -165.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -85.3 -43.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -79.32 -45.0 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.964 -166.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.877 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 5.9 t80 -52.5 -53.59 51.84 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -163.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 72.7 Cg_exo -55.11 -38.87 93.27 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.659 2.24 . . . . 0.0 112.302 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.67 -46.76 35.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.969 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.73 -28.04 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.46 84.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 -24.58 67.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -96.37 5.79 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.76 74.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.466 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -116.99 -172.23 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.872 0.368 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.34 -173.8 26.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.581 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.62 159.74 28.4 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.643 2.229 . . . . 0.0 112.45 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 276' ' ' ALA . 33.9 t70 -75.63 -38.87 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 171.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -131.99 139.83 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -136.37 136.29 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -103.36 135.39 45.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -141.35 155.9 45.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.926 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.23 -106.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.068 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.412 ' CG ' ' N ' ' A' ' 65' ' ' ASP . 12.6 p80 -109.79 -54.83 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 64' ' ' HIS . 38.9 t70 -62.37 -48.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -164.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -79.57 -36.34 38.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -58.58 -51.26 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.835 -168.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.37 -51.46 54.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.571 -171.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -40.85 92.15 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.44 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -70.1 -30.38 67.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 0.0 110.994 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -64.03 -42.64 97.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.014 174.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -65.8 -28.06 68.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.923 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -85.17 2.76 42.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.74 36.1 86.75 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.522 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.32 -23.83 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.24 144.71 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 -159.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.26 157.59 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.71 138.22 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.8 pt -107.81 151.03 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.2 p -128.54 69.4 79.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.555 0.693 . . . . 0.0 111.16 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.06 141.65 26.72 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.786 2.324 . . . . 0.0 112.214 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -79.27 169.59 17.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.95 -30.44 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.12 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.016 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -77.98 -35.82 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.858 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -61.64 -44.19 97.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.26 -28.32 65.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.812 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.836 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.0 mt -100.5 -113.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.872 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 22.4 t80 -158.92 133.08 5.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.992 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 86.1 Cg_exo -57.28 -41.0 77.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.745 2.297 . . . . 0.0 112.363 -173.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.22 -39.11 93.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.6 p -71.9 -24.84 61.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.187 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.427 ' HA ' HG22 ' A' ' 97' ' ' VAL . 60.9 m95 -71.16 -36.33 71.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.85 -28.68 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.55 -27.69 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 94' ' ' TRP . 36.0 m -110.97 10.95 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -100.22 130.05 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.973 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -129.3 120.47 25.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 58.53 35.13 24.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.46 5.01 90.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.88 145.62 47.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 110.975 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.68 125.8 34.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.45 ' HB ' HD13 ' A' ' 76' ' ' LEU . 40.9 pt -120.89 -6.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 -169.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -161.77 164.48 28.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 -172.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.1 m-85 -108.46 134.64 20.17 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.669 0.747 . . . . 0.0 110.962 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.3 Cg_exo -64.07 121.0 8.52 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.243 . . . . 0.0 112.321 171.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.98 -40.07 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.48 151.62 20.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.065 -166.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.9 t -129.67 129.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 46.1 mt-10 -128.52 153.08 47.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.93 157.04 41.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.3 tp -71.1 131.81 44.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.0 m -139.7 155.94 47.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.91 126.33 40.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 85.0 mt -108.5 127.41 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -137.48 154.71 49.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.9 t-20 -91.32 118.22 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.812 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.659 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -68.21 -29.58 68.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.906 -172.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.05 -38.56 44.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.17 -35.31 42.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.95 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.2 tp -134.43 111.19 11.63 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.624 0.726 . . . . 0.0 111.006 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.594 ' O ' ' C ' ' A' ' 124' ' ' ASN . 84.2 Cg_endo -74.87 172.29 16.61 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 170.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.7 t30 22.5 96.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 110.959 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.21 156.4 65.88 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 144.98 60.44 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.744 2.296 . . . . 0.0 112.331 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.07 -29.45 15.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.8 p -126.04 158.8 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 -175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -68.75 -32.76 72.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.51 -26.45 54.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.828 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.16 -20.97 60.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.1 mm -58.86 -54.29 57.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.647 0.737 . . . . 0.0 111.129 -169.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 26.3 Cg_endo -65.15 -41.32 16.89 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.738 2.292 . . . . 0.0 112.399 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.65 93.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.02 -37.37 87.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.87 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.01 -40.15 94.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.31 -37.88 81.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 60.5 mt -70.38 -35.45 73.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.09 -32.29 64.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.998 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.45 66.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -104.29 4.79 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.83 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.49 26.42 67.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.498 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 82.4 mttt -113.16 156.44 23.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.6 t -113.4 148.8 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.817 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.22 38.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.2 mt -139.75 149.85 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.9 mmm -137.28 115.81 12.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.23 165.83 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.54 148.19 22.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 57.6 tp -107.01 -0.01 23.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -78.74 -11.17 59.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -138.45 145.44 46.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.561 0.696 . . . . 0.0 110.932 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.771 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.2 Cg_endo -68.04 -25.53 37.89 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.715 2.277 . . . . 0.0 112.286 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.03 -46.41 85.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.804 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.28 -26.04 58.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.806 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.5 p -82.39 -18.44 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -58.54 -45.55 99.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.432 0.634 . . . . 0.0 110.875 -169.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 79.2 Cg_exo -46.93 -38.66 23.88 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.627 2.218 . . . . 0.0 112.335 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.89 -41.06 26.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.428 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.7 mt -77.95 -47.57 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -68.58 -17.26 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.36 -33.12 74.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -99.14 -2.55 36.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.45 11.19 20.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.496 168.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -108.26 138.18 14.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.451 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 19.4 t80 -165.56 175.7 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -167.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.81 -59.74 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.221 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -142.42 150.1 40.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -85.95 133.12 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.827 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -108.34 114.28 28.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -147.47 140.08 24.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -170.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.58 41.01 9.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.03 6.64 68.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.516 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -137.32 152.75 50.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.99 133.8 36.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -107.97 109.14 20.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -174.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -67.52 -20.09 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.102 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -82.08 -16.6 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -168.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.49 87.24 2.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 184' ' ' ASP . 12.7 m -129.63 166.87 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.129 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -87.18 2.19 86.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.1 m -98.56 -16.77 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 111.097 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 181' ' ' VAL . 25.7 p30 -80.3 7.91 8.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 170.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 85.3 m-20 84.19 -7.05 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 161.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.55 -47.59 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.86 -46.55 22.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -71.54 -31.79 67.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.385 . . . . 0.0 111.096 -163.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.45 -44.35 94.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -160.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.69 97.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.428 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.04 -40.09 98.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.434 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.15 -41.02 90.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.7 m -62.46 -42.15 99.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.15 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.75 -40.44 88.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.45 -48.79 79.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.07 -39.6 86.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -41.11 98.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.6 OUTLIER -73.01 -32.12 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -177.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.78 -38.0 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 173.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.47 -34.82 78.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -85.91 -3.73 58.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 61.5 36.87 16.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.937 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -75.38 -17.45 60.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.69 156.15 47.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -101.71 134.18 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.792 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.14 -32.39 74.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.035 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.58 -5.72 45.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -164.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.1 m -61.74 130.72 47.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.184 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -135.87 -172.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.921 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.48 -47.47 79.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.924 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.7 m -63.65 -42.62 98.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.65 -44.93 93.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.0 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.66 -45.12 88.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.47 87.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.062 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.4 98.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -65.82 -38.69 89.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.828 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.39 -29.44 70.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.66 -19.82 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.86 21.4 50.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -77.41 -24.0 50.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.924 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -133.64 149.46 51.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.066 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.37 -20.82 20.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -138.06 154.9 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 -170.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -159.54 162.43 35.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.08 120.82 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 71.0 m-80 -145.92 158.61 43.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -176.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -95.54 -151.85 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.592 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 29.4 Cg_endo -65.2 -25.15 57.89 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.729 2.286 . . . . 0.0 112.291 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -66.0 -18.09 65.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -87.35 23.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -63.44 -29.98 71.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.1 t -66.41 107.78 2.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -149.31 129.98 14.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.45 81.18 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -84.68 72.86 10.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.4 p -114.54 -13.83 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.182 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.1 p -94.39 -169.94 2.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.61 175.74 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.852 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.31 107.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.121 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -120.42 -59.32 1.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 52.1 p90 -111.62 160.5 17.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.659 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -148.86 167.13 29.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.7 134.17 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 111.1 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -136.99 174.86 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 -171.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -79.74 161.48 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -176.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.62 142.83 86.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.508 0.671 . . . . 0.0 110.907 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.14 166.49 27.9 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.65 2.233 . . . . 0.0 112.253 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 66.8 p -118.74 150.74 39.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -128.18 115.25 18.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.81 35.13 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.29 21.14 46.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.553 173.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.8 144.78 53.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.582 0.706 . . . . 0.0 111.021 -172.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.43 141.97 70.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.626 2.217 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.7 t -68.8 -58.88 3.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.749 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 158' ' ' TRP . 5.5 tmtt? -150.8 110.59 3.12 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 0.0 110.916 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.39 122.5 7.05 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.684 2.256 . . . . 0.0 112.474 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -163.89 113.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.2 p -141.67 135.87 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.655 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -117.93 140.11 15.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.92 125.14 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.205 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 61.6 tp -73.37 137.25 44.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.7 m -123.88 141.56 51.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -119.87 128.02 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.34 158.2 15.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.1 127.13 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.889 0.376 . . . . 0.0 111.15 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -56.98 120.63 8.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.85 -26.13 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.04 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.72 -11.45 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.1 t -70.77 130.1 89.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 110.748 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.08 -13.11 37.23 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -110.12 27.06 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -55.19 -33.91 63.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -67.94 -37.93 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.851 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.01 -42.42 94.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.429 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . . . -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -174.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -63.32 -45.63 90.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.25 -54.16 23.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -36.37 71.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -171.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 284' ' ' LEU . 64.6 tp -58.98 -47.74 84.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 176.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -75.26 -35.0 61.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -98.28 -9.16 25.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -164.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.819 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 80.2 m-85 -127.59 -55.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 177.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.477 ' HB2' HD12 ' A' ' 280' ' ' LEU . 51.3 mt -76.76 -28.88 55.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -170.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.7 mm? -108.1 51.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.7 p -132.49 168.47 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -56.16 -46.05 79.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.15 -42.71 45.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.819 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.39 -50.77 6.44 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -171.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.77 -40.11 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.738 0.304 . . . . 0.0 110.899 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.24 -42.6 99.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.855 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.5 -32.57 74.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.2 t -71.04 -36.82 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.096 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -70.53 -12.75 61.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.838 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.09 -24.31 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -97.83 -7.67 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -87.18 145.15 37.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 110.96 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.47 -62.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.528 2.152 . . . . 0.0 112.369 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.17 -47.98 39.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.95 -170.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 88.23 -5.67 84.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.615 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.62 119.68 16.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 111.091 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.15 160.3 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -171.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.43 -12.46 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 172.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.8 tp -73.37 118.32 16.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.38 -44.6 90.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 74.6 m -59.32 -44.66 92.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.03 -34.52 68.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -60.54 -36.72 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -75.71 -38.31 58.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.05 -28.7 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.91 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.62 -12.32 52.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.073 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.23 -19.93 55.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -88.75 118.45 69.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.599 0.714 . . . . 0.0 110.795 173.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.43 -35.35 65.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.717 2.278 . . . . 0.0 112.328 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -72.81 -44.26 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.77 -41.04 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.99 73.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.0 84.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 51.6 m -66.35 -41.92 88.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.7 mmm -67.53 -35.38 78.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.39 -36.11 82.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -68.2 -38.05 81.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.819 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.28 90.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -66.88 -16.39 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.92 -6.9 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.36 -165.13 36.24 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.361 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -129.97 143.41 50.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.902 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.577 HG13 ' HD2' ' A' ' 331' ' ' PRO . 5.0 tp -67.28 134.34 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.215 -168.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.655 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 59.4 mtt -51.96 -55.69 28.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.577 ' HD2' HG13 ' A' ' 329' ' ' ILE . 34.4 Cg_endo -62.64 86.53 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.774 2.316 . . . . 0.0 112.309 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.642 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 70.1 m-80 -107.88 22.97 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 46.0 mm 89.05 134.83 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.724 0.774 . . . . 0.0 111.02 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.65 -30.58 66.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.692 2.262 . . . . 0.0 112.252 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -59.96 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.907 -176.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.0 mmm -70.11 -24.66 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.86 -40.7 97.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.45 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -65.54 -33.79 76.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.66 -43.84 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.947 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -67.74 -34.98 77.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.4 82.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.171 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 29.4 m -75.65 -27.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.199 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.771 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 80.6 ttt180 -57.45 -41.88 81.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.809 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.6 m -63.4 -45.86 89.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -61.92 -43.85 97.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.39 -50.74 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.152 -174.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.96 -45.53 90.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.027 -175.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.76 -35.79 82.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.57 61.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.52 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -76.04 -13.52 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.27 7.45 87.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.34 -30.11 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 0.0 110.959 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -136.2 154.92 50.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.5 m -67.94 150.98 47.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.83 -47.97 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.177 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.42 -40.64 89.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.38 -46.13 64.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.87 85.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 188' ' ' ALA . 62.0 tp -62.71 -46.91 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 110.959 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -48.7 69.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.04 -37.24 81.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -80.39 -43.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -78.49 -31.85 47.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.81 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.9 m -59.08 -37.8 77.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.18 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.42 -29.07 68.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.88 -44.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.03 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.1 p -97.46 -6.34 34.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.191 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -178.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.759 0.314 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.4 mt -81.75 123.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.33 166.75 20.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.985 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.0 131.49 45.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.96 17.49 56.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.24 163.53 35.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.831 0.348 . . . . 0.0 110.92 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 33' ' ' ILE . 1.8 pt? -145.65 153.93 41.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.14 127.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.645 ' HB3' HD22 ' A' ' 43' ' ' LEU . 26.8 m0 -110.08 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.5 tt -150.13 153.72 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -55.9 134.01 51.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.39 -16.21 75.42 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 -171.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.92 -43.16 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 -168.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.82 80.79 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 149.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.8 -52.56 1.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.496 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.07 -48.9 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -156.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.86 -53.16 51.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.84 -151.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.726 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -67.77 -49.89 45.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.465 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.65 -41.32 98.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.855 0.36 . . . . 0.0 110.996 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.7 73.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.56 -46.84 77.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.07 -45.81 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.082 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -62.77 -34.19 89.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.26 -45.82 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.861 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.82 -45.1 94.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -66.64 -37.86 85.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -60.56 -34.78 74.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.753 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.37 -38.88 74.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.03 -40.57 24.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -172.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -107.5 -15.35 14.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -171.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.03 1.2 88.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.418 168.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -85.99 127.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.931 0.396 . . . . 0.0 111.185 176.145 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.53 129.99 38.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.406 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.8 t -108.19 129.07 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.18 177.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.84 115.88 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.59 124.98 66.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -126.83 143.22 51.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.41 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 28.0 p80 -139.94 65.34 30.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 46.5 Cg_endo -72.18 -21.68 23.29 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.794 2.33 . . . . 0.0 112.247 -174.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 69.6 m-20 67.02 14.32 9.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 -172.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.63 -1.82 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.645 HD22 ' HB3' ' A' ' 10' ' ' TRP . 60.3 mt -52.33 -49.1 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 -152.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -65.84 -27.64 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.808 -169.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.39 -42.85 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -76.96 -40.19 47.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.627 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 47.1 t80 -51.39 -57.81 12.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.729 . . . . 0.0 110.839 -169.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.2 Cg_endo -60.93 -29.68 88.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.241 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.18 -47.03 30.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 33.4 m -75.0 -29.6 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.87 87.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.13 -23.94 66.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.3 p -96.05 5.33 51.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -174.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.97 67.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.538 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.7 t0 -120.0 -174.17 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.933 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.97 -170.9 13.59 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.25 162.99 19.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.35 -40.87 16.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 169.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.54 142.78 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -171.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -122.22 131.36 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -112.31 122.37 47.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.464 ' CZ2' HD12 ' A' ' 43' ' ' LEU . 95.1 m95 -148.48 156.7 42.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 168.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -81.96 -103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.029 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -112.07 -54.98 2.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.75 -50.19 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 -168.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.21 -31.56 69.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.944 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -60.71 -48.17 83.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -50.41 63.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.533 -172.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.14 98.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -70.91 -29.83 66.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 110.933 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.48 98.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.083 173.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.92 -26.37 65.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.895 173.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -84.89 1.86 45.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.02 36.67 51.33 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.515 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 mp -81.16 -10.06 59.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.564 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -132.98 144.45 50.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -178.09 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.47 162.96 12.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.49 134.66 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -112.39 153.27 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.3 p -132.16 65.43 75.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 111.194 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.16 148.21 43.93 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.383 171.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -77.57 -179.82 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.49 -31.43 72.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.36 -38.49 77.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.991 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.09 -38.74 86.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.57 -43.39 97.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -71.06 -31.28 67.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.66 -30.55 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.414 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.8 mp -108.77 -92.7 0.42 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -175.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 29.6 t80 -167.19 133.05 1.74 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.997 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 99.1 Cg_exo -54.05 -40.17 82.49 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.745 2.297 . . . . 0.0 112.336 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 92' ' ' PHE . 1.3 t80 -65.27 -39.44 92.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 p -70.9 -26.74 63.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.414 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 79.1 m95 -79.75 -32.59 41.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 174.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.43 -29.67 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 169.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.78 67.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.068 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.29 15.79 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -98.93 133.62 42.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.917 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -136.29 125.42 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 58.43 34.5 24.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.82 2.29 90.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.507 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.45 144.84 49.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.73 132.01 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.6 pt -118.37 -8.61 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.053 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.007 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.5 m-85 -106.53 132.62 20.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.668 0.746 . . . . 0.0 110.913 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 10.1 Cg_exo -72.85 132.71 18.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.746 2.297 . . . . 0.0 112.323 173.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.79 -50.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.151 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.15 151.62 33.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 -163.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.87 132.63 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.823 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 98.1 mt-10 -129.46 150.55 50.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.93 155.06 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -71.34 141.42 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -145.24 163.73 33.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' A' ' 248' ' ' PRO . 45.9 tp -96.57 127.55 42.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.5 mt -113.68 125.77 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -133.49 157.07 46.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.8 t-20 -94.67 118.14 31.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -65.72 -35.33 80.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -173.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.54 -35.43 58.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.56 -45.19 17.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 64.8 tp -126.62 108.62 23.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.709 . . . . 0.0 110.926 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 124' ' ' ASN . 98.7 Cg_endo -75.52 164.91 31.56 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.329 173.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.552 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.5 t30 24.96 96.3 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.56 155.4 70.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.721 2.281 . . . . 0.0 112.356 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.28 150.36 64.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.593 2.195 . . . . 0.0 112.357 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.11 -21.16 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.923 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.9 p -129.22 159.48 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.706 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 85.0 m95 -73.21 -24.66 60.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.965 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.46 -25.09 64.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.79 -20.02 50.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.675 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.2 mm -58.85 -55.43 46.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.626 0.727 . . . . 0.0 111.15 -168.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.0 Cg_endo -74.24 -37.34 2.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.45 95.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.01 -39.49 93.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 173.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.91 -37.48 87.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.54 -42.8 99.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.79 -36.29 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.764 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.594 HD12 ' HB2' ' A' ' 146' ' ' ALA . 71.6 mt -70.06 -30.93 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.39 -33.69 63.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.71 -25.03 67.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -102.55 2.82 36.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.7 30.77 61.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 89.1 mttt -116.61 162.63 17.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.517 ' H ' ' HA ' ' A' ' 222' ' ' THR . 44.7 t -120.98 146.91 46.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.594 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -82.7 -25.63 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.126 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 tp -137.79 136.27 37.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 -173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 91.6 mmm -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -161.61 161.16 29.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.893 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -86.28 133.41 33.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 41.1 tp -103.38 4.31 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -74.39 -13.1 60.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.95 146.91 63.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 0.0 110.929 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.556 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 42.4 Cg_endo -67.77 -24.93 40.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.571 2.18 . . . . 0.0 112.331 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -49.96 -42.08 48.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -80.33 -23.31 40.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -170.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.9 p -79.27 -23.22 43.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.581 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 49.1 m0 -57.26 -45.72 99.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.533 0.682 . . . . 0.0 110.932 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 91.3 Cg_exo -50.9 -37.34 55.63 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 2.229 . . . . 0.0 112.306 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.17 -40.28 24.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 347' ' ' VAL . 96.7 mt -73.44 -50.01 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -72.17 -14.96 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.048 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -61.68 -31.76 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.047 -174.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -102.28 1.77 36.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.47 1.58 40.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -86.84 136.61 14.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.363 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.472 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 21.3 t80 -169.95 176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.931 0.395 . . . . 0.0 110.978 -176.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.91 83.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -139.83 153.22 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.18 130.59 35.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.815 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -100.21 115.64 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -148.63 140.11 23.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.93 37.4 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.902 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.13 82.32 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -136.34 151.2 49.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.846 0.355 . . . . 0.0 110.958 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.48 131.71 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 171.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -94.28 109.71 21.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.49 -20.79 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.37 -10.35 46.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -130.21 95.5 3.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 174.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 183' ' ' VAL . 35.0 m -109.47 159.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -173.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -95.86 -2.24 61.26 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 167.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.437 HG22 ' HB ' ' A' ' 181' ' ' VAL . 8.0 m -85.96 -5.94 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 54.6 p30 -76.18 10.66 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 171.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 81.8 m-20 84.55 -4.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 168.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.38 -51.98 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.34 -50.2 7.64 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.13 73.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.61 -40.49 97.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -173.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.14 96.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.67 96.46 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.435 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 361' ' ' LEU . 78.8 mt -65.36 -34.93 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.927 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.4 m -56.36 -51.91 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -172.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -68.16 -44.95 74.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.9 tt -59.83 -50.82 72.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.809 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.32 -37.86 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.132 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.16 -36.83 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.818 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -36.07 83.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.67 -39.84 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.87 -39.81 94.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -84.34 5.41 27.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.1 32.17 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -87.86 -22.92 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -139.58 145.21 38.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.52 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 54.1 t-20 -94.67 134.72 36.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 176.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.09 -25.18 64.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.074 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -95.69 -15.16 22.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.732 -171.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.52 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 55.2 m -64.79 137.69 57.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.25 176.67 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.902 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -65.07 -29.64 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.2 m -64.73 -42.95 94.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.906 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.83 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.201 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.86 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.068 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.95 -43.99 90.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.798 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.77 77.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.086 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.0 97.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -64.0 -35.79 81.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 0.0 110.927 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.68 -28.88 69.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.55 -18.99 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.22 47.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.477 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.83 -19.72 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 110.91 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.517 ' HA ' ' H ' ' A' ' 145' ' ' SER . 15.2 t -130.7 144.5 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -94.46 -35.01 12.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 56.2 ttp -145.55 153.81 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -154.48 168.09 27.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.5 tt -126.3 123.45 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.066 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.52 162.44 41.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.22 -165.9 37.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.549 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.823 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 35.7 Cg_endo -66.39 -21.52 53.72 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -65.96 -18.12 65.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.46 5.63 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -62.72 -40.11 96.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.5 t -55.65 109.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -150.17 159.86 44.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.832 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.22 80.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.03 75.09 10.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.976 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.4 p -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.183 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 76.6 p -104.19 -174.8 2.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.27 176.89 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.884 172.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.09 104.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -113.3 -54.56 2.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 50.8 p90 -114.09 159.31 20.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.62 165.04 27.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.463 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 85.7 t -132.34 135.15 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.092 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.41 -179.84 6.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.6 160.49 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.089 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.14 139.27 90.03 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.543 0.687 . . . . 0.0 110.915 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.503 ' HD3' HD22 ' A' ' 115' ' ' LEU . 59.1 Cg_endo -75.1 167.09 27.72 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.359 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.8 p -106.7 158.45 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -132.01 118.93 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.829 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 55.16 34.92 23.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.6 6.24 87.53 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -119.77 150.34 50.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 110.862 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.93 149.72 89.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.626 2.217 . . . . 0.0 112.38 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.706 ' HB3' ' HE1' ' A' ' 129' ' ' TRP . 87.8 p -67.37 -62.23 1.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -170.75 127.25 0.69 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.508 0.671 . . . . 0.0 110.818 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.04 132.69 14.31 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.328 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -157.16 124.24 5.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.95 133.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 167.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.35 135.23 12.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.538 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.76 129.93 75.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.771 0.319 . . . . 0.0 111.158 -174.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 55.8 tp -74.99 132.34 41.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.9 m -130.4 145.42 51.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.04 51.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.04 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -123.54 170.15 15.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -112.77 129.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.294 . . . . 0.0 111.178 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -59.0 120.87 9.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.3 -25.14 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.94 -9.83 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.218 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.0 t -71.04 131.31 87.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.75 -15.03 43.47 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.377 172.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -109.09 21.86 16.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.51 -35.74 21.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.41 -35.07 70.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -178.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.83 -41.38 91.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.31 83.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.134 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -64.83 -34.49 78.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.936 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.62 -47.86 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.412 ' HE2' HG13 ' A' ' 33' ' ' ILE . 15.2 m-30 -65.41 -49.29 69.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.597 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.6 tt -57.05 -48.81 77.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -170.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -77.5 -22.63 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.828 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -101.96 -8.16 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -112.68 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 45.3 tp -73.49 -45.54 53.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -168.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.6 60.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.2 p -132.94 160.57 36.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -59.41 -44.93 92.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -71.47 -46.2 60.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.07 -45.45 41.02 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.42 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.445 HD21 ' HB ' ' A' ' 302' ' ' VAL . 28.4 tp -71.33 -37.72 71.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.973 -173.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.9 -40.75 95.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.56 99.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.726 HG23 ' HA3' ' A' ' 19' ' ' GLY . 15.0 p -76.48 -29.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -65.06 -24.32 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.11 -24.02 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -91.64 -13.0 32.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -78.68 155.54 78.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.708 . . . . 0.0 110.88 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.88 -95.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.608 2.205 . . . . 0.0 112.43 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -66.09 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.13 25.1 71.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 168.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.431 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -81.77 132.11 35.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.058 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.4 m -124.28 160.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.06 -12.67 59.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.013 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 59.5 tp -74.26 120.27 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.903 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.62 -45.75 91.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.3 m -60.6 -42.43 96.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.72 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.527 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.0 OUTLIER -71.81 -32.49 67.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -61.93 -32.02 72.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.01 -38.3 82.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -75.17 -38.28 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 301' ' ' ALA . 94.1 mt -65.13 -27.58 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.85 -16.64 43.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.109 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -71.79 -22.63 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 63.7 t0 -90.33 117.44 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.822 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 37.0 Cg_endo -61.54 -25.32 79.33 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.3 mtm-85 -70.36 -39.72 74.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 51.1 mm -79.98 -39.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.255 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.116 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.63 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.9 p -73.45 -35.83 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.2 mtm -68.06 -38.72 82.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -65.27 -42.65 92.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -71.79 -35.33 69.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.32 91.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.25 -19.07 65.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -108.37 -4.93 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.67 -167.09 42.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.532 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.773 0.321 . . . . 0.0 110.948 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.489 ' HA ' HD12 ' A' ' 329' ' ' ILE . 2.8 tp -66.35 124.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 -169.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.594 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -46.44 -52.22 30.84 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.847 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 330' ' ' MET . 38.9 Cg_endo -63.99 85.54 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.768 2.312 . . . . 0.0 112.349 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.691 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 72.0 m-80 -108.74 30.52 6.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.691 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 71.4 mt 93.56 131.07 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.71 0.767 . . . . 0.0 111.06 -169.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.18 -25.58 50.31 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.768 2.312 . . . . 0.0 112.308 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.423 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.4 mt-30 -60.7 -24.64 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 176.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.7 mmm -63.8 -30.89 71.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.8 m -62.93 -43.08 99.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.12 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -60.57 -38.97 86.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -64.43 -38.28 90.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.177 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.39 -42.97 94.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.144 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.556 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 55.7 ttp180 -55.3 -43.81 75.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.4 m -59.91 -42.93 94.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.16 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.78 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 161' ' ' ILE . 54.4 t -67.05 -52.36 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.67 -45.18 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -171.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.58 -37.86 89.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.32 -44.24 68.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.79 74.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.8 p -76.05 -12.58 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.32 8.24 87.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.482 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -78.26 -25.7 46.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.917 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -135.12 155.99 49.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 90.9 m -71.88 151.5 43.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.21 -48.8 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.63 -42.34 86.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.21 -46.51 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.882 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.0 95.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.154 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 55.7 tp -66.08 -43.05 88.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.63 -48.43 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.922 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.02 -37.01 84.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.904 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.02 -43.58 64.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 7.6 mm-40 -77.16 -26.94 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.2 m -56.1 -35.64 67.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.161 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.95 -30.17 70.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.46 -41.92 89.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.3 p -94.04 -15.08 25.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.226 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.764 0.316 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.8 mt -85.74 125.97 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -136.62 176.92 8.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -171.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.95 132.06 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.96 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.79 59.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.64 159.97 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.886 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.869 ' O ' HD12 ' A' ' 7' ' ' LEU . 2.9 pp -147.15 149.51 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 177.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -120.58 127.6 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.185 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.583 HG22 ' HB ' ' A' ' 59' ' ' ILE . 3.3 pt -121.8 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.169 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.444 ' HB3' HD22 ' A' ' 43' ' ' LEU . 26.7 m0 -114.8 132.34 56.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.404 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.4 tt -149.23 153.71 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 -172.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.429 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.9 t-20 -55.87 128.54 35.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.66 -19.44 79.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.472 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.93 -46.4 90.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.904 -163.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.98 66.57 1.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.838 150.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -99.55 -46.15 2.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.552 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -69.95 -43.35 71.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.983 -159.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -65.63 -49.95 66.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 -160.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.66 -50.45 58.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.469 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 20' ' ' LEU . 53.7 mt -64.87 -37.24 86.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.12 -48.81 61.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -68.03 -45.77 73.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 p -69.85 -35.61 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.107 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.53 84.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.15 -46.32 89.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.32 -38.42 87.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -61.92 -35.66 79.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.782 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.39 -38.71 68.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.1 -41.05 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -171.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.0 p -105.57 -17.89 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.207 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.58 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.479 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 33' ' ' ILE . 19.5 tt -82.91 127.39 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.21 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -67.17 124.48 23.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.73 130.94 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.162 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.3 m -123.16 113.76 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.445 HG22 HD11 ' A' ' 9' ' ' ILE . 58.4 t -100.78 122.02 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.063 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.7 mt-10 -129.49 139.3 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -140.02 68.86 35.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 0.0 110.86 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 36.8 Cg_endo -75.7 -15.62 19.15 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.396 -165.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.8 m-20 73.13 8.34 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -171.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.75 -4.85 54.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.873 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' A' ' 10' ' ' TRP . 81.5 mt -51.74 -50.01 61.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -156.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.01 -35.3 78.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -88.05 -40.34 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -73.91 -45.26 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -167.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.675 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.9 t80 -51.69 -58.43 11.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.642 0.734 . . . . 0.0 110.834 -166.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 19.9 Cg_endo -63.9 -31.04 67.68 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.754 2.303 . . . . 0.0 112.274 -173.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -75.35 -47.25 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.2 m -76.24 -26.05 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.171 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.35 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.044 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.99 -24.47 66.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.053 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.7 p -95.09 4.51 53.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 22.72 61.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.518 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.8 t0 -119.52 -176.12 3.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.31 -170.3 15.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.503 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.37 158.96 17.28 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.81 -42.28 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 167.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.583 ' HB ' HG22 ' A' ' 9' ' ' ILE . 88.1 mt -133.23 139.53 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 tp -128.8 132.44 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.221 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -101.3 135.93 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -139.88 153.61 47.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.2 -102.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -122.27 -54.66 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.9 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -67.13 -46.08 75.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -73.26 -32.34 64.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.83 -47.31 85.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.859 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.17 -50.3 61.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.576 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.21 -41.98 99.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.532 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -70.05 -31.27 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.89 99.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 174.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.93 -26.28 64.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -85.02 2.1 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 37.1 61.37 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.554 173.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -80.33 -8.8 59.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 110.883 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -132.24 144.17 50.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 157.83 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 139.09 52.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.29 156.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.075 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -134.34 62.62 56.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.532 0.682 . . . . 0.0 111.161 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.01 149.93 42.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.745 2.297 . . . . 0.0 112.257 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -77.27 176.45 8.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.08 -29.92 67.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.98 69.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.07 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -63.21 -37.05 85.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -65.39 -39.97 92.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.81 -35.85 79.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.24 -29.31 66.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.2 mp -104.71 -106.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 23.0 t80 -162.89 133.96 3.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.67 0.748 . . . . 0.0 110.952 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.4 Cg_exo -56.21 -42.96 60.76 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.297 -174.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.14 -40.53 94.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 p -71.44 -25.64 62.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.429 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 54.5 m95 -80.13 -29.33 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 173.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -62.67 -30.11 71.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.827 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.71 -25.22 66.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.52 21.95 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.131 -174.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -109.94 139.58 44.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -141.54 126.85 18.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.65 34.46 22.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.888 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.45 90.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 173.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.16 144.82 50.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.85 130.73 35.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 pt -118.12 -12.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -169.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.28 165.33 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.036 -170.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.2 m-85 -109.83 134.31 20.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.663 0.745 . . . . 0.0 110.927 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.4 Cg_exo -66.31 126.8 16.25 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.318 173.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -111.61 -40.29 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.95 155.83 23.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.056 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.23 131.97 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -128.91 144.7 51.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.12 155.08 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.86 138.47 44.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.948 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -147.86 163.93 35.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.88 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.31 129.84 42.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.6 mt -107.09 128.02 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -136.23 148.19 47.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -90.72 117.08 29.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HE2' ' HA3' ' A' ' 243' ' ' GLY . 66.9 mttm -70.83 -30.61 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -171.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -76.85 -36.32 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -77.32 -38.71 49.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.5 tp -136.53 111.86 9.86 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.897 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 124' ' ' ASN . 87.8 Cg_endo -74.98 169.3 22.94 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.659 2.239 . . . . 0.0 112.35 170.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.2 t30 25.22 96.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 110.961 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.03 158.99 54.99 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.72 147.58 69.81 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.4 -29.7 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.871 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.6 p -127.94 159.6 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -68.56 -33.4 74.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.5 -29.78 64.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.813 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.57 -21.19 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.577 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 28.5 mm -60.93 -51.5 78.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.701 0.763 . . . . 0.0 111.09 -168.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 48.5 Cg_endo -70.35 -38.78 6.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.754 2.303 . . . . 0.0 112.324 -174.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.16 94.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.91 -36.91 83.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.73 -37.44 86.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.7 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.33 -37.3 83.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.8 mt -69.32 -36.46 76.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.73 -35.1 70.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.22 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.3 3.1 46.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.0 29.47 60.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -123.49 163.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.498 ' H ' ' HA ' ' A' ' 222' ' ' THR . 35.4 t -118.54 150.48 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 171.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -81.06 -23.96 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.82 141.73 50.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 68.8 mmm -140.1 119.93 13.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 161.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -160.05 164.99 32.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.7 t-20 -84.2 110.7 18.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.878 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 206' ' ' ALA . 27.1 tp -98.37 5.63 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -174.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.75 -2.27 57.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 148.46 69.67 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.656 0.741 . . . . 0.0 110.804 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.757 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 56.6 Cg_endo -74.76 -22.48 15.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.613 2.208 . . . . 0.0 112.265 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -52.79 -43.9 66.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 150' ' ' ASN . 81.3 m-85 -83.51 -20.4 33.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.713 -172.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.2 p -81.88 -21.26 37.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 4.4 m95 -60.08 -45.5 97.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.431 0.634 . . . . 0.0 110.884 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 99.2 Cg_exo -45.71 -31.1 7.15 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.258 . . . . 0.0 112.339 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 160' ' ' LEU . 2.7 tm? -82.29 -45.17 15.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.629 HG23 ' HA3' ' A' ' 191' ' ' GLY . 92.1 mt -74.66 -44.06 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 167' ' ' TYR . . . -69.77 -19.01 63.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.84 -29.64 70.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -102.91 0.19 32.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.6 15.12 9.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 165.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 161' ' ' ILE . . . -114.83 126.34 7.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.423 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 162' ' ' ALA . 17.9 t80 -159.56 172.17 18.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 110.921 -171.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.11 65.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.89 149.38 43.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -82.78 139.47 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -97.55 104.2 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 170.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.96 122.75 11.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.74 36.43 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -172.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.09 82.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.21 151.6 50.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -97.94 141.58 30.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -103.61 117.34 34.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 170.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.14 -18.07 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.04 -10.25 55.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -128.91 75.5 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.917 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.498 HG23 ' H ' ' A' ' 184' ' ' ASP . 15.4 m -134.95 172.96 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.92 -11.97 75.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.562 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.6 m -91.84 -7.68 10.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 111.044 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 35.3 p30 -85.45 7.22 23.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 86.3 m-20 83.72 -8.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 165.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.53 10.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.09 -44.68 34.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.533 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.495 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -70.15 -32.68 70.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -166.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -62.89 -45.59 91.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.949 -164.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.94 95.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.629 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.38 -41.26 99.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.43 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.19 -44.26 88.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.037 0.446 . . . . 0.0 111.008 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.5 m -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.216 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.05 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.828 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.71 -40.31 94.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.33 -36.83 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.173 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.26 -36.33 82.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.38 -41.71 80.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.63 -35.5 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.95 -35.96 81.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -84.08 2.98 36.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 62.71 35.14 14.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.914 173.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -76.98 -25.73 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.963 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -147.46 149.38 32.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 53.1 t-20 -95.1 136.73 35.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.43 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -63.02 -26.84 69.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -175.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.21 -13.79 27.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.899 -172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.8 m -65.63 134.93 54.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 49.9 p30 -112.91 173.83 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -71.36 -25.56 62.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.01 -38.47 88.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.42 -32.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.179 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.76 72.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.047 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.59 -46.96 85.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.834 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.64 76.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.42 96.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -65.09 -35.97 82.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.04 -29.31 70.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.82 -20.67 16.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.16 25.42 31.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.405 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.42 -26.75 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.498 ' HA ' ' H ' ' A' ' 145' ' ' SER . 7.2 t -128.99 147.49 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.05 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.73 18.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 175.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.1 mtm -140.23 160.05 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -169.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -150.15 161.79 41.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -121.34 120.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -146.27 159.58 43.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -104.77 -137.46 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -70.49 -26.24 24.35 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.692 2.261 . . . . 0.0 112.278 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -66.49 -16.13 63.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.7 23.06 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -62.5 -30.65 71.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 t -69.19 107.16 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -144.88 127.85 16.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.928 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.43 80.33 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -85.29 74.22 10.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.832 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 75.5 p -119.89 -14.97 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.2 p -92.96 -170.05 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.39 175.29 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.935 170.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.71 107.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.192 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -118.48 -57.08 2.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -113.49 160.03 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.578 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . -146.76 166.4 28.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.438 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 96.2 t -130.12 134.75 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.72 177.14 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.93 159.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.5 144.94 98.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.561 0.696 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.95 158.37 56.94 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.681 2.254 . . . . 0.0 112.252 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.1 p -107.22 151.33 25.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -128.76 116.0 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 55.18 36.47 27.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.97 69.21 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -125.32 147.08 56.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 110.996 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.3 154.83 72.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 0.0 112.379 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -67.08 -58.44 4.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 110.914 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -169.91 141.89 1.88 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 0.0 110.864 168.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.65 129.04 11.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.417 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -163.12 112.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.09 135.05 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.25 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -114.45 119.08 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.749 0.309 . . . . 0.0 111.211 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.6 130.01 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.1 m -130.54 145.04 51.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -170.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.0 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.07 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -117.09 155.19 16.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.412 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.6 mt -104.49 126.75 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 111.164 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.98 120.06 8.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.91 67.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.075 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.69 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -72.48 131.06 85.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.738 0.78 . . . . 0.0 110.846 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.65 -12.8 33.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.214 . . . . 0.0 112.32 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.05 27.54 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.854 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -53.85 -34.42 59.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.39 -38.98 91.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.37 -41.01 90.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.816 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.0 79.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.126 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.86 -47.84 79.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 98.3 mt-10 -69.36 -53.04 21.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -175.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 8.5 m-30 -65.48 -39.6 92.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.83 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.479 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.1 tt -61.55 -48.07 82.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.978 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -83.06 -26.64 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 93.0 m-20 -100.56 -21.03 15.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -169.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 21.3 m-30 -118.69 -56.38 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.862 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.02 -37.1 78.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -174.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' A' ' 106' ' ' TYR . 89.2 mt -94.84 60.99 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.1 p -127.75 168.82 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.17 171.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -53.24 -44.37 68.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.48 -42.12 30.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.33 -49.33 12.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.434 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 304' ' ' LEU . 25.0 tp -72.05 -35.5 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.938 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.97 -40.06 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.835 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.36 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.98 -35.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.157 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -77.27 -24.54 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.38 -27.29 68.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -88.01 -15.33 36.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.65 153.11 93.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 0.0 110.987 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.6 -55.95 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.573 2.182 . . . . 0.0 112.33 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -82.05 -46.62 13.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 84.98 -8.84 68.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.423 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -55.29 118.54 4.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.061 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 307' ' ' TYR . 4.3 p -128.72 153.49 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 -170.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.42 -17.19 56.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.489 ' HB2' HD23 ' A' ' 290' ' ' LEU . 56.1 tp -70.86 124.91 25.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.06 -37.39 84.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -61.29 -51.0 70.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.739 ' HB3' HG11 ' A' ' 302' ' ' VAL . 1.6 t80 -73.73 -33.25 64.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.67 -38.29 89.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.56 -40.18 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -73.76 -37.77 64.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.802 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.89 -28.23 68.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.66 -16.62 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.43 -21.77 60.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.885 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -90.17 119.55 69.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.796 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -62.32 -25.44 76.51 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.408 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.4 mtm-85 -70.12 -40.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 50.9 mm -79.64 -40.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.96 76.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.06 93.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.079 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 72.0 p -71.25 -36.52 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.13 -34.64 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -65.02 -40.86 95.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -72.03 -35.04 69.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.93 90.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -72.86 -14.37 61.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.818 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -107.72 -8.34 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.858 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.25 -158.37 34.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.483 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -127.11 140.1 52.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 329' ' ' ILE . 2.9 tp -68.24 120.24 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.551 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -47.95 -51.51 47.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.608 0.718 . . . . 0.0 110.878 -174.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 330' ' ' MET . 68.8 Cg_endo -69.23 79.53 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.423 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 53.5 t-20 -119.58 -3.08 10.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 336' ' ' MET . 18.2 tt 164.97 124.9 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 111.114 -165.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.75 -29.35 12.8 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.587 2.191 . . . . 0.0 112.334 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -64.98 -17.76 64.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.914 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 333' ' ' ILE . 61.4 ttp -62.97 -27.94 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -174.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -60.77 -41.73 96.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.6 71.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.134 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -65.6 -30.61 71.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -56.57 -41.2 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.17 -37.31 78.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.46 -43.57 85.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.93 -29.11 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.757 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 60.5 ttt180 -57.31 -44.96 84.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.0 m -62.21 -44.39 96.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.23 81.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.82 -50.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.0 mm -65.9 -45.43 91.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -66.21 -37.27 85.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.85 63.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.9 -35.04 76.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -80.71 -10.85 59.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.69 14.39 81.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.575 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -79.87 -26.6 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -137.0 156.22 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.006 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 98.9 m -68.6 145.86 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.1 -49.94 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.177 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.43 -40.84 85.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.52 -46.43 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 188' ' ' ALA . 63.5 tp -64.16 -46.59 83.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.97 -48.31 71.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.58 -38.8 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -78.6 -46.39 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -78.97 -30.87 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -169.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -59.0 -36.06 74.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.88 -30.1 69.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.5 mt -67.89 -44.67 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.127 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.2 p -98.18 -11.23 22.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.057 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.762 0.315 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -89.76 135.1 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.166 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -129.73 165.03 22.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -71.31 122.04 19.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.12 20.09 50.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.542 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 34' ' ' LYS . 93.5 mttt -139.84 155.11 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.805 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.6 pp -149.15 148.75 30.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -123.16 125.35 71.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.464 HG12 ' HB ' ' A' ' 59' ' ' ILE . 53.2 mt -119.01 130.73 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -110.83 136.68 49.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 -173.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 tt -144.56 147.63 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -75.0 172.4 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.62 -19.97 15.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.507 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -79.4 51.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 110.857 174.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 17' ' ' TYR . 54.5 pttt -80.14 117.63 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.956 -159.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.65 10.03 1.64 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.543 154.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' H ' ' C ' ' A' ' 15' ' ' LYS . 23.1 t80 -39.99 -36.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -57.63 -47.12 83.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.8 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -72.63 -38.18 57.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.405 174.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -36.87 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.009 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.55 95.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.221 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -62.02 -45.87 91.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.0 m -75.08 -28.28 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.6 89.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.404 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.42 -40.71 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.82 -45.85 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.972 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.78 -43.27 93.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.46 -33.16 74.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -74.99 -40.37 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.003 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -78.78 -40.53 32.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -101.04 -25.15 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -172.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.58 6.46 87.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.735 HD13 HD13 ' A' ' 275' ' ' LEU . 96.6 mt -78.69 125.05 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 111.094 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 89.3 tttt -64.42 118.06 8.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 173.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.82 129.34 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -134.8 110.1 8.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.228 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.93 126.51 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.069 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -125.93 152.8 45.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -133.69 67.68 75.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.574 0.702 . . . . 0.0 110.892 172.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 30.8 Cg_endo -78.89 -15.38 13.29 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.612 2.208 . . . . 0.0 112.329 -164.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 64.3 m-20 77.28 10.97 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.22 -5.1 34.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -49.88 -60.06 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.929 -154.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.11 -34.82 77.06 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.52 -33.45 54.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -78.49 -30.17 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.805 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.551 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 8.6 m-30 -49.38 -52.15 51.84 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.586 0.707 . . . . 0.0 110.877 -168.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 60.9 Cg_endo -69.56 -27.57 27.28 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.642 2.228 . . . . 0.0 112.337 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.63 -49.98 12.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.17 -33.46 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.099 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.96 86.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.129 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.35 53.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.66 -1.21 50.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.195 -173.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.05 74.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.82 145.4 25.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.943 0.401 . . . . 0.0 110.863 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.49 82.19 0.22 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.428 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.24 124.19 12.22 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.71 2.274 . . . . 0.0 112.451 157.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.13 -42.64 23.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 -156.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.464 ' HB ' HG12 ' A' ' 9' ' ' ILE . 74.7 mt -130.07 133.19 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.096 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.2 mm -125.01 127.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -132.93 115.64 15.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.519 ' O ' ' C ' ' A' ' 63' ' ' ALA . 26.2 p-90 -177.13 173.2 1.83 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 175.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 62' ' ' TRP . . . -25.71 96.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' TRP . 76.2 t60 -59.03 -32.37 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -172.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -51.65 -50.18 60.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.847 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -74.63 -26.64 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.04 -26.68 67.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -64.91 -37.73 94.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.28 -35.45 84.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -72.06 -24.9 61.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' A' ' 76' ' ' LEU . . . -59.73 -39.43 84.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 171.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.17 -28.64 68.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -84.96 4.16 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.98 32.4 69.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.563 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.3 tp -72.9 -24.37 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.748 0.308 . . . . 0.0 110.825 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -132.09 145.99 51.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -170.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -74.96 152.23 38.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -174.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.81 131.34 50.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.972 171.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.84 140.08 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.212 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.8 m -92.72 121.91 65.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 0.0 111.189 -174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -54.96 130.71 42.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.75 2.3 . . . . 0.0 112.343 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.46 118.32 35.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.01 -46.11 89.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.96 87.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.066 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.59 -39.95 95.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -58.06 -43.62 87.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.03 -33.0 74.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.22 -27.2 68.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 304' ' ' LEU . 5.9 mp -112.47 -125.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -129.78 148.05 67.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.671 0.748 . . . . 0.0 110.919 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.65 -30.32 60.21 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.683 2.255 . . . . 0.0 112.277 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -71.69 -35.65 70.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.4 p -71.81 -24.67 61.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.131 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -39.93 71.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 171.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.84 -34.53 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.87 74.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.033 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.78 HG21 ' HD3' ' A' ' 107' ' ' PRO . 34.3 m -111.36 14.06 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -164.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -119.98 149.94 41.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -135.73 119.57 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.961 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.9 t30 61.86 35.2 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.87 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.54 89.08 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.465 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -122.18 149.92 42.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 103' ' ' LEU . 50.9 mt -74.95 133.82 41.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -174.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.8 pt -115.72 -7.36 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.99 174.03 10.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.111 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.45 139.29 28.49 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.711 0.767 . . . . 0.0 110.99 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.78 ' HD3' HG21 ' A' ' 97' ' ' VAL . 56.5 Cg_endo -79.82 132.28 9.6 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -172.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.1 -42.01 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.53 147.99 27.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -163.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.6 t -130.73 132.35 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.02 149.91 47.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.25 142.89 27.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.42 126.38 29.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.7 m -142.59 159.09 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.815 -166.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -98.93 123.87 43.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.6 mt -110.48 133.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -137.25 156.63 48.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.95 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.425 ' HB3' HD21 ' A' ' 121' ' ' LEU . 54.9 t-20 -96.53 120.08 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.03 -27.74 69.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -67.39 -42.25 83.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -165.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.636 ' H ' HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -99.97 -24.76 14.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.5 tp -124.21 99.5 37.15 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.648 0.737 . . . . 0.0 110.936 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.15 -14.96 11.82 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.665 2.243 . . . . 0.0 112.326 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.441 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.4 t-20 -157.77 103.94 1.78 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.597 0.713 . . . . 0.0 110.97 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.5 Cg_endo -68.75 147.11 68.59 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 64.7 Cg_exo -55.09 145.03 66.55 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.769 2.313 . . . . 0.0 112.308 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.72 -17.65 37.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -143.79 161.13 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.295 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -68.64 -27.32 65.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.886 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.04 -29.62 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.65 -15.68 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 38.7 mm -59.17 -54.34 57.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.721 0.772 . . . . 0.0 111.12 -171.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 24.5 Cg_endo -62.51 -39.89 42.18 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.318 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.27 99.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.134 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.18 -40.29 97.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.561 ' O ' HD23 ' A' ' 139' ' ' LEU . 10.0 t70 -62.16 -41.65 98.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.97 -39.6 92.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.49 -44.19 75.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -176.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 39.0 ttpt -56.08 -26.2 48.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 169.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.11 -20.27 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.46 11.5 37.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.7 30.46 66.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.51 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 96.7 mttt -125.29 157.25 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 110.876 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 t -116.51 153.69 31.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.945 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.21 66.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.2 pp -145.88 146.07 30.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.7 ttm -148.05 132.32 17.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.914 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -156.7 169.79 23.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.16 122.89 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 -174.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.58 7.41 18.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -85.1 -8.68 58.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.845 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -127.19 149.37 69.39 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 110.97 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 -31.99 9.27 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.79 -39.99 40.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -80.5 -37.57 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.9 p -83.82 -14.02 52.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.1 -170.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.609 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 24.1 m0 -49.99 -53.51 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.711 . . . . 0.0 110.827 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 9.5 Cg_endo -53.43 -33.99 69.51 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.453 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.94 -45.4 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.801 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 89.3 mt -74.22 -41.67 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -175.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.13 -6.78 51.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.13 -35.03 59.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.3 5.35 52.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.36 10.58 63.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.525 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -130.05 86.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 63.1 t80 -167.49 153.88 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 74.94 -91.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.08 170.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -167.35 155.03 9.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.954 -171.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.7 129.34 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -116.89 128.91 55.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.94 140.21 25.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.956 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 51.01 45.81 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 10.91 71.05 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.513 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.65 146.87 52.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.891 -174.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -99.35 137.2 38.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -94.82 112.67 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 178' ' ' ILE . 6.4 tp -71.24 -20.01 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.16 -8.76 53.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -120.19 91.34 3.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 173.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.3 m -106.04 155.87 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.78 7.47 65.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.488 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -97.5 -19.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 111.221 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -101.6 14.3 32.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 167.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -93.95 154.23 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -170.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.35 -33.36 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.073 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.67 92.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.477 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.94 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.842 0.353 . . . . 0.0 111.082 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.4 -39.2 91.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.855 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.54 95.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.801 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -42.18 98.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.592 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.62 -39.71 91.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 110.831 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 86.1 m -59.75 -41.71 91.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.086 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.44 -47.23 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.19 -43.13 96.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.83 -40.83 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.98 -38.01 84.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.4 OUTLIER -60.97 -35.88 77.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.982 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.41 -40.0 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.97 -35.18 79.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -80.15 0.74 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.034 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 63.64 30.07 14.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -92.01 -21.61 20.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 83.9 mmm -131.98 155.0 48.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 169.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 94.4 m-20 -104.71 139.14 39.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 173.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.98 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.101 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -96.47 0.43 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 98.5 m -56.57 125.94 24.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.194 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -119.12 179.76 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.92 -39.69 90.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.1 m -58.62 -42.95 89.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.92 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.18 -43.44 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.35 -42.9 87.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.48 87.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.91 97.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.08 -37.84 84.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.867 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.0 -28.64 69.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.11 -22.25 15.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 21.67 40.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.542 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.04 -25.91 29.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 110.827 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 79.1 m -126.48 135.34 51.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.084 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.78 -40.37 48.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.185 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 78.3 mtm -133.7 156.45 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -164.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -151.8 158.34 43.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.202 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 46.2 mm -115.85 114.97 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -163.36 178.39 8.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -99.21 -171.68 31.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.463 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.77 -15.11 40.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -63.49 -12.24 30.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.919 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.6 78.21 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.143 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -66.32 -22.76 66.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 50.1 m -54.14 169.84 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 233' ' ' SER . 91.6 m-20 73.86 55.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 -169.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.0 128.46 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -68.92 81.4 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.809 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -58.18 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.3 p -69.12 -15.3 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -160.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.61 170.52 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.15 119.77 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.093 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -122.02 -42.42 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.925 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -105.13 153.38 21.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.933 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.93 160.41 24.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.427 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.33 131.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.97 0.414 . . . . 0.0 111.101 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.16 179.13 7.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -84.84 159.63 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.124 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.4 mt -68.43 150.03 97.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 110.765 -169.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 44.6 Cg_exo -56.74 150.53 53.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -91.17 163.2 14.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -136.33 113.19 10.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 56.71 43.48 25.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.735 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.68 1.29 80.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 169.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -149.99 147.04 21.3 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.524 0.678 . . . . 0.0 110.991 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.84 127.04 11.68 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 88.9 p -56.71 -57.05 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -170.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -165.09 119.97 0.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.68 149.87 23.92 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.617 2.212 . . . . 0.0 112.324 175.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -138.84 120.51 15.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.863 171.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.04 125.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.132 177.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.65 139.36 15.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.459 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.14 124.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.349 . . . . 0.0 111.052 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 262' ' ' LEU . 28.3 mt -78.96 144.67 34.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 169.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 53.6 p -142.42 163.77 31.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.73 135.56 52.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.099 176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.68 156.5 15.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.52 126.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.146 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -65.8 129.25 39.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.07 -28.99 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.44 -11.42 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -80.11 127.93 75.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.655 0.74 . . . . 0.0 110.899 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.53 -6.69 19.09 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.675 2.25 . . . . 0.0 112.319 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -108.05 24.12 13.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.889 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -57.56 -34.12 68.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 -172.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.79 -45.91 63.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.735 HD13 HD13 ' A' ' 33' ' ' ILE . 4.5 pp -76.44 -31.5 57.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.524 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -66.24 -40.83 90.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 174.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -66.56 -39.49 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.59 -38.67 77.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -56.9 -45.51 82.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 62.9 tp -63.79 -50.8 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.82 -34.65 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.8 -27.87 13.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -163.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.777 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 87.1 m-85 -120.45 -49.55 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 80.4 mt -73.63 -35.91 65.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.924 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.98 74.05 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.971 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.0 p -141.87 170.17 16.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.006 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.25 -43.09 74.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -76.45 -46.07 28.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.91 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.777 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.92 -44.15 25.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.01 -36.43 84.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.911 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.97 -41.64 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.34 -34.82 74.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.8 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 97.0 t -80.84 -45.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -71.15 -28.78 64.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.26 -10.97 12.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.47 -33.08 62.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.98 150.02 42.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 0.0 110.903 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -58.39 -57.13 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.394 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.54 -53.19 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.41 62.56 6.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.509 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -81.95 123.12 28.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.123 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.667 HG22 HD21 ' A' ' 311' ' ' LEU . 33.2 m -115.49 156.24 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.074 -163.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.43 -17.07 55.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.055 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.407 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 60.8 tp -78.25 117.85 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.95 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.7 -46.84 87.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.1 t -63.67 -50.99 67.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.771 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.09 -34.06 72.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -57.28 -39.5 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -55.51 -38.12 68.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.667 HD21 HG22 ' A' ' 302' ' ' VAL . 4.3 pp -74.88 -22.05 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -73.01 -6.37 45.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.998 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.82 -12.03 61.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.69 129.94 63.3 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -32.39 32.06 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -69.76 -37.04 76.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.883 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.43 HG21 HD12 ' A' ' 311' ' ' LEU . 48.6 mm -80.37 -40.98 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.35 -35.88 70.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -169.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.71 91.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.175 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 95.4 m -68.52 -39.88 81.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mmt -67.58 -35.42 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.92 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 327' ' ' GLY . 84.5 m-20 -69.27 -35.93 76.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 176.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.15 85.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -72.83 -22.91 60.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.93 -5.71 17.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.37 -159.65 32.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -130.01 123.45 30.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 329' ' ' ILE . 1.1 mp -75.24 124.12 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 329' ' ' ILE . 92.0 mtp 60.56 160.18 0.11 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.535 0.683 . . . . 0.0 110.886 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -64.96 -103.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.0 112.438 161.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -139.96 -48.88 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 158.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.545 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 46.5 pt -130.04 161.36 60.38 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.648 0.737 . . . . 0.0 111.121 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 19.5 Cg_endo -60.72 -22.03 71.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -69.81 -16.41 63.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.3 mmt -66.18 -26.09 67.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 87.7 p -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.08 -51.33 25.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -171.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 339' ' ' PHE . 1.0 OUTLIER -65.22 -26.24 68.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.953 178.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -66.15 -39.5 89.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -63.57 -37.47 87.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.98 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.163 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.68 -32.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -49.75 -47.92 50.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.8 m -60.35 -39.67 87.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.143 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -64.47 -37.62 88.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.095 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.84 -44.86 88.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.9 -43.09 97.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.119 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.06 -39.86 93.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.74 68.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.046 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.21 -36.64 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -174.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.9 p -78.6 -9.61 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.904 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.56 9.53 85.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.37 -31.17 65.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.865 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -133.66 160.02 38.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -76.02 169.92 17.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.76 -44.52 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.83 -45.9 91.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.9 -46.45 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.48 89.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.56 -37.37 82.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.64 -35.27 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.58 -31.4 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -65.02 -47.5 77.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.7 m -60.48 -42.18 95.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.122 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.82 -39.24 80.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 89.9 mt -62.69 -42.14 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.108 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 64.9 p -90.8 -14.56 31.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.565 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 85.9 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.701 0.286 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.411 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 86.3 mt -76.04 129.08 37.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -130.11 166.76 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.937 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.43 121.94 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 20.02 52.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.489 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -141.49 156.36 45.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.8 pp -149.29 150.64 32.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.3 t -124.99 121.46 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.426 HG12 ' HB ' ' A' ' 59' ' ' ILE . 87.1 mt -119.58 132.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.212 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.1 m0 -115.75 140.42 49.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.935 HD13 ' HA3' ' A' ' 16' ' ' GLY . 17.3 tt -144.06 143.65 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -73.71 -179.82 3.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -172.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.0 -2.28 4.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.52 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.636 ' O ' ' C ' ' A' ' 15' ' ' LYS . 46.9 t0 -67.34 70.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.856 173.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 14' ' ' ASP . 87.2 tttt -14.55 107.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -166.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.935 ' HA3' HD13 ' A' ' 11' ' ' ILE . . . -108.98 -11.05 23.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.45 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -66.3 -41.75 89.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 110.896 -151.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.68 -52.52 62.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.911 -162.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -66.61 -44.33 90.04 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.415 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.2 mt -58.46 -40.48 82.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 110.896 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.33 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.35 -46.84 88.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 m -74.24 -28.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.32 -37.73 95.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.458 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.63 -41.46 96.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.874 0.369 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.39 -43.93 89.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.1 -43.52 95.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.83 -34.86 76.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.25 -40.1 67.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -79.08 -40.65 30.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -172.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.4 p -100.72 -24.54 14.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.174 -171.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.56 8.53 86.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.406 HG21 HD23 ' A' ' 7' ' ' LEU . 89.6 mt -80.34 124.9 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.21 118.88 8.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 24' ' ' GLY . 70.0 t -98.46 134.31 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -132.65 112.39 11.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.21 121.55 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -128.21 149.98 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.822 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -135.04 68.55 70.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.577 0.703 . . . . 0.0 110.918 171.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 29.0 Cg_endo -79.39 -14.35 13.13 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.683 2.256 . . . . 0.0 112.29 -162.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.4 m-20 76.49 8.95 3.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.14 -9.99 37.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.948 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 3.2 mp -51.34 -55.56 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 -156.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -54.33 -38.98 66.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.65 -32.84 62.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.94 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.96 -29.69 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 43' ' ' LEU . 8.7 m-30 -49.81 -51.59 59.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.706 0.765 . . . . 0.0 110.968 -164.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 96.0 Cg_endo -79.41 -29.11 3.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.576 2.184 . . . . 0.0 112.357 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -75.54 -46.08 34.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.835 -171.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.5 m -56.78 -33.39 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.08 87.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.58 -32.6 47.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.2 p -95.02 -4.9 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.092 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.95 24.71 66.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.435 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -80.94 143.05 32.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.843 0.354 . . . . 0.0 110.843 172.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' A' ' 2' ' ' ILE . . . -122.1 62.9 0.53 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -164.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.88 121.06 7.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.686 2.257 . . . . 0.0 112.377 159.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -83.18 -48.93 9.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 -161.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.426 ' HB ' HG12 ' A' ' 9' ' ' ILE . 70.1 mt -132.55 136.08 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.168 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.07 132.36 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 72.5 m-85 -116.32 115.72 26.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.889 172.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -168.36 179.76 4.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.25 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.132 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 263' ' ' SER . 73.3 t60 -60.21 -25.05 65.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -50.42 -44.16 55.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.13 -24.19 47.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.585 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 1.7 t80 -65.43 -28.79 69.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -172.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.46 -38.35 62.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.457 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.15 -37.31 71.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.631 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -71.64 -25.06 61.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' A' ' 76' ' ' LEU . . . -59.93 -39.58 85.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.15 -26.44 64.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.4 p -85.0 2.47 42.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.76 32.22 73.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.53 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -74.82 -24.33 58.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -126.86 144.11 51.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -168.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -75.99 154.52 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.83 134.07 52.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -115.98 142.27 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.191 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -93.5 123.91 58.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.516 0.674 . . . . 0.0 111.16 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 143.59 28.91 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.789 2.326 . . . . 0.0 112.275 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -107.86 116.13 31.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.14 -43.1 73.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.0 98.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.179 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.17 -35.71 74.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.24 -44.64 88.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.07 -32.45 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.2 -28.38 65.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.04 -105.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -152.69 139.29 12.37 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.745 0.783 . . . . 0.0 110.925 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.37 -28.13 22.71 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.833 2.356 . . . . 0.0 112.298 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -71.22 -34.28 70.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.9 p -74.33 -21.88 59.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.54 -35.18 80.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.017 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.86 -35.06 74.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.97 -37.83 75.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.767 HG21 ' HD3' ' A' ' 107' ' ' PRO . 35.4 m -104.32 18.36 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -169.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -123.52 149.94 44.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -138.77 124.42 19.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 58.18 35.99 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.06 88.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.538 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.03 150.66 41.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 31.9 mt -75.03 135.19 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.994 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.0 pt -113.76 -12.48 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.18 169.57 20.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.053 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -112.86 130.53 23.41 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.622 0.725 . . . . 0.0 111.02 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.767 ' HD3' HG21 ' A' ' 97' ' ' VAL . 54.6 Cg_endo -72.8 125.71 10.73 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.358 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.49 -50.38 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.84 157.07 42.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.09 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 147.16 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.85 147.76 51.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.2 145.22 28.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -68.54 128.81 37.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.5 m -138.29 157.84 45.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.748 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.95 121.13 38.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.5 mt -109.87 130.06 63.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.175 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -135.23 157.53 46.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.58 117.4 29.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.943 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.14 -28.53 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.837 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.94 -35.1 32.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.29 -44.25 25.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.8 tp -127.44 105.99 21.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.65 -15.65 15.26 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.329 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -150.33 105.58 3.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.72 . . . . 0.0 110.966 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.59 146.52 73.98 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.728 2.285 . . . . 0.0 112.371 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.94 147.75 68.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.24 -21.46 24.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.8 p -131.88 159.95 37.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -74.04 -23.64 59.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.23 -21.86 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.31 -21.63 55.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.597 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 40.0 mm -64.35 -45.52 78.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.676 0.75 . . . . 0.0 111.158 -162.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 77.0 Cg_exo -53.52 -49.49 17.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 0.0 112.323 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -38.72 83.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.566 ' O ' HD23 ' A' ' 135' ' ' LEU . 4.5 tt -61.97 -39.39 91.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 25.5 t70 -64.24 -41.87 96.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.74 -40.05 75.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.23 -56.52 9.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -170.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 136' ' ' ASP . 1.3 pt? -82.04 -12.33 58.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -174.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.5 tttt -58.51 -27.3 64.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 168.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.35 -17.9 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.34 6.47 42.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 26.94 65.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.493 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 2.7 mptp? -118.26 159.82 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.957 173.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.404 ' O ' HD11 ' A' ' 139' ' ' LEU . 47.8 t -113.8 153.49 29.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 172.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -66.82 -52.5 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.159 -175.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.83 ' O ' HD12 ' A' ' 147' ' ' LEU . 2.7 pp -151.76 147.65 26.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.968 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.3 mtp -127.27 134.35 50.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -143.37 164.95 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 54.4 t-20 -70.0 110.32 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.895 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 206' ' ' ALA . 48.7 tp -106.84 0.31 23.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.97 -5.83 59.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -132.97 149.66 73.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.528 0.68 . . . . 0.0 110.825 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -79.4 -25.92 5.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.62 2.214 . . . . 0.0 112.317 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -59.68 -44.62 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 150' ' ' ASN . 81.0 m-85 -79.31 -28.4 42.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 m -77.4 -20.89 53.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 172.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.612 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 10.7 t90 -47.37 -53.99 25.12 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.595 0.712 . . . . 0.0 110.879 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.4 Cg_endo -55.19 -32.88 82.26 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.621 2.214 . . . . 0.0 112.401 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.536 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.8 tt -71.04 -54.2 12.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.007 -172.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 91.0 mt -78.61 -40.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 -173.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.22 -14.99 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 -173.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 250' ' ' PHE . . . -59.07 -28.52 66.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -174.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -90.5 -1.88 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.21 20.41 30.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.419 ' HA3' ' N ' ' A' ' 188' ' ' ALA . . . -138.61 85.06 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.444 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 9.4 t80 -177.31 154.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 74.97 -87.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 164.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -148.84 155.58 41.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -168.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -118.28 124.3 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.943 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -113.8 129.8 56.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -145.02 136.47 25.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 52.2 38.93 25.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.889 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.08 8.93 65.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.431 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.72 145.6 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -87.92 123.65 32.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 168.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -98.85 117.71 33.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.88 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.9 tp -68.13 -21.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.35 -12.03 28.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -124.57 82.19 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.6 p -113.21 148.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.61 25.39 27.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -167.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.73 -14.51 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 111.186 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -102.27 20.39 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -102.46 -175.04 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.78 69.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.025 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.56 -38.61 96.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.419 ' N ' ' HA3' ' A' ' 166' ' ' GLY . . . -59.48 -39.85 85.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.12 -40.49 96.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.81 94.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.06 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.19 -43.88 96.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.93 -41.28 91.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.353 . . . . 0.0 110.883 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.4 m -60.01 -43.21 95.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -56.62 -52.43 64.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.76 65.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.39 -39.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.169 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.99 -39.46 92.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.826 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.82 -41.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.936 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -82.43 3.27 28.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.95 34.92 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.85 -28.74 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.1 mtt -137.78 152.74 49.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . 0.414 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.9 m-20 -101.24 141.41 34.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.862 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . 0.422 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -65.13 -27.28 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.045 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.63 2.85 54.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 94.5 m -58.59 130.18 45.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 2.8 p30 -125.79 165.44 18.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 172.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -70.08 -27.67 64.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.926 -172.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -65.88 -48.3 71.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.5 pt -69.45 -23.65 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.134 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.45 94.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -71.93 -34.99 69.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.972 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.84 85.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.091 171.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.06 82.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -62.88 -38.26 90.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.831 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.07 -27.42 69.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.71 -21.87 16.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.26 20.28 52.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.485 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -82.62 -26.53 32.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 86.3 m -127.34 134.38 49.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.155 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.21 -36.06 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.415 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 77.6 mtm -134.84 151.41 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -168.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -150.4 158.85 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.28 119.49 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -163.06 174.18 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.405 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -94.21 -175.75 39.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.22 -19.76 66.23 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.623 2.216 . . . . 0.0 112.383 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.405 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 43.7 p90 -68.86 -9.63 52.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.8 84.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -65.82 -25.85 67.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 61.7 m -52.54 160.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 233' ' ' SER . 73.7 m-20 72.72 56.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -170.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.77 130.07 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.71 79.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.871 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 71.2 p -58.76 -176.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 165.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.9 p -72.49 -14.7 61.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.816 -160.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.61 164.96 18.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.781 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t -93.01 114.99 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -120.77 -39.99 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.46 155.29 19.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.97 167.12 25.49 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.568 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.16 136.19 56.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.074 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -143.46 -179.66 6.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.74 159.42 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 94.0 mt -71.36 138.98 84.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 0.0 110.855 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 53.1 Cg_exo -57.05 156.0 26.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.379 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -99.18 164.74 12.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.144 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.401 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 25.7 t80 -141.95 119.98 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 -176.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 61.39 39.71 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.828 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 6.48 84.97 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.468 165.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.94 151.64 49.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.538 0.685 . . . . 0.0 111.019 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.36 130.19 24.46 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.686 2.258 . . . . 0.0 112.408 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 77.8 p -61.09 -42.65 98.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.813 -170.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -172.99 127.66 0.51 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 110.851 166.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.24 142.79 24.6 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.252 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -163.93 124.89 2.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.82 128.92 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 170.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -103.56 144.81 16.02 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.429 171.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.28 127.32 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 263' ' ' SER . 6.5 tt -96.97 128.6 44.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 166.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.573 ' N ' HD23 ' A' ' 262' ' ' LEU . 8.7 m -139.09 172.12 13.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.79 -172.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.508 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -121.99 135.96 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.133 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.585 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -117.39 155.05 16.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 -177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.94 127.93 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 111.119 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -67.77 128.42 36.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -170.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.81 -28.98 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.054 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.67 -10.88 59.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.9 t -77.67 126.98 83.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.649 0.737 . . . . 0.0 110.879 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 -8.4 23.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.455 174.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.736 ' HB3' HD23 ' A' ' 275' ' ' LEU . 97.0 m-20 -112.97 27.45 9.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -172.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.73 -28.34 33.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -66.03 -40.17 90.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 272' ' ' ASN . 0.7 OUTLIER -72.55 -31.27 65.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.617 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.1 -42.04 85.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.01 -40.69 91.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.63 -47.85 83.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 3.2 tt -66.85 -49.45 65.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.949 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.51 -33.73 76.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -101.35 -29.8 11.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -164.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.764 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.3 m-85 -119.93 -50.5 2.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 -169.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 94.5 mt -73.66 -37.79 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -171.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 42.3 tp -126.71 75.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.5 p -140.79 174.62 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.208 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.92 -44.26 74.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.0 -44.24 49.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.764 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.83 -45.82 19.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.545 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.4 -36.92 84.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.351 . . . . 0.0 110.953 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.78 -39.73 95.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.97 88.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.022 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.862 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 10.2 p -87.75 -32.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.76 -23.03 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -174.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.62 -15.25 6.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -82.91 -23.9 33.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -91.03 151.48 43.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.89 -61.07 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.808 2.339 . . . . 0.0 112.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 97.1 mt -98.88 -50.12 4.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 54.56 59.91 9.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.517 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.74 129.01 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 111.048 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.38 153.92 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -166.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.73 -14.99 58.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.5 tp -76.63 120.26 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.923 -175.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.1 -44.91 96.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -173.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -48.11 78.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 -173.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.89 -32.94 71.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.472 ' HA ' ' HE1' ' A' ' 321' ' ' MET . 42.7 tt0 -61.69 -38.93 89.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.798 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.64 -40.67 79.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.08 -41.58 58.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.428 ' HB3' HG21 ' A' ' 317' ' ' ILE . 91.9 mt -65.34 -29.97 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.51 -9.78 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.96 -19.44 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -86.76 120.13 71.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.573 0.701 . . . . 0.0 110.892 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.87 -34.97 57.8 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.661 2.24 . . . . 0.0 112.322 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.33 -39.78 62.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.428 HG21 ' HB3' ' A' ' 311' ' ' LEU . 96.7 mt -74.12 -39.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.4 -33.24 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.03 93.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.6 m -69.75 -41.17 75.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.472 ' HE1' ' HA ' ' A' ' 308' ' ' GLU . 40.3 mtt -68.37 -34.61 76.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.12 -37.03 85.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -67.08 -36.5 82.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.78 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.31 -23.46 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.958 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 -2.05 23.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.801 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.06 -166.37 40.64 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.433 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.8 128.19 44.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 0.0 111.015 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.452 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 28.7 mm -73.28 111.54 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -176.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.0 mmm 63.23 158.15 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.578 0.704 . . . . 0.0 110.744 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . 0.477 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 66.9 Cg_endo -73.66 -111.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 169.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.73 -47.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 170.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 19.5 pt -138.82 159.78 65.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.552 0.691 . . . . 0.0 111.199 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 40.8 Cg_endo -66.74 -14.71 44.92 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.742 2.295 . . . . 0.0 112.257 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -5.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.949 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.477 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.8 ptm -52.47 -30.14 28.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -32.94 74.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.16 72.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.038 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 339' ' ' PHE . 0.7 OUTLIER -72.27 -25.14 61.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -58.79 -48.0 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -63.68 -40.55 97.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.67 95.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.099 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.04 -26.26 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -61.13 -45.85 92.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.7 p -67.18 -34.37 77.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -66.16 -47.3 74.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 348' ' ' ILE . 7.3 p -71.53 -41.61 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 -172.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.418 ' N ' HG13 ' A' ' 347' ' ' VAL . 93.7 mt -64.46 -43.97 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -64.65 -36.41 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.23 -43.85 69.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.33 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.13 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.6 p -75.03 -14.99 60.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.23 86.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.84 -29.86 67.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.614 0.245 . . . . 0.0 110.807 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -140.01 158.64 43.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.894 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.9 p -73.43 169.4 17.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.03 -48.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.98 -40.08 75.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -70.87 -42.36 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.909 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.98 89.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.098 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 30.3 tp -65.21 -36.4 84.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.09 -35.41 75.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.92 -29.1 70.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -65.14 -48.83 72.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -64.35 -39.84 94.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -60.75 -43.67 97.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.111 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -72.32 -35.47 68.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.96 -43.08 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 67.1 p -89.89 -12.74 38.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.796 0.331 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 81.5 mt -83.17 132.29 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -123.62 161.13 25.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.73 119.61 19.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.46 24.27 31.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.459 -173.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -146.52 154.69 41.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 110.863 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.84 143.1 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.5 122.42 57.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.153 -171.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.41 140.56 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.462 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 55.5 m95 -116.45 126.76 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 tt -148.87 141.02 17.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 -170.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.406 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.8 t-20 -47.87 118.46 2.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -166.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.19 64.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.462 -171.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.13 -56.18 24.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.949 0.404 . . . . 0.0 110.929 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -137.37 78.26 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 152.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.76 -34.31 1.18 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.472 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -75.15 -46.08 36.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.933 -158.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -51.59 61.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -157.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.2 -48.75 57.38 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.467 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 tp -59.6 -42.09 91.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.05 84.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.059 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -63.22 -37.25 86.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.8 t -68.15 -41.65 84.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.4 -35.05 87.65 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.453 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.35 -40.2 89.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.896 0.379 . . . . 0.0 110.905 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.5 tptt -60.62 -46.91 88.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.926 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 33' ' ' ILE . 28.3 t80 -68.8 -36.29 78.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -64.49 -33.13 75.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.64 -36.05 73.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.16 -40.65 26.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.883 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -109.12 -18.11 13.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 -171.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.25 4.8 87.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.54 -176.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.4 tt -72.94 121.99 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -68.91 121.61 16.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.946 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.3 p -102.22 142.63 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.151 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -136.09 114.24 11.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.1 t -104.86 127.34 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -124.8 160.61 28.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -93.48 125.0 55.65 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.559 0.695 . . . . 0.0 110.855 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.436 ' CB ' HD22 ' A' ' 43' ' ' LEU . 66.1 Cg_endo -87.78 81.72 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.665 2.243 . . . . 0.0 112.349 -167.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -93.88 -27.8 16.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 166.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -92.31 -15.02 27.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.841 -169.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD22 ' CB ' ' A' ' 40' ' ' PRO . 2.3 mp -53.14 -46.06 68.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.891 -159.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -50.03 -40.98 46.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.14 -35.05 32.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -73.0 -25.07 60.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.903 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.2 m-30 -50.05 -55.79 22.07 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 0.0 110.875 -165.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.9 Cg_endo -71.18 -29.77 16.96 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.732 2.288 . . . . 0.0 112.382 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -76.54 -49.95 15.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.914 -172.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.691 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 28.0 m -60.37 -34.98 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -40.47 86.72 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.086 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.86 66.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.091 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -93.73 1.36 56.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.114 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.57 8.32 66.83 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.463 171.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -171.3 95.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.898 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.691 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.99 -129.34 3.36 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 156.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 41.7 Cg_endo -70.21 154.53 65.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.644 2.229 . . . . 0.0 112.35 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -88.08 -39.78 14.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.61 136.89 52.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.0 mm -119.68 134.55 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.151 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -77.8 159.47 28.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.952 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CB ' ' H ' ' A' ' 263' ' ' SER . 41.9 t90 -85.84 147.4 26.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -176.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -112.57 0.25 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.104 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -110.74 -83.04 0.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 157.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -94.58 -19.51 20.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mtp180 -60.05 -27.59 67.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 -163.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -58.06 -33.26 68.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.87 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -64.3 -41.24 98.29 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.18 80.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.427 170.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -65.84 -36.7 84.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.72 94.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.105 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -64.96 -29.27 70.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.1 m -82.39 1.5 36.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.76 30.16 75.8 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.5 mt -82.71 -6.17 59.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.881 0.372 . . . . 0.0 110.921 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.546 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.46 146.17 47.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -91.11 163.6 14.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -63.71 128.76 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.908 175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -110.41 148.83 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.136 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -95.64 124.6 52.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.506 0.67 . . . . 0.0 111.204 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.83 140.67 42.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.392 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -103.83 109.91 21.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.856 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.38 -42.59 98.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.03 -43.06 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.099 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 14.9 m-30 -68.2 -35.81 78.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -55.09 -45.45 75.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.941 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -64.33 -39.15 93.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.891 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.16 -22.48 62.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 304' ' ' LEU . 75.5 mt -105.02 -145.09 0.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -126.78 145.7 54.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.626 0.727 . . . . 0.0 110.887 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -70.0 -39.83 5.62 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.706 2.271 . . . . 0.0 112.338 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -68.7 -23.28 64.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.984 -173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 80.6 p -72.29 -24.87 61.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.438 ' HA ' HG22 ' A' ' 97' ' ' VAL . 88.8 m95 -72.82 -33.02 65.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -170.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.65 -34.51 72.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.506 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -71.42 -25.14 62.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.171 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.49 HG21 ' HD3' ' A' ' 107' ' ' PRO . 34.6 m -108.42 14.08 8.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.147 -176.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 79.0 mtm180 -118.02 143.87 46.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 172.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -143.4 130.86 21.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.1 t30 57.01 33.3 23.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.963 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 3.07 90.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.47 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.33 150.41 37.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.775 0.322 . . . . 0.0 110.908 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 37.0 tp -81.18 123.87 28.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.0 pt -115.25 -9.67 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 -174.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.459 ' HB1' ' H ' ' A' ' 264' ' ' ALA . . . -161.33 169.3 22.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.668 ' HB3' HD21 ' A' ' 285' ' ' LEU . 75.1 m-85 -110.03 140.0 21.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.693 0.758 . . . . 0.0 110.984 167.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HD3' HG21 ' A' ' 97' ' ' VAL . 94.1 Cg_endo -79.04 117.14 3.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.652 2.234 . . . . 0.0 112.308 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.7 mt -109.1 -29.99 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.15 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.61 149.51 22.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.12 -170.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -123.07 124.97 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.086 -172.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -116.53 129.42 56.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.71 149.7 30.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 94.6 mt -72.87 144.89 47.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.926 -176.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.6 m -143.9 160.86 40.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 tp -89.33 118.55 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 244' ' ' VAL . 56.2 mt -109.6 119.66 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.082 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -133.24 155.09 50.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -164.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -91.03 115.73 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.874 176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.62 -25.46 68.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.889 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -76.0 -35.76 59.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.12 -52.8 5.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.952 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 96.2 mt -124.59 105.18 30.45 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.546 0.689 . . . . 0.0 110.876 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.92 -12.65 19.74 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.342 178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.421 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 57.5 t-20 -147.91 100.02 3.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.69 0.757 . . . . 0.0 110.911 -175.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 56.8 Cg_endo -69.09 164.58 33.31 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.678 2.252 . . . . 0.0 112.333 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.407 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 44.1 Cg_endo -72.43 145.15 42.14 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.682 2.255 . . . . 0.0 112.347 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.02 -19.35 27.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.944 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.2 t -144.48 163.01 35.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.098 -173.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -70.58 -25.16 62.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.848 -174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.48 -33.01 74.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.936 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -75.02 -22.59 58.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -172.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.609 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 77.6 mt -62.55 -53.63 55.49 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.682 0.753 . . . . 0.0 111.143 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.1 Cg_endo -60.43 -40.4 57.93 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.674 2.249 . . . . 0.0 112.29 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.05 87.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.112 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 51.5 tp -61.32 -39.93 92.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 173.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 132' ' ' ILE . 9.3 t70 -65.99 -41.31 91.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.35 -38.79 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.64 -45.33 75.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 146' ' ' ALA . 3.7 pp -83.58 -20.34 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.867 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 136' ' ' ASP . 84.6 tttt -56.46 -28.81 60.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 168.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.16 -18.67 63.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.066 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -105.21 7.51 33.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.08 29.72 62.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.48 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -108.13 161.58 14.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.8 t -116.93 148.51 41.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 139' ' ' LEU . . . -86.22 -34.63 20.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.2 tp -130.72 141.1 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.905 -174.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -112.91 134.91 54.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -164.25 160.45 21.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.849 167.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.7 p30 -127.27 -10.56 5.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 199' ' ' ILE . 37.8 mt 50.82 35.54 12.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.946 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -93.68 -20.88 19.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.921 170.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -139.62 149.75 60.9 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.703 0.763 . . . . 0.0 110.884 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -62.66 -22.86 74.37 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.355 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -50.04 -36.27 28.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -70.74 -35.7 72.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.887 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.436 HG21 HG11 ' A' ' 347' ' ' VAL . 39.2 p -80.33 -28.49 38.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.133 -172.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.541 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 42.1 m0 -56.91 -45.0 100.0 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 -164.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.593 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 98.1 Cg_exo -48.9 -38.19 38.0 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.705 2.27 . . . . 0.0 112.297 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 83.1 mt -80.32 -44.67 19.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.887 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.681 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.4 mt -72.18 -47.53 53.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 -169.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.1 -16.71 59.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.171 -175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.51 -27.07 65.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.079 -167.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -97.73 8.47 44.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.41 16.78 3.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.454 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.35 161.16 38.87 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.491 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -168.0 150.57 5.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.923 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.26 -62.21 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.83 146.65 47.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.918 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -79.19 136.79 37.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 175.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.553 ' CE2' ' HB3' ' A' ' 176' ' ' TYR . 57.4 m-85 -115.29 126.3 54.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.891 175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -146.13 141.41 27.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.865 177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.3 t30 49.78 45.59 24.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.878 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.34 8.85 66.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.511 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.63 148.66 52.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.848 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.553 ' HB3' ' CE2' ' A' ' 171' ' ' TYR . 49.2 p90 -93.4 138.2 31.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -96.11 109.81 22.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 173.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.434 ' O ' HD12 ' A' ' 178' ' ' ILE . 2.2 tp -64.13 -20.01 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.176 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -92.05 -4.82 53.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.921 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -117.02 97.53 5.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.6 m -102.9 154.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.132 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.75 28.76 12.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.519 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 m -99.99 -23.37 4.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.152 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -97.35 20.44 11.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 171.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.01 155.31 19.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 -171.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.39 -35.01 67.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.055 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.03 93.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.458 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.03 78.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -62.87 -41.68 99.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.57 92.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.109 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.33 -42.52 97.72 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.404 HD23 HG13 ' A' ' 357' ' ' VAL . 24.7 tp -69.19 -34.36 74.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.899 0.38 . . . . 0.0 110.884 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.9 m -58.77 -40.85 85.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.166 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -58.05 -44.22 87.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.957 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 62.0 tp -58.12 -44.98 88.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 64.7 t -65.14 -40.71 89.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.13 -177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -38.6 91.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.838 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.3 OUTLIER -62.27 -38.64 90.09 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.973 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.407 HD11 HD11 ' A' ' 151' ' ' LEU . 53.1 mt -81.59 -42.16 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.131 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.56 -41.68 88.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.904 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.79 5.23 29.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.87 31.99 11.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 173.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -75.01 -28.86 60.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.863 170.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.8 tpt -146.09 151.62 37.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.428 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -89.19 134.76 33.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.909 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.34 -27.01 62.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 -174.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -100.66 -17.54 16.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 77.8 m -64.45 134.99 55.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -89.97 166.25 13.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -66.34 -37.05 84.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.948 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.5 p -68.68 -38.3 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.855 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.01 -43.97 85.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.79 -36.94 73.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.076 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.6 -38.41 83.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.29 95.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.99 -36.01 82.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.141 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CZ ' HG22 ' A' ' 116' ' ' ILE . 83.2 t80 -66.77 -42.15 86.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 174.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -61.29 -26.33 67.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.834 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.03 -9.03 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.03 15.32 67.46 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.445 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.66 -28.63 33.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 110.936 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 90.0 m -120.14 130.19 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.132 171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.65 -43.68 75.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.093 -169.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.9 mtm -140.44 150.33 43.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -169.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.4 p -145.47 171.77 14.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.166 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mm -118.15 126.08 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -159.8 172.36 17.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -80.2 -164.2 29.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.469 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.27 -15.97 19.89 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.24 . . . . 0.0 112.382 -173.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -70.28 -29.23 65.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.943 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 28.61 2.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.126 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.496 ' O ' ' C ' ' A' ' 233' ' ' SER . 37.3 m0 -72.79 -46.2 54.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.875 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.496 ' C ' ' O ' ' A' ' 232' ' ' TRP . 58.2 m 33.87 -99.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 170.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -151.1 39.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.933 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.19 157.79 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.094 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.657 ' O ' ' C ' ' A' ' 237' ' ' THR . 95.0 m-20 -108.13 148.73 29.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.848 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.657 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.2 m -6.62 82.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.216 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 94.6 p -61.88 161.18 10.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -134.62 -5.45 2.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.905 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 241' ' ' ASN . 52.5 t -89.14 73.37 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.07 -171.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 240' ' ' VAL . 83.7 m-20 40.97 47.51 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 171.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -101.81 147.26 26.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 165.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.69 164.95 26.61 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 -175.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.424 HG22 HG12 ' A' ' 116' ' ' ILE . 52.6 t -131.52 134.99 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -176.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -140.52 177.26 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.181 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.2 m -80.95 160.01 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.183 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.518 ' HB2' ' HD3' ' A' ' 257' ' ' PRO . 26.8 mt -78.97 151.06 75.84 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.473 ' HG2' HD11 ' A' ' 132' ' ' ILE . 50.3 Cg_exo -62.05 154.57 61.34 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.404 -174.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.461 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 96.1 m -133.14 138.12 46.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.144 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -114.15 118.17 33.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.869 -167.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 50.48 40.14 22.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 169.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.63 24.19 73.22 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 98.7 mm-40 -106.14 161.7 22.03 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.599 0.714 . . . . 0.0 110.956 -169.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.7 Cg_endo -63.94 70.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.641 2.228 . . . . 0.0 112.384 173.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 68.5 m -102.63 15.29 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.808 -167.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 257' ' ' PRO . 58.4 mttp -106.97 160.8 25.03 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.564 0.697 . . . . 0.0 110.909 -161.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 247' ' ' LEU . 11.5 Cg_endo -60.96 154.93 53.03 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.382 -172.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -76.73 163.14 27.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.923 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.49 125.66 70.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.143 -175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.57 143.27 15.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 171.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.23 126.5 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.906 0.384 . . . . 0.0 111.151 -174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.8 tp -64.81 129.26 39.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.428 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 20.1 m -135.32 155.02 51.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 -166.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.459 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -140.3 137.04 33.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.082 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.64 146.56 18.08 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.477 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 86.2 mt -114.61 124.76 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.928 0.394 . . . . 0.0 111.087 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -58.56 122.07 12.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.892 -172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.29 -25.92 66.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.077 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.62 -8.02 59.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.103 -176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.2 t -69.17 128.49 92.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.669 0.747 . . . . 0.0 110.908 -175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.71 -12.58 36.5 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.683 2.255 . . . . 0.0 112.406 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -111.92 25.04 12.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 -175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -55.45 -33.09 63.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -73.37 -38.8 65.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 47.6 mt -61.13 -44.2 97.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.47 85.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.27 -46.45 83.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.11 -50.79 66.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.98 -34.87 71.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -172.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.737 ' O ' HD23 ' A' ' 280' ' ' LEU . 2.5 tt -52.48 -51.79 57.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.993 -176.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -79.54 -22.39 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.828 -171.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -98.55 -14.06 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -166.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.62 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.6 m-85 -120.58 -52.38 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -174.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.54 -32.3 73.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.848 -168.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.908 ' O ' HD12 ' A' ' 285' ' ' LEU . 1.7 pp -136.72 76.63 1.6 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.971 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.8 p -143.02 170.02 16.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.187 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -53.69 -46.27 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.842 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.02 -42.99 22.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.862 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.04 -46.78 20.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.45 -170.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 46.9 tp -66.03 -36.02 82.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.78 0.324 . . . . 0.0 110.831 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.75 -43.74 85.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -66.7 -43.07 85.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 3.2 p -75.42 -31.27 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.153 -170.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -71.34 -16.44 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -58.83 -22.85 59.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -89.25 -22.62 22.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.823 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -100.36 155.27 36.58 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.575 0.702 . . . . 0.0 110.913 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -64.95 -63.29 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.737 2.292 . . . . 0.0 112.409 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 76.5 mt -107.35 -50.5 3.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.865 -175.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 105.88 -49.2 0.9 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.445 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.78 72.69 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.443 HG22 HD21 ' A' ' 311' ' ' LEU . 20.1 m -109.2 155.86 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.121 -154.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.93 -13.77 59.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.075 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.487 ' HA ' HD23 ' A' ' 89' ' ' LEU . 58.1 tp -80.57 117.48 21.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.16 -44.82 96.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 88.6 p -65.7 -51.93 55.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -172.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -68.85 -34.03 74.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.929 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.1 -40.44 89.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.58 -37.78 73.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.846 -174.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -75.79 -47.8 24.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.817 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.443 HD21 HG22 ' A' ' 302' ' ' VAL . 4.0 pp -74.72 -19.51 60.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -72.35 -4.63 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.161 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -71.9 -10.36 59.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -85.47 130.12 52.58 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.561 0.696 . . . . 0.0 110.845 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.54 -30.51 16.24 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.737 2.291 . . . . 0.0 112.325 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -65.17 -37.9 88.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.89 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 30.8 mm -87.85 -43.1 15.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.165 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.43 68.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.091 -164.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.45 79.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.11 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.8 m -68.06 -39.21 83.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.176 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 68.0 ttp -65.28 -42.62 92.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.905 177.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -65.94 -46.26 78.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.849 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 327' ' ' GLY . 43.3 p30 -80.07 -13.76 59.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.76 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.014 167.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -74.7 -18.26 60.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.29 -10.54 13.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -79.46 -162.22 23.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.506 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -125.59 126.49 44.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.767 0.318 . . . . 0.0 110.91 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 96' ' ' ALA . 7.4 tp -65.65 126.89 25.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.19 -176.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 65.1 ttp -71.22 119.92 76.48 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.12 144.49 69.39 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.702 2.268 . . . . 0.0 112.388 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.87 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.5 p30 -99.98 11.42 39.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.828 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 335' ' ' GLN . 34.5 mt -68.42 135.12 90.88 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.65 0.738 . . . . 0.0 111.123 -176.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -51.41 -34.39 50.51 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.376 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.585 ' H ' HG22 ' A' ' 333' ' ' ILE . 25.5 mm100 -65.34 -10.53 33.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.9 mmm -63.85 -25.74 68.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 67.4 m -63.77 -39.4 94.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.83 -33.88 68.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.099 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -60.84 -38.86 86.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 174.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 82.3 t90 -59.98 -53.33 59.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -63.27 -36.73 84.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.23 -42.41 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.03 -44.18 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -57.17 -46.2 83.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.8 m -66.7 -42.94 85.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.464 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -61.17 -42.07 97.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.16 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.436 HG11 HG21 ' A' ' 157' ' ' THR . 54.1 t -67.86 -46.74 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.13 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.7 mt -61.37 -43.38 96.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 88.8 m-20 -64.77 -37.41 87.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.851 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.08 -45.67 69.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.92 -33.99 72.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.092 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.6 p -83.19 -8.26 59.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.62 13.33 83.6 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.5 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.95 -28.14 39.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.752 0.31 . . . . 0.0 110.88 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.567 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.1 tt0 -148.2 145.17 28.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.013 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.0 p -73.43 164.97 25.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.404 HG13 HD23 ' A' ' 192' ' ' LEU . 58.8 t -69.77 -45.99 75.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.094 -171.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.31 -36.08 82.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -74.44 -41.05 61.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -64.99 -42.58 94.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.087 177.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -69.35 -32.04 70.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.39 -39.9 94.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -69.12 -31.49 70.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.872 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.53 -46.33 73.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -69.98 -31.38 69.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 86.1 m -63.02 -43.19 99.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -65.38 -40.79 93.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.847 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 97.7 mt -64.67 -42.43 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.11 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.9 p -89.63 -2.15 58.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 -174.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.1 mt -82.86 133.17 29.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -126.81 159.19 34.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -74.76 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.38 21.94 55.4 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -142.92 162.6 35.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.5 mt -130.39 135.83 48.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 72.2 t -125.11 110.17 24.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.22 139.43 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 -172.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.473 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 66.1 m95 -116.84 126.73 53.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.95 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.469 HG23 ' HA3' ' A' ' 16' ' ' GLY . 21.1 tt -148.93 140.09 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.033 -169.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -47.83 118.64 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.946 -166.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.09 -25.42 62.09 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.429 -170.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -57.42 -53.39 58.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.917 -169.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -137.94 88.77 2.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.917 148.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.469 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -116.71 -36.98 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.486 174.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -77.23 -50.12 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.837 0.351 . . . . 0.0 110.85 -154.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -67.95 -52.55 34.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.893 -154.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.27 -45.74 84.18 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.4 -39.52 79.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -42.16 98.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.17 -41.02 90.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.0 t -65.23 -48.5 83.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.68 -33.85 86.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.385 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -64.93 -43.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.925 0.393 . . . . 0.0 110.951 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -57.85 -45.07 86.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.909 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -68.24 -35.61 78.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -64.13 -34.96 79.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.6 -34.37 65.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.917 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -77.17 -41.75 40.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.6 p -108.21 -18.13 13.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.229 -172.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.49 4.6 89.17 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.54 -173.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 33' ' ' ILE . 16.1 tt -74.29 116.79 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.859 0.361 . . . . 0.0 111.156 -177.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.38 124.87 23.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.8 t -109.09 140.0 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.176 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -134.41 113.6 12.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 -174.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.5 128.78 60.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.082 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -126.2 161.67 27.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -95.45 122.52 59.13 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.562 0.696 . . . . 0.0 110.8 -174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HB3' HD22 ' A' ' 43' ' ' LEU . 88.7 Cg_endo -86.84 80.05 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.718 2.279 . . . . 0.0 112.284 -168.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -93.58 -25.63 17.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.855 168.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.17 -16.54 23.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 -171.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.412 HD22 ' HB3' ' A' ' 40' ' ' PRO . 2.3 mp -56.92 -42.31 79.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.922 -157.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -52.23 -38.94 59.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 -176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -81.01 -34.02 33.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.838 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -71.92 -23.65 61.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.494 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 1.9 m-30 -49.63 -55.95 19.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.724 . . . . 0.0 110.915 -164.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.2 Cg_endo -70.75 -29.3 19.37 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.751 2.3 . . . . 0.0 112.323 -177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -76.4 -50.1 15.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.927 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.578 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 30.9 m -61.49 -35.78 69.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.046 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.71 86.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 176.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.17 -27.33 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.4 p -95.05 2.28 55.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.113 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.98 8.83 65.22 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.486 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -170.76 95.86 0.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -127.63 -116.95 2.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.474 154.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 48.4 Cg_endo -69.08 152.48 72.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.614 2.209 . . . . 0.0 112.353 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -87.06 -39.97 15.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.7 mt -138.09 139.31 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 -174.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.5 mm -110.09 133.54 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.103 -166.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.451 ' CB ' ' HA ' ' A' ' 11' ' ' ILE . 11.5 p90 -67.38 170.94 6.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.905 -174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.468 ' CG ' ' HG ' ' A' ' 262' ' ' LEU . 39.9 p-90 -87.03 143.76 27.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.806 -173.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -112.05 -121.11 0.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.181 167.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -133.86 -79.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 154.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -84.01 -13.89 52.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.825 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -61.35 -20.38 62.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 -167.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 263' ' ' SER . 55.2 m-85 -56.89 -30.13 63.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -174.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -62.36 -43.75 98.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.508 174.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.375 170.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' A' ' 70' ' ' TYR . 5.0 m-30 -62.91 -38.65 91.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.877 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.46 95.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -65.07 -31.03 72.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.4 m -89.86 -4.91 57.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.74 27.63 73.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.558 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.83 -9.73 59.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.84 0.353 . . . . 0.0 110.875 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.516 HD23 ' HA3' ' A' ' 265' ' ' GLY . 0.0 OUTLIER -131.23 140.56 49.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.825 176.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -92.32 169.34 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.101 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -65.06 125.05 23.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.54 151.25 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.5 m -99.87 121.66 53.48 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.635 0.731 . . . . 0.0 111.169 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.16 144.6 37.74 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.312 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -104.72 118.28 36.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.909 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.73 -38.98 73.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.51 -41.95 81.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.137 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -70.83 -32.63 69.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.0 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.444 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 87.3 mt-30 -58.52 -46.77 86.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.931 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -61.65 -35.93 79.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -76.41 -20.56 56.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.817 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.438 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 85.3 mt -107.3 -147.35 0.41 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.961 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -129.33 143.59 49.48 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.665 0.745 . . . . 0.0 110.91 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.34 -36.73 65.62 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.29 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -65.34 -36.41 83.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.959 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.59 -23.13 60.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.211 -174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.444 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 88.4 m95 -70.04 -38.91 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.45 -31.49 70.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.82 -31.1 69.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 35.4 m -109.75 8.66 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.095 -172.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -108.24 141.48 39.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 174.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -132.05 121.28 23.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.946 178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 58.74 34.14 23.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.962 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.93 2.84 90.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.539 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.8 mmtp -120.02 148.59 43.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 0.0 110.917 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 24.3 tp -81.0 129.02 34.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -173.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.8 pt -118.43 -7.6 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.121 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -162.45 166.95 24.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -175.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 82.1 m-85 -113.52 139.57 23.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.654 0.74 . . . . 0.0 110.982 171.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 19.9 Cg_exo -67.41 116.33 4.16 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.288 174.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.35 -33.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.058 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -164.94 154.98 13.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.133 -166.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.4 t -121.48 127.77 75.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -114.22 126.37 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.921 173.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.82 148.28 30.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.5 mt -75.03 150.66 38.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.7 m -145.72 162.75 36.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.765 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.6 tp -92.06 120.07 32.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.903 -175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.431 HG12 HG22 ' A' ' 244' ' ' VAL . 73.5 mt -106.89 124.15 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.007 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -133.43 155.43 49.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.837 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -89.95 115.1 27.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.852 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.55 -26.61 65.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -77.92 -35.01 51.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -175.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.8 mt -81.75 -52.2 7.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 95.9 mt -124.75 108.58 28.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.647 0.737 . . . . 0.0 110.959 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.38 -15.08 17.98 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.701 2.268 . . . . 0.0 112.362 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -140.82 105.33 6.28 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -72.24 164.25 36.22 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.784 2.322 . . . . 0.0 112.374 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.6 152.45 59.5 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.88 -24.67 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.939 -176.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 131' ' ' GLU . 9.2 t -143.38 157.21 44.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.117 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -68.4 -29.95 68.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.43 -28.96 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.963 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 128' ' ' THR . 87.3 tt0 -75.72 -24.69 56.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.771 -175.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.593 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 26.4 mm -55.76 -53.41 63.17 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.605 0.717 . . . . 0.0 110.982 -169.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.0 Cg_endo -66.1 -42.82 10.03 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.669 2.246 . . . . 0.0 112.314 -172.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.45 91.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.21 -36.81 84.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.79 -40.81 95.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.38 -37.75 84.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.92 -44.54 76.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.929 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 139' ' ' LEU . 3.4 pp -84.49 -20.62 31.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.946 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -57.01 -27.77 61.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 169.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.89 -19.5 65.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -106.07 10.04 32.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.85 28.4 67.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.431 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -104.7 157.17 17.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.39 . . . . 0.0 110.768 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.6 t -110.49 146.12 36.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.72 166.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.37 -33.96 32.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.7 tp -130.81 145.49 51.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.6 ttm -109.07 127.12 53.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.914 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -163.78 158.49 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.884 173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -130.91 -9.9 3.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.876 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.5 mt 54.12 34.94 21.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.28 -17.07 20.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.878 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -134.35 153.43 79.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.732 0.777 . . . . 0.0 110.877 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 49.0 Cg_endo -64.11 -24.76 66.08 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.666 2.244 . . . . 0.0 112.346 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -57.17 -38.02 72.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -71.91 -42.2 66.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.795 -173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.416 HG23 HD22 ' A' ' 195' ' ' LEU . 99.3 m -80.81 -35.4 33.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 -170.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.513 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 85.5 t90 -53.91 -43.96 97.42 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.606 0.717 . . . . 0.0 110.909 -163.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.707 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 87.2 Cg_exo -48.76 -39.14 38.54 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.692 2.261 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 75.7 mt -72.11 -36.71 69.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.412 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 91.7 mt -69.03 -42.23 81.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.253 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.25 -14.05 59.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.154 -175.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 255' ' ' SER . . . -55.8 -32.88 63.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 -168.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -97.32 11.58 36.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 -170.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 115.16 18.25 6.38 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.479 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -83.41 158.38 35.77 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.408 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.589 ' H ' ' HA3' ' A' ' 182' ' ' GLY . 87.3 m-85 -140.01 151.72 45.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.949 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.22 -61.11 2.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 173.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -137.15 147.47 45.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.962 168.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -68.25 124.22 22.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -110.86 110.9 21.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.926 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -144.14 143.76 31.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.856 -175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 48.07 42.79 17.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.86 10.09 80.1 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.583 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 148.07 52.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.833 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -91.29 129.72 37.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.974 167.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.43 109.87 20.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 175.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 178' ' ' ILE . 2.5 tp -64.56 -21.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.008 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -91.27 -6.72 52.81 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -173.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -119.92 96.2 5.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 33.0 m -104.33 153.84 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.589 ' HA3' ' H ' ' A' ' 167' ' ' TYR . . . -105.02 30.81 9.37 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.519 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.13 -16.78 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.907 0.384 . . . . 0.0 111.148 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.9 p-10 -101.56 12.58 37.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 171.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -89.98 155.19 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 -174.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.88 -35.73 64.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.085 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.85 -38.33 94.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.477 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -62.75 -38.01 88.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 111.13 176.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -63.85 -37.85 88.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.45 -41.9 88.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.063 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -63.95 -41.12 98.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.457 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.23 -36.18 82.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -58.57 -39.98 81.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.167 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -55.45 -46.31 76.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.958 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.416 HD22 HG23 ' A' ' 157' ' ' THR . 60.5 tp -62.44 -44.87 95.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.887 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.17 -40.38 86.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.187 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -63.03 -40.42 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.8 OUTLIER -60.89 -42.91 98.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 177.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.0 mt -70.17 -41.77 78.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -63.9 -34.83 78.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -81.81 4.33 22.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.0 34.16 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 172.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -75.61 -16.41 60.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 61.1 tpp -140.23 148.11 41.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.527 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.7 t-20 -89.63 134.95 33.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.04 -29.69 70.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.062 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -96.05 -13.38 23.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 -171.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.527 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.7 m -70.15 139.02 52.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.166 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.58 174.1 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -62.43 -48.61 78.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.4 p -67.51 -34.46 77.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.797 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -66.97 -44.6 88.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.68 70.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.093 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -69.96 -36.77 75.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.803 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.49 -37.2 82.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.076 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.59 97.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 171.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -64.0 -38.28 90.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.841 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.75 -24.5 65.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.745 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.64 -10.14 25.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.895 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.15 59.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.448 -174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -82.47 -24.04 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.886 0.374 . . . . 0.0 110.993 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.2 m -121.01 130.67 53.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.205 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.32 -43.75 69.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.051 -172.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 76.1 mtm -135.25 150.47 50.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -168.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.4 p -145.84 165.5 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.103 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.65 124.26 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.196 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -154.29 162.59 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.944 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -86.64 -159.57 33.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.52 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.18 -16.42 19.82 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.599 2.199 . . . . 0.0 112.316 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 53.0 m0 -65.26 -37.21 86.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 59.59 17.99 6.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.127 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.493 ' O ' ' C ' ' A' ' 233' ' ' SER . 50.6 m0 -76.56 -53.21 8.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 232' ' ' TRP . 64.7 p 31.91 -94.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.867 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.6 t30 -151.27 38.7 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.943 175.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.8 tt -159.86 156.93 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.149 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -100.4 139.44 36.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.864 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 91.9 m -7.26 82.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.144 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 236' ' ' ASP . 87.7 p -62.15 160.37 12.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.761 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -139.81 -9.21 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.9 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 46.6 t -84.75 79.89 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 -167.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 55.92 34.39 23.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.872 169.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -102.68 150.14 23.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 170.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.88 162.68 26.3 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.509 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 116' ' ' ILE . 58.8 t -126.16 130.28 72.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.878 0.37 . . . . 0.0 111.197 -177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -135.63 174.71 10.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.78 158.34 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 90.2 mt -82.87 145.89 51.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.57 0.7 . . . . 0.0 110.952 -172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -56.36 146.1 74.92 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.738 2.292 . . . . 0.0 112.371 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.476 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 77.7 p -130.48 143.82 51.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.12 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -116.86 118.96 33.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 -169.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 51.44 39.46 24.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 170.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.01 63.83 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.559 166.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -109.99 157.34 38.1 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.631 0.729 . . . . 0.0 111.007 -170.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.9 74.67 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.357 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 49.7 m -98.52 14.37 28.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 -160.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -109.48 155.88 40.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.61 0.719 . . . . 0.0 110.858 -169.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.707 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 36.8 Cg_endo -68.65 171.81 12.59 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.67 2.247 . . . . 0.0 112.394 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -56.94 159.97 3.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 96.5 t -121.41 128.7 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.45 147.26 16.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.428 -176.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.22 125.0 69.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 111.165 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.468 ' HG ' ' CG ' ' A' ' 62' ' ' TRP . 4.3 tt -68.18 125.34 26.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . 6.5 m -139.42 154.93 47.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.816 -166.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.89 137.87 36.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.115 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.516 ' HA3' HD23 ' A' ' 76' ' ' LEU . . . -119.12 152.55 17.22 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.519 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 88.1 mt -111.5 120.45 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.372 . . . . 0.0 111.132 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -55.9 124.35 17.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.795 -173.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.61 -25.43 65.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.138 -178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.05 -9.2 59.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.078 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.7 t -68.85 128.35 92.86 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.637 0.732 . . . . 0.0 110.954 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.14 -11.43 32.0 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.789 2.326 . . . . 0.0 112.366 170.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -109.27 24.26 13.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.831 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -54.85 -33.73 62.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.941 -172.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.36 -41.11 57.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.39 -43.4 98.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.12 94.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.129 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.67 -47.17 76.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -174.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.41 -50.22 66.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.794 -172.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.423 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -69.98 -34.94 74.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 -173.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.699 ' O ' HD23 ' A' ' 280' ' ' LEU . 2.5 tt -56.03 -52.14 65.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.893 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.45 -26.39 55.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.833 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -100.06 -22.24 15.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 -168.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.84 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 65.4 m-85 -122.66 -50.34 1.97 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -173.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 37.3 tp -68.65 -39.04 80.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.642 ' C ' HD23 ' A' ' 285' ' ' LEU . 3.0 tt -124.98 79.92 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 25.3 p -142.75 171.42 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 165.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.63 -42.11 67.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -75.96 -44.59 39.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.795 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.84 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.36 -47.93 8.59 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.44 -168.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 293' ' ' VAL . 0.5 OUTLIER -65.13 -33.41 75.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.869 -175.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -59.42 -41.04 88.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -40.23 94.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 290' ' ' LEU . 9.5 p -78.39 -28.44 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.172 -175.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -65.16 -18.79 65.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.987 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.95 -18.19 43.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -71.69 -30.49 65.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -107.83 153.09 41.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.626 0.727 . . . . 0.0 110.868 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.05 -61.32 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.723 2.282 . . . . 0.0 112.406 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 77.7 mt -89.94 -53.78 4.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -170.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 116.16 -56.36 0.53 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.47 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 46.86 69.2 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.35 . . . . 0.0 111.184 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.437 HG22 HD21 ' A' ' 311' ' ' LEU . 19.3 m -111.49 155.9 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -162.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.58 -17.01 60.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.3 tp -81.81 120.59 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.917 -176.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.48 -44.2 96.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -173.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -63.59 -49.99 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.834 -168.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -70.48 -32.62 70.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 175.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.1 -42.44 98.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.793 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.57 -35.29 72.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.846 -172.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -79.76 -46.43 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.879 -176.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.437 HD21 HG22 ' A' ' 302' ' ' VAL . 2.5 pp -73.41 -22.91 60.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.956 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.39 -5.63 34.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.114 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -73.97 -11.75 60.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.42 131.12 51.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.693 . . . . 0.0 110.844 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.58 -30.1 20.78 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.707 2.271 . . . . 0.0 112.298 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -64.97 -39.23 93.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 34.5 mm -86.12 -42.51 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.106 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.03 -38.5 68.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.076 -166.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.35 -35.46 73.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.0 m -67.78 -41.74 82.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.9 mmt -69.8 -35.38 74.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -65.04 -37.78 88.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.788 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 327' ' ' GLY . 95.0 m-20 -67.97 -35.71 78.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.808 175.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.32 -43.07 78.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.03 -19.66 60.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.943 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -108.34 -7.19 15.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -86.14 -163.11 37.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -128.7 135.93 49.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.677 0.275 . . . . 0.0 110.894 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.7 126.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.111 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 58.4 ttm -61.15 122.11 67.44 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.587 0.708 . . . . 0.0 110.91 175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.03 132.16 37.25 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.68 2.253 . . . . 0.0 112.306 174.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.424 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 50.6 p30 -95.12 10.07 37.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.765 -176.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 pt -80.57 152.11 72.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.625 0.726 . . . . 0.0 111.128 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.91 -25.04 67.78 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.755 2.303 . . . . 0.0 112.403 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.07 -16.5 60.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 98.8 mmm -64.79 -29.96 70.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 72.6 m -61.59 -41.37 97.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.758 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.49 -33.86 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.101 172.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -57.28 -46.1 83.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -60.02 -52.31 65.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.97 -46.04 89.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.93 89.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.154 -172.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.79 -44.85 81.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.176 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.436 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 44.2 ttp180 -60.95 -43.34 98.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.877 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.1 m -64.99 -43.8 91.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.102 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.01 -43.16 93.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.061 -178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.6 -47.24 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.128 -174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 89.7 mt -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.152 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 85.8 m-20 -63.41 -39.19 93.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.48 -43.94 68.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.58 -34.02 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.058 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.3 p -82.37 -7.49 59.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.86 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 12.36 84.69 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.452 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -79.37 -29.02 41.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 48.1 tt0 -147.07 143.86 28.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 -175.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.6 p -72.07 163.79 27.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -175.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 67.3 t -71.27 -45.77 68.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.14 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.58 -40.8 93.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -72.07 -46.14 58.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.956 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -65.38 -45.01 85.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.043 -176.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.71 -34.47 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -64.32 -39.71 94.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -68.94 -31.57 70.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.824 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -71.82 -46.99 56.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.147 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -67.24 -31.32 71.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 94.6 m -63.74 -40.17 96.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.161 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -70.0 -38.41 75.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 94.0 mt -63.89 -41.27 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.086 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.8 p -96.04 16.13 18.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.156 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.958 -178.907 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.789 0.328 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.2 mt -86.91 133.79 29.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.258 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -121.97 160.21 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.02 119.47 19.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.03 24.39 32.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.469 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -150.59 154.99 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.367 . . . . 0.0 110.824 -170.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -151.14 146.78 26.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.2 t -129.61 124.22 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -122.97 140.93 45.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.105 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.435 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 56.0 m95 -115.0 123.2 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.0 tt -151.85 139.75 13.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 -167.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -49.59 115.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -166.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.67 -21.95 61.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.485 -171.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -55.43 -50.67 69.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -135.45 83.33 2.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 147.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.01 -34.91 1.42 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.505 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -80.39 -46.81 15.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.361 . . . . 0.0 110.871 -159.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -67.62 -55.28 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.901 -155.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -66.72 -46.98 70.59 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.416 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.3 tp -59.3 -38.55 80.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.841 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.98 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.074 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -63.14 -38.3 90.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.906 0.384 . . . . 0.0 110.922 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.57 -43.52 94.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.103 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.43 -36.79 92.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.448 175.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.28 -45.51 84.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.881 0.372 . . . . 0.0 110.918 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.3 -45.2 94.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -68.87 -34.98 76.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.837 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -63.69 -35.16 79.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -68.89 -32.37 71.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.797 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -86.57 -39.38 16.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.1 p -108.34 -22.87 12.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.195 -170.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.57 7.33 84.64 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.532 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.8 tt -72.07 125.36 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.879 0.371 . . . . 0.0 111.064 -175.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.96 125.7 27.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -109.7 140.11 29.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.164 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.3 m -134.85 115.64 13.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.192 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.7 t -104.82 130.81 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.084 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -124.94 157.77 35.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.95 176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -85.02 122.86 74.15 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.459 0.647 . . . . 0.0 110.931 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HA ' HD13 ' A' ' 43' ' ' LEU . 71.3 Cg_endo -84.45 80.1 2.36 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.241 . . . . 0.0 112.239 -171.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -110.79 -15.41 13.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.791 166.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.8 -21.34 29.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 40' ' ' PRO . 4.6 mp -53.33 -45.65 69.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -157.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -48.27 -42.18 29.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -80.46 -32.28 37.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.896 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.18 -26.36 56.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -172.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 6.0 m-85 -52.56 -55.32 33.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.603 0.716 . . . . 0.0 110.891 -164.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 51.3 Cg_endo -69.16 -29.77 26.18 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.71 2.273 . . . . 0.0 112.384 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -76.6 -50.53 13.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.744 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 27.0 m -61.27 -35.32 65.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.45 85.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.08 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.74 -26.41 66.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.5 p -92.17 2.85 56.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.117 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.73 7.5 65.57 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.414 171.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -172.75 97.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.363 . . . . 0.0 110.924 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.744 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -124.07 -132.88 3.98 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.46 157.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 45.2 Cg_endo -71.81 154.61 58.76 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.582 2.188 . . . . 0.0 112.367 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.51 -37.95 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -137.31 137.0 46.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.127 -172.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.9 mm -119.4 134.29 63.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 -176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -76.97 134.9 38.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.466 ' CB ' ' H ' ' A' ' 263' ' ' SER . 31.3 t90 -60.36 144.26 51.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.875 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.08 -98.09 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 -176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -127.17 -89.15 0.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.932 158.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.4 -23.02 37.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -59.59 -30.98 69.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 -161.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.415 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 58.6 t80 -58.23 -33.99 69.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -174.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.74 -44.49 97.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.448 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.42 -32.28 76.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.512 173.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.1 m-30 -63.95 -37.05 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.946 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.75 97.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 174.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -66.01 -28.16 68.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.6 m -81.43 -0.22 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.823 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.33 28.9 73.05 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.88 -6.79 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.844 0.354 . . . . 0.0 110.998 -177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.0 pp -135.99 146.15 46.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.905 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.8 163.23 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 176.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.48 128.52 36.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.836 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -112.87 148.17 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -175.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -103.51 124.53 37.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.515 0.674 . . . . 0.0 111.139 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.59 142.7 44.92 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.691 2.26 . . . . 0.0 112.305 -175.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -106.13 121.68 44.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.953 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -54.86 -39.27 68.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.08 87.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -68.35 -35.0 77.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.421 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.2 mt-30 -60.59 -47.98 83.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -61.28 -37.88 84.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.932 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.33 -24.27 61.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.833 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.6 mt -109.41 -149.78 0.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.84 150.23 75.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.598 0.713 . . . . 0.0 110.923 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.72 -33.55 76.39 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.684 2.256 . . . . 0.0 112.343 173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -59.96 -43.94 94.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.947 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.7 p -70.13 -27.07 64.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.097 -172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.421 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 50.5 m95 -69.25 -39.95 78.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -59.77 -35.13 73.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.914 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.639 ' HB2' HD11 ' A' ' 329' ' ' ILE . . . -70.25 -30.93 68.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.157 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.413 HG21 ' HD3' ' A' ' 107' ' ' PRO . 35.3 m -105.27 14.09 7.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 -172.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -115.63 143.59 45.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -139.25 127.56 22.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.91 35.06 25.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.871 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.81 3.47 89.2 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.59 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -113.97 149.89 34.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.794 0.33 . . . . 0.0 110.957 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.7 tp -84.08 124.18 30.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.4 pt -116.35 -8.8 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.116 -172.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.421 ' HB1' ' H ' ' A' ' 264' ' ' ALA . . . -161.74 167.9 24.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.076 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 77.4 m-85 -114.88 135.38 22.42 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.676 0.75 . . . . 0.0 111.008 167.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 32.2 Cg_exo -59.86 117.35 4.09 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.689 2.259 . . . . 0.0 112.294 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 90.9 mt -102.94 -29.27 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.105 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -163.15 153.32 15.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 -172.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.05 127.22 69.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.161 -177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -118.94 132.22 56.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.06 151.11 27.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 95.4 mt -71.76 145.93 48.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -173.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.8 m -142.23 160.96 39.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.6 tp -90.49 121.4 32.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.977 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.436 HG12 HG22 ' A' ' 244' ' ' VAL . 66.2 mt -110.0 123.97 66.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.124 175.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -133.93 155.28 50.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -170.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -91.93 116.34 28.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.835 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.03 -27.18 66.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.94 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -79.3 -35.36 41.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.858 -174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.8 -46.1 12.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.951 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -127.34 110.09 21.24 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.613 0.721 . . . . 0.0 110.894 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.83 -15.22 16.96 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 0.0 112.372 -178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -149.39 108.86 3.38 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.617 0.723 . . . . 0.0 110.847 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.47 157.43 61.79 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.681 2.254 . . . . 0.0 112.279 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.66 145.1 56.67 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 0.0 112.353 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.17 -24.96 19.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.91 -173.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -149.4 163.85 36.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -170.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -69.85 -28.26 65.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.83 -169.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -65.3 -28.71 69.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.987 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -77.32 -20.48 54.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.884 -175.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 24.7 mm -57.73 -53.36 66.52 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.617 0.723 . . . . 0.0 111.095 -171.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 35.4 Cg_endo -68.23 -43.06 4.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 -173.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.77 -44.82 92.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.199 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.2 tp -62.66 -36.47 82.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.941 173.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.58 -41.28 96.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -59.55 -40.04 85.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.844 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -67.26 -45.35 76.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 139' ' ' LEU . 3.4 pp -85.46 -20.07 30.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.32 -26.47 65.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.942 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.95 -19.51 65.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.109 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -105.38 9.47 33.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.881 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.31 28.36 64.08 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.505 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -106.57 158.72 16.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 110.826 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.4 t -110.68 146.95 35.34 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.772 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.09 -35.29 28.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.102 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.8 tp -132.21 145.05 51.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -109.16 128.71 55.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -170.32 163.92 8.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 52.2 p30 -129.11 -7.44 4.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 54.7 mt 54.33 32.5 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -94.22 -10.23 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -141.12 149.85 56.86 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.721 0.772 . . . . 0.0 110.87 171.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.74 -16.73 51.14 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.686 2.257 . . . . 0.0 112.354 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -54.98 -41.61 71.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -70.5 -33.67 71.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.3 p -83.13 -22.62 33.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 7.6 m0 -58.76 -48.97 95.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.618 0.723 . . . . 0.0 111.002 -168.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 99.8 Cg_exo -49.31 -38.85 43.15 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.694 2.263 . . . . 0.0 112.222 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.56 -35.41 73.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.9 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.482 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.1 mt -78.93 -39.09 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.115 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.91 -17.08 63.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.125 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.19 87.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.428 ' O ' ' HA3' ' A' ' 187' ' ' GLY . 98.9 m-20 -106.58 -0.38 23.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 -172.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.35 36.01 2.01 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.464 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.661 ' HA3' ' HB2' ' A' ' 188' ' ' ALA . . . -120.75 146.38 17.54 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 166.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -155.26 156.18 35.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.812 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -43.7 -50.4 7.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.168 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -138.63 155.75 48.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -89.42 126.47 35.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -119.61 115.21 23.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.0 0.429 . . . . 0.0 110.879 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.43 143.49 29.05 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.873 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 48.09 44.03 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.936 -175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.51 5.77 60.76 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -129.69 148.87 51.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 110.86 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -93.39 126.24 38.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 171.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.84 112.93 24.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.6 tp -74.99 -23.19 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.02 -12.47 33.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -128.18 95.3 4.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.961 174.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.0 p -103.07 147.11 9.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.3 31.66 8.47 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.532 -172.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.9 m -93.76 -19.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.867 0.365 . . . . 0.0 111.106 172.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -103.3 24.06 11.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.965 -176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -87.76 160.61 17.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -173.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.09 89.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.064 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 164' ' ' ASP . . . -66.51 -41.58 94.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.509 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.661 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . . . -61.29 -40.11 92.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.831 0.348 . . . . 0.0 111.173 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.44 -38.63 90.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.19 -44.45 88.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.126 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.34 -41.57 96.53 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.388 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 51.0 tp -66.33 -41.01 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.982 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 70.5 m -60.15 -40.17 88.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.069 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -60.34 -42.64 96.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.27 -45.1 92.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.905 174.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.06 -40.16 88.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -176.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.12 -36.1 82.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.8 OUTLIER -63.97 -38.25 90.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.002 179.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -38.21 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.071 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.24 -39.09 91.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -83.48 3.06 33.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.833 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 64.42 38.51 7.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.89 170.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -75.01 -10.32 59.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.1 tpt -143.49 152.33 41.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.509 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 65.7 t30 -86.16 142.74 28.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.76 -34.61 74.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.055 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -96.73 -14.4 22.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 -169.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 64.3 m -66.67 134.83 53.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.196 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -110.8 171.38 7.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.835 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -64.79 -35.79 82.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.6 p -70.85 -38.42 73.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.802 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.0 mt -65.02 -42.61 95.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.092 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -69.68 -35.67 75.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.43 -39.44 77.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.85 -39.45 94.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.043 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.17 -41.03 97.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.102 174.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -64.45 -39.33 93.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -61.55 -27.15 68.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.83 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.41 -9.35 32.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.921 -173.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.3 16.46 64.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 -173.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -82.67 -22.7 34.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.42 . . . . 0.0 110.907 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.4 m -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.194 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.87 -38.06 73.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -171.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 69.6 mtm -135.16 154.91 51.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.6 t -152.99 165.68 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.2 mm -116.44 124.4 72.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -155.09 164.63 38.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.922 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.62 12.2 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.545 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.84 -16.49 33.0 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.704 2.269 . . . . 0.0 112.328 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 56.8 m95 -75.04 -25.26 58.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 56.17 21.98 5.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.099 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.506 ' O ' ' C ' ' A' ' 233' ' ' SER . 44.9 m0 -76.63 -48.54 18.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.909 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.506 ' C ' ' O ' ' A' ' 232' ' ' TRP . 51.1 p 32.32 -96.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.034 0.445 . . . . 0.0 110.867 172.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' A' ' 232' ' ' TRP . 64.1 t30 -143.65 36.29 1.31 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.907 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.7 tt -159.99 158.08 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.663 ' O ' ' C ' ' A' ' 237' ' ' THR . 69.9 m-20 -104.2 138.31 40.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.663 ' C ' ' O ' ' A' ' 236' ' ' ASP . 53.0 m -8.92 82.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.215 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 236' ' ' ASP . 85.8 p -70.29 169.31 14.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -153.65 13.76 0.48 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 47.4 t -88.78 77.84 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 53.37 36.91 24.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.895 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -102.19 151.09 22.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 169.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.78 159.82 24.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 116' ' ' ILE . 58.1 t -128.44 130.75 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.0 0.429 . . . . 0.0 111.157 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -142.11 178.21 7.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.11 160.09 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.055 -176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 33.9 mt -79.16 155.99 76.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.565 0.698 . . . . 0.0 110.932 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -56.44 140.45 89.01 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.763 2.308 . . . . 0.0 112.355 -173.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.5 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 86.6 m -123.74 130.86 53.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.121 -176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -103.37 112.24 25.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.872 -172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 93.3 mttt 46.74 41.13 9.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 168.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.87 26.2 65.29 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.443 170.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 96.3 mm-40 -113.56 159.07 36.85 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.639 0.733 . . . . 0.0 110.915 -169.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 71.8 Cg_endo -68.95 68.76 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.662 2.241 . . . . 0.0 112.376 174.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 79.6 p -92.02 24.71 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.417 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 63.3 mttp -114.88 158.91 39.42 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.613 0.721 . . . . 0.0 110.87 -163.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.426 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 43.7 Cg_endo -73.57 171.79 17.05 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.708 2.272 . . . . 0.0 112.247 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -62.0 161.76 10.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.56 127.7 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.141 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.71 143.54 15.79 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.454 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 87.3 t -123.76 126.01 72.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.982 0.42 . . . . 0.0 111.085 -174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 1.5 tt -67.7 126.48 29.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.466 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 24.9 m -129.38 148.07 51.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.841 -166.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.421 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -142.98 137.93 29.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.09 159.35 18.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.556 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.42 123.55 66.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 111.038 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -56.15 126.15 24.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.98 -27.5 65.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.118 -177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.73 -9.37 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.071 -174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.7 t -67.61 129.47 93.46 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.659 0.742 . . . . 0.0 110.906 -175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.89 -14.03 42.2 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.792 2.328 . . . . 0.0 112.295 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -115.36 27.02 9.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.851 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -54.06 -30.96 50.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.901 -173.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -72.97 -37.87 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.413 HD13 HD12 ' A' ' 33' ' ' ILE . 39.5 mt -65.42 -45.39 84.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.969 0.414 . . . . 0.0 110.936 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.61 91.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.139 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -67.41 -46.75 72.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.05 -49.32 76.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 -171.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 0.3 OUTLIER -68.2 -34.64 76.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -174.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.4 tt -57.08 -51.49 69.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 177.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.89 -38.88 73.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.831 -173.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -102.49 -23.07 13.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.843 -162.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.691 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 48.5 m-85 -118.73 -45.97 2.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.995 -172.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 36.0 tp -73.29 -43.97 60.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.901 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 54.9 tp -121.1 73.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 33.1 p -141.53 172.24 12.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.147 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -52.6 -46.71 67.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.811 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.95 -40.18 32.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.806 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.691 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.7 -45.79 20.89 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.568 -171.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 26.2 tp -64.86 -32.98 74.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.832 0.349 . . . . 0.0 110.94 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.42 -43.48 98.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.01 -41.25 99.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.05 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.505 HG23 ' HA3' ' A' ' 19' ' ' GLY . 14.5 p -80.39 -33.27 13.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 -177.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.502 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 39.7 t30 -72.91 -21.3 60.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -55.92 -22.97 28.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 -177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -88.85 -20.61 24.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 -175.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -99.68 156.12 35.72 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.645 0.736 . . . . 0.0 110.896 176.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -59.81 -62.42 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.789 2.326 . . . . 0.0 112.346 -171.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 87.0 mt -113.31 -48.0 2.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.866 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.502 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 101.68 -43.79 1.65 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.463 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 43.47 71.69 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 111.116 -177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.2 m -104.53 153.24 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.125 -155.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.6 -18.62 58.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.094 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.8 tp -79.13 114.18 17.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 -176.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.74 -45.62 93.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 -166.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.1 m -67.23 -48.45 67.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 -171.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -68.83 -34.88 76.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.853 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -59.53 -38.99 82.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.853 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -36.53 71.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.861 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.26 -47.61 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.88 -15.39 60.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.97 -5.51 35.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.143 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -73.24 -9.6 58.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.947 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -87.75 125.23 65.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.541 0.686 . . . . 0.0 110.846 174.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -47.27 -28.73 8.45 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.716 2.277 . . . . 0.0 112.321 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.414 ' HG2' HG21 ' A' ' 244' ' ' VAL . 88.8 mtm180 -63.93 -37.3 86.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 40.7 mm -88.69 -42.9 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.146 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.9 -37.56 76.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.144 -166.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.79 -37.6 79.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 92.8 m -67.21 -39.65 86.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.067 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -65.15 -44.41 88.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -65.84 -46.32 78.97 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.905 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 327' ' ' GLY . 4.3 p-10 -79.49 -15.72 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.839 -174.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.42 82.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.053 168.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -71.3 -17.14 62.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -112.63 -9.76 13.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -81.37 -165.46 34.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.481 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -129.19 147.19 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 0.0 110.918 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.639 HD11 ' HB2' ' A' ' 96' ' ' ALA . 6.0 tp -64.22 128.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -172.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 64.7 ttp -55.06 136.08 67.41 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.543 0.687 . . . . 0.0 110.908 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -71.48 80.52 1.37 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.38 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -103.02 4.91 37.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.846 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.434 HG22 ' H ' ' A' ' 335' ' ' GLN . 50.8 mm -81.37 137.58 48.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.628 0.728 . . . . 0.0 111.127 178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -47.41 -35.5 21.52 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.713 2.275 . . . . 0.0 112.293 -175.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.434 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.0 mm-40 -82.04 -30.97 31.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.946 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 60.9 mtt -67.43 -18.58 65.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.902 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 84.4 p -60.65 -25.66 66.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.836 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.27 75.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.061 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -66.91 -38.86 87.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.81 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -62.98 -54.05 44.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -59.63 -45.69 91.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.783 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.21 83.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -173.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.9 p -75.35 -30.3 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -59.84 -46.55 88.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 79.9 m -64.65 -44.44 90.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.625 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -62.73 -43.78 97.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.12 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.51 -49.26 61.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.209 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.49 -43.6 97.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.128 -175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 82.2 m-20 -61.31 -35.81 78.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.89 -45.81 70.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.34 -34.87 70.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.172 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.4 p -80.95 -8.35 59.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.79 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.41 11.75 85.2 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.482 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -80.51 -24.33 39.46 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.661 0.267 . . . . 0.0 110.788 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 59.3 tt0 -148.39 146.84 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.009 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 56.8 p -73.58 165.19 25.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.04 -45.85 74.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.063 -171.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.27 -41.33 98.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -72.72 -42.43 64.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.934 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.625 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -63.0 -43.69 98.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.111 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 85.9 mt -69.1 -33.77 74.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.818 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.69 -43.5 98.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.928 173.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -66.95 -30.98 71.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -69.45 -45.2 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -65.12 -38.3 90.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 80.5 m -59.82 -41.68 91.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -68.97 -40.65 78.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.3 mt -63.9 -44.83 98.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.162 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 53.2 p -103.4 33.78 3.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.202 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 -175.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.792 0.33 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.9 mt -87.44 136.67 22.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.204 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.1 mt-10 -129.71 162.61 27.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.83 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.78 122.57 24.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.884 -175.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.99 22.87 34.31 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 92.6 mttt -145.45 165.67 27.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 -174.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.93 144.82 25.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.98 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 64.9 t -130.29 122.82 54.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.128 -173.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -120.87 140.09 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.061 -174.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 58.8 m95 -118.41 123.71 45.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.937 178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.497 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 21.2 tt -148.79 139.92 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.2 -169.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -47.49 119.03 2.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -164.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.81 -24.26 64.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.496 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -53.7 -57.0 12.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.001 0.429 . . . . 0.0 110.953 -170.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -139.6 89.91 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.84 148.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.73 -29.13 1.92 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.428 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -80.45 -47.98 13.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.949 -154.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -65.94 -51.73 55.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -154.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.74 -45.95 71.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.483 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.2 tp -58.62 -40.26 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.759 0.314 . . . . 0.0 110.899 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.75 -42.17 98.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.054 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.34 -41.61 98.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.885 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.04 -48.02 80.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.06 -35.97 92.23 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -67.02 -42.72 84.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 110.792 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -58.81 -42.71 89.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.958 174.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.492 ' CE2' HG21 ' A' ' 33' ' ' ILE . 19.7 t80 -66.81 -35.3 79.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 174.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.86 -35.93 82.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.857 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -72.25 -33.99 67.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -80.51 -42.16 22.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 -173.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 60.3 p -107.77 -15.45 14.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.195 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.05 4.33 89.97 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.504 -175.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.2 tt -73.41 116.42 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 111.15 -178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -65.28 123.99 21.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.946 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -104.49 145.48 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.15 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -140.62 116.96 10.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.075 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.0 t -108.35 129.97 61.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.08 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -125.17 161.45 26.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.943 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -94.6 121.9 62.09 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.546 0.688 . . . . 0.0 110.809 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' CB ' HD22 ' A' ' 43' ' ' LEU . 72.0 Cg_endo -86.67 81.21 1.48 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.634 2.223 . . . . 0.0 112.318 -167.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -91.98 -26.3 18.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 166.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -92.36 -17.37 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.965 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.412 HD22 ' CB ' ' A' ' 40' ' ' PRO . 1.9 mp -54.03 -43.75 70.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.941 -157.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -49.28 -40.98 36.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -80.66 -33.93 35.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.817 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -71.33 -25.67 62.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.938 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.484 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.9 m-30 -49.55 -55.83 20.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.797 0.808 . . . . 0.0 110.968 -163.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 58.2 Cg_endo -71.4 -29.26 16.98 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.737 2.291 . . . . 0.0 112.321 -177.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -76.72 -50.58 13.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.886 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.694 ' HB ' ' HA3' ' A' ' 56' ' ' GLY . 35.4 m -59.5 -34.01 53.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.092 -175.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.71 84.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.073 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.78 -25.76 65.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.148 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.8 p -93.3 3.11 56.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.85 3.77 60.5 Favored Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.494 171.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -172.5 95.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.954 0.407 . . . . 0.0 110.872 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.694 ' HA3' ' HB ' ' A' ' 50' ' ' VAL . . . -123.26 -132.42 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 154.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 50.6 Cg_endo -73.8 155.0 48.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.617 2.211 . . . . 0.0 112.343 -173.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -84.6 -39.61 18.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -173.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.3 mt -135.1 134.78 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.119 -169.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.5 mm -119.1 135.28 60.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.16 -171.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.497 ' HB3' ' HA ' ' A' ' 11' ' ' ILE . 17.7 p90 -74.13 158.67 33.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -174.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.473 ' CB ' ' H ' ' A' ' 263' ' ' SER . 49.0 t90 -88.13 147.8 24.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.824 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.46 -95.46 0.45 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.081 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -127.05 -85.87 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 156.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -86.38 -13.18 47.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.878 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -58.52 -25.94 62.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 -154.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.404 ' HA ' ' CD2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -60.0 -32.13 70.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 -176.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.782 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -60.74 -44.75 97.58 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.47 171.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.31 -37.7 93.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.404 ' CD2' ' HA ' ' A' ' 67' ' ' PHE . 12.8 m-30 -61.79 -42.48 99.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.877 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.68 -43.82 97.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -64.97 -30.1 71.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.5 m -84.68 -1.0 55.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.843 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.34 29.02 74.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.44 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 267' ' ' ASN . 66.0 mt -74.63 -17.38 60.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.37 . . . . 0.0 110.957 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -135.02 145.78 48.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 -166.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -82.64 158.29 23.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.112 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.42 131.05 45.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.38 147.82 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.244 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -101.55 123.22 45.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.536 0.684 . . . . 0.0 111.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -75.88 147.49 30.83 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.749 2.299 . . . . 0.0 112.365 -173.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -108.38 119.05 38.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.12 -39.61 75.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.45 -42.97 83.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.099 177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.4 m-30 -69.57 -34.05 73.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.941 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.466 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 88.5 mt-30 -60.73 -44.74 96.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.0 -41.04 91.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.886 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.53 -24.8 59.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 304' ' ' LEU . 83.6 mt -108.23 -145.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.883 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -137.29 140.18 30.05 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.617 0.723 . . . . 0.0 110.866 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.18 -35.43 63.95 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.705 2.27 . . . . 0.0 112.229 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -63.83 -37.74 88.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.882 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.6 p -74.09 -25.13 59.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.164 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.466 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 49.3 m95 -74.08 -38.39 63.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 176.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -61.31 -34.14 74.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.968 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.93 -24.93 67.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 27.4 m -112.62 19.18 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.136 -173.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 103' ' ' LEU . 58.9 mtm180 -116.37 140.13 49.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.774 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' HB3' HG21 ' A' ' 104' ' ' ILE . 85.2 t80 -139.64 127.92 22.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.948 -175.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 56.12 32.77 20.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -174.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.75 3.24 90.66 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.415 174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -115.57 150.03 37.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.821 0.343 . . . . 0.0 110.927 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 98' ' ' ARG . 64.5 tp -85.01 120.74 26.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' A' ' 99' ' ' TYR . 36.9 pt -115.19 -13.88 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.047 -167.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.517 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -156.63 161.46 39.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.486 ' HB3' HD11 ' A' ' 285' ' ' LEU . 79.7 m-85 -103.22 134.66 19.65 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.701 0.762 . . . . 0.0 110.977 170.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.479 ' HD3' HG21 ' A' ' 97' ' ' VAL . 62.9 Cg_endo -81.65 118.99 3.24 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.652 2.235 . . . . 0.0 112.236 175.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 97.0 mt -108.31 -31.13 2.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 -171.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.51 153.69 19.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.146 -163.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.43 124.46 73.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.131 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -111.28 113.87 26.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.79 146.36 34.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.69 147.17 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.1 m -142.25 159.71 41.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.6 tp -91.59 119.99 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.99 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 244' ' ' VAL . 31.0 mt -112.78 124.34 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.104 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -132.65 156.06 47.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.891 -165.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -91.96 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -61.71 -24.46 66.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.902 -175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -75.75 -37.24 59.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.835 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.52 -51.12 8.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 90.0 mt -118.98 105.74 44.62 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.591 0.71 . . . . 0.0 110.895 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.01 -14.89 26.25 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.664 2.243 . . . . 0.0 112.373 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.438 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.7 t-20 -155.92 104.08 2.11 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 0.0 110.837 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.6 Cg_endo -66.83 160.51 46.42 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.713 2.275 . . . . 0.0 112.312 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.414 ' HD3' ' CD2' ' A' ' 135' ' ' LEU . 34.1 Cg_endo -68.46 144.27 60.69 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.722 2.282 . . . . 0.0 112.364 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.17 -17.26 31.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.985 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.8 t -148.52 166.03 29.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.136 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -69.16 -25.69 64.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.787 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.79 -30.3 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.873 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -79.54 -22.4 43.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.901 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.631 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 81.3 mt -63.39 -50.44 73.92 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.604 0.716 . . . . 0.0 111.12 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 36.4 Cg_endo -67.83 -40.28 9.88 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.686 2.257 . . . . 0.0 112.254 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.52 95.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.069 170.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.414 ' CD2' ' HD3' ' A' ' 126' ' ' PRO . 57.1 tp -60.66 -38.84 86.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 171.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 132' ' ' ILE . 10.3 t70 -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -60.62 -37.93 83.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.35 -45.47 80.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.819 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.412 ' H ' ' HG ' ' A' ' 139' ' ' LEU . 3.5 pp -85.08 -20.32 30.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -178.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.402 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -58.23 -27.04 63.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.924 170.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.38 -17.92 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.083 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -104.98 9.25 34.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 29.31 63.58 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.476 -176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -112.3 158.58 19.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.776 0.322 . . . . 0.0 110.85 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.3 t -114.74 151.04 34.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 164.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -78.02 -43.92 28.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.042 -173.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.81 144.43 50.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.952 -172.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 17.7 tmm? -109.95 131.32 55.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -166.74 159.12 13.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 173.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -122.32 -16.22 7.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.4 mt 50.68 36.72 14.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -99.29 -14.07 19.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.891 174.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -142.59 148.66 47.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.569 0.7 . . . . 0.0 110.95 170.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.55 -25.07 75.48 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -54.23 -42.79 70.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.418 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 70.4 m-85 -73.19 -30.33 63.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.949 -177.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -76.83 -25.1 52.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.176 -174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.519 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 24.1 m0 -56.48 -46.15 99.85 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.602 0.715 . . . . 0.0 110.917 -164.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.758 ' HG3' ' HB3' ' A' ' 257' ' ' PRO . 74.9 Cg_exo -47.62 -44.57 25.67 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.674 2.249 . . . . 0.0 112.377 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.3 mt -75.28 -34.35 61.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.85 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.96 -42.15 94.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -77.54 -18.53 56.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.171 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.14 80.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 -160.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -98.88 13.39 32.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -173.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.08 12.45 6.98 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.436 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.51 170.63 53.54 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.498 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -165.07 165.0 20.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.919 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.94 -73.54 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.067 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -139.88 148.8 42.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -66.12 125.41 25.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.871 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -114.86 114.33 25.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -151.35 144.9 24.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.863 -175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 47.71 44.25 17.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.889 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.0 7.85 71.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 170.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -128.65 146.95 50.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.843 0.354 . . . . 0.0 110.865 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -90.5 130.6 36.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 166.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -87.17 107.52 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.9 tp -64.77 -19.92 26.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.159 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -93.44 -2.93 53.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.951 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -120.57 95.98 4.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.815 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.8 m -98.21 153.25 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.148 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . -105.03 28.59 14.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.538 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 34.1 m -112.04 -12.9 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.313 . . . . 0.0 111.066 176.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.418 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 53.8 p-10 -103.33 13.48 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 169.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -89.95 156.58 18.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -171.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.06 66.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.38 -41.1 96.7 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.423 176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -65.48 -34.88 79.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.155 175.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -63.94 -40.34 96.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.79 -42.06 86.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.05 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.97 -44.03 95.09 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.428 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.407 HD23 HG13 ' A' ' 357' ' ' VAL . 34.3 tp -68.23 -40.0 82.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.952 0.406 . . . . 0.0 110.957 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 75.7 m -58.85 -40.81 85.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.219 174.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -61.66 -43.23 99.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.974 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 23.5 tp -59.32 -42.48 91.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 176.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.71 -39.98 87.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.184 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.27 -35.59 79.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -37.34 86.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.961 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -71.13 -38.2 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.222 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.56 -38.22 90.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.869 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -82.24 1.82 34.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.826 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.78 34.95 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.92 -16.49 58.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.811 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 205' ' ' ASN . 19.0 tmm? -137.81 141.81 40.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.444 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 60.8 t30 -92.73 134.93 34.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.916 -174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.75 73.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.144 -167.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -96.35 -11.0 26.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -173.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.444 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 51.9 m -75.49 140.12 42.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.102 -176.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -98.64 167.28 10.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -66.48 -36.61 83.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.7 p -71.96 -36.33 69.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.781 177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.69 -43.69 82.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.185 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 216' ' ' ALA . . . -73.39 -32.55 64.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.066 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -70.69 -36.11 73.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.867 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.41 -37.16 84.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.085 169.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 221' ' ' GLU . . . -60.91 -39.07 87.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.136 171.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -63.81 -40.21 96.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -59.59 -21.83 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.787 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -102.27 -9.94 19.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.848 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.72 16.97 59.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.44 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.547 ' HB2' ' HB1' ' A' ' 216' ' ' ALA . 95.8 mt-10 -84.63 -28.33 26.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.014 0.435 . . . . 0.0 110.973 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 97.0 m -123.43 130.08 52.19 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.139 173.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.93 92.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.03 -166.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.9 mtm -137.81 155.26 49.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -167.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 72.4 p -141.8 167.38 22.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.159 173.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.8 mm -118.88 115.03 46.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.193 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -135.65 156.81 48.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.44 -170.05 46.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.516 173.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.51 -19.06 11.81 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.345 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -69.96 -30.96 68.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.97 14.9 9.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.659 ' O ' ' C ' ' A' ' 233' ' ' SER . 33.5 m0 -74.28 -50.25 19.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 172.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.659 ' C ' ' O ' ' A' ' 232' ' ' TRP . 89.4 p -4.64 -80.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.843 172.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -171.92 4.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.944 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 86.1 mt -119.98 117.83 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.135 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.646 ' O ' ' C ' ' A' ' 237' ' ' THR . 40.6 t0 -130.58 150.61 51.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.646 ' C ' ' O ' ' A' ' 236' ' ' ASP . 92.1 m -6.68 75.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.182 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 236' ' ' ASP . 93.0 p -63.22 153.96 32.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 170.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -135.52 -16.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 52.3 t -88.89 75.35 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 44.44 44.39 6.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.903 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -104.41 148.76 26.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 164.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.56 165.93 26.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.47 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 116' ' ' ILE . 46.4 t -128.6 131.06 69.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.924 0.392 . . . . 0.0 111.164 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -143.0 -177.59 5.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -88.09 158.6 3.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.209 -176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.532 HD22 ' HD3' ' A' ' 257' ' ' PRO . 13.3 tp -76.72 139.58 66.82 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.592 0.711 . . . . 0.0 110.98 -173.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.83 138.0 15.65 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.647 2.231 . . . . 0.0 112.419 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 96.9 m -138.82 137.39 36.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.129 -168.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -106.02 116.33 31.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.798 -166.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 45.34 42.93 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.16 31.36 52.67 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.442 165.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -114.83 158.36 40.75 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.688 0.756 . . . . 0.0 110.969 -169.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -64.93 74.75 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.693 2.262 . . . . 0.0 112.352 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 61.3 m -92.46 3.34 55.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 -169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' A' ' 323' ' ' ASN . 62.8 mttp -107.07 157.1 36.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.61 0.719 . . . . 0.0 110.9 -157.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.758 ' HB3' ' HG3' ' A' ' 159' ' ' PRO . 34.5 Cg_endo -65.82 160.42 43.96 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.621 2.214 . . . . 0.0 112.297 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -75.14 166.45 23.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 74.3 t -125.35 131.07 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.138 -167.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.64 147.08 16.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.483 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.12 122.73 67.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.927 0.394 . . . . 0.0 111.105 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.29 128.79 37.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.841 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.473 ' H ' ' CB ' ' A' ' 62' ' ' TRP . 27.8 m -130.22 152.3 49.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.814 -164.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -142.97 136.44 28.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.06 175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.29 160.18 17.84 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.472 -174.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.0 mm -110.1 125.63 67.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.903 0.382 . . . . 0.0 111.084 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 54.9 t-20 -58.91 124.71 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.813 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.31 -29.29 68.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.052 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.28 -9.7 58.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.0 -173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -68.15 128.55 93.22 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.738 0.78 . . . . 0.0 110.913 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.31 -11.7 32.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -114.91 25.0 11.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.902 -177.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.74 -32.67 53.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.89 -172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -74.11 -37.96 63.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 48.7 mt -63.63 -45.42 90.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.023 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.63 -43.28 76.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.08 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -65.11 -51.25 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.61 -44.81 92.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -35.24 74.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -175.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.642 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.5 tt -55.62 -52.04 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.955 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.21 -27.28 47.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 -172.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -96.34 -7.26 35.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 -169.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.751 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 32.4 m-85 -115.94 -57.6 2.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 92.8 mt -68.64 -37.61 79.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 -172.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.486 HD11 ' HB3' ' A' ' 106' ' ' TYR . 49.8 mt -99.94 41.4 1.16 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.96 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 75.1 p -137.74 162.09 34.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 171.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -56.53 -48.54 77.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.82 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.45 -38.92 71.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.751 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -76.41 -46.32 12.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.547 -175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.0 tp -65.44 -36.37 83.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.49 -44.75 89.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.64 95.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -30.67 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -172.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.436 ' OD1' ' HA3' ' A' ' 300' ' ' GLY . 52.2 t30 -74.12 -12.15 60.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.943 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -58.39 -25.99 62.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.5 p30 -93.57 0.0 56.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.873 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -116.39 155.88 47.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.607 0.717 . . . . 0.0 110.923 169.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.52 -62.58 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.704 2.269 . . . . 0.0 112.412 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.0 mt -108.81 -43.97 4.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.436 ' HA3' ' OD1' ' A' ' 294' ' ' ASN . . . 97.97 -61.31 0.95 Allowed Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.533 -177.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 54.97 85.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.825 0.345 . . . . 0.0 111.082 -173.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.75 156.94 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.22 -156.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.64 -18.99 60.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.063 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 89' ' ' LEU . 47.7 tp -79.78 117.82 21.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.11 -44.26 95.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.881 -171.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 90.2 p -67.11 -52.81 37.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -171.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -66.53 -34.67 78.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -62.37 -40.11 95.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.38 -36.88 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.876 -174.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -74.69 -47.83 29.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.87 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.413 HD12 HG21 ' A' ' 317' ' ' ILE . 3.9 pp -74.7 -16.59 60.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -74.12 -4.67 37.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.195 -178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -73.67 -10.22 59.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -87.18 131.22 45.16 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.536 0.684 . . . . 0.0 110.844 175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.26 -29.23 12.54 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.649 2.233 . . . . 0.0 112.336 177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -66.35 -39.09 88.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 311' ' ' LEU . 36.0 mm -84.62 -42.59 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.91 67.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.118 -169.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.49 -38.97 81.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.06 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 98.3 m -68.43 -40.81 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.214 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.9 ttp -64.33 -43.91 93.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.56 -45.28 79.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 256' ' ' LYS . 44.9 p30 -78.52 -18.76 54.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.894 -173.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.64 -39.81 84.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -72.98 -17.4 61.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.004 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -110.16 -9.13 14.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -85.16 -161.34 34.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.472 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -125.7 129.27 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.754 0.312 . . . . 0.0 110.914 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 38.2 mm -67.51 123.61 21.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.207 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.82 123.62 85.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.485 0.66 . . . . 0.0 110.887 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.3 146.4 40.52 Favored 'Trans proline' 0 N--CA 1.466 -0.123 0 C-N-CA 122.627 2.218 . . . . 0.0 112.366 175.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.782 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 55.5 p30 -99.99 13.64 33.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.849 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.441 HG12 ' H ' ' A' ' 335' ' ' GLN . 16.7 tt -75.18 138.94 72.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.65 0.738 . . . . 0.0 111.091 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.62 -25.7 20.65 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.735 2.29 . . . . 0.0 112.372 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.441 ' H ' HG12 ' A' ' 333' ' ' ILE . 99.5 mm-40 -63.89 -14.54 54.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.991 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.1 mmm -62.86 -25.89 68.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -58.91 -40.12 83.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.779 176.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.25 -36.28 69.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.114 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 368' ' ' ILE . 87.3 t80 -58.43 -43.67 88.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -59.87 -57.58 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -61.62 -33.69 74.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.88 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.61 -41.19 84.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.183 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.2 t -69.84 -39.94 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.151 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -57.49 -49.63 75.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.817 -172.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.3 m -65.88 -43.89 86.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.77 -43.39 98.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.093 -176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 56.4 t -68.94 -49.89 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.214 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 94.4 mt -61.59 -41.85 91.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.155 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 84.1 m-20 -61.86 -38.17 87.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.793 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.37 73.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.51 -35.09 68.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.137 -175.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.7 p -80.41 -7.96 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.844 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.48 11.93 84.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.446 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -77.98 -27.13 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.744 0.307 . . . . 0.0 110.793 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 62.6 tt0 -147.51 146.4 29.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 72.0 p -71.11 164.56 25.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.24 177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.407 HG13 HD23 ' A' ' 192' ' ' LEU . 76.8 t -73.33 -45.6 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.099 -170.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.44 -38.37 90.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.849 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -73.23 -37.75 66.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.975 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.93 89.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 184' ' ' ASP . 0.4 OUTLIER -64.68 -36.16 83.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 179.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.18 -40.43 97.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.888 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -69.97 -33.12 71.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.792 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.2 -48.38 62.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.153 -174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.92 -32.27 70.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.911 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 75.1 m -63.29 -41.99 99.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.99 -38.27 75.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.88 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 339' ' ' PHE . 86.5 mt -63.64 -43.51 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.219 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 44.3 p -102.5 35.61 2.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.638 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.773 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -86.47 133.77 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.148 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 90.9 mt-10 -123.87 158.96 30.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.29 122.35 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.79 22.62 49.22 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.497 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 96.4 mttt -140.54 156.04 46.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 110.851 -176.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.37 137.92 50.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.5 t -123.89 113.72 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.132 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.55 137.84 53.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.089 -174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.409 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 59.8 m95 -113.66 123.28 49.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.879 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.654 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 18.1 tt -150.94 144.08 16.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 -168.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -48.54 119.72 3.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.964 -170.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.5 -21.51 60.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.477 -172.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.51 -48.31 81.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 0.0 110.938 -172.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.24 83.43 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 149.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.57 -46.23 1.56 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.532 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.05 -44.86 29.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.917 0.389 . . . . 0.0 110.9 -157.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.09 -53.09 42.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 -154.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -65.27 -48.53 68.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.446 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.405 HD22 HG21 ' A' ' 11' ' ' ILE . 2.7 mp -61.84 -36.84 82.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.719 0.295 . . . . 0.0 110.897 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.91 -45.94 83.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.33 -41.39 96.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.44 -41.59 88.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.07 -36.34 90.14 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.535 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.06 -48.74 80.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.41 -43.09 99.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.988 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.42 -36.21 80.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.91 -34.29 78.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.23 -34.0 77.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -88.4 -39.71 14.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.844 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.429 ' HB ' HG22 ' A' ' 33' ' ' ILE . 62.2 m -110.1 -24.46 10.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.191 -167.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.35 7.75 79.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.476 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.757 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -87.07 127.63 40.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.906 0.384 . . . . 0.0 111.02 -177.343 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.94 137.34 39.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.57 140.03 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.187 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.8 m -128.52 111.84 13.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 11' ' ' ILE . 94.4 t -104.32 127.98 58.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.032 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -124.77 158.23 33.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -83.67 135.98 42.66 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.577 0.703 . . . . 0.0 110.865 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.654 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 71.8 Cg_endo -90.0 68.31 1.9 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -166.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -101.04 -32.29 10.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.793 173.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.22 -16.06 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.894 -172.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 40' ' ' PRO . 5.9 mp -50.94 -51.61 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 -158.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -57.57 -37.47 73.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 -170.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.14 -35.6 36.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.7 mmtt -76.13 -30.06 58.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.812 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.516 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 2.0 m-30 -51.29 -56.12 23.02 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.646 0.736 . . . . 0.0 110.844 -167.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 43.4 Cg_endo -67.76 -29.84 34.95 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.733 2.289 . . . . 0.0 112.314 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -78.58 -49.96 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.919 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.429 HG21 ' HD2' ' A' ' 57' ' ' PRO . 32.1 m -66.93 -32.02 56.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.093 -174.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.04 -38.9 92.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.8 -26.16 67.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -94.31 1.08 55.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.153 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.35 78.88 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.422 171.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -169.66 101.87 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 110.924 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' CA ' ' HB ' ' A' ' 50' ' ' VAL . . . -125.05 -130.74 3.53 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.471 161.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.429 ' HD2' HG21 ' A' ' 50' ' ' VAL . 49.2 Cg_endo -71.42 156.64 58.12 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 -175.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.07 -43.28 11.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -136.65 138.27 46.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.14 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.9 mm -118.14 134.98 60.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.427 ' CE1' HD21 ' A' ' 262' ' ' LEU . 83.4 t80 -78.71 136.31 37.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -62.87 143.96 57.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.1 -100.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.145 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -127.33 -85.9 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 160.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -87.13 -21.76 25.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.909 175.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -57.63 -28.92 64.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -166.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -61.72 -33.65 74.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 332' ' ' ASN . . . -65.01 -43.59 95.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.546 174.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.43 -32.98 85.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.512 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -66.72 -34.29 77.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.86 99.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.073 170.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -67.43 -27.49 67.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.825 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.7 m -83.2 -1.0 51.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.907 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.84 28.63 71.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.509 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -82.79 -7.69 59.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.905 0.383 . . . . 0.0 110.982 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.0 pp -135.13 146.01 48.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.66 159.65 21.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.1 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.64 129.37 39.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.866 171.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -113.33 150.6 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.153 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -105.21 124.16 37.37 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.255 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.9 139.58 40.09 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.718 2.278 . . . . 0.0 112.282 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.4 t0 -96.74 121.72 38.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -54.82 -39.36 68.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.97 -43.52 95.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.082 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -65.79 -34.68 78.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -60.32 -43.94 95.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.23 -41.87 93.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.74 -24.43 62.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.98 -177.59 3.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.16 150.24 37.7 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.942 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.3 -38.13 36.6 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.737 2.291 . . . . 0.0 112.322 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -76.79 -20.13 56.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 71.7 p -75.5 -26.0 57.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.111 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -69.99 -37.15 75.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.995 -172.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -61.67 -33.95 74.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.52 -28.23 65.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 30.6 m -105.63 11.36 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.4 ttp-105 -111.4 140.33 46.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -138.01 125.14 21.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.022 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.19 34.8 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.45 1.71 88.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.435 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.22 147.99 44.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.875 0.369 . . . . 0.0 110.886 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 21.1 tp -78.6 129.37 34.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.913 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.3 pt -118.16 -5.41 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.09 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.453 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -162.42 166.67 24.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.477 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.4 m-85 -112.44 136.84 21.46 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.713 0.768 . . . . 0.0 110.981 167.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 39.1 Cg_exo -61.76 117.17 3.98 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.696 2.264 . . . . 0.0 112.246 174.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 96.6 mt -104.33 -38.43 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 262' ' ' LEU . . . -156.74 155.33 31.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.195 -170.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.0 t -124.19 128.32 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.147 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -115.59 120.0 37.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.832 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.86 147.33 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.104 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.3 mt -76.58 148.96 36.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 -175.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.0 m -141.53 161.08 38.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.836 177.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 tp -93.76 122.16 35.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.974 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.6 mp -111.08 128.39 67.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.053 175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -133.49 154.37 50.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -172.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -91.87 116.34 28.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.829 176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.86 -26.99 68.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.823 -174.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -81.17 -32.25 33.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.881 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.7 mt -86.08 -48.5 8.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.873 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.6 tp -127.69 111.71 20.67 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.662 0.744 . . . . 0.0 110.967 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.53 -15.15 17.62 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.818 2.346 . . . . 0.0 112.335 -178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.44 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 45.5 t30 -149.68 107.13 3.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.578 0.704 . . . . 0.0 110.879 -173.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.2 Cg_endo -67.63 161.87 41.75 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.682 2.255 . . . . 0.0 112.336 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.42 ' HD3' HD13 ' A' ' 135' ' ' LEU . 44.8 Cg_endo -72.7 144.38 39.38 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.609 2.206 . . . . 0.0 112.477 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.98 -22.99 21.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.992 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.9 t -149.92 167.31 26.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 -174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -67.13 -29.93 69.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 -171.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.07 -30.22 71.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.998 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -78.77 -22.76 45.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 80.9 mt -62.34 -51.37 74.12 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.669 0.747 . . . . 0.0 111.075 -167.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.28 -39.05 10.72 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.252 -174.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.76 -42.48 90.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.064 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.625 ' O ' HD23 ' A' ' 135' ' ' LEU . 4.7 tt -62.18 -37.02 83.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.866 172.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 140' ' ' LYS . 8.7 t70 -66.35 -42.76 87.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.98 -38.72 73.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.18 -49.67 66.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.856 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.0 pp -80.22 -18.43 49.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.945 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.461 ' N ' HD12 ' A' ' 139' ' ' LEU . 84.4 tttt -57.13 -30.42 64.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 171.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.88 65.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -103.59 7.92 37.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.5 29.86 61.11 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.486 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -106.48 164.48 12.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.1 t -116.05 149.09 39.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.8 165.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.5 -28.48 28.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.105 175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 tp -137.86 143.35 40.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -173.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 48.4 ttm -120.46 128.94 53.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.915 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -166.32 163.19 17.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.758 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -130.14 -4.36 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.869 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 59.3 mt 53.07 34.31 16.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -92.11 -16.61 26.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 171.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -132.42 146.2 60.5 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.677 0.751 . . . . 0.0 110.866 172.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -59.97 -23.25 72.23 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.326 172.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.5 m-30 -54.57 -32.51 58.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -71.81 -36.67 70.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.4 p -86.19 -23.74 26.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 -172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.482 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.6 m95 -56.09 -44.99 99.96 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.585 0.707 . . . . 0.0 110.936 -168.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.534 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 72.2 Cg_exo -46.42 -40.23 22.63 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.719 2.279 . . . . 0.0 112.31 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.5 mt -80.4 -38.08 30.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 93.3 mt -69.87 -51.41 40.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -172.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.71 -15.7 60.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 -176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.38 -31.71 69.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.119 -169.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -92.02 0.78 57.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 -172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.05 13.75 6.95 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.556 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -90.36 166.37 31.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.423 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -174.43 154.45 2.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.83 0.347 . . . . 0.0 110.936 175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -41.6 -63.38 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.077 -172.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.503 ' CD1' ' HB2' ' A' ' 176' ' ' TYR . 20.6 p90 -142.09 155.61 45.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 -172.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -72.29 123.65 23.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.867 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -119.74 117.18 27.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.913 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -147.58 142.36 26.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -172.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 51.9 40.43 28.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.12 7.28 76.55 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.522 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.09 146.87 52.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.809 0.337 . . . . 0.0 110.829 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.503 ' HB2' ' CD1' ' A' ' 169' ' ' PHE . 17.1 p90 -101.56 141.61 34.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.63 110.97 23.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.2 tp -71.42 -19.66 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.08 -5.23 57.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -125.25 95.03 4.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.857 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 32.0 m -101.09 158.44 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.89 16.64 39.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.451 174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 30.8 m -100.01 -19.95 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 111.076 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -98.99 19.82 14.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.52 154.2 20.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -172.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.26 70.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.018 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.71 -37.54 94.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.493 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.5 81.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 111.195 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.02 -38.55 88.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.88 -41.56 97.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.112 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -61.88 -40.11 98.41 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.429 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.418 HD23 HG13 ' A' ' 357' ' ' VAL . 38.8 tp -67.86 -38.13 82.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 177.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 83.1 m -60.45 -41.19 93.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.182 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -57.85 -45.48 86.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 65.1 tp -60.4 -45.11 94.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.92 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.5 -41.51 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.157 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.45 -39.58 94.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.897 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.1 mp -63.24 -38.24 90.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 62.3 mt -74.43 -38.27 46.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.132 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.0 -32.03 73.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -81.56 3.32 25.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.55 33.96 10.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.999 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -77.07 -18.96 57.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.0 tpt -143.83 150.09 37.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.813 172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 66.2 t30 -87.49 141.8 28.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -71.3 -32.62 68.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -175.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -96.16 -16.2 21.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -171.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 70.9 m -67.26 135.62 53.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.033 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -102.22 169.92 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -65.0 -47.54 77.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.924 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -63.35 -39.97 95.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.863 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.31 -43.62 98.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.108 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.38 -32.67 70.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -64.22 -40.59 96.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.17 -37.74 84.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.034 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.072 175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -63.81 -39.83 95.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.934 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -61.47 -25.88 67.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.784 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.22 -8.11 40.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.04 17.3 63.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.495 -175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -83.5 -21.75 32.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.5 m -123.15 131.02 53.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.18 174.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.37 -38.88 65.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -171.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 74.2 mtm -135.51 154.88 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.902 -172.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -152.33 166.77 30.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.0 mm -119.17 125.33 74.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.169 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -147.47 155.56 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.846 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.79 -163.42 31.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.458 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.21 -14.88 18.44 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.755 2.303 . . . . 0.0 112.346 -175.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -62.84 -30.55 71.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.983 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 64.79 20.06 12.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.666 ' O ' ' C ' ' A' ' 233' ' ' SER . 48.0 m0 -71.38 -41.1 70.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 171.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.666 ' C ' ' O ' ' A' ' 232' ' ' TRP . 52.8 p 2.92 -91.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -153.99 3.04 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.876 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 19.5 tt -164.92 155.36 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.105 -168.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . 0.599 ' O ' ' N ' ' A' ' 238' ' ' SER . 54.6 p30 -102.17 -173.86 2.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.56 ' C ' ' O ' ' A' ' 236' ' ' ASP . 48.2 m -9.96 82.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.204 163.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 236' ' ' ASP . 45.6 m -40.86 136.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.874 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 -31.76 1.84 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 175.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 240' ' ' VAL . 61.4 t -89.12 68.03 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.062 -174.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 54.29 33.02 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.814 171.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 238' ' ' SER . 91.4 m-85 -105.56 152.66 22.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 167.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.09 158.86 24.12 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.465 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 316' ' ' ARG . 62.1 t -130.2 130.68 65.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.803 0.335 . . . . 0.0 111.208 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.18 177.49 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.158 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -80.16 160.29 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -78.58 148.88 74.05 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.575 0.702 . . . . 0.0 110.903 -172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.31 144.26 72.45 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.609 2.206 . . . . 0.0 112.417 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.1 p -129.18 150.03 50.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.148 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -125.77 111.19 14.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 48.34 37.95 9.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 167.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.96 26.08 56.51 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.508 167.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -109.6 156.78 39.07 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.551 0.691 . . . . 0.0 110.965 -169.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.38 75.2 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.672 2.248 . . . . 0.0 112.438 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 87.3 p -92.24 -1.37 57.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -170.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -102.29 155.86 35.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.539 0.685 . . . . 0.0 110.945 -167.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.79 167.47 24.39 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -68.01 153.91 42.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.839 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.6 t -118.69 130.04 74.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.151 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -100.25 141.9 15.64 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.477 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.5 124.57 71.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.961 0.41 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 109' ' ' ALA . 0.1 OUTLIER -65.02 124.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.812 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.6 m -128.74 155.28 45.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.837 -168.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.417 ' H ' ' HB1' ' A' ' 105' ' ' ALA . . . -138.19 134.97 35.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.074 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.04 141.95 15.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.52 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.2 mt -113.81 125.03 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.903 0.382 . . . . 0.0 111.067 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -59.09 125.07 22.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.832 -173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.0 -27.32 65.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.06 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.89 -8.17 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.058 -173.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.1 t -66.21 130.3 94.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.719 0.771 . . . . 0.0 110.883 -175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -65.73 -16.32 52.78 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.816 2.344 . . . . 0.0 112.275 170.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -110.92 21.11 16.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.881 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -51.8 -34.54 40.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.899 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -76.21 -36.5 58.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.658 HD21 HG13 ' A' ' 33' ' ' ILE . 40.7 tp -61.06 -45.27 95.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.837 174.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.074 177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -65.05 -45.76 84.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -62.76 -51.28 67.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.828 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.19 -35.29 76.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -172.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.632 ' O ' HD23 ' A' ' 280' ' ' LEU . 3.9 tt -55.91 -50.33 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.996 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -73.63 -35.68 65.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 -173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -102.74 -23.34 13.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.835 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.729 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 61.9 m-85 -122.16 -43.84 2.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.993 -171.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 30.8 tp -74.18 -42.31 60.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.918 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 51.0 tp -124.57 74.87 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 37.0 p -141.48 173.44 11.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.201 167.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.3 -45.15 68.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.14 -44.09 31.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.827 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.729 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.07 -45.89 18.41 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.443 -168.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 302' ' ' VAL . 45.6 tp -61.99 -34.49 76.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.813 0.34 . . . . 0.0 110.879 -176.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -59.88 -40.26 88.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.874 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.95 94.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.472 HG23 ' HA3' ' A' ' 19' ' ' GLY . 11.1 p -81.98 -35.81 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.236 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -73.35 -22.55 60.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.953 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -61.84 -13.4 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -171.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -83.46 0.16 47.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.799 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -111.58 153.32 44.3 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.868 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.59 -61.98 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.717 2.278 . . . . 0.0 112.368 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 84.2 mt -98.63 -36.1 9.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.824 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 111.44 -58.09 0.41 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.498 167.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . 49.26 70.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.126 170.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.412 ' HB ' HD21 ' A' ' 290' ' ' LEU . 35.6 m -112.18 152.2 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.162 -167.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.37 -13.4 59.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 55.3 tp -76.61 120.2 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.8 -47.03 86.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.954 -172.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -64.96 -48.36 74.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.783 -172.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -69.26 -36.68 77.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -65.64 -34.54 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.45 -39.38 94.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -69.77 -43.57 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.02 -24.13 65.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.888 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.27 -5.55 19.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.088 -173.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.49 -17.75 62.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.843 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -86.96 128.62 55.22 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.531 0.681 . . . . 0.0 110.915 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.32 -30.7 20.67 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.358 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.429 ' HG2' HG21 ' A' ' 244' ' ' VAL . 94.4 mtt-85 -69.91 -37.39 75.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 39.2 mm -79.14 -40.98 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.212 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.14 94.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.116 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.49 -41.94 83.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.123 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 67.8 m -64.8 -41.52 95.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.214 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 67.2 ttp -64.94 -42.81 94.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.941 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -66.39 -46.2 77.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.908 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 327' ' ' GLY . 25.8 p30 -78.21 -18.12 55.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.857 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.13 -40.48 82.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.112 170.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.24 -25.45 59.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -101.78 -9.97 20.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.83 -155.95 31.47 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.457 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -122.75 129.4 51.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.0 110.896 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.2 mm -72.73 127.47 34.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.264 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.406 ' HA ' ' HD2' ' A' ' 331' ' ' PRO . 59.8 ttm -63.37 124.89 85.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 330' ' ' MET . 36.5 Cg_endo -64.21 135.12 45.39 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.745 2.297 . . . . 0.0 112.329 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.662 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 56.7 p30 -95.08 13.22 25.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.763 -172.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 335' ' ' GLN . 48.3 mm -75.12 130.36 80.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 111.203 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -62.98 -28.11 74.79 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.66 2.24 . . . . 0.0 112.324 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.518 ' H ' HG22 ' A' ' 333' ' ' ILE . 92.2 mt-30 -64.95 -13.86 58.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.973 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 82.3 mmm -64.87 -21.49 66.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -58.57 -35.6 72.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 172.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.58 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.133 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -63.0 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.957 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -58.69 -52.01 67.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.922 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -64.32 -44.65 90.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.959 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -42.53 94.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.167 -170.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 76.5 t -71.79 -42.39 70.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.106 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -57.52 -45.79 84.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.3 m -65.53 -44.64 86.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.065 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.456 ' HA ' ' HB1' ' A' ' 360' ' ' ALA . . . -63.76 -40.57 97.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.086 -176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.66 -48.61 75.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.8 mt -60.5 -45.36 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.237 -172.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 355' ' ' GLN . 83.5 m-20 -63.54 -37.08 85.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.985 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.91 -45.52 67.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.16 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.78 -34.21 73.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.175 -175.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.7 p -81.9 -8.98 59.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.45 12.11 84.85 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -81.0 -25.68 37.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.72 0.295 . . . . 0.0 110.823 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 349' ' ' ASN . 41.7 tt0 -149.9 145.38 26.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 49.4 p -72.55 163.73 27.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.135 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.418 HG13 HD23 ' A' ' 192' ' ' LEU . 54.3 t -65.32 -45.93 91.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.116 -176.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.08 -42.82 96.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.891 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -71.32 -46.23 61.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 -172.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -62.08 -42.14 98.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.024 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 78.5 mt -65.3 -39.97 93.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.906 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.06 -41.69 90.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.873 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -72.53 -44.02 62.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.33 -48.08 11.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.222 -168.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -70.95 -32.31 69.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 -170.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 59.0 m -60.61 -33.26 72.49 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.158 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -59.8 -27.97 67.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.78 -40.18 59.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.148 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.3 p -102.54 -16.7 16.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 178.259 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.0 mttm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.699 0.285 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -88.27 128.99 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -131.02 166.28 21.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -73.77 123.91 25.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.946 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.28 26.01 29.46 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.453 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -141.07 154.78 46.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.847 0.356 . . . . 0.0 110.929 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 33' ' ' ILE . 7.2 tt -139.07 130.36 26.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.796 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.24 124.79 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 36.6 mt -118.84 134.82 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.824 ' HB3' HD21 ' A' ' 43' ' ' LEU . 39.7 m0 -111.7 123.73 50.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.965 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.51 160.22 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.165 -174.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.867 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.7 t-20 -55.85 120.14 6.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 167.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.54 -20.89 79.42 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.482 -171.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -57.74 -45.47 85.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 0.0 110.844 -167.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.3 mmtt -130.67 75.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 148.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.5 -46.3 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.504 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -75.82 -45.75 34.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.902 0.382 . . . . 0.0 110.939 -154.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -63.98 -52.66 58.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -157.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -64.18 -43.91 96.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.532 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.5 -37.52 83.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.893 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.99 -44.57 95.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.158 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -58.47 -52.2 66.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.858 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.6 m -75.25 -34.01 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.145 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.88 -39.6 93.43 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.484 175.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -70.11 -42.97 71.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -62.72 -39.64 94.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.98 176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -69.28 -35.09 75.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.91 171.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.63 -34.12 77.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.81 -33.6 72.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -83.96 -39.96 19.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.2 p -109.09 -16.98 13.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.142 -170.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.67 5.39 86.66 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.502 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 7' ' ' LEU . 14.1 pt -88.07 125.0 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 0.0 111.195 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.84 129.64 39.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG21 ' HA3' ' A' ' 24' ' ' GLY . 14.4 p -100.78 139.35 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.081 -175.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -140.95 121.41 14.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.19 128.67 61.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.158 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 88.3 tt0 -112.24 151.85 29.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -79.28 161.46 67.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.839 -175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.867 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 59.9 Cg_endo -102.97 24.05 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.638 2.225 . . . . 0.0 112.386 -160.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -76.45 -43.62 39.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.99 -14.32 36.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.824 HD21 ' HB3' ' A' ' 10' ' ' TRP . 3.5 mp -52.03 -50.9 60.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 -161.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -51.9 -41.28 61.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.25 -35.56 61.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.863 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -73.25 -28.93 62.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.53 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.1 m-30 -49.24 -54.91 24.7 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.593 0.711 . . . . 0.0 110.898 -162.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 86.8 Cg_endo -80.03 -31.11 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.732 2.288 . . . . 0.0 112.211 -177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -74.65 -48.32 26.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.93 -168.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.48 -30.76 49.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 -174.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.52 -37.82 87.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.67 -25.83 63.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.055 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.6 p -97.68 -1.11 44.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.101 -171.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.591 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 75.63 18.46 79.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.523 -176.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -109.73 -175.16 2.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 110.864 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.7 -165.9 12.28 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.505 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.617 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 89.5 Cg_endo -82.79 178.45 6.03 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -87.88 -38.72 15.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.862 164.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.9 mt -131.06 139.6 50.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mt -131.2 143.23 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.058 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -100.05 142.85 30.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.897 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.51 126.65 44.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.98 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.76 -90.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.035 -167.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -110.75 -83.16 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -95.91 -17.44 21.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.889 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 80.3 mtp180 -59.72 -25.7 65.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -169.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.435 ' CD2' HD11 ' A' ' 104' ' ' ILE . 10.1 p90 -52.39 -37.43 56.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -49.06 9.86 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.495 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.53 -35.6 86.17 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.48 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.568 ' HB3' HD21 ' A' ' 75' ' ' LEU . 25.4 m-85 -71.66 -30.4 65.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.888 0.375 . . . . 0.0 110.942 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.63 -34.93 69.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.137 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -62.63 -29.86 70.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.794 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -83.98 -1.74 55.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 110.934 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.35 25.02 66.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.4 pp -85.99 -5.41 59.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.825 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -131.41 146.09 52.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.944 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.95 147.62 24.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.09 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.21 142.88 50.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.819 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' A' ' 103' ' ' LEU . 39.2 pt -101.99 145.97 10.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 65.6 p -132.25 70.26 80.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.578 0.704 . . . . 0.0 111.08 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.37 144.35 45.5 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.636 2.224 . . . . 0.0 112.381 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.8 p30 -86.61 -174.52 5.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.896 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.71 -37.48 84.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.888 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.46 94.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.143 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -67.14 -36.18 81.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -65.82 -37.76 87.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.838 175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -54.42 -29.43 49.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.856 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 93.2 mttt -54.02 -36.83 63.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.254 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 160.22 123.28 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 178.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.503 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 13.7 m-85 -158.26 51.6 0.47 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.611 0.72 . . . . 0.0 110.862 167.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 55.7 Cg_endo -70.8 -71.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.642 2.228 . . . . 0.0 112.335 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.41 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 42.9 p90 -102.76 -19.06 14.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.892 168.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.2 p -69.14 -20.53 64.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.142 -170.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 90' ' ' TYR . 17.6 t90 -58.86 -43.23 90.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.78 -27.2 68.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.565 ' HB1' ' HB ' ' A' ' 261' ' ' VAL . . . -74.5 -30.6 61.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.033 -169.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -116.43 14.99 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.04 -169.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.479 ' HB3' HD23 ' A' ' 103' ' ' LEU . 52.4 ptt85 -118.25 147.15 43.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -135.43 125.39 25.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.953 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 t30 60.29 35.13 20.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.857 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.65 5.28 90.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.574 174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 148.5 44.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 98' ' ' ARG . 83.9 mt -86.95 122.26 30.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.435 HD11 ' CD2' ' A' ' 67' ' ' PHE . 44.6 pt -122.79 -1.9 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.127 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.92 163.71 31.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 -174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -111.47 146.26 34.26 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.68 0.752 . . . . 0.0 110.902 174.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -75.59 122.46 6.94 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.712 2.275 . . . . 0.0 112.402 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -105.7 -37.02 3.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.079 -176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.42 152.09 10.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -171.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.5 128.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.122 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -122.55 126.37 47.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.53 155.97 38.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.071 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.447 HD12 ' HG2' ' A' ' 257' ' ' PRO . 94.7 mt -76.46 144.33 39.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.1 m -140.66 156.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.923 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.453 ' HB2' HD23 ' A' ' 247' ' ' LEU . 43.0 tp -94.47 127.65 40.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -172.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 244' ' ' VAL . 68.7 mt -113.98 130.5 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.169 172.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -136.76 155.83 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.904 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 36.4 t-20 -92.0 111.7 23.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.848 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.581 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.5 mttt -65.17 -28.29 69.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 31.7 t70 -76.04 -33.22 59.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.827 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.84 -44.96 13.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.4 tp -121.03 109.62 35.38 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.71 0.767 . . . . 0.0 110.954 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.5 -15.6 19.59 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.0 112.361 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -147.12 109.55 3.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.65 0.738 . . . . 0.0 110.845 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.35 154.39 74.41 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.686 2.258 . . . . 0.0 112.356 178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.24 140.71 37.78 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.65 2.234 . . . . 0.0 112.374 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -88.64 -25.75 22.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.4 t -149.97 174.32 12.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.119 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 64.2 p-90 -74.53 -24.44 58.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.837 -169.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.73 -32.4 73.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.895 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.75 -23.18 58.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 -172.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 88.7 mt -66.31 -51.78 41.52 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.63 0.728 . . . . 0.0 111.126 -168.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.56 -40.42 56.49 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.703 2.268 . . . . 0.0 112.303 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.2 -43.6 98.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.062 173.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.3 mt -59.3 -38.36 80.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.949 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 9.8 t70 -64.59 -36.23 83.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.816 -175.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.49 -37.05 85.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.95 -58.0 4.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 -172.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -78.7 -11.76 59.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 136' ' ' ASP . 86.6 tttt -56.46 -30.37 62.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.921 169.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.03 -21.03 66.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -99.9 6.64 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.858 -176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.24 28.06 64.83 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.502 -174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 7.0 mptt -119.72 156.52 30.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.887 0.375 . . . . 0.0 110.92 174.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.4 t -115.76 153.97 30.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.786 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -72.55 -49.34 33.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 52.8 tp -143.44 125.7 15.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.2 mmm -133.19 131.42 40.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.835 174.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.93 167.65 28.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 210' ' ' TYR . 60.1 t-20 -50.87 111.52 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.814 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 206' ' ' ALA . 8.0 tp -115.31 19.96 15.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.005 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -92.19 -2.46 56.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.991 176.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.04 145.8 53.43 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.612 0.72 . . . . 0.0 110.874 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.477 ' HB3' ' HB2' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -68.15 -27.66 35.19 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.697 2.265 . . . . 0.0 112.331 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -58.79 -35.43 72.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.912 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -88.21 -26.63 22.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.828 -174.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 73.8 p -87.57 -32.31 19.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 -174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.65 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 58.6 t90 -55.01 -52.3 72.24 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.516 0.674 . . . . 0.0 110.99 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.6 Cg_endo -54.98 -32.18 77.52 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.624 2.216 . . . . 0.0 112.402 -175.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.3 tp -70.46 -35.19 73.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.014 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.424 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -72.42 -41.66 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 170.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.17 -18.89 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.164 -171.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.9 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.111 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.97 2.63 53.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.914 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.13 11.87 6.06 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.597 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.17 165.19 53.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 172.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.45 ' HD2' ' HA3' ' A' ' 182' ' ' GLY . 98.1 m-85 -140.33 175.86 9.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.989 0.423 . . . . 0.0 110.882 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 339' ' ' PHE . . . -112.03 -33.68 6.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 176.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.434 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.6 OUTLIER -148.35 134.76 19.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.995 0.426 . . . . 0.0 110.825 -173.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 1.072 ' HD3' ' H ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -89.89 121.55 32.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.899 -170.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -127.46 113.12 15.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.942 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.02 142.66 24.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.929 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.0 32.77 10.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.16 -2.8 64.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.475 173.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.3 152.99 49.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.731 0.301 . . . . 0.0 110.888 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 64.9 m-85 -83.15 122.74 28.77 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.713 ' O ' ' HG3' ' A' ' 170' ' ' LYS . 63.0 t0 -128.77 118.67 23.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -175.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.793 ' HA ' ' HE3' ' A' ' 170' ' ' LYS . 8.5 tp -57.04 -20.8 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.111 -172.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -81.21 -15.77 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 -174.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -110.58 47.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.704 ' HA ' ' HB3' ' A' ' 170' ' ' LYS . 8.6 p -99.11 145.66 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 -176.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.45 ' HA3' ' HD2' ' A' ' 167' ' ' TYR . . . -110.75 22.8 21.09 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.539 -171.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 m -92.09 -23.27 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 0.0 111.143 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -106.63 25.12 11.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -99.06 -171.95 2.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.3 -37.41 80.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.001 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -43.21 93.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.75 88.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.918 0.39 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.06 -41.71 97.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.22 -41.11 86.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.424 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -68.14 -47.2 60.52 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.449 -175.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.2 tp -67.05 -38.7 86.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.892 0.377 . . . . 0.0 110.899 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 72.9 m -57.67 -43.36 84.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.158 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -66.04 -43.61 87.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.99 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.8 tt -55.96 -46.36 78.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.936 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.57 -39.37 84.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -60.1 -34.74 73.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.791 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.77 -33.86 76.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.862 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -74.95 -39.84 45.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.201 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -66.66 -38.59 87.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -86.94 2.11 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.838 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 61.69 31.41 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -83.85 -30.88 26.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.0 mtt -139.55 145.5 38.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.835 173.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.587 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 55.1 t-20 -97.32 135.78 38.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.434 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -67.61 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.068 -175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -98.25 -12.7 21.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 -166.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 53.1 m -59.03 127.36 31.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.132 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -95.5 171.3 8.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 169.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.417 ' HB2' ' HB2' ' A' ' 150' ' ' ASN . 70.5 t80 -57.8 -39.39 77.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.96 173.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -59.04 -43.69 91.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.91 -45.53 80.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.08 -35.67 81.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.41 -41.11 80.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.822 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.36 96.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.044 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.29 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -64.74 -39.71 94.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.805 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -63.88 -24.0 67.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.851 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -94.76 -10.0 32.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.58 20.14 52.24 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.456 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -87.66 -21.07 25.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.972 0.415 . . . . 0.0 110.898 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 91.0 m -127.17 133.25 50.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.185 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.16 -32.31 64.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -172.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 73.4 mtm -135.44 148.55 49.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.916 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.1 t -148.68 165.39 31.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.158 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 91.8 mt -130.99 127.9 61.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.406 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 46.2 p30 -152.7 167.25 29.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.946 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -119.84 -129.59 3.86 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.404 -168.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.97 -18.64 18.65 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.734 2.29 . . . . 0.0 112.433 -165.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -55.02 -30.77 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.917 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.07 42.43 28.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.99 169.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.517 ' O ' ' C ' ' A' ' 233' ' ' SER . 67.5 m95 -56.64 -25.01 52.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.899 167.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.517 ' C ' ' O ' ' A' ' 232' ' ' TRP . 28.1 p 30.64 64.13 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 170.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -68.48 -12.13 60.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.919 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 37.3 pt -90.24 -5.14 10.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.163 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.54 -48.52 10.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.891 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 98.9 m -61.33 -57.81 10.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.105 -176.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 40.7 t -161.21 128.23 4.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.797 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.55 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.09 174.46 10.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.02 -66.0 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -163.98 94.75 0.76 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 27.7 m-85 -115.45 160.28 20.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.818 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.581 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -138.98 168.4 24.81 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.425 177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.432 HG22 HG12 ' A' ' 116' ' ' ILE . 60.4 t -125.02 129.19 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.102 -177.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 18.9 p -131.18 171.61 13.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.83 165.33 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.024 167.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.483 ' HB2' ' HE2' ' A' ' 256' ' ' LYS . 90.8 mt -77.55 145.23 71.15 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.617 0.722 . . . . 0.0 110.968 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 75.6 Cg_exo -55.63 148.87 51.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.659 2.239 . . . . 0.0 112.374 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.9 p -131.12 154.72 48.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -132.06 109.65 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 46.76 42.68 12.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 164.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.63 25.11 57.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 162.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -108.58 157.89 35.41 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.557 0.694 . . . . 0.0 110.914 -171.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.01 74.97 0.33 Allowed 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.727 2.285 . . . . 0.0 112.426 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 93.5 p -86.42 -7.66 58.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.8 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 247' ' ' LEU . 13.9 ptpt -135.38 155.37 78.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.546 0.688 . . . . 0.0 110.869 -168.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.466 ' HG3' ' HG3' ' A' ' 159' ' ' PRO . 53.6 Cg_exo -61.3 164.91 13.87 Favored 'Trans proline' 0 C--O 1.23 0.118 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 8.7 m-30 -60.34 162.27 6.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.901 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.437 HG21 ' HA ' ' A' ' 324' ' ' ALA . 98.1 t -116.23 129.86 71.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.148 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.89 133.67 11.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.481 -173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.565 ' HB ' ' HB1' ' A' ' 96' ' ' ALA . 86.8 t -122.16 125.43 72.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 111.112 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 54.0 tp -71.41 134.32 46.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 92.6 p -132.23 156.78 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.69 137.15 51.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.071 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.71 169.74 23.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.495 -175.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.4 mp -107.73 133.89 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.163 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -61.85 125.54 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.46 -27.17 68.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.14 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.591 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -80.65 -13.86 58.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.9 t -72.49 130.49 85.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.633 0.73 . . . . 0.0 110.903 -176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.91 -10.32 28.16 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.716 2.277 . . . . 0.0 112.388 170.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -107.01 33.87 3.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.928 -169.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -53.06 -40.2 63.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.9 -36.95 75.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 48.0 tp -61.11 -48.26 82.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.021 176.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.46 77.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.094 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.55 -47.32 79.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.67 -42.38 82.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 -177.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 37.0 t80 -60.82 -44.5 96.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.892 177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 284' ' ' LEU . 31.8 tp -65.89 -51.13 61.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -76.25 -35.18 59.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 -170.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -106.27 -16.45 14.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.843 -161.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 87.2 m-85 -120.52 -50.96 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.924 -177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 280' ' ' LEU . 49.6 mt -71.22 -42.79 68.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.947 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 5.2 mp -85.03 62.0 7.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 176.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.9 p -136.73 168.0 20.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -55.0 -45.44 75.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.95 -41.03 37.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.09 -47.43 13.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.47 -171.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 20.1 tp -69.54 -35.38 75.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.788 0.328 . . . . 0.0 110.951 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -59.04 -45.21 91.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.868 177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.24 -35.77 76.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.103 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.517 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 84.3 t -78.94 -47.9 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -73.84 -16.39 61.14 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.07 -23.28 7.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 92.6 m-20 -73.95 -19.62 60.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -175.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -85.69 152.2 56.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.563 0.697 . . . . 0.0 110.938 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.32 -22.49 52.88 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.753 2.302 . . . . 0.0 112.318 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 95.5 mt -101.89 -46.22 4.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.14 25.04 72.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.444 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -67.87 128.8 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 111.051 -177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 307' ' ' TYR . 19.8 m -117.76 151.98 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.049 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.02 60.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.0 tp -73.85 120.62 19.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -60.07 -48.36 82.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.896 -171.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -59.13 -46.93 87.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 -170.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.457 ' HB3' HG21 ' A' ' 302' ' ' VAL . 2.2 t80 -73.93 -32.98 63.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.925 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -60.54 -35.65 76.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.11 -34.74 73.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.72 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -76.13 -39.69 54.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.833 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 302' ' ' VAL . 96.1 mt -68.96 -23.33 64.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 176.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.62 -9.36 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.057 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -76.72 -17.16 59.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.907 177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -88.21 120.0 70.45 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.522 0.677 . . . . 0.0 110.932 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.77 -31.96 34.97 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.681 2.254 . . . . 0.0 112.23 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.422 ' HG2' HG21 ' A' ' 244' ' ' VAL . 94.5 mtm-85 -69.34 -44.8 70.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 -176.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.12 -39.93 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.67 -39.15 83.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.094 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.21 -39.82 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.078 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 75.0 m -66.68 -43.01 85.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.193 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.15 -36.33 81.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.67 -33.58 72.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 176.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -65.21 -34.78 79.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.869 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.437 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -60.82 -36.86 80.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.08 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -73.5 -23.37 60.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -100.01 -11.44 20.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -173.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.44 -159.89 34.89 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -124.18 127.98 48.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 175.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.6 ' O ' ' O ' ' A' ' 330' ' ' MET . 37.5 mm -79.95 119.13 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.133 -165.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.6 ' O ' ' O ' ' A' ' 329' ' ' ILE . 2.1 ppp? 37.14 171.43 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.615 0.721 . . . . 0.0 110.899 -163.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 330' ' ' MET . 90.4 Cg_endo -69.95 -157.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.653 2.235 . . . . 0.0 112.378 171.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -135.08 -46.06 0.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.453 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 37.9 pt -129.79 158.44 73.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.532 0.682 . . . . 0.0 111.234 167.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 33.1 Cg_endo -63.61 -21.62 70.31 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.424 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -14.89 59.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.515 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 37.1 mmt -64.94 -27.95 69.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -60.52 -39.02 86.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.66 67.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.109 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.7 t80 -55.81 -49.37 73.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -58.88 -44.12 91.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.012 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -59.03 -42.79 91.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.925 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.9 -36.75 85.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.096 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.53 -40.81 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.218 177.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 154' ' ' PRO . 42.6 ttt180 -54.2 -52.64 60.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.845 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 74.8 p -66.41 -36.04 81.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -175.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.93 -42.36 94.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.069 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.07 -49.43 73.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.9 mt -64.6 -41.87 93.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.14 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -64.3 -38.49 91.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.37 71.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.053 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.84 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -80.36 -7.92 59.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.68 12.71 81.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.458 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -77.64 -28.56 51.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.63 0.252 . . . . 0.0 110.775 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -139.52 155.87 47.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 71.9 p -79.01 168.13 20.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.08 -47.69 84.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.158 -174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.62 -42.34 91.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -71.89 -37.92 70.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.06 94.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.075 174.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.99 -35.28 78.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -65.02 -42.36 94.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -67.29 -34.14 76.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.68 -46.51 68.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.162 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -62.77 -40.43 97.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.962 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 84.4 m -63.02 -41.88 99.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.044 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.92 -35.11 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.65 -41.51 85.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.228 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.5 p -94.09 -11.6 30.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.874 -178.404 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.664 0.268 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -80.74 135.8 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.193 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -149.79 179.87 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.919 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.2 120.43 20.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.99 23.54 27.35 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.389 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -143.24 151.86 41.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.807 0.337 . . . . 0.0 110.967 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.835 ' O ' HD12 ' A' ' 7' ' ' LEU . 1.7 pp -143.77 144.0 31.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.816 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.06 125.22 69.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.061 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.0 mt -117.01 134.07 61.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.672 ' CZ3' ' HD3' ' A' ' 57' ' ' PRO . 27.6 m0 -114.87 128.13 56.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 17.6 tt -152.4 157.91 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.448 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.7 t-20 -56.65 120.35 7.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 166.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.713 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -77.36 -22.07 71.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.466 -168.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -54.39 -48.89 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 -164.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.6 mmtt -130.32 79.6 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 145.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -117.62 -38.79 0.82 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.49 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -74.59 -44.79 49.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.912 -160.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -66.02 -51.67 56.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.912 -159.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -60.23 -44.49 97.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.576 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -59.29 -39.05 81.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.757 0.313 . . . . 0.0 110.849 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.1 -46.94 85.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.062 175.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -56.17 -49.56 73.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.44 -32.3 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.68 -42.71 93.14 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.522 -176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -70.04 -43.07 72.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.807 0.337 . . . . 0.0 110.891 -176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.3 -40.41 96.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.97 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -65.09 -39.79 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.861 172.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -62.99 -33.58 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.895 177.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -73.3 -35.55 66.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.907 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -82.05 -41.32 20.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.4 p -103.0 -22.25 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.209 -172.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.21 4.99 87.8 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.454 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.7 mt -76.55 120.55 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 0.0 111.195 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.85 120.44 11.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG13 HD11 ' A' ' 7' ' ' LEU . 78.8 t -96.9 135.23 31.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.3 m -136.31 116.65 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.73 126.4 68.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.169 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -110.46 162.04 15.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -64.87 163.34 29.77 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.535 0.683 . . . . 0.0 110.944 -173.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.713 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 70.2 Cg_endo -99.03 -2.16 0.89 Allowed 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.706 2.271 . . . . 0.0 112.397 -161.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -75.66 -31.27 59.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -160.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.64 -10.59 24.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 -174.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 47' ' ' PHE . 61.3 mt -51.56 -55.74 17.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -158.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.3 -32.35 68.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -168.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -75.21 -34.69 61.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.912 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -74.54 -28.35 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.515 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 8.2 m-30 -48.75 -54.41 27.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.641 0.734 . . . . 0.0 110.789 -163.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 83.8 Cg_endo -78.59 -29.23 3.79 Favored 'Trans proline' 0 C--O 1.231 0.132 0 C-N-CA 122.877 2.384 . . . . 0.0 112.272 -177.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.66 -49.42 18.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.0 -170.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.8 m -65.95 -30.71 50.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.07 -175.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.511 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.89 -37.13 85.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.056 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.47 -26.25 63.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.013 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 65.5 p -97.96 -1.24 43.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.124 -172.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.13 18.36 80.12 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -107.71 -174.95 2.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.92 -166.99 13.21 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.672 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 89.7 Cg_endo -82.89 173.5 10.18 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' OD2' ' HA ' ' A' ' 7' ' ' LEU . 30.5 m-20 -85.9 -36.41 19.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 166.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.2 mt -132.37 139.74 49.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.137 -174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 47' ' ' PHE . 7.2 mt -131.89 143.24 40.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -105.88 139.78 39.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.51 ' O ' HD12 ' A' ' 262' ' ' LEU . 23.9 m-90 -121.14 133.2 55.19 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 173.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -52.29 -90.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.096 -171.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -110.97 -81.45 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -79.49 -23.71 42.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 -168.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -59.68 -27.16 66.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -159.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -55.79 -38.06 69.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.868 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.24 -51.17 7.69 Favored Glycine 0 CA--C 1.517 0.164 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.496 -168.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -37.13 91.75 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' HB3' HD21 ' A' ' 75' ' ' LEU . 27.9 m-85 -74.86 -31.25 61.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.56 68.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.084 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -61.35 -28.11 68.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.809 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -85.24 3.48 39.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 -175.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.32 25.46 64.84 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.469 176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.7 pp -87.41 -5.14 58.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 0.0 110.892 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 76' ' ' LEU . 4.2 pp -133.15 144.8 50.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.878 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.1 152.31 19.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.153 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.35 144.57 48.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.827 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.1 pt -109.09 152.54 11.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.091 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -133.46 67.13 75.62 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.671 0.748 . . . . 0.0 111.139 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.66 143.05 41.18 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.617 2.211 . . . . 0.0 112.325 166.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -81.0 -176.58 6.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.774 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.79 -32.24 73.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.819 -173.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.97 64.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.137 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -67.23 -36.27 81.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.844 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -59.87 -43.99 94.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.21 -35.13 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.523 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 97.4 mttt -67.23 -31.33 71.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -171.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.235 ' O ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER 173.99 78.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.929 -177.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.636 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 38.0 m-85 -151.06 41.49 0.22 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.639 0.733 . . . . 0.0 110.885 168.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 67.1 Cg_endo -72.48 -70.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.628 2.218 . . . . 0.0 112.27 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.493 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 99.1 m-85 -92.98 -28.04 16.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.564 HG21 ' HB1' ' A' ' 303' ' ' ALA . 66.7 p -71.94 -22.17 61.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -162.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -62.47 -42.86 99.77 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.96 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.42 -24.56 66.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.568 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -74.54 -31.91 62.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.08 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -111.37 16.08 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 -170.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -119.39 145.56 46.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -136.33 127.18 27.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.942 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 59.48 34.82 22.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.855 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.6 5.65 89.79 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.481 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -116.6 145.04 43.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.6 tp -94.91 113.58 25.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.872 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.6 pt -124.21 -2.3 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.093 -161.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.96 157.25 37.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -170.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.1 m-85 -106.35 136.89 19.31 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.724 0.773 . . . . 0.0 110.911 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 24.4 Cg_exo -65.3 114.37 2.83 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.749 2.3 . . . . 0.0 112.372 174.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.5 mm -101.42 -31.75 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.89 152.27 6.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.106 -169.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.74 124.8 68.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.062 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -123.85 137.57 54.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.975 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -74.79 144.13 43.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.2 m -142.92 158.94 43.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.466 ' HB2' HD23 ' A' ' 247' ' ' LEU . 64.0 tp -92.31 120.08 32.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -173.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 244' ' ' VAL . 61.9 mt -108.52 126.32 65.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.163 175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -136.13 157.49 46.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.981 -167.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.459 ' HB2' ' CE2' ' A' ' 242' ' ' TYR . 30.2 t-20 -94.0 112.24 24.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.862 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.484 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 98.6 mttt -63.89 -26.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -81.89 -33.66 30.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 -175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.86 -48.73 13.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 173.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -123.23 109.4 31.4 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.623 0.725 . . . . 0.0 110.941 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.34 -15.05 20.22 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.562 2.175 . . . . 0.0 112.387 -176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.451 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.5 t-20 -148.43 107.11 3.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.759 0.79 . . . . 0.0 110.841 -178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -66.06 152.34 81.52 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.669 2.246 . . . . 0.0 112.302 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -69.23 142.7 51.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.287 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -88.62 -17.08 30.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.881 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 14.9 t -147.66 166.29 27.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -68.13 -29.34 68.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.881 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.21 -27.86 69.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -172.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.21 -33.47 71.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -172.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.568 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 97.9 mt -67.66 -45.09 45.41 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 111.052 -159.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.568 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 80.3 Cg_exo -50.78 -49.56 16.47 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.22 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.447 ' O ' HD23 ' A' ' 135' ' ' LEU . 2.1 tt -54.23 -35.61 62.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 175.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 25.1 t70 -65.82 -34.82 79.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -176.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.29 -37.54 87.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 -172.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -69.64 -56.91 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -172.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 145' ' ' SER . 1.9 pt? -79.8 -11.87 59.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -173.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -53.53 -30.27 40.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.936 166.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.3 -19.8 65.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -104.71 12.58 32.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.829 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.72 24.84 73.54 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.531 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -117.77 156.22 28.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.805 0.336 . . . . 0.0 110.857 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.456 ' O ' HD11 ' A' ' 139' ' ' LEU . 48.2 t -115.78 153.48 31.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.874 173.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -71.92 -53.29 13.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -174.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.8 tp -147.1 135.4 21.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.8 mtp -124.04 134.58 53.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 169.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -149.24 165.34 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.807 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.448 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 55.3 t-20 -64.72 113.56 3.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.866 -172.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.912 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.8 tm? -92.88 -23.91 18.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 175.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -77.77 -4.38 46.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 -176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -130.89 152.2 80.21 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.606 0.717 . . . . 0.0 110.889 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 61.7 Cg_endo -79.65 -20.71 9.1 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.616 2.21 . . . . 0.0 112.404 -174.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -57.28 -45.53 83.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.945 -175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.448 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 45.5 m-85 -81.32 -27.02 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -174.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.419 HG21 HD22 ' A' ' 151' ' ' LEU . 72.1 p -87.12 -30.06 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.049 -171.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 82.5 t90 -56.2 -47.72 98.3 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.474 0.654 . . . . 0.0 110.96 -172.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.646 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 99.1 Cg_exo -49.52 -39.31 45.56 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.614 2.209 . . . . 0.0 112.383 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.691 ' O ' HD23 ' A' ' 160' ' ' LEU . 4.9 tt -74.06 -38.86 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.957 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.477 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.5 mt -67.32 -37.94 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.41 -13.67 59.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 -174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.92 67.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.098 -167.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -94.55 5.93 50.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.899 -171.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.98 15.2 3.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.538 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.65 153.38 38.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.512 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.519 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 98.7 m-85 -135.06 152.04 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.906 177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.01 -38.04 7.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -143.67 140.29 29.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.812 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -98.55 125.61 43.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.92 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -115.05 110.06 19.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.007 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -151.17 140.77 21.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 48.97 37.33 10.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.844 -171.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 4.47 64.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.477 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.48 153.49 49.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.965 -173.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -94.14 131.23 39.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.979 168.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -110.79 120.2 41.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.5 tp -69.99 -20.38 23.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -83.49 -16.77 44.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.893 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -98.94 66.54 1.58 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 171.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.5 p -108.47 139.16 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.16 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.519 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -107.88 32.22 7.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.511 -168.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.0 t -90.0 -35.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.659 0.266 . . . . 0.0 110.995 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -102.88 29.13 5.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.72 -175.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -99.09 -172.2 2.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.941 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.82 -40.97 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.036 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.81 -44.89 94.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.515 -172.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.89 -37.03 86.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.861 0.362 . . . . 0.0 111.12 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -65.77 -40.23 91.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.809 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.53 -43.49 89.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.45 -43.53 94.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.522 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.8 tp -66.01 -38.4 88.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 110.944 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.6 m -58.93 -43.65 91.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.071 173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -63.24 -42.37 99.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.841 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.58 -45.09 92.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.84 -40.24 85.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.38 -39.38 94.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.874 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.44 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.7 OUTLIER -63.57 -42.67 98.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.8 mt -73.59 -38.73 52.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.149 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.16 -36.82 80.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -83.78 3.62 32.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 64.56 33.73 10.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -78.91 -24.69 43.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.849 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 28.3 ptm -147.7 160.59 42.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.847 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -94.13 134.08 36.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.03 -23.94 67.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.204 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -89.44 -3.27 58.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.897 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.2 m -56.46 126.71 27.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 -177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -103.48 170.12 8.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 169.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -65.88 -32.71 74.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.009 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 92.2 p -69.74 -36.08 75.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.835 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.2 mm -65.14 -42.31 93.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.134 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.71 94.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.103 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -69.69 -38.77 77.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.814 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.2 -46.05 85.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.023 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.2 -39.35 92.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -66.5 -40.91 89.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 -176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.27 -19.77 65.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.97 -10.51 30.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.13 15.98 65.84 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.471 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -80.09 -25.82 39.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.976 0.417 . . . . 0.0 110.861 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 224' ' ' MET . 73.9 m -128.23 133.82 48.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.49 -27.04 61.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.171 -169.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.419 ' H ' HG22 ' A' ' 222' ' ' THR . 74.8 mtm -132.56 152.41 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.812 -173.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -152.13 165.85 33.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.116 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 79.1 mt -126.54 125.04 66.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.139 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -127.21 136.63 52.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.438 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -105.03 -134.34 7.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.479 -169.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.438 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.0 Cg_endo -70.82 -19.47 31.03 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.764 2.309 . . . . 0.0 112.299 -166.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -58.17 -30.32 66.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 62.09 22.82 13.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.018 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.53 ' O ' ' C ' ' A' ' 233' ' ' SER . 39.3 m0 -61.13 -33.78 73.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.92 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 232' ' ' TRP . 67.5 p 31.34 67.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.896 167.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -81.15 35.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.908 -160.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 244' ' ' VAL . 38.3 pt -115.26 6.04 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.096 171.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -81.6 -54.27 5.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.806 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.5 m -60.44 -59.61 5.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.114 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -153.5 126.29 8.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.488 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.52 172.86 11.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 98.6 t -86.37 -71.73 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.61 76.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' ASN . 44.9 m-85 -114.93 154.24 29.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.896 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.484 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -146.01 170.61 27.15 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.422 -174.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.456 HG22 HG12 ' A' ' 116' ' ' ILE . 60.7 t -123.49 134.88 65.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.904 0.383 . . . . 0.0 111.157 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.7 176.86 8.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.193 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.0 m -79.8 162.8 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.109 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.466 HD23 ' HB2' ' A' ' 115' ' ' LEU . 97.6 mt -81.38 151.3 68.9 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.708 0.766 . . . . 0.0 110.886 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 153.47 70.44 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.74 2.293 . . . . 0.0 112.352 -173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.477 ' HA ' ' HB2' ' A' ' 255' ' ' SER . 81.7 p -131.19 146.57 52.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.182 177.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -121.28 115.62 23.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 51.38 37.07 18.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 171.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.25 26.98 56.57 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.456 167.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.0 mm-40 -112.4 159.55 33.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.611 0.72 . . . . 0.0 110.907 -168.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 59.9 Cg_endo -63.39 75.05 0.14 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.722 2.281 . . . . 0.0 112.418 171.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' A' ' 249' ' ' THR . 49.5 m -94.28 6.64 48.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 -164.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.499 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 12.1 ptpt -135.12 158.6 74.43 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.869 -170.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 29.4 Cg_endo -69.84 168.2 22.36 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.672 2.248 . . . . 0.0 112.298 -170.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -70.18 172.16 8.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.956 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.3 t -121.6 132.84 69.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.185 -175.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -106.14 142.99 15.69 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.502 ' HB ' ' HB1' ' A' ' 96' ' ' ALA . 96.3 t -127.43 127.99 69.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.816 0.341 . . . . 0.0 111.165 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 62' ' ' TRP . 51.5 tp -72.47 135.1 45.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.976 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 67.2 m -121.27 137.24 54.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.842 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -123.73 132.6 53.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 174.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.74 170.73 23.86 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.6 mp -105.98 130.39 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 111.16 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -59.82 128.9 39.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.959 -176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.43 68.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . . . -80.67 -13.22 59.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.041 -178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.0 t -69.7 133.59 88.53 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.627 0.727 . . . . 0.0 110.856 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.33 -8.9 23.52 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.585 2.19 . . . . 0.0 112.35 171.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -106.82 30.53 6.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -167.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -52.17 -43.47 64.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -169.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -73.17 -41.62 63.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.807 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.04 -52.16 65.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.008 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.72 94.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.095 -175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -65.88 -50.25 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.9 -47.58 71.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.832 -170.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -71.95 -33.26 68.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -176.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 284' ' ' LEU . 41.6 tp -57.11 -46.39 82.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 177.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -82.9 -28.86 29.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.967 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -101.42 -9.78 20.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -168.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 76.2 t80 -125.38 -59.66 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.946 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.407 ' HB2' HD12 ' A' ' 280' ' ' LEU . 68.6 mt -71.19 -44.5 65.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 -174.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 20.4 tp -85.03 67.51 10.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.0 p -139.69 170.19 16.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.171 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.22 -45.26 79.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.835 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -75.89 -41.3 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.841 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.17 -45.9 9.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.558 -171.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.2 tp -71.29 -35.66 71.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.981 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -56.58 -41.04 76.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.897 177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.24 69.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.086 -175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.451 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 76.7 t -76.95 -45.1 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.052 -176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -73.05 -7.75 52.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 -174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -52.83 -21.95 4.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.916 173.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 89.2 m-20 -79.15 -24.2 43.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.806 -174.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -96.34 148.47 34.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.629 0.728 . . . . 0.0 110.878 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.24 -25.62 26.18 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.637 2.225 . . . . 0.0 112.295 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 98.0 mt -106.56 -48.41 3.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.019 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.4 22.24 78.59 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.527 178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.8 110.34 0.79 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 0.0 111.072 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 307' ' ' TYR . 5.2 p -112.77 149.13 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 -159.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' A' ' 93' ' ' THR . . . -72.29 -18.84 61.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.21 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.457 ' H ' HG22 ' A' ' 302' ' ' VAL . 55.8 tp -79.38 124.36 28.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 -174.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.06 -45.4 90.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 -174.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.2 t -62.44 -50.0 73.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.844 -171.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.481 ' HB3' HG11 ' A' ' 302' ' ' VAL . 3.9 t80 -70.93 -36.87 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -65.58 -33.38 75.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.881 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -57.26 -38.5 73.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.81 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.6 -38.69 58.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.829 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.13 -29.81 70.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.51 -8.27 45.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.127 -172.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.53 -15.8 60.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.982 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -91.39 120.68 68.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.628 0.728 . . . . 0.0 110.878 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.9 -29.03 19.8 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.766 2.31 . . . . 0.0 112.295 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -70.11 -44.72 68.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.905 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -77.41 -38.12 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.0 -34.7 73.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.072 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.07 -41.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 83.2 m -67.09 -41.86 85.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.132 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.5 tpt -66.82 -38.02 85.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.835 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -66.44 -35.31 79.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -65.36 -34.83 79.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.805 172.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.34 95.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -74.24 -23.28 59.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -104.67 -5.79 21.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.11 -161.64 37.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.432 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -127.2 127.18 44.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 110.846 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.568 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 38.3 mm -74.64 121.93 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.101 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.5 mmt 63.48 156.23 0.12 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.458 0.647 . . . . 0.0 111.033 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.905 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 56.5 Cg_endo -74.67 -107.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.408 165.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -138.94 -58.6 0.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 165.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.55 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 34.0 pt -139.12 169.25 12.87 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.602 0.715 . . . . 0.0 111.158 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 87.1 Cg_exo -53.09 -17.01 7.28 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -61.3 -6.15 2.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.922 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.905 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.5 ptm -56.6 -29.95 62.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.013 172.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 96.9 p -66.05 -30.1 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -80.58 -34.85 34.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.132 175.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -59.65 -54.79 42.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.979 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.551 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 68.6 m95 -60.76 -38.08 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.995 -177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -60.02 -46.7 88.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 175.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.35 80.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.047 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 69.1 t -74.5 -36.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.188 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.501 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 76.0 ttt180 -56.01 -47.17 78.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 82.8 p -66.62 -35.81 81.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.16 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -64.95 -44.0 90.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.182 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.96 -47.57 81.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.5 mt -64.03 -44.34 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -65.21 -36.96 85.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.52 -44.72 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.051 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.18 -35.05 73.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.5 p -80.86 -7.78 59.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.04 82.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.555 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.13 -28.01 54.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.807 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -140.44 157.13 45.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.829 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.7 p -74.62 171.98 12.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.124 167.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 20.6 m -72.55 -34.21 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -67.61 -40.28 84.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 174.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -69.3 -44.73 71.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.817 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.89 -45.17 93.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.047 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 82.5 mt -69.77 -35.5 74.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.87 -46.85 88.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 175.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -69.41 -31.1 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -70.01 -48.02 59.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.157 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -64.95 -38.73 91.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.4 m -62.53 -41.48 98.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.051 178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -71.52 -39.12 70.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.802 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.3 mt -62.24 -46.05 97.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.141 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.9 p -105.51 6.95 32.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.18 -172.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.812 -178.119 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.698 0.285 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 91.8 mt -80.1 129.26 37.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.163 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -125.09 164.3 20.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -76.5 118.38 19.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.807 175.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.21 26.17 24.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.467 -170.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.41 152.22 40.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.109 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -145.49 146.63 31.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 174.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.6 t -128.67 129.74 68.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.9 mp -111.56 135.68 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.548 ' HB3' HD21 ' A' ' 43' ' ' LEU . 34.9 m0 -111.28 120.56 42.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 175.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.1 tt -153.16 159.21 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 -170.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.7 t-20 -60.0 119.85 8.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 168.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.776 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -76.22 -18.54 79.23 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.54 -173.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.27 -47.72 72.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.0 110.938 -166.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.26 80.04 1.95 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 144.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -120.56 -48.69 0.3 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.443 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -70.0 -43.72 70.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.91 -164.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -66.14 -51.98 52.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.925 -160.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.1 -44.29 97.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.437 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 24' ' ' GLY . 64.3 mt -61.28 -37.94 84.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.891 0.377 . . . . 0.0 110.882 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.37 85.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.028 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -56.22 -47.1 79.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.804 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -79.16 -33.27 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -67.49 -40.09 91.14 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.57 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -71.57 -40.01 70.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 0.0 110.906 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.4 -41.16 98.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -68.54 -38.58 80.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.79 -31.55 72.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.979 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.83 -37.35 67.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.819 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.3 -39.3 25.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.7 p -105.27 -18.2 14.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.182 -172.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.7 5.14 90.09 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.49 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 33' ' ' ILE . 7.8 pt -97.14 132.8 40.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 111.062 -175.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.95 131.01 45.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 7' ' ' LEU . 67.3 t -101.48 136.88 31.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 172.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -141.39 120.15 12.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.125 -177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.24 131.37 60.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -109.76 151.8 26.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.851 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.424 ' O ' HD13 ' A' ' 43' ' ' LEU . 32.4 p80 -74.28 167.02 39.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.548 0.69 . . . . 0.0 110.885 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.776 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 43.1 Cg_endo -104.03 12.01 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.67 2.247 . . . . 0.0 112.387 -161.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -89.53 -37.14 14.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.759 -166.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -90.82 -17.24 26.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.896 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' A' ' 40' ' ' PRO . 0.7 OUTLIER -57.3 -43.94 83.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -161.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -50.03 -39.94 43.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.84 -33.92 64.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.868 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -74.0 -25.39 59.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.881 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.537 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 5.1 m-30 -49.97 -53.99 37.32 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.606 0.717 . . . . 0.0 110.936 -160.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 91.5 Cg_endo -79.98 -29.93 2.46 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.77 2.313 . . . . 0.0 112.32 -177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.48 -49.69 21.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -168.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.7 m -66.09 -28.95 45.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.066 -171.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.78 -37.61 85.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.8 -24.99 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.2 p -96.97 0.35 48.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.082 -171.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.632 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 77.2 17.57 79.37 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.394 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -110.88 -174.72 2.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.823 0.344 . . . . 0.0 110.864 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.33 -167.49 12.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.574 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD3' ' CZ3' ' A' ' 10' ' ' TRP . 87.9 Cg_endo -77.64 169.44 20.89 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.668 2.245 . . . . 0.0 112.344 175.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -85.09 -37.01 20.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 160.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.5 mt -129.35 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 47' ' ' PHE . 16.4 tt -137.14 135.34 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.161 -172.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -99.96 145.09 28.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.947 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.681 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 26.7 m95 -126.82 127.05 44.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.852 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.31 -91.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.038 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -112.89 -78.7 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 170.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -71.46 -22.84 61.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -165.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.681 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 94.9 mtt-85 -55.44 -28.61 55.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -164.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.45 ' CG ' ' N ' ' A' ' 68' ' ' GLY . 16.7 p90 -49.39 -44.06 44.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.88 -174.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.45 ' N ' ' CG ' ' A' ' 67' ' ' PHE . . . -74.99 -58.7 3.93 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 -169.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.54 -41.34 95.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.504 -172.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.656 ' HB3' HD21 ' A' ' 75' ' ' LEU . 60.1 m-85 -75.08 -32.57 61.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.962 0.411 . . . . 0.0 110.892 -175.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.01 64.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.134 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -61.33 -27.05 68.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.0 m -83.07 2.36 35.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.016 0.436 . . . . 0.0 110.837 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.24 24.85 63.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.523 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.656 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.1 pp -85.81 -4.54 59.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.868 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.848 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.4 pp -131.57 143.58 50.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.69 154.96 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -71.43 140.45 50.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.891 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 pt -104.14 148.59 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.5 p -131.8 67.14 79.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.604 0.716 . . . . 0.0 111.131 -175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.82 144.85 49.46 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.698 2.265 . . . . 0.0 112.467 169.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 p30 -84.57 -175.16 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -70.35 -31.93 69.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.35 84.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -60.43 -43.84 96.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.96 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -59.65 -41.36 90.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.936 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -52.4 -34.5 48.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.826 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 75.9 mmtt -68.13 -21.3 64.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.189 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.94 124.78 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.923 -177.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.53 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 4.8 p90 -173.08 49.19 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.734 0.778 . . . . 0.0 110.907 162.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 61.4 Cg_endo -73.32 -72.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.645 2.23 . . . . 0.0 112.42 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.473 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 97.3 m-85 -94.87 -29.68 14.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 174.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -71.72 -22.47 61.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.054 -161.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -60.75 -44.33 96.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -172.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.11 -30.74 71.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.897 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.574 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.73 -32.97 71.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -173.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -103.13 14.35 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.23 -169.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -120.99 145.89 47.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -137.96 127.94 25.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.95 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 53.6 t30 58.22 32.91 22.62 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.848 -175.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.38 4.11 89.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -118.13 150.01 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 69.4 mt -84.65 121.37 27.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -113.3 -15.14 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.077 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.49 163.88 24.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.081 -166.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -105.18 146.81 33.43 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.684 0.754 . . . . 0.0 110.891 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.455 ' HG2' HD21 ' A' ' 89' ' ' LEU . 98.0 Cg_endo -76.78 120.13 5.39 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.701 2.267 . . . . 0.0 112.358 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.2 mm -99.8 -46.32 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.037 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.05 152.18 10.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 -163.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 66.7 t -122.37 130.82 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.098 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -125.37 143.07 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.854 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.17 157.01 36.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.05 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.402 HD22 ' HG3' ' A' ' 257' ' ' PRO . 10.0 mp -75.17 146.98 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.915 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.4 m -143.58 160.38 40.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.897 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.479 ' HB2' HD23 ' A' ' 247' ' ' LEU . 60.6 tp -94.99 122.9 38.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.938 -175.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.413 HG12 HG22 ' A' ' 244' ' ' VAL . 61.6 mt -111.74 126.65 69.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.096 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -136.59 158.02 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 -168.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -89.82 111.61 22.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.649 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -65.41 -30.09 70.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.905 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.01 -35.95 61.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.839 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.2 mt -79.02 -49.54 12.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 tp -122.41 108.58 33.57 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.659 0.742 . . . . 0.0 110.903 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.45 -15.19 17.77 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.704 2.269 . . . . 0.0 112.317 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.6 t-20 -147.55 106.81 3.78 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 49.8 Cg_endo -66.72 152.81 79.87 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.677 2.252 . . . . 0.0 112.288 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.44 144.07 60.05 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.65 2.234 . . . . 0.0 112.261 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -83.39 -22.03 32.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.1 t -150.15 170.98 17.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.161 -172.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.74 -32.58 69.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.856 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -71.67 -22.27 61.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.829 -170.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -74.5 -27.96 60.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.562 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 94.4 mt -66.32 -45.14 59.86 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.729 . . . . 0.0 111.061 -164.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.562 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 99.1 Cg_exo -49.62 -48.24 19.85 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.645 2.23 . . . . 0.0 112.332 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.96 -39.38 90.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.014 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.5 ' O ' HD23 ' A' ' 135' ' ' LEU . 2.6 tt -54.98 -35.32 64.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.871 175.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.594 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 26.4 t70 -66.03 -35.05 79.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.902 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.13 -41.23 90.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -70.45 -54.06 13.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.916 -171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 140' ' ' LYS . 1.1 pt? -78.61 -12.54 60.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -173.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.1 tttt -54.55 -29.38 50.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.795 166.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.58 -20.75 65.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.076 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.84 8.49 37.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.923 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.25 58.1 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.509 -176.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -121.8 154.69 36.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.28 . . . . 0.0 110.974 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 42.7 t -110.93 154.98 23.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -70.31 -56.65 6.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.036 -173.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.8 tp -144.35 129.05 18.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.958 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.7 mmm -130.25 132.53 45.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -150.97 174.55 13.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.85 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -67.39 109.71 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.995 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.99 0.12 40.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -85.62 0.26 53.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -128.48 145.72 57.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.555 0.693 . . . . 0.0 110.938 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.489 ' HG3' ' O ' ' A' ' 340' ' ' TRP . 63.9 Cg_endo -79.66 -28.16 3.61 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.603 2.202 . . . . 0.0 112.393 -174.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -53.87 -37.94 64.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -82.14 -36.79 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 -174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 74.3 p -88.36 -30.28 19.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.133 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.626 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 69.4 t90 -54.85 -48.28 96.11 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.535 0.683 . . . . 0.0 110.994 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 75.2 Cg_exo -48.41 -36.44 30.65 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.654 2.236 . . . . 0.0 112.34 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.668 ' O ' HD23 ' A' ' 160' ' ' LEU . 3.7 tt -73.04 -38.63 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.981 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.566 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.2 mt -68.09 -38.06 79.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.207 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -80.5 -15.01 57.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -171.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.06 69.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.111 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.25 7.19 46.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 -171.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.77 12.78 4.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.474 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 162' ' ' ALA . . . -76.6 158.74 49.15 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.489 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.633 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 91.0 m-85 -136.82 152.08 49.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 110.887 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 158' ' ' TRP . . . -101.21 -36.16 9.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.076 171.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.414 ' HD1' ' HA ' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -150.1 130.02 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -175.435 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 55.5 tptt -92.83 120.76 33.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 -173.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.406 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 55.5 t80 -112.47 112.38 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.992 -176.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -150.53 142.74 24.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.929 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 51.2 40.67 26.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.89 -176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 6.32 78.81 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.492 170.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -127.94 146.26 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 41.7 m-85 -89.91 127.85 36.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.911 167.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -102.39 116.62 33.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.839 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 178' ' ' ILE . 7.5 tp -77.77 -19.96 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.139 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -85.9 -7.26 58.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -116.12 92.79 4.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 170.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.0 140.0 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.633 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -99.82 38.87 2.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.477 -168.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.9 m -101.2 -14.53 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.111 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -104.97 18.78 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.851 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -106.7 -171.49 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.854 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -70.11 -38.93 75.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.064 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.6 90.81 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.462 -172.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.75 -37.78 87.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 111.044 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -62.47 -42.46 99.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.901 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.62 -44.64 89.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.088 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -67.2 -46.68 69.51 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.52 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 42.6 tp -66.87 -38.1 85.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.9 0.381 . . . . 0.0 110.916 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 55.8 m -56.96 -43.82 81.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.079 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -64.22 -46.01 85.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.13 -44.87 96.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.825 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 62.9 t -64.99 -40.71 89.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.103 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.54 -36.45 82.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.2 OUTLIER -63.67 -43.97 95.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.76 -39.51 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.161 -176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.51 -32.39 73.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.85 173.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.99 2.48 38.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.97 32.66 10.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.949 173.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -78.93 -30.94 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.814 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 23.5 ptp -150.48 160.06 44.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.872 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.422 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.6 m-20 -100.64 138.63 37.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.23 -24.38 64.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 -175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -97.5 0.6 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 86.2 m -55.1 124.83 18.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.099 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -99.06 170.04 8.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 227' ' ' ASN . 52.5 t80 -62.79 -41.46 99.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.949 175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -62.43 -37.63 86.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.764 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -70.06 -46.3 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.15 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.83 84.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.135 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.73 -41.36 83.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.61 -45.52 86.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.089 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.97 94.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.144 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -64.52 -47.03 80.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.847 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -60.28 -25.78 65.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.77 -5.34 45.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.906 -172.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 16.66 63.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -82.5 -26.98 32.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.89 0.376 . . . . 0.0 110.825 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 224' ' ' MET . 88.0 m -129.3 134.53 47.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.103 177.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.85 -27.71 55.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.115 -169.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.412 ' H ' HG22 ' A' ' 222' ' ' THR . 74.8 mtm -135.19 151.98 51.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.801 -173.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -152.08 165.23 35.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.191 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.7 mt -132.24 133.24 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.123 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 210' ' ' TYR . 37.6 p30 -152.91 160.93 43.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.808 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -107.33 -126.83 5.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.424 -171.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -74.52 -19.17 19.37 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.715 2.277 . . . . 0.0 112.356 -166.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.0 m0 -53.28 -39.83 64.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.28 31.17 11.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.033 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.499 ' O ' ' C ' ' A' ' 233' ' ' SER . 54.2 m0 -60.44 -36.1 77.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 172.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 232' ' ' TRP . 90.1 p 34.26 71.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 163.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -74.85 3.39 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.85 -7.9 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.089 177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -81.18 -50.15 9.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 85.5 m -64.8 -59.52 4.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.077 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 41.3 t -156.23 121.65 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 0.0 110.784 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.65 ' HD2' ' C ' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -165.28 176.02 8.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.884 -176.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.0 t -86.01 -70.91 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.198 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -161.37 90.0 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.817 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.431 ' CD1' ' HB2' ' A' ' 239' ' ' LYS . 75.0 m-85 -114.3 162.39 16.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.649 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -147.17 170.18 28.07 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.5 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.413 HG22 HG12 ' A' ' 116' ' ' ILE . 59.2 t -123.74 131.37 73.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.942 0.401 . . . . 0.0 111.091 -175.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -142.71 177.94 7.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.172 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.64 160.7 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -175.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 115' ' ' LEU . 89.0 mt -77.65 149.73 78.22 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.621 0.724 . . . . 0.0 110.944 -176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -56.21 146.86 69.21 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.47 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 81.8 p -128.87 146.21 51.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -125.49 111.66 15.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.3 mttt 45.03 40.36 4.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 167.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 78.01 28.34 56.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 166.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 97.6 mm-40 -109.99 159.52 31.53 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.936 -170.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 60.0 Cg_endo -65.33 73.96 0.27 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 73.8 p -98.47 4.14 48.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 -168.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.473 ' HB3' ' HE2' ' A' ' 256' ' ' LYS . 13.2 ptpt -139.84 158.37 67.8 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.552 0.691 . . . . 0.0 110.835 -173.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 33.4 Cg_endo -71.89 167.24 27.19 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.627 2.218 . . . . 0.0 112.389 -169.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -72.91 176.65 5.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.423 HG23 ' HA3' ' A' ' 327' ' ' GLY . 96.5 t -118.69 134.31 62.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.142 -171.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.02 146.37 16.07 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.433 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.0 t -128.48 128.71 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.774 0.321 . . . . 0.0 111.266 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 60.4 tp -76.96 135.3 38.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.92 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 93.1 p -129.87 150.93 50.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 -175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.41 130.31 44.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.033 176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.95 162.89 15.55 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.515 -170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 40.6 mm -100.65 129.5 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -62.85 124.9 22.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.94 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.43 -27.9 67.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.078 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.632 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -81.96 -13.85 56.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 20.2 t -72.28 132.67 83.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.645 0.736 . . . . 0.0 110.86 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.07 -7.75 21.7 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.687 2.258 . . . . 0.0 112.407 170.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -104.04 27.62 7.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 -168.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -50.85 -47.74 60.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.39 -38.93 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.938 -174.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.5 tp -56.81 -53.13 61.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.11 -42.58 75.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.117 -173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.39 -48.93 65.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 -171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.29 -47.72 72.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.957 -172.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -70.63 -33.67 71.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -176.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 284' ' ' LEU . 36.3 tp -55.97 -47.96 76.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.947 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -83.07 -27.0 30.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.31 -10.91 19.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -169.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 86.8 t80 -124.98 -60.1 1.38 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.416 ' HB2' HD12 ' A' ' 280' ' ' LEU . 77.6 mt -70.29 -41.27 73.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.981 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.32 65.22 8.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.0 p -138.09 169.34 17.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 172.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -56.92 -42.08 79.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -77.0 -42.54 38.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -78.1 -47.89 8.04 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.546 -170.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.0 -35.06 79.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.767 0.318 . . . . 0.0 110.932 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.52 -42.82 99.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.96 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.95 -30.21 71.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.126 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.6 t -77.36 -45.65 29.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.068 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.473 ' HB3' ' CA ' ' A' ' 300' ' ' GLY . 59.0 m-20 -74.73 -5.5 43.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -54.41 -18.97 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -74.79 -18.07 60.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.06 154.18 42.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 0.0 110.947 175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.71 -41.81 10.23 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.69 2.26 . . . . 0.0 112.331 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 299' ' ' LEU . 3.3 mm? -92.59 -44.35 8.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.907 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 294' ' ' ASN . . . 62.33 54.42 34.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.432 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -56.69 124.31 17.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.844 0.354 . . . . 0.0 111.072 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.2 m -110.15 149.31 13.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.164 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.63 -14.61 61.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.062 165.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.18 119.26 22.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.895 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.414 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 87.7 tttt -61.77 -44.46 96.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.865 -166.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.0 t -58.83 -49.84 76.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.843 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -74.23 -31.49 62.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.97 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.445 ' HG3' ' HE1' ' A' ' 321' ' ' MET . 89.0 tt0 -56.83 -39.44 74.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.829 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.23 -32.42 73.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -48.05 23.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.846 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.536 HD11 ' HE1' ' A' ' 321' ' ' MET . 3.4 pp -73.55 -18.71 61.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.19 -7.93 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.008 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -72.9 -11.23 60.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.94 -173.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -86.43 122.01 72.17 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.678 0.751 . . . . 0.0 110.94 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.98 -31.78 28.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.642 2.228 . . . . 0.0 112.373 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.65 -42.48 74.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.811 -176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 311' ' ' LEU . 3.0 tp -80.99 -29.86 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.069 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.58 84.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.128 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.4 86.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 65.9 m -67.38 -43.87 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.536 ' HE1' HD11 ' A' ' 311' ' ' LEU . 58.2 mtt -69.61 -34.82 74.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.799 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -66.26 -37.33 85.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 174.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -64.96 -34.04 77.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.49 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.042 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -70.31 -21.04 62.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.955 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.96 -5.96 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.893 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -96.11 -163.0 33.36 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.478 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -128.93 137.06 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 39.6 mm -78.3 115.67 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 26.3 mmt 61.72 155.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.576 0.703 . . . . 0.0 110.895 173.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.91 -113.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.257 . . . . 0.0 112.349 168.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -162.22 -52.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 169.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.89 164.35 31.82 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 111.231 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.41 -19.77 52.97 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.823 2.349 . . . . 0.0 112.318 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -58.87 -23.58 61.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.869 -173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.543 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 94.8 mmm -69.66 -24.83 63.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.886 -176.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.73 -37.12 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.95 -30.76 64.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.155 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.543 ' HB3' ' O ' ' A' ' 336' ' ' MET . 21.8 t80 -57.63 -49.95 74.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.988 175.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.489 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.7 m95 -61.36 -44.16 97.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.91 -175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.68 -43.81 76.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.83 78.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 63.8 t -70.76 -44.92 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.191 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -57.34 -48.11 79.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.87 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 73.9 p -66.65 -32.95 74.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.2 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.92 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.2 t -66.76 -47.87 81.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.136 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 41.5 mm -64.73 -44.69 96.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -176.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.17 -38.13 89.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.67 -44.91 69.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.53 -33.9 69.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.5 p -79.51 -8.46 59.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.0 82.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.455 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.44 -29.52 57.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 0.0 110.837 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -140.01 157.86 44.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.91 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 37.1 p -78.12 172.97 12.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.135 171.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.91 -45.26 95.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -70.43 -38.92 74.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.847 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -71.68 -39.28 70.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 -173.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.54 96.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.026 173.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.5 -35.09 78.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.933 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -64.64 -42.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -68.17 -31.41 70.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.75 -46.43 63.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.143 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -63.21 -38.31 90.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.911 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.2 m -59.48 -40.34 86.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.02 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.94 -36.81 62.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.85 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 339' ' ' PHE . 71.4 mt -63.02 -48.46 87.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.06 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.9 p -96.21 -0.72 49.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -174.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.9 tttt . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.767 0.317 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -83.49 136.83 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.01 -178.98 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.992 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -75.14 119.62 19.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.961 -177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.04 25.27 27.26 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.435 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.93 152.94 41.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 0.0 110.904 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.695 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.7 pp -149.03 148.76 30.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 84.6 t -126.12 128.13 71.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 49.0 mt -117.46 134.33 61.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.66 ' CH2' ' HD3' ' A' ' 57' ' ' PRO . 30.7 m0 -113.07 127.19 56.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 40' ' ' PRO . 18.1 tt -152.94 159.34 3.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.164 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.67 ' HA ' ' HG3' ' A' ' 40' ' ' PRO . 59.3 t-20 -55.88 118.53 4.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.916 169.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.661 ' H ' ' HG3' ' A' ' 40' ' ' PRO . . . -74.12 -24.72 72.93 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.487 -170.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -54.03 -47.11 71.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.806 0.336 . . . . 0.0 110.824 -167.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 74.9 mmtt -129.58 80.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 146.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -115.05 -36.63 1.21 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.527 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.54 -43.51 17.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.935 0.398 . . . . 0.0 110.957 -157.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -67.72 -52.58 35.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 -158.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.8 -45.25 96.61 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.582 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 24' ' ' GLY . 50.0 mt -59.43 -37.98 79.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.918 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.95 92.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.087 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -56.87 -49.7 74.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.819 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -77.25 -33.48 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.185 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' LEU . . . -66.12 -42.57 94.38 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.562 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.6 -43.15 69.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.814 0.34 . . . . 0.0 110.882 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.59 -40.21 93.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.942 175.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -65.39 -41.2 93.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 171.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.23 -31.94 72.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.835 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -74.81 -34.86 62.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.3 -40.79 20.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.863 -174.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.1 p -104.16 -22.07 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.157 -173.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.85 4.21 88.85 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.415 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.415 HG21 HD23 ' A' ' 7' ' ' LEU . 97.7 mt -76.61 121.7 29.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 111.205 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.83 120.52 12.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.9 t -100.2 135.77 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.097 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -139.39 117.81 12.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 76.7 t -106.6 127.71 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -117.19 160.74 20.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.988 -178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -68.82 162.31 64.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.555 0.693 . . . . 0.0 110.859 -173.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.67 ' HG3' ' HA ' ' A' ' 12' ' ' ASN . 60.5 Cg_endo -98.82 -3.95 0.84 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.725 2.283 . . . . 0.0 112.384 -164.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -81.46 -30.81 33.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.843 -154.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.45 -16.94 31.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.616 HD21 ' HB3' ' A' ' 10' ' ' TRP . 5.7 mp -61.18 -36.52 80.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.921 -156.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 47' ' ' PHE . 50.2 mt-10 -48.75 -35.98 15.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.58 -36.01 57.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -75.52 -29.53 59.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -173.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 3.6 m-85 -48.18 -54.52 24.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.616 0.722 . . . . 0.0 110.903 -160.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 95.7 Cg_endo -80.16 -29.31 2.63 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.825 2.35 . . . . 0.0 112.19 -177.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -75.15 -48.93 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.016 0.436 . . . . 0.0 111.046 -167.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -64.92 -32.63 59.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.122 -175.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' A' ' 269' ' ' ALA . . . -62.7 -38.26 89.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.033 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.43 63.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -98.92 0.09 43.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.09 -171.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 75.14 17.91 80.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.515 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -109.72 -174.43 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.769 0.319 . . . . 0.0 110.888 -177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.72 -171.3 15.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.495 175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.66 ' HD3' ' CH2' ' A' ' 10' ' ' TRP . 83.7 Cg_endo -79.46 174.67 11.59 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.357 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.36 -38.38 22.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 164.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -134.35 139.03 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.213 -172.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 mt -130.86 144.76 36.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.061 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -100.87 139.71 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.879 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 6.1 m95 -126.63 123.41 37.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.73 -91.99 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 -167.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -112.52 -82.39 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -73.9 -19.29 60.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.841 -164.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 96.4 mtt-85 -52.71 -30.71 33.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.842 -168.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -51.09 -39.38 55.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 -171.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.05 -59.46 3.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.531 -168.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.56 -38.08 90.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.387 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.609 ' HB3' HD21 ' A' ' 75' ' ' LEU . 47.3 m-85 -76.47 -32.62 58.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.944 0.402 . . . . 0.0 110.874 -174.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.13 -36.39 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -62.64 -28.51 69.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -82.4 1.42 37.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.852 -177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.78 23.77 59.26 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.461 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.609 HD21 ' HB3' ' A' ' 70' ' ' TYR . 4.3 pp -85.89 1.15 51.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.752 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.1 pp -134.21 144.34 48.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.928 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -86.04 153.13 22.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.073 -174.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.92 132.99 46.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG21 ' CE2' ' A' ' 106' ' ' TYR . 66.8 mt -109.35 139.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.182 -173.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 p -130.81 76.9 76.45 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.68 0.753 . . . . 0.0 111.161 -167.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.96 152.53 31.93 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.743 2.295 . . . . 0.0 112.407 167.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -83.19 -176.98 6.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.848 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.6 -34.51 78.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.957 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.75 99.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.102 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -66.85 -35.08 79.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.922 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -64.77 -41.57 95.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.904 176.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -53.07 -30.07 33.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.851 ' O ' ' HB3' ' A' ' 89' ' ' LEU . 45.0 mtmt -65.1 -17.78 64.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.942 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.167 ' O ' HD22 ' A' ' 89' ' ' LEU . 0.0 OUTLIER 159.62 123.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 178.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 90' ' ' TYR . 8.2 p90 -174.75 51.16 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.692 0.758 . . . . 0.0 110.957 166.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 90' ' ' TYR . 59.3 Cg_endo -72.22 -71.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.67 2.247 . . . . 0.0 112.186 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.46 ' H ' ' HG2' ' A' ' 91' ' ' PRO . 33.1 p90 -104.48 -19.26 14.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.8 p -67.55 -25.25 65.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.173 -168.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 90' ' ' TYR . 47.8 t-105 -62.28 -42.26 99.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.967 -174.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.34 -29.69 70.46 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.547 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.35 -34.35 74.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.122 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.3 m -105.45 13.46 7.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 -170.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -117.75 149.3 41.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.86 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -139.12 128.13 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.0 t30 58.32 34.03 23.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.65 4.71 90.21 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.543 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -119.36 149.13 42.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.949 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.4 tp -83.96 125.06 31.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.882 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 pt -116.71 -10.09 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.79 167.61 22.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.171 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.471 ' CE2' HG21 ' A' ' 79' ' ' ILE . 74.9 m-85 -109.6 144.78 30.58 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.786 0.803 . . . . 0.0 110.91 171.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.4 Cg_exo -65.41 117.11 4.3 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.751 2.301 . . . . 0.0 112.341 173.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.7 mm -100.54 -32.92 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.153 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -169.23 151.69 4.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.114 -170.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.8 t -118.5 124.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.112 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -118.48 130.14 55.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.893 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.03 153.02 30.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.134 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.427 HD22 ' HG3' ' A' ' 257' ' ' PRO . 10.8 mp -74.33 147.82 41.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -175.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 85.0 p -141.46 158.64 43.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.43 ' HB2' HD23 ' A' ' 247' ' ' LEU . 46.1 tp -98.85 125.89 44.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.952 -175.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.44 HG12 HG22 ' A' ' 244' ' ' VAL . 63.9 mt -111.7 130.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.173 172.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -135.35 155.8 49.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -96.16 112.92 24.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.5 -24.05 67.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.017 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -82.88 -34.45 26.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.865 -175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.83 -47.36 13.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.7 tp -123.37 108.88 31.37 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.655 0.741 . . . . 0.0 110.92 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.53 -13.43 22.54 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.67 2.247 . . . . 0.0 112.424 -175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -147.12 108.34 3.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.637 0.732 . . . . 0.0 110.887 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.49 153.78 76.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 0.0 112.349 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -70.75 141.83 42.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.583 2.189 . . . . 0.0 112.251 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.72 -17.77 26.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 175.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 15.0 t -144.37 165.02 29.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.144 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -67.26 -28.87 68.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -60.34 -29.53 68.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.848 -174.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.12 -21.09 60.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.588 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 34.6 mm -59.8 -53.47 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.133 -167.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.1 Cg_endo -64.72 -45.79 7.96 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.729 2.286 . . . . 0.0 112.31 -173.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.41 -42.68 96.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.045 176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 25.5 mt -60.98 -38.65 86.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.939 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 10.2 t70 -64.63 -36.1 83.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.05 -36.16 83.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.54 -57.53 5.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 -173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 145' ' ' SER . 1.7 pt? -81.09 -11.45 59.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -175.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 86.4 tttt -56.18 -29.32 60.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.783 166.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.09 65.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -102.88 11.17 37.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.946 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.21 75.3 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.426 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 39.9 mmtm -117.89 157.28 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.53 ' O ' HD11 ' A' ' 139' ' ' LEU . 30.0 t -115.14 154.44 28.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.82 175.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -73.79 -55.0 6.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.0 tp -143.69 130.62 20.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.8 mtp -122.86 134.8 54.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -149.69 165.96 30.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.809 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 156' ' ' PHE . 57.7 t-20 -58.9 111.9 1.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.937 -172.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.985 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.7 tm? -89.44 -21.57 22.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.981 174.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.31 -2.5 38.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 -174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -133.83 149.97 73.31 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.647 0.736 . . . . 0.0 110.94 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 71.2 Cg_endo -77.84 -21.6 10.94 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.633 2.222 . . . . 0.0 112.37 -177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -59.7 -40.97 89.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.927 -176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 150' ' ' ASN . 56.2 m-85 -85.16 -27.75 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.753 -175.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 76.2 p -89.07 -31.03 18.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.137 -172.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.619 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 70.8 t90 -55.32 -47.84 97.65 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.558 0.694 . . . . 0.0 110.909 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 73.9 Cg_exo -47.96 -38.45 31.33 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.638 2.225 . . . . 0.0 112.294 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 160' ' ' LEU . 4.0 tt -73.85 -38.62 64.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.941 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.56 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 97.3 mt -67.47 -37.14 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.78 -14.35 58.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.04 -174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.01 68.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.064 -166.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -96.83 5.03 51.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 123.38 12.89 4.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.575 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.75 158.37 48.5 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.561 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.718 ' HB2' ' HA3' ' A' ' 182' ' ' GLY . 90.0 m-85 -136.85 155.2 50.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.959 0.409 . . . . 0.0 110.915 177.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.21 -31.12 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.049 171.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.11 130.11 12.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 54.9 tptt -93.55 121.73 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.852 -174.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.429 ' HB2' ' CE1' ' A' ' 176' ' ' TYR . 64.2 t80 -113.89 113.06 24.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.997 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -150.11 143.8 25.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.878 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 51.06 41.0 26.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.855 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.73 5.99 76.1 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.549 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -128.87 146.2 51.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.721 0.296 . . . . 0.0 110.881 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.429 ' CE1' ' HB2' ' A' ' 171' ' ' TYR . 30.2 m-85 -88.08 129.58 35.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.918 167.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -103.17 114.12 28.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.811 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 6.7 tp -77.32 -20.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.104 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -87.3 -8.88 56.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.812 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -114.11 92.96 4.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.943 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.54 141.44 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.183 -176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.718 ' HA3' ' HB2' ' A' ' 167' ' ' TYR . . . -102.86 29.79 11.76 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.402 -170.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 p -91.55 -22.4 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.773 0.32 . . . . 0.0 111.145 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 51.3 p-10 -104.95 24.75 11.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.809 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -104.45 -174.5 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.9 -40.25 87.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.987 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.61 -44.01 93.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -36.72 84.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.775 0.321 . . . . 0.0 111.102 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.51 -42.23 98.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.832 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.99 -45.04 87.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.045 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -66.07 -44.21 91.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.442 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 50.5 tp -64.98 -40.47 95.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.954 0.407 . . . . 0.0 110.892 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 77.5 m -57.75 -43.3 85.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.058 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -63.73 -44.44 93.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.885 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 63.8 tp -59.06 -45.34 91.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.938 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.76 -40.1 86.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -64.76 -39.87 94.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.855 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 198' ' ' LEU . 1.7 mp -65.77 -44.27 86.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.49 -38.39 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.221 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.3 -35.44 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.825 171.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -84.59 4.62 31.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.45 31.58 10.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.0 174.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -77.51 -29.58 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 65.7 ttp -147.9 150.09 33.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 174.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -86.35 136.88 32.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.905 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.95 -22.99 67.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -91.11 0.0 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.879 -177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.2 m -59.98 129.09 40.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 -176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -108.66 169.01 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.841 167.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -68.98 -32.61 72.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.034 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.0 p -69.37 -38.79 78.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.788 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 92.1 mt -66.87 -39.53 83.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.145 174.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.14 -36.9 85.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -69.14 -38.23 78.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.76 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.45 -45.43 90.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.52 -40.59 93.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.124 174.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.75 -40.98 92.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.81 -19.88 66.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -96.67 -10.11 27.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.99 63.24 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.44 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -80.78 -25.75 37.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 110.813 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 74.6 m -128.48 133.7 48.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.68 -28.74 60.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 -169.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 70.9 mtm -131.85 151.59 51.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 -175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.5 t -150.04 161.5 42.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.4 mt -127.7 128.7 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.157 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -122.29 150.85 41.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.897 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.416 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -120.32 -131.19 4.07 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.465 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.416 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 20.5 Cg_endo -67.06 -24.1 45.49 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.714 2.276 . . . . 0.0 112.302 -170.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -53.44 -33.09 52.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 60.62 36.3 19.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.028 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.577 ' O ' ' C ' ' A' ' 233' ' ' SER . 78.3 m95 -41.97 -36.97 1.22 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.905 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.577 ' C ' ' O ' ' A' ' 232' ' ' TRP . 18.8 p 15.08 60.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -171.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 232' ' ' TRP . 78.8 m-20 -78.51 20.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -169.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 pt -117.59 -9.89 11.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 170.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -69.43 -61.27 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.809 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 99.4 m -54.27 -48.06 71.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.0 t -155.47 140.92 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.845 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.1 166.32 30.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.0 t -92.65 -70.37 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.134 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -150.66 70.81 1.02 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -108.93 160.51 15.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.43 167.18 25.6 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 116' ' ' ILE . 41.2 t -124.23 131.39 72.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 0.0 111.064 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.47 175.83 9.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.61 162.87 3.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 115' ' ' LEU . 96.9 mt -77.25 149.01 78.71 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.586 0.708 . . . . 0.0 110.96 -174.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.79 156.13 67.17 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.693 2.262 . . . . 0.0 112.374 -176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.443 ' HA ' ' OG ' ' A' ' 255' ' ' SER . 12.9 t -142.87 150.23 39.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.234 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.32 114.92 20.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.836 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt 50.04 36.13 11.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.912 170.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.28 29.16 51.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.512 166.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.48 ' HB3' ' HD2' ' A' ' 254' ' ' PRO . 99.2 mm-40 -110.07 161.62 23.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 110.82 -167.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 253' ' ' GLN . 46.4 Cg_endo -60.98 75.45 0.08 OUTLIER 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 0.0 112.416 174.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 249' ' ' THR . 81.5 p -94.85 -4.83 46.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.784 -162.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 257' ' ' PRO . 10.7 ptpt -136.42 158.43 73.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.643 0.735 . . . . 0.0 110.871 -167.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 256' ' ' LYS . 28.4 Cg_endo -70.26 166.92 26.62 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 122.643 2.229 . . . . 0.0 112.342 -169.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -68.93 170.03 10.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.42 HG23 ' HA3' ' A' ' 327' ' ' GLY . 61.5 t -120.13 133.31 67.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.093 -170.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.21 141.6 16.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.0 t -125.23 128.36 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 66.9 tp -74.05 135.23 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 94.2 p -126.95 147.67 50.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.84 126.2 42.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -123.39 163.61 16.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.431 -170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.4 mt -106.36 129.96 58.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.37 . . . . 0.0 111.147 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -61.98 126.52 27.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.969 -177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.79 -27.98 69.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.492 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -80.49 -13.11 59.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.133 -175.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 25.3 t -72.29 127.59 90.04 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.684 0.754 . . . . 0.0 110.934 -174.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -69.59 -6.54 18.76 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.728 2.285 . . . . 0.0 112.435 169.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.43 25.65 7.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -169.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -51.04 -40.87 59.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.877 -173.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.19 -39.57 89.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 -178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 70.3 mt -64.89 -52.45 56.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.28 89.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 -164.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -69.78 -49.84 48.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.939 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.78 -53.63 47.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 -162.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.482 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 7.5 p90 -75.21 -25.63 58.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.48 -50.44 69.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.92 175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -80.19 -29.28 38.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.953 -175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -101.97 -23.45 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.846 -164.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 93.6 t80 -118.16 -50.67 2.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -175.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.98 -39.31 61.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.943 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 106' ' ' TYR . 6.7 mp -83.33 62.27 6.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 52.9 p -135.74 165.29 25.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.157 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -51.91 -49.68 62.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.77 -39.02 53.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.17 -46.69 20.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 -170.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 23.7 tp -70.19 -35.35 73.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.825 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -58.46 -43.19 88.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.85 64.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.156 -173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.592 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 88.9 t -77.33 -41.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.75 -18.53 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -54.72 -18.97 5.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' LYS . 87.7 m-20 -81.18 -30.15 34.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -100.64 150.26 36.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.668 0.747 . . . . 0.0 110.876 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.83 -22.78 10.02 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.635 2.223 . . . . 0.0 112.364 -173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.5 tp -68.49 -58.22 4.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 89.02 3.85 75.74 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.66 34.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.851 0.358 . . . . 0.0 111.034 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 25.3 m -120.46 156.19 23.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.038 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.16 -12.89 60.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 51.4 tp -74.59 120.47 20.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.889 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.457 ' H ' ' HB3' ' A' ' 89' ' ' LEU . 59.6 tttm -62.3 -46.82 87.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 -172.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.6 m -57.29 -47.15 82.22 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.91 -33.63 70.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.951 176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.17 -37.6 85.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.823 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -57.7 -34.96 70.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -78.2 -38.43 43.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.893 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 97.3 mt -66.27 -25.12 66.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.07 -7.94 20.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.06 -173.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -79.33 -16.7 55.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.988 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -88.54 120.86 70.39 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -50.46 -31.99 32.82 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.721 2.281 . . . . 0.0 112.232 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 39.3 ttp-105 -69.7 -48.61 58.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 92.5 mt -76.2 -39.15 35.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.132 -174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.29 -38.82 84.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.075 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.19 -40.07 90.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 58.1 m -63.06 -45.76 90.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.141 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 24.2 mmt -68.67 -37.6 79.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -65.28 -40.06 93.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.5 -34.17 76.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.875 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.8 -39.15 90.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -71.79 -20.18 61.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.991 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -102.83 -8.19 20.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.958 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.42 ' HA3' HG23 ' A' ' 259' ' ' VAL . . . -94.56 -160.0 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.434 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -124.51 132.1 53.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 0.0 110.871 175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.547 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 39.0 mm -79.94 120.48 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.121 -174.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 26.2 mmt 64.59 156.12 0.12 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.513 0.673 . . . . 0.0 110.958 169.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.433 ' HB2' ' H ' ' A' ' 332' ' ' ASN . 75.3 Cg_endo -69.83 -147.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.581 2.187 . . . . 0.0 112.363 164.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.433 ' H ' ' HB2' ' A' ' 331' ' ' PRO . 48.7 t30 -147.79 -54.02 0.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 174.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.9 pt -124.99 164.02 34.04 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.662 0.744 . . . . 0.0 111.176 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -58.32 -20.92 50.14 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.779 2.319 . . . . 0.0 112.411 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -59.01 -23.08 61.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 -171.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.494 ' O ' ' HB3' ' A' ' 339' ' ' PHE . 93.5 mmm -67.44 -26.9 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.6 m -62.33 -36.73 83.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.797 175.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.36 -31.3 65.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.089 173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 336' ' ' MET . 39.4 t80 -58.19 -49.99 75.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.004 176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.644 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 85.8 m95 -61.71 -42.56 99.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.992 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -57.31 -42.49 81.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.21 -37.12 86.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 72.7 t -73.26 -40.27 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.173 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.654 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 78.8 ttt-85 -55.79 -44.98 78.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.835 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.4 m -62.11 -42.79 99.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -62.36 -43.72 98.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.13 -49.89 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.115 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.93 -44.09 99.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.099 -177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -65.04 -37.75 88.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.44 69.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.048 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.26 -35.28 73.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.161 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -79.92 -7.11 58.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.96 11.82 84.09 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.584 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.1 -29.87 60.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.309 . . . . 0.0 110.88 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -140.67 155.2 46.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 42.2 p -74.49 172.17 12.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.07 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 33.0 m -71.58 -35.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.227 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.16 -40.77 86.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 174.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -69.73 -45.26 68.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.917 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.4 92.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.184 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 89.0 mt -69.18 -36.04 76.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.931 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -65.04 -42.44 94.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 174.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.46 -31.76 73.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -69.46 -45.04 69.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.16 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -61.84 -39.1 90.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 92.4 m -59.99 -41.54 92.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -73.63 -34.68 65.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.5 mt -59.98 -40.01 81.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.185 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.8 p -93.5 -11.46 31.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 370' ' ' LYS . 88.5 tttt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.628 0.251 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 77.4 mt -90.38 132.54 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.189 176.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 93.8 mt-10 -131.75 166.91 20.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.964 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.62 124.57 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.71 23.15 43.57 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.465 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 90.5 mttt -144.71 159.0 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.803 ' C ' HD12 ' A' ' 7' ' ' LEU . 1.8 pp -146.45 145.91 30.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.89 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.7 t -125.99 124.74 66.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -175.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.61 HG22 ' HB ' ' A' ' 59' ' ' ILE . 7.8 pt -126.61 132.46 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.529 ' HB3' HD21 ' A' ' 43' ' ' LEU . 37.2 m0 -116.27 137.8 51.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.7 tt -148.06 154.12 11.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.479 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.4 t-20 -55.5 127.87 31.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.854 174.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.77 79.35 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.586 -167.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.36 -53.46 57.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.908 0.385 . . . . 0.0 110.921 -162.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.06 73.95 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 147.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -103.31 -40.19 2.46 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.5 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -70.44 -42.1 71.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.943 0.401 . . . . 0.0 110.97 -156.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -67.69 -51.81 45.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.88 -157.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.77 -48.56 83.3 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.42 -177.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.2 mt -60.81 -36.78 79.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 0.0 110.886 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.17 95.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.052 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.37 -52.0 67.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -72.74 -32.55 41.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.047 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.12 -43.04 96.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.52 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.93 -49.22 71.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.71 -43.06 90.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -63.47 -44.29 94.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.93 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -63.12 -33.8 76.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -71.83 -42.2 67.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -83.43 -38.03 22.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.796 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 90.4 m -99.59 -24.0 14.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 -173.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.18 1.01 86.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.43 124.72 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 0.0 111.17 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.04 130.54 43.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -170.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 7' ' ' LEU . 77.8 t -109.03 135.22 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 93.0 m -127.63 111.9 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.148 -176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG22 HD11 ' A' ' 9' ' ' ILE . 52.6 t -101.76 120.56 51.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 54.9 mt-10 -131.88 153.15 50.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.937 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.423 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.8 p80 -132.3 75.13 74.93 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.637 0.732 . . . . 0.0 110.876 173.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 12.7 Cg_endo -69.76 -29.65 23.54 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.672 2.248 . . . . 0.0 112.452 -160.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.5 m-20 78.0 4.06 2.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -174.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -94.36 -2.02 52.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 172.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.529 HD21 ' HB3' ' A' ' 10' ' ' TRP . 79.9 mt -48.95 -57.25 6.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -152.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.33 -41.66 94.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.854 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -83.44 -40.33 19.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -170.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -75.51 -49.99 17.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -166.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.831 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 82.9 t80 -55.3 -52.22 73.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.694 0.759 . . . . 0.0 110.81 -163.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.831 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 88.0 Cg_exo -52.48 -38.7 74.96 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 0.0 112.35 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -73.88 -47.26 39.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.888 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.0 m -74.83 -26.15 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.44 91.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.047 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -23.58 65.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -93.03 6.75 46.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.01 18.95 73.72 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.482 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.0 t0 -117.18 -172.96 2.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.773 0.321 . . . . 0.0 110.962 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.45 167.02 22.8 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.49 176.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 59.8 Cg_endo -68.51 168.45 19.73 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.605 2.203 . . . . 0.0 112.337 176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -73.27 -42.61 62.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' A' ' 9' ' ' ILE . 75.7 mt -136.73 143.3 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.198 -171.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.7 mm -118.28 136.61 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.186 173.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.74 122.44 47.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -147.71 157.61 43.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.919 169.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -87.5 -103.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -95.75 -50.03 5.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -62.04 -61.44 2.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.931 -162.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -77.92 -31.93 51.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 -172.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -57.42 -48.23 79.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.77 -166.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.4 -48.21 87.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.556 -173.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.34 -39.36 64.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 174.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.0 m-30 -65.68 -32.99 74.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.943 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.39 80.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.45 -25.88 65.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.0 m -82.52 0.02 44.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.867 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.74 30.3 76.96 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.476 177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.9 mt -85.41 -5.21 59.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.785 0.326 . . . . 0.0 110.846 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -128.58 143.39 50.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.827 -173.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 154.33 20.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -69.05 136.76 52.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 pt -109.31 151.72 11.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.8 p -130.11 68.16 80.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.547 0.689 . . . . 0.0 111.197 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.3 141.8 32.64 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.719 2.279 . . . . 0.0 112.284 172.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -78.23 172.05 14.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.55 -31.97 73.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.811 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.52 84.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.058 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -79.87 -31.85 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.94 -43.63 94.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -70.8 -28.39 64.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -66.12 -26.49 67.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.862 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 mt -97.01 -137.7 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.922 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -132.33 139.59 35.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.762 0.791 . . . . 0.0 110.884 173.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.9 -42.0 70.23 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.778 2.318 . . . . 0.0 112.408 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -70.44 -24.82 62.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -77.42 -28.66 52.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.129 173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.432 ' HA ' HG22 ' A' ' 97' ' ' VAL . 64.2 m95 -73.02 -33.21 65.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 176.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -59.53 -34.43 72.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.09 -28.54 65.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 34.8 m -106.47 12.48 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.158 -174.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.8 ttp-105 -108.35 133.76 52.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -134.97 126.02 27.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 58.29 34.81 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.28 5.24 89.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.396 175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -120.91 146.4 46.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.89 0.376 . . . . 0.0 110.85 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.73 125.28 33.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 -178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.447 ' HB ' HD13 ' A' ' 76' ' ' LEU . 38.3 pt -121.65 -8.13 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -167.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.39 161.98 37.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.053 -171.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 98.8 m-85 -109.14 130.93 22.15 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.623 0.725 . . . . 0.0 110.987 174.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 26.5 Cg_exo -62.53 115.58 2.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.749 2.299 . . . . 0.0 112.302 172.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.6 mm -104.85 -34.49 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.53 153.63 21.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.048 -169.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.6 t -123.24 129.85 74.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 -175.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 229' ' ' PRO . 10.2 pt-20 -131.16 149.21 52.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.897 171.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.48 154.88 37.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.6 tp -71.5 133.69 46.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.936 175.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.9 p -142.46 160.78 39.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -174.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -97.48 128.39 44.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.892 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 91.4 mt -111.43 129.61 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.046 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -129.06 153.9 47.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -95.33 118.87 32.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.64 -32.27 73.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -84.31 -35.43 23.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.909 -171.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.71 -44.36 50.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.867 173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.4 tp -139.34 109.54 7.49 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.582 0.706 . . . . 0.0 110.985 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.586 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.8 Cg_endo -74.39 177.07 8.81 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.695 2.263 . . . . 0.0 112.436 171.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.586 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.1 t30 21.5 96.41 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.51 0.671 . . . . 0.0 110.922 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 45.8 Cg_endo -65.51 156.74 61.98 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.373 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -66.27 144.66 75.4 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.676 2.251 . . . . 0.0 112.363 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -87.92 -21.63 24.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 70.0 p -134.75 159.46 41.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.138 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -68.03 -33.44 74.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.981 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -55.49 -25.46 37.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.773 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.22 -20.84 60.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 27.6 mm -56.26 -54.77 49.26 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.532 0.682 . . . . 0.0 111.101 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 20.5 Cg_endo -61.86 -40.81 41.76 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.661 2.24 . . . . 0.0 112.371 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.209 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 mt -64.8 -35.22 80.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.939 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -63.05 -36.91 85.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -68.84 -43.21 75.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.25 -37.76 78.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 35.0 mt -70.32 -35.04 73.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -55.88 -32.84 64.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.944 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.82 -23.6 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.141 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -102.85 6.4 39.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.822 -177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.17 25.66 70.46 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.516 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 90.3 mttt -112.95 154.66 26.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.803 0.335 . . . . 0.0 110.881 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.8 t -106.77 151.6 24.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 167.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.39 -42.44 68.37 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.107 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 89.5 mt -139.95 146.0 38.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 86.8 mmm -136.7 124.25 22.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.879 157.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.78 167.45 30.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.804 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 54.7 t-20 -67.39 117.95 10.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.88 -167.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 86.4 mt -108.08 4.61 25.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.42 ' N ' ' OD1' ' A' ' 150' ' ' ASN . 79.2 mt-30 -84.59 -0.96 55.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.946 172.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.87 143.22 36.51 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.626 0.726 . . . . 0.0 110.844 176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.6 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 33.2 Cg_endo -70.61 -27.19 22.73 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.72 2.28 . . . . 0.0 112.37 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.401 ' HA ' ' CD1' ' A' ' 158' ' ' TRP . 82.7 t80 -56.11 -46.74 79.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.89 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 61.1 m-85 -80.37 -20.07 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -173.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.3 p -75.45 -22.15 57.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.171 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 162' ' ' ALA . 2.5 m95 -59.84 -46.18 98.31 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.522 0.677 . . . . 0.0 110.863 -168.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.569 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 52.3 Cg_exo -41.97 -36.26 3.62 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.697 2.265 . . . . 0.0 112.334 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.1 tp -81.5 -49.12 10.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.717 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.3 mt -81.33 -49.72 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 -170.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -63.32 -19.0 64.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.138 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -61.43 -28.28 69.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.213 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -101.42 2.26 39.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.918 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 103.4 10.27 36.47 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.444 170.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -112.4 135.09 12.44 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.375 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -153.6 170.04 21.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.941 -165.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.62 -48.03 80.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.06 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -145.87 155.32 42.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -80.92 124.43 29.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -104.62 110.84 23.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -149.48 138.76 21.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -169.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 49.0 38.98 13.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 -173.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.88 10.39 72.4 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.393 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -136.77 154.81 50.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.735 0.303 . . . . 0.0 110.857 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -70.33 147.62 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.863 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -129.63 107.73 9.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 -174.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.0 mm -76.93 -29.1 17.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -83.79 -22.81 31.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 -170.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -120.54 65.25 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.823 166.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 7.4 p -106.37 149.59 9.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.079 -169.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -86.93 11.67 64.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.404 -168.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.0 m -105.54 -3.57 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.075 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 51.1 p-10 -78.42 16.64 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.938 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 74.1 m-80 91.21 0.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.836 166.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.54 -58.31 3.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -84.54 -55.66 2.67 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.7 -31.0 68.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 111.137 -166.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.02 -45.16 86.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.971 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.19 -41.75 96.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.121 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.717 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.8 -41.38 98.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.506 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.9 mt -65.62 -39.18 91.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 0.0 110.904 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.2 m -61.17 -42.11 97.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.208 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.84 -42.99 94.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.838 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 60.4 tp -61.86 -45.65 92.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.17 -40.0 87.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.12 -37.58 87.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.876 177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.439 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.1 OUTLIER -68.24 -34.2 75.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.978 -179.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.55 -40.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.054 175.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.06 -41.16 86.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -85.46 2.49 44.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.02 31.89 10.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -81.25 -29.55 34.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 170.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 67.4 mtt -135.47 147.32 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.843 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -97.66 124.03 41.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.63 -22.72 67.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 -170.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -90.01 -6.09 55.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -173.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.4 m -57.22 131.07 48.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -128.68 -179.48 5.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.815 171.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -58.04 -34.88 70.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 -172.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 71.2 m -67.73 -36.08 79.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.91 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.55 -42.14 94.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.225 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.65 -41.19 98.92 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.085 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.05 -43.03 79.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.61 81.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.059 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.1 86.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.157 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -65.38 -35.41 80.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.825 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -60.54 -29.73 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.951 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -97.42 -21.07 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.829 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.94 23.59 32.29 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.462 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -83.43 -25.76 30.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.925 -172.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 87.1 m -125.62 137.28 53.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.086 -168.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.56 -38.77 25.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 77.0 mtm -140.51 157.7 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.869 -166.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.3 t -151.8 167.83 27.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.223 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.4 mt -123.01 119.29 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.122 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 58.6 m-80 -148.62 160.87 42.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -173.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -104.6 -136.55 8.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.482 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.529 ' HB3' ' HB2' ' A' ' 111' ' ' GLU . 28.0 Cg_endo -70.61 -26.92 23.03 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.666 2.244 . . . . 0.0 112.289 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -66.83 -18.79 65.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.858 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -89.47 11.97 17.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.031 -176.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 298' ' ' PRO . 46.4 m0 -67.01 -28.72 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 36.7 t -59.31 107.95 0.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.837 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -150.51 130.11 13.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.2 mt -89.64 80.52 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.138 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -84.7 73.8 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.1 p -116.81 -1.72 11.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.147 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 80.3 p -114.74 -169.15 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.742 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.18 178.79 2.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.931 171.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 66.7 t -61.06 106.68 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -174.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.5 -63.45 1.27 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 175.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -107.35 154.96 20.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.88 160.48 25.73 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 89.9 t -123.16 130.31 74.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.378 . . . . 0.0 111.177 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.38 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.131 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.1 m -80.78 159.21 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.069 -175.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.2 mt -70.19 139.85 87.67 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 121.574 0.702 . . . . 0.0 110.967 -173.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 40.6 Cg_exo -60.43 165.38 11.26 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.33 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.8 p -120.62 148.07 44.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.077 172.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -126.62 117.21 22.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.944 -173.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 54.57 35.74 24.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.841 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.28 16.58 62.28 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -130.02 146.67 62.42 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.88 145.46 85.97 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.627 2.218 . . . . 0.0 112.431 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 36.6 t -67.17 -57.73 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.432 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 9.0 tmtt? -163.52 117.38 1.08 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.525 0.678 . . . . 0.0 110.935 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.54 128.03 11.52 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.709 2.273 . . . . 0.0 112.442 177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -161.31 111.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.07 132.54 50.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.073 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -117.09 137.42 13.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.558 171.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 98.6 t -118.04 125.17 74.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 111.158 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 57.0 tp -65.35 127.35 31.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.969 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 27.0 m -133.2 148.83 52.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.815 -166.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.86 132.75 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.123 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -112.14 148.05 18.21 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.435 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.1 mt -106.1 125.79 61.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.12 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -59.04 118.26 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.1 -24.72 67.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.039 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.24 -9.58 58.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.116 -176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -68.82 132.53 90.64 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.636 0.731 . . . . 0.0 110.913 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.53 -14.31 39.4 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.636 2.224 . . . . 0.0 112.302 171.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -115.6 29.43 8.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.968 0.413 . . . . 0.0 110.93 -167.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -58.28 -35.61 72.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.797 -177.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -65.6 -36.46 83.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 62.6 tp -64.56 -42.85 95.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.4 90.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.109 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -65.15 -43.97 90.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.85 -172.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.73 -51.36 62.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -172.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.96 -32.61 70.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -172.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 59.6 mt -61.74 -50.58 71.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -74.11 -42.88 59.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -175.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -98.66 -14.35 19.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.862 -160.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -123.23 -53.73 1.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.864 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 59.5 tp -68.07 -46.93 69.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 106' ' ' TYR . 84.2 mt -83.78 63.79 7.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.865 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.1 p -135.54 165.31 25.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.087 173.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.87 -44.45 70.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -80.91 -40.85 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.52 -48.59 35.63 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.609 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.47 -34.41 72.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 110.904 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.28 -40.04 84.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.08 -33.2 68.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.036 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.496 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 78.7 t -79.07 -51.79 16.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.154 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -79.3 -19.84 49.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.962 -166.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -57.85 -18.14 20.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.896 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -93.23 -21.33 19.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -71.98 149.75 92.46 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.617 0.722 . . . . 0.0 110.906 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.429 ' HB2' ' HB3' ' A' ' 232' ' ' TRP . 79.7 Cg_exo -57.87 -44.14 42.99 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.658 2.239 . . . . 0.0 112.405 -174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 40.5 tp -95.06 -45.86 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 83.54 9.74 82.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.54 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.89 20.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.739 0.304 . . . . 0.0 111.122 -177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.3 m -115.83 156.19 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -77.18 -9.01 58.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 171.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 54.0 tp -79.37 120.19 23.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -61.66 -43.9 97.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 38.6 t -58.75 -48.93 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.924 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.615 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.5 t80 -71.02 -35.39 72.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.849 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.4 tm-20 -62.34 -32.82 73.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.57 -36.95 77.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -77.83 -38.44 46.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.1 mt -65.69 -26.69 67.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.981 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.44 -12.46 43.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.11 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.83 -18.1 59.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.844 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -90.19 119.0 69.28 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.608 0.718 . . . . 0.0 110.809 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -51.99 -32.92 50.27 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.345 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -70.75 -40.63 72.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.897 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -73.41 -40.72 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.88 -36.4 72.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.191 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.59 89.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.7 m -65.13 -46.35 81.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.163 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -68.18 -34.82 76.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.936 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -63.12 -39.97 96.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -72.9 -38.87 66.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.69 91.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.012 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . 0.403 ' HG3' ' HG3' ' A' ' 326' ' ' LYS . 20.8 pt20 -71.3 -14.49 62.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.818 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.403 ' HG3' ' HG3' ' A' ' 325' ' ' GLN . 90.3 mttt -110.35 -6.52 14.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -175.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.93 -160.55 36.62 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.437 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -130.16 148.25 51.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.875 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.426 HG22 ' HG2' ' A' ' 331' ' ' PRO . 45.5 mm -68.97 117.67 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.115 -171.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.556 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.4 tmt? -47.93 -53.73 29.79 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.62 0.724 . . . . 0.0 110.902 -165.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 330' ' ' MET . 45.5 Cg_endo -64.91 101.2 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.703 2.268 . . . . 0.0 112.366 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.641 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 62.8 m-80 -121.56 34.56 5.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -168.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 45.9 mm 88.94 136.56 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.609 0.719 . . . . 0.0 111.071 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.26 -26.66 20.89 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.701 2.268 . . . . 0.0 112.266 -173.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 333' ' ' ILE . 98.7 mm-40 -57.44 -23.11 47.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.999 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 66.5 ttp -63.29 -32.7 74.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.9 -178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.3 m -64.35 -38.12 89.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.06 78.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -65.28 -45.76 83.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -57.39 -48.67 78.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.853 -172.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -64.3 -45.66 87.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.942 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.39 93.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.082 -171.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 32.6 m -76.62 -29.87 18.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.6 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 73.7 ttt-85 -58.93 -43.07 91.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.6 m -59.69 -41.5 90.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.32 -40.21 93.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.0 t -67.44 -50.93 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.5 mm -65.05 -46.46 91.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.041 -176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.11 -36.34 83.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.814 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.24 -48.1 62.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.41 -34.44 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.054 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -79.0 -9.45 59.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.1 10.1 86.46 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.448 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -75.82 -28.6 58.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.319 . . . . 0.0 110.85 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -138.26 155.76 48.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.953 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 357' ' ' VAL . 97.0 m -71.52 152.28 43.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.158 174.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.401 ' N ' HG22 ' A' ' 356' ' ' THR . 64.1 t -65.66 -47.25 86.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 -173.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.99 -41.16 99.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -71.91 -44.47 63.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -174.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 346' ' ' ALA . . . -64.84 -40.24 94.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.4 -37.84 77.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.8 tttt -61.88 -41.99 98.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -65.26 -31.6 72.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 175.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -71.64 -47.16 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.083 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.9 pp0? -68.54 -31.52 70.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 98.9 m -63.26 -44.06 96.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.048 174.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -64.51 -37.68 88.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.797 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.93 -46.19 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.4 p -95.19 -6.16 42.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.233 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.2 mt -75.1 127.68 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.123 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -128.48 165.39 20.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.81 119.95 15.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.5 24.03 34.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.497 -172.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -145.0 154.27 42.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.851 0.358 . . . . 0.0 110.882 -173.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -142.26 142.93 32.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.8 t -125.48 125.75 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.128 -173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.45 131.75 64.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.594 ' HB3' HD22 ' A' ' 43' ' ' LEU . 24.0 m0 -113.16 129.84 56.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.856 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.4 tt -151.43 153.33 10.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -55.37 127.04 27.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 172.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.09 -20.93 78.99 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.515 -165.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -55.07 -48.84 72.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.922 0.391 . . . . 0.0 110.91 -163.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -138.42 83.21 1.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.821 145.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -111.3 -34.38 2.13 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.526 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -77.17 -43.83 32.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.899 0.38 . . . . 0.0 110.966 -159.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -65.77 -60.01 3.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -155.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -61.23 -45.68 96.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.54 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -58.39 -41.47 84.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.943 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.142 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.87 -48.83 80.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.913 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.28 -33.88 42.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.074 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.67 -37.2 94.37 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.369 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.35 -45.88 85.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.86 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -60.88 -44.48 97.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -64.38 -37.26 86.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.833 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -64.86 -35.29 80.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -71.16 -37.71 72.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -82.47 -41.5 19.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -172.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -104.67 -17.35 14.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.182 -172.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.87 88.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.55 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 33' ' ' ILE . 17.3 tt -76.15 125.24 35.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.36 121.58 18.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 p -103.66 140.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.088 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.0 m -134.24 112.18 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.143 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.02 122.76 60.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -128.59 150.93 50.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.939 -173.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 26.3 p80 -133.77 73.19 72.22 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.669 0.747 . . . . 0.0 110.871 170.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 16.9 Cg_endo -70.04 -28.04 24.41 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.633 2.222 . . . . 0.0 112.427 -162.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 57.8 m-20 78.23 2.39 2.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.914 -172.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.93 -2.04 44.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.594 HD22 ' HB3' ' A' ' 10' ' ' TRP . 84.7 mt -46.0 -55.54 6.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.97 -154.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -70.0 -26.64 64.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -168.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -84.34 -43.43 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -79.98 -41.39 26.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -172.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.864 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 29.7 t80 -51.88 -52.97 56.3 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.613 0.721 . . . . 0.0 110.825 -165.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 73.3 Cg_exo -54.25 -38.05 88.26 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.564 2.176 . . . . 0.0 112.388 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -76.2 -48.47 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.924 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -72.18 -30.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.14 -172.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.07 -39.21 91.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.051 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.09 -24.28 67.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.6 p -96.54 7.12 47.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.47 22.59 67.03 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.493 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -119.92 -170.33 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.983 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.56 -173.23 20.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.581 177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -80.02 159.97 23.9 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.662 2.242 . . . . 0.0 112.364 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.409 ' OD2' ' HB2' ' A' ' 276' ' ' ALA . 29.7 t70 -79.34 -43.99 22.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 169.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 75.2 mt -129.35 142.97 42.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.055 -171.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.36 132.08 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.191 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -113.8 127.28 55.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.878 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -146.99 154.46 41.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.957 168.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.34 -102.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.023 -176.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 -51.28 1.91 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.869 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -63.07 -47.98 80.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -171.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -79.69 -33.38 41.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -56.52 -47.93 78.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -167.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.16 81.7 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.509 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.13 -43.22 95.37 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.59 176.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -70.82 -30.02 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.975 0.417 . . . . 0.0 110.981 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.31 95.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.089 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.43 -24.38 65.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -83.45 3.67 31.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.46 36.91 69.31 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.478 172.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mp -79.77 -9.56 59.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.785 0.326 . . . . 0.0 110.869 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -132.68 143.18 49.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.948 -173.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.74 164.32 13.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.078 175.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -66.31 134.95 53.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -107.92 151.76 9.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.088 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.5 m -127.44 75.06 77.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.583 0.706 . . . . 0.0 111.218 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -78.49 141.0 17.44 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.659 2.24 . . . . 0.0 112.251 169.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -80.62 179.95 7.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.913 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.71 -36.13 82.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 -173.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.24 -41.94 98.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.128 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 m-30 -69.0 -40.72 78.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -65.81 -42.2 90.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.859 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.79 -27.11 64.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -62.99 -27.32 69.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.925 -169.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.4 mt -104.48 -110.26 0.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -175.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 31.6 t80 -156.76 134.71 7.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.667 0.746 . . . . 0.0 111.01 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 80.8 Cg_exo -56.38 -41.66 73.92 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.714 2.276 . . . . 0.0 112.377 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.27 -40.58 97.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.5 p -71.5 -25.5 62.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.152 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.402 ' HA ' HG22 ' A' ' 97' ' ' VAL . 63.4 m95 -74.38 -34.31 63.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.876 173.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -67.15 -31.3 71.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.832 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.06 -26.45 68.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.122 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 35.9 m -108.04 15.72 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.149 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -100.34 131.42 46.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -130.74 121.83 26.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.897 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.6 t30 59.28 34.97 23.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.93 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.9 4.17 90.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.436 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -122.04 146.23 47.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.772 0.32 . . . . 0.0 110.918 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -86.37 127.77 34.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.935 -177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.435 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.6 pt -117.93 -8.63 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 -169.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -159.67 163.23 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -170.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.73 129.01 24.77 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.714 0.769 . . . . 0.0 110.966 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.66 122.32 9.71 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.701 2.267 . . . . 0.0 112.309 172.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 73.8 mt -109.64 -40.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -155.54 156.25 34.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.023 -167.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -136.89 137.53 46.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.635 ' HB2' ' HG3' ' A' ' 229' ' ' PRO . 24.9 pt-20 -142.8 154.94 44.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.984 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.95 160.25 41.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.175 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.7 tp -66.42 142.36 57.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.874 175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.4 m -138.85 156.37 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.6 tp -97.01 123.89 40.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.411 HG12 HG22 ' A' ' 244' ' ' VAL . 74.6 mt -113.3 125.23 70.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.029 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -134.94 157.72 46.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -170.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -91.64 112.56 24.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.698 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 96.4 mttt -67.69 -29.09 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 -174.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -78.11 -35.68 48.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.861 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.6 -45.78 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 68.9 tp -121.71 106.7 36.87 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.646 0.736 . . . . 0.0 110.913 -171.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.532 ' O ' ' C ' ' A' ' 124' ' ' ASN . 97.1 Cg_endo -74.86 157.02 43.61 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.65 2.233 . . . . 0.0 112.284 168.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.6 t30 25.06 96.55 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.594 0.712 . . . . 0.0 110.953 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.8 Cg_endo -65.25 155.69 67.17 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.728 2.285 . . . . 0.0 112.405 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -67.96 142.13 55.76 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.751 2.301 . . . . 0.0 112.297 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -91.04 -25.62 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.845 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 249' ' ' THR . 68.7 p -128.69 159.99 33.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.186 -175.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -74.06 -23.59 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.979 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.5 -28.57 67.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.792 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -75.98 -20.08 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.628 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 31.2 mm -57.71 -56.25 36.38 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.573 0.701 . . . . 0.0 111.11 -168.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 29.9 Cg_endo -69.44 -39.69 6.79 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -172.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.18 99.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.196 172.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.1 tp -63.74 -39.54 94.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -63.45 -41.4 98.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.02 -39.6 86.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.07 -45.87 79.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -84.6 -18.92 34.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.415 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.0 tttt -57.47 -30.04 64.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.48 -20.42 66.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.153 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -100.2 9.31 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.861 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.65 27.03 68.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.527 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -108.97 161.43 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 110.849 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 36.5 t -115.84 152.66 32.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 167.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.97 -42.35 57.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.109 177.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.97 153.15 47.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -175.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 77.7 mmm -128.38 120.27 26.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.842 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -166.08 165.01 18.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -97.22 141.21 30.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.92 -168.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 52.4 tp -105.57 2.45 28.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.043 175.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -76.54 -8.6 57.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 174.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.48 145.07 39.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.737 0.78 . . . . 0.0 110.832 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.568 ' HG3' ' HB2' ' A' ' 344' ' ' ARG . 50.5 Cg_endo -68.73 -24.59 34.62 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.532 2.155 . . . . 0.0 112.295 176.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -57.72 -47.62 81.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -71.64 -26.5 62.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 69.4 p -84.13 -17.19 40.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.5 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 7.2 m0 -56.97 -46.4 99.87 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 -170.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.554 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 88.9 Cg_exo -51.08 -33.57 43.84 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.765 2.31 . . . . 0.0 112.306 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 48.5 tp -81.37 -46.15 15.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.429 HG23 ' HA3' ' A' ' 191' ' ' GLY . 94.8 mt -83.14 -48.17 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.107 -171.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -66.62 -16.64 64.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.82 -28.56 66.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.115 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -102.51 -6.35 22.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.9 6.75 13.8 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.5 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -95.84 115.04 5.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.427 177.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -162.33 175.31 11.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.846 0.355 . . . . 0.0 110.936 -161.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.634 ' HB1' ' HB3' ' A' ' 339' ' ' PHE . . . -82.88 -23.64 33.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.191 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.794 ' HB3' ' CD1' ' A' ' 176' ' ' TYR . 86.1 m-85 -130.89 143.95 51.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -172.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -112.15 127.15 55.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.857 163.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -108.99 111.68 23.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.84 -170.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.15 141.32 25.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 52.42 37.96 24.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.63 4.33 70.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -131.35 150.63 52.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.813 0.339 . . . . 0.0 110.907 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.794 ' CD1' ' HB3' ' A' ' 169' ' ' PHE . 57.9 m-85 -86.19 130.78 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 172.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -115.83 117.37 30.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.931 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -78.62 -20.17 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.03 -16.19 41.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.9 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -113.97 71.31 0.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.79 166.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.32 150.95 16.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.181 -165.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -88.21 22.24 20.36 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.509 -170.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.6 m -105.65 0.02 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 174.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.668 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 52.6 p-10 -80.98 17.82 1.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.668 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.0 m-80 94.22 -4.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 167.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -76.81 -57.69 3.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.072 174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -90.79 -53.73 2.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.512 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.58 ' HA ' ' HA3' ' A' ' 166' ' ' GLY . . . -67.38 -35.22 78.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.741 0.305 . . . . 0.0 111.023 -165.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.81 -43.45 93.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.975 -170.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.08 -41.27 95.18 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.074 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.429 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -62.79 -39.57 98.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.454 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.93 -40.86 95.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.3 m -60.2 -42.17 94.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.151 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.78 -44.0 97.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 59.1 tp -58.72 -45.52 89.4 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 175.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 351' ' ' ALA . 50.4 t -63.36 -39.74 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.171 -177.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -61.46 -39.87 92.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 133' ' ' PRO . 0.3 OUTLIER -70.05 -40.65 74.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.847 -178.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.62 -39.29 84.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.156 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.13 -38.16 87.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -87.94 3.67 47.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.895 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 60.6 35.55 19.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -80.78 -20.19 43.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.826 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -139.44 153.08 47.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -98.46 132.4 43.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.848 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.0 72.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.138 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -89.85 -4.1 57.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.903 -168.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 66.9 m -62.94 135.44 57.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -128.43 179.92 5.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.89 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -62.04 -34.64 76.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.931 -172.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.7 m -69.66 -41.34 75.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.838 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.07 -39.67 86.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.168 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.1 93.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -65.05 -43.45 92.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.862 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.51 75.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.097 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.64 -42.39 98.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.105 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.48 ' HD1' ' HA ' ' A' ' 217' ' ' PHE . 0.9 OUTLIER -64.91 -37.08 86.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 172.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -102.64 -22.88 13.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.85 23.32 36.0 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -82.92 -22.55 33.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.962 0.41 . . . . 0.0 110.923 -171.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.5 t -126.26 144.92 50.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -75.57 -35.98 60.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 73.0 mtm -138.61 148.03 43.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -168.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 64.9 p -139.5 164.96 28.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.101 168.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 87.9 mt -121.65 119.14 58.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -143.5 160.05 41.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -174.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -90.94 -164.42 39.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.446 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.635 ' HG3' ' HB2' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -66.46 -20.99 54.02 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.661 2.24 . . . . 0.0 112.274 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.7 p-90 -65.56 -20.66 66.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -99.66 3.86 45.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 79.0 t90 -69.99 -43.15 72.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.849 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 43.7 t -68.67 105.84 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.865 -170.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -139.69 154.05 47.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 81.6 mt -78.25 88.38 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -82.23 74.97 9.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 73.8 p -122.32 0.79 9.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 83.7 p -100.49 -170.0 1.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.62 179.87 7.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.97 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.74 112.33 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.178 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -119.6 -56.71 2.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -115.43 162.99 16.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.698 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -143.03 169.27 25.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.47 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 116' ' ' ILE . 58.4 t -122.93 130.2 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 111.127 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.82 175.55 9.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.178 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.84 161.05 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.072 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 90.0 mt -73.48 136.44 78.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.56 0.695 . . . . 0.0 110.94 -173.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 49.0 Cg_exo -62.38 159.33 36.2 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.746 2.297 . . . . 0.0 112.22 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 128' ' ' THR . 81.9 p -114.09 160.02 19.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.126 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -133.73 116.28 15.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.7 35.12 23.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.19 20.5 57.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.543 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -130.21 145.24 56.48 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.61 0.719 . . . . 0.0 110.902 -174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.92 152.07 77.42 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.652 2.234 . . . . 0.0 112.399 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 95.7 p -65.1 -61.5 2.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 -175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -165.88 147.01 5.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.566 0.698 . . . . 0.0 110.911 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.36 126.1 8.18 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.589 2.193 . . . . 0.0 112.417 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -163.89 111.61 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.859 170.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.77 132.87 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.129 163.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.81 139.14 15.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.495 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.62 119.52 59.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.803 0.335 . . . . 0.0 111.101 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.7 129.87 41.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -132.1 139.9 48.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -170.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.59 137.77 52.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.147 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -129.89 166.54 21.96 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -176.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 70.6 mt -112.4 129.81 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.854 0.359 . . . . 0.0 111.191 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -59.36 123.21 16.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.939 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.46 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.34 -11.48 59.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.2 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -76.06 131.46 75.75 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-O 121.619 0.723 . . . . 0.0 110.852 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.52 -10.86 28.84 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.65 2.233 . . . . 0.0 112.313 173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -108.91 28.62 8.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 -166.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.35 -37.75 62.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.757 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.54 -38.59 84.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.95 -176.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.13 -43.09 93.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.862 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.409 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . . . -65.63 -44.55 86.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.125 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -63.15 -49.64 73.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 97.9 mt-10 -66.47 -45.15 80.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.78 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 19.1 t80 -59.98 -41.65 92.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.934 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 28.6 tp -70.33 -54.6 11.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.905 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -83.34 -30.76 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 -167.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.575 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.2 m-20 -98.57 -18.45 18.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.799 -167.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.605 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.6 m-85 -122.15 -53.44 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -175.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 59.6 mt -72.35 -41.83 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 -176.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.79 60.7 6.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 176.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 51.1 p -136.9 170.2 16.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.159 172.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -55.12 -48.17 74.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.796 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.63 -39.93 43.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.874 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.39 -46.09 27.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.422 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.7 tp -67.74 -36.32 80.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.749 0.309 . . . . 0.0 110.905 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.04 -41.18 96.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.809 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.41 -42.21 99.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.099 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.06 -32.16 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.131 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -67.56 -24.39 65.52 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.831 -178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.3 -26.25 39.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.56 -15.74 38.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.76 154.83 61.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.53 0.681 . . . . 0.0 110.988 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -65.02 -97.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.577 2.184 . . . . 0.0 112.433 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.29 -25.87 67.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 60.98 31.87 78.03 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.551 165.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.91 127.28 31.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.774 0.321 . . . . 0.0 111.104 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 34.7 m -116.75 152.62 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.081 -164.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.95 -10.84 59.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 174.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.0 tp -76.08 118.54 18.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.888 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.37 -51.73 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -170.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 87.7 p -62.27 -43.07 99.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -171.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.429 ' O ' ' CD1' ' A' ' 307' ' ' TYR . 1.3 t80 -70.56 -37.1 73.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.975 177.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -66.24 -32.61 74.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.905 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.0 -36.58 81.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -72.79 -39.68 66.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 79.2 mt -65.37 -26.77 68.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.935 174.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.78 -11.27 44.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.047 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.07 -18.14 58.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -85.52 118.93 71.64 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.768 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.09 -34.94 60.08 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.69 2.26 . . . . 0.0 112.383 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -70.17 -41.11 74.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 -175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 90.6 mt -76.04 -38.59 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.184 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.01 73.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.57 -41.37 88.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.04 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.5 m -63.73 -44.62 93.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.159 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 14.8 tpt -65.6 -38.82 90.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.886 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.35 -38.16 89.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.53 -38.56 84.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 174.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.96 85.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 -178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -67.3 -18.26 65.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.832 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.27 -8.13 20.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.889 -172.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -102.88 -162.68 25.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.502 -173.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -133.98 156.68 47.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.469 HG13 ' HD2' ' A' ' 331' ' ' PRO . 4.9 tp -63.21 124.84 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.118 -171.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.602 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.9 tmt? -44.46 -52.27 17.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.525 0.678 . . . . 0.0 110.847 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 330' ' ' MET . 34.8 Cg_endo -60.71 84.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.716 2.277 . . . . 0.0 112.34 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.657 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 74.0 m-80 -104.23 29.36 6.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -170.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.657 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 50.3 mt 89.62 135.45 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.579 0.704 . . . . 0.0 111.146 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -51.41 -26.86 22.45 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 0.0 112.239 -173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.461 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.3 mm-40 -59.97 -18.16 43.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.881 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 62.1 ttp -57.97 -34.61 70.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.949 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.93 -38.83 92.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.772 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.14 -38.2 66.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.634 ' HB3' ' HB1' ' A' ' 168' ' ' ALA . 7.2 m-30 -67.17 -35.97 80.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 91.4 t90 -55.5 -48.8 74.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -64.94 -42.36 94.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.895 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.16 -40.79 94.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.104 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.77 -38.11 71.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.083 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 154' ' ' PRO . 71.2 ttt-85 -53.51 -39.92 64.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.91 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -57.04 -45.13 83.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.072 177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -65.84 -43.71 87.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.1 t -67.89 -58.48 5.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.151 -166.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.7 mt -66.57 -45.0 89.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.105 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 97.9 m-20 -63.6 -37.65 88.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.78 59.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.08 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 196' ' ' VAL . . . -71.74 -35.45 70.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.11 -172.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.7 p -75.47 -14.5 60.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.79 7.75 87.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.403 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -75.22 -24.27 57.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 0.0 110.962 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 83.4 mm-40 -136.01 157.08 47.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.0 m -67.17 150.62 48.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 172.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 79.0 t -66.56 -46.99 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.15 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.46 -40.14 95.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.92 -42.52 66.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 -174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.25 -39.27 93.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 32.7 tp -71.93 -35.1 69.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.829 177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.2 tttt -62.5 -40.27 96.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.922 173.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.97 -31.28 72.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -74.59 -43.18 56.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.174 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 4.9 pp0? -69.29 -28.91 66.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.9 m -66.75 -44.18 82.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.139 173.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.19 -40.16 68.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.901 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 11.6 tt -66.38 -30.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 -171.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 74.8 p -92.17 -2.82 56.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.181 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -177.394 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.736 0.303 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -80.73 133.9 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -157.08 -179.44 8.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.61 126.62 30.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.991 -172.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.57 19.01 59.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.562 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -142.19 158.55 43.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.922 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -142.44 147.57 36.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 173.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.13 126.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.431 HG13 HD13 ' A' ' 7' ' ' LEU . 62.8 mt -118.74 133.22 66.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.129 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.536 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 30.2 m0 -114.12 128.2 56.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 174.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 tt -151.78 154.07 8.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.141 -172.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -55.14 127.36 28.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.1 -19.44 79.79 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.519 -168.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -58.57 -51.23 70.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -163.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -134.19 78.84 1.78 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 147.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.0 -35.88 2.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.428 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -80.5 -44.46 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.942 0.401 . . . . 0.0 110.989 -160.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -66.72 -52.08 48.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.872 -155.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -65.3 -47.71 77.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.472 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.01 -38.41 85.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.87 -45.15 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.011 176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.42 -47.33 82.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 -179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.7 t -66.96 -45.03 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.117 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.659 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -60.8 -36.31 91.65 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.363 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.16 -45.52 93.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.882 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.19 -44.77 90.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.864 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -64.49 -41.8 96.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.92 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -63.8 -33.66 76.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.12 -38.23 85.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.1 -37.02 17.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.758 -173.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 85.8 m -101.19 -24.51 14.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.105 -171.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.01 3.36 87.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.459 175.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.53 125.27 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.939 0.4 . . . . 0.0 111.185 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -66.48 128.03 34.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -172.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.659 HG11 ' HA3' ' A' ' 24' ' ' GLY . 95.5 t -104.26 132.9 49.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.133 176.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -135.9 116.93 14.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -175.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.3 t -111.6 125.13 68.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.127 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -128.49 153.06 47.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 27.9 p80 -133.23 75.12 71.42 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 0.0 110.838 172.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.561 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.6 Cg_endo -69.24 -29.32 26.56 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.656 2.238 . . . . 0.0 112.401 -162.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.6 m-20 77.67 3.42 3.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -175.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -97.8 2.09 49.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 10' ' ' TRP . 82.9 mt -48.65 -55.14 12.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -154.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -62.65 -28.91 70.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 -169.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -86.48 -47.07 9.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.811 -172.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -79.98 -46.33 16.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -163.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 7.6 t80 -50.66 -54.0 40.52 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.679 0.752 . . . . 0.0 110.88 -162.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 33.1 Cg_endo -62.9 -31.8 77.25 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.295 -177.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -77.13 -47.82 19.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 15.7 m -74.95 -26.41 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.201 -174.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -35.25 76.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.33 -24.28 65.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.028 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.5 p -96.43 4.96 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.37 23.17 61.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.502 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.9 t0 -119.88 -176.24 3.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.002 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.32 -179.18 24.67 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.582 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.91 161.1 24.13 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.677 2.251 . . . . 0.0 112.38 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -76.26 -38.58 56.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 170.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.63 138.77 48.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.8 tt -138.27 140.86 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -100.2 143.34 30.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 -177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -140.05 152.37 46.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.98 -114.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.087 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.46 ' NE2' ' N ' ' A' ' 261' ' ' VAL . 70.8 m80 -116.94 -57.47 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.65 -45.42 90.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.878 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -74.97 -36.67 62.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.84 -49.55 75.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.21 -49.48 61.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.453 -175.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.31 94.48 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.528 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -71.9 -29.94 64.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.984 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.07 -42.67 96.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 175.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.46 -28.63 69.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 173.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.3 m -84.97 5.73 28.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.009 0.433 . . . . 0.0 110.879 -176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.49 35.66 82.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.434 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.05 -15.49 60.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 110.874 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.415 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -129.61 143.64 50.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -169.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.15 159.33 16.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.064 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.44 136.87 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.5 pt -109.41 152.29 11.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.3 p -130.49 63.07 68.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.557 0.694 . . . . 0.0 111.157 -174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -72.67 143.28 37.45 Favored 'Trans proline' 0 C--N 1.34 0.131 0 C-N-CA 122.717 2.278 . . . . 0.0 112.255 167.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.4 p30 -75.08 177.7 6.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.81 -30.35 70.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.929 -175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.94 -36.52 70.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.023 -177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -64.71 -38.06 89.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.801 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -65.55 -40.13 92.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.991 175.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.21 -36.59 83.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.913 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -67.93 -30.98 70.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.937 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.05 -107.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -168.66 131.05 1.19 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.658 0.742 . . . . 0.0 110.957 174.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -54.19 -38.73 88.02 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.716 2.278 . . . . 0.0 112.328 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.56 -35.47 80.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -76.3 -24.74 54.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.204 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -75.46 -26.52 58.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 173.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -60.1 -33.23 71.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.31 -26.16 67.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.09 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.98 16.63 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 -175.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.9 ttp-105 -109.97 138.27 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.934 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -136.29 124.96 23.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 57.66 34.86 25.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.27 4.72 89.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.421 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.53 144.13 48.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.52 126.4 33.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.818 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.415 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.2 pt -119.67 -10.06 10.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.104 -168.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -160.27 165.17 31.89 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 -171.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -108.61 137.92 20.13 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.667 0.746 . . . . 0.0 110.867 173.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 21.4 Cg_exo -66.53 120.24 7.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.673 2.248 . . . . 0.0 112.284 173.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.5 mm -103.36 -36.67 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.176 -175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.93 151.28 14.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -168.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 85.8 t -130.2 133.36 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -134.09 149.9 51.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.886 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.22 156.0 34.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.9 tp -69.98 140.4 52.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 66.7 m -142.93 159.05 42.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.1 tp -99.74 129.92 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.9 mt -110.89 132.92 58.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -132.59 154.76 49.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -93.28 117.19 29.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.786 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.35 -31.75 73.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 -173.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -82.89 -35.09 26.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 -171.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 99.1 mt -74.21 -52.56 12.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.967 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.402 HD13 HD21 ' A' ' 135' ' ' LEU . 94.3 mt -127.48 115.77 21.26 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.1 Cg_endo -75.04 171.14 18.91 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 0.0 112.37 170.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.559 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.9 t30 24.81 96.6 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.639 0.733 . . . . 0.0 110.939 175.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.464 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.1 Cg_endo -65.0 155.04 70.41 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.625 2.217 . . . . 0.0 112.405 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -68.49 143.94 59.29 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.595 2.197 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.48 -20.48 20.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 78.1 p -129.35 157.93 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -71.9 -25.47 61.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.49 -30.5 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.807 177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.53 -20.05 57.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.597 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 33.8 mm -60.77 -54.03 58.54 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.604 0.716 . . . . 0.0 111.088 -169.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 23.5 Cg_endo -61.82 -40.05 47.67 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.753 2.302 . . . . 0.0 112.304 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.06 -39.36 90.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.402 HD21 HD13 ' A' ' 122' ' ' LEU . 62.4 tp -64.93 -40.37 94.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.96 -40.81 95.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.45 -42.92 83.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -173.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.44 -44.07 75.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 pp -83.03 -22.83 33.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.899 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -61.59 -25.87 67.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 173.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -18.78 65.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.109 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -101.26 9.98 41.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.827 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.02 25.68 73.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.477 -177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -108.73 157.52 18.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.836 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.8 t -111.24 144.19 40.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 169.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.24 -44.12 63.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.179 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -129.11 157.05 42.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 37.8 mmm -138.8 116.44 11.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -164.39 169.51 17.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.842 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -93.47 138.14 32.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -166.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 206' ' ' ALA . 89.6 mt -114.38 3.52 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 174.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -81.54 -3.8 54.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.925 175.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -136.68 145.06 49.59 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.689 0.757 . . . . 0.0 110.907 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.699 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 29.7 Cg_endo -69.12 -25.85 31.14 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.63 2.22 . . . . 0.0 112.256 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -57.72 -47.95 80.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.954 0.407 . . . . 0.0 110.85 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.425 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 52.7 m-85 -79.98 -21.88 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.869 -174.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.425 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 71.5 p -77.31 -22.43 51.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.458 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 9.4 m0 -56.43 -46.48 99.81 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.488 0.661 . . . . 0.0 110.892 -170.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 60.8 Cg_exo -45.2 -37.21 13.2 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.62 2.213 . . . . 0.0 112.35 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.424 ' HB2' HD12 ' A' ' 195' ' ' LEU . 89.2 mt -82.59 -44.15 16.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 95.1 mt -78.33 -45.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 -171.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -69.94 -16.14 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.013 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.24 -31.96 73.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.098 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -107.22 0.67 23.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.821 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 116.82 11.08 9.52 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.47 163.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -93.78 129.56 9.94 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.411 176.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -166.48 159.01 14.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.958 0.408 . . . . 0.0 110.909 -168.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.93 -51.53 68.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.098 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -151.51 155.73 39.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.007 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 176' ' ' TYR . 32.4 tptt -87.33 141.07 28.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 -173.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -97.72 112.58 24.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -150.34 137.21 19.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.87 177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 48.13 38.12 9.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -174.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 69.64 10.22 63.45 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.416 175.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -133.51 152.64 51.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.887 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 170' ' ' LYS . 11.3 p90 -61.54 146.06 49.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -137.97 103.09 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' A' ' 181' ' ' VAL . 8.3 tp -65.15 -15.14 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.173 -170.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.3 -17.62 45.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.808 -165.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -124.06 60.7 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.852 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 182' ' ' GLY . 58.2 t -130.26 157.63 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.132 -171.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.509 ' N ' HG12 ' A' ' 181' ' ' VAL . . . -72.03 10.54 4.35 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.498 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 m -94.79 -24.56 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 111.101 172.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 4.9 p30 -83.34 3.93 29.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.8 m-20 84.1 -2.34 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 158.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.9 -48.45 11.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.126 176.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.85 -42.1 11.64 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.546 -174.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -65.19 -43.1 92.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 111.158 -163.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -67.65 -42.85 81.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.942 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.11 -44.03 97.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.078 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.82 -41.99 97.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.441 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.1 mt -66.24 -36.18 82.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.955 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.3 m -59.84 -46.92 87.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -65.1 -44.12 89.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.802 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 160' ' ' LEU . 5.8 tt -60.01 -54.26 48.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 176.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.71 -37.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.078 -170.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.25 -37.55 83.52 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.75 -36.56 78.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.65 -41.66 88.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.043 174.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.84 -32.94 73.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -84.66 -1.76 56.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 96.0 mttt 60.71 39.98 16.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.944 171.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -78.53 -25.81 45.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.829 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -145.84 153.01 40.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.896 -177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -96.97 134.7 39.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.99 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.419 ' HA ' HD12 ' A' ' 151' ' ' LEU . . . -65.34 -31.52 72.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -173.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -90.0 -4.75 57.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.889 -166.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -61.16 135.19 57.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.7 p30 -134.67 -175.2 3.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -56.98 -45.3 83.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 -175.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -62.56 -42.73 99.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.86 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.3 mt -66.2 -44.8 91.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.55 -38.29 90.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.2 -43.47 91.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.852 177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -34.99 79.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 174.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.62 98.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -65.07 -33.46 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.64 -26.03 68.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -104.48 -23.23 13.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.37 27.02 13.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.456 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -80.71 -25.81 37.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.907 -171.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -127.41 139.7 52.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.98 -29.93 26.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.135 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 52.7 mtt -140.21 164.7 29.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 -172.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.5 t -152.82 160.99 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -118.66 114.86 46.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.143 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -149.36 160.41 43.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.796 -171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -100.07 -139.55 10.87 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.335 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.681 ' HB3' HD22 ' A' ' 299' ' ' LEU . 30.3 Cg_endo -68.3 -25.88 35.97 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.707 2.271 . . . . 0.0 112.353 -176.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 32.3 p90 -67.94 -16.97 64.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -175.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -91.09 15.13 12.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.027 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -56.2 -33.71 65.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.5 t -62.19 120.19 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -170.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -147.65 128.1 14.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.979 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.6 mt -95.5 86.75 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.183 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -84.77 74.92 10.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 68.4 p -112.55 -6.46 13.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.095 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.8 p -115.12 -165.25 1.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.777 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -69.33 177.04 3.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.902 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 80.6 t -65.74 111.19 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -106.38 -70.41 0.79 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -108.3 158.5 17.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.34 166.57 26.39 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.563 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 61.9 t -124.62 132.08 71.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.912 0.387 . . . . 0.0 111.176 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.37 178.51 7.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.111 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -90.63 160.01 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.093 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 99.2 mt -71.48 143.28 87.49 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.599 0.714 . . . . 0.0 110.9 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.84 169.9 21.32 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.306 -176.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.8 p -107.93 162.08 14.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 -175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -139.02 120.28 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 96.8 mttt 54.97 33.93 21.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.41 15.04 74.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.47 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -123.44 151.16 62.56 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.618 0.723 . . . . 0.0 110.858 -172.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.04 152.21 83.13 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.717 2.278 . . . . 0.0 112.395 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.9 p -64.99 -58.39 6.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.845 -174.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -168.2 142.42 2.78 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.632 0.73 . . . . 0.0 110.904 171.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -73.15 126.03 10.8 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.368 174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -169.36 119.98 0.7 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.858 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.77 130.54 19.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.178 159.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.94 144.26 15.8 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.463 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.46 ' N ' ' NE2' ' A' ' 64' ' ' HIS . 77.8 t -126.95 122.97 61.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.83 0.348 . . . . 0.0 111.2 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 62.5 tp -73.09 138.22 45.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 50.7 m -125.75 144.7 50.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.795 -171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.4 132.01 51.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.087 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.64 157.12 15.38 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.427 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 96.2 mt -105.07 127.24 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.163 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -56.57 119.91 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.896 -175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.59 -23.95 65.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.08 -9.96 59.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.066 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -72.17 133.67 83.4 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.672 0.749 . . . . 0.0 110.827 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.45 -11.23 30.79 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.598 2.199 . . . . 0.0 112.379 172.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -106.65 36.37 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -168.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -54.77 -43.54 72.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.78 -174.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -68.13 -36.8 80.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.891 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 62.9 tp -63.73 -48.56 76.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.798 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.432 ' HA ' ' CE2' ' A' ' 279' ' ' PHE . . . -60.32 -43.52 96.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.05 -171.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -66.39 -43.94 84.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.811 -174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -62.34 -58.63 6.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -169.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.455 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 5.5 p90 -74.94 -25.84 59.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.917 -167.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.445 ' O ' HD23 ' A' ' 280' ' ' LEU . 1.8 tt -63.6 -45.82 88.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.968 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -86.39 -27.13 24.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -99.89 -11.64 20.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.831 -167.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.642 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.3 m-85 -128.54 -52.13 1.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.427 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 5.8 mp -70.39 -41.94 72.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -170.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.53 70.71 1.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.952 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 81.6 p -135.3 169.97 16.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 172.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -52.26 -47.85 65.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.07 -41.49 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.22 -48.49 8.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.591 -169.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 304' ' ' LEU . 19.0 tp -70.4 -34.39 72.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.79 0.328 . . . . 0.0 110.969 -176.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -61.82 -41.14 97.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 173.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 295' ' ' LYS . . . -66.1 -34.96 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.051 -173.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.594 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 11.6 p -84.07 -36.02 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.163 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -80.94 -24.68 37.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -172.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 292' ' ' ALA . 62.5 pttt -61.99 -16.1 48.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.886 176.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -94.56 -23.84 17.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 177.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 71.8 mmtt -64.63 146.54 98.3 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.551 0.691 . . . . 0.0 110.946 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 71.5 Cg_exo -57.93 -57.52 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.567 2.178 . . . . 0.0 112.413 -174.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 229' ' ' PRO . 58.8 tp -73.33 -48.22 36.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 -172.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.05 -15.11 62.7 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.483 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.97 126.2 29.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 111.082 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.619 HG21 ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -124.4 160.15 29.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 -171.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.5 -15.11 59.97 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 173.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.479 ' HB2' HD23 ' A' ' 290' ' ' LEU . 50.8 tp -74.7 120.01 19.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.906 -175.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.41 -41.97 90.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.896 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 69.1 m -58.09 -48.87 78.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -174.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.619 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.2 t80 -70.02 -32.63 70.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -59.19 -36.41 75.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.69 -39.79 85.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -77.13 -38.59 51.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.81 -29.1 70.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.908 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -13.01 57.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.095 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -78.71 -22.31 46.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.848 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 64.6 t0 -87.69 119.95 70.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.564 0.697 . . . . 0.0 110.826 173.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 36.4 Cg_endo -62.4 -24.83 75.86 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.645 2.23 . . . . 0.0 112.409 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.489 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 17.9 ttp180 -68.08 -51.36 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 176.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.39 -37.14 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 -173.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.34 -37.7 84.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.185 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.54 -37.82 85.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.062 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 59.9 m -66.42 -39.93 89.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.23 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 75.9 mtm -66.3 -37.46 85.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -64.31 -39.69 94.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.851 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -66.63 -35.09 79.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 176.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.97 -39.83 94.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.085 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -71.43 -23.26 61.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -101.92 -5.94 24.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.874 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.07 -168.2 41.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -134.55 151.18 50.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 0.0 110.841 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.494 ' O ' ' CG2' ' A' ' 329' ' ' ILE . 2.2 tp -68.42 125.54 26.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.083 -166.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.577 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 95.8 mtp -56.95 -52.01 77.26 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.569 0.699 . . . . 0.0 110.87 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 330' ' ' MET . 55.7 Cg_endo -67.97 83.55 0.44 Allowed 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.799 2.332 . . . . 0.0 112.3 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.513 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 22.3 t-20 -122.92 -6.89 8.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 333' ' ' ILE . 10.8 tp 161.77 118.24 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.569 0.699 . . . . 0.0 111.094 -157.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.42 -31.36 91.01 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.6 2.2 . . . . 0.0 112.255 174.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.442 ' H ' HG13 ' A' ' 333' ' ' ILE . 91.9 mt-30 -62.62 -10.74 13.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.993 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.9 tmm? -59.18 -35.08 72.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.7 m -62.8 -38.52 90.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.863 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.31 72.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.409 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 8.9 m-30 -65.28 -37.91 88.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -56.22 -49.75 73.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.973 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -65.81 -42.18 90.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.71 85.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 53.3 t -71.49 -37.74 65.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.081 174.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.699 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 57.2 ttt180 -53.25 -47.99 68.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.5 m -62.61 -41.91 99.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.147 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' A' ' 364' ' ' ALA . . . -64.91 -41.79 95.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 63.8 t -69.18 -47.72 72.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.19 -175.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -62.92 -46.37 96.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.09 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -64.98 -36.33 84.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.824 -177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.91 -47.39 52.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.088 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -71.64 -34.92 70.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.101 -173.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 84.8 p -74.85 -14.99 60.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.3 7.21 87.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.464 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.74 -30.07 66.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.299 . . . . 0.0 110.823 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -136.07 155.95 49.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.991 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.4 m -66.0 150.5 48.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 171.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.98 -49.81 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.112 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.0 -36.36 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -70.95 -40.52 71.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.97 -38.76 89.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.161 173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.8 mt -64.82 -38.74 91.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.44 -45.54 93.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -74.3 -42.07 60.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 346' ' ' ALA . . . -81.56 -42.76 19.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.098 -167.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 365' ' ' GLN . 8.7 mm-40 -73.52 -24.08 60.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.801 -171.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 63.7 m -53.06 -33.64 52.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.074 173.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -61.12 -30.96 70.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.877 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 72.5 mt -72.13 -42.62 67.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 62.3 p -89.03 -11.07 45.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.101 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.843 -179.194 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.721 0.296 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.3 mt -83.58 127.34 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.179 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -126.71 163.24 23.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -69.91 119.8 14.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.006 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.18 23.79 39.55 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.427 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.48 153.52 40.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.357 . . . . 0.0 110.905 -173.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.673 ' C ' HD12 ' A' ' 7' ' ' LEU . 2.3 pp -145.96 146.0 30.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.89 174.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.1 126.54 71.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 -175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.606 HG22 ' HB ' ' A' ' 59' ' ' ILE . 1.4 pt -120.19 131.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.467 ' HB3' HD22 ' A' ' 43' ' ' LEU . 23.0 m0 -113.44 132.7 55.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.4 tt -150.01 155.71 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 -172.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 58.2 t-20 -56.33 126.89 28.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 172.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.57 -21.72 79.18 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -168.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.54 -51.53 69.08 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.892 0.377 . . . . 0.0 110.973 -163.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -135.01 77.59 1.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 148.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.72 -35.23 1.9 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -73.36 -48.33 35.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.834 0.349 . . . . 0.0 111.003 -155.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -69.76 -50.47 43.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.844 -155.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.73 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -61.06 -48.19 87.35 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.445 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -60.2 -36.85 78.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.44 96.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.075 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.18 -48.36 73.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.8 t -64.97 -45.75 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.058 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.675 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.76 -38.32 95.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.479 177.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.03 -45.38 89.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.921 0.391 . . . . 0.0 110.888 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.43 -46.79 86.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.927 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -64.55 -40.67 96.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -62.36 -35.21 78.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -71.36 -39.55 71.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 -176.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.7 -39.88 23.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.788 -174.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.0 m -102.78 -18.31 15.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.174 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.81 4.1 87.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.469 173.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.788 HG13 HD21 ' A' ' 275' ' ' LEU . 0.0 OUTLIER -88.02 130.96 36.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.166 179.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -70.91 129.5 39.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.675 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.5 t -109.73 136.68 44.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 176.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -128.1 113.71 16.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.129 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.426 HG22 HD11 ' A' ' 9' ' ' ILE . 61.5 t -98.57 120.58 48.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.062 176.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.9 mt-10 -129.48 145.96 51.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.9 p80 -134.81 72.91 67.92 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.618 0.723 . . . . 0.0 110.809 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 15.3 Cg_endo -70.53 -25.41 25.08 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.276 . . . . 0.0 112.431 -161.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.3 m-20 77.59 4.03 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -172.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -96.55 0.8 50.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 173.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 10' ' ' TRP . 89.1 mt -48.33 -55.37 10.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -153.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -58.26 -33.97 69.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.893 -169.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.28 -43.59 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -76.5 -48.04 20.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 -164.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.7 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.1 t80 -49.08 -57.37 11.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.644 0.735 . . . . 0.0 110.916 -160.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 31.8 Cg_endo -66.9 -30.04 40.54 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 0.0 112.289 -174.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -75.55 -46.61 31.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.921 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 21.0 m -74.91 -27.18 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.126 -176.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -36.07 77.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.158 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.04 -24.14 66.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 p -96.08 4.74 52.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.14 21.84 69.67 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.425 -177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.2 t0 -120.02 -174.78 2.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.783 0.325 . . . . 0.0 110.944 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.35 -173.72 23.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.51 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.03 157.04 23.56 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.64 2.226 . . . . 0.0 112.323 -177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -71.7 -40.71 69.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.849 172.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.606 ' HB ' HG22 ' A' ' 9' ' ' ILE . 97.5 mt -136.9 142.64 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -131.95 137.13 55.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.154 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -103.17 134.4 46.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -140.03 156.14 46.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.07 -102.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -124.13 -54.69 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.937 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.01 -50.06 72.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -170.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -71.04 -34.99 71.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.59 -49.09 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.793 -174.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.44 -51.18 54.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.432 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -42.68 95.06 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.566 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -70.01 -31.28 68.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.995 0.426 . . . . 0.0 110.994 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.43 98.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.119 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.69 -25.17 64.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.6 m -85.11 3.95 36.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.48 35.15 74.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.528 173.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mp -78.79 -10.9 59.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.88 0.372 . . . . 0.0 110.899 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -131.86 144.02 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.916 -175.056 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -89.89 157.96 17.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.083 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.23 137.11 56.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -109.98 151.77 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.09 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.422 ' H ' ' HE2' ' A' ' 277' ' ' LYS . 26.5 m -134.98 72.09 68.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.596 0.713 . . . . 0.0 111.117 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.83 142.21 34.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.756 2.304 . . . . 0.0 112.316 168.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -79.05 -179.64 6.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.73 -37.85 88.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.8 -45.64 88.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 -178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -65.96 -38.58 88.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.882 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.65 -39.42 91.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 175.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -64.82 -29.49 70.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -64.69 -25.87 68.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.918 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.448 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 60.6 mt -101.87 -123.97 0.18 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.928 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -160.05 134.88 5.55 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.689 0.757 . . . . 0.0 110.956 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -54.88 -38.81 92.44 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.715 2.276 . . . . 0.0 112.345 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -65.72 -36.5 83.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -74.98 -23.26 58.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.185 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.448 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 57.3 m95 -69.98 -32.13 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 173.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -62.37 -30.16 70.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.815 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 329' ' ' ILE . . . -67.35 -27.2 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.009 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 36.0 m -112.66 8.62 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.206 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -100.27 135.31 41.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -134.94 124.94 25.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.966 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 58.1 34.79 24.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.58 3.92 89.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.417 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.79 145.97 47.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.933 0.397 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -85.97 125.99 33.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 -176.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.41 ' HB ' HD13 ' A' ' 76' ' ' LEU . 42.7 pt -118.64 -8.9 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.162 -169.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.7 161.29 37.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.108 -171.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -106.92 129.87 23.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.626 0.727 . . . . 0.0 110.94 175.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -62.01 120.3 7.82 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.745 2.297 . . . . 0.0 112.282 173.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.3 mm -102.39 -37.86 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 -177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -162.08 151.73 16.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.06 -169.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.0 t -126.75 130.57 71.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.16 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.905 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 94.8 mt-10 -128.16 145.05 51.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.41 155.11 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.021 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.2 tp -68.69 145.93 53.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.5 p -141.02 157.59 45.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.4 tp -98.06 126.19 43.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.945 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.45 HG12 HG22 ' A' ' 244' ' ' VAL . 75.9 mt -112.72 129.35 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.152 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -135.73 153.65 51.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -92.69 114.21 26.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.796 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.48 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.7 mttt -67.55 -27.87 67.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -172.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.55 -36.53 29.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.908 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.401 HD22 ' HE2' ' A' ' 144' ' ' LYS . 98.0 mt -78.63 -43.26 26.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 176.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 50.9 tp -136.23 111.89 10.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.689 0.757 . . . . 0.0 110.904 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.551 ' O ' ' C ' ' A' ' 124' ' ' ASN . 93.1 Cg_endo -75.78 173.59 14.24 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.629 2.22 . . . . 0.0 112.31 174.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.551 ' C ' ' O ' ' A' ' 123' ' ' PRO . 55.3 t30 24.0 96.85 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.643 0.735 . . . . 0.0 110.98 175.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.0 157.35 62.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.733 2.289 . . . . 0.0 112.249 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.95 144.45 58.38 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.639 2.226 . . . . 0.0 112.361 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.39 -32.79 14.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 249' ' ' THR . 76.7 p -126.45 159.64 32.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.196 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.445 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 67.3 m95 -74.62 -26.81 60.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.97 -173.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -63.67 -20.64 65.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.86 -24.11 55.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.586 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 31.4 mm -61.33 -51.78 75.44 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.556 0.693 . . . . 0.0 111.079 -164.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 38.7 Cg_endo -69.06 -42.38 4.19 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.694 2.262 . . . . 0.0 112.343 -173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.49 -43.14 91.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.156 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.81 -38.98 92.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.933 175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -60.92 -43.37 98.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.853 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.19 -41.15 78.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.36 -46.49 73.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.865 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.7 pp -83.41 -21.29 33.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.908 -177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.449 ' N ' HD12 ' A' ' 139' ' ' LEU . 85.8 tttt -59.38 -26.61 65.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.75 -19.59 65.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.12 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -102.29 9.49 39.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.63 26.97 66.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.453 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.401 ' HE2' HD22 ' A' ' 121' ' ' LEU . 83.2 mttt -106.06 160.81 15.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 0.0 110.851 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -114.26 147.21 39.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.764 164.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -74.5 -30.68 61.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.095 -176.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.0 mt -142.12 149.83 40.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.7 mmm -130.43 125.85 35.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.873 169.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -165.47 165.04 19.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.443 ' O ' ' HB2' ' A' ' 156' ' ' PHE . 32.5 t-20 -84.2 134.22 34.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.808 -169.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 93.4 mt -109.52 16.41 22.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.946 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -83.66 -12.53 55.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.959 174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -137.87 147.22 55.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.611 0.719 . . . . 0.0 110.944 -171.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.758 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 37.3 Cg_endo -65.63 -27.31 53.19 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.539 2.159 . . . . 0.0 112.329 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -58.55 -48.04 82.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.925 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 56.3 m-85 -80.36 -19.39 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.786 -174.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 77.8 p -79.75 -21.1 44.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 174.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.529 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 8.7 m0 -57.37 -42.51 96.34 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 121.472 0.653 . . . . 0.0 110.902 -170.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.599 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 84.1 Cg_exo -47.13 -33.45 15.47 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.674 2.25 . . . . 0.0 112.325 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 195' ' ' LEU . 86.3 mt -83.14 -43.79 15.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 172.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 94.0 mt -81.4 -52.32 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 -169.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -68.47 -17.45 64.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.599 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.59 -31.93 72.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.084 175.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -103.43 0.07 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.69 5.14 22.61 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.508 168.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 188' ' ' ALA . . . -91.27 130.03 10.09 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.481 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -166.04 175.27 8.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.905 0.383 . . . . 0.0 110.881 -169.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.7 -57.31 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.136 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -141.12 151.89 44.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.924 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 81.4 tttt -81.7 135.3 35.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -109.34 114.15 27.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -148.44 143.16 26.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.885 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 49.21 39.92 16.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.42 5.45 67.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.396 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.57 154.08 51.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.78 0.324 . . . . 0.0 110.876 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -84.38 129.71 34.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.974 0.416 . . . . 0.0 110.884 173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -95.6 110.16 22.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 9.7 tp -69.84 -20.62 23.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.143 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.95 -15.32 29.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 -175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 170' ' ' LYS . 65.0 t0 -133.59 90.62 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.834 174.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 27.6 m -109.03 162.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.079 -174.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.32 5.18 84.1 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.427 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 31.6 m -109.62 -2.58 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 111.07 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.65 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 44.3 p30 -74.15 13.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 175.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.65 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 72.4 m-80 94.66 -5.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.816 166.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -78.3 -56.95 4.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.126 173.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -83.79 -51.56 3.99 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.511 -176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.571 ' HB3' HD21 ' A' ' 361' ' ' LEU . . . -65.94 -35.55 80.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.35 . . . . 0.0 111.213 -164.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -68.22 -44.55 75.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -170.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.96 -41.53 95.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.59 98.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.468 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 77.8 mt -66.67 -37.5 84.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.836 0.351 . . . . 0.0 110.903 178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 88.4 m -61.77 -45.43 93.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.198 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.88 -42.79 99.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.866 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 160' ' ' LEU . 3.6 tt -59.57 -51.53 69.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.791 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.58 -39.52 82.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.144 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -59.58 -41.17 89.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.3 mp -65.83 -37.53 86.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 71.2 mt -70.46 -40.53 77.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.065 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -65.01 -31.55 72.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -80.49 1.75 28.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 64.48 34.67 10.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.933 171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -80.85 -23.22 39.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 172.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -148.17 150.05 33.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -86.63 140.51 29.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 -176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.19 68.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.128 -175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.3 p-10 -93.03 0.86 57.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.922 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.0 m -59.43 128.72 38.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.231 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -133.62 179.92 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.904 174.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -62.22 -34.06 75.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.84 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -64.41 -44.15 92.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 97.7 mt -65.6 -39.58 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.141 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.46 96.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.11 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.81 -46.32 79.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.51 -44.7 86.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.059 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 222' ' ' THR . . . -64.4 -39.55 94.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.081 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -71.48 -44.36 64.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.838 177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -66.82 -27.51 67.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 -176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -92.81 -9.7 39.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.29 15.26 78.89 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.79 -28.94 60.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.961 0.41 . . . . 0.0 110.957 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.493 HG23 ' HB1' ' A' ' 216' ' ' ALA . 82.4 p -129.83 149.87 51.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.166 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.43 -31.94 48.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -171.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 89.8 mtp -135.29 157.68 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.859 -165.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.9 t -154.17 155.83 36.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.6 mt -119.07 118.93 59.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.049 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -147.09 159.85 43.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.97 -166.66 42.62 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.465 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.905 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 32.6 Cg_endo -64.05 -21.66 68.11 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.699 2.266 . . . . 0.0 112.396 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 65.8 p-90 -66.13 -16.99 64.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 178.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.11 -1.58 58.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -62.23 -40.04 94.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 174.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 44.9 t -58.88 119.23 6.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.1 m-80 -155.85 159.27 39.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 74.0 mt -89.2 77.18 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.091 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -80.49 73.25 7.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.925 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.5 p -122.3 5.36 9.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.134 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 67.0 p -108.09 -175.6 2.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -72.75 176.8 5.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.883 172.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.5 t -75.04 113.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.178 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -114.18 -53.45 2.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.912 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -117.46 164.98 14.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.943 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.48 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -140.41 167.06 25.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.432 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 116' ' ' ILE . 56.2 t -126.02 130.41 72.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 111.056 -177.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -141.18 174.83 10.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.118 -173.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.2 m -83.73 162.52 3.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.123 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.0 mt -73.33 139.98 79.11 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.504 0.669 . . . . 0.0 110.9 -172.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 255' ' ' SER . 51.3 Cg_endo -75.04 160.34 40.16 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.641 2.228 . . . . 0.0 112.367 -177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 128' ' ' THR . 78.4 p -114.42 158.08 22.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.185 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -127.67 116.28 20.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -174.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.11 35.87 23.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.887 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.2 17.68 64.31 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.511 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -127.82 147.91 64.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.96 -172.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.04 149.29 89.47 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.633 2.222 . . . . 0.0 112.39 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 248' ' ' PRO . 91.9 p -71.69 -53.8 12.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.965 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.479 ' HD3' ' HD3' ' A' ' 159' ' ' PRO . 46.4 pttt -168.93 144.15 2.68 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.528 0.68 . . . . 0.0 110.94 170.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.413 ' HA ' ' HA2' ' A' ' 327' ' ' GLY . 87.7 Cg_endo -78.14 128.91 9.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.64 2.227 . . . . 0.0 112.335 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -165.0 116.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 173.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 9.7 p -142.8 132.59 22.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 156.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.5 134.28 11.61 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.479 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 82.1 t -119.02 120.74 64.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.744 0.307 . . . . 0.0 111.195 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 65.3 tp -65.28 132.01 47.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.805 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.3 m -128.9 141.29 51.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.813 -167.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.24 130.24 50.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.134 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.32 154.01 16.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.497 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.8 mt -102.92 127.81 56.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.94 0.4 . . . . 0.0 111.168 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -60.02 119.61 8.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.5 67.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.079 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.24 -11.15 58.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.6 t -70.04 130.86 89.39 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.747 0.784 . . . . 0.0 110.771 -176.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -67.44 -14.05 41.23 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -112.87 27.97 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.818 -170.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -53.35 -34.14 56.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.45 -36.72 79.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.788 HD21 HG13 ' A' ' 33' ' ' ILE . 69.5 tp -65.34 -41.82 93.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 174.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -60.32 -45.12 94.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.05 -176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.422 ' HE2' ' H ' ' A' ' 80' ' ' THR . 63.4 tttm -64.79 -45.55 85.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -175.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -63.15 -54.24 40.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -170.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.99 -33.56 72.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -171.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.498 ' O ' HD23 ' A' ' 280' ' ' LEU . 5.0 tt -61.29 -51.61 68.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.924 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.09 -26.1 43.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.85 -173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -99.29 -23.77 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -167.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.403 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 68.3 m-85 -123.24 -50.26 1.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 60.1 tp -69.9 -49.02 56.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.88 -176.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.6 mp -86.41 62.65 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 178.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 60.4 p -135.39 167.62 20.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 173.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -57.17 -44.44 83.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.856 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -77.08 -42.0 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.921 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -75.61 -45.7 16.99 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.448 -173.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 290' ' ' LEU . 14.1 tp -70.16 -29.84 66.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 110.9 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -61.49 -36.54 80.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 175.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.14 -43.05 93.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.73 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 9.1 p -80.82 -36.38 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.075 -169.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -74.18 -16.39 60.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -54.92 -23.39 18.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -92.52 -19.17 22.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.924 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.58 156.23 59.05 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.51 0.671 . . . . 0.0 110.933 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.12 -93.6 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.643 2.229 . . . . 0.0 112.291 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.725 HD22 ' HB3' ' A' ' 229' ' ' PRO . 49.1 tp -45.13 -42.28 8.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.24 8.63 85.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.442 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.401 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -80.36 133.67 35.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -173.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.9 m -121.23 157.29 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -170.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.43 -12.49 60.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.075 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 50.6 tp -73.93 117.71 16.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.96 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -60.76 -48.85 79.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.937 -171.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.6 t -59.95 -46.58 88.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.698 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -71.47 -35.63 70.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.892 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.74 -36.53 83.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.832 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.22 -35.06 76.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -74.79 -39.6 61.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.866 176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 301' ' ' ALA . 89.6 mt -65.04 -27.92 69.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.98 174.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.68 -10.2 34.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.72 -17.82 57.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.859 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -82.71 116.52 64.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.641 0.734 . . . . 0.0 110.81 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.51 -32.51 43.79 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.623 2.215 . . . . 0.0 112.354 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.4 mtm-85 -69.97 -39.36 76.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.3 mt -80.19 -41.39 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.195 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.87 -35.29 68.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.082 -174.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.32 95.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.081 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 69.7 p -71.07 -33.89 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 33.3 mmt -72.71 -39.93 66.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.84 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -67.89 -38.09 82.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.912 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -68.75 -36.47 78.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.904 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.41 93.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.096 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -66.09 -17.92 65.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.768 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -104.46 -4.8 22.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.897 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 257' ' ' PRO . . . -97.31 -164.68 32.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.364 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -131.94 154.61 49.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.794 0.33 . . . . 0.0 110.923 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.438 HD12 ' HB2' ' A' ' 96' ' ' ALA . 45.0 mm -64.66 124.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.174 -171.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.549 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 18.2 tpt -56.81 -55.26 45.38 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.516 0.674 . . . . 0.0 110.833 -168.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 330' ' ' MET . 42.3 Cg_endo -63.83 100.39 0.29 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.736 2.291 . . . . 0.0 112.306 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.698 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 67.1 m-80 -121.55 27.85 8.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -168.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.698 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 68.5 mt 93.68 134.35 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.719 0.771 . . . . 0.0 111.117 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.36 -32.21 80.58 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.675 2.25 . . . . 0.0 112.334 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.457 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.4 mt-30 -61.56 -21.84 64.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.4 mmm -67.17 -28.08 67.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -65.62 -40.32 92.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.5 -37.45 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 22.9 m-30 -66.05 -32.83 74.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -55.68 -43.9 76.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.976 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -66.49 -35.63 80.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.7 -35.47 80.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.08 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 68.8 t -70.07 -39.25 76.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.758 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 55.3 ttt180 -54.05 -45.52 71.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.7 m -62.3 -42.76 99.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -65.2 -44.29 88.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.071 -177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.92 -49.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.9 mm -66.12 -44.79 91.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.069 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -65.01 -38.64 91.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.79 -177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.63 -45.54 65.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.114 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.84 -34.83 74.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.107 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.0 p -75.91 -11.65 60.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.88 6.39 87.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.533 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -77.16 -24.81 51.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -131.76 153.86 49.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.981 174.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 99.5 m -69.61 147.99 49.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.112 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.95 -49.26 70.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.162 -170.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -65.09 -42.41 94.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.853 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -70.74 -43.84 68.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.04 95.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.105 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.571 HD21 ' HB3' ' A' ' 188' ' ' ALA . 49.6 tp -70.0 -38.19 75.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.93 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.61 -44.72 93.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.814 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -66.57 -30.45 70.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 176.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -77.86 -43.71 29.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.048 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -64.96 -30.1 71.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.84 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 99.7 m -62.11 -45.71 92.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -71.73 -35.32 70.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.17 -43.28 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.077 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.4 p -93.97 -5.93 46.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.095 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.454 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.8 mttt . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.694 0.283 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 99.3 mt -76.59 129.07 37.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.129 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -126.65 166.87 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 -174.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -70.01 119.42 14.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.01 24.05 39.1 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.431 -172.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -144.44 154.25 42.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.941 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.497 ' O ' HD12 ' A' ' 7' ' ' LEU . 4.6 pp -151.57 148.46 28.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.868 174.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.4 t -124.48 123.01 65.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.192 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.8 mt -114.35 127.58 71.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.139 -174.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -115.12 131.64 56.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.5 tt -150.74 155.2 7.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.426 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.6 t-20 -54.74 126.86 25.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 170.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.19 -20.57 79.01 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.479 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -56.14 -51.59 67.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.905 0.383 . . . . 0.0 110.882 -162.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -135.25 77.12 1.66 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 147.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -111.34 -33.32 2.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -77.45 -45.3 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.944 0.402 . . . . 0.0 110.952 -160.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.59 -52.03 59.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.851 -156.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.87 -48.95 65.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.528 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.7 mt -62.77 -41.75 99.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 0.0 110.875 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.21 -49.77 63.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.089 -176.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.74 -46.24 89.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.829 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.87 -41.88 79.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.11 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -61.53 -33.55 85.23 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.505 175.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -66.78 -43.04 85.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.399 . . . . 0.0 110.866 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.39 -39.85 94.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -61.79 -42.46 99.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.73 -34.83 75.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.8 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -72.02 -36.6 69.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.963 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -82.68 -42.0 18.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.82 -172.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.2 p -100.15 -22.04 15.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.09 -172.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.98 5.21 89.53 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.537 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 91.2 mt -75.94 123.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.892 0.377 . . . . 0.0 111.214 175.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.31 116.14 6.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.893 175.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG11 ' HA3' ' A' ' 24' ' ' GLY . 92.4 t -103.96 133.85 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.8 m -132.93 111.51 11.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.166 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.3 t -105.15 121.9 57.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.096 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -129.02 148.75 51.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.854 -174.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -138.03 67.63 48.55 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.546 0.689 . . . . 0.0 110.857 172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.542 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 40.2 Cg_endo -78.65 -14.66 14.07 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 -164.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 59.1 m-20 77.16 6.44 3.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.856 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -94.34 -8.59 38.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 mp -48.73 -52.82 21.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 -159.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -53.8 -43.86 69.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -82.72 -40.87 20.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.944 -168.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.07 -43.51 28.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.952 -167.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.6 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 19.5 t80 -49.85 -54.6 30.52 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.647 0.737 . . . . 0.0 110.887 -164.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 21.3 Cg_endo -60.4 -31.1 92.23 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.69 2.26 . . . . 0.0 112.337 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -78.46 -49.88 12.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.526 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 19.5 m -74.23 -28.1 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.91 88.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.23 -23.84 66.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.076 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.7 p -95.69 6.02 49.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.225 -174.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 22.81 60.54 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.426 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.9 t0 -120.03 -172.95 2.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.331 . . . . 0.0 110.94 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.38 -172.44 14.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.541 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HG3' HD11 ' A' ' 60' ' ' ILE . 94.4 Cg_endo -81.64 160.72 19.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.589 2.193 . . . . 0.0 112.391 -174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.14 -43.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 170.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 83.1 mt -132.4 141.85 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.141 -170.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.4 HD11 ' HG3' ' A' ' 57' ' ' PRO . 18.1 mm -123.15 131.95 72.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.214 -177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -114.93 121.36 42.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.944 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -148.11 165.0 32.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.877 169.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.49 -102.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.028 -174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -114.11 -56.59 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.79 -51.71 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -166.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 95.3 mtt-85 -75.36 -32.77 60.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -58.53 -49.44 77.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.852 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.62 -50.6 60.57 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.529 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.01 -40.88 94.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.533 175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 66' ' ' ARG . 14.8 m-30 -69.6 -31.94 70.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.948 0.404 . . . . 0.0 110.901 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.51 96.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.039 177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -68.44 -25.96 65.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.3 m -85.59 3.45 40.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.53 36.38 76.72 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.447 173.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.498 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 1.1 mp -75.27 -15.68 60.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.94 177.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -130.96 143.53 50.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 -170.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.94 162.3 14.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.143 175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.51 137.71 56.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -110.66 153.35 12.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.094 177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.2 p -130.07 64.92 74.11 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.604 0.716 . . . . 0.0 111.126 -175.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -75.67 144.96 28.7 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.732 2.288 . . . . 0.0 112.27 167.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 41.5 p30 -76.5 178.48 6.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -68.27 -31.27 70.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -174.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.68 -34.4 67.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -61.79 -39.34 91.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.814 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -65.08 -40.22 94.32 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.927 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -68.3 -37.53 80.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.906 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -70.84 -29.5 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.1 -107.05 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.815 -178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -165.02 133.09 2.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.721 0.772 . . . . 0.0 110.974 175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -66.25 -33.33 39.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.689 2.259 . . . . 0.0 112.34 -172.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -65.93 -36.51 83.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.4 p -75.47 -24.32 56.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.406 ' HA ' HG22 ' A' ' 97' ' ' VAL . 57.0 m95 -76.44 -28.65 56.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.951 173.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -60.34 -33.74 72.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.432 ' HB2' HD12 ' A' ' 329' ' ' ILE . . . -66.65 -26.43 67.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.147 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 30.2 m -109.15 16.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.2 -175.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.6 ttp-105 -109.79 136.53 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -136.76 125.65 24.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.5 t30 57.71 34.71 24.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.922 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.32 4.44 89.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.461 174.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -121.76 144.91 48.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.0 mt -84.39 125.59 32.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 -176.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.416 ' HB ' HD13 ' A' ' 76' ' ' LEU . 43.0 pt -118.22 -11.65 11.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.144 -167.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -158.65 162.51 37.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.057 -170.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.8 m-85 -106.56 135.89 19.46 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.697 0.76 . . . . 0.0 110.89 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.9 Cg_exo -65.47 118.52 5.53 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 172.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.4 mm -104.26 -36.05 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.065 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -163.83 153.25 14.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.142 -170.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.58 128.35 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.192 -174.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 53.8 mp0 -123.06 150.73 42.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.944 175.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.47 153.77 35.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.084 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 tp -71.03 136.2 48.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.002 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.6 m -138.72 158.21 44.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' HB2' HD23 ' A' ' 247' ' ' LEU . 38.7 tp -95.39 127.8 41.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 244' ' ' VAL . 81.0 mt -111.34 127.66 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.97 157.49 45.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -96.95 114.94 26.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -67.47 -29.44 68.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.007 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -81.68 -35.19 30.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.4 mt -78.14 -43.93 27.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 tp -131.21 109.2 15.09 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.637 0.732 . . . . 0.0 110.921 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.566 ' O ' ' C ' ' A' ' 124' ' ' ASN . 88.4 Cg_endo -73.29 167.65 26.77 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.648 2.232 . . . . 0.0 112.379 173.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.566 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.6 t30 24.96 96.43 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.597 0.713 . . . . 0.0 110.955 175.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 44.8 Cg_endo -65.32 154.66 72.58 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.401 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -68.22 144.72 63.8 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.72 2.28 . . . . 0.0 112.378 -177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -92.97 -22.04 19.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.747 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 76.7 p -130.43 158.97 38.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.229 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.453 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 93.4 m95 -73.08 -24.58 60.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.91 -25.26 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.864 178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -75.92 -21.48 57.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.589 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 32.9 mm -60.05 -51.92 77.09 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.534 0.683 . . . . 0.0 111.101 -166.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.4 Cg_endo -68.99 -42.74 3.89 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.705 2.27 . . . . 0.0 112.448 -174.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.7 -40.43 92.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.203 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -63.01 -38.2 90.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.889 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -62.17 -39.87 94.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.873 -178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.66 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.85 -49.09 61.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 pp -80.76 -16.52 53.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.961 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -53.59 -29.12 36.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.885 170.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.44 -19.88 64.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -103.34 7.73 38.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.92 28.45 62.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.47 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -106.49 157.23 17.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.904 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -106.88 149.66 27.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.902 160.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.56 -42.58 74.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.076 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 38.1 mt -138.2 141.98 40.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.857 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 75.4 mmm -140.22 118.18 11.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 163.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -154.24 168.44 26.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.791 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -72.41 104.29 3.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 -172.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 206' ' ' ALA . 13.5 tp -87.66 -4.82 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.872 -174.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -87.59 10.27 18.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 -171.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -133.64 148.1 67.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.67 0.747 . . . . 0.0 110.803 174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 344' ' ' ARG . 28.6 Cg_endo -68.68 -30.25 28.25 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.668 2.245 . . . . 0.0 112.32 -174.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -57.59 -37.27 72.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.925 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.86 -28.62 27.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.765 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -77.75 -22.93 49.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.72 ' HB3' ' HG3' ' A' ' 256' ' ' LYS . 1.6 m95 -59.79 -46.81 98.4 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 121.445 0.64 . . . . 0.0 110.88 -169.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 61.8 Cg_exo -44.43 -37.57 10.83 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.77 2.313 . . . . 0.0 112.337 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 89.7 mt -81.32 -44.37 17.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.865 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.408 ' O ' ' HA3' ' A' ' 191' ' ' GLY . 96.5 mt -72.97 -46.8 50.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -70.78 -17.59 62.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.35 -28.19 69.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.085 -166.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -100.31 7.16 44.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -170.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.7 4.66 55.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.507 169.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 187' ' ' GLY . . . -109.98 147.02 17.2 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.434 171.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.419 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 43.3 t80 -164.5 173.36 12.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.377 . . . . 0.0 110.858 -167.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.48 -54.6 44.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.156 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -141.39 148.88 40.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -83.88 130.95 34.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.808 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -104.15 113.05 26.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -148.68 140.66 23.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -172.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 47.14 41.76 12.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.94 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.06 7.82 67.8 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.486 173.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.64 151.8 50.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -83.92 134.5 34.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -109.57 114.12 27.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.839 -174.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.1 tp -68.81 -19.99 24.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.107 -175.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.63 -17.56 44.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 -168.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -132.02 87.34 2.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.848 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 184' ' ' ASP . 13.9 m -127.23 166.2 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 -171.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 188' ' ' ALA . . . -93.42 7.6 75.09 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 176.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 181' ' ' VAL . 11.0 m -96.61 -16.45 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.786 0.327 . . . . 0.0 111.072 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 6.6 p30 -79.87 10.56 4.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 167.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 91.2 m-20 84.45 -4.54 1.02 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.75 158.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.22 -48.34 10.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.571 ' O ' ' HA3' ' A' ' 166' ' ' GLY . . . -75.92 -44.1 20.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.552 -172.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 182' ' ' GLY . . . -67.0 -34.72 78.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.841 0.353 . . . . 0.0 111.085 -160.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.49 -41.83 97.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -165.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.82 95.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 161' ' ' ILE . . . -65.48 -42.84 95.57 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.462 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 80.1 mt -66.89 -35.04 79.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 0.0 110.956 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 84.4 m -58.02 -47.96 81.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.117 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -65.11 -43.45 91.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.821 -176.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.89 -48.69 79.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.3 t -64.2 -38.69 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.192 -175.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.12 -36.27 83.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 198' ' ' LEU . 0.2 OUTLIER -65.19 -36.4 84.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.993 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.91 -40.09 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.102 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.87 -39.56 93.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -85.42 5.0 32.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 64.72 31.93 11.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 173.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -83.05 -27.29 30.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 168.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 66.2 mtt -133.37 151.0 51.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.868 171.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.411 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 57.3 t-20 -95.64 132.55 40.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.895 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.431 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -67.44 -28.01 67.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.097 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -92.11 -8.88 44.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.89 -168.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 87.0 m -55.5 126.48 25.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 55.2 p30 -121.14 -174.42 2.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.41 -44.78 92.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.019 -176.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.0 m -60.73 -42.62 97.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.865 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.76 -42.28 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.83 95.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.26 -44.65 78.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.7 -35.71 81.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.121 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.88 -47.02 87.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.097 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -35.62 80.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.81 176.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -62.38 -29.94 70.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -99.14 -21.95 15.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.888 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 22.9 36.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.98 -27.07 43.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.863 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.5 t -124.95 140.0 53.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.98 -35.18 50.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.1 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.2 mtm -139.68 155.92 47.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -166.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -152.1 164.87 36.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 80.1 mt -120.63 118.08 55.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -151.79 163.19 39.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.783 -173.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.415 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -100.57 -141.31 11.94 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.45 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.638 ' HB3' HD22 ' A' ' 299' ' ' LEU . 39.8 Cg_endo -71.24 -25.52 21.96 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.688 2.258 . . . . 0.0 112.366 -177.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -65.79 -19.98 66.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -94.77 9.4 39.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 89.7 t90 -65.99 -38.78 89.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.916 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.2 t -54.63 111.49 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.871 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.424 ' HB3' ' OH ' ' A' ' 242' ' ' TYR . 68.7 m-80 -152.73 142.1 21.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.82 78.18 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -83.54 75.22 10.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.6 p -115.27 -9.03 12.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 82.9 p -103.2 -171.55 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.81 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.84 177.65 3.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.836 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 94.9 t -59.66 110.3 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.59 -57.87 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.814 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.424 ' OH ' ' HB3' ' A' ' 234' ' ' ASN . 49.2 p90 -110.2 159.52 17.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -141.95 167.61 25.93 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.49 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 116' ' ' ILE . 64.0 t -129.13 130.87 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.215 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.06 -177.25 5.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.197 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.5 m -90.17 160.04 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.101 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' A' ' 115' ' ' LEU . 83.8 mt -70.9 143.27 88.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.559 0.695 . . . . 0.0 110.937 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.429 ' O ' ' HB3' ' A' ' 255' ' ' SER . 57.7 Cg_endo -74.96 170.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 0.0 112.391 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 76.7 p -104.33 162.12 13.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.046 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -135.53 118.52 16.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.829 -176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 54.6 34.8 22.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.13 12.66 80.56 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 175.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 89.1 mm-40 -122.72 147.36 50.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.615 0.722 . . . . 0.0 110.94 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 51.4 Cg_exo -54.81 145.53 60.7 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.618 2.212 . . . . 0.0 112.424 175.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.453 ' HB3' ' HE1' ' A' ' 129' ' ' TRP . 95.3 p -70.53 -63.07 1.16 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.992 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' A' ' 158' ' ' TRP . 14.1 tmtt? -172.32 125.93 0.53 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.561 0.696 . . . . 0.0 110.917 173.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.71 134.37 12.11 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.716 2.277 . . . . 0.0 112.313 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -161.08 110.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.05 134.98 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.133 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.816 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -119.86 147.26 18.05 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.463 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.9 t -122.59 121.75 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 0.0 111.125 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.54 130.99 45.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.954 174.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.0 m -127.72 139.85 52.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.712 -165.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.19 137.21 49.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.101 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.0 168.11 23.07 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.339 -176.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.79 129.14 65.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.842 0.353 . . . . 0.0 111.108 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -57.44 125.37 22.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -176.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.68 -22.25 66.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.97 -12.48 55.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.145 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.0 t -70.77 136.65 85.46 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.773 0.797 . . . . 0.0 110.826 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -74.16 -14.63 23.24 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.625 2.216 . . . . 0.0 112.35 174.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -108.03 36.87 2.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.832 -167.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -57.94 -38.71 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -176.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.17 -38.78 91.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.913 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.38 -49.38 67.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.54 -48.55 66.64 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.137 -168.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -66.48 -47.46 72.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.916 -172.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -47.94 72.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.1 OUTLIER -72.14 -36.02 69.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.873 -173.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 280' ' ' LEU . 5.1 tt -56.58 -47.81 78.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.915 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -82.01 -25.56 34.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.816 -174.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -99.81 -13.12 19.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 -171.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 70.6 t80 -124.36 -58.83 1.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.893 -176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 79.7 mt -69.71 -39.87 76.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 -175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 82.2 mt -85.02 66.34 9.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 175.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 73.7 p -136.27 168.35 19.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -54.52 -45.25 73.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.925 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.87 -41.86 42.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.815 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.96 -49.63 9.65 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.497 -169.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 40.0 tp -68.32 -38.92 82.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.781 0.324 . . . . 0.0 110.914 -175.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -61.56 -43.22 99.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.83 76.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.068 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.6 t -74.38 -45.06 47.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -73.86 -14.28 61.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.3 -27.07 13.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.942 178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -91.91 -4.24 54.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -91.15 151.29 42.9 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.573 0.702 . . . . 0.0 110.871 172.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.55 -57.72 0.16 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.666 2.244 . . . . 0.0 112.392 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.638 HD22 ' HB3' ' A' ' 229' ' ' PRO . 61.8 tp -65.8 -47.78 73.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -167.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.47 -4.06 86.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.469 ' HB1' ' SD ' ' A' ' 321' ' ' MET . . . -75.16 125.55 29.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 0.0 111.114 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.515 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -124.71 159.71 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.161 -173.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.36 60.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 57.2 tp -75.3 123.57 25.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.838 -175.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -62.65 -39.39 93.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.871 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 45.1 t -59.46 -48.37 81.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.515 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.6 t80 -71.38 -33.68 69.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -59.12 -39.45 82.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.86 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -57.56 -37.82 73.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -76.97 -37.31 55.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.8 mt -64.87 -31.61 72.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.11 -12.66 57.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.11 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -76.03 -20.05 58.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -91.81 117.93 68.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.614 0.721 . . . . 0.0 110.801 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.74 -33.64 60.93 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.673 2.248 . . . . 0.0 112.337 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 91.8 mtm-85 -72.55 -43.2 63.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 -173.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.2 mt -78.43 -38.6 22.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.141 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.99 72.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.72 89.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 80.9 m -67.2 -43.09 82.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.225 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.469 ' SD ' ' HB1' ' A' ' 301' ' ' ALA . 96.3 mmm -66.11 -34.62 78.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -62.14 -40.24 95.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.959 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -72.76 -34.57 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.18 -41.78 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -69.94 -17.03 63.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.807 177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.03 -5.35 16.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 -175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.1 -164.07 39.86 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.476 -170.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -133.61 147.53 51.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.832 0.349 . . . . 0.0 110.885 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.432 HD12 ' HB2' ' A' ' 96' ' ' ALA . 39.2 mm -67.43 126.92 28.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 -166.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.816 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 54.2 mtt -52.64 -58.83 10.4 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.586 0.708 . . . . 0.0 110.914 -171.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.524 ' CD ' ' HB2' ' A' ' 330' ' ' MET . 36.2 Cg_endo -63.98 101.08 0.32 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.762 2.308 . . . . 0.0 112.375 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.68 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 69.1 m-80 -123.06 28.49 7.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.861 -169.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.8 mt 90.23 135.0 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.667 0.746 . . . . 0.0 111.104 -176.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -54.79 -29.94 65.13 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.618 2.212 . . . . 0.0 112.332 -171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.437 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.6 mt-30 -64.09 -23.69 67.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -174.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 96.1 mmm -68.88 -26.82 65.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -62.38 -40.18 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -78.15 -34.88 49.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.183 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -66.68 -40.13 88.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.07 -38.55 83.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.966 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -64.99 -36.26 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.72 -35.01 79.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 73.0 t -70.67 -40.2 76.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.17 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.613 ' HB2' ' HD3' ' A' ' 154' ' ' PRO . 58.0 ttp180 -56.38 -44.79 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.2 m -64.2 -44.46 91.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.485 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -63.52 -45.38 90.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.075 -176.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 14.6 p -71.97 -36.68 58.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.09 -171.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 91.5 mt -68.98 -44.16 81.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.068 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -64.39 -35.74 81.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.817 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.84 -45.58 67.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.31 -36.31 68.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.3 p -75.78 -12.69 60.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.77 6.99 88.6 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -72.22 -30.09 64.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.864 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -139.28 156.8 46.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.903 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 70.8 p -75.02 164.09 26.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.092 171.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.8 t -65.39 -50.25 73.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -70.51 -36.67 73.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -69.21 -48.06 63.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.55 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.079 174.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 41.1 tp -65.09 -44.08 90.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.09 -46.51 88.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.68 -35.07 78.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.901 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.485 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -79.01 -43.28 24.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.172 -172.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 10.3 mm100 -77.97 -31.13 50.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -171.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 78.0 m -59.99 -38.03 81.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.106 174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.48 -30.0 70.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.81 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.41 -45.42 93.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.4 p -97.85 -4.62 36.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -177.915 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.703 0.287 . . . . 0.0 110.928 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.422 HG21 ' HD2' ' A' ' 271' ' ' PRO . 88.6 mt -61.76 125.8 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.083 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 164.35 24.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -66.93 121.99 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.944 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.73 19.76 59.25 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 -173.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -146.39 153.34 40.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.798 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.9 pp -143.15 145.87 33.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 174.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.08 124.79 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.164 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.553 HG22 ' HB ' ' A' ' 59' ' ' ILE . 5.7 pt -124.95 132.26 71.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.104 -171.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.774 ' HB3' HD22 ' A' ' 43' ' ' LEU . 38.3 m0 -113.72 135.34 54.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.533 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.2 tt -148.17 155.09 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.241 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.455 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.1 t-20 -55.77 128.01 32.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.873 173.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.12 -16.86 76.94 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.441 -168.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.44 -47.7 80.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.921 0.391 . . . . 0.0 110.973 -165.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -134.58 63.46 1.62 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 152.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.533 ' HA3' HG23 ' A' ' 11' ' ' ILE . . . -100.53 -50.49 1.3 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -67.74 -43.54 79.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.921 0.391 . . . . 0.0 110.984 -160.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -68.38 -49.52 59.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.74 -163.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -62.48 -48.44 81.97 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.488 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.2 mt -63.89 -34.57 78.24 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.843 0.354 . . . . 0.0 110.88 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.07 95.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.049 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -62.06 -49.37 76.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.85 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 292' ' ' ALA . 25.5 m -72.84 -32.68 41.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.48 -40.15 97.45 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.45 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.86 -43.94 91.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.754 0.311 . . . . 0.0 110.819 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.88 -47.25 78.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.956 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 27' ' ' PHE . 6.9 m-30 -64.6 -41.85 95.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.889 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -65.09 -34.22 77.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -68.89 -40.71 79.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.83 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.77 -39.64 23.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -172.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.2 m -102.11 -26.35 13.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.15 -172.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.89 5.45 83.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 -175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 33' ' ' ILE . 19.5 tt -76.55 126.96 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.907 0.384 . . . . 0.0 111.188 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.49 124.14 23.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.7 t -109.35 130.51 62.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.185 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.0 m -125.19 114.42 18.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.152 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 9' ' ' ILE . 51.7 t -103.83 120.23 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.025 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 57.6 mt-10 -131.12 146.46 52.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -139.92 67.81 35.0 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.699 0.762 . . . . 0.0 110.789 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.548 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -73.91 -16.62 23.1 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.694 2.262 . . . . 0.0 112.387 -167.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 62.0 m-20 74.74 7.6 4.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.911 -173.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.51 -1.32 57.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 172.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.774 HD22 ' HB3' ' A' ' 10' ' ' TRP . 34.5 mt -48.32 -54.33 14.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -156.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -67.79 -27.34 66.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 -167.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.61 -47.44 10.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -173.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -80.26 -40.97 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.998 -166.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.638 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 37.4 t80 -55.48 -58.88 13.05 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.604 0.716 . . . . 0.0 110.862 -165.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.8 Cg_endo -59.74 -30.7 92.7 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -75.05 -45.1 43.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.962 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 47' ' ' PHE . 33.2 m -73.75 -23.34 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.147 -174.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.096 177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.36 -24.8 66.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.32 4.61 53.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.085 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.0 22.29 74.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 173.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -139.39 -163.18 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.878 0.37 . . . . 0.0 110.882 177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.82 -165.83 22.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.627 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.495 ' HG2' HD11 ' A' ' 60' ' ' ILE . 84.4 Cg_endo -81.62 165.09 18.33 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.689 2.259 . . . . 0.0 112.339 -173.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' HA ' HD11 ' A' ' 2' ' ' ILE . 43.6 t0 -83.95 -49.26 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.553 ' HB ' HG22 ' A' ' 9' ' ' ILE . 82.9 mt -133.97 138.55 50.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 -171.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.495 HD11 ' HG2' ' A' ' 57' ' ' PRO . 7.1 mm -120.86 139.69 47.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.239 173.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -99.53 130.9 45.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -139.69 158.3 44.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -87.8 -100.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.614 ' HB3' ' HD3' ' A' ' 331' ' ' PRO . 3.8 p80 -110.94 -54.87 2.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -176.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.07 -49.8 75.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 -163.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -78.37 -33.63 48.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -61.66 -48.36 81.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.813 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.71 -49.16 65.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.559 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.04 98.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.504 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -70.14 -30.02 67.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -62.95 -44.17 96.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.098 175.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -67.49 -28.09 67.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.901 174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.5 m -85.57 0.14 53.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -173.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.52 34.85 80.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.423 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mp -87.07 -2.6 58.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.84 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.467 HD13 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.19 142.92 51.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.932 -175.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.38 152.63 22.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -67.04 135.34 53.55 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.48 HG13 ' HB3' ' A' ' 103' ' ' LEU . 30.5 pt -118.42 146.45 22.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -134.96 69.66 70.8 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.622 0.725 . . . . 0.0 111.165 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.96 144.54 43.18 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.712 2.274 . . . . 0.0 112.38 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -76.05 178.56 6.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.56 -31.91 73.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.36 -44.87 95.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.068 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -67.82 -38.45 83.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.801 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.94 -41.55 95.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.14 -33.85 72.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.844 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -68.21 -22.48 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.892 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.7 mt -95.78 -125.06 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 34.3 t80 -153.68 136.48 9.78 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.743 0.782 . . . . 0.0 110.941 178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.2 Cg_exo -58.24 -41.51 65.95 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.79 2.326 . . . . 0.0 112.316 -172.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.6 -43.54 84.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.7 p -72.13 -26.76 62.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.155 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -70.04 -40.07 75.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.941 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -63.91 -36.14 82.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.817 173.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.66 65.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.078 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.491 HG23 HD11 ' A' ' 103' ' ' LEU . 26.8 m -107.4 19.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.131 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -109.95 141.02 43.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -138.42 125.89 21.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.96 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.3 t30 58.38 35.05 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.831 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.31 2.65 89.44 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.485 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -123.64 139.71 53.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.931 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.491 HD11 HG23 ' A' ' 97' ' ' VAL . 10.7 tp -80.44 132.99 35.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.818 -176.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.467 ' HB ' HD13 ' A' ' 76' ' ' LEU . 37.7 pt -124.38 -11.25 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 -165.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -157.32 162.49 39.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.009 -170.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.412 ' HB3' HD11 ' A' ' 285' ' ' LEU . 97.1 m-85 -113.15 140.78 24.67 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.623 0.725 . . . . 0.0 110.995 168.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.66 121.84 8.32 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 170.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -103.86 -42.7 8.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.009 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.72 153.34 29.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.127 -175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -133.84 133.77 56.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.117 -171.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.659 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 11.7 mp0 -130.8 155.87 45.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 174.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.43 155.09 41.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.05 -173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 35.3 tp -73.3 134.3 44.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.944 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.4 p -143.16 161.3 38.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.81 -173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.0 tp -98.99 127.89 45.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.918 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 84.2 mt -108.05 131.09 59.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.013 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -132.31 149.89 52.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.889 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -90.69 118.77 30.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 171.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -60.76 -34.66 74.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -81.63 -35.13 30.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.819 -171.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.59 -44.72 23.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.44 HD12 ' HG3' ' A' ' 224' ' ' MET . 72.6 mt -131.68 115.79 15.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.667 0.746 . . . . 0.0 110.861 173.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.554 ' O ' ' C ' ' A' ' 124' ' ' ASN . 90.2 Cg_endo -74.47 170.09 21.05 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.738 2.292 . . . . 0.0 112.368 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.554 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.4 t30 25.06 97.11 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.544 0.688 . . . . 0.0 110.916 177.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 41.9 Cg_endo -65.49 157.16 59.68 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.401 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.85 149.91 60.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.576 2.184 . . . . 0.0 112.342 -177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.66 -27.71 13.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.9 p -126.25 156.44 40.3 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.171 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -66.24 -30.37 70.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.81 -26.58 58.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.915 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.93 -21.51 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 -177.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.686 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 32.2 mm -59.74 -55.37 46.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.655 0.741 . . . . 0.0 111.14 -167.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.686 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 52.0 Cg_endo -75.0 -37.65 1.93 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.73 2.287 . . . . 0.0 112.354 -172.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.54 -40.85 96.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 173.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.76 -42.43 90.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.871 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -62.62 -41.52 99.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.988 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.52 -43.86 84.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.95 -45.58 67.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 140' ' ' LYS . 4.5 pp -79.4 -22.51 44.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.007 -175.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' N ' HD12 ' A' ' 139' ' ' LEU . 83.9 tttt -61.06 -30.93 70.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.019 173.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.8 -20.4 64.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.186 173.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.36 6.54 47.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.45 28.85 60.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.516 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.417 ' HB2' HD13 ' A' ' 139' ' ' LEU . 91.6 mttt -108.79 165.18 11.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 0.0 110.884 171.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.8 t -120.31 140.1 51.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 163.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.7 -33.66 66.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 -177.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.5 mt -137.02 150.25 47.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.881 -179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 93.7 mmm -133.52 131.75 40.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 166.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -160.43 162.48 33.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.6 t-20 -84.24 110.71 18.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.876 -177.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 39.9 tp -96.09 4.49 52.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -173.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -81.21 2.12 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -145.53 151.92 48.12 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.667 0.746 . . . . 0.0 110.935 175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.681 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.9 Cg_endo -72.61 -17.37 26.43 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.676 2.251 . . . . 0.0 112.256 -174.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -52.47 -48.58 65.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.95 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.423 ' O ' ' HD2' ' A' ' 159' ' ' PRO . 51.9 m-85 -83.51 -11.68 57.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -172.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -80.49 -19.02 46.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.159 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.485 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 6.5 m95 -59.79 -44.23 96.72 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.477 0.656 . . . . 0.0 110.921 -172.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 66.6 Cg_exo -43.82 -31.22 3.44 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.714 2.276 . . . . 0.0 112.324 176.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 160' ' ' LEU . 3.4 tm? -87.61 -49.24 7.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.926 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.423 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.6 mt -78.55 -47.66 23.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 -169.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 158' ' ' TRP . . . -64.85 -26.42 68.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.041 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -62.09 -31.75 72.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -95.96 0.31 51.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.43 2.75 38.02 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.423 170.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -92.46 129.03 9.67 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.408 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -168.3 175.2 6.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.018 0.437 . . . . 0.0 110.808 -172.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -71.79 -42.76 66.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.127 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -137.42 150.7 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.86 -179.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -99.6 127.56 45.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 172.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -97.35 112.49 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.903 -174.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -149.91 138.43 20.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 52.65 35.16 17.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.55 4.6 75.71 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.532 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.49 149.96 50.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -77.4 135.25 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.942 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.45 107.25 18.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.8 tp -65.5 -19.71 26.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.06 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.55 -8.45 56.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -122.63 76.25 1.33 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.846 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.604 ' CG2' HG22 ' A' ' 183' ' ' VAL . 31.0 m -131.19 164.34 34.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -171.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -85.43 13.13 56.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.602 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.604 HG22 ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -99.74 -20.17 5.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.754 0.312 . . . . 0.0 111.082 174.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 99.7 m-20 -78.36 3.0 16.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 167.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 84.4 m-20 83.81 -4.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.792 163.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -74.1 -50.8 17.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.13 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -78.61 -42.1 14.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.45 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.13 -37.7 78.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 -164.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -63.27 -44.69 94.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -166.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.95 98.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.039 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.423 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.95 -42.28 98.36 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.424 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.34 -43.15 91.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.857 -177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.6 m -61.76 -44.21 97.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.505 ' CD2' HD21 ' A' ' 160' ' ' LEU . 1.1 t80 -63.11 -41.51 99.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 57.3 tp -61.89 -40.53 95.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.34 -37.74 75.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.13 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -66.11 -35.13 79.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.46 -41.46 89.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.913 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.1 -36.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.042 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.65 -37.06 84.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -84.43 3.19 37.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 60.78 39.8 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 173.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -79.28 -26.85 42.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.878 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -149.46 150.86 33.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -95.37 149.83 20.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.877 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.66 -25.62 68.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.151 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -92.82 -7.28 46.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.779 -174.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 78.8 m -58.61 125.54 23.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 59.6 p30 -139.07 -179.96 6.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 177.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -62.65 -33.05 74.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.003 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.9 m -63.79 -44.13 94.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.73 -40.04 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.168 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.03 -42.76 99.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.096 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.9 -43.89 91.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.95 82.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.83 -41.37 99.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -66.21 -35.56 80.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.807 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -64.44 -29.59 70.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.58 -19.0 19.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 -179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.01 25.18 38.4 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.566 -178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -84.68 -19.53 32.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.041 0.448 . . . . 0.0 110.955 -172.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -128.19 144.52 51.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.098 -176.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.44 -35.29 14.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.506 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.2 mtm -142.29 160.6 39.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.933 -169.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.0 t -150.46 160.31 43.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.149 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.21 118.92 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 65.0 m-80 -151.94 160.33 43.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.961 -173.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -107.34 -135.58 7.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.418 -176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.659 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 25.4 Cg_endo -68.0 -28.13 35.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.652 2.235 . . . . 0.0 112.365 -175.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -67.38 -15.08 63.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.892 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -88.7 21.26 3.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.056 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -62.57 -31.36 72.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 47.0 t -63.72 106.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.816 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -149.13 130.01 14.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.8 mt -91.08 80.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.165 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -84.96 73.71 10.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.85 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.9 p -120.25 -12.38 9.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 89.9 p -110.1 -170.06 1.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -66.22 172.86 3.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.0 t -61.14 104.48 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.114 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -105.08 -59.35 1.76 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.941 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -110.02 153.85 24.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.41 159.54 23.87 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.504 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.73 128.16 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.999 0.428 . . . . 0.0 111.102 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.01 174.71 10.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.178 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.04 159.51 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.21 146.09 96.59 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.44 160.23 50.61 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.734 2.289 . . . . 0.0 112.313 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.0 p -104.52 151.54 23.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.023 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -130.78 116.08 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 55.53 33.88 21.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.0 14.75 68.78 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.518 175.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -126.25 148.88 65.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.874 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.36 144.25 79.5 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.673 2.249 . . . . 0.0 112.387 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -74.08 -57.0 4.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -172.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.421 ' HG3' ' HD3' ' A' ' 159' ' ' PRO . 10.0 tmtt? -150.1 111.18 3.28 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.519 0.676 . . . . 0.0 110.974 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.96 127.62 11.6 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.784 2.323 . . . . 0.0 112.299 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.407 ' CE2' ' SD ' ' A' ' 330' ' ' MET . 31.0 t80 -158.91 119.44 3.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 -178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.43 130.89 15.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.168 167.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.05 135.09 12.05 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.455 172.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -124.86 128.47 73.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.141 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 68.3 tp -73.18 135.01 44.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.856 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 79.2 p -133.87 160.68 36.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.803 -178.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.94 136.81 48.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.058 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -113.13 148.95 18.59 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.477 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 93.5 mt -108.71 124.88 65.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 -176.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 270' ' ' SER . 45.1 t-20 -51.6 120.14 4.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -174.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.72 -22.59 66.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.5 -8.93 58.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.193 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 267' ' ' ASN . 29.4 t -71.41 129.19 89.16 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.74 0.781 . . . . 0.0 110.786 -171.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.422 ' HD2' HG21 ' A' ' 2' ' ' ILE . 90.6 Cg_endo -71.59 -14.86 30.6 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.646 2.231 . . . . 0.0 112.267 170.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -107.79 29.14 7.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.929 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.23 -33.62 67.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.754 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.39 -38.96 92.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.832 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.4 mt -67.88 -41.62 82.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.907 174.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -63.62 -50.35 69.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.042 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -71.13 -38.62 72.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.841 -173.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 96.4 mt-10 -72.19 -48.28 44.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 -173.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -62.73 -40.41 97.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.99 -176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 284' ' ' LEU . 2.8 tt -60.68 -48.4 81.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 -177.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -83.57 -31.13 26.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.938 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 92.0 m-20 -97.99 -22.15 16.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.807 -166.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.456 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 m-85 -121.37 -51.82 2.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 280' ' ' LEU . 58.9 tp -70.64 -46.87 62.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.912 -176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 106' ' ' TYR . 92.2 mt -87.05 63.54 7.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.6 p -135.23 169.39 17.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.11 172.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -55.72 -44.35 77.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.826 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.14 -44.3 22.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.952 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -70.95 -47.11 40.48 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -170.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 30.1 tp -67.82 -35.41 78.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.778 0.323 . . . . 0.0 110.86 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -62.05 -40.01 94.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.759 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' A' ' 23' ' ' VAL . . . -64.93 -38.56 91.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.138 -174.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 12.0 p -80.75 -33.71 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.126 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -72.23 -31.74 66.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -172.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -59.54 -22.5 61.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.924 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -94.15 -10.16 34.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.38 152.03 75.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.551 0.691 . . . . 0.0 110.922 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.47 -61.58 0.08 OUTLIER 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.559 2.173 . . . . 0.0 112.385 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -81.95 -43.2 18.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.939 0.4 . . . . 0.0 110.922 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.75 14.86 79.02 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.551 173.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -84.39 127.63 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 111.047 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.54 160.03 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.134 -173.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.4 -10.32 59.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.185 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 52.8 tp -74.22 121.13 20.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -62.37 -49.05 77.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.871 -171.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.6 m -60.76 -43.41 98.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.884 -172.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -70.12 -35.67 74.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.834 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -64.03 -31.12 72.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.808 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.85 -39.19 90.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.858 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.05 -37.68 61.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.819 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.405 ' HB3' HG21 ' A' ' 317' ' ' ILE . 90.9 mt -65.06 -27.47 68.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 176.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.26 -15.62 57.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.117 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.59 -21.05 61.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.843 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -86.58 120.73 72.14 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 0.0 110.807 171.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.87 -27.78 80.6 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.631 2.221 . . . . 0.0 112.383 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -70.03 -39.67 75.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 311' ' ' LEU . 47.4 mm -77.27 -36.37 23.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.242 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.67 -39.11 76.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.243 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.38 -41.42 89.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.144 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 86.2 m -64.14 -47.16 80.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.198 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 8.5 tpt -66.89 -36.99 83.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -61.96 -43.27 99.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.888 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 99.9 m-20 -74.97 -36.42 62.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.915 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.58 93.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.127 -176.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -69.72 -18.99 63.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -109.51 -6.56 15.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.912 -172.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.38 -160.52 36.57 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.43 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -126.38 139.26 53.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.9 0.381 . . . . 0.0 110.813 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.544 HG13 ' HD2' ' A' ' 331' ' ' PRO . 2.2 tp -70.54 136.61 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.178 -170.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.573 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 83.0 mmm -52.51 -52.57 62.38 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -172.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 64' ' ' HIS . 51.2 Cg_endo -66.86 82.29 0.33 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.757 2.305 . . . . 0.0 112.337 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.639 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 76.5 m-20 -107.15 29.63 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.809 -177.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.639 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 63.7 mt 86.96 135.09 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.592 0.711 . . . . 0.0 111.127 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -52.76 -31.81 52.8 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 0.0 112.259 -172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.414 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.9 mt-30 -61.46 -28.49 69.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.965 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 18.5 tmm? -64.94 -37.06 86.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.17 -39.69 95.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.795 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -38.17 80.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.448 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.6 m-30 -65.75 -32.91 74.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.937 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -59.09 -40.08 84.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.984 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -70.99 -36.28 72.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.992 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.95 -42.13 90.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.126 -176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.5 m -74.1 -25.38 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.121 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.681 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 75.0 ttt-85 -55.8 -40.56 72.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.0 m -60.79 -45.55 93.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.165 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' A' ' 364' ' ' ALA . . . -65.44 -43.52 90.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.103 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.38 -53.73 26.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.141 -170.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 93.9 mt -67.97 -44.97 84.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.039 -173.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -63.64 -37.33 86.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -177.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.22 -46.62 66.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.58 -35.33 75.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.08 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.9 p -80.47 -10.83 59.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.841 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.95 13.2 81.65 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.496 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.36 -30.08 57.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.678 0.275 . . . . 0.0 110.845 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -137.33 156.88 47.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.9 m -70.74 149.7 46.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 175.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.06 -49.3 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.087 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.67 -43.09 90.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.3 -47.07 65.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.899 -174.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.33 -40.59 96.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.184 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.407 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 59.6 tp -65.62 -44.8 85.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.917 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.08 -49.6 71.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.932 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.74 -38.39 83.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 346' ' ' ALA . . . -73.99 -42.74 59.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.06 -174.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 9.5 mm100 -78.26 -27.65 47.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -173.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 51.6 m -58.27 -37.07 74.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 173.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.88 -29.6 70.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.08 -40.0 87.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 57.8 p -94.04 -12.76 27.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.147 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.911 179.061 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.704 0.287 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.6 mt -76.38 135.1 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.163 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -150.19 173.63 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.835 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.53 122.5 18.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.914 -175.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 23.81 39.37 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -145.92 154.87 42.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.459 ' C ' HD12 ' A' ' 7' ' ' LEU . 4.3 pp -150.98 149.26 29.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 172.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 58' ' ' ASP . 97.2 t -125.63 129.61 72.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.109 -172.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.3 mt -115.32 130.46 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.567 ' HB3' HD22 ' A' ' 43' ' ' LEU . 22.6 m0 -114.6 129.82 56.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.813 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.3 tt -152.67 155.24 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.134 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 57.2 t-20 -54.77 127.18 27.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.841 173.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.94 -18.34 80.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.472 -167.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -56.59 -50.88 70.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.929 0.395 . . . . 0.0 110.857 -163.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -134.8 75.41 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 147.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -104.69 -37.56 2.75 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -78.18 -46.58 20.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.91 0.386 . . . . 0.0 110.957 -157.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -65.7 -52.15 53.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.903 -153.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.46 -48.86 60.28 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.454 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.1 mt -62.44 -41.59 98.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.891 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.83 -49.05 69.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.997 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.26 -47.15 80.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.876 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.7 t -68.56 -44.82 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -60.24 -36.48 90.89 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.399 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -65.48 -40.61 93.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 110.861 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -61.06 -39.87 91.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.943 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -65.27 -40.07 93.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.845 171.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -59.95 -35.84 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -71.77 -37.39 70.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.912 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.2 -40.37 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 -172.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 64.5 m -104.36 -18.13 14.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.181 -172.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.29 86.66 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.471 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -88.46 128.18 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.914 0.388 . . . . 0.0 111.197 177.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -71.28 129.6 39.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -172.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 83.5 t -110.23 136.13 47.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.16 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.6 m -133.9 112.62 11.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.139 -174.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.3 t -106.52 124.02 61.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -129.89 152.55 49.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.428 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 25.7 p80 -134.38 74.05 67.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.615 0.721 . . . . 0.0 110.828 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 19.2 Cg_endo -71.13 -27.39 20.21 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.725 2.283 . . . . 0.0 112.297 -162.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 60.6 m-20 77.7 4.17 2.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.847 -172.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -98.04 -0.46 44.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.567 HD22 ' HB3' ' A' ' 10' ' ' TRP . 89.2 mt -48.91 -56.59 8.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.952 -152.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -65.06 -27.8 69.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.786 -165.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -85.3 -43.03 14.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.908 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -79.32 -45.0 20.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.964 -166.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.877 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 5.9 t80 -52.5 -53.59 51.84 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -163.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 72.7 Cg_exo -55.11 -38.87 93.27 Favored 'Trans proline' 0 C--O 1.23 0.119 0 C-N-CA 122.659 2.24 . . . . 0.0 112.302 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.67 -46.76 35.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.969 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.5 m -73.73 -28.04 23.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -174.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.02 -37.46 84.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.068 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 -24.58 67.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -96.37 5.79 50.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.22 20.76 74.78 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.466 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -116.99 -172.23 2.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.872 0.368 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.34 -173.8 26.61 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.581 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.62 159.74 28.4 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.643 2.229 . . . . 0.0 112.45 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 276' ' ' ALA . 33.9 t70 -75.63 -38.87 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 171.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 97.5 mt -131.99 139.83 49.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.163 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.3 tp -136.37 136.29 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.178 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -103.36 135.39 45.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -141.35 155.9 45.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.926 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -91.23 -106.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.068 177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.412 ' CG ' ' N ' ' A' ' 65' ' ' ASP . 12.6 p80 -109.79 -54.83 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 64' ' ' HIS . 38.9 t70 -62.37 -48.1 81.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 -164.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -79.57 -36.34 38.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -58.58 -51.26 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.835 -168.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.37 -51.46 54.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.571 -171.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.11 -40.85 92.15 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.44 175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -70.1 -30.38 67.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 0.0 110.994 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HA ' HD11 ' A' ' 76' ' ' LEU . . . -64.03 -42.64 97.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.014 174.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -65.8 -28.06 68.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.923 173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -85.17 2.76 42.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.74 36.1 86.75 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.522 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.32 -23.83 62.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.843 0.354 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.476 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -129.24 144.71 51.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 -159.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.26 157.59 17.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -68.71 138.22 54.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.831 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.8 pt -107.81 151.03 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.076 176.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.2 p -128.54 69.4 79.15 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.555 0.693 . . . . 0.0 111.16 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.06 141.65 26.72 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.786 2.324 . . . . 0.0 112.214 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -79.27 169.59 17.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.802 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -60.95 -30.44 70.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.957 -176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.89 -43.12 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.016 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -77.98 -35.82 49.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.858 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -61.64 -44.19 97.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.26 -28.32 65.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.812 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -68.43 -23.51 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.836 -172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.0 mt -100.5 -113.41 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.872 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 22.4 t80 -158.92 133.08 5.17 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.614 0.721 . . . . 0.0 110.992 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 86.1 Cg_exo -57.28 -41.0 77.92 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.745 2.297 . . . . 0.0 112.363 -173.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -64.22 -39.11 93.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.942 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.6 p -71.9 -24.84 61.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.187 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.427 ' HA ' HG22 ' A' ' 97' ' ' VAL . 60.9 m95 -71.16 -36.33 71.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.85 -28.68 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.55 -27.69 67.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 94' ' ' TRP . 36.0 m -110.97 10.95 8.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -100.22 130.05 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.973 177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -129.3 120.47 25.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.975 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.9 t30 58.53 35.13 24.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.46 5.01 90.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.437 176.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.88 145.62 47.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.796 0.332 . . . . 0.0 110.975 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.68 125.8 34.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.914 -176.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.45 ' HB ' HD13 ' A' ' 76' ' ' LEU . 40.9 pt -120.89 -6.0 9.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.194 -169.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . . . -161.77 164.48 28.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.092 -172.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.1 m-85 -108.46 134.64 20.17 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.669 0.747 . . . . 0.0 110.962 174.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 22.3 Cg_exo -64.07 121.0 8.52 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.665 2.243 . . . . 0.0 112.321 171.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.7 mm -104.98 -40.07 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.122 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.48 151.62 20.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.065 -166.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.9 t -129.67 129.34 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 -176.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.592 ' HB3' ' HB3' ' A' ' 229' ' ' PRO . 46.1 mt-10 -128.52 153.08 47.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.908 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -151.93 157.04 41.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.145 -174.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.3 tp -71.1 131.81 44.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 175.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.0 m -139.7 155.94 47.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.5 tp -94.91 126.33 40.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 -177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 85.0 mt -108.5 127.41 64.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -137.48 154.71 49.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.9 t-20 -91.32 118.22 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.812 177.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.659 ' HE3' ' HA3' ' A' ' 243' ' ' GLY . 97.4 mttt -68.21 -29.58 68.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.906 -172.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -78.05 -38.56 44.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -79.17 -35.31 42.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.95 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 58.2 tp -134.43 111.19 11.63 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.624 0.726 . . . . 0.0 111.006 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.594 ' O ' ' C ' ' A' ' 124' ' ' ASN . 84.2 Cg_endo -74.87 172.29 16.61 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.744 2.296 . . . . 0.0 112.328 170.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.594 ' C ' ' O ' ' A' ' 123' ' ' PRO . 56.7 t30 22.5 96.44 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.595 0.712 . . . . 0.0 110.959 174.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.21 156.4 65.88 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.762 2.308 . . . . 0.0 112.293 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 144.98 60.44 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.744 2.296 . . . . 0.0 112.331 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -94.07 -29.45 15.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.8 p -126.04 158.8 34.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 -175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -68.75 -32.76 72.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.946 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -56.51 -26.45 54.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.828 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.16 -20.97 60.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 25.1 mm -58.86 -54.29 57.91 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.647 0.737 . . . . 0.0 111.129 -169.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 26.3 Cg_endo -65.15 -41.32 16.89 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.738 2.292 . . . . 0.0 112.399 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.28 -41.65 93.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.02 -37.37 87.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.87 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -65.01 -40.15 94.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.31 -37.88 81.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 144' ' ' LYS . 60.5 mt -70.38 -35.45 73.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 178.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -56.09 -32.29 64.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.998 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.45 66.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.097 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -104.29 4.79 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.83 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.49 26.42 67.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.498 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 82.4 mttt -113.16 156.44 23.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.868 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.6 t -113.4 148.8 35.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.817 172.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.22 38.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.2 mt -139.75 149.85 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.9 mmm -137.28 115.81 12.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 168.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -165.23 165.83 19.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.54 148.19 22.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -170.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 57.6 tp -107.01 -0.01 23.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -78.74 -11.17 59.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.964 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -138.45 145.44 46.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.561 0.696 . . . . 0.0 110.932 -178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.771 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 36.2 Cg_endo -68.04 -25.53 37.89 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.715 2.277 . . . . 0.0 112.286 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.03 -46.41 85.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.804 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -75.28 -26.04 58.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.806 -176.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 50.5 p -82.39 -18.44 41.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.166 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -58.54 -45.55 99.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.432 0.634 . . . . 0.0 110.875 -169.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 79.2 Cg_exo -46.93 -38.66 23.88 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.627 2.218 . . . . 0.0 112.335 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.0 tp -79.89 -41.06 26.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.428 HG23 ' HA3' ' A' ' 191' ' ' GLY . 96.7 mt -77.95 -47.57 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -68.58 -17.26 64.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.36 -33.12 74.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -99.14 -2.55 36.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.45 11.19 20.33 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.496 168.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -108.26 138.18 14.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.451 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 19.4 t80 -165.56 175.7 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.945 0.402 . . . . 0.0 110.904 -167.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.81 -59.74 4.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.221 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -142.42 150.1 40.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -85.95 133.12 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.827 -177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -108.34 114.28 28.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -147.47 140.08 24.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -170.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.58 41.01 9.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.942 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.03 6.64 68.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.516 173.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -137.32 152.75 50.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.897 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -78.99 133.8 36.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.015 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -107.97 109.14 20.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -174.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -67.52 -20.09 25.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.102 -173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -82.08 -16.6 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -168.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -135.49 87.24 2.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.52 HG23 ' H ' ' A' ' 184' ' ' ASP . 12.7 m -129.63 166.87 26.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.129 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -87.18 2.19 86.71 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.446 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.1 m -98.56 -16.77 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 111.097 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.52 ' H ' HG23 ' A' ' 181' ' ' VAL . 25.7 p30 -80.3 7.91 8.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 170.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 85.3 m-20 84.19 -7.05 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 161.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.55 -47.59 11.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.86 -46.55 22.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.442 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -71.54 -31.79 67.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.385 . . . . 0.0 111.096 -163.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -63.45 -44.35 94.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.919 -160.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.55 -40.69 97.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.086 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.428 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.04 -40.09 98.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.434 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 81.4 mt -66.15 -41.02 90.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 110.983 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 90.7 m -62.46 -42.15 99.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.15 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -59.75 -40.44 88.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.45 -48.79 79.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.885 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.0 t -65.07 -39.6 86.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.072 -173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -41.11 98.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.825 -176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.6 OUTLIER -73.01 -32.12 64.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -177.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.2 mp -65.78 -38.0 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 173.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -66.47 -34.82 78.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 172.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -85.91 -3.73 58.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 61.5 36.87 16.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.937 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -75.38 -17.45 60.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.69 156.15 47.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.891 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -101.71 134.18 45.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.792 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.14 -32.39 74.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.035 -169.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -94.58 -5.72 45.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.857 -164.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.1 m -61.74 130.72 47.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.184 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -135.87 -172.54 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.921 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.48 -47.47 79.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.924 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.7 m -63.65 -42.62 98.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 95.5 mt -65.65 -44.93 93.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.175 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.25 85.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.0 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.66 -45.12 88.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.25 -37.47 87.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.062 175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.4 98.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.081 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -65.82 -38.69 89.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.828 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -64.39 -29.44 70.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.66 -19.82 16.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.768 -176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.86 21.4 50.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -77.41 -24.0 50.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.945 0.402 . . . . 0.0 110.924 -176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.6 t -133.64 149.46 51.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.066 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -92.37 -20.82 20.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 97.0 mtp -138.06 154.9 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.946 -170.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -159.54 162.43 35.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.075 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 67.7 mt -121.08 120.82 63.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.127 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 71.0 m-80 -145.92 158.61 43.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -176.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -95.54 -151.85 28.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.434 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.592 ' HB3' ' HB3' ' A' ' 111' ' ' GLU . 29.4 Cg_endo -65.2 -25.15 57.89 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.729 2.286 . . . . 0.0 112.291 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -66.0 -18.09 65.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -87.35 23.37 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 -179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -63.44 -29.98 71.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.1 t -66.41 107.78 2.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -149.31 129.98 14.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -176.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.0 mt -92.45 81.18 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -84.68 72.86 10.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 79.4 p -114.54 -13.83 12.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.182 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.1 p -94.39 -169.94 2.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.777 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.61 175.74 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.852 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 96.0 t -57.31 107.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.121 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -120.42 -59.32 1.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.916 -178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 52.1 p90 -111.62 160.5 17.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.659 ' HA3' ' HE3' ' A' ' 119' ' ' LYS . . . -148.86 167.13 29.35 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.545 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.7 134.17 62.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 111.1 -177.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -136.99 174.86 10.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.069 -171.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -79.74 161.48 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 -176.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 95.4 mt -71.62 142.83 86.62 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.508 0.671 . . . . 0.0 110.907 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.14 166.49 27.9 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.65 2.233 . . . . 0.0 112.253 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 66.8 p -118.74 150.74 39.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.124 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -128.18 115.25 18.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 54.81 35.13 23.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.29 21.14 46.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.553 173.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -133.8 144.78 53.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.582 0.706 . . . . 0.0 111.021 -172.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.43 141.97 70.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.626 2.217 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.7 t -68.8 -58.88 3.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.749 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 158' ' ' TRP . 5.5 tmtt? -150.8 110.59 3.12 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.549 0.69 . . . . 0.0 110.916 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.39 122.5 7.05 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.684 2.256 . . . . 0.0 112.474 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -163.89 113.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.917 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.2 p -141.67 135.87 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.655 ' HA3' ' SD ' ' A' ' 330' ' ' MET . . . -117.93 140.11 15.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.92 125.14 74.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.349 . . . . 0.0 111.205 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 61.6 tp -73.37 137.25 44.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.7 m -123.88 141.56 51.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.831 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -119.87 128.02 53.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.153 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.34 158.2 15.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 -174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 93.8 mt -106.1 127.13 61.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.889 0.376 . . . . 0.0 111.15 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -56.98 120.63 8.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.85 -26.13 68.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.04 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.72 -11.45 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.083 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.1 t -70.77 130.1 89.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.788 0.804 . . . . 0.0 110.748 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.08 -13.11 37.23 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.698 2.265 . . . . 0.0 112.301 173.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -110.12 27.06 9.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.904 -171.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -55.19 -33.91 63.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -67.94 -37.93 82.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.851 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.01 -42.42 94.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 173.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.429 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . . . -63.89 -47.96 78.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.122 -174.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -63.32 -45.63 90.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -171.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.25 -54.16 23.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.18 -36.37 71.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -171.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 284' ' ' LEU . 64.6 tp -58.98 -47.74 84.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.952 176.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -75.26 -35.0 61.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.817 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -98.28 -9.16 25.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -164.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.819 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 80.2 m-85 -127.59 -55.6 1.32 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 177.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.477 ' HB2' HD12 ' A' ' 280' ' ' LEU . 51.3 mt -76.76 -28.88 55.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -170.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 285' ' ' LEU . 3.7 mm? -108.1 51.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.914 -178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.7 p -132.49 168.47 18.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -56.16 -46.05 79.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -76.15 -42.71 45.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.819 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -77.39 -50.77 6.44 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -171.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 41.8 tp -65.77 -40.11 91.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.738 0.304 . . . . 0.0 110.899 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.24 -42.6 99.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.855 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.5 -32.57 74.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 79.2 t -71.04 -36.82 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.096 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -70.53 -12.75 61.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.838 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -58.09 -24.31 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -97.83 -7.67 29.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -87.18 145.15 37.36 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 110.96 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.47 -62.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.528 2.152 . . . . 0.0 112.369 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.17 -47.98 39.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.95 -170.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 88.23 -5.67 84.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.615 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -71.62 119.68 16.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.343 . . . . 0.0 111.091 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.5 m -122.15 160.3 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.206 -171.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.43 -12.46 60.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.03 172.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.8 tp -73.37 118.32 16.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.919 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.38 -44.6 90.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.883 -174.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 74.6 m -59.32 -44.66 92.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -72.03 -34.52 68.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -60.54 -36.72 79.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.919 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.852 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -75.71 -38.31 58.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.913 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.05 -28.7 69.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.91 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.62 -12.32 52.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.073 -175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -77.23 -19.93 55.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -88.75 118.45 69.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.599 0.714 . . . . 0.0 110.795 173.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.43 -35.35 65.27 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.717 2.278 . . . . 0.0 112.328 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -72.81 -44.26 61.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 -174.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 96.6 mt -76.77 -41.04 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.106 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.99 73.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.051 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.0 84.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.07 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 51.6 m -66.35 -41.92 88.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.7 mmm -67.53 -35.38 78.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.885 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -65.39 -36.11 82.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -68.2 -38.05 81.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.819 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.28 90.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.053 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -66.88 -16.39 64.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -108.92 -6.9 15.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -94.36 -165.13 36.24 Favored Glycine 0 C--N 1.329 0.171 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.361 -171.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -129.97 143.41 50.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.887 0.375 . . . . 0.0 110.902 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.577 HG13 ' HD2' ' A' ' 331' ' ' PRO . 5.0 tp -67.28 134.34 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.215 -168.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.655 ' SD ' ' HA3' ' A' ' 260' ' ' GLY . 59.4 mtt -51.96 -55.69 28.36 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 0.0 110.846 -175.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.577 ' HD2' HG13 ' A' ' 329' ' ' ILE . 34.4 Cg_endo -62.64 86.53 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.774 2.316 . . . . 0.0 112.309 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.642 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 70.1 m-80 -107.88 22.97 15.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -171.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.642 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 46.0 mm 89.05 134.83 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.724 0.774 . . . . 0.0 111.02 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -54.65 -30.58 66.67 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.692 2.262 . . . . 0.0 112.252 -171.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -59.96 -22.79 62.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.907 -176.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 94.0 mmm -70.11 -24.66 63.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.3 m -63.86 -40.7 97.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.1 -36.45 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.102 175.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -65.54 -33.79 76.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.888 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -55.66 -43.84 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.947 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -67.74 -34.98 77.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.4 82.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.171 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 29.4 m -75.65 -27.59 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.199 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.771 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 80.6 ttt180 -57.45 -41.88 81.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.809 175.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.6 m -63.4 -45.86 89.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.105 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.431 ' HB2' ' CB ' ' A' ' 364' ' ' ALA . . . -61.92 -43.85 97.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.117 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.39 -50.74 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.152 -174.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.96 -45.53 90.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.027 -175.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -64.76 -35.79 82.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.85 -175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.93 -47.57 61.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.07 -35.52 69.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.119 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 86.6 p -76.04 -13.52 60.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.891 -176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.27 7.45 87.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.531 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.34 -30.11 66.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 0.0 110.959 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -136.2 154.92 50.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 96.5 m -67.94 150.98 47.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 65.7 t -64.83 -47.97 86.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.177 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.42 -40.64 89.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.38 -46.13 64.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 -175.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.32 -36.87 85.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 188' ' ' ALA . 62.0 tp -62.71 -46.91 85.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 110.959 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -66.42 -48.7 69.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 -176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.04 -37.24 81.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 346' ' ' ALA . . . -80.39 -43.76 20.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.055 -172.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -78.49 -31.85 47.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.81 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.9 m -59.08 -37.8 77.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.18 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.42 -29.07 68.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 80.8 mt -66.88 -44.46 88.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.03 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.1 p -97.46 -6.34 34.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.191 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -178.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.759 0.314 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.4 mt -81.75 123.16 37.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -131.33 166.75 20.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.985 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -69.0 131.49 45.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.907 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.96 17.49 56.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.459 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -159.24 163.53 35.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.831 0.348 . . . . 0.0 110.92 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 33' ' ' ILE . 1.8 pt? -145.65 153.93 41.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -119.77 129.92 74.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -117.14 127.62 74.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.164 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.645 ' HB3' HD22 ' A' ' 43' ' ' LEU . 26.8 m0 -110.08 131.23 55.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.5 tt -150.13 153.72 10.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.246 -171.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -55.9 134.01 51.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.867 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.39 -16.21 75.42 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.47 -171.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.92 -43.16 99.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 -168.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -137.82 80.79 1.82 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.858 149.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.8 -52.56 1.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.496 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -77.07 -48.9 16.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.886 0.374 . . . . 0.0 110.956 -156.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -64.86 -53.16 51.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.84 -151.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.726 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -67.77 -49.89 45.92 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.465 -176.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.65 -41.32 98.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.855 0.36 . . . . 0.0 110.996 -177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.7 73.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.059 -178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.56 -46.84 77.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.841 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 56.3 t -65.07 -45.81 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.082 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -62.77 -34.19 89.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.486 176.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.26 -45.82 83.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 0.0 110.861 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.82 -45.1 94.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.904 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -66.64 -37.86 85.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -60.56 -34.78 74.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.753 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -70.37 -38.88 74.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -81.03 -40.57 24.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -172.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.5 p -107.5 -15.35 14.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -171.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.03 1.2 88.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.418 168.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.785 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -85.99 127.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.931 0.396 . . . . 0.0 111.185 176.145 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -74.53 129.99 38.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.885 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.406 HG11 ' HA3' ' A' ' 24' ' ' GLY . 71.8 t -108.19 129.07 63.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.18 177.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -121.84 115.88 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.1 t -109.59 124.98 66.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.126 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -126.83 143.22 51.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.902 177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.41 ' O ' ' ND1' ' A' ' 39' ' ' HIS . 28.0 p80 -139.94 65.34 30.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.644 0.735 . . . . 0.0 110.903 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 46.5 Cg_endo -72.18 -21.68 23.29 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.794 2.33 . . . . 0.0 112.247 -174.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 69.6 m-20 67.02 14.32 9.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 -172.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.63 -1.82 57.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 170.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.645 HD22 ' HB3' ' A' ' 10' ' ' TRP . 60.3 mt -52.33 -49.1 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 -152.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -65.84 -27.64 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.808 -169.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.39 -42.85 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -76.96 -40.19 47.84 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -171.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.627 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 47.1 t80 -51.39 -57.81 12.93 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.632 0.729 . . . . 0.0 110.839 -169.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 47' ' ' PHE . 19.2 Cg_endo -60.93 -29.68 88.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.632 2.221 . . . . 0.0 112.241 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -75.18 -47.03 30.32 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 33.4 m -75.0 -29.6 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -175.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.42 -37.87 87.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.13 -23.94 66.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.096 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 58.3 p -96.05 5.33 51.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -174.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.96 21.97 67.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.538 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 11.7 t0 -120.0 -174.17 2.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.812 0.339 . . . . 0.0 110.933 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.97 -170.9 13.59 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.25 162.99 19.94 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.655 2.237 . . . . 0.0 112.359 -174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -85.35 -40.87 16.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 169.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.7 mt -129.54 142.78 43.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.15 -171.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.0 mm -122.22 131.36 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.087 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -112.31 122.37 47.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.963 177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.464 ' CZ2' HD12 ' A' ' 43' ' ' LEU . 95.1 m95 -148.48 156.7 42.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.908 168.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 262' ' ' LEU . . . -81.96 -103.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.029 -172.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -112.07 -54.98 2.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.75 -50.19 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 -168.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.21 -31.56 69.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.944 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -60.71 -48.17 83.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.25 -50.41 63.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.533 -172.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.14 98.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -70.91 -29.83 66.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.884 0.373 . . . . 0.0 110.933 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.48 98.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.083 173.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.92 -26.37 65.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.895 173.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -84.89 1.86 45.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.87 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.02 36.67 51.33 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.515 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HG ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 mp -81.16 -10.06 59.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.88 0.371 . . . . 0.0 110.935 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.564 ' HB3' ' HA3' ' A' ' 265' ' ' GLY . 0.4 OUTLIER -132.98 144.45 50.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.956 -178.09 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -99.47 162.96 12.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.49 134.66 54.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.7 pt -112.39 153.27 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.111 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 71.3 p -132.16 65.43 75.14 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 0.0 111.194 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.16 148.21 43.93 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.697 2.265 . . . . 0.0 112.383 171.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 43.9 p30 -77.57 -179.82 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -66.49 -31.43 72.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.36 -38.49 77.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.991 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -67.09 -38.74 86.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -63.57 -43.39 97.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -71.06 -31.28 67.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.839 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -62.66 -30.55 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 -168.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.414 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.8 mp -108.77 -92.7 0.42 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -175.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 29.6 t80 -167.19 133.05 1.74 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.997 176.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 99.1 Cg_exo -54.05 -40.17 82.49 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.745 2.297 . . . . 0.0 112.336 -173.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 92' ' ' PHE . 1.3 t80 -65.27 -39.44 92.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 p -70.9 -26.74 63.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.414 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 79.1 m95 -79.75 -32.59 41.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.881 174.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -66.43 -29.67 69.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.851 169.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -24.78 67.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.068 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.29 15.79 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.162 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -98.93 133.62 42.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.917 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -136.29 125.42 24.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 58.43 34.5 24.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.82 2.29 90.05 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.507 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -123.45 144.84 49.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.73 132.01 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.6 pt -118.37 -8.61 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.053 -173.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.89 164.83 35.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.007 -172.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.485 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 88.5 m-85 -106.53 132.62 20.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.668 0.746 . . . . 0.0 110.913 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 10.1 Cg_exo -72.85 132.71 18.87 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.746 2.297 . . . . 0.0 112.323 173.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.79 -50.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.151 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.15 151.62 33.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.064 -163.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -128.87 132.63 67.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.116 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.823 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 98.1 mt-10 -129.46 150.55 50.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.93 155.06 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 -173.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.1 tp -71.34 141.42 50.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.955 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -145.24 163.73 33.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.503 HD22 ' HD3' ' A' ' 248' ' ' PRO . 45.9 tp -96.57 127.55 42.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.5 mt -113.68 125.77 71.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -133.49 157.07 46.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 242' ' ' TYR . 22.8 t-20 -94.67 118.14 31.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 172.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -65.72 -35.33 80.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -173.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -76.54 -35.43 58.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.812 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.56 -45.19 17.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 223' ' ' ALA . 64.8 tp -126.62 108.62 23.03 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.709 . . . . 0.0 110.926 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.552 ' O ' ' C ' ' A' ' 124' ' ' ASN . 98.7 Cg_endo -75.52 164.91 31.56 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.329 173.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.552 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.5 t30 24.96 96.3 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.56 155.4 70.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.721 2.281 . . . . 0.0 112.356 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.28 150.36 64.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.593 2.195 . . . . 0.0 112.357 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.11 -21.16 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.923 -178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.9 p -129.22 159.48 35.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.183 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.706 ' HE1' ' HB3' ' A' ' 255' ' ' SER . 85.0 m95 -73.21 -24.66 60.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.965 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.46 -25.09 64.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -78.79 -20.02 50.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.675 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 29.2 mm -58.85 -55.43 46.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.626 0.727 . . . . 0.0 111.15 -168.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 53.0 Cg_endo -74.24 -37.34 2.65 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.387 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.65 -42.45 95.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 172.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.0 tp -65.01 -39.49 93.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.951 173.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -62.91 -37.48 87.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.54 -42.8 99.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 174.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.79 -36.29 80.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.764 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.594 HD12 ' HB2' ' A' ' 146' ' ' ALA . 71.6 mt -70.06 -30.93 68.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.39 -33.69 63.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.71 -25.03 67.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.177 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -102.55 2.82 36.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.904 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.7 30.77 61.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 139' ' ' LEU . 89.1 mttt -116.61 162.63 17.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.517 ' H ' ' HA ' ' A' ' 222' ' ' THR . 44.7 t -120.98 146.91 46.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.768 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.594 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -82.7 -25.63 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.126 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 54.0 tp -137.79 136.27 37.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 -173.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 91.6 mmm -139.48 134.9 32.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 171.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -161.61 161.16 29.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.893 175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -86.28 133.41 33.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.889 175.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 41.1 tp -103.38 4.31 36.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -177.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -74.39 -13.1 60.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.914 176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -129.95 146.91 63.37 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 0.0 110.929 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.556 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 42.4 Cg_endo -67.77 -24.93 40.13 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.571 2.18 . . . . 0.0 112.331 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -49.96 -42.08 48.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.887 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -80.33 -23.31 40.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -170.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.9 p -79.27 -23.22 43.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.581 ' HB2' ' HD3' ' A' ' 159' ' ' PRO . 49.1 m0 -57.26 -45.72 99.89 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.533 0.682 . . . . 0.0 110.932 -167.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 158' ' ' TRP . 91.3 Cg_exo -50.9 -37.34 55.63 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.643 2.229 . . . . 0.0 112.306 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 96.7 mt -81.17 -40.28 24.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 -176.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 347' ' ' VAL . 96.7 mt -73.44 -50.01 33.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.101 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 166' ' ' GLY . . . -72.17 -14.96 61.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.048 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.58 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -61.68 -31.76 71.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.047 -174.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -102.28 1.77 36.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.9 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.47 1.58 40.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 173.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 162' ' ' ALA . . . -86.84 136.61 14.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.363 177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.472 ' O ' ' HA3' ' A' ' 182' ' ' GLY . 21.3 t80 -169.95 176.3 4.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.931 0.395 . . . . 0.0 110.978 -176.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -64.98 -45.91 83.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -139.83 153.22 47.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -79.18 130.59 35.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.815 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -100.21 115.64 30.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -148.63 140.11 23.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 -175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 54.93 37.4 28.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.902 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.13 82.32 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.412 173.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -136.34 151.2 49.33 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.846 0.355 . . . . 0.0 110.958 -177.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -82.48 131.71 35.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.904 171.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -94.28 109.71 21.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 7.7 tp -66.49 -20.79 27.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.118 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.37 -10.35 46.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -130.21 95.5 3.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 174.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 183' ' ' VAL . 35.0 m -109.47 159.55 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.029 -173.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 167' ' ' TYR . . . -95.86 -2.24 61.26 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.539 167.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.437 HG22 ' HB ' ' A' ' 181' ' ' VAL . 8.0 m -85.96 -5.94 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.634 0.254 . . . . 0.0 111.025 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 54.6 p30 -76.18 10.66 1.84 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.887 171.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 81.8 m-20 84.55 -4.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 168.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -81.38 -51.98 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -76.34 -50.2 7.64 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.66 -32.13 73.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.116 -168.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.61 -40.49 97.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -173.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.14 96.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.86 -38.67 96.46 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.435 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 361' ' ' LEU . 78.8 mt -65.36 -34.93 79.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.898 0.38 . . . . 0.0 110.927 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.4 m -56.36 -51.91 66.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.126 -172.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -68.16 -44.95 74.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.805 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 195' ' ' LEU . 8.9 tt -59.83 -50.82 72.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.809 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.32 -37.86 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.132 -176.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.16 -36.83 83.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.818 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.95 -36.07 83.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.67 -39.84 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.012 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -64.87 -39.81 94.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -84.34 5.41 27.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.1 32.17 10.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -87.86 -22.92 24.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -139.58 145.21 38.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.52 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 54.1 t-20 -94.67 134.72 36.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 176.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.09 -25.18 64.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.074 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -95.69 -15.16 22.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.732 -171.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.52 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 55.2 m -64.79 137.69 57.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.25 176.67 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.902 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -65.07 -29.64 70.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.988 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.2 m -64.73 -42.95 94.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.906 178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.83 -40.55 89.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.201 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.38 -40.86 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.068 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.95 -43.99 90.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.798 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.76 -34.77 77.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.086 174.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.0 97.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.095 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -64.0 -35.79 81.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 0.0 110.927 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.68 -28.88 69.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.833 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.55 -18.99 18.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.85 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.77 23.22 47.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.477 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -83.83 -19.72 34.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 110.91 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.517 ' HA ' ' H ' ' A' ' 145' ' ' SER . 15.2 t -130.7 144.5 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 122' ' ' LEU . . . -94.46 -35.01 12.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 56.2 ttp -145.55 153.81 41.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.861 -169.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -154.48 168.09 27.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.108 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 226' ' ' ILE . 18.5 tt -126.3 123.45 63.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.066 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -152.52 162.44 41.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.22 -165.9 37.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.549 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.823 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 35.7 Cg_endo -66.39 -21.52 53.72 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.74 2.293 . . . . 0.0 112.375 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 69.3 p-90 -65.96 -18.12 65.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.83 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -92.46 5.63 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.063 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -62.72 -40.11 96.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.5 t -55.65 109.36 0.55 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.869 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -150.17 159.86 44.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.832 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.22 80.07 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -85.03 75.09 10.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.976 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.4 p -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.183 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 76.6 p -104.19 -174.8 2.63 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.798 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.27 176.89 3.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.884 172.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 91.6 t -56.09 104.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -113.3 -54.56 2.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 50.8 p90 -114.09 159.31 20.17 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 175.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -144.62 165.04 27.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.463 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 85.7 t -132.34 135.15 58.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.984 0.421 . . . . 0.0 111.092 -176.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -141.41 -179.84 6.37 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 -175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 34.3 m -83.6 160.49 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.089 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.14 139.27 90.03 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.543 0.687 . . . . 0.0 110.915 -173.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.503 ' HD3' HD22 ' A' ' 115' ' ' LEU . 59.1 Cg_endo -75.1 167.09 27.72 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.359 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.8 p -106.7 158.45 16.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -132.01 118.93 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.829 -177.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 55.16 34.92 23.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.956 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.6 6.24 87.53 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.461 175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -119.77 150.34 50.26 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 110.862 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.93 149.72 89.96 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.626 2.217 . . . . 0.0 112.38 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.706 ' HB3' ' HE1' ' A' ' 129' ' ' TRP . 87.8 p -67.37 -62.23 1.53 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.836 -173.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -170.75 127.25 0.69 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.508 0.671 . . . . 0.0 110.818 173.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -76.04 132.69 14.31 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.223 . . . . 0.0 112.328 -176.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -157.16 124.24 5.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.944 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.95 133.34 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.112 167.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.35 135.23 12.27 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.538 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.76 129.93 75.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.771 0.319 . . . . 0.0 111.158 -174.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 63' ' ' ALA . 55.8 tp -74.99 132.34 41.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 175.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 43.9 m -130.4 145.42 51.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 -173.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.04 51.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.04 173.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 76' ' ' LEU . . . -123.54 170.15 15.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -112.77 129.41 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.716 0.294 . . . . 0.0 111.178 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -59.0 120.87 9.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.859 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -66.3 -25.14 66.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.99 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.94 -9.83 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.218 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.0 t -71.04 131.31 87.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.75 -15.03 43.47 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.638 2.225 . . . . 0.0 112.377 172.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -109.09 21.86 16.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.51 -35.74 21.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.41 -35.07 70.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.908 -178.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 26.5 tp -65.83 -41.38 91.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 173.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.31 -44.31 83.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.134 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -64.83 -34.49 78.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.936 -172.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -71.62 -47.86 51.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.412 ' HE2' HG13 ' A' ' 33' ' ' ILE . 15.2 m-30 -65.41 -49.29 69.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.597 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.6 tt -57.05 -48.81 77.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -170.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -77.5 -22.63 50.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.828 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -101.96 -8.16 21.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 14.8 m-30 -112.68 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 45.3 tp -73.49 -45.54 53.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.833 -168.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.6 60.22 2.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.974 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 66.2 p -132.94 160.57 36.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.133 173.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -59.41 -44.93 92.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -71.47 -46.2 60.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.945 -178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.07 -45.45 41.02 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.42 -173.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.445 HD21 ' HB ' ' A' ' 302' ' ' VAL . 28.4 tp -71.33 -37.72 71.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.781 0.324 . . . . 0.0 110.973 -173.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.9 -40.75 95.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.808 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.34 -42.56 99.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.106 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.726 HG23 ' HA3' ' A' ' 19' ' ' GLY . 15.0 p -76.48 -29.86 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.186 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -65.06 -24.32 67.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.871 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.11 -24.02 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -91.64 -13.0 32.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.908 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -78.68 155.54 78.28 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.708 . . . . 0.0 110.88 -176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.88 -95.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.608 2.205 . . . . 0.0 112.43 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -66.09 -22.91 66.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 74.13 25.1 71.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.483 168.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.431 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -81.77 132.11 35.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.058 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.527 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.4 m -124.28 160.83 28.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.162 -176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.06 -12.67 59.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.013 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 59.5 tp -74.26 120.27 19.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.903 -173.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.62 -45.75 91.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 -172.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 73.3 m -60.6 -42.43 96.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.72 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.527 ' HB3' HG21 ' A' ' 302' ' ' VAL . 1.0 OUTLIER -71.81 -32.49 67.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -61.93 -32.02 72.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.01 -38.3 82.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -75.17 -38.28 60.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.842 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 301' ' ' ALA . 94.1 mt -65.13 -27.58 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.85 -16.64 43.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.109 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -71.79 -22.63 61.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.804 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 63.7 t0 -90.33 117.44 68.02 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.822 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' A' ' 314' ' ' ASP . 37.0 Cg_endo -61.54 -25.32 79.33 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 177.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.401 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.3 mtm-85 -70.36 -39.72 74.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 51.1 mm -79.98 -39.22 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.255 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.67 70.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.116 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.63 96.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.9 p -73.45 -35.83 65.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 77.2 mtm -68.06 -38.72 82.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -65.27 -42.65 92.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.827 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -71.79 -35.33 69.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.5 -42.32 91.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.25 -19.07 65.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -108.37 -4.93 16.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.933 -175.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -88.67 -167.09 42.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.532 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.773 0.321 . . . . 0.0 110.948 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.489 ' HA ' HD12 ' A' ' 329' ' ' ILE . 2.8 tp -66.35 124.79 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.11 -169.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.594 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -46.44 -52.22 30.84 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.591 0.71 . . . . 0.0 110.847 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 330' ' ' MET . 38.9 Cg_endo -63.99 85.54 0.15 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.768 2.312 . . . . 0.0 112.349 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.691 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 72.0 m-80 -108.74 30.52 6.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.859 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.691 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 71.4 mt 93.56 131.07 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.71 0.767 . . . . 0.0 111.06 -169.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.18 -25.58 50.31 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.768 2.312 . . . . 0.0 112.308 -172.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.423 ' H ' HG22 ' A' ' 333' ' ' ILE . 88.4 mt-30 -60.7 -24.64 65.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 176.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.7 mmm -63.8 -30.89 71.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 -177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.8 m -62.93 -43.08 99.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.887 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.12 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -67.5 -38.5 84.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.804 -179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -60.57 -38.97 86.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 175.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -64.43 -38.28 90.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.57 -35.87 80.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.177 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.39 -42.97 94.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.144 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.556 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 55.7 ttp180 -55.3 -43.81 75.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 177.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.4 m -59.91 -42.93 94.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.16 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.78 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 161' ' ' ILE . 54.4 t -67.05 -52.36 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.67 -45.18 92.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.083 -171.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.58 -37.86 89.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.32 -44.24 68.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -70.25 -36.79 74.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.126 -173.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.8 p -76.05 -12.58 60.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.32 8.24 87.93 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.482 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -78.26 -25.7 46.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.761 0.315 . . . . 0.0 110.917 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -135.12 155.99 49.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 90.9 m -71.88 151.5 43.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.077 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 68.9 t -60.21 -48.8 86.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.127 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.63 -42.34 86.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.928 -178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -70.21 -46.51 64.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.882 -174.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.0 95.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.154 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 55.7 tp -66.08 -43.05 88.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.891 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.63 -48.43 79.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.922 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.02 -37.01 84.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.904 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.02 -43.58 64.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.149 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 7.6 mm-40 -77.16 -26.94 53.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 -173.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.2 m -56.1 -35.64 67.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.161 175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.95 -30.17 70.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.936 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.46 -41.92 89.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.112 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.3 p -94.04 -15.08 25.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.226 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.764 0.316 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.8 mt -85.74 125.97 40.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.095 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -136.62 176.92 8.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -171.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.95 132.06 44.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.96 -176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 16.79 59.33 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.64 159.97 43.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.854 0.359 . . . . 0.0 110.886 -177.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.869 ' O ' HD12 ' A' ' 7' ' ' LEU . 2.9 pp -147.15 149.51 33.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.841 177.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.5 t -120.58 127.6 75.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.185 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.583 HG22 ' HB ' ' A' ' 59' ' ' ILE . 3.3 pt -121.8 131.93 72.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.169 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.444 ' HB3' HD22 ' A' ' 43' ' ' LEU . 26.7 m0 -114.8 132.34 56.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.404 HG23 ' HA3' ' A' ' 16' ' ' GLY . 18.4 tt -149.23 153.71 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.224 -172.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.429 ' O ' ' HA3' ' A' ' 16' ' ' GLY . 56.9 t-20 -55.87 128.54 35.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.939 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.66 -19.44 79.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.472 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.93 -46.4 90.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.914 0.388 . . . . 0.0 110.904 -163.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -134.98 66.57 1.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.838 150.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 12' ' ' ASN . . . -99.55 -46.15 2.02 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.552 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -69.95 -43.35 71.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.958 0.408 . . . . 0.0 110.983 -159.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -65.63 -49.95 66.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.863 -160.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.66 -50.45 58.79 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.469 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 20' ' ' LEU . 53.7 mt -64.87 -37.24 86.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.12 -48.81 61.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 -178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -68.03 -45.77 73.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.2 p -69.85 -35.61 65.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.107 178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.99 -33.53 84.12 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.442 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -62.22 -44.76 95.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.378 . . . . 0.0 110.902 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -62.15 -46.32 89.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -66.32 -38.42 87.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -61.92 -35.66 79.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.782 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.39 -38.71 68.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.845 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -81.1 -41.05 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.844 -171.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.0 p -105.57 -17.89 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.207 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.99 7.58 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.479 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 33' ' ' ILE . 19.5 tt -82.91 127.39 39.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.21 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -67.17 124.48 23.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.922 176.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.73 130.94 59.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.162 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 95.3 m -123.16 113.76 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.133 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.445 HG22 HD11 ' A' ' 9' ' ' ILE . 58.4 t -100.78 122.02 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.063 177.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 98.7 mt-10 -129.49 139.3 51.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.92 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -140.02 68.86 35.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.644 0.735 . . . . 0.0 110.86 174.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 36.8 Cg_endo -75.7 -15.62 19.15 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 0.0 112.396 -165.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 58.8 m-20 73.13 8.34 5.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.935 -171.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -91.75 -4.85 54.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.873 173.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' A' ' 10' ' ' TRP . 81.5 mt -51.74 -50.01 61.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -156.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -62.01 -35.3 78.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 -169.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -88.05 -40.34 13.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -73.91 -45.26 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 -167.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.675 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 24.9 t80 -51.69 -58.43 11.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.642 0.734 . . . . 0.0 110.834 -166.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.675 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 19.9 Cg_endo -63.9 -31.04 67.68 Favored 'Trans proline' 0 C--O 1.23 0.116 0 C-N-CA 122.754 2.303 . . . . 0.0 112.274 -173.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -75.35 -47.25 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 17.2 m -76.24 -26.05 16.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.171 -176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.35 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.044 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.99 -24.47 66.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.053 178.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.7 p -95.09 4.51 53.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.47 22.72 61.88 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.518 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 10.8 t0 -119.52 -176.12 3.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.31 -170.3 15.52 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.503 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.37 158.96 17.28 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -72.81 -42.28 64.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 167.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.583 ' HB ' HG22 ' A' ' 9' ' ' ILE . 88.1 mt -133.23 139.53 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.182 -178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 tp -128.8 132.44 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.221 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -101.3 135.93 41.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -139.88 153.61 47.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.865 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.2 -102.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.086 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -122.27 -54.66 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.9 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -67.13 -46.08 75.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.838 -170.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -73.26 -32.34 64.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -61.83 -47.31 85.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.859 -171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.17 -50.3 61.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.576 -172.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.21 -41.98 99.72 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.532 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-30 -70.05 -31.27 68.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.93 -42.89 99.95 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 174.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.93 -26.28 64.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.928 174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.1 m -85.02 2.1 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 37.1 61.37 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.554 173.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -80.33 -8.8 59.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 110.883 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -132.24 144.17 50.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.846 -176.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.01 157.83 17.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.93 139.09 52.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.833 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.2 pt -114.29 156.65 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.075 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 74.6 p -134.34 62.62 56.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.532 0.682 . . . . 0.0 111.161 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.01 149.93 42.51 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.745 2.297 . . . . 0.0 112.257 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -77.27 176.45 8.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -70.08 -29.92 67.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.98 69.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.07 -175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -63.21 -37.05 85.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.836 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -65.39 -39.97 92.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.81 -35.85 79.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.24 -29.31 66.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.885 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.429 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 10.2 mp -104.71 -106.35 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 23.0 t80 -162.89 133.96 3.66 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.67 0.748 . . . . 0.0 110.952 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 88.4 Cg_exo -56.21 -42.96 60.76 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.673 2.248 . . . . 0.0 112.297 -174.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.14 -40.53 94.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 -175.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 p -71.44 -25.64 62.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.125 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.429 ' HE1' ' HB2' ' A' ' 89' ' ' LEU . 54.5 m95 -80.13 -29.33 38.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 173.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -62.67 -30.11 71.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.827 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.71 -25.22 66.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.044 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.52 21.95 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.131 -174.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.7 ttp-105 -109.94 139.58 44.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -141.54 126.85 18.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.65 34.46 22.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.888 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.45 90.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.448 173.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.16 144.82 50.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 110.901 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 98.6 mt -79.85 130.73 35.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.872 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 pt -118.12 -12.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.152 -169.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -158.28 165.33 35.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.036 -170.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 91.2 m-85 -109.83 134.31 20.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.663 0.745 . . . . 0.0 110.927 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 20.4 Cg_exo -66.31 126.8 16.25 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.318 173.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.5 mm -111.61 -40.29 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.168 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -160.95 155.83 23.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.056 -172.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.5 t -126.23 131.97 70.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 -174.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -128.91 144.7 51.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.12 155.08 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -174.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.86 138.47 44.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.948 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.3 p -147.86 163.93 35.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.88 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.31 129.84 42.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 80.6 mt -107.09 128.02 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.16 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -136.23 148.19 47.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -90.72 117.08 29.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.578 ' HE2' ' HA3' ' A' ' 243' ' ' GLY . 66.9 mttm -70.83 -30.61 67.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -171.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -76.85 -36.32 56.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 95.1 mt -77.32 -38.71 49.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.5 tp -136.53 111.86 9.86 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.673 0.749 . . . . 0.0 110.897 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 124' ' ' ASN . 87.8 Cg_endo -74.98 169.3 22.94 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.659 2.239 . . . . 0.0 112.35 170.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 123' ' ' PRO . 54.2 t30 25.22 96.59 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 110.961 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.03 158.99 54.99 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.712 2.274 . . . . 0.0 112.364 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.72 147.58 69.81 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.679 2.253 . . . . 0.0 112.325 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.4 -29.7 12.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.871 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 66.6 p -127.94 159.6 34.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -68.56 -33.4 74.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.5 -29.78 64.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.813 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -75.57 -21.19 58.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.577 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 28.5 mm -60.93 -51.5 78.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.701 0.763 . . . . 0.0 111.09 -168.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 48.5 Cg_endo -70.35 -38.78 6.09 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.754 2.303 . . . . 0.0 112.324 -174.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.16 94.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.166 172.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.91 -36.91 83.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 174.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.73 -37.44 86.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.885 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.7 -43.21 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.822 174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.33 -37.3 83.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.8 mt -69.32 -36.46 76.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.73 -35.1 70.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.969 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.22 65.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.2 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -99.3 3.1 46.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.0 29.47 60.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.482 -176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -123.49 163.42 20.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.821 0.343 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.498 ' H ' ' HA ' ' A' ' 222' ' ' THR . 35.4 t -118.54 150.48 39.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 171.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -81.06 -23.96 38.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.82 141.73 50.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 -174.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 68.8 mmm -140.1 119.93 13.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 161.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -160.05 164.99 32.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 -176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 61.7 t-20 -84.2 110.7 18.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.878 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 206' ' ' ALA . 27.1 tp -98.37 5.63 48.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -174.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.75 -2.27 57.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.959 169.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.9 148.46 69.67 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.656 0.741 . . . . 0.0 110.804 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.757 ' HD3' ' HG3' ' A' ' 344' ' ' ARG . 56.6 Cg_endo -74.76 -22.48 15.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.613 2.208 . . . . 0.0 112.265 -178.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -52.79 -43.9 66.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.45 ' CE1' ' HB3' ' A' ' 150' ' ' ASN . 81.3 m-85 -83.51 -20.4 33.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.713 -172.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 51.2 p -81.88 -21.26 37.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' A' ' 159' ' ' PRO . 4.4 m95 -60.08 -45.5 97.94 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.431 0.634 . . . . 0.0 110.884 -172.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 158' ' ' TRP . 99.2 Cg_exo -45.71 -31.1 7.15 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.258 . . . . 0.0 112.339 174.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 160' ' ' LEU . 2.7 tm? -82.29 -45.17 15.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.629 HG23 ' HA3' ' A' ' 191' ' ' GLY . 92.1 mt -74.66 -44.06 46.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 167' ' ' TYR . . . -69.77 -19.01 63.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.099 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.84 -29.64 70.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.123 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -102.91 0.19 32.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.6 15.12 9.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 165.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.554 ' O ' HG22 ' A' ' 161' ' ' ILE . . . -114.83 126.34 7.18 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.423 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.485 ' CD1' ' HB2' ' A' ' 162' ' ' ALA . 17.9 t80 -159.56 172.17 18.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.918 0.39 . . . . 0.0 110.921 -171.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.52 -52.11 65.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -139.89 149.38 43.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -82.78 139.47 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -97.55 104.2 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.957 170.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -144.96 122.75 11.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 47.74 36.43 5.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.922 -172.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 8.09 82.28 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -135.21 151.6 50.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.873 0.368 . . . . 0.0 110.9 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -97.94 141.58 30.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.937 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -103.61 117.34 34.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 170.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.14 -18.07 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 -174.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.04 -10.25 55.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -128.91 75.5 1.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.917 175.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.498 HG23 ' H ' ' A' ' 184' ' ' ASP . 15.4 m -134.95 172.96 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.185 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.92 -11.97 75.42 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.562 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 22.6 m -91.84 -7.68 10.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.706 0.289 . . . . 0.0 111.044 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 35.3 p30 -85.45 7.22 23.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.886 171.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 184' ' ' ASP . 86.3 m-20 83.72 -8.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 165.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -82.53 -48.53 10.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.059 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.09 -44.68 34.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.533 -175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.495 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -70.15 -32.68 70.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.893 0.377 . . . . 0.0 111.148 -166.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -62.89 -45.59 91.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.949 -164.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.33 -39.94 95.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.055 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.629 ' HA3' HG23 ' A' ' 161' ' ' ILE . . . -63.38 -41.26 99.46 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.43 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.19 -44.26 88.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.037 0.446 . . . . 0.0 111.008 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.5 m -62.7 -42.79 99.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.216 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -61.05 -43.69 98.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.828 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.71 -40.31 94.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -62.33 -36.83 76.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.173 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.26 -36.33 82.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 88.7 mt -68.38 -41.71 80.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.63 -35.5 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 175.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.95 -35.96 81.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.887 175.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -84.08 2.98 36.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 62.71 35.14 14.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.914 173.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -76.98 -25.73 53.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.963 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -147.46 149.38 32.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.517 ' HB3' ' OG1' ' A' ' 208' ' ' THR . 53.1 t-20 -95.1 136.73 35.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.908 179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.43 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -63.02 -26.84 69.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.034 -175.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -93.21 -13.79 27.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.899 -172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 205' ' ' ASN . 54.8 m -65.63 134.93 54.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 49.9 p30 -112.91 173.83 6.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 174.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -71.36 -25.56 62.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.951 -177.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.01 -38.47 88.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.858 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 88.1 mt -59.42 -32.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.179 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.76 72.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.047 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.59 -46.96 85.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.834 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.94 -33.64 76.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.42 96.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -65.09 -35.97 82.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.915 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.04 -29.31 70.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -98.82 -20.67 16.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.16 25.42 31.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.405 -178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -81.42 -26.75 35.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.906 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.498 ' HA ' ' H ' ' A' ' 145' ' ' SER . 7.2 t -128.99 147.49 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.05 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -90.1 -28.73 18.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.158 175.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.443 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 74.1 mtm -140.23 160.05 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.883 -169.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.2 t -150.15 161.79 41.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.161 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 71.5 mt -121.34 120.23 61.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -146.27 159.58 43.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.83 -176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -104.77 -137.46 9.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.442 -175.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -70.49 -26.24 24.35 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.692 2.261 . . . . 0.0 112.278 -175.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -66.49 -16.13 63.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.7 23.06 2.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.065 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 58.3 p-90 -62.5 -30.65 71.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.926 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 t -69.19 107.16 3.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -144.88 127.85 16.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.928 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.43 80.33 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -85.29 74.22 10.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.832 177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 75.5 p -119.89 -14.97 8.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 81.2 p -92.96 -170.05 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.852 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -71.39 175.29 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.935 170.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.71 107.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.192 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -118.48 -57.08 2.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.865 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -113.49 160.03 18.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.578 ' HA3' ' HE2' ' A' ' 119' ' ' LYS . . . -146.76 166.4 28.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.438 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 316' ' ' ARG . 96.2 t -130.12 134.75 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.969 0.414 . . . . 0.0 111.121 -178.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.6 t -140.72 177.14 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.115 -176.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 35.2 m -79.93 159.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.5 144.94 98.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.561 0.696 . . . . 0.0 110.909 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.95 158.37 56.94 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.681 2.254 . . . . 0.0 112.252 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 74.1 p -107.22 151.33 25.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -128.76 116.0 18.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt 55.18 36.47 27.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.54 13.97 69.21 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -125.32 147.08 56.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.607 0.718 . . . . 0.0 110.996 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.3 154.83 72.71 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.653 2.235 . . . . 0.0 112.379 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 42.4 t -67.08 -58.44 4.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.971 0.415 . . . . 0.0 110.914 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -169.91 141.89 1.88 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 0.0 110.864 168.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.65 129.04 11.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.666 2.244 . . . . 0.0 112.417 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -163.12 112.14 1.31 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.914 172.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.09 135.05 28.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.128 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.25 135.0 10.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.4 t -114.45 119.08 60.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.749 0.309 . . . . 0.0 111.211 -174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.6 130.01 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.1 m -130.54 145.04 51.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -170.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -117.96 130.0 55.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.07 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -117.09 155.19 16.31 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.412 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 94.6 mt -104.49 126.75 59.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 0.0 111.164 -177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -59.98 120.06 8.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.852 -176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.91 67.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.075 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.01 -12.69 57.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.088 -176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -72.48 131.06 85.03 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.738 0.78 . . . . 0.0 110.846 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.65 -12.8 33.88 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.214 . . . . 0.0 112.32 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -105.05 27.54 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.854 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -53.85 -34.42 59.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.838 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.39 -38.98 91.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 81.8 mt -66.37 -41.01 90.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.816 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.92 -47.0 79.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.126 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -63.86 -47.84 79.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.827 -175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 98.3 mt-10 -69.36 -53.04 21.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -175.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 8.5 m-30 -65.48 -39.6 92.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.83 -171.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.479 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.1 tt -61.55 -48.07 82.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.978 -177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -83.06 -26.64 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 93.0 m-20 -100.56 -21.03 15.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -169.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 279' ' ' PHE . 21.3 m-30 -118.69 -56.38 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.862 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 38.4 mt -69.02 -37.1 78.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.853 -174.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' A' ' 106' ' ' TYR . 89.2 mt -94.84 60.99 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 72.1 p -127.75 168.82 14.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.17 171.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -53.24 -44.37 68.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.839 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.48 -42.12 30.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.33 -49.33 12.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.434 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 304' ' ' LEU . 25.0 tp -72.05 -35.5 69.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.938 -176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.97 -40.06 96.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.835 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.36 99.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.129 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.98 -35.21 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.157 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -77.27 -24.54 51.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -62.38 -27.29 68.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -88.01 -15.33 36.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -71.65 153.11 93.57 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.466 0.651 . . . . 0.0 110.987 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.6 -55.95 0.6 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.573 2.182 . . . . 0.0 112.33 -176.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 96.3 mt -82.05 -46.62 13.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 84.98 -8.84 68.26 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.423 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -55.29 118.54 4.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.831 0.348 . . . . 0.0 111.061 -176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.739 HG11 ' HB3' ' A' ' 307' ' ' TYR . 4.3 p -128.72 153.49 38.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 -170.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.42 -17.19 56.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.04 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.489 ' HB2' HD23 ' A' ' 290' ' ' LEU . 56.1 tp -70.86 124.91 25.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -62.06 -37.39 84.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -61.29 -51.0 70.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.83 -175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.739 ' HB3' HG11 ' A' ' 302' ' ' VAL . 1.6 t80 -73.73 -33.25 64.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 178.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.67 -38.29 89.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.56 -40.18 82.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.921 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -73.76 -37.77 64.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.802 176.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.89 -28.23 68.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.66 -16.62 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -73.43 -21.77 60.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.885 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -90.17 119.55 69.25 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.61 0.719 . . . . 0.0 110.796 172.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -62.32 -25.44 76.51 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.729 2.286 . . . . 0.0 112.299 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.408 ' HA ' ' HB ' ' A' ' 244' ' ' VAL . 93.4 mtm-85 -70.12 -40.14 75.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.85 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 50.9 mm -79.64 -40.1 20.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.208 -178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.96 76.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.99 -43.06 93.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.079 -178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 72.0 p -71.25 -36.52 71.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.188 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.13 -34.64 73.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -65.02 -40.86 95.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -72.03 -35.04 69.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.93 90.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -72.86 -14.37 61.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.818 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -107.72 -8.34 16.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.858 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.25 -158.37 34.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.483 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -127.11 140.1 52.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.908 0.385 . . . . 0.0 110.843 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 329' ' ' ILE . 2.9 tp -68.24 120.24 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.183 -175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.551 ' N ' ' HD2' ' A' ' 331' ' ' PRO . 1.6 tmt? -47.95 -51.51 47.0 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.608 0.718 . . . . 0.0 110.878 -174.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 330' ' ' MET . 68.8 Cg_endo -69.23 79.53 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.671 2.247 . . . . 0.0 112.423 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 53.5 t-20 -119.58 -3.08 10.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 336' ' ' MET . 18.2 tt 164.97 124.9 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.641 0.734 . . . . 0.0 111.114 -165.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.75 -29.35 12.8 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.587 2.191 . . . . 0.0 112.334 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -64.98 -17.76 64.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.914 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.48 ' HB2' HG23 ' A' ' 333' ' ' ILE . 61.4 ttp -62.97 -27.94 69.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 -174.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -60.77 -41.73 96.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.49 -36.6 71.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.134 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -65.6 -30.61 71.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -56.57 -41.2 76.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.933 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.17 -37.31 78.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.46 -43.57 85.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.146 -176.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 20.0 m -74.93 -29.11 21.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.1 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.757 ' HG3' ' HD3' ' A' ' 154' ' ' PRO . 60.5 ttt180 -57.31 -44.96 84.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.0 m -62.21 -44.39 96.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.76 -44.23 81.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.82 -50.07 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.0 mm -65.9 -45.43 91.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.978 -173.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -66.21 -37.27 85.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.812 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.18 -46.85 63.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.149 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.9 -35.04 76.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.031 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -80.71 -10.85 59.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.69 14.39 81.15 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.575 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -79.87 -26.6 40.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 -137.0 156.22 48.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.006 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 98.9 m -68.6 145.86 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.107 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 72.6 t -64.1 -49.94 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.177 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.43 -40.84 85.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.52 -46.43 66.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.893 -175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.64 -37.63 88.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.17 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 188' ' ' ALA . 63.5 tp -64.16 -46.59 83.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -65.97 -48.31 71.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.58 -38.8 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 -174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -78.6 -46.39 19.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.06 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -78.97 -30.87 44.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -169.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -59.0 -36.06 74.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.88 -30.1 69.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 82.5 mt -67.89 -44.67 85.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.127 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 76.2 p -98.18 -11.23 22.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.057 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.762 0.315 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -89.76 135.1 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.166 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -129.73 165.03 22.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -71.31 122.04 19.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.12 20.09 50.76 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.542 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 34' ' ' LYS . 93.5 mttt -139.84 155.11 47.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.89 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.805 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.6 pp -149.15 148.75 30.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.0 t -123.16 125.35 71.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.2 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.464 HG12 ' HB ' ' A' ' 59' ' ' ILE . 53.2 mt -119.01 130.73 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.095 -177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -110.83 136.68 49.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.963 -173.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 tt -144.56 147.63 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -75.0 172.4 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.895 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.62 -19.97 15.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.507 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -79.4 51.27 1.2 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 110.857 174.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 17' ' ' TYR . 54.5 pttt -80.14 117.63 21.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.956 -159.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.65 10.03 1.64 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.543 154.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' H ' ' C ' ' A' ' 15' ' ' LYS . 23.1 t80 -39.99 -36.1 0.44 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 177.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -57.63 -47.12 83.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.8 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -72.63 -38.18 57.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.405 174.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.58 -36.87 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.009 -174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.55 95.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.221 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.9 tp10 -62.02 -45.87 91.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 32.0 m -75.08 -28.28 20.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.146 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.6 89.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.404 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.42 -40.71 93.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.82 -45.85 80.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.972 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -64.78 -43.27 93.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -62.46 -33.16 74.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -74.99 -40.37 60.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.003 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -78.78 -40.53 32.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -172.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.4 p -101.04 -25.15 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.163 -172.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.58 6.46 87.35 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.547 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.735 HD13 HD13 ' A' ' 275' ' ' LEU . 96.6 mt -78.69 125.05 37.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 0.0 111.094 176.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 89.3 tttt -64.42 118.06 8.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 173.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.82 129.34 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.7 m -134.8 110.1 8.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.228 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.6 t -110.93 126.51 68.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.069 -176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -125.93 152.8 45.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.861 -173.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -133.69 67.68 75.2 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.574 0.702 . . . . 0.0 110.892 172.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 30.8 Cg_endo -78.89 -15.38 13.29 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.612 2.208 . . . . 0.0 112.329 -164.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 64.3 m-20 77.28 10.97 2.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 177.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -98.22 -5.1 34.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.913 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -49.88 -60.06 3.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.929 -154.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -62.11 -34.82 77.06 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.889 -170.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.52 -33.45 54.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -78.49 -30.17 47.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.805 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.551 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 8.6 m-30 -49.38 -52.15 51.84 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.586 0.707 . . . . 0.0 110.877 -168.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 60.9 Cg_endo -69.56 -27.57 27.28 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.642 2.228 . . . . 0.0 112.337 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -78.63 -49.98 12.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.17 -33.46 58.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.099 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.96 86.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.129 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.35 53.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.3 p -95.66 -1.21 50.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.195 -173.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.05 74.03 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.438 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -88.82 145.4 25.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.943 0.401 . . . . 0.0 110.863 172.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.49 82.19 0.22 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.428 -161.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.24 124.19 12.22 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.71 2.274 . . . . 0.0 112.451 157.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.13 -42.64 23.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.888 -156.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.464 ' HB ' HG12 ' A' ' 9' ' ' ILE . 74.7 mt -130.07 133.19 64.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.096 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.2 mm -125.01 127.17 72.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.146 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -132.93 115.64 15.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.889 -177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.519 ' O ' ' C ' ' A' ' 63' ' ' ALA . 26.2 p-90 -177.13 173.2 1.83 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.867 175.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 62' ' ' TRP . . . -25.71 96.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.119 175.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 62' ' ' TRP . 76.2 t60 -59.03 -32.37 69.67 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -172.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -51.65 -50.18 60.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.847 -167.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -74.63 -26.64 60.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.04 -26.68 67.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 71' ' ' ALA . . . -64.91 -37.73 94.65 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.431 176.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.28 -35.45 84.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.476 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -72.06 -24.9 61.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 110.899 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB2' HD21 ' A' ' 76' ' ' LEU . . . -59.73 -39.43 84.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.148 171.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -66.17 -28.64 68.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.82 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 82.7 p -84.96 4.16 34.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.98 32.4 69.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.563 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.3 tp -72.9 -24.37 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.748 0.308 . . . . 0.0 110.825 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.582 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.8 pp -132.09 145.99 51.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -170.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.523 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -74.96 152.23 38.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 -174.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -58.81 131.34 50.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.972 171.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -114.84 140.08 37.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.212 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.8 m -92.72 121.91 65.11 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.588 0.709 . . . . 0.0 111.189 -174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -54.96 130.71 42.19 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.75 2.3 . . . . 0.0 112.343 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.46 118.32 35.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.825 173.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.01 -46.11 89.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.96 87.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.066 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -62.59 -39.95 95.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.828 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -58.06 -43.62 87.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 173.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.03 -33.0 74.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.853 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.22 -27.2 68.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.925 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 304' ' ' LEU . 5.9 mp -112.47 -125.06 0.28 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 176.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -129.78 148.05 67.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.671 0.748 . . . . 0.0 110.919 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.65 -30.32 60.21 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.683 2.255 . . . . 0.0 112.277 169.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -71.69 -35.65 70.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.878 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.4 p -71.81 -24.67 61.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.131 175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.09 -39.93 71.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.973 171.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.84 -34.53 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.864 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 -32.87 74.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.033 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.78 HG21 ' HD3' ' A' ' 107' ' ' PRO . 34.3 m -111.36 14.06 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -164.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -119.98 149.94 41.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -135.73 119.57 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.961 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 52.9 t30 61.86 35.2 16.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.87 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.64 1.54 89.08 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.465 171.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -122.18 149.92 42.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.891 0.377 . . . . 0.0 110.892 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 103' ' ' LEU . 50.9 mt -74.95 133.82 41.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 -174.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.8 pt -115.72 -7.36 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.99 174.03 10.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.111 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -120.45 139.29 28.49 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.711 0.767 . . . . 0.0 110.99 169.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.78 ' HD3' HG21 ' A' ' 97' ' ' VAL . 56.5 Cg_endo -79.82 132.28 9.6 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.605 2.203 . . . . 0.0 112.399 -172.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.1 -42.01 5.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.114 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.53 147.99 27.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.127 -163.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.6 t -130.73 132.35 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.102 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -125.02 149.91 47.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.25 142.89 27.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.42 126.38 29.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.7 m -142.59 159.09 42.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.815 -166.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -98.93 123.87 43.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 66.6 mt -110.48 133.57 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -137.25 156.63 48.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.95 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.425 ' HB3' HD21 ' A' ' 121' ' ' LEU . 54.9 t-20 -96.53 120.08 36.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.03 -27.74 69.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -168.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -67.39 -42.25 83.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.973 -165.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.636 ' H ' HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -99.97 -24.76 14.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.952 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.5 tp -124.21 99.5 37.15 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.648 0.737 . . . . 0.0 110.936 175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.15 -14.96 11.82 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.665 2.243 . . . . 0.0 112.326 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.441 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 58.4 t-20 -157.77 103.94 1.78 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.597 0.713 . . . . 0.0 110.97 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.5 Cg_endo -68.75 147.11 68.59 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.725 2.283 . . . . 0.0 112.315 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 64.7 Cg_exo -55.09 145.03 66.55 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.769 2.313 . . . . 0.0 112.308 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.72 -17.65 37.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -143.79 161.13 39.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.295 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -68.64 -27.32 65.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.886 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.04 -29.62 70.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.877 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.65 -15.68 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 38.7 mm -59.17 -54.34 57.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.721 0.772 . . . . 0.0 111.12 -171.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 24.5 Cg_endo -62.51 -39.89 42.18 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.586 2.191 . . . . 0.0 112.318 -175.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.27 99.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.134 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.18 -40.29 97.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 174.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.561 ' O ' HD23 ' A' ' 139' ' ' LEU . 10.0 t70 -62.16 -41.65 98.5 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.97 -39.6 92.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.906 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.49 -44.19 75.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.019 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -89.97 -17.95 26.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 -176.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 39.0 ttpt -56.08 -26.2 48.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 169.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.11 -20.27 66.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.128 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -102.46 11.5 37.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.7 30.46 66.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.51 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 96.7 mttt -125.29 157.25 37.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.876 0.37 . . . . 0.0 110.876 177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.2 t -116.51 153.69 31.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.945 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.21 66.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.883 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.2 pp -145.88 146.07 30.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.7 ttm -148.05 132.32 17.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.914 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -156.7 169.79 23.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -59.16 122.89 14.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 -174.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.58 7.41 18.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.852 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -85.1 -8.68 58.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.845 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -127.19 149.37 69.39 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.514 0.673 . . . . 0.0 110.97 -174.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 -31.99 9.27 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.702 2.268 . . . . 0.0 112.336 -176.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -49.79 -39.99 40.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -80.5 -37.57 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.971 -174.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.9 p -83.82 -14.02 52.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.1 -170.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.609 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 24.1 m0 -49.99 -53.51 42.44 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.592 0.711 . . . . 0.0 110.827 -174.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 9.5 Cg_endo -53.43 -33.99 69.51 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.696 2.264 . . . . 0.0 112.453 -174.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 77.6 mt -73.94 -45.4 50.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.951 -176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.801 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 89.3 mt -74.22 -41.67 51.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -175.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.13 -6.78 51.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.13 -35.03 59.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 -169.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.3 5.35 52.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.936 -168.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 90.36 10.58 63.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.525 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -130.05 86.01 0.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 63.1 t80 -167.49 153.88 7.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 74.94 -91.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.08 170.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -167.35 155.03 9.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.954 -171.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.7 129.34 34.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.829 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -116.89 128.91 55.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.966 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -146.94 140.21 25.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.956 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 51.01 45.81 27.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.39 10.91 71.05 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.513 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.65 146.87 52.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.766 0.317 . . . . 0.0 110.891 -174.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -99.35 137.2 38.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -94.82 112.67 24.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.885 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 178' ' ' ILE . 6.4 tp -71.24 -20.01 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.134 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.16 -8.76 53.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -120.19 91.34 3.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 173.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.3 m -106.04 155.87 6.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -96.78 7.47 65.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.488 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.7 m -97.5 -19.77 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 111.221 -170.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -101.6 14.3 32.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 167.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -93.95 154.23 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -170.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.35 -33.36 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.073 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.04 -36.67 92.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.477 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.94 78.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.842 0.353 . . . . 0.0 111.082 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -65.4 -39.2 91.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.855 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.01 -41.54 95.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.079 177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.801 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -42.18 98.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.592 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 70.9 mt -65.62 -39.71 91.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.742 0.305 . . . . 0.0 110.831 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 86.1 m -59.75 -41.71 91.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.086 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -58.44 -47.23 84.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.866 177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 55.1 tp -64.19 -43.13 96.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.9 t -65.83 -40.83 88.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -60.98 -38.01 84.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.418 ' HA ' HD12 ' A' ' 198' ' ' LEU . 0.4 OUTLIER -60.97 -35.88 77.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.982 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.4 mt -82.41 -40.0 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.97 -35.18 79.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -80.15 0.74 30.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.034 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 63.64 30.07 14.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.839 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 65.6 m170 -92.01 -21.61 20.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 83.9 mmm -131.98 155.0 48.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 169.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 94.4 m-20 -104.71 139.14 39.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 173.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -65.88 -24.98 66.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.101 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -96.47 0.43 50.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.863 -174.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 98.5 m -56.57 125.94 24.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.194 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -119.12 179.76 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.911 172.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.92 -39.69 90.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.974 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.1 m -58.62 -42.95 89.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.92 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 87.7 mt -65.18 -43.44 95.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.29 94.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.154 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -66.35 -42.9 87.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.27 -37.48 87.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.43 -42.91 97.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.967 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -67.08 -37.84 84.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.951 0.405 . . . . 0.0 110.867 175.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -65.0 -28.64 69.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.86 178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.11 -22.25 15.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.26 21.67 40.63 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.542 -177.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -84.04 -25.91 29.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.411 . . . . 0.0 110.827 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 79.1 m -126.48 135.34 51.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.084 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.78 -40.37 48.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.185 -175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 78.3 mtm -133.7 156.45 47.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -164.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.7 t -151.8 158.34 43.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.202 173.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 46.2 mm -115.85 114.97 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -163.36 178.39 8.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.909 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -99.21 -171.68 31.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.463 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.77 -15.11 40.37 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -63.49 -12.24 30.3 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.919 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.6 78.21 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.143 175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -66.32 -22.76 66.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.982 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 50.1 m -54.14 169.84 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 233' ' ' SER . 91.6 m-20 73.86 55.87 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 -169.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.0 128.46 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.109 -177.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -68.92 81.4 0.3 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.809 -176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 80.0 p -58.18 -177.03 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.106 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.3 p -69.12 -15.3 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -160.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.61 170.52 11.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.803 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.7 t -93.15 119.77 41.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.093 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -122.02 -42.42 2.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.925 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -105.13 153.38 21.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.933 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -134.93 160.41 24.29 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.427 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.33 131.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.97 0.414 . . . . 0.0 111.101 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -142.16 179.13 7.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.182 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 m -84.84 159.63 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.124 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 96.4 mt -68.43 150.03 97.83 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.74 0.781 . . . . 0.0 110.765 -169.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 44.6 Cg_exo -56.74 150.53 53.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.752 2.301 . . . . 0.0 112.29 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 64.7 p -91.17 163.2 14.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.098 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -136.33 113.19 10.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.888 -177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 56.71 43.48 25.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.735 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.68 1.29 80.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 169.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -149.99 147.04 21.3 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.524 0.678 . . . . 0.0 110.991 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.84 127.04 11.68 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.618 2.212 . . . . 0.0 112.386 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 88.9 p -56.71 -57.05 14.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.903 -170.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -165.09 119.97 0.99 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.576 0.703 . . . . 0.0 110.9 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.68 149.87 23.92 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.617 2.212 . . . . 0.0 112.324 175.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -138.84 120.51 15.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.863 171.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 73.7 t -125.04 125.94 70.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.132 177.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.65 139.36 15.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.459 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 94.6 t -122.14 124.66 71.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.834 0.349 . . . . 0.0 111.052 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 262' ' ' LEU . 28.3 mt -78.96 144.67 34.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 169.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 53.6 p -142.42 163.77 31.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.73 135.56 52.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.099 176.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.68 156.5 15.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.52 126.98 60.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.874 0.369 . . . . 0.0 111.146 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -65.8 129.25 39.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -172.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.07 -28.99 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.44 -11.42 59.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.203 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.0 t -80.11 127.93 75.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.655 0.74 . . . . 0.0 110.899 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -69.53 -6.69 19.09 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.675 2.25 . . . . 0.0 112.319 168.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -108.05 24.12 13.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.889 -174.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -57.56 -34.12 68.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.907 -172.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -70.79 -45.91 63.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -171.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.735 HD13 HD13 ' A' ' 33' ' ' ILE . 4.5 pp -76.44 -31.5 57.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.524 ' N ' HD12 ' A' ' 275' ' ' LEU . . . -66.24 -40.83 90.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 174.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -66.56 -39.49 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -69.59 -38.67 77.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -56.9 -45.51 82.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 62.9 tp -63.79 -50.8 67.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.94 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.82 -34.65 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.8 -27.87 13.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.869 -163.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.777 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 87.1 m-85 -120.45 -49.55 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 80.4 mt -73.63 -35.91 65.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.924 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 49.6 tp -124.98 74.05 1.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.971 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.0 p -141.87 170.17 16.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.006 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.25 -43.09 74.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.769 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -76.45 -46.07 28.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.91 177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.777 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.92 -44.15 25.23 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 -169.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.01 -36.43 84.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.769 0.319 . . . . 0.0 110.911 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.97 -41.64 96.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.34 -34.82 74.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.8 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 97.0 t -80.84 -45.55 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -71.15 -28.78 64.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.916 -168.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -62.26 -10.97 12.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.47 -33.08 62.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -89.98 150.02 42.81 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.589 0.709 . . . . 0.0 110.903 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -58.39 -57.13 1.17 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.394 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 94.1 mt -100.54 -53.19 3.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 59.41 62.56 6.02 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.509 170.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -81.95 123.12 28.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.123 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.667 HG22 HD21 ' A' ' 311' ' ' LEU . 33.2 m -115.49 156.24 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.074 -163.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.43 -17.07 55.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.055 177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.407 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 60.8 tp -78.25 117.85 19.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.95 -175.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.7 -46.84 87.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.919 -170.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 31.1 t -63.67 -50.99 67.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.771 -171.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -70.09 -34.06 72.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -57.28 -39.5 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.833 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -55.51 -38.12 68.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -76.78 -46.56 24.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -174.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.667 HD21 HG22 ' A' ' 302' ' ' VAL . 4.3 pp -74.88 -22.05 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -73.01 -6.37 45.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.998 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -71.82 -12.03 61.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -81.69 129.94 63.3 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.635 0.731 . . . . 0.0 110.868 176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -32.39 32.06 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.654 2.236 . . . . 0.0 112.357 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -69.76 -37.04 76.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.883 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.43 HG21 HD12 ' A' ' 311' ' ' LEU . 48.6 mm -80.37 -40.98 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.157 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.35 -35.88 70.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -169.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.25 -38.71 91.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.175 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 95.4 m -68.52 -39.88 81.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 36.4 mmt -67.58 -35.42 78.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.948 -178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -64.92 -38.47 91.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 327' ' ' GLY . 84.5 m-20 -69.27 -35.93 76.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.796 176.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.29 -45.15 85.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -72.83 -22.91 60.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -107.93 -5.71 17.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -176.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.37 -159.65 32.12 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -171.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -130.01 123.45 30.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 110.911 -174.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.437 ' O ' HG22 ' A' ' 329' ' ' ILE . 1.1 mp -75.24 124.12 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.418 ' O ' ' O ' ' A' ' 329' ' ' ILE . 92.0 mtp 60.56 160.18 0.11 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.535 0.683 . . . . 0.0 110.886 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -64.96 -103.51 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.0 112.438 161.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -139.96 -48.88 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.918 158.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.545 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 46.5 pt -130.04 161.36 60.38 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.648 0.737 . . . . 0.0 111.121 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 19.5 Cg_endo -60.72 -22.03 71.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.666 2.244 . . . . 0.0 112.34 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -69.81 -16.41 63.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 37.3 mmt -66.18 -26.09 67.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 87.7 p -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.839 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.08 -51.33 25.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -171.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 339' ' ' PHE . 1.0 OUTLIER -65.22 -26.24 68.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.953 178.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 5.6 m0 -66.15 -39.5 89.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 171.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -63.57 -37.47 87.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.904 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.79 -30.98 71.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.163 172.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.68 -32.91 36.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -49.75 -47.92 50.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.859 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 92.8 m -60.35 -39.67 87.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.143 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -64.47 -37.62 88.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.095 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.84 -44.86 88.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 43.5 mm -63.9 -43.09 97.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.119 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.06 -39.86 93.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.979 -177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.74 68.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.046 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -72.21 -36.64 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.069 -174.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.9 p -78.6 -9.61 59.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.904 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.56 9.53 85.59 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.439 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.37 -31.17 65.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.809 0.338 . . . . 0.0 110.865 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -133.66 160.02 38.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -76.02 169.92 17.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 170.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.76 -44.52 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.08 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.83 -45.9 91.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -69.9 -46.45 65.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -44.48 89.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 21.2 tp -67.56 -37.37 82.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.936 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -67.64 -35.27 78.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.58 -31.4 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.943 176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -65.02 -47.5 77.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -64.65 -38.79 92.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.886 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.7 m -60.48 -42.18 95.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.122 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.82 -39.24 80.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 89.9 mt -62.69 -42.14 95.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.108 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 64.9 p -90.8 -14.56 31.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.565 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 85.9 mttt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.701 0.286 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.411 ' CD1' ' HA3' ' A' ' 56' ' ' GLY . 86.3 mt -76.04 129.08 37.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.167 -177.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -130.11 166.76 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.937 -176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -71.43 121.94 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.838 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.75 20.02 52.11 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.489 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -141.49 156.36 45.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 0.0 110.951 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.744 ' O ' HD12 ' A' ' 7' ' ' LEU . 3.8 pp -149.29 150.64 32.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 175.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.3 t -124.99 121.46 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.121 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.426 HG12 ' HB ' ' A' ' 59' ' ' ILE . 87.1 mt -119.58 132.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.212 -176.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.1 m0 -115.75 140.42 49.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.996 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.935 HD13 ' HA3' ' A' ' 16' ' ' GLY . 17.3 tt -144.06 143.65 23.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.134 174.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -73.71 -179.82 3.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 -172.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.0 -2.28 4.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.52 -170.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.636 ' O ' ' C ' ' A' ' 15' ' ' LYS . 46.9 t0 -67.34 70.06 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.856 173.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.636 ' C ' ' O ' ' A' ' 14' ' ' ASP . 87.2 tttt -14.55 107.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.969 -166.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.935 ' HA3' HD13 ' A' ' 11' ' ' ILE . . . -108.98 -11.05 23.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.45 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -66.3 -41.75 89.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.928 0.394 . . . . 0.0 110.896 -151.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.68 -52.52 62.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.911 -162.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' A' ' 293' ' ' VAL . . . -66.61 -44.33 90.04 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.415 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.2 mt -58.46 -40.48 82.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.756 0.312 . . . . 0.0 110.896 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.33 76.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.089 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.35 -46.84 88.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 -175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.9 m -74.24 -28.23 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.13 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.32 -37.73 95.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.458 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.63 -41.46 96.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.874 0.369 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.39 -43.93 89.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -64.1 -43.52 95.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -61.83 -34.86 76.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.873 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.25 -40.1 67.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.956 -177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -79.08 -40.65 30.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.836 -172.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.4 p -100.72 -24.54 14.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.174 -171.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.56 8.53 86.0 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.511 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.406 HG21 HD23 ' A' ' 7' ' ' LEU . 89.6 mt -80.34 124.9 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 0.0 111.148 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -63.21 118.88 8.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' A' ' 24' ' ' GLY . 70.0 t -98.46 134.31 37.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.158 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 90.1 m -132.65 112.39 11.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.21 121.55 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -128.21 149.98 50.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.822 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -135.04 68.55 70.36 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.577 0.703 . . . . 0.0 110.918 171.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 29.0 Cg_endo -79.39 -14.35 13.13 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.683 2.256 . . . . 0.0 112.29 -162.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 61.4 m-20 76.49 8.95 3.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.14 -9.99 37.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.948 175.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 3.2 mp -51.34 -55.56 17.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 -156.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -54.33 -38.98 66.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 -173.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.65 -32.84 62.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.94 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -76.96 -29.69 55.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.873 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 43' ' ' LEU . 8.7 m-30 -49.81 -51.59 59.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.706 0.765 . . . . 0.0 110.968 -164.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 96.0 Cg_endo -79.41 -29.11 3.2 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.576 2.184 . . . . 0.0 112.357 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -75.54 -46.08 34.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.835 -171.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.5 m -56.78 -33.39 40.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.047 -176.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.08 87.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.157 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.58 -32.6 47.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 77.2 p -95.02 -4.9 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.092 -173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.95 24.71 66.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.435 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -80.94 143.05 32.91 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.843 0.354 . . . . 0.0 110.843 172.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' A' ' 2' ' ' ILE . . . -122.1 62.9 0.53 Allowed Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.404 -164.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.88 121.06 7.92 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.686 2.257 . . . . 0.0 112.377 159.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -83.18 -48.93 9.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.86 -161.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.426 ' HB ' HG12 ' A' ' 9' ' ' ILE . 70.1 mt -132.55 136.08 56.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.168 -172.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.8 mm -119.07 132.36 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 264' ' ' ALA . 72.5 m-85 -116.32 115.72 26.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.889 172.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -168.36 179.76 4.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.918 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -48.25 99.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.132 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 263' ' ' SER . 73.3 t60 -60.21 -25.05 65.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -174.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -50.42 -44.16 55.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.13 -24.19 47.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.585 ' HE2' ' HA3' ' A' ' 265' ' ' GLY . 1.7 t80 -65.43 -28.79 69.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.916 -172.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.46 -38.35 62.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.457 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -56.15 -37.31 71.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.631 176.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -71.64 -25.06 61.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' A' ' 76' ' ' LEU . . . -59.93 -39.58 85.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.188 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -69.15 -26.44 64.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.4 p -85.0 2.47 42.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 68.76 32.22 73.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.53 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -74.82 -24.33 58.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.691 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.2 pp -126.86 144.11 51.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -168.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -75.99 154.52 35.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.049 -175.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.83 134.07 52.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.97 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.8 mt -115.98 142.27 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.191 -175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -93.5 123.91 58.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.516 0.674 . . . . 0.0 111.16 -177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.11 143.59 28.91 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.789 2.326 . . . . 0.0 112.275 -175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -107.86 116.13 31.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 170.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -55.14 -43.1 73.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.964 -178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.0 98.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.179 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -70.17 -35.71 74.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.856 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -58.24 -44.64 88.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -66.07 -32.45 73.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -70.2 -28.38 65.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.004 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.04 -105.42 0.32 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -152.69 139.29 12.37 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.745 0.783 . . . . 0.0 110.925 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.37 -28.13 22.71 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.833 2.356 . . . . 0.0 112.298 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -71.22 -34.28 70.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 76.9 p -74.33 -21.88 59.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.116 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.54 -35.18 80.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.017 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -59.86 -35.06 74.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' A' ' 329' ' ' ILE . . . -69.97 -37.83 75.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.767 HG21 ' HD3' ' A' ' 107' ' ' PRO . 35.4 m -104.32 18.36 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -169.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 49.4 ptt85 -123.52 149.94 44.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 175.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -138.77 124.42 19.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.991 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.9 t30 58.18 35.99 25.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.42 3.06 88.83 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.538 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -122.03 150.66 41.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 31.9 mt -75.03 135.19 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.994 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.0 pt -113.76 -12.48 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.18 169.57 20.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.053 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -112.86 130.53 23.41 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.622 0.725 . . . . 0.0 111.02 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.767 ' HD3' HG21 ' A' ' 97' ' ' VAL . 54.6 Cg_endo -72.8 125.71 10.73 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.659 2.239 . . . . 0.0 112.358 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -105.49 -50.38 8.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 -173.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.84 157.07 42.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.09 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.11 147.16 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -129.85 147.76 51.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.2 145.22 28.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 21.9 tp -68.54 128.81 37.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.5 m -138.29 157.84 45.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.748 -165.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.95 121.13 38.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.964 -176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 86.5 mt -109.87 130.06 63.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.175 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -135.23 157.53 46.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.934 -172.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -90.58 117.4 29.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.943 175.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -65.14 -28.53 69.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.837 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -80.94 -35.1 32.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.3 mt -78.29 -44.25 25.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 54.8 tp -127.44 105.99 21.36 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.541 0.686 . . . . 0.0 110.942 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.65 -15.65 15.26 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.329 -176.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -150.33 105.58 3.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.611 0.72 . . . . 0.0 110.966 -177.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.59 146.52 73.98 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.728 2.285 . . . . 0.0 112.371 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.94 147.75 68.8 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.736 2.291 . . . . 0.0 112.351 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -88.24 -21.46 24.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.8 p -131.88 159.95 37.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -74.04 -23.64 59.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.23 -21.86 66.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -76.31 -21.63 55.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.597 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 40.0 mm -64.35 -45.52 78.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.676 0.75 . . . . 0.0 111.158 -162.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 77.0 Cg_exo -53.52 -49.49 17.16 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 0.0 112.323 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -38.72 83.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.096 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.566 ' O ' HD23 ' A' ' 135' ' ' LEU . 4.5 tt -61.97 -39.39 91.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 25.5 t70 -64.24 -41.87 96.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.74 -40.05 75.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.23 -56.52 9.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -170.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 136' ' ' ASP . 1.3 pt? -82.04 -12.33 58.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -174.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.5 tttt -58.51 -27.3 64.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 168.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.35 -17.9 63.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -101.34 6.47 42.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 26.94 65.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.493 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 2.7 mptp? -118.26 159.82 22.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.957 173.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.404 ' O ' HD11 ' A' ' 139' ' ' LEU . 47.8 t -113.8 153.49 29.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.826 172.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -66.82 -52.5 43.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.159 -175.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.83 ' O ' HD12 ' A' ' 147' ' ' LEU . 2.7 pp -151.76 147.65 26.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.968 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.3 mtp -127.27 134.35 50.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.836 169.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -143.37 164.95 28.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 209' ' ' ASP . 54.4 t-20 -70.0 110.32 5.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.895 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 206' ' ' ALA . 48.7 tp -106.84 0.31 23.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -85.97 -5.83 59.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 171.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -132.97 149.66 73.48 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.528 0.68 . . . . 0.0 110.825 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -79.4 -25.92 5.32 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.62 2.214 . . . . 0.0 112.317 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -59.68 -44.62 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.989 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.488 ' CD2' ' HB3' ' A' ' 150' ' ' ASN . 81.0 m-85 -79.31 -28.4 42.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.993 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 37.1 m -77.4 -20.89 53.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.154 172.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.612 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 10.7 t90 -47.37 -53.99 25.12 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.595 0.712 . . . . 0.0 110.879 -169.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 12.4 Cg_endo -55.19 -32.88 82.26 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.621 2.214 . . . . 0.0 112.401 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.536 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.8 tt -71.04 -54.2 12.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.007 -172.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 91.0 mt -78.61 -40.01 23.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.13 -173.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.22 -14.99 63.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 -173.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 250' ' ' PHE . . . -59.07 -28.52 66.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -174.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -90.5 -1.88 57.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.825 -178.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 94.21 20.41 30.37 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.419 ' HA3' ' N ' ' A' ' 188' ' ' ALA . . . -138.61 85.06 0.23 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.444 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 168' ' ' ALA . 9.4 t80 -177.31 154.08 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.918 0.39 . . . . 0.0 110.999 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 167' ' ' TYR . . . 74.97 -87.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.107 164.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -148.84 155.58 41.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 -168.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -118.28 124.3 47.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.943 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -113.8 129.8 56.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -145.02 136.47 25.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 52.2 38.93 25.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.889 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 71.08 8.93 65.86 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.431 174.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -128.72 145.6 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.76 0.314 . . . . 0.0 110.902 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -87.92 123.65 32.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 168.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -98.85 117.71 33.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.88 174.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 8.9 tp -68.13 -21.21 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.35 -12.03 28.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -124.57 82.19 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.874 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 12.6 p -113.21 148.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.61 25.39 27.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.481 -167.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 28.5 m -97.73 -14.51 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 111.186 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -102.27 20.39 16.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 46.0 p30 -102.46 -175.04 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 -173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -72.01 -35.78 69.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.025 -177.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.56 -38.61 96.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.529 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.419 ' N ' ' HA3' ' A' ' 166' ' ' GLY . . . -59.48 -39.85 85.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 0.0 111.095 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.12 -40.49 96.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.81 94.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.06 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.19 -43.88 96.46 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.532 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.93 -41.28 91.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.353 . . . . 0.0 110.883 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 81.4 m -60.01 -43.21 95.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.132 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -56.62 -52.43 64.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.9 pp -73.0 -32.76 65.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.988 -172.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 45.4 t -67.39 -39.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.169 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -61.99 -39.46 92.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.9 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.33 -39.73 95.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.826 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 64.4 mt -71.82 -41.17 69.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.134 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -64.42 -32.4 74.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.936 175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -82.43 3.27 28.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 63.95 34.92 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.973 172.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -88.85 -28.74 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.1 mtt -137.78 152.74 49.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.872 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . 0.414 ' HB2' ' OG1' ' A' ' 208' ' ' THR . 95.9 m-20 -101.24 141.41 34.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.862 178.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.422 ' HA ' HD23 ' A' ' 151' ' ' LEU . . . -65.13 -27.28 68.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.045 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.63 2.85 54.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 205' ' ' ASN . 94.5 m -58.59 130.18 45.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.082 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 150' ' ' ASN . 2.8 p30 -125.79 165.44 18.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 172.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -70.08 -27.67 64.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.926 -172.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 75.6 m -65.88 -48.3 71.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.947 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.5 pt -69.45 -23.65 26.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.134 175.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.45 94.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.146 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -71.93 -34.99 69.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.972 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.84 85.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.091 171.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.72 -37.06 82.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.039 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -62.88 -38.26 90.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.831 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.07 -27.42 69.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.838 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.71 -21.87 16.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.938 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.26 20.28 52.87 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.485 -176.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -82.62 -26.53 32.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.913 0.387 . . . . 0.0 110.868 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 86.3 m -127.34 134.38 49.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.155 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.21 -36.06 47.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -173.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.415 ' HB2' ' HB3' ' A' ' 147' ' ' LEU . 77.6 mtm -134.84 151.41 50.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -168.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.8 t -150.4 158.85 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.089 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.28 119.49 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 -175.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -163.06 174.18 12.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.405 ' HA3' ' CZ3' ' A' ' 230' ' ' TRP . . . -94.21 -175.75 39.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.22 -19.76 66.23 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.623 2.216 . . . . 0.0 112.383 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.405 ' CZ3' ' HA3' ' A' ' 228' ' ' GLY . 43.7 p90 -68.86 -9.63 52.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.852 178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.8 84.95 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.114 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -65.82 -25.85 67.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.951 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 61.7 m -52.54 160.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.907 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 233' ' ' SER . 73.7 m-20 72.72 56.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 -170.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.77 130.07 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.11 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -69.71 79.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.871 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 71.2 p -58.76 -176.8 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 165.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.9 p -72.49 -14.7 61.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.816 -160.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -123.61 164.96 18.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.781 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t -93.01 114.99 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -120.77 -39.99 2.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -106.46 155.29 19.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.97 167.12 25.49 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.568 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.16 136.19 56.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.956 0.408 . . . . 0.0 111.074 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.4 t -143.46 -179.66 6.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.162 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.8 m -82.74 159.42 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 94.0 mt -71.36 138.98 84.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.672 0.748 . . . . 0.0 110.855 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 53.1 Cg_exo -57.05 156.0 26.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 0.0 112.379 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 62.2 p -99.18 164.74 12.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.144 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.401 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 25.7 t80 -141.95 119.98 12.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 -176.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt 61.39 39.71 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.828 -177.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 6.48 84.97 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.468 165.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -144.94 151.64 49.63 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.538 0.685 . . . . 0.0 111.019 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -49.36 130.19 24.46 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.686 2.258 . . . . 0.0 112.408 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 77.8 p -61.09 -42.65 98.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.813 -170.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -172.99 127.66 0.51 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 110.851 166.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.24 142.79 24.6 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.252 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -163.93 124.89 2.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 64.3 t -129.82 128.92 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 170.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -103.56 144.81 16.02 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.429 171.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.28 127.32 73.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 111.118 -167.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 263' ' ' SER . 6.5 tt -96.97 128.6 44.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 166.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.573 ' N ' HD23 ' A' ' 262' ' ' LEU . 8.7 m -139.09 172.12 13.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.79 -172.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.508 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -121.99 135.96 54.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.133 176.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.585 ' HA3' ' HE2' ' A' ' 67' ' ' PHE . . . -117.39 155.05 16.36 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 -177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.94 127.93 68.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.803 0.335 . . . . 0.0 111.119 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -67.77 128.42 36.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -170.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.81 -28.98 69.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.054 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.67 -10.88 59.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.9 t -77.67 126.98 83.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.649 0.737 . . . . 0.0 110.879 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.76 -8.4 23.01 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.22 . . . . 0.0 112.455 174.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.736 ' HB3' HD23 ' A' ' 275' ' ' LEU . 97.0 m-20 -112.97 27.45 9.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -172.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -53.73 -28.34 33.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 -173.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -66.03 -40.17 90.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 272' ' ' ASN . 0.7 OUTLIER -72.55 -31.27 65.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.617 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.1 -42.04 85.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.151 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -66.01 -40.69 91.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -69.89 -41.42 74.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.93 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.63 -47.85 83.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 176.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 3.2 tt -66.85 -49.45 65.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.949 -172.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -65.51 -33.73 76.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 -171.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -101.35 -29.8 11.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -164.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.764 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 91.3 m-85 -119.93 -50.5 2.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.954 -169.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 94.5 mt -73.66 -37.79 65.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.95 -171.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 42.3 tp -126.71 75.1 1.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 40.5 p -140.79 174.62 10.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.208 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.92 -44.26 74.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.858 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -75.0 -44.24 49.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.764 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -74.83 -45.82 19.95 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.545 -171.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 42.4 tp -66.4 -36.92 84.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.351 . . . . 0.0 110.953 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.78 -39.73 95.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.857 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.97 88.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.022 -175.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.862 ' HA ' ' HA3' ' A' ' 19' ' ' GLY . 10.2 p -87.75 -32.53 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -177.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.76 -23.03 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -174.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -57.62 -15.25 6.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -82.91 -23.9 33.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -91.03 151.48 43.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.609 0.718 . . . . 0.0 110.906 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.89 -61.07 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.808 2.339 . . . . 0.0 112.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 97.1 mt -98.88 -50.12 4.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.005 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 54.56 59.91 9.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.517 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -77.74 129.01 34.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.956 0.408 . . . . 0.0 111.048 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.38 153.92 21.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.111 -166.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.73 -14.99 58.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.092 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 61.5 tp -76.63 120.26 21.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.923 -175.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -61.1 -44.91 96.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -173.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.9 t -63.49 -48.11 78.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.802 -173.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.89 -32.94 71.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.472 ' HA ' ' HE1' ' A' ' 321' ' ' MET . 42.7 tt0 -61.69 -38.93 89.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.798 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.64 -40.67 79.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -75.08 -41.58 58.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.428 ' HB3' HG21 ' A' ' 317' ' ' ILE . 91.9 mt -65.34 -29.97 70.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -67.51 -9.78 45.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.15 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -76.96 -19.44 57.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.951 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -86.76 120.13 71.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.573 0.701 . . . . 0.0 110.892 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -51.87 -34.97 57.8 Favored 'Trans proline' 0 C--N 1.34 0.117 0 C-N-CA 122.661 2.24 . . . . 0.0 112.322 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -74.33 -39.78 62.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.428 HG21 ' HB3' ' A' ' 311' ' ' LEU . 96.7 mt -74.12 -39.66 50.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.153 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.4 -33.24 69.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.03 93.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 99.6 m -69.75 -41.17 75.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.088 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.472 ' HE1' ' HA ' ' A' ' 308' ' ' GLU . 40.3 mtt -68.37 -34.61 76.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 -178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -64.12 -37.03 85.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.931 175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -67.08 -36.5 82.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.867 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.78 90.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.106 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -74.31 -23.46 59.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.958 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.75 -2.05 23.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.801 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.06 -166.37 40.64 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.433 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -127.8 128.19 44.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.912 0.387 . . . . 0.0 111.015 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.452 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 28.7 mm -73.28 111.54 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 -176.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.0 mmm 63.23 158.15 0.12 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.578 0.704 . . . . 0.0 110.744 173.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.477 ' HG3' ' SD ' ' A' ' 336' ' ' MET . 66.9 Cg_endo -73.66 -111.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 169.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -141.73 -47.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 170.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 334' ' ' PRO . 19.5 pt -138.82 159.78 65.75 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.552 0.691 . . . . 0.0 111.199 -173.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 333' ' ' ILE . 40.8 Cg_endo -66.74 -14.71 44.92 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.742 2.295 . . . . 0.0 112.257 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -5.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.949 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.477 ' SD ' ' HG3' ' A' ' 331' ' ' PRO . 28.8 ptm -52.47 -30.14 28.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 90.6 p -65.82 -32.94 74.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.77 -46.16 72.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.038 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 339' ' ' PHE . 0.7 OUTLIER -72.27 -25.14 61.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.89 -174.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -58.79 -48.0 82.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -63.68 -40.55 97.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.853 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.99 -40.67 95.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.099 -173.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.04 -26.26 11.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -61.13 -45.85 92.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.843 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.7 p -67.18 -34.37 77.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -66.16 -47.3 74.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.418 HG13 ' N ' ' A' ' 348' ' ' ILE . 7.3 p -71.53 -41.61 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.085 -172.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.418 ' N ' HG13 ' A' ' 347' ' ' VAL . 93.7 mt -64.46 -43.97 96.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.103 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -64.65 -36.41 84.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.23 -43.85 69.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.058 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.33 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.13 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 85.6 p -75.03 -14.99 60.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.98 8.23 86.88 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.84 -29.86 67.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.614 0.245 . . . . 0.0 110.807 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -140.01 158.64 43.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.894 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.9 p -73.43 169.4 17.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.03 -48.12 87.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -69.98 -40.08 75.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.896 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -70.87 -42.36 70.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.909 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.98 89.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.098 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 30.3 tp -65.21 -36.4 84.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.929 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -60.09 -35.41 75.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.92 -29.1 70.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.856 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -65.14 -48.83 72.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -64.35 -39.84 94.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -60.75 -43.67 97.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.111 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -72.32 -35.47 68.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.856 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.96 -43.08 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 67.1 p -89.89 -12.74 38.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.883 179.862 . . . . . . . . 0 0 . 1 stop_ save_